PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Berner, AZ; Fuentes, S; Dostal, A; Payne, AN; Gutierrez, PV; Chassard, C; Grattepanche, F; de Vos, WM; Lacroix, C				Berner, Annina Zihler; Fuentes, Susana; Dostal, Alexandra; Payne, Amanda N.; Gutierrez, Pamela Vazquez; Chassard, Christophe; Grattepanche, Franck; de Vos, Willem M.; Lacroix, Christophe			Novel Polyfermentor Intestinal Model (PolyFermS) for Controlled Ecological Studies: Validation and Effect of pH	PLOS ONE			English	Article							IN-VITRO MODEL; BUTYRATE-PRODUCING BACTERIA; COLONIC FERMENTATION MODEL; HUMAN GUT; CHILD GUT; PHYLOGENETIC MICROARRAY; MICROBIAL COMMUNITIES; SPECIES COMPOSITION; FECAL MICROBIOTA; HUMAN FECES	In vitro gut fermentation modeling offers a useful platform for ecological studies of the intestinal microbiota. In this study we describe a novel Polyfermentor Intestinal Model (PolyFermS) designed to compare the effects of different treatments on the same complex gut microbiota. The model operated in conditions of the proximal colon is composed of a first reactor containing fecal microbiota immobilized in gel beads, and used to continuously inoculate a set of parallel second-stage reactors. The PolyFermS model was validated with three independent intestinal fermentations conducted for 38 days with immobilized human fecal microbiota obtained from three child donors. The microbial diversity of reactor effluents was compared to donor feces using the HITChip, a high-density phylogenetic microarray targeting small subunit rRNA sequences of over 1100 phylotypes of the human gastrointestinal tract. Furthermore, the metabolic response to a decrease of pH from 5.7 to 5.5, applied to balance the high fermentative activity in inoculum reactors, was studied. We observed a reproducible development of stable intestinal communities representing major taxonomic bacterial groups at ratios similar to these in feces of healthy donors, a high similarity of microbiota composition produced in second-stage reactors within a model, and a high time stability of microbiota composition and metabolic activity over 38 day culture. For all tested models, the pH-drop of 0.2 units in inoculum reactors enhanced butyrate production at the expense of acetate, but was accompanied by a donor-specific reorganization of the reactor community, suggesting a concerted metabolic adaptation and trigger of community-specific lactate or acetate cross-feeding pathways in response to varying pH. Our data showed that the PolyFermS model allows the stable cultivation of complex intestinal microbiota akin to the fecal donor and can be developed for the direct comparison of different experimental conditions in parallel reactors continuously inoculated with the exact same microbiota.	[Berner, Annina Zihler; Dostal, Alexandra; Payne, Amanda N.; Gutierrez, Pamela Vazquez; Chassard, Christophe; Grattepanche, Franck; Lacroix, Christophe] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Fuentes, Susana; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Dept Basic Vet Med, FIN-00014 Helsinki, Finland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Helsinki	Lacroix, C (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016	Lacroix, Christophe/0000-0003-4360-2020				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P226, DOI 10.1111/j.1574-6941.2006.00118.x; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; CUMMINGS JH, 1995, HUMAN COLONIC BACTER, P101; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Flint Harry J., 2007, P101; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Gumienna M, 2011, INT J FOOD SCI NUTR, V62, P226, DOI 10.3109/09637486.2010.532115; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Le Blay G, 2009, FEMS MICROBIOL ECOL, V67, P198, DOI 10.1111/j.1574-6941.2008.00625.x; Le Blay G, 2010, BRIT J NUTR, V103, P403, DOI 10.1017/S0007114509991796; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Maccaferri S, 2010, J ANTIMICROB CHEMOTH, V65, P2556, DOI 10.1093/jac/dkq345; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Matsumoto M, 2002, CURR MICROBIOL, V44, P212, DOI 10.1007/s00284-001-0087-4; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Pompei A, 2008, ANAEROBE, V14, P280, DOI 10.1016/j.anaerobe.2008.07.002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M., 2012, ENV MICROBIOL; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; RAJILICSTOJANOV.M, 2009, ENV MICROBIOL; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scott KP, 2012, PHARM RES; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wang QJ, 2012, CAN J MICROBIOL, V58, P93, DOI 10.1139/W11-108; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264; Zihler A, 2010, MICROBIOL-SGM, V156, P3342, DOI 10.1099/mic.0.042036-0; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x	54	53	57	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77772	10.1371/journal.pone.0077772	http://dx.doi.org/10.1371/journal.pone.0077772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204958	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500056
J	Slodka, A; Wiktorska, M; Brzezinska-Blaszczyk, E				Slodka, Aleksandra; Wiktorska, Magdalena; Brzezinska-Blaszczyk, Ewa			IgE by Itself Affects Mature Rat Mast Cell Preformed and De Novo-Synthesized Mediator Release and Amplifies Mast Cell Migratory Response	PLOS ONE			English	Article							FC-EPSILON-RI; SERUM IGE; HISTAMINE SYNTHESIS; IMMUNOGLOBULIN-E; SURVIVAL; ACTIVATION; MECHANISMS; ELEVATION; PATHWAYS; ANTIGEN	Background: findings have revealed that IgE by itself may regulate various aspects of mast cell biology, however, detailed data is still limited. Methodology/Findings: Here, we have examined the influence of IgE alone, used at different concentrations, on mast cell activity and releasability. For the study we have employed in vivo differentiated mature tissue mast cells isolated from rat peritoneal cavity. Mast cells were exposed to IgE alone and then the release of preformed and de novo-synthesized mediators, surface Fc epsilon RI expression and mast cell migratory response were assessed. IgE by itself was found to up-regulate FceRI expression and activate mast cells to degranulation, as well as de novo synthesis and release of cysteinyl leukotrienes and TNF. We have provided evidence that IgE alone also amplified spontaneous and CCL5- or TNF-induced migration of mast cells. Importantly, IgE was effective only at concentrations >= 3 mu g/mL. A molecular basis investigation using an array of specific inhibitors showed that Src kinases, PLC/PLA(2), MAP kinases (ERK and p38) and PI3K were entirely or partially involved in IgE-induced mast cell response. Furthermore, IgE alone stimulated the phosphorylation of MAP kinases and PI3K in rat mast cells. Conclusion: Our results clearly demonstrated that IgE by itself, at higher concentrations, influences mast cell activity and releasability. As there are different conditions when the IgE level is raised it might be supposed that in vivo IgE is one of the important factors modulating mast cell biology within tissues.	[Slodka, Aleksandra; Brzezinska-Blaszczyk, Ewa] Med Univ Lodz, Dept Expt Immunol, Lodz, Poland; [Wiktorska, Magdalena] Med Univ Lodz, Dept Mol & Med Biophys, Lodz, Poland	Medical University Lodz; Medical University Lodz	Brzezinska-Blaszczyk, E (corresponding author), Med Univ Lodz, Dept Expt Immunol, Lodz, Poland.	ewab@csk.umed.lodz.pl		Slodka, Aleksandra/0000-0002-9598-2347; Brzezinska-Blaszczyk, Ewa/0000-0002-1466-4321; Wiktorska, Magdalena/0000-0001-7346-0380	Medical University of Lodz [502-03/6-164-01/502-64-037]	Medical University of Lodz	This work was supported by grant number 502-03/6-164-01/502-64-037, funded by the Medical University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BORISH L, 1993, J ALLERGY CLIN IMMUN, V92, P123, DOI 10.1016/0091-6749(93)90046-I; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Brzezinska-Blaszczyk E, 2007, J INTERF CYTOK RES, V27, P911, DOI 10.1089/jir.2006.0158; CHANG C C, 1991, Pediatric Asthma Allergy and Immunology, V5, P253, DOI 10.1089/pai.1991.5.253; Cruse G, 2005, EUR RESPIR J, V25, P858, DOI 10.1183/09031936.05.00091704; Cruse G, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-2; Ellis Anne K, 2009, Allergy Asthma Clin Immunol, V5, P12, DOI 10.1186/1710-1492-5-12; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Heimall J, 2010, CLIN REV ALLERG IMMU, V38, P32, DOI 10.1007/s12016-009-8134-1; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Ishizuka T, 2001, J IMMUNOL, V167, P2298, DOI 10.4049/jimmunol.167.4.2298; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Juremalm M, 2002, BIOCHEM BIOPH RES CO, V297, P480, DOI 10.1016/S0006-291X(02)02244-1; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kohno M, 2005, BLOOD, V105, P2059, DOI 10.1182/blood-2004-07-2639; Koutsonikolis A, 1997, ANN ALLERG ASTHMA IM, V78, P27, DOI 10.1016/S1081-1206(10)63366-2; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubo S, 2001, J IMMUNOL, V167, P3427, DOI 10.4049/jimmunol.167.6.3427; Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176; Marone G, 2000, CRIT REV IMMUNOL, V20, P477; Matsuda K, 2005, J ALLERGY CLIN IMMUN, V116, P1357, DOI 10.1016/j.jaci.2005.08.042; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Misiak-Tloczek A, 2009, APMIS, V117, P558, DOI 10.1111/j.1600-0463.2009.02518.x; Neuber K, 1996, DERMATOLOGY, V192, P110, DOI 10.1159/000246332; Ovcina-Kurtovic Nermina, 2010, Med Arh, V64, P28; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; Roth K, 2008, ARCH IMMUNOL THER EX, V56, P385, DOI 10.1007/s00005-008-0041-2; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Suurmond J, 2011, ANN RHEUM DIS, V70, pI55, DOI 10.1136/ard.2010.138032; Tanaka S, 2002, J EXP MED, V196, P229, DOI 10.1084/jem.20012037; Tanaka S, 2005, EUR J IMMUNOL, V35, P460, DOI 10.1002/eji.200425622; Vasudev M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032556; Watanabe N, 2005, TRENDS PARASITOL, V21, P175, DOI 10.1016/j.pt.2005.02.010; Weller CL, 2011, CLIN SCI, V120, P473, DOI 10.1042/CS20100459; Wierzbicki M, 2009, MICROBIOL IMMUNOL, V53, P694, DOI 10.1111/j.1348-0421.2009.00174.x; WRIGHT DN, 1990, J ALLERGY CLIN IMMUN, V85, P445, DOI 10.1016/0091-6749(90)90154-V; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Zar HJ, 2002, PEDIATR ALLERGY IMMU, V13, P328, DOI 10.1034/j.1399-3038.2002.02019.x	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79286	10.1371/journal.pone.0079286	http://dx.doi.org/10.1371/journal.pone.0079286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205379	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500148
J	Wu, SC; Yang, JCS; Rau, CS; Chen, YC; Lu, TH; Lin, MW; Tzeng, SL; Wu, YC; Wu, CJ; Hsieh, CH				Wu, Shao-Chun; Yang, Johnson Chia-Shen; Rau, Cheng-Shyuan; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua			Profiling Circulating MicroRNA Expression in Experimental Sepsis Using Cecal Ligation and Puncture	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ANIMAL DEVELOPMENT; HOST GENES; BIOMARKERS; CELLS; SERUM; DISEASES; PROTEIN; MODELS; CANCER	The levels of circulating microRNAs (miRNAs) in mice with experimental sepsis induced by cecal ligation and puncture (CLP) were determined using whole blood samples obtained from C57BL/6 mice at 4, 8, and 24 h after CLP; miRNA expression analysis was performed in these samples using an miRNA array. Microarray analysis revealed upregulation of 10 miRNA targets (miR-16, miR-17, miR-20a, miR-20b, miR-26a, miR-26b, miR-106a, miR-106b, miR-195, and miR-451). The expression of these miRNA targets in the whole blood, serum, and white blood cells (WBCs) of CLP mice was quantified using quantitative real-time PCR; these values were compared to those in sham-operated C57BL/6 mice, and the results indicated that these miRNA targets were significantly up-regulated in the whole blood and serum but not in the WBCs. In addition, the levels of these 10 miRNA targets in the serum of Tlr2-/-, Tlr4-/-, and NF-kappa B-/- mice at 8 h after CLP did not decrease significantly., which indicated that the transcription of these miRNAs was not directly mediated by the TLR2/NF-kappa B or TLR4/NF-kappa B pathway, and pathways induced by exposure to the gram-positive or gram-negative bacteria. Immunoprecipitation with the Argonaute 2 ribonucleoprotein complex revealed significantly increased expression of the 10 miRNA targets in the serum of mice after CLP, and the levels of 6 (miR-16, miR-17, miR-20a, miR-20b, miR-26a, and miR-26b) of these 10 miRNA targets increased significantly in exosomes isolated using ExoQuick precipitation solution. In this study, we identified circulating miRNAs that were up-regulated after CLP and determined the increase in the levels of these miRNAs, and our results suggest that circulating Ago2 complexes and exosomes may be responsible for the stability of miRNAs in the serum.	[Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Yang, Johnson Chia-Shen; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Wu, Shao-Chun; Yang, Johnson Chia-Shen; Rau, Cheng-Shyuan; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan.	m93chinghua@gmail.com	Yang, Johnson Chia-Shen/AAT-6599-2020	WU, Shaochun/0000-0002-0984-6921	Taiwan National Science Council [NMRPG8A6082]; Chang Gung Memorial Hospital [CMRPG8A1051, CMRPG8B1131]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The work was supported by Taiwan National Science Council (NMRPG8A6082) and Chang Gung Memorial Hospital (CMRPG8A1051 & CMRPG8B1131) to Ching-Hua Hsieh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cuenca AG, 2010, CURR PROTOC IMMUNOL, V19, P13; Ding J, 2013, HEPATOLOGY, V11, P26378; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Hsieh CH, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-2; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Min M, 2013, CHINESE MED J-PEKING, V126, P1532, DOI 10.3760/cma.j.issn.0366-6999.20122989; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Philippe L, 2012, ANN RHEUM DIS, V27, P27; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Podolska A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-459; Precone V, 2013, LIVER INT, V16, P12169; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang HJ, 2012, CLIN CHEM LAB MED, V50, P1423, DOI 10.1515/cclm-2011-0826; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang JP, 2007, CHINESE MED J-PEKING, V120, P313, DOI 10.1097/00029330-200702020-00011; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Warren HS, 1997, NEW ENGL J MED, V336, P952, DOI 10.1056/NEJM199703273361311; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu D, 2013, J ALLERGY CLIN IMMUN, V4; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	48	42	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77936	10.1371/journal.pone.0077936	http://dx.doi.org/10.1371/journal.pone.0077936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205035	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500079
J	Xu, XX; An, L; Mi, XC; Zhang, T				Xu, Xiaxia; An, Lei; Mi, Xichao; Zhang, Tao			Impairment of Cognitive Function and Synaptic Plasticity Associated with Alteration of Information Flow in Theta and Gamma Oscillations in Melamine-Treated Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PHASE SYNCHRONIZATION; WATER-MAZE; FREQUENCY; MODEL; LTP; REDUCTION; CHANNELS; RHYTHMS; MEMORY	Changes of neural oscillations at a variety of physiological rhythms are effectively associated with cognitive performance. The present study investigated whether the directional indices of neural information flow (NIF) could be used to symbolize the synaptic plasticity impairment in hippocampal CA3-CA1 network in a rat model of melamine. Male Wistar rats were employed while melamine was administered at a dose of 300 mg/kg/day for 4 weeks. Behavior was measured by the Morris water maze(MWM)test. Local field potentials (LFPs) were recorded before long-term potentiation (LTP) induction. Generalized partial directed coherence (gPDC) and phase-amplitude coupling conditional mutual information (PAC_CMI) were used to measure the unidirectional indices in both theta and low gamma oscillations (LG, similar to 30-50 Hz). Our results showed that melamine induced the cognition deficits consistent with the reduced LTP in CA1 area. Phase locking values (PLVs) showed that the synchronization between CA3 and CA1 in both theta and LG rhythms was reduced by melamine. In both theta and LG rhythms, unidirectional indices were significantly decreased in melamine treated rats while a similar variation trend was observed in LTP reduction, implying that the effects of melamine on cognitive impairment were possibly mediated via profound alterations of NIF on CA3-CA1 pathway in hippocampus. The results suggested that LFPs activities at these rhythms were most likely involved in determining the alterations of information flow in the hippocampal CA3-CA1 network, which might be associated with the alteration of synaptic transmission to some extent.	[Zhang, Tao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, T (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	zhangtao@nankai.edu.cn	An, Lei/GQB-0039-2022		National Natural Science Foundation of China [31171053, 11232005]; Tianjin research program of application foundation and advanced technology [12JCZDJC22300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin research program of application foundation and advanced technology	This work was supported by grants from the National Natural Science Foundation of China (31171053, 11232005) and Tianjin research program of application foundation and advanced technology (12JCZDJC22300). The founder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2011, TOXICOL LETT, V206, P276, DOI 10.1016/j.toxlet.2011.08.009; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; BAUER LO, 1993, J STUD ALCOHOL, V54, P577, DOI 10.15288/jsa.1993.54.577; Behrendt RP, 2010, NEUROSCI BIOBEHAV R, V34, P1121, DOI 10.1016/j.neubiorev.2009.12.009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Colgin LL, 2012, NEURON, V75, P549, DOI 10.1016/j.neuron.2012.08.006; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Colon-Ramos DA, 2009, CURR TOP DEV BIOL, V87, P53, DOI 10.1016/S0070-2153(09)01202-2; DeShazer DJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.044101; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Guan N, 2009, NEW ENGL J MED, V360, P1067, DOI 10.1056/NEJMoa0809550; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; Lante F, 2006, HIPPOCAMPUS, V16, P345, DOI 10.1002/hipo.20146; Li ZY, 2011, NEUROCHEM RES, V36, P1840, DOI 10.1007/s11064-011-0502-6; Liang H, 2000, MED BIOL ENG COMPUT, V38, P35, DOI 10.1007/BF02344686; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MAREN S, 1994, BEHAV NEUROSCI, V108, P44, DOI 10.1037/0735-7044.108.1.44; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Ozerdem A, 2008, BRAIN RES, V1235, P98, DOI 10.1016/j.brainres.2008.06.101; Palus M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.055201; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Skarsfeldt T, 1996, PSYCHOPHARMACOLOGY, V124, P126, DOI 10.1007/BF02245612; Sun N, 2009, CHINESE MED J-PEKING, V122, P245, DOI 10.3760/cma.j.issn.0366-6999.2009.03.002; Taylor GW, 1995, J NEUROSCI, V15, P8039; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Xu X, 2012, NEUROSCIENCE, V206, P136, DOI 10.1016/j.neuroscience.2011.12.050; Xu XX, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00027; Yang JJ, 2010, TOXICOL LETT, V198, P171, DOI 10.1016/j.toxlet.2010.06.013; Yang JJ, 2010, TOXICOL IN VITRO, V24, P397, DOI 10.1016/j.tiv.2009.10.019; Yang JJ, 2011, TOXICOLOGY, V289, P167, DOI 10.1016/j.tox.2011.08.011; Zhang M, 2011, NEUROSIGNALS, V19, P189, DOI 10.1159/000329302; Zheng CG, 2013, COGN NEURODYNAMICS, V7, P167, DOI 10.1007/s11571-012-9225-x; Zheng CG, 2011, NEUROSCI LETT, V490, P52, DOI 10.1016/j.neulet.2010.12.024	45	32	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77796	10.1371/journal.pone.0077796	http://dx.doi.org/10.1371/journal.pone.0077796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204970	gold, Green Published			2022-12-25	WOS:000326334500061
J	Mortensen, LJ; Levy, O; Phillips, JP; Stratton, T; Triana, B; Ruiz, JP; Gu, FQ; Karp, JM; Lin, CP				Mortensen, Luke J.; Levy, Oren; Phillips, Joseph P.; Stratton, Tara; Triana, Brian; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.; Lin, Charles P.			Quantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopy	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW; STROMAL CELLS; IFN-GAMMA; ATTENUATE; TRAFFICKING; ENGRAFTMENT; EXPRESSION; CXCR4; MICE	The ability to deliver cells to appropriate target tissues is a prerequisite for successful cell-based therapy. To optimize cell therapy it is therefore necessary to develop a robust method of in vivo cell delivery quantification. Here we examine Mesenchymal Stem Cells (MSCs) labeled with a series of 4 membrane dyes from which we select the optimal dye combination for pair-wise comparisons of delivery to inflamed tissue in the mouse ear using confocal fluorescence imaging. The use of an optimized dye pair for simultaneous tracking of two cell populations in the same animal enables quantification of a test population that is referenced to an internal control population, thereby eliminating intra-subject variations and variations in injected cell numbers. Consistent results were obtained even when the administered cell number varied by more than an order of magnitude, demonstrating an ability to neutralize one of the largest sources of in vivo experimental error and to greatly reduce the number of cells required to evaluate cell delivery. With this method, we are able to show a small but significant increase in the delivery of cytokine pre-treated MSCs (TNF-alpha & IFN-gamma) compared to control MSCs. Our results suggest future directions for screening cell strategies using our in vivo cell delivery assay, which may be useful to develop methods to maximize cell therapeutic potential.	[Mortensen, Luke J.; Stratton, Tara; Triana, Brian; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Mortensen, Luke J.; Stratton, Tara; Triana, Brian; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Levy, Oren; Phillips, Joseph P.; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Harvard MIT Div Hlth Sci &, Ctr Regenerat Therapeut,Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Levy, Oren; Phillips, Joseph P.; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Harvard MIT Div Hlth Sci &, Dept Med,Brigham & Womens Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu	Mortensen, Luke/N-2640-2018; Levey, Allan/F-2104-2011	Mortensen, Luke/0000-0002-4331-4099; Levey, Allan/0000-0002-3153-502X; Sancheznieto, Fatima/0000-0002-1335-8840	Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722] Funding Source: NIH RePORTER	Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to acknowledge Sanofi for funding to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancin H, 1996, CYTOMETRY, V25, P221; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Forero MG, 2011, IMAGE PROCESSING MET; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Halter M, 2007, CYTOM PART A, V71A, P827, DOI 10.1002/cyto.a.20461; Han JY, 2007, J KOREAN MED SCI, V22, P242, DOI 10.3346/jkms.2007.22.2.242; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Joo SY, 2011, CELL BIOL INT, V35, P417, DOI 10.1042/CBI20100563; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Lin YC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-88; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Mortensen LJ, 2011, BIOMED OPT EXPRESS, V2, P1610, DOI 10.1364/BOE.2.001610; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Salomatina E, 2008, PHYS MED BIOL, V53, P2797, DOI 10.1088/0031-9155/53/11/003; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Sarkar D, 2011, BIOMATERIALS, V32, P3053, DOI 10.1016/j.biomaterials.2010.12.036; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; von Bahr L, 2011, BIOL BLOOD MARROW TR; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Zhao WA, 2011, NAT NANOTECHNOL, V6, P524, DOI [10.1038/NNANO.2011.101, 10.1038/nnano.2011.101]	45	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78145	10.1371/journal.pone.0078145	http://dx.doi.org/10.1371/journal.pone.0078145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205131	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700079
J	Hua, KF; Yang, SM; Kao, TY; Chang, JM; Chen, HL; Tsai, YJ; Chen, A; Yang, SS; Chao, LK; Ka, SM				Hua, Kuo-Feng; Yang, Shun-Min; Kao, Tzu-Yang; Chang, Jia-Ming; Chen, Hui-Ling; Tsai, Yung-Jen; Chen, Ann; Yang, Sung-Sen; Chao, Louis Kuoping; Ka, Shuk-Man			Osthole Mitigates Progressive IgA Nephropathy by Inhibiting Reactive Oxygen Species Generation and NF-kappa B/NLRP3 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME ACTIVATION; HUMAN MESANGIAL CELLS; PROTEIN-KINASE-C; OXIDATIVE STRESS; CRESCENTIC GLOMERULONEPHRITIS; PROINFLAMMATORY CYTOKINES; DIABETIC-NEPHROPATHY; SIGNALING PATHWAYS; RENAL PROGNOSIS	Renal reactive oxygen species (ROS) and mononuclear leukocyte infiltration are involved in the progressive stage (exacerbation) of IgA nephropathy (IgAN), which is characterized by glomerular proliferation and renal inflammation. The identification of the mechanism responsible for this critical stage of IgAN and the development of a therapeutic strategy remain a challenge. Osthole is a pure compound isolated from Cnidiummonnieri (L.) Cusson seeds, which are used as a traditional Chinese medicine, and is anti-inflammatory, anti-apoptotic, and anti-fibrotic both in vitro and in vivo. Recently, we showed that osthole acts as an anti-inflammatory agent by reducing nuclear factor-kappa B (NF-kappa B) activation in and ROS release by activated macrophages. In this study, we examined whether osthole could prevent the progression of IgAN using a progressive IgAN (Prg-IgAN) model in mice. Our results showed that osthole administration resulted in prevention of albuminuria, improved renal function, and blocking of renal progressive lesions, including glomerular proliferation, glomerular sclerosis, and periglomerular mononuclear leukocyte infiltration. These findings were associated with (1) reduced renal superoxide anion levels and increased Nrf2 nuclear translocation, (2) inhibited renal activation of NF-kappa B and the NLRP3 inflammasome, (3) decreased renal MCP-1 expression and mononuclear leukocyte infiltration, (4) inhibited ROS production and NLRP3 inflammasome activation in cultured, activated macrophages, and (5) inhibited ROS production and MCP-1 protein levels in cultured, activated mesangial cells. The results suggest that osthole exerts its reno-protective effects on the progression of IgAN by inhibiting ROS production and activation of NF-kappa B and the NLRP3 inflammasome in the kidney. Our data also confirm that ROS generation and activation of NF-kappa B and the NLRP3 inflammasome are crucial mechanistic events involved in the progression of the renal disorder.	[Hua, Kuo-Feng; Kao, Tzu-Yang] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Yang, Shun-Min; Chen, Ann] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Chang, Jia-Ming; Tsai, Yung-Jen] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, Taipei, Taiwan; [Chen, Hui-Ling] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, IND Core Team, Taipei, Taiwan; [Yang, Sung-Sen] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chao, Louis Kuoping] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Ilan University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; National Defense Medical Center	Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	shukmanka@gmail.com	chen, hui/HDO-2955-2022		Ministry of Economic Affairs [101-EC-17-A-19-S1-161]; National Science Council, Taiwan, ROC [NSC 99-2320-B-016-006-MY3, NSC 102-2321-B-016-002, NSC 102-2628-B-197-001-MY3]	Ministry of Economic Affairs; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Economic Affairs (101-EC-17-A-19-S1-161) and National Science Council (NSC 99-2320-B-016-006-MY3; NSC 102-2321-B-016-002; NSC 102-2628-B-197-001-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIMA S, 1991, KIDNEY INT, V39, P684, DOI 10.1038/ki.1991.82; Ashizawa M, 2003, AM J KIDNEY DIS, V42, P76, DOI 10.1016/S0272-6386(03)00411-6; Silva GEB, 2012, CLINICS, V67, P697, DOI 10.6061/clinics/2012(07)01; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bertelli R, 2010, CLIN EXP IMMUNOL, V161, P151, DOI 10.1111/j.1365-2249.2010.04160.x; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Chan Loretta Y Y, 2004, Clin Exp Nephrol, V8, P297; Chao TK, 2006, KIDNEY INT, V70, P283, DOI 10.1038/sj.ki.5001533; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Chen A, 1997, AM J KIDNEY DIS, V30, P693, DOI 10.1016/S0272-6386(97)90495-9; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; Chen R, 2011, TOXICOL APPL PHARM, V256, P168, DOI 10.1016/j.taap.2011.08.005; Chen XH, 2010, EUR J PHARMACOL, V629, P40, DOI 10.1016/j.ejphar.2009.12.008; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Coppo R, 2010, NEPHRON CLIN PRACT, V116, pC196, DOI 10.1159/000317199; Coppo R, 2010, J NEPHROL, V23, P626; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Danilewicz M, 1998, J NEPHROL, V11, P255; de Haan JB, 2011, DIABETES, V60, P2683, DOI 10.2337/db11-1072; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Hahn WH, 2009, PEDIATR NEPHROL, V24, P1329, DOI 10.1007/s00467-009-1146-5; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hou XH, 2009, J ASIAN NAT PROD RES, V11, P663, DOI 10.1080/10286020902975772; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Ka SM, 2007, J AM SOC NEPHROL, V18, P2473, DOI 10.1681/ASN.2006111242; Ka SM, 2011, AM J PHYSIOL-RENAL, V301, pF1218, DOI 10.1152/ajprenal.00050.2011; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim MJ, 2012, J IMMUNOL, V189, P3751, DOI 10.4049/jimmunol.1102603; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Lai KN, 2011, PEDIATR NEPHROL, V26, P257, DOI 10.1007/s00467-010-1703-y; Leung JCK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-169; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Maljaars PWJ, 2011, BRIT J NUTR, V106, P1609, DOI 10.1017/S0007114511002054; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Matsumoto K, 2001, NEPHRON, V88, P334, DOI 10.1159/000046017; Minhas U, 2011, DRUG DISCOV THER, V5, P195, DOI 10.5582/ddt.2011.v5.4.195; MONTINARO V, 1992, KIDNEY INT, V42, P341, DOI 10.1038/ki.1992.295; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P509, DOI 10.1111/j.1440-1681.2008.05107.x; Okamoto T, 2003, BIOCHEM PHARMACOL, V65, P677, DOI 10.1016/S0006-2952(02)01606-4; Ootaka T, 1997, AM J KIDNEY DIS, V29, P843, DOI 10.1016/S0272-6386(97)90457-1; Qiu LQ, 2004, J AM SOC NEPHROL, V15, P79, DOI 10.1097/01.ASN.0000104573.54132.2E; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi BL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/728417; Shi Y, 2013, EUR J PHARM SCI, V48, P819, DOI 10.1016/j.ejps.2012.12.031; Silva GEB, 2011, DIS MARKERS, V31, P9, DOI [10.1155/2011/940827, 10.3233/DMA-2011-0795]; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Torres DD, 2008, KIDNEY INT, V73, P327, DOI 10.1038/sj.ki.5002621; Tsai PY, 2012, ARTHRITIS RHEUM-US, V64, P232, DOI 10.1002/art.33328; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Urushihara M, 2010, AM J PHYSIOL-RENAL, V298, pF167, DOI 10.1152/ajprenal.00124.2009; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wagrowska-Danilewicz Malgorzata, 2005, Polish Journal of Pathology, V56, P121; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Yano N, 1997, J CLIN IMMUNOL, V17, P396, DOI 10.1023/A:1027368308453; Zhang JJ, 2011, PHYTOTHER RES, V25, P638, DOI 10.1002/ptr.3315; Zheng Y, 2013, UROL INT	65	60	68	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77794	10.1371/journal.pone.0077794	http://dx.doi.org/10.1371/journal.pone.0077794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204969	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200041
J	Liao, BL; Wang, ZH; Lin, SW; Xu, Y; Yi, JQ; Xu, M; Huang, ZX; Zhou, Y; Zhang, FC; Hou, JL				Liao, Baolin; Wang, Zhanhui; Lin, Siwei; Xu, Ying; Yi, Junqing; Xu, Min; Huang, Zuxiong; Zhou, Ying; Zhang, Fuchun; Hou, Jinlin			Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT	PLOS ONE			English	Article							HBV-DNA LEVELS; ALANINE AMINOTRANSFERASE LEVELS; VIRUS-INFECTION; LIVER HISTOLOGY; CARRIERS; ANTIGEN; DISEASE; LAMIVUDINE; BIOPSY; GENOTYPE	Background: Limited studies have been done on chronic hepatitis B (CHB) patients defined according to the latest Asian-Pacific Association for the Study of the Liver guideline with liver histology by a large sample size. Methods: We retrospectively evaluated liver histological characteristics on a cohort of consecutive treatment-naive CHB patients with persistent normal alanine aminotransferase (PNALT) or elevated ALT from May 2005 to October 2011. Histological assessment was based on the Metavir scoring system, significant abnormality was defined as necroinflammation grade >= A2 and/or fibrosis stage >= F2. Results: A total of 675 CHB patients were recruited, including 516 HBeAg-positive and 159 HBeAg-negative patients. In HBeAg-positive patients, significant fibrosis was found 49.4% (42/85) in PNALT, 69.8% (88/126) in ALT 1-2xupper limit normal (ULN) and 81.6% (249/305) in ALT>2xULN group, respectively. In HBeAg-negative patients, significant fibrosis was found 30.9% (17/55) in PNALT, 73.3% (33/45) in ALT 1-2xULN and 94.9% (56/59) in ALT>2xULN group, respectively. HBeAg-positive patients with PNALT over 30 years old had a higher frequency of significant fibrosis than those under 30 years old (87.5% vs. 45.5%, P = 0.058). Multivariate logistic regression analysis indicated increasing age (P = 0.012), higher aspartate aminotransferase (AST) (P < 0.001) and lower HBV DNA (P < 0.001) were associated with significant necroinflammation, while higher AST (P < 0.001), lower albumin (P = 0.027) and HBV DNA (P = 0.004) were associated with significant fibrosis in HBeAg-positive patients with elevated ALT. Higher AST was associated with significant necroinflammation in HBeAg-negative patients with elevated ALT (P = 0.009). Conclusions: Significant fibrosis is not rare in Chinese CHB patients with PNALT, especially HBeAg-positive patients over 30 years old.	[Liao, Baolin; Wang, Zhanhui; Xu, Ying; Huang, Zuxiong; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Liao, Baolin; Wang, Zhanhui; Xu, Ying; Huang, Zuxiong; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Liao, Baolin; Yi, Junqing; Xu, Min; Zhou, Ying; Zhang, Fuchun] Guangzhou Med Univ, Dept Hepatol, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China; [Lin, Siwei] Yuexiu Dist Tradit Chinese Med Hosp, Dept Internal Med 3, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University	Zhang, FC (corresponding author), Guangzhou Med Univ, Dept Hepatol, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.	gz8hzfc@126.com; jlhousmu@163.com	Shen, Jianzhong/AAH-8184-2019		National Science and Technology Major Project of China [2012ZX10002003]	National Science and Technology Major Project of China	This study was supported by grants from National Science and Technology Major Project of China (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Assy N, 2009, WORLD J GASTROENTERO, V15, P3025, DOI 10.3748/wjg.15.3025; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Chan HLY, 2002, AM J GASTROENTEROL, V97, P406; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fung J, 2011, HEPATOL INT, V5, P868, DOI 10.1007/s12072-011-9288-5; Han KH, 2008, HEPATOL INT, V2, P185, DOI 10.1007/s12072-008-9068-z; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Lesmana CRA, 2011, J DIGEST DIS, V12, P476, DOI 10.1111/j.1751-2980.2011.00540.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2008, HEPATOLOGY, V48, P1451, DOI 10.1002/hep.22518; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Shao J, 2007, WORLD J GASTROENTERO, V13, P2104, DOI 10.3748/wjg.v13.i14.2104; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Wong GLH, 2008, AM J GASTROENTEROL, V103, P3071, DOI 10.1111/j.1572-0241.2008.02157.x; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	39	43	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78672	10.1371/journal.pone.0078672	http://dx.doi.org/10.1371/journal.pone.0078672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205292	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400096
J	Marson, KG; Tapia, K; Kohler, P; McGrath, CJ; John-Stewart, GC; Richardson, BA; Njoroge, JW; Kiarie, JN; Sakr, SR; Chung, MH				Marson, Kara G.; Tapia, Kenneth; Kohler, Pamela; McGrath, Christine J.; John-Stewart, Grace C.; Richardson, Barbra A.; Njoroge, Julia W.; Kiarie, James N.; Sakr, Samah R.; Chung, Michael H.			Male, Mobile, and Moneyed: Loss to Follow-Up vs. Transfer of Care in an Urban African Antiretroviral Treatment Clinic	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; THERAPY PROGRAMS; PUBLIC-SECTOR; RETROSPECTIVE ANALYSIS; MORTALITY; MALAWI; RETENTION	Objectives: The purpose of this study was to analyze characteristics, reasons for transferring, and reasons for discontinuing care among patients defined as lost to follow-up (LTFU) from an antiretroviral therapy (ART) clinic in Nairobi, Kenya. Design: The study used a prospective cohort of patients who participated in a randomized, controlled ART adherence trial between 2006 and 2008. Methods: Participants were followed from pre-ART clinic enrollment to 18 months after ART initiation, and were defined as LTFU if they failed to return to clinic 4 weeks after their last scheduled visit. Reasons for loss were captured through phone call or home visit. Characteristics of LTFU who transferred care and LTFU who did not transfer were compared to those who remained in clinic using log-binomial regression to estimate risk ratios. Results: Of 393 enrolled participants, total attrition was 83 (21%), of whom 75 (90%) were successfully traced. Thirty-seven (49%) were alive at tracing and 22 (59%) of these reported having transferred their antiretroviral care. In the final model, transfers were more likely to have salaried employment [Risk Ratio (RR), 2.7; 95% confidence interval (CI), 1.2-6.1; p=0.020)] and pay a higher monthly rent (RR, 5.8; 95% CI, 1.3-25.0; p=0.018) compared to those retained in clinic. LTFU who did not transfer care were three times as likely to be men (RR, 3.1; 95% CI, 1.1-8.1; p=0.028) and nearly 4 times as likely to have a primary education or less (RR, 3.8; 95% CI, 1.3-10.6; p=0.013). Overall, the most common reason for LTFU was moving residence, predominantly due to job loss or change in employment. Conclusion: A broad definition of LTFU may include those who have transferred their antiretroviral care and thereby overestimate negative effects on ART continuation. Interventions targeting men and considering mobility due to employment may improve retention in urban African ART clinics.	[Marson, Kara G.; Tapia, Kenneth; Kohler, Pamela; McGrath, Christine J.; John-Stewart, Grace C.; Njoroge, Julia W.; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Richardson, Barbra A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kiarie, James N.] Univ Nairobi, Nairobi, Kenya; [Sakr, Samah R.] Copt Hosp, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Nairobi	Marson, KG (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	marsonk@uw.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019; Kohler, Pamela/GYE-0155-2022	Kohler, Pamela/0000-0001-6176-6374; John-Stewart, Grace/0000-0002-4301-1573; kiarie, james/0000-0003-4180-7858	K23 grant from the National Institutes of Health [K23AI065222-04]; University of Washington Center for AIDS Research (CFAR), an NIH [P30 AI027757]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; President's Emergency Plan for AIDS Relief (PEPFAR) from the US Centers for Disease Control and Prevention (CDC) [U62/CCU024512-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065222, P30AI027757] Funding Source: NIH RePORTER	K23 grant from the National Institutes of Health; University of Washington Center for AIDS Research (CFAR), an NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); President's Emergency Plan for AIDS Relief (PEPFAR) from the US Centers for Disease Control and Prevention (CDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a K23 grant from the National Institutes of Health (K23AI065222-04) and the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). The Coptic Hope Center for Infectious Diseases is supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement (U62/CCU024512-04) from the US Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Ahonkhai AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032993; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bajunirwe Francis, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P139, DOI 10.1177/1545109709332470; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bigsten A, 1996, J Afr Econ, V5, P1, DOI 10.1093/oxfordjournals.jae.a020893; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Chung MH, 2010, JAIDS-J ACQ IMM DEF, V53, P422, DOI 10.1097/QAI.0b013e3181b32bd6; Dahab M, 2011, AIDS PATIENT CARE ST, V25, P53, DOI 10.1089/apc.2010.0140; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gerver SM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-29; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Myer L, 2004, SAMJ S AFR MED J, V94, P273; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Ogutu Z A, 1993, GeoJournal, V30, P409, DOI 10.1007/BF00807222; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Program NASC, 2011, GUID ANT THER KEN; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Pyne-Mercier LD, 2011, AIDS CARE, V23, P562, DOI 10.1080/09540121.2010.525615; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Scuteri A, 2009, NUTR METAB CARDIOVAS, V19, P532, DOI 10.1016/j.numecd.2008.11.004; Tayler-Smith K, 2011, TROP MED INT HEALTH, V16, P579, DOI 10.1111/j.1365-3156.2011.02740.x; Todaro MP, 1996, INT LABOUR REV, V135, P421; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78900	10.1371/journal.pone.0078900	http://dx.doi.org/10.1371/journal.pone.0078900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205345	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300085
J	Zulian, A; Cancello, R; Ruocco, C; Gentilini, D; Di Blasio, AM; Danelli, P; Micheletto, G; Cesana, E; Invitti, C				Zulian, Alessandra; Cancello, Raffaella; Ruocco, Chiara; Gentilini, Davide; Di Blasio, Anna Maria; Danelli, Piergiorgio; Micheletto, Giancarlo; Cesana, Elisabetta; Invitti, Cecilia			Differences in Visceral Fat and Fat Bacterial Colonization between Ulcerative Colitis and Crohn's Disease. An In Vivo and In Vitro Study	PLOS ONE			English	Article							ADIPOSE-TISSUE; TRANSLOCATION; OBESITY	Crohn's disease (CD) is notably characterized by the expansion of visceral fat with small adipocytes expressing a high proportion of anti-inflammatory genes. Conversely, visceral fat depots in ulcerative colitis (UC) patients have never been characterized. Our study aims were a) to compare adipocyte morphology and gene expression profile and bacterial translocation in omental (OM) and mesenteric (MES) adipose tissue of patients with UC and CD, and b) to investigate the effect of bacterial infection on adipocyte proliferation in vitro. Specimens of OM and MES were collected from 11 UC and 11 CD patients, processed and examined by light microscopy. Gene expression profiles were evaluated in adipocytes isolated from visceral adipose tissue using microarray and RTqPCR validations. Bacteria within adipose tissue were immuno-detected by confocal scanning laser microscopy. Adipocytes were incubated with Enterococcus faecalis and cells counted after 24h. Morphology and molecular profile of OM and MES revealed that UC adipose tissue is less inflamed than CD adipose tissue. Genes linked to inflammation, bacterial response, chemotaxis and angiogenesis were down-regulated in adipocytes from UC compared to CD, whereas genes related to metallothioneins, apoptosis pathways and growth factor binding were up-regulated. A dense perinuclear positivity for Enterococcus faecalis was detected in visceral adipocytes from CD, whereas positivity was weak in UC. In vitro bacterial infection was associated with a five-fold increase in the proliferation rate of OM preadipocytes. Compared to UC, visceral adipose tissue from CD is more inflamed and more colonized by intestinal bacteria, which increase adipocyte proliferation. The influence of bacteria stored within adipocytes on the clinical course of IBD warrants further investigations.	[Zulian, Alessandra; Ruocco, Chiara] Ist Auxol Italiano, Diabet Res Lab, Milan, Italy; [Cancello, Raffaella; Gentilini, Davide; Di Blasio, Anna Maria] Ist Auxol Italiano, Mol Biol Lab, Milan, Italy; [Danelli, Piergiorgio] Univ Milan, Luigi Sacco Hosp, Dept Clin Sci, Milan, Italy; [Micheletto, Giancarlo] Univ Milan, Dept Med & Surg Pathophysiol & Transplants, Milan, Italy; [Cesana, Elisabetta] Ist Auxol Italiano, Microbiol Lab, Milan, Italy; [Invitti, Cecilia] Ist Auxol Italiano, Dept Med Sci & Rehabil, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Invitti, C (corresponding author), Ist Auxol Italiano, Dept Med Sci & Rehabil, Milan, Italy.	invitti@auxologico.it	Gentilini, Davide/AAB-2567-2019; Danelli, Piergiorgio/AAB-1698-2021; Danelli, Piergiorgio/R-5992-2017	Danelli, Piergiorgio/0000-0003-1461-9835; Danelli, Piergiorgio/0000-0003-1461-9835; Gentilini, Davide/0000-0002-8391-0725; Ruocco, Chiara/0000-0002-6544-2067; micheletto, giancarlo/0000-0003-3687-1126	Istituto Auxologico Italiano	Istituto Auxologico Italiano	This study was supported by Istituto Auxologico Italiano. Istituto Auxologico Italiano, funder of this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Bamias G, 2011, CLIN GASTROENT-SER, P41, DOI 10.1007/978-1-60327-433-3_4; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Goossens GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039930; Goossens H, 1999, CURR OPIN INFECT DIS, V12, P537, DOI 10.1097/00001432-199912000-00002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Zulian A, 2012, GUT, V61, P86, DOI 10.1136/gutjnl-2011-300391	15	40	42	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78495	10.1371/journal.pone.0078495	http://dx.doi.org/10.1371/journal.pone.0078495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205244	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300064
J	Akers, JC; Ramakrishnan, V; Kim, R; Skog, J; Nakano, I; Pingle, S; Kalinina, J; Hua, W; Kesari, S; Mao, Y; Breakefield, XO; Hochberg, FH; Van Meir, EG; Carter, BS; Chen, CC				Akers, Johnny C.; Ramakrishnan, Valya; Kim, Ryan; Skog, Johan; Nakano, Ichiro; Pingle, Sandeep; Kalinina, Juliya; Hua, Wei; Kesari, Santosh; Mao, Ying; Breakefield, Xandra O.; Hochberg, Fred H.; Van Meir, Erwin G.; Carter, Bob S.; Chen, Clark C.			miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development	PLOS ONE			English	Article							QUANTITATIVE PCR; RNA EXPRESSION; CELL-LINES; MICROVESICLES; EXOSOMES; MICRORNA; GLIOMA; MULTIFORME; TUMORS; GENES	Glioblastoma cells secrete extra-cellular vesicles (EVs) containing microRNAs (miRNAs). Analysis of these EV miRNAs in the bio-fluids of afflicted patients represents a potential platform for biomarker development. However, the analytic algorithm for quantitative assessment of EV miRNA remains under-developed. Here, we demonstrate that the reference transcripts commonly used for quantitative PCR (including GAPDH, 18S rRNA, and hsa-miR-103) were unreliable for assessing EV miRNA. In this context, we quantitated EV miRNA in absolute terms and normalized this value to the input EV number. Using this method, we examined the abundance of miR-21, a highly over-expressed miRNA in glioblastomas, in EVs. In a panel of glioblastoma cell lines, the cellular levels of miR-21 correlated with EV miR-21 levels (p<0.05), suggesting that glioblastoma cells actively secrete EVs containing miR-21. Consistent with this hypothesis, the CSF EV miR-21 levels of glioblastoma patients (n=13) were, on average, ten-fold higher than levels in EVs isolated from the CSF of non-oncologic patients (n=13, p<0.001). Notably, none of the glioblastoma CSF harbored EV miR-21 level below 0.25 copies per EV in this cohort. Using this cut-off value, we were able to prospectively distinguish CSF derived from glioblastoma and non-oncologic patients in an independent cohort of twenty-nine patients (Sensitivity=87%; Specificity=93%; AUC=0.91, p<0.01). Our results suggest that CSF EV miRNA analysis of miR-21 may serve as a platform for glioblastoma biomarker development.	[Akers, Johnny C.; Ramakrishnan, Valya; Kim, Ryan; Carter, Bob S.; Chen, Clark C.] Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA; [Skog, Johan] Exosome Diagnost, New York, NY USA; [Nakano, Ichiro] Ohio State Univ, Dept Neurosurg, Dardinger Lab Neurosci, Columbus, OH 43210 USA; [Pingle, Sandeep; Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Breakefield, Xandra O.; Hochberg, Fred H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurol Serv, Boston, MA USA; [Breakefield, Xandra O.; Hochberg, Fred H.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kalinina, Juliya; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg & Hematol & Med Oncol, Atlanta, GA USA; [Kalinina, Juliya; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Hua, Wei; Mao, Ying] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	University of California System; University of California San Diego; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Emory University; Emory University; Fudan University	Chen, CC (corresponding author), Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA.	clarkchen@ucsd.edu	Nakano, Ichiro/AAR-9562-2020; Chen, Clark C/C-8714-2013; Nakano, Ichiro/F-2076-2014; RAMAKRISHNAN, VALYA/L-6415-2016; Kesari, Santosh/E-8461-2013; Carter, Bob/AAB-4868-2021	Nakano, Ichiro/0000-0002-0916-3207; Chen, Clark C/0000-0001-6258-9277; Nakano, Ichiro/0000-0002-6734-3468; Carter, Bob/0000-0002-3586-1324; Mao, Ying/0000-0001-8055-115X; Skog, Johan/0000-0002-0926-1691; Van Meir, Erwin G./0000-0003-2444-7707	Doris Duke Charitable Foundation; Sontag Foundation; Burroughs Wellcome Fund; Forbeck Foundation; Kimmel Foundation; NATIONAL CANCER INSTITUTE [R01CA163722, P01CA069246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000931, UH3TR000931] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sontag Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Forbeck Foundation; Kimmel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CCC is supported by the Doris Duke Charitable Foundation http://www.ddcf.org/, Sontag Foundation http://www.sontagfoundation.com/display.aspx?page=home, Burroughs Wellcome Fund http://www.bwfund.org/, Forbeck Foundation http://wgfrf.org/, and Kimmel Foundation http://www.kimmelfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air EL, 2009, J NEUROSURG, V111, P820, DOI 10.3171/2009.3.JNS081695; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Alberts B, 2002, MOL BIOL CELL; [Anonymous], 1908, BIOMETRIKA, V6, P1; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bhagat TD, 2013, BLOOD, V121, P2875, DOI 10.1182/blood-2011-12-397067; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Camussi G, 2011, AM J CANCER RES, V1, P98; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CC, 2009, CLIN NEUROL NEUROSUR, V111, P835, DOI 10.1016/j.clineuro.2009.08.013; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Ghosh A, 2010, IMMUNOL LETT, V131, P3, DOI 10.1016/j.imlet.2010.03.003; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gonda DD, 2013, NEUROSURGERY, V72, P501, DOI 10.1227/NEU.0b013e3182846e63; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Gu C, 2013, STEM CELLS; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Huan J, 2013, CANCER RES, V73, P918, DOI 10.1158/0008-5472.CAN-12-2184; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Ng Kimberly, 2009, Clin Neurosurg, V56, P107; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Santangelo PJ, 2012, METHOD ENZYMOL, V505, P383, DOI 10.1016/B978-0-12-388448-0.00028-0; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stigler S, 1989, STAT SCI, V4, P7; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Teodori L, 2006, CYTOM PART A, V69A, P75, DOI 10.1002/cyto.a.20208; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Thang NNT, 2010, CANCER RES, V70, P4829, DOI 10.1158/0008-5472.CAN-09-3074; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; Van Meir EG, 2012, CA-CANCER J CLIN, V60, P166; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055314; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wang H, 2003, CANCER RES, V63, P4315; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Witwer KW, 2012, J EXTRACELL IN PRESS; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Wright Matthew, 2012, Methods Mol Biol, V906, P511, DOI 10.1007/978-1-61779-953-2_41; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	207	215	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78115	10.1371/journal.pone.0078115	http://dx.doi.org/10.1371/journal.pone.0078115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205116	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600072
J	Daly, R; Froneman, PW; Smale, MJ				Daly, Ryan; Froneman, Pierre W.; Smale, Malcolm J.			Comparative Feeding Ecology of Bull Sharks (Carcharhinus leucas) in the Coastal Waters of the Southwest Indian Ocean Inferred from Stable Isotope Analysis	PLOS ONE			English	Article							APEX PREDATORY SHARKS; TROPHIC POSITION; MOVEMENT PATTERNS; SOUTHERN AFRICA; FLORIDA ESTUARY; HABITAT USE; FOOD-WEB; DIET; FISHES; CONSERVATION	As apex predators, sharks play an important role shaping their respective marine communities through predation and associated risk effects. Understanding the predatory dynamics of sharks within communities is, therefore, necessary to establish effective ecologically based conservation strategies. We employed non-lethal sampling methods to investigate the feeding ecology of bull sharks (Carcharhinus leucas) using stable isotope analysis within a subtropical marine community in the southwest Indian Ocean. The main objectives of this study were to investigate and compare the predatory role that sub-adult and adult bull sharks play within a top predatory teleost fish community. Bull sharks had significantly broader niche widths compared to top predatory teleost assemblages with a wide and relatively enriched range of delta C-13 values relative to the local marine community. This suggests that bull sharks forage from a more diverse range of delta C-13 sources over a wider geographical range than the predatory teleost community. Adult bull sharks appeared to exhibit a shift towards consistently higher trophic level prey from an expanded foraging range compared to sub-adults, possibly due to increased mobility linked with size. Although predatory teleost fish are also capable of substantial migrations, bull sharks may have the ability to exploit a more diverse range of habitats and appeared to prey on a wider diversity of larger prey. This suggests that bull sharks play an important predatory role within their respective marine communities and adult sharks in particular may shape and link ecological processes of a variety of marine communities over a broad range.	[Daly, Ryan; Froneman, Pierre W.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Smale, Malcolm J.] Port Elizabeth Museum Bayworld, Port Elizabeth, Eastern Cape, South Africa; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, Eastern Cape, South Africa	Rhodes University; Nelson Mandela University	Daly, R (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	ryandaly.mail@gmail.com	Froneman, William/GLS-0460-2022; Froneman, William/C-9085-2012	Froneman, William/0000-0003-0615-1355; Smale, Malcolm/0000-0002-1135-8687	Professional Development Programme of the South African National Research Foundation (NRF); Rhodes University; Port Elizabeth Museum at Bayworld; Fathoms Research; Bayworld Center for Research and Education	Professional Development Programme of the South African National Research Foundation (NRF); Rhodes University; Port Elizabeth Museum at Bayworld; Fathoms Research; Bayworld Center for Research and Education	This study would not have been possible without funding and support from the Professional Development Programme of the South African National Research Foundation (NRF), Rhodes University, Port Elizabeth Museum at Bayworld and Bayworld Center for Research and Education who administered the grant, as well as Fathoms Research who contributed to the research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; [Anonymous], 2004, COASTAL FISHES SO AF; Bachok Z, 2004, DIET COMPOSITION FOO, V27, P41; Bass A.J., 1973, SHARKS E COAST SO AF, P33; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Borrell A, 2011, ENVIRON BIOL FISH, V92, P559, DOI 10.1007/s10641-011-9879-y; Boyle MD, 2012, J FISH BIOL, V80, P1485, DOI 10.1111/j.1095-8649.2012.03243.x; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V20, P169, DOI 10.1007/BF00004952; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Celliers L, 2008, BIODIVERS CONSERV, V17, P3097, DOI 10.1007/s10531-007-9271-6; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Compagno LJV, 1984, FAO FISHERIES SYNO 2, V4; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cruz-Martinez A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P367; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Daly R, 2013, AFR J MAR SCI, V35, P129, DOI 10.2989/1814232X.2013.769910; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Floros C, 2012, AFR J MAR SCI, V34, P55, DOI 10.2989/1814232X.2012.673284; Froese F., 2009, FISHBASE; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Hammerschlag Neil, 2011, Endangered Species Research, V14, P135, DOI 10.3354/esr00354; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; HARMELINVIVIEN ML, 1981, OCEANOL ACTA, V4, P365; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; KIM SL, 2011, ENVIRON BIOL FISH, V95, P37, DOI DOI 10.1007/S10641-011-9919-7; Kim SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045068; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Mann BQ, 2000, OCEANOGRAPHIC RES I, V7; Matich P, 2014, J ANIM ECOL, V83, P199, DOI 10.1111/1365-2656.12106; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Smale MJ., 1986, S AFRICAN J MARINE S, V4, P11, DOI [10.2989/025776186784461873, DOI 10.2989/025776186784461873]; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Sudekum AE, 1991, FISH B-NOAA, V89, P413; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Vorwerk PD, 2009, AFR J AQUAT SCI, V34, P137, DOI 10.2989/AJAS.2009.34.2.4.891; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Wintner SP, 2002, MAR FRESHWATER RES, V53, P557, DOI 10.1071/MF01062; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	75	26	26	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78229	10.1371/journal.pone.0078229	http://dx.doi.org/10.1371/journal.pone.0078229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205168	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600085
J	Seung, E; Dudek, TE; Allen, TM; Freeman, GJ; Luster, AD; Tager, AM				Seung, Edward; Dudek, Timothy E.; Allen, Todd M.; Freeman, Gordon J.; Luster, Andrew D.; Tager, Andrew M.			PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-LYMPHOCYTE DYSFUNCTION; HUMAN IMMUNE-SYSTEM; T-CELL EXHAUSTION; SCID-HU MOUSE; HIV-1 INFECTION; NEW-GENERATION; BLT MICE; IN-VIVO; RESPONSES	An estimated 34 million people are living with HIV worldwide (UNAIDS, 2012), with the number of infected persons rising every year. Increases in HIV prevalence have resulted not only from new infections, but also from increases in the survival of HIV-infected persons produced by effective anti-retroviral therapies. Augmentation of anti-viral immune responses may be able to further increase the survival of HIV-infected persons. One strategy to augment these responses is to reinvigorate exhausted anti-HIV immune cells present in chronically infected persons. The PD-1-PD-L1 pathway has been implicated in the exhaustion of virus-specific T cells during chronic HIV infection. Inhibition of PD-1 signaling using blocking anti-PD-1 antibodies has been shown to reduce simian immunodeficiency virus (SIV) loads in monkeys. We now show that PD-1 blockade can improve control of HIV replication in vivo in an animal model. BLT (Bone marrow-Liver-Thymus) humanized mice chronically infected with HIV-1 were treated with an anti-PD-1 antibody over a 10-day period. The PD-1 blockade resulted in a very significant 45-fold reduction in HIV viral loads in humanized mice with high CD8(+) T cell expression of PD-1, compared to controls at 4 weeks post-treatment. The anti-PD-1 antibody treatment also resulted in a significant increase in CD8(+) T cells. PD-1 blockade did not affect T cell expression of other inhibitory receptors co-expressed with PD-1, including CD244, CD160 and LAG-3, and did not appear to affect virus-specific humoral immune responses. These data demonstrate that inhibiting PD-1 signaling can reduce HIV viral loads in vivo in the humanized BLT mouse model, suggesting that blockade of the PD-1-PD-L1 pathway may have therapeutic potential in the treatment of patients already infected with the AIDS virus.	[Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Harvard Univ, Sch Med, Charlestown, MA USA; [Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Tager, Andrew M.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Charlestown, MA USA; [Dudek, Timothy E.; Allen, Todd M.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Dudek, Timothy E.; Allen, Todd M.] Harvard, Cambridge, MA USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Seung, E (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA.	seung.edward@mgh.harvard.edu; amtager@partners.org	Allen, Todd/F-5473-2011; Luster, Andrew/ABE-6504-2020; Freeman, Gordon/AAC-5380-2019	Allen, Todd/0000-0002-6609-1318; Luster, Andrew/0000-0001-9679-7912; Freeman, Gordon/0000-0002-7210-5616	Harvard University; Ragon Institute of MGH, Massachusetts Institute of Technology; Harvard Platform Award; National Institutes of Health [P30AI060354, P01AI078897, U19-AI082630, R01-AI090698, HIVRAD P01-AI104715, 5T32-AI07387-22, P01AI080192]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI080192, P01AI078897, U19AI082630, P01AI104715, R01AI090698, T32AI007387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Harvard University; Ragon Institute of MGH, Massachusetts Institute of Technology; Harvard Platform Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Harvard University CFAR Scholar Award (ES) and Subcontract (AMT), a Ragon Institute of MGH, Massachusetts Institute of Technology and Harvard Platform Award (AMT), and National Institutes of Health grants P30AI060354, P01AI078897, U19-AI082630 (TMA), R01-AI090698 (TMA), HIVRAD P01-AI104715 (TMA) and training grant 5T32-AI07387-22 (TED) and P01AI080192 (GJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boliar S, 2012, J VIROL, V86, P8031, DOI 10.1128/JVI.00771-12; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MOSIER DE, 1991, SCIENCE, V251, P791, DOI 10.1126/science.1990441; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Palmer BE, 2013, J IMMUNOL, V190, P211, DOI 10.4049/jimmunol.1201108; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Power K.A., 2012, SCI TRANSL MED, V4; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang OO, 1999, J VIROL, V73, P4582, DOI 10.1128/JVI.73.6.4582-4589.1999; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	47	69	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77780	10.1371/journal.pone.0077780	http://dx.doi.org/10.1371/journal.pone.0077780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204962	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600047
J	Subramaniam, S; Preeyanon, L; Cheng, HH				Subramaniam, Sugalesini; Preeyanon, Likit; Cheng, Hans H.			Transcriptional Profiling of MEq-Dependent Genes in Marek's Disease Resistant and Susceptible Inbred Chicken Lines	PLOS ONE			English	Article							VIRUS-INFECTION; EXPRESSION; PATHWAYS; ONCOPROTEIN; RESPONSES; COMPLEX; PROTEIN	Marek's disease (MD) is an economically significant disease in chickens caused by the highly oncogenic Marek's disease virus (MDV). Understanding the genes and biological pathways that confer MD genetic resistance should lead towards the development of more disease resistant commercial poultry flocks or improved MD vaccines. MDV mEq, a bZIP transcription factor, is largely attributed to viral oncogenicity though only a few host target genes have been described, which has impeded our understanding of MDV-induced tumorigenesis. Given the importance of mEq in MDV-induced pathogenesis, we explored the role of mEq in genetic resistance to MDV. Using global transcriptome analysis and cells from MD resistant or susceptible birds, we compared the response to infection with either wild type MDV or a nononcogenic recombinant lacking mEq. As a result, we identified a number of specific genes and pathways associated with either MD resistance or susceptibility. Additionally, integrating prior information from ChIP-seq, microarray analysis, and SNPs exhibiting allele-specific expression (ASE) in response to MDV infection, we were able to provide evidence for 24 genes that are polymorphic within mEq binding sites are likely to account for gene expression in an allele-specific manner and potentially for the underlying genetic differences in MD incidence.	[Subramaniam, Sugalesini] Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA; [Subramaniam, Sugalesini; Cheng, Hans H.] ARS, USDA, Avian Dis & Oncol Lab, E Lansing, MI USA; [Preeyanon, Likit] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; United States Department of Agriculture (USDA); Michigan State University	Cheng, HH (corresponding author), ARS, USDA, Avian Dis & Oncol Lab, E Lansing, MI USA.	hans.cheng@ars.usda.gov		Preeyanon, Likit/0000-0002-2728-7625; Cheng, Hans/0000-0003-2071-4644	National Research Initiative Competitive Grant USDA National Institute of Food and Agriculture [2007-04201]; ARS [ARS-0423660] Funding Source: Federal RePORTER	National Research Initiative Competitive Grant USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by National Research Initiative Competitive Grant no. 2007-04201 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon LD, 2001, CURR TOP MICROBIOL, V255, P121; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Boudny V, 2002, NEOPLASMA, V49, P349; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Bumstead N., 2004, MAREKS DIS EVOLVING, P112; Burgess SC, 2001, VET PATHOL, V38, P129, DOI 10.1354/vp.38-2-129; Cheng H, 2008, DEV BIOLOGICALS, V132, P365, DOI 10.1159/000317187; Cheng HH, 2013, ANNU REV ANIM BIOSCI, V1, P239, DOI 10.1146/annurev-animal-031412-103701; COLE RK, 1968, AVIAN DIS, V12, P9, DOI 10.2307/1588081; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Gimeno IM, 2008, VACCINE, V26, pC31, DOI 10.1016/j.vaccine.2008.04.009; JONES D, 1992, P NATL ACAD SCI USA, V89, P4042, DOI 10.1073/pnas.89.9.4042; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Liu HC, 2001, P NATL ACAD SCI USA, V98, P9203, DOI 10.1073/pnas.161466898; Liu JL, 1997, J VIROL, V71, P3188, DOI 10.1128/JVI.71.4.3188-3196.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longenecker B M, 1977, Adv Exp Med Biol, V88, P287; Maceachern S., 2011, FRONT GENET, V2, P113, DOI [10.3389/fgene.2011.00113, DOI 10.3389/fgene.2011.00113]; McElroy JP, 2005, POULTRY SCI, V84, P1678, DOI 10.1093/ps/84.11.1678; Niikura M, 2007, VIROLOGY, V359, P212, DOI 10.1016/j.virol.2006.09.010; Niikura M, 2011, J GEN VIROL, V92, P598, DOI 10.1099/vir.0.026864-0; Perumbakkam S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-64; Sarson AJ, 2008, ANIM GENET, V39, P232, DOI 10.1111/j.1365-2052.2008.01710.x; Silva RF, 2010, AVIAN DIS, V54, P862, DOI 10.1637/9048-090409-Reg.1; Smith J, 2011, J VIROL, V85, P11146, DOI 10.1128/JVI.05499-11; STONE HA, 1975, TECHNICAL B, V1514; Subramaniam S, 2013, J VIROL, V87, P9016, DOI 10.1128/JVI.01163-13; Vallejo RL, 1998, GENETICS, V148, P349; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Witter RL, 1997, AVIAN DIS, V41, P149, DOI 10.2307/1592455; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-501	31	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78171	10.1371/journal.pone.0078171	http://dx.doi.org/10.1371/journal.pone.0078171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205146	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600078
J	Blaskovich, MA; Yendluri, V; Lawrence, HR; Lawrence, NJ; Sebti, SM; Springett, GM				Blaskovich, Michelle A.; Yendluri, Vimala; Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.; Springett, Gregory M.			Lysophosphatidic Acid Acyltransferase Beta Regulates mTOR Signaling	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; CELL-CYCLE PROGRESSION; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; TUMOR-CELLS; COMPLEX; IDENTIFICATION; ACTIVATION; APOPTOSIS	Lysophosphatidic acid acyltransferase (LPAAT-beta) is a phosphatidic acid (PA) generating enzyme that plays an essential role in triglyceride synthesis. However, LPAAT-beta is now being studied as an important regulator of cell growth and differentiation and as a potential therapeutic target in cancer since PA is necessary for the activity of key proteins such as Raf, PKC-zeta and mTOR. In this report we determine the effect of LPAAT-beta silencing with siRNA in pancreatic adenocarcinoma cell lines. We show for the first time that LPAAT-beta knockdown inhibits proliferation and anchorage-independent growth of pancreatic cancer cells. This is associated with inhibition of signaling by mTOR as determined by levels of mTORC1- and mTORC2-specific phosphorylation sites on 4E-BP1, S6K and Akt. Since PA regulates the activity of mTOR by modulating its binding to FKBP38, we explored the possibility that LPAAT-beta might regulate mTOR by affecting its association with FKBP38. Coimmunoprecipitation studies of FKBP38 with mTOR show increased levels of FKBP38 associated with mTOR when LPAAT-beta protein levels are knocked down. Furthermore, depletion of LPAAT-beta results in increased Lipin 1 nuclear localization which is associated with increased nuclear eccentricity, a nuclear shape change that is dependent on mTOR, further confirming the ability of LPAAT-beta to regulate mTOR function. Our results provide support for the hypothesis that PA generated by LPAAT-beta regulates mTOR signaling. We discuss the implications of these findings for using LPAAT-beta as a therapeutic target.	[Blaskovich, Michelle A.; Yendluri, Vimala; Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.; Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Lawrence, Harshani R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Chem Biol Core, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.] Univ S Florida, Dept Oncol Sci, Tampa, FL USA; [Sebti, Said M.] Univ S Florida, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Blaskovich, MA (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA.	michelle.blaskovich@moffitt.org			National Institutes of Health (NIH) [RO1CA131400-01A2]; American Cancer Society [93-032-10]; Shirley E. Noland Foundation, Melbourne, FL; National Cancer Institute [P30-CA076292]; NATIONAL CANCER INSTITUTE [R01CA131400, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Shirley E. Noland Foundation, Melbourne, FL; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) RO1CA131400-01A2, Institutional Research Grant number 93-032-10 from the American Cancer Society, and the Shirley E. Noland Foundation, Melbourne, FL. The H. Lee Moffitt Cancer Center Chemical Biology and Analytical Microscopy Cores are supported by the National Cancer Institute Award number P30-CA076292 as a Cancer Center Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Coon M, 2003, MOL CANCER THER, V2, P1067; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Hideshima T, 2003, CANCER RES, V63, P8428; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; La Rosee P, 2006, CLIN CANCER RES, V12, P6540, DOI 10.1158/1078-0432.CCR-06-0140; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Litosch I, 2003, BIOCHEMISTRY-US, V42, P1618, DOI 10.1021/bi026414h; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Pagel JM, 2005, CLIN CANCER RES, V11, P4857, DOI 10.1158/1078-0432.CCR-04-2352; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Tang WW, 2006, J BIOCHEM MOL BIOL, V39, P626; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	38	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78632	10.1371/journal.pone.0078632	http://dx.doi.org/10.1371/journal.pone.0078632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205284	Green Submitted, gold, Green Published			2022-12-25	WOS:000326373800021
J	Poutahidis, T; Kearney, SM; Levkovich, T; Qi, PM; Varian, BJ; Lakritz, JR; Ibrahim, YM; Chatzigiagkos, A; Alm, EJ; Erdman, SE				Poutahidis, Theofilos; Kearney, Sean M.; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Chatzigiagkos, Antonis; Alm, Eric J.; Erdman, Susan E.			Microbial Symbionts Accelerate Wound Healing via the Neuropeptide Hormone Oxytocin	PLOS ONE			English	Article							REGULATORY T-CELLS; GUT MICROBIOTA; IMMUNE-SYSTEM; VAGUS NERVE; INTESTINAL MICROBIOTA; INFLAMMATORY RESPONSE; SOCIAL-BEHAVIOR; MICE; LYMPHOCYTES; VASOPRESSIN	Wound healing capability is inextricably linked with diverse aspects of physical fitness ranging from recovery after minor injuries and surgery to diabetes and some types of cancer. Impact of the microbiome upon the mammalian wound healing process is poorly understood. We discover that supplementing the gut microbiome with lactic acid microbes in drinking water accelerates the wound-healing process to occur in half the time required for matched control animals. Further, we find that Lactobacillus reuteri enhances wound-healing properties through up-regulation of the neuropeptide hormone oxytocin, a factor integral in social bonding and reproduction, by a vagus nerve-mediated pathway. Bacteria-triggered oxytocin serves to activate host CD4+Foxp3+CD25+ immune T regulatory cells conveying transplantable wound healing capacity to naive Rag2-deficient animals. This study determined oxytocin to be a novel component of a multi-directional gut microbe-brain-immune axis, with wound-healing capability as a previously unrecognized output of this axis. We also provide experimental evidence to support long-standing medical traditions associating diet, social practices, and the immune system with efficient recovery after injury, sustained good health, and longevity.	[Poutahidis, Theofilos; Kearney, Sean M.; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Chatzigiagkos, Antonis] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, GR-54006 Thessaloniki, Greece; [Kearney, Sean M.; Alm, Eric J.] MIT, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Erdman, SE (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869	National Institutes of Health [P30-ES002109, U01 CA164337, RO1CA108854]; NATIONAL CANCER INSTITUTE [U01CA164337, R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to SEE and EJA), U01 CA164337 (to SEE and EJA), and RO1CA108854 (to SEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber C, 2011, J INVEST DERMATOL, V131, P278, DOI 10.1038/jid.2010.409; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Barnard A, 2008, NEUROIMMUNOMODULAT, V15, P7, DOI 10.1159/000135619; Belkaid Y, 2010, CLIN EXP IMMUNOL, V160, P35, DOI 10.1111/j.1365-2249.2010.04131.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Chow J, 2009, CELL HOST MICROBE, V5, P8, DOI 10.1016/j.chom.2008.12.006; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Costa RA, 2011, WOUND REPAIR REGEN, V19, P487, DOI 10.1111/j.1524-475X.2011.00700.x; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cukjati D, 2001, MED BIOL ENG COMPUT, V39, P263, DOI 10.1007/BF02344811; Davari S, 2013, NEUROSCIENCE; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; DREIFUSS JJ, 1988, BRAIN RES BULL, V20, P765, DOI 10.1016/0361-9230(88)90089-5; DVORAK AM, 1986, NEW ENGL J MED, V315, P969; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; Erdman SE, 2001, GASTROENTEROLOGY, V120, pA524, DOI 10.1016/S0016-5085(08)82601-7; Erdman SE, 2009, P NATL ACAD SCI US; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Frank S, 2003, METH MOLEC MED, V78, P3; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gajendrareddy PK, 2013, BRAIN BEHAV IMMUN, V28, P44, DOI 10.1016/j.bbi.2012.10.016; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hansenne I, 2009, NEUROIMMUNOMODULAT, V16, P35, DOI 10.1159/000179665; Ho JM, 2013, ENDOCRINOLOGY, V154, P589, DOI 10.1210/en.2012-1751; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jercinovic A., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P225, DOI 10.1109/86.340876; JOHNSON HM, 1985, J IMMUNOL, V135, pS773; Johnston GR, 2009, BRIT J ANAESTH, V102, P453, DOI 10.1093/bja/aep037; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Maccio A, 2010, IN VIVO, V24, P157; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McVey Neufeld KA, 2013, TRENDS NEUROSCI; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Ndiaye K, 2008, BIOL REPROD, V78, P786, DOI 10.1095/biolreprod.107.065938; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nomura T, 2007, NAT IMMUNOL, V8, P333, DOI 10.1038/ni0407-333; Oliveira-Pelegrin GR, 2013, NEUROIMMUNOMODULAT, V20, P65, DOI 10.1159/000345044; Pittman QJ, 2011, J NEUROENDOCRINOL, V23, P1296, DOI 10.1111/j.1365-2826.2011.02176.x; Poutahidis T, 2013, PLOS ONE, V10; Poutahidis T, 2007, CARCINOGENESIS, V28, P2614, DOI 10.1093/carcin/bgm180; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Ran VP, 2007, CANCER RES, V67, P847, DOI 10.1158/0008-5472.CAN-06-3468; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Richards H, 2010, IMMUNOLOGY, V131, P583, DOI 10.1111/j.1365-2567.2010.03333.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Shanahan F, 2012, NAT REV GASTRO HEPAT, V9, P609, DOI 10.1038/nrgastro.2012.145; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Swift ME, 1999, LAB INVEST, V79, P1479; Tkalcevic VI, 2009, TOXICOL PATHOL, V37, P183, DOI 10.1177/0192623308329280; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Williams Z, 2012, NEW ENGL J MED, V367, P1159, DOI 10.1056/NEJMcibr1207279; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	85	157	160	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78898	10.1371/journal.pone.0078898	http://dx.doi.org/10.1371/journal.pone.0078898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205344	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500139
J	Preuschoft, H; Klein, N				Preuschoft, Holger; Klein, Nicole			Torsion and Bending in the Neck and Tail of Sauropod Dinosaurs and the Function of Cervical Ribs: Insights from Functional Morphology and Biomechanics	PLOS ONE			English	Article							POSTURE	The long necks of sauropods have been subject to many studies regarding their posture and flexibility. Length of the neck varies among groups. Here, we investigate neck posture and morphology in several clades from a mechanical viewpoint. Emphasis is put on comparing sauropod necks and tails with structures in living archosaurs and mammals. Differences in the use made of necks and tails lead to clear-cut differences in the mechanical loads occurring in the same models. Ways of sustaining loads are identified by theoretical considerations. If the observed skeletal structures are suited to resist the estimated loading in a particular posture, this concordance is taken as an argument that this posture or movement was of importance during the life of the individual. Apart from the often-discussed bending in side view, we analyze the often overlooked torsion. Because torsional stresses in a homogenous element concentrate near the periphery, a cylindrical cross section gives greatest strength, and the direction of forces is oblique. In a vertebrate neck, during e. g. shaking the head and twisting the neck, oblique muscles, like the mm. scaleni, if activated unilaterally initiate movement, counterbalance the torsional moments and keep the joints between neck vertebrae in equilibrium. If activated bilaterally, these muscles keep the neck balanced in an energy-saving upright posture. The tendons of the mm. scaleni may have ossified as cervical ribs The long cervical ribs in brachiosaurids and mamenchisaurids seem to have limited flexibility, whereas the shorter cervical ribs in Diplodocidae allowed free movement. The tails of sauropods do not show pronounced adaptation to torsion, and seem to have been carried more or less in a horizontal, extended posture. In this respect, sauropod tails resemble the necks of herbivorous cursorial mammals. These analyses provide an improved understanding of neck use that will be extended to other sauropods in subsequent studies.	[Preuschoft, Holger] Ruhr Univ Bochum, Inst Anat, Bochum, Germany; [Klein, Nicole] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany	Ruhr University Bochum	Klein, N (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany.	nicole.klein@smns-bw.de			DFG [FOR 533/N2]	DFG(German Research Foundation (DFG))	NK (second and corresponding author) was funded by the DFG (DFG Projekt FOR 533/N2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 1909, ABH ZOOL BOT GESELLS, V5, P1; Cerda IA, 2009, AMEGHINIANA, V46, P193; Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Bird Roland T., 1944, NAT HIST [NEW YORK], V53, P60; Blickhan R, 2007, BIOMECHANIK AXIALEN, P179; Bock W. J., 1974, AVIAN BIOL, V4, P119; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; Christian A, 2002, MITTEILUNGEN MUSEUMS, V5, P269; Christian Andreas, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P73; Christian Andreas, 2007, Fossil Record, V10, P38; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Dubbel H, 1981, TASCHENBUCH MASCHINE; Dzemski G, 2006, THESIS U FLENSBURG F; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Fechner R, 2009, THESIS U MUNCHEN MUN; Fechner R, 2013, J ANAT, V222, P305, DOI 10.1111/joa.12015; Frey E, 1997, ENCY DINOSAURS, P406; Furbringer M, 1876, MORPHOL JB, V1, P636; Gasc J.-P., 1981, Biology of Reptilia, V11, P355; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Guibe J, 1970, TRAITE ZOOL, VXIV, P701; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hohn Bianca, 2011, P182; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; KNESE KH, 1958, Z ZELLFORSCH MIK ANA, V49, P142, DOI 10.1007/BF00324425; Kummer B., 1959, BAUPRINZIPIEN SAUGER; Lehmann T, 1974, ELEMENTE MECH, V1-3; Mallison Heinrich, 2011, P237; Mallison H, 2005, J VERTEBR PALEONTOL, V25, p88A; Martin John, 1998, Oryctos, V1, P113; Nickel R, 1973, LEHRBUCH ANATOMIE HA, V5; Nishi S, 1938, HDB VERGLEICHENDEN A, V5, P351; Organ CL, 2005, J VERTEBR PALEONTOL, V25, P602, DOI 10.1671/0272-4634(2005)025[0602:THOOTI]2.0.CO;2; Pauwels F., 1965, GESAMMELTE ABHANDLUN; PREUSCHO.H, 1974, Z ANAT ENTWICKLUNGS, V143, P315, DOI 10.1007/BF00519872; PREUSCHOFT H, 1969, Z ANAT ENTWICKLUNGS, V129, P285, DOI 10.1007/BF00521122; Preuschoft H, 2005, ZBLT GEO PAL 2, VII, P339; Preuschoft H, 1976, NATURFORSCH GES EVOL, P98; Preuschoft H, 1993, EVOLUTION ANPASSUNG, P43; Preuschoft H, 2007, MERTENSIELLA, V16, P58; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; Preuschoft H., 1973, THE CHIMPANZEE, V6, P34; Preuschoft Holger, 2011, P197; Preuschoft Holger, 1994, Verhandlungen der Deutschen Zoologischen Gesellschaft, V87, P147; Romer A, 1956, OSTEOLOGY REPTILES; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2009, SCIENCE, V323, P1671; Shorrocks B, 2009, GIRAFFA, V3, P22; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Thulborn T., 1989, DINOSAUR TRACKS TRAC, P39; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WITTE H, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P407; Wolff J, 1892, GESETZ TRANSFORMATIO	67	17	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78574	10.1371/journal.pone.0078574	http://dx.doi.org/10.1371/journal.pone.0078574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205268	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500127
J	Spence, S; Delve, J; Stamp, E; Matthews, JNS; White, M; Adamson, AJ				Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Matthews, John N. S.; White, Martin; Adamson, Ashley J.			The Impact of Food and Nutrient-Based Standards on Primary School Children's Lunch and Total Dietary Intake: A Natural Experimental Evaluation of Government Policy in England	PLOS ONE			English	Article							NUTRITIONAL INTAKE; PACKED LUNCHES; OBESITY	In 2005, the nutritional content of children's school lunches in England was widely criticised, leading to a major policy change in 2006. Food and nutrient-based standards were reintroduced requiring primary schools to comply by September 2008. We aimed to determine the effect of the policy on the nutritional content at lunchtime and in children's total diet. We undertook a natural experimental evaluation, analysing data from cross-sectional surveys in 12 primary schools in North East England, pre and post policy. Dietary data were collected on four consecutive days from children aged 4-7 years (n = 385 in 2003-4; n = 632 in 2008-9). We used linear mixed effect models to analyse the effects of gender, year, and lunch type on children's mean total daily intake. Both pre- and post-implementation, children who ate a school lunch consumed less sodium (mean change -128 mg, 95% CI: -183 to -73 mg) in their total diet than children eating home-packed lunches. Post-implementation, children eating school lunches consumed a lower % energy from fat (-1.8%, -2.8 to -0.9) and saturated fat (-1.0%; -1.6 to -0.5) than children eating packed lunches. Children eating school lunches post implementation consumed significantly more carbohydrate (16.4 g, 5.3 to 27.6), protein (3.6 g, 1.1 to 6.0), non-starch polysaccharides (1.5 g, 0.5 to 1.9), vitamin C (0.7 mg, 0.6 to 0.8), and folate (12.3 mu g, 9.7 to 20.4) in their total diet than children eating packed lunches. Implementation of school food policy standards was associated with significant improvements in the nutritional content of school lunches; this was reflected in children's total diet. School food-and nutrient-based standards can play an important role in promoting dietary health and may contribute to tackling childhood obesity. Similar policy measures should be considered for other environments influencing children's diet.	[Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin; Adamson, Ashley J.] UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Adamson, AJ (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ashley.adamson@ncl.ac.uk	Matthews, John N S/H-7502-2013	Matthews, John N S/0000-0003-2559-037X; Spence, Suzanne/0000-0002-7089-7197; Adamson, Ashley/0000-0003-3735-2846; White, Martin/0000-0002-1861-6757	Department of Health (DH) Policy Research Programme; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the auspices of the UKCRC; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001, PHCS/C4/4/008] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI	Department of Health (DH) Policy Research Programme; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the auspices of the UKCRC; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was undertaken as part of the research programme of the Public Health Research Consortium. The Public Health Research Consortium is funded by the Department of Health (DH) Policy Research Programme. The views expressed in this publication are those of the authors and not necessarily those of DH. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk/. The funders had no role in the study design, data collection or analysis, interpretation of findings, writing of, or the decision to submit for publication. All authors had access to data, and take responsibility for the integrity of the data and the accuracy of the data analysis. MW and AJA are partly funded as members of Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UKCRC, is gratefully acknowledged. AJA is funded by the National Institute of Health Research. Opinions expressed are not necessarily those of the funders.	ADAMSON A, 1992, BRIT J NUTR, V68, P543, DOI 10.1079/BJN19920114; Adamson A, 2011, PROCESS IMPACT CHANG; Adamson A. J., 2003, Proceedings of the Nutrition Society, V62, p84A; [Anonymous], 2003, DIET NUTR PREV CHRON; Bates B, 2011, NATL DIET NUTR SURVE; Bates B, 2010, NATL DIET NUTR SURV; Bates CJ, 2000, NATL DIET NUTR SURVE; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department for Education and Skills, 2006, NUTR STAND SCH LUNCH; Department of Health, 1991, DIET REF VAL FOOD EN; Department of Health, 2011, NAT CHILD MEAS PROGR; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Evans CEL, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.085977; Evans CEL, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.085837; Fletcher ES, 2004, BRIT J NUTR, V92, P321, DOI 10.1079/BJN20041199; Foresight, 2007, TACKL OB FUT CHOIC P; Gatenby LA, 2011, NUTR BULL, V36, P87, DOI 10.1111/j.1467-3010.2010.01872.x; Golley R, 2011, PUBLIC HEALTH NUTR, V14, P271, DOI 10.1017/S1368980010002120; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; HM Government, 2010, HLTH LIV HLTH PEOPL; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marmot Review, 2010, FAIR SOC HLTH LIV; Nelson M., 2006, SCH MEALS PRIMARY SC; Nelson M, 2004, SCH MEALS SECONDARY; Pearce J, 2011, PUBLIC HEALTH NUTR, V14, P1507, DOI 10.1017/S1368980010003605; Public Health England, 2021, MCCANCE WIDDOWSONS C; Rees GA, 2008, J HUM NUTR DIET, V21, P420, DOI 10.1111/j.1365-277X.2008.00885.x; Rogers IS, 2007, EUR J CLIN NUTR, V61, P856, DOI 10.1038/sj.ejcn.1602592; Ruag-Gunn AJ, 2007, PUBLIC HEALTH NUTR, V10, P354, DOI 10.1017/S1368980007249729; School Meals Review Panel, 2005, TURN TABL TRANSF SCH; Spence D, 2005, BRIT MED J, P330, DOI DOI 10.1136/BMJ.330.7492.678; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taber DR, 2013, JAMA PEDIATR, V167, P513, DOI 10.1001/jamapediatrics.2013.399	35	34	34	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78298	10.1371/journal.pone.0078298	http://dx.doi.org/10.1371/journal.pone.0078298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205190	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500112
J	Diamantopoulos, AP; Hoff, M; Hochberg, M; Haugeberg, G				Diamantopoulos, Andreas P.; Hoff, Mari; Hochberg, Marc; Haugeberg, Glenn			Predictors of Short- and Long-Term Mortality in Males and Females with Hip Fracture - A Prospective Observational Cohort Study	PLOS ONE			English	Article							EXCESS MORTALITY; OLDER WOMEN; INSTITUTIONALIZATION; COMPLICATIONS; OSTEOPOROSIS; METAANALYSIS; RISK; MEN	Background: Hip fracture is associated with increased mortality. Our aim was to study potential risk factors, including osteoporosis, associated with short-and long-term mortality in a prospectively recruited cohort of fragility hip fracture patients. Methodology/Principal Findings: Fragility hip fracture patients aged >50 years admitted to a county hospital in Southern Norway in 2004 and 2005 were consecutively identified and invited for assessment. Patients with high energy or pathological fractures, patients with confusion, serious infections or who were non-residents in the catchment area were excluded. As part of a clinical routine, data were collected using questionnaires. Standardized bone density measurements of lumbar spine and hip were performed. Potential predictors of hip fracture mortality were tested using univariate and multivariate logistic regression analysis. A total of 432 hip fracture patients (129 males and 303 females) were prospectively identified. Among them 296 (85 males and 211 females) patients [mean age 80.7 (SD 9.1)] were assessed at the Osteoporosis center. Variables independently associated with short-term mortality (after 1 year) were in females older age [Odds Ratio (OR) 6.95] and in males older age (OR 5.74) and pulmonary disease (OR 3.20), whereas no associations were observed with mortality for 3 months after the fragility hip fracture. Variables independently associated with 5 years mortality in males was osteoporosis (OR 3.91) and older age (OR 6.95), and in females was dementia (OR 4.16) and older age (OR 2.80). Conclusion: Apart from known predictors as age and comorbidity osteoporosis in our study was identified as a potential independent predictor of long-term hip fracture mortality in males. This is of particular importance as treatment with bisphosphonates after hip fracture has been shown to reduce hip fracture mortality and may be a clinical target to reduce the burden of the disease. Further studies however are needed to confirm the validity of this finding.	[Diamantopoulos, Andreas P.; Haugeberg, Glenn] Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway; [Diamantopoulos, Andreas P.] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Hoff, Mari] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Prevent Med, Baltimore, MD 21201 USA; [Haugeberg, Glenn] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Hoff, Mari] St Olavs Hosp, Dept Rheumatol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Agder; Norwegian University of Science & Technology (NTNU)	Diamantopoulos, AP (corresponding author), Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway.	andreas.diamantopoulos@sshf.no	Hoff, Mari/AAZ-7302-2021	Hoff, Mari/0000-0002-9992-8663	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Alegre-Lopez J, 2005, OSTEOPOROSIS INT, V16, P729, DOI 10.1007/s00198-004-1740-0; Beaupre LA, 2011, OSTEOPOROSIS INT, V22, P983, DOI 10.1007/s00198-010-1411-2; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Consensus Development Conference, 1993, AM J MED, V94, P646; Cree MW, 2003, OSTEOPOROSIS INT, V14, P722, DOI 10.1007/s00198-003-1430-3; Diamantopoulos AP, 2013, CLIN INTERV AGING, V8, P817, DOI 10.2147/CIA.S45468; Fransen M, 2002, J AM GERIATR SOC, V50, P685, DOI 10.1046/j.1532-5415.2002.50163.x; Giversen IM, 2007, OSTEOPOROSIS INT, V18, P721, DOI 10.1007/s00198-006-0300-1; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lyles KW, 2007, N ENGL J MED, V357; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; Mathew RO, 2013, AM J PHYS MED REHABI; McLellan AR, 2003, OSTEOPOROSIS INT, V14, P1028, DOI 10.1007/s00198-003-1507-z; Meyer HE, 2000, OSTEOPOROSIS INT, V11, P228, DOI 10.1007/s001980050285; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Pioli G, 2006, AGING CLIN EXP RES, V18, P381; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P1583, DOI 10.1007/s00198-007-0403-3	23	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78169	10.1371/journal.pone.0078169	http://dx.doi.org/10.1371/journal.pone.0078169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205145	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700081
J	Jiang, CM; Lim, VK; Wang, H; Hamm, JP				Jiang, Cunmei; Lim, Vanessa K.; Wang, Hang; Hamm, Jeff P.			Difficulties with Pitch Discrimination Influences Pitch Memory Performance: Evidence from Congenital Amusia	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FREQUENCY DISCRIMINATION; PHONOLOGICAL SIMILARITY; SPEECH INTONATION; WORKING-MEMORY; PERCEPTION; TONES; INTERFERENCE; RECOGNITION; SENSITIVITY	Music processing is influenced by pitch perception and memory. Additionally these features interact, with pitch memory performance decreasing as the perceived distance between two pitches decreases. This study examined whether or not the difficulty of pitch discrimination influences pitch retention by testing individuals with congenital amusia. Pitch discrimination difficulty was equated by determining an individual's threshold with a two down one up staircase procedure and using this to create conditions where two pitches (the standard and the comparison tones) differed by 1x, 2x, and 3x the threshold setting. For comparison with the literature a condition that employed a constant pitch difference of four semitones was also included. The results showed that pitch memory performance improved as the discrimination between the standard and the comparison tones was made easier for both a music and control groups, and more importantly, that a musics did not show any pitch retention deficits when the discrimination difficulty was equated. In contrast, consistent with previous literature, a musics performed worse than controls when the physical pitch distance was held constant at four semitones. This impaired performance has been interpreted as evidence for pitch memory impairment in the past. However, employing a constant pitch distance always makes the difference closer to the discrimination threshold for the a music group than for the control group. Therefore, reduced performance in this condition may simply reflect differences in the perceptual difficulty of the discrimination. The findings indicate the importance of equating the discrimination difficulty when investigating memory.	[Jiang, Cunmei; Wang, Hang] Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China; [Lim, Vanessa K.; Hamm, Jeff P.] Univ Auckland, Cognit Neurosci Res Grp, Auckland 1, New Zealand	Shanghai Normal University; University of Auckland	Jiang, CM (corresponding author), Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China.	cunmeijiang@126.com; j.hamm@auckland.ac.nz	Jiang, Jan/ABF-1730-2020	Jiang, Cunmei/0000-0002-0264-5924	Shanghai Normal University	Shanghai Normal University	This work was supported by funding provided by Shanghai Normal University to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233, DOI 10.1080/14640748408402157; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P362, DOI 10.1080/14640746608400055; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; COOK N, 1987, MUSIC PERCEPT, V5, P197; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; DEUTSCH D, 1975, MEM COGNITION, V3, P263, DOI 10.3758/BF03212909; DEUTSCH D, 1972, SCIENCE, V175, P1020, DOI 10.1126/science.175.4025.1020; DEUTSCH D, 1973, J EXP PSYCHOL, V100, P228, DOI 10.1037/h0035440; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Halliday LF, 2006, J RES READ, V29, P213, DOI 10.1111/j.1467-9817.2006.00286.x; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hautus MJ, 2002, PERCEPT PSYCHOPHYS, V64, P89, DOI 10.3758/BF03194559; Huron D., 1993, PSYCHOMUSICOLOGY J R, V12, P154, DOI DOI 10.1037/H0094110; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Jiang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041411; Jiang CM, 2012, MEM COGNITION, V40, P1109, DOI 10.3758/s13421-012-0208-2; Jiang CM, 2011, MUSIC PERCEPT, V28, P519, DOI 10.1525/MP.2011.28.5.519; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu F, 2012, BRAIN COGNITION, V79, P209, DOI 10.1016/j.bandc.2012.03.008; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030374; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Macmillan N. A., 2005, DETECTION THEORY USE; Marin MM, 2012, NEUROPSYCHOLOGIA, V50, P367, DOI 10.1016/j.neuropsychologia.2011.12.006; McDonald C, 2008, MUSIC PERCEPT, V25, P345, DOI 10.1525/MP.2008.25.4.345; Mengler ED, 2005, DYSLEXIA, V11, P155, DOI 10.1002/dys.302; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; Schacter DL, 2000, OXFORD HDB MEMORY, P627; Schulze K, 2011, EUR J NEUROSCI, V33, P189, DOI 10.1111/j.1460-9568.2010.07470.x; Schulze K, 2012, MUSIC PERCEPT, V29, P255, DOI 10.1525/MP.2012.29.3.255; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Semal C, 1996, J ACOUST SOC AM, V100, P1132, DOI 10.1121/1.416298; SURPRENANT AM, 1993, Q J EXP PSYCHOL-A, V46, P193, DOI 10.1080/14640749308401044; Surprenant AM, 1999, MEMORY, V7, P405, DOI 10.1080/741944920; Thompson WF, 2012, P NATL ACAD SCI USA, V109, P19027, DOI 10.1073/pnas.1210344109; Tillmann B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00120; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; Williamson VJ, 2012, NEUROPSYCHOLOGIA, V50, P172, DOI 10.1016/j.neuropsychologia.2011.11.015; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Williamson VJ, 2010, ADV COGN PSYCHOL, V6, P15, DOI 10.2478/v10053-008-0073-5; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79216	10.1371/journal.pone.0079216	http://dx.doi.org/10.1371/journal.pone.0079216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205375	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400114
J	Tortelli, F; Pisano, M; Briquez, PS; Martino, MM; Hubbell, JA				Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.			Fibronectin Binding Modulates CXCL11 Activity and Facilitates Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; HEPARIN; CXCR3; KERATINOCYTES; FIBRIN(OGEN); EXPRESSION; FIBRINOGEN; DOMAIN; IP-10	Engineered biomatrices offer the potential to recapitulate the regenerative microenvironment, with important implications in tissue repair. In this context, investigation of the molecular interactions occurring between growth factors, cytokines and extracellular matrix (ECM) has gained increasing interest. Here, we sought to investigate the possible interactions between the ECM proteins fibronectin (FN) and fibrinogen (Fg) with the CXCR3 ligands CXCL9, CXCL10 and CXCL11, which are expressed during wound healing. New binding interactions were observed and characterized. Heparin-binding domains within Fg (residues 15-66 of the beta chain, Fg beta 15-66) and FN (FNI1-5, but not FNIII12-14) were involved in binding to CXCL10 and CXCL11 but not CXCL9. To investigate a possible influence of FN and Fg interactions with CXCL11 in mediating its role during re-epithelialization, we investigated human keratinocyte migration in vitro and wound healing in vivo in diabetic db/db mice. A synergistic effect on CXCL11-induced keratinocyte migration was observed when cells were treated with CXCL11 in combination with FN in a transmigration assay. Moreover, wound healing was enhanced in full thickness excisional wounds treated with fibrin matrices functionalized with FN and containing CXCL11. These findings highlight the importance of the interactions occurring between cytokines and ECM and point to design concepts to develop functional matrices for regenerative medicine.	[Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Hubbell, Jeffrey A/A-9266-2008; Martino, Mikaël M/N-9345-2013	Hubbell, Jeffrey A/0000-0003-0276-5456; Martino, Mikaël M/0000-0002-5012-4605; Briquez, Priscilla/0000-0002-4680-9636	European Commission project Angioscaff; Swiss National Science Foundation	European Commission project Angioscaff; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by the European Commission project Angioscaff and by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artlett CM, 2013, J PATHOL, V229, P157, DOI 10.1002/path.4116; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Davidson JM, 2010, AM J PATHOL, V176, P1588, DOI 10.2353/ajpath.2010.100064; De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Fluhr H, 2011, FERTIL STERIL, V95, P1272, DOI 10.1016/j.fertnstert.2010.04.061; Haapasalmi K, 1996, J INVEST DERMATOL, V106, P42, DOI 10.1111/1523-1747.ep12327199; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Najjam S, 1997, CYTOKINE, V9, P1013, DOI 10.1006/cyto.1997.0246; Orosz F, 2002, J IMMUNOL METHODS, V270, P155, DOI 10.1016/S0022-1759(02)00295-8; Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2010, AM J PATHOL, V176, P1743, DOI 10.2353/ajpath.2010.090564; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x	36	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79610	10.1371/journal.pone.0079610	http://dx.doi.org/10.1371/journal.pone.0079610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205388	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400117
J	Adhikari, BM; Quinn, KM; Dhamala, M				Adhikari, Bhim M.; Quinn, Kristen M.; Dhamala, Mukesh			Is the Brain's Inertia for Motor Movements Different for Acceleration and Deceleration?	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; FREQUENCY-DEPENDENT CHANGES; FINGER MOVEMENTS; PARAHIPPOCAMPAL CORTEX; BASAL GANGLIA; SENSORIMOTOR SYNCHRONIZATION; CONTEXTUAL ASSOCIATIONS; SENSORY STIMULATION; TEMPORAL CONTROL; TIME PERCEPTION	The brain's ability to synchronize movements with external cues is used daily, yet neuroscience is far from a full understanding of the brain mechanisms that facilitate and set behavioral limits on these sequential performances. This functional magnetic resonance imaging (fMRI) study was designed to help understand the neural basis of behavioral performance differences on a synchronizing movement task during increasing (acceleration) and decreasing (deceleration) metronome rates. In the MRI scanner, subjects were instructed to tap their right index finger on a response box in synchrony to visual cues presented on a display screen. The tapping rate varied either continuously or in discrete steps ranging from 0.5 Hz to 3 Hz. Subjects were able to synchronize better during continuously accelerating rhythms than in continuously or discretely decelerating rhythms. The fMRI data revealed that the precuneus was activated more during continuous deceleration than during acceleration with the hysteresis effect significant at rhythm rates above 1 Hz. From the behavioral data, two performance measures, tapping rate and synchrony index, were derived to further analyze the relative brain activity during acceleration and deceleration of rhythms. Tapping rate was associated with a greater brain activity during deceleration in the cerebellum, superior temporal gyrus and parahippocampal gyrus. Synchrony index was associated with a greater activity during the continuous acceleration phase than during the continuous deceleration or discrete acceleration phases in a distributed network of regions including the prefrontal cortex and precuneus. These results indicate that the brain's inertia for movement is different for acceleration and deceleration, which may have implications in understanding the origin of our perceptual and behavioral limits.	[Adhikari, Bhim M.; Quinn, Kristen M.; Dhamala, Mukesh] Georgia State Univ, Dept Phys & Astron, Ctr Behav Neurosci, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Adhikari, BM (corresponding author), Georgia State Univ, Dept Phys & Astron, Ctr Behav Neurosci, Inst Neurosci, Atlanta, GA 30303 USA.	badhikari1@student.gsu.edu	Dhamala, Mukesh/AAX-3207-2021; Adhikari, Bhim/K-7390-2019		Georgia State University faculty Brains and Behavior seed grant; National Science Foundation CAREER award [BCS 0955037]; Center for Behavioral Neuroscience, Georgia State University; Direct For Social, Behav & Economic Scie [0955037] Funding Source: National Science Foundation	Georgia State University faculty Brains and Behavior seed grant; National Science Foundation CAREER award(National Science Foundation (NSF)); Center for Behavioral Neuroscience, Georgia State University; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by Georgia State University faculty Brains and Behavior seed grant and the National Science Foundation CAREER award (BCS 0955037) to the author MD. The Institute on Neuroscience (ION) program directed by Dr. Kyle Franz at the Center for Behavioral Neuroscience, Georgia State University provided a summer fellowship to the author KQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2008, CEREB CORTEX, V18, P1233, DOI 10.1093/cercor/bhm170; BERNS GS, 1999, J NEUROSCI, V19, P1; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Carver FW, 2002, CLIN NEUROPHYSIOL, V113, P1921, DOI 10.1016/S1388-2457(02)00299-7; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dhamala M, 2003, NEUROIMAGE, V20, P918, DOI 10.1016/S1053-8119(03)00304-5; Dhamala M, 2007, NEUROIMAGE, V34, P764, DOI 10.1016/j.neuroimage.2006.07.044; Fraisse P., 2009, PSYCHOMUSICOLOGY MUS, V20, P170; Fraisse P, 1982, RHYTHM TEMPO; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gardini S, 2011, BEHAV NEUROL, V24, P123, DOI [10.3233/BEN-2011-0279, 10.1155/2011/547451]; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Habas C, 2004, NEUROREPORT, V15, P1571, DOI 10.1097/01.wnr.0000133970.53139.e3; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hardy MW, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00019; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lutz K, 2000, NEUROREPORT, V11, P1301, DOI 10.1097/00001756-200004270-00031; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mayville JM, 2002, HUM BRAIN MAPP, V17, P214, DOI 10.1002/hbm.10065; Molinari M, 2003, ANN NY ACAD SCI, V999, P313, DOI 10.1196/annals.1284.042; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Olmo MFD, 2007, J NEUROPHYSIOL, V98, P145; Ramnani N, 2001, J COGNITIVE NEUROSCI, V13, P952, DOI 10.1162/089892901753165863; RAO SM, 1993, NEUROLOGY, V43, P2311, DOI 10.1212/WNL.43.11.2311; Rao SM, 1997, J NEUROSCI, V17, P5528; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rivkin MJ, 2003, PEDIATR NEUROL, V28, P89, DOI 10.1016/S0887-8994(02)00492-7; ROLAND PE, 1985, HUM NEUROBIOL, V4, P155; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Sadato N, 1996, J CEREBR BLOOD F MET, V16, P23, DOI 10.1097/00004647-199601000-00003; Sakai K, 1999, J NEUROSCI, V19, P10074; Salman MS, 2002, J CHILD NEUROL, V17, P1, DOI 10.1177/088307380201700101; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Tal D, 2001, NEUROSCI LETT, V300, P21, DOI 10.1016/S0304-3940(01)01534-8; Talairach J, 1988, CO PLANAR STEREOTAXI; Thaut MH, 2006, ANN NY ACAD SCI, V999, P364; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; Toib A, 1998, J NEUROSCI, V18, P1893; Turgeon M, 2012, PSYCHIAT RES, V197, P13, DOI 10.1016/j.psychres.2012.03.003; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Wendelken C, 2011, DEV COGN NEUROS-NETH, V1, P175, DOI 10.1016/j.dcn.2010.11.001; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; WESSEL K, 1995, BRAIN, V118, P379, DOI 10.1093/brain/118.2.379; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151	75	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78055	10.1371/journal.pone.0078055	http://dx.doi.org/10.1371/journal.pone.0078055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205088	gold, Green Published			2022-12-25	WOS:000326032600065
J	Fischer, S; Kittler, S; Klein, G; Glunder, G				Fischer, Samuel; Kittler, Sophie; Klein, Guenter; Gluender, Gerhard			Impact of a Single Phage and a Phage Cocktail Application in Broilers on Reduction of Campylobacter jejuni and Development of Resistance	PLOS ONE			English	Article							CONTROL STRATEGIES; THERMOPHILIC CAMPYLOBACTER; EXPOSURE ASSESSMENT; BACTERIOPHAGES; POULTRY; CONTAMINATION; PREVALENCE; NUMBERS; IDENTIFICATION; SENSITIVITY	Campylobacteriosis is currently the most frequent foodborne zoonosis in many countries. One main source is poultry. The aim of this study was to enhance the knowledge about the potential of bacteriophages in reducing colonization of broilers with Campylobacter, as there are only a few in vivo studies published. Commercial broilers were inoculated with 10(4) CFU/bird of a Campylobacter jejuni field strain. Groups of 88 birds each were subsequently treated with a single phage or a four-phage cocktail (10(7) PFU/bird in CaCO3 buffered SM-Buffer). Control birds received the solvent only. Afterwards, subgroups of eleven birds each were examined for their loads with phages and Campylobacter on day 1, 3, 7, 14, 21, 28, 35 and 42 after phage application. The susceptibility of the Campylobacter population to phage infection was determined using ten isolates per bird. In total 4180 re-isolates were examined. The study demonstrated that the deployed phages persisted over the whole investigation period. The Campylobacter load was permanently reduced by the phage-cocktail as well as by the single phage. The reduction was significant between one and four weeks after treatment and reached a maximum of log(10) 2.8 CFU/g cecal contents. Phage resistance rates of initially up to 43% in the single phage treated group and 24% in the cocktail treated group later stabilized at low levels. The occurrence of phage resistance influenced but did not override the Campylobacter reducing effect. Regarding the reduction potential, the cocktail treatment had only a small advantage over the singe phage treatment directly after phage administration. However, the cocktail moderated and delayed the emergence of phage resistance.	[Fischer, Samuel; Gluender, Gerhard] Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany; [Kittler, Sophie; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Fischer, S (corresponding author), Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany.	samuel.fischer@tiho-hannover.de	Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701				Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Atterbury RJ, 2005, APPL ENVIRON MICROB, V71, P4885, DOI 10.1128/AEM.71.8.4885-4887.2005; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; ECDC, 2011, EUROSURVEILLANCE, V16, P17; El-Shibiny A, 2005, APPL ENVIRON MICROB, V71, P1259, DOI 10.1128/AEM.71.3.1259-1266.2005; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Ellerbroek LI, 2010, ZOONOSES PUBLIC HLTH, V57, pE81, DOI 10.1111/j.1863-2378.2009.01267.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053899; Ghareeb K, 2013, WORLD POULTRY SCI J, V69, P57, DOI 10.1017/S0043933913000068; Glunder G, 1998, P 1 INT S TURK DIS 1, P307; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Havelaar AH, 2007, RISK ANAL, V27, P831, DOI 10.1111/j.1539-6924.2007.00926.x; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x; Hirsch K, 2010, THESIS U VET MED HAN; Hwang S, 2009, MICROBIOL IMMUNOL, V53, P559, DOI 10.1111/j.1348-0421.2009.00163.x; Lammerding AM, 2000, INT J FOOD MICROBIOL, V58, P147, DOI 10.1016/S0168-1605(00)00269-5; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Louwen R, 2012, EUROPEAN J CLIN MICR; Luria SE, 1943, GENETICS, V28, P491; Ma YS, 2008, APPL ENVIRON MICROB, V74, P4799, DOI 10.1128/AEM.00246-08; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Moran L, 2009, J FOOD PROTECT, V72, P1830, DOI 10.4315/0362-028X-72.9.1830; Nather G, 2009, POULTRY SCI, V88, P1299, DOI 10.3382/ps.2008-00389; Ogden ID, 2009, FOODBORNE PATHOG DIS, V6, P1161, DOI 10.1089/fpd.2009.0327; Osiriphun S, 2011, POULTRY SCI, V90, P1562, DOI 10.3382/ps.2009-00577; Pasquali F, 2011, WORLD POULTRY SCI J, V67, P5, DOI 10.1017/S0043933911000018; Reich F, 2008, INT J FOOD MICROBIOL, V127, P116, DOI 10.1016/j.ijfoodmicro.2008.06.018; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rudi K, 2004, APPL ENVIRON MICROB, V70, P790, DOI 10.1128/AEM.70.2.790-797.2004; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Tsuei AC, 2007, INT J FOOD MICROBIOL, V116, P121, DOI 10.1016/j.ijfoodmicro.2006.12.028; Uffing B, 2011, EINFLUSS MISCHFUTTER; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	43	71	74	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78543	10.1371/journal.pone.0078543	http://dx.doi.org/10.1371/journal.pone.0078543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205254	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600107
J	Low, C; Yau, YH; Pardon, E; Jegerschold, C; Wahlin, L; Quistgaard, EM; Moberg, P; Geifman-Shochat, S; Steyaert, J; Nordlund, P				Low, Christian; Yau, Yin Hoe; Pardon, Els; Jegerschold, Caroline; Wahlin, Lisa; Quistgaard, Esben M.; Moberg, Per; Geifman-Shochat, Susana; Steyaert, Jan; Nordlund, Par			Nanobody Mediated Crystallization of an Archeal Mechanosensitive Channel	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SIZE-EXCLUSION CHROMATOGRAPHY; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; BINDING-PROTEINS; MOLECULAR-BASIS; DOMAIN; OVEREXPRESSION; IDENTIFICATION; OPTIMIZATION	Mechanosensitive channels (MS) are integral membrane proteins and allow bacteria to survive sudden changes in external osmolarity due to transient opening of their pores. The efflux of cytoplasmic osmolytes reduces the membrane tension and prevents membrane rupture. Therefore these channels serve as emergency valves when experiencing significant environmental stress. The preparation of high quality crystals of integral membrane proteins is a major bottleneck for structure determination by X-ray crystallography. Crystallization chaperones based on various protein scaffolds have emerged as promising tool to increase the crystallization probability of a selected target protein. So far archeal mechanosensitive channels of small conductance have resisted crystallization in our hands. To structurally analyse these channels, we selected nanobodies against an archeal MS channel after immunization of a llama with recombinant expressed, detergent solubilized and purified protein. Here we present the characterization of 23 different binders regarding their interaction with the channel protein using analytical gel filtration, western blotting and surface plasmon resonance. Selected nanobodies bound the target with affinities in the pico- to nanomolar range and some binders had a profound effect on the crystallization of the MS channel. Together with previous data we show that nanobodies are a versatile and valuable tool in structural biology by widening the crystallization space for highly challenging proteins, protein complexes and integral membrane proteins.	[Low, Christian; Quistgaard, Esben M.; Moberg, Per; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Yau, Yin Hoe; Wahlin, Lisa; Geifman-Shochat, Susana] Nanyang Technol Univ, Div Chem Biol & Biotechnol, Singapore 639798, Singapore; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Brussels, Belgium; [Jegerschold, Caroline] Royal Inst Technol, Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Jegerschold, Caroline] Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Karolinska Institutet; Royal Institute of Technology; Royal Institute of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.low@ki.se; par.nordlund@ki.se	Steyaert, Jan/H-4662-2011; Hoe, YAU Yin/A-2817-2011; steyaert, jan/GQP-7811-2022	Steyaert, Jan/0000-0002-3825-874X; Hoe, YAU Yin/0000-0001-8136-2393; Jegerschold, Caroline/0000-0003-2419-6354; Quistgaard, Esben/0000-0002-1381-3364; Pardon, Els/0000-0002-2466-0172; Loew, Christian/0000-0003-0764-7483	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO) postdoctoral fellowship; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G011110N, G049512N]; Innoviris Brussels through Impulse Life Science program [BRGEOZ132]; Belgian Federal Science Policy Office [IAP7-40]; SBO program from the Flemish Agency for Innovation by Science and Technology [IWT120026]; Swedish Research Council; Swedish Cancer Society; integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO) postdoctoral fellowship; Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Innoviris Brussels through Impulse Life Science program(Innoviris); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); SBO program from the Flemish Agency for Innovation by Science and Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant(National Research Foundation, Singapore)	E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C. L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. E. P. and J.S. were supported by the Fonds Wetenschappelijk Onderzoek-Vlaanderen through research grants G011110N and G049512N, Innoviris Brussels through Impulse Life Science program BRGEOZ132, the Belgian Federal Science Policy Office through IAP7-40 and by SBO program IWT120026 from the Flemish Agency for Innovation by Science and Technology. This research was further supported by grants from the Swedish Research Council, Swedish Cancer Society and the integrated EU project EDICT (European drug initiative on channels and transporters), as well as a Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand D, 2008, HYBRIDOMA, V27, P353, DOI 10.1089/hyb.2008.0014; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide S, 2009, CURR OPIN STRUC BIOL, V19, P449, DOI 10.1016/j.sbi.2009.04.008; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; LAI JY, 2013, PROTEIN SCI; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lieberman RL, 2011, METHODS, V55, P293, DOI 10.1016/j.ymeth.2011.08.004; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; PARK YJ, 2012, NATURE, V487, P119; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; STERN J, 1992, BIOCHIM BIOPHYS ACTA, V1128, P227, DOI 10.1016/0005-2760(92)90312-J; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109	66	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77984	10.1371/journal.pone.0077984	http://dx.doi.org/10.1371/journal.pone.0077984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205053	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600057
J	Yi, GH; Brendel, VP; Shu, C; Li, PW; Palanathan, S; Kao, CC				Yi, Guanghui; Brendel, Volker P.; Shu, Chang; Li, Pingwei; Palanathan, Satheesh; Kao, C. Cheng			Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides	PLOS ONE			English	Article							CYTOSOLIC DNA SENSOR; DI-GMP; AMP; ADAPTER; 2ND-MESSENGER; RECOGNITION; RECEPTORS; IDENTIFICATION; STIMULATOR; REVEALS	The STING (stimulator of interferon genes) protein can bind cyclic dinucleotides to activate the production of type I interferons and inflammatory cytokines. The cyclic dinucleotides can be bacterial second messengers c-di-GMP and c-di-AMP, 3'5'-3'5' cyclic GMP-AMP (3'3' cGAMP) produced by Vibrio cholerae and metazoan second messenger 2'5'-3'5' Cyclic GMP-AMP (2'3' cGAMP). Analysis of single nucleotide polymorphism (SNP) data from the 1000 Genome Project revealed that R71H-G230A-R293Q (HAQ) occurs in 20.4%, R232H in 13.7%, G230A-R293Q (AQ) in 5.2%, and R293Q in 1.5% of human population. In the absence of exogenous ligands, the R232H, R293Q and AQ SNPs had only modest effect on the stimulation of IFN-beta and NF-kappa B promoter activities in HEK293T cells, while HAQ had significantly lower intrinsic activity. The decrease was primarily due to the R71H substitution. The SNPs also affected the response to the cyclic dinucleotides. In the presence of c-di-GMP, the R232H variant partially decreased the ability to activate IFN-beta signaling, while it was defective for the response to c-di-AMP and 3'3' cGAMP. The R293Q dramatically decreased the stimulatory response to all bacterial ligands. Surprisingly, the AQ and HAQ variants maintained partial abilities to activate the IFN-beta signaling in the presence of ligands due primarily to the G230A substitution. Biochemical analysis revealed that the recombinant G230A protein could affect the conformation of the C-terminal domain of STING and the binding to c-di-GMP. Comparison of G230A structure with that of WT revealed that the conformation of the lid region that clamps onto the c-di-GMP was significantly altered. These results suggest that hSTING variation can affect innate immune signaling and that the common HAQ haplotype expresses a STING protein with reduced intrinsic signaling activity but retained the ability to response to bacterial cyclic dinucleotides.	[Yi, Guanghui; Palanathan, Satheesh; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Brendel, Volker P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Brendel, Volker P.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Shu, Chang; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	shu, chang/H-4452-2015	shu, chang/0000-0002-6738-8973				Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burdette Dara L, 2013, Nat Immunol, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kim S, 2013, ACS CHEM BIOL; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pothlichet J, 2013, INT REV IMMUNOL, V32, P157, DOI 10.3109/08830185.2013.777064; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	45	143	172	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77846	10.1371/journal.pone.0077846	http://dx.doi.org/10.1371/journal.pone.0077846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204993	Green Submitted, gold, Green Published			2022-12-25	WOS:000326032600050
J	Sy, BT; Ratsch, BA; Toan, NL; Song, LH; Wollboldt, C; Bryniok, A; Nguyen, HM; Luong, HV; Velavan, TP; Wedemeyer, H; Kremsner, PG; Bock, CT				Bui Tien Sy; Ratsch, Boris A.; Nguyen Linh Toan; Le Huu Song; Wollboldt, Christian; Bryniok, Agnes; Hung Minh Nguyen; Hoang Van Luong; Velavan, Thirumalaisamy P.; Wedemeyer, Heiner; Kremsner, Peter G.; Bock, C-Thomas			High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naive HBsAg-Positive Patients in Northern Vietnam	PLOS ONE			English	Article							B-VIRUS; LIVER-DISEASE; CLINICAL-SIGNIFICANCE; FULMINANT-HEPATITIS; VANISHING DISEASE; ENDEMIC AREA; GENOTYPE-I; DELTA; HDV; MANAGEMENT	Background: Hepatitis D virus (HDV) infection is considered to cause more severe hepatitis than hepatitis B virus (HBV) monoinfection. With more than 9.5 million HBV-infected people, Vietnam will face an enormous health burden. The prevalence of HDV in Vietnamese HBsAg-positive patients is speculative. Therefore, we assessed the prevalence of HDV in Vietnamese patients, determined the HDV-genotype distribution and compared the findings with the clinical outcome. Methods: 266 sera of well-characterized HBsAg-positive patients in Northern Vietnam were analysed for the presence of HDV using newly developed HDV-specific RT-PCRs. Sequencing and phylogenetic analysis were performed for HDV-genotyping. Results: The HDV-genome prevalence observed in the Vietnamese HBsAg-positive patients was high with 15.4% while patients with acute hepatitis showed 43.3%. Phylogenetic analysis demonstrated a predominance of HDV-genotype 1 clustering in an Asian clade while HDV-genotype 2 could be also detected. The serum aminotransferase levels (AST, ALT) as well as total and direct bilirubin were significantly elevated in HDV-positive individuals (p<0.05). HDV loads were mainly low (<300 to 4.108 HDV-copies/ml). Of note, higher HDV loads were mainly found in HBV-genotype mix samples in contrast to single HBV-infections. In HBV/HDV-coinfections, HBV loads were significantly higher in HBV-genotype C in comparison to HBV-genotype A samples (p<0.05). Conclusion: HDV prevalence is high in Vietnamese individuals, especially in patients with acute hepatitis B. HDV replication activity showed a HBV-genotype dependency and could be associated with elevated liver parameters. Besides serological assays molecular tests are recommended for diagnosis of HDV. Finally, the high prevalence of HBV and HDV prompts the urgent need for HBV-vaccination coverage.	[Bui Tien Sy; Ratsch, Boris A.; Wollboldt, Christian; Bryniok, Agnes; Bock, C-Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Bui Tien Sy; Nguyen Linh Toan; Hoang Van Luong] Vietnam Mil Med Univ, Dept Pathophysiol, Hanoi, Ha Dong, Vietnam; [Le Huu Song] Tran Hung Dao Hosp, Inst Clin Med & Pharmaceut Sci 108, Hanoi, Vietnam; [Hung Minh Nguyen] Duy Tan Univ, Ctr Res & Dev, Da Nang, Vietnam; [Velavan, Thirumalaisamy P.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Bock, C-Thomas] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany	Robert Koch Institute; Duy Tan University; Eberhard Karls University of Tubingen; Hannover Medical School; Eberhard Karls University of Tubingen	Bock, CT (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	bockc@rki.de	Velavan, Thirumalaisamy P/C-1223-2010; Bock, C.-Thomas/A-3518-2012	Velavan, Thirumalaisamy P/0000-0002-9809-9883; Ratsch, Boris/0000-0003-0478-1652; Bock, C.-Thomas/0000-0002-2773-486X	project 322 of Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Tuebingen University	project 322 of Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	B.T. Sy was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam. The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2011, INFECT GENET EVOL, V11, P1462, DOI 10.1016/j.meegid.2011.05.020; Babiker ZOE, 2012, J MED MICROBIOL, V61, P1780, DOI 10.1099/jmm.0.046649-0; Barros LMF, 2011, VIRUS RES, V160, P333, DOI 10.1016/j.virusres.2011.07.006; Brichler S, 2013, CLIN GASTROENTEROL H, V11, P734, DOI 10.1016/j.cgh.2013.01.025; Casey JL, 1996, J INFECT DIS, V174, P920, DOI 10.1093/infdis/174.5.920; CIANCIO A, 2002, P 10 INT S VIR HEP L, P271; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; Davaalkham D, 2006, AM J TROP MED HYG, V75, P365, DOI 10.4269/ajtmh.2006.75.365; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Duraisamy G, 1994, Med J Malaysia, V49, P212; Flodgren E, 2000, J CLIN MICROBIOL, V38, P3311, DOI 10.1128/JCM.38.9.3311-3316.2000; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Gish RG, 2012, J GASTROEN HEPATOL, V27, P238, DOI 10.1111/j.1440-1746.2011.06974.x; Gomes-Gouvea MS, 2009, J GEN VIROL, V90, P2638, DOI 10.1099/vir.0.013615-0; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Huo TI, 1997, J GASTROEN HEPATOL, V12, P747, DOI 10.1111/j.1440-1746.1997.tb00364.x; IMAZEKI F, 1990, J VIROL, V64, P5594, DOI 10.1128/JVI.64.11.5594-5599.1990; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709; Kabacam G, 2012, CLIN INFECT DIS, V55, P645, DOI 10.1093/cid/cis459; Kim HS, 2011, J MED VIROL, V83, P1172, DOI 10.1002/jmv.22095; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lu SN, 2003, J MED VIROL, V70, P74, DOI 10.1002/jmv.10361; Lusida MI, 2003, MICROBIOL IMMUNOL, V47, P969, DOI 10.1111/j.1348-0421.2003.tb03457.x; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; Mumtaz K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-312; NAVASCUES CA, 1995, AM J GASTROENTEROL, V90, P1981; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Niro GA, 2010, J HEPATOL, V53, P834, DOI 10.1016/j.jhep.2010.06.008; Pascarella S, 2011, LIVER INT, V31, P7, DOI 10.1111/j.1478-3231.2010.02320.x; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Popescu GA, 2013, J MED VIROL, V85, P769, DOI 10.1002/jmv.23524; Rizzetto M, 2013, LIVER INT, V33, P195, DOI 10.1111/liv.12058; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;366::AID-JMV8&gt;3.0.CO;2-X; Song LH, 2004, J MED VIROL, V73, P244, DOI 10.1002/jmv.20082; Song LH, 2003, J CLIN VIROL, V28, P93, DOI 10.1016/S1386-6532(02)00271-8; Stroffolini T, 2009, J MED VIROL, V81, P1999, DOI 10.1002/jmv.21643; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAN D S K, 1989, SMJ Singapore Medical Journal, V30, P34; Taylor JM, 2006, VIROLOGY, V344, P71, DOI 10.1016/j.virol.2005.09.033; Taylor JM, 2012, SEMIN LIVER DIS, V32, P195, DOI 10.1055/s-0032-1323623; Taylor JM, 2009, ADV VIRUS RES, V74, P103, DOI 10.1016/S0065-3527(09)74003-5; Theamboonlers A, 2002, INFECTION, V30, P140, DOI 10.1007/s15010-002-2061-x; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2011, LIVER INT, V31, P140, DOI 10.1111/j.1478-3231.2010.02408.x; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Wu JC, 2006, CURR TOP MICROBIOL, V307, P173; Wu JC, 1995, HEPATOLOGY, V22, P1656, DOI 10.1016/0270-9139(95)90187-6	55	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78094	10.1371/journal.pone.0078094	http://dx.doi.org/10.1371/journal.pone.0078094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205106	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300138
J	Haileselassie, Y; Johansson, MA; Zimmer, CL; Bjorkander, S; Petursdottir, DH; Dicksved, J; Petersson, M; Persson, JO; Fernandez, C; Roos, S; Holmlund, U; Sverremark-Ekstrom, E				Haileselassie, Yeneneh; Johansson, Maria A.; Zimmer, Christine L.; Bjorkander, Sophia; Petursdottir, Dagbjort H.; Dicksved, Johan; Petersson, Mikael; Persson, Jan-Olov; Fernandez, Carmen; Roos, Stefan; Holmlund, Ulrika; Sverremark-Ekstrom, Eva			Lactobacilli Regulate Staphylococcus aureus 161:2-Induced Pro-Inflammatory T-Cell Responses In Vitro	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INTESTINAL MICROFLORA; DENDRITIC CELLS; IMMUNE-RESPONSES; GUT MICROBIOTA; BACTERIA; HEALTHY; BIFIDOBACTERIUM; ALLERGY; GENE	There seems to be a correlation between early gut microbiota composition and postnatal immune development. Alteration in the microbial composition early in life has been associated with immune mediated diseases, such as autoimmunity and allergy. We have previously observed associations between the presence of lactobacilli and Staphylococcus (S.) aureus in the early-life gut microbiota, cytokine responses and allergy development in children. Consistent with the objective to understand how bacteria modulate the cytokine response of intestinal epithelial cell (IEC) lines and immune cells, we exposed IEC lines (HT29, SW480) to UV-killed bacteria and/or culture supernatants (-sn) from seven Lactobacillus strains and three S. aureus strains, while peripheral blood mononuclear cells (PBMC) and cord blood mononuclear cells (CBMC) from healthy donors were stimulated by bacteria-sn or with bacteria conditioned IEC-sn. Although the overall IEC response to bacterial exposure was characterized by limited sets of cytokine and chemokine production, S. aureus 161: 2-sn induced an inflammatory response in the IEC, characterized by CXCL1/GROa and CXCL8/IL-8 production, partly in a MyD88-dependent manner. UV-killed bacteria did not induce a response in the IEC line, and a combination of both UV-killed bacteria and the bacteria-sn had no additive effect to that of the supernatant alone. In PBMC, most of the Lactobacillus-sn and S. aureus-sn strains were able to induce a wide array of cytokines, but only S. aureus-sn induced the T-cell associated cytokines IL-2, IL-17 and IFN-gamma, independently of IEC-produced factors, and induced up regulation of CTLA-4 expression and IL-10 production by T-regulatory cells. Notably, S. aureus-sn-induced T-cell production of IFN-gamma and IL-17 was down regulated by the simultaneous presence of any of the different Lactobacillus strains, while the IEC CXCL8/IL-8 response was unaltered. Thus these studies present a possible role for lactobacilli in induction of immune cell regulation, although the mechanisms need to be further elucidated.	[Haileselassie, Yeneneh; Johansson, Maria A.; Zimmer, Christine L.; Bjorkander, Sophia; Petursdottir, Dagbjort H.; Fernandez, Carmen; Holmlund, Ulrika; Sverremark-Ekstrom, Eva] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Dicksved, Johan] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Petersson, Mikael; Persson, Jan-Olov] Stockholm Univ, Dept Math, Div Math Stat, S-10691 Stockholm, Sweden; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Stockholm University; Swedish University of Agricultural Sciences	Haileselassie, Y (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	yeneneh.haileselassie@su.se; eva.sverremark@su.se	Sverremark-Ekström, Eva/A-2305-2016	Sverremark-Ekström, Eva/0000-0001-6271-8681; Roos, Stefan/0000-0002-1606-1794; Dicksved, Johan/0000-0002-7515-4480; Haileselassie, Yeneneh/0000-0003-3726-7393	Swedish Research Council [57X-15160-07-03, 57X-15160-10-4]; Ragnar Soderberg Foundation; Cancer and Allergy Foundation; Swedish Asthma and Allergy Association's Research Foundation; Mjolkdroppen Foundation; Konsul Th C Bergh Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Cancer and Allergy Foundation; Swedish Asthma and Allergy Association's Research Foundation; Mjolkdroppen Foundation; Konsul Th C Bergh Foundation	The Swedish Research Council (grants 57X-15160-07-03, 57X-15160-10-4), The Ragnar Soderberg Foundation (http://www.ragnarsoderbergsstiftelse.se/), The Cancer and Allergy Foundation (http://www.cancerochallergifonden.se/), The Swedish Asthma and Allergy Association's Research Foundation (http://www.astmaoallergiforbundet.se/), The Mjolkdroppen Foundation (http://www.mjolkdroppen.se) and The Konsul Th C Bergh Foundation (www.konsulbergh.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoudruz P, 2005, J ALLERGY CLIN IMMUN, V115, P1304, DOI 10.1016/j.jaci.2005.02.036; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Biazik JM, 2010, WORLD J GASTROENTERO, V16, P2743, DOI 10.3748/wjg.v16.i22.2743; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; BJORNEHOLM S, 2011, MICROB ECOL HLTH DIS, V14, P57564; Edwards LA, 2012, INFLAMM BOWEL DIS, V18, P624, DOI 10.1002/ibd.21852; Fournier B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00167; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Holmlund U, 2010, CLIN EXP IMMUNOL, V162, P500, DOI 10.1111/j.1365-2249.2010.04275.x; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Johansson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049315; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; MAUDSDOTTER L, 2011, ANTIMICROB AGENTS CH, P45448; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Niebuhr M, 2011, INFECT IMMUN, V79, P1615, DOI 10.1128/IAI.00958-10; Nowrouzian FL, 2011, J INFECT DIS, V204, P714, DOI 10.1093/infdis/jir388; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Rosengren A, 2010, INT J FOOD MICROBIOL, V144, P263, DOI 10.1016/j.ijfoodmicro.2010.10.004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmaler M, 2011, J IMMUNOL, V186, P443, DOI 10.4049/jimmunol.1001407; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Smith AW, 2011, J NEUROIMMUNOL, V232, P179, DOI 10.1016/j.jneuroim.2010.09.030; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Sun KY, 2013, J BIOMED RES, V27, P116, DOI 10.7555/JBR.27.20120074; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vesterlund S, 2006, MICROBIOL-SGM, V152, P1819, DOI 10.1099/mic.0.28522-0; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	45	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77893	10.1371/journal.pone.0077893	http://dx.doi.org/10.1371/journal.pone.0077893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205015	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300123
J	Lopez, P; Alonso-Perez, E; Rodriguez-Carrio, J; Suarez, A				Lopez, Patricia; Alonso-Perez, Elisa; Rodriguez-Carrio, Javier; Suarez, Ana			Influence of Atg5 Mutation in SLE Depends on Functional IL-10 Genotype	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; APOPTOTIC CELLS; SERUM-LEVELS; AUTOPHAGY; POPULATION; CLEARANCE; DISEASE; POLYMORPHISMS	Increasing evidence supports the involvement of autophagy in the etiopathology of autoimmune diseases. Despite the identification of autophagy-related protein (Atg)-5 as one of the susceptibility loci in systemic Lupus erythematosus (SLE), the consequences of the carriage of these mutations for patients remain unclear. The present work analyzed the association of Atg5 rs573775 single nucleotide polymorphism (SNP) with SLE susceptibility, IFN alpha, TNF alpha and IL-10 serum levels, and clinical features, in 115 patients and 170 healthy individuals. Patients who where carriers of the rs573775 T* minor allele presented lower IFNa levels than those with the wild genotype, whereas the opposite result was detected for IL-10. Thus, since IL-10 production was regulated by rs1800896 polymorphisms, we evaluated the effect of this Atg5 mutation in genetically high and low IL-10 producers. Interestingly, we found that the rs573775 T* allele was a risk factor for SLE in carriers of the high IL-10 producer genotype, but not among genetically low producers. Moreover, IL-10 genotype influences SLE features in patients presenting the Atg5 mutated allele. Specifically, carriage of the rs573775 T* allele led to IL-10 upregulation, reduced IFNa and TNFa production and a low frequency of cytopenia in patients with the high IL-10 producer genotype, whereas patients with the same Atg5 allele that were low IL-10 producers presented reduced amounts of all these cytokines, had a lower prevalence of anti-dsDNA antibodies and the latest onset age. In conclusion, the Atg5 rs573775 T* allele seems to influence SLE susceptibility, cytokine production and disease features depending on other factors such as functional IL-10 genotype.	[Lopez, Patricia; Rodriguez-Carrio, Javier; Suarez, Ana] Univ Oviedo, Fac Med, Immunol Area, Dept Funct Biol, Oviedo, Spain; [Alonso-Perez, Elisa] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Lab Invest, Santiago De Compostela, Spain	University of Oviedo; Complexo Hospitalario Universitario de Santiago de Compostela	Lopez, P (corresponding author), Univ Oviedo, Fac Med, Immunol Area, Dept Funct Biol, Oviedo, Spain.	lopezpatricia@uniovi.es	López, Patricia/B-8603-2018; Suarez, Ana/F-4492-2015	López, Patricia/0000-0002-1843-0653; Suarez, Ana/0000-0002-4452-7539; Rodriguez-Carrio, Javier/0000-0002-0011-5102	European Union FEDER funds; Fondo de Investigacion Sanitaria (FIS) [PI08/0570, PI12/0053]; FPU grant from the Ministerio de Educacion	European Union FEDER funds(European Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); FPU grant from the Ministerio de Educacion(German Research Foundation (DFG))	This work was supported by European Union FEDER funds and the Fondo de Investigacion Sanitaria (FIS, PI08/0570 and PI12/0053). J.R.-C. is a recipient of a FPU grant from the Ministerio de Educacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3818; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gomez J, 2006, MEDICINE, V85, P157, DOI 10.1097/01.md.0000224711.54886.b1; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Gualtierotti R, 2010, AUTOIMMUN REV, V10, P3, DOI 10.1016/j.autrev.2010.09.007; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lleo A, 2007, J AUTOIMMUN, V29, P61, DOI 10.1016/j.jaut.2007.06.003; Lopez P, 2003, LUPUS, V12, P860, DOI 10.1191/0961203303lu469xx; Lopez P, 2008, J RHEUMATOL, V35, P1559; Lopez P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1897; Lopez P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/838390; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Towns R, 2005, AUTOPHAGY, V1, P163, DOI 10.4161/auto.1.3.2068; WEISSMANN G, 1964, LANCET, V2, P1373; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	43	34	35	1	335	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78756	10.1371/journal.pone.0078756	http://dx.doi.org/10.1371/journal.pone.0078756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205307	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300162
J	Zhao, X; Zhai, SY; An, MS; Wang, YH; Yang, YF; Ge, HQ; Liu, JH; Pu, XP				Zhao, Xin; Zhai, Shenyu; An, Ming-Sheng; Wang, Yue-Hua; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping			Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; IN-VITRO; DOPAMINERGIC-NEURONS; COGNITIVE DECLINE; UP-REGULATION; PC12 CELLS; DJ-1; HIPPOCAMPAL	Protocatechuic aldehyde (PAL) has been reported to bind to DJ-1, a key protein involved in Parkinson's disease (PD), and exerts potential neuroprotective effects via DJ-1 in SH-SY5Y cells. In this study, we investigated the neuroprotective pharmacological effects of PAL against neurotoxin-induced cell and animal models of PD. In cellular models of PD, PAL markedly increased cell viability rates, mitochondrial oxidation-reduction activity and mitochondrial membrane potential, and reduced intracellular ROS levels to prevent neurotoxicity in PC12 cells. In animal models of PD, PAL reduced the apomorphine injection, caused turning in 6-OHDA treated rats, and increased the motor coordination and stride decreases in MPTP treated mice. Meanwhile, in an MPTP mouse model, PAL prevented a decrease of the contents of dopamine (DA) and its metabolites in the striatum and TH-positive dopaminergic neuron loss in the substantia nigra (SN). In addition, PAL increased the protein expression of DJ-1 and reduced the level of a-synuclein in the SN of MPTP lesioned mice. PAL also increased the spine density in hippocampal CA1 neurons. The current study demonstrates that PAL can efficiently protect dopaminergic neurons against neurotoxin injury in vitro and in vivo, and that the potential mechanisms may be related to its effects in increasing DJ-1, decreasing a-synuclein and its growth-promoting effect on spine density.	[Zhao, Xin; An, Ming-Sheng; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping] Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhao, Xin; An, Ming-Sheng; Wang, Yue-Hua; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China; [Zhai, Shenyu] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wang, Yue-Hua] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Drug Target Identificat & Drug Sc, Beijing 100050, Peoples R China; [Wang, Yue-Hua] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Peking University; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pu, XP (corresponding author), Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	pxp123@bjmu.edu.cn		Zhai, Shenyu/0000-0002-7097-9387	National Natural Science Funds of China [81202937, 30973889]; Significant new drugs creation Five-Year plan special science and Technology Major [2012ZX09103201-042]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Significant new drugs creation Five-Year plan special science and Technology Major	This work was supported by National Natural Science Funds of China (Grant No. 81202937, No. 30973889) and a Grant from Significant new drugs creation Five-Year plan special science and Technology Major (No. 2012ZX09103201-042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Beyer MK, 2013, J NEUROL NEUROSUR PS, V84, P23, DOI 10.1136/jnnp-2012-303054; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Carlesimo GA, 2012, NEUROLOGY, V78, P1939, DOI 10.1212/WNL.0b013e318259e1c5; Chang ZQ, 2011, J NUTR SCI VITAMINOL, V57, P118, DOI 10.3177/jnsv.57.118; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gao JW, 2011, J PHARMACOL SCI, V115, P36, DOI 10.1254/jphs.10271FP; INGHAM CA, 1989, BRAIN RES, V503, P334, DOI 10.1016/0006-8993(89)91686-7; Khan W, 2012, CNS NEUROL DISORD-DR, V11, P456, DOI 10.2174/187152712800792929; Kim ST, 2010, BRAIN RES, V1306, P176, DOI 10.1016/j.brainres.2009.09.103; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Li CM, 2012, PHARM BIOL, V50, P413, DOI 10.3109/13880209.2011.608193; Li S, 2011, BIOL PHARM BULL, V34, P1291, DOI 10.1248/bpb.34.1291; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; Ottolini D, 2013, HUM MOL GENET; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Poewe W, 2009, NEUROLOGY, V72, pS65, DOI 10.1212/WNL.0b013e31819908ce; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; REBOIS RV, 1980, BIOCHEMISTRY-US, V19, P1240, DOI 10.1021/bi00547a031; Satoh T, 1996, J BIOCHEM-TOKYO, V120, P540; Schnabel J, 2010, NATURE, V466, pS2, DOI 10.1038/466S2b; Shiozaki S, 1999, PSYCHOPHARMACOLOGY, V147, P90, DOI 10.1007/s002130051146; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Soderstrom KE, 2010, EUR J NEUROSCI, V31, P478, DOI 10.1111/j.1460-9568.2010.07077.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun SY, 2012, BRAIN RES BULL, V88, P609, DOI 10.1016/j.brainresbull.2012.05.013; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wang YH, 2013, J FUNCT FOODS, V5, P337, DOI 10.1016/j.jff.2012.11.004; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Xing YL, 2012, PHYTOTHER RES, V26, P1334, DOI 10.1002/ptr.3720; Xu Y, 2012, BASIC CLIN PHARMACOL, V110, P384, DOI 10.1111/j.1742-7843.2011.00827.x; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zhang SP, 2010, BIOL PHARM BULL, V33, P1529, DOI 10.1248/bpb.33.1529; Zhao X, 2007, PROTEOM CLIN APPL, V1, P1559, DOI 10.1002/prca.200700077; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029; Zhou Z, 2007, ANTIVIR RES, V74, P59, DOI 10.1016/j.antiviral.2006.12.005	58	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78220	10.1371/journal.pone.0078220	http://dx.doi.org/10.1371/journal.pone.0078220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205164	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300149
J	Zhao, WN; Liu, Y; Timani, KA; He, JJ				Zhao, Weina; Liu, Ying; Timani, Khalid Amine; He, Johnny J.			Tip110 Protein Binds to Unphosphorylated RNA Polymerase II and Promotes Its Phosphorylation and HIV-1 Long Terminal Repeat Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Phosphorylation; Promoters; RNA Polymerase II; Transcription; Viral Replication; Long Terminal Repeat; Tip110; Transcription Elongation; Transcription Initiation	VIRUS TYPE-1 TRANSCRIPTION; TUMOR-REJECTION ANTIGEN; TAT-INTERACTING PROTEIN; EMBRYONIC STEM-CELLS; P-TEFB; IN-VITRO; MESSENGER-RNA; 110 KDA; TETRATRICOPEPTIDE REPEAT; HISTONE METHYLATION	Transcription plays an important role in both HIV-1 gene expression and replication and mandates complicated but coordinated interactions between the host and virus. Our previous studies have shown that an HIV-1 Tat-interacting protein of 110 kDa, Tip110, binds to and enhances Tat function in Tat-mediated HIV-1 gene transcription and replication (Liu, Y., Li, J., Kim, B. O., Pace, B. S., and He, J. J. (2002) HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. J. Biol. Chem. 277, 23854-23863). However, the underlying molecular mechanisms by which this takes place were not understood. In this study, we demonstrated that Tip110 bound to unphosphorylated RNA polymerase II (RNAPII) in a direct and specific manner. In addition, we detected Tip110 at the HIV-1 long terminal repeat (LTR) promoter and found that Tip110 expression was associated with increased phosphorylation of serine 2 of the heptapeptide repeats within the RNAPII C-terminal domain and increased recruitment of positive transcription elongation factor b to the LTR promoter. Consistent with these findings, we showed that Tip110 interaction with Tat directly enhanced transcription elongation of the LTR promoter. Taken together, these findings have provided additional and mechanistic evidence to support Tip110 function in HIV-1 transcription.	[Zhao, Weina; He, Johnny J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Liu, Ying; Timani, Khalid Amine; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA	Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Health Science Center	He, JJ (corresponding author), Univ N Texas, Hlth Sci Ctr, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu		Timani, Khalid/0000-0002-4862-9348	National Institutes of Health, NINDS [R01NS065785]; National Institutes of Health, NIMH [R01092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065785] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01NS065785 and National Institutes of Health, NIMH, Grant R01092673 (to J. J. H.).	Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Brockman MA, 2006, J VIROL METHODS, V131, P134, DOI 10.1016/j.jviromet.2005.08.003; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chen D, 1999, MOL CELL BIOL, V19, P2863; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Garber ME, 2000, MOL CELL BIOL, V20, P6958, DOI 10.1128/MCB.20.18.6958-6969.2000; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gu JA, 1998, BBA-GENE STRUCT EXPR, V1399, P1, DOI 10.1016/S0167-4781(98)00082-7; Harada K, 2001, INT J CANCER, V93, P623, DOI 10.1002/ijc.1391; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Herrmann CH, 2001, J CELL SCI, V114, P1491; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kawagoe N, 2000, J UROLOGY, V164, P2090, DOI 10.1016/S0022-5347(05)66975-3; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu Y, 2004, J BIOL CHEM, V279, P21766, DOI 10.1074/jbc.M314321200; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu Y, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0271; Liu Y, 2012, STEM CELLS DEV, V21, P829, DOI 10.1089/scd.2011.0512; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; ROBERTS S, 1992, GENE DEV, V6, P1562, DOI 10.1101/gad.6.8.1562; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sasatomi T, 2002, CANCER, V94, P1636, DOI 10.1002/cncr.10421; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sundaravaradan V, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-126; Sune C, 2000, VIROLOGY, V274, P356, DOI 10.1006/viro.2000.0480; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yang D, 1999, CANCER RES, V59, P4056; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	53	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					190	202		10.1074/jbc.M113.529784	http://dx.doi.org/10.1074/jbc.M113.529784			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24217245	hybrid, Green Published			2022-12-25	WOS:000329370900017
J	Blinowska, KJ; Kaminski, M				Blinowska, Katarzyna J.; Kaminski, Maciej			Functional Brain Networks: Random, "Small World'' or Deterministic?	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; EEG ACTIVITY; PROPAGATION; DYNAMICS; COHERENCE; FMRI; CONNECTIVITY; INFORMATION; MOVEMENT; SLEEP	Lately the problem of connectivity in brain networks is being approached frequently by graph theoretical analysis. In several publications based on bivariate estimators of relations between EEG channels authors reported random or "small world'' structure of networks. The results of these works often have no relation to other evidence based on imaging, inverse solutions methods, physiological and anatomical data. Herein we try to find reasons for this discrepancy. We point out that EEG signals are very much interdependent, thus bivariate measures applied to them may produce many spurious connections. In fact, they may outnumber the true connections. Giving all connections equal weights, as it is usual in the framework of graph theoretical analysis, further enhances these spurious links. In effect, close to random and disorganized patterns of connections emerge. On the other hand, multivariate connectivity estimators, which are free of the artificial links, show specific, well determined patterns, which are in a very good agreement with other evidence. The modular structure of brain networks may be identified by multivariate estimators based on Granger causality and formalism of assortative mixing. In this way, the strength of coupling may be evaluated quantitatively. During working memory task, by means of multivariate Directed Transfer Function, it was demonstrated that the modules characterized by strong internal bonds exchange the information by weaker connections.	[Blinowska, Katarzyna J.; Kaminski, Maciej] Warsaw Univ, Dept Biomed Phys, Fac Phys, Warsaw, Poland	University of Warsaw	Blinowska, KJ (corresponding author), Warsaw Univ, Dept Biomed Phys, Fac Phys, Warsaw, Poland.	kjbli@fuw.edu.pl		Blinowska, Katarzyna/0000-0001-6429-4421; Kaminski, Maciej/0000-0001-5346-4050	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The work was supported by the Statutory Grant of Polish Ministry of Science and Higher Education to Faculty of Physics of Univeristy of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; [Anonymous], [No title captured]; [Anonymous], 2011, PRACTICAL BIOMEDICAL; [Anonymous], [No title captured]; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bialonski S, 2010, CHAOS, V20, DOI 10.1063/1.3360561; Blinowska K, 2010, BRAIN TOPOGR, V23, P205, DOI 10.1007/s10548-010-0137-y; Blinowska KJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0614; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Brzezicka A, 2011, ACTA NEUROBIOL EXP, V71, P479; Brzezicka A, 2011, BRAIN TOPOGR, V24, P1, DOI 10.1007/s10548-010-0158-6; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Ferri R, 2005, CLIN NEUROPHYSIOL, V116, P2783, DOI 10.1016/j.clinph.2005.08.013; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Gerloff C, 1996, HUM BRAIN MAPP, V4, P199, DOI 10.1002/(SICI)1097-0193(1996)4:3<199::AID-HBM4>3.0.CO;2-Z; Ginter J, 2005, METHOD INFORM MED, V44, P106, DOI 10.1055/s-0038-1633932; Ginter J, 2001, J NEUROSCI METH, V110, P113, DOI 10.1016/S0165-0270(01)00424-1; Goel V, 2009, NEUROPSYCHOLOGIA, V47, P2790, DOI 10.1016/j.neuropsychologia.2009.06.002; Hlinka J, 2012, CHAOS, V22, DOI 10.1063/1.4732541; Jalili M, 2011, J INTEGR NEUROSCI, V10, P213, DOI 10.1142/S0219635211002725; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Kaminski M, 1997, ELECTROEN CLIN NEURO, V102, P216, DOI 10.1016/S0013-4694(96)95721-5; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kawasaki M, 2007, NEUROSCI LETT, V422, P141, DOI 10.1016/j.neulet.2007.04.079; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Korzeniewska A, 2008, HUM BRAIN MAPP, V29, P1170, DOI 10.1002/hbm.20458; Kuhnert MT, 2012, CHAOS, V22, DOI 10.1063/1.4729185; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Kus R, 2006, ACTA NEUROBIOL EXP, V66, P195; Langer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053199; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nunez P.L., 1981, ELECT FIELDS BRAIN; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfurtscheller G, 1999, HANDB EL CL, V6, P89; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	50	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78763	10.1371/journal.pone.0078763	http://dx.doi.org/10.1371/journal.pone.0078763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205313	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500133
J	Li, S; Wang, XJ; Li, YF; Kost, CK; Martin, DS				Li, Shuai; Wang, Xuejun; Li, Yifan; Kost, Curtis K., Jr.; Martin, Douglas S.			Bortezomib, a Proteasome Inhibitor, Attenuates Angiotensin II-Induced Hypertension and Aortic Remodeling in Rats	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CELLS IN-VIVO; MATRIX METALLOPROTEINASES; ANG-II; THERAPEUTIC IMPLICATIONS; ENDOTHELIAL DYSFUNCTION; CELLULAR HYPERTROPHY; UP-REGULATION; EXPRESSION; MICROCIRCULATION	Background: Hypertension is a highly prevalent disorder and a major risk factor for cardiovascular diseases. Hypertensive vascular remodeling is the pathological mal-adaption of blood vessels to the hypertensive condition that contributes to further development of high blood pressure and end-organ damage. Hypertensive remodeling involves, at least in part, changes in protein turnover. The ubiquitin proteasome system (UPS) is a major protein quality and quantity control system. This study tested the hypothesis that the proteasome inhibitor, bortezomib, would attenuate AngII-induced hypertension and its sequelae such as aortic remodeling in rats. Methodology/Principal Findings: Male Sprague Dawley rats were subjected to AngII infusion for two weeks in the absence or presence of bortezomib. Mean arterial pressure was measured in conscious rats. Aortic tissue was collected for estimation of wall area, collagen deposition and expression of tissue inhibitors of matrix metalloproteases (TIMP), Ki67 (a marker of proliferation), reactive oxygen species (ROS) and VCAM-1 (a marker of inflammation). AngII infusion increased arterial pressure significantly (160+/-4 mmHg vs. vehicle treatment 133+/-2 mmHg). This hypertensive response was attenuated by bortezomib (138+/-5 mmHg). AngII hypertension was associated with significant increases in aortic wall to lumen ratio (similar to 29%), collagen deposition (similar to 14%) and expression of TIMP1 and TIMP2. AngII also increased MMP2 activity, proteasomal chymotrypsin-like activity, Ki67 staining, ROS generation and VCAM-1 immunoreactivity. Co-treatment of AngII-infused rats with bortezomib attenuated these AngII-induced responses. Conclusions: Collectively, these data support the idea that proteasome activity contributes to AngII-induced hypertension and hypertensive aortic vascular remodeling at least in part by modulating TIMP1/2 and MMP2 function. Preliminary observations are consistent with a role for ROS, inflammatory and proliferative mechanisms in this effect. Further understanding of the mechanisms by which the proteasome is involved in hypertension and vascular structural remodeling may reveal novel targets for pharmacological treatment of hypertension, hypertensive remodeling or both.	[Li, Shuai; Wang, Xuejun; Li, Yifan; Kost, Curtis K., Jr.; Martin, Douglas S.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Martin, DS (corresponding author), Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA.	dsmartin@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343	National Institutes of Health [2R01HL063053, R01HL072166, R01HL085629]; Biomedical Research Infrastructure Network (BRIN) pilot grant [244705]; Basic Biomedical Sciences program of Sanford School of Medicine; graduate school of the University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629, R01HL063053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Infrastructure Network (BRIN) pilot grant; Basic Biomedical Sciences program of Sanford School of Medicine; graduate school of the University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (grant no. 2R01HL063053 to DS Martin; grant nos. R01HL072166 and R01HL085629 to XJ Wang), a Biomedical Research Infrastructure Network (BRIN) pilot grant (no. 244705) (NIGMS), the Basic Biomedical Sciences program of Sanford School of Medicine, and the graduate school of the University of South Dakota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulakis E, 2012, CURR TOP MED CHEM, V12, P1149, DOI 10.2174/1568026611208011149; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; BrouwersCeiler DL, 1997, CARDIOVASC RES, V33, P478, DOI 10.1016/S0008-6363(96)00213-1; Castoldi G, 2007, CLIN EXP PHARMACOL P, V34, P205, DOI 10.1111/j.1440-1681.2007.04573.x; Castoldi G, 2003, AM J PHYSIOL-HEART C, V284, pH635, DOI 10.1152/ajpheart.00986.2001; Castro MM, 2011, PHARMACOL RES, V64, P567, DOI 10.1016/j.phrs.2011.04.002; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Deguchi JO, 2009, LAB INVEST, V89, P315, DOI 10.1038/labinvest.2008.167; Demasi M, 2012, CARDIOVASC RES, V95, P183, DOI 10.1093/cvr/cvs128; Depre C, 2010, CARDIOVASC RES, V85, P251, DOI 10.1093/cvr/cvp362; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Feihl F, 2008, CARDIOVASC RES, V78, P274, DOI 10.1093/cvr/cvn022; Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128; HENRICH H, 1978, PFLUG ARCH EUR J PHY, V375, P153, DOI 10.1007/BF00584238; Kim SC, 2003, J CARDIOVASC PHARM, V42, P554, DOI 10.1097/00005344-200310000-00014; Kim SY, 2012, AM J RESP CELL MOL, V47, P698, DOI 10.1165/rcmb.2011-0331OC; Kim W, 2009, METHODS MOL BIOL, V579, P261, DOI 10.1007/978-1-60761-322-0_13; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; KORSGAARD N, 1988, HYPERTENSION, V12, P162, DOI 10.1161/01.HYP.12.2.162; Kuroki MT, 2012, AM J PHYSIOL-HEART C, V302, pH763, DOI 10.1152/ajpheart.00930.2011; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Lorenz M, 2009, LIFE SCI, V84, P929, DOI 10.1016/j.lfs.2009.04.016; Ludwig A, 2009, J MOL MED, V87, P793, DOI 10.1007/s00109-009-0469-9; Mancia G, 2007, HYPERTENSION, V50, P299, DOI 10.1161/HYPERTENSIONAHA.107.090290; Marfella R, 2006, DIABETES, V55, P622, DOI 10.2337/diabetes.55.03.06.db05-0832; Meiners S, 2004, HYPERTENSION, V44, P471, DOI 10.1161/01.HYP.0000142772.71367.65; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; Meiners S, 2008, HYPERTENSION, V51, P302, DOI 10.1161/HYPERTENSIONAHA.107.097816; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Mulvany MJ, 2008, MED BIOL ENG COMPUT, V46, P461, DOI 10.1007/s11517-008-0305-3; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; OWENS GK, 1983, CIRC RES, V53, P491, DOI 10.1161/01.RES.53.4.491; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Pashevin DA, 2011, PHARMACOL REP, V63, P1009, DOI 10.1016/S1734-1140(11)70617-X; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Rizzoni D, 2000, HYPERTENSION, V35, P931, DOI 10.1161/01.HYP.35.4.931; Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; SIMON G, 1995, AM J HYPERTENS, V8, P67, DOI 10.1016/0895-7061(94)00192-E; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Takaoka M, 1998, LIFE SCI, V63, pPL65, DOI 10.1016/S0024-3205(98)00276-8; Takaoka M, 2001, CLIN EXP PHARMACOL P, V28, P466, DOI 10.1046/j.1440-1681.2001.03461.x; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Watts SW, 2007, AM J PHYSIOL-HEART C, V292, pH2438, DOI 10.1152/ajpheart.00900.2006; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736	57	20	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78564	10.1371/journal.pone.0078564	http://dx.doi.org/10.1371/journal.pone.0078564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205262	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500124
J	Cvitic, S; Longtine, MS; Hackl, H; Wagner, K; Nelson, MD; Desoye, G; Hiden, U				Cvitic, Silvija; Longtine, Mark S.; Hackl, Hubert; Wagner, Karin; Nelson, Michael D.; Desoye, Gernot; Hiden, Ursula			The Human Placental Sexome Differs between Trophoblast Epithelium and Villous Vessel Endothelium	PLOS ONE			English	Article							FETAL SEX; GENE-EXPRESSION; MATERNAL ASTHMA; CELLS; SYNCYTIOTROPHOBLASTS; DIFFERENTIATION; ASSOCIATION; SENSITIVITY; CHROMOSOME; MICROARRAY	Molecular mechanisms underlying sexual dimorphism in mammals, fetal sex influences on intrauterine development, and the sex-biased susceptibility for selected diseases in adulthood are novel areas of current research. As importantly, two decades of multifaceted research has established that susceptibility to many adult disorders originates in utero, commonly secondary to the effects of placental dysfunction. We hypothesized that fetal sex influences gene expression and produces functional differences in human placentas. We thus extended previous studies on sexual dimorphism in mammals, which used RNA isolated from whole tissues, to investigate the effects of sex on four cell-phenotypes within a single key tissue, human placental villi. The cells studied included cytotrophoblasts, syncytiotrophoblast, arterial and venous endothelial cells. The cells were isolated from placentas of male or female fetuses and subjected to microarray analysis. We found that fetal sex differentially affected gene expression in a cell-phenotype dependent manner among all four cell-phenotypes. The markedly enriched pathways in males were identified to be signaling pathways for graft-versus-host disease as well as the immune and inflammatory systems that parallel the reported poorer outcome of male fetuses. Our study is the first to compare global gene expression by microarray analysis in purified, characterized, somatic cells from a single human tissue, i.e. placental villi. Importantly, our findings demonstrate that there are cell-phenotype specific, and tissue-specific, sex-biased responses in the human placenta, suggesting fetal sex should be considered as an independent variable in gene expression analysis of human placental villi.	[Cvitic, Silvija; Desoye, Gernot; Hiden, Ursula] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Longtine, Mark S.; Nelson, Michael D.] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Wagner, Karin] Med Univ Graz, Med Res Ctr, Graz, Austria	Medical University of Graz; Washington University (WUSTL); Medical University of Innsbruck; Medical University of Graz	Hiden, U (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria.	ursula.hiden@medunigraz.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Longtine, Mark/0000-0002-3315-1732; Desoye, Gernot/0000-0002-5715-3230; Hiden, Ursula/0000-0001-8009-020X	Ph.D. Program Molecular Medicine of the Medical University of Graz	Ph.D. Program Molecular Medicine of the Medical University of Graz	This work was funded by the Ph.D. Program Molecular Medicine of the Medical University of Graz (to S. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cui W, 2005, BIRTH DEFECTS RES A, V73, P876, DOI 10.1002/bdra.20196; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Engel PJ, 2008, AUST NZ J OBSTET GYN, V48, P375, DOI 10.1111/j.1479-828X.2008.00863.x; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Ghidini A, 2005, ACTA OBSTET GYN SCAN, V84, P547, DOI 10.1111/j.0001-6349.2005.00694.x; Graves JAM, 2010, PLACENTA, V31, pS27, DOI 10.1016/j.placenta.2009.12.029; Hache S, 2011, J CELL MOL MED, V15, P654, DOI 10.1111/j.1582-4934.2010.01039.x; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x; Miao F, 2013, PHYSIOL GENOMICS, V45, P287, DOI 10.1152/physiolgenomics.00001.2013; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Nielsen HS, 2009, HUM MOL GENET, V18, P1684, DOI 10.1093/hmg/ddp077; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Scott NM, 2009, J IMMUNOL, V182, P1411, DOI 10.4049/jimmunol.182.3.1411; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stark MJ, 2008, PEDIATR RES, V63, P415, DOI 10.1203/01.pdr.0000304937.38669.63; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Abeelen AFM, 2011, PLACENTA, V32, P694, DOI 10.1016/j.placenta.2011.06.012; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zeitlin J, 2004, AM J OBSTET GYNECOL, V190, P1322, DOI 10.1016/j.ajog.2003.10.703	41	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79233	10.1371/journal.pone.0079233	http://dx.doi.org/10.1371/journal.pone.0079233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205377	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700104
J	Gao, ZR; Liu, CL; Zhang, YZ; Li, Y; Yi, KK; Zhao, XH; Cui, ML				Gao, Zhenrui; Liu, Chuanliang; Zhang, Yanzhao; Li, Ying; Yi, Keke; Zhao, Xinhua; Cui, Min-Long			The Promoter Structure Differentiation of a MYB Transcription Factor RLC1 Causes Red Leaf Coloration in Empire Red Leaf Cotton under Light	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; REGULATORY GENE; DNA-BINDING; ARABIDOPSIS; PROTEIN; PIGMENTATION; EXPRESSION; FAMILY; DOMAIN; FRUIT	The red leaf coloration of Empire Red Leaf Cotton (ERLC) (Gossypium hirsutum L.), resulted from anthocyanin accumulation in light, is a well known dominant agricultural trait. However, the underpin molecular mechanism remains elusive. To explore this, we compared the molecular biological basis of anthocyanin accumulation in both ERLC and the green leaf cotton variety CCRI 24 (Gossypium hirsutum L.). Introduction of R2R3-MYB transcription factor Rosea1, the master regulator anthocyanin biosynthesis in Antirrhinum majus, into CCRI 24 induced anthocyanin accumulation, indicating structural genes for anthocyanin biosynthesis are not defected and the leaf coloration might be caused by variation of regulatory genes expression. Expression analysis found that a transcription factor RLC1 (Red Leaf Cotton 1) which encodes the ortholog of PAP1/Rosea1 was highly expressed in leaves of ERLC but barely expressed in CCRI 24 in light. Ectopic expression of RLC1 from ERLC and CCRI 24 in hairy roots of Antirrhinum majus and CCRI 24 significantly enhanced anthocyanin accumulation. Comparison of RLC1 promoter sequences between ERLC and CCRI 24 revealed two 228-bp tandem repeats presented in ERLC with only one repeat in CCRI 24. Transient assays in cotton leave tissue evidenced that the tandem repeats in ERLC is responsible for light-induced RLC1 expression and therefore anthocyanin accumulation. Taken together, our results in this article strongly support an important step toward understanding the role of R2R3-MYB transcription factors in the regulatory menchanisms of anthocyanin accumulation in red leaf cotton under light.	[Gao, Zhenrui; Zhang, Yanzhao; Li, Ying; Cui, Min-Long] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Liu, Chuanliang; Zhao, Xinhua; Cui, Min-Long] State Key Lab Cotton Biol, Anyang, Peoples R China; [Liu, Chuanliang; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Peoples R China; [Yi, Keke] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Zhejiang Academy of Agricultural Sciences	Cui, ML (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China.	min-long.cui@iae.ac.cn	Yi, Keke/P-3964-2017; cui, min/HGD-8340-2022; Yi, Keke/N-8482-2019	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X	Chinese Academy of Sciences [KSCX3-EW-N-03]; Yunnan Provincial Science and Technology Department [2012IB011]	Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Provincial Science and Technology Department	This work was supported by the Chinese Academy of Sciences (grant no. KSCX3-EW-N-03), and the Yunnan Provincial Science and Technology Department (grant no. 2012IB011) to M. L. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2005, J EXP BOT, V56, P37, DOI 10.1093/jxb/eri004; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Ali I, 2009, PAK J BOT, V41, P1127; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Cui M, 2001, PLANT CELL REP, V20, P55, DOI 10.1007/s002990000277; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; FITT GP, 1994, ANNU REV ENTOMOL, V39, P543, DOI 10.1146/annurev.en.39.010194.002551; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jefferson R A, 1987, EMBO J, V6, P3901; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Killough DT, 1933, GENETICS, V18, P0329; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YJ, 2013, J PROTEOMICS, V78, P374, DOI 10.1016/j.jprot.2012.10.005; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Park KI, 2007, PLANT J, V49, P641, DOI 10.1111/j.1365-313X.2006.02988.x; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Payne CT, 2000, GENETICS, V156, P1349; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Piazza P, 2002, PLANT PHYSIOL, V128, P1077, DOI 10.1104/pp.010799; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rose A, 1999, PLANT J, V20, P641, DOI 10.1046/j.1365-313X.1999.00638.x; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; SHEN WJ, 1989, NUCLEIC ACIDS RES, V17, P8385, DOI 10.1093/nar/17.20.8385; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; STEPHENS SG, 1974, J GENET, V61, P128, DOI 10.1007/BF02984077; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	65	25	26	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77891	10.1371/journal.pone.0077891	http://dx.doi.org/10.1371/journal.pone.0077891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205014	gold, Green Submitted, Green Published			2022-12-25	WOS:000326270700058
J	Hu, ZG; Shen, WJ; Cortez, Y; Tang, XD; Liu, LF; Kraemer, FB; Azhar, S				Hu, Zhigang; Shen, Wen-Jun; Cortez, Yuan; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.; Azhar, Salman			Hormonal Regulation of MicroRNA Expression in Steroid Producing Cells of the Ovary, Testis and Adrenal Gland	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; RECEPTOR CLASS-B; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; STEROIDOGENESIS; IDENTIFICATION; CHOLESTEROL; PROTEIN; MIRNAS; BIOSYNTHESIS	Background: Given the emerging roles of miRNAs as potential posttranscriptional/posttranslational regulators of the steroidogenic process in adrenocortical and gonadal cells, we sought to determine miRNA profiles in rat adrenals from animals treated with vehicle, ACTH, 17 alpha-E2 or dexamethasone. Key observations were also confirmed using hormone (Bt(2)cAMP)-treated mouse Leydig tumor cells, MLTC-1, and primary rat ovarian granulosa cells. Methodology: RNA was extracted from rat adrenal glands and miRNA profiles were established using microarray and confirmed with qRT-PCR. The expression of some of the hormone-sensitive miRNAs was quantified in MLTC-1 and granulosa cells after stimulation with Bt(2)cAMP. Targets of hormonally altered miRNAs were explored by qRT-PCR and Western blotting in adrenals and granulosa cells. Results: Adrenals from ACTH, 17 alpha-E2 and dexamethasone treated rats exhibited miRNA profiles distinct from control animals. ACTH up-regulated the expression of miRNA-212, miRNA-182, miRNA-183, miRNA-132, and miRNA-96 and down-regulated the levels of miRNA-466b, miRNA-214, miRNA-503, and miRNA-27a. The levels of miR-212, miRNA-183, miRNA-182, miRNA-132, miRNA-370, miRNA-377, and miRNA-96 were up-regulated, whereas miR-125b, miRNA-200b, miR-122, miRNA-466b, miR-138, miRNA-214, miRNA-503 and miRNA27a were down-regulated in response to 17 alpha-E2 treatment. Dexamethasone treatment decreased miRNA-200b, miR-122, miR-19a, miRNA-466b and miRNA27a levels, but increased miRNA-183 levels. Several adrenal miRNAs are subject to regulation by more than one hormone. Significant cAMP-induced changes in certain miRNAs were also noted in MLTC-1 and granulosa cells. Some of the hormone-induced miRNAs in steroidogenic cells were predicted to target proteins involved in lipid metabolism/steroidogenesis. We also obtained evidence that miR-132 and miRNA-214 inhibit the expression of SREBP-1c and LDLR, respectively. Conclusion: Our results demonstrate that expression of a number of miRNAs in steroidogenic cells of the testis, ovary and adrenal glands is subject to hormonal regulation and that miRNAs and their regulation by specific hormones are likely to play a key role in posttranscriptional/posttranslational regulation of steroidogenesis.	[Hu, Zhigang; Shen, Wen-Jun; Cortez, Yuan; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Hu, Zhigang; Shen, Wen-Jun; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Azhar, Salman] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Azhar, S (corresponding author), VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA.	salman.azhar@va.gov	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services [R01HL33881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001923, I01BX000398] Funding Source: NIH RePORTER	Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services Grant R01HL33881. The fund sponsors had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azhar S, 2002, J LIPID RES, V43, P861; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Christenson L. K., 2010, Animal Reproduction, V7, P129; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; EPSTEIN LF, 1991, MOL CELL ENDOCRINOL, V81, P113, DOI 10.1016/0303-7207(91)90210-J; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hossain MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-443; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Hu ZG, 2013, J BIOL CHEM, V288, P11416, DOI 10.1074/jbc.M112.437368; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KOVANEN PT, 1980, J BIOL CHEM, V255, P5591; KOVANEN PT, 1979, J BIOL CHEM, V254, P1367; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Krishnan K, 2013, RNA, V19, P230, DOI 10.1261/rna.034926.112; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; LeHoux JG, 1998, ENDOCRINOLOGY, V139, P3913, DOI 10.1210/en.139.9.3913; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Manna P. R., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Miles JR, 2012, ANIM REPROD SCI, V130, P16, DOI 10.1016/j.anireprosci.2011.12.021; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; PAYNE AH, 1992, J STEROID BIOCHEM, V43, P895, DOI 10.1016/0960-0760(92)90317-C; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PON LA, 1988, ENDOCRINOLOGY, V123, P1942, DOI 10.1210/endo-123-4-1942; PON LA, 1986, J BIOL CHEM, V261, P3309; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; SIMPSON E, 1992, J STEROID BIOCHEM, V41, P409, DOI 10.1016/0960-0760(92)90366-Q; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Venkataraman S, 2013, J BIOL CHEM, V288, P1918, DOI 10.1074/jbc.M112.396762; VERSCHOORKLOOTWYK AH, 1982, J BIOL CHEM, V257, P7666; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	72	55	61	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78040	10.1371/journal.pone.0078040	http://dx.doi.org/10.1371/journal.pone.0078040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205079	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200050
J	Yang, ZY; Sun, YF; Xue, J; Yao, ZF; Xu, JY; Cheng, JY; Shi, W; Zhu, BL; Zhang, YP; Zhang, YJ				Yang, Zhongyi; Sun, Yifei; Xue, Jing; Yao, Zhifeng; Xu, Junyan; Cheng, Jingyi; Shi, Wei; Zhu, Beiling; Zhang, Yongping; Zhang, Yingjian			Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer?-A Pilot Study	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMOTHERAPY; PET; ESTROGEN; THERAPY; F-18-FLUOROESTRADIOL; WOMEN; ER	Objective: To assess the clinical value of dual tracers Positron emission tomography/computed tomography (PET/CT) F-18-fluoroestradiol (F-18-FES) and F-18-fluorodeoxyglucose (F-18-FDG) in predicting neoadjuvant chemotherapy response (NAC) of breast cancer. Methods: Eighteen consecutive patients with newly diagnosed, non-inflammatory, stage II and III breast cancer undergoing NAC were included. Before chemotherapy, they underwent both F-18-FES and F-18-FDG PET/CT scans. Surgery was performed after three to six cycles of chemotherapy. Tumor response was graded and divided into two groups: the responders and non-responders. We used the maximum standardized uptake value (SUVmax) to qualify each primary lesion. Results: Pathologic analysis revealed 10 patients were responders while the other 8 patients were non-responders. There was no statistical difference of SUVmax-FDG and tumor size between these two groups (P>0.05). On the contrary, SUVmax-FES was lower in responders (1.75+/-0.66 versus 4.42+/-1.14; U=5, P=0.002); and SUVmax-FES/FDG also showed great value in predicting outcome (0.16+/-0.06 versus 0.54+/-0.22; U=5, P=0.002). Conclusions: Our study showed F-18-FES PET/CT might be feasible to predict response of NAC. However, whether the use of dual tracers F-18-FES and F-18-FDG has complementary value should be further studied.	[Yang, Zhongyi; Sun, Yifei; Xue, Jing; Yao, Zhifeng; Xu, Junyan; Cheng, Jingyi; Shi, Wei; Zhu, Beiling; Zhang, Yongping; Zhang, Yingjian] Fudan Univ, Dept Nucl Med, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Dept Nucl Med, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	profzhangyj@163.com						Ah-See MLW, 2008, CLIN CANCER RES, V14, P6580, DOI 10.1158/1078-0432.CCR-07-4310; Aitken SJ, 2010, ANN ONCOL, V21, P1254, DOI 10.1093/annonc/mdp427; Bassa P, 1996, J NUCL MED, V37, P931; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Burcombe RJ, 2002, EUR J CANCER, V38, P375, DOI 10.1016/S0959-8049(01)00379-3; Cochet Alexandre, 2011, Journal of the National Cancer Institute Monographs, P111, DOI 10.1093/jncimonographs/lgr035; Colleoni M, 2012, ANN ONCOL, V23, P243, DOI 10.1093/annonc/mds305; Croshaw R, 2011, ANN SURG ONCOL, V18, P3160, DOI 10.1245/s10434-011-1919-5; Danishad KKA, 2010, NMR BIOMED, V23, P233, DOI 10.1002/nbm.1436; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emmering J, 2008, ANN ONCOL, V19, P1573, DOI 10.1093/annonc/mdn185; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Kim SJ, 2004, ANN ONCOL, V15, P1352, DOI 10.1093/annonc/mdh345; Kurland BF, 2011, J NUCL MED, V52, P1541, DOI 10.2967/jnumed.111.091439; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002; Pickles MD, 2006, MAGN RESON IMAGING, V24, P843, DOI 10.1016/j.mri.2005.11.005; Precht LM, 2010, BREAST J, V16, P362, DOI 10.1111/j.1524-4741.2010.00935.x; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Rousseau C, 2006, J CLIN ONCOL, V24, P5366, DOI 10.1200/JCO.2006.05.7406; SATALOFF DM, 1995, J AM COLL SURGEONS, V180, P297; Sharangpani GM, 2007, J MICROSC-OXFORD, V226, P244, DOI 10.1111/j.1365-2818.2007.01772.x; Smith IC, 2000, J CLIN ONCOL, V18, P1676, DOI 10.1200/JCO.2000.18.8.1676; Sundararajan L, 2007, SEMIN NUCL MED, V37, P470, DOI 10.1053/j.semnuclmed.2007.08.003; Tan MC, 2009, AM J SURG, V198, P520, DOI 10.1016/j.amjsurg.2009.06.004; van Kruchten M, 2012, J NUCL MED, V53, P182, DOI 10.2967/jnumed.111.092734; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Zhang Yu, 2011, Chinese Journal of Applied and Environmental Biology, V17, P196, DOI 10.3724/SP.J.1145.2011.00196	34	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78192	10.1371/journal.pone.0078192	http://dx.doi.org/10.1371/journal.pone.0078192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205151	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600081
J	Darvekar, S; Rekdal, C; Johansen, T; Sjottem, E				Darvekar, Sagar; Rekdal, Cecilie; Johansen, Terje; Sjottem, Eva			A Phylogenetic Study of SPBP and RAI1: Evolutionary Conservation of Chromatin Binding Modules	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; TANDEM PHD FINGER; HISTONE H3 TAIL; COMBINATORIAL READOUT; ADD DOMAIN; RECOGNITION; PROTEIN; TRANSCRIPTION; MUTATIONS; MECHANISM	Our genome is assembled into and array of highly dynamic nucleosome structures allowing spatial and temporal access to DNA. The nucleosomes are subject to a wide array of post-translational modifications, altering the DNA-histone interaction and serving as docking sites for proteins exhibiting effector or "reader" modules. The nuclear proteins SPBP and RAI1 are composed of several putative "reader" modules which may have ability to recognise a set of histone modification marks. Here we have performed a phylogenetic study of their putative reader modules, the C-terminal ePHD/ADD like domain, a novel nucleosome binding region and an AT-hook motif. Interactions studies in vitro and in yeast cells suggested that despite the extraordinary long loop region in their ePHD/ADD-like chromatin binding domains, the C-terminal region of both proteins seem to adopt a cross-braced topology of zinc finger interactions similar to other structurally determined ePHD/ADD structures. Both their ePHD/ADD-like domain and their novel nucleosome binding domain are highly conserved in vertebrate evolution, and construction of a phylogenetic tree displayed two well supported clusters representing SPBP and RAI1, respectively. Their genome and domain organisation suggest that SPBP and RAI1 have occurred from a gene duplication event. The phylogenetic tree suggests that this duplication has happened early in vertebrate evolution, since only one gene was identified in insects and lancelet. Finally, experimental data confirm that the conserved novel nucleosome binding region of RAI1 has the ability to bind the nucleosome core and histones. However, an adjacent conserved AT-hook motif as identified in SPBP is not present in RAI1, and deletion of the novel nucleosome binding region of RAI1 did not significantly affect its nuclear localisation.	[Darvekar, Sagar; Rekdal, Cecilie; Johansen, Terje; Sjottem, Eva] Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Sjottem, E (corresponding author), Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway.	eva.sjottem@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Sjottem, Eva/0000-0003-2668-1708	Norwegian Research Council; Familien Blix Fond; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Familien Blix Fond; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council, Familien Blix Fond and the Norwegian Cancer Society to Professor Terje Johansen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Callebaut I, 2012, BIOCHIMIE, V94, P2006, DOI 10.1016/j.biochi.2012.05.025; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Hayes S, 2000, HUM MOL GENET, V9, P1753, DOI 10.1093/hmg/9.12.1753; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Kumar GS, 2012, J MOL BIOL, V422, P519, DOI 10.1016/j.jmb.2012.06.013; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lallous N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027599; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; SANZ L, 1995, MOL CELL BIOL, V15, P3164; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vilboux T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022861; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	40	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78907	10.1371/journal.pone.0078907	http://dx.doi.org/10.1371/journal.pone.0078907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205348	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300167
J	Liu, FC; Tsai, YF; Yu, HP				Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping			Maraviroc Attenuates Trauma-Hemorrhage-Induced Hepatic Injury through PPAR Gamma-Dependent Pathway in Rats	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CCR5 ANTAGONIST MARAVIROC; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; NUCLEAR RECEPTORS; SHOCK; INFLAMMATION; AGONIST; MICE; ANDROSTENEDIOL	Maraviroc is a CC-chemokine receptor 5 (CCR5) antagonist with potent antiviral and cancer preventive effects. Recent evidence suggests that the co-existence of CCR5 in various cell types is involved in inflammation. However, the effects that CCR5 antagonists produce in trauma-hemorrhage remain unknown. The peroxisome proliferator-activated receptor gamma (PPAR(gamma)) pathway exerts anti-inflammatory effects in injury. In this study, we hypothesized that maraviroc administration in male rats, after trauma-hemorrhage, decreases cytokine production and protects against hepatic injury through a PPAR(gamma)-dependent pathway. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 minutes), followed by fluid resuscitation. During resuscitation, a single dose of maraviroc (3 mg/kg, intravenously) with and without a PPAR(gamma) antagonist GW9662 (1 mg/kg, intravenously), GW9662 or vehicle was administered. Plasma alanine aminotransferase (ALT) with aspartate aminotransferase (AST) concentrations and various hepatic parameters were measured (n=8 rats/group) at 24 hours after resuscitation. The results showed that trauma-hemorrhage increased hepatic myeloperoxidase activity, intercellular adhesion molecule-1 and interleukin-6 levels, and plasma ALT and AST concentrations. These parameters were significantly improved in the maraviroc-treated rats subjected to trauma-hemorrhage. Maraviroc treatment also increased hepatic PPAR(gamma) expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of GW9662 with maraviroc abolished the maraviroc-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of maraviroc administration on alleviation of hepatic injury after trauma-hemorrhage, which is, at least in part, through PPAR(gamma)-dependent pathway.	[Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, FC (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	ana5189@adm.cgmh.org.tw; yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053	National Science Council [NSC101-2314-B-182A-010, NSC101-2314-B-182-082]; Chang Gung Memorial Hospital [CMRPG3B1052, CMRPG3B1621]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC101-2314-B-182A-010) and Chang Gung Memorial Hospital (CMRPG3B1052) to Huang-Ping Yu. Support was also provided by the National Science Council(NSC101-2314-B-182-082) and Chang Gung Memorial Hospital (CMRPG3B1621) to Fu-Chao Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Capetti Amedeo F, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P201, DOI 10.1177/1545109710372671; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Collin M, 2004, EUR J PHARMACOL, V486, P233, DOI 10.1016/j.ejphar.2003.12.032; Collino M, 2005, KIDNEY INT, V68, P529, DOI 10.1111/j.1523-1755.2005.00430.x; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Ito H, 2003, LAB INVEST, V83, P1715, DOI 10.1097/01.LAB.0000106724.29121.DA; Jung Y, 2008, IMMUNOL LETT, V117, P63, DOI 10.1016/j.imlet.2007.12.002; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Lee YK, 2013, NEUROPHARMACOLOGY, V67, P57, DOI 10.1016/j.neuropharm.2012.10.030; Li J, 2011, J IMMUNOL, V186, P3753, DOI 10.4049/jimmunol.1002143; Lisi L, 2012, J NEUROCHEM, V120, P106, DOI 10.1111/j.1471-4159.2011.07549.x; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Napimoga MH, 2008, J IMMUNOL, V180, P609, DOI 10.4049/jimmunol.180.1.609; Ochoa-Callejero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053992; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Reel B, 2013, J SURG RES, V182, P176, DOI 10.1016/j.jss.2012.08.020; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Shimizu T, 2005, SURGERY, V138, P204, DOI 10.1016/j.surg.2005.03.017; Shimizu T, 2006, ANN SURG, V244, P131, DOI 10.1097/01.sla.0000217709.00863.82; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Suzuki T, 2011, J CELL PHYSIOL, V226, P205, DOI 10.1002/jcp.22327; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yu HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065916; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Zingarelli B, 2009, CRIT CARE MED, V37, P1978, DOI 10.1097/CCM.0b013e31819feb4d	34	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78861	10.1371/journal.pone.0078861	http://dx.doi.org/10.1371/journal.pone.0078861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205332	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300164
J	Vinader, V; Ahmet, DS; Ahmed, MS; Patterson, LH; Afarinkia, K				Vinader, Victoria; Ahmet, Djevdet S.; Ahmed, Mohaned S.; Patterson, Laurence H.; Afarinkia, Kamyar			Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER METASTASIS; THERAPEUTIC TARGET; HOMOLOGY MODELS; TUMOR-GROWTH; INHIBITION; CTCE-9908; AXIS; MECHANISM; BICYCLAM	Amongst the chemokine signalling axes involved in cancer, chemokine CXCL12 acting on chemokine receptor CXCR4 is particularly significant since it orchestrates migration of cancer cells in a tissue-specific metastatic process. High CXCR4 tumour expression is associated with poor prognosis of lung, brain, CNS, blood and breast cancers. We have identified a new class of small molecule CXCR4 antagonists based on the use of computational modelling studies in concert with experimental determination of in vitro activity against CXCL12-induced intracellular calcium mobilisation, proliferation and chemotaxis. Molecular modelling proved to be a useful tool in rationalising our observed potencies, as well as informing the direction of the synthetic efforts aimed at producing more potent compounds.	[Vinader, Victoria; Ahmet, Djevdet S.; Ahmed, Mohaned S.; Patterson, Laurence H.; Afarinkia, Kamyar] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Afarinkia, K (corresponding author), Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England.	k.afarinkia@bradford.ac.uk	Afarinkia, Kamyar/B-7965-2010	Afarinkia, Kamyar/0000-0003-2819-4364; Vinader, Victoria/0000-0002-7706-8586	Yorkshire Cancer Research	Yorkshire Cancer Research	The authors thank Yorkshire Cancer Research for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Ben-Baruch A, 2008, CLIN EXP METASTAS, V25, P345, DOI 10.1007/s10585-007-9097-3; Bestebroer J, 2010, FEMS MICROBIOL REV, V34, P395, DOI 10.1111/j.1574-6976.2009.00202.x; Bhattacharya S, 2013, PROTEINS, V81, P729, DOI 10.1002/prot.24195; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Burger JA, 2011, EXPERT REV ANTICANC, V11, P621, DOI [10.1586/era.11.11, 10.1586/ERA.11.11]; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Choi HY, 2010, ANN PHARMACOTHER, V44, P117, DOI 10.1345/aph.1M380; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gangadhar Tara, 2010, Cancer Biol Ther, V9, P409, DOI 10.4161/cbt.9.6.11233; Gosselin RD, 2008, CURR MED CHEM, V15, P2866, DOI 10.2174/092986708786242822; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Hirbe AC, 2010, CURR PHARM DESIGN, V16, P1284, DOI 10.2174/138161210791034012; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Jantunen E, 2011, EXPERT OPIN BIOL TH, V11, P1241, DOI 10.1517/14712598.2011.601737; Jenkinson S, 2010, ANTIMICROB AGENTS CH, V54, P817, DOI 10.1128/AAC.01293-09; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Kozhevnikov VN, 2008, TETRAHEDRON, V64, P8963, DOI 10.1016/j.tet.2008.06.040; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Moyle G, 2009, CLIN INFECT DIS, V48, P798, DOI 10.1086/597097; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neves MAC, 2010, J COMPUT AID MOL DES, V24, P1023, DOI 10.1007/s10822-010-9393-x; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ramsey DM, 2013, BIOORG MED CHEM LETT, V23, P20, DOI 10.1016/j.bmcl.2012.10.138; Richert MM, 2009, ONCOL REP, V21, P761, DOI 10.3892/or_00000282; Rodima T, 2002, J ORG CHEM, V67, P1873, DOI 10.1021/jo016185p; Ros-Blanco L, 2012, J MED CHEM, V55, P7560, DOI 10.1021/jm300862u; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Ruffini PA, 2007, CANCER-AM CANCER SOC, V109, P2392, DOI 10.1002/cncr.22706; Shachar I, 2013, J LEUKOCYTE BIOL, V93, P51, DOI 10.1189/jlb.0612293; Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Terasaki M, 2011, BRAIN TUMOR PATHOL, V28, P89, DOI 10.1007/s10014-010-0013-1; Vinader V, 2012, FUTURE MED CHEM, V4, P845, DOI [10.4155/FMC.12.49, 10.4155/fmc.12.49]; Vinader V, 2011, J PHARMACOL TOX MET, V64, P213, DOI 10.1016/j.vascn.2011.01.004; Vitry C, 2001, TETRAHEDRON, V57, P9101, DOI 10.1016/S0040-4020(01)00887-0; White FA, 2009, MOL INTERV, V9, P188, DOI 10.1124/mi.9.4.7; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	65	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78744	10.1371/journal.pone.0078744	http://dx.doi.org/10.1371/journal.pone.0078744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205302	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300161
J	Beperet, I; Barrera, G; Simon, O; Williams, T; Lopez-Ferber, M; Gasmi, L; Herrero, S; Caballero, P				Beperet, Ines; Barrera, Gloria; Simon, Oihane; Williams, Trevor; Lopez-Ferber, Miguel; Gasmi, Laila; Herrero, Salvador; Caballero, Primitivo			The sf32 Unique Gene of Spodoptera frugiperda Multiple Nucleopolyhedrovirus (SfMNPV) Is a Non-Essential Gene That Could Be Involved in Nucleocapsid Organization in Occlusion-Derived Virions	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GENOME SEQUENCE; DELETION MUTANT; BACULOVIRUS; PROTEIN; PREDICTION; INSECT; MYRISTOYLATION; IDENTIFICATION; HETEROGENEITY	A recombinant virus lacking the sf32 gene (Sf32null), unique to the Spodoptera frugiperda multiple nucleopolyhedrovirus (SfMNPV), was generated by homologous recombination from a bacmid comprising the complete viral genome (Sfbac). Transcriptional analysis revealed that sf32 is an early gene. Occlusion bodies (OBs) of Sf32null contained 62% more genomic DNA than viruses containing the sf32 gene, Sfbac and Sf32null-repair, although Sf32null DNA was three-fold less infective when injected in vivo. Sf32null OBs were 18% larger in diameter and contained 17% more nucleocapsids within ODVs than those of Sfbac. No significant differences were detected in OB pathogenicity (50% lethal concentration), speed-of-kill or budded virus production in vivo. In contrast, the production of OBs/larva was reduced by 39% in insects infected by Sf32null compared to those infected by Sfbac. The SF32 predicted protein sequence showed homology (25% identity, 44% similarity) to two adhesion proteins from Streptococcus pyogenes and a single N-mirystoylation site was predicted. We conclude that SF32 is a non-essential protein that could be involved in nucleocapsid organization during ODV assembly and occlusion, resulting in increased numbers of nucleocapsids within ODVs.	[Beperet, Ines; Barrera, Gloria; Simon, Oihane; Caballero, Primitivo] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Barrera, Gloria] Corp Colombiana Invest Agr CORPOICA, Bogota, Colombia; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Lopez-Ferber, Miguel] Ecole Mines Ales, Ales, France; [Gasmi, Laila; Herrero, Salvador] Univ Valencia, Dept Genet, Valencia, Spain; [Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Instituto de Ecologia - Mexico; IMT - Institut Mines-Telecom; IMT Mines Ales; University of Valencia; Universidad Publica de Navarra	Caballero, P (corresponding author), CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain.	pcm92@unavarra.es	Williams, Trevor/J-4239-2013; Williams, Trevor/F-1447-2011; Caballero, Primitivo/D-5063-2009; Williams, Trevor/ABG-3961-2020; Herrero, Salva/ABE-5123-2020; Lopez-Ferber, Miguel/F-5465-2012; Herrero, Salvador/J-5767-2013; Simon, Oihane/G-5703-2014; gasmi, laila/AAT-6469-2021	Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625; Herrero, Salva/0000-0001-5690-2108; Lopez-Ferber, Miguel/0000-0002-3850-1703; Herrero, Salvador/0000-0001-5690-2108; Simon, Oihane/0000-0003-1239-1486; gasmi, laila/0000-0003-1553-8252	Spanish Ministry for Science and Technology [AGL2008-05456-C03-01, AGL2011-30352-C02-01]; CSIC	Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	This study received financial support from the Spanish Ministry for Science and Technology (AGL2008-05456-C03-01, AGL2011-30352-C02-01). I. B. received a CSIC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An SH, 2006, VIRUS GENES, V32, P21, DOI 10.1007/s11262-005-5841-4; Black B.C., 1997, BACULOVIRUSES, DOI [10.1007/978-1-4899-1834-5_13, DOI 10.1007/978-1-4899-1834-5_13]; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Castillejos V, 2002, BIOL CONTROL, V24, P300, DOI 10.1016/S1049-9644(02)00030-0; Cory JS, 2004, FUNCT ECOL, V18, P443, DOI 10.1111/j.0269-8463.2004.00853.x; Crawley M.J., 1993, GLIM ECOLOGISTS; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Escribano A, 1999, J ECON ENTOMOL, V92, P1079, DOI 10.1093/jee/92.5.1079; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fuxa JR, 2004, AGR ECOSYST ENVIRON, V103, P27, DOI 10.1016/j.agee.2003.10.013; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Groner A., 1986, BIOL BACULOVIRUSES, V1, P177; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525; Hernandez-Crespo P, 2001, APPL ENVIRON MICROB, V67, P1140, DOI 10.1128/AEM.67.3.1140-1146.2001; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hodgson DJ, 2001, EVOL ECOL RES, V3, P687; Hong Jiang, 2008, Acta Entomologica Sinica, V51, P322; Hughes AL, 2003, MOL BIOL EVOL, V20, P979, DOI 10.1093/molbev/msg107; Hughes PR, 1987, BIOL BACULOVIRUSES, P1; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Katsuma S, 1999, J GEN VIROL, V80, P783, DOI 10.1099/0022-1317-80-3-783; KNELL JD, 1981, VIROLOGY, V112, P190, DOI 10.1016/0042-6822(81)90624-3; LeOra Software, 1987, POLO PC US GUID PROB; Lung OY, 2003, J VIROL, V77, P328, DOI 10.1128/JVI.77.1.328-339.2003; LYNN DE, 1992, BIOTECHNIQUES, V13, P282; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Possee RD., 1992, BACULOVIRUS EXPRESSI; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Rohrmann GF, 2008, BACULOVIRUS MOL BIOL; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; SHAPIRO DI, 1991, J INVERTEBR PATHOL, V58, P96, DOI 10.1016/0022-2011(91)90167-O; Simon O, 2005, APPL ENVIRON MICROB, V71, P4254, DOI 10.1128/AEM.71.8.4254-4262.2005; Simon O, 2004, APPL ENVIRON MICROB, V70, P5579, DOI 10.1128/AEM.70.9.5579-5588.2004; Simon O, 2008, J VIROL, V82, P7897, DOI 10.1128/JVI.00099-08; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; Thiem SM, 2009, IN VITRO CELL DEV-AN, V45, P111, DOI 10.1007/s11626-008-9170-5; Todd JW, 1996, J VIROL, V70, P2307, DOI 10.1128/JVI.70.4.2307-2317.1996; Valicente F. H., 2008, Revista Brasileira de Milho e Sorgo, V7, P77; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P1	52	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77683	10.1371/journal.pone.0077683	http://dx.doi.org/10.1371/journal.pone.0077683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204916	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500043
J	Zhang, WS; Edwards, A; Flemington, EK; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Flemington, Erik K.; Zhang, Kun			Inferring Polymorphism-Induced Regulatory Gene Networks Active in Human Lymphocyte Cell Lines by Weighted Linear Mixed Model Analysis of Multiple RNA-Seq Datasets	PLOS ONE			English	Article							BCL-2 FAMILY; EXPRESSION; VARIANTS; INHIBITOR; LONGEVITY	Single-nucleotide polymorphisms (SNPs) contribute to the between-individual expression variation of many genes. A regulatory (trait-associated) SNP is usually located near or within a (host) gene, possibly influencing the gene's transcription or/and post-transcriptional modification. But its targets may also include genes that are physically farther away from it. A heuristic explanation of such multiple-target interferences is that the host gene transfers the SNP genotypic effects to the distant gene(s) by a transcriptional or signaling cascade. These connections between the host genes (regulators) and the distant genes (targets) make the genetic analysis of gene expression traits a promising approach for identifying unknown regulatory relationships. In this study, through a mixed model analysis of multi-source digital expression profiling for 140 human lymphocyte cell lines (LCLs) and the genotypes distributed by the international HapMap project, we identified 45 thousands of potential SNP-induced regulatory relationships among genes (the significance level for the underlying associations between expression traits and SNP genotypes was set at FDR <0.01). We grouped the identified relationships into four classes (paradigms) according to the two different mechanisms by which the regulatory SNPs affect their cis- and trans-regulated genes, modifying mRNA level or altering transcript splicing patterns. We further organized the relationships in each class into a set of network modules with the cis-regulated genes as hubs. We found that the target genes in a network module were often characterized by significant functional similarity, and the distributions of the target genes in three out of the four networks roughly resemble a power-law, a typical pattern of gene networks obtained from mutation experiments. By two case studies, we also demonstrated that significant biological insights can be inferred from the identified network modules.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik K.] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70118 USA; [Flemington, Erik K.] Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Tulane University; Tulane University	Zhang, K (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA.	kzhang@xula.edu			National Institutes of Health [NIMHD RCMI 8G12MD007595]; US Department of Army [W911NF-12-1-0066]; Louisiana Cancer Research Consortium (LCRC); State of Louisiana; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; Louisiana Cancer Research Consortium (LCRC); State of Louisiana; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by a National Institutes of Health grant (NIMHD RCMI 8G12MD007595), an US Department of Army grant (W911NF-12-1-0066), and Louisiana Cancer Research Consortium (LCRC) and the State of Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Bates D., 2012, COMPUTATIONAL METHOD; Brown EM, 2007, HAPMAP HAPLOTYPE MAP, P35; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Casella G, 2002, STAT INFERENCE, Vxxviii; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Clauset A., 2009, POWER LAW DISTRIBUTI; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hogan MC, 2003, HUM MOL GENET, V12, P685, DOI 10.1093/hmg/ddg068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Littell RC., 2006, SAS MIXED MODELS, Vxii; MAK TK, 1992, J ROY STAT SOC B MET, V54, P649; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Outteryck O, 2012, NEUROLOGY, V79, P386, DOI 10.1212/WNL.0b013e318260451b; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rao C. R., 1999, LINEAR MODELS LEAST; Real PJ, 2004, CANCER RES, V64, P7947, DOI 10.1158/0008-5472.CAN-04-0945; Rung J, 2002, BIOINFORMATICS, V18, pS202, DOI 10.1093/bioinformatics/18.suppl_2.S202; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang XS, 2010, EXP AGING RES, V36, P79, DOI 10.1080/03610730903418729; Yuasa T, 2002, GENOMICS, V79, P376, DOI 10.1006/geno.2002.6719; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429	53	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78868	10.1371/journal.pone.0078868	http://dx.doi.org/10.1371/journal.pone.0078868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205334	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500137
J	Boboc, IA; Dinica, MC				Boboc, Ioana-Andreea; Dinica, Mihai-Cristian			An Algorithm for Testing the Efficient Market Hypothesis	PLOS ONE			English	Article							FOREIGN-EXCHANGE MARKET; TECHNICAL TRADING RULES; US STOCK-MARKET; REALITY CHECK; RETURN PREDICTABILITY; PROFITS; TIME	The objective of this research is to examine the efficiency of EUR/USD market through the application of a trading system. The system uses a genetic algorithm based on technical analysis indicators such as Exponential Moving Average (EMA), Moving Average Convergence Divergence (MACD), Relative Strength Index (RSI) and Filter that gives buying and selling recommendations to investors. The algorithm optimizes the strategies by dynamically searching for parameters that improve profitability in the training period. The best sets of rules are then applied on the testing period. The results show inconsistency in finding a set of trading rules that performs well in both periods. Strategies that achieve very good returns in the training period show difficulty in returning positive results in the testing period, this being consistent with the efficient market hypothesis (EMH).	[Boboc, Ioana-Andreea] Ecole Polytech Fed Lausanne, Swiss Finance Inst, Financial Engn Sect, Lausanne, Switzerland; [Dinica, Mihai-Cristian] Bucharest Univ Econ Studies, Dept Finance, Bucharest, Romania	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Finance Institute (SFI); Bucharest University of Economic Studies	Dinica, MC (corresponding author), Bucharest Univ Econ Studies, Dept Finance, Bucharest, Romania.	mihai.dinica@gmail.com	Dinica, Mihai Cristian/D-9261-2014; Chanelian, Serena/ABE-4873-2021	Dinica, Mihai Cristian/0000-0002-2197-1389; Chanelian, Serena/0000-0001-5727-6137	European Social Fund through Sectorial Operational Programme Human Resources Development [POSDRU/107/1.5/S/77213]	European Social Fund through Sectorial Operational Programme Human Resources Development	This work was co-financed from the European Social Fund through Sectorial Operational Programme Human Resources Development 2007-2013, project number POSDRU/107/1.5/S/77213, Ph.D. for a career in interdisciplinary economic research at the European standards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounooria E, 2012, PHYSICA A, V391, P3170, DOI 10.1016/j.physa.2011.12.045; Allen F, 1999, J FINANC ECON, V51, P245, DOI 10.1016/S0304-405X(98)00052-X; Alvarez-Ramirez J, 2012, PHYSICA A, V391, P5643, DOI 10.1016/j.physa.2012.06.051; Armeanu D, 2008, ECON COMPUT ECON CYB, V42, P201; Charles A, 2012, J INT MONEY FINANC, V31, P1607, DOI 10.1016/j.jimonfin.2012.03.003; Charles Amelie, 2009, ECON SYST, V33, P117; Cheung YW, 2001, J INT MONEY FINANC, V20, P439, DOI 10.1016/S0261-5606(01)00002-X; De Grauwe P, 1992, J INT COMP EC, V1, P87; Dempster M. A. H., 2001, Quantitative Finance, V1, P397, DOI 10.1088/1469-7688/1/4/301; Deng SK, 2012, PROCEDIA COMPUT SCI, V13, P86, DOI 10.1016/j.procs.2012.09.117; Dragota V, 2009, ROM J ECON FORECAST, V10, P147; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Grolund A, 2012, PLOS ONE, V7; Harris L, 2013, FINANC ANAL J, V69, P6; Hasan MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037047; Holland J., 1962, J ACM, V3, P297; Hsu P.H., 2005, J FINANCIAL ECONOMET, V3, P606, DOI [10.1093/jjfinec/nbi026, DOI 10.1093/JJFINEC/NBI026]; Hsu PH, 2010, J EMPIR FINANC, V17, P471, DOI 10.1016/j.jempfin.2010.01.001; Kim JH, 2008, J EMPIR FINANC, V15, P518, DOI 10.1016/j.jempfin.2007.07.001; Kim JH, 2011, J EMPIR FINANC, V18, P868, DOI 10.1016/j.jempfin.2011.08.002; Kwon K.-Y., 2002, Q REV EC FINANCE, V42, P611, DOI DOI 10.1016/51062-9769(01)00089-8; Mendes L, 2012, J HEURISTICS, V18, P627, DOI 10.1007/s10732-012-9201-y; Metghalchi M, 2012, APPL ECON, V44, P1539, DOI 10.1080/00036846.2010.543084; Neely C, 1997, J FINANC QUANT ANAL, V32, P405, DOI 10.2307/2331231; Olson D, 2004, J BANK FINANC, V28, P85, DOI 10.1016/S0378-4266(02)00399-0; Osler CL, 2000, FEDERAL RESERVE BANK, V6, P53; Park CH, 2010, J FUTURES MARKETS, V30, P633, DOI 10.1002/fut.20435; Qi M, 2006, J MONEY CREDIT BANK, V38, P2135, DOI 10.1353/mcb.2007.0006; Ready MJ, 2002, FINANC MANAGE, V31, P43, DOI 10.2307/3666314; Roberts MC, 2005, J FUTURES MARKETS, V25, P643, DOI 10.1002/fut.20161; Rosillo R, 2013, APPL ECON, V45, P1541, DOI 10.1080/00036846.2011.631894; Savin G, 2007, J FINANC ECONOMET, V5, P243, DOI 10.1093/jjfinec/nb1012; Shynkevich A, 2012, J BANK FINANC, V36, P193, DOI 10.1016/j.jbankfin.2011.07.001; Sullivan R, 1999, J FINANC, V54, P1647, DOI 10.1111/0022-1082.00163; Szakmary AC, 2010, J BANK FINANC, V34, P409, DOI 10.1016/j.jbankfin.2009.08.004; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Trolle AB, 2010, J DERIV, V17, P15, DOI 10.3905/jod.2010.17.3.015; White H, 2000, ECONOMETRICA, V68, P1097, DOI 10.1111/1468-0262.00152	38	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78177	10.1371/journal.pone.0078177	http://dx.doi.org/10.1371/journal.pone.0078177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24205148	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700082
J	Zook, JD; Molugu, TR; Jacobsen, NE; Lin, GX; Soll, J; Cherry, BR; Brown, MF; Fromme, P				Zook, James D.; Molugu, Trivikram R.; Jacobsen, Neil E.; Lin, Guangxin; Soll, Juergen; Cherry, Brian R.; Brown, Michael F.; Fromme, Petra			High-Resolution NMR Reveals Secondary Structure and Folding of Amino Acid Transporter from Outer Chloroplast Membrane	PLOS ONE			English	Article							TRIPLE-RESONANCE NMR; CHEMICAL-SHIFTS; HETERONUCLEAR NMR; BACKBONE DYNAMICS; LARGER PROTEINS; LIPID-BILAYERS; SPIN-LATTICE; RELAXATION; OEP16; N-15	Solving high-resolution structures for membrane proteins continues to be a daunting challenge in the structural biology community. In this study we report our high-resolution NMR results for a transmembrane protein, outer envelope protein of molar mass 16 kDa (OEP16), an amino acid transporter from the outer membrane of chloroplasts. Three-dimensional, high-resolution NMR experiments on the C-13, N-15, H-2-triply-labeled protein were used to assign protein backbone resonances and to obtain secondary structure information. The results yield over 95% assignment of N, H-N, CO, C-alpha, and C-beta chemical shifts, which is essential for obtaining a high resolution structure from NMR data. Chemical shift analysis from the assignment data reveals experimental evidence for the first time on the location of the secondary structure elements on a per residue basis. In addition T-1Z and T-2 relaxation experiments were performed in order to better understand the protein dynamics. Arginine titration experiments yield an insight into the amino acid residues responsible for protein transporter function. The results provide the necessary basis for high-resolution structural determination of this important plant membrane protein.	[Zook, James D.; Cherry, Brian R.; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85069 USA; [Molugu, Trivikram R.; Jacobsen, Neil E.; Lin, Guangxin; Brown, Michael F.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Lin, Guangxin] Saudi Basic Ind Corp, Mt Vernon, IA USA; [Soll, Juergen] Univ Munich, Dept Biol, Munich, Germany; [Brown, Michael F.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Arizona State University; Arizona State University-Tempe; University of Arizona; Saudi Basic Industries Corporation (SABIC); University of Munich; University of Arizona	Fromme, P (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85069 USA.	pfromme@asu.edu	Molugu, Trivikram Rao/I-6637-2019	Molugu, Trivikram Rao/0000-0002-3254-0445	U.S. National Institutes of Health [GM095583, EY012049, EY018891]; NATIONAL EYE INSTITUTE [R01EY012049, R01EY018891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (GM095583 to P. F. and EY012049 and EY018891 to M. F. B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BROWN MF, 1982, J CHEM PHYS, V77, P1576, DOI 10.1063/1.443940; Brown MF., 1996, ENCY NUCL MAGNETIC R; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CUATRECASAS P, 1974, ANNU REV BIOCHEM, V43, P169, DOI 10.1146/annurev.bi.43.070174.001125; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Goddard T. D., 2008, SPARKY 3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Linke D, 2004, BIOPHYS J, V86, P1479, DOI 10.1016/S0006-3495(04)74216-2; Linke D, 2000, BIOCHEMISTRY-US, V39, P11050, DOI 10.1021/bi001034m; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Meirovitch E, 2010, PROG NUCL MAG RES SP, V56, P360, DOI 10.1016/j.pnmrs.2010.03.002; Nevzorov AA, 1998, PHYS REV E, V58, P2259, DOI 10.1103/PhysRevE.58.2259; Nevzorov AA, 1997, J CHEM PHYS, V107, P10288, DOI 10.1063/1.474169; Ni D, 2011, PROTEIN EXPRES PURIF, V80, P157, DOI 10.1016/j.pep.2011.08.004; Pohlmeyer K, 1997, P NATL ACAD SCI USA, V94, P9504, DOI 10.1073/pnas.94.17.9504; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Steinkamp T, 2000, J BIOL CHEM, V275, P11758, DOI 10.1074/jbc.275.16.11758; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78116	10.1371/journal.pone.0078116	http://dx.doi.org/10.1371/journal.pone.0078116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205117	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700077
J	Buchel, F; Mittag, F; Wrzodek, C; Zell, A; Gasser, T; Sharma, M				Buechel, Finja; Mittag, Florian; Wrzodek, Clemens; Zell, Andreas; Gasser, Thomas; Sharma, Manu			Integrative Pathway-Based Approach for Genome-Wide Association Studies: Identification of New Pathways for Rheumatoid Arthritis and Type 1 Diabetes	PLOS ONE			English	Article							B-CELL RESPONSES; GENE ONTOLOGY; TOOL; PREVALENCE; DISEASES; IGA	Genome-wide association studies (GWAS) led to the identification of numerous novel loci for a number of complex diseases. Pathway-based approaches using genotypic data provide tangible leads which cannot be identified by single marker approaches as implemented in GWAS. The available pathway analysis approaches mainly differ in the employed databases and in the applied statistics for determining the significance of the associated disease markers. So far, pathway-based approaches using GWAS data failed to consider the overlapping of genes among different pathways or the influence of protein-interactions. We performed a multistage integrative pathway (MIP) analysis on three common diseases - Crohn's disease (CD), rheumatoid arthritis (RA) and type 1 diabetes (T1D) - incorporating genotypic, pathway, protein-and domain-interaction data to identify novel associations between these diseases and pathways. Additionally, we assessed the sensitivity of our method by studying the influence of the most significant SNPs on the pathway analysis by removing those and comparing the corresponding pathway analysis results. Apart from confirming many previously published associations between pathways and RA, CD and T1D, our MIP approach was able to identify three new associations between disease phenotypes and pathways. This includes a relation between the influenza-A pathway and RA, as well as a relation between T1D and the phagosome and toxoplasmosis pathways. These results provide new leads to understand the molecular underpinnings of these diseases. The developed software herein used is available at http://www.cogsys.cs.uni-tuebingen. de/software/GWASPathwayIdentifier/index.htm.	[Buechel, Finja; Mittag, Florian; Wrzodek, Clemens; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Gasser, Thomas; Sharma, Manu] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany; [Gasser, Thomas; Sharma, Manu] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Sharma, Manu] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Sharma, M (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany.	manu.sharma@uni-tuebingen.de	Gasser, Thomas/GNH-5293-2022; Sharma, Manu/AAX-2594-2020	Gasser, Thomas/0000-0002-1069-1146; Wrzodek, Clemens/0000-0003-4995-780X; Wrzodek, Finja/0000-0001-5031-1016; Mittag, Florian/0000-0002-6472-0221	Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+) [01GS08134]; Michael J Fox Foundation	Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+)(Federal Ministry of Education & Research (BMBF)); Michael J Fox Foundation	The research leading to these results has received funding from the Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+) under grant number 01GS08134. This study is also supported by the Michael J Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Braun R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002101; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Farber CR, 2013, G3-GENES GENOM GENET, V3, P119, DOI 10.1534/g3.112.004788; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; JORGENSEN C, 1993, CLIN EXP RHEUMATOL, V11, P541; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kobie JJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3542; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LIBLAU RS, 1992, APMIS, V100, P709, DOI 10.1111/j.1699-0463.1992.tb03988.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makhlouf L, 2003, J AM SOC NEPHROL, V14, P2168, DOI 10.1097/01.ASN.0000079041.15707.A9; McDonnell M, 2011, INFLAMM BOWEL DIS, V17, P298, DOI 10.1002/ibd.21424; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Ngwa Julius S, 2011, BMC Proc, V5 Suppl 9, pS18, DOI 10.1186/1753-6561-5-S9-S18; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Shahbaba B, 2012, STAT MED, V31, P988, DOI 10.1002/sim.4477; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Zamar D, 2009, BIOINFORMATICS, V25, P2444, DOI 10.1093/bioinformatics/btp431; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78577	10.1371/journal.pone.0078577	http://dx.doi.org/10.1371/journal.pone.0078577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205270	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400088
J	Huang, VJ; Stein, KC; True, HL				Huang, Vincent J.; Stein, Kevin C.; True, Heather L.			Spontaneous Variants of the [RNQ plus ] Prion in Yeast Demonstrate the Extensive Conformational Diversity Possible with Prion Proteins	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHAIN RELEASE FACTOR; SACCHAROMYCES-CEREVISIAE; PSI+ PRION; GUANIDINE-HYDROCHLORIDE; TRANSLATION TERMINATION; ENVIRONMENTAL-STRESS; STRAIN DIFFERENCES; GENETIC-VARIATION; IN-VIVO	Prion strains (or variants) are structurally distinct amyloid conformations arising from a single polypeptide sequence. The existence of prion strains has been well documented in mammalian prion diseases. In many cases, prion strains manifest as variation in disease progression and pathology, and in some cases, these prion strains also show distinct biochemical properties. Yet, the underlying basis of prion propagation and the extent of conformational possibilities available to amyloidogenic proteins remain largely undefined. Prion proteins in yeast that are also capable of maintaining multiple self-propagating structures have provided much insight into prion biology. Here, we explore the vast structural diversity of the yeast prion [RNQ+] in Saccharomyces cerevisiae. We screened for the formation of [RNQ+] in vivo, allowing us to calculate the rate of spontaneous formation as similar to 2.96x10(-6), and successfully isolate several different [RNQ+] variants. Through a comprehensive set of biochemical and biological analyses, we show that these prion variants are indeed novel. No individual property or set of properties, including aggregate stability and size, was sufficient to explain the physical basis and range of prion variants and their resulting cellular phenotypes. Furthermore, all of the [RNQ+] variants that we isolated were able to facilitate the de novo formation of the yeast prion [PSI+], an epigenetic determinant of translation termination. This supports the hypothesis that [RNQ+] acts as a functional amyloid in regulating the formation of [PSI+] to produce phenotypic diversity within a yeast population and promote adaptation. Collectively, this work shows the broad spectrum of available amyloid conformations, and thereby expands the foundation for studying the complex factors that interact to regulate the propagation of distinct aggregate structures.	[Huang, Vincent J.; Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	True, HL (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	National Institutes of Health [F31AG040899, GM072778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072778, T32GM007067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants F31AG040899 (KCS) and GM072778 (HLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bardill JP, 2009, J MOL BIOL, V388, P583, DOI 10.1016/j.jmb.2009.03.036; Bateman DA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003257; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Foo CK, 2011, J MOL BIOL, V408, P1, DOI 10.1016/j.jmb.2011.02.025; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hines JK, 2011, PRION, V5, P164, DOI 10.4161/pri.5.3.16895; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kalastavadi T, 2010, J BIOL CHEM, V285, P20748, DOI 10.1074/jbc.M110.115303; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Lancaster DL, 2013, J BIOL CHEM, V288, P1266, DOI 10.1074/jbc.M112.377564; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 2000, ARCH VIROL, P227; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sharma J, 2013, J MOL BIOL, V425, P3046, DOI 10.1016/j.jmb.2013.06.006; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; TUITE MF, 1981, GENETICS, V98, P691; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	78	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79582	10.1371/journal.pone.0079582	http://dx.doi.org/10.1371/journal.pone.0079582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205387	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400116
J	Mendenhall, E; Richter, LM; Stein, A; Norris, SA				Mendenhall, Emily; Richter, Linda M.; Stein, Alan; Norris, Shane A.			Psychological and Physical Co-Morbidity among Urban South African Women	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; MIDDLE-INCOME COUNTRIES; ADULT-POPULATION; DEPRESSION; HEALTH; POVERTY; PREVALENCE; ILLNESS; ANXIETY; DISEASE	Objectives: There is substantial evidence for the links between poverty and both physical and mental health; but limited research on the relationship of physical and mental health problems exists in low-and middle-income countries. The objective of this paper is to evaluate the prevalence and co-morbidity of psychological distress among women with common physical diseases in a socio-economically disadvantaged urban area of South Africa. Methods: Women enrolled in the Birth to twenty (Bt20) cohort study were evaluated for this paper. Bt20 was founded in 1990 and has followed more than 3,000 children and their caregivers since birth; this study evaluates the health of the caregivers (average age 44) of these children. Psychological distress was evaluated by administering the General Health Questionnaire (GHQ-28) and we evaluated the presence of physical disease by self-report. Results: Forty percent of the sample presented with psychological distress using the GHQ scoring method. More than half of the women who reported a history of a physical disease, including diabetes, heart attack, asthma, arthritis, osteoporosis, epilepsy, and tuberculosis, reported psychological disorder. Presence of one physical disease was not associated with increased rates of psychological distress. However, women who reported two diseases had increased rates of psychological symptoms, and this upward trend continued with each additional physical disease reported (measured to five). Conclusions: These data indicate high prevalence rates of co-morbid psychological distress among women with physical disease. This argues for the need of greater mental health support for women living with physical diseases.	[Mendenhall, Emily; Richter, Linda M.; Stein, Alan; Norris, Shane A.] Univ Witwatersrand, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Mendenhall, Emily] Georgetown Univ, Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Washington, DC USA; [Richter, Linda M.] Human Sci Res Council, Durban, South Africa; [Stein, Alan] Univ Oxford, Oxford, England	University of Witwatersrand; Georgetown University; Human Sciences Research Council-South Africa; University of Oxford	Mendenhall, E (corresponding author), Univ Witwatersrand, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	em1061@georgetown.edu	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Stein, Alan/0000-0001-8207-2822; Mendenhall, Emily/0000-0002-5826-1321	Medical Research Council of South Africa; Wellcome Trust; MRC/DFID African Research Leader Scheme; MRC [G1001333] Funding Source: UKRI; Medical Research Council [G1001333] Funding Source: researchfish	Medical Research Council of South Africa(South African Medical Research Council); Wellcome Trust(Wellcome Trust); MRC/DFID African Research Leader Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council of South Africa, Wellcome Trust, and MRC/DFID African Research Leader Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Cameron N, 1998, AM J HUM BIOL, V10, P495, DOI 10.1002/(SICI)1520-6300(1998)10:4<495::AID-AJHB9>3.0.CO;2-F; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Kagee A, 2008, J HEALTH PSYCHOL, V13, P547, DOI 10.1177/1359105308088527; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Rumble S, 1996, PSYCHOL MED, V26, P997, DOI 10.1017/S0033291700035327; Shidhaye R, 2013, INT REV PSYCHIATR, V25, P65, DOI 10.3109/09540261.2012.748651; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368	21	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78803	10.1371/journal.pone.0078803	http://dx.doi.org/10.1371/journal.pone.0078803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205319	Green Published, gold			2022-12-25	WOS:000326155400106
J	Kroeger, PT; Shoue, DA; Mezzacappa, FM; Gerlach, GF; Wingert, RA; Schulz, RA				Kroeger, Paul T., Jr.; Shoue, Douglas A.; Mezzacappa, Frank M.; Gerlach, Gary F.; Wingert, Rebecca A.; Schulz, Robert A.			Knockdown of SCFSkp2 Function Causes Double-Parked Accumulation in the Nucleus and DNA Re-Replication in Drosophila Plasmatocytes	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; CDT1 DEGRADATION; CYCLIN-E; S-PHASE; IN-VIVO; GEMININ; PROTEIN; ORIGIN; HEMATOPOIESIS; HEMOCYTES	In Drosophila, circulating hemocytes are derived from the cephalic mesoderm during the embryonic wave of hematopoiesis. These cells are contributed to the larva and persist through metamorphosis into the adult. To analyze this population of hemocytes, we considered data from a previously published RNAi screen in the hematopoietic niche, which suggested several members of the SCF complex play a role in lymph gland development. eaterGal4; UAS-GFP flies were crossed to UAS-RNAi lines to knockdown the function of all known SCF complex members in a plasmatocyte-specific fashion, in order to identify which members are novel regulators of plasmatocytes. This specific SCF complex contains five core members: Lin-19-like, SkpA, Skp2, Roc1a and complex activator Nedd8. The complex was identified by its very distinctive large cell phenotype. Furthermore, these large cells stained for anti-P1, a plasmatocyte-specific antibody. It was also noted that the DNA in these cells appeared to be over-replicated. Gamma-tubulin and DAPI staining suggest the cells are undergoing re-replication as they had multiple centrioles and excessive DNA content. Further experimentation determined enlarged cells were BrdU-positive indicating they have progressed through S-phase. To determine how these cells become enlarged and undergo re-replication, cell cycle proteins were analyzed by immunofluorescence. This analysis identified three proteins that had altered subcellular localization in these enlarged cells: Cyclin E, Geminin and Double-parked. Previous research has shown that Double-parked must be degraded to exit S-phase, otherwise the DNA will undergo re-replication. When Double-parked was titrated from the nucleus by an excess of its inhibitor, geminin, the enlarged cells and aberrant protein localization phenotypes were partially rescued. The data in this report suggests that the SCFSkp2 complex is necessary to ubiquitinate Double-parked during plasmatocyte cell division, ensuring proper cell cycle progression and the generation of a normal population of this essential blood cell type.	[Kroeger, Paul T., Jr.; Shoue, Douglas A.; Mezzacappa, Frank M.; Gerlach, Gary F.; Wingert, Rebecca A.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Schulz, RA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu	Wingert, Rebecca A/ABE-2786-2020	Wingert, Rebecca A/0000-0003-3133-7549; Mezzacappa, Frank/0000-0003-3933-4844; Kroeger, Paul/0000-0002-9067-170X	National Institutes of Health, NIH [HL071540]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health, NIH HL071540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Das T, 2002, DEV GENES EVOL, V212, P134, DOI 10.1007/s00427-002-0222-7; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kroeger PT, 2012, GENESIS, V50, P41, DOI 10.1002/dvg.20787; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Liu J, 2012, MOL BIOL CELL, V23, P200, DOI 10.1091/mbc.E11-05-0409; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; May NR, 2005, J CELL SCI, V118, P4207, DOI 10.1242/jcs.02534; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Rodriguez S, 2011, BLOOD, V117, P6509, DOI 10.1182/blood-2010-11-321521; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014051; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Ullah Z, 2009, CELL CYCLE, V8, P1501, DOI 10.4161/cc.8.10.8325; Vilmos P, 2004, DEV COMP IMMUNOL, V28, P555, DOI 10.1016/j.dci.2003.10.001; Wang J, 2011, BLOOD, V118, P5429, DOI 10.1182/blood-2010-10-312785; Whittaker AJ, 2000, GENE DEV, V14, P1765; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	56	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79019	10.1371/journal.pone.0079019	http://dx.doi.org/10.1371/journal.pone.0079019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205363	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300088
J	Munkhuu, B; Essig, S; Renchinnyam, E; Schmid, R; Wilhelm, C; Bohlius, J; Chuluunbaatar, B; Shonkhuuz, E; Baumann, T				Munkhuu, Bayalag; Essig, Stefan; Renchinnyam, Erdenesuvd; Schmid, Raoul; Wilhelm, Corina; Bohlius, Julia; Chuluunbaatar, Battulga; Shonkhuuz, Enkhtur; Baumann, Thomas			Incidence and Treatment of Developmental Hip Dysplasia in Mongolia: A Prospective Cohort Study	PLOS ONE			English	Article							CONGENITAL DISLOCATION; RISK-FACTORS; ULTRASOUND	Background: In Mongolia, adequate early diagnosis and treatment of developmental hip dysplasia (DDH) have been unavailable and its incidence was unknown. We determined the incidence of ultrasonographic DDH in newborns and established adequate procedures for diagnosis and treatment of DDH at the largest maternity hospital in Ulaanbaatar, Mongolia. Methodology/Principal Findings: During one year (Sept 2010 - Aug 2011) we assessed the hips newborns using ultrasound and Graf's classification of DDH. 8,356 newborns were screened; median age at screening was 1 day. We identified 14,873 Type 1 (89.0%), 1715 Type 2a (10.3%), 36 Type 2c (0.2%), 70 Type D (0.4%), 14 Type 3 (0.08%), and 4 Type 4 hips (0.02%). Children with Type 1 hips (normal) were discharged. Children with Type 2a hips (physiologically immature) received follow-up ultrasounds at monthly intervals. Children with Type 2c to 4 (DDH; deformed or misaligned hip joint) hips were treated with a Tubingen hip flexion splint and also followed up. The hip abnormalities resolved to mature hips in all children who were followed up. There was no evidence for severe treatment related complications. Conclusion/Significance: This study suggests that the incidence of DDH in Mongolian neonates is comparable to that in neonates in Europe. Early ultrasound-based assessment and splinting treatment of DDH led to mature hips in all children followed up. Procedures are feasible and will be continued.	[Munkhuu, Bayalag; Renchinnyam, Erdenesuvd; Chuluunbaatar, Battulga; Shonkhuuz, Enkhtur] Natl Ctr Maternal & Child Hlth, Ulaanbaatar, Mongolia; [Essig, Stefan; Bohlius, Julia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Schmid, Raoul] Baarer Kinderarztpraxis Baar, Baar, Switzerland; [Baumann, Thomas] Zentrum Korper & Sinnesbehinderte Kinder, Solothurn, Switzerland	University of Bern	Baumann, T (corresponding author), Zentrum Korper & Sinnesbehinderte Kinder, Solothurn, Switzerland.	tombaum@me.com		Bohlius, Julia/0000-0003-1955-1585; Essig, Stefan/0000-0003-3228-7010	Swiss Association of Pediatric Ultrasound (SVUPP); group medical practice in Solothurn	Swiss Association of Pediatric Ultrasound (SVUPP); group medical practice in Solothurn	Funding came from the supporters of Swiss Association of Pediatric Ultrasound (SVUPP) for sponsoring the ultrasound device http://www.svupp.ch/, and the group medical practice in Solothurn for sponsoring the fixating unit http://www.gruprax.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Intelligence Agency, 2010, WORLD FACTB 2010; Chan A, 1997, ARCH DIS CHILD-FETAL, V76, pF94, DOI 10.1136/fn.76.2.F94; Clarke NMP, 2012, ARCH DIS CHILD, V97, P423, DOI 10.1136/archdischild-2011-301085; Dezateux C, 2007, LANCET, V369, P1541, DOI 10.1016/S0140-6736(07)60710-7; el-Shazly M, 1994, J Med Screen, V1, P165; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; Graf R, 2006, HIP SONOGRAPHY DIAGN; Heitner H, 1977, Beitr Orthop Traumatol, V24, P543; HOLEN KJ, 1994, J PEDIATR ORTHOPED, V14, P667, DOI 10.1097/01241398-199409000-00022; Kosar P, 2011, J ULTRAS MED, V30, P677, DOI 10.7863/jum.2011.30.5.677; Lehmann HP, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e57; Mahan ST, 2009, J BONE JOINT SURG AM, V91A, P1705, DOI 10.2106/JBJS.H.00122; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; National Statistical Office of Mongolia, 2010, 2010 POP HOUS CENS M; Padilla CD, 2012, J COMMUN GENET, V3, P35, DOI 10.1007/s12687-011-0076-7; Peled E, 2008, CLIN ORTHOP RELAT R, V466, P771, DOI 10.1007/s11999-008-0132-8; Rosendahl K, 1996, ACTA PAEDIATR, V85, P64, DOI 10.1111/j.1651-2227.1996.tb13892.x; Sewell MD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4454; Shipman SA, 2006, PEDIATRICS, V117, pE557, DOI 10.1542/peds.2005-1597; Sodnompil T, 2007, HLTH IND, P13; Tschauner C, 2011, J CHILD ORTHOP, V5, P415, DOI 10.1007/s11832-011-0366-y	21	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79427	10.1371/journal.pone.0079427	http://dx.doi.org/10.1371/journal.pone.0079427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205385	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300095
J	Samanic, I; Simunic, J; Riha, K; Puizina, J				Samanic, Ivica; Simunic, Juraj; Riha, Karel; Puizina, Jasna			Evidence for Distinct Functions of MRE11 in Arabidopsis Meiosis	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; MEIOTIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; NUCLEASE ACTIVITY; COMPLEX; RAD50; GENE; YEAST	The evolutionary conserved Mre11/Rad50/Nbs1 complex functions as one of the guardians of genome integrity in eukaryotes; it is required for the double-strand break repair, meiosis, DNA checkpoint, and telomere maintenance. To better understand the role of the MRE11 gene in Arabidopsis, we performed comparative analysis of several mre11 alleles with respect to genome stability and meiosis. The mre11-4 and mre11-2 alleles presumably produce truncated MRE11 proteins composed of the first 499 and 529 amino acids, respectively. Although the putative MRE11 truncated proteins differ only by 30 amino acids, the mutants exhibited strikingly different phenotypes in regards to growth morphology, genome stability and meiosis. While the mre11-2 mutants are fully fertile and undergo normal meiosis, the mre11-4 plants are sterile due to aberrant repair of meiotic DNA breaks. Structural homology analysis suggests that the T-DNA insertion in the mre11-4 allele probably disrupted the putative RAD50 interaction and/or homodimerization domain, which is assumed to be preserved in mre11-2 allele. Intriguingly, introgression of the atm-2 mutant plant into the mre11-2 background renders the double mutant infertile, a phenotype not observed in either parent line. This data indicate that MRE11 partially compensates for ATM deficiency in meiosis of Arabidopsis.	[Samanic, Ivica; Puizina, Jasna] Univ Split, Fac Sci, Dept Biol, Split, Croatia; [Simunic, Juraj] Univ Split, Fac Sci, Dept Phys, Split, Croatia; [Riha, Karel] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Riha, Karel] Cent European Inst Technol CEITEC, Brno, Czech Republic	University of Split; University of Split; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Puizina, J (corresponding author), Univ Split, Fac Sci, Dept Biol, Split, Croatia.	puizina@pmfst.hr	Riha, Karel/AAM-4429-2021; Puizina, Jasna/E-2517-2017; Riha, Karel/P-9614-2018; Šamanić, Ivica/D-5728-2017; Riha, Karel/A-7717-2008	Riha, Karel/0000-0002-6124-0118; Puizina, Jasna/0000-0001-7097-7261; Riha, Karel/0000-0002-6124-0118; Šamanić, Ivica/0000-0001-8807-8184; 	Croatian Ministry of Science, Education and Sport [177-11911196]; Austrian Science Fund (FWF) [P 23495] Funding Source: researchfish	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work received financial support from project of the Croatian Ministry of Science, Education and Sport to Jasna Puizina (No. 177-11911196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIMURA M, 1993, GENETICS, V133, P51; Amiard S, 2010, PLANT CELL, V22, P3020, DOI 10.1105/tpc.110.078527; Armstrong SJ, 2003, J EXP BOT, V54, P1, DOI 10.1093/jxb/54.380.1; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bleuyard JY, 2004, CHROMOSOMA, V113, P197, DOI 10.1007/s00412-004-0309-1; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Bundock P, 2002, PLANT CELL, V14, P2451, DOI 10.1105/tpc.005959; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Gallego ME, 2001, PLANT J, V25, P31, DOI 10.1046/j.1365-313x.2001.00928.x; Gallego ME, 2001, P NATL ACAD SCI USA, V98, P1711, DOI 10.1073/pnas.98.4.1711; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gherbi H, 2001, EMBO REP, V2, P287, DOI 10.1093/embo-reports/kve069; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hartung F., 1999, Plant Physiology, V121, P312; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Puizina J, 2004, PLANT CELL, V16, P1968, DOI 10.1105/tpc.104.022749; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Rupnik A, 2010, CHROMOSOMA, V119, P115, DOI 10.1007/s00412-009-0242-4; Slijepcevic P, 2006, DNA REPAIR, V5, P1299, DOI 10.1016/j.dnarep.2006.05.038; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Waterworth WM, 2007, PLANT J, V52, P41, DOI 10.1111/j.1365-313X.2007.03220.x; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2005, MOL CELL, V19, P724, DOI 10.1016/j.molcel.2005.07.006; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	52	12	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78760	10.1371/journal.pone.0078760	http://dx.doi.org/10.1371/journal.pone.0078760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205310	Green Submitted, gold, Green Published			2022-12-25	WOS:000326032600110
J	Saha, P; Chowdhury, AR; Dutta, S; Chatterjee, S; Ghosh, I; Datta, K				Saha, Paramita; Chowdhury, Anindya Roy; Dutta, Shubhra; Chatterjee, Soumya; Ghosh, Ilora; Datta, Kasturi			Autophagic Vacuolation Induced by Excess ROS Generation in HABP1/p32/gC1qR Overexpressing Fibroblasts and Its Reversal by Polymeric Hyaluronan	PLOS ONE			English	Article							BINDING PROTEIN-1 HABP1/P32/GC1QR; SPLICING FACTOR SF2; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; OXIDATIVE STRESS; SYNOVIAL-FLUID; FREE-RADICALS; CELL-DEATH; ACID; APOPTOSIS	The ubiquitous hyaladherin, hyaluronan-binding protein 1 (HABP1/p32/gC1qR) upon stable overexpression in normal fibroblasts (F-HABP07) has been reported to induce mitochondrial dysfunction, growth retardation and apoptosis after 72 h of growth. HABP1 has been observed to accumulate in the mitochondria resulting in generation of excess Reactive Oxygen Species (ROS), mitochondrial Ca++ efflux and drop in mitochondrial membrane potential. In the present study, autophagic vacuolation was detected with monodansylcadaverin (MDC) staining from 36 h to 60 h of culture period along with elevated level of ROS in F-HABP07 cells. Increased expression of autophagic markers like MAP-LC3-II, Beclin 1 and autophagic modulator, DRAM confirmed the occurrence of the phenomenon. Reduced vacuole formation was observed upon treatment with 3-MA, a known PI3 kinase inhibitor, only at 32 h and was ineffective if treated later, as high ROS level was already attained. Treatment of F111 and F-HABP07 cells with bafilomycin A1 further indicated an increase in autophagosome formation along with autophagic degradation in HABP1 overexpressed fibroblasts. Comparison between normal fibroblast (F111) and F-HABP07 cells indicate reduced level of polymeric HA, its depolymerization and perturbed HA-HABP1 interaction in F-HABP07. Interestingly, supplementation of polymeric HA, an endogenous ROS scavenger, in the culture medium prompted reduction in number of vacuoles in F-HABP07 along with drop in ROS level, implying that excess ROS generation triggers initiation of autophagic vacuole formation prior to apoptosis due to overexpression of HABP1. Thus, the phenomenon of autophagy takes place prior to apoptosis induction in the HABP1 overexpressing cell line, F-HABP07.	[Saha, Paramita; Chowdhury, Anindya Roy; Dutta, Shubhra; Chatterjee, Soumya; Ghosh, Ilora; Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, Toxicol & Biochem Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Ghosh, I (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, Toxicol & Biochem Lab, New Delhi 110067, India.	ighosh@mail.jnu.ac.in; kdatta@mail.jnu.ac.in		Dutta, Shubhra/0000-0003-0024-9618; Chatterjee, Soumya/0000-0002-7889-8389; Ghosh, Ilora/0000-0003-3957-8152	Department of Biotechnology (DBT), Government of India, New Delhi; Department of Science and Technology (DST), Government of India, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi, India	Department of Biotechnology (DBT), Government of India, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India, New Delhi(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	KD received financial support from Department of Biotechnology (DBT), Government of India, New Delhi. IG is financially supported by Department of Science and Technology (DST), Government of India, New Delhi. PS obtained individual fellowship for her doctoral work from Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; ARTOLA A, 1993, OPHTHALMIC RES, V25, P172, DOI 10.1159/000267286; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Balogh GT, 2003, ARCH BIOCHEM BIOPHYS, V410, P76, DOI 10.1016/S0003-9861(02)00661-6; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Campo GM, 2008, J APPL TOXICOL, V28, P509, DOI 10.1002/jat.1302; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chowdhury AR, 2008, EXP CELL RES, V314, P651, DOI 10.1016/j.yexcr.2007.10.033; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dutta S, 2011, FREE RADICAL RES, V45, P1279, DOI 10.3109/10715762.2011.610794; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; GREENWALD RA, 1980, ARTHRITIS RHEUM-US, V23, P455, DOI 10.1002/art.1780230408; Grishko V, 2009, J BIOL CHEM, V284, P9132, DOI 10.1074/jbc.M804178200; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hawkins CL, 1998, FREE RADICAL BIO MED, V24, P1396, DOI 10.1016/S0891-5849(98)00009-4; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kaul R, 2012, J BIOL CHEM, V287, P19750, DOI 10.1074/jbc.M111.266270; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li Y, 2011, NEUROSCIENCE, V199, P346, DOI 10.1016/j.neuroscience.2011.10.003; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Majumdar M, 1998, GENOMICS, V51, P476, DOI 10.1006/geno.1998.5364; MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Meenakshi J, 2003, BIOCHEM BIOPH RES CO, V300, P686, DOI 10.1016/S0006-291X(02)02788-2; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Nguyen KT, 2002, J BIOL CHEM, V277, P11107, DOI 10.1074/jbc.M108166200; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Reef S, 2007, ONCOGENE, V26, P6677, DOI 10.1038/sj.onc.1210485; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rees MD, 2003, J AM CHEM SOC, V125, P13719, DOI 10.1021/ja0370591; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; SATO H, 1988, ARTHRITIS RHEUM, V31, P63, DOI 10.1002/art.1780310110; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tolkacheva T, 2000, ONCOGENE, V19, P680, DOI 10.1038/sj.onc.1203331; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yamazaki Kenji, 2003, Pathophysiology, V9, P215, DOI 10.1016/S0928-4680(03)00024-5; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	70	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78131	10.1371/journal.pone.0078131	http://dx.doi.org/10.1371/journal.pone.0078131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205125	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300143
J	Van Avondt, K; Fritsch-Stork, R; Derksen, RHWM; Meyaard, L				Van Avondt, Kristof; Fritsch-Stork, Ruth; Derksen, Ronald H. W. M.; Meyaard, Linde			Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus	PLOS ONE			English	Article							HUMAN PHAGOCYTES; CLASSIFICATION; BLOOD	Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of systemic Lupus erythematosus (SLE), since netting neutrophils release potentially immunogenic autoantigens including histones, LL37, human neutrophil peptide (HNP), and self-DNA. In turn, these NETs activate plasmacytoid dendritic cells resulting in aggravation of inflammation and disease. How suppression of NET formation can be targeted for treatment has not been reported yet. Signal Inhibitory Receptor on Leukocytes-1 (SIRL-1) is a surface molecule exclusively expressed on phagocytes. We recently identified SIRL-1 as a negative regulator of human neutrophil function. Here, we determine whether ligation of SIRL-1 prevents the pathogenic release of NETs in SLE. Peripheral blood neutrophils from SLE patients with mild to moderate disease activity and healthy donors were freshly isolated. NET release was assessed spontaneously or after exposure to anti-neutrophil antibodies or plasma obtained from SLE patients. The formation of NETs was determined by microscopic evaluation using DNA dyes and immunostaining of NET components, as well as by live cell imaging. We show that SLE neutrophils spontaneously release NETs. NET formation is enhanced by stimulation with antibodies against LL37. Inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and MEK-ERK signaling prevents NET release in response to these antibodies. Signaling via the inhibitory receptor SIRL-1 was induced by ligation with anti-SIRL-1 specific antibodies. Both spontaneous and anti-neutrophil antibody-induced NET formation is suppressed by engagement of SIRL-1. Furthermore, NET release by healthy neutrophils exposed to SLE plasma is inhibited by SIRL-1 ligation. Thus, SIRL-1 engagement can dampen spontaneous and anti-neutrophil antibody-induced NET formation in SLE, likely by suppressing NAPDH oxidase and MEK-ERK activity. Together, these findings reveal a regulatory role for SIRL-1 in NET formation, potentially providing a novel therapeutic target to break the pathogenic loop in SLE.	[Van Avondt, Kristof; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Fritsch-Stork, Ruth; Derksen, Ronald H. W. M.] Univ Med Ctr Utrecht, Lab Translat Immunol, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Meyaard, L (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	l.meyaard@umcutrecht.nl		Meyaard, Linde/0000-0003-0707-4793; Fritsch-Stork, ruth/0000-0003-0217-3629	Netherlands Organization for Scientific Research, division of Earth and Life Sciences [819.02.002]; ReumaFonds [12-2-406] Funding Source: researchfish	Netherlands Organization for Scientific Research, division of Earth and Life Sciences; ReumaFonds	This work was supported by grant 819.02.002 from the Netherlands Organization for Scientific Research, division of Earth and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Marian V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3917; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Steevels TAM, 2013, EUR J IMMUNOL, V43, P1297, DOI 10.1002/eji.201242916; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450	17	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78459	10.1371/journal.pone.0078459	http://dx.doi.org/10.1371/journal.pone.0078459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205237	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300156
J	Currie, S; Hoggard, N; Clark, MJR; Sanders, DS; Wilkinson, ID; Griffiths, PD; Hadjivassiliou, M				Currie, Stuart; Hoggard, Nigel; Clark, Matthew J. R.; Sanders, David S.; Wilkinson, Iain D.; Griffiths, Paul D.; Hadjivassiliou, Marios			Alcohol Induces Sensitization to Gluten in Genetically Susceptible Individuals: A Case Control Study	PLOS ONE			English	Article							CELIAC-DISEASE; CEREBELLAR DEGENERATION; TISSUE TRANSGLUTAMINASE; LIVER-DISEASE; BRAIN IMAGES; MR-IMAGES; ATAXIA; ROBUST; REGISTRATION; SPECTROSCOPY	Background: The mechanisms of cerebellar degeneration attributed to prolonged and excessive alcohol intake remain unclear. Additional or even alternative causes of cerebellar degeneration are often overlooked in suspected cases of alcohol-related ataxia. The objectives of this study were two fold: (1) to investigate the prevalence of gluten-related serological markers in patients with alcohol-related ataxia and; (2) to compare the pattern of brain involvement on magnetic resonance imaging between patients with alcohol and gluten ataxias. Materials & Methods: Patients diagnosed with alcohol and gluten ataxias were identified from a retrospective review of patients attending a tertiary clinic. HLA genotype and serological markers of gluten-related disorders were recorded. Cerebellar volumetry, MR spectroscopy and voxel-based morphometric analyses were performed on patients and compared with matched control data. Results: Of 904 registered patients, 104 had alcohol ataxia and 159 had gluten ataxia. 61% of the alcohol ataxia group and 70% of the gluten ataxia group had HLA DQ2/DQ8 genotype compared to 30% in healthy local blood donors. 44% of patients with alcohol ataxia had antigliadin antibodies compared to 12% in the healthy local population and 10% in patients with genetically confirmed ataxias. None of the patients with alcohol ataxia and antigliadin antibodies had celiac disease compared to 40% in patients with gluten ataxia. The pattern of structural brain abnormality in patients with alcohol ataxia who had antigliadin antibodies differed from gluten ataxia and was identical to that of alcohol ataxia. Conclusions: Alcohol related cerebellar degeneration may, in genetically susceptible individuals, induce sensitization to gluten. Such sensitization may result from a primary cerebellar insult, but a more systemic effect is also possible. The duration and amount of exposure to alcohol may not be the only factors responsible for the cerebellar insult.	[Currie, Stuart; Hoggard, Nigel; Clark, Matthew J. R.; Wilkinson, Iain D.; Griffiths, Paul D.] Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England; [Sanders, David S.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Gastroenterol, Sheffield, S Yorkshire, England; [Hadjivassiliou, Marios] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Currie, S (corresponding author), Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England.	s.currie@sheffield.ac.uk		Clark, Matthew/0000-0003-2152-2257; Wilkinson, Iain/0000-0003-2703-6890				Alikunju S, 2011, BRAIN BEHAV IMMUN, V25, pS129, DOI 10.1016/j.bbi.2011.01.007; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Bradunaite R, 2002, ACTA MED LITUANICA, V9, P245; Cavanagh JB, 1997, NEUROPATH APPL NEURO, V23, P355; Currie S, 2013, CEREBELLUM, V12, P205, DOI 10.1007/s12311-012-0415-1; Currie S, 2013, CEREBELLUM, V12, P245, DOI 10.1007/s12311-012-0405-3; Currie S, 2012, J NEUROL NEUROSUR PS, V83, P1216, DOI 10.1136/jnnp-2012-303281; Dewar D, 2004, INT J BIOCHEM CELL B, V36, P17, DOI 10.1016/S1357-2725(03)00239-5; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; FLOREANI A, 1992, ITAL J GASTROENTEROL, V24, P457; Germenis AE, 2005, CLIN DIAGN LAB IMMUN, V12, P941, DOI 10.1128/CDLI.12.8.941-948.2005; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; GREENLEE JE, 1995, ACTA NEUROPATHOL, V89, P341; Hadjivassiliou M, 2003, BRAIN, V126, P685, DOI 10.1093/brain/awg050; Hadjivassiliou M, 2006, NEUROLOGY, V66, P373, DOI 10.1212/01.wnl.0000196480.55601.3a; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Hadjivassiliou Marios, 2012, Handb Clin Neurol, V103, P189, DOI 10.1016/B978-0-444-51892-7.00011-5; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Koivisto H, 2008, DIGEST DIS SCI, V53, P500, DOI 10.1007/s10620-007-9874-5; Kril JJ, 1997, HEPATOLOGY, V26, P837, DOI 10.1053/jhep.1997.v26.pm0009328301; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mascalchi M, 2002, J MAGN RESON IMAGING, V16, P532, DOI 10.1002/jmri.10189; Meyerhoff DJ, 2004, ALCOHOL CLIN EXP RES, V28, P650, DOI 10.1097/01.ALC.0000121805.12350.CA; Michalak S, 2010, FOLIA NEUROPATHOL, V48, P93; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nissenkorn A, 2011, J PEDIATR-US, V159, P466, DOI 10.1016/j.jpeds.2011.02.005; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shams'ili S, 2003, BRAIN, V126, P1409, DOI 10.1093/brain/awg133; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamnaes J, 2010, AMINO ACIDS, V39, P1183, DOI 10.1007/s00726-010-0554-y; Waszkiewicz Napoleon, 2010, Pol Merkur Lekarski, V29, P269; Wilkinson ID, 2005, J NEUROL NEUROSUR PS, V76, P1011, DOI 10.1136/jnnp.2004.049809; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77638	10.1371/journal.pone.0077638	http://dx.doi.org/10.1371/journal.pone.0077638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204900	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100088
J	Li, N; Liu, EQ; Guo, J; Pan, L; Li, BJ; Wang, P; Liu, J; Wang, Y; Liu, GS; Hu, G				Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu; Hu, Gang			Maternal Prepregnancy Body Mass Index and Gestational Weight Gain on Offspring Overweight in Early Infancy	PLOS ONE			English	Article							HIGH BIRTH-WEIGHT; CHILDHOOD OVERWEIGHT; OBESITY; PREGNANCY; ASSOCIATIONS; DISEASE; GROWTH; TRENDS; RISK; AGE	Objective: The aim of the present study was to evaluate the association of maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG) with anthropometry in the offspring from birth to 12 months old in Tianjin, China. Methods: Between 2009 and 2011, health care records of 38,539 pregnant women had been collected, and their children had been measured body weight and length at birth, 3, 6, 9 and 12 months of age. The independent and joint associations of pre-pregnancy BMI and GWG based on the Institute of Medicine (IOM) guidelines with anthropometry in the offspring were examined using General Linear Model and Logistic Regression. Results: Prepregnancy BMI and maternal GWG were positively associated with Z-scores for birth weight-for-gestational age, birth length-for-gestational age, and birth weight-for-length. Infants born to mothers with excessive GWG had the greatest changes in Z-scores for weight-for-age from birth to Month 3, and from Month 6 to Month 12, and the greatest changes in Z-scores for length-for-age from birth to months 3 and 12 compared with infants born to mothers with adequate GWG. Excessive GWG was associated with an increased risk of offspring overweight or obesity at 12 months old in all BMI categories except underweight. Conclusions: Maternal prepregnancy overweight/obesity and excessive GWG were associated with greater weight gain and length gain of offspring in early infancy. Excessive GWG was associated with increased infancy overweight and obesity risk.	[Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China; [Li, Nan; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA USA.	gang.hu@pbrc.edu	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Tianjin Women's and Children's Health Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Tianjin Women's and Children's Health Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All phases of this study were supported by Tianjin Women's and Children's Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Deierlein AL, 2012, PEDIATR OBES, V7, P134, DOI 10.1111/j.2047-6310.2011.00025.x; Deierlein AL, 2011, J PEDIATR-US, V158, P221, DOI 10.1016/j.jpeds.2010.08.008; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; Mamun AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-62; Min J, 2012, PEDIATR OBES, V7, P365, DOI [10.1111/j.2047-6310.2012.00074, 10.1111/j.2047-6310.2012.00074.x]; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Olson Christine M, 2010, Child Obes, V6, P201, DOI 10.1089/chi.2010.0419; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; SUITOR CW, 1991, J AM DIET ASSOC, V91, P96; Tianjin Women's and Children's Health Center, 2010, TIANJ WOM CHILDR HLT; von Kries R, 2011, INT J PEDIATR OBES, V6, P45, DOI 10.3109/17477161003792564; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO, 2006, WHO CHILD GROWTH STA; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818; Yang Yan-dong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P646; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	35	79	84	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77809	10.1371/journal.pone.0077809	http://dx.doi.org/10.1371/journal.pone.0077809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24204979	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400139
J	Yoshida, H; Miyachi, M; Sakamoto, K; Ouchi, K; Yagyu, S; Kikuchi, K; Kuwahara, Y; Tsuchiya, K; Imamura, T; Iehara, T; Kakazu, N; Hojo, H; Hosoi, H				Yoshida, H.; Miyachi, M.; Sakamoto, K.; Ouchi, K.; Yagyu, S.; Kikuchi, K.; Kuwahara, Y.; Tsuchiya, K.; Imamura, T.; Iehara, T.; Kakazu, N.; Hojo, H.; Hosoi, H.			PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells	ONCOGENE			English	Article						rhabdomyosarcoma; PAX3-NCOA2; PAX3-FOXO1A; tumorigenesis; inhibiting differentiation	STEROID-RECEPTOR COACTIVATOR; NUCLEAR-RECEPTOR; ALVEOLAR RHABDOMYOSARCOMA; LXXLL MOTIF; EMBRYONAL RHABDOMYOSARCOMA; TRANSCRIPTIONAL ACTIVITY; PAX3-FKHR; BINDING; PAX; DOMAIN	We analyzed a complex chromosomal translocation in a case of embryonal rhabdomyosarcoma (RMS) and showed that it generates the fusion gene PAX3 (paired box 3)-NCOA2 (nuclear receptor coactivator 2). To understand the role of this translocation in RMS tumorigenesis, we established two types of stable mouse myoblast C2C12 cell lines expressing PAX3-NCOA2 and PAX3-FOXO1A (forkhead box O1A), respectively. Compared with control cells, PAX3-NCOA2 cells grew faster, were more motile, were less anchorage dependent, progressed more quickly through the G1/S phase of cell cycle and showed greater transcriptional activation of the PAX3 consensus-binding site. However, PAX3-NCOA2 cells proliferated more slowly and differentiated more weakly than did PAX3-FOXO1A cells. Both PAX3-NCOA2 cells and PAX3-FOXO1A cells formed tumors in nude mice, although the PAX3-NCOA2-induced tumors grew more slowly. Our results may explain why NCOA2 rearrangement is mainly found in embryonal rhabdomyosarcoma, which has a better prognosis than alveolar rhabdomyosarcoma, which expresses the PAX3-FOXO1A fusion gene. These results indicate that the PAX3-NCOA2 fusion gene has a dual role in the tumorigenesis of RMS: promotion of the proliferation and inhibition of the myogenic differentiation of RMS cells.	[Yoshida, H.; Miyachi, M.; Sakamoto, K.; Ouchi, K.; Yagyu, S.; Kikuchi, K.; Kuwahara, Y.; Tsuchiya, K.; Imamura, T.; Iehara, T.; Hosoi, H.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto 6028566, Japan; [Kakazu, N.] Shimane Univ, Dept Environm & Prevent Med, Sch Med, Matsue, Shimane, Japan; [Hojo, H.] Fukushima Med Univ, Sch Med, Dept Pathol 1, Fukushima, Japan	Kyoto Prefectural University of Medicine; Shimane University; Fukushima Medical University	Hosoi, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamigyo Ku, Kajii Cho Hirokoji, Kyoto 6028566, Japan.	hhosoi@koto.kpu-m.ac.jp	Yagyu, Shigeki/H-9070-2019; Kikuchi, Ken/ABG-8290-2020	Yagyu, Shigeki/0000-0003-4256-9783; Kikuchi, Ken/0000-0003-3097-7480; Miyachi, Mitsuru/0000-0003-4522-2478	Ministry of Education, Culture, Sports, Science and Technology of Japan [21249085, 25253095, 22390239, 22591166, 24791078]; Grants-in-Aid for Scientific Research [24659500] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (A) 21249085, (A) 25253095, (B) 22390239, (C) 22591166, Grant-in-aid for Young Scientists (B) 24791078 and Grant-in-aid for Project for Development of Innovative Research on Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson J, 2001, AM J PATHOL, V159, P1089, DOI 10.1016/S0002-9440(10)61784-1; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Calhabeu F, 2013, ONCOGENE, V32, P651, DOI 10.1038/onc.2012.73; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen SL, 2000, GENE DEV, V14, P1209; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hamburger AW, 1978, CANCER RES, V38, P4118; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4946; Hosoi H, 2009, CANCER GENET CYTOGEN, V189, P98, DOI 10.1016/j.cancergencyto.2008.10.016; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Jothi M, 2012, CELL CYCLE, V11, P895, DOI 10.4161/cc.11.5.19346; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Litterst CM, 2002, J BIOL CHEM, V277, P36052, DOI 10.1074/jbc.M203556200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma H, 1999, MOL CELL BIOL, V19, P6164; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Mosquera JM, 2013, GENE CHROMOSOME CANC, V52, P538, DOI 10.1002/gcc.22050; Naini S, 2008, CANCER RES, V68, P9583, DOI 10.1158/0008-5472.CAN-07-6178; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Parker D, 1999, MOL CELL BIOL, V19, P5601; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Sumegi J, 2010, GENE CHROMOSOME CANC, V49, P224, DOI 10.1002/gcc.20731; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TREMBLAY P, 1994, PHARMACOL THERAPEUT, V61, P205, DOI 10.1016/0163-7258(94)90063-9; Tsuchiya K, 2007, INT J ONCOL, V31, P41; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang W, 1998, CANCER RES, V58, P4426; Zhang YB, 2009, INT J CLIN EXP PATHO, V2, P370	41	15	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5601	5608		10.1038/onc.2013.491	http://dx.doi.org/10.1038/onc.2013.491			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24213582				2022-12-25	WOS:000346088700004
J	Ye, H; Zhang, C; Wang, BJ; Tan, XH; Zhang, WP; Teng, Y; Yang, X				Ye, H.; Zhang, C.; Wang, B-J; Tan, X-H; Zhang, W-P; Teng, Y.; Yang, X.			Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice	ONCOGENE			English	Article						hepatocellular carcinoma; Kras(G12D); HBx; mouse model; Cre-LoxP; transgenic mice	HEPATITIS-B-VIRUS; X-PROTEIN; UP-REGULATION; SIGNALING PATHWAY; RAS ONCOGENES; BETA-CATENIN; GENE; EXPRESSION; LIVER; HEPATOCARCINOGENESIS	Although the activation of Ras pathway is frequently observed in human hepatocellular carcinoma (HCC), the in vivo role of Ras activation in HCC initiation and progression is underdetermined. To test the consequence of Kras activation in hepatocyte, we generated a hepatocyte-specific Kras(G12D) transgenic mouse strain and observed spontaneous development of HCC in these mice. Remarkably, HBV X protein (HBx) expression significantly promotes the formation and malignant progression of Kras(G12D)-driven HCC as shown with the accelerated tumor onset, the increased tumor burden and the more poorly differentiated lesions. At the cellular level, concomitant expression of Kras(G12D) and HBx results in a robust increase in hepatocellular proliferation. We reveal that the Akt, MAPK, p53 and TGF-beta pathways are deregulated in the Kras(G12D)-driven HCCs. Also, the dysregulation is more pronounced in the HCCs developed in Kras(G12D) and HBx double transgenic mice. In addition, the altered expressions of beta-catenin, CD44 and E-cadherin are only observed in the Kras(G12D) and HBx double transgenic mice. These results demonstrate a crucial role of Ras activation in hepatocellular carcinogenesis and the functional synergy between Kras(G12D) and HBx in HCC initiation and progression. The novel genetic mouse models that closely recapitulate the histopathologic progression and molecular alterations of human HCC may potentially facilitate the future therapeutic studies.	[Ye, H.; Zhang, C.; Yang, X.] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Univ, Model Organism Div, Shanghai, Peoples R China; [Ye, H.; Zhang, C.; Wang, B-J; Tan, X-H; Teng, Y.; Yang, X.] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China; [Zhang, W-P] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Teng, Y (corresponding author), Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, 20 Dongdajie, Beijing 100071, Peoples R China.	tengyan0919@163.com; yangx@bmi.ac.cn	XIAO, YANG/GPW-5529-2022	Yang, Xiao/0000-0002-0298-9831	National Natural Science Foundation of China [81272702, 31171249, 31071295, 81123001]; Chinese National Key Program on Basic Research [2011CB504202, 2012CB945103, 2011CB910601]; National High Technology Research and Development program of China [2012AA022402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Program on Basic Research; National High Technology Research and Development program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (81272702; 31171249; 31071295; 81123001), Chinese National Key Program on Basic Research (2011CB504202; 2012CB945103; 2011CB910601) and National High Technology Research and Development program of China (2012AA022402). We thank Xiao-Yan Chang for histopathologic analysis, You-Liang Wang, Xiu-Bin Li, Xiao-Jie Xu, Qi-Long Ye and Xin Chen for technical support.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Bock CT, 2008, INTERVIROLOGY, V51, P432, DOI 10.1159/000209672; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Cui F, 2006, PROTEOMICS, V6, P498, DOI 10.1002/pmic.200500218; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan RH, 2011, J MOL HISTOL, V42, P473, DOI 10.1007/s10735-011-9353-3; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123; Hsieh A, 2011, CANCER LETT, V300, P162, DOI 10.1016/j.canlet.2010.09.018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Keng VW, 2011, HEPATOLOGY, V53, P781, DOI 10.1002/hep.24091; Kim HR, 2010, FEBS LETT, V584, P525, DOI 10.1016/j.febslet.2009.11.091; Kim YC, 2001, ONCOGENE, V20, P16, DOI 10.1038/sj.onc.1203840; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Lee SG, 2000, ONCOGENE, V19, P468, DOI 10.1038/sj.onc.1203312; Lee YI, 2001, J BIOL CHEM, V276, P16969, DOI 10.1074/jbc.M011263200; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Longato L, 2009, HEPATOLOGY, V49, P1935, DOI 10.1002/hep.22856; MacNee W, 2013, THORAX, V68, P738, DOI 10.1136/thoraxjnl-2012-202744; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; NISHIDA N, 1994, INT J ONCOL, V4, P615; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sun Q, 2007, CANCER BIOL THER, V6, P668, DOI 10.4161/cbt.6.5.3955; Sun Q, 2007, CANCER BIOL THER, V6, P1532, DOI 10.4161/cbt.6.10.4683; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Wang SN, 2012, EUR J CLIN INVEST, V42, P1295, DOI 10.1111/eci.12003; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yang SF, 2007, J CLIN PATHOL, V60, P642, DOI 10.1136/jcp.2006.036970; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003	45	38	40	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5133	5138		10.1038/onc.2013.468	http://dx.doi.org/10.1038/onc.2013.468			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24213574				2022-12-25	WOS:000343768400008
J	Papakostas, K; Botou, M; Frillingos, S				Papakostas, Konstantinos; Botou, Maria; Frillingos, Stathis			Functional Identification of the Hypoxanthine/Guanine Transporters YjcD and YgfQ and the Adenine Transporters PurP and YicO of Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Evolution; Homology Modeling; Membrane Transport; Nucleoside Nucleotide Analogs; Nucleoside Nucleotide Transport; Purine; Adenine; Guanine; Hypoxanthine; Purine Analogs; Substrate Selectivity	CYSTEINE-SCANNING ANALYSIS; XANTHINE PERMEASE; SIGNATURE MOTIF; ACID TRANSPORTER; PROTEIN; FAMILY; MECHANISM; RESIDUES; CLONING; GENE	The evolutionarily broad family nucleobase-cation symporter-2 (NCS2) encompasses transporters that are conserved in binding site architecture but diverse in substrate selectivity. Putative purine transporters of this family fall into one of two homology clusters: COG2233, represented by well studied xanthine and/or uric acid permeases, and COG2252, consisting of transporters for adenine, guanine, and/or hypoxanthine that remain unknown with respect to structure-function relationships. We analyzed the COG2252 genes of Escherichia coli K-12 with homology modeling, functional overexpression, and mutagenesis and showed that they encode high affinity permeases for the uptake of adenine (PurP and YicO) or guanine and hypoxanthine (YjcD and YgfQ). The two pairs of paralogs differ clearly in their substrate and ligand preferences. Of 25 putative inhibitors tested, PurP and YicO recognize with low micromolar affinity N-6-benzoyladenine, 2,6-diaminopurine, and purine, whereas YjcD and YgfQ recognize 1-methylguanine, 8-azaguanine, 6-thioguanine, and 6-mercaptopurine and do not recognize any of the PurP ligands. Furthermore, the permeases PurP and YjcD were subjected to site-directed mutagenesis at highly conserved sites of transmembrane segments 1, 3, 8, 9, and 10, which have been studied also in COG2233 homologs. Residues irreplaceable for uptake activity or crucial for substrate selectivity were found at positions occupied by similar role amino acids in the Escherichia coli xanthine- and uric acid-transporting homologs (XanQ and UacT, respectively) and predicted to be at or around the binding site. Our results support the contention that the distantly related transporters of COG2233 and COG2252 use topologically similar side chain determinants to dictate their function and the distinct purine selectivity profiles.	[Papakostas, Konstantinos; Botou, Maria; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES; European Social Fund	European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES(Thales Group); European Social Fund(European Social Fund (ESF))	This work was co-supported by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES, investing in knowledge society through the European Social Fund.	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burzle M, 2013, MOL ASPECTS MED, V34, P436, DOI 10.1016/j.mam.2012.12.002; BURTON K, 1983, J GEN MICROBIOL, V129, P3505; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; DANIELSEN S, 1992, MOL MICROBIOL, V6, P1335, DOI 10.1111/j.1365-2958.1992.tb00854.x; Frillingos Stathis, 2012, Int J Biochem Mol Biol, V3, P250; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kose M, 2009, FUTURE MED CHEM, V1, P303, DOI [10.4155/fmc.09.29, 10.4155/FMC.09.29]; Kosti V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041939; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Kozmin SG, 2013, MBIO, V4, DOI 10.1128/mBio.00661-13; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Madej MG, 2013, P NATL ACAD SCI USA, V110, P5870, DOI 10.1073/pnas.1303538110; Mansfield TA, 2009, FEBS LETT, V583, P481, DOI 10.1016/j.febslet.2008.12.048; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Papakostas K, 2012, J BIOL CHEM, V287, P15684, DOI 10.1074/jbc.M112.355818; ROYBURMAN S, 1975, J BIOL CHEM, V250, P9270; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	40	31	35	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36827	36840		10.1074/jbc.M113.523340	http://dx.doi.org/10.1074/jbc.M113.523340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214977	Green Published, hybrid			2022-12-25	WOS:000329189700006
J	Acloque, H; Bonnet-Garnier, A; Mompart, F; Pinton, A; Yerle-Bouissou, M				Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine			Sperm Nuclear Architecture Is Locally Modified in Presence of a Robertsonian Translocation t(13;17)	PLOS ONE			English	Article							DEFINED GENOME ARCHITECTURE; IN-SITU HYBRIDIZATION; PERICENTRIC HETEROCHROMATIN; CHROMOSOME TERRITORIES; CHROMATIN ORGANIZATION; MEIOTIC SEGREGATION; SEX-CHROMOSOMES; CELLS; SPERMATOZOA; FISH	In mammals, the non-random organization of the sperm nucleus supports an early function during embryonic development. Altering this organization may interfere with the zygote development and reduce fertility or prolificity. Thus, rare studies on sperm cells from infertile patients described an altered nuclear organization that may be a cause or a consequence of their respective pathologies. Thereby, chromosomal rearrangements and aneuploidy can be studied not only for their adverse effects on production of normal/balanced gametes at meiosis but also for their possible impact on sperm nuclear architecture and the epigenetic consequences of altered chromosome positioning. We decided to compare the global architecture of sperm nuclei from boars, either with a normal chromosome composition or with a Robertsonian translocation involving chromosomes 13 and 17. We hypothesized that the fusion between these chromosomes may change their spatial organization and we examined to what extend it could also modify the global sperm nuclear architecture. Analysis of telomeres, centromeres and gonosomes repartition does not support a global nuclear disorganization. But specific analysis of chromosomes 13 and 17 territories highlights an influence of chromosome 17 for the positioning of the fused chromosomes within the nucleus. We also observed a specific clustering of centromeres depending of the chromosome subtypes. Altogether our results showed that chromosome fusion does not significantly alter sperm nucleus architecture but suggest that centromere remodelling after chromosome fusion locally impacts chromosome positioning.	[Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine] INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine] Univ Toulouse, INP, ENVT, Genet Cellulaire UMR444, Toulouse, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Acloque, H (corresponding author), INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France.	herve.acloque@toulouse.inra.fr	Pinton, Alain/AAQ-1648-2020; Bonnet-Garnier, Amelie/AAF-6841-2020	Pinton, Alain/0000-0002-0809-7180; Bonnet-Garnier, Amelie/0000-0002-2095-3365; Acloque, Herve/0000-0003-4761-1055	INRA	INRA	This work was funded by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Baumann C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-29; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; de Vries M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031485; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Foster HA, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-30; Garagna S, 2001, J CELL SCI, V114, P4429; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2003, CHROMOSOME RES, V11, P503, DOI 10.1023/A:1024982929452; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Gurevitch M, 2001, MOL REPROD DEV, V60, P507, DOI 10.1002/mrd.1116; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hassanane M, 1999, MOL REPROD DEV, V53, P407, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;407::AID-MRD6&gt;3.0.CO;2-O; Hazzouri M, 2000, MOL REPROD DEV, V55, P307, DOI 10.1002/(SICI)1098-2795(200003)55:3<307::AID-MRD9>3.0.CO;2-P; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Ioannou D, 2011, CYTOGENET GENOME RES, V133, P269, DOI 10.1159/000322060; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Manvelyan M, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-25; Meyer-Ficca M, 1998, J CELL SCI, V111, P1363; Midro AT, 2006, AM J MED GENET A, V140A, P245, DOI 10.1002/ajmg.a.31083; Milan D, 1996, MAMM GENOME, V7, P194, DOI 10.1007/s003359900053; MILLER JR, 1993, CYTOGENET CELL GENET, V62, P37, DOI 10.1159/000133441; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mompart F, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-30; Mudrak OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052944; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Olszewska M, 2008, CHROMOSOME RES, V16, P875, DOI 10.1007/s10577-008-1246-2; Pinton A, 2009, HUM REPROD, V24, P2034, DOI 10.1093/humrep/dep118; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rogel-Gaillard C, 1997, CYTOGENET CELL GENET, V79, P79, DOI 10.1159/000134687; Scascitelli M, 2003, CYTOGENET GENOME RES, V101, P136, DOI 10.1159/000074169; SCHMID M, 1979, CHROMOSOMA, V75, P215, DOI 10.1007/BF00292209; Schroeder-Reiter E, 2009, CYTOGENET GENOME RES, V124, P239, DOI 10.1159/000218129; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Solinhac R, 2011, CHROMOSOMA, V120, P501, DOI 10.1007/s00412-011-0328-7; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Solovei IV, 1998, CHROMOSOMA, V107, P184, DOI 10.1007/s004120050295; Stimpson KM, 2010, CURR OPIN CELL BIOL, V22, P772, DOI 10.1016/j.ceb.2010.07.002; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Tsend-Ayush E, 2009, CHROMOSOMA, V118, P53, DOI 10.1007/s00412-008-0177-1; Volpi EV, 2000, J CELL SCI, V113, P1565; Wiland E, 2008, PRENATAL DIAG, V28, P36, DOI 10.1002/pd.1899; Wiland E, 2008, CHROMOSOME RES, V16, P291, DOI 10.1007/s10577-007-1194-2; YERLE M, 1993, GENOMICS, V16, P97, DOI 10.1006/geno.1993.1146; Yerle-Bouissou M, 2009, CHROMOSOME RES, V17, P847, DOI 10.1007/s10577-009-9074-6; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zalensky AO, 1997, EXP CELL RES, V232, P29, DOI 10.1006/excr.1997.3482; ZALENSKY AO, 1995, CHROMOSOMA, V103, P577	55	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78005	10.1371/journal.pone.0078005	http://dx.doi.org/10.1371/journal.pone.0078005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205066	gold, Green Published, Green Submitted			2022-12-25	WOS:000326373800012
J	AlFadhli, S; Al-Jafer, H; Hadi, M; Al-Mutairi, M; Nizam, R				AlFadhli, Suad; Al-Jafer, Hassan; Hadi, Mays; Al-Mutairi, Mashael; Nizam, Rasheeba			The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; DIPHOSPHO-GLUCURONOSYLTRANSFERASE 1A1; GILBERTS-SYNDROME; GENETIC POLYMORPHISMS; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; BREAST-CANCER; TATA-BOX; ASSOCIATION; POPULATION; ANEMIA	Present study was aimed to explore the effect of (TA)(n) UGT1A1 gene promoter polymorphism on bilirubin metabolism, bilirubinaemia, predisposition to cholelithiasis and subsequent cholecystectomy, in Sickle-Cell Anemia (SCA) and beta-Thalasemia major (bTH) in Kuwaiti subjects compared to other population. This polymorphism was analyzed and correlated to total bilirubin and cholelithiasis in 270 age, gender, ethnically matched subjects (92 bTH, 116 SCA and 62 Controls) using PCR, dHPLC, fragment analysis and direct sequencing. Four genotypes of UGT1A1 were detected in this study (TA6/6, TA6/7, TA6/8 and TA7/7). (TA)6/8 was found only in four individuals; hence it was not included in the analysis. There was a statistically significant association of genotypes with serum total bilirubin levels in both bTH and SCA groups (p<0.001). Subjects with (TA)7/7 had the highest total serum bilirubin level (178.7 +/- 3.5 mu mole/l). A significant association was observed between allele (TA) 7 and cholelithiasis development (p = 0.0001). The 40%, 67.5% and 100% of SCA with (TA)6/6, (TA)6/7 and (TA) 7/7 respectively developed cholelithiasis and were subsequently cholecystectomized. Our results confirm UGT1A1 (TA) 7 allele as one of the factors accounting for the hyperbilirubinemia and cholelithiasis observed in SCA and bTH.	[AlFadhli, Suad; Hadi, Mays; Al-Mutairi, Mashael; Nizam, Rasheeba] Kuwait Univ, Dept Med Lab Sci, Jabriya, Kuwait; [Al-Jafer, Hassan] Minist Hlth, Al Amiri Hosp Med Lab, Kuwait, Kuwait	Kuwait University	AlFadhli, S (corresponding author), Kuwait Univ, Dept Med Lab Sci, Jabriya, Kuwait.	s.alfadhli@hsc.edu.kw			Kuwait University research administration grant [NM 01/07]	Kuwait University research administration grant	This work was supported by Kuwait University research administration grant NM 01/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2009, PEDIATR RES, V65, P675, DOI 10.1203/PDR.0b013e31819ed5de; Arambula E, 2002, BLOOD CELL MOL DIS, V28, P86, DOI 10.1006/bcmd.2001.0481; Babaoglu MO, 2006, BASIC CLIN PHARMACOL, V98, P377, DOI 10.1111/j.1742-7843.2006.pto_341.x; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Biondi ML, 1999, CLIN CHEM, V45, P897; Borlak J, 2000, HEPATOLOGY, V32, P792, DOI 10.1053/jhep.2000.18193; Bosma PJ, 2003, J HEPATOL, V38, P107, DOI 10.1016/S0168-8278(02)00359-8; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Clarke DJ, 1997, CLIN CHIM ACTA, V266, P63, DOI 10.1016/S0009-8981(97)00167-8; Deming SL, 2008, CANCER EPIDEM BIOMAR, V17, P563, DOI 10.1158/1055-9965.EPI-07-0752; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Fertrin KY, 2002, AM J MED GENET, V108, P117, DOI 10.1002/ajmg.10209; Grant DJ, 2004, MUTAT RES-GEN TOX EN, V560, P1, DOI 10.1016/j.mrgentox.2004.01.010; Guillemette C, 2000, CANCER RES, V60, P950; Guillemette C, 2001, CANCER EPIDEM BIOMAR, V10, P711; Haberkern CM, 1997, BLOOD, V89, P1533; Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/01213011-199910000-00006; Heeney MM, 2003, J LAB CLIN MED, V141, P279, DOI 10.1067/mlc.2003.28; Huo DZ, 2008, BREAST CANCER RES TR, V110, P367, DOI 10.1007/s10549-007-9720-7; Kalotychou V, 2003, BLOOD CELL MOL DIS, V31, P38, DOI 10.1016/S1079-9796(03)00118-9; Ki CS, 2003, CLIN CHEM, V49, P2078, DOI 10.1373/clinchem.2003.024174; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; MCCALL IW, 1977, AM J HEMATOL, V3, P15, DOI 10.1002/ajh.2830030102; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Nikolac N, 2008, CLIN CHEM LAB MED, V46, P174, DOI 10.1515/CCLM.2008.035; Ostanek B, 2007, BLOOD CELL MOL DIS, V38, P78, DOI 10.1016/j.bcmd.2006.10.160; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Raijmakers MTM, 2000, J HEPATOL, V33, P348, DOI 10.1016/S0168-8278(00)80268-8; Rantner B, 2008, CLIN CHEM, V54, P851, DOI 10.1373/clinchem.2007.102046; Samilchuk E, 2003, BLOOD CELL MOL DIS, V31, P201, DOI 10.1016/S1079-9796(03)00125-6; Sampietro M, 1999, HAEMATOLOGICA, V84, P150; SARNAIK S, 1980, J PEDIATR-US, V96, P1005, DOI 10.1016/S0022-3476(80)80626-3; SCHUBERT TT, 1986, GASTROENTEROLOGY, V90, P2013, DOI 10.1016/0016-5085(86)90276-3; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; Sugatani J, 2008, N-S ARCH PHARMACOL, V377, P597, DOI 10.1007/s00210-007-0226-y; te Morsche RHM, 2001, HEPATOLOGY, V33, P765, DOI 10.1053/jhep.2001.0103303le03; Tsezou A, 2009, GENET TEST MOL BIOMA, V13, P143, DOI 10.1089/gtmb.2008.0095; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; WEBB DKH, 1989, ARCH DIS CHILD, V64, P693, DOI 10.1136/adc.64.5.693	40	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77681	10.1371/journal.pone.0077681	http://dx.doi.org/10.1371/journal.pone.0077681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204915	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500042
J	Magera, AM; Flemming, JEM; Kaschner, K; Christensen, LB; Lotze, HK				Magera, Anna M.; Flemming, Joanna E. Mills; Kaschner, Kristin; Christensen, Line B.; Lotze, Heike K.			Recovery Trends in Marine Mammal Populations	PLOS ONE			English	Article							EXTINCTION RISK; HARBOR SEALS; ABUNDANCE; CONSERVATION; WHALES; IMPACTS; SIZE; DEPLETION; DOLPHINS; FISHERY	Marine mammals have greatly benefitted from a shift from resource exploitation towards conservation. Often lauded as symbols of conservation success, some marine mammal populations have shown remarkable recoveries after severe depletions. Others have remained at low abundance levels, continued to decline, or become extinct or extirpated. Here we provide a quantitative assessment of (1) publicly available population-level abundance data for marine mammals worldwide, (2) abundance trends and recovery status, and (3) historic population decline and recent recovery. We compiled 182 population abundance time series for 47 species and identified major data gaps. In order to compare across the largest possible set of time series with varying data quality, quantity and frequency, we considered an increase in population abundance as evidence of recovery. Using robust log-linear regression over three generations, we were able to classify abundance trends for 92 spatially non-overlapping populations as Significantly Increasing (42%), Significantly Decreasing (10%), Non-Significant Change (28%) and Unknown (20%). Our results were comparable to IUCN classifications for equivalent species. Among different groupings, pinnipeds and other marine mammals (sirenians, polar bears and otters) showed the highest proportion of recovering populations, likely benefiting from relatively fast life histories and nearshore habitats that provided visibility and protective management measures. Recovery was less frequent among cetaceans, but more common in coastal than offshore populations. For marine mammals with available historical abundance estimates (n = 47), larger historical population declines were associated with low or variable recent recoveries so far. Overall, our results show that many formerly depleted marine mammal populations are recovering. However, data-deficient populations and those with decreasing and non-significant trends require attention. In particular, increased study of populations with major data gaps, including offshore small cetaceans, cryptic species, and marine mammals in low latitudes and developing nations, is needed to better understand the status of marine mammal populations worldwide.	[Magera, Anna M.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna E. Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Kaschner, Kristin] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Kaschner, Kristin] Domaine Petit Arbois, CESAB Ctr Synth & Anal Biodivers, Aix En Provence, France; [Christensen, Line B.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Dalhousie University; Dalhousie University; University of Freiburg; University of British Columbia	Magera, AM (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	ammagera@gmail.com	Kaschner, Kristin/GQQ-6475-2022	Lotze, Heike/0000-0001-6258-1304; Mills Flemming, Joanna/0000-0002-3517-3089; Kaschner, Kristin/0000-0002-4061-626X	Census of Marine Life's Future of Marine Animal Populations (FMAP) program; Natural Sciences and Engineering Research Council (NSERC); Dalhousie University; Pew Charitable Trusts	Census of Marine Life's Future of Marine Animal Populations (FMAP) program; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University; Pew Charitable Trusts	Financial support was provided by the Census of Marine Life's Future of Marine Animal Populations (FMAP) program (www.fmap.ca) with a grant to HKL, the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) with grants to HKL and JMF, and Dalhousie University (www.dal.ca). Financial support for data collection was provided by Pew Charitable Trusts (www.pewtrusts.org) through the Sea Around Us Project (www.seaaroundus.org) for populating the abundance databases provided by KK and LBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2004, EXTINCTION STORY CON, DOI 10.4324/9781849770415; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Angliss RP, 2009, ALASKA MARINE MAMMAL; [Anonymous], 2010, OXFORD DICT; ARON W, 1988, COAST MANAGE, V16, P99, DOI 10.1080/08920758809362051; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; BEST PB, 1993, ICES J MAR SCI, V50, P169, DOI 10.1006/jmsc.1993.1018; Bhargava M, 2005, ECOL LAW QUART, V32, P939; BIGG MA, 1988, CAN FIELD NAT, V102, P315; Boyd IL, 2002, ENCY MARINE MAMMALS; Brown RE, 2005, MAR MAMMAL SCI, V21, P657, DOI 10.1111/j.1748-7692.2005.tb01258.x; Christensen LB, 2006, MARINE MAMMAL POPULA; Clapham PJ, 1999, MAMMAL REV, V29, P35; Colten RH, 2002, INT J OSTEOARCHAEOL, V12, P12, DOI 10.1002/oa.609; COSEWIC, 2008, COSEWIC ASS UPD STAT; COSEWIC, 2005, COSEWIC ASS UPD STAT; *COSEWIC, 2006, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; Dale A, 2011, MAR POLICY, V35, P440, DOI 10.1016/j.marpol.2010.10.019; David J, 2008, S AFR J SCI, V104, P107; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Fisheries and Oceans Canada, 2011, 2011 2015 INT FISH M; Forcada J, 2012, BIOL CONSERV, V149, P40, DOI 10.1016/j.biocon.2012.02.002; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; Freeman Milton M. R., 2008, Endangered Species Research, V6, P173, DOI 10.3354/esr00102; Garner GW, 1999, MARINE MAMMALS SURVE, pXI; Gerber Leah, 1998, Integrative Biology, V1, P90, DOI 10.1002/(SICI)1520-6602(1998)1:3<90::AID-INBI3>3.3.CO;2-H; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.29.773; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; GERRODETTE T, 1990, MAR MAMMAL SCI, V6, P1, DOI 10.1111/j.1748-7692.1990.tb00221.x; Gerrodette T, 2008, ESTIMATES 2006 DOLPH; Gotelli N.J., 1995, PRIMER ECOLOGY; Hoezel AR, 2002, MARINE MAMMAL BIOL E; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Hutchings JA, 2001, J FISH BIOL, V59, P306, DOI 10.1006/jfbi.2001.1756; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hutchings JA, 2012, TRENDS ECOL EVOL, V27, P542, DOI 10.1016/j.tree.2012.06.005; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K, 2004, MODELLING MAPPING RE; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kasuya T, 2007, ENVIRON SCI POLLUT R, V14, P39, DOI 10.1065/espr2006.09.346; Kirkman SP, 2010, S AFR J SCI, V106, P1, DOI 10.4102/sajs.v106i3/4.166; Kovacs KM, 2006, POPULATION STRUCTURE, P416; Lake S, 2008, MAR ECOL PROG SER, V366, P259, DOI 10.3354/meps07502; Lavigne David M., 1999, P10; Lotze HK, 2007, FISH RES, V87, P208, DOI 10.1016/j.fishres.2006.12.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Marsh H, 2002, DUGONG STATUS REPORT; Neiman S., 2009, MORAL CLARITY GUIDE; Nichol LM, 2005, ASSESSMENT ABUNDANCE; NMFS, 2005, REC PLAN N ATL RIGHT; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Perry S.L., 1999, MAR FISH REV, V61, P1; Pyenson ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021295; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; Reeves RR, 1996, INTERCIENCIA, V21, P246; REIJNDERS PJH, 1994, HYDROBIOLOGIA, V283, P557; REIJNDERS PJH, 1993, SEALS FUR SEALS SEA; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sanderson EW, 2006, BIOSCIENCE, V56, P911, DOI 10.1641/0006-3568(2006)56[911:HMADWW]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sea Otter Recovery Team, 2007, REC STRAT SEA OTT EN, pvii; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Silva MA, 2001, MAR MAMMAL SCI, V17, P418, DOI 10.1111/j.1748-7692.2001.tb01285.x; Smith I, 2005, EXPLOITATION AND CULTURAL IMPORTANCE OF SEA MAMMALS, P6; Southwell C, 2008, J APPL ECOL, V45, P622, DOI 10.1111/j.1365-2664.2007.01399.x; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas L, 2008, ESTIMATING SIZE UK G; Thomas L, 2007, FISHERIES OCEANS CAN; Valade JA, 2009, MAN POP EC MAN WORKS; Wade PR, 2007, MAR ECOL PROG SER, V343, P1, DOI 10.3354/meps07069; Wade PR, SOCIAL BEHAV F UNPUB; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H, 2000, CETACEAN SOCIETIES, P219; Whitehead H, 2012, ENDANGER SPECIES RES, V19, P47, DOI 10.3354/esr00458; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zamar R, 2009, PACKAGE ROBUST	96	113	113	2	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77908	10.1371/journal.pone.0077908	http://dx.doi.org/10.1371/journal.pone.0077908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205025	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500077
J	Meng, L; Wan, YJ; Sun, YY; Zhang, YL; Wang, ZY; Song, Y; Wang, F				Meng, Li; Wan, Yongjie; Sun, Yanyan; Zhang, Yanli; Wang, Ziyu; Song, Yang; Wang, Feng			Generation of Five Human Lactoferrin Transgenic Cloned Goats Using Fibroblast Cells and Their Methylation Status of Putative Differential Methylation Regions of IGF2R and H19 Imprinted Genes	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; LARGE-SCALE PRODUCTION; SOMATIC-CELLS; ADULT; PIGS; EXPRESSION; FETAL; CLONING; SHEEP; MILK	Background: Somatic cell nuclear transfer (SCNT) is a promising technique to produce transgenic cloned mammalian, including transgenic goats which may produce Human Lactoferrin (hLF). However, success percentage of SCNT is low, because of gestational and neonatal failure of transgenic embryos. According to the studies on cattle and mice, DNA methylation of some imprinted genes, which plays a vital role in the reprogramming of embryo in NT maybe an underlying mechanism. Methodology/Principal Findings: Fibroblast cells were derived from the ear of a two-month-old goat. The vector expressing hLF was constructed and transfected into fibroblasts. G418 selection, EGFP expression, PCR, and cell cycle distribution were applied sequentially to select transgenic cells clones. After NT and embryo transfer, five transgenic cloned goats were obtained from 240 cloned transgenic embryos. These transgenic goats were identified by 8 microsatellites genotyping and southern blot. Of the five transgenic goats, 3 were lived after birth, while 2 were dead during gestation. We compared differential methylation regions (DMR) pattern of two paternally imprinted genes (H19 and IGF2R) of the ear tissues from the lived transgenic goats, dead transgenic goats, and control goats from natural reproduction. Hyper-methylation pattern appeared in cloned aborted goats, while methylation status was relatively normal in cloned lived goats compared with normal goats. Conclusions/Significance: In this study, we generated five hLF transgenic cloned goats by SCNT. This is the first time the DNA methylation of lived and dead transgenic cloned goats was compared. The results demonstrated that the methylation status of DMRs of H19 and IGF2R were different in lived and dead transgenic goats and therefore this may be potentially used to assess the reprogramming status of transgenic cloned goats. Understanding the pattern of gene imprinting may be useful to improve cloning techniques in future.	[Meng, Li; Wan, Yongjie; Zhang, Yanli; Wang, Ziyu; Song, Yang; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China; [Meng, Li] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Sun, Yanyan] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands	Nanjing Agricultural University; Wageningen University & Research; Wageningen University & Research	Wang, F (corresponding author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	caeet@njau.edu.cn	Song, Yang/HGU-4953-2022	sun, yanyan/0000-0001-6425-7786; Wan, Yongjie/0000-0001-6846-3755	National Major Special Projects on New Cultivation for Transgenic Organisms [2013ZX08008-004]; National Natural Science Foundation of China [31272443]; Fundamental Research Funds for the Central Universities [KYZ201211]	National Major Special Projects on New Cultivation for Transgenic Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported by the National Major Special Projects on New Cultivation for Transgenic Organisms (number 2013ZX08008-004), National Natural Science Foundation of China (31272443) and Fundamental Research Funds for the Central Universities (number KYZ201211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Arat S, 2002, BIOL REPROD, V66, P1768, DOI 10.1095/biolreprod66.6.1768; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bhure S, 2007, DNA SEQUENCE, V18, P39, DOI 10.1080/10425170601017145; Bondioli K, 2001, MOL REPROD DEV, V60, P189, DOI 10.1002/mrd.1076; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Chen SH, 2002, BIOL REPROD, V67, P1488, DOI 10.1095/biolreprod.102.006981; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Ezashi T, 2012, REPROD DOMEST ANIM, V47, P92, DOI 10.1111/j.1439-0531.2012.02061.x; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Gong GC, 2004, MOL REPROD DEV, V69, P278, DOI 10.1002/mrd.20130; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hill JR, 2000, BIOL REPROD, V62, P1135, DOI 10.1095/biolreprod62.5.1135; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Keefer CL, 2002, BIOL REPROD, V66, P199, DOI 10.1095/biolreprod66.1.199; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Kurome M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-43; Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Pollock DP, 1999, J IMMUNOL METHODS, V231, P147, DOI 10.1016/S0022-1759(99)00151-9; Reinius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056611; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Robl JM, 2007, THERIOGENOLOGY, V67, P127, DOI 10.1016/j.theriogenology.2006.09.034; Rosen JM, 1999, ANNU REV NUTR, V19, P407, DOI 10.1146/annurev.nutr.19.1.407; Salmon V, 1997, PROTEIN EXPRES PURIF, V9, P203, DOI 10.1006/prep.1996.0687; Shen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032812; Shen W, 2007, MOL REPROD DEV, V74, P428, DOI 10.1002/mrd.20595; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Does AM, 2012, J IMMUNOL, V188, P5012, DOI 10.4049/jimmunol.1102777; Verma OP, 2012, IN VITRO CELL DEV-AN, V48, P349, DOI 10.1007/s11626-012-9515-y; Wakayama T, 2007, J REPROD DEVELOP, V53, P13, DOI 10.1262/jrd.18120; Wan YJ, 2012, THERIOGENOLOGY, V78, P583, DOI 10.1016/j.theriogenology.2012.03.004; WARD PP, 1995, BIO-TECHNOL, V13, P498, DOI 10.1038/nbt0595-498; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilmut I, 2007, CLONING STEM CELLS, V9, P3, DOI 10.1089/clo.2006.0002; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Zhang L, 2009, ANIM REPROD SCI, V112, P182, DOI 10.1016/j.anireprosci.2008.04.017; Zhang YL, 2010, THERIOGENOLOGY, V73, P681, DOI 10.1016/j.theriogenology.2009.11.008; Zhao LX, 2012, REPROD DOMEST ANIM, V47, P504, DOI 10.1111/j.1439-0531.2011.01911.x	53	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77798	10.1371/journal.pone.0077798	http://dx.doi.org/10.1371/journal.pone.0077798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204972	Green Published, gold			2022-12-25	WOS:000326334500062
J	Priebe, S; Menzel, U; Zarse, K; Groth, M; Platzer, M; Ristow, M; Guthke, R				Priebe, Steffen; Menzel, Uwe; Zarse, Kim; Groth, Marco; Platzer, Matthias; Ristow, Michael; Guthke, Reinhard			Extension of Life Span by Impaired Glucose Metabolism in Caenorhabditis elegans Is Accompanied by Structural Rearrangements of the Transcriptomic Network	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; DIETARY RESTRICTION; C. ELEGANS; RECONSTRUCTION; COEXPRESSION; BIOLOGY; MODEL; TOR	Glucose restriction mimicked by feeding the roundworm Caenorhabditis elegans with 2-deoxy-D-glucose (DOG) - a glucose molecule that lacks the ability to undergo glycolysis - has been found to increase the life span of the nematodes considerably. To facilitate understanding of the molecular mechanisms behind this life extension, we analyzed transcriptomes of DOG-treated and untreated roundworms obtained by RNA-seq at different ages. We found that, depending on age, DOG changes the magnitude of the expression values of about 2 to 24 percent of the genes significantly, although our results reveal that the gross changes introduced by DOG are small compared to the age-induced changes. We found that 27 genes are constantly either up-or down-regulated by DOG over the whole life span, among them several members of the cytochrome P450 family. The monotonic change with age of the temporal expression patterns of the genes was investigated, leading to the result that 21 genes reverse their monotonic behaviour under impaired glycolysis. Put simply, the DOG-treatment reduces the gross transcriptional activity but increases the interconnectedness of gene expression. However, a detailed analysis of network parameters discloses that the introduced changes differ remarkably between individual signalling pathways. We found a reorganization of the hubs of the mTOR pathway when standard diet is replaced by DOG feeding. By constructing correlation based difference networks, we identified those signalling pathways that are most vigorously changed by impaired glycolysis. Taken together, we have found a number of genes and pathways that are potentially involved in the DOG-driven extension of life span of C. elegans. Furthermore, our results demonstrate how the network structure of ageing-relevant signalling pathways is reorganised under impaired glycolysis.	[Priebe, Steffen; Menzel, Uwe; Guthke, Reinhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Grp, Jena, Germany; [Zarse, Kim; Ristow, Michael] Univ Jena, Inst Nutr, Dept Human Nutr, Jena, Germany; [Groth, Marco; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal Grp, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Priebe, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Grp, Jena, Germany.	steffen.priebe@hki-jena.de	Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Groth, Marco/0000-0002-9199-8990	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) [BMBF 0315581]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF))	This work is part of the research program of the Jena Centre for Systems Biology of Ageing funded by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF; support code BMBF 0315581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birnby DA, 2000, GENETICS, V155, P85; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Ha MK, 2006, PROTEOMICS, V6, P3339, DOI 10.1002/pmic.200500395; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; R Development Core Team, 2012, R LANG ENV STAT COMP; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zahn JM, 2007, CURR OPIN BIOTECH, V18, P355, DOI 10.1016/j.copbio.2007.07.004; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	47	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77776	10.1371/journal.pone.0077776	http://dx.doi.org/10.1371/journal.pone.0077776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204961	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500059
J	Wedel, MJ; Taylor, MP				Wedel, Mathew J.; Taylor, Michael P.			Caudal Pneumaticity and Pneumatic Hiatuses in the Sauropod Dinosaurs Giraffatitan and Apatosaurus	PLOS ONE			English	Article							SP-NOV SAUROPODA; POSTCRANIAL PNEUMATICITY; VERTEBRAL PNEUMATICITY; THEROPOD DINOSAURS; AIR SACS; EVOLUTION; SKELETON; RECONSTRUCTION; DIPLODOCOIDEA; REDESCRIPTION	Skeletal pneumaticity is found in the presacral vertebrae of most sauropod dinosaurs, but pneumaticity is much less common in the vertebrae of the tail. We describe previously unrecognized pneumatic fossae in the mid-caudal vertebrae of specimens of Giraffatitan and Apatosaurus. In both taxa, the most distal pneumatic vertebrae are separated from other pneumatic vertebrae by sequences of three to seven apneumatic vertebrae. Caudal pneumaticity is not prominent in most individuals of either of these taxa, and its unpredictable development means that it may be more widespread than previously recognised within Sauropoda and elsewhere in Saurischia. The erratic patterns of caudal pneumatization in Giraffatitan and Apatosaurus, including the pneumatic hiatuses, show that pneumatic diverticula were more broadly distributed in the bodies of the living animals than are their traces in the skeleton. Together with recently published evidence of cryptic diverticula-those that leave few or no skeletal traces-in basal sauropodomorphs and in pterosaurs, this is further evidence that pneumatic diverticula were widespread in ornithodirans, both across phylogeny and throughout anatomy.	[Wedel, Mathew J.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA; [Taylor, Michael P.] Univ Bristol, Dept Earth Sci, Bristol BS8 1TH, Avon, England	Western University of Health Sciences; Western University of Health Sciences; University of Bristol	Wedel, MJ (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA.	mathew.wedel@gmail.com; dino@miketaylor.org.uk		Taylor, Mike/0000-0002-1003-5675	DFG Research Unit 533: Biology of the Sauropod Dinosaurs; Jurassic Foundation	DFG Research Unit 533: Biology of the Sauropod Dinosaurs; Jurassic Foundation	Research for this study was conducted on a field trip sponsored by DFG Research Unit 533: Biology of the Sauropod Dinosaurs; DFG 533 also supported our travel to Germany. The authors thank Martin Sander (University of Bonn) and the organisers and participants of the field trip. The Field Museum of Natural History supported our travel to Chicago. Research at the Carnegie Museum was supported by a grant from the Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, PNEUMATIC POSTCRANIA; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Britt B., 1997, ENCY DINOSAURS, P590; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Calvo JO, 2007, AN ACAD BRAS CIENC, V79, P529, DOI 10.1590/S0001-37652007000300013; Campos D.D.A., 2005, ARQ MUS NAC, V63, P565; Carvalho ID, 2003, CRETACEOUS RES, V24, P697, DOI 10.1016/j.cretres.2003.07.005; Casal Gabriel, 2007, Revista Brasileira de Paleontologia, V10, P53; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; COVER MS, 1953, AM J VET RES, V14, P239; Cranford TW, 1996, J MORPHOL, V228, P223; Duncker H.-R., 1971, ADV ANAT EMBRYOL CEL, V45, P1; Fanti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3080; Fronimos J, 2011, J VERTEBR PALEONTOL, V31, P112; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; GILMORE CHARLES W., 1932, PROC U S NATION MUS, V81, P1; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; Hatcher JB., 1903, MEM CARNEGIE MUS, V2, P1; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; HOGG DA, 1984, J ANAT, V139, P105; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P27; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P95; Janensch W., 1929, PALAEONTOGRAPHICA S7, V2, P35; Janensch W., 1947, PALAEONTOGRAPHICA S, V7, P1; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING A. S., 1957, ACTA ANAT, V31, P220; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; Lu Junchang, 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P43; Lull R. S., 1919, MEMOIRS CONNECTICUT, V6, P1; Mannion PD, 2011, J SYSTEMATIC PALAEON, V10, P521; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2011, CRETACEOUS RES, V32, P774, DOI 10.1016/j.cretres.2011.05.005; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Marsh O. C, 1896, 16 US GEOL SURV, P133; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Matthew W. D., 1905, American Museum Journal, V5; MAZZETTA G. V., 2004, HIST BIOL, V16, P1; McIntosh JS, 2005, LIFE O PAST, P38; Migeod FWH, 1931, NATURAL HIST MAGAZIN, V3, P87; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Osborn H. F., 1899, tt cc, P191; Osborn H. F., 1898, Bulletin of the American Museum of Natural History, Vx, P219; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Otero A, 2010, ACTA PALAEONTOL POL, V55, P399, DOI 10.4202/app.2009.0099; OWEN R, 1859, MONOGRAPHS PALAEONTO, P1; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Remes K, 2006, J VERTEBR PALEONTOL, V26, P651, DOI 10.1671/0272-4634(2006)26[651:ROTTSD]2.0.CO;2; Riggs ES., 1904, FIELD COLUMBIAN MUSE, V2, P229; RIGGS ES, 1903, FIELD COLUMBIAN MUSE, V2, P165; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Schwarz-Wings D, 2008, PALAEONTOL ELECTRON, V11; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2005, 53 S VERT PAL COMP A, P25; Tidwell Virginia, 1999, Oryctos, V2, P21; Tidwell Virginia, 2001, P139; Fernandez-Baldor FT, 2011, ACTA PALAEONTOL POL, V56, P535, DOI 10.4202/app.2010.0003; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P., 2004, NATL SCI MUS MONOGR, V26, P1; Upchurch P, 2009, PALAEONTOLOGY, V52, P1195, DOI 10.1111/j.1475-4983.2009.00909.x; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Weiglein A.H., 1999, PARANASAL SINUSES HI, P35; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075	95	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78213	10.1371/journal.pone.0078213	http://dx.doi.org/10.1371/journal.pone.0078213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205162	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500104
J	Liu, Y; Gu, DD; Wu, W; Wen, XX; Liao, YC				Liu, Yang; Gu, Dandan; Wu, Wei; Wen, Xiaoxia; Liao, Yuncheng			The Relationship between Polyamines and Hormones in the Regulation of Wheat Grain Filling	PLOS ONE			English	Article							ABSCISIC-ACID; POSTANTHESIS DEVELOPMENT; ENDOGENOUS HORMONES; SUPERIOR SPIKELETS; CYTOKININ CONTENT; MAIZE KERNELS; RICE; PLANT; GROWTH; ETHYLENE	The grain weight of wheat is strongly influenced by filling. Polyamines (PA) are involved in regulating plant growth. However, the effects of PA on wheat grain filling and its mechanism of action are unclear. The objective of the present study was to investigate the relationship between PAs and hormones in the regulation of wheat grain filling. Three PAs, spermidine (Spd), spermine (Spm), and putrescine (Put), were exogenously applied, and the grain filling characteristics and changes in endogenous PA and hormones, i.e., indole-3-acetic acid (IAA), zeatin (Z) + zeatin riboside (ZR), abscisic acid (ABA), ethylene (ETH) and gibberellin 1+4 (GAs), were quantified during wheat grain filling. Exogenous applications of Spd and Spm significantly increased the grain filling rate and weight, but exogenous Put had no significant effects on these measures. Exogenous Spd and Spm significantly increased the endogenous Spd, Spm, Z+ZR, ABA, and IAA contents and significantly decreased ETH evolution in grains. The endogenous Spd, Spm and Z+ZR contents were positively and significantly correlated with the grain filling rate and weight of wheat, and the endogenous ETH evolution was negatively and significantly correlated with the wheat grain filling rate and weight. Based upon these results, we concluded that PAs were involved in the balance of hormones that regulated the grain filling of wheat.	[Liu, Yang; Wu, Wei; Wen, Xiaoxia; Liao, Yuncheng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Gu, Dandan] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Liao, YC (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	yunchengliao@126.com	Wu, Wei/AAG-3230-2020	Wu, Wei/0000-0003-1867-1446	National Natural Science Foundation of China [31070375, 31171506]; Program of Introducing Talents of Discipline to Universities [B12007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Project No. 31070375, 31171506) and the Program of Introducing Talents of Discipline to Universities (B12007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; BUENO M, 1992, PHYSIOL PLANTARUM, V85, P531, DOI 10.1111/j.1399-3054.1992.tb05822.x; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; DIETRICH JT, 1995, PLANT PHYSIOL BIOCH, V33, P327; FUHRER J, 1982, PLANT PHYSIOL, V70, P1597, DOI 10.1104/pp.70.6.1597; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KUROGOCHI S, 1979, PLANTA, V146, P185, DOI 10.1007/BF00388230; Kusano T, 2007, J PLANT RES, V120, P345, DOI 10.1007/s10265-007-0074-3; Liang YL, 2002, CROP SCI, V42, P1217, DOI 10.2135/cropsci2002.1217; Liu J, 2005, J INTEGR PLANT BIOL, V47, P1326, DOI 10.1111/j.1744-7909.2005.00183.x; Liu J., 2002, TEC MET, V38, P596; Liu Y, 2011, PLANT GROWTH REGUL, V65, P247, DOI 10.1007/s10725-011-9594-x; MICHAEL G, 1972, CROP SCI, V12, P162, DOI 10.2135/cropsci1972.0011183X001200020002x; MORRIS RO, 1993, AUST J PLANT PHYSIOL, V20, P621, DOI 10.1071/PP9930621; Paschalidis KA, 2005, PLANT PHYSIOL, V138, P2174, DOI 10.1104/pp.105.063941; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAHA S, 1986, Canadian Journal of Botany, V64, P2068, DOI 10.1139/b86-271; Saini HS, 2000, ADV AGRON, V68, P59; SETH AK, 1967, J EXP BOT, V18, P65, DOI 10.1093/jxb/18.1.65; SINGH G, 1982, Plant Physiology and Biochemistry, V9, P22; SMITH MA, 1985, PLANT PHYSIOL, V78, P92, DOI 10.1104/pp.78.1.92; Steiner N, 2007, PLANT CELL TISS ORG, V89, P55, DOI 10.1007/s11240-007-9216-5; SUZUKI Y, 1981, PLANT CELL PHYSIOL, V22, P1085; Tan GuiLu, 2009, Acta Agronomica Sinica, V35, P2225, DOI 10.3724/SP.J.1006.2009.02225; Tomosugi M, 2006, PLANTA, V223, P349, DOI 10.1007/s00425-005-0083-1; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Xu GW, 2007, FIELD CROP RES, V101, P53, DOI 10.1016/j.fcr.2006.09.008; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2008, PLANTA, V228, P137, DOI 10.1007/s00425-008-0725-1; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Zahedi M, 2003, J AGR SCI-CAMBRIDGE, V141, P203, DOI 10.1017/S0021859603003411; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZC, 2009, J AGR SCI-CAMBRIDGE, V147, P423, DOI 10.1017/S0021859609008557	36	36	38	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78196	10.1371/journal.pone.0078196	http://dx.doi.org/10.1371/journal.pone.0078196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205154	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700083
J	Melvin, AT; Woss, GS; Park, JH; Dumberger, LD; Waters, ML; Allbritton, NL				Melvin, Adam T.; Woss, Gregery S.; Park, Jessica H.; Dumberger, Lukas D.; Waters, Marcey L.; Allbritton, Nancy L.			A Comparative Analysis of the Ubiquitination Kinetics of Multiple Degrons to Identify an Ideal Targeting Sequence for a Proteasome Reporter	PLOS ONE			English	Article							SINGLE CELLS; CAPILLARY-ELECTROPHORESIS; DEGRADATION; PROTEIN; PEPTIDE; SUBSTRATE; INHIBITOR; LIGASE; PHOSPHORYLATION; QUANTIFICATION	The ubiquitin proteasome system (UPS) is the primary pathway responsible for the recognition and degradation of misfolded, damaged, or tightly regulated proteins. The conjugation of a polyubiquitin chain, or polyubiquitination, to a target protein requires an increasingly diverse cascade of enzymes culminating with the E3 ubiquitin ligases. Protein recognition by an E3 ligase occurs through a specific sequence of amino acids, termed a degradation sequence or degron. Recently, degrons have been incorporated into novel reporters to monitor proteasome activity; however only a limited few degrons have successfully been incorporated into such reporters. The goal of this work was to evaluate the ubiquitination kinetics of a small library of portable degrons that could eventually be incorporated into novel single cell reporters to assess proteasome activity. After an intensive literary search, eight degrons were identified from proteins recognized by a variety of E3 ubiquitin ligases and incorporated into a four component degron-based substrate to comparatively calculate ubiquitination kinetics. The mechanism of placement of multiple ubiquitins on the different degron-based substrates was assessed by comparing the data to computational models incorporating first order reaction kinetics using either multi-monoubiquitination or polyubiquitination of the degron-based substrates. A subset of three degrons was further characterized to determine the importance of the location and proximity of the ubiquitination site lysine with respect to the degron. Ultimately, this work identified three candidate portable degrons that exhibit a higher rate of ubiquitination compared to peptidase-dependent degradation, a desired trait for a proteasomal targeting motif.	[Melvin, Adam T.; Woss, Gregery S.; Park, Jessica H.; Dumberger, Lukas D.; Waters, Marcey L.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Allbritton, Nancy L.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Allbritton, Nancy L.] N Carolina State Univ, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Allbritton, NL (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	nlallbri@unc.edu			National Institutes of Biomedical Imaging and Bioengineering [R01EB011763]; National Cancer Institute [F32CA162574]; NATIONAL CANCER INSTITUTE [F32CA162574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011763] Funding Source: NIH RePORTER	National Institutes of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Biomedical Imaging and Bioengineering, R01EB011763 (NLA), and the National Cancer Institute, F32CA162574 (ATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; Brazhnik P, 2007, MATH BIOSCI, V210, P60, DOI 10.1016/j.mbs.2007.05.005; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; Chen SJ, 2001, ANAL CHEM, V73, P111, DOI 10.1021/ac0009088; Cheng ZH, 2007, CHEMBIOCHEM, V8, P880, DOI 10.1002/cbic.200600565; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cline LL, 2009, BIOPOLYMERS, V92, P502, DOI 10.1002/bip.21266; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Geiger M, 2012, ANAL CHEM, V84, P577, DOI 10.1021/ac203205a; Gonzalez-Vera JA, 2012, CHEM SOC REV, V41, P1652, DOI 10.1039/c1cs15198c; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jiang DC, 2010, ELECTROPHORESIS, V31, P2558, DOI 10.1002/elps.201000054; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Lee K, 2010, BIOCHEM PHARMACOL, V80, P982, DOI 10.1016/j.bcp.2010.06.018; Li CK, 2008, LINEAR MULTILINEAR A, V56, P1, DOI 10.1080/03081080701538074; Li J, 2011, J BIOMOL SCREEN, V16, P450, DOI 10.1177/1087057111399191; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Melvin A, 2013, CELL BIOCH BIOPHYSIC; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Proctor A, 2012, ANAL CHEM, V84, P7195, DOI 10.1021/ac301489d; Proctor A, 2012, ANALYST, V137, P3028, DOI 10.1039/c2an16162a; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sonyang Z, 1995, NATURE, V373, P536; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Tobinai K, 2007, INT J CLIN ONCOL, V12, P318, DOI 10.1007/s10147-007-0695-5; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09	55	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78082	10.1371/journal.pone.0078082	http://dx.doi.org/10.1371/journal.pone.0078082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205101	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700072
J	Degen, M; Barron, P; Natarajan, E; Widlund, HR; Rheinwald, JG				Degen, Martin; Barron, Patricia; Natarajan, Easwar; Widlund, Hans R.; Rheinwald, James G.			RSK Activation of Translation Factor eIF4B Drives Abnormal Increases of Laminin gamma 2 and MYC Protein during Neoplastic Progression to Squamous Cell Carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; S6 KINASE; INITIATION-FACTORS; HELICASE ACTIVITY; MAMMALIAN TARGET; NECK-CANCER; IN-VITRO; HEAD; INHIBITOR; GROWTH	Overexpression of the basement membrane protein Laminin gamma 2 (Lam gamma 2) is a feature of many epidermal and oral dysplasias and all invasive squamous cell carcinomas (SCCs). This abnormality has potential value as an immunohistochemical biomarker of premalignancy but its mechanism has remained unknown. We recently reported that Lam gamma 2 overexpression in culture is the result of deregulated translation controls and depends on the MAPK-RSK signaling cascade. Here we identify eIF4B as the RSK downstream effector responsible for elevated Lam gamma 2 as well as MYC protein in neoplastic epithelial cells. Premalignant dysplastic keratinocytes, SCC cells, and keratinocytes expressing the E6 oncoprotein of human papillomavirus (HPV) type 16 displayed MAPK-RSK and mTOR-S6K1 activation and overexpressed Lam gamma 2 and MYC in culture. Immunohistochemical staining of oral dysplasias and SCCs for distinct, RSK- and S6K1-specific S6 phosphorylation events revealed that their respective upstream pathways become hyperactive at the same time during neoplastic progression. However, pharmacologic kinase inhibitor studies in culture revealed that Lam gamma 2 and MYC overexpression depends on MAPK-RSK activity, independent of PI3K-mTOR-S6K1. eIF4B knockdown reduced Lam gamma 2 and MYC protein expression, consistent with the known requirement for eIF4B to translate mRNAs with long, complex 5' untranslated regions (5'-UTRs). Accordingly, expression of a luciferase reporter construct preceded by the Lam gamma 2 5'-UTR proved to be RSK-dependent and mTOR-independent. These results demonstrate that RSK activation of eIF4B is causally linked to elevated Lam gamma 2 and MYC protein levels during neoplastic progression to invasive SCC. These findings have potential clinical significance for identifying premalignant lesions and for developing targeted drugs to treat SCC.	[Degen, Martin; Barron, Patricia; Widlund, Hans R.; Rheinwald, James G.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Degen, Martin; Barron, Patricia; Widlund, Hans R.; Rheinwald, James G.] Harvard Skin Dis Res Ctr, Boston, MA USA; [Natarajan, Easwar] Univ Connecticut, Ctr Hlth, Sect Oral & Maxillofacial Pathol, Farmington, CT USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Connecticut	Rheinwald, JG (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jimrheinwald@gmail.com		Degen, Martin/0000-0002-4356-3714; Widlund, Hans/0000-0002-7506-2447	Brigham and Women's Hospital BRI grant; Swiss National Science Foundation; Novartis Foundation; Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien)	Brigham and Women's Hospital BRI grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien)	This work was supported by a Brigham and Women's Hospital BRI grant to J.G.R. and by postdoctoral fellowships from the Swiss National Science Foundation, Novartis Foundation, and the Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien) to M. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bremmer JF, 2011, ORAL ONCOL, V47, P956, DOI 10.1016/j.oraloncology.2011.07.025; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Dabelsteen S, 2009, STEM CELLS, V27, P1388, DOI 10.1002/stem.64; Degen M, 2012, AM J PATHOL, V180, P2462, DOI 10.1016/j.ajpath.2012.02.028; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FERRARI S, 1991, J BIOL CHEM, V266, P22770; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Holmstrup P, 2006, ORAL ONCOL, V42, P461, DOI 10.1016/j.oraloncology.2005.08.011; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin C, 2013, ONCOGENE, V32, P2179, DOI 10.1038/onc.2012.236; Klein JD, 2010, CANCER BIOL THER, V9, P1; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Koshikawa N, 1999, CANCER RES, V59, P5596; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lingen MW, 2012, ORAL ONCOL; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; MIETZ JA, 1992, EMBO J, V11, P5013, DOI 10.1002/j.1460-2075.1992.tb05608.x; Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Natarajan E, 2003, AM J PATHOL, V163, P477, DOI 10.1016/S0002-9440(10)63677-2; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Nordemar S, 2003, ANTICANCER RES, V23, P4985; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pinto AP, 2013, MOD PATHOL IN PRESS; PYKE C, 1994, AM J PATHOL, V145, P782; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Venkatesan A, 2003, VIRUS RES, V94, P85, DOI 10.1016/S0168-1702(03)00136-9; Wakeling AE, 2002, CANCER RES, V62, P5749	54	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78979	10.1371/journal.pone.0078979	http://dx.doi.org/10.1371/journal.pone.0078979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205356	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200060
J	Schwartz, LM; Persson, EC; Weinstein, SJ; Graubard, BI; Freedman, ND; Mannisto, S; Albanes, D; McGlynn, KA				Schwartz, Lauren M.; Persson, E. Christina; Weinstein, Stephanie J.; Graubard, Barry I.; Freedman, Neal D.; Mannisto, Satu; Albanes, Demetrius; McGlynn, Katherine A.			Alcohol Consumption, One-Carbon Metabolites, Liver Cancer and Liver Disease Mortality	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CIGARETTE-SMOKING; UNITED-STATES; FOLATE INTAKE; COHORT; RISK; CARCINOGENESIS; BURDEN; REPRODUCIBILITY; VITAMIN-B-12	Background: Excess alcohol consumption adversely affects one-carbon metabolism and increases the risk of liver disease and liver cancer. Conversely, higher folate levels have been inversely associated with liver damage. The current study investigated the effects of alcohol and one-carbon metabolite intake on liver cancer incidence and liver disease mortality within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Methods: Cox proportional hazards modeling was used to calculate hazard ratios and 95% confidence intervals (CIs) in a population of 27,086 Finnish males with 194 incident liver cancers and 213 liver disease deaths. In a nested case-control subset (95 liver cancers, 103 controls), logistic regression was used to calculate odds ratios and 95% CIs for serum one-carbon metabolites in relation to liver cancer risk. Results: Daily alcohol consumption of more than 20.44 g was associated with an increased risk of both liver cancer incidence (Hazard Ratio (HR) 1.52, 95% CI 1.06-2.18) and liver disease mortality (HR 6.68, 95% CI 4.16-10.71). These risks were unaffected by one-carbon metabolite intake. Similarly, in the case-control study, none of the serum one-carbon metabolites were associated with liver cancer. Conclusions: The current study provided no convincing evidence for a protective association of one-carbon metabolite intake or serum level on the risk of liver cancer or liver disease mortality.	[Schwartz, Lauren M.; Persson, E. Christina; Weinstein, Stephanie J.; Graubard, Barry I.; Freedman, Neal D.; Albanes, Demetrius; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Persson, E. Christina] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut; Finland National Institute for Health & Welfare	McGlynn, KA (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	mcglynnk@mail.nih.gov	Albanes, Demetrius/B-9749-2015; Freedman, Neal David/B-9741-2015; Weinstein, Stephanie J/P-1627-2017	Freedman, Neal David/0000-0003-0074-1098; Weinstein, Stephanie J/0000-0002-3834-1535; Schwartz, Lauren/0000-0002-2264-3029; Mannisto, Satu/0000-0002-8668-3046	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the Intramural Research Program of the National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Dong CH, 2011, J STUD ALCOHOL DRUGS, V72, P892, DOI 10.15288/jsad.2011.72.892; Fears TR, 2002, CANCER EPIDEM BIOMAR, V11, P785; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Gabriel HE, 2006, AM J CLIN NUTR, V83, P835, DOI 10.1093/ajcn/83.4.835; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; Heinen MM, 2009, AM J EPIDEMIOL, V169, P1233, DOI 10.1093/aje/kwp028; Ibiebele TI, 2011, J NUTR, V141, P274, DOI 10.3945/jn.110.131235; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Mannino DM, 2003, NICOTINE TOB RES, V5, P357, DOI 10.1080/1462220031000094330; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shimazu T, 2012, INT J CANCER, V130, P2645, DOI 10.1002/ijc.26255; SHINBUEHRING YS, 1981, CLIN CHIM ACTA, V112, P257, DOI 10.1016/0009-8981(81)90448-4; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Trichopoulos D, 2011, JNCI-J NATL CANCER I, V103, P1686, DOI 10.1093/jnci/djr395; Welzel TM, 2007, CANCER EPIDEM BIOMAR, V16, P1279, DOI 10.1158/1055-9965.EPI-06-0853; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; ZEMPLENI J, 1992, INT J VITAM NUTR RES, V62, P165	28	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78156	10.1371/journal.pone.0078156	http://dx.doi.org/10.1371/journal.pone.0078156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205137	gold, Green Submitted, Green Published			2022-12-25	WOS:000326241200054
J	Barth, JMI; Matschiner, M; Robertson, BC				Barth, Julia M. I.; Matschiner, Michael; Robertson, Bruce C.			Phylogenetic Position and Subspecies Divergence of the Endangered New Zealand Dotterel (Charadrius obscurus)	PLOS ONE			English	Article							MTDNA CONTROL REGION; SUBSTITUTION MODELS; MITOCHONDRIAL-DNA; BIRDS; EVOLUTION; SEQUENCES; AVES; CHARADRIIFORMES; SYSTEMATICS; SHOREBIRDS	The New Zealand Dotterel (Charadrius obscurus), an endangered shorebird of the family Charadriidae, is endemic to New Zealand where two subspecies are recognized. These subspecies are not only separated geographically, with C. o. aquilonius being distributed in the New Zealand North Island and C. o. obscurus mostly restricted to Stewart Island, but also differ substantially in morphology and behavior. Despite these divergent traits, previous work has failed to detect genetic differentiation between the subspecies, and the question of when and where the two populations separated is still open. Here, we use mitochondrial and nuclear markers to address molecular divergence between the subspecies, and apply maximum likelihood and Bayesian methods to place C. obscurus within the non-monophyletic genus Charadrius. Despite very little overall differentiation, distinct haplotypes for the subspecies were detected, thus supporting molecular separation of the northern and southern populations. Phylogenetic analysis recovers a monophyletic clade combining the New Zealand Dotterel with two other New Zealand endemic shorebirds, the Wrybill and the Double-Banded Plover, thus suggesting a single dispersal event as the origin of this group. Divergence dates within Charadriidae were estimated with BEAST 2, and our results indicate a Middle Miocene origin of New Zealand endemic Charadriidae, a Late Miocene emergence of the lineage leading to the New Zealand Dotterel, and a Middle to Late Pleistocene divergence of the two New Zealand Dotterel subspecies.	[Barth, Julia M. I.; Robertson, Bruce C.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Matschiner, Michael] Univ Canterbury, Dept Math & Stat, Allan Wilson Ctr Mol Ecol & Evolut, Christchurch 1, New Zealand	University of Otago; University of Canterbury	Barth, JMI (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	jmi.barth@gmail.com		Barth, Julia/0000-0001-5125-819X; Matschiner, Michael/0000-0003-4741-3884	New Zealand Department of Conservation's Conservation Management Units Fund; Swiss National Science Foundation [PBBSP3-138680]; University of Otago	New Zealand Department of Conservation's Conservation Management Units Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Otago	This work was supported by the New Zealand Department of Conservation's Conservation Management Units Fund (JB and BR), the Swiss National Science Foundation (PBBSP3-138680) (MM), and the University of Otago (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Baker AJ, 2012, MOL PHYLOGENET EVOL, V65, P631, DOI 10.1016/j.ympev.2012.07.018; Baker Allan J., 1997, P51, DOI 10.1016/B978-012498315-1/50005-4; Banks JC, 2007, NEW ZEAL J ZOOL, V34, P141, DOI 10.1080/03014220709510072; Barlow Maida, 1993, Notornis, V40, P15; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bock WJ, 1958, B MUS COMP ZOOL HARV, V118, P25; Buller WL., 1888, HIST BIRDS NZ, V2; BURTON P J K, 1972, Notornis, V19, P26; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; CHRISTIAN PD, 1992, AUST J ZOOL, V40, P225, DOI 10.1071/ZO9920225; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; Crocker T, 2010, NOTORNIS, V57, P27; DOWDING J E, 1991, Notornis, V38, P89; Dowding J.E., 2007, NZ DOTTEREL CHARADRI; Dowding JE, 1997, PRED WORKSH; Dowding JE, 1993, NZ DOTTEREL RECOVERY; Dowding JE, 2006, HABITAT NETWORKS IND; Dowding John E., 1999, Notornis, V46, P167; Dowding John E., 1993, Notornis, V40, P1; Dowding John E., 1994, Notornis, V41, P221; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Field BD., 2002, REV MEXICANA CIENCIA, V19, P242; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gray GR, 1862, IBIS, V4, P214; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Herbert JM, 1993, CONSERVATION ADVISOR, V41; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Holloway J., 1977, LEPIDOPTERA NORFOLK; Hou LH, 2002, CONDOR, V104, P896, DOI 10.1650/0010-5422(2002)104[0896:AMESFC]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2022, IUCN RED LIST THREAT; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Joseph L, 1999, J BIOGEOGR, V26, P329, DOI 10.1046/j.1365-2699.1999.00269.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kuro-O M, 2010, CONSERV GENET, V11, P127, DOI 10.1007/s10592-009-0011-1; Lee DE, 2001, AUST J BOT, V49, P341, DOI 10.1071/BT00031; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; MACLEAN GL, 1977, EMU, V77, P199, DOI 10.1071/MU9770199; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2011, B GEOL SOC DENMARK, V59, P23; MCDOUGALL I, 1981, J GEOL SOC AUST, V28, P155, DOI 10.1080/00167618108729154; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Miskelly Colin M., 2008, Notornis, V55, P117; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OSNZ Checklist Committee, 2022, ORNITHOLOGICAL SOC N, V1, P208; Pang JF, 2003, CONSERV GENET, V4, P109, DOI 10.1023/A:1021817925740; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Paton TA, 2006, MOL PHYLOGENET EVOL, V39, P657, DOI 10.1016/j.ympev.2006.01.011; PHILLIPS RE, 1980, EMU, V80, P177, DOI 10.1080/01584197.1980.11799274; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robertson BC, 2011, MOL PHYLOGENET EVOL, V61, P949, DOI 10.1016/j.ympev.2011.08.001; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Seebohm H., 1888, GEOGRAPHICAL DISTRIB; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Thomas GH, 2004, MOL PHYLOGENET EVOL, V30, P516, DOI 10.1016/S1055-7903(03)00222-7; Trewick SA, 2001, EVOLUTION, V55, P2170; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Wu CH, 2013, MOL BIOL EVOL, V30, P669, DOI 10.1093/molbev/mss258; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zwickl D., 2006, GARLI GENETIC ALGORI	84	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78068	10.1371/journal.pone.0078068	http://dx.doi.org/10.1371/journal.pone.0078068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205094	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400069
J	Kevorkova, O; Martineau, C; Martin-Falstrault, L; Sanchez-Dardon, J; Brissette, L; Moreau, R				Kevorkova, Olha; Martineau, Corine; Martin-Falstrault, Louise; Sanchez-Dardon, Jaime; Brissette, Louise; Moreau, Robert			Low-Bone- Mass Phenotype of Deficient Mice for the Cluster of Differentiation 36 (CD36)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SCAVENGER RECEPTOR; DOWN-REGULATION; OSTEOPOROSIS; METABOLISM; LIPOPROTEIN; NEOVASCULARIZATION; THROMBOSPONDIN-1; CALCIFICATION; ANGIOGENESIS	Bone tissue is continuously remodeled by bone cells and maintenance of its mass relies on the balance between the processes of resorption and formation. We have reported the expression of numerous scavenger receptors, namely scavenger receptor (SR) class B type I and II (SR-BI and SR-BII), and CD36, in bone-forming osteoblasts but their physiological roles in bone metabolism are still unknown. To unravel the role of CD36 in bone metabolism, we determined the bone phenotype of CD36 knockout (CD36KO) mice and characterized the cell functions of osteoblasts lacking CD36. Weights of CD36KO mice were significantly lower than corresponding wild-type (WT) mice, yet no significant difference was found in femoral nor tibial length between CD36KO and WT mice. Analysis of bone architecture by micro-computed tomography revealed a low bone mass phenotype in CD36KO mice of both genders. Femoral trabecular bone from 1 to 6 month-old CD36KO mice showed lower bone volume, higher trabecular separation and reduced trabeculae number compared to WT mice; similar alterations were noticed for lumbar vertebrae. Plasma levels of osteocalcin (OCN) and N-terminal propeptide of type I procollagen (PINP), two known markers of bone formation, were significantly lower in CD36KO mice than in WT mice, whereas plasma levels of bone resorption markers were similar. Accordingly, histology highlighted lower osteoblast perimeter and reduced bone formation rate. In vitro functional characterization of bone marrow stromal cells and osteoblasts isolated from CD36KO mice showed reduced cell culture expansion and survival, lower gene expression of osteoblastic Runt-related transcription factor 2 (Runx2) and osterix (Osx), as well as bone sialoprotein (BSP) and osteocalcin (OCN). Our results indicate that CD36 is mandatory for adequate bone metabolism, playing a role in osteoblast functions ensuring adequate bone formation.	[Kevorkova, Olha; Martineau, Corine; Sanchez-Dardon, Jaime; Moreau, Robert] Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Osseux, Montreal, PQ H3C 3P8, Canada; [Martin-Falstrault, Louise; Brissette, Louise] Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Lipoprot, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Moreau, R (corresponding author), Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Osseux, CP 8888, Montreal, PQ H3C 3P8, Canada.	moreau.robert@uqam.ca		Martineau, Corine/0000-0002-1550-2420	Canadian Institute of Health Research (CIHR); Le Fond de la Recherche en Sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council (NSERC) of Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Le Fond de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute of Health Research (CIHR). OK and CM are recipients of scholarships from Le Fond de la Recherche en Sante du Quebec (FRSQ) and Natural Sciences and Engineering Research Council (NSERC) of Canada, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Carron JA, 2000, BIOCHEM BIOPH RES CO, V270, P1124, DOI 10.1006/bbrc.2000.2574; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Faje A, 2012, CURR OSTEOPOROS REP, V10, P208, DOI 10.1007/s11914-012-0106-3; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Frost HM, 2001, AM J HUM BIOL, V13, P235, DOI 10.1002/1520-6300(200102/03)13:2<235::AID-AJHB1034>3.3.CO;2-D; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Haque WA, 2002, J CLIN ENDOCR METAB, V87, P2395, DOI 10.1210/jc.87.5.2395; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Luangrath V, 2008, ARTERIOSCL THROM VAS, V28, P1290, DOI 10.1161/ATVBAHA.107.161653; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Moreau R, 1997, J BONE MINER RES, V12, P1984, DOI 10.1359/jbmr.1997.12.12.1984; Mwaikambo BR, 2008, CORNEA, V27, P1037, DOI 10.1097/ICO.0b013e31817780b6; PARFITT AM, 1984, CALCIFIED TISSUE INT, V36, pS123, DOI 10.1007/BF02406145; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ruiz-Gaspa S, 2010, CALCIFIED TISSUE INT, V86, P220, DOI 10.1007/s00223-010-9336-5; Shen CL, 2009, NUTR RES, V29, P437, DOI 10.1016/j.nutres.2009.06.008; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Yamazaki H, 2004, ONCOL REP, V11, P371	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77701	10.1371/journal.pone.0077701	http://dx.doi.org/10.1371/journal.pone.0077701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204923	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400051
J	Witham, KL; Butcher, NJ; Sugamori, KS; Brenneman, D; Grant, DM; Minchin, RF				Witham, Katey L.; Butcher, Neville J.; Sugamori, Kim S.; Brenneman, Debbie; Grant, Denis M.; Minchin, Rodney F.			5-Methyl-Tetrahydrofolate and the S-Adenosylmethionine Cycle in C57BL/6J Mouse Tissues: Gender Differences and Effects of Arylamine N-Acetyltransferase-1 Deletion	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; FOLATE INTAKE; FOLIC-ACID; METABOLISM; MICE; ACETYLTRANSFERASE; DISEASE; CANCER; GENE; DEFECTS	Folate catabolism involves cleavage of the C-9-N-10 bond to form p-aminobenzoylgluamate (PABG) and pterin. PABG is then acetylated by human arylamine N-acetyltransferase 1 (NAT1) before excretion in the urine. Mice null for the murine NAT1 homolog (Nat2) show several phenotypes consistent with altered folate homeostasis. However, the exact role of Nat2 in the folate pathway in vivo has not been reported. Here, we examined the effects of Nat2 deletion in male and female mice on the tissue levels of 5-methyl-tetrahydrofolate and the methionine-S-adenosylmethionine cycle. We found significant gender differences in hepatic and renal homocysteine, S-adenosylmethionine and methionine levels consistent with a more active methionine-S-adenosylmethionine cycle in female tissues. In addition, methionine levels were significantly higher in female liver and kidney. PABG was higher in female liver tissue but lower in kidney compared to male tissues. In addition, qPCR of mRNA extracted from liver tissue suggested a significantly lower level of Nat2 expression in female animals. Deletion of Nat2 affected liver 5- methyl-tetrahydrofolate in female mice but had little effect on other components of the methionine-S-adenosylmethionine cycle. No N-acetyl-PABG was observed in any tissues in Nat2 null mice, consistent with the role of Nat2 in PABG acetylation. Surprisingly, tissue PABG levels were similar between wild type and Nat2 null mice. These results show that Nat2 is not required to maintain tissue PABG homeostasis in vivo under normal conditions.	[Witham, Katey L.; Butcher, Neville J.; Minchin, Rodney F.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Sugamori, Kim S.; Brenneman, Debbie; Grant, Denis M.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Queensland; University of Toronto	Minchin, RF (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	r.minchin@uq.edu.au		Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	Australian National Health and Medical Research Council; Canadian Institutes of Health Research	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Australian National Health and Medical Research Council, and by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; Christensen KE, 2010, J NUTR, V140, P1736, DOI 10.3945/jn.110.124917; Crider KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028144; Ernest S, 2005, PHYSIOL GENOMICS, V21, P404, DOI 10.1152/physiolgenomics.00199.2004; Estrada-Rodgers L, 1998, DRUG METAB DISPOS, V26, P502; Jensen LE, 2005, BIRTH DEFECTS RES A, V73, P512, DOI 10.1002/bdra.20143; Kawamura A, 2008, BIOCHEM PHARMACOL, V75, P1550, DOI 10.1016/j.bcp.2007.12.012; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Lammer EJ, 2004, BIRTH DEFECTS RES A, V70, P846, DOI 10.1002/bdra.20081; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; McMullen MH, 2002, ARCH BIOCHEM BIOPHYS, V401, P73, DOI 10.1016/S0003-9861(02)00030-9; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Ponziani FR, 2012, EUR REV MED PHARMACO, V16, P376; SCHMITZ JC, 1994, BIOCHEM PHARMACOL, V48, P319, DOI 10.1016/0006-2952(94)90103-1; Solimando R, 2011, BEST PRACT RES CL GA, V25, P555, DOI 10.1016/j.bpg.2011.09.004; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Wakefield L, 2007, MAMM GENOME, V18, P270, DOI 10.1007/s00335-007-9010-z; Wang ZM, 2011, FOLATE RISK CORONARY; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77923	10.1371/journal.pone.0077923	http://dx.doi.org/10.1371/journal.pone.0077923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205029	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400060
J	Bouvier, LA; Camara, MD; Canepa, GE; Miranda, MR; Pereira, CA				Bouvier, Leon A.; de los Milagros Camara, Maria; Canepa, Gaspar E.; Miranda, Mariana R.; Pereira, Claudio A.			Plasmid Vectors and Molecular Building Blocks for the Development of Genetic Manipulation Tools for Trypanosoma cruzi	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION VECTOR; PURIFICATION; CONSTRUCTION; MECHANISM; PROTEINS; SEQUENCE; BIOLOGY; SYSTEM; HOST	The post genomic era revealed the need for developing better performing, easier to use and more sophisticated genetic manipulation tools for the study of Trypanosoma cruzi, the etiological agent of Chagas disease. In this work a series of plasmids that allow genetic manipulation of this protozoan parasite were developed. First of all we focused on useful tools to establish selection strategies for different strains and which can be employed as expression vectors. On the other hand molecular building blocks in the form of diverse selectable markers, modifiable fluorescent protein and epitope-tag coding sequences were produced. Both types of modules were harboured in backbone molecules conceived to offer multiple construction and sub-cloning strategies. These can be used to confer new properties to already available genetic manipulation tools or as starting points for whole novel designs. The performance of each plasmid and building block was determined independently. For illustration purposes, some simple direct practical applications were conducted.	[Bouvier, Leon A.] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bouvier, LA (corresponding author), Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina.	lbouvier@gmail.com	Pereira, Claudio A/F-5382-2012	Pereira, Claudio A/0000-0001-7874-1894; Miranda, Mariana/0000-0002-0692-5675; Canepa, Gaspar/0000-0002-4195-8835	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2010-0685, 2011-0263]; Agencia Nacional de Promocion Cientifica y Tecnologica [FONCYT PICT 2008-1209, 2010-0289]; Fundacion Bunge y Born; E.P. Abraham Cephalosporin Fund; Wood-Whelan Research Fellowship	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Bunge y Born; E.P. Abraham Cephalosporin Fund; Wood-Whelan Research Fellowship	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2010-0685 and 2011-0263), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT 2008-1209 and 2010-0289), and Fundacion Bunge y Born (grant 2012). CAP and MRM are members of the career of scientific investigator and MMC and LAB are research fellows from CONICET. LAB's research visit was financed by the E.P. Abraham Cephalosporin Fund and a Wood-Whelan Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bouvier LA, 2006, BBA-GEN SUBJECTS, V1760, P913, DOI 10.1016/j.bbagen.2006.02.013; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cevallos AM, 2003, EXP PARASITOL, V103, P27, DOI 10.1016/S0014-4894(03)00066-3; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LIGHT A, 1980, ANAL BIOCHEM, V106, P199, DOI 10.1016/0003-2697(80)90138-4; Lorenzi HA, 2003, GENE, V310, P91, DOI 10.1016/S0378-1119(03)00502-X; Cevallos AM, 2011, EXP PARASITOL, V127, P249, DOI 10.1016/j.exppara.2010.08.003; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; NOZAKI T, 1994, MOL BIOCHEM PARASIT, V67, P91, DOI 10.1016/0166-6851(94)90099-X; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Xu D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-90	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e80217	10.1371/journal.pone.0080217	http://dx.doi.org/10.1371/journal.pone.0080217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205392	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300097
J	Diaz-de-Durana, Y; Lau, J; Knee, D; Filippi, C; Londei, M; McNamara, P; Nasoff, M; DiDonato, M; Glynne, R; Herman, AE				Diaz-de-Durana, Yaiza; Lau, Janet; Knee, Deborah; Filippi, Christophe; Londei, Marco; McNamara, Peter; Nasoff, Marc; DiDonato, Michael; Glynne, Richard; Herman, Ann E.			IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes	PLOS ONE			English	Article							ANTI-CD3 MONOCLONAL-ANTIBODY; NOD MICE; PANCREATIC-ISLETS; T-CELLS; TYPE-1; INTERLEUKIN-2; PROLIFERATION; THERAPY; ONSET; ALPHA	Type-1 diabetes (T1D) is an autoimmune disease targeting insulin-producing beta cells, resulting in dependence on exogenous insulin. To date, significant efforts have been invested to develop immune-modulatory therapies for T1D treatment. Previously, IL-2 immunotherapy was demonstrated to prevent and reverse T1D at onset in the non-obese diabetic (NOD) mouse model, revealing potential as a therapy in early disease stage in humans. In the NOD model, IL-2 deficiency contributes to a loss of regulatory T cell function. This deficiency can be augmented with IL-2 or antibody bound to IL-2 (Ab/IL-2) therapy, resulting in regulatory T cell expansion and potentiation. However, an understanding of the mechanism by which reconstituted regulatory T cell function allows for reversal of diabetes after onset is not clearly understood. Here, we describe that Ab/IL-2 immunotherapy treatment, given at the time of diabetes onset in NOD mice, not only correlated with reversal of diabetes and expansion of Treg cells, but also demonstrated the ability to significantly increase beta cell proliferation. Proliferation appeared specific to Ab/IL-2 immunotherapy, as anti-CD3 therapy did not have a similar effect. Furthermore, to assess the effect of Ab/IL-2 immunotherapy well after the development of diabetes, we tested the effect of delaying treatment for 4 weeks after diabetes onset, when beta cells were virtually absent. At this late stage after diabetes onset, Ab/IL-2 treatment was not sufficient to reverse hyperglycemia. However, it did promote survival in the absence of exogenous insulin. Proliferation of beta cells could not account for this improvement as few beta cells remained. Rather, abnormal insulin and glucagon dual-expressing cells were the only insulin-expressing cells observed in islets from mice with established disease. Thus, these data suggest that in diabetic NOD mice, beta cells have an innate capacity for regeneration both early and late in disease, which is revealed through IL-2 immunotherapy.	[Diaz-de-Durana, Yaiza; Lau, Janet; Filippi, Christophe; Glynne, Richard; Herman, Ann E.] Novartis Res Fdn, Genom Inst, Dept Genet, San Diego, CA USA; [Knee, Deborah; Nasoff, Marc] Novartis Res Fdn, Genom Inst, Biotherapeut Dept, San Diego, CA USA; [Londei, Marco] Novartis Inst Biomed Res, San Diego, CA USA; [McNamara, Peter] Novartis Res Fdn, Genom Inst, Dept Pharmacol, San Diego, CA USA; [DiDonato, Michael] Novartis Res Fdn, Genom Inst, Dept Biol Struct, San Diego, CA USA	Novartis; Novartis; Novartis; Novartis; Novartis	Glynne, R (corresponding author), Novartis Res Fdn, Genom Inst, Dept Genet, San Diego, CA USA.	rglynne@gnf.org	Cerviño, Alejandro/L-5853-2014	Cerviño, Alejandro/0000-0001-8014-3279; DiDonato, Michael/0000-0002-9074-7284	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	Funding for this work was provided by the Novartis Research Foundation and the Novartis Institute of Biomedical Research (NIBR). J. Lau was supported as a postdoctoral fellow by an agreement between the Genomics Institute of the Novartis Research Foundation (GNF) and the Juvenile Diabetes Research Foundation (JDRF). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript. Legal approval for publication before submission was obtained from GNF and NIBR	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Atkinson MJ, 2009, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-540-74386-6_1; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1992, CR ACAD SCI III-VIE, V315, P225; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gianani R, 2011, SEMIN IMMUNOPATHOL, V33, P23, DOI 10.1007/s00281-010-0235-7; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Herold KC, 2011, SCI TRANSL MED, V3; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Klatzmann MD, 2011, DOSE EFFECT RELATION; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Long SA, 2013, CLIN IMMUNOL; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Piemonti L, 2011, DIABETOLOGIA, V54, P433, DOI 10.1007/s00125-010-1959-6; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; SERREZE DV, 1988, J IMMUNOL, V140, P3801; Shen W, 2013, J AM CHEM SOC, V135, P1669, DOI 10.1021/ja309304m; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tooley JE, 2012, TRENDS MOL MED, V18, P173, DOI 10.1016/j.molmed.2012.01.001; Tyrberg B, 2001, DIABETES, V50, P301, DOI 10.2337/diabetes.50.2.301; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang M, 2012, SCI TRANSL MED, V4; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009	56	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78483	10.1371/journal.pone.0078483	http://dx.doi.org/10.1371/journal.pone.0078483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205242	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300062
J	Mishra, R; Kaur, G				Mishra, Rachana; Kaur, Gurcharan			Aqueous Ethanolic Extract of Tinospora cordifolia as a Potential Candidate for Differentiation Based Therapy of Glioblastomas	PLOS ONE			English	Article							ADHESION MOLECULE NCAM; CELL-ADHESION; CYCLIN D1; POLYSIALIC ACID; IN-VITRO; DICHLOROMETHANE EXTRACT; NEUROBLASTOMA-CELLS; ANTITUMOR-ACTIVITY; OXIDATIVE STRESS; GENE-EXPRESSION	Glioblastomas are the most aggressive primary brain tumors and their heterogeneity and complexity often renders them non responsive to various conventional treatments. Search for herbal products having potential anti-cancer activity is an active area of research in the Indian traditional system of medicine i.e., Ayurveda. Tinospora cordifolia, also named as 'heavenly elixir' is used in various ayurvedic decoctions as panacea to treat several body ailments. The current study investigated the anti-brain cancer potential of 50% ethanolic extract of Tinospora cordifolia (TCE) using C6 glioma cells. TCE significantly reduced cell proliferation in dose-dependent manner and induced differentiation in C6 glioma cells, resulting in astrocyte-like morphology as indicated by phase contrast images, GFAP expression and process outgrowth data of TCE treated cells which exhibited higher number and longer processes than untreated cells. Reduced proliferation of cells was accompanied by enhanced expression of senescence marker, mortalin and its translocation from perinuclear to pancytoplasmic spaces. Further, TCE showed anti-migratory and anti-invasive potential as depicted by wound scratch assay and reduced expression of plasticity markers NCAM and PSA-NCAM along with MMP-2 and 9. On analysis of the cell cycle and apoptotic markers, TCE treatment was seen to arrest the C6 cells in G0/G1 and G2/M phase, suppressing expression of G1/S phase specific protein cyclin D1 and anti-apoptotic protein Bcl-xL, thus supporting its anti-proliferative and apoptosis inducing potential. Present study provides the first evidence for the presence of anti-proliferative, differentiation-inducing and anti-migratory/anti-metastatic potential of TCE in glioma cells and possible signaling pathways involved in its mode of action. Our primary data suggests that TCE and its active components may prove to be promising phytotherapeutic interventions in gliobalstoma multiformae.	[Mishra, Rachana; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Mishra, Rachana/Q-1706-2019; Kaur, Gurcharan/V-6033-2019		UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India); DBT, GOI	UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India); DBT, GOI(Department of Biotechnology (DBT) India)	The study was partially supported by UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India) Grant to the University. Ms Rachana Mishra is thankful to the DBT, GOI for the research fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhvaryu MR, 2008, AFR J TRADIT COMPLEM, V5, P409; Agrawal SS, 2012, FOOD CHEM TOXICOL, V50, P3126, DOI 10.1016/j.fct.2012.05.057; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; [Anonymous], 1998, BUSINESS MEDIA, DOI DOI 10.1007/978-94-009-5570-7; Aranha I, 2012, J ETHNOPHARMACOL, V139, P366, DOI 10.1016/j.jep.2011.11.013; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BATES S, 1994, ONCOGENE, V9, P1633; Bishayi Biswadev, 2002, J Toxicol Sci, V27, P139, DOI 10.2131/jts.27.139; BLACK MM, 1991, J NEUROSCI, V11, P1163; Bussolati B, 2006, EXP CELL RES, V312, P913, DOI 10.1016/j.yexcr.2005.12.004; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chaudhary R, 2008, J ENVIRON PATHOL TOX, V27, P233, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i3.70; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Daniel L, 2003, HUM PATHOL, V34, P528, DOI 10.1016/S0046-8177(03)00178-3; Das A, 2008, BRAIN RES, V1227, P207, DOI 10.1016/j.brainres.2008.06.045; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Desai VR, 2007, INT IMMUNOPHARMACOL, V7, P1375, DOI 10.1016/j.intimp.2007.06.004; Dhanasekaran M, 2009, INVEST NEW DRUG, V27, P347, DOI 10.1007/s10637-008-9181-9; DOLE MG, 1995, CANCER RES, V55, P2576; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; Fauzi FM, 2013, J CHEM INF MODEL, V53, P661, DOI 10.1021/ci3005513; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Goel H. C., 2002, Indian Journal of Experimental Biology, V40, P727; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Guruprasad K P, 2010, J Ayurveda Integr Med, V1, P40, DOI 10.4103/0975-9476.59826; Hamsa TP, 2012, EXP TOXICOL PATHOL, V64, P307, DOI 10.1016/j.etp.2010.09.003; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HEIKKILA JJ, 1993, DEV GENET, V14, P87, DOI 10.1002/dvg.1020140202; Jagetia GC, 2006, EVID-BASED COMPL ALT, V3, P267, DOI 10.1093/ecam/nel011; Jagetia GC, 2006, BIOL PHARM BULL, V29, P460, DOI 10.1248/bpb.29.460; Jain BNG, 2010, J ADV PHARM TECHNOL, V1, P30; Kataria H, 2012, PLOS ONE, V5; Kokate C. K., 2001, PHARMACOGNOSY, V16th; Koppada R, 2009, BASIC CLIN PHARMACOL, V105, P217, DOI 10.1111/j.1742-7843.2009.00383.x; Leyon PV, 2004, INT IMMUNOPHARMACOL, V4, P1569, DOI 10.1016/j.intimp.2004.06.015; Liu Wei, 2011, Reports in Parasitology, V1, P1; Loones MT, 2000, CELL STRESS CHAPERON, V5, P291, DOI 10.1379/1466-1268(2000)005<0291:TDOHSP>2.0.CO;2; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nadig PD, 2012, INDIAN J PHARMACOL, V44, P580, DOI 10.4103/0253-7613.100380; Nair R B, 1992, Anc Sci Life, V12, P280; Pandey VK, 2012, INT IMMUNOPHARMACOL, V14, P641, DOI 10.1016/j.intimp.2012.09.020; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Patel MB, 2011, PHYTOMEDICINE, V18, P1045, DOI 10.1016/j.phymed.2011.05.006; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; PIERCE GB, 1961, CANCER, V14, P1017, DOI 10.1002/1097-0142(196109/10)14:5<1017::AID-CNCR2820140516>3.0.CO;2-P; Prince Ponnaian Stanely Mainzen, 2004, Acta Pol Pharm, V61, P283; Raghu R, 2009, IMMUNOL LETT, V123, P60, DOI 10.1016/j.imlet.2009.02.005; Rao PR, 2005, BIOL PHARM BULL, V28, P2319, DOI 10.1248/bpb.28.2319; Rao SK, 2010, INTEGR CANCER THER, V9, P378, DOI 10.1177/1534735410387598; Rawal Avinash K, 2004, BMC Complement Altern Med, V4, P11, DOI 10.1186/1472-6882-4-11; Reddy SS, 2009, FOOD CHEM TOXICOL, V47, P2224, DOI 10.1016/j.fct.2009.06.008; Rege NN, 1999, PHYTOTHER RES, V13, P275, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;275::AID-PTR510&gt;3.0.CO;2-S; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTKA JT, 1994, CANCER RES, V54, P3267; Saha S, 2012, ANC SCI LIFE, V31, P151, DOI 10.4103/0257-7941.107344; Sallinen SL, 1999, J PATHOL, V188, P289; Sangeetha MK, 2011, J NAT MED-TOKYO, V65, P544, DOI 10.1007/s11418-011-0538-6; Schmidt F, 2000, CELL PHYSIOL BIOCHEM, V10, P159, DOI 10.1159/000016346; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Sengupta M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-102; Sengupta S, 2009, J ENZYM INHIB MED CH, V24, P684, DOI 10.1080/14756360802333075; Sharma P, 2011, EVID-BASED COMPL ALT, V2011, DOI [10.1155/2011/643847, DOI 10.1155/2011/643847.PUBMED:21350610]; Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027; Sharma V, 2010, Toxicol Int, V17, P12, DOI 10.4103/0971-6580.68343; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Singh AP, 2012, INT J ONCOL, V40, P99, DOI 10.3892/ijo.2011.1225; Singh N, 2005, IMMUNOPHARM IMMUNOT, V27, P1, DOI 10.1081/IPH-200051287; Subramanian M, 2002, REDOX REP, V7, P137, DOI 10.1179/135100002125000370; Sukumari-Ramesh S, 2011, INT J DEV NEUROSCI, V29, P701, DOI 10.1016/j.ijdevneu.2011.06.002; Thippeswamy G, 2008, EUR J PHARMACOL, V588, P141, DOI 10.1016/j.ejphar.2008.04.027; Thippeswamy G, 2007, ENVIRON TOXICOL PHAR, V23, P212, DOI 10.1016/j.etap.2006.10.004; Toda M, 1999, NEUROCHEM RES, V24, P339, DOI 10.1023/A:1022538810581; Velazquez EA, 2009, BASIC CLIN PHARMACOL, V105, P301, DOI 10.1111/j.1742-7843.2009.00447.x; WADHWA R, 1995, EXP CELL RES, V216, P101, DOI 10.1006/excr.1995.1013; WADHWA R, 1993, EXP CELL RES, V207, P442, DOI 10.1006/excr.1993.1213; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082	80	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78764	10.1371/journal.pone.0078764	http://dx.doi.org/10.1371/journal.pone.0078764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205314	Green Published, gold			2022-12-25	WOS:000326152300082
J	Calvo, J; Sanchez-Cid, L; Munoz, M; Lozano, JJ; Thomson, TM; Fernandez, PL				Calvo, Julia; Sanchez-Cid, Lourdes; Munoz, Montserrat; Jose Lozano, Juan; Thomson, Timothy M.; Fernandez, Pedro L.			Infrequent Loss of Luminal Differentiation in Ductal Breast Cancer Metastasis	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; ESTROGEN-RECEPTOR; CARBONIC-ANHYDRASES; ALPHA EXPRESSION; GATA3 EXPRESSION; ER-ALPHA; SURVIVAL; GROWTH; FOXA1; CLASSIFICATION	Lymph node involvement is a major prognostic variable in breast cancer. Whether the molecular mechanisms that drive breast cancer cells to colonize lymph nodes are shared with their capacity to form distant metastases is yet to be established. In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases. The transcription factor GATA3 critically determines luminal lineage specification of mammary epithelium and is widely considered a tumor and metastasis suppressor in breast cancer. Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases. These observations suggest that loss of luminal differentiation is not a major factor driving the ability of breast cancer cells to colonize regional lymph nodes.	[Calvo, Julia; Sanchez-Cid, Lourdes; Fernandez, Pedro L.] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain; [Sanchez-Cid, Lourdes; Thomson, Timothy M.] Natl Res Council CSIC, Mol Biol Inst Barcelona IBMB, Dept Cell Biol, Barcelona, Spain; [Munoz, Montserrat] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Munoz, Montserrat; Fernandez, Pedro L.] Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Jose Lozano, Juan] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Jose Lozano, Juan] CEK, Ctr Invest Esther Koplowitz, Barcelona, Spain; [Thomson, Timothy M.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain; [Sanchez-Cid, Lourdes; Fernandez, Pedro L.] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Thomson, TM (corresponding author), Natl Res Council CSIC, Mol Biol Inst Barcelona IBMB, Dept Cell Biol, Barcelona, Spain.	titbmc@ibmb.csic.es; plfernan@clinic.ub.es	Fernandez, Pedro L/H-2594-2017; Muñoz, Montserrat/AAO-9617-2020; Thomson, Timothy/Z-6271-2019	Muñoz, Montserrat/0000-0001-7772-1437; Thomson, Timothy/0000-0002-4670-9440; Lozano, Juan Jose/0000-0001-7613-3908	Institut d'Investigacions Biomediques August Pi y Sunyer; Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia; Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa"; Red de Biobancos RETIC [RD06/0020]; Red Tematica de Investigacion Cooperativa del Cancer from The National Institute of Health Carlos III [RD06/0020/0039, RD12/0036/0023]; Ministry of Economy and Competitivity [SAF2012-40017-C02-02, SAF2012-40017-C02-01]; Ministry of Science and Innovation [FIS-PI080274, SAF2008-04136-C02-01, SAF2011-24686]; AECC of Barcelona; Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya [2009SGR1482]	Institut d'Investigacions Biomediques August Pi y Sunyer; Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia; Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa"; Red de Biobancos RETIC; Red Tematica de Investigacion Cooperativa del Cancer from The National Institute of Health Carlos III; Ministry of Economy and Competitivity; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AECC of Barcelona; Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya(Generalitat de Catalunya)	JC and LS were supported by grants from the Institut d'Investigacions Biomediques August Pi y Sunyer. This study was supported by grants from the Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia and Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa", Red de Biobancos RETIC RD06/0020 and Red Tematica de Investigacion Cooperativa del Cancer (RD06/0020/0039, RD12/0036/0023) from The National Institute of Health Carlos III, grant SAF2012-40017-C02-02 (Ministry of Economy and Competitivity) and grant FIS-PI080274 (Ministry of Science and Innovation) to PLF; and grants SAF2008-04136-C02-01 and SAF2011-24686 (Ministry of Science and Innovation), SAF2012-40017-C02-01 (Ministry of Economy and Competitivity), AECC of Barcelona and 2009SGR1482 (Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya) to TMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Beug H, 2009, CELL, V138, P623, DOI 10.1016/j.cell.2009.08.007; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; CIMINOMATHEWS A, 2013, HUM PATHOL; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoch RV, 1999, INT J CANCER, V84, P122; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Jiang Shoulei, 2010, Hormones & Cancer, V1, P11, DOI 10.1007/s12672-010-0006-x; Kawada K, 2011, CANCER RES, V71, P1214, DOI 10.1158/0008-5472.CAN-10-3277; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lakhani SR, 2012, WHO CLASSIFICATION T; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Rakha EA, 2011, ADV ANAT PATHOL, V18, P255, DOI 10.1097/PAP.0b013e318220f5d1; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Hamburg JP, 2008, MOL IMMUNOL, V45, P3085, DOI 10.1016/j.molimm.2008.03.018; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Weigelt B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2734; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78097	10.1371/journal.pone.0078097	http://dx.doi.org/10.1371/journal.pone.0078097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205108	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600071
J	Hsu, J; Weiss, EL				Hsu, Jonathan; Weiss, Eric L.			Cell Cycle Regulated Interaction of a Yeast Hippo Kinase and Its Activator MO25/Hym1	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; SIGNALING NETWORK; PATHWAY; DROSOPHILA; PHOSPHORYLATION; PROMOTES; PROLIFERATION; SALVADOR	Hippo pathways are ancient signaling systems that contribute to cell growth and proliferation in a wide diversity of eukaryotes, and have emerged as a conserved regulator of organ size control in metazoans. In budding yeast, a Hippo signaling pathway called the Regulation of Ace2 and Morphogenesis (RAM) network promotes polarized cell growth and the final event in the separation of mother and daughter cells. A crucial regulatory input for RAM network control of cell separation is phosphorylation of a conserved hydrophobic motif (HM) site on the NDR/LATS family kinase Cbk1. Here we provide the first direct evidence that the Hippo-like kinase Kic1 in fact phosphorylates the HM site of Cbk1, and show that Kic1 is allosterically activated by Hym1, a highly conserved protein related to mammalian MO25. Using the structure of mammalian MO25 in complex with the Kic1-related pseudokinase STRAD, we identified conserved residues on Kic1 that are required for interaction with Hym1. We find that Kic1 and Hym1 protein levels remain constant throughout the cell cycle but the proteins' association is regulated, with maximal interaction coinciding with peak Cbk1 HM site phosphorylation. We show that this association is necessary but not sufficient for this phosphorylation, suggesting another level of regulation is required to promote the complex to act upon its substrates. This work presents a previously undiscovered cell cycle regulated interaction between a Hippo kinase and a broadly conserved allosteric activator. Because of the conserved nature of this pathway in higher eukaryotes, this work may also provide insight into the modularity of Hippo signaling pathways.	[Hsu, Jonathan; Weiss, Eric L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Weiss, EL (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	elweiss@northwestern.edu			National Institutes of Health - NIGMS [R01 GM084223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084223] Funding Source: NIH RePORTER	National Institutes of Health - NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health - NIGMS. The relevant grant number is R01 GM084223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bogomolnaya LM, 2006, CURR GENET, V49, P384, DOI 10.1007/s00294-006-0069-y; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brace J, 2011, MOL CELL BIOL, V31, P721, DOI 10.1128/MCB.00403-10; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cong JL, 2001, DEVELOPMENT, V128, P2793; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fang XL, 2010, DEV BIOL, V341, P360, DOI 10.1016/j.ydbio.2010.02.029; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Goshima T, 2010, J BIOL CHEM, V285, P35196, DOI 10.1074/jbc.M110.176867; Gupta S, 2013, CURR BIOL, V23, P333, DOI 10.1016/j.cub.2013.01.014; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2009, BIOFACTORS, V35, P338, DOI 10.1002/biof.47; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mayhew MB, 2011, BIOINFORMATICS, V27, pI295, DOI 10.1093/bioinformatics/btr244; Mehellou Y, 2013, BIOCHEM BIOPH RES CO, V431, P604, DOI 10.1016/j.bbrc.2012.12.113; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Orlando DA, 2007, CELL CYCLE, V6, P478, DOI 10.4161/cc.6.4.3859; Orlando DA, 2009, ANN APPL STAT, V3, P1521, DOI 10.1214/09-AOAS264; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Panozzo C, 2010, MOL GENET GENOMICS, V283, P111, DOI 10.1007/s00438-009-0501-3; Rajakulendran T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3111pe8; Rock JM, 2013, SCIENCE, V340, P871, DOI 10.1126/science.1235822; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78334	10.1371/journal.pone.0078334	http://dx.doi.org/10.1371/journal.pone.0078334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205201	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600097
J	Linville, JL; Rodriguez, M; Land, M; Syed, MH; Engle, NL; Tschaplinski, TJ; Mielenz, JR; Cox, CD				Linville, Jessica L.; Rodriguez, Miguel, Jr.; Land, Miriam; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.; Cox, Chris D.			Industrial Robustness: Understanding the Mechanism of Tolerance for the Populus Hydrolysate-Tolerant Mutant Strain of Clostridium thermocellum	PLOS ONE			English	Article							DEGRADATION-PRODUCTS; TRANSCRIPTIONAL ANALYSIS; ETHANOL TOLERANCE; CORN STOVER; FERMENTATION; PRETREATMENT; BIOMASS; SPORULATION; BACTERIA; GROWTH	Background: An industrially robust microorganism that can efficiently degrade and convert lignocellulosic biomass into ethanol and next-generation fuels is required to economically produce future sustainable liquid transportation fuels. The anaerobic, thermophilic, cellulolytic bacterium Clostridium thermocellum is a candidate microorganism for such conversions but it, like many bacteria, is sensitive to potential toxic inhibitors developed in the liquid hydrolysate produced during biomass processing. Microbial processes leading to tolerance of these inhibitory compounds found in the pretreated biomass hydrolysate are likely complex and involve multiple genes. Methodology/Principal Findings: In this study, we developed a 17.5% v/v Populus hydrolysate tolerant mutant strain of C. thermocellum by directed evolution. The genome of the wild type strain, six intermediate population samples and seven single colony isolates were sequenced to elucidate the mechanism of tolerance. Analysis of the 224 putative mutations revealed 73 high confidence mutations. A longitudinal analysis of the intermediate population samples, a pan-genomic analysis of the isolates, and a hotspot analysis revealed 24 core genes common to all seven isolates and 8 hotspots. Genetic mutations were matched with the observed phenotype through comparison of RNA expression levels during fermentation by the wild type strain and mutant isolate 6 in various concentrations of Populus hydrolysate (0%, 10%, and 17.5% v/v). Conclusion/Significance: The findings suggest that there are multiple mutations responsible for the Populus hydrolysate tolerant phenotype resulting in several simultaneous mechanisms of action, including increases in cellular repair, and altered energy metabolism. To date, this study provides the most comprehensive elucidation of the mechanism of tolerance to a pretreated biomass hydrolysate by C. thermocellum. These findings make important contributions to the development of industrially robust strains of consolidated bioprocessing microorganisms.	[Linville, Jessica L.; Cox, Chris D.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Linville, Jessica L.; Rodriguez, Miguel, Jr.; Land, Miriam; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.; Cox, Chris D.] Oak Ridge Natl Lab, Bioenergy Sci Ctr, Oak Ridge, TN USA; [Rodriguez, Miguel, Jr.; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Cox, Chris D.] Univ Tennessee, Inst Secure & Sustainable Environm, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Cox, CD (corresponding author), Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA.	ccox9@utk.edu	Tschaplinski, Timothy/D-6382-2018; Land, Miriam L/A-6200-2011; Engle, Nancy L/D-6494-2018; Cox, Chris D/A-9451-2013	Tschaplinski, Timothy/0000-0002-9540-6622; Land, Miriam L/0000-0001-7102-0031; Engle, Nancy L/0000-0003-0290-7987; Cox, Chris D/0000-0001-9818-5477	BioEnergy Science Center, a Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the Department of Energy Office of Science; Institute for a Secure and Sustainable Environment at the University of Tennessee; DOE [DE-AC05-00OR22725]	BioEnergy Science Center, a Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the Department of Energy Office of Science; Institute for a Secure and Sustainable Environment at the University of Tennessee; DOE(United States Department of Energy (DOE))	This research was supported by the BioEnergy Science Center, a Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. Additional support was provided by the Institute for a Secure and Sustainable Environment at the University of Tennessee. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the DOE under Contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; [Anonymous], 2006, SC 0095 BREAK BIOL B; Bahari L, 2011, J IND MICROBIOL BIOT, V38, P825, DOI 10.1007/s10295-010-0848-9; Barber MS, 2000, PHYTOCHEMISTRY, V54, P53, DOI 10.1016/S0031-9422(00)00038-8; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Conrad TM, 2011, MOL SYST BIOL, V7, P11; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; CUDECK R, 1989, PSYCHOL BULL, V105, P317, DOI 10.1037/0033-2909.105.2.317; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Du BW, 2010, BIOTECHNOL BIOENG, V107, P430, DOI 10.1002/bit.22829; Ezeji T, 2007, BIOTECHNOL BIOENG, V97, P1460, DOI 10.1002/bit.21373; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Geng AL, 2010, INT J CHEM REACT ENG, V8; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; Hosokawa K, 2002, ENVIRON MICROBIOL, V4, P703, DOI 10.1046/j.1462-2920.2002.00348.x; Ichinose H, 2012, PROCESS BIOCHEM, V47, P358, DOI 10.1016/j.procbio.2011.06.002; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Joh LD, 2010, EFFECTS PHENOLIC MON, P1; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Lee ASG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031934; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Malik S, 2012, PLOS ONE, V7, P10; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller EN, 2009, APPL ENVIRON MICROB, V75, P4315, DOI 10.1128/AEM.00567-09; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Moeller R, 2012, ARCH MICROBIOL, V194, P759, DOI 10.1007/s00203-012-0811-4; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozkan M, 2001, J IND MICROBIOL BIOT, V27, P275, DOI 10.1038/sj.jim.7000082; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Raman B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-134; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rani KS, 1999, WORLD J MICROB BIOT, V15, P173, DOI 10.1023/A:1008863410460; Riederer A, 2011, APPL ENVIRON MICROB, V77, P1243, DOI 10.1128/AEM.02008-10; Roberts SB, 2010, BMC SYST BIOL, V4; Schell DJ, 2003, APPL BIOCHEM BIOTECH, V105, P69, DOI 10.1385/ABAB:105:1-3:69; Shao XJ, 2011, APPL MICROBIOL BIOT, V92, P641, DOI 10.1007/s00253-011-3492-z; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Syed MH, 2012, BIOINFORMATICS, V28, P750, DOI 10.1093/bioinformatics/bts016; Tomas CA, 2003, J BACTERIOL, V185, P4539, DOI 10.1128/JB.185.15.4539-4547.2003; Varga E, 2004, BIOTECHNOL BIOENG, V88, P567, DOI 10.1002/bit.20222; Williams TI, 2007, APPL MICROBIOL BIOT, V74, P422, DOI 10.1007/s00253-006-0689-7; Yu TT, 2012, MICROBIOL RES, V167, P364, DOI 10.1016/j.micres.2012.02.006; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang Y, 2011, NEW BIOTECHNOLOGY; Zhang YH, 2003, ANAL CHEM, V75, P219, DOI 10.1021/ac020271n; Zhang YHP, 2005, J BACTERIOL, V187, P99, DOI 10.1128/JB.187.1.99-106.2005	65	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78829	10.1371/journal.pone.0078829	http://dx.doi.org/10.1371/journal.pone.0078829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205326	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600112
J	Sivova, N; Launay, D; Wemeau-Stervinou, L; De Groote, P; Remy-Jardin, M; Denis, G; Lambert, M; Lamblin, N; Morell-Dubois, S; Fertin, M; Lefevre, G; Sobanski, V; Le Rouzic, O; Hatron, PY; Wallaert, B; Hachulla, E; Perez, T				Sivova, Nadia; Launay, David; Wemeau-Stervinou, Lidwine; De Groote, Pascal; Remy-Jardin, Martine; Denis, Guillaume; Lambert, Marc; Lamblin, Nicolas; Morell-Dubois, Sandrine; Fertin, Marie; Lefevre, Guillaume; Sobanski, Vincent; Le Rouzic, Olivier; Hatron, Pierre-Yves; Wallaert, Benoit; Hachulla, Eric; Perez, Thierry			Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; CAPILLARY BLOOD-VOLUME; MEMBRANE DIFFUSING-CAPACITY; ARTERIAL-HYPERTENSION; FIBROSING ALVEOLITIS; STANDARDIZATION; PNEUMONIA; EXCHANGE; NO; CO	We investigated whether partitioning DLCO into membrane conductance for CO (DmCO) and pulmonary capillary blood volume (Vcap) was helpful in suspecting precapillary pulmonary (arterial) hypertension (P(A) H) in systemic sclerosis (SSc) patients with or without interstitial lung disease (ILD). We included 63 SSc patients with isolated PAH (n=6), isolated ILD (n=19), association of both (n=12) or without PAH and ILD (n=26). Partitioning of DLCO was performed by the combined DLNO/DLCO method. DLCO, DmCO and Vcap were equally reduced in patients with isolated PAH and patients with isolated ILD but Vcap/alveolar volume (VA) ratio was significantly lower in the isolated PAH group. In patients without ILD, DLCO, DmCO, Vcap and Vcap/VA ratio were reduced in patients with isolated PAH when compared to patients without PAH and both Vcap/VA and DLCO had the highest AUC to detect PAH. In patients with ILD, Vcap had the highest AUC and performed better than DLCO to detect PH in this subgroup. In conclusion, Vcap/VA was lower in PAH than in ILD in SSC whereas DLCO was not different. Vcap/VA ratio and DLCO had similar high performance to detect PAH in patients without ILD. Vcap had better AUC than DLCO, DmCO and FVC/DLCO ratio to detect PH in SSC patients with ILD. These results suggest that partitioning of DLCO might be of interest to detect P(A) H in SSC patients with or without ILD.	[Sivova, Nadia; Launay, David; Denis, Guillaume; Lambert, Marc; Morell-Dubois, Sandrine; Lefevre, Guillaume; Sobanski, Vincent; Hatron, Pierre-Yves; Hachulla, Eric] Univ Lille Nord France, CHRU Lille, Hop Claude Huriez,Ctr Competence Hypertens Arteri, Serv Med Interne,Ctr Reference Malad Autoimmunes, Lille, France; [Launay, David; Lefevre, Guillaume; Sobanski, Vincent] Univ Lille Nord France, Fac Med, Lab Immunol EA2686, Lille, France; [Wemeau-Stervinou, Lidwine; Le Rouzic, Olivier; Wallaert, Benoit; Perez, Thierry] Univ Lille Nord France, CHRU Lille, Hop Calmette,Ctr Competence Malad Pulm Rares, Clin Malad Resp,Ctr Competence Hypertens Arteriel, Lille, France; [De Groote, Pascal; Lamblin, Nicolas; Fertin, Marie] Univ Lille Nord France, CHRU Lille, Hop Cardiol,Serv Cardiol, Ctr Competence Hypertens Arterielle Pulm Severe, Lille, France; [Remy-Jardin, Martine] Univ Lille Nord France, CHRU Lille, Hop Calmette, Serv Radiol Thorac, Lille, France; [Perez, Thierry] Univ Lille Nord France, CHRU Lille, Hop Calmette, Serv Explorat Fonct Resp, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Perez, T (corresponding author), Univ Lille Nord France, CHRU Lille, Hop Calmette,Ctr Competence Malad Pulm Rares, Clin Malad Resp,Ctr Competence Hypertens Arteriel, Lille, France.	thierry.perez@chru-lille.fr	lambert, marc/V-7380-2017; Thierry, PEREZ/AAB-4853-2020; Launay, David/H-1674-2016; Sobanski, Vincent/Q-6411-2016; Launay, David/A-5270-2018; HACHULLA, ERIC/R-8488-2018; Sobanski, Vincent/U-5676-2019; LEFEVRE, Guillaume/I-7168-2018	lambert, marc/0000-0002-3485-8238; Launay, David/0000-0003-1840-1817; Sobanski, Vincent/0000-0003-3083-2441; Launay, David/0000-0003-1840-1817; HACHULLA, ERIC/0000-0001-7432-847X; LAMBLIN, NICOLAS/0000-0003-3754-1241; de Groote, Pascal/0000-0002-6211-0147; LEFEVRE, Guillaume/0000-0002-9427-7267; Le Rouzic, Olivier/0000-0003-4439-2950				Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; AGUSTI AGN, 1991, AM REV RESPIR DIS, V143, P219, DOI 10.1164/ajrccm/143.2.219; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Chang B, 2003, J RHEUMATOL, V30, P2398; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Degano B, 2009, J APPL PHYSIOL, V107, P139, DOI 10.1152/japplphysiol.91621.2008; Desai SR, 2004, RADIOLOGY, V232, P560, DOI 10.1148/radiol.2322031223; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; GUENARD H, 1987, RESP PHYSIOL, V70, P113, DOI 10.1016/S0034-5687(87)80036-1; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Launay D, 2012, ANN RHEUM D IN PRESS; Launay D, 2007, J RHEUMATOL, V34, P1005; Launay D, 2006, J RHEUMATOL, V33, P1789; Le Pavec J, 2011, CLIN REV ALLERG IMMU, V40, P104, DOI 10.1007/s12016-009-8194-2; Lefevre G, 2013, ARTHRITIS R IN PRESS; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mathai SC, 2009, ARTHRITIS RHEUM-US, V60, P569, DOI 10.1002/art.24267; Overbeek MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-68; PANDE JN, 1975, RESPIRATION, V32, P317, DOI 10.1159/000193670; Pernot J, 2012, RESPIRATION, V84, P461, DOI 10.1159/000335473; Plummer AL, 2008, CHEST, V134, P663, DOI 10.1378/chest.07-1771; Renzoni EA, 2003, AM J RESP CRIT CARE, V167, P438, DOI 10.1164/rccm.200202-135OC; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Trad S, 2006, ARTHRITIS RHEUM-US, V54, P184, DOI 10.1002/art.21538; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wemeau-Stervinou L, 2012, RESP MED, V106, P564, DOI 10.1016/j.rmed.2011.12.011	32	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78001	10.1371/journal.pone.0078001	http://dx.doi.org/10.1371/journal.pone.0078001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205063	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300131
J	Zhang, DT; Liu, WT; Yang, P; Zhang, Y; Li, XY; Germ, KE; Tang, S; Sun, WJ; Wang, QY				Zhang, Daitao; Liu, Wenting; Yang, Peng; Zhang, Yi; Li, Xinyu; Germ, Kaylyn E.; Tang, Song; Sun, Wenjie; Wang, Quanyi			Factors Associated with Household Transmission of Pandemic (H1N1) 2009 among Self-Quarantined Patients in Beijing, China	PLOS ONE			English	Article							INFLUENZA-A H1N1; SECONDARY ATTACK RATES; APRIL-MAY 2009; UNITED-STATES; VIRUS; INTERVENTIONS; INFECTION; STUDENTS; CONTACTS; ILLNESS	As the pandemic (H1N1) 2009 progressed, the Ministry of Health of China advised cases with mild symptoms to remain home for isolation and observation, which may have increased the risk for infection among other household members. Describing the transmission characteristics of this novel virus is indispensable to effectively controlling the spread of disease; thus, the aim of this study was to assess risk factors associated with household transmission of pandemic H1N1 from self-quarantined patients in Beijing, the capital city of China. A 1: 2 case-control study with 54 case households and 108 control households was conducted between August 1 and September 30, 2009 in Beijing. Cases were households with a self-quarantined index patient and a secondary case, while controls were households with a self-quarantined index patient and a close contact. Controls were also matched to cases for sex and age of index case-patient. A structured interview guide was used to collect the data. Conditional logistical models were employed to estimate Odds Ratios (OR) with 95% confidence intervals (95% CI). Results indicated that higher education level (OR 0.42; 95% CI 0.22-0.83), sharing room with an index case-patient (OR 3.29; 95% CI 1.23-8.78), daily room ventilation (OR 0.28; 95% CI 0.08-0.93), and hand washing >= 3/d (OR 0.71; 95% CI 0.48-0.94) were related to the household transmission of pandemic H1N1 from self-quarantined patients. These results highlight that health education, as well as the quarantine of the index case-patient immediately after infection, frequent hand hygiene, and ventilation are critical to mitigating household spread of pandemic H1N1 virus and minimizing its impact. Household contacts should be educated to promote these in-home practices to contain transmission, particularly when household members are quarantined at home.	[Zhang, Daitao; Liu, Wenting; Yang, Peng; Zhang, Yi; Li, Xinyu; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Germ, Kaylyn E.; Tang, Song] Texas Tech Univ, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA USA	Texas Tech University System; Texas Tech University; Tulane University	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.	bjcdcxm@126.com	sun, wenjie/J-8928-2013; Tang, Song/E-9843-2013; Sun, Wenjie/I-7692-2013	Tang, Song/0000-0003-3219-1422	National High Technology Research and Development Program of China (863 Program) [2008AA02Z416]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by grant from the National High Technology Research and Development Program of China (http://www.863.gov.cn/) (863 Program; 2008AA02Z416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carcione D, 2011, EUROSURVEILLANCE, V16, P1; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Guh A, 2011, CLIN INFECT DIS, V52, pS131, DOI 10.1093/cid/ciq029; Hirotsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031519; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Kim CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038166; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-258; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; van Boven M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011442; van Gemert C, 2011, EMERG INFECT DIS, V17, P1599, DOI 10.3201/eid1709.101948; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5; World Health Organization, 2009, WHO GUID HAND HYG HL; Zhang Y, 2013, INFLUENZA OTHER RESP, V7, P466, DOI 10.1111/irv.12025	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77873	10.1371/journal.pone.0077873	http://dx.doi.org/10.1371/journal.pone.0077873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205006	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300121
J	Takizawa, N; Fujiwara, T; Yamasaki, M; Saito, A; Fukao, A; Nomoto, A; Mizumoto, K				Takizawa, Naoki; Fujiwara, Toshinobu; Yamasaki, Manabu; Saito, Ayako; Fukao, Akira; Nomoto, Akio; Mizumoto, Kiyohisa			The Essential Role for the RNA Triphosphatase Cet1p in Nuclear Import of the mRNA Capping Enzyme Cet1p-Ceg1p Complex of Saccharomyces cerevisiae	PLOS ONE			English	Article							CARBOXY-TERMINAL DOMAIN; POLYMERASE-II; CAP METHYLTRANSFERASE; FAMILY-MEMBERS; IN-VIVO; YEAST; GUANYLYLTRANSFERASE; METHYLATION; APPARATUS; SUBUNIT	mRNA capping is the first cotranscriptional modification of mRNA in the nucleus. In Saccharomyces cerevisiae, the first two steps of mRNA capping are catalyzed by the RNA triphosphatase Cet1p and the RNA guanylyltransferase Ceg1p. Cet1p and Ceg1p interact to form a mRNA capping enzyme complex and the guanylyltransferase activity of Ceg1p is stimulated by binding with Cet1p. The Cet1p-Ceg1p complex needs to be transported into the nucleus, where mRNA capping occurs. However, the molecular mechanism of nuclear transport of the Cet1p-Ceg1p complex is not known. Here, we show that Cet1p is responsible and that the Cet1p-Ceg1p interaction is essential for the nuclear localization of the Cet1p-Ceg1p complex. The results indicate that the Cet1p-Ceg1p interaction is important not only for the activation of Ceg1p, but also for nuclear import of the complex.	[Takizawa, Naoki; Fujiwara, Toshinobu; Yamasaki, Manabu; Fukao, Akira; Nomoto, Akio] Inst Microbial Chem, Lab Basic Biol, Tokyo 141, Japan; [Saito, Ayako] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Nagoya, Aichi, Japan; [Mizumoto, Kiyohisa] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Tokyo 108, Japan	Nagoya City University; Kitasato University	Takizawa, N (corresponding author), Inst Microbial Chem, Lab Basic Biol, Tokyo 141, Japan.	takizawan@bikaken.or.jp		Takizawa, Naoki/0000-0002-3714-2219	Ministry of Education, Culture, Sports, Science and Technology Japan [23390113]; Grants-in-Aid for Scientific Research [24659139] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research to A.N. (No. 23390113) from the Ministry of Education, Culture, Sports, Science and Technology Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gonatopoulos-Pournatzis T, 2011, MOL CELL, V44, P585, DOI 10.1016/j.molcel.2011.08.041; Gu MG, 2010, STRUCTURE, V18, P216, DOI 10.1016/j.str.2009.12.009; Hausmann S, 2001, J BIOL CHEM, V276, P36116, DOI 10.1074/jbc.M105856200; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 1999, NUCLEIC ACIDS RES, V27, P4671, DOI 10.1093/nar/27.24.4671; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; ITOH N, 1987, J BIOL CHEM, V262, P1989; ITOH N, 1984, J BIOL CHEM, V259, P3923; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lehman K, 2001, J BIOL CHEM, V276, P14996, DOI 10.1074/jbc.M100588200; Lehman K, 1999, J BIOL CHEM, V274, P22668, DOI 10.1074/jbc.274.32.22668; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; MAO XD, 1995, MOL CELL BIOL, V15, P4167; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; MIZUMOTO K, 1987, PROG NUCLEIC ACID RE, V34, P1, DOI 10.1016/S0079-6603(08)60491-2; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Radomski N, 2002, BBA-MOL CELL RES, V1590, P93, DOI 10.1016/S0167-4889(02)00205-7; Schwer B, 2000, GENETICS, V155, P1561; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; Shuman S, 1997, P NATL ACAD SCI USA, V94, P12758, DOI 10.1073/pnas.94.24.12758; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Takase Y, 2000, MOL CELL BIOL, V20, P9307, DOI 10.1128/MCB.20.24.9307-9316.2000; Topisirovic I, 2012, WILEY INTERDISCIP RE, V2, P277; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V251, P27, DOI 10.1006/bbrc.1998.9402; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; Varani G, 1997, STRUCTURE, V5, P855, DOI 10.1016/S0969-2126(97)00239-6; Wen YX, 2000, GENE DEV, V14, P2944, DOI 10.1101/gad.848200; Yamada-Okabe T, 1998, NUCLEIC ACIDS RES, V26, P1700, DOI 10.1093/nar/26.7.1700; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78000	10.1371/journal.pone.0078000	http://dx.doi.org/10.1371/journal.pone.0078000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205062	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500088
J	Salonen, J; Ronnholm, G; Kalkkinen, N; Vihinen, M				Salonen, Johanna; Ronnholm, Gunilla; Kalkkinen, Nisse; Vihinen, Mauno			Proteomic Changes during B Cell Maturation: 2D-DIGE Approach	PLOS ONE			English	Article							FUNCTIONALLY RELATED PROTEINS; X-LINKED AGAMMAGLOBULINEMIA; ANTIGEN RECEPTOR; PLASMA-CELL; TYROSINE KINASE; GENE-EXPRESSION; MESSENGER-RNA; BURKITT-LYMPHOMA; CROSS-LINKING; LINE	B cells play a pivotal role in adaptive immune system, since they maintain a delicate balance between recognition and clearance of foreign pathogens and tolerance to self. During maturation, B cells progress through a series of developmental stages defined by specific phenotypic surface markers and the rearrangement and expression of immunoglobulin (Ig) genes. To get insight into B cell proteome during the maturation pathway, we studied differential protein expression in eight human cell lines, which cover four distinctive developmental stages; early pre-B, pre-B, plasma cell and immature B cell upon anti-IgM stimulation. Our two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry based proteomic study indicates the involvement of large number of proteins with various functions. Notably, proteins related to cytoskeleton were relatively highly expressed in early pre-B and pre-B cells, whereas plasma cell proteome contained endoplasmic reticulum and Golgi system proteins. Our long time series analysis in anti-IgM stimulated Ramos B cells revealed the dynamic regulation of cytoskeleton organization, gene expression and metabolic pathways, among others. The findings are related to cellular processes in B cells and are discussed in relation to experimental information for the proteins and pathways they are involved in. Representative 2D-DIGE maps of different B cell maturation stages are available online at http://structure.bmc.lu.se/BcellProteome/.	[Salonen, Johanna; Vihinen, Mauno] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Salonen, Johanna; Vihinen, Mauno] BioMediTech, Tampere, Finland; [Salonen, Johanna; Vihinen, Mauno] Tampere Univ Hosp, Res Unit, Tampere, Finland; [Ronnholm, Gunilla; Kalkkinen, Nisse] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Lund University	Vihinen, M (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	mauno.vihinen@med.lu.se	Vihinen, Mauno/A-8452-2012	Vihinen, Mauno/0000-0002-9614-7976; Salonen, Johanna/0000-0002-1039-3392	Medical Research Fund of Tampere University Hospital; Magnus Ehrnrooth foundation; Orion-Farmos research foundation; Finnish Cultural Fund; Sigrid Juselius foundation; University of Tampere; BioMediTech Finland	Medical Research Fund of Tampere University Hospital; Magnus Ehrnrooth foundation; Orion-Farmos research foundation; Finnish Cultural Fund(Finnish Cultural Foundation); Sigrid Juselius foundation(Sigrid Juselius Foundation); University of Tampere; BioMediTech Finland	Funding provided by Medical Research Fund of Tampere University Hospital, Magnus Ehrnrooth foundation, Orion-Farmos research foundation, Finnish Cultural Fund, Sigrid Juselius foundation, University of Tampere and BioMediTech Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballow M, 2002, J ALLERGY CLIN IMMUN, V109, P581, DOI 10.1067/mai.2002.122466; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Besnault L, 2001, J IMMUNOL, V167, P733, DOI 10.4049/jimmunol.167.2.733; Blom B, 2012, BONE MARROW LYMPHOID, P1; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; CAMBIER JC, 1984, J IMMUNOL, V133, P576; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Daniel PT, 1997, EUR J IMMUNOL, V27, P1029, DOI 10.1002/eji.1830270433; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FINDLEY HW, 1982, BLOOD, V60, P1305; Fischer A, 2004, NAT IMMUNOL, V5, P23, DOI 10.1038/ni1023; Fukata Y, 1999, BIOPHYS CHEM, V82, P139, DOI 10.1016/S0301-4622(99)00113-1; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harwood NE, 2010, COLD SPRING HARB PER, V3; Hoffmann R, 2003, CURR OPIN IMMUNOL, V15, P239, DOI 10.1016/S0952-7915(03)00047-5; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jeon HK, 2005, IMMUNOL LETT, V98, P303, DOI 10.1016/j.imlet.2004.12.005; Jin SH, 2003, PROTEOMICS, V3, P2428, DOI 10.1002/pmic.200300576; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Korte J, 2013, PROTEOMICS, V13, P119, DOI 10.1002/pmic.201200177; Laurent J, 2006, FREE RADICAL BIO MED, V40, P1971, DOI 10.1016/j.freeradbiomed.2006.01.029; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; LILIENBAUM A, 1986, EMBO J, V5, P2809, DOI 10.1002/j.1460-2075.1986.tb04572.x; MADSEN PS, 1995, BLOOD, V85, P510; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; MINOWADA J, 1979, LEUKEMIA RES, V3, P261, DOI 10.1016/0145-2126(79)90050-X; Mongini PKA, 1998, BLOOD, V92, P3756, DOI 10.1182/blood.V92.10.3756.422k42_3756_3771; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nilsson J, 2004, IMMUNOL LETT, V94, P83, DOI 10.1016/j.imlet.2004.04.004; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Notarangelo Luigi D, 2003, Rev Clin Exp Hematol, V7, P84; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Ollila J, 2003, GENES IMMUN, V4, P343, DOI 10.1038/sj.gene.6363974; Ollila J, 2002, VITAM HORM, V64, P77, DOI 10.1016/S0083-6729(02)64003-8; Ollila J, 1998, BIOCHEM BIOPH RES CO, V249, P475, DOI 10.1006/bbrc.1998.9176; Ollila J, 2007, MOL IMMUNOL, V44, P3537, DOI 10.1016/j.molimm.2007.03.009; Paris LL, 2010, J BIOL CHEM, V285, P39844, DOI 10.1074/jbc.M110.164509; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Perrot A, 2011, BLOOD, V118, pE1, DOI 10.1182/blood-2011-02-335125; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; RAMBOTTI MG, 1993, CELL MOL BIOL RES, V39, P579; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Salonen JM, 2006, PROTEOMICS, V6, P5152, DOI 10.1002/pmic.200600156; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIECKMANN DG, 1980, IMMUNOL REV, V52, P181, DOI 10.1111/j.1600-065X.1980.tb00335.x; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Toledano BJ, 1997, J IMMUNOL, V158, P3705; Tsai CM, 2008, J IMMUNOL, V181, P4570, DOI 10.4049/jimmunol.181.7.4570; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vettermann C, 2011, PROTEOMICS, V11, P1228, DOI 10.1002/pmic.201000491; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yoshida T, 2000, INT IMMUNOL, V12, P517, DOI 10.1093/intimm/12.4.517; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang DH, 2007, INT J ONCOL, V31, P577	89	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77894	10.1371/journal.pone.0077894	http://dx.doi.org/10.1371/journal.pone.0077894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700059
J	Furuya-Kanamori, L; Kelly, MD; McKenzie, SJ				Furuya-Kanamori, Luis; Kelly, Mark D.; McKenzie, Samantha J.			Co-Morbidity, Ageing and Predicted Mortality in Antiretroviral Treated Australian Men: A Quantitative Analysis	PLOS ONE			English	Article							HIV-INFECTION; GENERAL-POPULATION; THERAPY; DISEASE; COHORT; RISK; AIDS; AGE; INDIVIDUALS; UPDATE	Background: Life expectancy has increased in HIV-positive individuals receiving combination antiretroviral therapy (cART); however, they still experience increased mortality due to ageing-associated comorbidities compared with HIV-negative individuals. Methods: A retrospective study of 314 Queensland HIV-infected males on cART was conducted. The negative impact of ageing was assessed by estimating the probability of 5-year mortality; comparisons were made between an HIV-specific predictive tool (VACS index) and the Australian Bureau of Statistics (ABS) life-tables to examine potential differences attributed to HIV. The negative impact of ageing was also assessed by the prevalence of comorbidities. Associations between comorbidity and estimates of predicted mortality by regression analysis were assessed. Results: The mean predicted 5-year mortality rate was 6% using the VACS index compared with 2.1% using the ABS life-table (p<0.001). The proportion of patients at predicted high risk of mortality (>9%) using the VACS index or ABS life-table were 17% and 1.8% respectively. Comorbidities were also more prevalent in this cohort compared with rates of comorbidities in age-matched Australian men from the general population. Metabolic disease (38.2%) was the most prevalent comorbidity followed by renal (33.1%) and cardiovascular disease (23.9%). Multivariate analysis demonstrated that patients with a history of cardiovascular disease had a higher predicted risk of mortality (OR=1.69; 95% CI: 1.17-2.45) whereas ex-smokers had a lower predicted risk of mortality (OR=0.61; 95% CI: 0.41-0.92). Conclusions: Using the VACS Index there is an increased predicted risk of mortality in cART-treated HIV infected Australian men compared with age-matched men using the ABS data. This increased predicted mortality risk is associated with cardiovascular disease and the number of comorbidities per subject; which suggests that the VACS Index may discriminate between high and low predicted mortality risks in this population. However, until the VACS Index is validated in Australia this data may suggest the VACS Index overestimates predicted mortality risk in this country.	[Furuya-Kanamori, Luis; McKenzie, Samantha J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia; [Kelly, Mark D.] Brisbane Sexual Hlth & HIV Serv, Brisbane, Qld, Australia	University of Queensland	Furuya-Kanamori, L (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia.	luis.furuyakanamori@uqconnect.edu.au	McKenzie, Samantha/A-2516-2010	McKenzie, Samantha/0000-0003-1328-4527; Furuya-Kanamori, Luis/0000-0002-4337-9757				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldaz P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-300; Althoff KN, 2013, EV OCC SIM AG COMP H; American Psychiatric Association, 2000, QUICK REF DIAGN CRIT; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Australasian Society for HIV Medicine, 2010, GUID AUSTR; Australian Bureau of Statistics, 2012, 3302 0 55 001 LIF TA; Australian Bureau of Statistics, 2012, NAT HLTH SURV SUMM R, P2011; Australian Bureau of Statistics, 2009, AUSTR SOC TRENDS; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Bloch M, 2012, JAIDS-J ACQ IMM DEF, V59, P478, DOI 10.1097/QAI.0b013e31824a5473; Boyle RG, 2000, PREV MED, V31, P177, DOI 10.1006/pmed.2000.0699; Brennan M, 2010, HIV AIDS-MED SOC PSY, P1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Frederic P, 2009, SOCIALIZED MED SOCIA; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Gracey D, 2013, INTERN MED J, V43, P410, DOI 10.1111/j.1445-5994.2012.02933.x; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hester EK, 2012, NUTR CLIN PRACT, V27, P51, DOI 10.1177/0884533611431985; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jacob T, 2013, ALCOHOL CLIN EXP RES, V28, P12071; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kelly MD, 2013, AIDS, V27, P479, DOI 10.1097/QAD.0b013e32835883bf; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Petoumenos Kathy, 2006, Sex Health, V3, P103, DOI 10.1071/SH05045; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Tate JP, 2012, INT COH M 2012; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; the Queensland Government, 2012, 2011 HIV AIDS REP EP; Wyatt CM, 2010, JAIDS-J ACQ IMM DEF, V55, P73, DOI 10.1097/QAI.0b013e3181cc1070	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78403	10.1371/journal.pone.0078403	http://dx.doi.org/10.1371/journal.pone.0078403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205222	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400080
J	Nakanishi, W; Yamaguchi, S; Matsuda, A; Suzukawa, M; Shibui, A; Nambu, A; Kondo, K; Suto, H; Saito, H; Matsumoto, K; Yamasoba, T; Nakae, S				Nakanishi, Wakako; Yamaguchi, Sachiko; Matsuda, Akira; Suzukawa, Maho; Shibui, Akiko; Nambu, Aya; Kondo, Kenji; Suto, Hajime; Saito, Hirohisa; Matsumoto, Kenji; Yamasoba, Tatuya; Nakae, Susumu			IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; AIRWAY INFLAMMATION; TSLP; INTERLEUKIN-33; EXPRESSION; RESPONSES; EXPOSURE; INNATE; ASTHMA; MODEL	Both interleukin (IL)-33 and IL-25 induce Th2 cytokine production by various cell types, suggesting that they contribute to development of allergic disorders. However, the precise roles of IL-33 and IL-25 in house dust mite (HDM)-induced allergic rhinitis (AR) remain unclear. Both IL-33 and IL-25 were produced mainly by nasal epithelial cells during HDM-induced AR. Eosinophil and goblet cell counts in the nose and IL-5 levels in lymph node cell culture supernatants were significantly decreased in IL-33-deficient, but not IL-25-deficient, mice compared with wild-type mice during HDM-induced AR, but the serum IgE and IgG1 levels did not differ. On the other hand, HDM-induced AR developed similarly in wild-type mice transferred with either IL-33-deficient BM cells or wild-type BM cells. IL-33, but not IL-25, produced by nasal epithelial cells was crucial for the development of murine HDM-induced AR. These observations suggest that IL-33 neutralization may be a potential approach for treatment of HDM-induced AR in humans.	[Nakanishi, Wakako; Kondo, Kenji; Yamasoba, Tatuya] Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Yamaguchi, Sachiko; Shibui, Akiko; Nambu, Aya; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Matsuda, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Suto, Hajime] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Tokyo 113, Japan; [Suzukawa, Maho] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 173, Japan; [Suzukawa, Maho] Natl Hosp Org, Tokyo Hosp, Tokyo, Japan; [Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; Juntendo University; Juntendo University; Teikyo University; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Nakae, S (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan.	snakae@ims.u-tokyo.ac.jp	Matsuda, Akira/A-9981-2010	Matsuda, Akira/0000-0002-0792-3663; Nambu, Aya/0000-0002-2797-6420; Shibui, Akiko/0000-0002-0428-5336; Suzukawa, Maho/0000-0002-2265-1950; Saito, Hirohisa/0000-0002-6630-8337	Global COE Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labour and Welfare, Japan; Grant of National Center for Child Health and Development [23A-5]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23390262] Funding Source: KAKEN	Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grant of National Center for Child Health and Development; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program, "Center of Education and Research for Advanced Genome-Based Medicine-For Personalized medicine and the control of worldwide infectious disease," from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (WN), Grants-in-Aid for Young Scientists (A), MEXT (SN), Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan (HS and KM), The Grant of National Center for Child Health and Development (23A-5) (KM), and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Ciprandi G, 2008, OTOLARYNG HEAD NECK, V138, P725, DOI 10.1016/j.otohns.2008.03.027; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kim YH, 2012, ALLERGY, V67, P183, DOI 10.1111/j.1398-9995.2011.02735.x; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ogita-Nakanishi Hiromi, 2009, Allergology International, V58, P171, DOI 10.2332/allergolint.08-OA-0021; Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004; Omori-Miyake M, 2012, ALLERGOL INT, V61, P27, DOI 10.2332/allergolint.11-RAI-0374; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Rydell-Tormanen K, 2008, AM J RESP CELL MOL, V39, P61, DOI 10.1165/rcmb.2007-0441OC; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; van Cauwenberge P, 2000, ALLERGY, V55, P116, DOI 10.1034/j.1398-9995.2000.00526.x; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Zhao CQ, 2010, ALLERGY, V65, P986, DOI 10.1111/j.1398-9995.2009.02295.x; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020	33	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78099	10.1371/journal.pone.0078099	http://dx.doi.org/10.1371/journal.pone.0078099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205109	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400071
J	Zhang, HH; Huang, TL; Liu, TT				Zhang, Haihan; Huang, Tinglin; Liu, Tingting			Sediment Enzyme Activities and Microbial Community Diversity in an Oligotrophic Drinking Water Reservoir, Eastern China	PLOS ONE			English	Article							FRESH-WATER; LAKE-SEDIMENTS; VARIABILITY; PHOSPHORUS; ADSORPTION; PROFILES; RIVER	Drinking water reservoir plays a vital role in the security of urban water supply, yet little is known about microbial community diversity harbored in the sediment of this oligotrophic freshwater environmental ecosystem. In the present study, integrating community level physiological profiles (CLPPs), nested polymerase chain reaction (PCR)denaturing gradient gel electrophoresis (DGGE) and clone sequence technologies, we examined the sediment urease and protease activities, bacterial community functional diversity, genetic diversity of bacterial and fungal communities in sediments from six sampling sites of Zhou cun drinking water reservoir, eastern China. The results showed that sediment urease activity was markedly distinct along the sites, ranged from 2.48 to 11.81 mg NH3-N/(g.24h). The highest average well color development (AWCD) was found in site C, indicating the highest metabolic activity of heterotrophic bacterial community. Principal component analysis (PCA) revealed tremendous differences in the functional (metabolic) diversity patterns of the sediment bacterial communities from different sites. Meanwhile, DGGE fingerprints also indicated spatial changes of genetic diversity of sediment bacterial and fungal communities. The sequence BLAST analysis of all the sediment samples found that Comamonas sp. was the dominant bacterial species harbored in site A. Alternaria alternate, Allomyces macrogynus and Rhizophydium sp. were most commonly detected fungal species in sediments of the Zhou cun drinking water reservoir. The results from this work provide new insights about the heterogeneity of sediment microbial community metabolic activity and genetic diversity in the oligotrophic drinking water reservoir.	[Zhang, Haihan; Huang, Tinglin; Liu, Tingting] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Architecture & Technology	Huang, TL (corresponding author), Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China.	huangtinglin@xauat.edu.cn			National Natural Science Foundation of China [51208413, 51008242]; National Science and Technology Pillar Program [2012BAC04B02]; Program of International ST Cooperation [2010DFA94550]; Doctoral Fund of Youth Scholar of Ministry of Education of China [20126120120002]; Shaanxi Provincial Natural Science Foundation [2012JQ7006]; Education Department of Shaanxi Province Special Research Project [12JK0646];  [2013T60873];  [2012M 521750]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Pillar Program; Program of International ST Cooperation; Doctoral Fund of Youth Scholar of Ministry of Education of China; Shaanxi Provincial Natural Science Foundation; Education Department of Shaanxi Province Special Research Project; ; 	This work was supported by the National Natural Science Foundation of China (51208413, 51008242), the National Science and Technology Pillar Program (2012BAC04B02), the Program of International S&T Cooperation (2010DFA94550), the Doctoral Fund of Youth Scholar of Ministry of Education of China (20126120120002), Shaanxi Provincial Natural Science Foundation (2012JQ7006), the Education Department of Shaanxi Province Special Research Project (12JK0646), and Postdoctoral Foundation (2013T60873, 2012M 521750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea KB, 2003, HYDROBIOLOGIA, V506-509, P721, DOI [10.1023/B:HYDR.0000008586.30395.f2, DOI 10.1023/B:HYDR.0000008586.30395.F2]; Bai YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037796; Biggs CA, 2011, ENVIRON TECHNOL, V32, P133, DOI 10.1080/09593330.2010.490852; BOAVIDA MJ, 1995, HYDROBIOLOGIA, V297, P11, DOI 10.1007/BF00033497; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Bushaw-Newton KL, 2012, ENVIRON SCI POLLUT R, V19, P1271, DOI 10.1007/s11356-011-0656-4; Choi KH, 1999, J MICROBIOL METH, V36, P203, DOI 10.1016/S0167-7012(99)00034-2; Curticapean MC, 2007, J BIOCHEM BIOPH METH, V69, P261, DOI 10.1016/j.jbbm.2006.03.003; [杜萍 Du Ping], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P1436; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Guan S, 1983, SOIL ENZYME ITS RES; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Huang LD, 2011, J SOIL SEDIMENT, V11, P185, DOI 10.1007/s11368-010-0305-4; [黄廷林 Huang Tinglin], 2012, [西安建筑科技大学学报, Journal of Xi'an University of Architecture & Technology], V44, P876; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Izaguirre G, 2007, WATER RES, V41, P492, DOI 10.1016/j.watres.2006.10.012; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Li WH, 2012, ECOTOX ENVIRON SAFE, V75, P198, DOI 10.1016/j.ecoenv.2011.08.021; Lymperopoulou DS, 2012, MICROBES ENVIRON, V27, P1, DOI 10.1264/jsme2.ME11253; Paerl HW, 1996, MICROB ECOL, V31, P225; Rees GN, 2006, J N AM BENTHOL SOC, V25, P370, DOI 10.1899/0887-3593(2006)25[370:VISMCI]2.0.CO;2; Roske K, 2012, SYST APPL MICROBIOL, V35, P35, DOI 10.1016/j.syapm.2011.09.002; Siba H, 2010, LIMNOLOGICA, V40, P54, DOI [10.1016/j.limno.2009.01.002, DOI 10.1016/J.LIMN0.2009.01.002]; Tiquia SM, 2010, ENVIRON POLLUT, V158, P1435, DOI 10.1016/j.envpol.2009.12.035; Wang Y, 2009, J HAZARD MATER, V162, P92, DOI 10.1016/j.jhazmat.2008.05.013; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wu YC, 2012, GEOMICROBIOL J, V29, P852, DOI 10.1080/01490451.2011.635760; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7; Zhang HH, 2010, EUR J SOIL BIOL, V46, P55, DOI 10.1016/j.ejsobi.2009.10.005; Zhao DY, 2011, INT J ENVIRON SCI TE, V8, P571, DOI 10.1007/BF03326243; Zhou WH, 2010, ENVIRON CHEM, V29, P629	32	14	18	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78571	10.1371/journal.pone.0078571	http://dx.doi.org/10.1371/journal.pone.0078571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205265	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400087
J	Liu, YH; Jiang, J; Wang, XJ; Zhai, F; Cheng, XX				Liu, Yanhua; Jiang, Jing; Wang, Xinjing; Zhai, Fei; Cheng, Xiaoxing			miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CANCER-CELLS; INNATE IMMUNITY; MICRORNAS; NECROSIS; PHOSPHORYLATION; INDUCTION; RESPONSES	Macrophage apoptosis is a host innate defense mechanism against tuberculosis (TB). In this study, we found that percentage of apoptotic cells in peripheral blood monocytes from patients with active TB was lower than that from healthy controls (p<0.001). To understand whether microRNAs can modulate apoptosis of monocytes, we investigated differentially expressed microRNAs in patients with active TB. miR-582-5p was mainly expressed in monocytes and was upregulated in patients with active TB. The apoptotic percentage of THP-1 cells transfected with miR-582-5p mimics was significantly lower than those transfected with negative control of microRNA mimics (p<0.001), suggesting that miR-582-5p could inhibit apoptosis of monocytes. To our knowledge, the role of miR-582-5p in regulating apoptosis of monocytes has not been reported so far. Systematic bioinformatics analysis indicated that FOXO1 might be a target gene for miR-582-5p and its 3'UTR contains potential binding sites for miR-582-5p. To determine whether miR-582-5p could influence FOXO1 expression, miR-582-5p mimics or negative control of microRNA mimics were transfected into THP-1 cells. RT-PCR and western blot analysis showed that the miR-582-5p could suppress both FOXO1 mRNA and protein expression. Co-transfection of miR-582-5p and FOXO1 3'UTR-luciferase reporter vector into cells demonstrated that significant decrease in luciferase activity was only found in reporter vector that contained a wild type sequence of FOXO1 3'UTR, suggesting that miR-582-5p could directly target FOXO1. In conclusion, miR-582-5p inhibited apoptosis of monocytes by down-regulating FOXO1 expression and might play an important role in regulating anti-M. tuberculosis directed immune responses.	[Liu, Yanhua; Jiang, Jing; Wang, Xinjing; Zhai, Fei; Cheng, Xiaoxing] 309 Hosp, Inst TB, Lab TB Prevent & Treatment PLA, Div Res, Beijing, Peoples R China		Cheng, XX (corresponding author), 309 Hosp, Inst TB, Lab TB Prevent & Treatment PLA, Div Res, Beijing, Peoples R China.	xcheng2@139.com	liu, yan/HCI-5542-2022		National Natural Science Foundation of China [81101219]; National Health and Family Planning Commission, China [2013ZX10003006-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission, China	The study was supported by a grant from the National Natural Science Foundation of China (81101219) (http://www.nsfc.gov.cn) and by a grant for infectious diseases from the National Health and Family Planning Commission, China (2013ZX10003006-003-001 (http://www.moh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba M, 2012, ANTI-CANCER AGENT ME, V12, P733, DOI 10.2174/187152012802650273; Aslam MI, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-128; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Berry E, 2009, GYNECOL ONCOL, V112, P331, DOI 10.1016/j.ygyno.2008.10.017; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lu HR, 2011, NEOPLASIA, V13, P854, DOI 10.1593/neo.11594; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Wang WR, 2013, APOPTOSIS, V18, P689, DOI 10.1007/s10495-013-0833-7; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Zhang HT, 2010, PROSTATE, V70, P1265, DOI 10.1002/pros.21162	29	14	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78381	10.1371/journal.pone.0078381	http://dx.doi.org/10.1371/journal.pone.0078381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205217	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300058
J	Kostrzewa, E; van Elburg, AA; Sanders, N; Sternheim, L; Adan, RAH; Kas, MJH				Kostrzewa, Elzbieta; van Elburg, Annemarie A.; Sanders, Nicole; Sternheim, Lot; Adan, Roger A. H.; Kas, Martien J. H.			Longitudinal Changes in the Physical Activity of Adolescents with Anorexia Nervosa and Their Influence on Body Composition and Leptin Serum Levels after Recovery	PLOS ONE			English	Article							WEIGHT-GAIN; FAT DISTRIBUTION; EXCESSIVE EXERCISE; HYPERACTIVITY; WOMEN; GHRELIN; REDISTRIBUTION; GONADOTROPIN; UNDERWEIGHT; BALANCE	Objective: Patients with anorexia nervosa (AN) are often observed to have high levels of physical activity, which do not necessarily diminish after a successful therapy. Previous studies have shown that body fat tissue recovery in these patients is associated with a disproportional restoration of the adipocyte hormone, leptin. Therefore, we wondered whether the individual variation in physical activity in AN patients prior to treatment may be related to body fat percentage and plasma leptin level outcome. Method: Body fat percentage, leptin serum, and physical activity levels (accelerometer) were measured in adolescents with an (n=37, age 13 to 17.5 years) at initial assessment, at the end of study participation (median 12 months), and at one-year follow-up. Results: Accelerometer data were used to split the patients in two groups: those with low (n=26) and those with high levels of physical activity (HLPA, n=11). These groups did not differ in terms of age, IQ, presence of menses, BMI and season of admission. The HLPA group was characterized by a longer total duration of illness. Physical activity levels during therapy decreased for the group with initially HLPA and increased for the group with low levels of physical activity (to comparable levels). Physical activity remained stable after one year. The increase in body fat percentage and leptin levels were dependent on the recovery status; however, recovered patients with initially HLPA had significantly higher fat mass during the follow-up. Discussion: HLPA, an important modulator of AN progression in adolescents, can be successfully diminished by therapeutic intervention. Among recovered patients, those with initially HLPA had higher fat mass levels than those with low levels of physical activity. This finding suggests that HLPA are an important modulator of the body composition recovery mechanism.	[Kostrzewa, Elzbieta; Adan, Roger A. H.; Kas, Martien J. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van Elburg, Annemarie A.; Sanders, Nicole; Sternheim, Lot] Altrecht Mental Hlth Inst, Rintveld Ctr Eating Disorders, Zeist, Netherlands	Utrecht University; Utrecht University Medical Center	Kas, MJH (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Kas, Martien J./G-8269-2018; Kostrzewa, Elzbieta/K-1698-2015; Zamora, Cristina Cuesta/E-2864-2016	Kas, Martien J./0000-0002-4471-8618; Kostrzewa, Elzbieta/0000-0001-5304-0143; Zamora, Cristina Cuesta/0000-0003-1121-9561	ZonMW VIDI-grant from The Netherlands Organization for Scientific Research (NOW) [91786327]	ZonMW VIDI-grant from The Netherlands Organization for Scientific Research (NOW)	These studies were supported by a ZonMW VIDI-grant (91786327) from The Netherlands Organization for Scientific Research (NOW; http://www.nwo.nl/) to Dr. Martien Kas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2013, MED SCI SPORT EXER, V45, P1643, DOI 10.1249/MSS.0b013e31828e8f07; BEUMONT PJV, 1994, INT J EAT DISORDER, V15, P21, DOI 10.1002/1098-108X(199401)15:1&lt;21::AID-EAT2260150104&gt;3.0.CO;2-K; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; Carrera O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041851; Carter JC, 2004, PSYCHOL MED, V34, P671, DOI 10.1017/S0033291703001168; Casper RC, 1996, J YOUTH ADOLESCENCE, V25, P499, DOI 10.1007/BF01537545; DAVIS C, 1993, J BEHAV MED, V16, P611, DOI 10.1007/BF00844722; Davis C, 1995, J PSYCHOSOM RES, V39, P967, DOI 10.1016/0022-3999(95)00064-X; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Djurovic M, 2004, J ENDOCRINOL INVEST, V27, P523, DOI 10.1007/BF03347473; Epling WF, 1992, SOLVING ANOREXIA PUZ; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Gelegen C, 2007, EUR NEUROPSYCHOPHARM, V17, P199, DOI 10.1016/j.euroneuro.2006.04.007; Grinspoon S, 2001, AM J CLIN NUTR, V73, P865; Gull WW, 1997, OBES RES, V5, P498, DOI 10.1002/j.1550-8528.1997.tb00677.x; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Holtkamp K, 2004, INT J EAT DISORDER, V36, P163, DOI 10.1002/eat.20035; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J CLIN ENDOCR METAB, V88, P5169, DOI 10.1210/jc.2003-030569; Holtkamp K, 2003, J PSYCHIATR RES, V37, P165, DOI 10.1016/S0022-3956(02)00100-0; Hubbard ST, 1998, EUR EAT DISORD REV, V6, P255, DOI 10.1002/(SICI)1099-0968(199812)6:4<255::AID-ERV262>3.0.CO;2-G; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Iketani T, 1999, INT J EAT DISORDER, V26, P275, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;275::AID-EAT4&gt;3.0.CO;2-I; Inoko K, 2005, PEDIATR INT, V47, P326, DOI 10.1111/j.1442-200x.2005.02072.x; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kopp W, 1997, MOL PSYCHIATR, V2, P335, DOI 10.1038/sj.mp.4000287; KRON L, 1978, COMPR PSYCHIAT, V19, P433, DOI 10.1016/0010-440X(78)90072-X; Lee S, 2003, AM J PSYCHIAT, V160, P967, DOI 10.1176/appi.ajp.160.5.967; Malendowicz LK, 2007, INT REV CYTOL, V263, P63, DOI 10.1016/S0074-7696(07)63002-2; Mathiak K, 1999, HORM METAB RES, V31, P274, DOI 10.1055/s-2007-978732; Mayer L, 2005, AM J CLIN NUTR, V81, P1286; Mayer LES, 2009, AM J CLIN NUTR, V90, P1132, DOI 10.3945/ajcn.2009.27820; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Mond JM, 2006, INT J EAT DISORDER, V39, P147, DOI 10.1002/eat.20214; Orphanidou CI, 1997, AM J CLIN NUTR, V65, P1034, DOI 10.1093/ajcn/65.4.1034; Otto B, 2001, Eur J Endocrinol, V145, P669; Pearce JMS, 2004, EUR NEUROL, V52, P191, DOI 10.1159/000082033; Popovic V, 2004, J CLIN ENDOCR METAB, V89, P1838, DOI 10.1210/jc.2003-031326; Probst M., 2010, OPEN COMPLEMENT MED, V2, P105, DOI [DOI 10.2174/1876391X010020010105, 10.2174/1876391X010020010105]; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Shroff H, 2006, INT J EAT DISORDER, V39, P454, DOI 10.1002/eat.20247; Soriano-Guillen L, 2004, J PEDIATR-US, V144, P36, DOI 10.1016/j.jpeds.2003.10.036; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Thome Jennifer L, 2007, Eat Behav, V8, P334, DOI 10.1016/j.eatbeh.2006.11.009; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; van Dijk G, 2001, J NEUROENDOCRINOL, V13, P913, DOI 10.1046/j.1365-2826.2001.00707.x; van Elburg AA, 2007, J NEURAL TRANSM, V114, P1233, DOI 10.1007/s00702-007-0740-6; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P274, DOI 10.1016/j.euroneuro.2010.11.006; Verhagen LAW, 2009, EUR NEUROPSYCHOPHARM, V19, P153, DOI 10.1016/j.euroneuro.2008.09.005; vonPrittwitz S, 1997, MOL PSYCHIATR, V2, P420, DOI 10.1038/sj.mp.4000300; Wabitsch M, 2001, J CLIN ENDOCR METAB, V86, P2982, DOI 10.1210/jc.86.7.2982	57	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78251	10.1371/journal.pone.0078251	http://dx.doi.org/10.1371/journal.pone.0078251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205172	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600087
J	Manchukonda, NK; Naik, PK; Santoshi, S; Lopus, M; Joseph, S; Sridhar, B; Kantevari, S				Manchukonda, Naresh Kumar; Naik, Pradeep Kumar; Santoshi, Seneha; Lopus, Manu; Joseph, Silja; Sridhar, Balasubramanian; Kantevari, Srinivas			Rational Design, Synthesis, and Biological Evaluation of Third Generation alpha-Noscapine Analogues as Potent Tubulin Binding Anti-Cancer Agents	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHODS; VALENCE BASIS-SETS; MICROTUBULE DYNAMICS; ACCURATE DOCKING; PERTURB MITOSIS; OVARIAN-CANCER; CELLS; POLYMERIZATION; COLCHICINE; APOPTOSIS	Systematic screening based on structural similarity of drugs such as colchicine and podophyllotoxin led to identification of noscapine, a microtubule-targeted agent that attenuates the dynamic instability of microtubules without affecting the total polymer mass of microtubules. We report a new generation of noscapine derivatives as potential tubulin binding anti-cancer agents. Molecular modeling experiments of these derivatives 5a, 6a-j yielded better docking score (-7.252 to -5.402 kCal/mol) than the parent compound, noscapine (-5.505 kCal/mol) and its existing derivatives (-5.563 to -6.412 kCal/mol). Free energy (Delta G(bind)) calculations based on the linear interaction energy (LIE) empirical equation utilizing Surface Generalized Born (SGB) continuum solvent model predicted the tubulin-binding affinities for the derivatives 5a, 6a-j (ranging from -4.923 to -6.189 kCal/mol). Compound 6f showed highest binding affinity to tubulin (-6.189 kCal/mol). The experimental evaluation of these compounds corroborated with theoretical studies. N-(3-brormobenzyl) noscapine (6f) binds tubulin with highest binding affinity (K-D, 38 +/- 4.0 mu M), which is similar to 4.0 times higher than that of the parent compound, noscapine (K-D, 144 +/- 1.0 mu M) and is also more potent than that of the first generation clinical candidate EM011, 9-bromonoscapine (K-D, 54 +/- 9.1 mu M). All these compounds exhibited substantial cytotoxicity toward cancer cells, with IC50 values ranging from 6.7 mu M to 72.9 mu M; compound 6f showed prominent anti-cancer efficacy with IC50 values ranging from 6.7 mu M to 26.9 mu M in cancer cells of different tissues of origin. These compounds perturbed DNA synthesis, delayed the cell cycle progression at G2/M phase, and induced apoptotic cell death in cancer cells. Collectively, the study reported here identified potent, third generation noscapinoids as new anti-cancer agents.	[Manchukonda, Naresh Kumar; Kantevari, Srinivas] Indian Inst Chem Technol, CSIR, Crop Protect Chem Div, Organ Chem Div 2, Hyderabad 500007, Andhra Pradesh, India; [Kantevari, Srinivas] Indian Inst Chem Technol, CSIR, Acad Sci & Innovat Res, Hyderabad 500007, Andhra Pradesh, India; [Sridhar, Balasubramanian] Indian Inst Chem Technol, CSIR, Xray Crystallog Lab, Hyderabad 500007, Andhra Pradesh, India; [Naik, Pradeep Kumar; Santoshi, Seneha] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Lopus, Manu; Joseph, Silja] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lopus, Manu; Joseph, Silja] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Lopus, Manu] Univ Mumbai Campus, UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Jaypee University of Information Technology; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; UM-DAE Centre for Excellence in Basic Sciences	Naik, PK (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	pknaik1973@gmail.com; kantevari@yahoo.com	Kantevari, Srinivas/B-3221-2008; Lopus, Manu/C-8470-2012; Kantevari, Srinivas/AAG-3892-2020; Santoshi, Seneha/ABI-5026-2020	Lopus, Manu/0000-0002-4829-3960; Santoshi, Seneha/0000-0001-8893-2221	MLP [0002]; CSIR [CSC0108-ORIGIN, CSC0205 - DENOVA]	MLP; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance through MLP 0002 & CSIR 12th five year projects (CSC0108-ORIGIN & CSC0205 - DENOVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya M. A., 1982, ANAL PROFILES DRUG S, V11, P407, DOI DOI 10.1016/S0099-5428(08)60271-3; Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, BIOORGAN MED CHEM, V14, P8352, DOI 10.1016/j.bmc.2006.09.012; Aneja R, 2006, MOL PHARMACOL, V69, P1801, DOI 10.1124/mol.105.021899; Aneja R, 2010, INT J CANCER, V126, P256, DOI 10.1002/ijc.24765; [Anonymous], 2010, MED PLANT BIOTECHNOL; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulduk I, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/493870; Chandra R, 2012, CURR DRUG METAB, V13, P1476, DOI 10.2174/138920012803762756; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeBono AJ, 2012, CHEMMEDCHEM, V7, P2122, DOI 10.1002/cmdc.201200365; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fang ZZ, 2012, BRIT J PHARMACOL, V167, P1271, DOI 10.1111/j.1476-5381.2012.02067.x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Jhaveri N, 2011, CANCER LETT, V312, P245, DOI 10.1016/j.canlet.2011.08.015; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2002, CANCER RES, V62, P4109; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Manchukonda NK, 2012, BIOORG MED CHEM LETT, V22, P2983, DOI 10.1016/j.bmcl.2012.02.033; McCamley K, 2003, J ORG CHEM, V68, P9847, DOI 10.1021/jo035243z; Mishra RC, 2011, BIOCHEM PHARMACOL, V82, P110, DOI 10.1016/j.bcp.2011.03.029; Naik PK, 2011, J COMPUT AID MOL DES, V25, P443, DOI 10.1007/s10822-011-9430-4; Naik PK, 2011, J MOL GRAPH MODEL, V29, P947, DOI 10.1016/j.jmgm.2011.03.004; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; PIETRO WJ, 1982, J AM CHEM SOC, V104, P5039, DOI 10.1021/ja00383a007; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Santoshi S, 2011, J BIOMOL SCREEN, V16, P1047, DOI 10.1177/1087057111418654; SEGAL MS, 1957, DIS CHEST, V32, P305; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh P, 2012, CURR DRUG METAB, DOI CDM-EPUB-20120824-11; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Verma AK, 2006, BIOORGAN MED CHEM, V14, P6733, DOI 10.1016/j.bmc.2006.05.069; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zhou RH, 2001, J PHYS CHEM B, V105, P10388, DOI 10.1021/jp011480z	54	47	49	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77970	10.1371/journal.pone.0077970	http://dx.doi.org/10.1371/journal.pone.0077970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205049	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600056
J	Tan, CW; Hirokawa, Y; Gardiner, BS; Smith, DW; Burgess, AW				Tan, Chin Wee; Hirokawa, Yumiko; Gardiner, Bruce S.; Smith, David W.; Burgess, Antony W.			Colon Cryptogenesis: Asymmetric Budding	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; EPITHELIAL-CELL TYPES; CRYPT FISSION; STEM-CELLS; COLORECTAL-CANCER; PANETH CELLS; BETA-CATENIN; LARGE-BOWEL; RENEWAL; MIGRATION	The process of crypt formation and the roles of Wnt and cell-cell adhesion signaling in cryptogenesis are not well described; but are important to the understanding of both normal and cancer colon crypt biology. A quantitative 3D-microscopy and image analysis technique is used to study the frequency, morphology and molecular topography associated with crypt formation. Measurements along the colon reveal the details of crypt formation and some key underlying biochemical signals regulating normal colon biology. Our measurements revealed an asymmetrical crypt budding process, contrary to the previously reported symmetrical fission of crypts. 3D immunofluorescence analyses reveals heterogeneity in the subcellular distribution of E-cadherin and beta-catenin in distinct crypt populations. This heterogeneity was also found in asymmetrical budding crypts. Singular crypt formation (i.e. no multiple new crypts forming from one parent crypt) were observed in crypts isolated from the normal colon mucosa, suggestive of a singular constraint mechanism to prevent aberrant crypt production. The technique presented improves our understanding of cryptogenesis and suggests that excess colon crypt formation occurs when Wnt signaling is perturbed (e. g. by truncation of adenomatous polyposis coli, APC protein) in most colon cancers.	[Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Tan, Chin Wee; Burgess, Antony W.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia; [Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Burgess, Antony W.] Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Ludwig Institute for Cancer Research; University of Western Australia; University of Melbourne	Tan, CW (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	cwtan@wehi.edu.au	Smith, David W/H-5856-2014; Tan, Chin Wee/B-1584-2015; Gardiner, Bruce/C-8593-2012	Smith, David W/0000-0003-4864-0288; Tan, Chin Wee/0000-0001-9695-7218; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council (NHMRC) [GNT1029628, 487922]; Operational Infrastructure Support Program by the Victorian Government, Australia	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program by the Victorian Government, Australia	This work is supported by National Health and Medical Research Council (NHMRC) Project Grant GNT1029628, Program Grant 487922 and by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally the manuscript is solely the responsibility of the institutions and individual authors and does not reflect the views of NHMRC.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahlquist DA, 2000, HUM PATHOL, V31, P51, DOI 10.1016/S0046-8177(00)80198-7; Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bashir O, 2004, CARCINOGENESIS, V25, P1507, DOI 10.1093/carcin/bgh137; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bjerknes M, 1997, AM J PATHOL, V150, P833; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CHANG WWL, 1982, VIRCHOWS ARCH B, V41, P17, DOI 10.1007/BF02890268; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1969, AM J ANAT, V126, P507, DOI 10.1002/aja.1001260409; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; CLARKE RM, 1972, J ANAT, V112, P27; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Efstathiou JA, 1998, AM J PATHOL, V153, P341, DOI 10.1016/S0002-9440(10)65576-9; Fauser JK, 2012, J PEDIATR GASTR NUTR, V55, P26, DOI 10.1097/MPG.0b013e318246b42d; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HALL PA, 1994, J CELL SCI, V107, P3569; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; KAUR P, 1986, CELL TISSUE KINET, V19, P601, DOI 10.1111/j.1365-2184.1986.tb00761.x; KEDINGER M, 1986, DEV BIOL, V113, P474, DOI 10.1016/0012-1606(86)90183-1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Le Blond CP, 1976, STEM CELLS RENEWING, P7; Luciano L, 2002, CELL TISSUE RES, V309, P393, DOI 10.1007/s00441-002-0593-0; Malpighi M, 1697, M MAGPIGHII PHILOS M; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MASKENS AP, 1981, CELL TISSUE KINET, V14, P467, DOI 10.1111/j.1365-2184.1981.tb00553.x; Mathworks, 2007, MATLAB VERS 7 4 0 28; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PARK HS, 1995, AM J PATHOL, V147, P1416; Polakis P, 2000, GENE DEV, V14, P1837; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Sherwood L, 2011, FUNDAMENTALS HUMAN P; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Takano-Maruyama M, 2006, AM J PHYSIOL-GASTR L, V291, pG163, DOI 10.1152/ajpgi.00019.2006; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0; Valizadeh A, 1997, AM J PATHOL, V150, P1977; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Wasan HS, 1998, J PATHOL, V185, P246; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	68	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78519	10.1371/journal.pone.0078519	http://dx.doi.org/10.1371/journal.pone.0078519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205248	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600105
J	Valzachi, MC; Teodorov, E; Marcourakis, T; Bailey, A; Camarini, R				Valzachi, Maria Cristina; Teodorov, Elizabeth; Marcourakis, Tania; Bailey, Alexis; Camarini, Rosana			Enhancement of Behavioral Sensitization, Anxiety-Like Behavior, and Hippocampal and Frontal Cortical CREB Levels Following Cocaine Abstinence in Mice Exposed to Cocaine during Adolescence	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; MEMORY RETRIEVAL; D-1 RECEPTOR; DOPAMINE; MODULATION; WITHDRAWAL; PHOSPHORYLATION	Adolescence has been linked to greater risk-taking and novelty-seeking behavior and a higher prevalence of drug abuse and risk of relapse. Decreases in cyclic adenosine monophosphate response element binding protein (CREB) and phosphorylated CREB (pCREB) have been reported after repeated cocaine administration in animal models. We compared the behavioral effects of cocaine and abstinence in adolescent and adult mice and investigated possible age-related differences in CREB and pCREB levels. Adolescent and adult male Swiss mice received one daily injection of saline or cocaine (10 mg/kg, i.p.) for 8 days. On day 9, the mice received a saline injection to evaluate possible environmental conditioning. After 9 days of withdrawal, the mice were tested in the elevated plus maze to evaluate anxiety-like behavior. Twelve days after the last saline/cocaine injection, the mice received a challenge injection of either cocaine or saline, and locomotor activity was assessed. One hour after the last injection, the brains were extracted, and CREB and pCREB levels were evaluated using Western blot in the prefrontal cortex (PFC) and hippocampus. The cocaine-pretreated mice during adolescence exhibited a greater magnitude of the expression of behavioral sensitization and greater cocaine withdrawal-induced anxiety-like behavior compared with the control group. Significant increases in CREB levels in the PFC and hippocampus and pCREB in the hippocampus were observed in cocaine-abstinent animals compared with the animals treated with cocaine in adulthood. Interestingly, significant negative correlations were observed between cocaine sensitization and CREB levels in both regions. These results suggest that the behavioral and neurochemical consequences of psychoactive substances in a still-developing nervous system can be more severe than in an already mature nervous system.	[Valzachi, Maria Cristina; Camarini, Rosana] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, BR-05508 Sao Paulo, Brazil; [Teodorov, Elizabeth] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Sao Paulo, Brazil; [Marcourakis, Tania] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Toxicol & Clin, Sao Paulo, Brazil; [Bailey, Alexis] Univ Surrey, Dept Biochem & Physiol, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; University of Surrey	Camarini, R (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, BR-05508 Sao Paulo, Brazil.	camarini@icb.usp.br	Bailey, Alexis/AAI-1489-2020; Marcourakis, Tânia/D-6667-2012; Camarini, Rosana/D-2251-2012	Bailey, Alexis/0000-0003-1541-1964; Marcourakis, Tânia/0000-0002-0076-5017; Camarini, Rosana/0000-0002-8131-6108	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was funded by the following: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Bailey A, 2007, J NEUROCHEM, V102, P1817, DOI 10.1111/j.1471-4159.2007.04661.x; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Bartlett E, 1997, NEUROPSYCHOPHARMACOL, V16, P77, DOI 10.1016/S0893-133X(96)00164-9; Beyer CE, 2000, PSYCHOPHARMACOLOGY, V151, P211, DOI 10.1007/s002139900345; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenhouse HC, 2008, BEHAV NEUROSCI, V122, P460, DOI 10.1037/0735-7044.122.2.460; Camarini R, 2008, BRAIN RES, V1193, P34, DOI 10.1016/j.brainres.2007.11.045; Camarini R, 2011, PHARMACOL BIOCHEM BE, V98, P173, DOI 10.1016/j.pbb.2010.12.017; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CARLEZON WA, 1995, SYNAPSE, V20, P1, DOI 10.1002/syn.890200102; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V33, P197, DOI 10.1016/0091-3057(89)90450-4; Cito MDD, 2012, BEHAV BRAIN RES, V231, P116, DOI 10.1016/j.bbr.2012.01.056; DIANA M, 1992, EUR J PHARMACOL, V221, P403, DOI 10.1016/0014-2999(92)90734-L; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Edwards S, 2007, EUR J NEUROSCI, V25, P2201, DOI 10.1111/j.1460-9568.2007.05473.x; El Hage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043535; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; Haghparast A, 2011, BEHAV BRAIN RES, V220, P112, DOI 10.1016/j.bbr.2011.01.045; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Hotte M, 2005, NEUROBIOL LEARN MEM, V84, P85, DOI 10.1016/j.nlm.2005.04.002; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Kroener S, 2010, NEUROPSYCHOPHARMACOL, V35, P2292, DOI 10.1038/npp.2010.107; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; McDaid J, 2006, MOL PHARMACOL, V70, P2064, DOI 10.1124/mol.106.023051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISERENDINO MJD, 1995, BRAIN RES, V674, P299, DOI 10.1016/0006-8993(95)00030-T; Muschamp JW, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012005; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Pandey SC, 1999, J PHARMACOL EXP THER, V288, P866; Pelloux Y, 2009, BEHAV BRAIN RES, V197, P311, DOI 10.1016/j.bbr.2008.08.029; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Philpot RM, 1999, PHARMACOL BIOCHEM BE, V62, P465, DOI 10.1016/S0091-3057(98)00198-1; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Robinson TE, 2000, ADDICTION, V95, pS91; ROGERIO R, 1992, PHARMACOL BIOCHEM BE, V43, P631, DOI 10.1016/0091-3057(92)90203-R; Rong YQ, 1996, J NEUROCHEM, V67, P662; Runyan JD, 2004, NEUROBIOL LEARN MEM, V82, P65, DOI 10.1016/j.nlm.2004.04.006; SHALABY IA, 1981, DEV BRAIN RES, V1, P434, DOI 10.1016/0165-3806(81)90082-1; SHIPPENBERG TS, 1991, PSYCHOPHARMACOLOGY, V103, P209, DOI 10.1007/BF02244205; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Stoker AK, 2011, BEHAV BRAIN RES, V223, P176, DOI 10.1016/j.bbr.2011.04.042; Tropea TF, 2008, J NEUROCHEM, V106, P1780, DOI 10.1111/j.1471-4159.2008.05518.x; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Williams JM, 2005, NEUROPHARMACOLOGY, V48, P51, DOI 10.1016/j.neuropharm.2004.09.004; Zelcer I, 2006, CEREB CORTEX, V16, P460, DOI 10.1093/cercor/bhi125	60	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78317	10.1371/journal.pone.0078317	http://dx.doi.org/10.1371/journal.pone.0078317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205196	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600092
J	Jawale, CV; Lee, JH				Jawale, Chetan V.; Lee, John Hwa			Development of a Biosafety Enhanced and Immunogenic Salmonella Enteritidis Ghost Using an Antibiotic Resistance Gene Free Plasmid Carrying a Bacteriophage Lysis System	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; EDWARDSIELLA-TARDA GHOSTS; ESCHERICHIA-COLI; VACCINE CANDIDATES; BACTERIAL GHOSTS; IMMUNE-RESPONSES; STAPHYLOCOCCAL NUCLEASE; PROTECTIVE EFFICACY; EXPRESSION SYSTEM; PROTEIN	In the development of genetically inactivated bacterial vaccines, plasmid retention often requires the antibiotic resistance gene markers, the presence of which can cause the potential biosafety hazards such as the horizontal spread of resistance genes. The new lysis plasmid was constructed by utilizing the approach of balanced-lethal systems based on auxotrophic gene Aspartate semialdehyde dehydrogenase (asd). The PhiX174 lysis gene E and.PR37-cI857 temperature-sensitive regulatory system was cloned in the asd gene positive plasmid and this novel approach allowed the production of antibiotic resistance marker free Salmonella Enteritidis (S. Enteritidis) ghost. The immunogenic potential of the biosafety enhanced antibiotic resistance gene free S. Enteritidis ghost was evaluated in chickens by employing the prime-boost vaccination strategy using a combination of oral and intramuscular routes. A total of 75 two-week-old chickens were equally divided into five groups: group A (non-immunized control), group B (intramuscularly primed and boosted), group C (primed intramuscularly and boosted orally), group D (primed and boosted orally), and group E (primed orally and boosted intramuscularly). Chickens from all immunized groups demonstrated significant increases in plasma IgG, intestinal secretory IgA levels, and antigen-specific lymphocyte proliferative response. After a virulent S. Enteritidis challenge, all immunized groups showed fewer gross lesions and decreased bacterial recovery from organs in comparison with the non-immunized control group. Among the immunized chickens, groups B and D chickens showed optimized protection, indicating that the prime-booster immunization with the ghost via intramuscular or oral route is efficient. Taken together, our results demonstrate that an antibiotic resistance gene free lysis plasmid was successfully constructed and utilized for production of safety enhanced S. Enteritidis ghost, which can be used as a safe and effective vaccine against virulent S. Enteritidis infections.	[Jawale, Chetan V.; Lee, John Hwa] Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea	Jeonbuk National University	Lee, JH (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea.	johnhlee@jbnu.ac.kr	jawale, chetan/AAR-1894-2021		Mid-career Researcher Program through NRF; MEST in Republic of Korea [2012R1A2A4A01002318]	Mid-career Researcher Program through NRF(National Research Foundation of Korea); MEST in Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2012R1A2A4A01002318) in Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2004, J CLIN MICROBIOL, V42, P1734, DOI 10.1128/JCM.42.4.1734-1738.2004; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Barrow PA, 2007, AVIAN PATHOL, V36, P1, DOI 10.1080/03079450601113167; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; BIELLMANN JF, 1980, EUR J BIOCHEM, V104, P53, DOI 10.1111/j.1432-1033.1980.tb04398.x; Bueno SM, 2007, IMMUNOL LETT, V111, P14, DOI 10.1016/j.imlet.2007.05.003; Cai K, 2013, VACCINE, V31, P334, DOI 10.1016/j.vaccine.2012.11.004; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; Choi SH, 2010, MOL BIOTECHNOL, V46, P127, DOI 10.1007/s12033-010-9277-2; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; Gogal RM, 1997, AVIAN DIS, V41, P714, DOI 10.2307/1592166; Haidinger W, 2003, APPL ENVIRON MICROB, V69, P6106, DOI 10.1128/AEM.69.10.6106-6113.2003; Haslberger AG, 2000, J BIOTECHNOL, V83, P57, DOI 10.1016/S0168-1656(00)00298-4; Hensel A, 2000, VACCINE, V18, P2945, DOI 10.1016/S0264-410X(00)00107-9; Hu M, 2013, CLIN VACCIN IN PRESS; Jalava K, 2002, J CONTROL RELEASE, V85, P17, DOI 10.1016/S0168-3659(02)00267-5; Jawale CV, 2012, INFECT IMMUN, V80, P1502, DOI 10.1128/IAI.06264-11; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Kwon SR, 2009, MOL BIOTECHNOL, V42, P154, DOI 10.1007/s12033-009-9147-y; Kwon SR, 2005, AQUACULTURE, V250, P16, DOI 10.1016/j.aquaculture.2005.02.052; Lee DJ, 2008, DIS AQUAT ORGAN, V81, P249, DOI 10.3354/dao01964; Londono-Arcila P, 2002, INFECT IMMUN, V70, P5096, DOI 10.1128/IAI.70.9.5096-5106.2002; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marchart J, 2003, VACCINE, V21, P3988, DOI 10.1016/S0264-410X(03)00383-9; Matsuda K, 2011, VACCINE, V29, P668, DOI 10.1016/j.vaccine.2010.11.039; Matsuda K, 2010, VET RES, V41, DOI 10.1051/vetres/2010031; Mayr UB, 2005, INFECT IMMUN, V73, P4810, DOI 10.1128/IAI.73.8.4810-4817.2005; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; Nandre RM, 2011, VET IMMUNOL IMMUNOP, V144, P299, DOI 10.1016/j.vetimm.2011.08.015; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Panthel K, 2003, INFECT IMMUN, V71, P109, DOI 10.1128/IAI.71.1.109-116.2003; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Peng W, 2011, IMMUNOBIOLOGY, V216, P558, DOI 10.1016/j.imbio.2010.10.001; Rana N, 2006, VET MICROBIOL, V115, P156, DOI 10.1016/j.vetmic.2006.01.011; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Smith AL, 2008, AVIAN IMMUNOLOGY, P243, DOI 10.1016/B978-012370634-8.50016-0; Szostak MP, 1996, J BIOTECHNOL, V44, P161, DOI 10.1016/0168-1656(95)00123-9; Thomas ME, 2009, APPL ENVIRON MICROB, V75, P6361, DOI 10.1128/AEM.00961-09; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; VILLAVERDE A, 1993, APPL ENVIRON MICROB, V59, P3485, DOI 10.1128/AEM.59.10.3485-3487.1993; Wang XP, 2009, VACCINE, V27, P1571, DOI 10.1016/j.vaccine.2009.01.002; WITTE A, 1992, ARCH MICROBIOL, V157, P381, DOI 10.1007/BF00248685; Yu SY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-206	48	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78193	10.1371/journal.pone.0078193	http://dx.doi.org/10.1371/journal.pone.0078193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205152	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300147
J	Ezzeddine, R; Al-Banaw, A; Tovmasyan, A; Craik, JD; Batinic-Haberle, I; Benov, LT				Ezzeddine, Rima; Al-Banaw, Anwar; Tovmasyan, Artak; Craik, James D.; Batinic-Haberle, Ines; Benov, Ludmil T.			Effect of Molecular Characteristics on Cellular Uptake, Subcellular Localization, and Phototoxicity of Zn(II) N-Alkylpyridylporphyrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fluorescence; Membrane Bilayer; Photodynamic Therapy; Porphyrin; Zn Porphyrin; Cellular Uptake; Photosensitizer; Phototoxicity; Subcellular Distribution	PHOTODYNAMIC THERAPY; PORPHYRIN DERIVATIVES; DEATH; PHOTOSENSITIZERS; MITOCHONDRIA; DERMATOLOGY; MECHANISMS; PATHWAYS; WATER	Background: Delivering molecules to selected cellular compartments is important for analytical and practical purposes. Results: Varying the length and positions of alkyl substituents results in preferential uptake of zinc porphyrins by particular cellular structures. Conclusion: Uptake, distribution, and phototoxicity of porphyrins depend on charge, lipophilicity, and molecular shape. Significance: Systematic chemical modification provides the basis for rational design of molecules targeting specific cellular compartments. Tetra-cationic Zn(II) meso-tetrakis(N-alkylpyridinium-2 (or -3 or -4)-yl)porphyrins (ZnPs) with progressively increased lipophilicity were synthesized to investigate how the tri-dimensional shape and lipophilicity of the photosensitizer (PS) affect cellular uptake, subcellular distribution, and photodynamic efficacy. The effect of the tri-dimensional shape of the molecule was studied by shifting the N-alkyl substituent attached to the pyridyl nitrogen from ortho to meta and para positions. Progressive increase of lipophilicity from shorter hydrophilic (methyl) to longer amphiphilic (hexyl) alkyl chains increased the phototoxicity of the ZnP PSs. PS efficacy was also increased for all derivatives when the alkyl substituents were shifted from ortho to meta, and from meta to para positions. Both cellular uptake and subcellular distribution of the PSs were affected by the lipophilicity and the position of the alkyl chains on the periphery of the porphyrin ring. Whereas the hydrophilic ZnPs demonstrated mostly lysosomal distribution, the amphiphilic hexyl derivatives were associated with mitochondria, endoplasmic reticulum, and plasma membrane. A comparison of hexyl isomers revealed that cellular uptake and partition into membranes followed the order para > meta > ortho. Varying the position and length of the alkyl substituents affects (i) the exposure of cationic charges for electrostatic interactions with anionic biomolecules and (ii) the lipophilicity of the molecule. The charge, lipophilicity, and the tri-dimensional shape of the PS are the major factors that determine cellular uptake, subcellular distribution, and as a consequence, the phototoxicity of the PSs.	[Ezzeddine, Rima; Craik, James D.; Benov, Ludmil T.] Kuwait Univ, Dept Biochem, Fac Med, Kuwait 13110, Kuwait; [Al-Banaw, Anwar] Kuwait Univ, Dept Med Lab Sci, Fac Allied Hlth Sci, Kuwait 13110, Kuwait; [Tovmasyan, Artak; Batinic-Haberle, Ines] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC 27708 USA	Kuwait University; Kuwait University; Duke University	Benov, LT (corresponding author), Kuwait Univ, Fac Med, Dept Biochem, POB 24923, Safat 13110, Kuwait.	lbenov@hsc.edu.kw	Tovmasyan, Artak/D-9101-2014; Benov, Ludmil/AAD-3714-2020	Tovmasyan, Artak/0000-0002-8612-1676; Benov, Ludmil/0000-0002-0205-0146; Ezzeddine, Rima/0000-0003-3817-5394	College of Graduate Studies; Kuwait University [YM05/11, SRUL02/13]; Ines Batinic-Haberle General Research Fund	College of Graduate Studies; Kuwait University; Ines Batinic-Haberle General Research Fund	This work was supported by the College of Graduate Studies and by grants YM05/11 and SRUL02/13 from Kuwait University.; Supported by the Ines Batinic-Haberle General Research Fund.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Babilas P, 2010, PHOTODERMATOL PHOTO, V26, P118, DOI 10.1111/j.1600-0781.2010.00507.x; Batinic-Haberle I, 2002, J CHEM SOC DALTON, P2689, DOI 10.1039/b201057g; Benov L, 2011, ANTI-CANCER AGENT ME, V11, P233, DOI 10.2174/187152011795255975; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bonnett R, 2006, WATER RES, V40, P1269, DOI 10.1016/j.watres.2006.01.014; Boyle RW, 1996, PHOTOCHEM PHOTOBIOL, V64, P469, DOI 10.1111/j.1751-1097.1996.tb03093.x; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Ehrenberg B, 1998, PHOTOCHEM PHOTOBIOL, V68, P135, DOI 10.1111/j.1751-1097.1998.tb02479.x; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Engelmann FM, 2007, INT J PHARM, V329, P12, DOI 10.1016/j.ijpharm.2006.08.008; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Jensen TJ, 2010, J PHOTOCH PHOTOBIO B, V100, P100, DOI 10.1016/j.jphotobiol.2010.05.007; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Kos I, 2009, J MED CHEM, V52, P7868, DOI 10.1021/jm900576g; Kos I, 2009, FREE RADICAL BIO MED, V47, P72, DOI 10.1016/j.freeradbiomed.2009.04.002; Kramer-Marek G, 2006, J PHOTOCH PHOTOBIO B, V84, P1, DOI 10.1016/j.jphotobiol.2005.12.011; Lee Y, 2011, SEMIN CUTAN MED SURG, V30, P199, DOI 10.1016/j.sder.2011.08.001; Lei WH, 2010, J PHOTOCH PHOTOBIO B, V98, P167, DOI 10.1016/j.jphotobiol.2009.12.003; Magaraggia M, 2006, J ENVIRON MONITOR, V8, P923, DOI 10.1039/b606975d; Meisel P, 2005, J PHOTOCH PHOTOBIO B, V79, P159, DOI 10.1016/j.jphotobiol.2004.11.023; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ricchelli F, 2005, INT J BIOCHEM CELL B, V37, P306, DOI 10.1016/j.biocel.2004.06.013; RODGERS MAJ, 1982, J AM CHEM SOC, V104, P5541, DOI 10.1021/ja00384a070; Silva JN, 2008, BIO-MED MATER ENG, V18, P319, DOI 10.3233/BME-2008-0546; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Spasojevic I, 2002, INORG CHEM, V41, P5874, DOI 10.1021/ic025556x; Szeimies RM, 2013, J DTSCH DERMATOL GES, V11, P632, DOI 10.1111/ddg.12119; Taub A. F., 2012, J COSMET DERMATOL, V25, P218; Wainwright M, 2002, CURR MED CHEM, V9, P127, DOI 10.2174/0929867023371355; Waksman R, 2008, J AM COLL CARDIOL, V52, P1024, DOI 10.1016/j.jacc.2008.06.023; Woodburn K W, 1996, J Clin Laser Med Surg, V14, P343	41	64	65	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36579	36588		10.1074/jbc.M113.511642	http://dx.doi.org/10.1074/jbc.M113.511642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214973	Green Published, hybrid			2022-12-25	WOS:000328883400038
J	Aguado-Llera, D; Hamidi, T; Domenech, R; Pantoja-Uceda, D; Gironella, M; Santoro, J; Velazquez-Campoy, A; Neira, JL; Iovanna, JL				Aguado-Llera, David; Hamidi, Tewfik; Domenech, Rosa; Pantoja-Uceda, David; Gironella, Meritxell; Santoro, Jorge; Velazquez-Campoy, Adrian; Neira, Jose L.; Iovanna, Juan L.			Deciphering the Binding between Nupr1 and MSL1 and Their DNA-Repairing Activity	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; LETHAL COMPLEX; PROTEIN; MOF; STRESS; P8; IDENTIFICATION; ACETYLATION; RECRUITMENT; ACTIVATION	The stress protein Nupr1 is a highly basic, multifunctional, intrinsically disordered protein (IDP). MSL1 is a histone acetyl transferase-associated protein, known to intervene in the dosage compensation complex (DCC). In this work, we show that both Nupr1 and MSL1 proteins were recruited and formed a complex into the nucleus in response to DNA-damage, which was essential for cell survival in reply to cisplatin damage. We studied the interaction of Nupr1 and MSL1, and their binding affinities to DNA by spectroscopic and biophysical methods. The MSL1 bound to Nupr1, with a moderate affinity (2.8 mu M) in an entropically-driven process. MSL1 did not bind to non-damaged DNA, but it bound to chemically-damaged-DNA with a moderate affinity (1.2 mu M) also in an entropically-driven process. The Nupr1 protein bound to chemically-damaged-DNA with a slightly larger affinity (0.4 mu M), but in an enthalpically-driven process. Nupr1 showed different interacting regions in the formed complexes with Nupr1 or DNA; however, they were always disordered ("fuzzy"), as shown by NMR. These results underline a stochastic description of the functionality of the Nupr1 and its other interacting partners.	[Aguado-Llera, David; Domenech, Rosa; Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Hamidi, Tewfik; Gironella, Meritxell; Iovanna, Juan L.] Aix Marseille Univ, INSERM, U1068, CRCM,CNRS,U7258, Marseille, France; [Hamidi, Tewfik; Gironella, Meritxell; Iovanna, Juan L.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Pantoja-Uceda, David; Santoro, Jorge] CSIC, IQFR, Madrid, Spain; [Gironella, Meritxell] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Velazquez-Campoy, Adrian; Neira, Jose L.] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Unidad Asociada IQFR CSIC BIFI, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Diputac Gen Aragon, Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza	Neira, JL (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	jlneira@umh.es; juan.iovanna@inserm.fr	Velazquez-Campoy, Adrian/E-7946-2012; Pantoja-Uceda, David/J-8097-2014; Neira, Jose/ABF-4210-2021; Llera, David Aguado/A-4349-2017; Iovanna, Juan/M-9805-2017	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Llera, David Aguado/0000-0002-8333-2857; Iovanna, Juan/0000-0003-1822-2237; Neira, Jose Luis/0000-0002-4933-0428; Pantoja-Uceda, David/0000-0003-4390-6972; Gironella, Meritxell/0000-0003-4437-5181	Spanish Ministerio de Ciencia e Innovacion (MCINN) [CTQ2011-24393, CSD2008-00005, BFU2010-19451, CTQ2011-22514]; intramural BIFI projects; Generalitat Valenciana [Prometeo 018/2013]; La Ligue Contre le Cancer; INCa; Canceropole PACA; INSERM	Spanish Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); intramural BIFI projects; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole PACA(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MCINN) [CTQ2011-24393 to JLN, CSD2008-00005 to JLN, BFU2010-19451 to AVC, and CTQ2011-22514 to JS], intramural BIFI 2011 projects (to JLN and AVC), Generalitat Valenciana [Prometeo 018/2013] (to JLN) and by La Ligue Contre le Cancer, INCa, Canceropole PACA and INSERM (to JLI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Llera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017068; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bravo J, 2010, SCI WORLD J, V10, P1613; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dmitriev RI, 2007, BIOCHEM BIOPH RES CO, V355, P1051, DOI 10.1016/j.bbrc.2007.02.073; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Hallacli E, 2012, MOL CELL, V48, P587, DOI 10.1016/j.molcel.2012.09.014; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Huang J, 2012, CELL RES, V22, P1078, DOI 10.1038/cr.2012.72; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Khan H, 2013, J MOL BIOL, V425, P1011, DOI 10.1016/j.jmb.2013.01.005; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li XZ, 2010, EPIGENETICS-US, V5; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Neira JL, 2013, PROTEIN PEPTIDE LETT, V20, P955, DOI 10.2174/09298665113209990040; Pantoja-Uceda D, 2008, J MAGN RESON, V195, P187, DOI 10.1016/j.jmr.2008.09.010; Pantoja-Uceda D, 2012, J BIOMOL NMR, V54, P145, DOI 10.1007/s10858-012-9665-y; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Sandi MJ, 2011, J CELL PHYSIOL, V226, P3442, DOI 10.1002/jcp.22702; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015	46	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78101	10.1371/journal.pone.0078101	http://dx.doi.org/10.1371/journal.pone.0078101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205110	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500096
J	Beitlich, T; Lorenz, T; Reinstein, J				Beitlich, Thorsten; Lorenz, Thorsten; Reinstein, Jochen			Folding Properties of Cytosine Monophosphate Kinase from E-coli Indicate Stabilization through an Additional Insert in the NMP Binding Domain	PLOS ONE			English	Article							ADENYLATE-KINASE; CMP KINASE; STRUCTURAL-CHARACTERIZATION; REFOLDING TRANSITION; CRYSTAL-STRUCTURE; UMP/CMP KINASE; PROTEINS; PATHWAY; SPECIFICITY; MECHANISM	The globular 25 kDa protein cytosine monophosphate kinase (CMPK, EC ID: 2.7.4.14) from E. coli belongs to the family of nucleoside monophosphate (NMP) kinases (NMPK). Many proteins of this family share medium to high sequence and high structure similarity including the frequently found alpha/beta topology. A unique feature of CMPK in the family of NMPKs is the positioning of a single cis-proline residue in the CORE-domain (cis-Pro124) in conjunction with a large insert in the NMP binding domain. This insert is not found in other well studied NMPKs such as AMPK or UMP/CMPK. We have analyzed the folding pathway of CMPK using time resolved tryptophan and FRET fluorescence as well as CD. Our results indicate that unfolding at high urea concentrations is governed by a single process, whereas refolding in low urea concentrations follows at least a three step process which we interpret as follows: Pro124 in the CORE-domain is in cis in the native state (N-c) and equilibrates with its trans-isomer in the unfolded state (U-c-U-t). Under refolding conditions, at least the U-t species and possibly also the U-c species undergo a fast initial collapse to form intermediates with significant amount of secondary structure, from which the trans-Pro124 fraction folds to the native state with a 100-fold lower rate constant than the cis-Pro124 species. CMPK thus differs from homologous NMP kinases like UMP/CMP kinase or AMP kinase, where folding intermediates show much lower content of secondary structure. Importantly also unfolding is up to 100-fold faster compared to CMPK. We therefore propose that the stabilizing effect of the long NMP-domain insert in conjunction with a subtle twist in the positioning of a single cis-Pro residue allows for substantial stabilization compared to other NMP kinases with alpha/beta topology.	[Beitlich, Thorsten; Lorenz, Thorsten; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg 1, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	Funded by the Max Planck Society, no specific grant number (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTHOFF S, 1988, J MOL BIOL, V199, P665, DOI 10.1016/0022-2836(88)90310-5; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bowman GR, 2011, CURR OPIN STRUC BIOL, V21, P4, DOI 10.1016/j.sbi.2010.10.006; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Briozzo P, 1998, STRUCTURE, V6, P1517, DOI 10.1016/S0969-2126(98)00150-6; Bucurenci N, 1996, J BIOL CHEM, V271, P2856, DOI 10.1074/jbc.271.5.2856; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fairclough R H, 1978, Methods Enzymol, V48, P347; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gunasekaran K, 2001, CURR OPIN STRUC BIOL, V11, P83, DOI 10.1016/S0959-440X(00)00173-1; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Huang F, 2007, P NATL ACAD SCI USA, V104, P123, DOI 10.1073/pnas.0609717104; Lavie A, 1998, BIOCHEMISTRY-US, V37, P3677, DOI 10.1021/bi9720787; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Lowe AR, 2007, J MOL BIOL, V365, P1245, DOI 10.1016/j.jmb.2006.10.060; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Orevi T, 2009, J MOL BIOL, V385, P1230, DOI 10.1016/j.jmb.2008.10.077; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Ratner V, 2005, J MOL BIOL, V352, P683, DOI 10.1016/j.jmb.2005.06.074; Ratner V, 2002, J MOL BIOL, V320, P1135, DOI 10.1016/S0022-2836(02)00520-X; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rundqvist L, 2009, BIOCHEMISTRY-US, V48, P1911, DOI 10.1021/bi8018042; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Schmid F X, 1986, Methods Enzymol, V131, P70; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schmid FX, 1992, PROTEIN FOLDING, P916; SCHULZ GE, 1974, NATURE, V250, P142, DOI 10.1038/250142a0; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Topalis D, 2007, FEBS J, V274, P3704, DOI 10.1111/j.1742-4658.2007.05902.x; Ulschmid JK, 2004, MOL BIOCHEM PARASIT, V136, P211, DOI 10.1016/j.molbiopara.2004.04.001; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zarrine-Afsar A, 2005, CURR OPIN STRUC BIOL, V15, P42, DOI 10.1016/j.sbi.2005.01.011; Zhang HJ, 1998, BIOCHEM J, V333, P401, DOI 10.1042/bj3330401	51	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78384	10.1371/journal.pone.0078384	http://dx.doi.org/10.1371/journal.pone.0078384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205218	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500114
J	Sidorenkov, G; Voorham, J; de Zeeuw, D; Haaijer-Ruskamp, FM; Denig, P				Sidorenkov, Grigory; Voorham, Jaco; de Zeeuw, Dick; Haaijer-Ruskamp, Flora M.; Denig, Petra			Do Treatment Quality Indicators Predict Cardiovascular Outcomes in Patients with Diabetes?	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; RISK-FACTOR CONTROL; TREATMENT INTENSIFICATION; PERFORMANCE-MEASURES; RANDOMIZED-TRIALS; GLYCEMIC CONTROL; CARE; METAANALYSIS; MELLITUS; THERAPY	Background: Landmark clinical trials have led to optimal treatment recommendations for patients with diabetes. Whether optimal treatment is actually delivered in practice is even more important than the efficacy of the drugs tested in trials. To this end, treatment quality indicators have been developed and tested against intermediate outcomes. No studies have tested whether these treatment quality indicators also predict hard patient outcomes. Methods: A cohort study was conducted using data collected from >10.000 diabetes patients in the Groningen Initiative to Analyze Type 2 Treatment (GIANTT) database and Dutch Hospital Data register. Included quality indicators measured glucose-, lipid-, blood pressure-and albuminuria-lowering treatment status and treatment intensification. Hard patient outcome was the composite of cardiovascular events and all-cause death. Associations were tested using Cox regression adjusting for confounding, reporting hazard ratios (HR) with 95% confidence intervals. Results: Lipid and albuminuria treatment status, but not blood pressure lowering treatment status, were associated with the composite outcome (HR = 0.77, 0.67-0.88; HR = 0.75, 0.59-0.94). Glucose lowering treatment status was associated with the composite outcome only in patients with an elevated HbA1c level (HR = 0.72, 0.56-0.93). Treatment intensification with glucose-lowering but not with lipid-, blood pressure-and albuminuria-lowering drugs was associated with the outcome (HR = 0.73, 0.60-0.89). Conclusion: Treatment quality indicators measuring lipid-and albuminuria-lowering treatment status are valid quality measures, since they predict a lower risk of cardiovascular events and mortality in patients with diabetes. The quality indicators for glucose-lowering treatment should only be used for restricted populations with elevated HbA1c levels. Intriguingly, the tested indicators for blood pressure-lowering treatment did not predict patient outcomes. These results question whether all treatment indicators are valid measures to judge quality of health care and its economics.	[Sidorenkov, Grigory; Voorham, Jaco; de Zeeuw, Dick; Haaijer-Ruskamp, Flora M.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Sidorenkov, Grigory; Voorham, Jaco; Haaijer-Ruskamp, Flora M.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Inst SHARE, Groningen, Netherlands	University of Groningen; University of Groningen	Denig, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands.	p.denig@umcg.nl	de Zeeuw, Dick/E-9080-2014; Denig, Petra/L-9865-2014	de Zeeuw, Dick/0000-0003-3434-7777; Denig, Petra/0000-0002-7929-4739; Voorham, Jaco/0000-0001-9002-1865; Sidorenkov, Grigory/0000-0002-1926-8862	Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands	Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands	The study was funded by the Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron D, 2008, QUAL SAF HEALTH CARE, V17, P315, DOI 10.1136/qshc.2007.026161; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Botsis T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-11; Bouma M, 2006, Ned Tijdschr Geneeskd, V150, P2251; Bulger JB, 2012, AM J MANAG CARE, V18, P407; Central Bureau of Statistics in the Netherlands, MICR SERV COND YOUR; de Vries FM, 2012, DRUGS, V72, P2365, DOI 10.2165/11638240-000000000-00000; Dutch Health Care Insurance Board, 2013, DUTCH PHARM COMP; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Ho PM, 2008, ARCH INTERN MED, V168, P271, DOI 10.1001/archinternmed.2007.72; Lamberts W, 1987, INT CLASSIFICATION P; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Martirosyan L, 2008, QUAL SAF HEALTH CARE, V17, P318, DOI 10.1136/qshc.2007.024224; National Quality Forum, 2010, NAT VOL CONS STAND A; NHS Employers, 2013, EINF28001 NHS CONF E; Nichols GA, 2013, J GEN INTERN MED, V28, P691, DOI 10.1007/s11606-012-2320-1; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Pittman DG, 2012, AM J CARDIOL, V110, P1459, DOI 10.1016/j.amjcard.2012.07.008; Rose AJ, 2009, CIRC-CARDIOVASC QUAL, V2, P385, DOI 10.1161/CIRCOUTCOMES.108.838649; Rose AJ, 2009, HYPERTENSION, V54, P524, DOI 10.1161/HYPERTENSIONAHA.109.133389; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sidorenkov G, 2013, BMJ QUAL SAF, V22, P339, DOI 10.1136/bmjqs-2012-001203; Sidorenkov G, 2013, MED CARE, V51, P172, DOI 10.1097/MLR.0b013e318277eaf5; Sidorenkov G, 2011, MED CARE RES REV, V68, P263, DOI 10.1177/1077558710394200; The GIANTT project, 2013, GRON IN AN TYP 2 DIA; Timbie JW, 2010, HEALTH SERV RES, V45, P437, DOI 10.1111/j.1475-6773.2009.01075.x; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; van Althuis TR, 2011, OVERVIEW DEFINITION; van Bruggen R, 2009, FAM PRACT, V26, P428, DOI 10.1093/fampra/cmp053; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2008, MED CARE, V46, P133, DOI 10.1097/MLR.0b013e31815b9da0; Voorham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038707; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78821	10.1371/journal.pone.0078821	http://dx.doi.org/10.1371/journal.pone.0078821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205325	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500135
J	Steinberg, MW; Huang, YJ; Wang-Zhu, Y; Ware, CF; Cheroutre, H; Kronenberg, M				Steinberg, Marcos W.; Huang, Yujun; Wang-Zhu, Yiran; Ware, Carl F.; Cheroutre, Hilde; Kronenberg, Mitchell			BTLA Interaction with HVEM Expressed on CD8(+) T Cells Promotes Survival and Memory Generation in Response to a Bacterial Infection	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; TNF SUPERFAMILY; CUTTING EDGE; IMMUNE-RESPONSES; LIGHT; ACTIVATION; MEMBERS; CD4(+)	The B and T lymphocyte attenuator (BTLA) is an Ig super family member that binds to the herpes virus entry mediator (HVEM), a TNF receptor super family (TNFRSF) member. Engagement of BTLA by HVEM triggers inhibitory signals, although recent evidence indicates that BTLA also may act as an activating ligand for HVEM. In this study, we reveal a novel role for the BTLA-HVEM pathway in promoting the survival of activated CD8(+) T cells in the response to an oral microbial infection. Our data show that both BTLA- and HVEM-deficient mice infected with Listeria monocytogenes had significantly reduced numbers of primary effector and memory CD8(+) T cells, despite normal proliferation and expansion compared to controls. In addition, blockade of the BTLA-HVEM interaction early in the response led to significantly reduced numbers of antigen-specific CD8(+) T cells. HVEM expression on the CD8(+) T cells as well as BTLA expression on a cell type other than CD8(+) T lymphocytes, was required. Collectively, our data demonstrate that the function of the BTLA-HVEM pathway is not limited to inhibitory signaling in T lymphocytes, and instead, that BTLA can provide crucial, HVEM-dependent signals that promote survival of antigen activated CD8(+) T cell during bacterial infection.	[Steinberg, Marcos W.; Huang, Yujun; Wang-Zhu, Yiran; Cheroutre, Hilde; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA	La Jolla Institute for Immunology; Sanford Burnham Prebys Medical Discovery Institute	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021		National Institutes of Health [RO1 AI61516, PO1 DK46763, AI064584, AI050265, R37AI33068, AI048073, AI067890]; Crohn's & Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050265, R01AI050265, R01AI067890, R37AI033068, R01AI061516, R01AI048073, R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health RO1 AI61516 and PO1 DK46763 to MK; AI064584 and AI050265 to HC; R37AI33068, AI048073 and AI067890 to CFW, and by a Research Fellowship Award from the Crohn's & Colitis Foundation of America to MWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda R, 1997, J IMMUNOL, V158, P3464; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Deppong C, 2008, J IMMUNOL, V181, P2973, DOI 10.4049/jimmunol.181.5.2973; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; DiMenna L, 2010, J IMMUNOL, V184, P5475, DOI 10.4049/jimmunol.0903808; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Krieg C, 2007, NAT IMMUNOL; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Liu JQ, 2003, INT IMMUNOL, V15, P861, DOI 10.1093/intimm/dxg082; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miller ML, 2009, J IMMUNOL, V183, P32, DOI 10.4049/jimmunol.0900690; Musicki K, 2010, INT IMMUNOL, V22, P353, DOI 10.1093/intimm/dxq013; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Sedgmen BJ, 2006, INT IMMUNOL, V18, P797, DOI 10.1093/intimm/dxl016; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Sun YL, 2009, J IMMUNOL, V183, P1946, DOI 10.4049/jimmunol.0801866; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944	32	42	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77992	10.1371/journal.pone.0077992	http://dx.doi.org/10.1371/journal.pone.0077992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205057	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500086
J	Sun, DW; Ostermaier, MK; Heydenreich, FM; Mayer, D; Jaussi, R; Standfuss, J; Veprintsev, DB				Sun, Dawei; Ostermaier, Martin K.; Heydenreich, Franziska M.; Mayer, Daniel; Jaussi, Rolf; Standfuss, Joerg; Veprintsev, Dmitry B.			AAscan, PCRdesign and MutantChecker: A Suite of Programs for Primer Design and Sequence Analysis for High-Throughput Scanning Mutagenesis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; HOMOLOGOUS RECOMBINATION; CLONING; RECEPTOR; PCR; PROTEOMICS; SELECTION; BINDING; SINGLE	Scanning mutagenesis is a powerful protein engineering technique used to study protein structure-function relationship, map binding sites and design more stable proteins or proteins with altered properties. One of the time-consuming tasks encountered in application of this technique is the design of primers for site-directed mutagenesis. Here we present an open-source multi-platform software AAscan developed to design primers for this task according to a set of empirical rules such as melting temperature, overall length, length of overlap regions, and presence of GC clamps at the 3' end, for any desired substitution. We also describe additional software tools which are used to analyse a large number of sequencing results for the presence of desired mutations, as well as related software to design primers for ligation independent cloning. We have used AAscan software to design primers to make over 700 mutants, with a success rate of over 80%. We hope that the open-source nature of our software and ready availability of freeware tools used for its development will facilitate its adaptation and further development. The software is distributed under GPLv3 licence and is available at http://www.psi.ch/lbr/aascan.	[Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; ETH, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Veprintsev, DB (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	dmitry.veprintsev@psi.ch	Veprintsev, Dmitry B/H-2228-2012; Standfuss, Joerg/G-5126-2011; Mayer, Daniel/ABB-5655-2020; Heydenreich, Franziska M/N-6314-2015	Veprintsev, Dmitry B/0000-0002-3583-5409; Heydenreich, Franziska M/0000-0002-8049-4383; Ostermaier, Martin Konrad/0000-0003-4297-9133; Sun, Dawei/0000-0002-2010-6051	Swiss National Foundation [135754, 141898, 132815]; NCCR Structural Biology	Swiss National Foundation(Swiss National Science Foundation (SNSF)); NCCR Structural Biology(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation grants 135754, 141898, 132815 and NCCR Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1994, PCR METH APPL, V4, P172; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Canaves JM, 2004, BIOTECHNIQUES, V36, P1040, DOI 10.2144/04366BC01; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Festa F, 2013, PROTEOMICS, V13, P1381, DOI 10.1002/pmic.201200456; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Liang XQ, 2012, ANAL BIOCHEM, V427, P99, DOI 10.1016/j.ab.2012.05.002; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Neuweiler H, 2009, J MOL BIOL, V390, P1060, DOI 10.1016/j.jmb.2009.05.011; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Warne T, 2011, NATURE; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0	21	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78878	10.1371/journal.pone.0078878	http://dx.doi.org/10.1371/journal.pone.0078878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205336	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500138
J	Chintapalli, VR; Al Bratty, M; Korzekwa, D; Watson, DG; Dow, JAT				Chintapalli, Venkateswara R.; Al Bratty, Mohammed; Korzekwa, Dominika; Watson, David G.; Dow, Julian A. T.			Mapping an Atlas of Tissue-Specific Drosophila melanogaster Metabolomes by High Resolution Mass Spectrometry	PLOS ONE			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYPOXIA TOLERANCE; STRESS; MUSCLE; MUTANT; LIPIDS; LINKS	Metabolomics can provide exciting insights into organismal function, but most work on simple models has focussed on the whole organism metabolome, so missing the contributions of individual tissues. Comprehensive metabolite profiles for ten tissues from adult Drosophila melanogaster were obtained here by two chromatographic methods, a hydrophilic interaction (HILIC) method for polar metabolites and a lipid profiling method also based on HILIC, in combination with an Orbitrap Exactive instrument. Two hundred and forty two polar metabolites were putatively identified in the various tissues, and 251 lipids were observed in positive ion mode and 61 in negative ion mode. Although many metabolites were detected in all tissues, every tissue showed characteristically abundant metabolites which could be rationalised against specific tissue functions. For example, the cuticle contained high levels of glutathione, reflecting a role in oxidative defence; the alimentary canal (like vertebrate gut) had high levels of acylcarnitines for fatty acid metabolism, and the head contained high levels of ether lipids. The male accessory gland uniquely contained decarboxylated S-adenosylmethionine. These data thus both provide valuable insights into tissue function, and a reference baseline, compatible with the FlyAtlas.org transcriptomic resource, for further metabolomic analysis of this important model organism, for example in the modelling of human inborn errors of metabolism, aging or metabolic imbalances such as diabetes.	[Al Bratty, Mohammed; Watson, David G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Chintapalli, Venkateswara R.; Korzekwa, Dominika; Dow, Julian A. T.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Dow, JAT (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	Julian.Dow@glasgow.ac.uk	Dow, Julian/M-2371-2019; Albratty, Mohammed/AHD-1350-2022	Dow, Julian/0000-0002-9595-5146; 	Wellcome Trust; BBSRC (Biotechnology and Biological Sciences Research Council); University of Glasgow; University of Strathclyde; Biotechnology and Biological Sciences Research Council [BB/K019953/1, BB/J002143/1] Funding Source: researchfish; BBSRC [BB/J002143/1, BB/K019953/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Glasgow; University of Strathclyde; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust, the BBSRC (Biotechnology and Biological Sciences Research Council), and by general funds of the Universities of Glasgow and Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bratty M, 2011, METABOLOMICS, V7, P542, DOI 10.1007/s11306-011-0275-6; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Buch S, 2009, FLY, V3, P74, DOI 10.4161/fly.3.1.7795; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ELIAS MS, 1983, J NEUROCHEM, V41, P562, DOI 10.1111/j.1471-4159.1983.tb04776.x; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; FRAENKEL G, 1948, NATURE, V161, P981, DOI 10.1038/161981a0; Green MM, 2010, GENETICS, V184, P3, DOI 10.1534/genetics.109.110015; HUBBY JL, 1962, GENETICS, V47, P109; Jackson AA, 1997, ARCH DIS CHILD-FETAL, V76, pF152, DOI 10.1136/fn.76.3.F152; Jeulin C, 1996, HUM REPROD UPDATE, V2, P87, DOI 10.1093/humupd/2.2.87; Kamleh A, 2008, RAPID COMMUN MASS SP, V22, P1912, DOI 10.1002/rcm.3564; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2008, BRIEF FUNCT GENOMIC; Kamleh MA, 2009, FEBS J, V276, P6798, DOI 10.1111/j.1742-4658.2009.07397.x; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Malmendal A, 2013, NATURWISSENSCHAFTEN, V100, P417, DOI 10.1007/s00114-013-1040-7; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; Reisse S, 2001, BIOL REPROD, V64, P1689, DOI 10.1095/biolreprod64.6.1689; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; ROBITAILLE PA, 1986, J EXP ZOOL, V238, P89, DOI 10.1002/jez.1402380111; Shekhawat Prem S, 2013, J Crohns Colitis, V7, pe197, DOI 10.1016/j.crohns.2012.08.011; Simpson S. J., 2012, INSECTS STRUCTURE FU; SULLIVAN DT, 1980, BIOCHEM GENET, V18, P1109, DOI 10.1007/BF00484342; TEARLE R, 1991, GENET RES, V57, P257, DOI 10.1017/S0016672300029402; TREHERNE JE, 1957, J EXP BIOL, V34, P478; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Watson DG, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301005; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618	45	50	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78066	10.1371/journal.pone.0078066	http://dx.doi.org/10.1371/journal.pone.0078066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205093	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000326270700070
J	Henson, J; Yates, T; Edwardson, CL; Khunti, K; Talbot, D; Gray, LJ; Leigh, TM; Carter, P; Davies, MJ				Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Talbot, Duncan; Gray, Laura J.; Leigh, Thomas M.; Carter, Patrice; Davies, Melanie J.			Sedentary Time and Markers of Chronic Low-Grade Inflammation in a High Risk Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACTIVITY ENERGY-EXPENDITURE; RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE REGULATION; DIABETES-MELLITUS; IMMUNE-SYSTEM	Background: Sedentary behaviour has been identified as a distinct risk factor for several health outcomes. Nevertheless, little research has been conducted into the underlying mechanisms driving these observations. This study aimed to investigate the association of objectively measured sedentary time and breaks in sedentary time with markers of chronic low-grade inflammation and adiposity in a population at a high risk of type 2 diabetes mellitus. Methods: This study reports data from an ongoing diabetes prevention programme conducted in Leicestershire, UK. High risk individuals were recruited from 10 primary care practices. Sedentary time (<25counts per 15s) was measured using Actigraph GT3X accelerometers (15s epochs). A break was considered as any interruption in sedentary time (>= 25counts per 15s). Biochemical outcomes included interleukin-6 (IL-6), C-reactive protein (CRP), leptin, adiponectin and leptin: adiponectin ratio (LAR). A sensitivity analysis investigated whether results were affected by removing participants with a CRP level >10 mg/L, as this can be indicative of acute inflammation. Results: 558 participants (age = 63.6 +/- 7.7years; male = 64.7%) had complete adipokine and accelerometer data. Following adjustment for various confounders, sedentary time was detrimentally associated with CRP (beta = 0.176 +/- 0.057, p = 0.002), IL-6 (beta = 0.24260.056, p = <0.001), leptin (beta = 0.146 +/- 0.043, p = <0.001) and LAR (beta = 0.208 +/- 0.052, p = <0.001). Associations were attenuated after further adjustment for moderate-to-vigorous physical activity (MVPA) with only IL-6 (beta = 0.231 +/- 0.073, p = 0.002) remaining significant; this result was unaffected after further adjustment for body mass index and glycosylated haemoglobin (HbA(1c)). Similarly, breaks in sedentary time were significantly inversely associated with IL-6 (beta = -0.094 +/- 0.047, p = 0.045) and leptin (beta = 20.075 +/- 0.037, p = 0.039); however, these associations were attenuated after adjustment for accelerometer derived variables. Excluding individuals with a CRP level >10 mg/L consistently attenuated the significant associations across all markers of inflammation. Conclusion: These novel findings from a high risk population recruited through primary care suggest that sedentary behaviour may influence markers associated with inflammation, independent of MVPA, glycaemia and adiposity.	[Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Carter, Patrice; Davies, Melanie J.] Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England; [Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Carter, Patrice; Davies, Melanie J.] Univ Leicester, Diabet Res Ctr, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Talbot, Duncan] Unilever Discover, Sharnbrook, Beds, England; [Gray, Laura J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Leigh, Thomas M.] Leicester Gen Hosp, Leicester Diabet Ctr, Univ Hosp Leicester, Leicester LE5 4PW, Leics, England	University of Leicester; Unilever; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Henson, J (corresponding author), Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England.	jjh18@le.ac.uk	/ABC-9527-2021; Stefanadis, Christodoulos/ABH-2232-2020	Davies, Melanie/0000-0002-9987-9371; Henson, Joseph/0000-0002-3898-7053; Gray, Laura/0000-0002-9284-9321; Carter, Patrice/0000-0003-3445-6754; Stefanadis, Christodoulos/0000-0001-5974-6454; Khunti, Kamlesh/0000-0003-2343-7099; Edwardson, Charlotte/0000-0001-6485-9330	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR); University of Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; Unilever Discover, UK	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR); University of Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; Unilever Discover, UK	The research was supported by The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR) (http://www.clahrc-lnr.nihr.ac.uk/index.php/walking-away-from-diabetes), the University of Leicester Clinical Trials Unit and the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester (http://www.ll.dlpa.bru.nihr.ac.uk/). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. C-reactive protein and adipokine analysis was carried out and funded by Unilever Discover, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Allison MA, 2012, AM J PREV MED, V42, P8, DOI 10.1016/j.amepre.2011.09.023; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Franks PW, 2003, J CLIN ENDOCR METAB, V88, P3258, DOI 10.1210/jc.2002-021426; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Gray LJ, 2012, DIABETOLOGIA, V55, P959, DOI 10.1007/s00125-011-2432-x; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Nader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Panagiotakos DB, 2005, PREV MED, V40, P432, DOI 10.1016/j.ypmed.2004.07.010; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2012, MED SCI SPORT EXER, V44, P392, DOI 10.1249/MSS.0b013e31822f94ac; Pedersen M, 2004, EXERC IMMUNOL REV, V10, P42; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Tataranni PA, 2005, DIABETES, V54, P917, DOI 10.2337/diabetes.54.4.917; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization, 2006, WHO 2006 DEF DIAGN D; Yates T, 2010, DIABETIC MED, V27, P1256, DOI 10.1111/j.1464-5491.2010.03091.x; Yates T, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-46; Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022	44	106	109	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78350	10.1371/journal.pone.0078350	http://dx.doi.org/10.1371/journal.pone.0078350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205208	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700088
J	Martins, LA; Fogaca, AC; Bijovsky, AT; Carballar-Lejarazu, R; Marinotti, O; Cardoso, AF				Martins, Larissa A.; Fogaca, Andrea C.; Tania Bijovsky, A.; Carballar-Lejarazu, Rebeca; Marinotti, Osvaldo; Cardoso, Andre F.			Culex quinquefasciatus Storage Proteins	PLOS ONE			English	Article							WEST-NILE-VIRUS; INSECTICIDE RESISTANCE; MOLECULAR-CLONING; AEDES-AEGYPTI; FAT-BODY; VITELLOGENIN SYNTHESIS; ARTHROPOD HEMOCYANINS; VECTOR COMPETENCE; PIPIENS DIPTERA; MOSQUITO	Insect storage proteins accumulate at high levels during larval development of holometabolous insects. During metamorphosis they are degraded, supplying energy and amino acids for the completion of adult development. The genome of Culex quinquefasciatus contains eleven storage protein-coding genes. Their transcripts are more abundant in larvae than in pupae and in adults. In fact, only four of these genes are transcribed in adults, two of which in blood-fed adult females but not in adult males. Transcripts corresponding to all Cx. quinquefasciatus storage proteins were detected by RTPCR, while mass spectrometric analysis of larval and pupal proteins identified all storage proteins with the exception of one encoded by Cq LSP1.8. Our results indicate that the identified Cx. quinquefasciatus storage protein-coding genes are candidates for identifying regulatory sequences for the development of molecular tools for vector control.	[Martins, Larissa A.; Fogaca, Andrea C.; Tania Bijovsky, A.; Cardoso, Andre F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Carballar-Lejarazu, Rebeca; Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Universidade de Sao Paulo; University of California System; University of California Irvine	Cardoso, AF (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	andreculex@gmail.com	Fogaca, Andrea/C-1322-2012; Fogaca, Andrea C/M-4267-2013; Martins, Larissa Almeida/M-4748-2013	Martins, Larissa Almeida/0000-0001-8127-6276; Marinotti, Osvaldo/0000-0002-7173-7160; Fogaca, Andrea/0000-0002-0890-6136; Carballar Lejarazu, Rebeca/0000-0002-9338-8774	FAPESP [2010/51241-0, 13/09211-4]; FAPESP fellowship; CAPES fellowship	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP (2010/51241-0 and 13/09211-4). During this work LAM was supported by FAPESP fellowship. AFC was supported by FAPESP and CAPES fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493; Bracco JE, 1999, MEM I OSWALDO CRUZ, V94, P115, DOI 10.1590/S0074-02761999000100022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Burmester T, 1996, J MOL EVOL, V42, P713, DOI 10.1007/BF02338804; Capurro MD, 2000, INSECT MOL BIOL, V9, P169, DOI 10.1046/j.1365-2583.2000.00173.x; Cardoso AF, 2010, MEM I OSWALDO CRUZ, V105, P254, DOI 10.1590/S0074-02762010000300003; Cruz CE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-63; Davey K, 2007, J INSECT PHYSIOL, V53, P1, DOI 10.1016/j.jinsphys.2006.10.005; FALLON AM, 1974, J INSECT PHYSIOL, V20, P1815, DOI 10.1016/0022-1910(74)90211-X; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; Federici BA, 2007, J AM MOSQUITO CONTR, V23, P164, DOI 10.2987/8756-971X(2007)23[164:DRBFCO]2.0.CO;2; Gordadze AV, 1999, INSECT MOL BIOL, V8, P55, DOI 10.1046/j.1365-2583.1999.810055.x; Gupta R, 2004, PREDICTION N GLYCOSY; Hall T, BIOEDIT; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; JONES G, 1990, J BIOL CHEM, V265, P8596; Korochkina SE, 1997, INSECT BIOCHEM MOLEC, V27, P813, DOI 10.1016/S0965-1748(97)00053-2; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levenbook L., 1985, P307; LINZEN B, 1989, NATURWISSENSCHAFTEN, V76, P206, DOI 10.1007/BF00627687; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahanta B., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P804; Malafronte RD, 2003, INSECT BIOCHEM MOLEC, V33, P63, DOI 10.1016/S0965-1748(02)00168-6; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; MUNN EA, 1969, J INSECT PHYSIOL, V15, P1935, DOI 10.1016/0022-1910(69)90023-7; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pan M L, 2001, J Insect Sci, V1, P2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RAIKHEL AS, 1987, TISSUE CELL, V19, P515, DOI 10.1016/0040-8166(87)90045-0; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; REDFERN CPF, 1982, J INSECT PHYSIOL, V28, P97, DOI 10.1016/0022-1910(82)90117-2; ROBERTS DB, 1981, EXPERIENTIA, V37, P103, DOI 10.1007/BF01963174; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Seo SJ, 1998, ARCH INSECT BIOCHEM, V37, P115, DOI 10.1002/(SICI)1520-6327(1998)37:2&lt;115::AID-ARCH1&gt;3.0.CO;2-T; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Simons FER, 2001, INT ARCH ALLERGY IMM, V124, P403, DOI 10.1159/000053771; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; Wheeler DE, 1996, J INSECT PHYSIOL, V42, P961, DOI 10.1016/0022-1910(96)00049-2; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; WILLOTT E, 1989, J BIOL CHEM, V264, P19052; Zakharkin SO, 1997, EUR J BIOCHEM, V246, P719, DOI 10.1111/j.1432-1033.1997.t01-1-00719.x; Zakharkin SO, 2001, EUR J BIOCHEM, V268, P5713, DOI 10.1046/j.0014-2956.2001.02514.x	58	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77664	10.1371/journal.pone.0077664	http://dx.doi.org/10.1371/journal.pone.0077664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204911	gold, Green Published			2022-12-25	WOS:000326270700047
J	Moreno-Letelier, A; Ortiz-Medrano, A; Pinero, D				Moreno-Letelier, Alejandra; Ortiz-Medrano, Alejandra; Pinero, Daniel			Niche Divergence versus Neutral Processes: Combined Environmental and Genetic Analyses Identify Contrasting Patterns of Differentiation in Recently Diverged Pine Species	PLOS ONE			English	Article							CHLOROPLAST DNA-SEQUENCES; PHYLOGEOGRAPHIC STRUCTURE; NONCODING REGIONS; UNIVERSAL PRIMERS; MITOCHONDRIAL; DELIMITATION; DIVERSITY; NUCLEAR; MODELS; MICROSATELLITES	Background and Aims: Solving relationships of recently diverged taxa, poses a challenge due to shared polymorphism and weak reproductive barriers. Multiple lines of evidence are needed to identify independently evolving lineages. This is especially true of long-lived species with large effective population sizes, and slow rates of lineage sorting. North American pines are an interesting group to test this multiple approach. Our aim is to combine cytoplasmic genetic markers with environmental information to clarify species boundaries and relationships of the species complex of Pinus flexilis, Pinus ayacahuite, and Pinus strobiformis. Methods: Mitochondrial and chloroplast sequences were combined with previously obtained microsatellite data and contrasted with environmental information to reconstruct phylogenetic relationships of the species complex. Ecological niche models were compared to test if ecological divergence is significant among species. Key Results and Conclusion: Separately, both genetic and ecological evidence support a clear differentiation of all three species but with different topology, but also reveal an ancestral contact zone between P. strobiformis and P. ayacahuite. The marked ecological differentiation of P. flexilis suggests that ecological speciation has occurred in this lineage, but this is not reflected in neutral markers. The inclusion of environmental traits in phylogenetic reconstruction improved the resolution of internal branches. We suggest that combining environmental and genetic information would be useful for species delimitation and phylogenetic studies in other recently diverged species complexes.	[Moreno-Letelier, Alejandra; Ortiz-Medrano, Alejandra; Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Moreno-Letelier, A (corresponding author), Imperial Coll London, Div Biol, Ascot, Berks, England.	a.moreno-letelier@imperial.ac.uk	Moreno-Letelier, Alejandra/AAF-8400-2020	Moreno-Letelier, Alejandra/0000-0001-7524-7639; Pinero, Daniel/0000-0002-2509-2445	CONACYT [0201/A1, 173276]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by CONACYT (http://www.conacyt.mx), grant number 0201/A1 to Daniel Pinero and doctoral fellowship no. 173276 to Alejandra Moreno-Letelier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anducho-Reyes MA, 2008, MOL PHYLOGENET EVOL, V49, P930, DOI 10.1016/j.ympev.2008.09.005; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Bower AD, 2011, US FOR SERV RMRS-P, V63, P98; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Arteaga MC, 2011, EVOLUTION, V65, P2470, DOI 10.1111/j.1558-5646.2011.01329.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delgado P, 2007, INT J PLANT SCI, V168, P861, DOI 10.1086/518260; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; DumolinLapegue S, 1997, GENETICS, V146, P1475; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; Gonzalez-Rodriguez A, 2004, MOL ECOL, V13, P3467, DOI 10.1111/j.1365-294X.2004.02344.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gugger PF, 2010, MOL ECOL, V19, P1877, DOI 10.1111/j.1365-294X.2010.04622.x; Gutierrez-Rodriguez C, 2011, MOL PHYLOGENET EVOL, V61, P603, DOI 10.1016/j.ympev.2011.08.023; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Martinez M., 1948, PINOS MEXICANOS; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Mendoza CFV, 2006, CAN J BOT, V84, P172, DOI 10.1139/b05-138; Moreno-Letelier A, 2009, J BIOGEOGR, V36, P121, DOI 10.1111/j.1365-2699.2008.02001.x; Navascues M, 2005, MOL ECOL, V14, P1333, DOI 10.1111/j.1365-294X.2005.02504.x; Navascues M, 2006, MOL ECOL, V15, P2691, DOI 10.1111/j.1365-294X.2006.02960.x; Ortiz Medrano A, 2008, B SOC BOT MEX, V83, P25; Parducci L, 1999, THEOR APPL GENET, V98, P802, DOI 10.1007/s001220051137; Perez de la Rosa JA, 1993, THESIS COLEGIO POSTG; Perry JP., 1991, PINES MEXICO CENTRAL; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Richardson David M., 1998, P3; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rivera PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022199; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salas-Lizana R, 2012, MYCOL PROG, V11, P569, DOI 10.1007/s11557-011-0774-x; Samano S, 2003, ECOSCIENCE, V10, P319, DOI 10.1080/11956860.2003.11682780; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Styles B.T., 1997, FLORA NEOTROPICA PIN; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Williams CG, 2010, AM J BOT, V97, P846, DOI 10.3732/ajb.0900255; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wu JY, 1998, GENETICS, V150, P1605; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	69	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78228	10.1371/journal.pone.0078228	http://dx.doi.org/10.1371/journal.pone.0078228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205167	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700085
J	Xiao, F; Liu, DR; Guo, YQ; Shi, B; Song, ZY; Tian, YC; Liang, CY				Xiao, Fei; Liu, Deruo; Guo, Yongqing; Shi, Bin; Song, Zhiyi; Tian, Yanchu; Liang, Chaoyang			Novel and Convenient Method to Evaluate the Character of Solitary Pulmonary Nodule-Comparison of Three Mathematical Prediction Models and Further Stratification of Risk Factors	PLOS ONE			English	Article							GUIDELINES 2ND EDITION; LUNG-CANCER; PROBABILITY; MALIGNANCY; CT; VALIDATION	Objective: To study risk factors that affect the evaluation of malignancy in patients with solitary pulmonary nodules (SPN) and verify different predictive models for malignant probability of SPN. Methods: Retrospectively analyzed 107 cases of SPN with definite post-operative histological diagnosis whom underwent surgical procedures in China-Japan Friendship Hospital from November of 2010 to February of 2013. Age, gender, smoking history, malignancy history of patients, imaging features of the nodule including maximum diameter, position, spiculation, lobulation, calcification and serum level of CEA and Cyfra21-1 were assessed as potential risk factors. Univariate analysis model was used to establish statistical correlation between risk factors and post-operative histological diagnosis. Receiver operating characteristic (ROC) curves were drawn using different predictive models for malignant probability of SPN to get areas under the curves (AUC values), sensitivity, specificity, positive predictive values, negative predictive values for each model, respectively. The predictive effectiveness of each model was statistically assessed subsequently. Results: In 107 patients, 78 cases were malignant (72.9%), 29 cases were benign (27.1%). Statistical significant difference was found between benign and malignant group in age, maximum diameter, serum level of Cyfra21-1, spiculation, lobulation and calcification of the nodules. The AUC values were 0.786 +/- 0.053 (Mayo model), 0.682 +/- 0.060 (VA model) and 0.810 +/- 0.051 (Peking University People's Hospital model), respectively. Conclusions: Serum level of Cyfra21-1, patient's age, maximum diameter of the nodule, spiculation, lobulation and calcification of the nodule are independent risk factors associated with the malignant probability of SPN. Peking University People's Hospital model is of high accuracy and clinical value for patients with SPN. Adding serum index (e. g. Cyfra21-1) into the prediction models as a new risk factor and adjusting the weight of age in the models might improve the accuracy of prediction for SPN.	[Xiao, Fei; Liu, Deruo; Guo, Yongqing; Shi, Bin; Song, Zhiyi; Tian, Yanchu; Liang, Chaoyang] China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China	China-Japan Friendship Hospital	Liang, CY (corresponding author), China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China.	chaoyangliang@hotmail.com						Albert RH, 2009, AM FAM PHYSICIAN, V80, P827; Ambrosini V, 2012, EUR J RADIOL, V81, P988, DOI 10.1016/j.ejrad.2011.03.020; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Kupert E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-513; Li Y, 2012, WORLD J SURG, V36, P830, DOI 10.1007/s00268-012-1449-8; Li Yun, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P450; Mery CM, 2004, CHEST, V125, P2175, DOI 10.1378/chest.125.6.2175; Mikita K, 2012, EUR J RADIOL, V81, pE548, DOI 10.1016/j.ejrad.2011.06.032; Nair A, 2011, EUR RADIOL, V21, P2445, DOI 10.1007/s00330-011-2219-y; Schultz EM, 2008, THORAX, V63, P335, DOI 10.1136/thx.2007.084731; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Swensen SJ, 2000, RADIOLOGY, V214, P73, DOI 10.1148/radiology.214.1.r00ja1473; Takashima S, 2003, AM J ROENTGENOL, V180, P955, DOI 10.2214/ajr.180.4.1800955; Tan BB, 2003, CHEST, V123, p89S, DOI 10.1378/chest.123.1_suppl.89S; Vineis P, 2006, INT J CANCER, V119, P169, DOI 10.1002/ijc.21801; Wahidi MM, 2007, CHEST, V132, p94S, DOI 10.1378/chest.07-1352; Yonemori K, 2007, RESPIROLOGY, V12, P856, DOI 10.1111/j.1440-1843.2007.01158.x	20	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78271	10.1371/journal.pone.0078271	http://dx.doi.org/10.1371/journal.pone.0078271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205175	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700087
J	Gao, JL; McIntyre, MSF; D'Souza, CA; Zhang, L				Gao, Julia; McIntyre, Megan S. Ford; D'Souza, Cheryl A.; Zhang, Li			Pretransplant Infusion of Donor B Cells Enhances Donor-Specific Skin Allograft Survival	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSPLANTATION TOLERANCE; LYMPHOCYTE INFUSION; IN-VIVO; ANTIGEN; SUPPRESSION; COMBINATION; TRANSFUSIONS; CHIMERISM; MECHANISM	Pretransplant donor lymphocyte infusion (DLI) has been shown to enhance donor-specific allograft survival in rodents, primates and humans. However, the cell subset that is critical for the DLI effect and the mechanisms involved remain elusive. In this study, we monitored donor cell subsets after DLI in a murine MHC class I L-d-mismatched skin transplantation model. We found that donor B cells, but not DCs, are the major surviving donor APCs in recipients following DLI. Infusing donor B, but not non-B, cells resulted in significantly enhanced donor-specific skin allograft survival. Furthermore, mice that had received donor B cells showed higher expression of Ly6A and CD62L on antigen-specific TCR alpha beta(+)CD3(+)CD4(-)CD8(-)NK1.1(-) double negative (DN) regulatory T cells (Tregs). B cells presented alloantigen to DN Tregs and primed their proliferation in an antigen-specific fashion. Importantly, DN Tregs, activated by donor B cells, showed increased cytotoxicity toward anti-donor CD8(+) T cells. These data demonstrate that donor B cells can enhance skin allograft survival, at least partially, by increasing recipient DN Treg-mediated killing of anti-donor CD8(+) T cells. These findings provide novel insights into the mechanisms underlying DLI-induced transplant tolerance and suggest that DN Tregs have great potential as an antigen-specific immune therapy to enhance allograft survival.	[Gao, Julia; McIntyre, Megan S. Ford; D'Souza, Cheryl A.; Zhang, Li] Univ Hlth Network, Univ Toronto, Inst Transplantat, Toronto Gen Res Inst, Toronto, ON, Canada; [Gao, Julia; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [McIntyre, Megan S. Ford; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Zhang, L (corresponding author), Univ Hlth Network, Univ Toronto, Inst Transplantat, Toronto Gen Res Inst, Toronto, ON, Canada.	lzhang@uhnres.utoronto.ca			Canadian Institutes of Health Research [MOP 14431]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research Grant (MOP 14431) to LZ. LZ is the Inaugural Maria H. Bacardi Chair in Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2003, TRANSPL P, V35, P2479, DOI 10.1016/j.transproceed.2003.08.030; Chen WH, 2005, J IMMUNOL, V175, P3409, DOI 10.4049/jimmunol.175.5.3409; Dugas V, 2010, J AUTOIMMUN, V35, P23, DOI 10.1016/j.jaut.2010.01.002; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Flye MW, 1995, TRANSPLANTATION, V60, P1395; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; Gao JF, 2011, EUR J IMMUNOL, V41, P2699, DOI 10.1002/eji.201141428; He KM, 2007, EUR J IMMUNOL, V37, P3455, DOI 10.1002/eji.200737408; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; HILLHOUSE EE, 2012, J AUTOIMMUN, P45237; Hoerbelt R, 2005, TRANSPLANTATION, V80, P1275, DOI 10.1097/01.tp.0000177638.56260.23; JOHNSON LL, 1988, TRANSPLANTATION, V46, P167; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; Kirk AD, 2010, NAT REV NEPHROL, V6, P584, DOI 10.1038/nrneph.2010.111; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Liu BL, 2006, AM J TRANSPLANT, V6, P933, DOI 10.1111/j.1600-6143.2006.01283.x; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; McIntyre MSF, 2011, INT IMMUNOPHARMACOL, V11, P597, DOI 10.1016/j.intimp.2010.11.015; McIver Z, 2008, BRIT J HAEMATOL, V141, P170, DOI 10.1111/j.1365-2141.2008.07021.x; Minagawa R, 2004, TRANSPLANTATION, V78, P799, DOI 10.1097/01.TP.0000129799.96439.6F; Prigozhina TB, 2007, TRANSPL P, V39, P678, DOI 10.1016/j.transproceed.2007.01.055; Rademacher J, 2006, Minerva Chir, V61, P85; Redfield RR, 2011, CURR OPIN IMMUNOL, V23, P685, DOI 10.1016/j.coi.2011.07.011; Sheng BD, 1999, TRANSPLANTATION, V68, P1024, DOI 10.1097/00007890-199910150-00021; SHENGTANNER X, 1992, J EXP MED, V176, P407, DOI 10.1084/jem.176.2.407; Urakami H, 2006, TRANSPLANT P, V38, P3244, DOI 10.1016/j.transproceed.2006.10.042; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang D, 2007, BLOOD, V109, P4071, DOI 10.1182/blood-2006-10-050625; ZHANG L, 1994, J IMMUNOL, V152, P2222; Zhang ZX, 2006, J IMMUNOL, V177, P6920, DOI 10.4049/jimmunol.177.10.6920; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513; Zhang ZX, 2002, EUR J IMMUNOL, V32, P1584, DOI 10.1002/1521-4141(200206)32:6<1584::AID-IMMU1584>3.0.CO;2-2	35	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77761	10.1371/journal.pone.0077761	http://dx.doi.org/10.1371/journal.pone.0077761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204953	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200038
J	Kenyon, NJ; Bratt, JM; Lee, J; Luo, JT; Franzi, LM; Zeki, AA; Lam, KS				Kenyon, Nicholas J.; Bratt, Jennifer M.; Lee, Joyce; Luo, Juntao; Franzi, Lisa M.; Zeki, Amir A.; Lam, Kit S.			Self-Assembling Nanoparticles Containing Dexamethasone as a Novel Therapy in Allergic Airways Inflammation	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; CLINICAL-PRACTICE; DRUG-DELIVERY; SEVERE ASTHMA; MURINE MODEL; OVALBUMIN; SYSTEM; MICE; ANTAGONIST; MECHANISMS	Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects. We have previously developed a well-defined non-toxic PEG-dendritic block telodendrimer for successful delivery of chemotherapeutics agents and, in these studies, we apply this technology for therapeutic development in asthma. In these proof-of-concept experiments, we hypothesized that dexamethasone contained in self-assembling nanoparticles (Dex-NP) and delivered systemically would target the lung and decrease allergic lung inflammation and airways hyper-responsiveness to a greater degree than equivalent doses of dexamethasone (Dex) alone. We found that ovalbumin (Ova)-exposed mice treated with Dex-NP had significantly fewer total cells (2.78 +/- 0.44x10(5) (n = 18) vs. 5.98 +/- 1.3x10(5) (n = 13), P<0.05) and eosinophils (1.09 +/- 0.28x10(5) (n = 18) vs. 2.94 +/- 0.6x10(5) (n = 12), p<0.05) in the lung lavage than Ova-exposed mice alone. Also, lower levels of the inflammatory cytokines IL-4 (3.43 +/- 1.2 (n = 11) vs. 8.5662.1 (n = 8) pg/ml, p<0.05) and MCP-1 (13.1 +/- 3.6 (n = 8) vs. 28.8 +/- 8.7 (n = 10) pg/ml, p<0.05) were found in lungs of the Dex-NP compared to control, and they were not lower in the Dex alone group. In addition, respiratory system resistance was lower in the Dex-NP compared to the other Ova-exposed groups suggesting a better therapeutic effect on airways hyperresponsiveness. Taken together, these findings from early-stage drug development studies suggest that the encapsulation and protection of anti-inflammatory agents such as corticosteroids in nanoparticle formulations can improve efficacy. Further development of novel drugs in nanoparticles is warranted to explore potential treatments for chronic inflammatory diseases such as asthma.	[Kenyon, Nicholas J.; Bratt, Jennifer M.; Lee, Joyce; Franzi, Lisa M.; Zeki, Amir A.; Lam, Kit S.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Luo, Juntao; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kenyon, NJ (corresponding author), Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA.	njkenyon@ucdavis.edu	Zeki, Amir A./I-3930-2019		National Heart, Lung and Blood Institute (NHLBI) [HL105573]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB012569]; T32 training [HL-07013, ES-07059]; National Center for Advancing Translational Sciences (NCATS) CTSC KL2 [TR000134]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105573, K08HL114882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007059] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); T32 training; National Center for Advancing Translational Sciences (NCATS) CTSC KL2; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funding for this work was through grants from National Heart, Lung and Blood Institute (NHLBI) (HL105573) to Nicholas J. Kenyon and National Institute of Biomedical Imaging and Bioengineering (NIBIB) (EB012569) to Kit S. Lam. Jennifer Bratt was supported by T32 training Grants (HL-07013 and ES-07059). Amir Zeki was supported by National Center for Advancing Translational Sciences (NCATS) CTSC KL2 grant (TR000134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow PG, 2008, CELL BIOL TOXICOL, V24, P243, DOI 10.1007/s10565-007-9033-y; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Bratt JM, 2010, TOXICOL APPL PHARM, V242, P1, DOI 10.1016/j.taap.2009.09.018; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; Chirino YI, 2010, TOXICOL LETT, V193, P209, DOI 10.1016/j.toxlet.2010.01.009; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Craparo EF, 2011, CNS NEUROSCI THER, V17, P670, DOI 10.1111/j.1755-5949.2010.00199.x; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Franzi LM, 2011, TOXICOL APPL PHARM, V257, P182, DOI 10.1016/j.taap.2011.09.003; Georen SK, 2009, ACTA OTO-LARYNGOL, V129, P182, DOI 10.1080/00016480802126561; Jackson JK, 2004, INT J PHARMACEUT, V270, P185, DOI 10.1016/j.ijpharm.2003.10.010; Kenyon NJ, 2008, TOXICOL APPL PHARM, V230, P269, DOI 10.1016/j.taap.2008.03.004; Kenyon NJ, 2009, EUR J PHARMACOL, V603, P138, DOI 10.1016/j.ejphar.2008.11.063; Kenyon NJ, 2003, TOXICOL APPL PHARM, V186, P90, DOI 10.1016/S0041-008X(02)00025-X; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Lewis Christina C, 2009, J Allergy Clin Immunol, V123, P795, DOI 10.1016/j.jaci.2009.01.003; Lim SB, 2012, J CONTROL RELEASE; McFadden ER, 2003, AM J RESP CRIT CARE, V168, P740, DOI 10.1164/rccm.200208-902SO; McGeehan M, 2002, MED CLIN N AM, V86, P1073, DOI 10.1016/S0025-7125(02)00034-2; Noel A, 2012, TOXICOL LETT; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Raemy DO, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-33; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sahib MN, 2012, DRUG DES DEV THER, V6, P29, DOI 10.2147/DDDT.S28265; Sanchez-Moreno P, 2012, INT J MOL SCI, V13, P4906, DOI 10.3390/ijms13044906; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Silkoff PE, 1999, CHEST, V116, P754, DOI 10.1378/chest.116.3.754; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Warheit DB, 1997, TOXICOL APPL PHARM, V145, P10, DOI 10.1006/taap.1997.8102; Wegesser TC, 2008, TOXICOL APPL PHARM, V230, P159, DOI 10.1016/j.taap.2008.02.013; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025; Xiao K, 2011, J CONTROL RELEASE, V155, P272, DOI 10.1016/j.jconrel.2011.07.018; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xiao K, 2009, BIOMATERIALS, V30, P6006, DOI 10.1016/j.biomaterials.2009.07.015; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC	36	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77730	10.1371/journal.pone.0077730	http://dx.doi.org/10.1371/journal.pone.0077730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204939	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400053
J	Martinov, T; Glenn-Finer, R; Burley, S; Tonc, E; Balsells, E; Ashbaugh, A; Swanson, L; Daughters, RS; Chatterjea, D				Martinov, Tijana; Glenn-Finer, Rose; Burley, Sarah; Tonc, Elena; Balsells, Evelyn; Ashbaugh, Alyssa; Swanson, Linnea; Daughters, Randy S.; Chatterjea, Devavani			Contact Hypersensitivity to Oxazolone Provokes Vulvar Mechanical Hyperalgesia in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAST-CELLS; FACTOR-ALPHA; RAT MODEL; AMITRIPTYLINE; SKIN; EOSINOPHILS; ELICITATION; SENSITIVITY; CHEMOKINES	The interplay among pain, allergy and dysregulated inflammation promises to yield significant conceptual advances in immunology and chronic pain. Hapten-mediated contact hypersensitivity reactions are used to model skin allergies in rodents but have not been utilized to study associated changes in pain perception in the affected skin. Here we characterized changes in mechanical hyperalgesia in oxazolone-sensitized female mice challenged with single and repeated labiar skin exposure to oxazolone. Female mice were sensitized with topical oxazolone on their flanks and challenged 1-3 times on the labia. We then measured mechanical sensitivity of the vulvar region with an electronic pressure meter and evaluated expression of inflammatory genes, leukocyte influx and levels of innervation in the labiar tissue. Oxazolone-sensitized mice developed vulvar mechanical hyperalgesia after a single labiar oxazolone challenge. Hyperalgesia lasted up to 24 hours along with local influx of neutrophils, upregulation of inflammatory cytokine gene expression, and increased density of cutaneous labiar nerve fibers. Three daily oxazolone challenges produced vulvar mechanical hyperalgesic responses and increases in nerve density that were detectable up to 5 days post-challenge even after overt inflammation resolved. This persistent vulvar hyperalgesia is resonant with vulvodynia, an understudied chronic pain condition that is remarkably prevalent in 18-60 year-old women. An elevated risk for vulvodynia has been associated with a history of environmental allergies. Our pre-clinical model can be readily adapted to regimens of chronic exposures and long-term assessment of vulvar pain with and without concurrent inflammation to improve our understanding of mechanisms underlying subsets of vulvodynia and to develop new therapeutics for this condition.	[Martinov, Tijana; Glenn-Finer, Rose; Tonc, Elena; Balsells, Evelyn; Ashbaugh, Alyssa; Swanson, Linnea; Chatterjea, Devavani] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Burley, Sarah; Daughters, Randy S.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Macalester College; University of Minnesota System; University of Minnesota Twin Cities	Chatterjea, D (corresponding author), Macalester Coll, Dept Biol, St Paul, MN 55105 USA.	chatterjead@macalester.edu	Martinov, Tijana/AFU-5047-2022	Martinov, Tijana/0000-0002-6027-3380; Burley, Sarah/0000-0003-0614-3267	National Vulvodynia Association; NIH [AREA - R15 NS067536-01A]; NHLBI Progenitor Cell Biology Consortium;  [NHLBI - R21 SR00002157/1U01-HL099997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067536] Funding Source: NIH RePORTER	National Vulvodynia Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Progenitor Cell Biology Consortium; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	DC is supported by the National Vulvodynia Association (http://www.nva.org/) and NIH AREA - R15 NS067536-01A. RSD is supported by the NHLBI Progenitor Cell Biology Consortium and NHLBI - R21 SR00002157/1U01-HL099997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi S, 1998, ANESTH ANALG, V87, P1360, DOI 10.1097/00000539-199812000-00027; ACTON J, 1992, EXP NEUROL, V117, P94, DOI 10.1016/0014-4886(92)90116-8; Altawil R, 2012, ARCH DERMATOL RES, V304, P273, DOI 10.1007/s00403-011-1202-4; Arnold LD, 2006, OBSTET GYNECOL, V107, P617, DOI 10.1097/01.AOG.0000199951.26822.27; Bomstein J, 2008, INT J GYNECOL PATHOL, V27, P136, DOI 10.1097/pgp.0b013e318140021b; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Gouveia ACC, 2013, J CLIN IMMUNOL, V33, P235, DOI 10.1007/s10875-012-9746-4; Chatterjea D, 2013, F1000 RES, P2; Chatterjea D, 2012, BIOCHEM BIOPH RES CO, V425, P237, DOI 10.1016/j.bbrc.2012.07.074; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; Done JD, 2012, J UROLOGY, V187, P1473, DOI 10.1016/j.juro.2011.11.116; Emtestam L, 2012, ARCH DERMATOL RES, V304, P781, DOI 10.1007/s00403-012-1246-0; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Foster DC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.038; Foster DC, 1997, OBSTET GYNECOL, V89, P291, DOI 10.1016/S0029-7844(96)00447-4; Funding AT, 2009, J INVEST DERMATOL, V129, P891, DOI 10.1038/jid.2008.322; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Gerber S, 2002, AM J OBSTET GYNECOL, V186, P696, DOI 10.1067/mob.2002.121869; Goetsch MF, 2010, AM J OBSTET GYNECOL, V202, pe1; Groysman V, 2010, DERMATOL CLIN, V28, P681, DOI 10.1016/j.det.2010.07.002; Harlow BL, 2009, ANN EPIDEMIOL, V19, P771, DOI 10.1016/j.annepidem.2009.06.006; Henry DE, 2011, PM&R, V3, P1116, DOI 10.1016/j.pmrj.2011.05.018; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Itakura A, 2006, INT ARCH ALLERGY IMM, V140, P8, DOI 10.1159/000092705; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Kubera M, 2000, PSYCHONEUROENDOCRINO, V25, P785, DOI 10.1016/S0306-4530(00)00026-3; Lavich TR, 2006, PAIN, V125, P180, DOI 10.1016/j.pain.2006.08.006; Lavich TR, 2003, EUR J PHARMACOL, V462, P185, DOI 10.1016/S0014-2999(02)02947-3; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUGER TA, 1990, J INVEST DERMATOL, V95, pS100, DOI 10.1111/1523-1747.ep12874944; Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011; Martinov T, 2013, J VIS EXP IN PRESS; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Ohno I, 1997, AM J RESP CELL MOL, V16, P212, DOI 10.1165/ajrcmb.16.3.9070604; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Pukall CF, 2002, PAIN, V96, P163, DOI 10.1016/S0304-3959(01)00442-0; Schneider C, 2009, J INVEST DERMATOL, V129, P899, DOI 10.1038/jid.2008.307; Shimada Y, 2003, J IMMUNOL, V170, P4325, DOI 10.4049/jimmunol.170.8.4325; Su X, 2009, ANESTH ANALG, V108, P1671, DOI 10.1213/ane.0b013e31819b0271; Suzuki A, 2005, BIOL PHARM BULL, V28, P1963, DOI 10.1248/bpb.28.1963; Suzuki A, 2004, BIOL PHARM BULL, V27, P1891, DOI 10.1248/bpb.27.1891; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Theoharides TC, 2005, BRAIN RES REV, V49, P65, DOI 10.1016/j.brainresrev.2004.11.006; Tsunematsu M, 2007, LIFE SCI, V80, P1388, DOI 10.1016/j.lfs.2006.12.038; van Houwelingen AH, 2002, J IMMUNOL, V168, P5297, DOI 10.4049/jimmunol.168.10.5297; Ventolini G, 2013, MED HYPOTHESES, V81, P228, DOI 10.1016/j.mehy.2013.04.043; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Webb EF, 1998, J INVEST DERMATOL, V111, P86, DOI 10.1046/j.1523-1747.1998.00239.x; Yokozeki H, 2000, J EXP MED, V191, P995, DOI 10.1084/jem.191.6.995	57	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78673	10.1371/journal.pone.0078673	http://dx.doi.org/10.1371/journal.pone.0078673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205293	Green Published, gold			2022-12-25	WOS:000326155400097
J	Ilanges, A; Jahanshahi, M; Balobin, DM; Pfleger, CM				Ilanges, Anoj; Jahanshahi, Maryam; Balobin, Denis M.; Pfleger, Cathie M.			Alcohol Interacts with Genetic Alteration of the Hippo Tumor Suppressor Pathway to Modulate Tissue Growth in Drosophila	PLOS ONE			English	Article							CELL-CYCLE EXIT; IMAGINAL DISC GROWTH; ORGAN SIZE CONTROL; BREAST-CANCER; SIGNALING PATHWAY; YAP PATHWAY; PROLIFERATION ARREST; PROMOTES APOPTOSIS; PROTEIN-KINASES; CONSUMPTION	Alcohol-mediated cancers represent more than 3.5% of cancer-related deaths, yet how alcohol promotes cancer is a major open question. Using Drosophila, we identified novel interactions between dietary ethanol and loss of tumor suppressor components of the Hippo Pathway. The Hippo Pathway suppresses tumors in flies and mammals by inactivating transcriptional co-activator Yorkie, and the spectrum of cancers associated with impaired Hippo signaling overlaps strikingly with those associated with alcohol. Therefore, our findings may implicate loss of Hippo Pathway tumor suppression in alcohol-mediated cancers. Ethanol enhanced overgrowth from loss of the expanded, hippo, or warts tumor suppressors but, surprisingly, not from over-expressing the yorkie oncogene. We propose that in parallel to Yorkie-dependent overgrowth, impairing Hippo signaling in the presence of alcohol may promote overgrowth via additional alcohol-relevant targets. We also identified interactions between alcohol and Hippo Pathway over-activation. We propose that exceeding certain thresholds of alcohol exposure activates Hippo signaling to maintain proper growth control and prevent alcohol-mediated mis-patterning and tissue overgrowth.	[Ilanges, Anoj; Jahanshahi, Maryam; Balobin, Denis M.; Pfleger, Cathie M.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA; [Ilanges, Anoj] Yale Univ, New Haven, CT USA; [Jahanshahi, Maryam; Pfleger, Cathie M.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Balobin, Denis M.] Columbia Univ, New York, NY USA	Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai; Columbia University	Pfleger, CM (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA.	cathie.pfleger@mssm.edu		Jahanshahi, Maryam/0000-0003-3469-6280	Children's Tumor Foundation; National Institutes of Health/National Cancer Institute [CA140451]; NATIONAL CANCER INSTITUTE [R01CA140451] Funding Source: NIH RePORTER	Children's Tumor Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Children's Tumor Foundation Young Investigator grant (MJ), a Leukemia & Lymphoma Society Scholar Award (CMP), and the National Institutes of Health/National Cancer Institute CA140451 (CMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Benedetti A, 2009, CANCER DETECT PREV, V32, P352, DOI 10.1016/j.canep.2009.03.001; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bowlin SJ, 1997, INT J EPIDEMIOL, V26, P915, DOI 10.1093/ije/26.5.915; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; *CANC WORLD RES FU, 2007, FOOD NUTR PHYS ACT P, P244; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; COLDITZ GA, 1993, CANCER-AM CANCER SOC, V71, P1480, DOI 10.1002/cncr.2820710413; Devineni AV, 2011, FLY, V5, P191, DOI 10.4161/fly.5.3.16987; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heberlein U, 2000, ALCOHOL RES HEALTH, V24, P185; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; LONGNECKER MP, 1994, CANCER CAUSE CONTROL, V5, P73, DOI 10.1007/BF01830729; Marcinkevicius E, 2013, DEVELOPMENT, V140, P433, DOI 10.1242/dev.083949; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Pelucchi C, 2011, NUTR CANCER, V63, P983, DOI 10.1080/01635581.2011.596642; Poschl G, 2004, P NUTR SOC, V63, P65, DOI 10.1079/PNS2003323; RANGANATHAN S, 1987, TERATOLOGY, V36, P45, DOI 10.1002/tera.1420360107; Rohan TE, 2000, CANCER CAUSE CONTROL, V11, P239, DOI 10.1023/A:1008933824645; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Voigt Michael D, 2005, Clin Liver Dis, V9, P151, DOI 10.1016/j.cld.2004.10.003; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	69	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78880	10.1371/journal.pone.0078880	http://dx.doi.org/10.1371/journal.pone.0078880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205337	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600113
J	Lubbert, M; Kyereme, J; Schobel, N; Beltran, L; Wetzel, CH; Hatt, H				Luebbert, Matthias; Kyereme, Jessica; Schoebel, Nicole; Beltran, Leopoldo; Wetzel, Christian Horst; Hatt, Hanns			Transient Receptor Potential Channels Encode Volatile Chemicals Sensed by Rat Trigeminal Ganglion Neurons	PLOS ONE			English	Article							BACKGROUND K+ CHANNEL; CAPSAICIN RECEPTOR; SENSORY NEURONS; TRP CHANNELS; ION-CHANNEL; POTASSIUM CHANNELS; DIRECT ACTIVATION; HEAT; PAIN; SYSTEM	Primary sensory afferents of the dorsal root and trigeminal ganglia constantly transmit sensory information depicting the individual's physical and chemical environment to higher brain regions. Beyond the typical trigeminal stimuli (e. g. irritants), environmental stimuli comprise a plethora of volatile chemicals with olfactory components (odorants). In spite of a complete loss of their sense of smell, anosmic patients may retain the ability to roughly discriminate between different volatile compounds. While the detailed mechanisms remain elusive, sensory structures belonging to the trigeminal system seem to be responsible for this phenomenon. In order to gain a better understanding of the mechanisms underlying the activation of the trigeminal system by volatile chemicals, we investigated odorant-induced membrane potential changes in cultured rat trigeminal neurons induced by the odorants vanillin, heliotropyl acetone, helional, and geraniol. We observed the dose-dependent depolarization of trigeminal neurons upon application of these substances occurring in a stimulus-specific manner and could show that distinct neuronal populations respond to different odorants. Using specific antagonists, we found evidence that TRPA1, TRPM8, and/or TRPV1 contribute to the activation. In order to further test this hypothesis, we used recombinantly expressed rat and human variants of these channels to investigate whether they are indeed activated by the odorants tested. We additionally found that the odorants dose-dependently inhibit two-pore potassium channels TASK1 and TASK3 heterologously expressed In Xenopus laevis oocytes. We suggest that the capability of various odorants to activate different TRP channels and to inhibit potassium channels causes neuronal depolarization and activation of distinct subpopulations of trigeminal sensory neurons, forming the basis for a specific representation of volatile chemicals in the trigeminal ganglia.	[Luebbert, Matthias; Kyereme, Jessica; Beltran, Leopoldo; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Schoebel, Nicole] Univ Dortmund, Leibniz Res Ctr Working Environm & Human Factors, D-44227 Dortmund, Germany; [Wetzel, Christian Horst] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of Regensburg	Lubbert, M (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Matthias.luebbert@rub.de	Wetzel, Christian/C-2501-2009; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/F-1366-2018	Wetzel, Christian/0000-0002-5762-0003; Wetzel, Christian H/0000-0002-5762-0003; 	Deutsche Forschungsgesellschaft [SFB 874]; Ruhr University Research School	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Ruhr University Research School	This project was funded by grants from the Deutsche Forschungsgesellschaft [SFB 874 H. H.] and the Ruhr University Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Bautista D, 2008, NAT NEUROSCI, V11, P528, DOI 10.1038/nn0508-528; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Beltran L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00063; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Cometto-Muniz JE, 2005, CHEM SENSES, V30, P627, DOI 10.1093/chemse/bji056; Darian-Smith I, 1973, HDB SENSORY PHYSL SO, V2, P271; DAVIES AM, 1988, DEVELOPMENT, V103, P175; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; Dubner R, 1979, NEURAL BASIS ORAL FA, P1; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Eid S R, 2009, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-540-79090-7_8; Eid SR, 2008, MOL PAIN, V10, P1; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hummel T, 2009, ANN NY ACAD SCI, V1170, P190, DOI 10.1111/j.1749-6632.2009.03910.x; Iwasaki Y, 2009, LIFE SCI, V85, P60, DOI 10.1016/j.lfs.2009.04.017; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Kawai F, 1999, NEUROSCI LETT, V269, P45, DOI 10.1016/S0304-3940(99)00424-3; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Lazarov NE, 2002, PROG NEUROBIOL, V66, P19, DOI 10.1016/S0301-0082(01)00021-1; Liu Y, 2007, TRANSIENT RECEPTOR P, P185; Luebbert M, 2010, PFLUG ARCH EUR J PHY, V459, P737, DOI 10.1007/s00424-009-0782-8; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morris JB, 2010, INFORM HEALTHCARE, V30; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Ohkawara S, 2010, BIOL PHARM BULL, V33, P1434, DOI 10.1248/bpb.33.1434; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pingle S, 2007, TRANSIENT RECEPTOR P, P156; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Riera CE, 2009, J NEUROSCI, V29, P2654, DOI 10.1523/JNEUROSCI.4694-08.2009; Rothermel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026158; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Sergeeva OA, 2010, J BIOL CHEM, V285, P23985, DOI 10.1074/jbc.M110.103309; SILVER WL, 1982, PHYSIOL BEHAV, V28, P927, DOI 10.1016/0031-9384(82)90216-5; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Szallasi A, 1999, PHARMACOL REV, V51, P159; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Tang ZX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3179; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Tucker D., 1971, P151; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	82	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77998	10.1371/journal.pone.0077998	http://dx.doi.org/10.1371/journal.pone.0077998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205061	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600058
J	Li, R; Ma, PF; Wen, J; Yi, TS				Li, Rong; Ma, Peng-Fei; Wen, Jun; Yi, Ting-Shuang			Complete Sequencing of Five Araliaceae Chloroplast Genomes and the Phylogenetic Implications	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; PLASTID GENOMES; SCALE DATA; EVOLUTION; GENES; DNA; MITOCHONDRIAL; NUCLEAR; RESOLVE	Background: The ginseng family (Araliaceae) includes a number of economically important plant species. Previously phylogenetic studies circumscribed three major clades within the core ginseng plant family, yet the internal relationships of each major group have been poorly resolved perhaps due to rapid radiation of these lineages. Recent studies have shown that phyogenomics based on chloroplast genomes provides a viable way to resolve complex relationships. Methodology/Principal Findings: We report the complete nucleotide sequences of five Araliaceae chloroplast genomes using next-generation sequencing technology. The five chloroplast genomes are 156,333-156,459 bp in length including a pair of inverted repeats (25,551-26,108 bp) separated by the large single-copy (86,028-86,566 bp) and small single-copy (18,021-19,117 bp) regions. Each chloroplast genome contains the same 114 unique genes consisting of 30 transfer RNA genes, four ribosomal RNA genes, and 80 protein coding genes. Gene size, content, and order, AT content, and IR/SC boundary structure are similar among all Araliaceae chloroplast genomes. A total of 140 repeats were identified in the five chloroplast genomes with palindromic repeat as the most common type. Phylogenomic analyses using parsimony, likelihood, and Bayesian inference based on the complete chloroplast genomes strongly supported the monophyly of the Asian Palmate group and the Aralia-Panax group. Furthermore, the relationships among the sampled taxa within the Asian Palmate group were well resolved. Twenty-six DNA markers with the percentage of variable sites higher than 5% were identified, which may be useful for phylogenetic studies of Araliaceae. Conclusion: The chloroplast genomes of Araliaceae are highly conserved in all aspects of genome features. The large-scale phylogenomic data based on the complete chloroplast DNA sequences is shown to be effective for the phylogenetic reconstruction of Araliaceae.	[Li, Rong; Ma, Peng-Fei; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Li, Rong; Ma, Peng-Fei; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; tingshuangyi@mail.kib.ac.cn			Knowledge Innovation Engineering Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Talent Project of Yunnan Province [2011CI042]; Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences [KLBB201204]	Knowledge Innovation Engineering Program of the Chinese Academy of Sciences; Talent Project of Yunnan Province; Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences	This project is supported by the Knowledge Innovation Engineering Program of the Chinese Academy of Sciences (grant no. KSCX2-EW-J-24), the Talent Project of Yunnan Province (grant no. 2011CI042), and the Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences (grant no. KLBB201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao L, 2010, J SYST EVOL, V48, P77, DOI 10.1111/j.1759-6831.2010.00071.x; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim JH, 2013, GENET RESOUR CROP EV, V60, P413, DOI 10.1007/s10722-012-9844-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Korpelainen H, 2004, NATURWISSENSCHAFTEN, V91, P505, DOI 10.1007/s00114-004-0571-3; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JH, 2010, J SYST EVOL, V48, P426, DOI 10.1111/j.1759-6831.2010.00098.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; Mitchell A, 2004, TAXON, V53, P29, DOI 10.2307/4135486; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Philipson WR, 1970, BOT J LINN SOC, V63, P87; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Plunkett GM, 2004, PLANT SYST EVOL, V245, P1, DOI 10.1007/s00606-003-0101-3; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ruhlman T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-222; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHIMADA H, 1989, CURR GENET, V16, P293, DOI 10.1007/BF00422116; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wen J, 2001, SYST BOT, V26, P144; Wen Jun, 2008, Acta Botanica Yunnanica, V30, P391; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; XIANG QB, 2007, FLORA CHINA, V13, P434; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Yi TS, 2004, TAXON, V53, P987, DOI 10.2307/4135565; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	64	58	63	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78568	10.1371/journal.pone.0078568	http://dx.doi.org/10.1371/journal.pone.0078568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205264	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300159
J	Mohan, N; Chakrabarti, M; Banik, NL; Ray, SK				Mohan, Nishant; Chakrabarti, Mrinmay; Banik, Naren L.; Ray, Swapan K.			Combination of LC3 shRNA Plasmid Transfection and Genistein Treatment Inhibited Autophagy and Increased Apoptosis in Malignant Neuroblastoma in Cell Culture and Animal Models	PLOS ONE			English	Article							CANCER-CELLS; SURVIVAL FACTORS; SH-SY5Y CELLS; BECLIN 1; N-MYC; DIFFERENTIATION; EXPRESSION; MECHANISM; SK-N-BE2; THERAPY	Malignant neuroblastoma is an extracranial solid tumor that usually occurs in children. Autophagy, which is a survival mechanism in many solid tumors including malignant neuroblastoma, deters the efficacy of conventional chemotherapeutic agents. To mimic starvation, we used 200 nM rapamycin that induced autophagy in human malignant neuroblastoma SK-N-BE2 and IMR-32 cells in cell culture and animal models. Combination of microtubule associated protein light chain 3 short hairpin RNA (LC3 shRNA) plasmid transfection and genistein (GST) treatment was tested for inhibiting rapamycin-induced autophagy and promoting apoptosis. The best synergistic efficacy caused the highest decrease in cell viability due to combination of 50 nM LC3 shRNA plasmid transfection and 25 mu M GST treatment in rapamycin-treated SK-N-BE2 cells while combination of 100 nM LC3 shRNA plasmid transfection and 25 mu M GST treatment in rapamycin-treated IMR-32 cells. Quantitation of acidic vesicular organelles confirmed that combination of LC3 shRNA plasmid transfection and GST treatment prevented rapamycin-induced autophagy due to down regulation of autophagy promoting marker molecules (LC3 II, Beclin 1, TLR-4, and Myd88) and upregulation of autophagy inhibiting marker molecules (p62 and mTOR) in both cell lines. Apoptosis assays showed that combination therapy most effectively activated mitochondrial pathway of apoptosis in human malignant neuroblastoma in cell culture and animal models. Collectively, our current combination of LC3 shRNA plasmid transfection and GST treatment could serve as a promising therapeutic strategy for inhibiting autophagy and increasing apoptosis in human malignant neuroblastoma in cell culture and animal models.	[Mohan, Nishant; Chakrabarti, Mrinmay; Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Ray, SK (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019					Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chakrabarti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055652; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Chuang JH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-65; Das A, 2009, INT J ONCOL, V34, P757, DOI 10.3892/ijo_00000201; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fimia GM, 2010, CELL MOL LIFE SCI, V67, P1581, DOI 10.1007/s00018-010-0284-z; Gimenez-Xavier P, 2008, INT J MOL MED, V22, P781, DOI 10.3892/ijmm_00000085; Hassan F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-281; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; JAYARAMAN T, 1993, J BIOL CHEM, V268, P25385; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Ma HT, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1109; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mohan N, 2011, CANCER BIOL THER, V12, P846, DOI 10.4161/cbt.12.9.17715; Mohan N, 2011, NEUROSCI LETT, V502, P24, DOI 10.1016/j.neulet.2011.07.016; Mohan N, 2011, NEUROCHEM RES, V36, P1383, DOI 10.1007/s11064-011-0463-9; Mohan N, 2009, BRAIN RES, V1283, P155, DOI 10.1016/j.brainres.2009.05.097; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	41	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78958	10.1371/journal.pone.0078958	http://dx.doi.org/10.1371/journal.pone.0078958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205354	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300168
J	de Candia, P; Torri, A; Gorletta, T; Fedeli, M; Bulgheroni, E; Cheroni, C; Marabita, F; Crosti, M; Moro, M; Pariani, E; Romano, L; Esposito, S; Mosca, F; Rossetti, G; Rossi, RL; Geginat, J; Casorati, G; Dellabona, P; Pagani, M; Abrignani, S				de Candia, Paola; Torri, Anna; Gorletta, Tatiana; Fedeli, Maya; Bulgheroni, Elisabetta; Cheroni, Cristina; Marabita, Francesco; Crosti, Mariacristina; Moro, Monica; Pariani, Elena; Romano, Luisa; Esposito, Susanna; Mosca, Fabio; Rossetti, Grazisa; Rossi, Riccardo L.; Geginat, Jens; Casorati, Giulia; Dellabona, Paolo; Pagani, Massimiliano; Abrignani, Sergio			Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation	PLOS ONE			English	Article							T-CELLS; CIRCULATING MICRORNAS; VESICLES; EXOSOMES; CANCER; EXPRESSION; RNAS	Activated lymphocytes release nano-sized vesicles (exosomes) containing microRNAs that can be monitored in the bloodstream. We asked whether elicitation of immune responses is followed by release of lymphocyte-specific microRNAs. We found that, upon activation in vitro, human and mouse lymphocytes down-modulate intracellular miR-150 and accumulate it in exosomes. In vivo, miR-150 levels increased significantly in serum of humans immunized with flu vaccines and in mice immunized with ovalbumin, and this increase correlated with elevation of antibody titers. Immunization of immune-deficient mice, lacking MHCII, resulted neither in antibody production nor in elevation of circulating miR-150. This study provides proof of concept that serum microRNAs can be detected, with minimally invasive procedure, as biomarkers of vaccination and more in general of adaptive immune responses. Furthermore, the prompt reduction of intracellular level of miR-150, a key regulator of mRNAs critical for lymphocyte differentiation and functions, linked to its release in the external milieu suggests that the selective extracellular disposal of microRNAs can be a rapid way to regulate gene expression during lymphocyte activation.	[de Candia, Paola; Torri, Anna; Gorletta, Tatiana; Bulgheroni, Elisabetta; Cheroni, Cristina; Marabita, Francesco; Crosti, Mariacristina; Moro, Monica; Rossetti, Grazisa; Rossi, Riccardo L.; Geginat, Jens; Pagani, Massimiliano; Abrignani, Sergio] INGM, Milan, Italy; [Fedeli, Maya; Casorati, Giulia; Dellabona, Paolo] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Pariani, Elena; Romano, Luisa] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Esposito, Susanna] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Clin 1, Milan, Italy; [Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	de Candia, P (corresponding author), INGM, Milan, Italy.	decandia@ingm.org; pagani@ingm.org; abrignani@ingm.org	Esposito, Susanna/K-3475-2016; de Candia, Paola/HGC-8826-2022; Fedeli, Maya/AAN-1930-2020; Geginat, Jens/AAA-5818-2019; Dellabona, Paolo/G-5416-2012; Rossi, Riccardo/M-8999-2019; rossetti, grazisa/C-3722-2015; de Candia, Paola/Z-1498-2019; Cheroni, Cristina/AAO-2316-2020; Pariani, Elena/M-3491-2016; Marabita, Francesco/AAD-6220-2019; MOSCA, FABIO/C-5826-2017; Casorati, Giulia/J-7141-2018	Esposito, Susanna/0000-0003-4103-2837; de Candia, Paola/0000-0003-4767-446X; Fedeli, Maya/0000-0002-9946-3683; Geginat, Jens/0000-0003-4813-0384; Dellabona, Paolo/0000-0002-1414-633X; Rossi, Riccardo/0000-0002-4964-3264; rossetti, grazisa/0000-0001-6361-311X; de Candia, Paola/0000-0003-4767-446X; Pariani, Elena/0000-0001-5681-3455; Marabita, Francesco/0000-0001-6180-0106; MOSCA, FABIO/0000-0001-6477-0299; Cheroni, Cristina/0000-0002-0832-2333; Casorati, Giulia/0000-0002-5102-4112; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	CARIPLO [2009-3603]; ERC [269022]; Fondazione Invernizzi; AIRC [IG11523]	CARIPLO(Fondazione Cariplo); ERC(European Research Council (ERC)European Commission); Fondazione Invernizzi; AIRC(Fondazione AIRC per la ricerca sul cancro)	This research was supported by a CARIPLO grant (N<SUP>o</SUP> 2009-3603) http://www.fondazionecariplo.it; by an ERC advanced grant to SA (N<SUP>o</SUP> 269022) http://erc.europa.eu; and by Fondazione Invernizzi. This study was also supported (in part) by research funding to GC from AIRC (IG11523) http://www.airc.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Esposito S, 2011, PEDIATRICS, V127, pE1161, DOI 10.1542/peds.2010-1920; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pagani M, 2013, IMMUNOL REV, V253, P82, DOI 10.1111/imr.12055; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	32	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75348	10.1371/journal.pone.0075348	http://dx.doi.org/10.1371/journal.pone.0075348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24205408	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000016
J	Mallmann, RT; Elgueta, C; Sleman, F; Castonguay, J; Wilmes, T; van den Maagdenberg, A; Klugbauer, N				Mallmann, Robert Theodor; Elgueta, Claudio; Sleman, Faten; Castonguay, Jan; Wilmes, Thomas; van den Maagdenberg, Arn; Klugbauer, Norbert			Ablation of Ca(V)2.1 Voltage-Gated Ca2+ Channels in Mouse Forebrain Generates Multiple Cognitive Impairments	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CALCIUM-CHANNELS; MICE LACKING; MIGRAINE; CURRENTS; RELEASE; ATAXIA; GENE; MUTATIONS; OLIGOMERS	Voltage-gated Ca(V)2.1 (P/Q-type) Ca2+ channels located at the presynaptic membrane are known to control a multitude of Ca2+-dependent cellular processes such as neurotransmitter release and synaptic plasticity. Our knowledge about their contributions to complex cognitive functions, however, is restricted by the limited adequacy of existing transgenic Ca(V)2.1 mouse models. Global Ca(V)2.1 knock-out mice lacking the alpha 1 subunit Cacna1a gene product exhibit early postnatal lethality which makes them unsuitable to analyse the relevance of Ca(V)2.1 Ca2+ channels for complex behaviour in adult mice. Consequently we established a forebrain specific Ca(V)2.1 knock-out model by crossing mice with a floxed Cacna1a gene with mice expressing Cre-recombinase under the control of the NEX promoter. This novel mouse model enabled us to investigate the contribution of Ca(V)2.1 to complex cognitive functions, particularly learning and memory. Electrophysiological analysis allowed us to test the specificity of our conditional knock-out model and revealed an impaired synaptic transmission at hippocampal glutamatergic synapses. At the behavioural level, the forebrain-specific Ca(V)2.1 knock-out resulted in deficits in spatial learning and reference memory, reduced recognition memory, increased exploratory behaviour and a strong attenuation of circadian rhythmicity. In summary, we present a novel conditional Ca(V)2.1 knock-out model that is most suitable for analysing the in vivo functions of Ca(V)2.1 in the adult murine forebrain.	[Mallmann, Robert Theodor; Sleman, Faten; Castonguay, Jan; Wilmes, Thomas; Klugbauer, Norbert] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Mallmann, Robert Theodor] Univ Freiburg, Fak Biol, D-79106 Freiburg, Germany; [Elgueta, Claudio] Univ Freiburg, Inst Physiol 2, D-79106 Freiburg, Germany; [van den Maagdenberg, Arn] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van den Maagdenberg, Arn] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Klugbauer, N (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Hugstetter Str 55, D-79106 Freiburg, Germany.	n.klugbauer@pharmakol.uni-freiburg.de	van den Maagdenberg, Arn M.J.M./AAE-9052-2019		DFG [SFB780]	DFG(German Research Foundation (DFG))	This work was supported by a DFG grant to NK (SFB780, project A1) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Bedrosian TA, 2011, P NATL ACAD SCI USA, V108, P11686, DOI 10.1073/pnas.1103098108; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hauw JJ, 2011, J NEUROPATH EXP NEUR, V70, P243, DOI 10.1097/NEN.0b013e318211488e; Holl AK, 2011, NEURODEGENER DIS, V8, P208, DOI 10.1159/000322230; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaja S, 2007, NEUROSCIENCE, V144, P1278, DOI 10.1016/j.neuroscience.2006.11.006; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; LeGates TA, 2011, JOVE-J VIS EXP, DOI 10.3791/2463; Liu L, 2003, J BIOENERG BIOMEMBR, V35, P671, DOI 10.1023/B:JOBB.0000008031.12485.ee; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Mezler M, 2012, BRIT J PHARMACOL, V165, P1572, DOI 10.1111/j.1476-5381.2011.01646.x; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nahm SS, 2005, J NEUROSCI, V25, P9304, DOI 10.1523/jneurosci.2733-05.2005; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Nimmrich V, 2009, REV NEUROSCIENCE, V20, P1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; RANDALL A, 1995, J NEUROSCI, V15, P2995; Scheuber A, 2004, J NEUROSCI, V24, P10402, DOI 10.1523/JNEUROSCI.1664-04.2004; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Todorov B, 2006, GENESIS, V44, P589, DOI 10.1002/dvg.20255; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Whishaw IQ, 1983, BEHAVIORAL APPROACHE, P141; Wu LG, 1999, J NEUROSCI, V19, P726; Xu M, 2003, J BIOL CHEM, V278, P40837, DOI 10.1074/jbc.M307598200; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	46	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78598	10.1371/journal.pone.0078598	http://dx.doi.org/10.1371/journal.pone.0078598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205277	Green Submitted, Green Published, gold			2022-12-25	WOS:000326373800020
J	Haas, MA; Bell, D; Slender, A; Lana-Elola, E; Watson-Scales, S; Fisher, EMC; Tybulewicz, VLJ; Guillemot, F				Haas, Matilda A.; Bell, Donald; Slender, Amy; Lana-Elola, Eva; Watson-Scales, Sheona; Fisher, Elizabeth M. C.; Tybulewicz, Victor L. J.; Guillemot, Francois			Alterations to Dendritic Spine Morphology, but Not Dendrite Patterning, of Cortical Projection Neurons in Tc1 and Ts1Rhr Mouse Models of Down Syndrome	PLOS ONE			English	Article							CRITICAL REGION; SYNAPTIC PLASTICITY; SYNDROME PHENOTYPES; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; IN-VITRO; ABNORMALITIES; CORTEX; GOLGI; HUMAN-CHROMOSOME-21	Down Syndrome (DS) is a highly prevalent developmental disorder, affecting 1/700 births. Intellectual disability, which affects learning and memory, is present in all cases and is reflected by below average IQ. We sought to determine whether defective morphology and connectivity in neurons of the cerebral cortex may underlie the cognitive deficits that have been described in two mouse models of DS, the Tc1 and Ts1Rhr mouse lines. We utilised in utero electroporation to label a cohort of future upper layer projection neurons in the cerebral cortex of developing mouse embryos with GFP, and then examined neuronal positioning and morphology in early adulthood, which revealed no alterations in cortical layer position or morphology in either Tc1 or Ts1Rhr mouse cortex. The number of dendrites, as well as dendrite length and branching was normal in both DS models, compared with wildtype controls. The sites of projection neuron synaptic inputs, dendritic spines, were analysed in Tc1 and Ts1Rhr cortex at three weeks and three months after birth, and significant changes in spine morphology were observed in both mouse lines. Ts1Rhr mice had significantly fewer thin spines at three weeks of age. At three months of age Tc1 mice had significantly fewer mushroom spines - the morphology associated with established synaptic inputs and learning and memory. The decrease in mushroom spines was accompanied by a significant increase in the number of stubby spines. This data suggests that dendritic spine abnormalities may be a more important contributor to cognitive deficits in DS models, rather than overall neuronal architecture defects.	[Haas, Matilda A.; Guillemot, Francois] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Bell, Donald] Natl Inst Med Res, MRC, Confocal Image Anal Lab, London NW7 1AA, England; [Slender, Amy; Lana-Elola, Eva; Watson-Scales, Sheona; Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Fisher, Elizabeth M. C.] UCL, Inst Neurol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; University College London	Haas, MA (corresponding author), Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia.	Matilda.Haas@monash.edu	Fisher, Elizabeth MC/C-2168-2008; Lana-Elola, Eva/ABE-4012-2020; Guillemot, Francois/AAV-1482-2021	Fisher, Elizabeth MC/0000-0003-2850-9936; Lana-Elola, Eva/0000-0003-3351-5820; Tybulewicz, Victor/0000-0003-2439-0798; Haas, Matilda/0000-0002-5149-0471	UK Medical Research Council [U117527252, U117570528]; Wellcome Trust; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [G0601056, MC_U117527252] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (program numbers U117527252 and U117570528) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Banks GT, 2011, J NEUROSCI, V31, P5483, DOI 10.1523/JNEUROSCI.5244-10.2011; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Martinez de Lagran M, 2012, CEREBRAL CORTEX; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Pacary E, 2012, JOVE-J VIS EXP, DOI 10.3791/4163; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; SHOLL DA, 1953, J ANAT, V87, P387; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1999, J NEUROSCI, V19, P10357; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; TAKASHIMA S, 1994, J INTELL DISABIL RES, V38, P265; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Velazquez-Zamora DA, 2011, INT J DEV NEUROSCI, V29, P515, DOI 10.1016/j.ijdevneu.2011.04.005; Vuksic M, 2002, PEDIATR NEUROL, V27, P36, DOI 10.1016/S0887-8994(02)00380-6; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	42	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78561	10.1371/journal.pone.0078561	http://dx.doi.org/10.1371/journal.pone.0078561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205261	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500123
J	Bryzgalov, LO; Antontseva, EV; Matveeva, MY; Shilov, AG; Kashina, EV; Mordvinov, VA; Merkulova, TI				Bryzgalov, Leonid O.; Antontseva, Elena V.; Matveeva, Marina Yu.; Shilov, Alexander G.; Kashina, Elena V.; Mordvinov, Viatcheslav A.; Merkulova, Tatyana I.			Detection of Regulatory SNPs in Human Genome Using ChIP-seq ENCODE Data	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-BINDING; SINGLE-NUCLEOTIDE POLYMORPHISM; DNA-BINDING; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; WIDE ANALYSIS; DISEASE; SITES; IDENTIFICATION; PREDICTION	A vast amount of SNPs derived from genome-wide association studies are represented by non-coding ones, therefore exacerbating the need for effective identification of regulatory SNPs (rSNPs) among them. However, this task remains challenging since the regulatory part of the human genome is annotated much poorly as opposed to coding regions. Here we describe an approach aggregating the whole set of ENCODE ChIP-seq data in order to search for rSNPs, and provide the experimental evidence of its efficiency. Its algorithm is based on the assumption that the enrichment of a genomic region with transcription factor binding loci (ChIP-seq peaks) indicates its regulatory function, and thereby SNPs located in this region are more likely to influence transcription regulation. To ensure that the approach preferably selects functionally meaningful SNPs, we performed enrichment analysis of several human SNP datasets associated with phenotypic manifestations. It was shown that all samples are significantly enriched with SNPs falling into the regions of multiple ChIP-seq peaks as compared with the randomly selected SNPs. For experimental verification, 40 SNPs falling into overlapping regions of at least 7 TF binding loci were selected from OMIM. The effect of SNPs on the binding of the DNA fragments containing them to the nuclear proteins from four human cell lines (HepG2, HeLaS3, HCT-116, and K562) has been tested by EMSA. A radical change in the binding pattern has been observed for 29 SNPs, besides, 6 more SNPs also demonstrated less pronounced changes. Taken together, the results demonstrate the effective way to search for potential rSNPs with the aid of ChIP-seq data provided by ENCODE project.	[Bryzgalov, Leonid O.; Antontseva, Elena V.; Matveeva, Marina Yu.; Shilov, Alexander G.; Kashina, Elena V.; Mordvinov, Viatcheslav A.; Merkulova, Tatyana I.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Merkulova, Tatyana I.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Antontseva, EV (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	antontseva@bionet.nsc.ru	Mordvinov, Viatcheslav A/S-8277-2017; Antontseva, Elena/AAD-3703-2020; Merkulova, Tatyana/R-9163-2016	Mordvinov, Viatcheslav A/0000-0002-6173-0774; 	Ministry of Education and Science of the Russian Federation [16.512.11.2274]; Integration Project of the Siberian Branch of the Russian Academy of Sciences [65]; program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine" [23]; Russian Foundation for Basic Research [13-04-01077]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Integration Project of the Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by State Contract no. 16.512.11.2274 of Ministry of Education and Science of the Russian Federation; by the Integration Project of the Siberian Branch of the Russian Academy of Sciences no. 65; by the program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine" no. 23; by the Russian Foundation for Basic Research project no. 13-04-01077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alj Y, 2004, GASTROENTEROLOGY, V126, P308, DOI 10.1053/j.gastro.2003.10.073; Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Bonadies N, 2010, ONCOGENE, V29, P1062, DOI 10.1038/onc.2009.371; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Colombo F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-81; Comings DE, 1996, PHARMACOGENETICS, V6, P307, DOI 10.1097/00008571-199608000-00004; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Drachkova IA, 2011, HEALTH, V3, P577; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FEI YJ, 1988, BIOCHEM BIOPH RES CO, V153, P741, DOI 10.1016/S0006-291X(88)81157-4; Gilchrist DA, 2009, METHODS, V48, P398, DOI 10.1016/j.ymeth.2009.02.024; Gonzalez S, 2012, BIOINFORMATICS, V28, P763, DOI 10.1093/bioinformatics/bts024; Halfon MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-578; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kolchanov NA, 2007, BRIEF BIOINFORM, V8, P266, DOI 10.1093/bib/bbm027; Li JG, 2012, IMMUNOGENETICS, V64, P361, DOI 10.1007/s00251-011-0597-6; Li MJ, 2012, CELL RES, V22, P1505, DOI 10.1038/cr.2012.106; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; Montgomery SB, 2007, PLOS COMPUT BIOL, V3, P1000, DOI 10.1371/journal.pcbi.0030106; Mottagui-Tabar S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-18; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ni YY, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-46; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Page SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022052; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; Ponomarenko JV, 2002, HUM MUTAT, V20, P239, DOI 10.1002/humu.10116; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Roy AL, 2011, TRENDS IMMUNOL, V32, P532, DOI 10.1016/j.it.2011.06.012; Sakabe NJ, 2010, WIRES SYST BIOL MED, V2, P422, DOI 10.1002/wsbm.70; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sharov AA, 2006, DNA RES, V13, P123, DOI 10.1093/dnares/dsl005; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Vasiliev GV, 1999, FEBS LETT, V462, P85, DOI 10.1016/S0014-5793(99)01513-6; Weth O, 2011, BIOCHEM CELL BIOL, V89, P459, DOI [10.1139/O11-033, 10.1139/o11-033]; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xing YJ, 2013, FUNCT INTEGR GENOMIC, V13, P143, DOI 10.1007/s10142-012-0305-0; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhao YQ, 2011, HUM MUTAT, V32, P1183, DOI 10.1002/humu.21559; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	62	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78833	10.1371/journal.pone.0078833	http://dx.doi.org/10.1371/journal.pone.0078833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205329	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700099
J	Kurzynska-Kokorniak, A; Koralewska, N; Tyczewska, A; Twardowski, T; Figlerowicz, M				Kurzynska-Kokorniak, Anna; Koralewska, Natalia; Tyczewska, Agata; Twardowski, Tomasz; Figlerowicz, Marek			A New Short Oligonucleotide-Based Strategy for the Precursor-Specific Regulation of microRNA Processing by Dicer	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; RNA INTERFERENCE; MESSENGER-RNAS; BIOGENESIS; EXPRESSION; TARGETS; BINDING; INHIBITION; MODULATION; REVEALS	The precise regulation of microRNA (miRNA) biogenesis seems to be critically important for the proper functioning of all eukaryotic organisms. Even small changes in the levels of specific miRNAs can initiate pathological processes, including carcinogenesis. Accordingly, there is a great need to develop effective methods for the regulation of miRNA biogenesis and activity. In this study, we focused on the final step of miRNA biogenesis; i.e., miRNA processing by Dicer. To test our hypothesis that RNA molecules can function not only as Dicer substrates but also as Dicer regulators, we previously identified by SELEX a pool of RNA oligomers that bind to human Dicer. We found that certain of these RNA oligomers could selectively inhibit the formation of specific miRNAs. Here, we show that these specific inhibitors can simultaneously bind both Dicer and pre-miRNAs. These bifunctional riboregulators interfere with miRNA maturation by affecting pre-miRNA structure and sequestering Dicer. Based on these observations, we designed a set of short oligomers (12 nucleotides long) that were capable of influencing pre-miRNA processing in vitro, both in reactions involving recombinant human Dicer and in cytosolic extracts. We propose that the same strategy may be used to develop effective and selective regulators to control the production of any miRNA. Overall, our findings indicate that the interactions between pre-miRNAs and other RNAs may form very complex regulatory networks that modulate miRNA biogenesis and consequently gene expression.	[Kurzynska-Kokorniak, Anna; Koralewska, Natalia; Tyczewska, Agata; Twardowski, Tomasz; Figlerowicz, Marek] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology	Figlerowicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	marekf@ibch.poznan.pl	Tyczewska, Agata/L-8060-2013; Koralewska, Natalia/W-4886-2018; Figlerowicz, Marek/B-9550-2015; Tyczewska, Agata/L-4590-2019	Tyczewska, Agata/0000-0002-8819-1539; Koralewska, Natalia/0000-0001-7096-0128; Tyczewska, Agata/0000-0002-8819-1539; Figlerowicz, Marek/0000-0002-6392-0192; Kurzynska-Kokorniak, Anna/0000-0002-7034-3370	European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science [Pomost/2011-3/5]; Polish Government through Ministry of Science and Higher Education [N301 265436]	European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science; Polish Government through Ministry of Science and Higher Education	This work was supported by the European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science (Pomost/2011-3/5 to A.K.-K.) and by the Polish Government through a grant from the Ministry of Science and Higher Education (N301 265436 to A.K.-K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Berkhout B, 2006, FEBS LETT, V580, P2896, DOI 10.1016/j.febslet.2006.02.070; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Haasnoot J, 2006, HANDB EXP PHARM, V173, P117; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Henn A, 2008, CHEMBIOCHEM, V9, P2722, DOI 10.1002/cbic.200800271; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kaul D, 2004, BIOCHEM BIOPH RES CO, V313, P552, DOI 10.1016/j.bbrc.2003.12.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurzynska-Kokorniak A, 2009, MINI-REV MED CHEM, V9, P927, DOI 10.2174/138955709788681573; Lehrbach NJ, 2010, ADV EXP MED BIOL, V700, P67; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; Lunse CE, 2010, ANGEW CHEM INT EDIT, V49, P4674, DOI 10.1002/anie.200906919; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Macrae IJ, 2006, COLD SH Q B, V71, P73; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Nowacka M, 2013, PLANT MOL BIOL, V83, P191, DOI 10.1007/s11103-013-0079-3; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Olejniczak M, 2010, NUCLEIC ACIDS RES, V38, P1, DOI 10.1093/nar/gkp829; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Plante Isabelle, 2012, Frontiers in Genetics, V3, P99, DOI 10.3389/fgene.2012.00099; Singh S, 2005, BIOCHEM BIOPH RES CO, V335, P643, DOI 10.1016/j.bbrc.2005.07.138; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tyczewska A, 2011, NUCLEIC ACID THER, V21, P333, DOI 10.1089/nat.2011.0304; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	51	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77703	10.1371/journal.pone.0077703	http://dx.doi.org/10.1371/journal.pone.0077703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204924	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700050
J	Barron, AM; Rosario, ER; Elteriefi, R; Pike, CJ				Barron, Anna M.; Rosario, Emily R.; Elteriefi, Reem; Pike, Christian J.			Sex-Specific Effects of High Fat Diet on Indices of Metabolic Syndrome in 3xTg-AD Mice: Implications for Alzheimer's Disease	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; TESTOSTERONE REPLACEMENT THERAPY; VISCERAL ADIPOSE-TISSUE; HYPOGONADAL MEN; PROSTATE-CANCER; RISK-FACTORS; OBESITY; DEMENTIA; INSULIN; MIDLIFE	Multiple factors of metabolic syndrome have been implicated in the pathogenesis of Alzheimer's disease (AD), including abdominal obesity, insulin resistance, endocrine dysfunction and dyslipidemia. High fat diet, a common experimental model of obesity and metabolic syndrome, has been shown to accelerate cognitive decline and AD-related neuropathology in animal models. However, sex interacts with the metabolic outcomes of high fat diet and, therefore, may alter neuropathological consequences of dietary manipulations. This study examines the effects of sex and high fat diet on metabolic and AD-related neuropathological outcomes in 3xTg-AD mice. Three month-old male and female 3xTg-AD mice were fed either standard or high fat diets for 4 months. Obesity was observed in all high fat fed mice; however, ectopic fat accumulation, hyperglycemia and hyperinsulinemia were observed only in males. Interestingly, despite the different metabolic outcomes of high fat diet, the neuropathological consequences were similar: both male and female mice maintained under high fat diet exhibited significant worsening in behavioral performance and hippocampal accumulation of beta-amyloid protein. Because high fat diet resulted in obesity and increased AD-like pathology in both sexes, these data support a role of obesity-related factors in promoting AD pathogenesis.	[Barron, Anna M.; Rosario, Emily R.; Elteriefi, Reem; Pike, Christian J.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA	University of Southern California	Pike, CJ (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	cjpike@usc.edu	Barron, Anna/AAT-7789-2020; Pike, Christian J/D-4013-2018	Barron, Anna/0000-0002-4715-9364; Pike, Christian/0000-0003-4577-7668	NIH [AG034103, AG026572]; American Australian Association; Japan Society for the Promotion of Science; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG034103] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Australian Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH grants AG034103 (CJP) and AG026572 (RD Brinton/CJP). AMB is funded by an American Australian Association Neurological Fellowship and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CA, 2008, J CLIN ENDOCR METAB, V93, P139, DOI 10.1210/jc.2007-1291; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1049, DOI 10.1210/jc.2006-2060; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Chiang CJ, 2007, AM J GERIAT PSYCHIAT, V15, P762, DOI 10.1097/JGP.0b013e318050c98f; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Erol A, 2008, J ALZHEIMERS DIS, V13, P241; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Ho L, 2004, FASEB J; Hong H, 2009, NEUROPHARMACOLOGY, V56, P1054, DOI 10.1016/j.neuropharm.2009.03.001; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530/EJE-06-0737; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lage MJ, 2007, UROLOGY, V70, P1104, DOI 10.1016/j.urology.2007.08.012; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Lee YH, 2009, NEUROENDOCRINOLOGY, V90, P383, DOI 10.1159/000235555; Levene AP, 2012, HISTOPATHOLOGY, V60, P971, DOI 10.1111/j.1365-2559.2012.04193.x; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Liu Y, 2008, NEUROSCIENCE, V153, P796, DOI 10.1016/j.neuroscience.2008.03.019; Luchsinger JA, 2007, CURR ALZHEIMER RES, V4, P127, DOI 10.2174/156720507780362100; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olivares A, 2010, GEN COMP ENDOCR, V166, P356, DOI 10.1016/j.ygcen.2009.12.007; PASQUALI R, 1991, METABOLISM, V40, P101, DOI 10.1016/0026-0495(91)90199-7; PASQUALI R, 1988, J ENDOCRINOL INVEST, V11, P205, DOI 10.1007/BF03350136; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	52	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78554	10.1371/journal.pone.0078554	http://dx.doi.org/10.1371/journal.pone.0078554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205258	gold, Green Published, Green Submitted			2022-12-25	WOS:000326241200058
J	Mickenautsch, S; Yengopal, V				Mickenautsch, Steffen; Yengopal, Veerasamy			Direct Contra Naive-Indirect Comparison of Clinical Failure Rates between High-Viscosity GIC and Conventional Amalgam Restorations: An Empirical Study	PLOS ONE			English	Article							IONOMER CEMENT RESTORATIONS; SURFACE ART RESTORATIONS; GLASS-IONOMER; PERMANENT DENTITION; SYSTEMATIC REVIEWS; SINGLE-SURFACE; SURVIVAL; LONGEVITY; TRIALS; TEETH	Background: Naive-indirect comparisons are comparisons between competing clinical interventions' evidence from separate (uncontrolled) trials. Direct comparisons are comparisons within randomised control trials (RCTs). The objective of this empirical study is to test the null-hypothesis that trends and performance differences inferred from naive-indirect comparisons and from direct comparisons/RCTs regarding the failure rates of amalgam and direct high-viscosity glass-ionomer cement (HVGIC) restorations in permanent posterior teeth have similar direction and magnitude. Methods: A total of 896 citations were identified through systematic literature search. From these, ten and two uncontrolled clinical longitudinal studies for HVGIC and amalgam, respectively, were included for naive-indirect comparison and could be matched with three out twenty RCTs. Summary effects sizes were computed as Odds ratios (OR; 95% Confidence intervals) and compared with those from RCTs. Trend directions were inferred from 95% Confidence interval overlaps and direction of point estimates; magnitudes of performance differences were inferred from the median point estimates (OR) with 25% and 75% percentile range, for both types of comparison. Mann-Whitney U test was applied to test for statistically significant differences between point estimates of both comparison types. Results: Trends and performance differences inferred from naive-indirect comparison based on evidence from uncontrolled clinical longitudinal studies and from direct comparisons based on RCT evidence are not the same. The distributions of the point estimates differed significantly for both comparison types (Mann-Whitney U = 25, n(indirect) = 26; n(direct) = 8; p = 0.0013, two-tailed). Conclusion: The null-hypothesis was rejected. Trends and performance differences inferred from either comparison between HVGIC and amalgam restorations failure rates in permanent posterior teeth are not the same. It is recommended that clinical practice guidance regarding HVGICs should rest on direct comparisons via RCTs and not on naive-indirect comparisons based on uncontrolled longitudinal studies in order to avoid inflation of effect estimates.	[Mickenautsch, Steffen; Yengopal, Veerasamy] Univ Witwatersrand Johannesburg, Systemat Review Initiat Evidence Based Minimum In, Dept Community Dent, Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand	Mickenautsch, S (corresponding author), Univ Witwatersrand Johannesburg, Systemat Review Initiat Evidence Based Minimum In, Dept Community Dent, Fac Hlth Sci, Johannesburg, South Africa.	neem@global.co.za	Mickenautsch, Steffen/D-1235-2013	Mickenautsch, Steffen/0000-0002-4994-2328				Abid A, 2002, East Mediterr Health J, V8, P315; Arabi Y, 2005, SAUDI MED J, V26, P1175; Bakhai A., 2006, CLIN TRIALS PRACTICA; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; Bresciani Eduardo, 2004, J. Appl. Oral Sci., V12, P344, DOI 10.1590/S1678-77572004000400017; Busanello L, 2009, REV ODONT CIENC, V24, P295; Carvalho CA, 2007, INT DENT SA, V9, P24; Cefaly DFG, 2007, J DENT CHILD, V74, P203; DGZ/DGZMK, 2005, DIR KOMP SEIT IND LE; Ercan E, 2009, J APPL ORAL SCI, V17, P307, DOI 10.1590/S1678-77572009000400008; Ericson Dan, 2003, Oral Health Prev Dent, V1, P59; Barata TJE, 2008, J APPL ORAL SCI, V16, P155, DOI 10.1590/S1678-77572008000200014; Frencken JE, 2006, J DENT RES, V85, P622, DOI 10.1177/154405910608500708; Frencken JE, 2004, J DENT RES, V83, P120, DOI 10.1177/154405910408300207; Fuks Anna B, 2002, Pediatr Dent, V24, P448; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Heintze SD, 2007, J ADHES DENT, V9, P77; Heintze Siegward D, 2011, Schweiz Monatsschr Zahnmed, V121, P1024; Huitema BE, 2011, ANAL COVARIANCE ALTE, P609; Ibiyemi O, 2011, Afr J Med Med Sci, V40, P127; Ibiyemi O, 2011, INT DENT J, V61, P2, DOI 10.1111/j.1875-595X.2011.00001.x; JAMES KE, 1973, BIOMETRICS, V29, P121, DOI 10.2307/2529681; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kiremitci A, 2003, J ORAL REHABIL, V30, P664, DOI 10.1046/j.1365-2842.2003.01007.x; Lo ECM, 2007, COMMUNITY DENT ORAL, V35, P387, DOI 10.1111/j.1600-0528.2006.00342.x; Lopez N, 2005, AM J PUBLIC HEALTH, V95, P1338, DOI 10.2105/AJPH.2004.056945; Manhart J, 2004, OPER DENT, V29, P481; Mickenautsch S, 2012, SADJ, V67, P329; Mickenautsch S, 2009, EUR J PAEDIATR DENT, V10, P41; Mickenautsch S, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-18; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Piwowarczyk A, 2001, J Prosthodont, V10, P140, DOI 10.1053/jpro.2001.27338; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Rahimtoola Salim, 2002, ASDC J Dent Child, V69, P16; REED RB, 1967, J DENT RES, V46, P1208, DOI 10.1177/00220345670460061401; Sachdeo A, 2004, Eur J Prosthodont Restor Dent, V12, P15; Soncini JA, 2007, J AM DENT ASSOC, V138, P763, DOI 10.14219/jada.archive.2007.0264; Sutherland S E, 2001, J Can Dent Assoc, V67, P375; Torabzadeh H, 2011, BRAZ J ORAL SCI, V10, P204; Turp J C, 2003, Schweiz Monatsschr Zahnmed, V113, P36; van Gemert-Schriks MCM, 2007, CLIN ORAL INVEST, V11, P337, DOI 10.1007/s00784-007-0138-8; Van Nieuwenhuysen JP, 2003, J DENT, V31, P395, DOI 10.1016/S0300-5712(03)00084-8; Wang Linda, 2004, Spec Care Dentist, V24, P28, DOI 10.1111/j.1754-4505.2004.tb01676.x; Wang X, 2012, J MINIM INTERV DENT, V5, P377; White A, 2001, COMPLEMENT THER MED, V9, P111, DOI 10.1054/ctim.2001.0441; Yip KHK, 2002, J AM DENT ASSOC, V133, P744, DOI 10.14219/jada.archive.2002.0272; Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301; Zahra Vivian N, 2011, Acta odontol. latinoam., V24, P200; Zanata RL, 2011, CLIN ORAL INVEST, V15, P265, DOI 10.1007/s00784-009-0378-x; Ziraps A, 2002, MED PRIN PRACT, V11, P44, DOI 10.1159/000057778	50	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78397	10.1371/journal.pone.0078397	http://dx.doi.org/10.1371/journal.pone.0078397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205220	gold, Green Published, Green Submitted			2022-12-25	WOS:000326241200056
J	Moskowitz, JT; Wrubel, J; Hult, JR; Maurer, S; Acree, M				Moskowitz, Judith Tedlie; Wrubel, Judith; Hult, Jen R.; Maurer, Stephanie; Acree, Michael			Illness Appraisals and Depression in the First Year after HIV Diagnosis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DISPOSITIONAL OPTIMISM; HIV/AIDS IDENTITY; PERSONAL MODELS; SOCIAL SUPPORT; SELF; PEOPLE; CANCER; QUESTIONNAIRE; PERCEPTIONS	Illness appraisals provide important context to help understand the way individuals cope with chronic illness. In the present study, a qualitative approach to the analysis of HIV diagnosis experience narratives in a sample of 100 people newly diagnosed with HIV revealed five groups that differed in their initial illness appraisals: HIV as Chronic Illness, Concern about Dying, Stigmatization, Threat to Identity, and Other Threats Overshadow HIV. When compared on quantitatively measured depressive mood, the groups differed on level and trajectory over the course of the first year post-diagnosis. Although the experience of living with HIV has changed significantly with the advent of effective Antiretroviral Therapies (ART), there were a number of similarities between the appraisals of this group of participants who were diagnosed post ART and groups who were diagnosed before ART became widely available. Posttest counselors and other HIV service providers should take individual differences in illness appraisals into account in order to help newly HIV-positive clients manage their healthcare and cope adaptively with their diagnosis.	[Moskowitz, Judith Tedlie; Wrubel, Judith; Hult, Jen R.; Maurer, Stephanie; Acree, Michael] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Moskowitz, JT (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.	moskj@ocim.ucsf.edu			National Institute of Mental Health [R01 MH068170, K24 MH093225]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068170, K24MH093225] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health R01 MH068170 and K24 MH093225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo AA, 2000, SOC SCI MED, V50, P1475, DOI 10.1016/S0277-9536(99)00399-8; Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; Baumgartner LM, 2013, QUAL REP, V18; Baumgartner LM, 2012, QUAL REP, V17; Baumgartner LM, 2009, QUAL HEALTH RES, V19, P1730, DOI 10.1177/1049732309352907; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Benner P., 1994, INTERPRETIVE PHENOME, P99, DOI DOI 10.4135/9781452204727.N6; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; BROWNE GB, 1988, NURS RES, V37, P368; Cain R, 2013, QUAL HEALTH RES, V23, P815, DOI 10.1177/1049732313482525; Carrico AW, HLTH PSYCHO IN PRESS; Chalfant AM, 2004, J TRAUMA STRESS, V17, P423, DOI 10.1023/B:JOTS.0000048955.65891.4c; Daher M, 2012, ANN ONCOL, V23, P66, DOI 10.1093/annonc/mds091; Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Farber EW, 2010, GEN HOSP PSYCHIAT, V32, P73, DOI 10.1016/j.genhosppsych.2009.09.011; Farber EW, 2003, PSYCHOSOMATICS, V44, P485, DOI 10.1176/appi.psy.44.6.485; Fife BL, 2005, SOC SCI MED, V61, P2132, DOI 10.1016/j.socscimed.2005.04.026; FIFE BL, 1995, SOC SCI MED, V40, P1021, DOI 10.1016/0277-9536(94)00174-R; FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6; Flowers P, 2006, PSYCHOL HEALTH, V21, P109, DOI 10.1080/14768320500286286; Flowers P, 2011, PSYCHOL HEALTH, V26, P1378, DOI 10.1080/08870446.2010.551213; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Folkman S, 1988, MANUAL WAYS COPING Q; Gallagher J, 2002, BRIT J HEALTH PSYCH, V7, P365, DOI 10.1348/135910702760213733; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; HAMPSON SE, 1990, HEALTH PSYCHOL, V9, P632, DOI 10.1037/0278-6133.9.5.632; HAMPSON SE, 1994, J BEHAV MED, V17, P143, DOI 10.1007/BF01858102; Hult JR, 2012, AIDS PATIENT CARE ST, V26, P181, DOI 10.1089/apc.2011.0282; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Ironson G, 2005, INT J BEHAV MED, V12, P86, DOI 10.1207/s15327558ijbm1202_6; Kamen C, 2013, J HEALTH PSYCHOL, V18, P658, DOI 10.1177/1359105312454039; Kelly C, 2012, J CLIN NURS, V21, P1554, DOI 10.1111/j.1365-2702.2011.04017.x; Lawson VL, 2010, BRIT J HEALTH PSYCH, V15, P623, DOI 10.1348/135910709X478664; Lazarus R.S., 1984, STRESS APPRAISAL COP; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H, 1997, PERCEPTIONS HLTH ILL; Luker KA, 1996, J ADV NURS, V23, P1194, DOI 10.1046/j.1365-2648.1996.13617.x; MacQueen K. M., 1998, CAM J, V10, P31, DOI [DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301, 10.1177/1525822X980100020301]; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Mosack KE, 2005, QUAL HEALTH RES, V15, P586, DOI 10.1177/1049732304271749; Moskowitz JT, 2005, PSYCHOL HEALTH, V20, P509, DOI 10.1080/08870440412331337075; Moskowitz JT, 2012, J COMMUNITY APPL SOC, V22, P502, DOI 10.1002/casp.1133; Moskowitz JT, 2009, PSYCHOL BULL, V135, P121, DOI 10.1037/a0014210; Park CL, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-009-0993-x; Paterson Barbara, 2002, Can J Nurs Res, V34, P61; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Petrie KJ, 1997, PERCEPTIONS HLTH ILL; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao D, 2012, AIDS BEHAV, V16, P711, DOI 10.1007/s10461-011-9915-0; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Sarna Linda, 2005, Oncol Nurs Forum, V32, pE9, DOI 10.1188/05.ONF.E9-E19; Schabert J, 2013, J OUTCOMES RES, P1; Schiaffino KM, 1995, J BEHAV MED, V18, P531, DOI 10.1007/BF01857894; Schwartzberg S, 1996, CRISIS MEANING GAY M; Siegel K, 2002, AIDS, V16, pS69, DOI 10.1097/00002030-200216004-00010; Skelton JA, 1991, CONTRIB PSYCHOL, p[x, 284]; Stevens P, 1997, AIDS CARE; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tomakowsky J, 2001, J PSYCHOSOM RES, V51, P577, DOI 10.1016/S0022-3999(01)00249-5; Turner-Cobb JM, 2002, J BEHAV MED, V25, P337, DOI 10.1023/A:1015814431481; Unger Hella Von, 2005, Health Care Women Int, V26, P308, DOI 10.1080/07399330590925835; Valle M, 2008, AIDS CARE, V20, P130, DOI 10.1080/09540120701459665; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wrubel J., 2011, PSYCHOLOGY, V2, P117, DOI DOI 10.4236/PSYCH.2011.22019	68	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78904	10.1371/journal.pone.0078904	http://dx.doi.org/10.1371/journal.pone.0078904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205346	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400111
J	Sun, Z; Yu, JT; Jiang, T; Li, MM; Tan, L; Zhang, Q; Tan, L				Sun, Zhen; Yu, Jin-Tai; Jiang, Teng; Li, Meng-Meng; Tan, Lin; Zhang, Qun; Tan, Lan			Genome-Wide microRNA Profiling of Rat Hippocampus after Status Epilepticus Induced by Amygdala Stimulation Identifies Modulators of Neuronal Apoptosis	PLOS ONE			English	Article							EXPRESSION PROFILE; IN-VIVO; EPILEPSY; NEUROPROTECTION; PREDICTION; PATHWAYS; SEIZURES; DAMAGE; DEATH; MODEL	MicroRNAs (miRNAs) are small and endogenously expressed non-coding RNAs that negatively regulate the expression of protein-coding genes at the translational level. Emerging evidence suggests that miRNAs play critical roles in central nervous system under physiological and pathological conditions. However, their expression and functions in status epilepticus (SE) have not been well characterized thus far. Here, by using high-throughput sequencing, we characterized miRNA expression profile in rat hippocampus at 24 hours following SE induced by amygdala stimulation. After confirmation by qRT-PCR, six miRNAs were found to be differentially expressed in brain after SE. Subsequent Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated that most of the predicted target genes for these six miRNAs were related to neuronal apoptosis. We then investigated the dynamic changes of these six miRNAs at different time-point (4 hours, 24 hours, 1 week and 3 weeks) after SE. Meanwhile, neuronal survival and apoptosis in the hippocampus after SE were evaluated by Nissl staining and terminal deoxynucleotidyl transferase-mediated dUTP end-labeling assay. We found that the expression of miR-874-3p, miR-20a-5p, miR-345-3p, miR-365-5p, and miR-764-3p were significantly increased from 24 hours to 1 week, whereas miR-99b-3p level was markedly decreased from 24 hours to 3 weeks after SE. Further analysis revealed that the levels of miR-365-5p and miR-99b-3p were significantly correlated with neuronal apoptosis after SE. Taken together, our data suggest that miRNAs are important modulators of SE-induced neuronal apoptosis. These findings also open new avenues for future studies aimed at developing strategies against neuronal apoptosis after SE.	[Sun, Zhen; Tan, Lan] Taishan Med Univ, Dept Neurol, Qingdao Municipal Hosp, Qingdao, Peoples R China; [Yu, Jin-Tai; Li, Meng-Meng; Tan, Lin; Zhang, Qun; Tan, Lan] Qingdao Univ, Sch Med, Dept Neurol, Qingdao Municipal Hosp, Qingdao 266071, Peoples R China; [Yu, Jin-Tai; Jiang, Teng; Tan, Lan] Nanjing Med Univ, Dept Neurol, Qingdao Municipal Hosp, Qingdao, Peoples R China	Qingdao Municipal Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Qingdao Municipal Hospital; Qingdao University; Nanjing Medical University; Qingdao Municipal Hospital	Yu, JT (corresponding author), Qingdao Univ, Sch Med, Dept Neurol, Qingdao Municipal Hosp, Qingdao 266071, Peoples R China.	yu-jintai@163.com; dr.tanlan@163.com	Yu, Jin-Tai/HDL-7766-2022	Yu, Jin-Tai/0000-0002-7686-0547	National Natural Science Foundation of China [81000544, 81171209]; Shandong Provincial Natural Science Foundation, China [ZR2010HQ004, ZR2011HZ001]; Medicine and Health Science Technology Development Project of Shandong Province [2011WSA02018, 2011WSA02020]; Shandong Provincial Outstanding Medical Academic Professional Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Medicine and Health Science Technology Development Project of Shandong Province; Shandong Provincial Outstanding Medical Academic Professional Program	This work was supported by grants from the National Natural Science Foundation of China (81000544, 81171209), the Shandong Provincial Natural Science Foundation, China (ZR2010HQ004, ZR2011HZ001), the Medicine and Health Science Technology Development Project of Shandong Province (2011WSA02018, 2011WSA02020), and the Shandong Provincial Outstanding Medical Academic Professional Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brandt C, 2004, EPILEPSIA, V45, P1488, DOI 10.1111/j.0013-9580.2004.16904.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Henshall DC, 2007, BIOCHEM SOC T, V35, P421, DOI 10.1042/BST0350421; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; Meng XF, 2013, J NEUROL SCI, V332, P4, DOI 10.1016/j.jns.2013.05.029; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Pitkanen A, 1999, EPILEPSY RES, V33, P67, DOI 10.1016/S0920-1211(98)00074-6; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Sun Z, 2013, CNS NEUROL DISORD DR; Thom Maria, 2004, Expert Rev Neurother, V4, P973, DOI 10.1586/14737175.4.6.973; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Yang YF, 2011, NEUROSCIENCE, V196, P25, DOI 10.1016/j.neuroscience.2011.08.059; Zhang Q, 2012, NEUROSCIENCE, V217, P113, DOI 10.1016/j.neuroscience.2012.05.009	31	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78375	10.1371/journal.pone.0078375	http://dx.doi.org/10.1371/journal.pone.0078375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205215	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400079
J	Amoabeng, BW; Gurr, GM; Gitau, CW; Nicol, HI; Munyakazi, L; Stevenson, PC				Amoabeng, Blankson W.; Gurr, Geoff M.; Gitau, Catherine W.; Nicol, Helen I.; Munyakazi, Louis; Stevenson, Phil C.			Tri-Trophic Insecticidal Effects of African Plants against Cabbage Pests	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; CRUDE SEED EXTRACTS; DIAMONDBACK MOTH; MELIA-AZEDARACH; AZADIRACHTA-INDICA; ANNONA-SQUAMOSA; STORAGE PESTS; MANAGEMENT; L.; FIELD	Botanical insecticides are increasingly attracting research attention as they offer novel modes of action that may provide effective control of pests that have already developed resistance to conventional insecticides. They potentially offer cost-effective pest control to smallholder farmers in developing countries if highly active extracts can be prepared simply from readily available plants. Field cage and open field experiments were conducted to evaluate the insecticidal potential of nine common Ghanaian plants: goat weed, Ageratum conyzoides (Asteraceae), Siam weed, Chromolaena odorata (Asteraceae), Cinderella weed, Synedrella nodiflora (Asteraceae), chili pepper, Capsicum frutescens (Solanaceae), tobacco, Nicotiana tabacum (Solanaceae) cassia, Cassia sophera (Leguminosae), physic nut, Jatropha curcas (Euphorbiaceae), castor oil plant, Ricinus communis (Euphorbiaceae) and basil, Ocimum gratissimum (Lamiaceae). In field cage experiments, simple detergent and water extracts of all botanical treatments gave control of cabbage aphid, Brevicoryne brassicae and diamondback moth, Plutella xylostella, equivalent to the synthetic insecticide Attack (R) (emamectin benzoate) and superior to water or detergent solution. In open field experiments in the major and minor rainy seasons using a sub-set of plant extracts (A. conyzoides, C. odorata, S. nodiflora, N. tabacum and R. communis), all controlled B. brassicae and P. xylostella more effectively than water control and comparably with or better than Attack (R). Botanical and water control treatments were more benign to third trophic level predators than Attack (R). Effects cascaded to the first trophic level with all botanical treatments giving cabbage head weights, comparable to Attack (R) in the minor season. In the major season, R. communis and A conyzoides treatment gave lower head yields than Attack (R) but the remaining botanicals were equivalent or superior to this synthetic insecticide. Simply-prepared extracts from readily-available Ghanaian plants give beneficial, tri-trophic benefits and merit further research as an inexpensive plant protection strategy for smallholder farmers in West Africa.	[Amoabeng, Blankson W.; Nicol, Helen I.] Charles Sturt Univ, Sch Agr & Wine Sci, Orange, NSW, Australia; [Gurr, Geoff M.; Gitau, Catherine W.] NSW Dept Primary Ind, EH Graham Ctr Agr Innovat, Orange, NSW, Australia; [Gurr, Geoff M.; Gitau, Catherine W.] Charles Sturt Univ, Orange, NSW, Australia; [Munyakazi, Louis] Kumasi Polytech, Dept Math & Stat, Kumasi, Ghana; [Stevenson, Phil C.] Royal Bot Gardens, Richmond, Surrey, England; [Amoabeng, Blankson W.] Crops Res Inst, Council Sci & Ind Res, Kumasi, Ghana	Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; Royal Botanic Gardens, Kew	Amoabeng, BW (corresponding author), Charles Sturt Univ, Sch Agr & Wine Sci, Orange Campus, Orange, NSW, Australia.	kblanksin@yahoo.com	GURR, GEOFFREY M/F-3519-2011; Clarke, Catherine Wanjiru/K-2944-2019; stevenson, philip c/E-8741-2013; Stevenson, Philip C/E-8822-2013	Clarke, Catherine Wanjiru/0000-0002-4397-9381; stevenson, philip c/0000-0002-0736-3619; Stevenson, Philip C/0000-0002-0736-3619; Gurr, Geoff/0000-0001-5008-7966	Charles Sturt University; AusAID	Charles Sturt University; AusAID(Australian Aid (AusAID))	Financial support was given by Charles Sturt University and AusAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Ahmed B. I., 2009, Journal of Biopesticides, V2, P37; [Anonymous], 1925, J ECON ENTOMOL; Ayalew G, 2006, J APPL ENTOMOL, V130, P343, DOI 10.1111/j.1439-0418.2006.01078.x; Baker GJ, 1999, AUST J ENTOMOL, V38, P132, DOI 10.1046/j.1440-6055.1999.00087.x; Buss EA, 2002, UF IFAS PUBLICATION; Charleston DS, 2006, BIOL CONTROL, V39, P105, DOI 10.1016/j.biocontrol.2006.05.012; Charleston DS, 2005, B ENTOMOL RES, V95, P457, DOI 10.1079/BER2005377; Coulibaly O., 2007, J VEG SCI, V12, P27; de Oliveira AC, 2011, SCI AGR, V68, P154, DOI 10.1590/S0103-90162011000200004; Devanand Peta, 2008, Journal of Biopesticides, V1, P170; Dubey NK, 2011, NATURAL PRODUCTS IN PLANT PEST MANAGEMENT, P1, DOI 10.1079/9781845936716.0001; Fening K. O., 2011, Organic is Life - Knowledge for Tomorrow. Volume 1 - Organic Crop Production. Proceedings of the Third Scientific Conference of the International Society of Organic Agriculture Research (ISOFAR), held at the 17th IFOAM Organic World Congress in cooperation with the International Federation of Organic Agriculture Movements (IFOAM) and the Korean Organizing Committee (KOC), 28. September - 1. October 2011 in Namyangju, Korea Republic, P567; Flint M, 1991, INTEGRATED PEST MANA; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gendo JO, 2008, J STORED PROD RES, V44, P328, DOI 10.1016/j.jspr.2008.02.009; Gerken A., 2001, PESTICIDE POLICY PRO, V10, P90; Grzywacz D, 2010, CROP PROT, V29, P68, DOI 10.1016/j.cropro.2009.08.009; HUGHES RD, 1963, J ANIM ECOL, V32, P393, DOI 10.2307/2600; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jansson R., 1997, P 3 INT WORKSH MAN D; Kawuki RS, 2005, CROP PROT, V24, P473, DOI 10.1016/j.cropro.2004.09.017; Kestenholz C, 2007, J STORED PROD RES, V43, P79, DOI 10.1016/j.jspr.2005.11.003; Kianmatee Supawan, 2007, Journal of Asia-Pacific Entomology, V10, P69, DOI 10.1016/S1226-8615(08)60333-7; Kibrom Gebremariam, 2012, Archives of Phytopathology and Plant Protection, V45, P1273, DOI 10.1080/03235408.2012.673260; Leatemia JA, 2004, INT J PEST MANAGE, V50, P129, DOI 10.1080/096708704100001691821; Liu SS, 2000, B ENTOMOL RES, V90, P221; Macharia I, 2005, CROP PROT, V24, P981, DOI 10.1016/j.cropro.2005.02.005; Mitchell ER, 1997, FLA ENTOMOL, V80, P477, DOI 10.2307/3495613; Mochiah M. B., 2011, Journal of Applied Biosciences, V38, P2564; Mochiah M.B., 2011, J ENTOMOL NEMATOL, V3, P85; Ntow WJ, 2006, PEST MANAG SCI, V62, P356, DOI 10.1002/ps.1178; Obeng-Ofori D., 2002, AGR FOOD SCI J GHANA, V1, P83; Obopile M, 2008, CROP PROT, V27, P1220, DOI 10.1016/j.cropro.2008.03.003; Opender Koul, 2003, Predators and parasitoids, P1; Rando J. S. S., 2011, Semina: Ciencias Agrarias (Londrina), V32, P503; Rathi JM, 2005, J CENT EUR AGRIC, V6, P223; Reuben S. O. W. M., 2006, Asian Journal of Plant Sciences, V5, P85; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; SAS, 2005, SAS US GUID SAS US G; Seffrin RD, 2010, CROP PROT, V29, P20, DOI 10.1016/j.cropro.2009.09.003; Waiganjo MM., 2011, E AFR AGR FORESTRY J, V77, P545; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weinberger Katinka, 2009, Journal of Asia-Pacific Entomology, V12, P253, DOI 10.1016/j.aspen.2009.08.003; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107	45	65	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78651	10.1371/journal.pone.0078651	http://dx.doi.org/10.1371/journal.pone.0078651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205287	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300077
J	Lesting, J; Daldrup, T; Narayanan, V; Himpe, C; Seidenbecher, T; Pape, HC				Lesting, Joerg; Daldrup, Thiemo; Narayanan, Venu; Himpe, Christian; Seidenbecher, Thomas; Pape, Hans-Christian			Directional Theta Coherence in Prefrontal Cortical to Amygdalo-Hippocampal Pathways Signals Fear Extinction	PLOS ONE			English	Article							PARVALBUMIN-CONTAINING INTERNEURONS; CONDITIONED FEAR; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; PHASE SYNCHRONIZATION; NEURONAL CIRCUITS; LATERAL AMYGDALA; NEURAL CIRCUITS; FIRING PATTERNS; MOUSE MODEL	Theta oscillations are considered crucial mechanisms in neuronal communication across brain areas, required for consolidation and retrieval of fear memories. One form of inhibitory learning allowing adaptive control of fear memory is extinction, a deficit of which leads to maladaptive fear expression potentially leading to anxiety disorders. Behavioral responses after extinction training are thought to reflect a balance of recall from extinction memory and initial fear memory traces. Therefore, we hypothesized that the initial fear memory circuits impact behavioral fear after extinction, and more specifically, that the dynamics of theta synchrony in these pathways signal the individual fear response. Simultaneous multi-channel local field and unit recordings were obtained from the infralimbic prefrontal cortex, the hippocampal CA1 and the lateral amygdala in mice. Data revealed that the pattern of theta coherence and directionality within and across regions correlated with individual behavioral responses. Upon conditioned freezing, units were phase-locked to synchronized theta oscillations in these pathways, characterizing states of fear memory retrieval. When the conditioned stimulus evoked no fear during extinction recall, theta interactions were directional with prefrontal cortical spike firing leading hippocampal and amygdalar theta oscillations. These results indicate that the directional dynamics of theta-entrained activity across these areas guide changes in appraisal of threatening stimuli during fear memory and extinction retrieval. Given that exposure therapy involves procedures and pathways similar to those during extinction of conditioned fear, one therapeutical extension might be useful that imposes artificial theta activity to prefrontal cortical-amygdalo-hippocampal pathways that mimics the directionality signaling successful extinction recall.	[Lesting, Joerg; Daldrup, Thiemo; Narayanan, Venu; Seidenbecher, Thomas; Pape, Hans-Christian] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Daldrup, Thiemo] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Himpe, Christian] Univ Munster, Inst Computat & Appl Math, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Pape, HC (corresponding author), Univ Munster, Inst Physiol 1, D-48149 Munster, Germany.	papechris@ukmuenster.de			German Research Foundation (DFG) [SFB-TRR58, TP A02]; Max-Planck Society; Humboldt Foundation; Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience	German Research Foundation (DFG)(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Humboldt Foundation(Alexander von Humboldt Foundation); Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience	This work was supported by the German Research Foundation (DFG, SFB-TRR58, TP A02, to TS and HCP; http://sfbtrr58.uni-muenster.de), the Max-Planck Society and Humboldt Foundation (Research Award 2007 to HCP; http://www.humboldt-foundation.de/web/max-planck-preis.html), and the Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience (scholarship to TD; http://www.uni-muenster.de/OCCMuenster/news/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Amir A, 2011, J NEUROPHYSIOL, V105, P3054, DOI 10.1152/jn.00136.2011; An B, 2012, J NEUROSCI, V32, P16845, DOI 10.1523/JNEUROSCI.3017-12.2012; Berens P., 2009, J STAT SOFTWARE, V31; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Busti D, 2011, J NEUROSCI, V31, P5131, DOI 10.1523/JNEUROSCI.6100-10.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cammarota M, 2007, REV BRAS PSIQUIATR, V29, P80, DOI 10.1590/S1516-44462007000100019; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Ertl M, 2013, NEUROIMAGE, V81, P412, DOI 10.1016/j.neuroimage.2013.05.044; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seidenbecher T, 2012, INSIGHTS AMYGDALA ST, P213; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009	57	60	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77707	10.1371/journal.pone.0077707	http://dx.doi.org/10.1371/journal.pone.0077707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204927	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300029
J	Sano, A; Matsushita, H; Wu, H; Jiao, JA; Kasinathan, P; Sullivan, EJ; Wang, ZD; Kuroiwa, Y				Sano, Akiko; Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi			Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle	PLOS ONE			English	Article							B-CELL RECEPTOR; INTRAVENOUS IMMUNOGLOBULIN; ANTIBODIES; DISEASE; PLASMA; CALVES; BETA	Therapeutic human polyclonal antibodies (hpAbs) derived from pooled plasma from human donors are Food and Drug Administration approved biologics used in the treatment of a variety of human diseases. Powered by the natural diversity of immune response, hpAbs are effective in treating diseases caused by complex or quickly-evolving antigens such as viruses. We previously showed that transchromosomic (Tc) cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin heavy-chain (hIGH) and kappa-chain (hIGK) germline loci (named as kappa HAC) are capable of producing functional hpAbs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, are homozygously inactivated (double knockouts or DKO). However, B lymphocyte development in these Tc cattle is compromised, and the overall production of hpAbs is low. Here, we report the construction of an improved HAC Delta, designated as cKSL-HAC Delta, by incorporating all of the human immunoglobulin germline loci into the HAC. Furthermore, for avoiding the possible human-bovine interspecies incompatibility between the human immunoglobulin mu chain protein (hIgM) and bovine transmembrane alpha and beta immunoglobulins (bIg alpha and bIg beta) in the pre-B cell receptor (pre-BCR) complex, we partially replaced (bovinized) the hIgM constant domain with the counterpart of bovine IgM (bIgM) that is involved in the interaction between bIgM and bIg alpha/Ig beta; human IgM bovinization would also improve the functionality of hIgM in supporting B cell activation and proliferation. We also report the successful production of DKO Tc cattle carrying the cKSL-HA Delta (cKSL-HAC Delta/DKO), the dramatic improvement of B cell development in these cattle and the high level production of hpAbs (as measured for the human IgG isotype) in the plasma. We further demonstrate that, upon immunization by tumor immunogens, high titer tumor immunogen-specific human IgG (hIgG) can be produced from such Tc cattle.	[Sano, Akiko; Kuroiwa, Yoshimi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Sullivan, Eddie J.] Sanford Appl Biosci LLC, Sioux Falls, SD USA; [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kasinathan, Poothappillai] Trans Ova Genet, Sioux Ctr, IA USA; [Sano, Akiko; Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi] Hematech Inc, Sioux Falls, SD USA	Kyowa Kirin Ltd; Utah System of Higher Education; Utah State University	Sullivan, EJ (corresponding author), Sanford Appl Biosci LLC, Sioux Falls, SD USA.	eddie.sullivan@sanfordhealth.org; zonda.wang@usu.edu		Sullivan, Eddie/0000-0001-7468-2006; Wang, Zhongde/0000-0003-2441-4729	Hematech, Inc.	Hematech, Inc.	This work was financed by internal funding of Hematech, Inc., which no longer exists and no longer has financial interest in the work. Hematech has transferred all of its business to Sanford Applied Biosciences, LLC. There are no current external funding sources for this study. Kyowa Hakko Kirin provided permission for the work to be published. Financial interest in this work is currently owned by Sanford Applied Biosciences who did have a role in the decision to publish as well as the preparation of the manuscript. While it is considered beneficial to the interests of Sanford Applied Biosciences to publish this work, this consideration played no role in the study design, data collection and analysis and preparation of the manuscript. This is evidenced by the inclusion of now independent authors with no affiliation to Sanford Applied Biosciences.	Ben-Nathan D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-18; Bonagura VR, 2013, J CLIN IMMUNOL, V33, pS90, DOI 10.1007/s10875-012-9838-1; Boothpur R, 2010, AM J KIDNEY DIS, V55, P141, DOI 10.1053/j.ajkd.2009.06.017; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; Fuentes-Panana EM, 2004, J IMMUNOL, V173, P1000, DOI 10.4049/jimmunol.173.2.1000; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Kreil TR, 2012, TRANSFUSION, V52, P803, DOI 10.1111/j.1537-2995.2011.03347.x; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Perez-Vera P, 2011, BONE MARROW RES, DOI 10.1155/2011/502751; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; Rasmussen SK, 2012, ARCH BIOCHEM BIOPHYS, V526, P139, DOI 10.1016/j.abb.2012.07.001; Sellahewa K. H., 1994, Ceylon Medical Journal, V39, P173; Stiehm ER, 2008, BIOLOGICALS, V36, P363, DOI 10.1016/j.biologicals.2008.07.002; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	21	29	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78119	10.1371/journal.pone.0078119	http://dx.doi.org/10.1371/journal.pone.0078119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205120	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300042
J	Yadav, D; Ramanathan, S; Goswami, P; Ramakrishnan, L; Saggurti, N; Sen, S; George, B; Paranjape, R				Yadav, Diwakar; Ramanathan, Shreena; Goswami, Prabuddhagopal; Ramakrishnan, Lakshmi; Saggurti, Niranjan; Sen, Shrabanti; George, Bitra; Paranjape, Ramesh			Role of Community Group Exposure in Reducing Sexually Transmitted Infection-Related Risk among Female Sex Workers in India	PLOS ONE			English	Article							HIV PREVENTION PROGRAMS; PROPENSITY SCORE; MATCHING METHODS; KARNATAKA STATE; PEER EDUCATION; ANDHRA-PRADESH; CONDOM USE; HIV/AIDS; INTERVENTION; HEALTH	Background: Empowering female sex workers (FSWs) to address structural barriers and forming community groups (CGs) through community mobilization are seen as essential components of HIV prevention programs in India. Taking the membership of a CG as an exposure intervention, we hypothesized whether participation in a CG lead to reduced sexually transmitted infections (STIs) and increased treatment-seeking behavior among FSWs in three selected states of India - Andhra Pradesh, Maharashtra and Tamil Nadu. Methods and Findings: The propensity score matching (PSM) approach examined the effect of CG membership, as against no membership, on STI-related risk, described as selected outcome measures - presence of any STI, self-reported STI symptoms, and treatment-seeking behavior among FSWs. A cross sectional bio-behavioral survey was administered in 2009-2010 and covered 7,806 FSWs through two-stage probability-based conventional and time location cluster sampling in 23 administrative districts of Andhra Pradesh, Maharashtra and Tamil Nadu. Only 2,939 FSWs were reported to be members of a CG and among them 4.5% had any STIs. A majority of FSWs were aged above 24 years (86.4%), had ever been married (73%), operated from a public place for solicitation (81.5%), and had ever received HIV test results (75.6%). The average effect of CG exposure was reduction in STI prevalence by 4%, while self-reported STI symptom treatment-seeking behavior increased by 13.7%. Conclusion: FSWs who were exposed to a CG were at a substantially lower risk of STIs than those who were unexposed. The FSWs exposed to a CG had a higher chance of seeking STI treatment from public and private health facilities. Collectivization related challenges must be overcome to provide access to tailored STI prevention and care services.	[Yadav, Diwakar; Ramanathan, Shreena; Goswami, Prabuddhagopal; Ramakrishnan, Lakshmi; Sen, Shrabanti; George, Bitra] FHI 360, New Delhi, India; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Paranjape, Ramesh] Natl AIDS Res Inst, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Yadav, D (corresponding author), FHI 360, Green Pk Extens, New Delhi, India.	yadavdiwakar7@gmail.com		Paranjape, Ramesh/0000-0003-2948-9148; Saggurti, Niranjan/0000-0002-5267-8425	Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative	Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative(Bill & Melinda Gates FoundationGates Foundation India)	Support for this study was provided by the Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation or Avahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, INT BEH BIOL ASS IBB; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beeker C, 1998, SOC SCI MED, V46, P831, DOI 10.1016/S0277-9536(97)00208-6; Benzaken Adele Schwartz, 2007, Rev. Saúde Pública, V41, P118, DOI 10.1590/S0034-89102007000900018; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; Biradavolu MR, 2012, J EPIDEMIOL COMMUNIT, V66, pii95, DOI [10.1136/jech-2011-200508., DOI 10.1136/JECH-2011-200508.PUBMED:22705653]; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; BMGF, 2008, AV IND AIDS IN BUS H; Busza J, 2004, AIDS CARE, V16, P507, DOI 10.1080/09540120410001683457; Campbell C, 2001, AM J PUBLIC HEALTH, V91, P1978, DOI 10.2105/AJPH.91.12.1978; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Chakravarthy JBR, 2012, J EPIDEMIOL COMMUN H, V66, pII78, DOI 10.1136/jech-2011-200487; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Cornish F, 2007, SOC SCI MED, V64, P496, DOI 10.1016/j.socscimed.2006.09.009; Cornish F, 2009, AM J COMMUN PSYCHOL, V44, P123, DOI 10.1007/s10464-009-9254-8; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Evans C, 2008, IMPLEMENTING COMMUNI; Ford K, 2002, SEX TRANSM DIS, V29, P50, DOI 10.1097/00007435-200201000-00009; Foundation BMG, 2008, AVAHAN INDIA AIDS IN; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Galavotti C, 2012, J EPIDEMIOL COMMUNIT, V66, pii9, DOI [10.1136/jech-2011-200465, DOI 10.1136/JECH-2011-200465.PUBMED:22760219]; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Guha M, 2012, J EPIDEMIOL COMMUN H, V66, pII55, DOI 10.1136/jech-2011-200562; Gunn RA, 1998, JAMA-J AM MED ASSOC, V279, P680, DOI 10.1001/jama.279.9.680; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Juneja S, 2013, AIDS BEHAV, V17, P1040, DOI 10.1007/s10461-012-0314-y; Kane S, 2010, INT J TUBERC LUNG D, V14, P1066; Lechner M, 2002, J R STAT SOC A STAT, V165, P59, DOI 10.1111/1467-985X.0asp2; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Mayaud P, 2001, BRIT MED BULL, V58, P129, DOI 10.1093/bmb/58.1.129; Narayanan P, 2012, J EPIDEMIOL COMMUN H, V66, pII34, DOI 10.1136/jech-2012-201065; Oakes JM, 2006, METHODS SOCIAL EPIDE, V1st; Parimi P, 2012, J EPIDEMIOL COMMUNIT, V66, pii62, DOI [10.1136/jech-2011-200832., DOI 10.1136/JECH-2011-200832.PUBMED:22493478]; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2002, AM J PUBLIC HEALTH, V92, P343, DOI 10.2105/AJPH.92.3.343; Pinto RM, 2008, WOMEN HEALTH, V47, P83, DOI 10.1300/J013v47n01_05; Punyam S, 2012, J EPIDEMIOL COMMUN H, V66, pII87, DOI 10.1136/jech-2011-200478; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Reddy DCS, 2006, PROJECTIONS HIV EPID; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Saidel T, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000343761.77702.04; Sarkar S, 2010, SEX TRANSM INFECT, V86, pI2, DOI 10.1136/sti.2009.039289; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; StataCorp, 2019, STATA STAT SOFTWARE; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483	62	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78361	10.1371/journal.pone.0078361	http://dx.doi.org/10.1371/journal.pone.0078361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205210	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300053
J	Becknell, B; Spencer, JD; Carpenter, AR; Chen, X; Singh, A; Ploeger, S; Kline, J; Ellsworth, P; Li, BR; Proksch, E; Schwaderer, AL; Hains, DS; Justice, SS; McHugh, KM				Becknell, Brian; Spencer, John David; Carpenter, Ashley R.; Chen, Xi; Singh, Aspinder; Ploeger, Suzanne; Kline, Jennifer; Ellsworth, Patrick; Li, Birong; Proksch, Ehrhardt; Schwaderer, Andrew L.; Hains, David S.; Justice, Sheryl S.; McHugh, Kirk M.			Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HUMAN BETA-DEFENSIN-1; DENDRITIC CELLS; RIBONUCLEASE 7; MURINE MODEL; IN-VITRO; PEPTIDE; BLADDER; INFECTION; MICE	Beta defensins (BDs) are cationic peptides with antimicrobial activity that defend epithelial surfaces including the skin, gastrointestinal, and respiratory tracts. However, BD expression and function in the urinary tract are incompletely characterized. The purpose of this study was to describe Beta Defensin-1 (BD-1) expression in the lower urinary tract, regulation by cystitis, and antimicrobial activity toward uropathogenic Escherichia coli (UPEC) in vivo. Human DEFB1 and orthologous mouse Defb1 mRNA are detectable in bladder and ureter homogenates, and human BD-1 protein localizes to the urothelium. To determine the relevance of BD-1 to lower urinary tract defense in vivo, we evaluated clearance of UPEC by Defb1 knockout (Defb1(-/-)) mice. At 6, 18, and 48 hours following transurethral UPEC inoculation, no significant differences were observed in bacterial burden in bladders or kidneys of Defb1(-/-) and wild type C57BL/6 mice. In wild type mice, bladder Defb1 mRNA levels decreased as early as two hours post-infection and reached a nadir by six hours. RT-PCR profiling of BDs identified expression of Defb3 and Defb14 mRNA in murine bladder and ureter, which encode for mBD-3 and mBD-14 protein, respectively. MBD-14 protein expression was observed in bladder urothelium following UPEC infection, and both mBD-3 and mBD-14 displayed dose-dependent bactericidal activity toward UPEC in vitro. Thus, whereas mBD-1 deficiency does not alter bladder UPEC burden in vivo, we have identified mBD-3 and mBD-14 as potential mediators of mucosal immunity in the lower urinary tract.	[Becknell, Brian; Spencer, John David; Schwaderer, Andrew L.; Hains, David S.] Nationwide Childrens Hosp, Nephrol Sect, Columbus, OH USA; [Becknell, Brian; Spencer, John David; Chen, Xi; Kline, Jennifer; Schwaderer, Andrew L.; Hains, David S.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Carpenter, Ashley R.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Carpenter, Ashley R.; McHugh, Kirk M.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Singh, Aspinder; Ploeger, Suzanne] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Ellsworth, Patrick] Univ Rochester, Dept Internal Med & Pediat, Rochester, NY USA; [Li, Birong; Justice, Sheryl S.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Proksch, Ehrhardt] Univ Kiel, Dept Dermatol, Kiel, Germany	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Rochester; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Kiel	Justice, SS (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA.	Sheryl.Justice@nationwidechildrens.org; Kirk.McHugh@nationwidechildrens.org	Schwaderer, Andrew/E-4049-2011; Becknell, Michael/E-6995-2014; Hains, David/AAR-1112-2020; Justice, Sheryl/E-3329-2011	Justice, Sheryl/0000-0002-7059-3759; Hains, David/0000-0001-6511-9561; Jackson, Ashley R./0000-0002-1571-3906	NIDDK [NIH R01 DK085242]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085242, K08DK094970] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by the NIDDK (NIH R01 DK085242). There are no commercial or other sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Barabas N, 2013, IMMUNOBIOLOGY, V218, P1005, DOI 10.1016/j.imbio.2012.11.007; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Bolton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033897; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; *HCUP NIS, 2010, HE HEALTHC COST UT P; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Huttner KM, 1997, FEBS LETT, V413, P45, DOI 10.1016/S0014-5793(97)00875-2; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jiang Yan, 2012, Antiviral Chemistry & Chemotherapy, V22, P255, DOI 10.3851/IMP2077; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nitschke M, 2002, EXP NEPHROL, V10, P332, DOI 10.1159/000065296; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2012, PEDIATR NEPHROL, V27, P2017, DOI 10.1007/s00467-011-2089-1; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; SPENCER JD, 2013, PEDIATR NEPHROL, P32397; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Spencer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031712; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Storm DW, 2012, J UROLOGY, V188, P236, DOI 10.1016/j.juro.2012.03.025; THAI KH, 2010, JOVE-J VIS EXP, P29806; Townes CL, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.019; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Zaalouk TK, 2004, INFECT IMMUN, V72, P2772, DOI 10.1128/IAI.72.5.2772-2779.2004; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zasloff M, 2013, KIDNEY INT, V83, P548, DOI 10.1038/ki.2012.467; Zucht H D, 1998, Eur J Med Res, V3, P315	53	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77714	10.1371/journal.pone.0077714	http://dx.doi.org/10.1371/journal.pone.0077714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204930	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600043
J	Di Guardo, M; Tadiello, A; Farneti, B; Lorenz, G; Masuero, D; Vrhovsek, U; Costa, G; Velasco, R; Costa, F				Di Guardo, Mario; Tadiello, Alice; Farneti, Brian; Lorenz, Giorgia; Masuero, Domenico; Vrhovsek, Urska; Costa, Guglielmo; Velasco, Riccardo; Costa, Fabrizio			A Multidisciplinary Approach Providing New Insight into Fruit Flesh Browning Physiology in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; TOMATO POLYPHENOL OXIDASE; ASCORBIC-ACID; LINKAGE DISEQUILIBRIUM; PHENOLIC COMPOSITION; GENE; QTL; IDENTIFICATION; ORGANIZATION; BIOCHEMISTRY	In terms of the quality of minimally processed fruit, flesh browning is fundamentally important in the development of an aesthetically unpleasant appearance, with consequent off-flavours. The development of browning depends on the enzymatic action of the polyphenol oxidase (PPO). In the 'Golden Delicious' apple genome ten PPO genes were initially identified and located on three main chromosomes (2, 5 and 10). Of these genes, one element in particular, here called Md-PPO, located on chromosome 10, was further investigated and genetically mapped in two apple progenies ('Fuji x Pink Lady' and 'Golden Delicious x Braeburn'). Both linkage maps, made up of 481 and 608 markers respectively, were then employed to find QTL regions associated with fruit flesh browning, allowing the detection of 25 QTLs related to several browning parameters. These were distributed over six linkage groups with LOD values spanning from 3.08 to 4.99 and showed a rate of phenotypic variance from 26.1 to 38.6%. Anchoring of these intervals to the apple genome led to the identification of several genes involved in polyphenol synthesis and cell wall metabolism. Finally, the expression profile of two specific candidate genes, up and downstream of the polyphenolic pathway, namely phenylalanine ammonia lyase (PAL) and polyphenol oxidase (PPO), provided insight into flesh browning physiology. Md-PPO was further analyzed and two haplotypes were characterised and associated with fruit flesh browning in apple.	[Di Guardo, Mario; Tadiello, Alice; Lorenz, Giorgia; Masuero, Domenico; Vrhovsek, Urska; Velasco, Riccardo; Costa, Fabrizio] Fdn Edmund, Genom & Crop Biol Dept, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Farneti, Brian; Costa, Guglielmo] Univ Bologna, Dept Fruit Trees & Woody Plant Sci, Bologna, Italy	Fondazione Edmund Mach; University of Bologna	Costa, F (corresponding author), Fdn Edmund, Genom & Crop Biol Dept, Res & Innovat Ctr, San Michele All Adige, Trento, Italy.	fabrizio.costa@fmach.it	Di Guardo, Mario/AAA-7498-2021	Farneti, Brian/0000-0001-7624-0084; Di Guardo, Mario/0000-0003-3339-2007; Velasco, Riccardo/0000-0002-8760-5031; Costa, Guglielmo/0000-0002-5036-3163; Costa, Fabrizio/0000-0003-1416-1078; Masuero, Domenico/0000-0003-0696-3206	Agroalimentare e Ricerca project (AGER) [2010-2119]	Agroalimentare e Ricerca project (AGER)	This work was supported by the Agroalimentare e Ricerca project (AGER grant no. 2010-2119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIOT MJ, 1992, J FOOD SCI, V57, P958, DOI 10.1111/j.1365-2621.1992.tb14333.x; Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; BOSS PK, 1995, PLANT MOL BIOL, V27, P429, DOI 10.1007/BF00020197; Buta JG, 1999, J AGR FOOD CHEM, V47, P1, DOI 10.1021/jf980712x; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Choi YJ, 2005, POSTHARVEST BIOL TEC, V37, P47, DOI 10.1016/j.postharvbio.2005.03.002; Chow YN, 2011, FOOD CHEM, V129, P761, DOI 10.1016/j.foodchem.2011.05.017; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; COSETENG MY, 1987, J FOOD SCI, V52, P985, DOI 10.1111/j.1365-2621.1987.tb14257.x; Costa F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-229; Costa F, 2010, J EXP BOT, V61, P3029, DOI 10.1093/jxb/erq130; Cova V, 2012, MOL BREEDING, V29, P699, DOI 10.1007/s11032-011-9584-8; Davey MW, 2006, PLANT PHYSIOL, V142, P343, DOI 10.1104/pp.106.083279; Demeke T, 2002, THEOR APPL GENET, V104, P813, DOI 10.1007/s00122-001-0847-3; Dunemann F, 2012, MOL BREEDING, V29, P609, DOI 10.1007/s11032-011-9577-7; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Folta Kevin M., 2009, V6, P315, DOI 10.1007/978-0-387-77491-6_15; Franck C, 2003, J AGR FOOD CHEM, V51, P4757, DOI 10.1021/jf026229a; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Gorny JR, 2002, POSTHARVEST BIOL TEC, V24, P271, DOI 10.1016/S0925-5214(01)00139-9; Gunes G, 2001, POSTHARVEST BIOL TEC, V22, P197, DOI 10.1016/S0925-5214(01)00083-7; Gupta PK, 2001, CURR SCI INDIA, V80, P524; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liebhard R, 2003, THEOR APPL GENET, V106, P1497, DOI 10.1007/s00122-003-1209-0; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Longhi S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-37; Longhi S, 2012, J EXP BOT, V63, P1107, DOI 10.1093/jxb/err326; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Mellidou I, 2012, PLANT PHYSIOL, V160, P1613, DOI 10.1104/pp.112.203786; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murata M, 2001, BIOSCI BIOTECH BIOCH, V65, P383, DOI 10.1271/bbb.65.383; MURATA M, 1995, J AGR FOODS CHEM, V43; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; NEWMAN SM, 1993, PLANT MOL BIOL, V21, P1035, DOI 10.1007/BF00023601; NICOLAS JJ, 1994, CRIT REV FOOD SCI, V34, P109, DOI 10.1080/10408399409527653; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; OHLSSON T, 1994, TRENDS FOOD SCI TECH, V5, P341, DOI 10.1016/0924-2244(94)90210-0; Pannala AS, 2001, BIOCHEM BIOPH RES CO, V282, P1161, DOI 10.1006/bbrc.2001.4705; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Serpen A, 2007, FOOD CHEM, V104, P721, DOI 10.1016/j.foodchem.2006.11.073; SPANOS GA, 1990, J AGR FOOD CHEM, V38, P1572, DOI 10.1021/jf00097a031; Theodoridis G, 2012, METABOLOMICS, V8, P175, DOI 10.1007/s11306-011-0298-z; Thipyapong P, 1997, PLANT PHYSIOL, V115, P409, DOI 10.1104/pp.115.2.409; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Treutter D, 2001, PLANT GROWTH REGUL, V34, P71, DOI 10.1023/A:1013378702940; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Ooijen J. W, 2009, MAPQTL 6 SOFTW MAPP; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vrhovsek U, 2012, J AGR FOOD CHEM, V60, P8831, DOI 10.1021/jf2051569; WILSON LM, 2004, PLANT CELL, DOI DOI 10.1105/TPC.P.104.025700; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2	68	44	45	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78004	10.1371/journal.pone.0078004	http://dx.doi.org/10.1371/journal.pone.0078004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205065	Green Published, gold			2022-12-25	WOS:000326029300132
J	Andersen, MN; Krzystanek, K; Petersen, F; Bomholtz, SH; Olesen, SP; Abriel, H; Jespersen, T; Rasmussen, HB				Andersen, Martin Nybo; Krzystanek, Katarzyna; Petersen, Frederic; Bomholtz, Sofia Hammami; Olesen, Soren-Peter; Abriel, Hugues; Jespersen, Thomas; Rasmussen, Hanne Borger			A Phosphoinositide 3-Kinase (PI3K)-serum- and glucocorticoid-inducible Kinase 1 (SGK1) Pathway Promotes Kv7.1 Channel Surface Expression by Inhibiting Nedd4-2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Endocytosis; Ion Channels; PI 3-Kinase (PI3K); Trafficking; KCNQ1	EPITHELIAL NA+ CHANNEL; POTASSIUM CHANNEL; CELL-SURFACE; K+ SECRETION; SERUM; KCNQ1; GENE; AKT; PHOSPHORYLATION; TRAFFICKING	Epithelial cell polarization involves several kinase signaling cascades that eventually divide the surface membrane into an apical and a basolateral part. One kinase, which is activated during the polarization process, is phosphoinositide 3-kinase (PI3K). In MDCK cells, the basolateral potassium channel Kv7.1 requires PI3K activity for surface-expression during the polarization process. Here, we demonstrate that Kv7.1 surface expression requires tonic PI3K activity as PI3K inhibition triggers endocytosis of these channels in polarized MDCK. Pharmacological inhibition of SGK1 gave similar results as PI3K inhibition, whereas overexpression of constitutively active SGK1 overruled it, suggesting that SGK1 is the primary downstream target of PI3K in this process. Furthermore, knockdown of the ubiquitin ligase Nedd4-2 overruled PI3K inhibition, whereas a Nedd4-2 interaction-deficient Kv7.1 mutant was resistant to both PI3K and SGK1 inhibition. Altogether, these data suggest that a PI3K-SGK1 pathway stabilizes Kv7.1 surface expression by inhibiting Nedd4-2-dependent endocytosis and thereby demonstrates that Nedd4-2 is a key regulator of Kv7.1 localization and turnover in epithelial cells.	[Andersen, Martin Nybo; Krzystanek, Katarzyna; Petersen, Frederic; Bomholtz, Sofia Hammami; Olesen, Soren-Peter; Jespersen, Thomas; Rasmussen, Hanne Borger] Univ Copenhagen, Dept Biomed Sci, Ctr Cardiac Arrhythmia, Danish Natl Res Fdn, DK-2200 Copenhagen N, Denmark; [Krzystanek, Katarzyna; Abriel, Hugues] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	Danmarks Grundforskningsfond; University of Copenhagen; University of Bern	Rasmussen, HB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Panum Inst, Dept Biomed Sci, 12-5-32,Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	hannebr@sund.ku.dk	Rasmussen, Hanne B/N-9652-2016; Abriel, Hugues/B-9800-2009; Olesen, Soren-Peter/H-4206-2011	Rasmussen, Hanne B/0000-0002-2218-5646; Abriel, Hugues/0000-0003-0465-5138; Andersen, Martin Nybo/0000-0003-1125-1553; Jespersen, Thomas/0000-0001-6575-360X; Krzystanek, Katarzyna/0000-0001-8525-9705; Olesen, Soren-Peter/0000-0002-4381-5192; Bomholtz, Sofia Hammami/0000-0001-7221-4532	Danish National Research Foundation; Velux Foundation; Danish Council for Independent Research-Medical Sciences; Desiree and Niels Yde Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Aase og Ejnar Danielsens Fond; Danish Cardiovascular Research Academy; Swiss National Science Foundation [310030B_135693]	Danish National Research Foundation(Danmarks Grundforskningsfond); Velux Foundation(Velux Fonden); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Desiree and Niels Yde Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Aase og Ejnar Danielsens Fond; Danish Cardiovascular Research Academy; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Danish National Research Foundation, The Velux Foundation, The Danish Council for Independent Research-Medical Sciences (to S.-P. O.), the Desiree and Niels Yde Foundation (to T. J.), The Novo Nordisk Foundation (to S.-P. O. and T. J.), the Lundbeck Foundation (to T. J.), the Aase og Ejnar Danielsens Fond (to H. B. R. and T. J.), the Danish Cardiovascular Research Academy (to K. K.), as well as the Swiss National Science Foundation (Grant 310030B_135693; to H. A.).	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Andersen Martin N, 2012, Commun Integr Biol, V5, P480, DOI 10.4161/cib.21200; Andersen MN, 2012, TRAFFIC, V13, P143, DOI 10.1111/j.1600-0854.2011.01295.x; Andersen MN, 2011, AM J PHYSIOL-CELL PH, V300, pC814, DOI 10.1152/ajpcell.00390.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Busjahn A, 2004, CELL PHYSIOL BIOCHEM, V14, P135, DOI 10.1159/000078105; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Dunn EF, 2009, J VIROL, V83, P11665, DOI 10.1128/JVI.01092-09; Embark HM, 2003, PFLUG ARCH EUR J PHY, V445, P601, DOI 10.1007/s00424-002-0982-y; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goldenberg I, 2008, CURR PROB CARDIOLOGY, V33, P629, DOI 10.1016/j.cpcardiol.2008.07.002; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jeanes A, 2009, J MOL HISTOL, V40, P395, DOI 10.1007/s10735-010-9253-y; Jespersen T, 2004, J CELL SCI, V117, P4517, DOI 10.1242/jcs.01318; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Krzystanek K, 2012, HEART RHYTHM, V9, P440, DOI 10.1016/j.hrthm.2011.10.026; Kuwahara K, 2000, J MOL CELL CARDIOL, V32, P1385, DOI 10.1006/jmcc.2000.1177; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Li YW, 2001, MOL CELL NEUROSCI, V17, P761, DOI 10.1006/mcne.2000.0967; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Rotte A, 2009, CELL PHYSIOL BIOCHEM, V23, P133, DOI 10.1159/000204102; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sandu C, 2007, PFLUG ARCH EUR J PHY, V455, P493, DOI 10.1007/s00424-007-0305-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Strutz-Seebohm N, 2009, CHANNELS, V3, P88, DOI 10.4161/chan.3.2.8086; Sunose H, 1997, HEARING RES, V114, P107, DOI 10.1016/S0378-5955(97)00152-4; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083	56	21	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36841	36854		10.1074/jbc.M113.525931	http://dx.doi.org/10.1074/jbc.M113.525931			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214981	Green Published, hybrid			2022-12-25	WOS:000329189700007
J	Quintero, OA; Unrath, WC; Stevens, SM; Manor, U; Kachar, B; Yengo, CM				Quintero, Omar A.; Unrath, William C.; Stevens, Stanley M., Jr.; Manor, Uri; Kachar, Bechara; Yengo, Christopher M.			Myosin 3A Kinase Activity Is Regulated by Phosphorylation of the Kinase Domain Activation Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Hearing; Molecular Motors; Myosin; Phosphorylation	STATISTICAL-MODEL; MST1 KINASE; PROTEIN; ACTIN; MECHANISM; AUTOPHOSPHORYLATION; LOCALIZATION; BINDING; STEREOCILIA; INHIBITION	Class III myosins are unique members of the myosin superfamily in that they contain both a motor and kinase domain. We have found that motor activity is decreased by autophosphorylation, although little is known about the regulation of the kinase domain. We demonstrate by mass spectrometry that Thr-178 and Thr-184 in the kinase domain activation loop and two threonines in the loop 2 region of the motor domain are autophosphorylated (Thr-908 and Thr-919). The kinase activity of MYO3A 2IQ with the phosphomimic (T184E) or phosphoblock (T184A) mutations demonstrates that kinase activity is reduced 30-fold as a result of the T184A mutation, although the Thr-178 site only had a minor impact on kinase activity. Interestingly, the actin-activated ATPase activity of MYO3A 2IQ is slightly reduced as a result of the T178A and T184A mutations suggesting coupling between motor and kinase domains. Full-length GFP-tagged T184A and T184E MYO3A constructs transfected into COS7 cells do not disrupt the ability of MYO3A to localize to filopodia structures. In addition, we demonstrate that T184E MYO3A reduces filopodia elongation in the presence of espin-1, whereas T184A enhances filopodia elongation in a similar fashion to kinase-dead MYO3A. Our results suggest that as MYO3A accumulates at the tips of actin protrusions, autophosphorylation of Thr-184 enhances kinase activity resulting in phosphorylation of the MYO3A motor and reducing motor activity. The differential regulation of the kinase and motor activities allows for MYO3A to precisely self-regulate its concentration in the actin bundle-based structures of cells.	[Quintero, Omar A.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Manor, Uri; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20894 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu		Quintero-Carmona, Omar/0000-0002-9314-1704; Stevens, Stanley/0000-0002-1399-0256; Manor, Uri/0000-0002-9802-1955	National Institutes of Health [EY0181416, K01CA160667]; Penn State College of Medicine; NATIONAL CANCER INSTITUTE [K01CA160667] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY0181416 (to C. M. Y.) and K01CA160667 (to O. A. Q.). This work was also supported by start-up funds from Penn State College of Medicine.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Dalal JS, 2011, J NEUROCHEM, V119, P772, DOI 10.1111/j.1471-4159.2011.07468.x; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Odronitz F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-173; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sasaki N, 2002, J MUSCLE RES CELL M, V23, P697, DOI 10.1023/A:1024415409406; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Unschuld PG, 2009, AM J MED GENET B, V150B, P1100, DOI 10.1002/ajmg.b.30938; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; Wang J, 2011, STRUCTURE, V19, P1752, DOI 10.1016/j.str.2011.10.013; Wang J, 2011, J BIOL CHEM, V286, P2689, DOI 10.1074/jbc.M110.156505; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhu GZ, 2005, J BIOL CHEM, V280, P36372, DOI 10.1074/jbc.M505031200	54	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37126	37137		10.1074/jbc.M113.511014	http://dx.doi.org/10.1074/jbc.M113.511014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214986	hybrid, Green Published			2022-12-25	WOS:000329189700032
J	Toda, Y; Nakagita, T; Hayakawa, T; Okada, S; Narukawa, M; Imai, H; Ishimaru, Y; Misaka, T				Toda, Yasuka; Nakagita, Tomoya; Hayakawa, Takashi; Okada, Shinji; Narukawa, Masataka; Imai, Hiroo; Ishimaru, Yoshiro; Misaka, Takumi			Two Distinct Determinants of Ligand Specificity in T1R1/T1R3 (the Umami Taste Receptor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; G Protein-coupled Receptors (GPCR); Glutamate Receptors Metabotropic; Mutagenesis in Vitro; Receptor Structure-Function; Taste Receptor; Umami	METABOTROPIC GLUTAMATE-RECEPTOR; SWEET TASTE; MOLECULAR-MECHANISM; MONOSODIUM GLUTAMATE; PROTEIN; EXPRESSION; RESPONSES; BINDING; CLONING; VARIANT	Umami taste perception in mammals is mediated by a heteromeric complex of two G-protein-coupled receptors, T1R1 and T1R3. T1R1/T1R3 exhibits species-dependent differences in ligand specificity; human T1R1/T1R3 specifically responds to l-Glu, whereas mouse T1R1/T1R3 responds more strongly to other l-amino acids than to l-Glu. The mechanism underlying this species difference remains unknown. In this study we analyzed chimeric human-mouse receptors and point mutants of T1R1/T1R3 and identified 12 key residues that modulate amino acid recognition in the human- and mouse-type responses in the extracellular Venus flytrap domain of T1R1. Molecular modeling revealed that the residues critical for human-type acidic amino acid recognition were located at the orthosteric ligand binding site. In contrast, all of the key residues for the mouse-type broad response were located at regions outside of both the orthosteric ligand binding site and the allosteric binding site for inosine-5-monophosphate (IMP), a known natural umami taste enhancer. Site-directed mutagenesis demonstrated that the newly identified key residues for the mouse-type responses modulated receptor activity in a manner distinct from that of the allosteric modulation via IMP. Analyses of multiple point mutants suggested that the combination of two distinct determinants, amino acid selectivity at the orthosteric site and receptor activity modulation at the non-orthosteric sites, may mediate the ligand specificity of T1R1/T1R3. This hypothesis was supported by the results of studies using nonhuman primate T1R1 receptors. A complex molecular mechanism involving changes in the properties of both the orthosteric and non-orthosteric sites of T1R1 underlies the determination of ligand specificity in mammalian T1R1/T1R3.	[Toda, Yasuka; Nakagita, Tomoya; Okada, Shinji; Narukawa, Masataka; Ishimaru, Yoshiro; Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Hayakawa, Takashi; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo 1020083, Japan	University of Tokyo; Kyoto University; Japan Society for the Promotion of Science	Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020; OKADA, Shinji/AFS-7710-2022; Hayakawa, Takashi/U-9518-2018	OKADA, Shinji/0000-0002-4465-9961; Hayakawa, Takashi/0000-0002-1037-0350; Misaka, Takumi/0000-0002-9547-5767; Toda, Yasuka/0000-0001-5912-6730; Imai, Hiroo/0000-0003-0729-0322	Cooperation Research Program of the Primate Research Institute of Kyoto University; Japan Society for the Promotion of Science [LS037]; Korea Food Research Institute [E0111501]	Cooperation Research Program of the Primate Research Institute of Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Korea Food Research Institute	The work was supported in part by the Cooperation Research Program of the Primate Research Institute of Kyoto University, by the Funding Program for Next Generation World-Leading Researchers of the Japan Society for the Promotion of Science (LS037 (to T. M.)), and by Korea Food Research Institute Grant E0111501 (to T. M.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Ikeda K, 2002, CHEM SENSES, V27, P847, DOI 10.1093/chemse/27.9.847; Inouye S, 2008, J BIOCHEM, V143, P711, DOI 10.1093/jb/mvn024; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kawai M, 2012, AMINO ACIDS, V43, P2349, DOI 10.1007/s00726-012-1315-x; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Koizumi A, 2011, P NATL ACAD SCI USA, V108, P16819, DOI 10.1073/pnas.1016644108; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; Laska M, 2004, J EXP ZOOL PART A, V301A, P898, DOI 10.1002/jez.a.118; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Cascales JJL, 2010, BIOPHYS CHEM, V152, P139, DOI 10.1016/j.bpc.2010.09.001; Madsen U, 2005, PHARM DEV, P797, DOI 10.1002/0471728780.ch18; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Roura E, 2011, FLAVOUR FRAG J, V26, P282, DOI 10.1002/ffj.2057; San Gabriel A, 2005, CHEM SENSES, V30, pI25, DOI 10.1093/chemse/bjh095; Toda Y, 2011, J AGR FOOD CHEM, V59, P12131, DOI 10.1021/jf2029835; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Toyono T, 2002, ARCH HISTOL CYTOL, V65, P91, DOI 10.1679/aohc.65.91; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; YAMAGUCHI S, 1971, J FOOD SCI, V36, P846, DOI 10.1111/j.1365-2621.1971.tb15541.x; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	37	65	69	10	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36863	36877		10.1074/jbc.M113.494443	http://dx.doi.org/10.1074/jbc.M113.494443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214976	Green Published, hybrid			2022-12-25	WOS:000329189700010
J	Tan, XS; Ma, JY; Feng, R; Ma, C; Chen, WJ; Sun, YP; Fu, J; Huang, M; He, CY; Shou, JW; He, WY; Wang, Y; Jiang, JD				Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong			Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; ION-TRAP-TIME; IN-VITRO; PROTEIN-KINASE; PLASMA; PHARMACOKINETICS; IDENTIFICATION; TRANSCRIPTION; TRANSPORT; URINE	Berberine (BBR) has been confirmed to have multiple bioactivities in clinic, such as cholesterol-lowering, anti-diabetes, cardiovascular protection and anti-inflammation. However, BBR's plasma level is very low; it cannot explain its pharmacological effects in patients. We consider that the in vivo distribution of BBR as well as of its bioactive metabolites might provide part of the explanation for this question. In this study, liquid chromatography coupled to ion trap time-of-flight mass spectrometry (LC/MSn-IT-TOF) as well as liquid chromatography that coupled with tandem mass spectrometry (LC-MS/MS) was used for the study of tissue distribution and pharmacokinetics of BBR in rats after oral administration (200 mg/kg). The results indicated that BBR was quickly distributed in the liver, kidneys, muscle, lungs, brain, heart, pancreas and fat in a descending order of its amount. The pharmacokinetic profile indicated that BBR's level in most of studied tissues was higher (or much higher) than that in plasma 4 h after administration. BBR remained relatively stable in the tissues like liver, heart, brain, muscle, pancreas etc. Organ distribution of BBR's metabolites was also investigated paralleled with that of BBR. Thalifendine (M1), berberrubine (M2) and jatrorrhizine (M4), which the metabolites with moderate bioactivity, were easily detected in organs like the liver and kidney. For instance, M1, M2 and M4 were the major metabolites in the liver, among which the percentage of M2 was up to 65.1%; the level of AUC((0-t)) (area under the concentration-time curve) for BBR or the metabolites in the liver was 10-fold or 30-fold higher than that in plasma, respectively. In summary, the organ concentration of BBR (as well as its bioactive metabolites) was higher than its concentration in the blood after oral administration. It might explain BBR's pharmacological effects on human diseases in clinic.	[Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, Y (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	wangyan@imm.ac.cn; jiang.jdong@163.com	Shou, JW/ABA-8850-2020		National Science and Technology Special Projects [2012ZX09301-002-001, 2012ZX09301-002006]; National Natural Science Foundation of China [30873115, 81072611]	National Science and Technology Special Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Science and Technology Special Projects (2012ZX09301-002-001, 2012ZX09301-002006), and the financial support from the National Natural Science Foundation of China (No. 30873115and 81072611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Bahar M, 2011, BIOORG MED CHEM LETT, V21, P2606, DOI 10.1016/j.bmcl.2011.01.101; Chae HW, 2008, ARCH PHARM RES, V31, P103, DOI 10.1007/s12272-008-1127-4; CHEN CM, 1995, J CHROMATOGR B, V665, P117, DOI 10.1016/0378-4347(94)00517-9; CHEN Q-M, 1986, Yaoxue Xuebao, V21, P401; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Chu Y, 2013, J CHROMATOGR B, V919, P75, DOI 10.1016/j.jchromb.2012.12.022; Dong SF, 2011, EUR J PHARMACOL, V660, P368, DOI 10.1016/j.ejphar.2011.03.024; Feng LA, 2010, ARCH PHARM RES, V33, P1975, DOI 10.1007/s12272-010-1213-2; Feng R, 2012, J PHARMACEUT BIOMED, V62, P228, DOI 10.1016/j.jpba.2012.01.014; Fu J, 2012, J PHARMACEUT BIOMED, V71, P162, DOI 10.1016/j.jpba.2012.07.028; Gao L, 2011, MOLECULES, V16, P9218, DOI 10.3390/molecules16119218; Hong Y, 2003, LIFE SCI, V72, P2499, DOI 10.1016/S0024-3205(03)00144-9; Hua WY, 2007, J PHARMACEUT BIOMED, V44, P931, DOI 10.1016/j.jpba.2007.03.022; HUANG WM, 1992, CHINESE MED J-PEKING, V105, P1014; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lan TA, 2010, ARCH BIOCHEM BIOPHYS, V502, P112, DOI 10.1016/j.abb.2010.07.012; Lee JH, 2003, J ETHNOPHARMACOL, V84, P5, DOI 10.1016/S0378-8741(02)00222-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li X, 1999, CHIN PHARM J, V34, P107; Li Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-62; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu T, 2006, J PHARMACEUT BIOMED, V40, P1218, DOI 10.1016/j.jpba.2005.09.023; Ma BL, 2011, J ETHNOPHARMACOL, V137, P1395, DOI 10.1016/j.jep.2011.08.002; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; MIYAZAKI H, 1978, J CHROMATOGR, V152, P79, DOI 10.1016/S0021-9673(00)85336-4; Shitan N, 2007, BIOSCI BIOTECH BIOCH, V71, P242, DOI 10.1271/bbb.60441; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tan G, 2009, RAPID COMMUNICATIONS, V24, P209; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; WANG YX, 1994, J CARDIOVASC PHARM, V23, P716, DOI 10.1097/00005344-199405000-00005; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Zhang DF, 2010, AQUAC RES, V41, P1095, DOI 10.1111/j.1365-2109.2009.02399.x; Zhang H, 2010, MOL CELL ENDOCRINOL, V330, P25, DOI 10.1016/j.mce.2010.07.022; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhao J, 2012, J PHARMACEUT BIOMED, V64-65, P94, DOI 10.1016/j.jpba.2012.02.017; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78; Zhu ZY, 2007, RAPID COMMUN MASS SP, V21, P1855, DOI 10.1002/rcm.3023	41	136	150	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77969	10.1371/journal.pone.0077969	http://dx.doi.org/10.1371/journal.pone.0077969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205048	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800011
J	Li, QH; Xu, J; Li, HQ; Wang, SX; Yan, X; Xin, ZM; Jiang, ZP; Wang, LL; Jia, ZQ				Li, Qinghe; Xu, Jun; Li, Huiqing; Wang, Saixiao; Yan, Xiu; Xin, Zhiming; Jiang, Zeping; Wang, Linlong; Jia, Zhiqing			Effects of Aspect on Clonal Reproduction and Biomass Allocation of Layering Modules of Nitraria tangutorum in Nebkha Dunes	PLOS ONE			English	Article							SAND BURIAL; WIND EROSION; RESOURCE-ALLOCATION; PHYTOGENIC MOUNDS; LAND DEGRADATION; GROWTH DYNAMICS; ORDOS PLATEAU; SHOOT GROWTH; BUD BANKS; PLANT	The formation of many nebkha dunes relies on the layering of clonal plants. The microenvironmental conditions of such phytogenic nebkha are heterogeneous depending on the aspect and slope. Exploring the effects of aspect on clonal reproduction and biomass allocation can be useful in understanding the ecological adaptation of species. We hypothesized that on the windward side layering propagation would be promoted, that biomass allocation to leaves and stems of ramets would increase, and that the effects of aspect would be greater in the layering with larger biomass. To test these hypotheses, we surveyed the depth of germination points of axillary buds, the rate of ramet sprouting, the density of adventitious root formation points, and the biomass of modules sprouting from layering located on the NE, SE, SW and NW, aspects of Nitraria tangutorum nebkhas. The windward side was located on the NW and SW aspects. The results indicated that conditions of the NW aspect were more conducive to clonal reproduction and had the highest rate of ramet sprouting and the highest density of adventitious formation points. For the modules sprouting from layering on the SW aspect, biomass allocation to leaves and stems was greatest with biomass allocation to adventitious roots being lowest. This result supported our hypothesis. Contrary to our hypothesis, the effects of aspect were greater in layering of smaller biomass. These results support the hypothesis that aspect does affect layering propagation capacity and biomass allocation in this species. Additionally, clonal reproduction and biomass allocation of modules sprouting from layering with smaller biomass was more affected by aspect. These results suggest that the clonal growth of N. tangutorum responses to the microenvironmental heterogeneity that results from aspect of the nebkha.	[Li, Qinghe; Li, Huiqing; Wang, Saixiao; Yan, Xiu; Jiang, Zeping; Wang, Linlong] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China; [Xu, Jun; Xin, Zhiming] Chinese Acad Forestry, Expt Ctr Desert Forestry, Dengkou, Inner Mongolia, Peoples R China; [Jia, Zhiqing] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Experimental Center of Desert Forestry, CAF; Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Jiang, ZP (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China.	jiangzp@caf.ac.cn; jiazq@caf.ac.cn		Li, Qinghe/0000-0001-8011-1322	Key Project of Research Institute of Forestry, Chinese Academy of Forestry [ZD200915]; National Promotion Program of Forestry Sci. & Tech Achievements [[2011]28]	Key Project of Research Institute of Forestry, Chinese Academy of Forestry; National Promotion Program of Forestry Sci. & Tech Achievements	This work was supported by the grants from the Key Project of Research Institute of Forestry, Chinese Academy of Forestry(ZD200915), the National Promotion Program of Forestry Sci. & Tech Achievements ([2011]28), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizaga S, 2002, AM J BOT, V89, P632, DOI 10.3732/ajb.89.4.632; Bach CE, 2000, AUST J BOT, V48, P159, DOI 10.1071/BT98030; Bauer BO, 2012, EARTH SURF PROC LAND, V37, P1661, DOI 10.1002/esp.3306; Bredmose N, 2001, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2001.547.21; BRISKE DD, 1980, J RANGE MANAGE, V33, P323, DOI 10.2307/3897875; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Dech JP, 2006, ANN BOT-LONDON, V98, P1095, DOI 10.1093/aob/mcl196; Deng ZM, 2013, AQUAT BOT, V104, P121, DOI 10.1016/j.aquabot.2012.08.004; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Dougill AJ, 2002, J ARID ENVIRON, V50, P413, DOI 10.1006/jare.2001.0909; Du JH, 2010, J GEOGR SCI, V20, P712, DOI 10.1007/s11442-010-0806-5; El-Bana MI, 2007, J VEG SCI, V18, P635, DOI 10.1111/j.1654-1103.2007.tb02577.x; El-Bana MI, 2003, RESTOR ECOL, V11, P317, DOI 10.1046/j.1526-100X.2003.00222.x; El-Bana MI, 2002, PLANT SOIL, V247, P283, DOI 10.1023/A:1021548711206; El-Sheikh MA, 2010, FLORA, V205, P832, DOI 10.1016/j.flora.2010.01.002; ELDRED RA, 1982, CAN J BOT, V60, P1371, DOI 10.1139/b82-174; Flores-Torres A, 2012, J ARID ENVIRON, V84, P63, DOI 10.1016/j.jaridenv.2012.04.006; Fratini G, 2009, EARTH SURF PROC LAND, V34, P1743, DOI 10.1002/esp.1857; Garwood EA, 1968, GRASS FORAGE SCI, V23, P117; HARA T, 1993, J ECOL, V81, P47, DOI 10.2307/2261223; Hara T, 1997, RES POPUL ECOL, V39, P83, DOI 10.1007/BF02765253; Hartmann H.T., 2010, PLANT PROPAGATION PR; Husen A, 2007, NEW FOREST, V34, P223, DOI 10.1007/s11056-007-9050-y; Klimesova J, 2003, OIKOS, V103, P225, DOI 10.1034/j.1600-0706.2003.12725.x; Klimesova J, 2008, PRESLIA, V80, P255; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; KRATZKE MG, 1992, AM POTATO J, V69, P561, DOI 10.1007/BF02852128; Liu LY, 2005, GEOMORPHOLOGY, V67, P283, DOI 10.1016/j.geomorph.2004.10.005; Liu YX, 1987, FLORA DESERTIS REIPU, V2; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 1996, ECOSCIENCE, V3, P93, DOI 10.1080/11956860.1996.11682320; MAUN MA, 1994, VEGETATIO, V111, P59; Moreira DR, 1998, PESQUI AGROPECU BRAS, V33, P721; MORENOCASASOLA P, 1986, VEGETATIO, V65, P67, DOI 10.1007/BF00044876; Nicholls AM, 2011, INT J PLANT SCI, V172, P1077, DOI 10.1086/662128; Nield JM, 2008, EARTH SURF PROC LAND, V33, P724, DOI 10.1002/esp.1571; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Paolillo DJ, 2002, AM J BOT, V89, P1361, DOI 10.3732/ajb.89.9.1361; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; SLADE AJ, 1987, NEW PHYTOL, V106, P759, DOI 10.1111/j.1469-8137.1987.tb00177.x; Stribling JM, 2006, MAR ECOL PROG SER, V320, P121, DOI 10.3354/meps320121; TENGBERG A, 1995, J ARID ENVIRON, V30, P265, DOI 10.1016/S0140-1963(05)80002-3; Thomas AD, 2001, SOIL EROSION RESEARCH FOR THE 21ST CENTURY, PROCEEDINGS, P490; Wang JC, 2011, J ARID LAND, V3, P34, DOI 10.3724/SP.J.1227.2011.00034; Wang X, 2006, J ARID ENVIRON, V65, P129, DOI 10.1016/j.jaridenv.2005.06.030; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; YU FH, 2001, EVOL ECOL, V15, P303; Zhang JH, 1996, ANN BOT-LONDON, V78, P591, DOI 10.1006/anbo.1996.0165; Zhang YF, 2013, J EARTH SYST SCI, V122, P831, DOI 10.1007/s12040-013-0308-9	53	11	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79927	10.1371/journal.pone.0079927	http://dx.doi.org/10.1371/journal.pone.0079927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205391	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700105
J	Aoshima, K; Baba, A; Makino, Y; Okada, Y				Aoshima, Keisuke; Baba, Ai; Makino, Yoshinori; Okada, Yuki			Establishment of Alternative Culture Method for Spermatogonial Stem Cells Using Knockout Serum Replacement	PLOS ONE			English	Article								Since spermatogonial stem cells (SSCs) are capable of both self-renewal and differentiation to daughter cells for subsequent spermatogenesis, the development of an efficient in vitro culture system is essential for studies related to spermatogenesis. Although the currently available system is serum-free and contains only chemically-defined components, it highly relies upon bovine serum albumin (BSA), a component with batch-to-batch quality variations similar to those of fetal bovine serum. Thus, we searched for an alternative BSA-free culture system that preserved the properties of SSCs. In this study, we utilized Knockout Serum Replacement (KSR) in the SSC culture medium, as a substitute for BSA. The results demonstrated that KSR supported the continuous growth of SSCs in vitro and the SSC activity in vivo without BSA, in a feeder-cell combination with mouse embryonic fibroblasts. The addition of BSA to KSR further facilitated cell cycle progression, whereas a transplantation assay revealed that the addition of BSA did not affect the number of SSCs in vivo. The combination of KSR with BSA also allowed the elimination of GFRA1 and FGF2, and the reduction of the GDNF concentration from 20 ng/ml to 5 ng/ml, while maintaining the growth rate and the expression of SSC markers. Furthermore, KSR was also useful with SSCs from non-DBA/2 strains, such as C57BL/6 and ICR. These results suggested that KSR is an effective substitute for BSA for long-term in vitro cultures of SSCs. Therefore, this method is practical for various studies related to SSCs, including spermatogenesis and germ stem cell biology.	[Aoshima, Keisuke; Makino, Yoshinori; Okada, Yuki] Univ Tokyo, Lab Pathol & Dev, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Aoshima, Keisuke; Baba, Ai; Makino, Yoshinori; Okada, Yuki] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto, Japan; [Aoshima, Keisuke] Hokkaido Univ, Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, Sapporo, Hokkaido, Japan; [Baba, Ai] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto, Japan; [Okada, Yuki] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	University of Tokyo; Kyoto University; Hokkaido University; Kyoto University; Japan Science & Technology Agency (JST)	Okada, Y (corresponding author), Univ Tokyo, Lab Pathol & Dev, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan.	ytokada@iam.u-tokyo.ac.jp		Aoshima, Keisuke/0000-0002-2987-0793	JST PRESTO program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [22125007]; MEXT; Naito Foundation; MEXT in Japan; Grants-in-Aid for Scientific Research [22125007, 13J01051] Funding Source: KAKEN	JST PRESTO program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the JST PRESTO program (Y.O.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (22125007 to Y.O.), the Special Coordination Fund for Promoting Science and Technology of MEXT (Y.O.), the Naito Foundation Subsidy for Female Researchers after Maternity Leave (Y.O.), and the Program to Disseminate Tenure Tracking System of MEXT in Japan (Y.O.). K. A. is a Research Fellow of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Hua JL, 2009, REPROD BIOMED ONLINE, V19, P238, DOI 10.1016/S1472-6483(10)60079-X; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2008, METHOD CELL BIOL, V86, P59, DOI 10.1016/S0091-679X(08)00004-6; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Rajala K, 2011, STEM CELL STUDIES, V1; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Wang Qing Zhong, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P162; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001	12	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77715	10.1371/journal.pone.0077715	http://dx.doi.org/10.1371/journal.pone.0077715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204931	gold, Green Submitted, Green Published			2022-12-25	WOS:000326241200037
J	Handke, LD; Hawkins, JC; Miller, AA; Jansen, KU; Anderson, AS				Handke, Luke D.; Hawkins, Julio C.; Miller, Alita A.; Jansen, Kathrin U.; Anderson, Annaliesa S.			Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative Stress	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; METAL SEQUESTRATION; RESISTANCE; VIRULENCE; GENE; BACTERIOPHAGE-L54A; ACQUISITION; MANGANESE; SEQUENCE; INTEGRATION	Staphylococcus aureus is a successful human pathogen that has developed several approaches to evade the immune system, including resistance strategies to prevent oxidative killing by immune cells. One mechanism by which this evasion occurs is by production of superoxide dismutase enzymes, which require manganese as a cofactor. Manganese is acquired by the manganese transporter MntABC. One component of this operon, MntC, has been proposed as a potential vaccine candidate due to its early in vivo expression and its ability to provide protection in preclinical models of staphylococcal infection. In the current study, we interrogate the role of this protein in protecting S. aureus from oxidative stress. We demonstrate that mutation of mntC in a number of invasive S. aureus clinical isolates results in increased sensitivity to oxidative stress. In addition, we show that while downregulation of mntC transcription is triggered upon exposure to physiological concentrations of manganese, MntC protein is still present on the bacterial surface at these same concentrations. Taken together, these results provide insight into the role of this antigen for the pathogen.	[Handke, Luke D.; Hawkins, Julio C.; Miller, Alita A.; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Vaccine Res, Pearl River, NY USA	Pfizer	Handke, LD (corresponding author), Pfizer Vaccine Res, Pearl River, NY USA.	luke.handke@pfizer.com			Pfizer Vaccine Research	Pfizer Vaccine Research	This work was supported by Pfizer Vaccine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Anderson AS, 2012, HUMAN VACCINES IMMUN, V8, P1; Ando M, 2003, INFECT IMMUN, V71, P2584, DOI 10.1128/IAI.71.5.2584-2590.2003; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; CARR RJG, 1986, APPL ENVIRON MICROB, V52, P1112, DOI 10.1128/AEM.52.5.1112-1116.1986; Cassat JE, 2012, SEMIN IMMUNOPATHOL, V34, P215, DOI 10.1007/s00281-011-0294-4; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Gallagher S, 2008, CURRENT PROTOCOLS MO, DOI DOI 10.18.11-10.18.28; Gribenko A, J MOL BIOL IN PRESS; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; Hammer ND, 2012, CURR OPIN MICROBIOL, V15, P10, DOI 10.1016/j.mib.2011.11.004; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Iordanescu S, 1976, Arch Roum Pathol Exp Microbiol, V35, P111; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; LEE CY, 1989, J BACTERIOL, V171, P1652, DOI 10.1128/jb.171.3.1652-1657.1989; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; McNamara Peter J., 2008, P89; NCCLS, 2012, M07A9 NCCLS; Niemeyer DM, 1996, J BACTERIOL, V178, P5464, DOI 10.1128/jb.178.18.5464-5471.1996; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Sambrook J, 2001, MOL CLONING LAB MANU; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001; Wichgers Schreur PJ, 2011, J BACTERIOL JB, P05305; YE ZH, 1990, J BACTERIOL, V172, P2568, DOI 10.1128/jb.172.5.2568-2575.1990; YE ZH, 1989, J BACTERIOL, V171, P4146, DOI 10.1128/JB.171.8.4146-4153.1989	42	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77874	10.1371/journal.pone.0077874	http://dx.doi.org/10.1371/journal.pone.0077874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205007	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200047
J	Anea, CB; Zhang, MX; Chen, F; Ali, MI; Hart, CMM; Stepp, DW; Kovalenkov, YO; Merloiu, AM; Pati, P; Fulton, D; Rudic, RD				Anea, Ciprian B.; Zhang, Maoxiang; Chen, Feng; Ali, M. Irfan; Hart, C. Michael M.; Stepp, David W.; Kovalenkov, Yevgeniy O.; Merloiu, Ana-Maria; Pati, Paramita; Fulton, David; Rudic, R. Daniel			Circadian Clock Control of Nox4 and Reactive Oxygen Species in the Vasculature	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NADPH OXIDASES; BLOOD-PRESSURE; DYSFUNCTION; SUPEROXIDE; METABOLISM; ACTIVATION	Recent studies have shown that circadian clock disruption is associated with pathological remodeling in the arterial structure and vascular stiffness. Moreover, chronic circadian disruption is associated with dysfunction in endothelial responses and signaling. Reactive oxygen species have emerged as key regulators in vascular pathology. Previously, we have demonstrated that circadian clock dysfunction exacerbates superoxide production through eNOS uncoupling. To date, the impact of circadian clock mutation on vascular NADPH oxidase expression and function is not known. The goal in the current study was to determine if the circadian clock controls vascular Nox4 expression and hydrogen peroxide formation in arteries, particularly in endothelial and vascular smooth muscle cells. In aorta, there was an increase in hydrogen peroxide and Nox4 expression in mice with a dysfunctional circadian rhythm (Bmal1-KO mice). In addition, the Nox4 gene promoter is activated by the core circadian transcription factors. Lastly, in synchronized cultured human endothelial cells, Nox4 gene expression exhibited rhythmic oscillations. These data reveal that the circadian clock plays an important role in the control of Nox4 and disruption of the clock leads to subsequent production of reaction oxygen species.	[Anea, Ciprian B.; Zhang, Maoxiang; Merloiu, Ana-Maria; Pati, Paramita; Rudic, R. Daniel] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30904 USA; [Chen, Feng; Ali, M. Irfan; Stepp, David W.; Kovalenkov, Yevgeniy O.; Fulton, David] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Stepp, David W.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Hart, C. Michael M.] Atlanta Vet Affairs, Dept Med, Atlanta, GA USA; [Hart, C. Michael M.] Emory Univ, Med Ctr, Atlanta, GA 30322 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University	Rudic, RD (corresponding author), Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30904 USA.	rrudic@gru.edu	Chen, Feng/E-1133-2011; Zhang, Maoxiang/G-1079-2015; Rudic, Dan/B-3432-2016	Zhang, Maoxiang/0000-0003-2790-0431; Rudic, Dan/0000-0001-9122-3127; Kovalenkov, Yevgeniy/0000-0003-2396-7962	National Institutes of Health [HL089576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL092446, R01HL089576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health (HL089576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750; Anea CB, 2010, ARTERIOSCL THROM VAS, V30, P2535, DOI 10.1161/ATVBAHA.110.214379; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Chatham JC, 2013, J MOL CELL CARDIOL, V55, P139, DOI 10.1016/j.yjmcc.2012.06.016; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Durgan DJ, 2010, CIRCULATION, V122; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Koinuma S, 2009, FEBS LETT, V583, P413, DOI 10.1016/j.febslet.2008.12.035; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Oishi K, 2009, J MOL CELL CARDIOL, V46, P545, DOI 10.1016/j.yjmcc.2009.01.001; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Rudic RD, 2009, CIRCULATION, V120, P1714, DOI 10.1161/CIRCULATIONAHA.109.853002; Rudic RD, 2005, METHOD ENZYMOL, V393, P524, DOI 10.1016/S0076-6879(05)93027-9; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Schroder EA, 2013, AM J PHYSIOL-CELL PH, V304, pC954, DOI 10.1152/ajpcell.00383.2012; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Su W, 2012, AM J PHYSIOL-HEART C, V302, pH621, DOI 10.1152/ajpheart.00825.2011; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	54	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78626	10.1371/journal.pone.0078626	http://dx.doi.org/10.1371/journal.pone.0078626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205282	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400091
J	Ma, XW; Kang, F; Xu, F; Feng, AL; Zhao, Y; Lu, TJ; Yang, WD; Wang, Z; Lin, M; Wang, J				Ma, Xiaowei; Kang, Fei; Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Yang, Weidong; Wang, Zhe; Lin, Min; Wang, Jing			Enhancement of Cerenkov Luminescence Imaging by Dual Excitation of Er3+, Yb3+-Doped Rare-Earth Microparticles	PLOS ONE			English	Article							UP-CONVERSION; NANOPARTICLES; NANOPHOSPHORS; CELLS; PET	Cerenkov luminescence imaging (CLI) has been successfully utilized in various fields of preclinical studies; however, CLI is challenging due to its weak luminescent intensity and insufficient penetration capability. Here, we report the design and synthesis of a type of rare-earth microparticles (REMPs), which can be dually excited by Cerenkov luminescence (CL) resulting from the decay of radionuclides to enhance CLI in terms of intensity and penetration. Methods: Yb3+- and Er3+- codoped hexagonal NaYF4 hollow microtubes were synthesized via a hydrothermal route. The phase, morphology, and emission spectrum were confirmed for these REMPs by power X-ray diffraction (XRD), scanning electron microscopy (SEM), and spectrophotometry, respectively. A commercial CCD camera equipped with a series of optical filters was employed to quantify the intensity and spectrum of CLI from radionuclides. The enhancement of penetration was investigated by imaging studies of nylon phantoms and nude mouse pseudotumor models. Results: the REMPs could be dually excited by CL at the wavelengths of 520 and 980 nm, and the emission peaks overlaid at 660 nm. This strategy approximately doubled the overall detectable intensity of CLI and extended its maximum penetration in nylon phantoms from 5 to 15 mm. The penetration study in living animals yielded similar results. Conclusions: this study demonstrated that CL can dually excite REMPs and that the overlaid emissions in the range of 660 nm could significantly enhance the penetration and intensity of CL. The proposed enhanced CLI strategy may have promising applications in the future.	[Ma, Xiaowei; Kang, Fei; Yang, Weidong; Wang, Zhe; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Lin, Min] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Lin, Min] Xi An Jiao Tong Univ, Bioinspired Engn & Biomech Ctr, Xian 710049, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University	Lin, M (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	minlin@mail.xjtu.edu.cn; wangjing@fmmu.edu.cn	Wang, Jing/G-5261-2018; Ma, Xiaowei/AAC-3232-2019; Lin, Min/F-1348-2018; Lu, Tian Jian/E-6063-2016; Xu, Feng/H-4468-2011; Xu, Feng/C-7430-2011	Ma, Xiaowei/0000-0002-3062-4063; Lin, Min/0000-0002-6198-9022; Xu, Feng/0000-0003-4351-0222; Kang, Fei/0000-0003-0267-7819	National Natural Science Foundation of China [81090270, 81230033]; Major International Joint Research Program of China [11120101002]; National 111 Project of China [B06024]; Fundamental Research Funds for the Central Universities [2012jdhz46]; China Young 1000-Talent Program; Shaanxi 100-Talent Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major International Joint Research Program of China; National 111 Project of China(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Young 1000-Talent Program; Shaanxi 100-Talent Program	This work was supported by the National Natural Science Foundation of China (81090270, 81230033), the Major International Joint Research Program of China (11120101002), the National 111 Project of China (B06024), the Fundamental Research Funds for the Central Universities (2012jdhz46). F Xu was also partially supported by the China Young 1000-Talent Program and Shaanxi 100-Talent Program. No other potential conflict of interest relevant to this article was reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; BALTHAZAR EJ, 1991, AM J ROENTGENOL, V156, P23, DOI 10.2214/ajr.156.1.1898566; Boschi F, 2011, EUR J NUCL MED MOL I, V38, P120, DOI 10.1007/s00259-010-1630-y; Bouzigues C, 2011, ACS NANO, V5, P8488, DOI 10.1021/nn202378b; Carpenter CM, 2012, OPT EXPRESS, V20, P11598, DOI 10.1364/OE.20.011598; Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051; Chen GY, 2012, ACS NANO, V6, P8280, DOI 10.1021/nn302972r; Cho JY, 2005, ULTRASOUND OBST GYN, V25, P253, DOI 10.1002/uog.1847; Gelovani JG, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013300, DOI 10.1371/J0URNAL.P0NE.0013300.PUBMED:20949021]; Holland JP, 2011, MOL IMAGING, V10, P177, DOI 10.2310/7290.2010.00047; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037623; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Kothapalli SR, 2012, BIOMED OPT EXPRESS, V3, P1215, DOI 10.1364/BOE.3.001215; Lee J, 2013, J NUCL MED, V54, P96, DOI 10.2967/jnumed.112.108043; Lewis MA, 2010, OPT LETT, V35, P3889, DOI 10.1364/OL.35.003889; Lin M, 2012, BIOTECHNOL ADV, V30, P1551, DOI 10.1016/j.biotechadv.2012.04.009; Liu HG, 2012, J NUCL MED, V53, P1579, DOI 10.2967/jnumed.111.098541; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Robertson R, 2011, J NUCL MED, V52, P1764, DOI 10.2967/jnumed.111.091710; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020502; Sudhagar S, 2011, BIOTECHNOL LETT, V33, P1891, DOI 10.1007/s10529-011-0641-5; Thorek DLJ, 2012, J NUCL MED, V53, P1438, DOI 10.2967/jnumed.112.104349; Thorek DLJ, 2012, AM J NUCL MED MOLEC, V2, P163; van der Ende BM, 2009, PHYS CHEM CHEM PHYS, V11, P11081, DOI 10.1039/b913877c; Wang XF, 2011, OPT LETT, V36, P4353, DOI 10.1364/OL.36.004353; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Wu XJ, 2011, EUR J INORG CHEM, P2158, DOI 10.1002/ejic.201001149; Xiong LQ, 2009, BIOMATERIALS, V30, P5592, DOI 10.1016/j.biomaterials.2009.06.015; Xiong LQ, 2010, BIOMATERIALS, V31, P7078, DOI 10.1016/j.biomaterials.2010.05.065; Xu H, 2011, BIOMATERIALS, V32, P9364, DOI 10.1016/j.biomaterials.2011.08.053; Xu YD, 2011, J NUCL MED, V52, P2009, DOI 10.2967/jnumed.111.092965; Zhong J., 2011, INT J BIOMEDICAL IMA, V2011, P1	39	81	82	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77926	10.1371/journal.pone.0077926	http://dx.doi.org/10.1371/journal.pone.0077926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205030	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400061
J	Caron, M; Grard, G; Paupy, C; Mombo, IM; Nso, BBB; Kassa, FRK; Nkoghe, D; Leroy, EM				Caron, Melanie; Grard, Gilda; Paupy, Christophe; Mombo, Illich Mamfred; Nso, Branly Bikie Bi; Kassa, Fabrice Roland Kassa; Nkoghe, Dieudonne; Leroy, Eric Maurice			First Evidence of Simultaneous Circulation of Three Different Dengue Virus Serotypes in Africa	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AEDES-ALBOPICTUS; FEBRILE PATIENTS; CHIKUNGUNYA; IDENTIFICATION; PATHOGENESIS; ENHANCEMENT; EMERGENCE; SENEGAL; GABON	Gabon, in Central Africa, was affected for the first time in 2007 and then in 2010 by simultaneous outbreaks of chikungunya and Dengue serotype 2 (DENV-2) viruses. Through the national surveillance of dengue-like syndromes between 2007 and 2010, we observed continuous circulation of DENV-2 in a southward movement. This rapid spread of DENV-2 was associated with the emergence of DENV-1 in 2007 and DENV-3 in 2010. Interestingly, we detected six DENV-2 infected patients with hemorrhagic signs during the second outbreak in 2010. Although these cases do not meet all standard WHO criteria for severe Dengue with hemorrhage (formerly DHF), this is the first report of several dengue fever cases associated with hemorrhagic signs during a simultaneous circulation of different DENV serotypes in Africa. Together, these findings suggest that DENV is becoming more widely established on this continent and that DHF will likely become a serious public-health problem in the near future.	[Caron, Melanie; Grard, Gilda; Paupy, Christophe; Mombo, Illich Mamfred; Nso, Branly Bikie Bi; Kassa, Fabrice Roland Kassa; Nkoghe, Dieudonne; Leroy, Eric Maurice] Ctr Int Rech Med Franceville, Franceville, Gabon; [Caron, Melanie; Paupy, Christophe; Mombo, Illich Mamfred; Leroy, Eric Maurice] IRD, Montpellier, France; [Nkoghe, Dieudonne] Minist Sante Publ, Libreville, Gabon	Institut de Recherche pour le Developpement (IRD)	Caron, M (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	melaniecaron.cirmf@gmail.com	Paupy, Christophe/I-4847-2017; LEROY, Eric M/I-4347-2016	Paupy, Christophe/0000-0002-7122-2079; LEROY, Eric M/0000-0003-0022-0890; MOMBO, Illich Manfred/0000-0001-9292-7943	CIRMF; Gabonese Government; Total Gabon; French Foreign Ministry; Fondation Christophe et Rodolphe Merieux; Institut de France; IRD	CIRMF; Gabonese Government; Total Gabon(Total SA); French Foreign Ministry; Fondation Christophe et Rodolphe Merieux; Institut de France; IRD	This work was supported by CIRMF which is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. It was also partially financed by grants from Fondation Christophe et Rodolphe Merieux, Institut de France and IRD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; [Anonymous], 2013, DENG DENG HAEM FEV; [Anonymous], WHOCDSCSRISR20001; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; CAREY DE, 1971, LANCET, V1, P105; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Franco L, 2010, EUROSURVEILLANCE, V15; Franco L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001251; Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006; GONZALEZ JP, 1985, B SOC PATHOL EXOT, V78, P7; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1982, PROG ALLERGY, V31, P301; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047; Holmes EC, 2009, VIRUS RES, V143, P1, DOI 10.1016/j.virusres.2009.02.020; HYAMS KC, 1986, AM J TROP MED HYG, V35, P860, DOI 10.4269/ajtmh.1986.35.860; JOHNSON BK, 1982, LANCET, V2, P208; KANESATHASAN N, 1994, LANCET, V343, P678, DOI 10.1016/S0140-6736(94)92678-6; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pourrut X, 2011, EMERG INFECT DIS, V17, P1568, DOI 10.3201/eid1708.110153; Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X; SALUZZO JF, 1986, T ROY SOC TROP MED H, V80, P5, DOI 10.1016/0035-9203(86)90182-3; Sang R, 2006, DENGUE AFRICA REPORT, P50; SHARP TW, 1995, AM J TROP MED HYG, V53, P89, DOI 10.4269/ajtmh.1995.53.89; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; WHO, 2009, WKLY EPIDEMIOL REC, V11, P85	40	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78030	10.1371/journal.pone.0078030	http://dx.doi.org/10.1371/journal.pone.0078030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205075	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600061
J	Nishino, T; Yachie-Kinoshita, A; Hirayama, A; Soga, T; Suematsu, M; Tomita, M				Nishino, Taiko; Yachie-Kinoshita, Ayako; Hirayama, Akiyoshi; Soga, Tomoyoshi; Suematsu, Makoto; Tomita, Masaru			Dynamic Simulation and Metabolome Analysis of Long-Term Erythrocyte Storage in Adenine-Guanosine Solution	PLOS ONE			English	Article							RED-BLOOD-CELLS; ADENOSINE-TRIPHOSPHATE LEVELS; IONIZATION MASS-SPECTROMETRY; OXIDATIVE STRESS; ACID; MODEL; 2,3-BISPHOSPHOGLYCERATE; 2,3-DIPHOSPHOGLYCERATE; PRESERVATION; MAINTENANCE	Although intraerythrocytic ATP and 2,3-bisphophoglycerate (2,3-BPG) are known as direct indicators of the viability of preserved red blood cells and the efficiency of post-transfusion oxygen delivery, no current blood storage method in practical use has succeeded in maintaining both these metabolites at high levels for long periods. In this study, we constructed a mathematical kinetic model of comprehensive metabolism in red blood cells stored in a recently developed blood storage solution containing adenine and guanosine, which can maintain both ATP and 2,3-BPG. The predicted dynamics of metabolic intermediates in glycolysis, the pentose phosphate pathway, and purine salvage pathway were consistent with time-series metabolome data measured with capillary electrophoresis time-of-flight mass spectrometry over 5 weeks of storage. From the analysis of the simulation model, the metabolic roles and fates of the 2 major additives were illustrated: (1) adenine could enlarge the adenylate pool, which maintains constant ATP levels throughout the storage period and leads to production of metabolic waste, including hypoxanthine; (2) adenine also induces the consumption of ribose phosphates, which results in 2,3-BPG reduction, while (3) guanosine is converted to ribose phosphates, which can boost the activity of upper glycolysis and result in the efficient production of ATP and 2,3-BPG. This is the first attempt to clarify the underlying metabolic mechanism for maintaining levels of both ATP and 2,3-BPG in stored red blood cells with in silico analysis, as well as to analyze the trade-off and the interlock phenomena between the benefits and possible side effects of the storage-solution additives.	[Nishino, Taiko; Yachie-Kinoshita, Ayako; Hirayama, Akiyoshi; Soga, Tomoyoshi; Suematsu, Makoto; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Nishino, Taiko; Tomita, Masaru] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Yachie-Kinoshita, Ayako] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Yachie-Kinoshita, Ayako; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan	Keio University; Keio University; University of Toronto; Keio University; Keio University	Yachie-Kinoshita, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	ayako.yachie.kinoshita@utoronto.ca	Suematsu, Makoto/I-8135-2013; Soga, Tomoyoshi/B-8105-2014; Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Suematsu, Makoto/0000-0002-7165-6336; Yachie, Ayako/0000-0003-2032-227X	Yamagata prefecture Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; Japan Society for the Promotion of Science (JSPS); Uehara foundation	Yamagata prefecture Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara foundation(Uehara Memorial Foundation)	This study is funded by a grant from Yamagata prefecture Japan; Next-Generation Supercomputer Project of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; and "Global-COE Program for Human Metabolomic Systems Biology," of Japan Society for the Promotion of Science (JSPS). TN is supported by Grant-in-Aid for Young Scientists of Japan Society for the Promotion of Science (JSPS). TN and AYK were supported by "Global-COE Program for Human Metabolomic Systems Biology" of Japan Society for the Promotion of Science (JSPS). AYK is supported by Uehara foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Burger P, 2010, TRANSFUSION, V50, P2386, DOI 10.1111/j.1537-2995.2010.02700.x; D'Amici GM, 2007, J PROTEOME RES, V6, P3242, DOI 10.1021/pr070179d; D'Amici GM, 2012, BLOOD TRANSFUS-ITALY, V10, pS46, DOI 10.2450/2012.008S; de Korte D, 2008, TRANSFUSION, V48, P1081, DOI 10.1111/j.1537-2995.2008.01689.x; DERN RJ, 1967, J LAB CLIN MED, V69, P968; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; Fedosov DA, 2010, BIOPHYS J, V98, P2215, DOI 10.1016/j.bpj.2010.02.002; Gevi F, 2012, J PROTEOMICS, V76, P168, DOI 10.1016/j.jprot.2012.03.012; Glicher RO, 2009, ROSSIS PRINCIPLES TR, V4th, P624; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; GUPPY M, 1992, VOX SANG, V62, P70, DOI 10.1111/j.1423-0410.1992.tb01173.x; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Hogman CF, 2006, TRANSFUSION, V46, P137, DOI 10.1111/j.1537-2995.2006.00681.x; Hogman CF, 2006, TRANSFUSION, V46, P1543, DOI 10.1111/j.1537-2995.2006.00893.x; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Lichtman MA., 2006, WILLIAMS HEMATOLOGY, V7th, P1183; Lion N, 2010, J PROTEOMICS, V73, P374, DOI 10.1016/j.jprot.2009.11.001; MERYMAN HT, 1991, VOX SANG, V60, P99, DOI 10.1111/j.1423-0410.1991.tb00881.x; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Nishino T, 2009, J BIOTECHNOL, V144, P212, DOI 10.1016/j.jbiotec.2009.08.010; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stoychev G, 2002, EUR J BIOCHEM, V269, P4048, DOI 10.1046/j.1432-1033.2002.03097.x; Suematsu M, 2002, MICROCIRCULATION, V9, P259, DOI 10.1038/sj.mn.7800141; SUGITA Y, 1965, J CLIN INVEST, V44, P629, DOI 10.1172/JCI105176; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Takahashi K, 2005, FEBS LETT, V579; Wolf MB, 2011, J APPL PHYSIOL, V110, P988, DOI 10.1152/japplphysiol.00514.2010	32	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71060	10.1371/journal.pone.0071060	http://dx.doi.org/10.1371/journal.pone.0071060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	24205395	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200021
J	Yang, HY; Lee, SM; Gao, BX; Zhang, JP; Fang, DY				Yang, Heeyoung; Lee, Sang-Myeong; Gao, Beixue; Zhang, Jinping; Fang, Deyu			Histone Deacetylase Sirtuin 1 Deacetylates IRF1 Protein and Programs Dendritic Cells to Control Th17 Protein Differentiation during Autoimmune Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Dendritic Cells; Epigenetics; Sirt1; T Cell; IL-27; IRF1; Acetylation	T-CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; IL-17 PRODUCTION; CUTTING EDGE; C-MAF; IL-27; ACTIVATION; INDUCTION; ALPHA	The type III histone deacetylase Sirt1 has recently emerged as a critical immune regulator by suppressing T cell immunity and macrophage activation during inflammation, but its role in dendritic cells (DCs) remains unknown. Here, we show that mice with genetic Sirt1 deletion specifically in DCs are resistant to MOG-induced experimental autoimmune encephalomyelitis. Loss of Sirt1 functions in DCs enhances their ability to produce IL-27 and interferon (IFN-). Co-cultivation of Sirt1-null DCs with CD4(+) T cells inhibited Th17 differentiation, which is reversed by anti-IL27 and anti-IFN- neutralization antibodies. Sirt1 antagonizes acetylation of IRF1, a transcription factor that drives IL-27 production. Genetic deletion of IRF1 in Sirt1-null DCs abolishes IL-27 production and suppresses Th17 differentiation. Our results show that the histone deacetylase Sirt1 programs DCs to regulate Th17 differentiation during inflammation.	[Yang, Heeyoung; Lee, Sang-Myeong; Gao, Beixue; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Jinping] Soochow Univ, Inst Biol Sci, Suzhou, Jiangsu, Peoples R China; [Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Northwestern University; Feinberg School of Medicine; Soochow University - China; Soochow University - China	Fang, DY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	fangd@northwestern.edu	zhang, jin/GXV-9154-2022; Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751	National Institutes of Health [R01AI079056, DP2DK083050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI079056 and DP2DK083050 (to D. F.).	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Chen A, 2011, MOL CELL BIOL, V31, P3445, DOI 10.1128/MCB.05383-11; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fraternale A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057866; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Gillum M. P., 2010, TRENDS MOL MED, V17, P22; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Kemp KL, 2013, J BIOL CHEM, V288, P33272, DOI 10.1074/jbc.M113.493171; Kim HS, 2011, J IMMUNOL, V187, P4007, DOI 10.4049/jimmunol.1101654; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Masumi A, 1999, MOL CELL BIOL, V19, P1810; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mattei F, 2012, NEOPLASIA, V14, P1223, DOI 10.1593/neo.121444; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Schuetze N, 2005, INT IMMUNOL, V17, P649, DOI 10.1093/intimm/dxh247; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139	49	52	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37256	37266		10.1074/jbc.M113.527531	http://dx.doi.org/10.1074/jbc.M113.527531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214980	hybrid, Green Published			2022-12-25	WOS:000329189700042
J	Luo, DX; Bu, YW; Ma, J; Rajput, S; He, YC; Cai, GX; Liao, DF; Cao, DL				Luo, Dixian; Bu, Yiwen; Ma, Jun; Rajput, Sandeep; He, Yingchun; Cai, Guangxian; Liao, Duan-Fang; Cao, Deliang			Heat Shock Protein 90-alpha Mediates Aldo-Keto Reductase 1B10 (AKR1B10) Protein Secretion through Secretory Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; HSP90; Lysosomes; Protein Secretion; Tumor Marker; Chaperone	GROWTH-FACTOR-I; MOLECULAR CHAPERONES; ENDOPLASMIC-RETICULUM; CELL MOTILITY; CANCER CELLS; MEMBER B10; FAMILY 1; HSP90; OVEREXPRESSION; PURIFICATION	Background: Aldo-keto reductase 1B10 (AKR1B10) protein is a new tumor biomarker in humans. Results: Heat shock protein 90 (HSP90) is a chaperone molecule that mediates transportation to lysosomes and secretion of AKR1B10. Helix 10 of AKR1B10 protein mediates its interaction with HSP90. Conclusion: HSP90 mediates AKR1B10 secretion through binding to its helix 10 domain. Significance: This finding is significant in exploiting the use of AKR1B10 in cancer clinics. Aldo-keto reductase 1B10 (AKR1B10) protein is a new tumor biomarker in humans. Our previous studies have shown that AKR1B10 is secreted through a lysosome-mediated nonclassical pathway, leading to an increase in the serum of breast cancer patients. This study illuminates the regulatory mechanism of AKR1B10 secretion. The cytosolic AKR1B10 associates with and is translocated to lysosomes by heat shock protein 90 (HSP90), a chaperone molecule. Ectopic expression of HSP90 significantly increased the secretion of endogenous AKR1B10 and exogenous GFP-AKR1B10 fusion protein when cotransfected. Geldanamycin, a HSP90 inhibitor, dissociated AKR1B10-HSP90 complexes and significantly reduced AKR1B10 secretion in a dose-dependent manner. We characterized the functional domain in AKR1B10 and found that helix 10 (amino acids 233-240), located at the C terminus, regulates AKR1B10 secretion. Targeted point mutations recognized that amino acids Lys-233, Glu-236, and Lys-240 in helix 10 mediate the interaction of AKR1B10 with HSP90. Together, our data suggest that HSP90 mediates AKR1B10 secretion through binding to its helix 10 domain. This finding is significant in exploiting the use of AKR1B10 in cancer clinics.	[Luo, Dixian; Bu, Yiwen; Rajput, Sandeep; Cao, Deliang] So Illinois Univ, Simmons Canc Inst, Dept Med Microbiol Immunol & Cell Biol, Sch Med, Springfield, IL 62794 USA; [Luo, Dixian] First Peoples Hosp Chenzhou, Inst Translat Med, Chenzhou 423000, Hunan, Peoples R China; [Luo, Dixian] First Peoples Hosp Chenzhou, Dept Lab Med, Chenzhou 423000, Hunan, Peoples R China; [Ma, Jun; Cao, Deliang] Med Coll Guangdong, Affiliated Shenzhen Futian Hosp, Shenzhen 518033, Peoples R China; [Ma, Jun; Cao, Deliang] Shenzhen Third Peoples Hosp, Guangdong Med Coll, Shenzhen 518112, Peoples R China; [He, Yingchun; Cai, Guangxian; Liao, Duan-Fang; Cao, Deliang] Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China	Southern Illinois University System; Southern Illinois University; Guangdong Medical University; Hunan University of Chinese Medicine	Liao, DF (corresponding author), Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China.	dfliao66@aliyun.com; dcao@siumed.edu	rajput, sandeep/Q-5408-2019		Department of Defense Breast Cancer Research Program [BC083555]; National Natural Science Foundation of China [81372825, 81272918]; China Hunan Provincial Science and Technology Department [2012SK3065]; Health Department of China Hunan Province Grant [B2012-157]; China Hunan Provincial Education Department [13C882]	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Hunan Provincial Science and Technology Department; Health Department of China Hunan Province Grant; China Hunan Provincial Education Department	This work was supported by Department of Defense Breast Cancer Research Program Grant BC083555 (to D. C.), by National Natural Science Foundation of China Grants 81372825 (to D. L.) and 81272918 (to D. C.), by China Hunan Provincial Science and Technology Department Grant 2012SK3065 (to D. L.), by Health Department of China Hunan Province Grant B2012-157 (to D. L.), and by China Hunan Provincial Education Department Grant 13C882 (to D. L.).	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Balendiran GK, 2009, CHEM-BIOL INTERACT, V178, P134, DOI 10.1016/j.cbi.2008.10.044; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gross M, 1996, J BIOL CHEM, V271, P16833, DOI 10.1074/jbc.271.28.16833; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Luo DX, 2011, BIOCHEM J, V438, P71, DOI 10.1042/BJ20110111; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Ma J, 2012, INT J CANCER, V131, pE862, DOI 10.1002/ijc.27618; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Martin HJO, 2006, DRUG METAB DISPOS, V34, P464, DOI 10.1124/dmd; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Quinn AM, 2008, CHEM RES TOXICOL, V21, P2207, DOI 10.1021/tx8002005; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Shen Y, 2010, BIOCHIMIE, V92, P530, DOI 10.1016/j.biochi.2010.02.001; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014; Zhong LL, 2009, BIOCHEM BIOPH RES CO, V387, P245, DOI 10.1016/j.bbrc.2009.06.123; Zimmermann R, 1998, BIOL CHEM, V379, P275; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	38	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36733	36740		10.1074/jbc.M113.514877	http://dx.doi.org/10.1074/jbc.M113.514877			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217247	hybrid, Green Published			2022-12-25	WOS:000328883400050
J	Leung, V; Gillis, J; Raboud, J; Cooper, C; Hogg, RS; Loutfy, MR; Machouf, N; Montaner, JSG; Rourke, SB; Tsoukas, C; Klein, MB				Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B.		CANOC Collaboration	Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; T-CELL SUBSETS; LYMPHOCYTE-ACTIVATION; PROGNOSTIC VALUE; CD4-CD8 RATIO; CD4/CD8 RATIO; CD4+; CD8; DISEASE; COUNTS	Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI) and death. Methods: A Canadian cohort of HIV-positive adults with CD4:CD8<1.2 prior to starting cART from 2000-2010 were analyzed. Predictors of (1) reaching a CD4:CD8 >= 1.2 on two separate follow-up visits >30 days apart, and (2) ADI and death from all causes were assessed using adjusted proportional hazards models. Results: 4206 patients were studied for a median of 2.77 years and 306 (7.2%) normalized their CD4:CD8 ratio. Factors associated with achieving a normal CD4:CD8 ratio were: baseline CD4+ T-cells >350 cells/mm(3), baseline CD8+ T-cells <500 cells/mm(3), time-updated HIV RNA suppression, and not reporting sex with other men as a risk factor. There were 213 ADIs and 214 deaths in 13476 person-years of follow-up. Achieving a normal CD4:CD8 ratio was not associated with time to ADI/death. Conclusions: In our study, few individuals normalized their CD4:CD8 ratios within the first few years of initiating modern cART. This large study showed no additional short-term predictive value of the CD4:CD8 ratio for clinical outcomes after accounting for other risk factors including age and HIV RNA.	[Leung, Victor] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Gillis, Jennifer; Raboud, Janet] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cooper, Curtis] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Hogg, Robert S.; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.] Maple Leaf Med Clin, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Machouf, Nima] Clin Med Actuel, Montreal, PQ, Canada; [Montaner, Julio S. G.] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada; [Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Tsoukas, Chris; Klein, Marina B.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Tsoukas, Chris; Klein, Marina B.] McGill Univ Hlth Ctr, Montreal, PQ, Canada	University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of British Columbia; McGill University; McGill University	Hogg, RS (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	rhogg@sfu.ca	Leung, Victor C.M./X-6823-2019; Leung, Victor C. M./AGU-2462-2022; Cooper, Curtis/M-9320-2019; Gillis, Jennifer/X-6384-2019	Leung, Victor C.M./0000-0003-3529-2640; Leung, Victor C. M./0000-0003-3529-2640; Gillis, Jennifer/0000-0001-5229-9911; Hogg, Robert/0000-0003-3463-5488; Klein, Marina/0000-0002-3063-8430	Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network [CTN 242]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR))	This work was supported by an Emerging Team Grant from the Canadian Institutes of Health Research (CIHR) and is supported by the CIHR Canadian HIV Trials Network (CTN 242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CIHR: http://www.cihr-irsc.gc.ca/e/193.html CTN: http://www.hivnet.ubc.ca/home/	ABOULKER JP, 1992, J IMMUNOL METHODS, V154, P155, DOI 10.1016/0022-1759(92)90187-X; Adleman LM, 1996, J ACQ IMMUN DEF SYND, V11, P334, DOI 10.1097/00042560-199604010-00003; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Amadori A, 1996, IMMUNOL TODAY, V17, P414, DOI 10.1016/0167-5699(96)10049-9; Badura R, 2010, 10 INT C DRUG THER H; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Bouscarat F, 1998, AIDS, V12, P1267, DOI 10.1097/00002030-199811000-00007; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; ECHANIZ P, 1993, CELL IMMUNOL, V150, P72, DOI 10.1006/cimm.1993.1179; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; FAHEY JL, 1987, ANN INST PASTEUR IMM, V138, P245, DOI 10.1016/S0769-2625(87)80075-2; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Grossman Z, 1998, J ACQ IMMUN DEF SYND, V17, P450, DOI 10.1097/00042560-199804150-00010; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Jiang WM, 2004, CLIN DIAGN LAB IMMUN, V11, P811, DOI 10.1128/CDLI.11.4.811-813.2004; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kulkarni H, 2011, JAIDS-J ACQ IMM DEF, V57, P387, DOI 10.1097/QAI.0b013e3182219113; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; MARGOLICK JB, 1993, J ACQ IMMUN DEF SYND, V6, P153; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; Mendez-Lagares G, 2012, J ANTIMICROB CHEMOTH, V67, P1228, DOI 10.1093/jac/dkr594; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Ndumbi P, 2011, 6 INT AIDS SOC C HIV; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer AK, 2011, INT J EPIDEMIOL, V40, P25, DOI 10.1093/ije/dyp393; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Schneider E, 2008, MORBIDITY MORTALITY, V57; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Shearer WT, 2007, J ALLERGY CLIN IMMUN, V120, P1449, DOI 10.1016/j.jaci.2007.08.037; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; SYRJALA H, 1991, CLIN EXP IMMUNOL, V83, P326; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Tuma RA, 2002, CURR OPIN IMMUNOL, V14, P348, DOI 10.1016/S0952-7915(02)00338-2; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009; Zaman MM, 2000, AIDS PATIENT CARE ST, V14, P647, DOI 10.1089/10872910050206568	48	60	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77665	10.1371/journal.pone.0077665	http://dx.doi.org/10.1371/journal.pone.0077665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204912	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500041
J	Mehta, A; Luck, JM; Luk, CC; Syed, NI				Mehta, Anita; Luck, Jean-Marc; Luk, Collin C.; Syed, Naweed I.			Synaptic Metaplasticity Underlies Tetanic Potentiation in Lymnaea: A Novel Paradigm	PLOS ONE			English	Article							FORM	We present a mathematical model that explains and interprets a novel form of short-term potentiation, which was found to be use-, but not time-dependent, in experiments done on Lymnaea neurons. The high degree of potentiation is explained using a model of synaptic metaplasticity, while the use-dependence (which is critically reliant on the presence of kinase in the experiment) is explained using a model of a stochastic and bistable biological switch.	[Mehta, Anita] SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India; [Luck, Jean-Marc] CEA Saclay, Inst Phys Theor, F-91191 Gif Sur Yvette, France; [Luck, Jean-Marc] CNRS, URA 2306, Gif Sur Yvette, France; [Luk, Collin C.; Syed, Naweed I.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Calgary	Mehta, A (corresponding author), SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India.	anita@bose.res.in		Luck, Jean-Marc/0000-0003-2151-5057				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; Mehta A, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/09/P09025; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	10	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78056	10.1371/journal.pone.0078056	http://dx.doi.org/10.1371/journal.pone.0078056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205089	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700069
J	Hung, MJ; Hsu, KH; Hu, WS; Chang, NC; Hung, MY				Hung, Ming-Jui; Hsu, Kuang-Hung; Hu, Wei-Syun; Chang, Nen-Chung; Hung, Ming-Yow			C-Reactive Protein for Predicting Prognosis and Its Gender-Specific Associations with Diabetes Mellitus and Hypertension in the Development of Coronary Artery Spasm	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; VASOSPASTIC ANGINA; NITRIC-OXIDE; FOLLOW-UP; RATS; INFLAMMATION; AGE	Background: While hypertension is negatively associated with coronary artery spasm (CAS), scarce data are available on diabetes mellitus in relation to CAS. In addition, outcome prediction in patients with CAS is challenging due to the lack of appropriate biomarkers. Therefore, we sought to identify the roles that gender, high-sensitivity C-reactive protein (hs-CRP), diabetes mellitus and hypertension play in CAS development and prognosis. Methodology/Prinicpal Findings: Patients (350 women and 547 men) undergoing diagnostic coronary angiography with or without proven CAS but without obstructive stenosis were evaluated at long-term follow-up (median 102 months). Diabetic women and diabetic men with low hs-CRP levels had a low and high risk of CAS (odds ratio [OR]: 0.16, 95% confidence interval [CI]: 0.01-1.88 and OR: 5.02, 95% CI: 1.03-24.54, respectively). The ORs of CAS in both women and men with the highest hs-CRP tertile (>3 mg/L) reduced from 4.41 to 1.45 and 2.98 to 1.52, respectively, if they had diabetes mellitus, and from 9.68 to 2.43 and 2.60 to 1.75, respectively, if they had hypertension. Hypertension had a more negative effect on CAS development in diabetic than non-diabetic women, which was not observed in men. The highest hs-CRP tertile was an independent predictor of adverse outcomes. Patients with the highest hs-CRP tertile had more coronary events than patients with the lowest hs-CRP tertitle (p = 0.021, log-rank test). Conclusions: Diabetes mellitus contributes to CAS development in men with low hs-CRP levels, but not in women. There are negative effects of diabetes mellitus and hypertension on CAS development in patients with high hs-CRP levels and especially in women. Elevated hs-CRP level independently predicts adverse outcomes.	[Hung, Ming-Jui] Chang Gung Mem Hosp, Dept Cardiol, Keelung, Taiwan; [Hung, Ming-Jui] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Tao Yuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Hu, Wei-Syun; Hung, Ming-Yow] Taipei Med Univ, Shuang Ho Hosp, Div Cardiol, Dept Internal Med, New Taipei City, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Hung, Ming-Yow] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hung, Ming-Yow] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Chang Gung University; Taipei Medical University	Hung, MY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Cardiol, Dept Internal Med, New Taipei City, Taiwan.	myhung6@ms77.hinet.net			Chang Gung Memorial Hospital at Keelung [23011, 250131]; National Science Council [95-2314-B-182A-058]; Healthy Aging Research Center of Chang Gung University, Taiwan [EMRPD1B0351, EMRPD1C0301]	Chang Gung Memorial Hospital at Keelung(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Healthy Aging Research Center of Chang Gung University, Taiwan	This work was supported by Chang Gung Medical Research Proposal grants 23011 and 250131 from Chang Gung Memorial Hospital at Keelung, National Science Council grant 95-2314-B-182A-058 and partly supported by the Healthy Aging Research Center of Chang Gung University (fund No. EMRPD1B0351 and EMRPD1C0301), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AA, 2003, DIABETES RES CLIN PR, V59, P11, DOI 10.1016/S0168-8227(02)00180-8; [Anonymous], 2010, CIRC J, V74, P1745; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Bory M, 1996, EUR HEART J, V17, P1015; Chen KY, 2010, J HUM HYPERTENS, V24, P77, DOI 10.1038/jhh.2009.40; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Dumont T, 2009, NEUROCRIT CARE, V11, P183, DOI 10.1007/s12028-009-9232-x; Fernandez N, 2002, CLIN SCI LOND S48, p376S; Fukuda N, 1999, J HYPERTENS, V17, P1099, DOI 10.1097/00004872-199917080-00009; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; GRUNWALD JE, 1987, OPHTHALMOLOGY, V94, P1614; Hung MY, 2013, INT J MED SCI, V10, P255, DOI 10.7150/ijms.5383; Hung MY, 2010, EUR J CLIN INVEST, V40, P1094, DOI 10.1111/j.1365-2362.2010.02360.x; Karanian JW, 1996, J CARDIOVASC PHARM, V27, P312, DOI 10.1097/00005344-199603000-00002; KAUSER K, 1995, HYPERTENSION, V25, P517, DOI 10.1161/01.HYP.25.4.517; Kengne AP, 2012, DIABETES CARE, V35, P396, DOI 10.2337/dc11-1588; Konishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060163; Kozakova M, 2000, HYPERTENSION, V36, P343, DOI 10.1161/01.HYP.36.3.343; Liu L, 2000, AM J PHYSIOL-HEART C, V278, pH1153, DOI 10.1152/ajpheart.2000.278.4.H1153; Lynch FM, 2012, J HYPERTENS, V30, P384, DOI 10.1097/HJH.0b013e32834e38a0; Miyao Y, 2000, J AM COLL CARDIOL, V36, P432, DOI 10.1016/S0735-1097(00)00729-4; Nakajima T, 1995, EUR J PHARMACOL, V294, P625, DOI 10.1016/0014-2999(95)00602-8; Nugent AG, 1996, DIABETES, V45, P105, DOI 10.2337/diabetes.45.1.105; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Oltman CL, 1997, CARDIOVASC RES, V34, P179, DOI 10.1016/S0008-6363(97)00016-3; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Ray KK, 2007, EUR HEART J, V28, P806, DOI 10.1093/eurheartj/ehm010; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sanz E, 2003, LIFE SCI, V72, P1537, DOI 10.1016/S0024-3205(02)02444-X; SATO I, 1986, CHEST, V89, P12, DOI 10.1378/chest.89.1.12; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Sharaf BL, 1997, J AM COLL CARDIOL, V29, P78, DOI 10.1016/S0735-1097(96)00444-5; SUGIISHI M, 1993, CIRCULATION, V87, P76, DOI 10.1161/01.CIR.87.1.76; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; TSCHUDI MR, 1995, CIRCULATION, V91, P2415, DOI 10.1161/01.CIR.91.9.2415; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Yugar-Toledo JC, 2004, CHEST, V125, P823, DOI 10.1378/chest.125.3.823; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	41	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77655	10.1371/journal.pone.0077655	http://dx.doi.org/10.1371/journal.pone.0077655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204905	gold, Green Published, Green Submitted			2022-12-25	WOS:000326241200036
J	Jensen, RJ				Jensen, Ralph J.			Effects of a Metabotropic Glutamate 1 Receptor Antagonist on Light Responses of Retinal Ganglion Cells in a Rat Model of Retinitis Pigmentosa	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GABA(C) RECEPTORS; AMACRINE CELLS; RHO-SUBUNITS; LOCALIZATION; INHIBITION; MGLUR1; MOUSE; ROD; TRANSMISSION	Background: Retinitis pigmentosa (RP) is a progressive retinal degenerative disease that causes deterioration of rod and cone photoreceptors. A well-studied animal model of RP is the transgenic P23H rat, which carries a mutation in the rhodopsin gene. Previously, I reported that blocking retinal GABA(C) receptors in the P23H rat increases light responsiveness of retinal ganglion cells (RGCs). Because activation of metabotropic glutamate 1 (mGlu1) receptors may enhance the release of GABA onto GABA(C) receptors, I examined the possibility that blocking retinal mGlu1 receptors might in itself increase light responsiveness of RGCs in the P23H rat. Methodology/Principal Findings: Electrical recordings were made from RGCs in isolated P23H rat retinas. Spike activity of RGCs was measured in response to brief flashes of light over a range of light intensities. Intensity-response curves were evaluated prior to and during bath application of the mGlu1 receptor antagonist JNJ16259685. I found that JNJ16259685 increased light sensitivity of all ON-center RGCs and most OFF-center RGCs studied. RGCs that were least sensitive to light showed the greatest JNJ16259685-induced increase in light sensitivity. On average, light sensitivity increased in ON-center RGCs by 0.58 log unit and in OFF-center RGCs by 0.13 log unit. JNJ16259685 increased the maximum peak response of ON-center RGCs by 7% but had no significant effect on the maximum peak response of OFF-center RGCs. The effects of JNJ16259685 on ON-center RGCs were occluded by a GABA(C) receptor antagonist. Conclusions: The results of this study indicate that blocking retinal mGlu1 receptors in a rodent model of human RP potentiates transmission of any, weak signals originating from photoreceptors. This augmentation of photoreceptor-mediated signals to RGCs occurs presumably through a reduction in GABA(C)-mediated inhibition.	VA Boston Healthcare Syst, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jensen, RJ (corresponding author), VA Boston Healthcare Syst, Boston, MA USA.	Ralph.jensen@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service [1I01RX000341-01]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (1I01RX000341-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEART PM, 1972, J NEUROCHEM, V19, P1855, DOI 10.1111/j.1471-4159.1972.tb01474.x; Cai WH, 1999, J COMP NEUROL, V407, P427, DOI 10.1002/(SICI)1096-9861(19990510)407:3<427::AID-CNE10>3.0.CO;2-9; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Enz R, 1996, J NEUROSCI, V16, P4479; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Fukunaga I, 2007, BRIT J PHARMACOL, V151, P870, DOI 10.1038/sj.bjp.0707286; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREFERATH U, 1993, VISUAL NEUROSCI, V10, P551, DOI 10.1017/S0952523800004764; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HARTVEIT E, 1995, EUR J NEUROSCI, V7, P1472, DOI 10.1111/j.1460-9568.1995.tb01142.x; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Koulen P, 1997, J NEUROSCI, V17, P2200; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Lavreysen H, 2004, NEUROPHARMACOLOGY, V47, P961, DOI 10.1016/j.neuropharm.2004.08.007; Martinez-Navarrete G, 2011, EXP EYE RES, V92, P227, DOI 10.1016/j.exer.2010.12.001; PENG YW, 1995, NEUROSCIENCE, V66, P483, DOI 10.1016/0306-4522(94)00569-Q; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; Vigh J, 2003, EUR J NEUROSCI, V17, P2237, DOI 10.1046/j.1460-9568.2003.02652.x; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Yu JN, 2009, J NEUROPHYSIOL, V102, P3728, DOI 10.1152/jn.00650.2009	29	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e79126	10.1371/journal.pone.0079126	http://dx.doi.org/10.1371/journal.pone.0079126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205371	gold, Green Published, Green Submitted			2022-12-25	WOS:000326241200061
J	Murphy, RA; Schairer, C; Gierach, GL; Byrne, C; Sherman, ME; Register, TC; Ding, JZ; Kritchevsky, SB; Harris, TB				Murphy, Rachel A.; Schairer, Catherine; Gierach, Gretchen L.; Byrne, Celia; Sherman, Mark E.; Register, Thomas C.; Ding, Jingzhong; Kritchevsky, Stephen B.; Harris, Tamara B.			Beyond Breast Cancer: Mammographic Features and Mortality Risk in a Population of Healthy Women	PLOS ONE			English	Article							BODY-MASS INDEX; TYPE-2 DIABETES-MELLITUS; SKELETAL-MUSCLE; FOLLOW-UP; INSULIN-RESISTANCE; UNITED-STATES; WHITE WOMEN; DENSITY; OBESITY; TISSUE	Background: Breast fibroglandular (dense) tissue is a risk factor for breast cancer. Beyond breast cancer, little is known regarding the prognostic significance of mammographic features. Methods: We evaluated relationships between nondense (fatty) breast area and dense area with all-cause mortality in 4,245 initially healthy women from the Breast Cancer Detection Demonstration Project; 1,361 died during a mean follow-up of 28.2 years. Dense area and total breast area were assessed using planimeter measurements from screening mammograms. Percent density reflects dense area relative to breast area and nondense area was calculated as the difference between total breast area and dense area. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated by Cox proportional hazards regression. Results: In age-adjusted models, greater nondense and total breast area were associated with increased risk of death (HR 1.17, 95% CI 1.10-1.24 and HR 1.13, 95% CI 1.06-1.19, per SD difference) while greater dense area and percent density were associated with lower risk of death (HR 0.91, 95% CI 0.86-0.95 and HR 0.87, 95% CI 0.83-0.92, per SD difference). Associations were not attenuated with adjustment for race, education, mammogram type (x-ray or xerogram), smoking status, diabetes and heart disease. With additional adjustment for body mass index, associations were diminished for all features but remained statistically significant for dense area (HR 0.94, 95% CI 0.89-0.99, per SD difference) and percent density (HR 0.93, 95% CI 0.87-0.98, per SD difference). Conclusions: These data indicate that dense area and percent density may relate to survival in healthy women and suggest the potential utility of mammograms beyond prediction of breast cancer risk.	[Murphy, Rachel A.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Schairer, Catherine; Gierach, Gretchen L.; Sherman, Mark E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Byrne, Celia] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Register, Thomas C.] Sticht Ctr Aging, Sect Comparat Med Pathol, Winston Salem, NC USA; [Ding, Jingzhong; Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging Sect Gerontol & Geriatr, Winston Salem, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; Wake Forest University	Murphy, RA (corresponding author), NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.	Rachel.murphy@nih.gov	Gierach, Gretchen L/E-1817-2016; Byrne, Celia/K-2964-2015	Gierach, Gretchen L/0000-0002-0165-5522; Byrne, Celia/0000-0001-8289-4252; Register, Thomas/0000-0002-4078-0166	NIH, National Institute on Aging; Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [ZIACP010183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. RAM is supported by a Banting Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benichou J, 2003, CANCER DETECT PREV, V27, P266, DOI 10.1016/S0361-090X(03)00092-8; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Claassen H, 2011, PROG HISTOCHEM CYTO, V45, P239, DOI 10.1016/j.proghi.2010.11.002; D'Orsi C, 2003, BREAST IMAGING REPOR; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Iso H, 2012, ATHEROSCLEROSIS, V224, P154, DOI 10.1016/j.atherosclerosis.2012.05.026; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Liberman L, 2002, RADIOL CLIN N AM, V40, P409, DOI 10.1016/S0033-8389(01)00017-3; Lokate M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3044; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Maskarinec G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3378; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Murphy RA, 2013, J GERONTOL A-BIOL, DOI [10.1093/gerona/glt070, DOI 10.1093/GER0NA/GLT070.PUBMED:23707956]; Ogden CL, 2010, PREVALENCE OVERWEIGH; Olsen AH, 2009, BRIT J CANCER, V100, P1205, DOI 10.1038/sj.bjc.6604989; Pettersson A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3041; Porter GJR, 2007, AM J ROENTGENOL, V188, P676, DOI 10.2214/AJR.05.1950; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Razzaghi H, 2012, BREAST CANCER RES TR, V135, P571, DOI 10.1007/s10549-012-2185-3; STONE BG, 1985, SEMIN LIVER DIS, V5, P8, DOI 10.1055/s-2008-1041754; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; van Gils CH, 1998, J EPIDEMIOL COMMUN H, V52, P267, DOI 10.1136/jech.52.4.267; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Yong LC, 1996, AM J EPIDEMIOL, V143, P985, DOI 10.1093/oxfordjournals.aje.a008681; Zhang SF, 2013, BREAST CANCER RES TR, V137, P273, DOI 10.1007/s10549-012-2310-3	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78722	10.1371/journal.pone.0078722	http://dx.doi.org/10.1371/journal.pone.0078722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205300	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400101
J	Oh, HY; Kim, MK; Lee, M; Kim, YO				Oh, Hea Young; Kim, Mi Kyung; Lee, Myoungsook; Kim, Young Ok			Macronutrient Composition and Sodium Intake of Diet Are Associated with Risk of Metabolic Syndrome and Hypertension in Korean Women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; NATIONAL-HEALTH; PATTERNS; PREVALENCE; POPULATION; OBESITY; STROKE	Hypertension and hypertriglycemia are the most important contributors to metabolic syndrome (MetS) and cardiovascular disease risk in South Koreans with a relatively lean body mass. These major contributors differ from those identified in Western populations. This study aimed to identify the characteristics of the Korean diet associated with increased risk of MetS, whose prevalence has been steadily increasing in South Korea. On the basis of data collected from 5,320 subjects by the 2007-2008 Korean National Health and Nutrition Examination Survey, 3 dietary patterns were identified using factor analysis and their association with the risk of MetS and its components was examined. The balanced Korean diet, a typical Korean diet of rice and kimchi intake supplemented by a variety of foods had a desirable macronutrient composition and was associated with a lower risk of elevated blood pressure (OR=0.61, 95% CI=0.45-0.84) and hypertriglyceridemia (0.69, 0.49-0.88) in men and a lower risk of elevated blood pressure (0.59, 0.41-0.85) and MetS (0.67, 0.47-0.96) in women. The unbalanced Korean diet, characterized by a high intake of carbohydrates and sodium and little variety, was associated with a higher risk of MetS (1.44, 1.03-2.01) and elevated blood pressure (1.41, 1.00-1.98) in women. The semi-western diet, characterized by a relatively high intake of meat, poultry, and alcohol, was associated with a lower risk of low high-density lipoprotein cholesterol (0.70, 0.54-0.89) in women. Thus, macronutrient composition and sodium intake are associated with the risk of MetS and prehypertension in women. Maintaining a desirable macronutrient composition and avoiding excessive consumption of carbohydrates and sodium should be emphasized for prevention of MetS and hypertension in South Korean women.	[Oh, Hea Young; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Translat Epidemiol Branch, Goyang, South Korea; [Lee, Myoungsook] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Kim, Young Ok] Dongduk Womens Univ, Coll Nat Sci, Dept Food & Nutr, Seoul, South Korea	National Cancer Center - Korea (NCC); Sungshin Women's University; Dongduk Women's University	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Prevent, Translat Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr		Lee, Myoungsook/0000-0003-1344-6979	National Cancer Center in Korea [1310361-1]; Korea Center for Disease Control and Prevention [2011E3500900]; Korean Food and Drug Administration [11162KFDA154]	National Cancer Center in Korea; Korea Center for Disease Control and Prevention; Korean Food and Drug Administration	This research was supported by grants from the National Cancer Center in Korea (1310361-1), the Korea Center for Disease Control and Prevention (2011E3500900), and the Korean Food and Drug Administration (11162KFDA154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-61; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202, DOI 10.5551/jat.13.202; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Beer-Borst S, 2000, EUR J CLIN NUTR, V54, P253, DOI 10.1038/sj.ejcn.1600934; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046, DOI 10.1093/oxfordjournals.aje.a009233; Hu FB, 2007, J AM COLL CARDIOL, V50, P22, DOI 10.1016/j.jacc.2007.04.027; Jensen KO, 1999, EUR J CLIN NUTR, V53, P351, DOI 10.1038/sj.ejcn.1600767; Kim BK, 2012, BLOOD PRESS MONIT, V17, P120, DOI 10.1097/MBP.0b013e328354079b; Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001; Korea Health Industry Development Institute Ministry of Health and Welfare, 2001, DEV NUTR DAT REC SIZ; Kris-Etherton PM, 2012, LIPIDS, V47, P931, DOI 10.1007/s11745-012-3704-z; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Majane OHI, 2009, HYPERTENSION, V54, P1376, DOI 10.1161/HYPERTENSIONAHA.108.127514; Ministry of Health Welfare, 2010, KOR HLTH STAT 2009 K; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Myong JP, 2012, INT J COLORECTAL DIS, V27, P1061, DOI 10.1007/s00384-012-1428-4; Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Roos E, 1998, SOC SCI MED, V46, P1519, DOI 10.1016/S0277-9536(98)00032-X; Rural Development Administration, 2001, FOOD COMP TABL; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Silventoinen K, 2005, INT J EPIDEMIOL, V34, P327, DOI 10.1093/ije/dyi007; Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002; Stanley WC, 2009, HYPERTENSION, V54, P1209, DOI 10.1161/HYPERTENSIONAHA.109.128660; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78088	10.1371/journal.pone.0078088	http://dx.doi.org/10.1371/journal.pone.0078088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205105	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400070
J	Stagge, F; Mitronova, GY; Belov, VN; Wurm, CA; Jakobs, S				Stagge, Franziska; Mitronova, Gyuzel Y.; Belov, Vladimir N.; Wurm, Christian A.; Jakobs, Stefan			Snap-, CLIP- and Halo-Tag Labelling of Budding Yeast Cells	PLOS ONE			English	Article							LIVING CELLS; FUSION PROTEINS; LIVE CELLS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBES; FLUOROPHORES; TECHNOLOGY; MICROSCOPY; MOLECULES; NANOSCOPY	Fluorescence microscopy of the localization and the spatial and temporal dynamics of specifically labelled proteins is an indispensable tool in cell biology. Besides fluorescent proteins as tags, tag-mediated labelling utilizing self-labelling proteins as the SNAP-, CLIP-, or the Halo-tag are widely used, flexible labelling systems relying on exogenously supplied fluorophores. Unfortunately, labelling of live budding yeast cells proved to be challenging with these approaches because of the limited accessibility of the cell interior to the dyes. In this study we developed a fast and reliable electroporation-based labelling protocol for living budding yeast cells expressing SNAP-, CLIP-, or Halo-tagged fusion proteins. For the Halo-tag, we demonstrate that it is crucial to use the 6'-carboxy isomers and not the 5'-carboxy isomers of important dyes to ensure cell viability. We report on a simple rule for the analysis of H-1 NMR spectra to discriminate between 6'- and 5'-carboxy isomers of fluorescein and rhodamine derivatives. We demonstrate the usability of the labelling protocol by imaging yeast cells with STED super-resolution microscopy and dual colour live cell microscopy. The large number of available fluorophores for these self-labelling proteins and the simplicity of the protocol described here expands the available toolbox for the model organism Saccharomyces cerevisiae.	[Stagge, Franziska; Mitronova, Gyuzel Y.; Belov, Vladimir N.; Wurm, Christian A.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Stagge, Franziska; Wurm, Christian A.; Jakobs, Stefan] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, Dept Neurol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Wurm, CA (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	cwurm@gwdg.de; sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121; Belov, Vladimir N/0000-0002-7741-4653; Mitronova, Gyuzel/0000-0003-4376-6981	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft [JA 1129/3]	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (http://www.cmpb.de) and through grant JA 1129/3 (all to SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2004, MOL CELL BIOL, V15, P5616, DOI [10.1091/mbc.E04-06-0454, DOI 10.1091/MBC.E04-06-0454.PUBMED:15469986]; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; Hell SW., 2009, SINGLE MOL SPECTROSC, P298; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jakobs S, 2008, FIASHLW MILLER PROTE, P73; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; Muster B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011910; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Pellett PA, 2011, BIOMED OPT EXPRESS, V2, P2364, DOI 10.1364/BOE.2.002364; SCHERRER R, 1974, J BACTERIOL, V118, P534, DOI 10.1128/JB.118.2.534-540.1974; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Testa I, 2010, BIOPHYS J, V99, P2686, DOI 10.1016/j.bpj.2010.08.012; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; Wurm CA, 2010, J MICROSC-OXFORD, V240, P6, DOI 10.1111/j.1365-2818.2010.03378.x	29	67	67	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78745	10.1371/journal.pone.0078745	http://dx.doi.org/10.1371/journal.pone.0078745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205303	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400102
J	Lu, GF; Matsuura, SE; Barrientos, A; Scott, WA				Lu, Gaofei; Matsuura, Suzanne E.; Barrientos, Antoni; Scott, Walter A.			HIV-1 Infection Is Blocked at an Early Stage in Cells Devoid of Mitochondrial DNA	PLOS ONE			English	Article							NONDIVIDING CELLS; PROTEIN P-32; VIRUS; RESPONSES; IDENTIFICATION; ENTRY; VISUALIZATION; TRANSDUCTION; RESTRICTION; EXPRESSION	Human immunodeficiency virus type I (HIV-1) exploits various host cellular pathways for efficient infection. Here we report that the absence of mitochondrial DNA (mtDNA) in rho(0) cells markedly attenuates HIV-1 infection. Importantly, reduced infection efficiency in rho(0) cells is not simply the result of impaired oxidative phosphorylation (OXPHOS) because pharmacological OXPHOS inhibition did not inhibit HIV-1 infection. Analysis of the early steps of virus infection by real-time PCR quantification of stage-specific HIV-1 DNA products in the infected rho(0) and parental cell line have allowed us to conclude that HIV-1 infection in rho(0) cells is blocked at the steps that occur after reverse transcription and prior to nuclear import. Additionally, confocal fluorescence microscope analysis showed that the majority of viral complexes containing HIV-1 p24 co-localize with mitochondria in target cells, suggesting an interaction between the two. Collectively, our data strongly indicate that mitochondria play an important role during early stages of HIV-1 infection, probably through direct association with HIV-1 intracellular complexes.	[Lu, Gaofei; Matsuura, Suzanne E.; Barrientos, Antoni; Scott, Walter A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	abarrientos@med.miami.edu			National Institutes of Health [AI-39973]; American Heart Association [09PRE2280106]; Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; National Institutes of Health (NIH) [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039973, P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant AI-39973 (to W. A. S.) and a predoctoral fellowship from the American Heart Association (09PRE2280106 to G. L.). The authors acknowledge support from the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine funded by a grant (P30AI073961) from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; Beatch MD, 2005, J VIROL, V79, P10807, DOI 10.1128/JVI.79.16.10807-10820.2005; Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Claus C, 2011, J VIROL, V85, P3881, DOI 10.1128/JVI.02492-10; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fukumori T, 1998, FEBS LETT, V432, P17, DOI 10.1016/S0014-5793(98)00824-2; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Han M, 2008, ARCH PHARM RES, V31, P749, DOI 10.1007/s12272-001-1222-5; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Hendrickson SL, 2010, JAIDS-J ACQ IMM DEF, V53, P451, DOI 10.1097/QAI.0b013e3181cb8319; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; KAMEOKA M, 1993, FEBS LETT, V331, P182, DOI 10.1016/0014-5793(93)80322-L; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LEBLONDLAROUCHE L, 1979, J GEN VIROL, V44, P323, DOI 10.1099/0022-1317-44-2-323; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Luo TC, 1998, VIROLOGY, V241, P224, DOI 10.1006/viro.1997.8966; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Moraes CT, 2001, METHOD CELL BIOL, V65, P397, DOI 10.1016/S0091-679X(01)65023-4; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Rojo G, 1998, J VIROL, V72, P7583, DOI 10.1128/JVI.72.9.7583-7588.1998; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zheng Y-H, 2012, RETROVIROLOGY, V9, P1, DOI [10.1186/1742-4690-9-S1-I1., DOI 10.1186/1742-4690-9-S1-I1.PUBMED:22214232]; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78035	10.1371/journal.pone.0078035	http://dx.doi.org/10.1371/journal.pone.0078035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205077	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600062
J	Wang, YI; Bettaieb, A; Sun, CX; DeVerse, JS; Radecke, CE; Mathew, S; Edwards, CM; Haj, FG; Passerini, AG; Simon, SI				Wang, Ying I.; Bettaieb, Ahmed; Sun, Chongxiu; DeVerse, J. Sherrod; Radecke, Christopher E.; Mathew, Steven; Edwards, Christina M.; Haj, Fawaz G.; Passerini, Anthony G.; Simon, Scott I.			Triglyceride-Rich Lipoprotein Modulates Endothelial Vascular Cell Adhesion Molecule (VCAM)-1 Expression via Differential Regulation of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INDUCED ER STRESS; HOMOLOGOUS PROTEIN; NECROSIS; INFLAMMATION; HOMEOSTASIS; PALMITATE; OBESITY; GENES	Circulating triglyceride-rich lipoproteins (TGRL) from hypertriglyceridemic subjects exacerbate endothelial inflammation and promote monocyte infiltration into the arterial wall. We have recently reported that TGRL isolated from human blood after a high-fat meal can elicit a pro- or anti-atherogenic state in human aortic endothelial cells (HAEC), defined as up- or down-regulation of VCAM-1 expression in response to tumor necrosis factor alpha (TNF alpha) stimulation, respectively. A direct correlation was found between subjects categorized at higher risk for cardiovascular disease based upon serum triglycerides and postprandial production of TGRL particles that increased VCAM-1-dependent monocyte adhesion to inflamed endothelium. To establish how TGRL metabolism is linked to VCAM-1 regulation, we examined endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) pathways. Regardless of its atherogenicity, the rate and extent of TGRL internalization and lipid droplet formation by HAEC were uniform. However, pro-atherogenic TGRL exacerbated ER membrane expansion and stress following TNF alpha stimulation, whereas anti-atherogenic TGRL ameliorated such effects. Inhibition of ER stress with a chemical chaperone 4-phenylbutyric acid decreased TNF alpha-induced VCAM-1 expression and abrogated TGRL's atherogenic effect. Activation of ER stress sensors PKR-like ER-regulated kinase (PERK) and inositol requiring protein 1 alpha (IRE1 alpha), and downstream effectors including eukaryotic initiation factor-2 alpha (eIF2 alpha), spliced X-box-binding protein 1 (sXBP1) and C/EBP homologous protein (CHOP), directly correlated with the atherogenic activity of an individual's TGRL. Modulation of ER stress sensors also correlated with changes in expression of interferon regulatory factor 1 (IRF-1), a transcription factor of Vcam-1 responsible for regulation of its expression. Moreover, knockdown studies using siRNA defined a causal relationship between the PERK/eIF2 alpha/CHOP pathway and IRF-1-mediated VCAM-1 expression. We conclude that ER stress and the UPR contribute to the regulation of Vcam-1 transcription as a function of the atherogenic nature of TGRL.	[Wang, Ying I.; Sun, Chongxiu; DeVerse, J. Sherrod; Radecke, Christopher E.; Mathew, Steven; Edwards, Christina M.; Passerini, Anthony G.; Simon, Scott I.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Bettaieb, Ahmed; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Simon, SI (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	sisimon@ucdavis.edu	Wang, Ying/AAW-4053-2021	Wang, Ying/0000-0003-0236-5962; Passerini, Anthony/0000-0001-8007-4672; , ChongXiu/0000-0001-8425-5024	National Institutes of Health [HL082689, R01DK090492]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants HL082689 to SIS and AGP, and R01DK090492 to FGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boden G, 2009, DIABETES, V58, P518, DOI 10.2337/db08-1746; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, ENDOPLASMIC RETICULU; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUS HG, 1991, ATHEROSCLEROSIS, V89, P247; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SUN CT, 2012, FRACTURE MECHANICS, P1, DOI DOI 10.1161/CIRCRESAHA.112.270314; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; Wang YI, 2011, AM J PHYSIOL-HEART C, V300, pH784, DOI 10.1152/ajpheart.01036.2010; Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	39	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78322	10.1371/journal.pone.0078322	http://dx.doi.org/10.1371/journal.pone.0078322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205197	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600093
J	Abramova, A; Sakaguchi, S; Schebesta, A; Hassan, H; Boucheron, N; Valent, P; Roers, A; Ellmeier, W				Abramova, Anastasia; Sakaguchi, Shinya; Schebesta, Alexandra; Hassan, Hammad; Boucheron, Nicole; Valent, Peter; Roers, Axel; Ellmeier, Wilfried			The Transcription Factor MAZR Preferentially Acts as a Transcriptional Repressor in Mast Cells and Plays a Minor Role in the Regulation of Effector Functions in Response to Fc epsilon RI Stimulation	PLOS ONE			English	Article							FINGER PROTEIN MAZR; LARGE GENE LISTS; TYROSINE KINASE; PATZ1 GENE; AT-HOOK; MITF; EXPRESSION; PHENOTYPE; FATE; MICE	Mast cells are key players in type I hypersensitivity reactions in humans and mice and their activity has to be tightly controlled. Previous studies implicated the transcription factor MAZR in the regulation of mast cell function. To study the role of MAZR in mast cells, we generated a conditional Mazr allele and crossed Mazr(F/F) mice with the Vav-iCre deleter strain, which is active in all hematopoietic cells. MAZR-null BM-derived mast cells (BMMC) were phenotypically indistinguishable from wild-type BMMCs, although the numbers of IL-3 generated Mazr(F/F)Vav-iCre BMMCs were reduced in comparison to Mazr(F/F) BMMCs, showing that MAZR is required for the efficient generation of BMMC in vitro. A gene expression analysis revealed that MAZR-deficiency resulted in the dysregulation of 128 genes, with more genes up-than down-regulated in the absence of MAZR, indicating that MAZR acts as a transcriptional repressor in mast cells. Among the up-regulated genes were the chemokines Ccl5, Cxcl10, Cxcl12, the chemokine receptor Ccr5 and the cytokine IL18, suggesting an immunoregulatory role for MAZR in mast cells. Enforced expression of MAZR in mature Mazr-deficient BMMCs rescued the altered expression pattern of some genes tested, suggesting direct regulation of these genes by MAZR. Upon Fc epsilon RI stimulation, Mazr expression was transiently down-regulated in BMMCs. However, early and late effector functions in response to Fc epsilon RI-mediated stimulation were not impaired in the absence of MAZR, with the exception of IL-6, which was slightly decreased. Taken together, out data indicate that MAZR preferentially acts as a transcriptional repressor in mast cells, however MAZR plays only a minor role in the transcriptional networks that regulate early and late effector functions in mast cells in response to Fc epsilon RI stimulation.	[Abramova, Anastasia; Sakaguchi, Shinya; Schebesta, Alexandra; Hassan, Hammad; Boucheron, Nicole; Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany	Medical University of Vienna; Medical University of Vienna; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Ellmeier, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at	Test, Test/Y-7921-2019; Hassan, Hammad/J-2125-2012; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, PV/U-9451-2019	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Boucheron, Nicole/0000-0002-4979-8311; Sakaguchi, Shinya/0000-0002-0591-2469; Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund/Medical University of Vienna doctoral program [DK W1212]; Austrian Science Fund [P19930, P23641, I00698]; EU Marie Curie RTN Chromatin Plasticity; Vienna Science and Technology Fund (WWTF) [LS09-031]; FWF [P24265, P23669]; Austrian Science Fund (FWF) [P 23669, P 23641] Funding Source: researchfish	Austrian Science Fund/Medical University of Vienna doctoral program; Austrian Science Fund(Austrian Science Fund (FWF)); EU Marie Curie RTN Chromatin Plasticity; Vienna Science and Technology Fund (WWTF); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work in the laboratory of W. E. was supported by the Austrian Science Fund/Medical University of Vienna doctoral program (DK W1212) "Inflammation and Immunity", by the Austrian Science Fund (P19930, P23641, I00698), by the EU Marie Curie RTN Chromatin Plasticity and by the Vienna Science and Technology Fund (WWTF; project LS09-031). N.B. and S. S. are funded by the FWF (P24265 and P23669, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Carmi I, 2007, IMMUNOL REV, V217, P280, DOI 10.1111/j.1600-065X.2007.00508.x; Cho JH, 2012, CELL DEATH DIFFER, V19, P703, DOI 10.1038/cdd.2011.142; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kitamura Y, 2002, MOL IMMUNOL, V38, P1173, DOI 10.1016/S0161-5890(02)00058-5; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Levy C, 2002, J BIOL CHEM, V277, P1962, DOI 10.1074/jbc.M109236200; Morii E, 2002, J BIOL CHEM, V277, P8566, DOI 10.1074/jbc.M110392200; Pero R, 2012, J BIOL CHEM, V287, P18308, DOI 10.1074/jbc.M112.346270; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shahlaee AH, 2007, J IMMUNOL, V178, P378, DOI 10.4049/jimmunol.178.1.378; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tshori S, 2012, BBA-MOL BASIS DIS, V1822, P42, DOI 10.1016/j.bbadis.2010.12.024; Valentino T, 2013, J CELL PHYSIOL, V228, P646, DOI 10.1002/jcp.24174	29	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77677	10.1371/journal.pone.0077677	http://dx.doi.org/10.1371/journal.pone.0077677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204913	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200063
J	Plumptre, CD; Ogunniyi, AD; Paton, JC				Plumptre, Charles D.; Ogunniyi, Abiodun D.; Paton, James C.			Vaccination against Streptococcus pneumoniae Using Truncated Derivatives of Polyhistidine Triad Protein D	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; SECONDARY STRUCTURE ANALYSES; VIRULENCE PROTEINS; BINDING PROTEIN; IN-VIVO; IMMUNOGENICITY; EXPRESSION; ANTIGENS; MICE; IDENTIFICATION	Polyhistidine triad protein D (PhtD) has been described as a promising vaccine candidate for use against Streptococcus pneumoniae, but there has been a lack of examination of its structure and of which region(s) of the protein are targeted by protective immune responses. In this study, we purified recombinant truncated derivatives of PhtD and examined their secondary structural composition, as well as their capacity to bind antibodies from polyclonal murine serum generated against the full length protein. This allowed the identification of a particularly immunogenic fragment of PhtD, which was also purified and characterised. The truncated derivatives were tested as vaccine antigens in mouse models of pneumococcal sepsis and colonisation, using alum and E. coli heat labile toxin B subunit respectively as adjuvants. These experiments revealed that whilst the immunogenic region identified may be a promising candidate to protect against sepsis, the full length PhtD was ineffective at conferring significant protective immunity. These results are significant for the potential for PhtD to be used in novel vaccines, which are currently being tested in clinical trials.	[Plumptre, Charles D.; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Paton, JC (corresponding author), Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	james.paton@adelaide.edu.au		Ogunniyi, Abiodun/0000-0001-9308-5629	National Health and Medical Research Council (NHMRC) of Australia [565526]; Australian Research Council [DP120101432]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/) of Australia (Program Grant 565526 to JCP) and the Australian Research Council (http://www.arc.gov.au/; Discovery Project Grant DP120101432 to JCP). JCP is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076; Briles DE, 2006, 2006 EUR INF LUNG DI; Briles DE, 2009, NEW GENERATION VACCI, P908; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kadioglu Aras, 2005, Briefings in Functional Genomics & Proteomics, V4, P241, DOI 10.1093/bfgp/4.3.241; Khan MN, 2013, INFECT IMMU IN PRESS; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; McCullers JA, 2001, FRONT BIOSCI-LANDMRK, V6, pD877, DOI 10.2741/McCullers; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; PATON JC, 1991, INFECT IMMUN, V59, P2297, DOI 10.1128/IAI.59.7.2297-2304.1991; Plumptre CD, 2013, INFECT IMMU IN PRESS; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Rioux S, 2010, MICROBIOLOGY, V157, P336; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang Y, 2001, INFECT IMMUN, V69, P3827, DOI 10.1128/IAI.69.6.3827-3836.2001	32	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78916	10.1371/journal.pone.0078916	http://dx.doi.org/10.1371/journal.pone.0078916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205351	Green Published, Green Submitted, gold			2022-12-25	WOS:000326373800026
J	Xie, B; Wang, DP; Duan, Y; Yu, J; Lei, HX				Xie, Bin; Wang, Dapeng; Duan, Yong; Yu, Jun; Lei, Hongxing			Functional Networking of Human Divergently Paired Genes (DPGs)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; VIRUS TYPE-1 INFECTION; CD8(+) T-CELLS; BIDIRECTIONAL PROMOTERS; EXPRESSION; CONSERVATION; PATHWAYS; DISEASE; ORGANIZATION; METASTASIS	Divergently paired genes (DPGs), also known as bidirectional (head-to-head positioned) genes, are conserved across species and lineages, and thus deemed to be exceptional in genomic organization and functional regulation. Despite previous investigations on the features of their conservation and gene organization, the functional relationship among DPGs in a given species and lineage has not been thoroughly clarified. Here we report a network-based comprehensive analysis on human DPGs and our results indicate that the two members of the DPGs tend to participate in different biological processes while enforcing related functions as modules. Comparing to randomly paired genes as a control, the DPG pairs have a tendency to be clustered in similar "cellular components" and involved in similar "molecular functions". The functional network bridged by DPGs consists of three major modules. The largest module includes many house-keeping genes involved in core cellular activities. This module also shows low variation in expression in both CNS (central nervous system) and non-CNS tissues. Based on analyses of disease transcriptome data, we further suggest that this particular module may play crucial roles in HIV infection and its disease mechanism.	[Xie, Bin; Wang, Dapeng; Yu, Jun; Lei, Hongxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Xie, Bin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Duan, Yong; Lei, Hongxing] UC Davis Genome Ctr, Davis, CA USA; [Duan, Yong; Lei, Hongxing] Dept Biomed Engn, Davis, CA USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn; leihx@big.ac.cn	Wang, Dapeng/HGD-4818-2022; Duan, Yong/D-3475-2013	Duan, Yong/0000-0003-3793-5099	NIH [GM67168]; NSFC [30870474]; MOST [2011CB944100]; CAS Youth Innovation Promotion Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS Youth Innovation Promotion Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from NIH (Grant GM67168 to YD), NSFC (Grant 30870474 to HL), and MOST (2011CB944100 to JY), and the special grant of CAS Youth Innovation Promotion Association awarded to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2004, REPROD FERT DEVELOP, V16, P527, DOI 10.1071/RD03096; Herr DR, 2004, FEBS LETT, V572, P147, DOI 10.1016/j.febslet.2004.07.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; LaBreche HG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-61; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Liu BC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S2; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Setlur SR, 2007, CANCER RES, V67, P10296, DOI 10.1158/0008-5472.CAN-07-2173; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Sun JY, 2012, J ALZHEIMERS DIS, V28, P389, DOI 10.3233/JAD-2011-111313; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Wang DP, 2012, EVOL BIOINFORM, V8, P39, DOI 10.4137/EBO.S8540; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Woo YH, 2011, P NATL ACAD SCI USA, V108, P3306, DOI 10.1073/pnas.1100210108; Yang L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-55; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	54	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78896	10.1371/journal.pone.0078896	http://dx.doi.org/10.1371/journal.pone.0078896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205343	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800024
J	Federolf, PA				Federolf, Peter Andreas			A Novel Approach to Solve the "Missing Marker Problem'' in Marker-Based Motion Analysis That Exploits the Segment Coordination Patterns in Multi-Limb Motion Data	PLOS ONE			English	Article							GAIT; STEREOPHOTOGRAMMETRY; VARIABILITY; KINEMATICS; ARTIFACT; SYSTEMS; PCA; AGE	Marker-based human motion analysis is an important tool in clinical research and in many practical applications. Missing marker information caused by occlusions or a marker falling off is a common problem impairing data quality. The current paper proposes a conceptually new gap filling algorithm and presents results from a proof-of-principle analysis. The underlying idea of the proposed algorithm was that a multitude of internal and external constraints govern human motion and lead to a highly subject-specific movement pattern in which all motion variables are intercorrelated in a specific way. Two principal component analyses were used to determine how the coordinates of a marker with gaps correlated with the coordinates of the other, gap-free markers. Missing marker data could then be reconstructed through a series of coordinate transformations. The proposed algorithm was tested by reconstructing artificially created gaps in a 20-step walking trial and in an 18-s one-leg balance trial. The measurement accuracy's dependence on the marker position, the length of the gap, and other parameters were evaluated. Even if only 2 steps of walking or 1.8 s of postural sway (10% of the whole marker data) were provided as input in the current study, the reconstructed marker trajectory differed on average no more than 11 mm from the originally measured trajectory. The reconstructed result improved further, on average, to distances below 5 mm if the marker trajectory was available more than 50% of the trial. The results of this proof-of-principle analysis supported the assumption that missing marker information can be reconstructed from the intercorrelations between marker coordinates, provided that sufficient data with complete marker information is available. Estimating missing information cannot be avoided entirely in many situations in human motion analysis. For some of these situations, the proposed reconstruction method may provide a better solution than what is currently available.	Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	Norwegian School of Sport Sciences	Federolf, PA (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	peter.federolf@nih.no	Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813				Aristidou A, 2013, VISUAL COMPUT, V29, P7, DOI 10.1007/s00371-011-0671-y; Baumann J, 2011, WORKSH VIRT REAL INT, V33; Benoit DL, 2006, GAIT POSTURE, V24, P152, DOI 10.1016/j.gaitpost.2005.04.012; Boyer KA, 2012, J BIOMECH, V45, P1619, DOI 10.1016/j.jbiomech.2012.04.010; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Dorfmuller-Ulhaas K, 2003, TECHNICAL REPORT; Erer KS, 2007, J BIOMECH, V40, P2934, DOI 10.1016/j.jbiomech.2007.02.019; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Federolf P, 2014, SCAND J MED SCI SPOR, V24, P491, DOI 10.1111/j.1600-0838.2012.01455.x; Federolf P, 2013, J BIOMECHAN IN PRESS, DOI [10.1016/j.jbiomech.2013.08.008, DOI 10.1016/J.JBI0MECH.2013.08.008]; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Federolf P, 2012, J BIOMECH, V45, P1127, DOI 10.1016/j.jbiomech.2012.02.008; Federolf PA, 2012, FOOTWEAR SCI, V4, P115, DOI 10.1080/19424280.2012.666270; Giakas G, 1997, J BIOMECH, V30, P851, DOI 10.1016/S0021-9290(97)00043-2; Howarth SJ, 2010, COMPUT METHOD BIOMEC, V13, P847, DOI 10.1080/10255841003664701; KAMM K, 1990, PHYS THER, V70, P763, DOI 10.1093/ptj/70.12.763; Ko YG, 2003, HUM MOVEMENT SCI, V22, P47, DOI 10.1016/S0167-9457(02)00177-X; Liu GD, 2006, VISUAL COMPUT, V22, P721, DOI 10.1007/s00371-006-0080-9; Lou H, 2010, IEEE T VIS COMPUT GR, V16, P870, DOI 10.1109/TVCG.2010.23; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; Nikolai Bernstein, 1967, COORDINATION REGULAT; Piazza T, 2009, LECT NOTES COMPUT SC, V5903, P125, DOI 10.1007/978-3-642-10470-1_11; Qiong Wu, 2011, 2011 XIII Symposium on Virtual Reality (SVR), P161, DOI 10.1109/SVR.2011.35; Stagni R, 2005, CLIN BIOMECH, V20, P320, DOI 10.1016/j.clinbiomech.2004.11.012; THELEN E, 1987, DEV REV, V7, P39, DOI 10.1016/0273-2297(87)90004-9; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; Xiao J, 2011, COMPUT ANIMAT VIRT W, V22, P221, DOI 10.1002/cav.413	32	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78689	10.1371/journal.pone.0078689	http://dx.doi.org/10.1371/journal.pone.0078689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205295	Green Submitted, gold, Green Published			2022-12-25	WOS:000326334500129
J	Prats, C; Gomez-Cabello, A; Nordby, P; Andersen, JL; Helge, JW; Dela, F; Baba, O; Ploug, T				Prats, Clara; Gomez-Cabello, Alba; Nordby, Pernille; Andersen, Jesper L.; Helge, Jorn W.; Dela, Flemming; Baba, Otto; Ploug, Thorkil			An Optimized Histochemical Method to Assess Skeletal Muscle Glycogen and Lipid Stores Reveals Two Metabolically Distinct Populations of Type I Muscle Fibers	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPIDS; EXERCISE; DROPLETS; RED	Skeletal muscle energy metabolism has been a research focus of physiologists for more than a century. Yet, how the use of intramuscular carbohydrate and lipid energy stores are coordinated during different types of exercise remains a subject of debate. Controversy arises from contradicting data from numerous studies, which used different methodological approaches. Here we review the "pros and cons" of previously used histochemical methods and describe an optimized method to ensure the preservation and specificity of detection of both intramyocellular carbohydrate and lipid stores. For optimal preservation of muscle energy stores, air drying cryosections or cycles of freezing-thawing need to be avoided. Furthermore, optimization of the imaging settings in order to specifically image intracellular lipid droplets stained with oil red O or Bodipy-493/503 is shown. When co-staining lipid droplets with associated proteins, Bodipy-493/503 should be the dye of choice, since oil red O creates precipitates on the lipid droplets blocking the light. In order to increase the specificity of glycogen stain, an antibody against glycogen is used. The resulting method reveals the existence of two metabolically distinct myosin heavy chain I expressing fibers: I-1 fibers have a smaller crossectional area, a higher density of lipid droplets, and a tendency to lower glycogen content compared to I-2 fibers. Type I-2 fibers have similar lipid content than IIA. Exhaustive exercise lead to glycogen depletion in type IIA and IIX fibers, a reduction in lipid droplets density in both type I-1 and I-2 fibers, and a decrease in the size of lipid droplets exclusively in type I-1 fibers.	[Prats, Clara; Andersen, Jesper L.; Helge, Jorn W.; Dela, Flemming] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Nordby, Pernille; Ploug, Thorkil] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Gomez-Cabello, Alba] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Andersen, Jesper L.] Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Copenhagen, Denmark; [Baba, Otto] Tokyo Med & Dent Univ, Tokyo, Japan	University of Copenhagen; University of Copenhagen; University of Zaragoza; University of Copenhagen; Bispebjerg Hospital; Tokyo Medical & Dental University (TMDU)	Prats, C (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.	cprats@sund.ku.dk	Dela, Flemming/AAU-1691-2021; Andersen, Jesper L/W-6813-2019; Dela, Flemming/B-3239-2008; Helge, Jørn Wulff/I-7096-2012; Gómez-Cabello, Alba/H-5891-2015; Prats, Clara/F-5993-2014	Dela, Flemming/0000-0001-9970-9535; Dela, Flemming/0000-0001-9970-9535; Helge, Jørn Wulff/0000-0001-9724-5423; Prats, Clara/0000-0001-6465-3068; Nordby, Pernille/0000-0002-3934-6952; Ploug, Thorkil/0000-0002-5375-6595	Nordea Foundation; Novonordisk Foundation	Nordea Foundation; Novonordisk Foundation(Novo Nordisk Foundation)	This work was financed by Nordea Foundation (https://www.nordeafonden.dk/om-fonden) and Novonordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2000, MUSCLE NERVE, V23, P1095; ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BONILLA E, 1987, J HISTOCHEM CYTOCHEM, V35, P619, DOI 10.1177/35.5.3559182; COSTILL DL, 1971, J APPL PHYSIOL, V31, P353, DOI 10.1152/jappl.1971.31.3.353; Decombaz J, 2001, AM J PHYSIOL-REG I, V281, pR760, DOI 10.1152/ajpregu.2001.281.3.R760; Donsmark M, 2005, EXERC SPORT SCI REV, V33, P127, DOI 10.1097/00003677-200507000-00005; Fairchild TJ, 2004, MED SCI SPORT EXER, V36, P2053, DOI 10.1249/01.MSS.0000147586.85615.C4; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; Nakamura-Tsuruta S, 2012, CARBOHYD RES, V350, P49, DOI 10.1016/j.carres.2011.12.029; Nordby P, 2010, EUR J APPL PHYSIOL, V109, P935, DOI 10.1007/s00421-010-1428-4; Oakes ND, 1997, DIABETES, V46, P2022, DOI 10.2337/diabetes.46.12.2022; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Thompson SW, 1966, ELECTED HISTOCHEMICA; van Loon LJC, 2003, J PHYSIOL-LONDON, V553, P611, DOI 10.1113/jphysiol.2003.052431; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820	25	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77774	10.1371/journal.pone.0077774	http://dx.doi.org/10.1371/journal.pone.0077774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204959	Green Submitted, gold, Green Published			2022-12-25	WOS:000326334500057
J	Robins, SC; Trudel, E; Rotondi, O; Liu, XH; Djogo, T; Kryzskaya, D; Bourque, CW; Kokoeva, MV				Robins, Sarah C.; Trudel, Eric; Rotondi, Olivia; Liu, Xiaohong; Djogo, Tina; Kryzskaya, Darya; Bourque, Charles W.; Kokoeva, Maia V.			Evidence for NG2-glia Derived, Adult-Born Functional Neurons in the Hypothalamus	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; SYNAPTIC PLASTICITY; NG2 PROTEOGLYCAN; NEUROGENESIS; TANYCYTES; LINEAGE; MARKER; FATE; NEURODEGENERATION	Accumulating evidence suggests that the adult murine hypothalamus, a control site of several fundamental homeostatic processes, has neurogenic capacity. Correspondingly, the adult hypothalamus exhibits considerable cell proliferation that is ongoing even in the absence of external stimuli, and some of the newborn cells have been shown to mature into cells that express neuronal fate markers. However, the identity and characteristics of proliferating cells within the hypothalamic parenchyma have yet to be thoroughly investigated. Here we show that a subset of NG2-glia distributed throughout the mediobasal hypothalamus are proliferative and express the stem cell marker Sox2. We tracked the constitutive differentiation of hypothalamic NG2-glia by employing genetic fate mapping based on inducible Cre recombinase expression under the control of the NG2 promoter, demonstrating that adult hypothalamic NG2-glia give rise to substantial numbers of APC+ oligodendrocytes and a smaller population of HuC/D+ or NeuN+ neurons. Labelling with the cell proliferation marker BrdU confirmed that some NG2-derived neurons have proliferated shortly before differentiation. Furthermore, patch-clamp electrophysiology revealed that some NG2-derived cells display an immature neuronal phenotype and appear to receive synaptic input indicative of their electrical integration in local hypothalamic circuits. Together, our studies show that hypothalamic NG2-glia are able to take on neuronal fates and mature into functional neurons, indicating that NG2-glia contribute to the neurogenic capacity of the adult hypothalamus.	[Robins, Sarah C.; Rotondi, Olivia; Liu, Xiaohong; Djogo, Tina; Kryzskaya, Darya; Kokoeva, Maia V.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Trudel, Eric; Bourque, Charles W.] McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Kokoeva, MV (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	maia.kokoeva@mcgill.ca		Migaud, Martine/0000-0002-9496-0517; Bourque, Charles/0000-0002-1594-742X	Canadian Institute of Health Research (CIHR) [MOP-102511]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute of Health Research (CIHR, website: http://www.cihr-irsc.gc.ca/e/193.html) via grant number MOP-102511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GRAUS F, 1990, NEUROSCI LETT, V112, P14, DOI 10.1016/0304-3940(90)90314-Y; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hughes EG, 2013, NAT NEUROSCI; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAGNUSON DSK, 1995, DEV BRAIN RES, V84, P130, DOI 10.1016/0165-3806(94)00166-W; Mangin JM, 2011, ASN NEURO, V3, P37, DOI 10.1042/AN20110001; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Robins SC, 2013, GLIA, V61, P1735, DOI 10.1002/glia.22554; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	48	62	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78236	10.1371/journal.pone.0078236	http://dx.doi.org/10.1371/journal.pone.0078236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205170	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700086
J	Schachtschabel, D; Arentshorst, M; Nitsche, BM; Morris, S; Nielsen, KF; van den Hondel, CAMJJ; Klis, FM; Ram, AFJ				Schachtschabel, Doreen; Arentshorst, Mark; Nitsche, Benjamin M.; Morris, Sam; Nielsen, Kristian F.; van den Hondel, Cees A. M. J. J.; Klis, Frans M.; Ram, Arthur F. J.			The Transcriptional Repressor TupA in Aspergillus niger Is Involved in Controlling Gene Expression Related to Cell Wall Biosynthesis, Development, and Nitrogen Source Availability	PLOS ONE			English	Article							CANDIDA-ALBICANS REVEALS; STRAIN IVIC PB9; SACCHAROMYCES-CEREVISIAE; ASEXUAL SPORULATION; FILAMENT FORMATION; IDENTIFICATION; PROTEIN; GROWTH; ALPHA-1,3-GLUCAN; TRANSFORMATION	The Tup1-Cyc8 (Ssn6) complex is a well characterized and conserved general transcriptional repressor complex in eukaryotic cells. Here, we report the identification of the Tup1 (TupA) homolog in the filamentous fungus Aspergillus niger in a genetic screen for mutants with a constitutive expression of the agsA gene. The agsA gene encodes a putative alpha-glucan synthase, which is induced in response to cell wall stress in A. niger. Apart from the constitutive expression of agsA, the selected mutant was also found to produce an unknown pigment at high temperatures. Complementation analysis with a genomic library showed that the tupA gene could complement the phenotypes of the mutant. Screening of a collection of 240 mutants with constitutive expression of agsA identified sixteen additional pigment-secreting mutants, which were all mutated in the tupA gene. The phenotypes of the tupA mutants were very similar to the phenotypes of a tupA deletion strain. Further analysis of the tupA-17 mutant and the DtupA mutant revealed that TupA is also required for normal growth and morphogenesis. The production of the pigment at 37 degrees C is nitrogen source-dependent and repressed by ammonium. Genome-wide expression analysis of the tupA mutant during exponential growth revealed derepression of a large group of diverse genes, including genes related to development and cell wall biosynthesis, and also protease-encoding genes that are normally repressed by ammonium. Comparison of the transcriptome of up-regulated genes in the tupA mutant showed limited overlap with the transcriptome of caspofungin-induced cell wall stress-related genes, suggesting that TupA is not a general suppressor of cell wall stress-induced genes. We propose that TupA is an important repressor of genes related to development and nitrogen metabolism.	[Schachtschabel, Doreen; Arentshorst, Mark; Morris, Sam; van den Hondel, Cees A. M. J. J.; Ram, Arthur F. J.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Nitsche, Benjamin M.] Berlin Univ Technol, Inst Biotechnol, Berlin, Germany; [Nielsen, Kristian F.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Ram, Arthur F. J.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; Technical University of Berlin; Technical University of Denmark; University of Amsterdam	Ram, AFJ (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	a.f.j.ram@biology.leidenuniv.nl	Ram, Arthur FJ/S-4648-2017; Nielsen, Kristian Fog/C-7233-2011	Ram, Arthur FJ/0000-0002-2487-8016; Nielsen, Kristian Fog/0000-0002-5848-0911; Van den Hondel, Kees/0000-0003-4782-2725	Netherlands Genomics Initiative	Netherlands Genomics Initiative	The research group of A.F.J. Ram is part of the Kluyver Centre for Genomics of Industrial Fermentation (http://www.kluyvercentre.nl), which is supported by the Netherlands Genomics Initiative (http://www.genomics.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; [Anonymous], FUNGAL GENET BIOL, V49, P284; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett J. W., 1991, MORE GENE MANIPULATI, P441; Biesebeke RT, 2005, APPL MICROBIOL BIOT, V67, P75, DOI 10.1007/s00253-004-1807-z; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P873, DOI 10.1016/j.fgb.2005.06.006; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875; DERUITERJACOBS YMJT, 1989, CURR GENET, V16, P159, DOI 10.1007/BF00391472; Elias-Villalobos A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002235; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Garcia I, 2008, FEMS MICROBIOL LETT, V289, P146, DOI 10.1111/j.1574-6968.2008.01379.x; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Green SR, 2005, MOL BIOL CELL, V16, P2605, DOI 10.1091/mbc.e05-02-0126; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Heintz-Buschart A, 2013, J BIOTECHNOL, V164, P137, DOI 10.1016/j.jbiotec.2012.12.004; Hicks J, 2001, MOL MICROBIOL, V39, P1482, DOI 10.1046/j.1365-2958.2001.02332.x; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janoo RTK, 2001, GENETICS, V157, P1205; JARAI G, 1994, CURR GENET, V26, P238, DOI 10.1007/BF00309554; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; KELLY JM, 1985, EMBO J, V4, P475, DOI 10.1002/j.1460-2075.1985.tb03653.x; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Knight SAB, 2002, MICROBIOL-SGM, V148, P29, DOI 10.1099/00221287-148-1-29; Kobayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1797, DOI 10.1271/bbb.70132; Kobayashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P50, DOI 10.1016/j.bbrc.2008.01.033; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Lee H, 2005, MOL MICROBIOL, V55, P1222, DOI 10.1111/j.1365-2958.2004.04458.x; Lee H, 2009, EUKARYOT CELL, V8, P1901, DOI 10.1128/EC.00256-09; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Levin AM, 2007, EUKARYOT CELL, V6, P2311, DOI 10.1128/EC.00244-07; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Masloff S, 1999, GENETICS, V152, P191; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; MITCHELL LH, 1979, EXP CELL RES, V120, P167, DOI 10.1016/0014-4827(79)90547-0; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Nitsche BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-486; Parnell EJ, 2011, GENE DEV, V25, P2429, DOI 10.1101/gad.181768.111; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Punt PJ, 2008, FUNGAL GENET BIOL, V45, P1591, DOI 10.1016/j.fgb.2008.09.007; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Robledo-Briones M, 2013, FEMS YEAST RES, V13, P74, DOI 10.1111/1567-1364.12011; Ruiz-Herrera J, 2002, ARCH MICROBIOL, V178, P477, DOI 10.1007/s00203-002-0478-3; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANBLAS F, 1976, J GEN MICROBIOL, V93, P209, DOI 10.1099/00221287-93-2-209; SANBLAS G, 1977, INFECT IMMUN, V15, P897, DOI 10.1128/IAI.15.3.897-902.1977; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Szabo R, 2002, FEMS MICROBIOL LETT, V206, P45, DOI 10.1111/j.1574-6968.2002.tb10984.x; Todd RB, 2003, MOL MICROBIOL, V48, P85, DOI 10.1046/j.1365-2958.2003.03426.x; Morales-Vargas AT, 2012, RES MICROBIOL, V163, P378, DOI 10.1016/j.resmic.2012.03.002; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; van den Hombergh JPTW, 1996, THESIS WAGENINGEN AG; VANGORCOM RFM, 1988, NUCLEIC ACIDS RES, V16, P9052, DOI 10.1093/nar/16.18.9052; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017	89	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78102	10.1371/journal.pone.0078102	http://dx.doi.org/10.1371/journal.pone.0078102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205111	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700074
J	Zhang, L; Sun, XY; Tian, Y; Gong, XQ				Zhang, Lu; Sun, Xiangyang; Tian, Yun; Gong, Xiaoqiang			Composted Green Waste as a Substitute for Peat in Growth Media: Effects on Growth and Nutrition of Calathea insignis	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; SEWAGE-SLUDGE; ORGANIC-MATTER; GROWING MEDIA; PLANT-GROWTH; COMPONENTS; EVOLUTION; COMMUNITY; BIOCHAR	Peat mined from endangered wetland ecosystems is generally used as a component in soilless potting media in horticulture but is a costly and non-renewable natural resource. The objective of this work was to study the feasibility of replacing peat with different percentages (0, 10, 30, 50, 70, 90, and 100%) of composted green waste (CGW) as growth media for the production of the ornamental plant Calathea insignis. Compared with 100% peat media, media containing CGW had improved physical and chemical characteristics to achieve the acceptable ranges. Moreover, CGW addition had increased the stability (i.e., reduced the decomposition rates) of growth media mixtures, as indicated by comparison of particle-size distribution at the start and end of a 7-month greenhouse experiment. Addition of CGW also supported increased plant growth (biomass production, root morphology, nutrient contents, and photosynthetic pigment contents). The physical and chemical characteristics of growth media and plant growth were best with a medium containing 70% CGW and were better in a medium with 100% CGW than in one with 100% peat media. These results indicate that CGW is a viable alternative to peat for the cultivation of Calathea insignis.	[Zhang, Lu; Sun, Xiangyang; Gong, Xiaoqiang] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Tian, Yun] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLYJ201308]; Major Project of the Science and Technology of Beijing, China [D09040903780801]; Fund Project of the Agricultural Science and Technology Achievements transformation of China [2011GB23600002]; Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology [39]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major Project of the Science and Technology of Beijing, China; Fund Project of the Agricultural Science and Technology Achievements transformation of China; Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology	This study was supported by the Fundamental Research Funds for the Central Universities (No. BLYJ201308); the Major Project of the Science and Technology of Beijing, China (D09040903780801); the Fund Project of the Agricultural Science and Technology Achievements transformation of China (2011GB23600002) "the Transformation and Demonstration of Flowers and Trees Peat Substitution Growth Media Production Key Technology"; and the Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology (No. 39, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci M, 2013, BIORESOURCE TECHNOL, V134, P10, DOI 10.1016/j.biortech.2013.02.022; Ahmed H. F. S., 2012, African Journal of Biotechnology, V11, P10079; Aklibasinda M, 2011, J ANIM PLANT SCI, V21, P535; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Belyaeva ON, 2012, ENVIRON EARTH SCI, V66, P1987, DOI 10.1007/s12665-011-1424-y; Benito M, 2005, BIORESOURCE TECHNOL, V96, P597, DOI 10.1016/j.biortech.2004.06.006; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bustamante MA, 2008, RESOUR CONSERV RECY, V52, P792, DOI 10.1016/j.resconrec.2007.11.005; Cao ShiWei, 2012, African Journal of Biotechnology, V11, P3825; De Boodt M.A.V.O., 1972, ACTA HORTIC, V26, P37, DOI [10.17660/ActaHortic.1972.26.5, DOI 10.17660/ACTAHORTIC.1972.26.5]; Elhindi K. M., 2012, Australian Journal of Crop Science, V6, P1249; Farrell M, 2010, WASTE MANAGE, V30, P1495, DOI 10.1016/j.wasman.2010.01.032; Fornes F, 2012, BIORESOURCE TECHNOL, V118, P296, DOI 10.1016/j.biortech.2012.05.028; Gabhane J, 2012, BIORESOURCE TECHNOL, V114, P382, DOI 10.1016/j.biortech.2012.02.040; Grigatti M, 2004, BIORESOURCE TECHNOL, V91, P163, DOI 10.1016/S0960-8524(03)00170-6; Hicklenton PR, 2001, SCI HORTIC-AMSTERDAM, V91, P365, DOI 10.1016/S0304-4238(01)00251-5; Jahromi M. G., 2012, African Journal of Biotechnology, V11, P9036; Jayasinghe GY, 2012, CLEAN TECHNOL ENVIR, V14, P625, DOI 10.1007/s10098-011-0423-8; JIMENEZ EI, 1992, AGR ECOSYST ENVIRON, V38, P331, DOI 10.1016/0167-8809(92)90154-4; Khalil A, 2008, BIORESOURCE TECHNOL, V99, P6037, DOI 10.1016/j.biortech.2007.11.043; Khattak A. M., 2011, Sarhad Journal of Agriculture, V27, P201; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Lallawmsanga, 2012, Annals of Biological Research, V3, P2268; Lazcano C, 2009, SPAN J AGRIC RES, V7, P944, DOI 10.5424/sjar/2009074-1107; Legind CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047002; Lindani N., 2012, African Journal of Plant Science, V6, P120; Medina E, 2009, BIORESOURCE TECHNOL, V100, P4227, DOI 10.1016/j.biortech.2009.03.055; Mininni C, 2012, HORTSCIENCE, V47, P1438, DOI 10.21273/HORTSCI.47.10.1438; Ostos JC, 2008, BIORESOURCE TECHNOL, V99, P1793, DOI 10.1016/j.biortech.2007.03.033; Pal A. K., 2005, Journal of Interacademicia, V9, P33; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Pascual I, 2008, PLANT SOIL, V310, P41, DOI 10.1007/s11104-008-9626-0; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Perez-Murcia MD, 2006, BIORESOURCE TECHNOL, V97, P123, DOI 10.1016/j.biortech.2005.02.005; Redjala T, 2011, ENVIRON EXP BOT, V71, P241, DOI 10.1016/j.envexpbot.2010.12.010; Ribeiro HM, 2007, BIORESOURCE TECHNOL, V98, P3294, DOI 10.1016/j.biortech.2006.07.002; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Suo LN, 2011, J HORTIC SCI BIOTECH, V86, P366, DOI 10.1080/14620316.2011.11512775; Tian Y, 2012, SCI HORTIC-AMSTERDAM, V143, P15, DOI 10.1016/j.scienta.2012.05.018; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhao SL, 2013, BIORESOURCE TECHNOL, V129, P249, DOI 10.1016/j.biortech.2012.11.075	41	24	28	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78121	10.1371/journal.pone.0078121	http://dx.doi.org/10.1371/journal.pone.0078121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205121	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700078
J	Li, SL; Zheng, QF; Ma, YY; Wang, YZ; Feng, Y; Zhao, BT; Yang, Y				Li, Shaolei; Zheng, Qingfeng; Ma, Yuanyuan; Wang, Yuzhao; Feng, Yuan; Zhao, Bingtian; Yang, Yue			Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of F-18-FDGPET/CT	PLOS ONE			English	Article							CELL LUNG-CANCER; VISCERAL PLEURAL INVASION; INTEGRATED FDG-PET/CT; RISK-FACTORS; METASTASIS; CT; TOMOGRAPHY; RECURRENCE; SURVIVAL; PATTERN	Background: Integrated F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) is widely performed in hilar and mediastinal lymph node (HMLN) staging of non-small cell lung cancer (NSCLC). However, the diagnostic efficiency of PET/CT remains controversial. This retrospective study is to evaluate the accuracy of PET/CT and the characteristics of false negatives and false positives to improve specificity and sensitivity. Methods: 219 NSCLC patients with systematic lymph node dissection or sampling underwent preoperative PET/CT scan. Nodal uptake with a maximum standardized uptake value (SUVmax) >2.5 was interpreted as PET/CT positive. The results of PET/CT were compared with the histopathological findings. The receiver operating characteristic (ROC) curve was generated to determine the diagnostic efficiency of PET/CT. Univariate and multivariate analysis were conducted to detect risk factors of false negatives and false positives. Results: The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PET/CT in detecting HMLN metastases were 74.2% (49/66), 73.2% (112/153), 54.4% (49/90), 86.8% (112/129), and 73.5% (161/219). The ROC curve had an area under curve (AUC) of 0.791 (95% CI 0.723-0.860). The incidence of false negative HMLN metastases was 13.2% (17 of 129 patients). Factors that are significantly associated with false negatives are: concurrent lung disease or diabetes (p<0.001), non-adenocarcinoma (p<0.001), and SUVmax of primary tumor >4.0 (p=0.009). Postoperatively, 45.5% (41/90) patients were confirmed as false positive cases. The univariate analysis indicated age >65 years old (p=0.009), well differentiation (p=0.002), and SUVmax of primary tumor <= 4.0 (p=0.007) as risk factors for false positive uptake. Conclusion: The SUVmax of HMLN is a predictor of malignancy. Lymph node staging using PET/CT is far from equal to pathological staging account of some risk factors. This study may provide some aids to pre-therapy evaluation and decision-making.	[Li, Shaolei; Zheng, Qingfeng; Ma, Yuanyuan; Wang, Yuzhao; Feng, Yuan; Zhao, Bingtian; Yang, Yue] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China	Peking University	Yang, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China.	zlyangyue@bjmu.edu.cn			Beijing Natural Science Foundation [11G2633]; National High Technology Research and Development Program of China (863 Program) [2012AA02A502]; Beijing Municipal Science & Technology Commission [Z111107067311018]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported partially by Beijing Natural Science Foundation (Grant Nos 11G2633), the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A502), and Beijing Municipal Science & Technology Commission (No. Z111107067311018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf N, 2008, EUR J CARDIO-THORAC, V33, P104, DOI 10.1016/j.ejcts.2007.09.026; Bayman NA, 2008, CLIN LUNG CANCER, V9, P92, DOI 10.3816/CLC.2008.n.014; Bilfinger Thomas V, 2003, Respir Care Clin N Am, V9, P141, DOI 10.1016/S1078-5337(02)00086-2; Bryant AS, 2006, ANN THORAC SURG, V82, P417, DOI 10.1016/j.athoracsur.2005.12.047; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007; Cerfolio RJ, 2006, CHEST, V130, P1791, DOI 10.1378/chest.130.6.1791; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Hu M, 2011, CLIN NUCL MED, V36, P429, DOI 10.1097/RLU.0b013e3182173810; Kamiyoshihara M, 2001, J CARDIOVASC SURG, V42, P119; Kanzaki R, 2011, LUNG CANCER, V71, P333, DOI 10.1016/j.lungcan.2010.06.008; Kubota K, 2011, ANN NUCL MED, V25, P777, DOI 10.1007/s12149-011-0529-4; Kudo Y, 2012, LUNG CANCER, V78, P153, DOI 10.1016/j.lungcan.2012.08.004; Lee PC, 2007, ANN THORAC SURG, V84, P177, DOI 10.1016/j.athoracsur.2007.03.081; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Senthi S, 2012, LANCET ONCOL, V13, P802, DOI 10.1016/S1470-2045(12)70242-5; Sheel ARG, 2013, ANN THORAC SURG, V95, P276, DOI 10.1016/j.athoracsur.2012.09.051; Shim SS, 2005, RADIOLOGY, V236, P1011, DOI 10.1148/radiol.2363041310; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; Tieu Brandon H, 2008, Thorac Surg Clin, V18, P403, DOI 10.1016/j.thorsurg.2008.07.004; Zhao L, 2012, SURG ONCOL, V21, P230, DOI 10.1016/j.suronc.2011.11.001	20	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78552	10.1371/journal.pone.0078552	http://dx.doi.org/10.1371/journal.pone.0078552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205256	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400085
J	Miyasaka, T; Akahori, Y; Toyama, M; Miyamura, N; Ishii, K; Saijo, S; Iwakura, Y; Kinjo, Y; Miyazaki, Y; Oishi, K; Kawakami, K				Miyasaka, Tomomitsu; Akahori, Yukiko; Toyama, Masahiko; Miyamura, Namiko; Ishii, Keiko; Saijo, Shinobu; Iwakura, Yoichiro; Kinjo, Yuki; Miyazaki, Yoshitsugu; Oishi, Kazunori; Kawakami, Kazuyoshi			Dectin-2-Dependent NKT Cell Activation and Serotype-Specific Antibody Production in Mice Immunized with Pneumococcal Polysaccharide Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; KILLER T-CELLS; COMMUNITY-ACQUIRED PNEUMONIA; MURINE B-CELLS; INTERFERON-GAMMA; HOST-DEFENSE; CAPSULAR POLYSACCHARIDES; DENDRITIC CELLS; ADULT PATIENTS; RESPONSES	Although thymus-independent type 2 antigens generally do not undergo Ig class switching from IgM to IgG, pneumococcal polysaccharide vaccine (PPV) induces the production of serotype-specific IgG. How this happens remains unclear, however. In the present study, PPV immunization induced production of IgG as well as IgM specific for a serotype 3-pneumococcal polysaccharide in the sera of wild-type (WT) mice, but this phenomenon was significantly reduced in Dectin-2 knockout (KO) mice. Immunization with PPV caused IL-12p40 production in WT mice, but this response was significantly reduced in Dectin-2KO mice. Likewise, immunization with PPV activated natural killer T (NKT) cells in WT mice but not in Dectin-2KO mice. Furthermore, administration of alpha-galactosylceramide, recombinant (r) IL-12 or rIFN-gamma improved the reduced IgG levels in Dectin-2KO mice, and treatment with neutralizing anti-IFN-gamma mAb resulted in the reduction of IgG synthesis in PPV-immunized WT mice. Transfer of spleen cells from PPV-immunized WT mice conferred protection against pneumococcal infection on recipient mice, whereas this effect was cancelled when the transferred spleen cells were harvested from PPV-immunized Dectin-2KO mice. These results suggest that the detection of PPV antigens via Dectin-2 triggers IL-12 production, which induces IFN-gamma synthesis by NKT cells and subsequently the production of serotype-specific IgG.	[Miyasaka, Tomomitsu; Akahori, Yukiko; Toyama, Masahiko; Miyamura, Namiko; Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan; [Saijo, Shinobu] Chiba Univ, Div Mol Immunol, Med Mycol Res Ctr, Chiba, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Div Lab Anim, Res Inst Biomed Sci, Tokyo 162, Japan; [Kinjo, Yuki; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Lab Immune Regulat, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Tohoku University; Chiba University; Tokyo University of Science; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Kawakami, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan.	kawakami@med.tohoku.ac.jp	Iwakura, Yoichiro/E-5457-2011; Miyasaka, Tomomitsu/AAK-1676-2021	Iwakura, Yoichiro/0000-0002-9934-5775; Miyasaka, Tomomitsu/0000-0001-7218-6981; miyazaki, yoshitsugu/0000-0001-8942-0869	Ministry of Education, Culture, Sports, Science and Technology [23659841]; Ministry of Health, Labor and Welfare of Japan [22-SHINKOU-IPPAN-014, H22-SEISAKUSOUYAKU-IPPAN-012, H25-SHINKOU-WAKATE-005]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant from the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Challenging Exploratory Research: 23659841 to K. K.), Grants from the Ministry of Health, Labor and Welfare of Japan (22-SHINKOU-IPPAN-014 to K. K.; H22-SEISAKUSOUYAKU-IPPAN-012 to Y.K.: H25-SHINKOU-WAKATE-005 to Y.K.) and aid funding from Takeda Science Foundation to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Buchanan RM, 1998, J IMMUNOL, V161, P5525; Buchanan RM, 2001, VACCINE, V19, P2020, DOI 10.1016/S0264-410X(00)00421-7; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; CHUDWIN DS, 1987, CLIN IMMUNOL IMMUNOP, V44, P114, DOI 10.1016/0090-1229(87)90057-2; Ekdahl K, 1997, CLIN INFECT DIS, V25, P654, DOI 10.1086/513763; Fernandes MJ, 1999, CANCER RES, V59, P2709; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Ishida T, 1998, CHEST, V114, P1588, DOI 10.1378/chest.114.6.1588; Janet Y, 2004, PNEUMOCOCCUS, P30; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 2000, CELL IMMUNOL, V199, P37, DOI 10.1006/cimm.1999.1602; Kobrynski LJ, 2005, J IMMUNOL, V174, P1787, DOI 10.4049/jimmunol.174.4.1787; Koppel EA, 2005, IMMUNOBIOLOGY, V210, P203, DOI 10.1016/j.imbio.2005.05.014; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Manoff SB, 2010, J INFECT DIS, V201, P525, DOI 10.1086/651131; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McLay J, 2002, J IMMUNOL, V168, P3437, DOI 10.4049/jimmunol.168.7.3437; Miyasaka T, 2012, VACCINE, V30, P3304, DOI 10.1016/j.vaccine.2012.03.007; Moens L, 2007, INFECT IMMUN, V75, P5748, DOI 10.1128/IAI.00574-07; Musher DM, 2010, J INFECT DIS, V201, P516, DOI 10.1086/649839; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Snapper CM, 1996, J IMMUNOL, V157, P2229; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; SNAPPER CM, 1995, J IMMUNOL, V154, P1177; Snapper CM, 1996, INT IMMUNOL, V8, P877, DOI 10.1093/intimm/8.6.877; Song JH, 2008, INT J ANTIMICROB AG, V31, P107, DOI 10.1016/j.ijantimicag.2007.09.014; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Tomura M, 1999, J IMMUNOL, V163, P93; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yamamoto N, 2004, MICROBES INFECT, V6, P1241, DOI 10.1016/j.micinf.2004.08.007	49	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78611	10.1371/journal.pone.0078611	http://dx.doi.org/10.1371/journal.pone.0078611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205278	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400089
J	Polgar, E; Durrieux, C; Hughes, DI; Todd, AJ				Polgar, Erika; Durrieux, Camille; Hughes, David I.; Todd, Andrew J.			A Quantitative Study of Inhibitory Interneurons in Laminae I-III of the Mouse Spinal Dorsal Horn	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; GREEN FLUORESCENT PROTEIN; CONSTRICTION INJURY MODEL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; NEUROPATHIC PAIN; ADULT-RAT; P RECEPTOR; INTRATHECAL SOMATOSTATIN; GABAERGIC NEURONS	Laminae I-III of the spinal dorsal horn contain many inhibitory interneurons that use GABA and/or glycine as a neurotransmitter. Distinct neurochemical populations can be recognised among these cells, and these populations are likely to have differing roles in inhibiting pain or itch. Quantitative studies in rat have shown that inhibitory interneurons account for 25-40% of all neurons in this region. The sst2A receptor is expressed by around half the inhibitory interneurons in laminae I-II, and is associated with particular neurochemically-defined populations. Although much of the work on spinal pain mechanisms has been performed on rat, the mouse is now increasingly used as a model, due to the availability of genetically altered lines. However, quantitative information on the arrangement of interneurons is lacking in the mouse, and it is possible that there are significant species differences in neuronal organisation. In this study, we show that as in the rat, nearly all neurons in laminae I-III that are enriched with glycine also contain GABA, which suggests that GABA-immunoreactivity can be used to identify inhibitory interneurons in this region. These cells account for 26% of the neurons in laminae I-II and 38% of those in lamina III. As in the rat, the sst2A receptor is only expressed by inhibitory interneurons in laminae I-II, and is present on just over half (54%) of these cells. Antibody against the neurokinin 1 receptor was used to define lamina I, and we found that although the receptor was concentrated in this lamina, it was expressed by many fewer cells than in the rat. By estimating the total numbers of neurons in each of these laminae in the L4 segment of the mouse, we show that there are around half as many neurons in each lamina as are present in the corresponding segment of the rat.	[Polgar, Erika; Durrieux, Camille; Hughes, David I.; Todd, Andrew J.] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Todd, AJ (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Andrew.Todd@glasgow.ac.uk	Hughes, David I/B-5692-2011; Todd, Andrew J/A-6855-2011	Hughes, David I/0000-0003-1260-3362; Todd, Andrew J/0000-0002-3007-6749	Biotechnology and Biological Sciences Research Council [BB/J001082/1]; Wellcome Trust [091505/Z/10/Z]; BBSRC [BB/J001082/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by Biotechnology and Biological Sciences Research Council, grant ref: BB/J001082/1 URL: http://www.bbsrc.ac.uk/home/home.aspx and Wellcome Trust, grant ref: 091505/Z/10/Z URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Bencivinni I, 2011, EUR J PAIN, V15, P591, DOI 10.1016/j.ejpain.2010.11.001; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; BLEAZARD L, 1994, J NEUROSCI, V14, P7655; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; CHAPMAN V, 1992, NEUROPEPTIDES, V23, P147, DOI 10.1016/0143-4179(92)90115-D; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; GAUMANN DM, 1988, ANESTHESIOLOGY, V68, P733, DOI 10.1097/00000542-198805000-00011; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; HOKFELT T, 1975, NEUROSCI LETT, V1, P231, DOI 10.1016/0304-3940(75)90066-X; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hughes DI, 2012, J PHYSIOL-LONDON, V590, P3927, DOI 10.1113/jphysiol.2012.235655; Hughes DI, 2003, J NEUROSCI, V23, P9491; HUNT SP, 1981, NEUROSCIENCE, V6, P1883, DOI 10.1016/0306-4522(81)90029-4; Imhof AK, 2011, ARTHRITIS RHEUM-US, V63, P2352, DOI 10.1002/art.30410; Jiang N, 2003, NEUROSCI RES, V47, P97, DOI 10.1016/S0168-0102(03)00183-4; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kim SJ, 2002, NEUROSCIENCE, V114, P1139, DOI 10.1016/S0306-4522(02)00245-2; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; LAING I, 1994, NEUROSCIENCE, V61, P123, DOI 10.1016/0306-4522(94)90065-5; Lemons LL, 2011, NEUROPEPTIDES, V45, P377, DOI 10.1016/j.npep.2011.08.002; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Lyck L, 2008, J HISTOCHEM CYTOCHEM, V56, P201, DOI 10.1369/jhc.7A7187.2007; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MAXWELL DJ, 1987, TRENDS NEUROSCI, V10, P117, DOI 10.1016/0166-2236(87)90056-7; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mesnage B, 2011, J COMP NEUROL, V519, P3139, DOI 10.1002/cne.22668; MOLLENHOLT P, 1988, PAIN, V32, P95, DOI 10.1016/0304-3959(88)90028-0; MOLLENHOLT P, 1992, PAIN, V51, P343, DOI 10.1016/0304-3959(92)90220-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakatsuka T, 2008, J PHYSIOL-LONDON, V586, P2511, DOI 10.1113/jphysiol.2007.146076; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; OTTERSEN OP, 1987, TRENDS NEUROSCI, V10, P250, DOI 10.1016/0166-2236(87)90168-8; Polgar E, 2005, J NEUROSCI, V25, P6658, DOI 10.1523/JNEUROSCI.1490-05.2005; Polgar E, 1999, J NEUROSCI, V19, P2637; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Polgar E, 2004, PAIN, V111, P144, DOI 10.1016/j.pain.2004.06.011; Polgar E, 2013, PAIN IN PRESS; Polgar E, 2011, J COMP NEUROL, V519, P1007, DOI 10.1002/cne.22570; POW DV, 1993, J NEUROSCI METH, V48, P51, DOI 10.1016/S0165-0270(05)80007-X; PROUDLOCK F, 1993, J COMP NEUROL, V327, P289, DOI 10.1002/cne.903270210; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; RIBEIRODASILVA A, 1982, J COMP NEUROL, V209, P176, DOI 10.1002/cne.902090205; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; Sardella TCP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-76; Schindler M, 1997, NEUROSCIENCE, V76, P225; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; Schulz S, 1998, EUR J NEUROSCI, V10, P3700, DOI 10.1046/j.1460-9568.1998.00386.x; SEYBOLD VS, 1982, PEPTIDES, V3, P49, DOI 10.1016/0196-9781(82)90141-3; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sloviter RS, 2001, J COMP NEUROL, V430, P283; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P240, DOI 10.1177/33.3.2579123; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tiong SYX, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-36; Todd AJ, 1998, NEUROSCIENCE, V85, P459, DOI 10.1016/S0306-4522(97)00669-6; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; VIGNA SR, 1994, J NEUROSCI, V14, P834; Villeda SA, 2006, NEUROSCIENCE, V139, P1385, DOI 10.1016/j.neuroscience.2006.01.042; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WIESENFELDHALLIN Z, 1985, NEUROSCI LETT, V62, P69, DOI 10.1016/0304-3940(85)90286-1; WIESENFELDHALLIN Z, 1986, NEUROSCI LETT, V67, P319, DOI 10.1016/0304-3940(86)90329-0; Wildner H, 2013, J NEUROSCI, V33, P7299, DOI 10.1523/JNEUROSCI.0491-13.2013; Wiley RG, 2009, NEUROSCIENCE, V161, P139, DOI 10.1016/j.neuroscience.2008.12.017; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Yang HW, 1997, EXP BRAIN RES, V114, P99, DOI 10.1007/PL00005627; Yasaka T, 2007, J PHYSIOL-LONDON, V581, P603, DOI 10.1113/jphysiol.2006.123919; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	92	75	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78309	10.1371/journal.pone.0078309	http://dx.doi.org/10.1371/journal.pone.0078309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205193	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400077
J	Shih, PC; Yang, YR; Wang, RY				Shih, Pei-Cheng; Yang, Yea-Ru; Wang, Ray-Yau			Effects of Exercise Intensity on Spatial Memory Performance and Hippocampal Synaptic Plasticity in Transient Brain Ischemic Rats	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; BDNF MESSENGER-RNA; TERM-MEMORY; VOLUNTARY EXERCISE; CEREBRAL-ISCHEMIA; DENDRITIC SPINES; DENTATE GYRUS; STRESS; PROTEIN; CORTICOSTERONE	Memory impairment is commonly noted in stroke survivors, and can lead to delay of functional recovery. Exercise has been proved to improve memory in adult healthy subjects. Such beneficial effects are often suggested to relate to hippocampal synaptic plasticity, which is important for memory processing. Previous evidence showed that in normal rats, low intensity exercise can improve synaptic plasticity better than high intensity exercise. However, the effects of exercise intensities on hippocampal synaptic plasticity and spatial memory after brain ischemia remain unclear. In this study, we investigated such effects in brain ischemic rats. The middle cerebral artery occlusion (MCAO) procedure was used to induce brain ischemia. After the MCAO procedure, rats were randomly assigned to sedentary (Sed), low-intensity exercise (Low-Ex), or high-intensity exercise (High-Ex) group. Treadmill training began from the second day post MCAO procedure, 30 min/ day for 14 consecutive days for the exercise groups. The Low-Ex group was trained at the speed of 8 m/min, while the High-Ex group at the speed of 20 m/min. The spatial memory, hippocampal brain-derived neurotrophic factor (BDNF), synapsin-I, postsynaptic density protein 95 (PSD-95), and dendritic structures were examined to document the effects. Serum corticosterone level was also quantified as stress marker. Our results showed the Low-Ex group, but not the High-Ex group, demonstrated better spatial memory performance than the Sed group. Dendritic complexity and the levels of BDNF and PSD-95 increased significantly only in the Low-Ex group as compared with the Sed group in bilateral hippocampus. Notably, increased level of corticosterone was found in the High-Ex group, implicating higher stress response. In conclusion, after brain ischemia, low intensity exercise may result in better synaptic plasticity and spatial memory performance than high intensity exercise; therefore, the intensity is suggested to be considered during exercise training.	[Shih, Pei-Cheng; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Shih, Pei-Cheng] Mackay Mem Hosp, Dept Phys Therapy, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw		Shih, Pei-Cheng/0000-0003-0017-752X	National Science Council [NSC 98-2314-B-010-004-MY3]; Ministry of Education, Aim for the Top University Plan [101AC-P508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was funded by the National Science Council (NSC 98-2314-B-010-004-MY3) and a grant from the Ministry of Education, Aim for the Top University Plan (101AC-P508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; El-Hussein AE, 2000, SCIENCE, V290, P1364; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Jacobsen JPR, 2006, BRAIN RES, V1110, P221, DOI 10.1016/j.brainres.2006.06.077; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lambert KG, 1998, PHYSIOL BEHAV, V65, P43, DOI 10.1016/S0031-9384(98)00114-0; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Numakawa Tadahiro, 2010, World J Biol Chem, V1, P133, DOI 10.4331/wjbc.v1.i5.133; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Shimada H, 2013, BEHAV BRAIN RES, V243, P21, DOI 10.1016/j.bbr.2012.12.018; SHOLL DA, 1953, J ANAT, V87, P387; Sim YJ, 2004, NEUROSCI LETT, V372, P256, DOI 10.1016/j.neulet.2004.09.060; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Takamatsu Y, 2010, BRAIN RES, V1355, P165, DOI 10.1016/j.brainres.2010.07.070; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128; Yang YR, 2012, J MOTOR BEHAV, V44, P97, DOI 10.1080/00222895.2012.654524; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang PY, 2013, INT J MOL SCI, V14, P6074, DOI 10.3390/ijms14036074	41	89	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78163	10.1371/journal.pone.0078163	http://dx.doi.org/10.1371/journal.pone.0078163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205142	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400074
J	Hiebert, PR; Boivin, WA; Zhao, HY; McManus, BM; Granville, DJ				Hiebert, Paul R.; Boivin, Wendy A.; Zhao, Hongyan; McManus, Bruce M.; Granville, David J.			Perforin and Granzyme B Have Separate and Distinct Roles during Atherosclerotic Plaque Development in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							LDL RECEPTOR-DEFICIENT; RHEUMATOID-ARTHRITIS; HUMAN KERATINOCYTES; SOLUBLE GRANZYME; AORTIC-ANEURYSM; MOUSE GRANZYME; CELL APOPTOSIS; T-LYMPHOCYTES; MURINE MODELS; EXPRESSION	The granzyme B/perforincytotoxic pathway is a well established mechanism of initiating target cell apoptosis. Previous studies have suggested a role for the granzyme B/perforin cytotoxic pathway in vulnerable atherosclerotic plaque formation. In the present study, granzyme B deficiency resulted in reduced atherosclerotic plaque development in the descending aortas of apolipoprotein E knockout mice fed a high fat diet for 30 weeks while perforindeficiency resulted in greater reduction in plaque development with significantly less plaque area than granzyme Bdeficient mice. In contrast to the descending aorta, no significant change in plaque size was observed in aortic roots from either granzyme Bdeficient or perforindeficient apolipoprotein E knockout mice. However, atherosclerotic plaques in the aortic roots did exhibit significantly more collagen in granzyme B, but not perforin deficient mice. Together these results suggest significant, yet separate roles for granzyme B and perforin in the pathogenesis of atherosclerosis that go beyond the traditional apoptotic pathway with additional implications in plaque development, stability and remodelling of extracellular matrix.	[Hiebert, Paul R.; Boivin, Wendy A.; Zhao, Hongyan; McManus, Bruce M.; Granville, David J.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Hiebert, Paul R.; Boivin, Wendy A.; McManus, Bruce M.; Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Granville, DJ (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	david.granville@hli.ubc.ca	Hiebert, Paul/AAY-2278-2021	Hiebert, Paul/0000-0001-8179-4217	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship; NSERC Canada Graduate Scholarship; Michael Smith Foundation for Health Research fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research fellowship(Michael Smith Foundation for Health Research)	This work was generously supported by a grant-in-aid from the Canadian Institutes of Health Research (CIHR) (D.J.G.). P. R. H. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship. W. A. B. was supported by a NSERC Canada Graduate Scholarship and a Michael Smith Foundation for Health Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Zen AA, 2006, ATHEROSCLEROSIS, V187, P31, DOI 10.1016/j.atherosclerosis.2005.08.023; Ang LS, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.88; Anthony DA, 2010, J IMMUNOL, V185, P1794, DOI 10.4049/jimmunol.1000430; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Boivin WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033163; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Bratke K, 2004, CLIN EXP IMMUNOL, V136, P542, DOI 10.1111/j.1365-2249.2004.02468.x; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Chamberlain CM, 2007, CAN J PHYSIOL PHARM, V85, P89, DOI 10.1139/Y06-090; Chamberlain CM, 2010, AM J PATHOL, V176, P1038, DOI 10.2353/ajpath.2010.090700; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; Cooper DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021484; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; Hendel A, 2013, MATRIX BIOL, V32, P14, DOI 10.1016/j.matbio.2012.11.013; Hendel A, 2012, CARDIOVASC PATHOL, V21, P28, DOI 10.1016/j.carpath.2010.12.002; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200; Hiebert PR, 2011, EXP GERONTOL, V46, P489, DOI 10.1016/j.exger.2011.02.004; Hirayasu H, 2008, BIOSCI BIOTECH BIOCH, V72, P2294, DOI 10.1271/bbb.80140; Horiuchi K, 2003, J RHEUMATOL, V30, P1799; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Kondo H, 2009, CIRC J, V73, P503, DOI 10.1253/circj.CJ-08-0668; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Merat S, 2000, J GERONTOL A-BIOL, V55, pB85; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Omoto Y, 2010, J DERMATOL SCI, V59, P129, DOI 10.1016/j.jdermsci.2010.05.004; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Schiller NK, 2002, ARTERIOSCL THROM VAS, V22, P1341, DOI 10.1161/01.ATV.0000024082.46387.38; SIMON MM, 1988, BIOL CHEM H-S, V369, P107; SIMON MM, 1991, IMMUNOLOGY, V73, P117; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; Takahashi Y, 2009, EPILEPSIA; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tremblay GM, 2000, J IMMUNOL, V165, P3966, DOI 10.4049/jimmunol.165.7.3966; Tschopp CM, 2006, BLOOD, V108, P2290, DOI 10.1182/blood-2006-03-010348; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; Vernooy JHJ, 2007, AM J RESP CRIT CARE, V175, P464, DOI 10.1164/rccm.200602-169OC; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Yoshikawa Y, 2010, CYTOTECHNOLOGY, V62, P325, DOI 10.1007/s10616-010-9275-z	57	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78939	10.1371/journal.pone.0078939	http://dx.doi.org/10.1371/journal.pone.0078939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205352	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300086
J	Hvidtfeldt, UA; Lange, T; Andersen, I; Diderichsen, F; Keiding, N; Prescott, E; Sorensen, TIA; Tjonneland, A; Rod, NH				Hvidtfeldt, Ulla Arthur; Lange, Theis; Andersen, Ingelise; Diderichsen, Finn; Keiding, Niels; Prescott, Eva; Sorensen, Thorkild I. A.; Tjonneland, Anne; Rod, Naja Hulvej			Educational Differences in Postmenopausal Breast Cancer - Quantifying Indirect Effects through Health Behaviors, Body Mass Index and Reproductive Patterns	PLOS ONE			English	Article							SEX-HORMONES; RISK-FACTORS; SOCIOECONOMIC POSITION; ENDOGENOUS ESTROGEN; ALCOHOL-CONSUMPTION; PROSPECTIVE COHORT; SOCIAL GRADIENT; POOLED ANALYSIS; WOMEN; REANALYSIS	Studying mechanisms underlying social inequality in postmenopausal breast cancer is important in order to develop prevention strategies. Standard methods for investigating indirect effects, by comparing crude models to adjusted, are often biased. We applied a new method enabling the decomposition of the effect of educational level on breast cancer incidence into indirect effects through reproductive patterns (parity and age at first birth), body mass index and health behavior (alcohol consumption, physical inactivity, and hormone therapy use). The study was based on a pooled cohort of 6 studies from the Copenhagen area including 33,562 women (1,733 breast cancer cases) aged 50-70 years at baseline. The crude absolute rate of breast cancer was 399 cases per 100,000 person-years. A high educational level compared to low was associated with 74 (95% CI 22-125) extra breast cancer cases per 100,000 person-years at risk. Of these, 26% (95% CI 14%-69%) could be attributed to alcohol consumption. Similar effects were observed for age at first birth (32%; 95% CI 10%-257%), parity (19%; 95% CI 10%-45%), and hormone therapy use (10%; 95% CI 6%-18%). Educational level modified the effect of physical activity on breast cancer. In conclusion, this analysis suggests that a substantial number of the excess postmenopausal breast cancer events among women with a high educational level compared to a low can be attributed to differences in alcohol consumption, use of hormone therapy, and reproductive patterns. Women of high educational level may be more vulnerable to physical inactivity compared to women of low educational level.	[Hvidtfeldt, Ulla Arthur; Andersen, Ingelise; Diderichsen, Finn; Rod, Naja Hulvej] Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen, Denmark; [Lange, Theis; Keiding, Niels] Univ Copenhagen, Dept Publ Hlth, Biostat Sect, Copenhagen, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Inst Canc Epidemiol, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Danish Cancer Society; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Hvidtfeldt, UA (corresponding author), Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen, Denmark.	ulah@sund.ku.dk	Prescott, Eva/AAJ-7441-2020; Diderichsen, Finn/P-4654-2019; Rod, Naja/B-9411-2015	Diderichsen, Finn/0000-0002-9998-4972; Rod, Naja/0000-0002-6400-5105; Prescott, Eva/0000-0002-4134-0349; Lange, Theis/0000-0001-6807-8347; Andersen, Ingelise/0000-0002-0076-265X; Tjonneland, Anne/0000-0003-4385-2097; Hvidtfeldt, Ulla Arthur/0000-0002-0335-4838	Danish Cancer Society, Commission of Social Inequality in Cancer [SU08004]	Danish Cancer Society, Commission of Social Inequality in Cancer	This work was supported by the Danish Cancer Society, Commission of Social Inequality in Cancer [grant no. SU08004]. The authors thank the collaborators behind the Social Inequality in Cancer Database: The Copenhagen City Heart Study, the Diet, Cancer and Health Study, and The Research Center for Prevention and Health in Glostrup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M., 1989, SCAND J SOC MED, V41, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Braaten T, 2005, CANCER EPIDEM BIOMAR, V14, P2591, DOI 10.1158/1055-9965.EPI-05-0345; Bratten T, 2004, INT J CANCER, V110, P579, DOI 10.1002/ijc.20141; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018; Dano H, 2004, INT J CANCER, V111, P451, DOI 10.1002/ijc.20203; Dano H, 2003, INT J EPIDEMIOL, V32, P218, DOI 10.1093/ije/dyg049; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; EWERTZ M, 1990, INT J CANCER, V46, P597, DOI 10.1002/ijc.2910460408; Farhat GN, 2011, JNCI-J NATL CANCER I, V103, P562, DOI 10.1093/jnci/djr031; FRIEDENREICH CM, 1993, EPIDEMIOLOGY, V4, P295, DOI 10.1097/00001648-199307000-00004; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hartz A, 2012, J CLIN ENDOCR METAB, V97, P227, DOI 10.1210/jc.2011-1151; Heck KE, 1997, AM J EPIDEMIOL, V145, P366, DOI 10.1093/oxfordjournals.aje.a009114; Hvidtfeldt UA, 2012, CANCER EPIDEM BIOMAR, V21, P1203, DOI 10.1158/1055-9965.EPI-12-0310; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Klassen AC, 2011, CANCER EPIDEMIOL, V35, P217, DOI 10.1016/j.canep.2011.02.009; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Larsen SB, 2011, CANCER EPIDEMIOL, V35, P438, DOI 10.1016/j.canep.2010.12.005; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Liedtke S, 2012, OBESITY, V20, P1088, DOI 10.1038/oby.2011.383; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Martinussen T., 2006, STAT BIOL HEALTH; Menvielle G, 2011, AM J EPIDEMIOL, V173, P26, DOI 10.1093/aje/kwq319; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Opdahl S, 2011, BRIT J CANCER, V105, P731, DOI 10.1038/bjc.2011.286; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pearl J., 2001, P 17 C UNC ART INT, P411, DOI DOI 10.5555/2074022.2074073; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Thomas HV, 1997, CANCER CAUSE CONTROL, V8, P922, DOI 10.1023/A:1018476631561; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; VanderWeele TJ, 2013, EPIDEMIOLOGY, V24, P224, DOI 10.1097/EDE.0b013e318281a64e; Euler-Chelpin M, 2008, EUR J CANCER PREV, V17, P273, DOI 10.1097/CEJ.0b013e3282f0c017; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	47	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78690	10.1371/journal.pone.0078690	http://dx.doi.org/10.1371/journal.pone.0078690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205296	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300079
J	Kang, CK; Moon, JY; Lee, SI; Jablonski, PG				Kang, Chang-ku; Moon, Jong-yeol; Lee, Sang-im; Jablonski, Piotr G.			Cryptically Patterned Moths Perceive Bark Structure When Choosing Body Orientations That Match Wing Color Pattern to the Bark Pattern	PLOS ONE			English	Article							RESTING SITE SELECTION; BACKGROUND SELECTIONS; DISRUPTIVE COLORATION; NOCTURNAL MOTHS; PREY; LEPIDOPTERA; CRYPSIS; FORMS; PALE	Many moths have wing patterns that resemble bark of trees on which they rest. The wing patterns help moths to become camouflaged and to avoid predation because the moths are able to assume specific body orientations that produce a very good match between the pattern on the bark and the pattern on the wings. Furthermore, after landing on a bark moths are able to perceive stimuli that correlate with their crypticity and are able to re-position their bodies to new more cryptic locations and body orientations. However, the proximate mechanisms, i.e. how a moth finds an appropriate resting position and orientation, are poorly studied. Here, we used a geometrid moth Jankowskia fuscaria to examine i) whether a choice of resting orientation by moths depends on the properties of natural background, and ii) what sensory cues moths use. We studied moths' behavior on natural (a tree log) and artificial backgrounds, each of which was designed to mimic one of the hypothetical cues that moths may perceive on a tree trunk (visual pattern, directional furrow structure, and curvature). We found that moths mainly used structural cues from the background when choosing their resting position and orientation. Our findings highlight the possibility that moths use information from one type of sensory modality (structure of furrows is probably detected through tactile channel) to achieve crypticity in another sensory modality (visual). This study extends our knowledge of how behavior, sensory systems and morphology of animals interact to produce crypsis.	[Kang, Chang-ku; Moon, Jong-yeol; Lee, Sang-im; Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Ctr Ecol Res, Dziekanow Lesny, Poland	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences	Jablonski, PG (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	SNULBEE@behecolpiotrsangim.org	Kang, Changku/S-3368-2019; Jablonski, Piotr G/A-2753-2015	/0000-0002-8333-0106	National Research Foundation of Korea [2010-0025546]; Brain Korea 21; Animal Behavior Society	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Animal Behavior Society	This work was supported by National Research Foundation of Korea (grant no. 2010-0025546), Brain Korea 21 and Animal Behavior Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOARDMAN M, 1974, J ZOOL, V172, P343, DOI 10.1111/j.1469-7998.1974.tb04110.x; Brechbuhl R, 2010, P ROY SOC B-BIOL SCI, V277, P739, DOI 10.1098/rspb.2009.1632; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2009, PHILOS T R SOC B, V364, P489, DOI 10.1098/rstb.2008.0266; Kang CK, 2012, J EVOLUTION BIOL, V25, P1695, DOI 10.1111/j.1420-9101.2012.02557.x; Kang CK, 2013, ANIM BEHAV IN PRESS; KETTLEWELL HBD, 1955, NATURE, V175, P943, DOI 10.1038/175943a0; Land MF, 2002, ANIMAL EYES; LEES DR, 1975, J ZOOL, V176, P341, DOI 10.1111/j.1469-7998.1975.tb03206.x; PIETREWICZ AT, 1977, SCIENCE, V195, P580, DOI 10.1126/science.195.4278.580; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SARGENT T D, 1969, Journal of the Lepidopterists' Society, V23, P1; SARGENT TD, 1968, SCIENCE, V159, P100, DOI 10.1126/science.159.3810.100; SARGENT TD, 1969, ANIM BEHAV, V17, P670, DOI 10.1016/S0003-3472(69)80010-2; SARGENT TD, 1969, NATURE, V222, P585, DOI 10.1038/222585b0; SARGENT TD, 1966, SCIENCE, V154, P1674, DOI 10.1126/science.154.3757.1674; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; STEWARD RC, 1985, BIOL J LINN SOC, V24, P285, DOI 10.1111/j.1095-8312.1985.tb00375.x; Thayer G. H, 1918, CONCEALING COLORATIO; Wang Z, 2012, ECOL RES, V27, P107, DOI 10.1007/s11284-011-0877-5; Webster RJ, 2009, PHILOS T R SOC B, V364, P503, DOI 10.1098/rstb.2008.0215; Zar JH, 1999, BIOSTATISTICAL ANAL	26	8	8	10	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78117	10.1371/journal.pone.0078117	http://dx.doi.org/10.1371/journal.pone.0078117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205118	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300041
J	Mitchell, A; Guan, WH; Staggs, R; Hamel, A; Hozayen, S; Adhikari, N; Grindle, S; Desir, S; John, R; Hall, JL; Eckman, P				Mitchell, Adam; Guan, Weihua; Staggs, Rodney; Hamel, Aimee; Hozayen, Sameh; Adhikari, Neeta; Grindle, Suzanne; Desir, Snider; John, Ranjit; Hall, Jennifer L.; Eckman, Peter			Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices	PLOS ONE			English	Article							MYOCARDIAL GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; HEART-FAILURE; CONTINUOUS-FLOW; RNA-SEQ; CELL-DEATH; PROTEIN; APOPTOSIS; SUPPORT; NIX	Introduction: Continuous-flow left ventricular assist devices (LVADs) are an established therapy for patients with end-stage heart failure. The short-and long-term impact of these devices on peripheral blood gene expression has not been characterized, and may provide insight into the molecular pathways mediated in response to left ventricular remodeling and an improvement in overall systemic circulation. We performed RNA sequencing to identify genes and pathways influenced by these devices. Methods: RNA was extracted from blood of 9 heart failure patients (8 male) prior to LVAD implantation, and at 7 and 180 days postoperatively. Libraries were sequenced on an Illumina HiSeq2000 and sequences mapped to the human Ensembl GRCh37.67 genome assembly. Results: A specific set of genes involved in regulating cellular immune response, antigen presentation, and T cell activation and survival were down-regulated 7 days after LVAD placement. 6 months following LVAD placement, the expression levels of these genes were significantly increased; yet importantly, remained significantly lower than age and sex-matched samples from healthy controls. Conclusions: In summary, this genomic analysis identified a significant decrease in the expression of genes that promote a healthy immune response in patients with heart failure that was partially restored 6 months following LVAD implant.	[Mitchell, Adam; Staggs, Rodney; Adhikari, Neeta; Grindle, Suzanne; Desir, Snider; Hall, Jennifer L.; Eckman, Peter] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Guan, Weihua] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Mitchell, Adam; Staggs, Rodney; Hozayen, Sameh; Hall, Jennifer L.; Eckman, Peter] Univ Minnesota, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Hamel, Aimee] Univ Minnesota, Lillehei Clin Res Unit, Minneapolis, MN USA; [John, Ranjit] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hall, JL (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	jlhall@umn.edu; eckmanp@umn.edu	Hozayen, Sameh/GQA-9754-2022	Hozayen, Sameh/0000-0002-4582-6530	Lillehei Heart Institute;  [1R21HL104596-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104596] Funding Source: NIH RePORTER	Lillehei Heart Institute; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by 1R21HL104596-01 awarded to JLH and the Lillehei Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8; Ankersmit HJ, 1999, CIRCULATION, V100, P211; Bartling B, 1999, CIRCULATION, V100, P216; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Clark AL, 2001, EUR HEART J, V22, P2275, DOI 10.1053/euhj.2001.2693; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Dorn GW, 2008, ONCOGENE, V27, pS158, DOI 10.1038/onc.2009.53; Dorn GW, 2011, J MOL CELL CARDIOL, V51, P497, DOI 10.1016/j.yjmcc.2010.09.011; Eckman PM, 2012, CIRCULATION, V125, P3038, DOI 10.1161/CIRCULATIONAHA.111.040246; Fermin DR, 2008, CIRC-CARDIOVASC GENE, V1, P117, DOI 10.1161/CIRCGENETICS.108.802652; Hall JL, 2007, EUR HEART J, V28, P613, DOI 10.1093/eurheartj/ehl365; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; HARRIS TJ, 1995, J AM COLL CARDIOL, V26, P102, DOI 10.1016/0735-1097(95)00123-H; Hellawell JL, 2012, CARDIOVASC THER, V30, P172, DOI 10.1111/j.1755-5922.2010.00247.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kimball P, 2006, TRANSPLANT P, V38, P3695, DOI 10.1016/j.transproceed.2006.10.153; Kimball PM, 2008, ANN THORAC SURG, V85, P1656, DOI 10.1016/j.athoracsur.2008.01.050; Kimura F, 2010, SURG TODAY, V40, P793, DOI 10.1007/s00595-010-4323-z; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Lou XY, 2012, J CARDIOVASC TRANSL, V5, P345, DOI 10.1007/s12265-011-9321-z; MAISEL AS, 1994, CIRCULATION, V90, P1774, DOI 10.1161/01.CIR.90.4.1774; Mankad AK, 2012, J CARD FAIL, V18, P433, DOI 10.1016/j.cardfail.2012.03.003; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, ANN THORAC SURG, V72, P2044, DOI 10.1016/S0003-4975(01)03172-1; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Schleicher M, 2005, MOL CELL BIOL, V25, P8251, DOI 10.1128/MCB.25.18.8251-8258.2005; Sinha A, 2010, HUM IMMUNOL, V71, P164, DOI 10.1016/j.humimm.2009.10.012; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Torre-Amione G, 1999, CIRCULATION, V100, P1189, DOI 10.1161/01.CIR.100.11.1189; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turbpaiboon C, 2010, FRONT BIOSCI-LANDMRK, V15, P1, DOI 10.2741/3601; VanBuren P, 2011, PHYSIOL GENOMICS, V43, P392, DOI 10.1152/physiolgenomics.00175.2010; Vrtovec B, 2009, EUR J HEART FAIL, V11, P1000, DOI 10.1093/eurjhf/hfp110; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wohlschlaeger J, 2012, J HEART LUNG TRANSPL, V31, P318, DOI 10.1016/j.healun.2011.11.015; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77951	10.1371/journal.pone.0077951	http://dx.doi.org/10.1371/journal.pone.0077951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205042	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600054
J	Sun, J; Mohlin, S; Lundby, A; Kazi, JU; Hellman, U; Pahlman, S; Olsen, JV; Ronnstrand, L				Sun, J.; Mohlin, S.; Lundby, A.; Kazi, J. U.; Hellman, U.; Pahlman, S.; Olsen, J. V.; Ronnstrand, L.			The PI3-kinase isoform p110 delta is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner	ONCOGENE			English	Article						c-Kit; c-Kit/D816V; PI3-kinase; p110 delta; phosphorylation; cell transformation	ACUTE MYELOID-LEUKEMIA; PHOSPHOINOSITIDE 3-KINASE; GENE-MUTATIONS; AGGRESSIVE MASTOCYTOSIS; SYSTEMIC MASTOCYTOSIS; TYROSINE KINASE; BREAST-CANCER; ACTIVATION; DASATINIB; GROWTH	PI3-kinase has a crucial role in transformation mediated by the oncogenic c-Kit mutant D816V. In this study, we demonstrate that the c-Kit/D816V-mediated cell survival is dependent on an intact direct binding of PI3-kinase to c-Kit. However, mutation of this binding site had little effect on the PI3-kinase activity in the cells, suggesting that c-Kit/D816V-mediated cell survival is dependent on PI3-kinase but not its kinase activity. Furthermore, inhibition of the lipid kinase activity of PI3-kinase led only to a slight inhibition of cell survival. Knockdown of the predominant PI3-kinase isoform p110 delta in c-Kit/D816V-expressing Ba/F3 cells led to reduced cell transformation both in vitro and in vivo without affecting the overall PI3-kinase activity. This suggests that p110 delta has a lipid-kinaseindependent role in c-Kit/D816V-mediated cell transformation. We furthermore demonstrate that p110 delta is phosphorylated at residues Y524 and S1039 and that phosphorylation requires an intact binding site for PI3-kinase in c-Kit/D816V. Overexpression of p110 delta carrying the Y523F and S1038A mutations significantly reduced c-Kit/D816V-mediated cell survival and proliferation. Taken together, our results demonstrate an important lipid-kinase-independent role of p110 delta in c-Kit/D816V-mediated cell transformation. This furthermore suggests that p110 delta could be a potential diagnostic factor and selective therapeutic target for c-Kit/D816V-expressing malignancies.	[Sun, J.; Kazi, J. U.; Ronnstrand, L.] Lund Univ, Skane Univ Hosp, Dept Lab Med, Expt Clin Chem, Malmo, Sweden; [Mohlin, S.; Pahlman, S.] Lund Univ, Skane Univ Hosp, CREATE Hlth, Dept Lab Med,Ctr Mol Pathol, Malmo, Sweden; [Lundby, A.; Olsen, J. V.] Univ Copenhagen, Fac Hlth Sci, Dept Prote, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Hellman, U.] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Copenhagen; Ludwig Institute for Cancer Research	Ronnstrand, L (corresponding author), Lund Univ, Dept Lab Med, Expt Clin Chem, Bldg 404 C3, SE-22381 Lund, Sweden.	Lars.Ronnstrand@med.lu.se	Lundby, Alicia/H-3322-2013; Olsen, Jesper/ABH-4638-2020; Kazi, Julhash U./D-9190-2011	Olsen, Jesper/0000-0002-4747-4938; Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809; Lundby, Alicia/0000-0002-1612-6041; Mohlin, Sofie/0000-0002-2458-3963	Swedish Cancer Society; Swedish Research Council; Strategic Cancer Research Program at Lund University; BioCARE; ALF governmental clinical grant; Stiftelsen Olle Engkvist Byggmastare; Alfred Osterlund Foundation; Gunnar Nilsson Cancer Society; MAS Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Cancer Research Program at Lund University; BioCARE; ALF governmental clinical grant; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Alfred Osterlund Foundation; Gunnar Nilsson Cancer Society; MAS Cancer Foundation	This research was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Strategic Cancer Research Program at Lund University, BioCARE, ALF governmental clinical grant, Stiftelsen Olle Engkvist Byggmastare, Alfred Osterlund Foundation, Gunnar Nilsson Cancer Society and MAS Cancer Foundation.	Aichberger KJ, 2008, EUR J CLIN INVEST, V38, P869, DOI 10.1111/j.1365-2362.2008.02036.x; Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Beghini A, 2000, BLOOD, V95, P726, DOI 10.1182/blood.V95.2.726; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; Cohen SM, 2012, AM J SURG, V204, P895, DOI 10.1016/j.amjsurg.2012.07.027; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Cornillet-Lefebvre P, 2006, LEUKEMIA, V20, P374, DOI 10.1038/sj.leu.2404054; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Czupalla C, 2003, J BIOL CHEM, V278, P11536, DOI 10.1074/jbc.M210351200; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hashimoto K, 2003, BLOOD, V101, P1094, DOI 10.1182/blood-2002-01-0177; Hongyo T, 2000, CANCER RES, V60, P2345; Jia SD, 2009, CURR OPIN CELL BIOL, V21, P199, DOI 10.1016/j.ceb.2008.12.007; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Lundby A, 2011, METHODS MOL BIOL, V753, P143, DOI 10.1007/978-1-61779-148-2_10; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nijenhuis CM, 2013, CANCER TREAT REV, V39, P305, DOI 10.1016/j.ctrv.2012.10.006; Ning ZQ, 2001, LEUKEMIA LYMPHOMA, V41, P513, DOI 10.3109/10428190109060342; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pardanani A, 2012, AM J HEMATOL, V87, P402, DOI 10.1002/ajh.23134; Sadrzadeh H, 2011, DISCOV MED, V12, P481; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Sawyer C, 2003, CANCER RES, V63, P1667; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun JM, 2009, J BIOL CHEM, V284, P11039, DOI 10.1074/jbc.M808058200; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Verstovsek S, 2008, CLIN CANCER RES, V14, P3906, DOI 10.1158/1078-0432.CCR-08-0366	43	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5360	5369		10.1038/onc.2013.479	http://dx.doi.org/10.1038/onc.2013.479			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24213578	Green Submitted			2022-12-25	WOS:000345120600006
J	Wang, IC; Ustiyan, V; Zhang, Y; Cai, Y; Kalin, TV; Kalinichenko, VV				Wang, I-C; Ustiyan, V.; Zhang, Y.; Cai, Y.; Kalin, T. V.; Kalinichenko, V. V.			Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D)	ONCOGENE			English	Article						FOXM1; K-Ras; non-small-cell lung cancer; transgenic mice	K-RAS; RESPIRATORY EPITHELIUM; TUMOR-SUPPRESSOR; EXPRESSION; FORKHEAD; CANCER; GENE; ADENOCARCINOMAS; ACTIVATION; SIGNATURE	Lung cancer is the leading cause of deaths in cancer patients in the United States. Identification of new molecular targets is clearly needed to improve therapeutic outcomes of this devastating human disease. Activating mutations in K-Ras oncogene and increased expression of FOXM1 protein are associated with poor prognosis in patients with non-small-cell lung cancer. Transgenic expression of activated Kras(G12D) in mouse respiratory epithelium is sufficient to induce lung adenocarcinomas; however, transcriptional mechanisms regulated by K-Ras during the initiation of lung cancer remain poorly understood. Foxm1 transcription factor, a downstream target of K-Ras, stimulates cellular proliferation during embryogenesis, organ repair and tumor growth, but its role in tumor initiation is unknown. In the present study, we used transgenic mice expressing KrasG12D under control of Sftpc promoter to demonstrate that Foxm1 was induced in type II epithelial cells before the formation of lung tumors. Conditional deletion of Foxm1 from Kras(G12D)-expressing respiratory epithelium prevented the initiation of lung tumors in vivo. The loss of Foxm1 inhibited expression of K-Ras target genes critical for the nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) pathways, including Ikbkb, Nfkb1, Nfkb2, Rela, Jnk1, N-Myc, Pttg1 and Cdkn2a. Transgenic overexpression of activated FOXM1 mutant was sufficient to induce expression of these genes in alveolar type II cells. FOXM1 directly bound to promoter regions of Ikbkb, Nfkb2, N-Myc, Pttg1 and Cdkn2a, indicating that these genes are direct FOXM1 targets. FOXM1 is required for K-Ras-mediated lung tumorigenesis by activating genes critical for the NF-kB and JNK pathways.	[Wang, I-C; Ustiyan, V.; Zhang, Y.; Cai, Y.; Kalin, T. V.; Kalinichenko, V. V.] Cincinnati Childrens Hosp Res Fdn, Perinatal Inst, Div Pulm Biol, Cincinnati, OH 45229 USA; [Wang, I-C] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Wang, I-C] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; National Tsing Hua University; National Tsing Hua University	Kalinichenko, VV (corresponding author), Cincinnati Childrens Hosp Res Fdn, Perinatal Inst, Div Pulm Biol, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Vladimir.Kalinichenko@cchmc.org		Wang, I-Ching/0000-0003-4398-2975	NIH [HL84151, CA142724]; Career Development Award from National Lung Cancer Partnership; National Science Council of Taiwan [102B0023V8]; Toward World-Class University Project of National Tsing Hua University [102N2052E1]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from National Lung Cancer Partnership; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Toward World-Class University Project of National Tsing Hua University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Ron Pratt for technical support with microCT imaging and Craig Bolte for helpful comments. This work was supported by NIH grants HL84151 (VVK) and CA142724 (TVK), the Career Development Award from National Lung Cancer Partnership (I-CW), research grants from National Science Council of Taiwan 102B0023V8 (I-CW) and Toward World-Class University Project of National Tsing Hua University 102N2052E1 (I-CW).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cellurale C, 2011, MOL CELL BIOL, V31, P1565, DOI 10.1128/MCB.01122-10; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Ihara Y, 2010, P NATL ACAD SCI USA, V107, P17309, DOI 10.1073/pnas.1001165107; Iwao K, 2001, INT J CANCER, V91, P433, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1059>3.0.CO;2-B; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang IC, 2010, DEV BIOL, V347, P301, DOI 10.1016/j.ydbio.2010.08.027; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Watters JW, 2006, MOL CANCER THER, V5, P2444, DOI 10.1158/1535-7163.MCT-06-0340; Whitsett JA, 1998, BIOCHIM BIOPHYS ACTA, V19, P2; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	33	54	54	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5391	5396		10.1038/onc.2013.475	http://dx.doi.org/10.1038/onc.2013.475			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24213573				2022-12-25	WOS:000345120600009
J	Kim, Y; Kim, J; Lee, HD; Jeong, J; Lee, W; Lee, KA				Kim, Yoonjung; Kim, Juwon; Lee, Hy-De; Jeong, Joon; Lee, Woochang; Lee, Kyung-A			Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; ACTIVATING MUTATIONS; ONCOGENIC MUTATIONS; TARGETED THERAPY; CETUXIMAB; TUMORS; RESISTANCE; GEFITINIB	Anti-epidermal growth factor receptor (EGFR) therapy has been tried in triple negative breast cancer (TNBC) patients without evaluation of molecular and clinical predictors in several randomized clinical studies. Only fewer than 20% of metastatic TNBCs showed response to anti-EGFR therapy. In order to increase the overall response rate, first step would be to classify TNBC into good or poor responders according to oncogenic mutation profiles. This study provides the molecular characteristics of TNBCs including EGFR gene copy number changes and mutation status of EGFR and KRAS gene in Korean TNBC patients. Mutation analysis for EGFR, KRAS, BRAF and TP53 from a total of 105 TNBC tissue samples was performed by direct sequencing, peptide nucleic acid-mediated PCR clamping method and real-time PCR. Copy number changes of EGFR gene were evaluated using multiplex ligation-dependent probe amplification. Out of all 105 TNBCs, 15.2% (16/105) showed EGFR copy number changes. Among them, increased or decreased EGFR copy number was detected in 13 (5 single copy gain, 2 amplification and 4 high-copy number amplification) and 3 cases (3 hemizygous deletion), respectively. The mutation frequencies of KRAS, EGFR and TP53 gene were 1.9% (G12V and G12D), 1.0% (exon 19 del) and 31.4%, respectively. There was no BRAF V600E mutation found. Future studies are needed to evaluate the clinical outcomes of TNBC patients who undergo anti-EGFR therapy according to the genetic status of EGFR.	[Kim, Yoonjung; Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Juwon] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Seoul 120749, South Korea; [Lee, Hy-De; Jeong, Joon] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Woochang] Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Woochang] Asan Med Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; University of Ulsan	Lee, KA (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	kal1119@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Kim, Yoonjung/0000-0002-4370-4265; Lee, Kyung-A/0000-0001-5320-6705	Yonsei University College of Medicine	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2011, ONCOL REP, V26, P1213, DOI 10.3892/or.2011.1391; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Carey LA, 2012, J CLIN ONCOL; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Dickler MN, 2009, BREAST CANCER RES TR, V115, P115, DOI 10.1007/s10549-008-0055-9; Fukui T, 2008, GEN THORAC CARDIOVAS, V56, P97, DOI 10.1007/s11748-007-0193-8; Grob TJ, 2012, BREAST CANCER RES TR, V134, P561, DOI 10.1007/s10549-012-2092-7; Han HS, 2012, J THORAC ONCOL, V7, P355, DOI 10.1097/JTO.0b013e31823c4c1b; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Jacot W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3079; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Kurebayashi J, 2007, BREAST, V16, pS72, DOI 10.1016/j.breast.2007.07.017; Kwon MJ, 2011, PATHOL RES PRACT, V207, P762, DOI 10.1016/j.prp.2011.10.002; Langer Corey J, 2011, P T, V36, P263; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lv S, 2012, INT J ONCOL; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Moran T, 2012, J CLIN ONCOL; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nakajima H, 2012, BREAST CANC; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Oden-Gangloff A, 2009, BRIT J CANCER, V100, P1330, DOI 10.1038/sj.bjc.6605008; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Olivier M, 2001, SEMIN CANCER BIOL, V11, P353, DOI 10.1006/scbi.2001.0390; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Powell B, 2000, CLIN CANCER RES, V6, P443; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tang CK, 2000, CANCER RES, V60, P3081; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Vargas AC, 2012, BREAST CANC RES TREA; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0	48	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79014	10.1371/journal.pone.0079014	http://dx.doi.org/10.1371/journal.pone.0079014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205362	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500142
J	Murray, CL; Obiang, P; Bannerman, D; Cunningham, C				Murray, Carol L.; Obiang, Pauline; Bannerman, David; Cunningham, Colm			Endogenous IL-1 in Cognitive Function and Anxiety: A Study in IL-1RI(-/-) Mice	PLOS ONE			English	Article							SPATIAL MEMORY; INTERLEUKIN-1; RECEPTOR; HIPPOCAMPUS; BEHAVIOR; FEAR; IL-1-BETA; C57BL/6J; MAZE; LIPOPOLYSACCHARIDE	Interleukin-1 (IL-1) is a key pro-inflammatory cytokine, produced predominantly by peripheral immune cells but also by glia and some neuronal populations within the brain. Its signalling is mediated via the binding of IL-1 alpha or IL-1 beta to the interleukin-1 type one receptor (IL-1RI). IL-1 plays a key role in inflammation-induced sickness behaviour, resulting in depressed locomotor activity, decreased exploration, reduced food and water intake and acute cognitive deficits. Conversely, IL-1 has also been suggested to facilitate hippocampal-dependent learning and memory: IL-1RI(-/-) mice have been reported to show deficits on tasks of visuospatial learning and memory. We sought to investigate whether there is a generalised hippocampal deficit in IL-1RI(-/-) animals. Therefore, in the current study we compared wildtype (WT) mice to IL-1RI(-/-) mice using a variety of hippocampal-dependent learning and memory tasks, as well as tests of anxiety and locomotor activity. We found no difference in performance of the IL-1RI(-/-) mice compared to WT mice in a T-maze working memory task. In addition, the IL-1RI(-/-) mice showed normal learning in various spatial reference memory tasks including the Y-maze and Morris mater maze, although there was a subtle deficit in choice behaviour in a spatial discrimination, beacon watermaze task. IL-1RI(-/-) mice also showed normal memory for visuospatial context in the contextual fear conditioning paradigm. In the open field, IL-1RI(-/-) mice showed a significant increase in distance travelled and rearing behaviour compared to the WT mice and in the elevated plus-maze spent more time in the open arms than did the WT animals. The data suggest that, contrary to prior studies, IL-1RI(-/-) mice are not robustly impaired on hippocampal-dependent memory and learning but do display open field hyperactivity and decreased anxiety compared to WT mice. The results argue for a careful evaluation of the roles of endogenous IL-1 in hippocampal and limbic system function.	[Murray, Carol L.; Obiang, Pauline; Cunningham, Colm] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Murray, Carol L.; Obiang, Pauline; Cunningham, Colm] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Bannerman, David] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Trinity College Dublin; Trinity College Dublin; University of Oxford	Cunningham, C (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	colm.cunningham@tcd.ie	Cunningham, Colm/A-1743-2010	Cunningham, Colm/0000-0003-1423-5209; Bannerman, David/0000-0002-3024-7595	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (SRF granted to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Balogh SA, 1999, BRAIN RES, V836, P38, DOI 10.1016/S0006-8993(99)01586-3; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Barkus C, 2012, GENES BRAIN BEHAV, V11, P342, DOI 10.1111/j.1601-183X.2012.00767.x; Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927; BLUTHE RM, 1992, BRAIN RES, V573, P318, DOI 10.1016/0006-8993(92)90779-9; Contet C, 2001, BEHAV BRAIN RES, V125, P261, DOI 10.1016/S0166-4328(01)00295-9; Cunningham C, 2005, J VIROL, V79, P5174, DOI 10.1128/JVI.79.8.5174-5184.2005; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Cunningham C, 2008, BRAIN BEHAV IMMUN, V22, P1117, DOI 10.1016/j.bbi.2008.05.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Engler H, 2011, BRAIN BEHAV IMMUN, V25, P1384, DOI 10.1016/j.bbi.2011.04.005; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Konsman JP, 2000, NEUROSCIENCE, V101, P957, DOI 10.1016/S0306-4522(00)00403-6; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Kuriyama K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00127; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wolff M, 2002, BEHAV BRAIN RES, V136, P463, DOI 10.1016/S0166-4328(02)00192-4; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072	45	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78385	10.1371/journal.pone.0078385	http://dx.doi.org/10.1371/journal.pone.0078385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205219	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500115
J	Ntie-Kang, F; Zofou, D; Babiaka, SB; Meudom, R; Scharfe, M; Lifongo, LL; Mbah, JA; Mbaze, LM; Sippl, W; Efange, SMN				Ntie-Kang, Fidele; Zofou, Denis; Babiaka, Smith B.; Meudom, Rolande; Scharfe, Michael; Lifongo, Lydia L.; Mbah, James A.; Mbaze, Luc Mevaa; Sippl, Wolfgang; Efange, Simon M. N.			AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants	PLOS ONE			English	Article							HERG K+ CHANNELS; DRUG DISCOVERY; ANTIMALARIAL ACTIVITY; FORCE-FIELD; PREDICTION; PERMEABILITY; SOLUBILITY; IDENTIFICATION; CONSTITUENTS; HYPOESTOXIDE	Computer-aided drug design (CADD) often involves virtual screening (VS) of large compound datasets and the availability of such is vital for drug discovery protocols. We assess the bioactivity and "drug-likeness" of a relatively small but structurally diverse dataset (containing >1,000 compounds) from African medicinal plants, which have been tested and proven a wide range of biological activities. The geographical regions of collection of the medicinal plants cover the entire continent of Africa, based on data from literature sources and information from traditional healers. For each isolated compound, the three dimensional (3D) structure has been used to calculate physico-chemical properties used in the prediction of oral bioavailability on the basis of Lipinski's "Rule of Five". A comparative analysis has been carried out with the "drug-like", "lead-like", and "fragment-like" subsets, as well as with the Dictionary of Natural Products. A diversity analysis has been carried out in comparison with the ChemBridge diverse database. Furthermore, descriptors related to absorption, distribution, metabolism, excretion and toxicity (ADMET) have been used to predict the pharmacokinetic profile of the compounds within the dataset. Our results prove that drug discovery, beginning with natural products from the African flora, could be highly promising. The 3D structures are available and could be useful for virtual screening and natural product lead generation programs.	[Ntie-Kang, Fidele; Lifongo, Lydia L.] Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon; [Ntie-Kang, Fidele] Univ Douala, Fac Sci, Ctr Atom Mol Phys Opt & Quantum, Douala, Cameroon; [Ntie-Kang, Fidele; Scharfe, Michael; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Sci, D-06108 Halle, Saale, Germany; [Zofou, Denis] Univ Buea, Fac Sci, Dept Biochem & Mol Biol, Biotechnol Unit, Buea, Cameroon; [Babiaka, Smith B.; Meudom, Rolande; Mbah, James A.; Efange, Simon M. N.] Univ Buea, Fac Sci, Dept Chem, Buea, Cameroon; [Mbaze, Luc Mevaa] Univ Douala, Dept Chem, Fac Sci, Douala, Cameroon	Martin Luther University Halle Wittenberg	Ntie-Kang, F (corresponding author), Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon.	ntiekfidele@gmail.com	Sippl, Wolfgang/P-5944-2014; Ntie-Kang, Fidele/B-5877-2013; Zofou, Denis/D-3538-2013	Sippl, Wolfgang/0000-0002-5985-9261; Ntie-Kang, Fidele/0000-0003-0795-394X; Zofou, Denis/0000-0002-3421-7609	Chemical and Bioactivity Information Centre, University of Buea; German Academic Exchange Service; ICTP [OEA-AC-071]; International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) [F/5122-1]	Chemical and Bioactivity Information Centre, University of Buea; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); ICTP; International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW)	Financial support is acknowledged from the Chemical and Bioactivity Information Centre, University of Buea, through a Lhasa grant and also from the German Academic Exchange Service to FNK for his stay in Halle, Germany for part of his PhD, as well as from the ICTP through the OEA-AC-071 program. DZ acknowledges an International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) grant (NoF/5122-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w; Aronov MM, 2005, DRUG DISCOV TODAY, V10, P149, DOI 10.1016/S1359-6446(04)03278-7; Banzouzi JT, 2004, PHYTOMEDICINE, V11, P338, DOI 10.1078/0944711041495245; Bickii J, 2000, J ETHNOPHARMACOL, V69, P27, DOI 10.1016/S0378-8741(99)00117-8; Block S, 2005, ANTICANCER RES, V25, P363; BUZBEE B, 1993, SCIENCE, V261, P852, DOI 10.1126/science.261.5123.852; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; ChemAxon, 2012, JCHEM SOFTW VERS 5 1; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Colmenarejo G, 2001, J MED CHEM, V44, P4370, DOI 10.1021/jm010960b; Couzin J, 1998, SCIENCE, V281, P762; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Efange S. M. N., 2002, Ethnomedicine and drug discovery, P61; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Grabowski K, 2008, NAT PROD REP, V25, P892, DOI 10.1039/b715668p; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hoet S, 2004, NAT PROD REP, V21, P353, DOI 10.1039/b311021b; Hoet S, 2004, PLANTA MED, V70, P407, DOI 10.1055/s-2004-818967; Holtje H.-D., 2008, MOL MODELING BASIC P; Hostettmann K, 2000, CURR ORG CHEM, V4, P973, DOI 10.2174/1385272003375923; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jackson SJ, 2000, PLANTA MED, V66, P758, DOI 10.1055/s-2000-9778; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kubinyi H, 1998, Curr Opin Drug Discov Devel, V1, P16; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Kuete V, 2010, PLANTA MED, V76, P1479, DOI 10.1055/s-0030-1250027; Lewell XQ, 1998, J CHEM INF COMP SCI, V38, P511, DOI 10.1021/ci970429i; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Luco JM, 1999, J CHEM INF COMP SCI, V39, P396, DOI 10.1021/ci980411n; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; Mdee LK, 1998, PHYTOCHEMISTRY, V49, P1107, DOI 10.1016/S0031-9422(97)01037-6; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Nkanwen ERS, 2013, FITOTERAPIA, V86, P108, DOI 10.1016/j.fitote.2013.02.003; Ntie-Kang F, 2013, RSC ADV UNPUB; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-147; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-88; Ojo-Amaize EA, 2002, CANCER RES, V62, P4007; Ojo-Amaize EA, 2001, CELL IMMUNOL, V209, P149, DOI 10.1006/cimm.2001.1798; OKOGUN JI, 1982, Z NATURFORSCH C, V37, P558; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Potterat Olivier, 2008, V65; POTTS RO, 1995, PHARMACEUT RES, V12, P1628, DOI 10.1023/A:1016236932339; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; R Core Team, 2012, R LANG ENV STAT COMP; Salama MM, 2012, NAT PROD RES, V26, P2057, DOI 10.1080/14786419.2011.606219; Schneider G, 2002, CURR MED CHEM, V9, P2095, DOI 10.2174/0929867023368755; Schrodinger, 2011, LIGPREP SOFTW VERS 2; Schrodinger, 2011, MAESTR VERS 9 2; Schrodinger, 2011, QIKPROP VERS 3 4; Schrodinger Press, 2011, QIKPROP 3 4 US MAN; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sob SVT, 2011, J ASIAN NAT PROD RES, V13, P1128, DOI 10.1080/10286020.2011.619182; Stenberg P, 2001, J MED CHEM, V44, P1927, DOI 10.1021/jm001101a; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355; World Health Organisation, 1993, HERBAL GRAM, V28, P13; Yazdanian M, 1998, PHARMACEUT RES, V15, P1490, DOI 10.1023/A:1011930411574; Zofou D, 2013, NAT PROD REP, V30, P1098, DOI 10.1039/c3np70030e	82	120	122	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78085	10.1371/journal.pone.0078085	http://dx.doi.org/10.1371/journal.pone.0078085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205103	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500094
J	Saby, JN; Meltzoff, AN; Marshall, PJ				Saby, Joni N.; Meltzoff, Andrew N.; Marshall, Peter J.			Infants' Somatotopic Neural Responses to Seeing Human Actions: I've Got You under My Skin	PLOS ONE			English	Article							MU RHYTHM; MOTOR ACTIVATION; SOCIAL COGNITION; EEG; PREMOTOR; IMITATION; ATTENTION; DYNAMICS; SPECTRUM	Human infants rapidly learn new skills and customs via imitation, but the neural linkages between action perception and production are not well understood. Neuroscience studies in adults suggest that a key component of imitation-identifying the corresponding body part used in the acts of self and other-has an organized neural signature. In adults, perceiving someone using a specific body part (e. g., hand vs. foot) is associated with activation of the corresponding area of the sensory and/or motor strip in the observer's brain-a phenomenon called neural somatotopy. Here we examine whether preverbal infants also exhibit somatotopic neural responses during the observation of others' actions. 14-month-old infants were randomly assigned to watch an adult reach towards and touch an object using either her hand or her foot. The scalp electroencephalogram (EEG) was recorded and event-related changes in the sensorimotor mu rhythm were analyzed. Mu rhythm desynchronization was greater over hand areas of sensorimotor cortex during observation of hand actions and was greater over the foot area for observation of foot actions. This provides the first evidence that infants' observation of someone else using a particular body part activates the corresponding areas of sensorimotor cortex. We hypothesize that this somatotopic organization in the developing brain supports imitation and cultural learning. The findings connect developmental cognitive neuroscience, adult neuroscience, action representation, and behavioral imitation.	[Saby, Joni N.; Marshall, Peter J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Washington; University of Washington Seattle	Saby, JN (corresponding author), Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA.	joni.saby@temple.edu	Meltzoff, Andrew N/GPC-8807-2022	Meltzoff, Andrew N/0000-0001-8683-0547	NIH [HD-68734]; NSF [SMA-0835854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by an NIH (HD-68734) award to PJM and NSF (SMA-0835854) award to ANM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Berchicci M, 2011, DEV NEUROSCI-BASEL, V33, P130, DOI 10.1159/000329095; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Dawson G, 1998, CHILD DEV, V69, P1276, DOI 10.2307/1132265; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; HAGNE I, 1972, ACTA PAEDIATR SCAND, P1; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marshall PJ, 2011, DEVELOPMENTAL SCI, V14, P474, DOI 10.1111/j.1467-7687.2010.00991.x; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Marshall PJ, 2013, INFANCY; MELTZOFF AN, 1988, DEV PSYCHOL, V24, P470, DOI 10.1037/0012-1649.24.4.470; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meltzoff AN, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P281; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; Nystrom P, 2011, DEVELOPMENTAL SCI, V14, P327, DOI 10.1111/j.1467-7687.2010.00979.x; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 2008, EUR J NEUROSCI, V28, P1419, DOI 10.1111/j.1460-9568.2008.06441.x; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pineda Jaime A., 2009, P135, DOI 10.1007/978-1-59745-479-7_7; Reid VM, 2011, DEV COGN NEUROS-NETH, V1, P124, DOI 10.1016/j.dcn.2011.01.001; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rogers SJ, 2006, IMITATION SOCIAL MIN; Saby JN, 2012, SOC NEUROSCI-UK, V7, P650, DOI 10.1080/17470919.2012.691429; Saby JN, 2012, DEV NEUROPSYCHOL, V37, P253, DOI 10.1080/87565641.2011.614663; Smith JR, 1941, J PSYCHOL, V11, P177, DOI 10.1080/00223980.1941.9917028; Southgate V, 2010, PSYCHOL SCI, V21, P355, DOI 10.1177/0956797610362058; Southgate V, 2009, BIOL LETTERS, V5, P769, DOI 10.1098/rsbl.2009.0474; Stapel JC, 2010, SOC NEUROSCI-UK, V5, P451, DOI 10.1080/17470919.2010.490667; Stroganova TA, 1999, CLIN NEUROPHYSIOL, V110, P997, DOI 10.1016/S1388-2457(98)00009-1; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P54, DOI 10.1111/j.1467-7687.2007.00564.x; Warreyn P, 2013, DEVELOPMENTAL SCI, V16, P173, DOI 10.1111/desc.12014; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	44	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77905	10.1371/journal.pone.0077905	http://dx.doi.org/10.1371/journal.pone.0077905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205023	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500075
J	Vasserman, G; Schneidman, E; Segev, R				Vasserman, Genadiy; Schneidman, Elad; Segev, Ronen			Adaptive Colour Contrast Coding in the Salamander Retina Efficiently Matches Natural Scene Statistics	PLOS ONE			English	Article							TEMPORAL CONTRAST; LIGHT ADAPTATION; GAIN-CONTROL; MECHANISMS; REDUNDANCY; CIRCUITRY; PRIMATE; VISION; CORTEX; CODE	The visual system continually adjusts its sensitivity to the statistical properties of the environment through an adaptation process that starts in the retina. Colour perception and processing is commonly thought to occur mainly in high visual areas, and indeed most evidence for chromatic colour contrast adaptation comes from cortical studies. We show that colour contrast adaptation starts in the retina where ganglion cells adjust their responses to the spectral properties of the environment. We demonstrate that the ganglion cells match their responses to red-blue stimulus combinations according to the relative contrast of each of the input channels by rotating their functional response properties in colour space. Using measurements of the chromatic statistics of natural environments, we show that the retina balances inputs from the two ( red and blue) stimulated colour channels, as would be expected from theoretical optimal behaviour. Our results suggest that colour is encoded in the retina based on the efficient processing of spectral information that matches spectral combinations in natural scenes on the colour processing level.	[Vasserman, Genadiy; Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Vasserman, Genadiy; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Ben Gurion University; Ben Gurion University; Weizmann Institute of Science	Vasserman, G (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	genawas@gmail.com		schneidman, elad/0000-0001-8653-9848; Segev, Ronen/0000-0002-8109-1076				Babadi B, 2010, J VISION, V10, DOI 10.1167/10.10.22; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COLLINS J. T, 1998, FIELD GUIDE REPTILES; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GREEN DG, 1982, VISION RES, V22, P209, DOI 10.1016/0042-6989(82)90120-1; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Himstedt W, 1972, J COMP PHYSL, V81, P229; Hurley JB, 2002, J GEN PHYSIOL, V119, P125, DOI 10.1085/jgp.119.2.125; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nascimento SMC, 2002, J OPT SOC AM A, V19, P1484, DOI 10.1364/JOSAA.19.001484; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PRZYREMBEL C, 1995, J COMP PHYSIOL A, V176, P575; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rodieck R.W., 1998, 1 STEPS SEEING; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Sharon R, 1997, J MORPHOL, V231, P149, DOI 10.1002/(SICI)1097-4687(199702)231:2<149::AID-JMOR4>3.0.CO;2-9; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Tailby C, 2008, J NEUROSCI, V28, P1131, DOI 10.1523/JNEUROSCI.4682-07.2008; Wandell B, 2008, CURR BIOL, V18, pR250, DOI 10.1016/j.cub.2008.01.045; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Webster MA, 1996, NETWORK-COMP NEURAL, V7, P587, DOI 10.1088/0954-898X/7/4/002; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P117; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; ZAIDI Q, 1993, BIOL CYBERN, V69, P415, DOI 10.1007/BF01185413; Zhou CH, 2008, J VISION, V8, DOI 10.1167/8.4.4	49	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79163	10.1371/journal.pone.0079163	http://dx.doi.org/10.1371/journal.pone.0079163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205373	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500146
J	Flynn, R; Hutchinson, T; Murphy, KM; Ware, CF; Croft, M; Salek-Ardakani, S				Flynn, Rachel; Hutchinson, Tarun; Murphy, Kenneth M.; Ware, Carl F.; Croft, Michael; Salek-Ardakani, Shahram			CD8 T Cell Memory to a Viral Pathogen Requires Trans Cosignaling between HVEM and BTLA	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; TNF SUPERFAMILY MEMBERS; LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; VACCINIA VIRUS; FAMILY-MEMBERS; CUTTING EDGE; INHIBITORY RECEPTORS; ACTIVATION; IMMUNITY	Defining the molecular interactions required to program activated CD8 T cells to survive and become memory cells may allow us to understand how to augment anti-viral immunity. HVEM (herpes virus entry mediator) is a member of the tumor necrosis factor receptor (TNFR) family that interacts with ligands in the TNF family, LIGHT and Lymphotoxin-alpha, and in the Ig family, B and T lymphocyte attenuator (BTLA) and CD160. The Ig family members initiate inhibitory signaling when engaged with HVEM, but may also activate survival gene expression. Using a model of vaccinia virus infection, we made the unexpected finding that deficiency in HVEM or BTLA profoundly impaired effector CD8 T cell survival and development of protective immune memory. Mixed adoptive transfer experiments indicated that BTLA expressed in CD8 alpha+ dendritic cells functions as a trans-activating ligand that delivers positive co-signals through HVEM expressed in T cells. Our data demonstrate a critical role of HVEM-BTLA bidirectional cosignaling system in antiviral defenses by driving the differentiation of memory CD8 T cells.	[Flynn, Rachel; Hutchinson, Tarun; Salek-Ardakani, Shahram] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Flynn, Rachel; Croft, Michael; Salek-Ardakani, Shahram] La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA USA; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, Lab Mol Immunol, La Jolla, CA USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Washington University (WUSTL); La Jolla Institute for Immunology; Sanford Burnham Prebys Medical Discovery Institute	Salek-Ardakani, S (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	ssalek@ufl.edu			National Institutes of Health [AI77079, AI087734, CA91837, AI67341, AI033068, AI048073, AI067890]; NATIONAL CANCER INSTITUTE [R01CA091837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R01AI067341, R37AI033068, R56AI067341, R01AI067890, R21AI077079, R01AI087734, R01AI033068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI77079 and AI087734 to SS-A, CA91837 and AI67341 to MC, AI033068, AI048073 and AI067890 to CFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Croft M, 2005, TRENDS IMMUNOL, V26, P292, DOI 10.1016/j.it.2005.03.010; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Davenport MP, 2009, TRENDS IMMUNOL, V30, P61, DOI 10.1016/j.it.2008.11.001; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Gavrieli M, 2006, BIOCHEM BIOPH RES CO, V345, P1440, DOI 10.1016/j.bbrc.2006.05.036; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Liu XK, 2009, J IMMUNOL, V182, P4516, DOI 10.4049/jimmunol.0803161; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Moutaftsi M, 2009, EUR J IMMUNOL, V39, P717, DOI 10.1002/eji.200838815; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056; Salek-Ardakani S, 2010, J INTERF CYTOK RES, V30, P205, DOI 10.1089/jir.2010.0026; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Truong W, 2009, J LEUKOCYTE BIOL, V86, P41, DOI [10.1189/JLB.1107753, 10.1189/jlb.1107753]; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Zhao Y, 2009, J IMMUNOL, V182, P6278, DOI 10.4049/jimmunol.0803682	48	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77991	10.1371/journal.pone.0077991	http://dx.doi.org/10.1371/journal.pone.0077991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205056	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700064
J	Cerminara, M; Campos, LA; Ramanathan, R; Munoz, V				Cerminara, Michele; Campos, Luis A.; Ramanathan, Ravishankar; Munoz, Victor			Slow Proton Transfer Coupled to Unfolding Explains the Puzzling Results of Single-Molecule Experiments on BBL, a Paradigmatic Downhill Folding Protein	PLOS ONE			English	Article							FREE-ENERGY BARRIERS; FLUORESCENCE SPECTROSCOPY; LANDSCAPE PERSPECTIVE; SPEED LIMIT; DYNAMICS; KINETICS; DOMAIN; 2-STATE; MODEL; RATES	A battery of thermodynamic, kinetic, and structural approaches has indicated that the small alpha-helical protein BBL folds-unfolds via the one-state downhill scenario. Yet, single-molecule fluorescence spectroscopy offers a more conflicting view. Single-molecule experiments at pH 6 show a unique half-unfolded conformational ensemble at mid denaturation, whereas other experiments performed at higher pH show a bimodal distribution, as expected for two-state folding. Here we use thermodynamic and laser T-jump kinetic experiments combined with theoretical modeling to investigate the pH dependence of BBL stability, folding kinetics and mechanism within the pH 6-11 range. We find that BBL unfolding is tightly coupled to the protonation of one of its residues with an apparent pK(a) of similar to 7. Therefore, in chemical denaturation experiments around neutral pH BBL unfolds gradually, and also converts in binary fashion to the protonated species. Moreover, under the single-molecule experimental conditions (denaturant midpoint and 279 K), we observe that proton transfer is much slower than the similar to 15 microseconds folding-unfolding kinetics of BBL. The relaxation kinetics is distinctly biphasic, and the overall relaxation time (i.e. 0.2-0.5 ms) becomes controlled by the proton transfer step. We then show that a simple theoretical model of protein folding coupled to proton transfer explains quantitatively all these results as well as the two sets of single-molecule experiments, including their more puzzling features. Interestingly, this analysis suggests that BBL unfolds following a one-state downhill folding mechanism at all conditions. Accordingly, the source of the bimodal distributions observed during denaturation at pH 7-8 is the splitting of the unique conformational ensemble of BBL onto two slowly inter-converting protonation species. Both, the unprotonated and protonated species unfold gradually (one-state downhill), but they exhibit different degree of unfolding at any given condition because the native structure is less stable for the protonated form.	[Cerminara, Michele; Campos, Luis A.; Ramanathan, Ravishankar; Munoz, Victor] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Cerminara, Michele; Campos, Luis A.; Munoz, Victor] IMDEA Nanociencia, Madrid, Spain; [Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IMDEA Nanociencia; University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	vmunoz@cnb.csic.es	Prieto, Luis Alberto Campos/A-1865-2019; Prieto, Luis Enrique/HFZ-7903-2022	Prieto, Luis Alberto Campos/0000-0003-4788-9102; Cerminara, Michele/0000-0002-2131-395X	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2008-03237, BIO2011-28092, CONSOLIDER CSD2009-00088]; European Research Council [MOLRHEOSTAT AG-ERC 323059]	Spanish Ministry of Economy and Competitiveness (MINECO); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the grants BFU2008-03237, BIO2011-28092 and CONSOLIDER CSD2009-00088 from the Spanish Ministry of Economy and Competitiveness (MINECO) and the grant MOLRHEOSTAT AG-ERC 323059 from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Campos LA, 2009, P NATL ACAD SCI USA, V106, pE139, DOI 10.1073/pnas.0912057107; Arbely E, 2010, J MOL BIOL, V403, P313, DOI 10.1016/j.jmb.2010.08.052; Arbely E, 2009, J MOL BIOL, V387, P986, DOI 10.1016/j.jmb.2008.12.055; Bamford CH, 1977, PROTON TRANSFER; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Campos LA, 2013, P NATL ACAD SCI USA, V110, pE1242, DOI 10.1073/pnas.1219166110; Campos LA, 2011, NAT METHODS, V8, P143, DOI 10.1038/NMETH.1553; Cerminara M, 2012, J AM CHEM SOC, V134, P8010, DOI 10.1021/ja301092z; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Cho SS, 2008, P NATL ACAD SCI USA, V105, P118, DOI 10.1073/pnas.0709376104; Crooks J. E., 1977, PROTON TRANSFER; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Ferguson N, 2006, J MOL BIOL, V356, P1237, DOI 10.1016/j.jmb.2005.12.016; Fung A, 2008, J AM CHEM SOC, V130, P7489, DOI 10.1021/ja801401a; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Garcia-Mira MM, 2001, BIOPHYS J, V81, P3489, DOI 10.1016/S0006-3495(01)75980-2; Hagen SJ, 1997, J PHYS CHEM B, V101, P2352, DOI 10.1021/jp9622997; Hao MH, 1998, ACCOUNTS CHEM RES, V31, P433, DOI 10.1021/ar960288q; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; Huang F, 2013, P NATL ACAD SCI USA, V110, pE331, DOI 10.1073/pnas.1217840110; Huang F, 2009, P NATL ACAD SCI USA, V106, P16239, DOI 10.1073/pnas.0909126106; IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Li P, 2009, P NATL ACAD SCI USA, V106, P103, DOI 10.1073/pnas.0802986106; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; Lin CW, 2013, J AM CHEM SOC, V135, P7668, DOI 10.1021/ja401473m; Liu JW, 2012, P NATL ACAD SCI USA, V109, P179, DOI 10.1073/pnas.1111164109; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Munoz V, 2007, ANNU REV BIOPH BIOM, V36, P395, DOI 10.1146/annurev.biophys.36.040306.132608; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; Naganathan AN, 2007, J AM CHEM SOC, V129, P5673, DOI 10.1021/ja0689740; Naganathan AN, 2006, BIOCHEMISTRY-US, V45, P8466, DOI 10.1021/bi060643c; Naganathan AN, 2011, PHYS CHEM CHEM PHYS, V13, P17064, DOI 10.1039/c1cp20156e; Naganathan AN, 2010, J AM CHEM SOC, V132, P11183, DOI 10.1021/ja103612q; Neuweiler H, 2009, J MOL BIOL, V387, P975, DOI 10.1016/j.jmb.2008.12.056; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Sadqi M, 2007, NATURE, V445, pE17, DOI 10.1038/nature05645; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	54	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78044	10.1371/journal.pone.0078044	http://dx.doi.org/10.1371/journal.pone.0078044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205082	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200051
J	Fortune, B; Reynaud, J; Wang, L; Burgoyne, CF				Fortune, Brad; Reynaud, Juan; Wang, Lin; Burgoyne, Claude F.			Does Optic Nerve Head Surface Topography Change Prior to Loss of Retinal Nerve Fiber Layer Thickness: A Test of the Site of Injury Hypothesis in Experimental Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; SCANNING LASER TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; LAMINA-CRIBROSA; GANGLION-CELLS; 3-D HISTOMORPHOMETRY; AXOPLASMIC-TRANSPORT; COHERENCE TOMOGRAPHY; CONNECTIVE-TISSUE; MONKEY	Purpose: To test the hypothesis that optic nerve head (ONH) deformation manifesting as changes in its mean surface height precedes thinning of the peripapillary retinal nerve fiber layer (RNFL) in experimental glaucoma (EG). Methods: 68 rhesus macaque monkeys each had three or more baseline imaging sessions under manometric intraocular pressure (IOP) control to obtain average RNFL thickness (RNFLT) and the ONH surface topography parameter mean position of the disc (MPD). Laser photocoagulation was then applied to the trabecular meshwork of one eye to induce chronic, mild-to-moderate IOP elevation and bi-weekly imaging continued. Event analysis was applied to determine for each parameter when an 'endpoint' occurred (signficant change from baseline) for eight different endpoint criteria. Specificity was assessed in the group of 68 fellow control eyes. Classical signal detection theory and survival analysis were used to compare MPD with RNFLT. Results: Regardless of the endpoint criterion, endpoints were always more frequent for MPD than for RNFLT. The discriminability index (d') was 2.7 +/- 0.2 for MPD and 1.9 +/- 0.2 for RNFLT (p<0.0001). Endpoints were reached by MPD an average of 1-2 months earlier than by RNFLT (p<0.01). At the onset of the first specific, detectable MPD change in EG eyes, there was still no significant change in RNFLT on average (p=0.29) and only 25% of individual eyes exhibited signficant reduction. In contrast, at onset of signficant RNFLT change, MPD had already changed an average of 101 mu m from baseline (p<0.0001) and 71% of the individual eyes had exhibited significant change. The magnitude of MPD change was more than could be explained on the basis of axon loss alone. Conclusions: This study demonstrates that the average surface height of the ONH changes prior to any detectable loss of average peripapillary RNFL thickness in non-human primate eyes with experimental glaucoma.	[Fortune, Brad] Legacy Hlth, Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR USA; Legacy Hlth, Legacy Res Inst, Portland, OR USA	Devers Eye Institute; Legacy Health; Legacy Health	Fortune, B (corresponding author), Legacy Hlth, Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR USA.	bfortune@deverseye.org		Wang, Lin/0000-0003-0385-8478; Burgoyne, Claude/0000-0002-2765-4739; Fortune, Brad/0000-0003-0284-5173	National Institutes of Health (NIH) of the U.S. Department of Health and Human Services [R01EY019327, R01-EY019939, R01-EY011610]; Heidelberg Engineering, GmbH, Heidelberg, Germany; NATIONAL EYE INSTITUTE [R01EY011610, R01EY019939, R01EY019327] Funding Source: NIH RePORTER	National Institutes of Health (NIH) of the U.S. Department of Health and Human Services; Heidelberg Engineering, GmbH, Heidelberg, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from The National Institutes of Health (NIH) of the U.S. Department of Health and Human Services: NIH R01EY019327 (BF), R01-EY019939 (LW), R01-EY011610 (CFB); http://www.nih.gov; as well as by The Legacy Good Samaritan Foundation. Additional support (equipment and unrestricted research support) was received from Heidelberg Engineering, GmbH, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Chauhan BC, 2001, ARCH OPHTHALMOL-CHIC, V119, P1492; Chauhan BC, 2000, INVEST OPHTH VIS SCI, V41, P775; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Cull G, 2013, INVEST OPHTH VIS SCI, V54, P4271, DOI 10.1167/iovs.13-12013; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; Dai C, 2012, GLIA, V60, P13, DOI 10.1002/glia.21242; Danesh-Meyer HV, 2009, INVEST OPHTHALMOL VI; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, P290; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Fortune B, 2012, INVEST OPHTH VIS SCI, V53, P3939, DOI 10.1167/iovs.12-9979; GAASTERLAND D, 1974, INVEST OPHTH VISUAL, V13, P455; GEIJSSEN HC, 1987, OPHTHALMIC SURG LAS, V18, P207; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS144, DOI 10.1016/j.survophthal.2007.08.010; Heickell AG, 2001, J GLAUCOMA, V10, P369, DOI 10.1097/00061198-200110000-00002; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Medeiros FA, 2013, OPHTHALMOLO IN PRESS; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; VANBUSKIRK EM, 1992, AM J OPHTHALMOL, V113, P447, DOI 10.1016/S0002-9394(14)76171-9; VRABEC F, 1976, A GRAEF ARCH KLIN EX, V198, P223, DOI 10.1007/BF00410715; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	50	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77831	10.1371/journal.pone.0077831	http://dx.doi.org/10.1371/journal.pone.0077831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204989	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400058
J	Juntti, SA; Hu, CK; Fernald, RD				Juntti, Scott A.; Hu, Caroline K.; Fernald, Russell D.			Tol2-Mediated Generation of a Transgenic Haplochromine Cichlid, Astatotilapia burtoni	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; TOL2 TRANSPOSABLE ELEMENT; EXPLOSIVE SPECIATION; AGGRESSIVE-BEHAVIOR; ADAPTIVE RADIATION; SOCIAL-BEHAVIOR; PARENTAL CARE; GENE-TRANSFER; MEDAKA FISH; ZEBRAFISH	Cichlid fishes represent one of the most species-rich and rapid radiations of a vertebrate family. These similar to 2200 species, predominantly found in the East African Great Lakes, exhibit dramatic differences in anatomy, physiology, and behavior. However, the genetic bases for this radiation, and for the control of their divergent traits, are unknown. A flood of genomic and transcriptomic data promises to suggest mechanisms underlying the diversity, but transgenic technology will be needed to rigorously test the hypotheses generated. Here we demonstrate the successful use of the Tol2 transposon system to generate transgenic Astatotilapia burtoni, a haplochromine cichlid from Lake Tanganyika, carrying the GFP transgene under the control of the ubiquitous EF1 alpha promoter. The transgene integrates into the genome, is successfully passed through the germline, and the widespread GFP expression pattern is stable across siblings and multiple generations. The stable inheritance and expression patterns indicate that the Tol2 system can be applied to generate A. burtoni transgenic lines. Transgenesis has proven to be a powerful technology for manipulating genes and cells in other model organisms and we anticipate that transgenic A. burtoni and other cichlids will be used to test the mechanisms underlying behavior and speciation.	[Juntti, Scott A.; Hu, Caroline K.; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Juntti, SA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sjuntti@stanford.edu		Juntti, Scott/0000-0001-7634-1395; Hu, Caroline/0000-0003-3772-5737	NIH [F32HD071755]; Gabilan Stanford Graduate Fellowship; NSF [IOS-0923588];  [NIH-NS 034950];  [MH 101373]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH101373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034950, R37NS034950, R56NS034950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabilan Stanford Graduate Fellowship; NSF(National Science Foundation (NSF)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by funding from NIH F32HD071755 to SAJ, a Gabilan Stanford Graduate Fellowship to CKH, and NIH-NS 034950, MH 101373, and NSF IOS-0923588 to RDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; BREM G, 1988, AQUACULTURE, V68, P209, DOI 10.1016/0044-8486(88)90354-7; Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1979, Z TIERPSYCHOL, V50, P180; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Fernald RD, 2012, ANNU REV NEUROSCI, V35, P133, DOI 10.1146/annurev-neuro-062111-150520; FERNO A, 1987, BEHAVIOUR, V103, P241, DOI 10.1163/156853987X00189; FERNO A, 1986, BEHAV PROCESS, V13, P367, DOI 10.1016/0376-6357(86)90031-8; Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI [10.1111/j.1440-169x.2007.00926.x, 10.1111/j.1440-169X.2007.00926.x]; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; Golan M, 2013, GEN COMP EN IN PRESS; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Greenwood AK, 2004, BIOL REPROD, V71, P909, DOI 10.1095/biolreprod.104.030072; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Hosemann KE, 2004, BEHAVIOUR, V141, P1345, DOI 10.1163/1568539042948097; INOUE K, 1990, CELL DIFFER DEV, V29, P123, DOI 10.1016/0922-3371(90)90030-Z; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kobayashi N, 2006, GENE, V373, P126, DOI 10.1016/j.gene.2006.01.016; Koblmuller S, 2008, MOL PHYLOGENET EVOL, V49, P153, DOI 10.1016/j.ympev.2008.05.045; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; KUWAMURA T, 1986, J ETHOL, V4, P129, DOI 10.1007/BF02348115; Lang M, 2006, J EXP ZOOL PART B, V306B, P35, DOI 10.1002/jez.b.21068; LIEM KF, 1980, AM ZOOL, V20, P295; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; Puertollano R, 2006, ENDOSOMES, P119; Rahman MA, 2000, TRANSGENIC RES, V9, P417, DOI 10.1023/A:1026517212807; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-96; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Sanetra M, 2009, GENETICS, V182, P387, DOI 10.1534/genetics.108.089367; STUART GW, 1988, DEVELOPMENT, V103, P403; Tasic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033332; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Turner GF, 2007, CURR BIOL, V17, pR827, DOI 10.1016/j.cub.2007.07.026; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wang TL, 2010, TRAFFIC, V11, P1119, DOI 10.1111/j.1600-0854.2010.01098.x; Wang YP, 2001, CHINESE SCI BULL, V46, P1174	59	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77647	10.1371/journal.pone.0077647	http://dx.doi.org/10.1371/journal.pone.0077647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204902	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400048
J	Libraty, DH; Zhang, L; Woda, M; Acosta, LP; Obcena, A; Brion, JD; Capeding, RZ				Libraty, Daniel H.; Zhang, Lei; Woda, Marcia; Acosta, Luz P.; Obcena, AnaMae; Brion, Job D.; Capeding, Rosario Z.			Toll-Like Receptor Induced Pro-Interleukin-1 beta and Interleukin-6 in Monocytes Are Lower in Healthy Infants Compared to Adults	PLOS ONE			English	Article								Infants have long been known to have higher infectious diseases morbidity and mortality and suboptimal vaccination responses compared to older children and adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. We compared Toll-like receptor (TLR)-induced production of pro-interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha between 2-month-old infants and adults. TLR 7/ 8-induced production of pro-IL-1 beta and IL-6 in monocytes was lower in 2-month-old infants compared to adults. There was no difference in TLR 7/8-induced production of TNF-alpha. Lower TLR-induced production of pro-IL-1 beta and IL-6 in innate immune cells during early infancy likely contributes to suboptimal vaccine responses and infectious diseases susceptibility.	[Libraty, Daniel H.; Zhang, Lei; Woda, Marcia] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Acosta, Luz P.] Res Inst Trop Med, Dept Immunol, Manila, Philippines; [Obcena, AnaMae; Capeding, Rosario Z.] Res Inst Trop Med, Dept Med, Manila, Philippines; [Brion, Job D.] San Pablo City Hlth Off, San Pablo, Philippines; [Capeding, Rosario Z.] Res Inst Trop Med, Dept Microbiol, Manila, Philippines	University of Massachusetts System; University of Massachusetts Worcester; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	daniel.libraty@umassmed.edu			National Institutes of Health [NIH/NIAID R01 AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant NIH/NIAID R01 AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; World Health Organization, 2011, WHO ANTHR PERS COMP	6	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78018	10.1371/journal.pone.0078018	http://dx.doi.org/10.1371/journal.pone.0078018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205068	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400068
J	Then, C; Wahl, S; Kirchhofer, A; Grallert, H; Krug, S; Kastenmuller, G; Romisch-Margl, W; Claussnitzer, M; Illig, T; Heier, M; Meisinger, C; Adamski, J; Thorand, B; Huth, C; Peters, A; Prehn, C; Heukamp, I; Laumen, H; Lechner, A; Hauner, H; Seissler, J				Then, Cornelia; Wahl, Simone; Kirchhofer, Anna; Grallert, Harald; Krug, Susanne; Kastenmueller, Gabi; Roemisch-Margl, Werner; Claussnitzer, Melina; Illig, Thomas; Heier, Margit; Meisinger, Christa; Adamski, Jerzy; Thorand, Barbara; Huth, Cornelia; Peters, Annette; Prehn, Cornelia; Heukamp, Ina; Laumen, Helmut; Lechner, Andreas; Hauner, Hans; Seissler, Jochen			Plasma Metabolomics Reveal Alterations of Sphingo- and Glycerophospholipid Levels in Non-Diabetic Carriers of the Transcription Factor 7-Like 2 Polymorphism rs7903146	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TCF7L2 GENE; INSULIN-SECRETION; ADIPOSE-TISSUE; RISK; ASSOCIATION; ACID; METABOLISM; INCREASES; VARIANTS	Aims/Hypothesis: Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene have been shown to display a powerful association with type 2 diabetes. The aim of the present study was to evaluate metabolic alterations in carriers of a common TCF7L2 risk variant. Methods: Seventeen non-diabetic subjects carrying the T risk allele at the rs7903146 TCF7L2 locus and 24 subjects carrying no risk allele were submitted to intravenous glucose tolerance test and euglycemic-hyperinsulinemic clamp. Plasma samples were analysed for concentrations of 163 metabolites through targeted mass spectrometry. Results: TCF7L2 risk allele carriers had a reduced first-phase insulin response and normal insulin sensitivity. Under fasting conditions, carriers of TCF7L2 rs7903146 exhibited a non-significant increase of plasma sphingomyelins (SMs), phosphatidylcholines (PCs) and lysophosphatidylcholines (lysoPCs) species. A significant genotype effect was detected in response to challenge tests in 6 SMs (C16:0, C16:1, C18:0, C18:1, C24:0, C24:1), 5 hydroxy-SMs (C14:1, C16:1, C22:1, C22:2, C24:1), 4 lysoPCs (C14:0, C16:0, C16:1, C17:0), 3 diacyl-PCs (C28:1, C36:6, C40:4) and 4 long-chain acyl-alkyl-PCs (C40:2, C40:5, C44:5, C44:6). Discussion: Plasma metabolomic profiling identified alterations of phospholipid metabolism in response to challenge tests in subjects with TCF7L2 rs7903146 genotype. This may reflect a genotype-mediated link to early metabolic abnormalities prior to the development of disturbed glucose tolerance.	[Then, Cornelia; Kirchhofer, Anna; Heukamp, Ina; Lechner, Andreas; Seissler, Jochen] Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Munich, Germany; [Then, Cornelia; Grallert, Harald; Lechner, Andreas; Seissler, Jochen] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany; [Then, Cornelia; Grallert, Harald; Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Lechner, Andreas; Hauner, Hans; Seissler, Jochen] Helmholtz Zentrum Munchen, Munich, Germany; [Wahl, Simone; Grallert, Harald] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Else Kroener Fresenius Ctr Nutr Med, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type Diabet 2, D-80290 Munich, Germany; [Kastenmueller, Gabi; Roemisch-Margl, Werner] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Heier, Margit; Meisinger, Christa; Thorand, Barbara; Huth, Cornelia; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Thorand, Barbara; Huth, Cornelia] German Ctr Diabet Res DZD, Neuherberg, Germany; [Adamski, Jerzy; Prehn, Cornelia] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Seissler, J (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Campus Innenstadt, Munich, Germany.	jochen.seissler@med.uni-muenchen.de	Peters, Annette/A-6117-2011; Grallert, Harald/B-3424-2013; Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Huth, Cornelia/B-5350-2014; Laumen, Helmut/M-5140-2013; Kastenmüller, Gabi/ABF-5987-2020	Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Huth, Cornelia/0000-0003-2421-433X; Laumen, Helmut/0000-0002-5885-5242; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education and Science, Research and Technology; State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen); Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen); German Center for Diabetes Research (DZD e.V.)	Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education and Science, Research and Technology; State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen); Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen); German Center for Diabetes Research (DZD e.V.)	The KORA research platform studies were initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Science, Research and Technology and by the State of Bavaria. The study was supported by a research grant from the Virtual Diabetes Institute (Helmholtz Zentrum Munchen), the Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen), the Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen) and in part by the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, DIABETES, V59, P836, DOI 10.2337/db09-0918; [Anonymous], HORM METAB RES, V43, P355, DOI [10.1055/s-0031-1275270, DOI 10.1055/S-0031-1275270.PUBMED:21448848]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Chen XY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-25; Dohi T, 2012, CLIN CHIM ACTA, V413, P207, DOI 10.1016/j.cca.2011.09.027; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gonzalez-Sanchez JL, 2008, DIABETOLOGIA, V51, P1993, DOI 10.1007/s00125-008-1129-2; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Ip W, 2012, AM J PHYSIOL-ENDOC M, V303, pE1166, DOI 10.1152/ajpendo.00249.2012; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Kaminska D, 2012, DIABETES, V61, P2807, DOI 10.2337/db12-0239; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marzi C, 2007, HORM METAB RES, V39, P46, DOI 10.1055/s-2007-957345; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pietilainen KH, 2006, J CLIN ENDOCR METAB, V91, P2776, DOI 10.1210/jc.2005-2848; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhang Y, 2009, APOPTOSIS, V14, P878, DOI 10.1007/s10495-009-0364-4; Zhu C, 2011, TALANTA, V85, P1711, DOI 10.1016/j.talanta.2011.05.036	48	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78430	10.1371/journal.pone.0078430	http://dx.doi.org/10.1371/journal.pone.0078430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205231	Green Published, gold			2022-12-25	WOS:000326152300060
J	Weixel, KM; Marciszyn, A; Alzamora, R; Li, H; Fischer, O; Edinger, RS; Hallows, KR; Johnson, JP				Weixel, Kelly M.; Marciszyn, Allison; Alzamora, Rodrigo; Li, Hui; Fischer, Oliver; Edinger, Robert S.; Hallows, Kenneth R.; Johnson, John P.			Resveratrol Inhibits the Epithelial Sodium Channel via Phopshoinositides and AMP-Activated Protein Kinase in Kidney Collecting Duct Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE NEDD4-2; NA+ CHANNEL; PHOSPHOINOSITIDE 3-KINASE; TRANSPORT; ENAC; PHOSPHATIDYLINOSITIDES; SUBUNIT; MECHANISMS; EXPRESSION; MUTATIONS	Resveratrol, a naturally occurring phytoalexin, has reported cardioprotective, anti-inflammatory, chemopreventative and antidiabetic properties. Several studies indicate the multiple effects of resveratrol on cellular function are due to its inhibition of class 1A phosphoinositide 3-kinase (PI3K) mediated signaling pathways, but it also activates AMP-activated protein kinase (AMPK). As sodium transport in the kidney via the Epithelial Sodium Channel (ENaC) is highly sensitive to changes in phosphoinositide signaling in the membrane and AMPK, we employed resveratrol to probe the relative effects of phosphatidylinositol species in the plasma membrane and AMPK activity and their impact on ENaC activity in mouse cortical collecting duct (mpkCCD(c14)) cells. Here we demonstrate that resveratrol acutely reduces amiloride-sensitive current in mpkCCD(c14) cells. The time course and dose dependency of this inhibition paralleled depletion of the PI(3,4,5)P-3 reporter (AKT-PH) in live-cell microscopy, indicating the early inhibition is likely mediated by resveratrol's known effects on PI3K activity. Additionally, resveratrol induces a late inhibitory effect (4-24 hours) that appears to be mediated via AMPK activation. Resveratrol treatment induces significant AMPK activation compared with vehicle controls after 4 h, which persists through 16 h. Knockdown of AMPK or treatment with the AMPK inhibitor Compound C reduced the late phase of current reduction but had no effect on the early inhibitory activity of resveratrol. Collectively, these data demonstrate that resveratrol inhibits ENaC activity by a dual effect: an early reduction in activity seen within 5 minutes related to depletion of membrane PIP3, and a sustained late (4-24 h) effect secondary to activation of AMPK.	[Marciszyn, Allison; Alzamora, Rodrigo; Li, Hui; Fischer, Oliver; Edinger, Robert S.; Hallows, Kenneth R.; Johnson, John P.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Hallows, Kenneth R.; Johnson, John P.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Weixel, Kelly M.] Washington & Jefferson Univ, Dept Biol, Washington, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weixel, KM (corresponding author), Washington & Jefferson Univ, Dept Biol, Washington, PA USA.	kweixel@washjeff.edu		Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [R01 DK075048, R01 DK047874]; AHA [0825540D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, R01DK047874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 DK075048 to KRH and R01 DK047874 to JPJ), and AHA #0825540D (to RA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamora R, 2010, AM J PHYSIOL-RENAL, V299, pF1308, DOI 10.1152/ajprenal.00423.2010; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blazer-Yost BL, 1999, AM J PHYSIOL-CELL PH, V277, pC531, DOI 10.1152/ajpcell.1999.277.3.C531; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen KH, 2011, CHEM-BIOL INTERACT, V190, P45, DOI 10.1016/j.cbi.2011.01.033; Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004; Das S, 2006, FREE RADICAL RES, V40, P1066, DOI 10.1080/10715760600833085; Ding DF, 2010, AM J NEPHROL, V31, P363, DOI 10.1159/000300388; Dolinsky VW, 2013, BIOCH BIOPHYS ACTA; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Ooms Lisa M., 2009, V462, P223, DOI 10.1007/978-1-60327-115-8_15; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Record RD, 1998, AM J PHYSIOL-ENDOC M, V274, pE611, DOI 10.1152/ajpendo.1998.274.4.E611; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang J, 2008, AM J PHYSIOL-RENAL, V295, pF843, DOI 10.1152/ajprenal.90348.2008; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78019	10.1371/journal.pone.0078019	http://dx.doi.org/10.1371/journal.pone.0078019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205069	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300039
J	Duan, JH; Hu, CH; Luo, SQ; Zhao, XY; Wang, TL				Duan, Jinghao; Hu, Chunhong; Luo, Shuqian; Zhao, Xinyan; Wang, Tailing			Microcomputed Tomography with Diffraction-Enhanced Imaging for Morphologic Characterization and Quantitative Evaluation of Microvessel of Hepatic Fibrosis in Rats	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; HIGH-RESOLUTION; LIVER FIBROSIS; BREAST; CT; SPECIMENS; VISUALIZATION; MAMMOGRAPHY; RADIATION; DIAGNOSIS	Backgroud: Hepatic fibrosis can lead to deformation of vessel morphology and structure. In the present feasibility study, high-resolution computed tomography (CT) using diffraction-enhanced imaging (DEI) was used to represent three-dimensional (3D) vessel microstructures of hepatic fibrosis in rats and to differentiate different stages of hepatic fibrosis using qualitative descriptions and quantitative measurement of microvessels. Material and Methods: Three typical specimens at different stages, i.e., mild, moderate and severe hepatic fibrosis, were imaged using DEI at 15 keV without contrast agents. The correspondence between DEI-CT images and histopathological findings was determined. The 3D visualizations from different stages of hepatic fibrosis were presented using DEI-CT. Additionally, Qualitative descriptions and quantitative evaluation of vessel features, such as vessel trend, vascular distortion deformation, thrombus formation and texture features on the inner wall of the vessel, were performed. Results: DEI-CT produced high-resolution images of the vessel microstructures in hepatic fibrosis that corresponded to information on actual structures observed from the histological sections. Combined with the 3D visualization technique, DEI-CT enabled the acquisition of an accurate description of the 3D vessel morphology from different stages of hepatic fibrosis. Qualitative descriptions and quantitative assessment of microvessels demonstrated clear differences between the different stages of hepatic fibrosis. The thrombus inside the vessel of severe liver fibrosis was accurately displayed, and corresponding analysis can provide an exact measurement of vessel stenosis rate. Conclusions: DEI-CT may allow morphologic descriptions and quantitative evaluation of vessel microstructures from different stages of hepatic fibrosis and can better characterize the various stages of fibrosis progression using high-resolution 3D vessel morphology.	[Duan, Jinghao; Hu, Chunhong] Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China; [Luo, Shuqian] Capital Med Univ, Coll Biomed Engn, Beijing, Peoples R China; [Zhao, Xinyan] Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing, Peoples R China; [Wang, Tailing] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China	Tianjin Medical University; Capital Medical University; Capital Medical University; China-Japan Friendship Hospital	Hu, CH (corresponding author), Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China.	chunhong_hu@hotmail.com			National Natural Science Foundation of China [30900333, 81371549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 30900333 and 81371549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; CARO JJ, 1991, AM J ROENTGENOL, V156, P825, DOI 10.2214/ajr.156.4.1825900; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Coan P, 2010, PHYS MED BIOL, V55, P7649, DOI 10.1088/0031-9155/55/24/017; Connor DM, 2009, NEUROIMAGE, V46, P908, DOI 10.1016/j.neuroimage.2009.03.019; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Diemoz PC, 2010, PHYS MED BIOL, V55, P7663, DOI 10.1088/0031-9155/55/24/018; Faulconer L, 2009, ACAD RADIOL, V16, P1329, DOI 10.1016/j.acra.2009.05.006; Gasilov S, 2013, BIOMED OPT EXPRESS, V4, P1512, DOI 10.1364/BOE.4.001512; Godfrey EM, 2013, SEMIN ULTRASOUND CT, V34, P81, DOI 10.1053/j.sult.2012.11.007; Hu CH, 2009, PROG NAT SCI-MATER, V19, P955, DOI 10.1016/j.pnsc.2008.06.031; Keyrilainen J, 2008, RADIOLOGY, V249, P321, DOI 10.1148/radiol.2491072129; Keyrilainen J, 2011, J SYNCHROTRON RADIAT, V18, P689, DOI 10.1107/S090904951102810X; Kottler C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3512871; Li H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3104860; Li XL, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-73; Liang KH, 1999, PORTAL HYPERTENSION; Lu JS, 1994, CHINESE J ANATOMY, V17, P220; Mannelli L, 2013, EUR RADIOL, V23, P367, DOI 10.1007/s00330-012-2623-y; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Muehleman C, 2006, J ANAT, V208, P115, DOI 10.1111/j.1469-7580.2006.00502.x; Muehleman C, 2010, CLIN ANAT, V23, P530, DOI 10.1002/ca.20993; Papatheodoridis GV, 2003, GUT, V52, P404, DOI 10.1136/gut.52.3.404; Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007; Patel KD, 2011, EXPERT REV GASTROENT, V5, P91, DOI [10.1586/egh.10.85, 10.1586/EGH.10.85]; Pisano ED, 2000, RADIOLOGY, V214, P895, DOI 10.1148/radiology.214.3.r00mr26895; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seo SJ, 2012, PHYS MED BIOL, V57, P1251, DOI 10.1088/0031-9155/57/5/1251; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019; Zhang X, 2013, EUR RADIOL, V23, P417, DOI 10.1007/s00330-012-2630-z; Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x; Zhao XY, 2009, CLIN EXP PHARMACOL P, V36, P963, DOI 10.1111/j.1440-1681.2009.05194.x; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	41	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78176	10.1371/journal.pone.0078176	http://dx.doi.org/10.1371/journal.pone.0078176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205147	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600079
J	Raudabaugh, DB; Miller, AN				Raudabaugh, Daniel B.; Miller, Andrew N.			Nutritional Capability of and Substrate Suitability for Pseudogymnoascus destructans, the Causal Agent of Bat White-Nose Syndrome	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; FUNGI; GROWTH; DEGRADATION; INFECTION; PH; PHYSIOLOGY; TOLERANCE; VIRULENCE; ECOLOGY	Pseudogymnoascus destructans, the causal agent of bat white-nose syndrome, has caused nearly six million deaths in North American bats since its introduction into the United States in 2006. Current research has shown that caves can harbor P. destructans even after the infected bats are removed and bats no longer visit or inhabit previously infected caves. Our research focuses on elucidating reservoir requirements by investigating the nutritional capabilities of and substrate suitability requirements for six different P. destructans isolates from various localities including Illinois, Indiana, New York (Type specimen), and Pennsylvania. Enzyme assays implicate that both urease and b-glucosidase appear to be constitutive, lipase and esterase activity were more rapid than proteinase activity on 6% gelatin, gelatin degradation was accompanied by medium alkalinization, the reduction of thiosulfate generated hydrogen sulfide gas, chitinase and manganese dependent peroxidase activity were not visually demonstrated within eight weeks, and keratinase activity was not evident at pH 8 within eight weeks. We demonstrate that all P. destructans isolates are capable of growth and sporulation on dead fish, insect, and mushroom tissues. Sole nitrogen source assays demonstrated that all P. destructans isolates exhibit Class 2 nitrogen utilization and that growth-dependent interactions occur among different pH and nitrogen sources. Substrate suitability assays demonstrated that all isolates could grow and sporulate on media ranging from pH 5-11 and tolerated media supplemented with 2000 mg/L of calcium and 700 mg/L of three separated sulfur compounds: thiosulfate L-cysteine, and sulfite. All isolates were intolerant to PEG-induced matric potential with delayed germination and growth at -2.5 MPa with no visible germination at -5 MPa. Interestingly, decreasing the surface tension with Tween 80 permitted germination and growth of P. destructans in -5 MPa PEG medium within 14 days suggesting a link between substrate suitability and aqueous surface tension altering substances.	[Raudabaugh, Daniel B.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Raudabaugh, Daniel B.; Miller, Andrew N.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Raudabaugh, DB (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	raudaba2@illinois.edu	Raudabaugh, Daniel/AAJ-8846-2020		Illinois Department of Natural Resources State Wildlife Grants Program [T-78-R-1]; Section 6 Endangered and Threatened Species Program [E-54-R-1]	Illinois Department of Natural Resources State Wildlife Grants Program; Section 6 Endangered and Threatened Species Program	This study was funded through awards given by the Illinois Department of Natural Resources State Wildlife Grants Program (Project NumberT-78-R-1) and the Section 6 Endangered and Threatened Species Program (Project Number E-54-R-1) to the Illinois Natural History Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhila Rajan, 2011, International Journal of Biological Chemistry, V5, P116, DOI 10.3923/ijbc.2011.116.126; ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; Anthony SR, 2003, TROPICAL SOILS PROPE, P47; Biggs AR, 1997, PLANT DIS, V81, P399, DOI 10.1094/PDIS.1997.81.4.399; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Brock Matthias, 2008, V5, P63; Carissimi M., 2007, TECNOLOGICA, V11, P33; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Deacon JW, 2006, FUNGAL BIOL-UK; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Garraway MO, 1991, FUNGAL NUTR PHYSL; Ghaedian R, 1998, J FOOD ENG, V35, P323, DOI 10.1016/S0260-8774(98)00027-2; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; HACSKAYLO J, 1954, MYCOLOGIA, V46, P691, DOI 10.1080/00275514.1954.12024407; Hayes MA, 2012, BIOSCIENCE, V62, P819, DOI 10.1525/bio.2012.62.9.7; Hennicke F, 2013, EUKARYOT CELL, V12, P604, DOI 10.1128/EC.00336-12; Hillel D., 1998, ENV SOIL PHYS; Hung CY, 2007, ANN NY ACAD SCI, V1111, P225, DOI 10.1196/annals.1406.020; Hutton BJ, 1996, ANN BOT-LONDON, V77, P399, DOI 10.1006/anbo.1996.0048; Ito S, 2005, MICROBIAL ENZYMES BI; Klaus U, 1994, COMP ANIMAL BIOCH; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Kunert J., 2000, REV IBER MICOL, V1, P77; Latge J.P., 2006, GROWTH DIFFERENTIATI, P73; Liu YS, 2012, J IND MICROBIOL BIOT, V39, P623, DOI 10.1007/s10295-011-1066-9; LOCKWOOD GF, 1968, MYCOPATH MYCOL APPL, V35, P377, DOI 10.1007/BF02050753; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Marin S, 1995, CAN J MICROBIOL, V41, P1063, DOI 10.1139/m95-149; MATHBON G. E., 1964, ANN SOC BELG MED TROP, V44, P767; MCVEIGH I, 1969, MYCOPATH MYCOL APPL, V37, P349, DOI 10.1007/BF02129882; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; MEXAL J, 1973, CAN J BOT, V51, P1579, DOI 10.1139/b73-201; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Murthy NKS, 2012, INTERNET J MICROBIOL, V10, pe2bc3, DOI [10.5580/2bc3, DOI 10.5580/2BC3]; Nagai Koji, 1998, Mycoscience, V39, P293, DOI 10.1007/BF02464011; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Overton BE, 2006, PHYTOPATHOL MEDITERR, V45, pS131; PICKETT MJ, 1991, J CLIN MICROBIOL, V29, P2322, DOI 10.1128/JCM.29.10.2322-2325.1991; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Power KC, 2008, GEOTECH TEST J, V31, P461, DOI 10.1520/GTJ101099; Ragab M. M. M., 2012, International Journal of Agriculture and Forestry, V2, P70, DOI 10.5923/j.ijaf.20120202.11; Raudabaugh DB, 2011, MYCOSPHERE, V2, P656, DOI 10.5943/mycosphere/2/6/6; ROBBINS CR, 2002, CHEM PHYS BEHAV HUMA; Rodde RH, 2008, CARBOHYD POLYM, V71, P388, DOI 10.1016/j.carbpol.2007.06.006; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sancholle M, 2001, MYCOTA, VIX, P63; Sarojini T. S., 1947, PROC INDIAN ACAD SCI SECT B, V26, P69; Scott JA, 2004, MED MYCOL, V42, P239, DOI 10.1080/13693780310001644680; Shepherd D, 1983, FUNGAL DIFFERENTIATI, P515; SISK MARY O., 1957, J MORPH, V101, P425, DOI 10.1002/jmor.1051010303; Smyth C, 2013, BAT RES NEWS, V54, P17; STALINSKI J, 1994, ACTA THERIOL, V39, P1, DOI 10.4098/AT.arch.94-1; STEUTER AA, 1981, PLANT PHYSIOL, V67, P64, DOI 10.1104/pp.67.1.64; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI US; WAWRZKIEWICZ K, 1987, J MED VET MYCOL, V25, P261; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Zabell R. A., 1992, WOOD MICROBIOLOGY DE, P90	63	39	39	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78300	10.1371/journal.pone.0078300	http://dx.doi.org/10.1371/journal.pone.0078300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205191	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600091
J	Stier, I; Kiss, A				Stier, Ildiko; Kiss, Antal			Cytosine-to-Uracil Deamination by SssI DNA Methyltransferase	PLOS ONE			English	Article							ESCHERICHIA-COLI; HPAII METHYLTRANSFERASE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; METHYLATION; MUTAGENESIS; RESTRICTION; EXPRESSION; BISULFITE; SEQUENCE	The prokaryotic DNA(cytosine-5)methyltransferase M. SssI shares the specificity of eukaryotic DNA methyltransferases (CG) and is an important model and experimental tool in the study of eukaryotic DNA methylation. Previously, M. SssI was shown to be able to catalyze deamination of the target cytosine to uracil if the methyl donor S-adenosyl-methionine (SAM) was missing from the reaction. To test whether this side-activity of the enzyme can be used to distinguish between unmethylated and C5-methylated cytosines in CG dinucleotides, we re-investigated, using a sensitive genetic reversion assay, the cytosine deaminase activity of M. SssI. Confirming previous results we showed that M. SssI can deaminate cytosine to uracil in a slow reaction in the absence of SAM and that the rate of this reaction can be increased by the SAM analogue 5'-amino-5'-deoxyadenosine. We could not detect M. SssI-catalyzed deamination of C5-methylcytosine (C-m5). We found conditions where the rate of M. SssI mediated C-to-U deamination was at least 100-fold higher than the rate of C-m5-to-T conversion. Although this difference in reactivities suggests that the enzyme could be used to identify C5-methylated cytosines in the epigenetically important CG dinucleotides, the rate of M. SssI mediated cytosine deamination is too low to become an enzymatic alternative to the bisulfite reaction. Amino acid replacements in the presumed SAM binding pocket of M. SssI (F17S and G19D) resulted in greatly reduced methyltransferase activity. The G19D variant showed cytosine deaminase activity in E. coli, at physiological SAM concentrations. Interestingly, the C-to-U deaminase activity was also detectable in an E. coli ung(+) host proficient in uracil excision repair.	[Stier, Ildiko; Kiss, Antal] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center	Kiss, A (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	kiss.antal@brc.mta.hu	Kiss, Antal/A-1656-2008		Hungarian Scientific Research Fund (OTKA) [K83983]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the K83983 grant from the Hungarian Scientific Research Fund (OTKA); URL: www.otka.hu/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDARU B, 1995, J BACTERIOL, V177, P2950, DOI 10.1128/jb.177.10.2950-2952.1995; Bandaru B, 1996, J BIOL CHEM, V271, P7851, DOI 10.1074/jbc.271.13.7851; Beletskii A, 2001, J BACTERIOL, V183, P6491, DOI 10.1128/JB.183.21.6491-6493.2001; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Jeltsch A, 2007, APPL MICROBIOL BIOT, V75, P1233, DOI 10.1007/s00253-007-0966-0; Koudan EV, 2004, J BIOMOL STRUCT DYN, V22, P339, DOI 10.1080/07391102.2004.10507005; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Luria SE, 1943, GENETICS, V28, P491; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Posfai G, 1997, J BACTERIOL, V179, P4426, DOI 10.1128/jb.179.13.4426-4428.1997; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Rathert P, 2007, CHEMBIOCHEM, V8, P202, DOI 10.1002/cbic.200600358; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sambrook J., 2006, CONDENSED PROTOCOLS; Sankpal UT, 2002, NUCLEIC ACIDS RES, V30, P2628, DOI 10.1093/nar/gkf380; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SHAPIRO R, 1973, J BIOL CHEM, V248, P4060; Sharath AN, 2000, BIOCHEMISTRY-US, V39, P14611, DOI 10.1021/bi001610e; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHEN JC, 1995, NUCLEIC ACIDS RES, V23, P4275, DOI 10.1093/nar/23.21.4275; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Stier I, 2010, NUCLEIC ACIDS RES, V38, P8231, DOI 10.1093/nar/gkq676; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; WYSZYNSKI M, 1994, P NATL ACAD SCI USA, V91, P1574, DOI 10.1073/pnas.91.4.1574; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; ZHANG XL, 1994, J BIOL CHEM, V269, P7066; Zingg JM, 1998, BIOCHEM J, V332, P223, DOI 10.1042/bj3320223; Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267	45	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79003	10.1371/journal.pone.0079003	http://dx.doi.org/10.1371/journal.pone.0079003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205358	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000326032600117
J	Tschinkel, WR; King, JR				Tschinkel, Walter R.; King, Joshua R.			The Role of Habitat in the Persistence of Fire Ant Populations	PLOS ONE			English	Article							SOLENOPSIS-INVICTA HYMENOPTERA; NATIVE ANTS; FORMICIDAE; FLORIDA; COMMUNITIES; DISTURBANCE; SUCCESSION; ABUNDANCE; POLYGYNE; PATTERNS	The association of the exotic fire ant, Solenopsis invicta with man-modified habitats has been amply demonstrated, but the fate of such populations if ecological succession proceeds has rarely been investigated. Resurvey of a fire ant population in a longleaf pine plantation after 25 years showed that the recovery of the site from habitat disturbance was associated with a large fire ant population decline. Most of the persisting colonies were associated with the disturbance caused by vehicle tracks. In a second study, mature monogyne fire ant colonies that had been planted in experimental plots in native groundcover of the north Florida longleaf pine forest had mostly vanished six years later. These observations and experiments show that S. invicta colonies rarely persist in the native habitat of these pine forests, probably because they are not replaced when they die. A single site harbored a modest population of polygyne fire ants whose persistence was probably facilitated by reproduction through colony fission.	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [King, Joshua R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; Florida State University; State University System of Florida; University of Central Florida	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation [DEB 1020415]	National Science Foundation(National Science Foundation (NSF))	This work was carried out with support from National Science Foundation grant DEB 1020415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPERSON CS, 1984, FLA ENTOMOL, V67, P383, DOI 10.2307/3494717; BROWN VK, 1986, J ECOL, V74, P963, DOI 10.2307/2260227; CAMILO GR, 1990, WESTV STUD, P190; Cherry R, 2001, J ENTOMOL SCI, V36, P411, DOI 10.18474/0749-8004-36.4.411; CHERRY RH, 1992, ENVIRON ENTOMOL, V21, P767, DOI 10.1093/ee/21.4.767; CLABORN DM, 1986, SOUTHWEST NAT, V31, P555, DOI 10.2307/3671722; Fraelich BA, 1991, THESIS U FLORIDA, P158; HENDRIX SD, 1988, J ANIM ECOL, V57, P1053, DOI 10.2307/5111; HOWARD FW, 1979, J GEORGIA ENTOMOL SO, V14, P259; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; King JR, 2013, ECOL ENTOMOL, V38, P68, DOI 10.1111/j.1365-2311.2012.01405.x; King JR, 2009, BIOL INVASIONS, V11, P373, DOI 10.1007/s10530-008-9254-x; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; King JR, 1998, BIODIVERS CONSERV, V7, P1627, DOI 10.1023/A:1008857214743; LeBrun EG, 2012, J ANIM ECOL, V81, P884, DOI 10.1111/j.1365-2656.2012.01954.x; LOFGREN CS, 1975, ANNU REV ENTOMOL, V20, P1, DOI 10.1146/annurev.en.20.010175.000245; Lubertazzi D, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.21; Majer JD, 1998, J APPL ECOL, V35, P161, DOI 10.1046/j.1365-2664.1998.00286.x; MARKIN GP, 1974, ENVIRON ENTOMOL, V3, P895, DOI 10.1093/ee/3.6.895; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Morrison LW, 2002, ECOLOGY, V83, P2337, DOI 10.1890/0012-9658(2002)083[2337:LTIOAA]2.0.CO;2; Pass BC, 1960, THESIS AUBURN U AUBU, P54; Phillips Jr SA, 1986, TEMPORAL FORAGING PA, P114; Phillips Jr SA, 1987, TEXAS J AGR NATURAL, V1, P11; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; PORTER SD, 1992, J ECON ENTOMOL, V85, P1155; PORTER SD, 1993, J ECON ENTOMOL, V86, P1344, DOI 10.1093/jee/86.5.1344; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Siemann E, 1999, ECOGRAPHY, V22, P406, DOI 10.1111/j.1600-0587.1999.tb00577.x; Steffan-Dewenter I, 2001, ECOGRAPHY, V24, P83, DOI 10.1034/j.1600-0587.2001.240110.x; Stiles JH, 1998, LANDSCAPE ECOL, V13, P335, DOI 10.1023/A:1008073813734; Stimac Jerry L., 1994, P353; Stuble KL, 2011, CONSERV BIOL, V25, P618, DOI 10.1111/j.1523-1739.2010.01634.x; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; TSCHINKEL WR, 1987, ANN ENTOMOL SOC AM, V80, P263, DOI 10.1093/aesa/80.2.263; Tschinkel WR., 2006, FIRE ANTS; WALKER LR, 1987, OIKOS, V50, P131, DOI 10.2307/3565409; Wetterer JK, 2004, SOCIOBIOLOGY, V44, P1; Wojcik Daniel P., 2001, American Entomologist, V47, P16; WOJCIK DP, 1983, FLA ENTOMOL, V66, P101, DOI 10.2307/3494556; Zettler JA, 2004, ANN ENTOMOL SOC AM, V97, P513, DOI 10.1603/0013-8746(2004)097[0513:COFCFN]2.0.CO;2	43	16	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78580	10.1371/journal.pone.0078580	http://dx.doi.org/10.1371/journal.pone.0078580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205272	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600108
J	Blasco-Lafarga, C; Martinez-Navarro, I; Mateo-March, M				Blasco-Lafarga, Cristina; Martinez-Navarro, Ignacio; Mateo-March, Manuel			Is Baseline Cardiac Autonomic Modulation Related to Performance and Physiological Responses Following a Supramaximal Judo Test?	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PARASYMPATHETIC REACTIVATION; RATE RECOVERY; HIGH-INTENSITY; EXERCISE; LACTATE; POWER; RELIABILITY; ADAPTATIONS; ENDURANCE	Little research exists concerning Heart Rate (HR) Variability (HRV) following supramaximal efforts focused on upper-body explosive strength-endurance. Since they may be very demanding, it seems of interest to analyse the relationship among performance, lactate and HR dynamics (i.e. HR, HRV and complexity) following them; as well as to know how baseline cardiac autonomic modulation mediates these relationships. The present study aimed to analyse associations between baseline and post-exercise HR dynamics following a supramaximal Judo test, and their relationship with lactate, in a sample of 22 highly-trained male judoists (20.70 +/- 4.56 years). A large association between the increase in HR from resting to exercise condition and performance suggests that individuals exerted a greater sympathetic response to achieve a better performance (Rating of Perceived Exertion: 20; post-exercise peak lactate: 11.57 +/- 2.24 mmol/L; 95.76 +/- 4.13 % of age-predicted HRmax). Athletes with higher vagal modulation and lower sympathetic modulation at rest achieved both a significant larger Delta HR and a faster post-exercise lactate removal. A enhanced resting parasympathetic modulation might be therefore related to a further usage of autonomic resources and a better immediate metabolic recovery during supramaximal exertions. Furthermore, analyses of variance displayed a persistent increase in alpha(1) and a decrease in lnRMSSD along the 15 min of recovery, which are indicative of a diminished vagal modulation together with a sympathovagal balance leaning to sympathetic domination. Eventually, time-domain indices (lnRMSSD) showed no lactate correlations, while nonlinear indices (alpha(1) and lnSaEn) appeared to be moderate to strongly correlated with it, thus pointing to shared mechanisms between neuroautonomic and metabolic regulation.	[Blasco-Lafarga, Cristina; Martinez-Navarro, Ignacio] Univ Valencia, Phys Educ & Sports Dept, Valencia, Spain; [Mateo-March, Manuel] Univ Miguel Hernandez, Alicante, Spain	University of Valencia; Universidad Miguel Hernandez de Elche	Mateo-March, M (corresponding author), Univ Miguel Hernandez, Alicante, Spain.	m.cristina.blasco@uv.es	Mateo-March, Manuel/AAF-8979-2021; Blasco-Lafarga, Cristina/J-1916-2012; March, Manuel Mateo/A-8938-2012	Mateo-March, Manuel/0000-0003-4418-8263; Blasco-Lafarga, Cristina/0000-0001-8798-306X; March, Manuel Mateo/0000-0003-4418-8263; MARTINEZ-NAVARRO, IGNACIO/0000-0002-2942-1293				Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Ba A, 2009, CLIN RES CARDIOL, V98, P52, DOI 10.1007/s00392-008-0723-0; Bastos FN, 2012, INT J SPORTS MED, V33, P873, DOI 10.1055/s-0032-1301905; Blasco Lafarga C, 2010, CIENCIA CULTURA DEPO, P1; Blasco Lafarga C, 2009, PROPUESTA RESULTADOS; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Borg G, 1998, BORGS PERCEIVED EXER, P104; Bosquet L, 2007, EUR J APPL PHYSIOL, V100, P363, DOI 10.1007/s00421-007-0438-3; Brooks GA, 2007, SPORTS MED, V37, P341, DOI 10.2165/00007256-200737040-00017; Buchheit M, 2009, EXP PHYSIOL, V94, P795, DOI 10.1113/expphysiol.2009.048041; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2010, APPL PHYSIOL NUTR ME, V35, P142, DOI 10.1139/H09-140; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; de Oliveira TP, 2013, CLIN PHYSIOL FUNCT I, V33, P143, DOI 10.1111/cpf.12009; Degoutte F, 2003, BRIT J SPORT MED, V37, P245, DOI 10.1136/bjsm.37.3.245; Esco MR, 2010, CLIN AUTON RES, V20, P33, DOI 10.1007/s10286-009-0033-2; Franchini E., 2004, REV BRASILEIRA CINEA, V6, P07; Franchini E, 2011, SPORTS MED, V41, P147, DOI 10.2165/11538580-000000000-00000; Fukusaki C, 2000, CLIN AUTON RES, V10, P123, DOI 10.1007/BF02278016; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Glaister M, 2005, J STRENGTH COND RES, V19, P831, DOI 10.1519/00124278-200511000-00018; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Goldberger Jeffrey J, 2006, Am J Physiol Heart Circ Physiol, V290, pH2446; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goulopoulou S, 2009, EUR J APPL PHYSIOL, V105, P525, DOI 10.1007/s00421-008-0930-4; GREEN S, 1993, SPORTS MED, V15, P312, DOI 10.2165/00007256-199315050-00003; Hale T, 2008, J SPORT SCI, V26, P365, DOI 10.1080/02640410701701016; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592; Hynynen E, 2008, INT J SPORTS MED, V29, P552, DOI 10.1055/s-2007-989286; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; Kaikkonen P, 2012, EUR J APPL PHYSIOL, V112, P829, DOI 10.1007/s00421-011-2031-z; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003; Leeper NJ, 2007, CIRCULATION, V115, P468, DOI 10.1161/CIRCULATIONAHA.106.666388; Mendonca GV, 2010, APPL PHYSIOL NUTR ME, V35, P439, DOI 10.1139/H10-028; Miladi I, 2011, J STRENGTH COND RES, V25, P205, DOI 10.1519/JSC.0b013e3181af5152; Millar PJ, 2011, INT J SPORTS MED, V32, P174, DOI 10.1055/s-0030-1268473; Millar PJ, 2009, APPL PHYSIOL NUTR ME, V34, P875, DOI 10.1139/H09-086; Nakamura FY, 2009, INT J SPORTS MED, V30, P808, DOI 10.1055/s-0029-1234055; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; Niewiadomski W, 2007, CLIN PHYSIOL FUNCT I, V27, P309, DOI 10.1111/j.1475-097X.2007.00753.x; Nunan D, 2010, RESTING AUTONOMIC MO, V8; Nunan D, 2009, MED SCI SPORT EXER, V41, P243, DOI 10.1249/MSS.0b013e318184a4b1; Obminski Z., 2010, J COMBAT SPORTS MART, V1, P95; Olek RA, 2010, J SPORT MED PHYS FIT, V50, P52; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Platisa MM, 2006, PHYSIOL MEAS, V27, P145, DOI 10.1088/0967-3334/27/2/005; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Ravier G, 2009, SCAND J MED SCI SPOR, V19, P687, DOI 10.1111/j.1600-0838.2008.00807.x; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; Saboul D, 2013, EUR J SPORT SCI, V13, P534, DOI 10.1080/17461391.2013.767947; Sbriccoli P, 2007, J STRENGTH COND RES, V21, P738; Simos RP, 2013, INT J SPORTS MED, V34, P991, DOI 10.1055/s-0033-1337946; Strobel G, 1999, MED SCI SPORT EXER, V31, P560, DOI 10.1097/00005768-199904000-00011; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; THOMAS SG, 1989, CAN J SPORT SCI, V14, P142; Tulppo MP, 2011, CLIN PHYSIOL FUNCT I, V31, P272, DOI 10.1111/j.1475-097X.2011.01012.x; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Zouhal H, 2001, J SPORT MED PHYS FIT, V41, P330	69	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78584	10.1371/journal.pone.0078584	http://dx.doi.org/10.1371/journal.pone.0078584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205273	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300160
J	Irague, R; Tarquis, L; Andre, I; Moulis, C; Morel, S; Monsan, P; Potocki-Veronese, G; Remaud-Simeon, M				Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali			Combinatorial Engineering of Dextransucrase Specificity	PLOS ONE			English	Article							LACTOBACILLUS-REUTERI STRAIN-180; AUTOMATED PROTEIN-STRUCTURE; I-TASSER; STRUCTURAL-CHARACTERIZATION; LEUCONOSTOC-CITREUM; GLUCANSUCRASE; GLUCAN; REUTERANSUCRASE; CONSTRUCTION; ENZYMES	We used combinatorial engineering to investigate the relationships between structure and linkage specificity of the dextransucrase DSR-S from Leuconostoc mesenteroides NRRL B-512F, and to generate variants with altered specificity. Sequence and structural analysis of glycoside-hydrolase family 70 enzymes led to eight amino acids (D306, F353, N404, W440, D460, H463, T464 and S512) being targeted, randomized by saturation mutagenesis and simultaneously recombined. Screening of two libraries totaling 3.6.10(4) clones allowed the isolation of a toolbox comprising 81 variants which synthesize high molecular weight alpha-glucans with different proportions of alpha(1 -> 3) linkages ranging from 3 to 20 %. Mutant sequence analysis, biochemical characterization and molecular modelling studies revealed the previously unknown role of peptide (DYVHT464)-D-460 in DSR-S linkage specificity. This peptide sequence together with residue S512 contribute to defining +2 subsite topology, which may be critical for the enzyme regiospecificity.	[Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] UPS, Univ Toulouse, INSA, INP,LISBP, Toulouse, France; [Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] CNRS, UMR5504, Toulouse, France; [Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Remaud-Simeon, M (corresponding author), UPS, Univ Toulouse, INSA, INP,LISBP, Toulouse, France.	remaud@insa-toulouse.fr	Veronese, Gabrielle/GTF-3473-2022	MOULIS, Claire/0000-0002-1937-9052	French National Institute for Agricultural Research (INRA); French National Center for Scientific Research (CNRS); Region Midi-Pyrenees, France; European Regional Development Fund; INRA;  [CEPIA-AIC2007-2010]	French National Institute for Agricultural Research (INRA); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Midi-Pyrenees, France(Region Occitanie); European Regional Development Fund(European Commission); INRA; 	This work was funded by the French National Institute for Agricultural Research (INRA) and the French National Center for Scientific Research (CNRS). Grant number : CEPIA-AIC2007-2010, http://www.inra.fr/, http://www.cnrs.fr/. ICEO is supported by grants from the Region Midi-Pyrenees, France, the European Regional Development Fund, and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2010, TOP CURR CHEM, V294, P25, DOI 10.1007/128_2010_52; Arguello-Morales MA, 2000, FEMS MICROBIOL LETT, V182, P81, DOI 10.1016/S0378-1097(99)00572-8; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COTE GL, 1982, CARBOHYD RES, V101, P57, DOI 10.1016/S0008-6215(00)80795-8; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Vidal RF, 2011, CURR MICROBIOL, V62, P1260, DOI 10.1007/s00284-010-9851-7; Funane K, 2004, BIOSCI BIOTECH BIOCH, V68, P1912, DOI 10.1271/bbb.68.1912; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Irague R, 2011, ANAL CHEM, V83, P1202, DOI 10.1021/ac1032148; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Ito K, 2010, ACTA CRYSTALLOGR F, V66, P1086, DOI 10.1107/S1744309110029714; Kang HK, 2011, J AGR FOOD CHEM, V59, P4148, DOI 10.1021/jf104629g; Kralj S, 2005, APPL ENVIRON MICROB, V71, P3942, DOI 10.1128/AEM.71.7.3942-3950.2005; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2008, FEBS J, V275, P6002, DOI 10.1111/j.1742-4658.2008.06729.x; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Moulis C, 2006, FEMS MICROBIOL LETT, V261, P203, DOI 10.1111/j.1574-6968.2006.00347.x; Pijning T, 2008, BIOCATAL BIOTRANSFOR, V26, P12, DOI 10.1080/10242420701789163; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEYMOUR FR, 1979, CARBOHYD RES, V74, P77, DOI 10.1016/S0008-6215(00)84766-7; SHIMAMURA A, 1994, J BACTERIOL, V176, P4845, DOI 10.1128/jb.176.16.4845-4850.1994; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumner JB, 1935, J BIOL CHEM, V108, P51; van der Veen BA, 2004, FEBS LETT, V560, P91, DOI 10.1016/S0014-5793(04)00077-8; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, BIOMACROMOLECULES, V9, P2251, DOI 10.1021/bm800410w; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	46	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77837	10.1371/journal.pone.0077837	http://dx.doi.org/10.1371/journal.pone.0077837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204991	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300117
J	Opoku-Acheampong, AB; Unis, D; Henningson, JN; Beck, AP; Lindshield, BL				Opoku-Acheampong, Alexander B.; Unis, Dave; Henningson, Jamie N.; Beck, Amanda P.; Lindshield, Brian L.			Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice	PLOS ONE			English	Article							AUTOCHTHONOUS PROSTATE-CANCER; STEROID 5-ALPHA-REDUCTASE; GENE-EXPRESSION; RISK; PROGRESSION; LESIONS; TOMATO; GROWTH; RAT	Background: The prostate cancer prevention trial (PCPT) and Reduction by dutasteride of Prostate Cancer Events (REDUCE) trial found that 5 alpha-reductase (5 alpha R) inhibitors finasteride and dutasteride respectively, decreased prostate cancer prevalence but also increased the incidence of high-grade tumors. 5 alpha R2 is the main isoenzyme in normal prostate tissue; however, most prostate tumors have high 5 alpha R1 and low 5 alpha R2 expression. Because finasteride inhibits only 5 alpha R2, we hypothesized that it would not be as efficacious in preventing prostate cancer development and/or progression in C57BL/6 TRAMP x FVB mice as dutasteride, which inhibits both 5 alpha R1 and 5 alpha R2. Method/Principal Findings: Six-week-old C57BL/6 TRAMP x FVB male mice were randomized to AIN93G control or pre- and post-finasteride and dutasteride diet (83.3 mg drug/kg diet) groups (n =30-33) that began at 6 and 12 weeks of age, respectively, and were terminated at 20 weeks of age. The pre-and post-finasteride and dutasteride groups were designed to test the preventive and therapeutic efficacy of the drugs, respectively. Final body weights, genitourinary tract weights, and genitourinary tract weights as percentage of body weights were significantly decreased in the Pre- and Post-dutasteride groups compared with the control. The Post-dutasteride group showed the greatest inhibition of prostatic intraepithelial neoplasia progression and prostate cancer development. Surprisingly, the Post-dutasteride group showed improved outcomes compared with the Pre-dutasteride group, which had increased incidence of high-grade carcinoma as the most common and most severe lesions in a majority of prostate lobes. Consistent with our hypothesis, we found little benefit from the finasteride diets, and they increased the incidence of high-grade carcinoma. Conclusion: Our findings have commonalities with previously reported PCPT, REDUCE, and the Reduction by dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial results. Our results may support the therapeutic use of dutasteride, but not finasteride, for therapeutic or preventive use.	[Opoku-Acheampong, Alexander B.; Unis, Dave; Lindshield, Brian L.] Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA; [Unis, Dave] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Henningson, Jamie N.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Beck, Amanda P.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	Kansas State University; Kansas State University; Kansas State University; Yale University	Lindshield, BL (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	blindsh@k-state.edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110; Opoku-Acheampong, Alexander/0000-0002-4589-3776	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant from NCRR) [P20-RR017686]; Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant from NCRR); Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant No: P20-RR017686 from NCRR) and the Johnson Center for Basic Cancer Research at Kansas State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. This is contribution no. 13-370-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2013, ANC FACTS FIG 2013, P57564; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084; Berman-Booty LD, 2012, TOXICOL PATHOL, V40, P5, DOI 10.1177/0192623311425062; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Cho YM, 2007, PROSTATE CANCER P D, V10, P378, DOI 10.1038/sj.pcan.4500971; Costello LC, 2011, CANCER BIOL THER, V12, P1078, DOI 10.4161/cbt.12.12.18367; Elliott CS, 2009, CLIN CANCER RES, V15, P4694, DOI 10.1158/1078-0432.CCR-08-2277; Fleshner NE, 2012, LANCET, V379, P1590, DOI 10.1016/S0140-6736(12)60678-3; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Iehle C, 1999, J STEROID BIOCHEM, V68, P189, DOI 10.1016/S0960-0760(99)00030-8; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Ku JH, 2009, SCAND J UROL NEPHROL, V43, P445, DOI 10.3109/00365590903337896; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Opoku-Acheampong AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029068; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Prahalada S, 1998, PROSTATE, V35, P157; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Shao TC, 2007, J UROLOGY, V178, P1521, DOI 10.1016/j.juro.2007.05.118; Soderstrom TG, 2001, J CLIN ENDOCR METAB, V86, P855, DOI 10.1210/jc.86.2.855; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tien A. H., 2013, ANDROGEN RESPONSIVE, P135; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Zuniga KE, 2013, CANCER PREV RES, V6, P548, DOI 10.1158/1940-6207.CAPR-12-0443	36	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77738	10.1371/journal.pone.0077738	http://dx.doi.org/10.1371/journal.pone.0077738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204943	gold, Green Published			2022-12-25	WOS:000326029300112
J	Slater, PG; Ramirez, VT; Gonzalez-Billault, C; Varela-Nallar, L; Inestrosa, NC				Slater, Paula G.; Ramirez, Valerie T.; Gonzalez-Billault, Christian; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.			Frizzled-5 Receptor Is Involved in Neuronal Polarity and Morphogenesis of Hippocampal Neurons	PLOS ONE			English	Article							N-TERMINAL KINASE; GROWTH CONE; AXON FORMATION; SYNAPTIC DIFFERENTIATION; RHO-GTPASES; ACTIN; WNTS; GUIDANCE; FAMILY; RAT	The Wnt signaling pathway plays important roles during different stages of neuronal development, including neuronal polarization and dendritic and axonal outgrowth. However, little is known about the identity of the Frizzled receptors mediating these processes. In the present study, we investigated the role of Frizzled-5 (Fzd5) on neuronal development in cultured Sprague-Dawley rat hippocampal neurons. We found that Fzd5 is expressed early in cultured neurons on actin-rich structures localized at minor neurites and axonal growth cones. At 4 DIV, Fzd5 polarizes towards the axon, where its expression is detected mainly at the peripheral zone of axonal growth cones, with no obvious staining at dendrites; suggesting a role of Fzd5 in neuronal polarization. Overexpression of Fzd5 during the acquisition of neuronal polarity induces mislocalization of the receptor and a loss of polarized axonal markers. Fzd5 knock-down leads to loss of axonal proteins, suggesting an impaired neuronal polarity. In contrast, overexpression of Fzd5 in neurons that are already polarized did not alter polarity, but decreased the total length of axons and increased total dendrite length and arborization. Fzd5 activated JNK in HEK293 cells and the effects triggered by Fzd5 overexpression in neurons were partially prevented by inhibition of JNK, suggesting that a non-canonical Wnt signaling mechanism might be involved. Our results suggest that, Fzd5 has a role in the establishment of neuronal polarity, and in the morphogenesis of neuronal processes, in part through the activation of the non-canonical Wnt mechanism involving JNK.	[Slater, Paula G.; Ramirez, Valerie T.; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile; [Gonzalez-Billault, Christian] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Alameda 340, Santiago, Chile.	ninestrosa@bio.puc.cl	Slater, Paula G/AAP-8728-2021; Varela-Nallar, Lorena/AAV-3304-2021; Gonzalez-Billault, Christian/P-2393-2019; Gonzalez-Billault, Christian/K-9622-2013	Slater, Paula G/0000-0003-2601-0613; Gonzalez-Billault, Christian/0000-0003-0335-1482; Varela-Nallar, Lorena/0000-0003-2588-6437	Basal Center of Excellence in Aging and Regeneration [CONICYT-PFB12/2007]; Fondecyt [1120156, 11110012]; CONICYT; Insertion of Postdoctoral Researchers in the Academy-CONICYT [79090027]	Basal Center of Excellence in Aging and Regeneration(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Insertion of Postdoctoral Researchers in the Academy-CONICYT	This work was supported by Basal Center of Excellence in Aging and Regeneration (CONICYT-PFB12/2007) and Fondecyt (1120156) to N.C.I., Predoctoral Fellowships from CONICYT to P. G. S and V. T. R, Fondecyt (11110012) and Insertion of Postdoctoral Researchers in the Academy-CONICYT (No 79090027) to LV-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Alvania RS, 2006, NEURON, V50, P813, DOI 10.1016/j.neuron.2006.06.001; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1986, J NEUROSCI, V6, P714; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Codocedo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047073; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Conde C, 2010, J NEUROSCI, V30, P6793, DOI 10.1523/JNEUROSCI.5420-09.2010; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Farrar NR, 2008, DEV BIOL, V318, P102, DOI 10.1016/j.ydbio.2008.03.012; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Georges PC, 2008, MOL NEUROBIOL, V38, P270, DOI 10.1007/s12035-008-8046-8; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HINE RJ, 1974, Z ANAT ENTWICKLUNGS, V144, P173, DOI 10.1007/BF00519773; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kobayashi T, 2010, J THEOR BIOL, V266, P712, DOI 10.1016/j.jtbi.2010.07.036; Komiya Yuko, 2008, Organogenesis, V4, P68; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Podkowa M, 2010, MOL CELL BIOL, V30, P2241, DOI 10.1128/MCB.01166-09; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Varela-Nallar L, 2012, CYTOSKELETON, V69, P528, DOI 10.1002/cm.21022; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x	70	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78892	10.1371/journal.pone.0078892	http://dx.doi.org/10.1371/journal.pone.0078892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205342	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300166
J	Barras, D; Lorusso, G; Ruegg, C; Widmann, C				Barras, D.; Lorusso, G.; Rueegg, C.; Widmann, C.			Inhibition of cell migration and invasion mediated by the TAT-RasGAP(317-326) peptide requires the DLC1 tumor suppressor	ONCOGENE			English	Article						RasGAP; DLC1; adhesion; migration; invasion; peptide	FOCAL ADHESION KINASE; RAS-GAP; CANCER; RHO; BINDING; PROTEIN; APOPTOSIS; CYTOSKELETON; INTEGRINS; GTPASE	TAT-RasGAP(317-326), a peptide corresponding to the 317-326 sequence of p120 RasGAP coupled with a cell-permeable TAT-derived peptide, sensitizes the death response of various tumor cells to several anticancer treatments. We now report that this peptide is also able to increase cell adherence, prevent cell migration and inhibit matrix invasion. This is accompanied by a marked modification of the actin cytoskeleton and focal adhesion redistribution. Interestingly, integrins and the small Rho GTP-binding protein, which are well-characterized proteins modulating actin fibers, adhesion and migration, do not appear to be required for the pro-adhesive properties of TAT-RasGAP(317-326). In contrast, deleted in liver cancer-1, a tumor suppressor protein, the expression of which is often deregulated in cancer cells, was found to be required for TAT-RasGAP(317-326) to promote cell adherence and inhibit migration. These results show that TAT-RasGAP(317-326), besides its ability to favor tumor cell death, hampers cell migration and invasion.	[Barras, D.; Widmann, C.] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Vaud, Switzerland; [Lorusso, G.; Rueegg, C.] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; University of Fribourg	Widmann, C (corresponding author), Univ Lausanne, Dept Physiol, Bugnon 7, CH-1005 Lausanne, Vaud, Switzerland.	Christian.Widmann@unil.ch	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Lorusso, Girieca/0000-0002-2807-3207	Oncosuisse [KFS-02543-02-2010]	Oncosuisse	This work was supported by a grant from Oncosuisse (KFS-02543-02-2010). We thank Professor Nicholas C. Popescu (National Cancer Institute, Bethesda) for the DLC1-null MEFs and Professor David Schlaepfer (Moores UCSD Cancer Center, La Jolla) for the FAK-null MEFs.	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Barras D, 2011, CURR PHARM BIOTECHNO, V12, P1153, DOI 10.2174/138920111796117337; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bulat N, 2009, J LIPID RES, V50, P81, DOI 10.1194/jlr.M800119-JLR200; Byron A, 2010, CURR BIOL, V20, pR1063, DOI 10.1016/j.cub.2010.10.059; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pittet O, 2007, J PHOTOCH PHOTOBIO B, V88, P29, DOI 10.1016/j.jphotobiol.2007.04.009; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	45	17	18	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5163	5172		10.1038/onc.2013.465	http://dx.doi.org/10.1038/onc.2013.465			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24213569	Green Accepted			2022-12-25	WOS:000343914900003
J	Woo, SK; Kwon, MS; Ivanov, A; Geng, ZH; Gerzanich, V; Simard, JM				Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Geng, Zhihua; Gerzanich, Volodymyr; Simard, J. Marc			Complex N-Glycosylation Stabilizes Surface Expression of Transient Receptor Potential Melastatin 4b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Glycoprotein; Ion Channels; Protein Stability; TRP Channels	NONSELECTIVE CATION CHANNEL; ADULT-RAT BRAIN; LINKED GLYCOSYLATION; TRPM8 CHANNEL; REACTIVE ASTROCYTES; COLD; GLYCOPROTEINS; TRAFFICKING; SENSITIVITY; OLIGOSACCHARIDES	Background:N-Glycosylation is important for the function and regulation of ion channels but has not been examined for Trpm4. Results:N-Glycosylation is not required for surface expression, but complex N-glycosylation stabilizes Trpm4b surface expression. Conclusion: Complex N-glycosylation of Trpm4b has important functional implications. Significance: By promoting surface expression, N-glycosylation contributes importantly to calcium regulation byTrpm4b. N-Glycosylation is important for the function and regulation of ion channels. We examined the role of N-glycosylation of transient receptor potential melastatin (Trpm) 4b, a membrane glycoprotein that regulates calcium influx. Trpm4b was expressed in vivo in all rat tissues examined. In each tissue, Trpm4b had a different molecular mass, between approximate to 129 and approximate to 141 kDa, but all reverted to approximate to 120 kDa following treatment with peptide:N-glycosidase F, consistent with N-glycosylation being the principal form of post-translational modification of Trpm4b in vivo. In six stable isogenic cell lines that express different levels of Trpm4b, two forms were found, high mannose, core-glycosylated and complex, highly glycosylated (HG), with HG-Trpm4b comprising 85% of the total Trpm4b expressed. For both forms, surface expression was directly proportional to the total Trpm4b expressed. Complex N-glycosylation doubled the percentage of Trpm4b at the surface, compared with high mannose N-glycosylation. Mutation of the single N-glycosylation consensus sequence at Asn-988 (Trpm4b-N988Q), located near the pore-forming loop between transmembrane helices 5 and 6, prevented glycosylation, but did not prevent surface expression, impair formation of functional membrane channels, or alter channel conductance. In transfection experiments, the time courses for appearance of HG-Trpm4b and Trpm4b-N988Q on the surface were similar. In experiments with cycloheximide inhibition of protein synthesis, the time course for disappearance of HG-Trpm4b from the surface was much slower than that for Trpm4b-N988Q. We conclude that N-glycosylation is not required for surface expression or channel function, but that complex N-glycosylation plays a crucial role in stabilizing surface expression of Trpm4b.	[Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Geng, Zhihua; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu			National Institutes of Health from the NINDS [NS060801, NS061808, NS061934, NS072501]; National Institutes of Health from the NHLBI [HL082517]; Department of Veterans Affairs (Baltimore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072501, R01NS061934, R01NS061808, R01NS060801] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs (Baltimore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS060801 and NS061808 from the NINDS and HL082517 from the NHLBI (to J. M. S.) and NS061934 and NS072501 from the NINDS (to V. G.). This work was also supported by a Department of Veterans Affairs (Baltimore) grant (to J. M. S.).	Banerjee DK, 2012, BBA-GEN SUBJECTS, V1820, P1338, DOI 10.1016/j.bbagen.2012.01.013; BENALLAL M, 1995, BIOSCIENCE REP, V15, P21, DOI 10.1007/BF01200212; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fozzard Harry A, 2002, Sci STKE, V2002, ppe19, DOI 10.1126/stke.2002.130.pe19; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liman Emily R., 2007, P203; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Vennekens R., 2007, V179, P269; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36409	36417		10.1074/jbc.M113.530584	http://dx.doi.org/10.1074/jbc.M113.530584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214984	Green Published, hybrid			2022-12-25	WOS:000328883400022
J	Taylor, MP; Wedel, MJ				Taylor, Michael P.; Wedel, Mathew J.			The Effect of Intervertebral Cartilage on Neutral Posture and Range of Motion in the Necks of Sauropod Dinosaurs	PLOS ONE			English	Article							CERVICAL VERTEBRAL COLUMN; SPINAL-CORD; DOGS; EVOLUTION; ANIMALS; JOINT; HEAD	The necks of sauropod dinosaurs were a key factor in their evolution. The habitual posture and range of motion of these necks has been controversial, and computer-aided studies have argued for an obligatory sub-horizontal pose. However, such studies are compromised by their failure to take into account the important role of intervertebral cartilage. This cartilage takes very different forms in different animals. Mammals and crocodilians have intervertebral discs, while birds have synovial joints in their necks. The form and thickness of cartilage varies significantly even among closely related taxa. We cannot yet tell whether the neck joints of sauropods more closely resembled those of birds or mammals. Inspection of CT scans showed cartilage: bone ratios of 4.5% for Sauroposeidon and about 20% and 15% for two juvenile Apatosaurus individuals. In extant animals, this ratio varied from 2.59% for the rhea to 24% for a juvenile giraffe. It is not yet possible to disentangle ontogenetic and taxonomic signals, but mammal cartilage is generally three times as thick as that of birds. Our most detailed work, on a turkey, yielded a cartilage: bone ratio of 4.56%. Articular cartilage also added 11% to the length of the turkey's zygapophyseal facets. Simple image manipulation suggests that incorporating 4.56% of neck cartilage into an intervertebral joint of a turkey raises neutral posture by 15 degrees. If this were also true of sauropods, the true neutral pose of the neck would be much higher than has been depicted. An additional 11% of zygapophyseal facet length translates to 11% more range of motion at each joint. More precise quantitative results must await detailed modelling. In summary, including cartilage in our models of sauropod necks shows that they were longer, more elevated and more flexible than previously recognised.	[Taylor, Michael P.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA	University of Bristol; Western University of Health Sciences; Western University of Health Sciences	Taylor, MP (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	dino@miketaylor.org.uk		Taylor, Mike/0000-0002-1003-5675				Bakker RT., 1986, DINOSAUR HERESIES; Baumel J.J, 1993, HDB AVIAN ANATOMY NO; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Burian Z, 1941, SNORKELLING BRACHIOS; Carpenter K., 2006, NEW MEXICO MUSEUM NA, V36, P131; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Cifelli R. L., 2005, OKLA GEOL NOTES, V65, P40; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; da Costa RC, 2006, VET RADIOL ULTRASOUN, V47, P523, DOI 10.1111/j.1740-8261.2006.00180.x; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; EMERSON CL, 1990, J ZOO WILDLIFE MED, V21, P345; Evans M., 1993, THESIS U COLL LONDON; Frey E, 1988, STUTTGARTER BEITRA A, V424, P1; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Glass K, 2003, CAMELID Q        JUN, P1; GRAF W, 1995, J ANAT, V186, P55; Haines T., 1999, WALKING DINOSAURS; Harvey E. B., 1968, ATLAS DOMESTIC TURKE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hudson NPH, 2005, EQUINE VET EDUC, V17, P34, DOI 10.1111/j.2042-3292.2005.tb00333.x; HULTGREN BD, 1987, J WILDLIFE DIS, V23, P705, DOI 10.7589/0090-3558-23.4.705; Janensch W., 1950, PALAEONTOGRAPHICA, V3, P27; Kapandji IA, 2008, PHYSL JOINTS ANNOTAT, V3; Kimball S, 2010, GIMP GNU IMAGE MANIP; Knight CR, 1897, RESTORATION BRONTOSA; Levitski RE, 1999, VET RADIOL ULTRASOUN, V40, P332, DOI 10.1111/j.1740-8261.1999.tb02120.x; Liem KF., 2001, FUNCTIONAL ANATOMY V; Mallison H., 2010, PALAEONTOLOGIA ELECT, V13; Mallison H, 2010, SWISS J GEOSCI, V103, P211, DOI 10.1007/s00015-010-0024-2; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Marsh O., 1883, AM J SCI, V26, P81; MARTIN J, 1987, OCCASIONAL PAPERS TY, V3, P154; Matthew W. D., 1905, American Museum Journal, V5; McIntosh J. S., 1981, BULL CARNEG MUS NAT, V18, P1; McKee WM, 1999, J SMALL ANIM PRACT, V40, P465, DOI 10.1111/j.1748-5827.1999.tb02997.x; McKenzie EC, 2010, JAVMA-J AM VET MED A, V237, P311, DOI 10.2460/javma.237.3.311; PAPAGEORGES M, 1987, VET RADIOLOGY, V28, P53, DOI 10.1111/j.1740-8261.1987.tb01725.x; Paul G.S., 1988, HUNTERIA, V2, P1; Paul GS., 2000, SCI AM BOOK DINOSAUR, P78; Sande, 1979, VET SURG, V8, P7, DOI DOI 10.1111/J.1532-950X.1979.TB00596.X; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarz D, 2007, J GEOL SOC LONDON, V164, P61, DOI 10.1144/0016-76492006-019; Spielberg S., 1993, JURASSIC PARK; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Upchurch P., 2000, SCIENCE, V287, P547, DOI [10.1126/science.287.5453.547b, DOI 10.1126/SCIENCE.287.5453.547B]; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wake M.H., 1992, HYMANS COMP VERTEBRA, V4th; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; WHITWELL KE, 1987, EQUINE VET J, V19, P8, DOI 10.1111/j.2042-3306.1987.tb02568.x; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zallinger RF, 1947, AGE REPTILES	62	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78214	10.1371/journal.pone.0078214	http://dx.doi.org/10.1371/journal.pone.0078214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205163	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500105
J	Yu, DG; Liu, FX; Liu, M; Zhao, X; Wang, XQ; Li, Y; Mao, YQ; Zhu, ZN				Yu, Degang; Liu, Fengxiang; Liu, Ming; Zhao, Xin; Wang, Xiaoqing; Li, Yang; Mao, Yuanqing; Zhu, Zhenan			The Inhibition of Subchondral Bone Lesions Significantly Reversed the Weight-Bearing Deficit and the Overexpression of CGRP in DRG Neurons, GFAP and Iba-1 in the Spinal Dorsal Horn in the Monosodium Iodoacetate Induced Model of Osteoarthritis Pain	PLOS ONE			English	Article							KNEE PAIN; OSTEOCHONDRAL JUNCTION; RAT MODEL; CARTILAGE; JOINT; PATHOPHYSIOLOGY; ANGIOGENESIS; ASSOCIATION; INNERVATION; PROGRESSION	Background: Chronic pain is the most prominent and disabling symptom of osteoarthritis (OA). Clinical data suggest that subchondral bone lesions contribute to the occurrence of joint pain. The present study investigated the effect of the inhibition of subchondral bone lesions on joint pain. Methods: Osteoarthritic pain was induced by an injection of monosodium iodoacetate (MIA) into the rat knee joint. Zoledronic acid (ZOL), a third generation of bisphosphonate, was used to inhibit subchondral bone lesions. Joint histomorphology was evaluated using X-ray micro computed tomography scanning and hematoxylin-eosin staining. The activity of osteoclast in subchondral bone was evaluated using tartrate-resistant acid phosphatase staining. Joint pain was evaluated using weight-bearing asymmetry, the expression of calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG), and spinal glial activation status using glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule-1 (Iba-1) immunofluorescence. Afferent neurons in the DRGs that innervated the joints were identified using retrograde fluorogold labeling. Results: MIA injections induced significant histomorphological alterations and joint pain. The inhibition of subchondral bone lesions by ZOL significantly reduced the MIA-induced weight-bearing deficit and overexpression of CGRP in DRG neurons, GFAP and Iba-1 in the spinal dorsal horn at 3 and 6 weeks after MIA injection; however, joint swelling and synovial reaction were unaffected. Conclusions: The inhibition of subchondral bone lesions alleviated joint pain. Subchondral bone lesions should be a key target in the management of osteoarthritic joint pain.	[Yu, Degang; Liu, Fengxiang; Liu, Ming; Zhao, Xin; Wang, Xiaoqing; Li, Yang; Mao, Yuanqing; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Mao, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China.	degangyu@yeah.net	ydg, nam/GNP-5078-2022		National Natural Science Foundation of China [81272036, 81171729]; Key Program of Basic Research of Science and Technology Commission of Shanghai [12JC1405600]; Fund for Key Disciplines of Shanghai Municipal Education Commission [J50206]; Program for the Shanghai Key Laboratory of Orthopedic Implants [08DZ2230330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Basic Research of Science and Technology Commission of Shanghai; Fund for Key Disciplines of Shanghai Municipal Education Commission; Program for the Shanghai Key Laboratory of Orthopedic Implants	This work was supported by grants from the National Natural Science Foundation of China (No. 81272036 and No. 81171729), Key Program of Basic Research of Science and Technology Commission of Shanghai (No. 12JC1405600), the Fund for Key Disciplines of Shanghai Municipal Education Commission (J50206) and the Program for the Shanghai Key Laboratory of Orthopedic Implants (Grant No. 08DZ2230330). The majority of this research was completed in the Shanghai Key Laboratory of Orthopedic Implants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bailey AJ, 2004, BIORHEOLOGY, V41, P349; Bellido M, 2011, OSTEOARTHR CARTILAGE, V19, P1228, DOI 10.1016/j.joca.2011.07.003; Beyreuther B, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2121; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Dray A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2178; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Felson DT, 2005, CURR OPIN RHEUMATOL, V17, P624, DOI 10.1097/01.bor.0000172800.49120.97; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2010, ARTHRITIS RHEUM-US, V62, P3677, DOI 10.1002/art.27713; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Hernandez-Molina G, 2008, ANN RHEUM DIS, V67, P43, DOI 10.1136/ard.2007.070565; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Hui C, 2011, AM J SPORT MED, V39, P64, DOI 10.1177/0363546510377445; Hunter DJ, 2008, RHEUM DIS CLIN N AM, V34, P623, DOI 10.1016/j.rdc.2008.05.004; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Kadri A, 2008, ARTHRITIS RHEUM-US, V58, P2379, DOI 10.1002/art.23638; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kidd BL, 2006, PAIN, V123, P6, DOI 10.1016/j.pain.2006.04.009; Lee Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-39; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Moisio K, 2009, ARTHRITIS RHEUM-US, V60, P3703, DOI 10.1002/art.25014; Nagy I, 2006, DRUG DISCOV TODAY, V3, P357; Nielsen RH, 2011, OSTEOARTHR CARTILAGE, V19, P466, DOI 10.1016/j.joca.2011.01.008; Orita S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-134; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Reichenbach S, 2011, ANN RHEUM DIS, V70, P293, DOI 10.1136/ard.2010.132985; Sagar DR, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-88; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sniekers YH, 2008, OSTEOARTHR CARTILAGE, V16, P533, DOI 10.1016/j.joca.2008.01.002; Steinmeyer J, 2006, ADV DRUG DELIVER REV, V58, P168, DOI 10.1016/j.addr.2006.01.007; Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007; Suri S, 2007, ANN RHEUM DIS, V66, P1423, DOI 10.1136/ard.2006.063354; Volker N, 2007, MOL PAIN, V3; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; Walsh DA, 2010, RHEUMATOLOGY, V49, P1852, DOI 10.1093/rheumatology/keq188; Wenham CYJ, 2009, NAT CLIN PRACT RHEUM, V5, P149, DOI 10.1038/ncprheum1023; Yoneda T, 2011, BONE, V48, P100, DOI 10.1016/j.bone.2010.07.009; Yu DG, 2012, ACTA PHARMACOL SIN, V33, P924, DOI 10.1038/aps.2012.28; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	48	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77824	10.1371/journal.pone.0077824	http://dx.doi.org/10.1371/journal.pone.0077824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204985	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500065
J	Peters, BS; Perry, M; Wierzbicki, AS; Wolber, LE; Blake, GM; Patel, N; Hoile, R; Duncan, A; Kulasegaram, R; Williams, FMK				Peters, Barry S.; Perry, Melissa; Wierzbicki, Anthony S.; Wolber, Lisa E.; Blake, Glen M.; Patel, Nishma; Hoile, Richard; Duncan, Alastair; Kulasegaram, Ranjababu; Williams, Frances M. K.			A Cross-Sectional Randomised Study of Fracture Risk in People with HIV Infection in the Probono 1 Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ANTIRETROVIRAL THERAPY; OSTEOPOROSIS; PREVALENCE; COHORT; RATES	Objective: To determine comparative fracture risk in HIV patients compared with uninfected controls. Design: A randomised cross-sectional study assessing bone mineral density (BMD), fracture history and risk factors in the 2 groups. Setting: Hospital Outpatients. Subbbjects: 222 HIV infected patients and an equal number of age-matched controls. Assessments: Fracture risk factors were assessed and biochemical, endocrine and bone markers measured. BMD was assessed at hip and spine. 10-year fracture probability (FRAX) and remaining lifetime fracture probability (RFLP) were calculated. Main Outcome Measures: BMD, and history of fractures. Results: Reported fractures occurred more frequently in HIV than controls, (45 vs. 16; 20.3 vs. 7%; OR=3.27; p=0.0001), and unsurprisingly in this age range, non-fragility fractures in men substantially contributed to this increase. Osteoporosis was more prevalent in patients with HIV (17.6% vs. 3.6%, p<0.0001). BMD was most reduced, and predicted fracture rates most increased, at the spine. Low BMD was associated with antiretroviral therapy (ART), low body mass index and PTH. 10-year FRAX risk was <5% for all groups. RLFP was greater in patients with HIV (OR=1.22; p=0.003) and increased with ART (2.4 vs. 1.50; OR=1.50; p=0.03). Conclusions: The increased fracture rate in HIV patients in our relatively youthful population is partly driven by fractures, including non-fragility fractures, in men. Nonetheless, these findings may herald a rise in osteoporotic fractures in HIV patients. An appropriate screening and management response is required to assess these risks and identify associated lifestyle factors that are also associated with other conditions such as cardiovascular disease and diabetes.	[Peters, Barry S.; Patel, Nishma] Kings Coll London, Dept Infect Dis, London, England; [Peters, Barry S.] Guys & St Thomas Fdn Hosp, London, England; [Perry, Melissa] Guys & St Thomas Fdn Hosp, Dept HIV & GU Med, London, England; [Wierzbicki, Anthony S.] Guys & St Thomas Fdn Hosp, Dept Chem Pathol, London, England; [Wolber, Lisa E.; Williams, Frances M. K.] Kings Coll London, Dept Rheumatol, Twins Res Unit, London, England; [Blake, Glen M.] Kings Coll London, Dept Nucl Med, London, England; [Hoile, Richard] Kings Coll London, Sch Med, London, England; [Duncan, Alastair] Guys & St Thomas Fdn Hosp, Dept Dietet, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Trust, Dept HIV & GU Med, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Peters, BS (corresponding author), Kings Coll London, Dept Infect Dis, London, England.	Barry.Peters@kcl.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X; Duncan, Alastair/0000-0002-6284-8192; Williams, Frances/0000-0002-2998-2744; Hoile, Richard/0000-0001-5003-1655	GlaxoSmithKline pharmaceuticals; ViiV pharmaceuticals; National Institute for Health Research [CDRF-2012-03-021] Funding Source: researchfish	GlaxoSmithKline pharmaceuticals(GlaxoSmithKline); ViiV pharmaceuticals; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was in part supported by an unrestricted educational grant from GlaxoSmithKline pharmaceuticals. A subsequent unrestricted grant to look at prospective follow-up of patients described in this manuscript has been granted by ViiV pharmaceuticals and is in progress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud M, 2010, INT J CLIN PRACT, V64, P1252, DOI 10.1111/j.1742-1241.2010.02424.x; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Brown Todd T, 2006, Curr Infect Dis Rep, V8, P162, DOI 10.1007/s11908-006-0012-x; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2004, J CLIN ENDOCR METAB, V89, P1200, DOI 10.1210/jc.2003-031506; Elgalib A, 2011, CURR MED RES OPIN, V27, P63, DOI 10.1185/03007995.2010.537212; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Haskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083; KELLY PJ, 1990, J BONE MINER RES, V5, P1169; Lippuner K, 2009, OSTEOPOROSIS INT, V20, P1131, DOI 10.1007/s00198-008-0779-8; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; *MEDSURF, 2000, REM LIF FRACT RISK P; Mondy K, 2005, JAIDS-J ACQ IMM DEF, V38, P426, DOI 10.1097/01.qai.0000145352.04440.1e; *NHS INF CTR, 2012, NAT HIP FRACT DAT; Ofotokun I, 2012, CURR HIV-AIDS REP, V9, P16, DOI 10.1007/s11904-011-0099-z; Ofotokun I, 2011, DISCOV MED, V11, P385; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Peters B, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01055.x; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; von Friesendorff M, 2011, J AM GERIATR SOC, V59, P806, DOI 10.1111/j.1532-5415.2011.03399.x; Wasnich R D, 1996, Hawaii Med J, V55, P141; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; Wierzbicki AS, 2008, CURR MED RES OPIN, V24, P609, DOI 10.1185/030079908X272742; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2011, FRAX WHO FRACT RISK; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78048	10.1371/journal.pone.0078048	http://dx.doi.org/10.1371/journal.pone.0078048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205086	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700068
J	Schwachmeyer, V; Damm, P; Bender, A; Dymke, J; Graichen, F; Bergmann, G				Schwachmeyer, Verena; Damm, Philipp; Bender, Alwina; Dymke, Joern; Graichen, Friedmar; Bergmann, Georg			In Vivo Hip Joint Loading during Post-Operative Physiotherapeutic Exercises	PLOS ONE			English	Article							CONTACT FORCES; SURGERY; MANAGEMENT; AMBULATION; FRACTURES; STABILITY; FIXATION	Introduction: After hip surgery, it is the orthopedist's decision to allow full weight bearing to prevent complications or to prescribe partial weight bearing for bone ingrowth or fracture consolidation. While most loading conditions in the hip joint during activities of daily living are known, it remains unclear how demanding physiotherapeutic exercises are. Recommendations for clinical rehabilitation have been established, but these guidelines vary and have not been scientifically confirmed. The aim of this study was to provide a basis for practical recommendations by determining the hip joint contact forces and moments that act during physiotherapeutic activities. Methods: Joint contact loads were telemetrically measured in 6 patients using instrumented hip endoprostheses. The resultant hip contact force, the torque around the implant stem, and the bending moment in the neck were determined for 13 common physiotherapeutic exercises, classified as weight bearing, isometric, long lever arm, or dynamic exercises, and compared to the loads during walking. Results: With peak values up to 441%BW, weight bearing exercises caused the highest forces among all exercises; in some patients they exceeded those during walking. During voluntary isometric contractions, the peak loads ranged widely and potentially reached high levels, depending on the intensity of the contraction. Long lever arms and dynamic exercises caused loads that were distributed around 50% of those during walking. Conclusion: Weight bearing exercises should be avoided or handled cautiously within the early post-operative period. The hip joint loads during isometric exercises depend strongly on the contraction intensity. Nonetheless, most physiotherapeutic exercises seem to be non-hazardous when considering the load magnitudes, even though the loads were much higher than expected. When deciding between partial and full weight bearing, physicians should consider the loads relative to those caused by activities of daily living.	[Schwachmeyer, Verena; Damm, Philipp; Bender, Alwina; Dymke, Joern; Graichen, Friedmar; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwachmeyer, V (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	verena.schwachmeyer@charite.de	Schwachmeyer, Verena/O-6745-2014	Bender, Alwina/0000-0002-4444-6309; Damm, Philipp/0000-0001-8471-7284	Deutsche Forschungsgemeinschaft [DFG - SFB 760, Be 804/19-1]; Deutsche Arthrose-Hilfe e.V.; ZVK-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe e.V.; ZVK-Stiftung	The study was funded by the Deutsche Forschungsgemeinschaft (project: DFG - SFB 760, Be 804/19-1), Deutsche Arthrose-Hilfe e.V. and the ZVK-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender A., 2011, COMPUTER METHODS BIO, P37; BERGMANN G, 1989, Z ORTHOP GRENZGEB, V127, P672, DOI 10.1055/s-2008-1040311; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2004, LANGENBECK ARCH SURG, V389, P53, DOI 10.1007/s00423-003-0434-y; BERGMANN G, 1995, J BIOMECH, V28, P535, DOI 10.1016/0021-9290(94)00105-D; Bieger R, 2012, CLIN BIOMECH, V27, P158, DOI 10.1016/j.clinbiomech.2011.08.004; Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7; BURKE DW, 1991, J BONE JOINT SURG BR, V73, P33, DOI 10.1302/0301-620X.73B1.1991771; Claes L, 2000, CLIN BIOMECH, V15, P750, DOI 10.1016/S0268-0033(00)00044-9; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; Fleischhauer M, 2006, LEITFADEN PHYSIOTHER; Heller MO, 2005, BIOMED TECH, V50, P394, DOI 10.1515/BMT.2005.054; Hol A, 2006, NEDERLANDS TIJSCHR E, V13e, P105; Jollenbeck T, 2005, Z ORTHOP, V143, P124; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Knobe M, 2009, Z ORTHOP UNFALLCHIR, V147, P306, DOI 10.1055/s-0029-1185349; Lorich DG, 2004, J BONE JOINT SURG AM, V86A, P398, DOI 10.2106/00004623-200402000-00028; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; Thomas S, 2011, PHYS THER, V91, P1490, DOI 10.2522/ptj.20100310; Van Vugt AB, 2007, INJURY, V38S, P51; Vasarhelyi A, 2006, GAIT POSTURE, V23, P99, DOI 10.1016/j.gaitpost.2004.12.005; Yang Huan, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P699; Zwartele RE, 2012, ARCH ORTHOP TRAUM SU, V132, P535, DOI 10.1007/s00402-011-1432-0	24	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77807	10.1371/journal.pone.0077807	http://dx.doi.org/10.1371/journal.pone.0077807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204977	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700055
J	Velayutham, TS; Kolli, D; Ivanciuc, T; Garofalo, RP; Casola, A				Velayutham, Thangam Sudha; Kolli, Deepthi; Ivanciuc, Teodora; Garofalo, Roberto P.; Casola, Antonella			Critical Role of TLR4 in Human Metapneumovirus Mediated Innate Immune Responses and Disease Pathogenesis	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTOR-4; INDUCIBLE GENE-I; AIRWAY HYPERRESPONSIVENESS; RECOGNITION; INFECTION; ACTIVATION; YOUNG; MACROPHAGES; CHILDREN	Human metapneumovirus (hMPV) is one of the main causes of acute respiratory tract infections in children, elderly and immunocompromised patients. The mammalian Toll-like receptors (TLR) were identified as critical regulators of innate immunity to a variety of microbes, including viruses. We have recently shown that hMPV-induced cytokine, chemokine and type I interferon secretion in dendritic cells occurs via TLR4, however, its role in hMPV-induced disease is unknown. In this study, wild-type(WT) and TLR4-deficient mice (TLR4(-/-)) were infected with hMPV and examined for clinical disease parameters, such as body weight loss and airway obstruction, viral clearance, lung inflammation, dendritic cell maturation, T-cell proliferation and antibody production. Our results demonstrate that absence of TLR4 in hMPV-infected mice significantly reduced the inflammatory response as well as disease severity, shown by reduced body weight loss and airway obstruction and hyperresponsiveness (AHR), compared to WT mice. Levels of cytokines and chemokines were also significantly lower in the TLR4(-/-) mice. Accordingly, recruitment of inflammatory cells in the BAL, lungs, as well as in lymph nodes, was significantly reduced in the TLR4(-/-) mice, however, viral replication and clearance, as well as T-cell proliferation and neutralizing antibody production, were not affected. Our findings indicate that TLR4 is important for the activation of the innate immune response to hMPV, however it does play a role in disease pathogenesis, as lack of TLR4 expression is associated with reduced clinical manifestations of hMPV disease, without affecting viral protection.	[Velayutham, Thangam Sudha; Kolli, Deepthi; Ivanciuc, Teodora; Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Casola, A (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	ancasola@utmb.edu	Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022		National Institutes of Health [R01 AI079246, P01 AI062885, P30 ES006676]; James W. McLaughlin Fellowship Fund from UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079246, P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James W. McLaughlin Fellowship Fund from UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01 AI079246, P01 AI062885 and P30 ES006676, and James W. McLaughlin Fellowship Fund from UTMB (TSV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Carey MA, 2007, AM J RESP CRIT CARE, V175, P126, DOI 10.1164/rccm.200509-1493OC; Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x; Castro SM, 2006, AM J RESP CRIT CARE, V174, P1361, DOI 10.1164/rccm.200603-319OC; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Cyr SL, 2009, VACCINE, V27, P421, DOI 10.1016/j.vaccine.2008.10.073; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Kolli D, 2013, PATHOGENS, V2, P232, DOI 10.3390/pathogens2020232; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	48	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78849	10.1371/journal.pone.0078849	http://dx.doi.org/10.1371/journal.pone.0078849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205331	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700100
J	Caut, S; Holden, M; Jowers, MJ; Boistel, R; Ineich, I				Caut, Stephane; Holden, Magaly; Jowers, Michael J.; Boistel, Renaud; Ineich, Ivan			Is Bocourt's Terrific Skink Really So Terrific? Trophic Myth and Reality	PLOS ONE			English	Article							STABLE-ISOTOPES; EXTINCTION; REDISCOVERY; RATS; DIET; TRAJECTORIES; DELTA-N-15; DYNAMICS; CAUTION; DECLINE	Many scientists argue that our planet is undergoing a mass extinction event that is largely due to human influences. In this context, rediscoveries of species presumed to be extinct are encouraging and of great potential interest. During a 2003 expedition to New Caledonia, Bocourt's terrific skink, Phoboscincus bocourti, was unexpectedly rediscovered on a small islet by one of us. This skink species had been described from a single specimen collected around 1872 in New Caledonia. Since that time, however, no data on the species' biology, trophic interactions, or role in the ecosystem have been collected, making it difficult to follow the established conservation plan. In this study, we used a multidisciplinary approach involving natural history, anatomy, morphology, genetics, and stable isotopes to elucidate the ecology of Bocourt's terrific skink. Over the course of three different expeditions to the islet (total of 55 days across 2005 and 2012), we captured 4 individuals and observed another 4 individuals. The species' dentition and trophic ecology suggest that it is a top predator in its ecosystem and a major consumer of small terrestrial reptiles. Its high degree of genetic relatedness to another New Caledonian skink, which has a broad distribution, suggests that P. bocourti underwent genetic isolation at a geographical remote location, where dispersal or colonization was highly improbable. Moreover, the lack of genetic variation among the four individuals we captured may imply that a unique lineage, characterized by few inter-island exchanges, exists on the islet. Bocourt's terrific skink may be the largest terrestrial squamate predator alive in New Caledonia today. As a result, it is likely vulnerable to habitat modifications and especially the invasive rodents found on this islet. Further information is necessary to assess the conservation plans and practices in place as no concrete changes have been made since the species' rediscovery almost 10 years ago.	[Caut, Stephane; Jowers, Michael J.] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Holden, Magaly] Ecole Prat Hautes Etud, Ctr Ecol Fonct, CNRS UMR 5175, Montpellier, France; [Boistel, Renaud] Univ Poitiers, CNRS INEE, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France; [Ineich, Ivan] Museum Natl Hist Nat, Dept Systemat & Evolut, CNRS, UMR 7205, F-75231 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Caut, S (corresponding author), CSIC, Estn Biol Donana, E-41080 Seville, Spain.	stephanecaut@gmail.com; ineich@mnhn.fr	Jowers, Michael/AAT-8514-2021	Jowers, Michael J/0000-0001-8935-5913	CSIC (Consejo Superior de Investigaciones Cientificas)	CSIC (Consejo Superior de Investigaciones Cientificas)	This work was supported by CSIC (Consejo Superior de Investigaciones Cientificas) contracts to S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; [Anonymous], 2004, THESIS; Balouet JC, 1987, CR HEBD ACAD SCI, P853; Balouet Jean Christophe, 1991, P1383; Bauer AM, 2000, HERPETOFAUNA NEW CAL; Bishop PJ, 2012, SAPIENS IUCN COMMISS, V5; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Carranza S., 2004, Systematics and Biodiversity, V2, P57, DOI 10.1017/S1477200004001355; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Caut S, 2013, BIOL OPEN, V2, P629, DOI 10.1242/bio.20134945; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Caut S, 2009, BIOL INVASIONS, V11, P1689, DOI 10.1007/s10530-008-9397-9; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Crowley BE, 2011, J BIOGEOGR, V38, P1633, DOI 10.1111/j.1365-2699.2011.02571.x; *CTRDP, 1987, EC NOUV CAL; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Dimond WJ, 2012, HERPETOL CONSERV BIO, V7, P132; Dulloo ME, 2002, INT FOREST REV, V4, P277, DOI 10.1505/ifor.4.4.277.40525; Edwards GP, 2013, AUST MAMMAL, V35, P144, DOI 10.1071/AM12031; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Fisher DO, 2011, GLOBAL ECOL BIOGEOGR, V20, P415, DOI 10.1111/j.1466-8238.2010.00624.x; Fisher DO, 2011, P ROY SOC B-BIOL SCI, V278, P1090, DOI 10.1098/rspb.2010.1579; Fitzpatrick JW, 2005, SCIENCE, V308, P1460, DOI 10.1126/science.1114103; Flannery TF, 1994, FUTURE EATERS, P423; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gidiere S, 2005, TRENDS, V37, P13; Girard Francis, 1998, Bulletin de la Societe Herpetologique de France, V85-86, P60; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grandcolas P, 2009, MEM MUS NAT HIST NAT, V198, P149; GREER AE, 1974, AUST J ZOOL, P1; Greer AE, 2001, J HERPETOL, V35, P383, DOI 10.2307/1565956; Hemerik L, 2006, ACTA BIOTHEOR, V54, P255, DOI 10.1007/s10441-007-9001-1; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Ineich I, 2006, ORYX, V40, P136; Ineich I, 2005, PREDATION HERPETOL R, V36, P445; Ineich I, 1999, REPTILES AMPHIBIENS, P60; Ineich I, 2013, MEMOIRES MU IN PRESS; *IUCN, 2010, INT UN CONS NAT RED; Jowers MJ, 2013, HERPETOLOGICA, V69, P227, DOI 10.1655/HERPETOLOGICA-D-12-00085; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Ladle RJ, 2009, NATURE, V461, P723, DOI 10.1038/461723c; Ladle RJ, 2011, FRONT J BIOGEOGR, V3, P11; LEVEY DJ, 1994, AUK, V111, P478, DOI 10.2307/4088614; Melbourne BA, 2004, BIODIVERS CONSERV, V13, P275, DOI 10.1023/B:BIOC.0000004321.58196.d8; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; OLSON SL, 1995, P BIOL SOC WASH, V108, P373; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pisanu B, 2011, POLAR BIOL, V34, P169, DOI 10.1007/s00300-010-0867-z; Posada D, 2008, JMODELTEST; Poulakakis N, 2005, MOL PHYLOGENET EVOL, V34, P245, DOI 10.1016/j.ympev.2004.10.006; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schander C, 2003, ORG DIVERS EVOL, V3, P195, DOI 10.1078/1439-6092-00071; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Struck U, 2002, NATURWISSENSCHAFTEN, V89, P470, DOI 10.1007/s00114-002-0361-8; Stuckas H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057116; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Ward EJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00190.1; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Whitaker AH, 2005, BIODIVERSITY C UNPUB, P59; White A, 2010, LIBR J, V135, P107	76	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78638	10.1371/journal.pone.0078638	http://dx.doi.org/10.1371/journal.pone.0078638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205285	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400093
J	Costola-De-Souza, C; Ribeiro, A; Ferraz-De-Paula, V; Calefi, AS; Aloia, TPA; Gimenes, JA; de Almeida, VI; Pinheiro, ML; Palermo-Neto, J				Costola-de-Souza, Carolina; Ribeiro, Alison; Ferraz-de-Paula, Viviane; Calefi, Atilio Sersun; Arrais Aloia, Thiago Pinheiro; Gimenes-Junior, Joao Antonio; de Almeida, Vinicius Izidio; Pinheiro, Milena Lobao; Palermo-Neto, Joao			Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CANNABINOID RECEPTOR AGONIST; MOLECULAR CHARACTERIZATION; ENDOGENOUS CANNABINOIDS; NEUTROPHIL AGGREGATION; INFLAMMATORY MEDIATORS; ACUTE-PANCREATITIS; ENDOTOXEMIC MICE; CB2 RECEPTORS; MODEL	Endocannabinoid signaling is terminated by enzymatic hydrolysis, a process that, for 2-Arachidonoylglycerol (2-AG), is mediated by monoacylglycerol lipase (MAGL). The piperidine carbamate, 4-nitrophenyl-4-(dibenzo[d] [ 1,3] dioxol-5-yl (hydroxy) methyl) piperidine-1-carboxylate (JZL184), is a drug that inhibits MAGL and presents high potency and selectivity. Thus, JZL184 increases the levels of 2-AG, an endocannabinoid that acts on the CB1 and CB2 cannabinoid receptors. Here, we investigated the effects of MAGL inhibition, with a single dose (16 mg/kg, intraperitoneally (i.p.)) of JZL184, in a murine model of lipopolysaccharide (LPS) -induced acute lung injury (ALI) 6, 24 and 48 hours after the inflammatory insult. Treatment with JZL184 decreased the leukocyte migration into the lungs as well as the vascular permeability measured through the bronchoalveolar lavage fluid (BAL) and histological analysis. JZL184 also reduced the cytokine and chemokine levels in the BAL and adhesion molecule expression in the blood and BAL. The CB1 and CB2 receptors were considered involved in the anti-inflammatory effects of JZL184 because the AM281 selective CB1 receptor antagonist (1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4morpholinyl- 1H-pyrazole-3-carboxamide) and the AM630 selective CB2 receptor antagonist ([ 6-iodo-2-methyl-1-[2-(4-morpholinyl) ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone) blocked the anti-inflammatory effects previously described for JZL184. It was concluded that MAGL inhibition, and consequently the increase in 2-AG levels, produced anti-inflammatory effects in a murine model of LPS-induced ALI, a finding that was considered a consequence of the activation of the CB1 and CB2 receptors.	[Costola-de-Souza, Carolina; Ribeiro, Alison; Calefi, Atilio Sersun; Arrais Aloia, Thiago Pinheiro; de Almeida, Vinicius Izidio; Pinheiro, Milena Lobao; Palermo-Neto, Joao] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil; [Ferraz-de-Paula, Viviane] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil; [Gimenes-Junior, Joao Antonio] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Palermo-Neto, J (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil.	jpalermo@usp.br	Calefi, Atilio/E-8085-2017; Gimenes-Junior, Joao A/F-4439-2014	Calefi, Atilio/0000-0002-1859-2046; Gimenes-Junior, Joao A/0000-0002-2958-1174; Pinheiro Arrais Aloia, Thiago/0000-0001-6913-8989	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/51886-3, 2011/10181-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [300764/2010-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was suppurted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Processes: 2009/51886-3 and 2011/10181-7) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Process: 300764/2010-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Asghari-Roodsari A, 2010, REPROD SCI, V17, P391, DOI 10.1177/1933719109358456; Balamayooran G, 2011, INFECT IMMUN, V79, P2567, DOI 10.1128/IAI.00067-11; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M., 2002, Current Drug Targets - Inflammation and Allergy, V1, P343; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Bhatia M, 2001, Curr Opin Investig Drugs, V2, P496; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Conti S, 2002, BRIT J PHARMACOL, V135, P181, DOI 10.1038/sj.bjp.0704466; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DELIMA WT, 1992, EUR J PHARMACOL, V213, P63, DOI 10.1016/0014-2999(92)90233-T; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2006, ANNU REV MED, V57, P553, DOI 10.1146/annurev.med.57.011205.135648; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2012, LAB INVEST, V92, P999, DOI 10.1038/labinvest.2012.55; Fukuda H, 2010, INT ARCH ALLERGY IMM, V152, P295, DOI 10.1159/000283042; Gamaleddin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029900; Grommes J, MOL MED CAMB MASS, V17, P293; Guabiraba R, 2013, INFLAMM RES, V62, P811, DOI 10.1007/s00011-013-0638-8; Kim K, 2010, J TRAUMA, V68, P373, DOI 10.1097/TA.0b013e3181a73eea; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Ligeiro-Oliveira AP, 2004, NEUROIMMUNOMODULAT, V11, P181, DOI 10.1159/000076767; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Massi P, 2000, EUR J PHARMACOL, V387, P343, DOI 10.1016/S0014-2999(99)00860-2; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Ribeiro A, 2012, EUR J PHARMACOL, V678, P78, DOI 10.1016/j.ejphar.2011.12.043; ROCHON YP, 1992, MED HYPOTHESES, V38, P132, DOI 10.1016/0306-9877(92)90086-R; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sacerdote P, 2000, J NEUROIMMUNOL, V109, P155, DOI 10.1016/S0165-5728(00)00307-6; SIMON SI, 1992, J IMMUNOL, V149, P2765; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Smith SR, 2001, EUR J PHARMACOL, V425, P73, DOI 10.1016/S0014-2999(01)01142-6; Smith SR, 2001, EUR J PHARMACOL, V432, P107, DOI 10.1016/S0014-2999(01)01477-7; Tasaka S, 2002, PULM PHARMACOL THER, V15, P83, DOI 10.1006/pupt.2001.0325; Vaseghi G, 2012, BASIC CLIN PHARMACOL, V111, P161, DOI 10.1111/j.1742-7843.2012.00881.x; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Weinacker AB, 2001, ANNU REV MED, V52, P221, DOI 10.1146/annurev.med.52.1.221; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	53	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77706	10.1371/journal.pone.0077706	http://dx.doi.org/10.1371/journal.pone.0077706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204926	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400052
J	Masuda, T; Sato, K; Murakoshi, T; Utsumi, K; Kimura, A; Shirai, N; Kanazawa, S; Yamaguchi, MK; Wada, Y				Masuda, Tomohiro; Sato, Kazuki; Murakoshi, Takuma; Utsumi, Ken; Kimura, Atsushi; Shirai, Nobu; Kanazawa, So; Yamaguchi, Masami K.; Wada, Yuji			Perception of Elasticity in the Kinetic Illusory Object with Phase Differences in Inducer Motion	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SUBJECTIVE CONTOURS; WATERCOLOR ILLUSION; COLOR; TRANSFORMATIONS; RECOVERY; HUMANS; DEPTH	Background: It is known that subjective contours are perceived even when a figure involves motion. However, whether this includes the perception of rigidity or deformation of an illusory surface remains unknown. In particular, since most visual stimuli used in previous studies were generated in order to induce illusory rigid objects, the potential perception of material properties such as rigidity or elasticity in these illusory surfaces has not been examined. Here, we elucidate whether the magnitude of phase difference in oscillation influences the visual impressions of an object's elasticity (Experiment 1) and identify whether such elasticity perceptions are accompanied by the shape of the subjective contours, which can be assumed to be strongly correlated with the perception of rigidity (Experiment 2). Methodology/Principal Findings: In Experiment 1, the phase differences in the oscillating motion of inducers were controlled to investigate whether they influenced the visual impression of an illusory object's elasticity. The results demonstrated that the impression of the elasticity of an illusory surface with subjective contours was systematically flipped with the degree of phase difference. In Experiment 2, we examined whether the subjective contours of a perceived object appeared linear or curved using multi-dimensional scaling analysis. The results indicated that the contours of a moving illusory object were perceived as more curved than linear in all phase-difference conditions. Conclusions/Significance: These findings suggest that the phase difference in an object's motion is a significant factor in the material perception of motion-related elasticity.	[Masuda, Tomohiro; Utsumi, Ken; Kimura, Atsushi; Wada, Yuji] Natl Agr & Food Res Org, Food Funct Div, Natl Food Res Inst, Ibaraki, Japan; [Sato, Kazuki; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Tokyo 112, Japan; [Murakoshi, Takuma] RIKEN BSI TOYOTA Collaborat Ctr, Behav & Cognit Neurosci Unit, Saitama, Japan; [Kimura, Atsushi] Tokyo Denki Univ, Dept Informat Environm, Chiba, Japan; [Shirai, Nobu] Niigata Univ, Dept Psychol, Niigata, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Tokyo, Kanagawa, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Chuo University; RIKEN; Tokyo Denki University; Niigata University; Japan Womens University	Wada, Y (corresponding author), Natl Agr & Food Res Org, Food Funct Div, Natl Food Res Inst, Ibaraki, Japan.	yujiwd@affrc.go.jp			Japan Society for Promotion of Science [23730718, 25780452];  [25135735]; Grants-in-Aid for Scientific Research [23730697] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grant-in-aids for Young Scientists (B) from the Japan Society for Promotion of Science (23730718 awarded to Y. Wada and 25780452 awarded to T. Masuda) and the Grant-in-Aid for Scientific Research on Innovative Areas (25135735 awarded to Y. Wada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2011, CURR BIOL, V21, P492, DOI 10.1016/j.cub.2011.02.011; BRESSAN P, 1986, PERCEPTION, V15, P409, DOI 10.1068/p150409; BRESSAN P, 1991, PERCEPTION, V20, P637, DOI 10.1068/p200637; Bressan P, 1997, PERCEPTION, V26, P1353, DOI 10.1068/p261353; Cicerone CM, 1992, ADV COLOR VISION, V4, P66; CORTESE JM, 1991, PERCEPT PSYCHOPHYS, V49, P315, DOI 10.3758/BF03205987; Ehrenstein W, 1941, Z PSYCHOLOGIE, V150, P83; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; Gori S, 2011, NEURAL NETWORKS, V24, P1082, DOI 10.1016/j.neunet.2011.06.017; Halko MA, 2008, J VIS, V8; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; JANSSON G, 1973, PERCEPTION, V2, P321, DOI 10.1068/p020321; JOHANSSON G, 1964, SCAND J PSYCHOL, V5, P181, DOI 10.1111/j.1467-9450.1964.tb01425.x; Kanizsa G., 1955, RIV PSICOL, V49, P7; KELLMAN PJ, 1984, PERCEPT PSYCHOPHYS, V35, P237, DOI 10.3758/BF03205937; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Liinasuo M, 2004, NEUROSCI LETT, V354, P18, DOI 10.1016/j.neulet.2003.09.069; Liinasuo M, 2000, NEUROSCI LETT, V281, P119, DOI 10.1016/S0304-3940(00)00818-1; Masuda T, 2011, JPN PSYCHOL RES, V53, P440, DOI 10.1111/j.1468-5884.2011.00487.x; Norman JF, 2007, PERCEPTION, V36, P980, DOI 10.1068/p5641; NORMAN JF, 1993, PERCEPT PSYCHOPHYS, V53, P279, DOI 10.3758/BF03205183; Pinna B, 2003, VISION RES, V43, P43, DOI 10.1016/S0042-6989(02)00132-3; Pinna B, 2001, VISION RES, V41, P2669, DOI 10.1016/S0042-6989(01)00105-5; Pinna B, 2005, J OPT SOC AM A, V22, P2207, DOI 10.1364/JOSAA.22.002207; Rao SS., 2010, MECH VIBRATIONS; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; Sato K, 2013, INFANT BEHAV DEV, V36, P557, DOI 10.1016/j.infbeh.2013.05.004; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Tse PU, 1998, PERCEPTION, V27, P977, DOI 10.1068/p270977; ULLMAN S, 1984, PERCEPTION, V13, P255, DOI 10.1068/p130255; VANTUIJL HFJM, 1975, ACTA PSYCHOL, V39, P441, DOI 10.1016/0001-6918(75)90042-6; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WARREN WH, 1987, PERCEPTION, V16, P309, DOI 10.1068/p160309; Yazdanbakhsh A, 2011, NEURAL NETWORKS, V24, P1093, DOI 10.1016/j.neunet.2011.06.016	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78621	10.1371/journal.pone.0078621	http://dx.doi.org/10.1371/journal.pone.0078621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205281	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400090
J	Kunasundari, B; Murugaiyah, V; Kaur, G; Maurer, FHJ; Sudesh, K				Kunasundari, Balakrishnan; Murugaiyah, Vikneswaran; Kaur, Gurjeet; Maurer, Frans H. J.; Sudesh, Kumar			Revisiting the Single Cell Protein Application of Cupriavidus necator H16 and Recovering Bioplastic Granules Simultaneously	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; HYDROGENOMONAS EUTROPHA; BIODEGRADABLE PLASTICS; ALCALIGENES-EUTROPHUS; RALSTONIA-EUTROPHA; POLYHYDROXYALKANOATES; RATS; POLY(3-HYDROXYBUTYRATE); EFFICIENT; ACID	Cupriavidus necator H16 (formerly known as Hydrogenomonas eutropha) was famous as a potential single cell protein (SCP) in the 1970s. The drawback however was the undesirably efficient accumulation of non-nutritive polyhydroxybutyrate (PHB) storage compound in the cytoplasm of this bacterium. Eventually, competition from soy-based protein resulted in SCP not receiving much attention. Nevertheless, C. necator H16 remained in the limelight as a producer of PHB, which is a material that resembles commodity plastics such as polypropylene. PHB is a 100% biobased and biodegradable polyester. Although tremendous achievements have been attained in the past 3 decades in the efficient production of PHB, this bioplastic is still costly. One of the main problems has been the recovery of PHB from the cell cytoplasm. In this study, we showed for the first time that kilogram quantities of PHB can be easily recovered in the laboratory without the use of any solvents and chemicals, just by using the cells as SCP. In addition, the present study also demonstrated the safety and tolerability of animal model used, Sprague Dawley given lyophilized cells of C. necator H16. The test animals readily produced fecal pellets that were whitish in color, as would be expected of PHB granules. The pellets were determined to contain about 82-97 wt% PHB and possessed molecular mass of around 930 kg/mol. The PHB granules recovered biologically possessed similar molecular mass compared to chloroform extracted PHB [950 kg/mol]. This method now allows the production and purification of substantial quantities of PHB for various experimental trials. The method reported here is easy, does not require expensive instrumentation, scalable and does not involve extensive use of solvents and strong chemicals.	[Kunasundari, Balakrishnan; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Murugaiyah, Vikneswaran] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Kaur, Gurjeet] Univ Sains Malaysia, Inst Res Mol Med, George Town, Malaysia; [Maurer, Frans H. J.] Lund Univ, Dept Chem Polymer & Mat Chem, Lund, Sweden	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Lund University	Sudesh, K (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	ksudesh@usm.my	Kaur, Gurjeet/AAN-7934-2020; Sudesh, Kumar/ABG-4333-2020; Kaur, Gurjeet/A-1085-2011; Sudesh, Kumar/C-2942-2011	Kaur, Gurjeet/0000-0002-6232-5703; Sudesh, Kumar/0000-0003-4756-9192; Kaur, Gurjeet/0000-0002-6232-5703; Sudesh, Kumar/0000-0003-4756-9192; Kunasundari, Balakrishnan/0000-0002-5998-8944; Murugaiyah, Vikneswaran/0000-0003-1768-7577	Long Term Research Grant Scheme (LRGS); International Research Collaboration Fund (IReC Fund) [1002/PBIOLOGI/910401]; USM's Fellowship	Long Term Research Grant Scheme (LRGS); International Research Collaboration Fund (IReC Fund); USM's Fellowship	This study was supported by Long Term Research Grant Scheme (LRGS) and International Research Collaboration Fund (IReC Fund), Grant No: 1002/PBIOLOGI/910401 entitled: A novel environmentally friendly extraction method of polyhydroxyalkanoates (PHA) from biomass through biological approach. BK acknowledges USM's Fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO E. J. A., 2005, ARQ CIEN VET ZOOL UN, V8, P139; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954; Bengtsson S, 2008, BIORESOURCE TECHNOL, V99, P509, DOI 10.1016/j.biortech.2007.01.020; Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004; Boon N, 2010, US Patent Application, Patent No. [2010/0093860, 20100093860]; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Budde CF, 2011, APPL MICROBIOL BIOT, V89, P1611, DOI 10.1007/s00253-011-3102-0; CALLOWAY DH, 1969, APPL MICROBIOL, V17, P176, DOI 10.1128/AEM.17.1.176-178.1969; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Choi J, 1999, APPL MICROBIOL BIOT, V51, P13, DOI 10.1007/s002530051357; Choi JI, 1999, BIOTECHNOL BIOENG, V62, P546, DOI 10.1002/(SICI)1097-0290(19990305)62:5<546::AID-BIT6>3.0.CO;2-0; CLIFFORD AJ, 1976, J NUTR, V106, P435, DOI 10.1093/jn/106.3.435; De Mey M, 2008, BIOLOGICALS, V36, P198, DOI 10.1016/j.biologicals.2007.10.001; Defoirdt T, 2009, BIOTECHNOL ADV, V27, P680, DOI 10.1016/j.biotechadv.2009.04.026; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Forni D, 1999, ANN ZOOTECH, V48, P163, DOI 10.1051/animres:19990302; Forni D, 1999, J ANIM PHYSIOL AN N, V81, P31, DOI 10.1046/j.1439-0396.1999.811190.x; Forni D, 1999, J ANIM PHYSIOL AN N, V81, P41, DOI 10.1046/j.1439-0396.1999.811190.x; Fukui T, 1998, APPL MICROBIOL BIOT, V49, P333, DOI 10.1007/s002530051178; Hahn Sei Kwang, 1993, Biotechnology Techniques, V7, P209, DOI 10.1007/BF02566149; HAHN SK, 1995, APPL ENVIRON MICROB, V61, P34, DOI 10.1128/AEM.61.1.34-39.1995; Jacquel N, 2008, BIOCHEM ENG J, V39, P15, DOI 10.1016/j.bej.2007.11.029; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kahar P, 2004, POLYM DEGRAD STABIL, V83, P79, DOI 10.1016/S0141-3910(03)00227-1; Kek YK, 2008, CAN J CHEM, V86, P533, DOI 10.1139/V08-001; KHOR GL, 1977, CAN J COMP MED, V41, P428; KIHLBERG R, 1972, ANNU REV MICROBIOL, V26, P427, DOI 10.1146/annurev.mi.26.100172.002235; Kim M, 2003, BIOTECHNOL LETT, V25, P55, DOI 10.1023/A:1021734216612; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Kuhad RC, 1997, NUTR REV, V55, P65, DOI 10.1111/j.1753-4887.1997.tb01599.x; Kunasundari B, 2011, EXPRESS POLYM LETT, V5, P620, DOI 10.3144/expresspolymlett.2011.60; Kuriyama M., 2006, US Patent, Patent No. [US 2006/0275253, 20060275253]; Lakshman K, 2006, ENZYME MICROB TECH, V39, P1471, DOI 10.1016/j.enzmictec.2006.03.037; Molck AM, 2002, TOXICOLOGY, V174, P183, DOI 10.1016/S0300-483X(02)00079-3; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Nasseri A. T., 2011, American Journal of Food Technology, V6, P103; Peoples O. P, 2001, US Patent, Patent No. [6207217, 06207217]; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; SCHARRER E, 1980, PFLUG ARCH EUR J PHY, V388, P165, DOI 10.1007/BF00584123; Schlegel H., 1971, ADV BIOCHEM ENG, P143; SCHOENMAKERS ACM, 1989, INT J VITAM NUTR RES, V59, P200; Selye H, 1950, MONTREAL ACTA, P1025; SHIMAMURA E, 1994, MACROMOLECULES, V27, P878, DOI 10.1021/ma00081a041; Shinaberger CS, 2008, AM J CLIN NUTR, V88, P1511, DOI 10.3945/ajcn.2008.26665; Subcommittee on Laboratory Animal Nutrition Committee on Animal Nutrition Board on Agriculture National Research Council, 1995, NUTR REQ LAB AN; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Sudesh K., 2010, International Patent, Patent No. [WO2010134798A1, 2010134798, WO 2010134798 A1]; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; WARNES TW, 1972, GUT, V13, P926, DOI 10.1136/gut.13.11.926; WASLIEN CI, 1969, APPL MICROBIOL, V18, P152, DOI 10.1128/AEM.18.2.152-155.1969; Yamada M, 2009, BIOMACROMOLECULES, V10, P677, DOI 10.1021/bm8013846; Yu J, 2006, BIOTECHNOL PROGR, V22, P547, DOI 10.1021/bp050362g	56	42	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78528	10.1371/journal.pone.0078528	http://dx.doi.org/10.1371/journal.pone.0078528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205250	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300066
J	Zhang, Y; Zhou, ZC; Yang, Q				Zhang, Yi; Zhou, Zhichun; Yang, Qing			Nitrogen (N) Deposition Impacts Seedling Growth of Pinus massoniana via N:P Ratio Effects and the Modulation of Adaptive Responses to Low P (Phosphorus)	PLOS ONE			English	Article							CUNNINGHAMIA-LANCEOLATA; LITTER DECOMPOSITION; PHOSPHATASE-ACTIVITY; NUTRIENT LIMITATION; USE EFFICIENCY; ROOT; TRAITS; AVAILABILITY; FRACTIONS; FOREST	Background: In forest ecosystems with phosphorus (P) deficiency, the impact of atmospheric nitrogen (N) deposition on nutritional traits related to P uptake and P use potentially determines plant growth and vegetation productivity. Methodology/Principal Findings: Two N deposition simulations were combined with three soil P conditions (homogeneous P deficiency with evenly low P; heterogeneous P deficiency with low subsoil P and high topsoil P; high P) using four full-sib families of Masson pine (Pinus massoniana). Under homogeneous P deficiency, N had a low effect on growth due to higher N:P ratios, whereas N-sensitive genotypes had lower N:P ratios and greater N sensitivity. The N effect increased under higher P conditions due to increased P concentration and balanced N:P ratios. An N:P threshold of 12.0-15.0 was detected, and growth was increased by N with an N:P ratio <= 12.0 and increased by P with an N:P ratio >= 15.0. Under homogeneous P deficiency, increased P use efficiency by N deposition improved growth. Under heterogeneous P deficiency, a greater P deficiency under N deposition due to increased N:P ratios induced greater adaptive responses to low P (root acid phosphatase secretion and topsoil root proliferation) and improved P acquisition and growth. Conclusions/Significance: N deposition diversely affected seedling growth across different P conditions and genotypes via N:P ratio effects and the modulation of adaptive responses to low P. The positive impact of N on growth was genotype-specific and increased by soil P addition due to balanced N:P ratios. These results indicate the significance of breeding N-sensitive tree genotypes and improving forest soil P status to compensate for increasing N deposition.	[Zhang, Yi; Zhou, Zhichun; Yang, Qing] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fu Yang, Zhe Jiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhang, Y (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fu Yang, Zhe Jiang, Peoples R China.	zhang1978yi@gmail.com			Hi-Tech Research and Development Program ("863" Program) [2011AA100203]; National Natural Science Foundation of China [31070599, 31370671]	Hi-Tech Research and Development Program ("863" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a research project from the Hi-Tech Research and Development Program ("863" Program) (2011AA100203), the National Natural Science Foundation of China (31070599), and the National Natural Science Foundation of China (31370671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Chen HJ, 2003, FOREST ECOL MANAG, V178, P301, DOI 10.1016/S0378-1127(02)00478-4; Chen M, 2007, GEODERMA, V142, P136, DOI 10.1016/j.geoderma.2007.08.004; COLE DW, 1995, PLANT SOIL, V168, P43, DOI 10.1007/BF00029312; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Fita A, 2011, EUPHYTICA, V181, P323, DOI 10.1007/s10681-011-0432-z; Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GILL JGS, 1987, SILVAE GENET, V36, P189; Goncalves PDS, 2005, GENET MOL BIOL, V28, P758, DOI 10.1590/S1415-47572005000500018; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hawkins BJ, 2007, TREE PHYSIOL, V27, P911, DOI 10.1093/treephys/27.6.911; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Hidaka A, 2009, J ECOL, V97, P984, DOI 10.1111/j.1365-2745.2009.01540.x; Hu Y, 2005, J PLANT NUTR, V33, P889; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Lambeth C., 2001, Forest Genetics, V8, P101; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Liu Y, 2004, PLANT SCI, V167, P217, DOI 10.1016/j.plantsci.2004.02.026; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Luizao FJ, 2007, PLANT ECOL, V192, P209, DOI 10.1007/s11258-007-9317-6; Nakaji T, 2001, TREES-STRUCT FUNCT, V15, P453, DOI 10.1007/s00468-001-0130-x; Plassard C, 2010, TREE PHYSIOL, V30, P1129, DOI 10.1093/treephys/tpq063; Radersma S, 2004, PLANT SOIL, V259, P209, DOI 10.1023/B:PLSO.0000020970.40167.40; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007; Wu PF, 2011, CAN J FOREST RES, V41, P228, DOI 10.1139/X10-198; Xie YX, 2008, ATMOS ENVIRON, V42, P5182, DOI 10.1016/j.atmosenv.2008.03.008; Zhang Y, 2013, PLANT SOIL, V364, P93, DOI 10.1007/s11104-012-1352-y; Zhang Y, 2012, PLANT BIOSYST, V146, P7, DOI 10.1080/11263504.2011.593199; Zhang Y, 2010, J FOREST RES-JPN, V15, P91, DOI 10.1007/s10310-009-0153-5; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	42	6	13	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79229	10.1371/journal.pone.0079229	http://dx.doi.org/10.1371/journal.pone.0079229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205376	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600119
J	Chikahisa, S; Kodama, T; Soya, A; Sagawa, Y; Ishimaru, Y; Sei, H; Nishino, S				Chikahisa, Sachiko; Kodama, Tohru; Soya, Atsushi; Sagawa, Yohei; Ishimaru, Yuji; Sei, Hiroyoshi; Nishino, Seiji			Histamine from Brain Resident MAST Cells Promotes Wakefulness and Modulates Behavioral States	PLOS ONE			English	Article							W-WV MICE; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; BODY-TEMPERATURE; IN-VIVO; SLEEP; RATS; DEFICIENT; AROUSAL; NEURONS	Mast cell activation and degranulation can result in the release of various chemical mediators, such as histamine and cytokines, which significantly affect sleep. Mast cells also exist in the central nervous system (CNS). Since up to 50% of histamine contents in the brain are from brain mast cells, mediators from brain mast cells may significantly influence sleep and other behaviors. In this study, we examined potential involvement of brain mast cells in sleep/wake regulations, focusing especially on the histaminergic system, using mast cell deficient (W/Wv) mice. No significant difference was found in the basal amount of sleep/wake between W/Wv mice and their wild-type littermates (WT), although W/Wv mice showed increased EEG delta power and attenuated rebound response after sleep deprivation. Intracerebroventricular injection of compound 48/80, a histamine releaser from mast cells, significantly increased histamine levels in the ventricular region and enhanced wakefulness in WT mice, while it had no effect in W/Wv mice. Injection of H1 antagonists (triprolidine and mepyramine) significantly increased the amounts of slow-wave sleep in WT mice, but not in W/Wv mice. Most strikingly, the food-seeking behavior observed in WT mice during food deprivation was completely abolished in W/Wv mice. W/Wv mice also exhibited higher anxiety and depression levels compared to WT mice. Our findings suggest that histamine released from brain mast cells is wake-promoting, and emphasizes the physiological and pharmacological importance of brain mast cells in the regulation of sleep and fundamental neurobehavior.	[Chikahisa, Sachiko; Soya, Atsushi; Sagawa, Yohei; Ishimaru, Yuji; Nishino, Seiji] Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA; [Chikahisa, Sachiko; Sei, Hiroyoshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Integrat Physiol, Tokushima 770, Japan; [Kodama, Tohru] Tokyo Metropolitan Inst Med Sci, Dept Psychophysiol, Tokyo 113, Japan	Stanford University; Tokushima University; Tokyo Metropolitan Institute of Medical Science	Nishino, S (corresponding author), Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA.	nishino@stanford.EDU		KODAMA, TOHRU/0000-0001-6915-4428	Japan Society for the Promotion of Science [21-8162]; Grants-in-Aid for Scientific Research [25860985] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.C. is supported by the Excellent Young Researcher Overseas Visit Program (21-8162) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, MED RES REV, V15, P33, DOI 10.1002/med.2610150104; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; BUGAJSKI AJ, 1994, AGENTS ACTIONS, V41, pC75, DOI 10.1007/BF02007774; CARR KD, 1985, NEUROPEPTIDES, V5, P411, DOI 10.1016/0143-4179(85)90041-1; Challet E, 1997, BEHAV BRAIN RES, V84, P275, DOI 10.1016/S0166-4328(97)83335-9; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Chikahisa S, 2009, NEUROPHARMACOLOGY, V57, P369, DOI 10.1016/j.neuropharm.2009.07.015; Cirulli F, 1998, BRAIN BEHAV IMMUN, V12, P123, DOI 10.1006/brbi.1998.0505; DEWASMES G, 1989, PHYSIOL BEHAV, V46, P179, DOI 10.1016/0031-9384(89)90252-7; Domino EF, 1999, PSYCHOSOM MED, V61, P591, DOI 10.1097/00006842-199909000-00002; Florenzano F, 2000, J COMP NEUROL, V424, P651; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; GALLI SJ, 1987, BLOOD, V69, P1661; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; HAYAISHI O, 1995, ADV NEUROIMMUNOL, V5, P211, DOI 10.1016/0960-5428(95)00010-Y; Hendrix S, 2006, NEUROSCI LETT, V392, P174, DOI 10.1016/j.neulet.2005.09.029; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Ikeda-Sagara M, 2012, BRIT J PHARMACOL, V165, P167, DOI 10.1111/j.1476-5381.2011.01547.x; JOHNSON D, 1992, NEUROCHEM RES, V17, P939, DOI 10.1007/BF00993271; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami S, 2000, BRAIN RES, V857, P313, DOI 10.1016/S0006-8993(99)02466-X; Kim YS, 2000, BRAIN RES, V881, P190, DOI 10.1016/S0006-8993(00)02860-2; KITAMURA Y, 1979, NATURE, V281, P154, DOI 10.1038/281154a0; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Lin JS, 1996, J NEUROSCI, V16, P1523; Valdes JL, 2010, EUR J NEUROSCI, V31, P2073, DOI 10.1111/j.1460-9568.2010.07241.x; MAEYAMA K, 1983, J NEUROCHEM, V41, P128, DOI 10.1111/j.1471-4159.1983.tb11823.x; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mattila OS, 2011, STROKE, V42, P3600, DOI 10.1161/STROKEAHA.111.632224; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOCHIZUKI T, 1991, N-S ARCH PHARMACOL, V343, P190, DOI 10.1007/BF00168609; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Okuro M, 2010, SLEEP, V33, P930, DOI 10.1093/sleep/33.7.930; OOHARA A, 1994, J NEUROCHEM, V63, P677; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; SAKATA T, 1994, BRAIN RES BULL, V35, P135, DOI 10.1016/0361-9230(94)90093-0; Sangalli BC, 1997, PROG NEUROBIOL, V52, P145, DOI 10.1016/S0301-0082(97)00011-7; SHIMADA M, 1980, NATURE, V283, P662, DOI 10.1038/283662a0; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Soya A, 2008, NEUROSCI LETT, V430, P224, DOI 10.1016/j.neulet.2007.11.002; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; Unno K, 2012, EUR J PHARMACOL, V683, P179, DOI 10.1016/j.ejphar.2012.03.017; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; WERSHIL BK, 1994, ADV EXP MED BIOL, V347, P39; Wilhelm M, 2000, ENDOCRINOLOGY, V141, P1178, DOI 10.1210/en.141.3.1178; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; YAMATODANI A, 1982, BIOCHEM PHARMACOL, V31, P305; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5; Yuzurihara M, 2000, PHARMACOL BIOCHEM BE, V67, P145, DOI 10.1016/S0091-3057(00)00320-8	59	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78434	10.1371/journal.pone.0078434	http://dx.doi.org/10.1371/journal.pone.0078434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205232	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300155
J	Rossi, C; Schwartzman, K; Oxlade, O; Klein, MB; Greenaway, C				Rossi, Carmine; Schwartzman, Kevin; Oxlade, Olivia; Klein, Marina B.; Greenaway, Chris			Hepatitis B Screening and Vaccination Strategies for Newly Arrived Adult Canadian Immigrants and Refugees: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							NEW-SOUTH-WALES; VIRUS INFECTION; CANCER-MORTALITY; ASIAN MIGRANTS; UNITED-STATES; RECOMMENDATIONS; CHINESE; HEALTH; EPIDEMIOLOGY; PREVENTION	Background: Immigrants have increased mortality from hepatocellular carcinoma as compared to the host populations, primarily due to undetected chronic hepatitis B virus (HBV) infection. Despite this, there are no systematic programs in most immigrant-receiving countries to screen for chronic HBV infection and immigrants are not routinely offered HBV vaccination outside of the universal childhood vaccination program. Methods and findings: A cost-effective analysis was performed to compare four HBV screening and vaccination strategies with no intervention in a hypothetical cohort of newly-arriving adult Canadian immigrants. The strategies considered were a) universal vaccination, b) screening for prior immunity and vaccination, c) chronic HBV screening and treatment, and d) combined screening for chronic HBV and prior immunity, treatment and vaccination. The analysis was performed from a societal perspective, using a Markov model. Seroprevalence estimates, annual transition probabilities, health-care costs (in Canadian dollars), and utilities were obtained from the published literature. Acute HBV infection, mortality from chronic HBV, quality-adjusted life years (QALYs), and costs were modeled over the lifetime of the cohort of immigrants. Costs and QALYs were discounted at a rate of 3% per year. Screening for chronic HBV infection, and offering treatment if indicated, was found to be the most cost-effective intervention and was estimated to cost $40,880 per additional QALY gained, relative to no intervention. This strategy was most cost-effective for immigrants < 55 years of age and would cost < $50,000 per additional QALY gained for immigrants from areas where HBV seroprevalence is >= 3%. Strategies that included HBV vaccination were either prohibitively expensive or dominated by the chronic HBV screening strategy. Conclusions: Screening for chronic HBV infection from regions where most Canadian immigrants originate, except for Latin America and the Middle East, was found to be reasonably cost-effective and has the potential to reduce HBV-associated morbidity and mortality.	[Rossi, Carmine; Schwartzman, Kevin; Klein, Marina B.; Greenaway, Chris] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rossi, Carmine; Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada; [Schwartzman, Kevin] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Schwartzman, Kevin] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Oxlade, Olivia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Klein, Marina B.] McGill Univ, Dept Med, Ctr Hlth, Div Infect Dis Immunodeficiency, Montreal, PQ, Canada; [Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; McGill University	Rossi, C (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	carmine.rossi@mail.mcgill.ca		Klein, Marina/0000-0002-3063-8430	Fonds de la recherche en sante du Quebec through the Bourse de Maitrise [22577]; Chercheur Boursier Clinicien programs; Canadian Institutes for Health Research	Fonds de la recherche en sante du Quebec through the Bourse de Maitrise; Chercheur Boursier Clinicien programs; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	CR, MK and CG receive salary support from the Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml) through the Bourse de Maitrise (CR) [grant number 22577] and the Chercheur Boursier Clinicien programs (MK, CG). OO receives salary support from a post-doctoral fellowship from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga-Rodriguez A, 2010, EUR J GASTROEN HEPAT, V22, P961, DOI 10.1097/MEG.0b013e32833783b4; BOUCHARDY C, 1994, INT J CANCER, V58, P638, DOI 10.1002/ijc.2910580504; Briggs AH, 1999, BRIT MED J, V319, P635, DOI 10.1136/bmj.319.7210.635; *COL BRIT MIN HLTH, 2012, MED SERV COMM PAYM S, P57564; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; DesMeules Marie, 2005, J Immigr Health, V7, P221, DOI 10.1007/s10903-005-5118-y; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Gagnon YM, 2004, J CLIN GASTROENTEROL, V38, pS179, DOI 10.1097/00004836-200411003-00011; Gray A., 2011, APPL METHODS COST EF; Greenaway C, 2011, CMAJ, V183, pE847; GRULICH AE, 1995, BRIT J CANCER, V71, P400, DOI 10.1038/bjc.1995.82; GRULICH AE, 1992, BRIT J CANCER, V66, P905, DOI 10.1038/bjc.1992.383; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Hemminki K, 2010, EUR J CANCER, V46, P926, DOI 10.1016/j.ejca.2009.12.031; Hislop TG, 2007, CAN J PUBLIC HEALTH, V98, P125, DOI 10.1007/BF03404323; Hu KQ, 2011, DIGEST DIS SCI, V56, P3163, DOI 10.1007/s10620-011-1840-6; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; *INT AG RES CANC, 2011, CANC INC 5 CONT ANN, P57564; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; *LASS REG MAL QUEB, 2012, LIST MED, P57564; *LASS REG MAL QUEB, 2011, MAN MED SPEC, P57564; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Luo Wei, 2004, J Immigr Health, V6, P41, DOI 10.1023/B:JOIH.0000014641.68476.2d; Ma Grace X, 2007, J Immigr Minor Health, V9, P213, DOI 10.1007/s10903-006-9028-4; Ma GX, 2008, AM J HEALTH BEHAV, V32, P178; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; McDermott S, 2011, J IMMIGR MINOR HEALT, V13, P15, DOI 10.1007/s10903-010-9347-3; McMahon BJ, 2010, CLIN LIVER DIS, V14, P381, DOI 10.1016/j.cld.2010.05.007; Merrett P, 2007, CLIN INFECT DIS, V44, P1040, DOI 10.1086/512673; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; Public Health Agency of Canada, 2011, BRIEF REP HEP B INF; Rein DB, 2010, J VIRAL HEPATITIS, V17, P28, DOI 10.1111/j.1365-2893.2009.01165.x; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shepard CW, 2005, PEDIATR INFECT DIS J, V24, P755, DOI 10.1097/01.inf.0000177279.72993.d5; Sherman M, 2007, CAN J GASTROENTER SC, V21, P5; *STAT CAN, 2011, TABLE 326 0020 CAN C, P57564; *STAT CAN, 2011, CANC INC 5 CONT ANN, P57564; Statistics Canada, 2006, PLAC BIRTH IMM POP P; Statistics Canada, 2007, IMM CAN PORTR FOR BO; Tong MJ, 2011, DIGEST DIS SCI, V56, P3143, DOI 10.1007/s10620-011-1841-5; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Wu H, 2009, CAN J GASTROENTEROL, V23, P31, DOI 10.1155/2009/608352	53	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78548	10.1371/journal.pone.0078548	http://dx.doi.org/10.1371/journal.pone.0078548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205255	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300158
J	Zhao, YY; Zhang, YH; Li, XC				Zhao, Yanyu; Zhang, Yanhua; Li, Xiaochen			Molecular Phylogeography and Population Genetic Structure of an Endangered Species Pachyhynobius shangchengensis (hynobiid Salamander) in a Fragmented Habitat of Southeastern China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MITOCHONDRIAL-DNA; LANDSCAPE GENETICS; CYTOCHROME-B; SKY ISLANDS; CONSEQUENCES; DIVERSITY; AMPHIBIA; CAUDATA; BIOGEOGRAPHY	The salamander Pachyhynobius shangchengensis (Hynobiidae) is a vulnerable species restricted to a patchy distribution associated with small mountain streams surrounded by forested slopes in the Mount Dabieshan region in southeastern China. However, molecular phylogeography and population genetic structure of P. shangchengensis remain poorly investigated. In this study, we explored the genetic structure and phylogeography of P. shangchengensis based on partial sequences of the mitochondrial DNA (mtDNA) cytochrome b and cytochrome c oxidase subunit I genes. Fifty-one haplotypes and four clades were found among 93 samples. Phylogenetic analyses revealed four deeply divergent and reciprocally monophyletic mtDNA lineages that approximately correspond to four geographic regions separated by complicated topography and long distances. The distinct geographic distributions of all lineages and the estimated divergence time suggest spatial and temporal separation coinciding with climatic changes during the Pleistocene. Analysis of molecular variance indicated that most of the observed genetic variation occurred among the four groups, implying long-term interruption of gene flow, and the possible separation of P. shangchengensis into four management units for conservation.	[Zhao, Yanyu; Li, Xiaochen] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Zhang, Yanhua] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Peoples R China	Shaanxi Normal University; Jiangsu Normal University	Zhao, YY (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	xznuzhao@163.com			National Natural Science Foundation of China [31071888]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 31071888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, J APPL ECOL, DOI DOI 10.2307/2404927; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Axelrod D, 1998, FLORISTIC CHARACTERI; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Cai San-yuan, 2001, Journal of Central China Normal University (Natural Sciences), V35, P203; Chen Xiao-Hong, 2001, Acta Zootaxonomica Sinica, V26, P383; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Craw D, 2008, J BIOGEOGR, V35, P1790, DOI 10.1111/j.1365-2699.2008.01936.x; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; deMaynadier PG, 1999, J WILDLIFE MANAGE, V63, P441, DOI 10.2307/3802629; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FEI L, 1985, Zoological Research, V6, P399; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu B, 2012, MOL ECOL, V21, P3308, DOI 10.1111/j.1365-294X.2012.05606.x; Madison DM, 1998, COPEIA, P402; Malyarchuk B, 2010, MOL PHYLOGENET EVOL, V56, P562, DOI 10.1016/j.ympev.2010.04.005; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Matsui M, 2008, MOL PHYLOGENET EVOL, V48, P84, DOI 10.1016/j.ympev.2008.04.010; Matsui M, 2007, MOL PHYLOGENET EVOL, V44, P204, DOI 10.1016/j.ympev.2006.11.031; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; NYLANDER J. A. A, 2004, MRMODELTEST V2 PROGR, V2, P2; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Rambaut A., 2006, FIGTREE 1 1 1; Rambaut A., 2012, TRACER V1 5; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TALLMON DA, 2000, J INFO; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wu Shuhui, 1994, Journal of Henan Normal University (Natural Science), V22, P106; Xiong JL, 2007, J HERPETOL, V41, P664, DOI 10.1670/07-054.1; Xiong JL, 2009, ANIMAL HUSBANDRY FEE, V30, P126; Yoshikawa N, 2008, MOL PHYLOGENET EVOL, V49, P249, DOI 10.1016/j.ympev.2008.07.016; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang Rong-Zu, 2004, Acta Zoologica Sinica, V50, P841	71	8	8	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78064	10.1371/journal.pone.0078064	http://dx.doi.org/10.1371/journal.pone.0078064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205092	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300137
J	Di Giandomenico, S; Frapolli, R; Bello, E; Uboldi, S; Licandro, SA; Marchini, S; Beltrame, L; Brich, S; Mauro, V; Tamborini, E; Pilotti, S; Casali, PG; Grosso, F; Sanfilippo, R; Gronchi, A; Mantovani, R; Gatta, R; Galmarini, CM; Sousa-Faro, JMF; D'Incalci, M				Di Giandomenico, S.; Frapolli, R.; Bello, E.; Uboldi, S.; Licandro, S. A.; Marchini, S.; Beltrame, L.; Brich, S.; Mauro, V.; Tamborini, E.; Pilotti, S.; Casali, P. G.; Grosso, F.; Sanfilippo, R.; Gronchi, A.; Mantovani, R.; Gatta, R.; Galmarini, C. M.; Sousa-Faro, J. M. F.; D'Incalci, M.			Mode of action of trabectedin in myxoid liposarcomas	ONCOGENE			English	Article						trabectedin; myxoid liposarcoma; xenografts; differentiation; transcription regulation	NUCLEOTIDE-EXCISION-REPAIR; ROUND-CELL LIPOSARCOMA; CHOP FUSION PROTEIN; ANTITUMOR-ACTIVITY; SOFT-TISSUE; TRANSCRIPTIONAL ACTIVATION; ADIPOCYTE DIFFERENTIATION; ECTEINASCIDIN 743; BINDING PROTEIN; MINOR-GROOVE	To elucidate the mechanisms behind the high sensitivity of myxoid/round cell liposarcoma (MRCL) to trabectedin and the suggested selectivity for specific subtypes, we have developed and characterized three MRCL xenografts, namely ML017, ML015 and ML004 differing for the break point of the fusion gene FUS-CHOP, respectively of type I, II and III. FUS-CHOP binding to the promoters of some target genes such as Pentraxin 3 or Fibronectin 1, assessed by chromatin immunoprecipitation, was strongly reduced in the tumor 24 h after the first or the third weekly dose of trabectedin, indicating that the drug at therapeutic doses causes a detachment of the FUS-CHOP chimera from its target promoters as previously shown in vitro. Moreover, the higher sensitivity of MRCL types I and II appears to be related to a more prolonged block of the transactivating activity of the fusion protein. Doxorubicin did not affect the binding of FUS-CHOP to target promoters. Histologically, the response to trabectedin in ML017 and ML015 was associated with a marked depletion of non-lipogenic tumoral cells and vascular component, as well as lipidic maturation as confirmed by PPAR gamma 2 expression in western Blot. By contrast, in ML004 no major changes either in the cellularity or in the amount of mature were found, and consistently PPAR gamma 2 was null. In conclusion, the data support the view that the selective mechanism of action of trabectedin in MRCL is specific and related to its ability to cause a functional inactivation of the oncogenic chimera with consequent derepression of the adypocytic differentiation.	[Di Giandomenico, S.; Frapolli, R.; Bello, E.; Uboldi, S.; Licandro, S. A.; Marchini, S.; Beltrame, L.; D'Incalci, M.] Ist Ric Farmacol Mario Negri, IRCCS, Dept Oncol, I-20156 Milan, Italy; [Brich, S.; Mauro, V.; Tamborini, E.; Pilotti, S.] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Casali, P. G.; Sanfilippo, R.] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Sarcoma Med Treatment Unit, Milan, Italy; [Grosso, F.] SS Antonio & Biagio Gen Hosp, Dept Oncol, Alessandria, Italy; [Gronchi, A.] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Milan, Italy; [Mantovani, R.; Gatta, R.] Univ Milan, Dipartimento Biosci, Milan, Italy; [Galmarini, C. M.; Sousa-Faro, J. M. F.] PharmaMar SA, Madrid, Spain	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; PharmaMar	D'Incalci, M (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, Dept Oncol, Via La Masa 19, I-20156 Milan, Italy.	maurizio.dincalci@marionegri.it	Tamborini, Elena/C-3307-2017; brich, silvia/K-4049-2016; D'Incalci, Maurizio/AAA-9021-2020; Marchini, sergio/J-3968-2018; Gronchi, Alessandro/O-6589-2016; casali, Paolo Giovanni/D-1524-2017; Bello, Ezia/AAB-2210-2020; Frapolli, Roberta/AAA-6729-2020; Brich, Silvia/AAC-1283-2019; Sanfilippo, Roberta/E-2123-2017; Beltrame, Luca/AAB-1998-2020	Tamborini, Elena/0000-0002-3819-8687; brich, silvia/0000-0002-6359-1712; D'Incalci, Maurizio/0000-0001-8784-1360; Marchini, sergio/0000-0003-1783-7651; Gronchi, Alessandro/0000-0002-4703-3534; casali, Paolo Giovanni/0000-0003-4056-8023; Bello, Ezia/0000-0001-5116-0758; Frapolli, Roberta/0000-0003-2907-273X; Brich, Silvia/0000-0002-6359-1712; Sanfilippo, Roberta/0000-0002-9704-0521; Beltrame, Luca/0000-0003-3631-6544; Licandro, Simonetta Andrea/0000-0001-7597-7084; Uboldi, Sarah/0000-0002-6430-0323; Galmarini, Carlos Maria/0000-0001-5494-6617	AIRC grants	AIRC grants(Fondazione AIRC per la ricerca sul cancro)	The study was supported by two AIRC grants to MD and SP.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; [Anonymous], 2002, PATHOLOGY GENETICS T; Antonescu CR, 2001, CLIN CANCER RES, V7, P3977; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bode-Lesniewska B, 2007, GENE CHROMOSOME CANC, V46, P961, DOI 10.1002/gcc.20478; Bonfanti M, 1999, ANTI-CANCER DRUG DES, V14, P179; BROGGINI M, 1994, ANTI-CANCER DRUG DES, V9, P373; BROGGINI M, 1995, NUCLEIC ACIDS RES, V23, P81, DOI 10.1093/nar/23.1.81; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; D'Incalci A, 2003, EXPERT OPIN INV DRUG, V12, P1843; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Damia G, 1996, INT J CANCER, V66, P779, DOI 10.1002/(SICI)1097-0215(19960611)66:6<779::AID-IJC12>3.0.CO;2-Z; Demicco EG, 2012, MODERN PATHOL, V25, P212, DOI 10.1038/modpathol.2011.148; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Erba E, 2001, EUR J CANCER, V37, P97, DOI 10.1016/S0959-8049(00)00357-9; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Frapolli R, 2010, CLIN CANCER RES, V16, P4958, DOI 10.1158/1078-0432.CCR-10-0317; Friedman D, 2002, CANCER RES, V62, P3377; Gajate C, 2002, J BIOL CHEM, V277, P41580, DOI 10.1074/jbc.M204644200; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Germano G, 2010, CANCER RES, V70, P2235, DOI 10.1158/0008-5472.CAN-09-2335; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Gronchi A, 2012, ANN ONCOL, V23, P771, DOI 10.1093/annonc/mdr265; Grosso F, 2009, ANN ONCOL, V20, P1439, DOI 10.1093/annonc/mdp004; Grosso F, 2007, LANCET ONCOL, V8, P595, DOI 10.1016/S1470-2045(07)70175-4; Hendriks HR, 1999, ANN ONCOL, V10, P1233, DOI 10.1023/A:1008364727071; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Izbicka E, 1998, ANN ONCOL, V9, P981, DOI 10.1023/A:1008224322396; Jin S, 2000, P NATL ACAD SCI USA, V97, P6775, DOI 10.1073/pnas.97.12.6775; KNIGHT JC, 1995, CANCER RES, V55, P24; Kuroda M, 1997, AM J PATHOL, V151, P735; Li WW, 2001, CLIN CANCER RES, V7, P2908; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Negri T, 2010, CLIN CANCER RES, V16, P3581, DOI 10.1158/1078-0432.CCR-09-2912; PANAGOPOULOS I, 1994, CANCER RES, V54, P6500; Perez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572; Perez-Mancera PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002569; Pommier Y, 1996, BIOCHEMISTRY-US, V35, P13303, DOI 10.1021/bi960306b; Powers MP, 2010, MODERN PATHOL, V23, P1307, DOI 10.1038/modpathol.2010.118; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Tavecchio M, 2008, EUR J CANCER, V44, P609, DOI 10.1016/j.ejca.2008.01.003; Valoti G, 1998, CLIN CANCER RES, V4, P1977; van Roggen JFG, 1999, HISTOPATHOLOGY, V35, P291; Wang WL, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-25; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zewail-Foote M, 1999, J MED CHEM, V42, P2493, DOI 10.1021/jm990241l	60	84	85	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5201	5210		10.1038/onc.2013.462	http://dx.doi.org/10.1038/onc.2013.462			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24213580				2022-12-25	WOS:000343914900007
J	Xie, XL; Sun, L; Pessetto, ZY; Zhao, Y; Zang, ZH; Zhong, L; Wu, M; Su, Q; Gao, XR; Zan, W; Sun, YY				Xie, Xingliang; Sun, Lin; Pessetto, Ziyan Yuan; Zhao, Yan; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Sun, Yiyi			Development of a Fluorescence Polarization Based High-Throughput Assay to Identify Casitas B-Lineage Lymphoma RING Domain Regulators	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; CBL-FAMILY; V-CBL; PROTEINS; UBIQUITINATION; INHIBITORS; ONCOGENE; LIGASES	The E3 ubiquitin protein ligase Casitas B-lineage Lymphoma (Cbl) proteins and their binding partners play an important role in regulating signal transduction pathways. It is important to utilize regulators to study the protein-protein interactions (PPIs) between these proteins. However, finding specific small-molecule regulators of PPIs remains a significant challenge due to the fact that the interfaces involved in PPIs are not well suited for effective small molecule binding. We report the development of a competitive, homogeneous, high-throughput fluorescence polarization (FP) assay to identify small molecule regulators of Cbl (RING) domain. The FP assay was used to measure binding affinities and inhibition constants of UbCH7 peptides and small molecule regulators of Cbl (RING) domains, respectively. In order to rule out promiscuous, aggregation-based inhibition, two assay conditions were developed and compared side by side. Under optimized conditions, we screened a 10,000 natural compound library in detergent-free and detergent-present (0.01% Triton X-100) systems. The results indicate that the detergent-present system is more suitable for high-throughput screens. Three potential compounds, methylprotodioscin, leonuride and catalpol, have been identified that bind to Cbl (RING) domain and interfere with the Cbl (RING)-UbCH7 protein-protein interaction.	[Xie, Xingliang; Zhao, Yan; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Sun, Yiyi] Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China; [Sun, Lin] Sichuan Univ, West China Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Pessetto, Ziyan Yuan] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Chengdu Medical College; Sichuan University; University of Kansas; University of Kansas Medical Center	Sun, YY (corresponding author), Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China.	yiyisun0363@gmail.com			National Natural Science Foundation of China (NSFC) [81102326]; Chengdu Medical College for Major Pharmacy Research Development Program [CYXK2012006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chengdu Medical College for Major Pharmacy Research Development Program	Project supported by the National Natural Science Foundation of China (NSFC, Grant No. 81102326) and by Chengdu Medical College for Major Pharmacy Research Development Program (Grant No. CYXK2012006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE TJ, 1991, ONCOGENE, V6, P653; Chan LL, 2009, IEEE ENG MED BIO, P788, DOI 10.1109/IEMBS.2009.5333796; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Deng YX, 2012, J ETHNOPHARMACOL, V144, P425, DOI 10.1016/j.jep.2012.09.039; Dong Z, 2013, PHYTOMEDICINE; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang WJ, 2010, J NAT PROD, V73, P1170, DOI 10.1021/np9008317; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Kumar EA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01639; Kumar EA, 2012, J MED CHEM, V55, P3583, DOI 10.1021/jm300078z; Kumar EA, 2011, ANAL BIOCHEM, V411, P254, DOI 10.1016/j.ab.2010.11.038; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Naramura M, 2011, ONCOTARGET, V2, P245; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; SANJAY A, 2001, SCI STKE, pPE40; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sun YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063354; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang G, 2006, CANCER LETT, V241, P102, DOI 10.1016/j.canlet.2005.10.050; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	25	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78042	10.1371/journal.pone.0078042	http://dx.doi.org/10.1371/journal.pone.0078042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205080	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800013
J	Bi, WJ; Gu, ZY; Zheng, YN; Zhang, X; Guo, J; Wu, G				Bi, Wenjuan; Gu, Zhiyuan; Zheng, Yuanna; Zhang, Xiao; Guo, Jing; Wu, Gang			Heterodimeric BMP-2/7 Antagonizes the Inhibition of All-Trans Retinoic Acid and Promotes the Osteoblastogenesis	PLOS ONE			English	Article							OSTEOCLASTIC BONE-RESORPTION; OSTEOGENIC DIFFERENTIATION; RHBMP2/7 HETERODIMER; GENE-EXPRESSION; RECEPTOR-GAMMA; CELL-CYCLE; SMAD; ETHANOL; STIMULATION; MECHANISM	Objectives: Hypervitaminosis A and alcoholism can result in a low mineral density and compromised regenerative capacity of bone, thus delaying implant osteointegration. The inhibitory effect of all-trans retinoic acid on osteoblastogenesis is considered to be one of the mechanisms. We hypothesized that heterodimeric bone morphogenetic protein-2/7 could antagonize all-trans retinoic acid and enhance osteoblastogenesis, with an aim to accelerate and enhance bone regeneration and implant osteointegration. Materials and Methods: We applied 5 ng/ml or 50 ng/ml bone morphogenetic protein-2/7 to restore the osteoblastogenesis of pre-osteoblasts (MC3T3-E1 cell line) that was inhibited by 1 mu M all-trans retinoic acid. We evaluated the efficacy by assessing cell numbers (proliferation), alkaline phosphatase activity (a marker for early differentiation), osteocalcin (a marker for late differentiation), calcium deposition (a marker for final mineralization) and the expression of osteoblastogenic genes (such as Runx2, Collagen Ia, alkaline phosphatase and osteocalcin) at different time points. Results: All-trans retinoic acid significantly inhibited the expression of all the tested osteoblastogenic genes and proteins except alkaline phosphatase activity. In the presence of ATRA, 50 ng/ml bone morphogenetic protein-2/7 not only completely restored but also significantly enhanced all the osteoblastogenic genes and proteins. On the 28th day, mineralization was completely inhibited by all-trans retinoic acid. In contrast, 50 ng/ml BMP-2/7 could antagonize ATRA and significantly enhance the mineralization about 2.5 folds in comparison with the control treatment (no ATRA, no BMP2/7). Conclusions: Heterodimeric bone morphogenetic protein-2/7 bears a promising application potential to significantly promote bone regeneration and implant osteointegration for the patients with hypervitaminosis A and alcoholism.	[Bi, Wenjuan; Gu, Zhiyuan] Zhejiang Univ, Sch Hosp Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Zhiyuan; Zheng, Yuanna] Zhejiang Chinese Med Univ, Sch Stomatol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiao] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Guo, Jing] Vrije Univ Amsterdam, Res Inst MOVE, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Guo, Jing; Wu, Gang] Univ Amsterdam, Amsterdam, Netherlands; [Wu, Gang] Vrije Univ Amsterdam, Res Inst MOVE, Acad Ctr Dent Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands	Zhejiang University; Zhejiang Chinese Medical University; Peking University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Zheng, YN (corresponding author), Zhejiang Chinese Med Univ, Sch Stomatol, Hangzhou, Zhejiang, Peoples R China.	gzy@zju.edu.cn	wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	Natural Science Foundation of Zhejiang Province [Y2111175, 17110008]; Research Foundation of Zhejiang Chinese Medical University	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Research Foundation of Zhejiang Chinese Medical University	This study is supported by the grants (No. Y2111175 and No. 17110008 to Dr. Y. Zheng) from Natural Science Foundation of Zhejiang Province and from Research Foundation of Zhejiang Chinese Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Camilli JA, 2004, ARCH ORAL BIOL, V49, P747, DOI 10.1016/j.archoralbio.2004.02.009; Chen M, 2010, BIRTH DEFECTS RES A, V88, P965, DOI 10.1002/bdra.20723; Cohen-Tanugi A, 1998, DIFFERENTIATION, V63, P115, DOI 10.1046/j.1432-0436.1998.6330115.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Karakida T, 2011, CONNECT TISSUE RES, V52, P365, DOI 10.3109/03008207.2010.541309; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Kuske B, 2011, METHODS MOL BIOL, V690, P195, DOI 10.1007/978-1-60761-962-8_14; Lima CC, 2011, BRAZ J BIOL, V71, P115, DOI 10.1590/S1519-69842011000100017; Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Nagasawa H, 2005, J NUTR SCI VITAMINOL, V51, P311, DOI 10.3177/jnsv.51.311; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Pratap J, 2003, CANCER RES, V63, P5357; Sampson HW, 1998, ALCOHOL HEALTH RES W, V22, P190; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Soares EV, 2010, J BONE MINER METAB, V28, P101, DOI 10.1007/s00774-009-0115-1; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Trevisiol CH, 2007, BONE, V41, P175, DOI 10.1016/j.bone.2007.04.189; Turner RT, 2000, ALCOHOL CLIN EXP RES, V24, P1693, DOI 10.1111/j.1530-0277.2000.tb01971.x; Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang JX, 2012, J CLIN PERIODONTOL, V39, P98, DOI 10.1111/j.1600-051X.2011.01807.x; Zheng YN, 2010, TISSUE ENG PT A, V16, P879, DOI [10.1089/ten.tea.2009.0312, 10.1089/ten.TEA.2009.0312]	39	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78198	10.1371/journal.pone.0078198	http://dx.doi.org/10.1371/journal.pone.0078198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205156	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500101
J	Guo, JS; Yuan, YM; Liu, ZX; Zhu, J				Guo, Jiansheng; Yuan, Yongming; Liu, Zhixue; Zhu, Jian			Development and Structure of Internal Glands and External Glandular Trichomes in Pogostemon cablin	PLOS ONE			English	Article							ESSENTIAL OIL; LEONOTIS-LEONURUS; MULTIVESICULAR BODIES; ULTRASTRUCTURE; SECRETION; LEAVES; HISTOCHEMISTRY; IDENTIFICATION; BIOSYNTHESIS; CAPITATE	Pogostemon cablin possesses two morphologically and ontogenetically different types of glandular trichomes, one type of bristle hair on the surfaces of leaves and stems and one type of internal gland inside the leaves and stems. The internal gland originates from elementary meristem and is associated with the biosynthesis of oils present inside the leaves and stems. However, there is little information on mechanism for the oil biosynthesis and secretion inside the leaves and stems. In this study, we identified three kinds of glandular trichome types and two kinds of internal gland in the Pogostemon cablin. The oil secretions from internal glands of stems and leaves contained lipids, flavones and terpenes. Our results indicated that endoplasmic reticulum and plastids and vacuoles are likely involved in the biosynthesis of oils in the internal glands and the synthesized oils are transported from endoplasmic reticulum to the cell wall via connecting endoplasmic reticulum membranes to the plasma membrane. And the comparative analysis of the development, distribution, histochemistry and ultrastructures of the internal and external glands in Pogostemon cablin leads us to propose that the internal gland may be a novel secretory structure which is different from external glands.	[Guo, Jiansheng; Liu, Zhixue; Zhu, Jian] Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, Shanghai 200092, Peoples R China; [Yuan, Yongming] Firmenich Co, Shanghai, Peoples R China	Tongji University; Firmenich	Zhu, J (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, Shanghai 200092, Peoples R China.	zhujian1@tongji.edu.cn						AMELUNXEN F, 1965, PLANTA MED, V13, P457, DOI 10.1055/s-0028-1100141; Ascensao L, 1998, ANN BOT-LONDON, V81, P263, DOI 10.1006/anbo.1997.0550; ASCENSAO L, 1995, ANN BOT-LONDON, V75, P619, DOI 10.1006/anbo.1995.1067; Ascensao L, 1997, INT J PLANT SCI, V158, P249, DOI 10.1086/297436; BOSABALIDIS A, 1982, PLANTA, V156, P496, DOI 10.1007/BF00392771; BOURETT TM, 1994, INT J PLANT SCI, V155, P623, DOI 10.1086/297202; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Cutter EG, 1980, PLANT ANATOMY EXPT 2; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; FRANCESCHI VR, 1983, BOT GAZ, V144, P175, DOI 10.1086/337358; Gersbach PV, 2002, ANN BOT-LONDON, V89, P255, DOI 10.1093/aob/mcf033; Goodger JQD, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-20; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; HEINRICH G, 1985, ISRAEL J BOT, V34, P205; HENDERSON W, 1970, PHYTOCHEMISTRY, V9, P1219, DOI 10.1016/S0031-9422(00)85312-1; Huang SS, 2008, J TORREY BOT SOC, V135, P155, DOI 10.3159/07-RA-045.1; Kelsey RG, 1984, BIOL CHEM PLANT TRIC, P187; Lawrence B.M., 1992, ADV LABIATE SCI, P399; Machado Silvia Rodrigues, 1995, Revista Brasileira de Botanica, V18, P197; Machado SR, 2006, ANN BOT-LONDON, V97, P357, DOI 10.1093/aob/mcj042; Maeda E, 1997, JPN J CROP SCI, V66, P307, DOI 10.1626/jcs.66.307; MEYBERG M, 1988, ANN BOT-LONDON, V62, P537, DOI 10.1093/oxfordjournals.aob.a087690; Moura MZD, 2005, BOT J LINN SOC, V148, P427, DOI 10.1111/j.1095-8339.2005.00426.x; NABETA K, 1993, DEV FOOD SCI, V32, P577; Plachno BJ, 2007, ANN BOT-LONDON, V100, P195, DOI 10.1093/aob/mcm109; Richardson PM, 1992, ADV LABIATAE SCI, P291; ROBARDS AW, 1988, PROTOPLASMA, V142, P79, DOI 10.1007/BF01290866; ROBINS RJ, 1980, NEW PHYTOL, V86, P279, DOI 10.1111/j.1469-8137.1980.tb00789.x; Rodriguez E., 1984, BIOL CHEM PLANT TRIC, V1st ed.; Sacchetti G, 1999, ANN BOT-LONDON, V83, P87, DOI 10.1006/anbo.1998.0778; SCHNEPF E, 1972, Biochemie und Physiologie der Pflanzen (BPP), V163, P113; Smaoui A, 2011, PROTOPLASMA, V248, P363, DOI 10.1007/s00709-010-0179-8; Spring O, 2000, ADV BOT RES, V31, P153, DOI 10.1016/S0065-2296(00)31009-6; Stpiczynska M, 2008, ANN BOT-LONDON, V101, P375, DOI 10.1093/aob/mcm297; SUGIMURA Y, 1991, JPN J CROP SCI, V60, P324, DOI 10.1626/jcs.60.324; TANCHAK MA, 1987, PROTOPLASMA, V138, P173, DOI 10.1007/BF01281026; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Turner GW, 2000, PLANT PHYSIOL, V124, P665, DOI 10.1104/pp.124.2.665; Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229; VASSILYEV AE, 1988, ANN BOT-LONDON, V62, P329, DOI 10.1093/oxfordjournals.aob.a087665; VENKATACHALAM KV, 1984, PLANT PHYSIOL, V76, P148, DOI 10.1104/pp.76.1.148; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; WERKER E, 1985, ISRAEL J BOT, V34, P31; WERKER E, 1993, ANN BOT-LONDON, V71, P43, DOI 10.1006/anbo.1993.1005; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Winkel-Shirley B, 1999, PHYSIOL PLANTARUM, V107, P142, DOI 10.1034/j.1399-3054.1999.100119.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; [郑宝江 Zheng Baojiang], 2002, [植物研究, Bulletin of Botanical Research], V22, P176	50	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77862	10.1371/journal.pone.0077862	http://dx.doi.org/10.1371/journal.pone.0077862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205002	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500070
J	Peng, C; Wang, MH; Shen, Y; Feng, HQ; Li, A				Peng, Chen; Wang, Minghui; Shen, Yi; Feng, Huanqing; Li, Ao			Reconstruction and Analysis of Transcription Factor-miRNA Co-Regulatory Feed-Forward Loops in Human Cancers Using Filter-Wrapper Feature Selection	PLOS ONE			English	Article							EXPRESSION PROFILES; MICRORNA; NETWORK; GENE; DATABASE	Background: As one of the most common types of co-regulatory motifs, feed-forward loops (FFLs) control many cell functions and play an important role in human cancers. Therefore, it is crucial to reconstruct and analyze cancer-related FFLs that are controlled by transcription factor (TF) and microRNA (miRNA) simultaneously, in order to find out how miRNAs and TFs cooperate with each other in cancer cells and how they contribute to carcinogenesis. Current FFL studies rely on predicted regulation information and therefore suffer the false positive issue in prediction results. More critically, FFLs generated by existing approaches cannot represent the dynamic and conditional regulation relationship under different experimental conditions. Methodology/Principal Findings: In this study, we proposed a novel filter-wrapper feature selection method to accurately identify co-regulatory mechanism by incorporating prior information from predicted regulatory interactions with parallel miRNA/mRNA expression datasets. By applying this method, we reconstructed 208 and 110 TF-miRNA co-regulatory FFLs from human pan-cancer and prostate datasets, respectively. Further analysis of these cancer-related FFLs showed that the top-ranking TF STAT3 and miRNA hsa-let-7e are key regulators implicated in human cancers, which have regulated targets significantly enriched in cellular process regulations and signaling pathways that are involved in carcinogenesis. Conclusions/Significance: In this study, we introduced an efficient computational approach to reconstruct co-regulatory FFLs by accurately identifying gene co-regulatory interactions. The strength of the proposed feature selection method lies in the fact it can precisely filter out false positives in predicted regulatory interactions by quantitatively modeling the complex co-regulation of target genes mediated by TFs and miRNAs simultaneously. Moreover, the proposed feature selection method can be generally applied to other gene regulation studies using parallel expression data with respect to different biological contexts.	[Peng, Chen; Wang, Minghui; Shen, Yi; Feng, Huanqing; Li, Ao] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Wang, Minghui; Li, Ao] Univ Sci & Technol China, Res Ctr Biomed Engn, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, A (corresponding author), Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Anhui, Peoples R China.	aoli@ustc.edu.cn	Li, aoyu/GXV-4925-2022; Li, Ao/GRR-5311-2022		National Natural Science Foundation of China [61101061, 31100955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (61101061 to MW, 31100955 to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2013, ADV EXP MED BIOL, V774, P149, DOI 10.1007/978-94-007-5590-1_9; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Budd WT, 2012, CHEM BIODIVERS, V9, P857, DOI 10.1002/cbdv.201100386; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORONNELLO C, 2013, NUCL ACIDS RES; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Esposito F, 2011, J PATHOL, V224, P110, DOI 10.1002/path.2846; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gu L, 2010, AM J PATHOL, V176, P1959, DOI 10.2353/ajpath.2010.090653; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoyos JM, 2009, ONCOGENE, V28, P876, DOI 10.1038/onc.2008.438; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang HF, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-2; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; JING N, 2011, DEV COMBINATION THER; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; MEYER PE, 2010, INFORM THEORETIC INF; Mitra D, 2011, J BIOL CHEM, V286, P40531, DOI 10.1074/jbc.M111.304865; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Powers D., 2011, ARXIV201016061, V2, P2229, DOI 10.9735/2229-3981; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Swami M, 2010, NAT REV CANCER, V10, DOI 10.1038/nrc2970; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883	47	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78197	10.1371/journal.pone.0078197	http://dx.doi.org/10.1371/journal.pone.0078197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205155	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700084
J	Ruwanpura, SM; McLeod, L; Lilja, AR; Brooks, G; Dousha, LF; Seow, HJ; Bozinovski, S; Vlahos, R; Hertzog, PJ; Anderson, GP; Jenkins, BJ				Ruwanpura, Saleela M.; McLeod, Louise; Lilja, Andrew R.; Brooks, Gavin; Dousha, Lovisa F.; Seow, Huei J.; Bozinovski, Steven; Vlahos, Ross; Hertzog, Paul J.; Anderson, Gary P.; Jenkins, Brendan J.			Non-Essential Role for TLR2 and Its Signaling Adaptor Mal/TIRAP in Preserving Normal Lung Architecture in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; INDUCED EMPHYSEMA; CUTTING EDGE; EXPRESSION; ASSOCIATION; MYD88; COPD; RECOGNITION; TOLL-LIKE-RECEPTOR-2	Myeloid differentiation factor 88 (MyD88) and MyD88-adaptor like (Mal)/Toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) play a critical role in transducing signals downstream of the Toll-like receptor (TLR) family. While genetic ablation of the TLR4/MyD88 signaling axis in mice leads to pulmonary cell death and oxidative stress culminating in emphysema, the involvement of Mal, as well as TLR2 which like TLR4 also signals via MyD88 and Mal, in the pathogenesis of emphysema has not been studied. By employing an in vivo genetic approach, we reveal here that unlike the spontaneous pulmonary emphysema which developed in Tlr4(-/-) mice by 6 months of age, the lungs of Tlr2(-/-) mice showed no physiological or morphological signs of emphysema. A more detailed comparative analysis of the lungs from these mice confirmed that elevated oxidative protein carbonylation levels and increased numbers of alveolar cell apoptosis were only detected in Tlr4(-/-) mice, along with up-regulation of NADPH oxidase 3 (Nox3) mRNA expression. With respect to Mal, the architecture of the lungs of Mal(-/-) mice was normal. However, despite normal oxidative protein carbonylation levels in the lungs of emphysema-free Mal(-/-) mice, these mice displayed increased levels of apoptosis comparable to those observed in emphysematous Tlr4(-/-) mice. In conclusion, our data provide in vivo evidence for the non-essential role for TLR2, unlike the related TLR4, in maintaining the normal architecture of the lung. In addition, we reveal that Mal differentially facilitates the anti-apoptotic, but not oxidant suppressive, activities of TLR4 in the lung, both of which appear to be essential for TLR4 to prevent the onset of emphysema.	[Ruwanpura, Saleela M.; McLeod, Louise; Brooks, Gavin; Hertzog, Paul J.; Jenkins, Brendan J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Lilja, Andrew R.; Dousha, Lovisa F.; Seow, Huei J.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.] Univ Melbourne, Dept Med & Pharmacol, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Jenkins, BJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.	Brendan.Jenkins@monash.edu	Hertzog, Paul J/I-7053-2013; Vlahos, Ross/AAM-3837-2020	Hertzog, Paul J/0000-0002-1373-8472; Vlahos, Ross/0000-0001-8443-7071; Ruwanpura, saleela/0000-0002-4074-2012; Seow, Huei/0000-0002-4790-4811; Jenkins, Brendan/0000-0002-7552-4656; Anderson, Gary/0000-0001-6580-3398; McLeod, Louise/0000-0002-7595-6432; Bozinovski, Steven/0000-0001-6533-8641	National Health and Medical Research Council (NHMRC, Australia); NHMRC Australian Biomedical Post-doctoral Fellowship; Senior Medical Research Fellowship; Sylvia and Charles Viertel Foundation; Victorian Government of Australia	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australian Biomedical Post-doctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Senior Medical Research Fellowship; Sylvia and Charles Viertel Foundation; Victorian Government of Australia	This study was supported by a research grant from the National Health and Medical Research Council (NHMRC, Australia), as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. S.M. Ruwanpura is supported by NHMRC Australian Biomedical Post-doctoral Fellowship. B.J. Jenkins is supported by a Senior Medical Research Fellowship awarded by the Sylvia and Charles Viertel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Budulac SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043124; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Comer D, 2012, EUR RESP J; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hantos Z, 2008, J APPL PHYSIOL, V105, P1864, DOI 10.1152/japplphysiol.90924.2008; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy C.L., 2013, ONCOGENE; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kim WJ, 2011, EUR RESPIR J, V37, P39, DOI 10.1183/09031936.00173009; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lee SW, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-106; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maes T, 2006, INT ARCH ALLERGY IMM, V141, P354, DOI 10.1159/000095462; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; O'Neill LAJ, 2005, NAT MED, V11, P1161, DOI 10.1038/nm1105-1161; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Pan Ming-Ming, 2008, Zhonghua Yi Xue Za Zhi, V88, P2103; Papadopoulos AI, 2012, CYTOKINE, V60, P104, DOI 10.1016/j.cyto.2012.05.008; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ruwanpura SM, 2012, AM J PHYSIOL-LUNG C, V302, P1627, DOI 10.1152/ajplung.00285.2011; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wu Q, 2011, AM J PHYSIOL-LUNG C, V300, pL579, DOI 10.1152/ajplung.00336.2010; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78095	10.1371/journal.pone.0078095	http://dx.doi.org/10.1371/journal.pone.0078095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205107	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700073
J	Reddy, AP; Simmons, CW; D'haeseleer, P; Khudyakov, J; Burd, H; Hadi, M; Simmons, BA; Singer, SW; Thelen, MP; VanderGheynst, JS				Reddy, Amitha P.; Simmons, Christopher W.; D'haeseleer, Patrik; Khudyakov, Jane; Burd, Helcio; Hadi, Masood; Simmons, Blake A.; Singer, Steven W.; Thelen, Michael P.; VanderGheynst, Jean S.			Discovery of Microorganisms and Enzymes Involved in High-Solids Decomposition of Rice Straw Using Metagenomic Analyses	PLOS ONE			English	Article							SP-NOV.; BINDING MODULE; GEN. NOV.; CELLULOSE; SOIL; IDENTIFICATION; DIVERSITY; COMMUNITY; ALIGNMENT; RESOURCE	High-solids incubations were performed to enrich for microbial communities and enzymes that decompose rice straw under mesophilic (35 degrees C) and thermophilic (55 degrees C) conditions. Thermophilic enrichments yielded a community that was 7.5 times more metabolically active on rice straw than mesophilic enrichments. Extracted xylanase and endoglucanse activities were also 2.6 and 13.4 times greater, respectively, for thermophilic enrichments. Metagenome sequencing was performed on enriched communities to determine community composition and mine for genes encoding lignocellulolytic enzymes. Proteobacteria were found to dominate the mesophilic community while Actinobacteria were most abundant in the thermophilic community. Analysis of protein family representation in each metagenome indicated that cellobiohydrolases containing carbohydrate binding module 2 (CBM2) were significantly overrepresented in the thermophilic community. Micromonospora, a member of Actinobacteria, primarily housed these genes in the thermophilic community. In light of these findings, Micromonospora and other closely related Actinobacteria genera appear to be promising sources of thermophilic lignocellulolytic enzymes for rice straw deconstruction under high-solids conditions. Furthermore, these discoveries warrant future research to determine if exoglucanases with CBM2 represent thermostable enzymes tolerant to the process conditions expected to be encountered during industrial biofuel production.	[Reddy, Amitha P.; Simmons, Christopher W.; D'haeseleer, Patrik; Khudyakov, Jane; Burd, Helcio; Hadi, Masood; Simmons, Blake A.; Singer, Steven W.; Thelen, Michael P.; VanderGheynst, Jean S.] Joint BioEnergy Inst, Emeryville, CA USA; [Reddy, Amitha P.; Simmons, Christopher W.; VanderGheynst, Jean S.] Univ Calif Davis, Davis, CA 95616 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [D'haeseleer, Patrik; Khudyakov, Jane; Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Hadi, Masood; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA USA; [Burd, Helcio] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	VanderGheynst, JS (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	jsvander@ucdavis.edu	Singer, STeven W/I-1851-2014; Thelen, Michael P/G-2032-2014; Khudyakov, Jane/C-1213-2014; Simmons, Blake/N-6022-2016; Thelen, Michael/C-6834-2008	Thelen, Michael P/0000-0002-2479-5480; Simmons, Blake/0000-0002-1332-1810; Thelen, Michael/0000-0002-2479-5480; Khudyakov, Jane/0000-0001-7038-102X	University of California Laboratory Fees Research Program [12-LR-237496]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; U.S. Department of Energy	University of California Laboratory Fees Research Program; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the University of California Laboratory Fees Research Program #12-LR-237496 and performed as part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla HM, 2007, WASTE MANAGE, V27, P850, DOI 10.1016/j.wasman.2006.06.006; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Aslam DN, 2008, BIORESOURCE TECHNOL, V99, P8735, DOI 10.1016/j.biortech.2008.04.074; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Cheng YS, 2010, APPL BIOCHEM BIOTECH, V162, P1768, DOI 10.1007/s12010-010-8958-4; CHOWDHURY NA, 1991, WORLD J MICROB BIOT, V7, P603, DOI 10.1007/BF00452840; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de Menezes AB, 2008, APPL ENVIRON MICROB, V74, P7080, DOI 10.1128/AEM.01092-08; DeAngelis KM, 2010, STRATEGIES ENHANCING; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Engelbrekston A, 2010, ISME J, V4; ERIKSON D, 1952, J GEN MICROBIOL, V6, P286, DOI 10.1099/00221287-6-3-4-286; Federal Agencies Environmental Protection Agency (EPA) National Highway Traffic Safety Administration (NHTSA) and Department of Transportation (DOT), 2017, FED REGISTER, V77; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERGUS CL, 1969, MYCOLOGIA, V61, P120, DOI 10.2307/3757350; Gallagher J, 1996, BIOTECHNOL LETT, V18, P537, DOI 10.1007/BF00140199; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gladden John M, 2011, Appl Environ Microbiol, V77, P5804, DOI 10.1128/AEM.00032-11; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haruta S, 2002, APPL MICROBIOL BIOT, V59, P529, DOI 10.1007/s00253-002-1026-4; Honein K, 2012, ENRGY PROCED, V18, P1271, DOI 10.1016/j.egypro.2012.05.143; Kadam KL, 2000, BIOMASS BIOENERG, V18, P369, DOI 10.1016/S0961-9534(00)00005-2; Kato S, 2005, APPL ENVIRON MICROB, V71, P7099, DOI 10.1128/AEM.71.11.7099-7106.2005; Kausar H, 2011, BIODEGRADATION, V22, P367, DOI 10.1007/s10532-010-9407-3; Kim BY, 2007, INT J SYST EVOL MICR, V57, P538, DOI 10.1099/ijs.0.64614-0; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Matteson GC, 2007, BIORESOURCE TECHNOL, V98, P3098, DOI 10.1016/j.biortech.2006.10.031; Mendu V, 2012, P NATL ACAD SCI USA, V109, P4014, DOI 10.1073/pnas.1112757109; Okeke BC, 2011, APPL BIOCHEM BIOTECH, V163, P869, DOI 10.1007/s12010-010-9091-0; Parker N, 2010, BIOMASS BIOENERG, V34, P1597, DOI 10.1016/j.biombioe.2010.06.007; Pati A, 2011, CLAMS CLASSIFIER MET; Ramin M, 2009, J RAPID METH AUT MIC, V17, P103, DOI 10.1111/j.1745-4581.2009.00160.x; Reddy AP, 2009, T ASABE, V52, P673, DOI 10.13031/2013.26806; Reddy AP, 2011, BIOTECHNOL BIOENG, V108, P2088, DOI 10.1002/bit.23176; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Summers MD, 2001, 5 INT BIOM C AM ORL; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Wang H, 2009, INT J SYST EVOL MICR, V59, P2854, DOI 10.1099/ijs.0.010447-0; Wang Y, 2011, INT J SYST EVOL MICR, V61, P1554, DOI 10.1099/ijs.0.025221-0; Weon HY, 2006, INT J SYST EVOL MICR, V56, P1777, DOI 10.1099/ijs.0.64242-0; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1282, DOI 10.1099/ijs.0.004333-0	60	18	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77985	10.1371/journal.pone.0077985	http://dx.doi.org/10.1371/journal.pone.0077985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205054	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400065
J	Doyle, TJ; Goodin, K; Hamilton, JJ				Doyle, Timothy J.; Goodin, Kate; Hamilton, Janet J.			Maternal and Neonatal Outcomes among Pregnant Women with 2009 Pandemic Influenza A(H1N1) Illness in Florida, 2009-2010: A Population-Based Cohort Study	PLOS ONE			English	Article							H1N1 VIRUS-INFECTION; RISK-FACTOR; A H1N1; INFANT-DEATH; OBESITY; HOSPITALIZATION	Introduction: Pregnant women have been identified as a high risk group for severe illness with 2009 pandemic influenza A(H1N1) virus infection (pH1N1). Obesity has also been identified as a risk factor for severe illness, though this has not been thoroughly assessed among pregnant women. The objectives of this study were to provide risk estimates for adverse maternal and neonatal outcomes associated with pH1N1 illness during pregnancy and to assess the role of obesity in these outcomes. Methods: We established a retrospective population-based cohort of all live births occurring in Florida during the first 15 months of the pandemic. Illness with pH1N1 during pregnancy was ascertained through record linkage with the Florida state notifiable disease surveillance database. Data from the birth record, including pre-pregnancy body mass index, were analyzed to assess risk of adverse outcomes associated with pH1N1 illness. Results: A total of 194 women were identified through surveillance with pH1N1 illness during pregnancy. Children born to women with pH1N1 illness during pregnancy were at increased risk for low birth weight [OR (95% CI): 1.78 (1.11-2.860)], premature birth [2.21 (1.47-3.330)], and infant death [4.46 (1.80-11.00)], after adjusting for other factors. Women with pH1N1 illness during pregnancy were at increased risk for severe outcomes including admission to an intensive care unit. Obesity was an observed risk factor, both for the more severe pH1N1 illness detected through surveillance, and for severe maternal outcomes. Conclusions: Case-patients in this analysis likely represent the most severely ill subset of all women infected with pH1N1 during pregnancy, limiting the generalizability of these findings to more severely ill patients rather than influenza infection in general. Nevertheless, these results suggest that more severe pH1N1 illness during pregnancy is associated with adverse neonatal outcomes and that pregnant women should continue to be targeted for appropriate prophylaxis and early treatment.	[Doyle, Timothy J.; Goodin, Kate; Hamilton, Janet J.] Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA; [Doyle, Timothy J.] Ctr Dis Control & Prevent, Atlanta, GA USA	Florida Department of Health; Centers for Disease Control & Prevention - USA	Doyle, TJ (corresponding author), Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA.	tdoyle@cdc.gov	Doyle, Timothy/AAM-3263-2021	Doyle, Timothy/0000-0002-4501-9157				Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS21, DOI 10.1016/j.fertnstert.2008.08.005; [Anonymous], FLOR ADM COD CHAP 64; Burch D, 2012, SEMIN PERINATOL, V36, P31, DOI 10.1053/j.semperi.2011.09.007; Coleman LA, 2013, INFLUENZA OTHER RESP, V7, P160, DOI 10.1111/j.1750-2659.2012.00377.x; Community Health Assessment, TOOL SET RES CHARTS; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dede FS, 2011, BJOG-INT J OBSTET GY, V118, P1216, DOI 10.1111/j.1471-0528.2011.03002.x; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Fine A., 2010, Morbidity and Mortality Weekly Report, V59, P321; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; Hernandez L, 2009, FLORIDAS PREGNANCY A; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Heyl PS, 2013, MATERN CHILD HLTH J, V17, P1230, DOI 10.1007/s10995-012-1117-5; Huo XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017995; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Knight M, 2011, BJOG-INT J OBSTET GY, V118, P232, DOI 10.1111/j.1471-0528.2010.02736.x; Kroger Andrew T., 2006, Morbidity and Mortality Weekly Report, V55, P1; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lowcock Elizabeth C, 2012, Am J Public Health, V102, pe51, DOI 10.2105/AJPH.2012.300814; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Memoli MJ, 2012, INFLUENZA OTHER RESP, DOI [10.1111/irv.12055, DOI 10.1111/IRV.12055.PUBMED:23170853]; Mendez-Figueroa H, 2011, AM J OBSTET GYNECOL, V204, pS58, DOI 10.1016/j.ajog.2011.02.058; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; Park S, 2011, MATERN CHILD HLTH J, V15, P851, DOI 10.1007/s10995-009-0544-4; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Schrauwers C, 2009, J MATERN-FETAL NEO M, V22, P218, DOI 10.1080/14767050902801652; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Thompson DR, 2008, PUBLIC HEALTH REP, V123, P487, DOI 10.1177/003335490812300410; U.S. Census Bureau, 2010, 2010 CENS DAT; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842	47	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79040	10.1371/journal.pone.0079040	http://dx.doi.org/10.1371/journal.pone.0079040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205364	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300089
J	Hardtke-Wolenski, M; Kraus, L; Schmetz, C; Trautewig, B; Noyan, F; Vondran, FWR; Bektas, H; Klempnauer, J; Jaeckel, E; Lieke, T				Hardtke-Wolenski, Matthias; Kraus, Lilli; Schmetz, Christel; Trautewig, Britta; Noyan, Fatih; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeckel, Elmar; Lieke, Thorsten			Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; V-BETA USAGE; ESTABLISHED MELANOMA; IMMUNE-RESPONSE; LYMPHOCYTES; EXPRESSION; TOLERANCE; INFECTION; BINDING; HUMANS	Background: T cells are known to participate in the response to tumor cells and react with cytotoxicity and cytokine release. At the same time tumors established versatile mechanisms for silencing the immune responses. The interplay is far from being completely understood. In this study we show contacts between tumor cells and lymphocytes revealing novel characteristics in the interaction of T cells and cancer cells in a way not previously described. Methods/Findings: Experiments are based on the usage of a hydrophilic fluorescent dye that occurs free in the cytosol and thus transfer of fluorescent cytosol from one cell to the other can be observed using flow cytometry. Tumor cells from cell lines of different origin or primary hepatocellular carcinoma (HCC) cells were incubated with lymphocytes from human and mice. This exposure provoked a contact dependent uptake of tumor derived cytosol by lymphocytes - even in CD4(+) T cells and murine B cells - which could not be detected after incubation of lymphocytes with healthy cells. The interaction was a direct one, not requiring the presence of accessory cells, but independent of cytotoxicity and TCR engagement. Electron microscopy disclosed 100-200 nm large gaps in the cell membranes of connected cells which separated viable and revealed astonishing outcome. While the lymphocytes were induced to proliferate in a long term fashion, the tumor cells underwent a temporary break in cell division. The in vitro results were confirmed in vivo using a murine acute lymphoblastic leukemia (ALL) model. The arrest of tumor proliferation resulted in a significant prolonged survival of challenged mice. Conclusions: The reported cell-cell contacts reveal new characteristics i.e. the enabling of cytosol flow between the cells including biological active proteins that influence the cell cycle and biological behaviour of the recipient cells. This adds a completely new aspect in tumor induced immunology.	[Hardtke-Wolenski, Matthias; Noyan, Fatih; Jaeckel, Elmar] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Kraus, Lilli; Trautewig, Britta; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Schmetz, Christel] Bernhard Nocht Inst Trop Med, Parasitol Sect, D-20359 Hamburg, Germany; [Vondran, Florian W. R.; Bektas, Hueseyin; Lieke, Thorsten] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany	Hannover Medical School; Hannover Medical School; Bernhard Nocht Institut fur Tropenmedizin; Hannover Medical School	Lieke, T (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany.	lieke.thorsten@mh-hannover.de	Noyan, Fatih/B-9449-2018; Hardtke-Wolenski, Matthias/I-2993-2019	Hardtke-Wolenski, Matthias/0000-0002-2827-7787	Novartis Pharma GmbH; HILF grant of the Hannover Medical School	Novartis Pharma GmbH; HILF grant of the Hannover Medical School	This work was funded by Novartis Pharma GmbH and the HILF grant of the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Blohm U, 2002, J IMMUNOL, V169, P5522, DOI 10.4049/jimmunol.169.10.5522; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Finn OJ, 2008, J IMMUNOL, V181, P1589, DOI 10.4049/jimmunol.181.3.1589; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; KAEFFER B, 1990, INT J CANCER, V46, P481, DOI 10.1002/ijc.2910460326; KURT RA, 1995, J IMMUNOL, V154, P3969; Kurt RA, 2000, INT IMMUNOL, V12, P639, DOI 10.1093/intimm/12.5.639; Lee BS, 1997, HEPATOLOGY, V25, P913, DOI 10.1002/hep.510250421; Lee KH, 1998, J IMMUNOL, V161, P4183; Lieke T, 2004, INT J MED MICROBIOL, V293, P72; Lieke T, 2011, PARASITOLOGY, P1; MARANO N, 1989, J IMMUNOL, V143, P931; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MELIEF CJM, 1989, COLD SH Q B, V54, P597; Musgrave BL, 2003, J INTERF CYTOK RES, V23, P67, DOI 10.1089/107999003321455462; Noyan F, 2012, CANCER GENE THER, V19, P352, DOI 10.1038/cgt.2012.8; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stevanovic S, 2012, LEUKEMIA, V26, P312, DOI 10.1038/leu.2011.222; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stripecke R, 1998, HUM GENE THER, V9, P2049, DOI 10.1089/hum.1998.9.14-2049; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WEINHOLD KJ, 1979, J EXP MED, V149, P732, DOI 10.1084/jem.149.3.732; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zhang Y, 2012, IMMUNOLOGY	39	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78558	10.1371/journal.pone.0078558	http://dx.doi.org/10.1371/journal.pone.0078558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205259	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300067
J	Lee, KC; Chan, CC; Yang, YY; Hsieh, YC; Huang, YH; Lin, HC				Lee, Kuei-Chuan; Chan, Che-Chang; Yang, Ying-Ying; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh			Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet	PLOS ONE			English	Article							NF-KAPPA-B; INCREASED ENERGY-EXPENDITURE; IMPROVES INSULIN-RESISTANCE; EFFECTIVE RENIN INHIBITOR; ACTIVATED PROTEIN-KINASE; MUSCLE GLUCOSE-TRANSPORT; STELLATE CELL ACTIVATION; ANGIOTENSIN-II; OXIDATIVE STRESS; LIVER-DISEASE	Background & Aims: Activation of the renin-angiotensin-system is known to play a role in nonalcoholic steatohepatitis. Renin knockout mice manifest decreased hepatic steatosis. Aliskiren is the first direct renin inhibitor to be approved for clinical use. Our study aims to evaluate the possible therapeutic effects and mechanism of the chronic administration of aliskiren in a dietary steatohepatitis murine model. Methods: Male C57BL/6 mice were fed with a methionine and choline-deficient (MCD) diet to induce steatohepatitis. After 8 weeks of feeding, the injured mice were randomly assigned to receive aliskiren (50 mg.kg(-1) per day) or vehicle administration for 4 weeks. Normal controls were also administered aliskiren (50 mg.kg(-1) per day) or a vehicle for 4 weeks. Results: In the MCD mice, aliskiren attenuated hepatic steatosis, inflammation and fibrosis. Aliskiren did not change expression of lipogenic genes but increase turnover of hepatic fat by up-regulating peroxisome proliferator-activated receptor alpha, carnitine palmitoyltransferase 1a, cytochrome P450-4A14 and phosphorylated AMP-activated protein kinase. Furthermore, aliskiren decreased the hepatic expression of angiotensin II and nuclear factor kappa B. The levels of oxidative stress, hepatocyte apoptosis, activation of Kupffer cells and hepatic stellate cells, and pro-fibrotic markers were also reduced in the livers of the MCD mice receiving aliskiren. Conclusions: Aliskiren attenuates steatohepatitis and fibrosis in mice fed with a MCD diet. Thus, the noted therapeutic effects might come from not only the reduction of angiotensin II but also the up-regulation of fatty acid oxidation-related genes.	[Lee, Kuei-Chuan; Chan, Che-Chang; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Kuei-Chuan; Chan, Che-Chang; Yang, Ying-Ying; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan; [Lee, Kuei-Chuan; Chan, Che-Chang; Huang, Yi-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw; hclin@vghtpe.gov.tw		Huang, Yi-Hsiang/0000-0001-5241-5425; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council of Taiwan [NSC 101-2314-B-075-017]; Taipei Veterans General Hospital, Taipei, Taiwan [V102B-017, V102C-014]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This work was supported by grant NSC 101-2314-B-075-017 from the National Science Council of Taiwan and grant V102B-017 and V102C-014 from the Taipei Veterans General Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2013, HEPATOL RES IN PRESS; Arellano-Plancarte A, 2010, BIOCHEM PHARMACOL, V79, P733, DOI 10.1016/j.bcp.2009.10.014; Bataller R, 2003, AM J PHYSIOL-GASTR L, V285, pG642, DOI 10.1152/ajpgi.00037.2003; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fisher NDL, 2008, CIRCULATION, V117, P3199, DOI 10.1161/CIRCULATIONAHA.108.767202; Gandhi S, 2013, J RENIN-ANGIO-ALDO S, V14, P3, DOI 10.1177/1470320312452766; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gradman AH, 2008, J AM COLL CARDIOL, V51, P519, DOI 10.1016/j.jacc.2007.10.027; Habibi J, 2008, ENDOCRINOLOGY, V149, P5643, DOI 10.1210/en.2008-0070; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kang YS, 2011, NEPHROL DIAL TRANSPL, V26, P1194, DOI 10.1093/ndt/gfq579; Kishina M, 2013, HEPATOL RES IN PRESS; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lastra G, 2009, ENDOCRINOLOGY, V150, P2561, DOI 10.1210/en.2008-1391; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Lee KC, 2012, EUR J CLIN INVEST, V42, P1261, DOI 10.1111/j.1365-2362.2012.02725.x; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Marchionne EM, 2012, AM J PHYSIOL-REG I, V302, pR137, DOI 10.1152/ajpregu.00448.2011; Maziere C, 1999, BIOCHEM BIOPH RES CO, V265, P116, DOI 10.1006/bbrc.1999.1644; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Nabeshima Y, 2009, J HEPATOL, V50, P1226, DOI 10.1016/j.jhep.2009.01.018; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Ruef T, 2001, BASIC RES CARDIOL, V96, P143, DOI 10.1007/s003950170064; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; Wiczer BM, 2009, BIOCHEM BIOPH RES CO, V387, P234, DOI 10.1016/j.bbrc.2009.06.114; Wood JM, 2003, BIOCHEM BIOPH RES CO, V308, P698, DOI 10.1016/S0006-291X(03)01451-7; Wood JM, 2005, J HYPERTENS, V23, P417, DOI 10.1097/00004872-200502000-00025	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77817	10.1371/journal.pone.0077817	http://dx.doi.org/10.1371/journal.pone.0077817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204981	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600049
J	Hu, JY; Wang, GH; Liu, XT; Zhou, LN; Jiang, ML; Yang, L				Hu, Jinyue; Wang, Guihua; Liu, Xueting; Zhou, Lina; Jiang, Manli; Yang, Li			Polo-Like Kinase 1 (PLK1) Is Involved in Toll-like Receptor (TLR)-Mediated TNF-alpha Production in Monocytic THP-1 Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; APOPTOSIS; SECRETION; IMMUNITY; INNATE	Polo-like kinases (PLKs) have been reported to be essential components of anti-viral pathways. However, the role of PLKs in the production of pro-inflammatory cytokines induced by TLR activation is uncertain. We report here that monocytic THP-1 cells expressed PLK1, PLK2, PLK3 and PLK4. When THP-1 cells were treated with GW843682X, an inhibitor of PLK1 and PLK3, the results showed that GW843682X down-regulated Pam3CSK4- and LPS-induced TNF-alpha at both the gene and protein levels. GW843682X did not impact Pam3CSK4-induced IL-1 beta and IL-8 or LPS-induced IL-1 beta, but it down-regulated LPS-induced IL-8 significantly. Moreover, western blot results showed that TLRs activated PLK1, and PLK1 inhibition by RNA interference down-regulated Pam3CSK4-induced TNF-alpha production, suggesting the involvement of PLK1 in TNF-alpha up-regulation. In addition, GW843682X treatment for 12 to 24 h induced cell death and down-regulated MyD88, but neither of these roles contributed to the down-regulation of TNF-alpha, as TNF-alpha gene expression was up-regulated at 1 h. Furthermore, GW843682X inhibited Pam3CSK4-induced activation of ERK and NF-kappa B, which contributed to Pam3CSK4-induced up-regulation of TNF-alpha. GW843682X also inhibited LPS-induced activation of ERK, p38 and NF-kappa B, which contributed to LPS-induced up-regulation of TNF-alpha. Taken together, these results suggested that PLK1 is involved in TLR2- and TLR4-induced inflammation, and GW843682X may be valuable for the regulation of the inflammatory response.	[Hu, Jinyue; Liu, Xueting; Jiang, Manli] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Wang, Guihua] Changsha Cent Hosp, Ctr Canc, Changsha, Hunan, Peoples R China; [Zhou, Lina] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan 430072, Hubei, Peoples R China; [Yang, Li] Changsha Cent Hosp, TB Res Ctr, Changsha, Hunan, Peoples R China	Wuhan University	Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com; YL7618@126.com			National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81172042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Du Q, 2012, J SURG RES, V173, P354, DOI 10.1016/j.jss.2010.10.016; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koida N, 2008, J BIOL CHEM, V283, P8555, DOI 10.1074/jbc.M710608200; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Martin BT, 2006, CELL CYCLE, V5, P2881, DOI 10.4161/cc.5.24.3538; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Masuda Y, 2003, ONCOGENE, V22, P1012, DOI 10.1038/sj.onc.1206200; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xiao Z, 2011, J CELL BIOCHEM, V112, P2257, DOI 10.1002/jcb.23144; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	28	24	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78832	10.1371/journal.pone.0078832	http://dx.doi.org/10.1371/journal.pone.0078832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205328	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300163
J	Goda, S; Isagawa, T; Chikaoka, Y; Kawamura, T; Aburatani, H				Goda, Satoshi; Isagawa, Takayuki; Chikaoka, Yoko; Kawamura, Takeshi; Aburatani, Hiroyuki			Control of Histone H3 Lysine 9 (H3K9) Methylation State via Cooperative Two-step Demethylation by Jumonji Domain Containing 1A (JMJD1A) Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Enzyme Mechanisms; Histone Methylation; Mass Spectrometry (MS); Surface Plasmon Resonance (SPR); JMJD1A; Chromatin Biology; Dimerization; Histone Lysine Demethylase	HYPOXIA-INDUCIBLE FACTOR-1; STRUCTURAL INSIGHTS; GENE-EXPRESSION; BINDING; DIMERIZATION; JHDM2A; PHOSPHORYLATION; TRANSCRIPTION; REVEALS; OBESITY	Post-translational histone methylation is a dynamic and reversible process that is involved in the spatio-temporal regulation of gene transcription and contributes to various cellular phenotypes. Methylation of histone H3 at lysine 9 (H3K9), which is generally a transcriptional repression mark, is demethylated by H3K9-specific demethylases, leading to transcriptional activation. However, how multiple demethylases with the same substrate specificity differ in their chromatin targeting mechanisms has not been well understood. Unlike other H3K9-specific demethylases, it has been reported that JMJD1A likely forms a homodimer, but a detailed mode of dimerization and the possible link between structure and enzymatic activity have remained unresolved. Here, we report the structure-function relationship of JMJD1A in detail. First, JMJD1A forms a homodimer through its catalytic domains, bringing the two active sites close together. Second, increasing the concentration of JMJD1A facilitates efficient production of unmethylated product from dimethyl-H3K9 and decreases the release of the monomethylated intermediate. Finally, substituting one of the two active sites with an inactive mutant results in a significant reduction of the demethylation rate without changing the affinity to the intermediate. Given this evidence, we propose a substrate channeling model for the efficient conversion of dimethylated H3K9 into the unmethylated state. Our study provides valuable information that will help in understanding the redundancy of H3K9-specific demethylases and the complementary activity of their unique structures and enzymatic properties for appropriate control of chromatin modification patterns.	[Goda, Satoshi; Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Isagawa, Takayuki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1538904, Japan; [Chikaoka, Yoko; Kawamura, Takeshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Aburatani, H (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan.	haburata-tky@umin.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant for the New Energy and Industrial Technology Development Organization (NEDO) (to H. A. and T. N.), Japan.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2013, BRIEF FUNCT GENOMICS, V12, P205, DOI 10.1093/bfgp/elt002; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osawa T, 2013, CANCER RES, V73, P3019, DOI 10.1158/0008-5472.CAN-12-3231; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sar A, 2009, CELL TISSUE RES, V337, P223, DOI 10.1007/s00441-009-0805-y; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Shiau C, 2013, CHEM BIOL, V20, P494, DOI 10.1016/j.chembiol.2013.03.008; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Wei H, 2010, P NATL ACAD SCI USA, V107, P18433, DOI 10.1073/pnas.1009911107; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang YHP, 2011, BIOTECHNOL ADV, V29, P715, DOI 10.1016/j.biotechadv.2011.05.020	49	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36948	36956		10.1074/jbc.M113.492595	http://dx.doi.org/10.1074/jbc.M113.492595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214985	Green Published, hybrid			2022-12-25	WOS:000329189700017
J	Henderson-Smith, A; Chow, D; Meechoovet, B; Aziz, M; Jacobson, SA; Shill, HA; Sabbagh, MN; Caviness, JN; Adler, CH; Driver-Dunckley, ED; Beach, TG; Yin, HW; Dunckley, T				Henderson-Smith, Adrienne; Chow, Donald; Meechoovet, Bessie; Aziz, Meraj; Jacobson, Sandra A.; Shill, Holly A.; Sabbagh, Marwan N.; Caviness, John N.; Adler, Charles H.; Driver-Dunckley, Erika D.; Beach, Thomas G.; Yin, Hongwei; Dunckley, Travis			SMG1 Identified as a Regulator of Parkinson's Disease-Associated alpha-Synuclein through siRNA Screening	PLOS ONE			English	Article							SERINE 129; PHOSPHORYLATION; RNA; KINASE; MUTATION; DUPLICATION; COMPLEX; SYSTEM	Synucleinopathies are a broad class of neurodegenerative disorders characterized by the presence of intracellular protein aggregates containing alpha-synuclein protein. The aggregated alpha-synuclein protein is hyperphosphorylated on serine 129 (S129) compared to the unaggregated form of the protein. While the precise functional consequences of S129 hyperphosphorylation are still being clarified, numerous in vitro and in vivo studies suggest that S129 phosphorylation is an early event in alpha-synuclein dysfunction and aggregation. Identifying the kinases and phosphatases that regulate this critical phosphorylation event may ultimately prove beneficial by allowing pharmacological mitigation of synuclein dysfunction and toxicity in Parkinson's disease and other synucleinopathies. We report here the development of a high-content, fluorescence-based assay to quantitate levels of total and S129 phosphorylated alpha-synuclein protein. We have applied this assay to conduct high-throughput loss-of-function screens with siRNA libraries targeting 711 known and predicted human kinases and 206 phosphatases. Specifically, knockdown of the phosphatidylinositol 3-kinase related kinase SMG1 resulted in significant increases in the expression of pS129 phosphorylated alpha-synuclein (p-syn). Moreover, SMG1 protein levels were significantly reduced in brain regions with high p-syn levels in both dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). These findings suggest that SMG1 may play an important role in increased alpha-synuclein pathology during the course of PDD, DLB, and possibly other synucleinopathies.	[Henderson-Smith, Adrienne; Meechoovet, Bessie; Dunckley, Travis] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Chow, Donald; Aziz, Meraj; Yin, Hongwei] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Jacobson, Sandra A.; Shill, Holly A.; Sabbagh, Marwan N.; Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Caviness, John N.; Adler, Charles H.; Driver-Dunckley, Erika D.] Mayo Clin Scottsdale, Dept Neurol, Movement Disorders Div, Scottsdale, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Dunckley, T (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA.	tdunckley@tgen.org	Adler, Charles/ABD-5276-2021; Yin, Hong/AAC-5784-2020		National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chawla R, 2008, CYTOGENET GENOME RES, V122, P194, DOI 10.1159/000167804; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gewandter JS, 2011, CELL CYCLE, V10, P2561, DOI 10.4161/cc.10.15.16347; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Lue LF, 2012, BRAIN PATHOL; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takahashi M, 2007, EUR J NEUROSCI, V26, P863, DOI 10.1111/j.1460-9568.2007.05736.x; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	31	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77711	10.1371/journal.pone.0077711	http://dx.doi.org/10.1371/journal.pone.0077711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204929	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500046
J	Lee, WY; Savage, JR; Zhang, JX; Jia, WJ; Oottamasathien, S; Prestwich, GD				Lee, Won Yong; Savage, Justin R.; Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.			Prevention of Anti-microbial Peptide LL-37-Induced Apoptosis and ATP Release in the Urinary Bladder by a Modified Glycosaminoglycan	PLOS ONE			English	Article							PAIN SYNDROME/INTERSTITIAL CYSTITIS; AMYLOID P-COMPONENT; RECEPTOR-LIKE 1; INTERSTITIAL CYSTITIS; CATHELICIDIN PEPTIDE; ANTIPROLIFERATIVE FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; MOUSE MODEL; LL-37	Interstitial cystitis (IC), often referred to in combination with painful bladder syndrome, is a chronic inflammatory disease of the bladder. Current therapies primarily focus on replenishing urothelial glycosaminoglycan (GAG) layer using GAG analogs and managing pain with supportive therapies. However, the elusive etiology of IC and the lack of animal models to study the disease have been major hurdles developing more effective therapeutics. Previously, we showed an increased urinary concentration of antimicrobial peptide LL-37 in spina bifida patients and used LL-37 to develop a mouse model of cystitis that mimics important clinical findings of IC. Here we investigate (1) the molecular mechanism of LL-37 induced cystitis in cultured human urothelial cells and in mice, (2) the protective effects of GM-0111, a modified GAG, within the context of this mechanism, (3) the physiological and molecular markers that correlate with the severity of the inflammation, and (4) the protective effects of several GAGs using these biomarkers in our LL-37 induced cystitis model. We find that LL-37 quickly induces release of ATP and apoptosis in the urothelium. These changes can be inhibited by a chemically-modified GAG, GM-0111. Furthermore, we also find that GAG analogs provide varying degrees of protection against LL-37 challenge in mice. These findings suggest that GM-0111 and possibly GAG molecules prevent the development of cystitis by blocking the apoptosis and the concurrent release of ATP from the urothelium.	[Lee, Won Yong; Savage, Justin R.; Zhang, Jianxing; Prestwich, Glenn D.] GlycoMira Therapeut Inc, Salt Lake City, UT USA; [Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT USA; [Oottamasathien, Siam] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Oottamasathien, Siam] Univ Utah, Div Pediat Urol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lee, WY (corresponding author), GlycoMira Therapeut Inc, Salt Lake City, UT USA.	lee.wonyong@glycomira.com; glenn.prestwich@pharm.utah.edu	jia, wanjian/C-3266-2016	Lee, Won Yong/0000-0001-7915-1829	SBIR grant from National Institutes of Health (NIH) [R43DK093413]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK093413] Funding Source: NIH RePORTER	SBIR grant from National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an SBIR grant from the National Institutes of Health (NIH) (R43DK093413, GlycoMira Therapeutics, Inc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Berry SH, 2010, J UROLOGY, V183, P1848, DOI 10.1016/j.juro.2009.12.103; Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Birder LA, 2010, NEUROUROL URODYNAM, V29, P88, DOI 10.1002/nau.20747; Blalock EM, 2012, J UROLOGY, V187, P725, DOI 10.1016/j.juro.2011.09.142; Brandao-Burch A, 2012, FRONT ENDOCRINOL, V3; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Crawley MJ., 2007, R BOOK; Cray C, 2009, COMPARATIVE MED, V59, P517; Davis EL, 2008, J UROLOGY, V179, P177, DOI 10.1016/j.juro.2007.08.170; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Dunning-Davies BM, 2013, BJU INT, V111, P505, DOI 10.1111/j.1464-410X.2012.11421.x; Engles CD, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.010; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022; HAYES AW, 2008, PRINCIPLES METHODS T; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Johnson DE, 1998, INFECT IMMUN, V66, P3059, DOI 10.1128/IAI.66.7.3059-3065.1998; Keay SK, 2004, P NATL ACAD SCI USA, V101, P11803, DOI 10.1073/pnas.0404509101; Keay S, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-17; Kiuchi H, 2009, BJU INT, V104, P826, DOI 10.1111/j.1464-410X.2009.08467.x; Kutlu O, 2010, INT UROL NEPHROL, V42, P393, DOI 10.1007/s11255-009-9632-z; Lai L, 1998, J IMMUNOL, V160, P3861; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; Lee SJ, 2006, WORLD J UROL, V24, P33, DOI 10.1007/s00345-005-0046-y; Liu HT, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.047; Mader JS, 2011, EXP CELL RES, V317, P531, DOI 10.1016/j.yexcr.2010.11.015; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Madersbacher H, 2013, NEUROUROL URODYNAM, V32, P9, DOI 10.1002/nau.22256; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Matsuo Tomohiro, 2011, Hinyokika Kiyo, V57, P513; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Neregard P, 2012, ANN RHEUM DIS, V71, pA12, DOI 10.1136/annrheumdis-2011-201230.26; Nishii H, 2006, INT J UROL, V13, P1339, DOI 10.1111/j.1442-2042.2006.01536.x; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Oottamasathien S, 2013, J UROLOGY, V190, P1596, DOI 10.1016/j.juro.2013.01.002; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; PARSONS CL, 1994, BRIT J UROL, V73, P504, DOI 10.1111/j.1464-410X.1994.tb07634.x; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Ren SX, 2012, CANC RES; Russell AL, 1999, MED HYPOTHESES, V52, P297, DOI 10.1054/mehy.1997.0652; Saban MR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-4; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; Shao Y, 2013, WORLD J UROL, V31, P535, DOI 10.1007/s00345-012-0839-8; Shie JH, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.049; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Suzuki K, 2011, INT IMMUNOL, V23, P185, DOI 10.1093/intimm/dxq471; Theoharides TC, 1998, ANN NY ACAD SCI, V840, P619, DOI 10.1111/j.1749-6632.1998.tb09601.x; Tseng LH, 2010, INT UROGYNECOL J, V21, P911, DOI 10.1007/s00192-010-1129-x; Van Molle W, 2000, INFECT IMMUN, V68, P5026, DOI 10.1128/IAI.68.9.5026-5029.2000; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Verhoef M, 2005, SPINAL CORD, V43, P331, DOI 10.1038/sj.sc.3101705; Vij M, 2012, EUR J OBSTET GYN R B, V161, P1, DOI 10.1016/j.ejogrb.2011.12.014; Yamada T, 2007, WORLD J UROL, V25, P407, DOI 10.1007/s00345-007-0174-7; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yoshimura N, 2006, J NEUROSCI, V26, P10847, DOI 10.1523/JNEUROSCI.3023-06.2006; You S, 2012, INT NEUROUROL J, V16, P159, DOI 10.5213/inj.2012.16.4.159; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016658	71	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77854	10.1371/journal.pone.0077854	http://dx.doi.org/10.1371/journal.pone.0077854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204996	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500068
J	Fry, EA; Taneja, P; Maglic, D; Zhu, SN; Sui, GC; Inoue, K				Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Sui, Guangchao; Inoue, Kazushi			Dmp1 alpha Inhibits HER2/neu-Induced Mammary Tumorigenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DMP1; CELL-CYCLE ARREST; BREAST-CANCER; TRANSGENIC MICE; GENE-EXPRESSION; ERBB RECEPTORS; CRITICAL ROLES; ARF; P53; INDUCTION	Our recent study shows a pivotal role of Dmp1 in quenching hyperproliferative signals from HER2 to the Arf-p53 pathway as a safety mechanism to prevent breast carcinogenesis. To directly demonstrate the role of Dmp1 in preventing HER2/neu-driven oncogenic transformation, we established Flag-Dmp1 alpha transgenic mice (MDTG) under the control of the mouse mammary tumor virus (MMTV) promoter. The mice were viable but exhibited poorly developed mammary glands with markedly reduced milk production; thus more than half of parous females were unable to support the lives of new born pups. The mammary glands of the MDTG mice had very low Ki-67 expression but high levels of Arf, Ink4a, p53, and p21(Cip1), markers of senescence and accelerated aging. In all strains of generated MDTG;neu mice, tumor development was significantly delayed with decreased tumor weight. Tumors from MDTG;neu mice expressed Flag-Dmp1 alpha and Ki-67 in a mutually exclusive fashion indicating that transgenic Dmp1 alpha prevented tumor growth in vivo. Genomic DNA analyses showed that the Dmp1 alpha transgene was partially lost in half of the MDTG;neu tumors, and Western blot analyses showed Dmp1 alpha protein downregulation in 80% of the cases. Our data demonstrate critical roles of Dmp1 in preventing mammary tumorigenesis and raise the possibility of treating breast cancer by restoring Dmp1 alpha expression.	[Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Dept Pathol, Winston Salem, NC USA; [Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Sui, Guangchao; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA; [Maglic, Dejan; Zhu, Sinan; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Grad Program Mol Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Sui, GC (corresponding author), Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA.	gsui@wakehealth.edu; kinoue2@triad.rr.com		Sui, Guangchao/0000-0002-8164-5585	American Cancer Society [RSG-07-207-01-MGO, 5R01CA106314, 116403-RSG-09-082-01-MGO]; Wake Forest University Health Sciences [20595]; Susan G. Komen Foundation [KG080179]; Department of Defense (DOD) [BC100907];  [IRSC-GTS 37540]; NATIONAL CANCER INSTITUTE [R01CA106314] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Wake Forest University Health Sciences; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense (DOD)(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K. Inoue has been supported by the American Cancer Society RSG-07-207-01-MGO, 5R01CA106314, and by Director's Challenge Award #20595 from Wake Forest University Health Sciences. G. Sui has been supported by the American Cancer Society 116403-RSG-09-082-01-MGO and 5R01CA106314. P. Taneja was supported by the Susan G. Komen Foundation postdoctoral fellowship KG080179. D. Maglic has been supported by Department of Defense (DOD) pre-doctoral fellowship BC100907. S. Zhu was supported by institutional grant IRSC-GTS 37540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; Bodner SM, 1999, GENE, V229, P223, DOI 10.1016/S0378-1119(98)00591-5; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Frazier DP, 2012, CANCER RES, V72, P1740, DOI 10.1158/0008-5472.CAN-11-2410; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inoue K, 2007, ONCOGENE, V26, P4329, DOI 10.1038/sj.onc.1210226; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Inoue K, 2000, GENE DEV, V14, P1797; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Inoue K, 2008, CANCER RES, V68, P4487, DOI 10.1158/0008-5472.CAN-07-6791; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kristjansson AK, 1997, ANTICANCER RES, V17, P93; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maglic D, 2013, ONCOGENE, V32, P4120, DOI 10.1038/onc.2012.423; Mallakin A, 2006, ONCOGENE, V25, P7703, DOI 10.1038/sj.onc.1209750; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Mallakin A, 2010, INT J CANCER, V126, P1403, DOI 10.1002/ijc.24938; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Morrow PKH, 2009, ANNU REV MED, V60, P153, DOI 10.1146/annurev.med.60.061107.145152; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Plante I, 2011, J VIS EXP, V21; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; Ross JS, 2005, MOL ONCOLOGY BREAST; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sugiyama T, 2008, EXPERT REV MOL DIAGN, V8, P435, DOI 10.1586/14737159.8.4.435; Sugiyama T, 2008, CLIN MED INSIGHTS-ON, V2, P209; Taneja P, 2007, ONCOGENE, V26, P7457, DOI 10.1038/sj.onc.1210568; Taneja P, 2010, CANCER RES, V70, P9084, DOI 10.1158/0008-5472.CAN-10-0159; Taneja P, 2009, EXPERT REV MOL DIAGN, V9, P423, DOI 10.1586/ERM.09.31; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yang CW, 2004, AM J PATHOL, V164, P1031, DOI 10.1016/S0002-9440(10)63190-2; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006; ZHU SY, 2013, HYPERFINE INTERACT, V220, P1, DOI DOI 10.1007/s10751-012-0749-6	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77870	10.1371/journal.pone.0077870	http://dx.doi.org/10.1371/journal.pone.0077870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205004	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700056
J	Henry, MJ; Obleser, J				Henry, Molly J.; Obleser, Jonas			Dissociable Neural Response Signatures for Slow Amplitude and Frequency Modulation in Human Auditory Cortex	PLOS ONE			English	Article							STEADY-STATE RESPONSES; SPEECH-INTELLIGIBILITY; PHASE; TONES; DISCRIMINATION; ADAPTATION; PATTERNS; STIMULI; MEG; AM	Natural auditory stimuli are characterized by slow fluctuations in amplitude and frequency. However, the degree to which the neural responses to slow amplitude modulation (AM) and frequency modulation (FM) are capable of conveying independent time-varying information, particularly with respect to speech communication, is unclear. In the current electroencephalography (EEG) study, participants listened to amplitude- and frequency-modulated narrow-band noises with a 3-Hz modulation rate, and the resulting neural responses were compared. Spectral analyses revealed similar spectral amplitude peaks for AM and FM at the stimulation frequency (3 Hz), but amplitude at the second harmonic frequency (6 Hz) was much higher for FM than for AM. Moreover, the phase delay of neural responses with respect to the full-band stimulus envelope was shorter for FM than for AM. Finally, the critical analysis involved classification of single trials as being in response to either AM or FM based on either phase or amplitude information. Time-varying phase, but not amplitude, was sufficient to accurately classify AM and FM stimuli based on single-trial neural responses. Taken together, the current results support the dissociable nature of cortical signatures of slow AM and FM. These cortical signatures potentially provide an efficient means to dissect simultaneously communicated slow temporal and spectral information in acoustic communication signals.	[Henry, Molly J.; Obleser, Jonas] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany	Max Planck Society	Henry, MJ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany.	henry@cbs.mpg.de	Obleser, Jonas/C-9891-2011	Obleser, Jonas/0000-0002-7619-0459	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research was funded by a grant to J.O. from the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN CF, 2013, HEARING RES, P33098; Byrne AJ, 2012, J ACOUST SOC AM, V132, P3375, DOI 10.1121/1.4754531; EDWARDS BW, 1994, J ACOUST SOC AM, V95, P2202, DOI 10.1121/1.408680; EGGERMONT JJ, 1994, HEARING RES, V74, P51, DOI 10.1016/0378-5955(94)90175-9; EGGERMONT JJ, 1979, J ACOUST SOC AM, V65, P463, DOI 10.1121/1.382345; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Geisler CD, 1960, 380 MIT RES LAB EL; Ghitza O, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00340; Greenberg S, 2003, J PHONETICS, V31, P465, DOI 10.1016/j.wocn.2003.09.005; Harrison D., 1988, J APPL STAT, V15, P197, DOI [10.1080/02664768800000026, DOI 10.1080/02664768800000026]; Hart HC, 2003, CEREB CORTEX, V13, P773, DOI 10.1093/cercor/13.7.773; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; HERRMANN B, 2013, J NEUROSCI, P89487; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; John MS, 2001, AUDIOL NEURO-OTOL, V6, P12, DOI 10.1159/000046805; John MS, 2000, HEARING RES, V141, P57, DOI 10.1016/S0378-5955(99)00209-9; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; LINS OG, 1995, EVOKED POTENTIAL, V96, P420, DOI 10.1016/0168-5597(95)00048-W; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2006, J NEUROPHYSIOL, V96, P2712, DOI 10.1152/jn.01256.2005; Macmillan N. A., 2005, DETECTION THEORY USE; MAISTE A, 1989, EAR HEARING, V10, P153, DOI 10.1097/00003446-198906000-00003; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; MOORE BCJ, 1987, HEARING RES, V28, P209, DOI 10.1016/0378-5955(87)90050-5; Moore BCJ, 1996, J ACOUST SOC AM, V100, P2320, DOI 10.1121/1.417941; MOORE BCJ, 1992, J ACOUST SOC AM, V92, P3119, DOI 10.1121/1.404208; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Ng BSW, 2013, CEREB CORTEX, V23, P389, DOI 10.1093/cercor/bhs031; Obleser J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00250; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Patel AD, 2004, CEREB CORTEX, V14, P35, DOI 10.1093/cercor/bhg089; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PICTON TW, 1987, J ACOUST SOC AM, V82, P165, DOI 10.1121/1.395560; REES A, 1986, HEARING RES, V23, P123, DOI 10.1016/0378-5955(86)90009-2; REGAN D, 1979, J ACOUST SOC AM, V65, P1249, DOI 10.1121/1.382792; RICKARDS FW, 1984, EVOKED POTENTIAL, V2, P163; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; SABERI K, 1995, NATURE, V374, P537, DOI 10.1038/374537a0; Sapsford DJ, 1996, ANESTH ANALG, V83, P1273; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Slaney M., 1998, 10 INT RES CORP; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; TANSLEY BW, 1983, J ACOUST SOC AM, V74, P765, DOI 10.1121/1.389864; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zwicker E., 2013, PSYCHOACOUSTICS FACT; ZWICKER EBERHARD, 1962, JOUR ACOUSTICAL SOC AMER, V34, P1425, DOI 10.1121/1.1918362	53	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78758	10.1371/journal.pone.0078758	http://dx.doi.org/10.1371/journal.pone.0078758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205309	Green Published, gold			2022-12-25	WOS:000326270700096
J	Breschi, GL; Cametti, M; Mastropietro, A; Librizzi, L; Baselli, G; Resnati, G; Metrangolo, P; de Curtis, M				Breschi, Gian Luca; Cametti, Massimo; Mastropietro, Alfonso; Librizzi, Laura; Baselli, Giuseppe; Resnati, Giuseppe; Metrangolo, Pierangelo; de Curtis, Marco			Different Permeability of Potassium Salts across the Blood-Brain Barrier Follows the Hofmeister Series	PLOS ONE			English	Article							GUINEA-PIG BRAIN; IN-VITRO; EPILEPTIFORM DISCHARGES; FLUORIDE; CURRENTS; 4-AMINOPYRIDINE; EPILEPSY; NEURONS; BIOLOGY; SYSTEM	The passage of ions across biological membranes is regulated by passive and active mechanisms. Passive ion diffusion into organs depends on the ion-pairing properties of salts present in the serum. Potassium ions could affect brain activity by crossing the blood-brain barrier (BBB) and its accumulation in the extracellular cerebral space could precipitate seizures. In the present study, we analyze passive diffusion of a series of potassium salts in the in vitro isolated guinea pig brain preparation. Different potassium counter-anions confer ion-pairing and lipophilicity properties that modulate membrane diffusion of the salt. Extracellular recordings in different cortical areas demonstrated the presence of epileptiform activities that strongly relate to anion identity, following the qualitative order of the Hofmeister series. Indeed, highly lipophilic salts that easily cross the BBB enhanced extracellular potassium concentration measured by ion-selective electrodes and were the most effective pro-epileptic species. This study constitutes a novel contribution for the understanding of the potential epileptogenicity of potassium salts and, more generally, of the role of counter-anions in the passive passage of salts through biological membranes.	[Breschi, Gian Luca; Librizzi, Laura; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unit Epileptol & Expt Neurophysiol, Milan, Italy; [Breschi, Gian Luca] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Cametti, Massimo; Resnati, Giuseppe; Metrangolo, Pierangelo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [Mastropietro, Alfonso] Fdn Ist Neurol Carlo Besta, Sci Direct Unit, Milan, Italy; [Mastropietro, Alfonso; Baselli, Giuseppe] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy	IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; Polytechnic University of Milan; IRCCS Istituto Neurologico Besta; Polytechnic University of Milan	de Curtis, M (corresponding author), Fdn Ist Neurol Carlo Besta, Unit Epileptol & Expt Neurophysiol, Milan, Italy.	decurtis@istituto-besta.it	Cametti, Massimo/F-6644-2013; de Curtis, Marco M/J-8704-2016; Resnati, Giuseppe/C-8650-2011; Cametti, Massimo/O-9808-2019; Metrangolo, Pierangelo/D-4106-2011; Mastropietro, Alfonso/AAY-7271-2020; Librizzi, Laura/J-7889-2016	Cametti, Massimo/0000-0002-9280-3155; de Curtis, Marco M/0000-0001-7443-6737; Resnati, Giuseppe/0000-0002-0797-9296; Cametti, Massimo/0000-0002-9280-3155; Mastropietro, Alfonso/0000-0003-3358-7111; Librizzi, Laura/0000-0002-2741-4452; METRANGOLO, PIERANGELO/0000-0002-7945-099X; de Curtis, Marco/0000-0002-5608-929X	CARIPLO Foundation [2009-2150]; Italian Ministry of Education, University, and Research; Italian Ministry of Health	CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by the CARIPLO Foundation grant (project 2009-2150, New Generation Fluorinated Materials as Smart Reporter Agents in 19F-MRI) by the Italian Ministry of Education, University, and Research (project Firb 2010 "Nanostructured Fluorinated Materials as Smart Reporter Agents in 19F MRI)" and by the Italian Ministry of Health (Ricerca Corrente 2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Arrhenius S., 1887, Z PHYS CHEM, V1U, P631, DOI [10.1515/zpch-1887-0164, DOI 10.1515/ZPCH-1887-0164]; Avoli M, 1996, J NEUROSCI, V16, P3912; BERTOLLINI L, 1994, NEUROREPORT, V5, P553, DOI 10.1097/00001756-199401000-00005; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Bostrom M, 2005, LANGMUIR, V21, P2619, DOI 10.1021/la047437v; Bruckner C, 2000, BRAIN RES, V859, P15, DOI 10.1016/S0006-8993(99)02348-3; de Curtis M, 1991, Hippocampus, V1, P341, DOI 10.1002/hipo.450010402; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; DECURTIS M, 1994, NEUROSCIENCE, V59, P775, DOI 10.1016/0306-4522(94)90194-5; Frohlich F, 2008, COMPUTATIONAL NEUROSCIENCE IN EPILEPSY, P419, DOI 10.1016/B978-012373649-9.50029-6; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; HERMANN A, 1981, J GEN PHYSIOL, V78, P63, DOI 10.1085/jgp.78.1.63; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; KAY AR, 1986, J NEUROSCI, V6, P2915; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; Lee G, 2001, PHARMACOL REV, V53, P569; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; LLINAS R, 1981, FED PROC, V40, P2240; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Mazzetti S, 2004, BRAIN RES, V999, P81, DOI 10.1016/j.brainres.2003.11.032; MCIVOR ME, 1990, DRUG SAFETY, V5, P79, DOI 10.2165/00002018-199005020-00001; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Miller JM, 2009, J CONTROL RELEASE, V137, P31, DOI 10.1016/j.jconrel.2009.02.018; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Pardridge William M, 2003, Methods Mol Med, V89, P385; Peruzzi N, 2012, J PHYS CHEM B, V116, P14398, DOI 10.1021/jp309157x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78553	10.1371/journal.pone.0078553	http://dx.doi.org/10.1371/journal.pone.0078553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205257	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200057
J	Bigot, R; Bertaux, J; Frere, J; Berjeaud, JM				Bigot, Renaud; Bertaux, Joanne; Frere, Jacques; Berjeaud, Jean-Marc			Intra-Amoeba Multiplication Induces Chemotaxis and Biofilm Colonization and Formation for Legionella	PLOS ONE			English	Article							PATHOGEN-HOST INTERACTIONS; AUTOINDUCER SYNTHASE LQSA; ACANTHAMOEBA-CASTELLANII; INTRACELLULAR REPLICATION; NAEGLERIA-LOVANIENSIS; FLOATING BIOFILMS; WATER-SYSTEMS; POTABLE-WATER; PNEUMOPHILA; GROWTH	Legionella pneumophila, a facultative intracellular bacterium, is the causative agent of legionellosis. In the environment this pathogenic bacterium colonizes the biofilms as well as amoebae, which provide a rich environment for the replication of Legionella. When seeded on pre-formed biofilms, L. pneumophila was able to establish and survive and was only found at the surface of the biofilms. Different phenotypes were observed when the L. pneumophila, used to implement pre-formed biofilms or to form mono-species biofilms, were cultivated in a laboratory culture broth or had grown intracellulary within the amoeba. Indeed, the bacteria, which developed within the amoeba, formed clusters when deposited on a solid surface. Moreover, our results demonstrate that multiplication inside the amoeba increased the capacity of L. pneumophila to produce polysaccharides and therefore enhanced its capacity to establish biofilms. Finally, it was shown that the clusters formed by L. pneumophila were probably related to the secretion of a chemotaxis molecular agent.	[Bigot, Renaud; Frere, Jacques; Berjeaud, Jean-Marc] Univ Poitiers, CNRS, Equipe Microbiol Eau Ecol & Biol Interact, UMR 7267, Poitiers, France; [Bertaux, Joanne] Univ Poitiers, CNRS, Equipe Ecol Evolut Symbiose Ecol & Biol Interact, UMR 7267, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Berjeaud, JM (corresponding author), Univ Poitiers, CNRS, Equipe Microbiol Eau Ecol & Biol Interact, UMR 7267, Poitiers, France.	jean-marc.berjeaud@univ-poitiers.fr	Berjeaud, Jean-Marc/ABF-9966-2021; Berjeaud, Jean-Marc/GOP-0237-2022	Berjeaud, Jean-Marc/0000-0001-9013-8430; 	ministere de l'Enseignement Superieur et de la Recherche	ministere de l'Enseignement Superieur et de la Recherche	The ministere de l'Enseignement Superieur et de la Recherche is acknowledged for R. Bigot Ph.D. funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare R, 2007, CELL MICROBIOL, V9, P1571, DOI 10.1111/j.1462-5822.2007.00894.x; Atlas RM, 1999, ENVIRON MICROBIOL, V1, P283, DOI 10.1046/j.1462-2920.1999.00046.x; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; BHOPAL RS, 1991, J INFECTION, V22, P97, DOI 10.1016/0163-4453(91)91178-Z; BOLLIN GE, 1985, J CLIN MICROBIOL, V21, P674, DOI 10.1128/JCM.21.5.674-677.1985; BOLLIN GE, 1985, APPL ENVIRON MICROB, V50, P1128, DOI 10.1128/AEM.50.5.1128-1131.1985; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cazalet C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000851; Cheng K J, 1986, Soc Appl Bacteriol Symp Ser, V13, P239; Declerck P, 2007, J APPL MICROBIOL, V103, P2697, DOI 10.1111/j.1365-2672.2007.03530.x; Declerck P, 2005, MICROB ECOL, V50, P536, DOI 10.1007/s00248-005-0258-0; Declerck P, 2007, CURR MICROBIOL, V55, P435, DOI 10.1007/s00284-007-9006-7; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; Dupuy M, 2011, WATER RES, V45, P1087, DOI 10.1016/j.watres.2010.10.025; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Faulkner G, 2008, J BACTERIOL, V190, P7728, DOI 10.1128/JB.00751-08; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Huws SA, 2005, J APPL MICROBIOL, V98, P238, DOI 10.1111/j.1365-2672.2004.02449.x; Ibey BL, 2005, ANAL CHEM, V77, P7039, DOI 10.1021/ac0507901; JONAS D, 1995, J CLIN MICROBIOL, V33, P1247, DOI 10.1128/JCM.33.5.1247-1252.1995; Kessler A, 2013, ENVIRON MICROBIOL, V15, P646, DOI 10.1111/j.1462-2920.2012.02889.x; Kikuhara Hiroyuki, 1994, Journal of UOEH, V16, P263; Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4; Koubar M, 2013, CURR MICROBIOL, V66, P437, DOI 10.1007/s00284-012-0295-0; Koubar M, 2011, FEMS MICROBIOL LETT, V325, P10, DOI 10.1111/j.1574-6968.2011.02402.x; Kuiper MW, 2004, APPL ENVIRON MICROB, V70, P6826, DOI 10.1128/AEM.70.11.6826-6833.2004; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Neu TR, 2002, APPL ENVIRON MICROB, V68, P901, DOI 10.1128/AEM.68.2.901-909.2002; Neumeister B, 2000, APPL ENVIRON MICROB, V66, P914, DOI 10.1128/AEM.66.3.914-919.2000; Pecastaings S, 2010, BIOFOULING, V26, P809, DOI 10.1080/08927014.2010.520159; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; PRUCKLER JM, 1995, INFECT IMMUN, V63, P4928, DOI 10.1128/IAI.63.12.4928-4932.1995; ROGERS J, 1992, APPL ENVIRON MICROB, V58, P2326, DOI 10.1128/AEM.58.7.2326-2330.1992; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Scott JE, 1996, EUR J ORAL SCI, V104, P2, DOI 10.1111/j.1600-0722.1996.tb00038.x; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Steinert M, 2002, FEMS MICROBIOL REV, V26, P149, DOI 10.1111/j.1574-6976.2002.tb00607.x; Stojek NM, 2011, ANN AGR ENV MED, V18, P330; Temmerman R, 2006, APPL ENVIRON MICROB, V72, P4323, DOI 10.1128/AEM.00070-06; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; Vervaeren H, 2006, FEMS MICROBIOL ECOL, V58, P583, DOI 10.1111/j.1574-6941.2006.00181.x	50	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77875	10.1371/journal.pone.0077875	http://dx.doi.org/10.1371/journal.pone.0077875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205008	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300034
J	Soto-Arias, JP; Groves, R; Barak, JD				Soto-Arias, Jose Pablo; Groves, Russell; Barak, Jeri D.			Interaction of Phytophagous Insects with Salmonella enterica on Plants and Enhanced Persistence of the Pathogen with Macrosteles quadrilineatus Infestation or Frankliniella occidentalis Feeding	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; THRIPS THYSANOPTERA; COLONIZATION; LETTUCE; OUTBREAK; VECTOR; INTERNALIZATION; TRANSMISSION; ARABIDOPSIS; MECHANISMS	Recently, most foodborne illness outbreaks of salmonellosis have been caused by consumption of contaminated fresh produce. Yet, the mechanisms that allow the human pathogen Salmonella enterica to contaminate and grow in plant environments remain poorly described. We examined the effect of feeding by phytophagous insects on survival of S. enterica on lettuce. Larger S. enterica populations were found on leaves infested with Macrosteles quadrilineatus. In contrast, pathogen populations among plants exposed to Frankliniella occidentalis or Myzus persicae were similar to those without insects. However, on plants infested with F. occidentalis, areas of the infested leaf with feeding damage sustained higher S. enterica populations than areas without damage. The spatial distribution of S. enterica cells on leaves infested with F. occidentalis may be altered resulting in higher populations in feeding lesions or survival may be different across a leaf dependent on local damage. Results suggest the possibility of some specificity with select insects and the persistence of S. enterica. Additionally, we demonstrated the potential for phytophagous insects to become contaminated with S. enterica from contaminated plant material. S. enterica was detected in approximately 50% of all M. quadrilineatus, F. occidentalis, and M. persicae after 24 h exposure to contaminated leaves. Particularly, 17% of F. occidentalis, the smallest of the insects tested, harbored more than 10(2) CFU/F. occidentalis. Our results show that phytophagous insects may influence the population dynamics of S. enterica in agricultural crops. This study provides evidence of a human bacterial pathogen interacting with phytophagous insect during plant infestation.	[Soto-Arias, Jose Pablo; Barak, Jeri D.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Groves, Russell] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Barak, JD (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	barak@plantpath.wisc.edu		Dundore-Arias, Jose Pablo (JP)/0000-0002-4944-0125	USDA-Hatch grant [WIS01574]	USDA-Hatch grant	This work was partially supported by USDA-Hatch grant WIS01574 to JDB and RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe H, 2008, PLANT CELL PHYSIOL, V49, P68, DOI 10.1093/pcp/pcm168; [Anonymous], 2010, R LANG ENV STAT COMP; Aruscavage D, 2008, J FOOD PROTECT, V71, P2384, DOI 10.4315/0362-028X-71.12.2384; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Batz M. B. S., 2011, FOOD SAFETY RES CONS; Beanland L, 2005, ANN ENTOMOL SOC AM, V98, P756, DOI 10.1603/0013-8746(2005)098[0756:TDOALS]2.0.CO;2; Blazar Jeffrey M., 2011, Terrestrial Arthropod Reviews, V4, P5, DOI 10.1163/187498311X543989; CHISHOLM IF, 1984, B ENTOMOL RES, V74, P663, DOI 10.1017/S0007485300014048; Cloyd RA., 2009, PEST TECH, V3, P1; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; De Vries EJ, 2006, EUR J ENTOMOL, V103, P779, DOI 10.14411/eje.2006.106; Erickson MC, 2010, J FOOD PROTECT, V73, P1809, DOI 10.4315/0362-028X-73.10.1809; Felkey K, 2006, HORTTECHNOLOGY, V16, P253, DOI 10.21273/HORTTECH.16.2.0253; Fletcher J, 2013, PHYTOPATHOLOGY, V103, P306, DOI 10.1094/PHYTO-09-12-0236-IA; Frost KE, 2011, J ECON ENTOMOL, V104, P1800, DOI 10.1603/EC11183; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Gitaitis RD, 2003, PLANT DIS, V87, P675, DOI 10.1094/PDIS.2003.87.6.675; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Jin S, 2012, J INSECT PHYSIOL, V58, P1235, DOI 10.1016/j.jinsphys.2012.06.008; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; Kwan G, 2013, MBIO, V4, DOI 10.1128/mBio.00557-12; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mian LS, 2002, J VECTOR ECOL, V27, P82; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mohle-Boetani JC, 2001, ANN INTERN MED, V135, P239, DOI 10.7326/0003-4819-135-4-200108210-00008; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Parker WE, 2002, CROP PROT, V21, P235, DOI 10.1016/S0261-2194(01)00090-4; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; van de Wetering F, 1998, ENTOMOL EXP APPL, V88, P9, DOI 10.1046/j.1570-7458.1998.00340.x; Wasala L, 2013, PHYTOPATHOLOGY, V103, P373, DOI [10.1094/PHYTO-09-12-0217-FI, 10]; Yamazaki A, 2011, APPL ENVIRON MICROB, V77, P156, DOI 10.1128/AEM.01079-10; YUDIN LS, 1988, ENVIRON ENTOMOL, V17, P522, DOI 10.1093/ee/17.3.522; Zheng J, 2013, APPL ENVIRON MICROB, V79, P2494, DOI 10.1128/AEM.03704-12	50	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79404	10.1371/journal.pone.0079404	http://dx.doi.org/10.1371/journal.pone.0079404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205384	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300094
J	Sun, Y; Liang, DY; Sahbaie, P; Clark, JD				Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David			Effects of Methyl Donor Diets on Incisional Pain in Mice	PLOS ONE			English	Article							DNA METHYLATION; GENE; SUPPLEMENTATION; EXPRESSION; SPARC	Background: Dietary supplementation with methyl donors can influence the programming of epigenetic patterns resulting in persistent alterations in disease susceptibility and behavior. However, the dietary effects of methyl donors on pain have not been explored. In this study, we evaluated the effects of dietary methyl donor content on pain responses in mice. Methods: Male and female C57BL/6J mice were treated with high or low methyl donor diets either in the perinatal period or after weaning. Mechanical and thermal nociceptive sensitivity were measured before and after incision. Results: Mice fed high or low methyl donor diets displayed equal weight gain over the course of the experiments. When exposed to these dietary manipulations in the perinatal period, only male offspring of dams fed a high methyl donor diet displayed increased mechanical allodynia. Hindpaw incision in these animals caused enhanced nociceptive sensitization, but dietary history did not affect the duration of sensitization. For mice exposed to high or low methyl donor diets after weaning, no significant differences were observed in mechanical or thermal nociceptive sensitivity either at baseline or in response to hindpaw incision. Conclusions: Perinatal dietary factors such as methyl donor content may impact pain experiences in later life. These effects, however, may be specific to sex and pain modality.	[Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA; [Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Clark, JD (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA.	djclark@stanford.edu	liang, dy/GZA-4770-2022		Department of Veterans Affairs Merit Review Award [1I01BX000881]	Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs)	The work was also supported by the Department of Veterans Affairs Merit Review Award 1I01BX000881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Liang DY, 2013, J PAIN RES, V6, P281, DOI 10.2147/JPR.S42561; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sun Y, 2012, ANESTHESIOLOGY, V117, P626, DOI 10.1097/ALN.0b013e31826571aa; Suter MA, 2009, SEMIN REPROD MED, V27, P380, DOI 10.1055/s-0029-1237426; Tajerian M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-65; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2003, J NUTR, V133, P238, DOI 10.1093/jn/133.1.238	25	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77881	10.1371/journal.pone.0077881	http://dx.doi.org/10.1371/journal.pone.0077881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205011	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300035
J	Franzen, M; Nilsson, SG; Johansson, V; Ranius, T				Franzen, Markus; Nilsson, Sven G.; Johansson, Victor; Ranius, Thomas			Population Fluctuations and Synchrony of Grassland Butterflies in Relation to Species Traits	PLOS ONE			English	Article							SPATIAL SYNCHRONY; LIFE-HISTORY; EXTINCTION; DYNAMICS; LANDSCAPE; CLIMATE; RANGES; EDGES; RISK	Population fluctuations and synchrony influence population persistence; species with larger fluctuations and more synchronised population fluctuations face higher extinction risks. Here, we analyse the effect of diet specialisation, mobility, length of the flight period, and distance to the northern edge of the species' distribution in relation to between-year population fluctuations and synchrony of butterfly species. All butterfly species associated with grasslands were surveyed over five successive years at 19 grassland sites in a forest-dominated landscape (50 km(2)) in southern Sweden. At both the local and regional level, we found larger population fluctuations in species with longer flight periods. Population fluctuations were more synchronous among localities in diet specialists. Species with a long flight period might move more to track nectar resources compared to species with shorter flight period, and if nectar sources vary widely between years and localities it may explain that population fluctuations increase with increasing flight length. Diet generalists can use different resources (in this case host plants) at different localities and this can explain the lower synchrony in population fluctuations among generalist species. Higher degree of synchrony is one possible explanation for the higher extinction risks that have been observed for more specialised species. Therefore, diet specialists are more often threatened and require more conservation efforts than generalists.	[Franzen, Markus] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Franzen, Markus; Nilsson, Sven G.] Lund Univ, Dept Biol Biodivers & Conservat Biol, Lund, Sweden; [Johansson, Victor; Ranius, Thomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Johansson, Victor] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Lund University; Swedish University of Agricultural Sciences; Stockholm University	Franzen, M (corresponding author), Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany.	markus.franzen@ufz.de		Johansson, Victor/0000-0003-1369-9351	Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Commission [244090-STEP-CP-FP]	Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and the European Commission Framework Programme (FP) 7 via the Integrated Project STEP (grant 244090-STEP-CP-FP), for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; Bellamy PE, 2003, ECOGRAPHY, V26, P338, DOI 10.1034/j.1600-0587.2003.03457.x; Eliasson C.U., 2005, NATIONALNYCKELN SVER; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HANSKI I, 1993, J ANIM ECOL, V62, P656, DOI 10.2307/5386; Hanski I., 1999, METAPOPULATION ECOLO; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Jones J, 2003, ECOLOGY, V84, P3024, DOI 10.1890/02-0639; Karsholt Ole, 1996, P1; Keith AB, 1990, ECOLOGY, V71, P1599, DOI [10.2307/1938295, DOI 10.2307/1938295]; Komonen A, 2004, OIKOS, V105, P41, DOI 10.1111/j.0030-1299.2004.12958.x; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Kuussaari M, 2007, J INSECT CONSERV, V11, P351, DOI 10.1007/s10841-006-9052-7; Matter SF, 2010, P ROY SOC B-BIOL SCI, V277, P729, DOI 10.1098/rspb.2009.1520; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Nilsson Sven G., 2002, Entomologisk Tidskrift, V123, P193; Nilsson SG, 2008, INSECT CONSERV DIVER, V1, P197, DOI 10.1111/j.1752-4598.2008.00027.x; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Powney GD, 2010, OIKOS, V119, P1690, DOI 10.1111/j.1600-0706.2010.18168.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Richards OW, 1968, TRE SOUTHWOOD, V4, P1; Saether BE, 2011, J ANIM ECOL, V80, P215, DOI 10.1111/j.1365-2656.2010.01751.x; Stefanescu C, 2013, ECOGRAPHY IN PRESS; Stoltze M, 1994, THESIS U COPENHAGEN; Sutcliffe OL, 1996, J ANIM ECOL, V65, P85, DOI 10.2307/5702; SVENSSON I, 1993, LEPIDOPTERA CALENDER; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; THOMAS JA, 1984, BIOL BUTTERFLIES, P333; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson Robert J., 2009, P81	35	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78233	10.1371/journal.pone.0078233	http://dx.doi.org/10.1371/journal.pone.0078233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24205169	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500070
J	Banu, S; Rahman, MT; Uddin, MKM; Khatun, R; Ahmed, T; Rahman, MM; Husain, MA; van Leth, F				Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Ahmed, Tahmeed; Rahman, Md. Mojibur; Husain, Md. Ashaque; van Leth, Frank			Epidemiology of Tuberculosis in an Urban Slum of Dhaka City, Bangladesh	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; STRAIN DIFFERENTIATION; MOLECULAR EPIDEMIOLOGY; DIAGNOSIS; IDENTIFICATION; PREVALENCE	Background: The objectives of this study were to assess the tuberculosis (TB) burden and to provide an insight into the type of circulating M. tuberculosis species in urban slums of Bangladesh. We also aimed to test the feasibility of a larger transmission study in this setting. Methods: This cross-sectional study was conducted in an urban slum of Dhaka city. The household members were actively screened to assess the presence of TB-related signs and symptoms; cough >= 3 weeks and body mass index (BMI) <17 kg/m(2). Sputum specimens from suspects were collected for acid fast bacilli (AFB) microscopy, culture and drug susceptibility testing. Genotyping of M. tuberculosis was done using spoligotyping and variable number tandem repeats of mycobacterial interspersed repetitive units typing. Results: Among 9,877 adult screened for pulmonary TB (PTB), 25 were positive for AFB on microscopy and/or culture and the prevalence of new PTB cases was estimated to be 253/100,000. Only one child TB case was diagnosed among 5,147 child screened. Out of 26 cases, 21(81%) had cough for several duration and 5(19%) did not present with cough at the time of screening. One multidrug resistant case was found. Fifty two percent of all TB cases had BMI <17 kg/m(2) (p = <0.001). Among the 20 analyzed isolates, 13 different spoligotype patterns were identified in which 5 clusters contained 12 strains and 8 strains had unique pattern. Conclusions: The study revealed high prevalence of TB in urban slums. Screening using low BMI can be beneficial among risk group population. It is important to conduct larger study to validate clinical variables like cough <3 weeks and low BMI to define TB suspect and also to investigate the transmission of TB in slum settings.	[Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Rahman, Md. Mojibur; Husain, Md. Ashaque] Directorate Gen Hlth Serv, Natl TB Control Program, Dhaka, Bangladesh; [van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	International Centre for Diarrhoeal Disease Research (ICDDR); University of Amsterdam; Academic Medical Center Amsterdam	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org		van Leth, Frank/0000-0002-5490-8968; Banu, Sayera/0000-0002-5121-1962	KNCV Tuberculosis Foundation, The Netherlands	KNCV Tuberculosis Foundation, The Netherlands(Netherlands Government)	This work was supported by grants from the KNCV Tuberculosis Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATL GUIDELINES OPER; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; (DGHS) DGoHS, 2011, TUB CONTR BANGL ANN; Ford CM, 2009, AM J TROP MED HYG, V81, P1097, DOI 10.4269/ajtmh.2009.08-0627; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; Hayward AC, 2003, INT J TUBERC LUNG D, V7, P751; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; KOX LFF, 1994, J CLIN MICROBIOL, V32, P672, DOI 10.1128/JCM.32.3.672-678.1994; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mehnaz Aisha, 2005, J Coll Physicians Surg Pak, V15, P543; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; SAHA K, 1989, EUR J CLIN NUTR, V43, P117; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; STEGEN G, 1969, PEDIATRICS, V43, P260; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Tessier-Sherman B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-51; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; WHO, 2011, WHO GLOBAL TUBERCULO; Zaman K, 2012, EPIDEMIOL INFECT, V140, P1018, DOI 10.1017/S0950268811001609; Zaman K, 2011, EPIDEMIOL INFECT, P1	37	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77721	10.1371/journal.pone.0077721	http://dx.doi.org/10.1371/journal.pone.0077721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204933	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600044
J	Chen, AJ; Tang, D; Zhou, YQ; Sun, BD; Li, XJ; Wang, LZ; Gao, WW				Chen, Amanda Juan; Tang, Dan; Zhou, Ying Qun; Sun, Bing Da; Li, Xiao Jin; Wang, Li Zhi; Gao, Wei Wei			Identification of Ochratoxin A Producing Fungi Associated with Fresh and Dry Liquorice	PLOS ONE			English	Article							ECOLOGICAL FARMS; POLISH CEREALS; RAW-MATERIALS; CONTAMINATION; PLANTS; FLORA	The presence of fungi on liquorice could contaminate the crop and result in elevated levels of mycotoxin. In this study, the mycobiota associated with fresh and dry liquorice was investigated in 3 producing regions of China. Potential toxigenic fungi were tested for ochratoxin A (OTA) and aflatoxin B1 (AFB1) production using liquid chromatography/mass spectrometry/mass spectrometry. Based on a polyphasic approach using morphological characters, beta-tubulin and RNA polymerase II second largest subunit gene phylogeny, a total of 9 genera consisting of 22 fungal species were identified, including two new Penicillium species (Penicillium glycyrrhizacola sp. nov. and Penicillium xingjiangense sp. nov.). The similarity of fungal communities associated with fresh and dry liquorice was low. Nineteen species belonging to 8 genera were detected from fresh liquorice with populations affiliated with P. glycyrrhizacola, P. chrysogenum and Aspergillus insuetus comprising the majority (78.74%, 33.33% and 47.06% of total) of the community from Gansu, Ningxia and Xinjiang samples, respectively. In contrast, ten species belonging to 4 genera were detected from dry liquorice with populations affiliated with P. chrysogenum, P. crustosum and Aspergillus terreus comprising the majority (64.00%, 52.38% and 90.91% of total) of the community from Gansu, Ningxia and Xinjiang samples, respectively. Subsequent LC/MS/MS analysis indicated that 5 fungal species were able to synthesize OTA in vitro including P. chrysogenum, P. glycyrrhizacola, P. polonicum, Aspergillus ochraceus and A. westerdijkiae, the OTA concentration varied from 12.99 to 39.03 mu g/kg. AFB1 was absent in all tested strains. These results demonstrate the presence of OTA producing fungi on fresh liquorice and suggest that these fungi could survive on dry liquorice after traditional sun drying. Penicillium chrysogenum derived from surrounding environments is likely to be a stable contributor to high OTA level in liquorice. The harvesting and processing procedure needs to be monitored in order to keep liquorice free of toxigenic fungi.	[Chen, Amanda Juan; Tang, Dan; Wang, Li Zhi; Gao, Wei Wei] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Chen, Amanda Juan; Tang, Dan; Wang, Li Zhi; Gao, Wei Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhou, Ying Qun] China Natl Corp Traditional & Herbal Med, Beijing, Peoples R China; [Sun, Bing Da] Chinese Acad Sci, China Gen Microbiol Culture Collect Ctr, Inst Microbiol, Beijing, Peoples R China; [Li, Xiao Jin] Xinjiang Inst Tradit Chinese Med & Ethnicdrug, Urumqi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, WW (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	wwgao411@sina.com			National Natural Science Foundations of China [30973882, 81274071]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundations of China no. 30973882 and no 81274071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accensi F, 2004, FOOD MICROBIOL, V21, P623, DOI 10.1016/j.fm.2003.12.003; Arino A, 2007, FOOD ADDIT CONTAM A, V24, P987, DOI 10.1080/02652030701317277; Arino A, 2007, INT J FOOD MICROBIOL, V114, P366, DOI 10.1016/j.ijfoodmicro.2006.08.005; BANNISTER P, 1968, J ECOL, V56, P27, DOI 10.2307/2258064; Bresch H, 2000, NAHRUNG, V44, P276, DOI [10.1002/1521-3803(20000701)44:4<276::AID-FOOD276>3.0.CO;2-A, 10.1002/1521-3803(20000701)44:4&lt;276::AID-FOOD276&gt;3.0.CO;2-A]; Carmichael J. W., 1980, Genera of Hyphomycetes.; Carmines EL, 2005, FOOD CHEM TOXICOL, V43, P1303, DOI 10.1016/j.fct.2005.01.012; Chen AJ, 2011, FOOD ADDIT CONTAM A, V28, P1091, DOI 10.1080/19440049.2011.576443; Chen AJ, 2010, MYCOSYSTEMA, V29, P335; Chinese Pharmacopoeia Council, 2005, CHINESE PHARMACOPOEI; Copetti MV, 2010, INT J FOOD MICROBIOL, V143, P67, DOI 10.1016/j.ijfoodmicro.2010.07.031; Creppy EE, 1999, J TOXICOL-TOXIN REV, V18, P277, DOI 10.3109/15569549909009258; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P1051, DOI 10.1080/02652030210156313; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P470, DOI 10.1080/02652030110113726; Efuntoye MO, 1996, MYCOPATHOLOGIA, V136, P115, DOI 10.1007/BF00437505; Esteban A, 2006, INT J FOOD MICROBIOL, V108, P188, DOI 10.1016/j.ijfoodmicro.2005.12.002; Frisvad JC, 2006, ADV EXP MED BIOL, V571, P33, DOI 10.1007/0-387-28391-9_2; FRISVAD JC, 1983, APPL ENVIRON MICROB, V46, P1301, DOI 10.1128/AEM.46.6.1301-1310.1983; Frisvad JC, 1985, ADV PENICILLIUM ASPE, P327; Gabriele D, 2001, J FOOD ENG, V48, P33, DOI 10.1016/S0260-8774(00)00140-0; Gil-Serna J, 2011, FOOD CONTROL, V22, P343, DOI 10.1016/j.foodcont.2010.06.018; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gonzalez G, 2005, INT J FOOD MICROBIOL, V105, P1, DOI 10.1016/j.ijfoodmicro.2005.05.001; Herrera M, 2009, FOOD CHEM TOXICOL, V47, P2002, DOI 10.1016/j.fct.2009.05.009; HITOKOTO H, 1978, APPL ENVIRON MICROB, V36, P252, DOI 10.1128/AEM.36.2.252-256.1978; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kabelitz L, 2004, FOOD TECHNOL, V1, P25; Klich MA, 1988, LAB GUIDE COMMON ASP; Kornerup A., 1978, METHUEN HDB COLOUR, V3rd, P252; Majerus P, 2000, DEUT LEBENSM-RUNDSCH, V96, P451; Muller P, 2007, J STORED PROD RES, V43, P323, DOI 10.1016/j.jspr.2006.08.005; O'Brien E, 2005, CRIT REV TOXICOL, V35, P33, DOI 10.1080/10408440590905948; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pietri A, 2010, TOXINS, V2, P758, DOI 10.3390/toxins2040758; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; PITT JI, 1987, APPL ENVIRON MICROB, V53, P266, DOI 10.1128/AEM.53.2.266-269.1987; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMSON RA, 2004, STUD MYCOL, V49, P1; Sanders T. H., 1993, Peanut Science, V20, P5, DOI 10.3146/i0095-3679-20-1-2; Singh P, 2008, MICROB ECOL, V56, P555, DOI 10.1007/s00248-008-9375-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Varga J, 2001, CEREAL RES COMMUN, V29, P85; Wang LZ, 2013, FOOD CHEM, V138, P1048, DOI 10.1016/j.foodchem.2012.11.066; Wang YQ, 2002, J SHANXI AGR U, V22, P366; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yang L, 2010, FOOD ADDIT CONTAM A, V27, P989, DOI 10.1080/19440041003647122	47	24	28	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78285	10.1371/journal.pone.0078285	http://dx.doi.org/10.1371/journal.pone.0078285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205182	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600090
J	Garcia-Bermudez, M; Lopez-Mejias, R; Genre, F; Castaneda, S; Gonzalez-Juanatey, C; Llorca, J; Corrales, A; Miranda-Filloy, JA; Rueda-Gotor, J; Gomez-Vaquero, C; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Pascual-Salcedo, D; Balsa, A; Lopez-Longo, FJ; Carreira, P; Blanco, R; Gonzalez-Alvaro, I; Martin, J; Gonzalez-Gay, MA				Garcia-Bermudez, Mercedes; Lopez-Mejias, Raquel; Genre, Fernanda; Castaneda, Santos; Gonzalez-Juanatey, Carlos; Llorca, Javier; Corrales, Alfonso; Miranda-Filloy, Jose A.; Rueda-Gotor, Javier; Gomez-Vaquero, Carmen; Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin; Pascual-Salcedo, Dora; Balsa, Alejandro; Lopez-Longo, Francisco J.; Carreira, Patricia; Blanco, Ricardo; Gonzalez-Alvaro, Isidoro; Martin, Javier; Gonzalez-Gay, Miguel A.			SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ENVIRONMENTAL CONTRIBUTIONS; CARDIOVASCULAR EVENTS; DISEASE; CLASSIFICATION; INFLAMMATION; ANTIBODIES; PHENOTYPES; HLA-DRB1; CRITERIA	Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease. Previous genome-wide association studies have described SMAD3 rs17228212 polymorphism as an important signal associated with CV events. The aim of the present study was to evaluate for the first time the relationship between this gene polymorphism and the susceptibility to CV manifestations and its potential association with the presence of subclinical atherosclerosis assessed by the evaluation of carotid intima-media thickness (cIMT) in patients with RA. Methods: One thousand eight hundred and ninety-seven patients fulfilling classification criteria for RA were genotyped for SMAD3 rs17228212 gene polymorphism through TaqMan genotyping assay. Also, subclinical atherosclerosis determined by the assessment of cIMT was analyzed in a subgroup of these patients by carotid ultrasonography. Results: No statistically significant differences were observed when allele frequencies of RA patients with or without CV events were compared. Nevertheless, when RA patients were stratified according to anti-cyclic citrullinated peptide (anti-CCP) status, we found that in RA patients who were negative for anti-CCP antibodies, the presence of C allele of SMAD3 rs17228212 polymorphism conferred a protective effect against the risk of cerebrovascular accident (CVA) after adjustment for demographic and classic CV risk factors (HR [95% CI]=0.36 [0.14-0.94], p=0.038) in a Cox regression model. Additionally, correlation between the presence of C allele of SMAD3 rs17228212 polymorphism and lower values of cIMT was found after adjustment for demographic and classic CV risk factors (p-value=0.0094) in the anti-CCP negative RA patients. Conclusions: Our results revealed that SMAD3 rs17228212 gene variant is associated with lower risk of CVA and less severe subclinical atherosclerosis in RA patients negative for anti-CCP antibodies. These findings may have importance to establish predictive models of CV disease in RA patients according to anti-CCP status.	[Martin, Javier] CSIC, IPBLN, Granada, Spain; [Lopez-Mejias, Raquel; Genre, Fernanda; Corrales, Alfonso; Rueda-Gotor, Javier; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Div Rheumatol, IFIMAV, Santander, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Hosp Univ la Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Gonzalez-Juanatey, Carlos] Hosp Lucus Augusti, Div Cardiol, Lugo, Spain; [Llorca, Javier] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, E-39005 Santander, Spain; [Llorca, Javier] IFIMAV, CIBERESP, Santander, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Div Rheumatol, Lugo, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Pascual-Salcedo, Dora; Balsa, Alejandro] Hosp Univ la Paz, Dept Rheumatol, Madrid, Spain; [Lopez-Longo, Francisco J.] Hosp Univ Gregorio, Dept Rheumatol, Madrid, Spain; [Carreira, Patricia] Univ Hosp, Dept Rheumatol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Lucus Augusti-Lugo; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinico San Carlos; Hospital Universitario La Paz	Gonzalez-Gay, MA (corresponding author), Hosp Univ Marques de Valdecilla, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Div Rheumatol, IFIMAV, Santander, Spain.	miguelaggay@hotmail.com	Martín, María/HDL-9512-2022; blanco, ricardo/AAA-1248-2020; González-Gay, Miguel A./B-2306-2008; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Carreira, Patricia E/D-4429-2018; Balsa, Alejandro/ABF-6456-2020; Martin, Javier/B-8141-2008; Rodriguez-Rodriguez, Luis/H-5880-2013; Llorca, Javier/F-7371-2011; García-Bermúdez, Mercedes/E-7708-2013; Martín, Javier/AAV-5209-2021	blanco, ricardo/0000-0003-2344-2285; González-Gay, Miguel A./0000-0002-7924-7406; Carreira, Patricia E/0000-0001-8279-3806; Martin, Javier/0000-0002-2202-0622; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Llorca, Javier/0000-0001-8569-861X; García-Bermúdez, Mercedes/0000-0002-2643-5956; Rueda-Gotor, Javier/0000-0002-1970-541X	"Fondo de Investigaciones Sanitarias" (Spain) [PS09/00748, PI12/00060]; RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII) (Spain) [RD12/0009/0013, RD12/0009/0004]; European IMI BTCure Program; Fundacion Espanola de Reumatologia (FER).; Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain); RETICS Program (RIER)	"Fondo de Investigaciones Sanitarias" (Spain)(Instituto de Salud Carlos III); RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII) (Spain); European IMI BTCure Program; Fundacion Espanola de Reumatologia (FER).; Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain); RETICS Program (RIER)	This study was supported by grants from "Fondo de Investigaciones Sanitarias" PS09/00748 and PI12/00060 (Spain). This work was also partially supported by RETICS Program (RIER) RD12/0009/0013 and RD12/0009/0004 from "Instituto de Salud Carlos III" (ISCIII) (Spain). This work was supported in part by grants from the European IMI BTCure Program. MGB is a beneficiary of a grant from Fundacion Espanola de Reumatologia (FER). RLM is a recipient of a Sara Borrell postdoctoral fellowship from the Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain). FG is supported by funds from the RETICS Program (RIER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; CORRALES A, 2013, ANN RHEUM DIS, P5241; Daha NA, 2011, NAT REV RHEUMATOL, V7, P203, DOI 10.1038/nrrheum.2011.28; Dessein PH, 2007, J RHEUMATOL, V34, P943; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Garcia-Bermudez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049214; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2006, ARTHRIT RHEUM-ARTHR, V55, P150, DOI 10.1002/art.21707; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Juo SHH, 2004, STROKE, V35, P2243, DOI 10.1161/01.STR.0000142132.20442.d8; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lopez-Mejias R, 2012, ATHEROSCLEROSIS, V224, P426, DOI 10.1016/j.atherosclerosis.2012.06.008; Naredo E, 2011, RHEUMATOLOGY, V50, P1860, DOI 10.1093/rheumatology/ker206; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Rodriguez-Rodriguez L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/574817; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Semb AG, 2013, J RHEUMATOL, V40, P359, DOI 10.3899/jrheum.120621; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77695	10.1371/journal.pone.0077695	http://dx.doi.org/10.1371/journal.pone.0077695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204921	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600042
J	Goutte, S; Dubois, A; Legendre, F				Goutte, Sandra; Dubois, Alain; Legendre, Frederic			The Importance of Ambient Sound Level to Characterise Anuran Habitat	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; ANTIPREDATOR BEHAVIOR; ADVERTISEMENT CALLS; ANTHROPOGENIC NOISE; TRAFFIC NOISE; TORRENT FROG; FOREST; SIGNALS; DEGRADATION; ECOLOGY	Habitat characterisation is a pivotal step of any animal ecology study. The choice of variables used to describe habitats is crucial and need to be relevant to the ecology and behaviour of the species, in order to reflect biologically meaningful distribution patterns. In many species, acoustic communication is critical to individuals' interactions, and it is expected that ambient acoustic conditions impact their local distribution. Yet, classic animal ecology rarely integrates an acoustic dimension in habitat descriptions. Here we show that ambient sound pressure level (SPL) is a strong predictor of calling site selection in acoustically active frog species. In comparison to six other habitat-related variables (i.e. air and water temperature, depth, width and slope of the stream, substrate), SPL had the most important explanatory power in microhabitat selection for the 34 sampled species. Ambient noise was particularly useful in differentiating two stream-associated guilds: torrents and calmer streams dwelling species. Guild definitions were strongly supported by SPL, whereas slope, which is commonly used in stream-associated habitat, had a weak explanatory power. Moreover, slope measures are non-standardized across studies and are difficult to assess at small scale. We argue that including an acoustic descriptor will improve habitat-species analyses for many acoustically active taxa. SPL integrates habitat topology and temporal information (such as weather and hour of the day, for example) and is a simple and precise measure. We suggest that habitat description in animal ecology should include an acoustic measure such as noise level because it may explain previously misunderstood distribution patterns.	[Goutte, Sandra; Dubois, Alain; Legendre, Frederic] MNHN, Dept Systemat & Evolut, Paris, France	Museum National d'Histoire Naturelle (MNHN)	Goutte, S (corresponding author), MNHN, Dept Systemat & Evolut, Paris, France.	goutte@mnhn.fr	Dubois, Arnaud/C-1791-2014; goutte, sandra/M-2633-2014; Legendre, Frederic/B-5101-2013	Legendre, Frederic/0000-0001-5900-8048	Action Transversale du Museum "biodivesite actuelle et passee"; Ecole Normale Superieure de Lyon; Museum national d'Histoire naturelle (Paris); Societe des Amis du Museum; National University of Singapore	Action Transversale du Museum "biodivesite actuelle et passee"; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Museum national d'Histoire naturelle (Paris); Societe des Amis du Museum; National University of Singapore(National University of Singapore)	This work was funded by the Action Transversale du Museum "biodivesite actuelle et passee", the Ecole Normale Superieure de Lyon (http://www.ens-lyon.eu), the Museum national d'Histoire naturelle (Paris) (http://www.mnhn.fr), the Societe des Amis du Museum (no website), and the National University of Singapore (http://www.nus.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Biju SD, 2010, ZOOTAXA, P31; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; Boeckle M, 2009, HERPETOLOGICA, V65, P154, DOI 10.1655/07-071R1.1; Boonman A, 2011, EVOL ECOL RES, V13, P197; Brumm H, 2005, COUST COMMUNICATION, P151; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Castellano S, 2003, BIOL J LINN SOC, V78, P11, DOI 10.1046/j.1095-8312.2003.00119.x; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Core R Team, 2012, R LANG ENV STAT COMP; DeRuiter SL, 2009, J EXP BIOL, V212, P3100, DOI 10.1242/jeb.030825; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; Dubois A, 1977, HIM EC ETHN C INT CN, P109; Dubois A, 1977, B SOC ZOOL FR, P163; Dubois Alain, 2001, Alytes (Paris), V19, P81; Ernst R, 2012, GLOBAL ECOL BIOGEOGR, V21, P704, DOI 10.1111/j.1466-8238.2011.00719.x; Feng AS, 2008, J COMP PHYSIOL A, V194, P159, DOI 10.1007/s00359-007-0267-1; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; FORREST TG, 1994, AM ZOOL, V34, P644; Frost DR, 2013, MPHIBIAN SPECIES WOR; Gerhardt H., 1983, ANIM BEHAV, V2, P82; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Grosjean Stephane, 2006, Alytes (Paris), V23, P103; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Hollen LI, 2009, ANIM BEHAV, V78, P791, DOI 10.1016/j.anbehav.2009.07.021; Hoskin CJ, 2009, J ZOOL, V278, P36, DOI 10.1111/j.1469-7998.2009.00550.x; Hoskin C. J., 2010, ROAD IMPACTS ABUNDAN; Husson F, 2012, FACTOMINER MULTIVARI; Husson F., 2010, PRINCIPAL COMPONENT; Keller A, 2009, J ANIM ECOL, V78, P305, DOI 10.1111/j.1365-2656.2008.01457.x; KELLOGG WN, 1953, SCIENCE, V117, P239, DOI 10.1126/science.117.3036.239; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Legendre F, 2012, ANIM BEHAV, V83, P361, DOI 10.1016/j.anbehav.2011.11.003; Li JT, 2011, ASIAN HERPETOL RES, V2, P1, DOI 10.3724/SP.J.1245.2011.00001; Lingnau R, 2007, J NAT HIST, V41, P1227, DOI 10.1080/00222930701395626; Lugli M, 2010, J COMP PHYSIOL A, V196, P439, DOI 10.1007/s00359-010-0528-2; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9; Moore SE, 2012, BIOSCIENCE, V62, P289, DOI 10.1525/bio.2012.62.3.10; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Nogueira SSC, 2012, ETHOLOGY, V118, P1001, DOI 10.1111/eth.12001; Owings DH, 2010, ADV STUD BEHAV, V41, P119, DOI 10.1016/S0065-3454(10)41004-9; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Picciulin M, 2012, J ACOUST SOC AM, V132, P3118, DOI 10.1121/1.4756928; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; POULTER TC, 1963, SCIENCE, V139, P753, DOI 10.1126/science.139.3556.753; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reby D, 1999, CR ACAD SCI III-VIE, V322, P271, DOI 10.1016/S0764-4469(99)80063-8; Ryan M. J., 1985, TUNGARA FROG STUDY S; Shen JX, 2011, J COMP PHYSIOL A, V197, P1027, DOI 10.1007/s00359-011-0660-7; Shen JX, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1339; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Skroblin A, 2012, AUSTRAL ECOL, V37, P874, DOI 10.1111/j.1442-9993.2011.02331.x; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wcislo WT, 1997, ARE BEHAV CLASSIFICA; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	73	29	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78020	10.1371/journal.pone.0078020	http://dx.doi.org/10.1371/journal.pone.0078020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205070	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600059
J	Salo, S; Bitu, C; Merkku, K; Nyberg, P; Bello, IO; Vuoristo, J; Sutinen, M; Vahanikkila, H; Costea, DE; Kauppila, J; Lehenkari, P; Dayan, D; Vered, M; Risteli, J; Salo, T				Salo, Sirpa; Bitu, Carolina; Merkku, Kalle; Nyberg, Pia; Bello, Ibrahim O.; Vuoristo, Jussi; Sutinen, Meeri; Vahanikkila, Hannu; Costea, Daniela E.; Kauppila, Joonas; Lehenkari, Petri; Dayan, Dan; Vered, Marilena; Risteli, Juha; Salo, Tuula			Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion	PLOS ONE			English	Article							FETAL ANTIGEN-2 FA2; TUMOR MICROENVIRONMENT; BREAST-CANCER; STROMAL REACTION; PROSTATE-CANCER; I COLLAGEN; EXPRESSION; GROWTH; METASTASIS; FIBROBLASTS	Tumor microenvironment (TME) is an active player in carcinogenesis and changes in its composition modify cancer growth. Carcinoma-associated fibroblasts, bone marrow-derived multipotent mesenchymal stem cells (BMMSCs), and inflammatory cells can all affect the composition of TME leading to changes in proliferation, invasion and metastasis formation of carcinoma cells. In this study, we confirmed an interaction between BMMSCs and oral tongue squamous cell carcinoma (OTSCC) cells by analyzing the invasion progression and gene expression pattern. In a 3-dimensional myoma organotypic invasion model the presence of BMMSCs inhibited the proliferation but increased the invasion of OTSCC cells. Furthermore, the signals originating from OTSCC cells up-regulated the expression of inflammatory chemokines by BMMSCs, whereas BMMSC products induced the expression of known invasion linked molecules by carcinoma cells. Particularly, after the cell-cell interactions, the chemokine CCL5 was abundantly secreted from BMMSCs and a function blocking antibody against CCL5 inhibited BMMSC enhanced cancer invasion area. However, CCL5 blocking antibody did not inhibit the depth of invasion. Additionally, after exposure to BMMSCs, the expression of type I collagen mRNA in OTSCC cells was markedly up-regulated. Interestingly, also high expression of type I collagen N-terminal propeptide (PINP) in vivo correlated with the cancer-specific mortality of OTSCC patients, whereas there was no association between cancer tissue CCL5 levels and the clinical parameters. In conclusion, our results suggest that the interaction between BMMSC and carcinoma cells induce cytokine and matrix molecule expression, of which high level of type I collagen production correlates with the prognosis of OTSCC patients.	[Salo, Sirpa; Bitu, Carolina; Merkku, Kalle; Nyberg, Pia; Vuoristo, Jussi; Sutinen, Meeri; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Bello, Ibrahim O.] King Saud Univ, Coll Dent, Dept Oral Med & Diagnost Oral Sci, Riyadh, Saudi Arabia; [Vahanikkila, Hannu] Univ Oulu, Inst Dent, Dept Pedodont Cardiol & Endodontol, Oulu, Finland; [Costea, Daniela E.] Univ Bergen, Haukeland Hosp, Gade Inst, Sect Pathol, N-5021 Bergen, Norway; [Kauppila, Joonas] Univ Oulu, Dept Pathol, Oulu, Finland; [Kauppila, Joonas] Univ Oulu, Dept Surg, Oulu, Finland; [Kauppila, Joonas; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Dept Anat, Oulu, Finland; [Dayan, Dan; Vered, Marilena] Tel Aviv Univ, Sch Dent, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel; [Vered, Marilena] Chaim Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel; [Risteli, Juha] Univ Oulu, Dept Clin Chem, Inst Diagnost, Oulu, Finland; [Risteli, Juha] Oulu Univ Hosp, NordLab, Oulu, Finland; [Salo, Tuula] Univ Helsinki, Inst Dent, Helsinki, Finland; [Salo, Tuula] Med Res Ctr, Oulu, Finland	University of Oulu; King Saud University; University of Oulu; University of Bergen; Haukeland University Hospital; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tel Aviv University; Chaim Sheba Medical Center; University of Oulu; University of Oulu; University of Helsinki	Salo, T (corresponding author), Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland.	tuula.salo@oulu.fi	Kauppila, Joonas/P-1363-2015; , tuula/ABG-2051-2021; Costea, Daniela Elena/AAB-9705-2020; Bello, Ibrahim O./K-7274-2012; Lehenkari, Petri/O-3009-2016	Kauppila, Joonas/0000-0001-6740-3726; Bello, Ibrahim O./0000-0003-2085-3185; Lehenkari, Petri/0000-0002-0055-5183; Salo, Sirpa/0000-0002-4113-4000; Costea, Daniela-Elena/0000-0001-7673-0358; Salo, Tuula/0000-0001-6039-0088	Academy of Finland; Finnish Cancer Society; Sigrid Juselius Foundation; Finnish Dental Society Apollonia; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Dental Society Apollonia; Emil Aaltonen Foundation	This study has been supported by the Academy of Finland, the Finnish Cancer Society, the Sigrid Juselius Foundation, the Finnish Dental Society Apollonia, and the Emil Aaltonen Foundation grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Amaral TMP, 2004, ORAL ONCOL, V40, P780, DOI 10.1016/j.oraloncology.2003.10.009; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Benelli R, 2013, PROSTATE, V73, P941, DOI 10.1002/pros.22640; Camacho DF, 2012, CLIN CANCER RES, V18, P2801, DOI 10.1158/1078-0432.CCR-12-0366; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Dayan D, 2012, CANCER MED-US, V1, P128, DOI 10.1002/cam4.24; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hogan NM, 2012, INT J CANCER, V131, P1, DOI 10.1002/ijc.27458; Jensen BV, 2002, INT J CANCER, V98, P582, DOI 10.1002/ijc.10187; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Koh BI, 2012, EMBO REP, V13, P412, DOI 10.1038/embor.2012.41; Kulasekara KK, 2009, ARCH ORAL BIOL, V54, P924, DOI 10.1016/j.archoralbio.2009.07.004; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Kylmaniemi M, 1996, J DENT RES, V75, P919, DOI 10.1177/00220345960750030901; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Marin L, 2011, ANN CLIN BIOCHEM, V48, P447, DOI 10.1258/acb.2011.011040; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Nurmenniemi S, 2010, EXP CELL RES, V316, P2676, DOI 10.1016/j.yexcr.2010.05.024; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Ohtani H, 1998, PATHOL INT, V48, P1, DOI 10.1111/j.1440-1827.1998.tb03820.x; Parikka V, 2005, MATRIX BIOL, V24, P438, DOI 10.1016/j.matbio.2005.06.009; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; RASMUSSEN HB, 1991, TUMOR BIOL, V12, P330; RASMUSSEN HB, 1992, APMIS, V100, P39, DOI 10.1111/j.1699-0463.1992.tb00837.x; RISTELI J, 1993, CLIN CHEM, V39, P635; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Simojoki M, 2003, GYNECOL ONCOL, V88, P358, DOI 10.1016/S0090-8258(02)00139-7; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; TORNEHAVE D, 1992, ANAT EMBRYOL, V186, P271; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Vered M, 2011, NAT REV CANCER, V11, P382, DOI 10.1038/nrc2982-c1; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Vered M, 2010, CANCER SCI, V101, P274, DOI 10.1111/j.1349-7006.2009.01357.x; Wang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035101; Waterman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045590; Yamada S, 2010, INT J ORAL MAX SURG, V39, P61, DOI 10.1016/j.ijom.2009.10.003; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang YM, 2009, ONCOL REP, V21, P1113, DOI 10.3892/or_00000331	54	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77692	10.1371/journal.pone.0077692	http://dx.doi.org/10.1371/journal.pone.0077692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204919	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600041
J	Yi, J; Xiong, W; Gong, X; Bellister, S; Ellis, LM; Liu, QY				Yi, Jing; Xiong, Wei; Gong, Xing; Bellister, Seth; Ellis, Lee M.; Liu, Qingyun			Analysis of LGR4 Receptor Distribution in Human and Mouse Tissues	PLOS ONE			English	Article							WNT/BETA-CATENIN; STEM-CELLS; POSTNATAL-DEVELOPMENT; DOWN-REGULATION; HAIR FOLLICLE; GENE; GPR48; WNT; DIFFERENTIATION; EXPRESSION	LGR4 is an R-spondin receptor with strong positive effect on Wnt signaling. It plays a critical role in development as its ablation in the mouse led to total embryonic/neonatal lethality with profound defects in multiple organs. Haplotype insufficiency of LGR4 in human was associated with several diseases, including increased risk of squamous cell carcinoma of the skin, reduced birth weights, electrolyte imbalance, and decreased levels of testosterone, which are similar to the phenotypes of LGR4-hypomorphic mice. Tissue distribution of LGR4 was extensively analyzed in the mouse using gene-trap reporter enzyme alleles. However, its expression pattern in human tissues remained largely unknown. We have developed LGR4-specific monoclonal antibodies and used them to examine the expression of LGR4 in selected adult human and mouse tissues by immunohistochemical analysis. Intense LGR4-like immunoreactivity was observed in the epidermis and hair follicle of the skin, pancreatic islet cells, and epithelial cells in both the male and female reproductive organs. Of particular interest is that LGR4 is highly expressed in germ cells and pancreatic islet cells, which have important implications given the role of R-spondin-LGR4 signaling in the survival of adult stem cells. In addition, the majority of colon tumors showed elevated levels of LGR4 receptor. Overall, the expression pattern of LGR4 in human tissues mapped by this IHC analysis is similar to that in the mouse as revealed from gene trap alleles. Importantly, the pattern lends strong support to the important role of LGR4 in the development and maintenance of skin, kidney, reproductive systems, and other organs.	[Yi, Jing; Xiong, Wei; Gong, Xing; Liu, Qingyun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Yi, Jing; Xiong, Wei; Gong, Xing; Liu, Qingyun] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Bellister, Seth; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Liu, QY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Qingyun.Liu@uth.tmc.edu	Yi, Jing/S-2586-2016	Yi, Jing/0000-0001-5037-1924	Cancer Prevention and Research Institute of Texas [RP100678]; National Institute of Health [R01GM102485]; Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102485] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant RP100678 from the Cancer Prevention and Research Institute of Texas (http://www.cprit.state.tx.us/), Grant R01GM102485 form the National Institute of Health (http://www.nih.gov/), and the Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Klauzinska M, 2012, J CELL PHYSIOL, V227, P1960, DOI 10.1002/jcp.22924; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Srinivasan V, 2002, ACTA CRYSTALLOGR D, V58, P867, DOI 10.1107/S0907444902005012; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wong VSC, 2010, J BIOL CHEM, V285, P21292, DOI 10.1074/jbc.M110.129874; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900	40	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78144	10.1371/journal.pone.0078144	http://dx.doi.org/10.1371/journal.pone.0078144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205130	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600074
J	Liu, SQ; Roberts, D; Zhang, B; Ren, YP; Zhang, LQ; Wu, YH				Liu, Shu Q.; Roberts, Derek; Zhang, Brian; Ren, Yupeng; Zhang, Li-Qun; Wu, Yu H.			Trefoil Factor 3 as an Endocrine Neuroprotective Factor from the Liver in Experimental Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ARTERIAL ELASTIC LAMINAE; TNF-ALPHA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPERIMENTAL COLITIS; INCREASED EXPRESSION; ISCHEMIC-STROKE; RAT HIPPOCAMPUS; GENE-EXPRESSION; BRAIN	Cerebral ischemia, while causing neuronal injury, can activate innate neuroprotective mechanisms, minimizing neuronal death. In this report, we demonstrate that experimental cerebral ischemia/reperfusion injury in the mouse causes upregulation of the secretory protein trefoil factor 3 (TFF3) in the hepatocyte in association with an increase in serum TFF3. Partial hepatectomy (similar to 60% liver resection) immediately following cerebral injury significantly lowered the serum level of TFF3, suggesting a contribution of the liver to the elevation of serum TFF3. Compared to wild-type mice, TFF3(-/-) mice exhibited a significantly higher activity of caspase 3 and level of cell death in the ischemic cerebral lesion, a larger fraction of cerebral infarcts, and a smaller fraction of the injured cerebral hemisphere, accompanied by severer forelimb motor deficits. Intravenous administration of recombinant TFF3 reversed changes in cerebral injury and forelimb motor function due to TFF3 deficiency. These observations suggest an endocrine neuroprotective mechanism involving TFF3 from the liver in experimental cerebral ischemia/reperfusion injury.	[Liu, Shu Q.; Roberts, Derek; Zhang, Brian; Wu, Yu H.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Ren, Yupeng; Zhang, Li-Qun] Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab	Liu, SQ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	sliu@northwestern.edu	Liu, Shu Q/B-7626-2009; Wu, Ying/B-7283-2009		National Science Foundation [0932131]; Div Of Chem, Bioeng, Env, & Transp Sys [0932131] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation (grant number 0932131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Ali C, 2001, J CEREBR BLOOD F MET, V21, P820, DOI 10.1097/00004647-200107000-00007; Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252; Ata KA, 1999, ACTA NEUROPATHOL, V97, P447, DOI 10.1007/s004010051013; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bhuiyan Mohammad Iqbal Hossain, 2010, Int Neurourol J, V14, P203, DOI 10.5213/inj.2010.14.4.203; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Burmeister M, 1997, MAMM GENOME, V8, P223, DOI 10.1007/s003359900637; Chinery R, 1996, GENE, V171, P249, DOI 10.1016/0378-1119(96)00074-1; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; COYLE P, 1982, STROKE, V13, P855, DOI 10.1161/01.STR.13.6.855; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163; Goldman J, 2003, AM J PHYSIOL-HEART C, V284, pH1839, DOI 10.1152/ajpheart.00470.2002; Gott P, 1996, EUR J HUM GENET, V4, P308; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; He X, 2012, CELL MOL LIFE SCI; Hertel SC, 2004, PEPTIDES, V25, P755, DOI 10.1016/j.peptides.2003.11.021; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2007, DIGEST DIS SCI, V52, P1050, DOI 10.1007/s10620-006-9256-4; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; Lee JC, 2013, BRAIN RES, V1510, P78, DOI 10.1016/j.brainres.2013.03.008; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Liu D, 1997, LAB INVEST, V77, P557; Liu J, 2000, AM J PHYSIOL-CELL PH, V278, pC144, DOI 10.1152/ajpcell.2000.278.1.C144; Liu SQ, 2008, MATRIX BIOL, V27, P282, DOI 10.1016/j.matbio.2008.01.001; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Liu Shu Q, 2010, Front Biosci (Elite Ed), V2, P711, DOI 10.2741/e131; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu SQ, 2009, CURRENT TOPICS BIOCH, V11, P65; Liu SQ, 2012, J CLIN EXP CARDIOL S, VS7; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Mahmood A, 2005, ALIMENT PHARM THER, V21, P1357, DOI 10.1111/j.1365-2036.2005.02436.x; Martins PNA, 2008, LIVER INT, V28, P3, DOI 10.1111/j.1478-3231.2007.01628.x; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; OSYPIW JC, 1994, BIOCHEM J, V304, P617, DOI 10.1042/bj3040617; Perez-Pinzon MA, 2007, COMP BIOCHEM PHYS A, V147, P291, DOI 10.1016/j.cbpa.2006.08.032; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Probst JC, 1996, FASEB J, V10, P1518, DOI 10.1096/fasebj.10.13.8940297; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schroeter M, 2003, MOL BRAIN RES, V117, P1, DOI 10.1016/S0169-328X(03)00255-9; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Sommer C, 2003, ACTA NEUROPATHOL, V105, P197, DOI 10.1007/s00401-002-0632-7; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Teng X, 2009, INFLAMMATION, V32, P120, DOI 10.1007/s10753-009-9110-x; Truettner J, 2002, MOL BRAIN RES, V103, P106, DOI 10.1016/S0169-328X(02)00191-2; Vandenbroucke K, 2004, GASTROENTEROLOGY, V127, P502, DOI 10.1053/j.gastro.2004.05.020; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Zhang Y, 2001, LIFE SCI, V68, P1013, DOI 10.1016/S0024-3205(00)01004-3; Zhou AM, 2004, NEUROSCI RES, V48, P397, DOI 10.1016/j.neures.2003.12.010; Zhu Y, 2001, NEUROSCIENCE, V107, P593, DOI 10.1016/S0306-4522(01)00357-8	80	21	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77732	10.1371/journal.pone.0077732	http://dx.doi.org/10.1371/journal.pone.0077732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204940	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300111
J	Voorhees, JL; Powell, ND; Moldovan, L; Mo, XK; Eubank, TD; Marsh, CB				Voorhees, Jeffrey L.; Powell, Nicole D.; Moldovan, Leni; Mo, Xiaokui; Eubank, Timothy D.; Marsh, Clay B.			Chronic Restraint Stress Upregulates Erythropoiesis through Glucocorticoid Stimulation	PLOS ONE			English	Article							VULGARIS PROPHYLACTIC TREATMENT; GENE-EXPRESSION; PSYCHOLOGICAL STRESS; ERYTHROID-CELLS; ADRENAL AXIS; STEM-CELL; DEPRESSION; RECEPTOR; MICE; BLOOD	In response to elevated glucocorticoid levels, erythroid progenitors rapidly expand to produce large numbers of young erythrocytes. Previous work demonstrates hematopoietic changes in rodents exposed to various physical and psychological stressors, however, the effects of chronic psychological stress on erythropoiesis has not be delineated. We employed laboratory, clinical and genomic analyses of a murine model of chronic restraint stress (RST) to examine the influence of psychological stress on erythropoiesis. Mice exposed to RST demonstrated markers of early erythroid expansion involving the glucocorticoid receptor. In addition, these RST-exposed mice had increased numbers of circulating reticulocytes and increased erythropoiesis in primary and secondary erythroid tissues. Mice also showed increases in erythroid progenitor populations and elevated expression of the erythroid transcription factor KLF1 in these cells. Together this work reports some of the first evidence of psychological stress affecting erythroid homeostasis through glucocorticoid stimulation.	[Voorhees, Jeffrey L.; Moldovan, Leni; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Voorhees, Jeffrey L.; Moldovan, Leni; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Powell, Nicole D.] Ohio State Univ, Coll Dent, Sect Oral Biol, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; Clay.Marsh@osumc.edu		Moldovan, Leni/0000-0003-1967-2408; Eubank, Tim/0000-0002-8225-7824	National Institutes of Health (NIH) [T32 HL07946, NIH R01 HL067176, NIH R01 HL102464]; TDE; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102464, R01HL067176, T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TDE; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) T32 HL07946, NIH R01 HL067176, NIH R01 HL102464, and startup funds from TDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Anisman H, 1998, BRAIN RES, V779, P177, DOI 10.1016/S0006-8993(97)01114-1; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Bauer ME, 2001, PHYSIOL BEHAV, V73, P525, DOI 10.1016/S0031-9384(01)00503-0; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dumitriu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012088; Dygai AM, 2011, B EXP BIOL MED+, V151, P171, DOI 10.1007/s10517-011-1282-3; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Ganguli G, 2002, EMBO REP, V3, P569, DOI 10.1093/embo-reports/kvf114; GOLDE DW, 1976, J CLIN INVEST, V57, P57, DOI 10.1172/JCI108269; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; HOLM S, 1979, SCAND J STAT, V6, P65; Kelly JJ, 2000, J HUM HYPERTENS, V14, P195, DOI 10.1038/sj.jhh.1000959; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Klinsey SG, 2007, BRAIN BEHAV IMMUN, V21, P458, DOI 10.1016/j.bbi.2006.11.001; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Landmark-Hoyvik H, 2009, PHARMACOGENOMICS J, V9, P333, DOI 10.1038/tpj.2009.27; Li YJ, 2012, BIOL TRACE ELEM RES, V147, P285, DOI 10.1007/s12011-011-9319-z; Lim GB, 1996, ENDOCRINOLOGY, V137, P1658, DOI 10.1210/en.137.5.1658; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Maes M, 1996, J AFFECT DISORDERS, V40, P23, DOI 10.1016/0165-0327(96)00038-9; Malacrida SA, 1997, IMMUNOPHARM IMMUNOT, V19, P523; Malacrida SA, 1997, INT J IMMUNOPHARMACO, V19, P227, DOI 10.1016/S0192-0561(97)00029-5; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Queiroz JD, 2004, IMMUNOPHARM IMMUNOT, V26, P455, DOI 10.1081/IPH-200026914; Queiroz JD, 2008, BRAIN BEHAV IMMUN, V22, P1056, DOI 10.1016/j.bbi.2008.03.002; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Sato S, 2010, INT J LAB HEMATOL, V32, pE137, DOI 10.1111/j.1751-553X.2009.01148.x; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Solomon MB, 2011, NEUROSCIENCE; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tang JI, 2011, ENDOCRINOLOGY, V152, P2716, DOI 10.1210/en.2010-1443; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; TURNEY TH, 1984, PHYSIOL BEHAV, V33, P559, DOI 10.1016/0031-9384(84)90371-8; UDUPA KB, 1986, BRIT J HAEMATOL, V62, P705, DOI 10.1111/j.1365-2141.1986.tb04094.x; van West Dirk, 1999, Neuro Endocrinol Lett, V20, P11; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	55	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77935	10.1371/journal.pone.0077935	http://dx.doi.org/10.1371/journal.pone.0077935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205034	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300126
J	Allen, CL; Clare, G; Stewart, EA; Branch, MJ; McIntosh, OD; Dadhwal, M; Dua, HS; Hopkinson, A				Allen, Claire L.; Clare, Gerry; Stewart, Elizabeth A.; Branch, Matthew J.; McIntosh, Owen D.; Dadhwal, Megha; Dua, Harminder S.; Hopkinson, Andrew			Augmented Dried versus Cryopreserved Amniotic Membrane as an Ocular Surface Dressing	PLOS ONE			English	Article							HUMAN CORNEAL; STEM-CELLS; MYOFIBROBLAST DIFFERENTIATION; PLACENTAL MEMBRANES; IN-VITRO; EX-VIVO; TRANSPLANTATION; RECONSTRUCTION; TREHALOSE; SUPPRESSION	Purpose: Dried amniotic membrane (AM) can be a useful therapeutic adjunct in ophthalmic surgery and possesses logistical advantages over cryopreserved AM. Differences in preservation techniques can significantly influence the biochemical composition and physical properties of AM, potentially affecting clinical efficacy. This study was established to investigate the biochemical and structural effects of drying AM in the absence and presence of saccharide lyoprotectants and its biocompatibility compared to cryopreserved material. Methods: AM was cryopreserved or dried with and without pre-treatment with trehalose or raffinose and the antioxidant epigallocatechin (EGCG). Structural and visual comparisons were assessed using electron microscopy. Localisation, expression and release of AM biological factors were determined using immunoassays and immunofluorescence. The biocompatibility of the AM preparations co-cultured with corneal epithelial cell (CEC) or keratocyte monolayers were assessed using cell proliferation, cytotoxicity, apoptosis and migration assays. Results: Drying devitalised AM epithelium, but less than cryopreservation and cellular damage was reduced in dried AM pre-treated with trehalose or raffinose. Dried AM alone, and with trehalose or raffinose showed greater factor retention efficiencies and bioavailability compared to cryopreserved AM and demonstrated a more sustained biochemical factor time release in vitro. Cellular health assays showed that dried AM with trehalose or raffinose are compatible and superior substrates compared to cryopreserved AM for primary CEC expansion, with increased proliferation and reduced LDH and caspase-3 levels. This concept was supported by improved wound healing in an immortalised human CEC line (hiCEC) cocultured with dried and trehalose or raffinose membranes, compared to cryopreserved and fresh AM. Conclusions: Our modified preservation process and our resultant optimised dried AM has enhanced structural properties and biochemical stability and is a superior substrate to conventional cryopreserved AM. In addition this product is stable and easily transportable allowing it to be globally wide reaching for use in clinical and military sectors.	[Allen, Claire L.; Clare, Gerry; Stewart, Elizabeth A.; Branch, Matthew J.; McIntosh, Owen D.; Dadhwal, Megha; Dua, Harminder S.; Hopkinson, Andrew] Univ Nottingham, Div Clin Neurosci, Nottingham NG7 2RD, England	University of Nottingham	Hopkinson, A (corresponding author), Univ Nottingham, Div Clin Neurosci, Nottingham NG7 2RD, England.	andrew.hopkinson@nottingham.ac.uk	Branch, Matthew/AAE-9105-2019; Verma, Megha/I-3172-2019; Stewart, Elizabeth/K-5013-2014	Branch, Matthew James/0000-0002-8734-0037; Verma, Megha/0000-0001-7767-612X; Stewart, Elizabeth A/0000-0002-6248-4464	University of Nottingham; Defence Science & Technology Laboratory [RC23AX]	University of Nottingham; Defence Science & Technology Laboratory	This work has been supported by the University of Nottingham and the Defence Science & Technology Laboratory (RC23AX), https://www.dstl.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonovska D, 2008, Prilozi, V29, P183; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arora R, 2005, EYE, V19, P273, DOI 10.1038/sj.eye.6701490; Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519; Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673; Calvin SE, 2007, ANN NY ACAD SCI, V1101, P166, DOI 10.1196/annals.1389.009; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064; Davis JS, 1910, SKIN TRANSPLANTATION; de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; FISHMAN IJ, 1987, J UROLOGY, V138, P1291, DOI 10.1016/S0022-5347(17)43586-5; Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432; Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783; Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415; Hopkinson A, 2006, J PROTEOME RES, V5, P2226, DOI 10.1021/pr050425q; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Jang IK, 2006, ARTIF ORGANS, V30, P424, DOI 10.1111/j.1525-1594.2006.00237.x; Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0; Kitagawa K, 2009, AM J OPHTHALMOL, V148, P383, DOI 10.1016/j.ajo.2009.03.030; Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6; Kobayashi N, 2002, CORNEA, V21, P62, DOI 10.1097/00003226-200201000-00014; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; LAWSON VG, 1985, ARCH OTOLARYNGOL, V111, P230; Liang HS, 2009, J NEUROTRAUM, V26, P1745, DOI [10.1089/neu.2008.0850, 10.1089/neu.2008-0850]; Libera RD, 2008, ARQ BRAS OFTALMOL, V71, P669, DOI 10.1590/S0004-27492008000500011; Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222; Lopez-Valladares MJ, 2010, ACTA OPHTHALMOL, V88, pe211, DOI 10.1111/j.1755-3768.2010.01908.x; Matsuo T, 2001, BRIT J OPHTHALMOL, V85, P610, DOI 10.1136/bjo.85.5.610; Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Niknejad H, 2008, EUR CELLS MATER, V15, P88; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; QUINBY WC, 1982, PLAST RECONSTR SURG, V70, P711, DOI 10.1097/00006534-198212000-00009; Rejzek A., 2001, Cell and Tissue Banking, V2, P95, DOI 10.1023/A:1014316232009; Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001; Saw VPJ, 2007, BRIT J OPHTHALMOL, V91, P1042, DOI 10.1136/bjo.2006.098525; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Sekiyama E, 2007, INVEST OPHTH VIS SCI, V48, P1528, DOI 10.1167/iovs.06-1104; Shanmuganathan VA, 2006, BRIT J OPHTHALMOL, V90, P55, DOI 10.1136/bjo.2005.071910; Singh Rita, 2004, Cell and Tissue Banking, V5, P129, DOI 10.1023/B:CATB.0000034077.05000.29; Solomon A, 2005, CLIN EXP ALLERGY, V35, P941, DOI 10.1111/j.1365-2222.2005.02285.x; Srinivas S, 2007, EUR J OPHTHALMOL, V17, P7, DOI 10.1177/112067210701700102; Rodriguez-Ares MT, 2009, ACTA OPHTHALMOL, V87, P396, DOI 10.1111/j.1755-3768.2008.01261.x; Thiex NW, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-117; Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X; Tuncer PB, 2011, THERIOGENOLOGY, V75, P1459, DOI 10.1016/j.theriogenology.2010.12.006; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306	54	58	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78441	10.1371/journal.pone.0078441	http://dx.doi.org/10.1371/journal.pone.0078441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205233	Green Published, gold			2022-12-25	WOS:000326334500119
J	Choudhary, AK; Rennie, J; Cairns, C; Borthwick, G; Hughes, J; Morton, NM; Kluth, D; Conway, BR				Choudhary, Abhijeet K.; Rennie, Jillian; Cairns, Carolynn; Borthwick, Gary; Hughes, Jeremy; Morton, Nicholas M.; Kluth, David; Conway, Bryan R.			Administration of Heme Arginate Ameliorates Murine Type 2 Diabetes Independently of Heme Oxygenase Activity	PLOS ONE			English	Article							PANCREATIC BETA-CELL; METABOLISM	Amelioration of rodent type 2 diabetes by hemin has been linked to increased heme oxygenase (HO) activity, however alternative mechanisms have recently been proposed for its anti-diabetic effect. We sought to determine the anti-diabetic efficacy of heme arginate (HA), a clinically licensed preparation of heme, and whether its predominant mode of action is via increased HO activity. Intravenous administration of HA reduced hyperglycemia in diabetic (db/db) mice. Co-administration of the HO inhibitor stannous (IV) mesoporphyrin IX dichloride (SM) resulted unexpectedly in a further improvement in glycaemic control despite restoring HO activity to baseline levels. The anti-diabetic effects of HA+/-SM were associated with increased adiposity, increased serum adiponectin levels, reduced adipose tissue and islet inflammation and preservation of islet beta-cell function. HO activity independent effects of HA on adipogenesis and beta-cell inflammation were further confirmed in cell culture models using the 3T3-L1 pre-adipocyte and MIN6 beta-cell lines, respectively. In conclusion, our work demonstrates that the heme component of HA ameliorates experimental type 2 diabetes by promoting metabolically favourable adipogenesis and preserving islet beta-cell function, but this is not mediated via increased HO activity.	[Choudhary, Abhijeet K.; Borthwick, Gary; Hughes, Jeremy; Kluth, David; Conway, Bryan R.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rennie, Jillian; Cairns, Carolynn; Morton, Nicholas M.; Conway, Bryan R.] Univ Edinburgh, Queens Med Res Inst, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Conway, BR (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	bryan.conway@ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020	Hughes, Jeremy/0000-0002-3470-0422	Clinician Scientist Fellowship from the Medical Research Council [Mrc G0501900]; University of Edinburgh Centre for Inflammation Research; MTEM Ltd, a University of Edinburgh spin-out company; Medical Research Council [G0501900] Funding Source: researchfish	Clinician Scientist Fellowship from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Centre for Inflammation Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MTEM Ltd, a University of Edinburgh spin-out company; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BC was supported by a Clinician Scientist Fellowship from the Medical Research Council (Mrc G0501900, www.mrc.ac.uk). AC was supported by a studentship from the University of Edinburgh Centre for Inflammation Research (www.cir.ed.ac.uk) and a scholarship from MTEM Ltd, a University of Edinburgh spin-out company. The funders of the current work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038626; Kato Y, 2003, DIABETOLOGIA, V46, P1228, DOI 10.1007/s00125-003-1173-x; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; LAZAR MA, 1999, J ANIM SCI S3, V77, P16, DOI DOI 10.2527/1999.77SUPPL_316X; Li M, 2008, DIABETES; McNally SJ, 2004, ANAL BIOCHEM, V332, P398, DOI 10.1016/j.ab.2004.06.024; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2627, DOI 10.1210/en.2008-1370; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; TENHUNEN R, 1987, J PHARM PHARMACOL, V39, P780, DOI 10.1111/j.2042-7158.1987.tb05119.x; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; TOKOLA O, 1986, BRIT J CLIN PHARMACO, V22, P331, DOI 10.1111/j.1365-2125.1986.tb02895.x; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78209	10.1371/journal.pone.0078209	http://dx.doi.org/10.1371/journal.pone.0078209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205160	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500103
J	Peterson, SW; Jurjevic, Z				Peterson, Stephen W.; Jurjevic, Zeljko			Talaromyces columbinus sp nov., and Genealogical Concordance Analysis in Talaromyces Clade 2a	PLOS ONE			English	Article							PENICILLIUM-PICEUM; TAXONOMY	During the course of mold surveys, a set of Talaromyces isolates were obtained that did not fit any described species. Phenotypic examination of these isolates showed that they were similar to T. piceus but differed in some growth characteristics. Multilocus DNA sequence data were obtained for the new isolates and some related species in the broader, more inclusive clade, and the data were analyzed using genealogical concordance. The new isolates are described as Talaromyces columbinus. From analysis of the related species, Penicillium rugulosum var. atricolum is given species status in Talaromyces as T. atricola. Penicillium tardum and P. chrysitis were showed to be synonyms of T. rugulosus. Penicillium scorteum and T. phialosporus were showed to be conspecific and under the rule of priority T. scorteus is the proper name for isolates previously known as T. phialosporus. Talaromyces wortmanii was showed to be distinct from Penicillium concavorugulosum and T. variabilis but the relationship of the latter two species remains unresolved. Examination of ITS sequences from GenBank showed that T. columbinus has previously been reported from human lung infections under the name Penicillium piceum.	[Peterson, Stephen W.] USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL USA; [Jurjevic, Zeljko] EMSL Analyt Inc, Cinnaminson, NJ USA	United States Department of Agriculture (USDA)	Peterson, SW (corresponding author), USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL USA.	Stephen.Peterson@ars.usda.gov						BERBEE ML, 1995, MYCOLOGIA, V87, P210, DOI 10.2307/3760907; De Ravin SS, 2011, CLIN INFECT DIS, V52, pE136, DOI 10.1093/cid/ciq250; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Eremin AN, 2008, APPL BIOCHEM MICRO+, V44, P590, DOI 10.1134/S0003683808060069; FRISVAD JC, 1990, NATO ADV SCI I A-LIF, V185, P83; Horn BW, 2013, MYCOLOGIA, V105, P1153, DOI 10.3852/13-101; Horre R, 2001, MYCOSES, V44, P502, DOI 10.1046/j.1439-0507.2001.00710.x; Hubka V, 2012, PERSOONIA, V29, P1, DOI 10.3767/003158512X658123; Manoch L, 2013, MYCOSCIENCE; McNeill J, 2012, REGNUM VEG, V154, P1; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pitt J.I., 2000, INTEGRATION MODERN T, P9; Pitt J. I., 1980, GENUS PENICILLIUM IT; Pitt JI, 1993, NAMES CURRENT USE FA, P13; Raper KB, 1949, MANUAL PENICILLIA; Ridgway R., 1912, COLOR STANDARDS COLO; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Santos PE, 2006, MED MYCOL, V44, P749, DOI 10.1080/13693780600967089; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sidrim JJC, 2010, J APPL MICROBIOL, V108, P1751, DOI 10.1111/j.1365-2672.2009.04573.x; Soares C, 2012, MYCOLOGIA, V104, P682, DOI 10.3852/11-088; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thom C, 1930, PENICILLIA; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trehane P., 1994, REGNUM VEGETABILE, V131; Ugaki N, 2012, J ANTIBIOT, V65, P15, DOI 10.1038/ja.2011.105; Visagie CM, 2012, PERSOONIA, V28, P14, DOI 10.3767/003158512X632455; Yilmaz N, 2012, PERSOONIA, V29, P39, DOI 10.3767/003158512X659500	30	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78084	10.1371/journal.pone.0078084	http://dx.doi.org/10.1371/journal.pone.0078084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205102	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500093
J	Rasmussen, JM; Entringer, S; Nguyen, A; van Erp, TGM; Guijarro, A; Oveisi, F; Swanson, JM; Piomelli, D; Wadhwa, PD; Buss, C; Potkin, SG				Rasmussen, Jerod M.; Entringer, Sonja; Nguyen, Annie; van Erp, Theo G. M.; Guijarro, Ana; Oveisi, Fariba; Swanson, James M.; Piomelli, Daniele; Wadhwa, Pathik D.; Buss, Claudia; Potkin, Steven G.			Brown Adipose Tissue Quantification in Human Neonates Using Water-Fat Separated MRI	PLOS ONE			English	Article							3-POINT DIXON METHOD; IDENTIFICATION; RELIABILITY; MICE	There is a major resurgence of interest in brown adipose tissue (BAT) biology, particularly regarding its determinants and consequences in newborns and infants. Reliable methods for non-invasive BAT measurement in human infants have yet to be demonstrated. The current study first validates methods for quantitative BAT imaging of rodents post mortem followed by BAT excision and re-imaging of excised tissues. Identical methods are then employed in a cohort of in vivo infants to establish the reliability of these measures and provide normative statistics for BAT depot volume and fat fraction. Using multi-echo water-fat MRI, fat-and water-based images of rodents and neonates were acquired and ratios of fat to the combined signal from fat and water (fat signal fraction) were calculated. Neonatal scans (n = 22) were acquired during natural sleep to quantify BAT and WAT deposits for depot volume and fat fraction. Acquisition repeatability was assessed based on multiple scans from the same neonate. Intra-and inter-rater measures of reliability in regional BAT depot volume and fat fraction quantification were determined based on multiple segmentations by two raters. Rodent BAT was characterized as having significantly higher water content than WAT in both in situ as well as ex vivo imaging assessments. Human neonate deposits indicative of bilateral BAT in spinal, supraclavicular and axillary regions were observed. Pairwise, WAT fat fraction was significantly greater than BAT fat fraction throughout the sample (Delta(WAT-BAT) = 38%, p<10(-4)). Repeated scans demonstrated a high voxelwise correlation for fat fraction (R-all = 0.99). BAT depot volume and fat fraction measurements showed high intra-rater (ICCBAT,VOL = 0.93, ICCBAT,FF = 0.93) and inter-rater reliability (ICCBAT,VOL = 0.86, ICCBAT,FF = 0.93). This study demonstrates the reliability of using multi-echo water-fat MRI in human neonates for quantification throughout the torso of BAT depot volume and fat fraction measurements.	[Rasmussen, Jerod M.; van Erp, Theo G. M.; Wadhwa, Pathik D.; Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Entringer, Sonja; Nguyen, Annie; Swanson, James M.; Wadhwa, Pathik D.; Buss, Claudia] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Guijarro, Ana; Oveisi, Fariba; Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Piomelli, Daniele] Inst Italiano Tecnol Italian, Genoa, Italy; [Buss, Claudia] Charite, Dept Med Psychol, Berlin, Germany	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buss, C (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	claudia.buss@charite.de; sgpotkin@uci.edu	Entringer, Sonja/ABB-9405-2020; Buss, Claudia/ABC-3687-2020	GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Potkin, Steven/0000-0003-1028-1013; Entringer, Sonja/0000-0002-9926-7076; Buss, Claudia/0000-0002-8738-3133	National Institutes of Health [RO1 MH-091351, RO1 HD-065825, R21 DK-098765]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK098765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this project was supported by National Institutes of Health grants RO1 MH-091351 to CB, RO1 HD-065825 to SE, and R21 DK-098765 to SE and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1964, P ROY SOC MED, V57, P1172, DOI 10.1177/003591576405701226; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Berglund J, 2010, MAGN RESON MED, V63, P1659, DOI 10.1002/mrm.22385; Carter Brett W, 2008, Proc (Bayl Univ Med Cent), V21, P328; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Holstila M, 2013, METABOLISM, V62, P1189, DOI 10.1016/j.metabol.2013.03.002; Hu HH, 2011, FRONT ENDOCRINOL, V2, P1; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Hu HH, 2012, MAGN RESON IMAGING, V20, P323, DOI 10.1016/j.mri.2011.12.004; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Hu HH, 2012, MAGN RESON MED, V68, P378, DOI 10.1002/mrm.24369; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Khanna A, 2012, MAGN RESON MED, V68, P1285, DOI 10.1002/mrm.24118; Lau AZ, 2014, INT J OBESITY, V38, P126, DOI 10.1038/ijo.2013.58; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lunati E, 1999, J LIPID RES, V40, P1395; Ma JF, 2004, MAGN RESON MED, V52, P415, DOI 10.1002/mrm.20146; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Peng XG, 2013, AM J PHYSIOL-ENDOC M, V304, pE160, DOI 10.1152/ajpendo.00401.2012; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; RYLANDER E, 1972, ACTA PAEDIATR SCAND, V61, P42, DOI 10.1111/j.1651-2227.1972.tb15901.x; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Steidle G, 2011, MAGN RESON MED, V65, P1119, DOI 10.1002/mrm.22699; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang Y, 1998, JMRI-J MAGN RESON IM, V8, P703, DOI 10.1002/jmri.1880080329; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	37	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77907	10.1371/journal.pone.0077907	http://dx.doi.org/10.1371/journal.pone.0077907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205024	Green Published, gold			2022-12-25	WOS:000326334500076
J	Campbell, N; Sinagra, G; Jones, KL; Slavov, D; Gowan, K; Merlo, M; Carniel, E; Fain, PR; Aragona, P; Di Lenarda, A; Mestroni, L; Taylor, MRG				Campbell, Nzali; Sinagra, Gianfranco; Jones, Kenneth L.; Slavov, Dobromir; Gowan, Katherine; Merlo, Marco; Carniel, Elisa; Fain, Pamela R.; Aragona, Pierluigi; Di Lenarda, Andrea; Mestroni, Luisa; Taylor, Matthew R. G.			Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE; VARIANTS; FREQUENCY; DIAGNOSIS; CAPTURE	Dilated cardiomyopathy (DCM) commonly causes heart failure and shows extensive genetic heterogeneity that may be amenable to newly developed next-generation DNA sequencing of the exome. In this study we report the successful use of exome sequencing to identify a pathogenic variant in the TNNT2 gene using segregation analysis in a large DCM family. Exome sequencing was performed on three distant relatives from a large family with a clear DCM phenotype. Missense, nonsense, and splice variants were analyzed for segregation among the three affected family members and confirmed in other relatives by direct sequencing. A c.517T C>T, Arg173Trp TNNT2 variant segregated with all affected family members and was also detected in one additional DCM family in our registry. The inclusion of segregation analysis using distant family members markedly improved the bioinformatics filtering process by removing from consideration variants that were not shared by all affected subjects. Haplotype analysis confirmed that the variant found in both DCM families was located on two distinct haplotypes, supporting the notion of independent mutational events in each family. In conclusion, an exome sequencing strategy that includes segregation analysis using distant affected relatives within a family represents a viable diagnostic strategy in a genetically heterogeneous disease like DCM.	[Campbell, Nzali; Slavov, Dobromir; Carniel, Elisa; Mestroni, Luisa; Taylor, Matthew R. G.] Univ Colorado, Cardiovasc Inst & Adult Med Genet, Aurora, CO 80045 USA; [Sinagra, Gianfranco; Merlo, Marco; Di Lenarda, Andrea] Osped Riuniti, Cardiovasc Dept, Trieste, Italy; [Sinagra, Gianfranco; Merlo, Marco; Di Lenarda, Andrea] Univ Trieste, Trieste, Italy; [Jones, Kenneth L.; Gowan, Katherine] Univ Colorado, Sch Med, Ctr Canc, Aurora, CO USA; [Jones, Kenneth L.; Gowan, Katherine] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA; [Aragona, Pierluigi] Osped Trebisacce, Cardiol Unit, Cosenza, Italy	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Trieste; University of Trieste; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mestroni, L (corresponding author), Univ Colorado, Cardiovasc Inst & Adult Med Genet, Aurora, CO 80045 USA.	Luisa.Mestroni@ucdenver.edu; matthew.taylor@ucdenver.edu	Di Lenarda, Andrea/AAC-2377-2022; sinagra, gianfranco gs/P-7643-2014; Jones, Kenneth/GXF-4945-2022; Sinagra, Gianfranco/AAE-3943-2020	Di Lenarda, Andrea/0000-0001-8482-4872; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Mestroni, Luisa/0000-0003-1116-2286	NIH [1R01HL109209]; NIH/NCRR Colorado CTSI [UL1 RR025780]; AHA [12GRNT11770055];  [R01HL69071]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069071, R01HL109209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was supported by NIH 1R01HL109209 (MT), R01HL69071, NIH/NCRR Colorado CTSI Grant Number UL1 RR025780, and AHA 12GRNT11770055 (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Jachymova M, 2012, PHYSIOL RES, V61, P169, DOI 10.33549/physiolres.932157; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Jordan DM, 2011, AM J HUM GENET, V88, P183, DOI 10.1016/j.ajhg.2011.01.011; Judge DP, 2009, JAMA-J AM MED ASSOC, V302, P2471, DOI 10.1001/jama.2009.1787; Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Majewski J, 2011, J MED GENET, V48, P593, DOI 10.1136/jmedgenet-2011-100288; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235; Morimoto S, 2007, ADV EXP MED BIOL, V592, P227; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Schrader KA, 2011, J PATHOL, V225, P12, DOI 10.1002/path.2941; Stefanelli CB, 2004, MOL GENET METAB, V83, P188, DOI 10.1016/j.ymgme.2004.04.013; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Theis JL, 2011, CIRC-CARDIOVASC GENE, V4, P585, DOI 10.1161/CIRCGENETICS.111.961052; Van Acker H, 2010, INT J CARDIOL, V144, P307, DOI 10.1016/j.ijcard.2009.03.003; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watkins D, 2011, J MED GENET, V48, P590, DOI 10.1136/jmedgenet-2011-100286; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	33	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78104	10.1371/journal.pone.0078104	http://dx.doi.org/10.1371/journal.pone.0078104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205113	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700075
J	Brown, RS; Deng, ZD; Cook, KV; Pflugrath, BD; Li, XY; Fu, T; Martinez, JJ; Li, HD; Trumbo, BA; Ahmann, ML; Seaburg, AG				Brown, Richard S.; Deng, Z. Daniel; Cook, Katrina V.; Pflugrath, Brett D.; Li, Xinya; Fu, Tao; Martinez, Jayson J.; Li, Huidong; Trumbo, Bradly A.; Ahmann, Martin L.; Seaburg, Adam G.			A Field Evaluation of an External and Neutrally Buoyant Acoustic Transmitter for Juvenile Salmon: Implications for Estimating Hydroturbine Passage Survival	PLOS ONE			English	Article							HYDRO-TURBINE PASSAGE; CHINOOK SALMON; SWIMMING PERFORMANCE; SNAKE RIVER; COLUMBIA RIVER; TELEMETRY TRANSMITTERS; ATTACHED TRANSMITTERS; ANADROMOUS SALMONIDS; AVIAN PREDATION; SMALLMOUTH BASS	Turbine-passed fish are exposed to rapid decreases in pressure which can cause barotrauma. The presence of an implanted telemetry tag increases the likelihood of injury or death from exposure to pressure changes, thus potentially biasing studies evaluating survival of turbine-passed fish. Therefore, a neutrally buoyant externally attached tag was developed to eliminate this bias in turbine passage studies. This new tag was designed not to add excess mass in water or take up space in the coelom, having an effective tag burden of zero with the goal of reducing pressure related biases to turbine survival studies. To determine if this new tag affects fish performance or susceptibility to predation, it was evaluated in the field relative to internally implanted acoustic transmitters (JSATS; Juvenile Salmon Acoustic Telemetry System) used widely for survival studies of juvenile salmonids. Survival and travel time through the study reach was compared between fish with either tag type in an area of high predation in the Snake and Columbia rivers, Washington. An additional group of fish affixed with neutrally-buoyant dummy external tags were implanted with passive integrated transponder (PIT) tags and recovered further downstream to assess external tag retention and injury. There were no significant differences in survival to the first detection site, 12 river kilometers (rkm) downstream of release. Travel times were also similar between groups. Conversely, externally-tagged fish had reduced survival (or elevated tag loss) to the second detection site, 65 rkm downstream. In addition, the retention study revealed that tag loss was first observed in fish recaptured approximately 9 days after release. Results suggest that this new tag may be viable for short term (< 8 days) single-dam turbine-passage studies and under these situations, may alleviate the turbine passage-related bias encountered when using internal tags, however further research is needed to confirm this.	[Brown, Richard S.; Cook, Katrina V.; Pflugrath, Brett D.] Pacific NW Natl Lab, Ecol Grp, Richland, WA 99352 USA; [Deng, Z. Daniel; Li, Xinya; Fu, Tao; Martinez, Jayson J.; Li, Huidong] Pacific NW Natl Lab, Hydrol Grp, Richland, WA 99352 USA; [Trumbo, Bradly A.; Ahmann, Martin L.] US Army, Corps Engineers, Walla Walla, WA USA; [Seaburg, Adam G.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; University of Washington; University of Washington Seattle	Brown, RS (corresponding author), Pacific NW Natl Lab, Ecol Grp, Richland, WA 99352 USA.	rich.brown@pnnl.gov	Deng, Zhiqun Daniel/A-9536-2011	Deng, Zhiqun Daniel/0000-0002-8300-8766; Li, Huidong/0000-0002-0096-2117	U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State) [W912EF-08-D-0004]	U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State)	This study was funded by the U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State) under contract number W912EF-08-D-0004. Funders were involved in study design and preparation of the manuscript (authors BAT and MLA).	Absolon RF, 2000, ANN REPORT US ARMY C; BERGMAN PK, 1992, FISHERIES, V17, P20, DOI 10.1577/1548-8446(1992)017<0020:PODUAM>2.0.CO;2; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Brown RS, 2012, FISH RES, V121, P43, DOI 10.1016/j.fishres.2012.01.006; Brown RS, 2012, T AM FISH SOC, V141, P147, DOI 10.1080/00028487.2011.650274; Brown RS, 2012, J RENEW SUSTAIN ENER, V4, DOI 10.1063/1.3682062; Brown RS, 2009, T AM FISH SOC, V138, P1285, DOI 10.1577/T08-122.1; Brown RS, FISHERIES IN PRESS; Brown RS, 2012, HYDROREVIEW      DEC, V31, P48; Carlson TJ, 2012, N AM J FISH MANAGE, V32, P249, DOI 10.1080/02755947.2012.661384; Connor WP, 2004, N AM J FISH MANAGE, V24, P545, DOI 10.1577/M02-161.1; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P11, DOI 10.1007/s11160-010-9184-4; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Counihan TD, 1999, T AM FISH SOC, V128, P965, DOI 10.1577/1548-8659(1999)128<0965:IOEATO>2.0.CO;2; DeHart M, 2012, ANN REPORT BONNEVILL; Deng ZD, 2012, FISH RES, V113, P94, DOI 10.1016/j.fishres.2011.08.018; Deng ZQ, 2007, SENSORS-BASEL, V7, P3399, DOI 10.3390/s7123399; Deng ZQ, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3501336; Deters KA, 2012, T AM FISH SOC, V141, P1, DOI 10.1080/00028487.2011.638594; Deters KA, 2010, T AM FISH SOC, V139, P888, DOI 10.1577/T09-043.1; Evans AF, 2012, T AM FISH SOC, V141, P975, DOI 10.1080/00028487.2012.676809; Evans AF, 2011, N AM J FISH MANAGE, V31, P79, DOI 10.1080/02755947.2011.562429; FOLMAR LC, 1981, AQUACULTURE, V23, P309, DOI 10.1016/0044-8486(81)90024-7; GALLEPP GW, 1972, T AM FISH SOC, V101, P507, DOI 10.1577/1548-8659(1972)101<507:EONBOT>2.0.CO;2; Giorgi A. E., 1997, North American Journal of Fisheries Management, V17, P268, DOI 10.1577/1548-8675(1997)017<0268:FTITDM>2.3.CO;2; Janak JM, 2012, T AM FISH SOC, V141, P1424, DOI 10.1080/00028487.2012.688915; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Li HD, 2012, SENSORS-BASEL, V12, P9098, DOI 10.3390/s120709098; MCCLEAVE JD, 1975, J FISH RES BOARD CAN, V32, P559, DOI 10.1139/f75-071; McMichael GA, 2006, PNWD3604; McMichael GA, 2010, FISHERIES, V35, P9, DOI 10.1577/1548-8446-35.1.9; Meduri P, 2011, ELECTROCHEM COMMUN, V13, P1344, DOI 10.1016/j.elecom.2011.08.006; MELLAS EJ, 1985, CAN J FISH AQUAT SCI, V42, P488, DOI 10.1139/f85-066; Monzyk FR, 2009, T AM FISH SOC, V138, P1093, DOI 10.1577/T08-108.1; MORGAN RIG, 1976, J FISH BIOL, V8, P289, DOI 10.1111/j.1095-8649.1976.tb03951.x; MUIR WD, 1994, AQUACULTURE, V127, P69, DOI 10.1016/0044-8486(94)90193-7; Naughton GP, 2004, N AM J FISH MANAGE, V24, P534, DOI 10.1577/M02-177.1; Panther JL, 2011, T AM FISH SOC, V140, P1492, DOI 10.1080/00028487.2011.637003; Peake S, 1997, T AM FISH SOC, V126, P707, DOI 10.1577/1548-8659(1997)126<0707:IOTAPO>2.3.CO;2; Perry RW, 2001, T AM FISH SOC, V130, P46, DOI 10.1577/1548-8659(2001)130&lt;0046:BCOJCS&gt;2.0.CO;2; Peven C, 2005, GUIDELINES RECOMMEND; Plumb JM, 2006, N AM J FISH MANAGE, V26, P438, DOI 10.1577/M04-177.1; POE TP, 1991, T AM FISH SOC, V120, P405, DOI 10.1577/1548-8659(1991)120<0405:FOPFOO>2.3.CO;2; ROSS MJ, 1981, PROG FISH CULT, V43, P67, DOI 10.1577/1548-8659(1981)43[67:EOERTO]2.0.CO;2; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Stephenson JR, 2010, FISH RES, V106, P271, DOI 10.1016/j.fishres.2010.08.006; Summerfelt R.C., 1990, P213; Tabor Roger A., 1993, North American Journal of Fisheries Management, V13, P831, DOI 10.1577/1548-8675(1993)013<0831:POJSBS>2.3.CO;2; Titzler PS, 2010, N AM J FISH MANAGE, V30, P853, DOI 10.1577/M09-143.1; Walsh MG, 2000, T AM FISH SOC, V129, P539, DOI 10.1577/1548-8659(2000)129<0539:EOIMAT>2.0.CO;2; WEDEMEYER GA, 1980, US NMFS MAR FISH REV, V42, P1; Weiland MA, 2011, SENSORS-BASEL, V11, P5645, DOI 10.3390/s110605645; Zabel Richard W., 1997, North American Journal of Fisheries Management, V17, P93, DOI 10.1577/1548-8675(1997)017<0093:AMOTTT>2.3.CO;2; ZAUGG WS, 1985, AQUACULTURE, V51, P33, DOI 10.1016/0044-8486(85)90238-8; ZIMMERMAN MP, 1995, NORTHWEST SCI, V69, P19	55	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77744	10.1371/journal.pone.0077744	http://dx.doi.org/10.1371/journal.pone.0077744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204947	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400054
J	Helfer, CM; Wang, RR; You, JX				Helfer, Christine M.; Wang, Ranran; You, Jianxin			Analysis of the Papillomavirus E2 and Bromodomain Protein Brd4 Interaction Using Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; INTRAEPITHELIAL NEOPLASIA; EPISOMAL MAINTENANCE; BINDING; DNA; CHROMATIN; COMPLEX; VACCINE; CHROMOSOMES; ASSOCIATION	The human papillomavirus (HPV) vaccines effectively protect against new infections of up to four HPV subtypes. However, these vaccines are not protective against many other clinically relevant HPV subtypes and are ineffective at treating established HPV infections. There is therefore a significant need for antiviral treatments for persistent HPV infections. A promising anti-HPV drug target is the interaction between the HPV E2 protein and cellular bromodomain-containing protein 4 (Brd4) since this protein complex mediates several processes important for the viral life cycle including viral genome maintenance, replication, and transcription. Using bimolecular fluorescence complementation (BiFC) technology, we demonstrate the E2 and Brd4 interaction on both interphase chromatin and mitotic chromosomes throughout mitosis. The E2-Brd4 BiFC was significantly diminished by mutating the Brd4 binding sites in E2 or by a dominant negative inhibitor of the E2-Brd4 interaction, demonstrating the potential of BiFC for identifying inhibitors of this important virus-host interaction. Importantly, when Brd4 was released from chromatin using the bromodomain inhibitor JQ1(+), the E2-Brd4 interacting complex relocated into foci that no longer associate with mitotic chromosomes, pointing to JQ1(+) as a promising antiviral inhibitor of HPV genome maintenance during HPV persistent infection.	[Helfer, Christine M.; Wang, Ranran; You, Jianxin] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	HIV-Associated Malignancies Pilot Project Award (National Cancer Institute); National Institutes of Health (NIH) [R01CA148768, R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA148768, R01CA142723] Funding Source: NIH RePORTER	HIV-Associated Malignancies Pilot Project Award (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the HIV-Associated Malignancies Pilot Project Award (National Cancer Institute), and National Institutes of Health (NIH) Grants R01CA148768 and R01CA142723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Ault KA, 2007, GYNECOL ONCOL, V107, pS31, DOI 10.1016/j.ygyno.2007.08.059; Bastien N, 2000, VIROLOGY, V270, P124, DOI 10.1006/viro.2000.0265; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Brannon AR, 2005, P NATL ACAD SCI USA, V102, P2998, DOI 10.1073/pnas.0407818102; Cardenas-Mora J, 2008, J VIROL, V82, P7298, DOI 10.1128/JVI.00772-08; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DOSTATNI N, 1988, EMBO J, V7, P3807, DOI 10.1002/j.1460-2075.1988.tb03265.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim J, 2003, BIOCHEM BIOPH RES CO, V305, P1008, DOI 10.1016/S0006-291X(03)00880-5; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kumar RA, 2007, J VIROL, V81, P2213, DOI 10.1128/JVI.01746-06; Lee D, 2000, J BIOL CHEM, V275, P7045, DOI 10.1074/jbc.275.10.7045; Lee D, 2002, J BIOL CHEM, V277, P6483, DOI 10.1074/jbc.M105085200; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nakagawa C, 2011, BIOSCI BIOTECH BIOCH, V75, P1399, DOI 10.1271/bbb.110189; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Piirsoo M, 1996, EMBO J, V15, P1; Schweiger MR, 2007, J VIROL, V81, P9612, DOI 10.1128/JVI.00447-07; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8; Stanley MA, 2012, J GEN VIROL, V93, P681, DOI 10.1099/vir.0.039677-0; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang R, 2012, J BIOL CHEM; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; White PW, 2011, CURR TOP MICROBIOL, V348, P61, DOI 10.1007/82_2010_92; White PW, 2005, ANTIMICROB AGENTS CH, V49, P4834, DOI 10.1128/AAC.49.12.4834-4842.2005; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77994	10.1371/journal.pone.0077994	http://dx.doi.org/10.1371/journal.pone.0077994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205059	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400066
J	Joo, D; Kwan, YS; Song, J; Pinho, C; Hey, J; Won, YJ				Joo, Deokjin; Kwan, Ye-seul; Song, Jongwoo; Pinho, Catarina; Hey, Jody; Won, Yong-Jin			Identification of Cichlid Fishes from Lake Malawi Using Computer Vision	PLOS ONE			English	Article							ECOLOGICAL CHARACTER DISPLACEMENT; SEXUAL SELECTION; SPECIES FLOCK; GENE FLOW; AUTOMATED CLASSIFICATION; MICROSATELLITE LOCI; MALE COLORATION; SPECIATION; POPULATION; POLYMORPHISM	Background: The explosively radiating evolution of cichlid fishes of Lake Malawi has yielded an amazing number of haplochromine species estimated as many as 500 to 800 with a surprising degree of diversity not only in color and stripe pattern but also in the shape of jaw and body among them. As these morphological diversities have been a central subject of adaptive speciation and taxonomic classification, such high diversity could serve as a foundation for automation of species identification of cichlids. Methodology/Principal Finding: Here we demonstrate a method for automatic classification of the Lake Malawi cichlids based on computer vision and geometric morphometrics. For this end we developed a pipeline that integrates multiple image processing tools to automatically extract informative features of color and stripe patterns from a large set of photographic images of wild cichlids. The extracted information was evaluated by statistical classifiers Support Vector Machine and Random Forests. Both classifiers performed better when body shape information was added to the feature of color and stripe. Besides the coloration and stripe pattern, body shape variables boosted the accuracy of classification by about 10%. The programs were able to classify 594 live cichlid individuals belonging to 12 different classes (species and sexes) with an average accuracy of 78%, contrasting to a mere 42% success rate by human eyes. The variables that contributed most to the accuracy were body height and the hue of the most frequent color. Conclusions: Computer vision showed a notable performance in extracting information from the color and stripe patterns of Lake Malawi cichlids although the information was not enough for errorless species identification. Our results indicate that there appears an unavoidable difficulty in automatic species identification of cichlid fishes, which may arise from short divergence times and gene flow between closely related species.	[Joo, Deokjin] Seoul Natl Univ, Dept Elect Engn & Comp Sci, Seoul, South Korea; [Kwan, Ye-seul; Won, Yong-Jin] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Song, Jongwoo] Ewha Womans Univ, Dept Stat, Seoul, South Korea; [Pinho, Catarina] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Hey, Jody] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Universidade do Porto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Won, YJ (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	won@ewha.ac.kr	Pinho, Catarina/A-7541-2010	Pinho, Catarina/0000-0001-5150-2850	Ewha Global Top5 Grant of Ewha Womans University, Korea; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/BIA-BDE/66210/2006]; FCT [SFRH/BPD/28869/2006]	Ewha Global Top5 Grant of Ewha Womans University, Korea; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Ewha Global Top5 Grant 2013 of Ewha Womans University, Korea. Field work was supported by grant PTDC/BIA-BDE/66210/2006 from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). CP is supported by a post-doc fellowship (SFRH/BPD/28869/2006) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Barlow GW, 2000, CICHLID FISHES; Benson B, 2009, FIELD PROGRAMMABLE G, P1; Bhanu Bir, 2008, American Entomologist, V54, P228; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Bruzzone L, 2006, IEEE T GEOSCI REMOTE, V44, P3363, DOI 10.1109/TGRS.2006.877950; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen AH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-274; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Collobert R., 2004, P 21 INT C MACHINE L, P23, DOI [10.1145/1015330.1015415, DOI 10.1145/1015330.1015415]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Danley PD, 2000, EVOLUTION, V54, P1725; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Delvaux D, 1996, MUS R AFR CENT TERVA, V1995-1996, P99; Deutsch JC, 1997, BIOL J LINN SOC, V62, P1; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goldstein HM, 2009, THESIS PENNSYLVANIA, P1; Grosjean P, 2004, ICES J MAR SCI, V61, P518, DOI 10.1016/j.icesjms.2004.03.012; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Huang K, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-78; Hulsey CD, 2007, P ROY SOC B-BIOL SCI, V274, P1867, DOI 10.1098/rspb.2007.0444; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kang SH, 2012, J ASIA-PAC ENTOMOL, V15, P437, DOI 10.1016/j.aspen.2012.05.005; Kassam DD, 2003, ANIM BIOL, V53, P59, DOI 10.1163/157075603769682585; KIRYATI N, 1991, PATTERN RECOGN, V24, P303, DOI 10.1016/0031-3203(91)90073-E; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Knight ME, 1999, ANIM BEHAV, V58, P761, DOI 10.1006/anbe.1999.1206; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2001, MALAWI CICHLIDS THEI; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; KORNFIELD IL, 1978, EXPERIENTIA, V34, P335, DOI 10.1007/BF01923020; Kornfield Irv, 1997, P25, DOI 10.1016/B978-012417540-2/50004-X; Larios N, 2008, MACH VISION APPL, V19, P105, DOI 10.1007/s00138-007-0086-y; Larsen R, 2009, LECT NOTES COMPUT SC, V5575, P745; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Markert JA, 2001, TRENDS ECOL EVOL, V16, P100, DOI 10.1016/S0169-5347(00)02064-4; Mayo M, 2007, KNOWL-BASED SYST, V20, P195, DOI 10.1016/j.knosys.2006.11.012; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MCELROY DM, 1991, NETH J ZOOL, V41, P250; MCKAYE ER, 1982, ZOOL J LINN SOC-LOND, V76, P91, DOI 10.1111/j.1096-3642.1982.tb01956.x; MCKAYE KR, 1984, EVOLUTION, V38, P215, DOI 10.1111/j.1558-5646.1984.tb00273.x; MORAN P, 1993, MOL BIOL EVOL, V10, P1015; Nagashima Y., 1998, Proceedings of IAPR Workshop on Machine Vision Applications, P306; Nicodemus KK, 2010, HUM GENET, V127, P441, DOI 10.1007/s00439-009-0782-y; Parker A, 1997, J MOL EVOL, V45, P70, DOI 10.1007/PL00006204; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2001, TPSDIG32 GEOMETRIC M; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Rova A., 2007, IAPR C MACHINE VISIO, P404; Rowley HA, 2006, VISAPP 2006: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P290; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seehausen O, 2004, P ROY SOC B-BIOL SCI, V271, P1345, DOI 10.1098/rspb.2004.2737; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O, 1999, ECOL LETT, V2, P367; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Stauffer JR, 1996, COPEIA, P203, DOI 10.2307/1446959; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Storbeck F, 2001, FISH RES, V51, P11, DOI 10.1016/S0165-7836(00)00254-X; Streelman JT, 2004, MOL ECOL, V13, P2471, DOI 10.1111/j.1365-294X.2004.02240.x; Talbot JF, 2006, IMPLEMENTING GRABCUT; Trewavas E, 1984, REV FRANCAISE AQUARI, V10, P97; VanOppen MJH, 1997, MOL ECOL, V6, P387, DOI 10.1046/j.1365-294X.1997.00188.x; Won YJ, 2006, MOL BIOL EVOL, V23, P828, DOI 10.1093/molbev/msj101; Won YJ, 2005, P NATL ACAD SCI USA, V102, P6581, DOI 10.1073/pnas.0502127102; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310	81	10	10	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77686	10.1371/journal.pone.0077686	http://dx.doi.org/10.1371/journal.pone.0077686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204918	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400049
J	Frappier, J; Toupin, I; Levy, JJ; Aubertin-Leheudre, M; Karelis, AD				Frappier, Julie; Toupin, Isabelle; Levy, Joseph J.; Aubertin-Leheudre, Mylene; Karelis, Antony D.			Energy Expenditure during Sexual Activity in Young Healthy Couples	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; BLOOD-PRESSURE RESPONSES; UPDATED RECOMMENDATION; PHYSICAL-ACTIVITY; SPORTS-MEDICINE; PUBLIC-HEALTH; UNITED-STATES; OLDER-ADULTS; ARMBAND; VALIDATION	Objective: To determine energy expenditure in kilocalories (kcal) during sexual activity in young healthy couples in their natural environment and compare it to a session of endurance exercise. Methods: The study population consisted of twenty one heterosexual couples (age: 22.6 +/- 2.8 years old) from the Montreal region. Free living energy expenditure during sexual activity and the endurance exercise was measured using the portable mini SenseWear armband. Perceived energy expenditure, perception of effort, fatigue and pleasure were also assessed after sexual activity. All participants completed a 30 min endurance exercise session on a treadmill at a moderate intensity. Results: Mean energy expenditure during sexual activity was 101 kCal or 4.2 kCal/min in men and 69.1 kCal or 3.1 kCal/min in women. In addition, mean intensity was 6.0 METS in men and 5.6 METS in women, which represents a moderate intensity. Moreover, the energy expenditure and intensity during the 30 min exercise session in men was 276 kCal or 9.2 kCal/min and 8.5 METS, respectively and in women 213 kCal or 7.1 kCal/min and 8.4 METS, respectively. Interestingly, the highest range value achieved by men for absolute energy expenditure can potentially be higher than that of the mean energy expenditure of the 30 min exercise session (i.e. 306.1 vs. 276 kCal, respectively) whereas this was not observed in women. Finally, perceived energy expenditure during sexual activity was similar in men (100 kCal) and in women (76.2 kCal) when compared to measured energy expenditure. Conclusion: The present study indicates that energy expenditure during sexual activity appears to be approximately 85 kCal or 3.6 kCal/min and seems to be performed at a moderate intensity (5.8 METS) in young healthy men and women. These results suggest that sexual activity may potentially be considered, at times, as a significant exercise.	[Frappier, Julie; Aubertin-Leheudre, Mylene; Karelis, Antony D.] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Levy, Joseph J.] Univ Quebec, Dept Sexol, Montreal, PQ H3C 3P8, Canada; [Toupin, Isabelle] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal	Karelis, AD (corresponding author), Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.	karelis.antony@uqam.ca	aubertin, rebeckah/O-9624-2015	aubertin, rebeckah/0000-0002-0558-7571	Foundation for the Scientific Study of Sexuality; l'Institut Sante et societe of the Universite du Quebec a Montreal	Foundation for the Scientific Study of Sexuality; l'Institut Sante et societe of the Universite du Quebec a Montreal	This study was supported by grants from The Foundation for the Scientific Study of Sexuality and l'Institut Sante et societe of the Universite du Quebec a Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; BARTLETT RG, 1956, J APPL PHYSIOL, V9, P469, DOI 10.1152/jappl.1956.9.3.469; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Ebrahim S, 2002, J EPIDEMIOL COMMUN H, V56, P99, DOI 10.1136/jech.56.2.99; Gormley J, 2013, EUR J SPORT SCI, P1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HELLERSTEIN HK, 1970, ARCH INTERN MED, V125, P987, DOI 10.1001/archinte.125.6.987; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; LARSON JL, 1980, HEART LUNG, V9, P1025; Laumann EO, 2009, INT J IMPOT RES, V21, P171, DOI 10.1038/ijir.2009.7; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101; MASINI V, 1980, Giornale Italiano di Cardiologia, V10, P1442; Masters WH., 1966, HUMAN SEXUAL RESPONS; McCall-Hosenfeld JS, 2008, J GEN INTERN MED, V23, P2000, DOI 10.1007/s11606-008-0820-9; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; NEMEC ED, 1976, AM HEART J, V92, P274, DOI 10.1016/S0002-8703(76)80106-8; Palmeri ST, 2007, AM J CARDIOL, V100, P1795, DOI 10.1016/j.amjcard.2007.07.040; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Steinke EE, 2013, CIRCULATION; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Wetten AA, 2013, J PHYS ACT HEALTH	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79342	10.1371/journal.pone.0079342	http://dx.doi.org/10.1371/journal.pone.0079342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205382	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300093
J	Liao, XG; Fang, WG; Lin, LC; Lu, HL; St Leger, RJ				Liao, Xinggang; Fang, Weiguo; Lin, Liangcai; Lu, Hsiao-Ling; St Leger, Raymond J.			Metarhizium robertsii Produces an Extracellular Invertase (MrINV) That Plays a Pivotal Role in Rhizospheric Interactions and Root Colonization	PLOS ONE			English	Article							CUTICLE-DEGRADING PROTEASES; TRICHODERMA-VIRENS; ENTOMOPATHOGENIC FUNGI; BIOLOGICAL-CONTROL; SEED TREATMENT; ANISOPLIAE; BIOCONTROL; MECHANISMS; FIELD; GENE	As well as killing pest insects, the rhizosphere competent insect-pathogenic fungus Metarhizium robertsii also boosts plant growth by providing nitrogenous nutrients and increasing resistance to plant pathogens. Plant roots secrete abundant nutrients but little is known about their utilization by Metarhizium spp. and the mechanistic basis of Metarhizium-plant associations. We report here that M. robertsii produces an extracellular invertase (MrInv) on plant roots. Deletion of MrInv (Delta MrInv) reduced M. robertsii growth on sucrose and rhizospheric exudates but increased colonization of Panicum virgatum and Arabidopsis thaliana roots. This could be accounted for by a reduction in carbon catabolite repression in Delta MrInv increasing production of plant cell wall-degrading depolymerases. A non-rhizosphere competent scarab beetle specialist Metarhizium majus lacks invertase which suggests that rhizospheric competence may be related to the sugar metabolism of different Metarhizium species.	[Liao, Xinggang; Lu, Hsiao-Ling; St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Fang, Weiguo] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Liangcai] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	University System of Maryland; University of Maryland College Park; Zhejiang University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	stleger@umd.edu	St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256; Lin, Liangcai/0000-0003-0645-1446	United States Department of Agriculture National Institute of Food and Agriculture [2011-33522-30742]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by Biotechnology Risk Assessment Grant Program competitive grant 2011-33522-30742 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Chacon MR, 2007, INT MICROBIOL, V10, P19, DOI 10.2436/20.1501.01.4; Chaudhuri A, 1999, FEMS MICROBIOL LETT, V177, P39, DOI 10.1111/j.1574-6968.1999.tb13711.x; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; De Weert S, 2006, PLANT-ASSOCIATED BACTERIA, P317; Fang WG, 2006, CAN J MICROBIOL, V52, P623, DOI 10.1139/W06-014; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Goetz M, 2000, J PLANT PHYSIOL, V157, P581, DOI 10.1016/S0176-1617(00)80115-7; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Herrera-Estrella A, 1999, EXS, V87, P171; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Liao XG, 2008, CURR MICROBIOL, V57, P121, DOI 10.1007/s00284-008-9163-3; Lin LC, 2011, J MICROBIOL METH, V87, P241, DOI 10.1016/j.mimet.2011.07.018; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lorito M, 2010, ANNU REV PHYTOPATHOL, V48, P395, DOI 10.1146/annurev-phyto-073009-114314; Mach RL, 1996, MOL MICROBIOL, V21, P1273, DOI 10.1046/j.1365-2958.1996.00094.x; Mahmood T, 2002, PLANTA, V214, P887, DOI 10.1007/s00425-001-0697-x; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Mastouri F, 2010, PHYTOPATHOLOGY, V100, P1213, DOI 10.1094/PHYTO-03-10-0091; Miche L, 2001, APPL ENVIRON MICROB, V67, P3046, DOI 10.1128/AEM.67.7.3046-3052.2001; Mukherjee P. K., 2008, V15, P243; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P155, DOI 10.1099/mic.0.052159-0; OBRIENT, 2009, THESIS U MARYLAND CO; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prade RA, 1999, BIOTECHNOL GENET ENG, V16, P361, DOI 10.1080/02648725.1999.10647984; Rubio MC, 2006, ENZYME MICROB TECH, V39, P601, DOI 10.1016/j.enzmictec.2005.11.011; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; SAMUELS RI, 1995, COMP BIOCHEM PHYS B, V110, P661, DOI 10.1016/0305-0491(94)00205-9; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; STLEGER RJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P221, DOI 10.1016/0003-9861(87)90655-2; STLEGER RJ, 1986, J GEN MICROBIOL, V132, P1509; Vargas WA, 2009, PLANT PHYSIOL, V151, P792, DOI 10.1104/pp.109.141291; Viterbo A, 2005, APPL ENVIRON MICROB, V71, P6241, DOI 10.1128/AEM.71.10.6241-6246.2005; Viterbo A, 2006, MOL PLANT PATHOL, V7, P249, DOI 10.1111/J.1364-3703.2006.00335.X; Voegele RT, 2006, MOL PLANT MICROBE IN, V19, P625, DOI 10.1094/MPMI-19-0625; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061	52	26	33	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78118	10.1371/journal.pone.0078118	http://dx.doi.org/10.1371/journal.pone.0078118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205119	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600073
J	Odone, A; Crampin, AC; Mwinuka, V; Malema, S; Mwaungulu, JN; Munthali, L; Glynn, JR				Odone, Anna; Crampin, Amelia C.; Mwinuka, Venance; Malema, Simon; Mwaungulu, J. Nimrod; Munthali, Lumbani; Glynn, Judith R.			Association between Socioeconomic Position and Tuberculosis in a Large Population-Based Study in Rural Malawi	PLOS ONE			English	Article							SOCIAL DETERMINANTS; RISK-FACTORS; HIV-INFECTION; PREVALENCE; COUNTRY; DISEASE; EPIDEMIOLOGY; AFRICA; BURDEN; TRENDS	Setting: There is increasing interest in social structural interventions for tuberculosis. The association between poverty and tuberculosis is well established in many settings, but less clear in rural Africa. In Karonga District, Malawi, we found an association between higher socioeconomic status and tuberculosis from 1986-1996, independent of HIV status and other factors. Objective: To investigate the relationship in the same area in 1997-2010. Design: All adults in the district with new laboratory-confirmed tuberculosis were included. They were compared with community controls, selected concurrently and frequency-matched for age, sex and area. Results: 1707 cases and 2678 controls were interviewed (response rates >95%). The odds of TB were increased in those working in the cash compared to subsistence economy (p<0.001), and with better housing (p-trend=0.006), but decreased with increased asset ownership (p-trend=0.003). The associations with occupation and housing were partly mediated by HIV status, but remained significant. Conclusion: Different socioeconomic measures capture different pathways of the association between socioeconomic status and tuberculosis. Subsistence farmers may be relatively unexposed whereas those in the cash economy travel more, and may be more likely to come forward for diagnosis. In this setting "better houses" may be less well ventilated and residents may spend more time indoors.	[Odone, Anna; Crampin, Amelia C.; Glynn, Judith R.] London Sch Hyg & Trop Med, London WC1, England; [Odone, Anna] Univ Parma, Sch Med, I-43100 Parma, Italy; [Crampin, Amelia C.; Mwinuka, Venance; Malema, Simon; Mwaungulu, J. Nimrod; Munthali, Lumbani] Karonga Prevent Study, Chilumba, Malawi; [Odone, Anna] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	University of London; London School of Hygiene & Tropical Medicine; University of Parma; Malawi Epidemiology and Intervention Research Unit; Harvard University; Harvard Medical School	Odone, A (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	anna.odone@mail.harvard.edu	Odone, Anna/AAC-4715-2022	Odone, Anna/0000-0002-5657-9774; Crampin, Amelia/0000-0002-1513-4330	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, with contributions from the British Leprosy Relief Association (LEPRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2012, J INFECT DIS, V205, pS293, DOI 10.1093/infdis/jir886; Aparicio JP, 2002, J THEOR BIOL, V215, P227, DOI 10.1006/jtbi.2001.2489; Blaas SH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-60; Boccia D, 2013, INT J TUBERC LUNG D, V17, P39, DOI 10.5588/ijtld.11.0387; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; *CHATH HOUS, 2012, CTR GLOB HLTH SEC SO; Crampin A, 2011, TROP MED INT HEALTH, V16, P811, DOI 10.1111/j.1365-3156.2011.02763.x; Crampin AC, 2008, INT J TUBERC LUNG D, V12, P612; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; Grundy E, 2005, INT J EPIDEMIOL, V34, P529, DOI 10.1093/ije/dyh272; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jaramillo E., 2011, International Journal of Tuberculosis and Lung Disease, V15, pS1; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lonnroth K, 2009, INT J TUBERC LUNG D, V13, P171; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Ploubidis GB, 2012, EUR RESPIR J, V40, P925, DOI 10.1183/09031936.00184011; Prost MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002684; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Rasanathan K, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P30, DOI 10.5588/ijtld.10.0691; RIEDER H, 1999, EPIDEMIOLOGICAL BASI, P50; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wanyeki I, 2006, SOC SCI MED, V63, P501, DOI 10.1016/j.socscimed.2005.12.015; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534	40	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77740	10.1371/journal.pone.0077740	http://dx.doi.org/10.1371/journal.pone.0077740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24204945	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600046
J	Pocquet, N; Milesi, P; Makoundou, P; Unal, S; Zumbo, B; Atyame, C; Darriet, F; Dehecq, JS; Thiria, J; Bheecarry, A; Iyaloo, DP; Weill, M; Chandre, F; Labbe, P				Pocquet, Nicolas; Milesi, Pascal; Makoundou, Patrick; Unal, Sandra; Zumbo, Betty; Atyame, Celestine; Darriet, Frederic; Dehecq, Jean-Sebastien; Thiria, Julien; Bheecarry, Ambicadutt; Iyaloo, Diana P.; Weill, Mylene; Chandre, Fabrice; Labbe, Pierrick			Multiple Insecticide Resistances in the Disease Vector Culex p. Quinquefasciatus from Western Indian Ocean	PLOS ONE			English	Article							RIFT-VALLEY FEVER; PIPIENS-QUINQUEFASCIATUS; ANOPHELES-GAMBIAE; PYRETHROID INSECTICIDES; BANCROFTIAN-FILARIASIS; GROWTH-REGULATOR; SINGLE MOSQUITOS; CULICIDAE; DIPTERA; GENE	Several mosquito-borne diseases affect the Western Indian Ocean islands. Culex pipiens quinquefasciatus is one of these vectors and transmits filariasis, Rift Valley and West Nile viruses and the Japanese encephalitis. To limit the impact of these diseases on public health, considerable vector control efforts have been implemented since the 50s, mainly through the use of neurotoxic insecticides belonging to Organochlorines (OC), Organophosphates (OP) and pyrethroids (PYR) families. However, mosquito control failures have been reported on site, and they were probably due to the selection of resistant individuals in response to insecticide exposure. In this study, we used different approaches to establish a first regional assessment of the levels and mechanisms of resistance to various insecticides. Bioassays were used to evaluate resistance to various insecticides, enzyme activity was measured to assess the presence of metabolic resistances through elevated detoxification, and molecular identification of known resistance alleles was investigated to determine the frequency of target-site mutations. These complementary approaches showed that resistance to the most used insecticides families (OC, OP and PYR) is widespread at a regional scale. However, the distribution of the different resistance genes is quite heterogeneous among the islands, some being found at high frequencies everywhere, others being frequent in some islands and absent in others. Moreover, two resistance alleles displayed clinal distributions in Mayotte and La Reunion, probably as a result of a heterogeneous selection due to local treatment practices. These widespread and diverse resistance mechanisms reduce the capacity of resistance management through classical strategies (e. g. insecticide rotation). In case of a disease outbreak, it could undermine the efforts of the vector control services, as only few compounds could be used. It thus becomes urgent to find alternatives to control populations of Cx. p. quinquefasciatus in the Indian Ocean.	[Pocquet, Nicolas; Darriet, Frederic; Chandre, Fabrice] IRD CNRS UM1 UM2 224 5290, UMR MIVEGEC, Inst Rech Dev, Montpellier, France; [Milesi, Pascal; Makoundou, Patrick; Unal, Sandra; Atyame, Celestine; Weill, Mylene; Labbe, Pierrick] Univ Montpellier 2, CNRS IRD UM2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Zumbo, Betty; Dehecq, Jean-Sebastien] Agence Sante Ocean Indien ARS OI, St Denis, La Reunion Isla, France; [Thiria, Julien] DASS Nouvelle Caledonie, Sante Environm, Noumea, New Caledonia; [Bheecarry, Ambicadutt; Iyaloo, Diana P.] Minist Hlth & Qual Life, Vector Biol & Control Div, Port Louis, Mauritius	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Labbe, P (corresponding author), Univ Montpellier 2, CNRS IRD UM2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France.	pierrick.labbe@univ-montp2.fr	Labbé, Pïerrick/AAL-5806-2020; Milesi, Pascal/K-3234-2019; Chandre, Fabrice/Q-3429-2019	Labbé, Pïerrick/0000-0003-0806-1919; Chandre, Fabrice/0000-0002-1994-9705; Darriet, Frederic/0000-0003-2486-5968; Iyaloo, Diana Pillay/0000-0001-5871-301X; Weill, Mylene/0000-0002-4043-1601; Pocquet, Nicolas/0000-0003-3928-6803	ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail) [IRD-ARS-ANSES 2009-CRD-38]	ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail)(French National Research Agency (ANR))	This work was supported by ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail) convention IRD-ARS-ANSES 2009-CRD-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Ben Cheikh H, 1998, J MED ENTOMOL, V35, P251, DOI 10.1093/jmedent/35.3.251; Berticat C, 2000, PEST MANAG SCI, V56, P727, DOI 10.1002/1526-4998(200009)56:9<727::AID-PS214>3.3.CO;2-9; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; CNEV, 2012, CIRC WUCH BANCR MAYO; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Finney DJ, 1971, ROBIT ANAL CAMB, P333; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 1998, WHOCDSCPCMAL986; Hollingworth RM, 2008, GLOBAL PESTICIDE RES, P169; HOLM S, 1979, SCAND J STAT, V6, P65; Jambulingam P, 2008, ACTA TROP, V107, P20, DOI 10.1016/j.actatropica.2008.04.005; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Julvez J, 1998, B SOC PATHOL EXOT, V91, P99; Labbe P, 2005, J EVOLUTION BIOL, V18, P1471, DOI 10.1111/j.1420-9101.2005.00938.x; Labbe P, 2011, EVOLUTION RESISTANCE, p[14, 409]; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Labbe P, 2009, GENETICS, V182, P303, DOI 10.1534/genetics.109.101444; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Lenormand T, 1998, GENETICS, V149, P1383; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marina CF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-95; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; METCALF RL, 1967, ANNU REV ENTOMOL, V12, P229, DOI 10.1146/annurev.en.12.010167.001305; Ministry of Health and Quality of Life Mauritius, 2009, OP PLAN PREV CONTR C, P94; Ministry of Health and Quality of Life Mauritius World Health Organization University of California San Francisco, 2012, EL MAL CAS STUD 4, P75; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; NASH RG, 1967, SCIENCE, V157, P924, DOI 10.1126/science.157.3791.924; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Pasteur N, 1999, J MED ENTOMOL, V36, P794, DOI 10.1093/jmedent/36.6.794; PASTEUR N, 1987, MANUEL TECHNIQUE GEN; PENNELL JT, 1964, B WORLD HEALTH ORGAN, V31, P669; PERRY AS, 1970, LIFE SCI 2-BIOCH GEN, V9, P335, DOI 10.1016/0024-3205(70)90178-5; PERRY AS, 1953, BIOL BULL, V104, P426, DOI 10.2307/1538495; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; RAYMOND M, 1989, GENETICS, V123, P543; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; RAYMOND M, 1986, J ECON ENTOMOL, V79, P1452, DOI 10.1093/jee/79.6.1452; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Receveur M C, 2004, Bull Soc Pathol Exot, V97, P265; Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Ridley M., 2004, EVOLUTION; Robert V, 2009, MISSION CONSEIL APPU, P53; Rogers SO., 1988, EXTRACTION DNA PLANT; SABATINELLI G, 1994, PARASITE, V1, P71, DOI 10.1051/parasite/1994011071; Sadanandane C, 2012, INDIAN J MED RES, V136, P783; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; StatSoft, 2011, STATISTICA LOG AN DO; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Tchen J, 2006, Med Trop (Mars), V66, P295; Fossog BT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/429817; Tomlin CDS, 2009, PESTICIDE MANUAL WOR; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN; Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718	81	29	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77855	10.1371/journal.pone.0077855	http://dx.doi.org/10.1371/journal.pone.0077855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204997	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600051
J	Ibrahim, Z; Ebenezer, G; Christensen, JM; Sarhane, KA; Hauer, P; Cooney, DS; Sacks, JM; Schneeberger, S; Lee, WPA; Polydefkis, M; Brandacher, G				Ibrahim, Zuhaib; Ebenezer, Gigi; Christensen, Joani M.; Sarhane, Karim A.; Hauer, Peter; Cooney, Damon S.; Sacks, Justin M.; Schneeberger, Stefan; Lee, W. P. Andrew; Polydefkis, Michael; Brandacher, Gerald			Cutaneous Collateral Axonal Sprouting Re-Innervates the Skin Component and Restores Sensation of Denervated Swine Osteomyocutaneous Alloflaps	PLOS ONE			English	Article							SOCIETIES/PERIPHERAL NERVE SOCIETY; JOINT TASK-FORCE; NEUROLOGICAL SOCIETIES; EUROPEAN FEDERATION; REINNERVATION; REGENERATION; GRAFTS; FIBERS; GUIDELINE; RECOVERY	Reconstructive transplantation such as extremity and face transplantation is a viable treatment option for select patients with devastating tissue loss. Sensorimotor recovery is a critical determinant of overall success of such transplants. Although motor function recovery has been extensively studied, mechanisms of sensory re-innervation are not well established. Recent clinical reports of face transplants confirm progressive sensory improvement even in cases where optimal repair of sensory nerves was not achieved. Two forms of sensory nerve regeneration are known. In regenerative sprouting, axonal outgrowth occurs from the transected nerve stump while in collateral sprouting, reinnervation of denervated tissue occurs through growth of uninjured axons into the denervated tissue. The latter mechanism may be more important in settings where transected sensory nerves cannot be re-apposed. In this study, denervated osteomyocutaneous alloflaps (hind-limb transplants) from Major Histocompatibility Complex (MHC)-defined MGH miniature swine were performed to specifically evaluate collateral axonal sprouting for cutaneous sensory re-innervation. The skin component of the flap was externalized and serial skin sections extending from native skin to the grafted flap were biopsied. In order to visualize regenerating axonal structures in the dermis and epidermis, 50um frozen sections were immunostained against axonal and Schwann cell markers. In all alloflaps, collateral axonal sprouts from adjacent recipient skin extended into the denervated skin component along the dermal-epidermal junction from the periphery towards the center. On day 100 post-transplant, regenerating sprouts reached 0.5 cm into the flap centripetally. Eight months following transplant, epidermal fibers were visualized 1.5 cm from the margin (rate of regeneration 0.06 mm per day). All animals had pinprick sensation in the periphery of the transplanted skin within 3 months post-transplant. Restoration of sensory input through collateral axonal sprouting can revive interaction with the environment; restore defense mechanisms and aid in cortical re-integration of vascularized composite allografts.	[Ibrahim, Zuhaib; Christensen, Joani M.; Sarhane, Karim A.; Cooney, Damon S.; Sacks, Justin M.; Schneeberger, Stefan; Lee, W. P. Andrew; Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Ebenezer, Gigi; Hauer, Peter; Polydefkis, Michael] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21218 USA; [Schneeberger, Stefan] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, A-6020 Innsbruck, Austria	Johns Hopkins University; Johns Hopkins University; Medical University of Innsbruck	Polydefkis, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21218 USA.	mpolyde@jhmi.edu; brandacher@jhmi.edu	Cooney, Damon/J-4762-2014; Schneeberger, Stefan/S-9329-2019; Brandacher, Gerald/L-7540-2016; Furtmüller, Georg J/D-8119-2019; Sarhane, Karim/CAG-5222-2022	Cooney, Damon/0000-0002-2786-287X; Schneeberger, Stefan/0000-0002-2619-8639; Furtmüller, Georg J/0000-0001-8286-0968; Sarhane, Karim/0000-0003-4458-4047; Brandacher, Gerald/0000-0001-7790-441X	US Armed Forces Institute of Regenerative Medicine AFIRM [DoD W8IXWH-08-2-0032]; Open Access Promotion Fund of the Johns Hopkins University Libraries	US Armed Forces Institute of Regenerative Medicine AFIRM; Open Access Promotion Fund of the Johns Hopkins University Libraries	This work was supported by the US Armed Forces Institute of Regenerative Medicine AFIRM (DoD W8IXWH-08-2-0032). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramicli M, 2000, BRIT J PLAST SURG, V53, P130, DOI 10.1054/bjps.1999.3204; DIAMOND J, 1992, J NEUROSCI, V12, P1467; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Ebenezer GJ, 2007, J NEUROPATH EXP NEUR, V66, P1059, DOI 10.1097/nen.0b013e31815c8989; Ebenezer GJ, 2007, BRAIN, V130, P2703, DOI 10.1093/brain/awm199; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Glaus SW, 2011, HAND CLIN, V27, P495, DOI 10.1016/j.hcl.2011.07.002; Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488; Hahn K, 2006, J PERIPHER NERV SYST, V11, P142, DOI 10.1111/j.1085-9489.2006.00079.x; HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1; Landin L, 2008, J PLAST RECONSTR AES, V61, P1034, DOI 10.1016/j.bjps.2007.12.084; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2012, CURR DIABETES REP, V12, P384, DOI 10.1007/s11892-012-0280-9; LEE WPA, 1991, PLAST RECONSTR SURG, V87, P401, DOI 10.1097/00006534-199103000-00001; McArthur JC, 2005, ANN NEUROL, V57, P163, DOI 10.1002/ana.20383; Navarro X, 1997, J COMP NEUROL, V380, P164, DOI 10.1002/(SICI)1096-9861(19970407)380:2<164::AID-CNE2>3.0.CO;2-1; Petruzzo P, 2010, TRANSPLANTATION, V90, P1590, DOI 10.1097/TP.0b013e3181ff1472; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Rajan B, 2003, J COMP NEUROL, V457, P24, DOI 10.1002/cne.10460; Ro LS, 1998, J FORMOS MED ASSOC, V97, P247; SAMULACK DD, 1986, NEUROSCI LETT, V72, P1, DOI 10.1016/0304-3940(86)90608-7; Santanelli F, 2011, PLAST RECONSTR SURG, V127, P1790, DOI 10.1097/PRS.0b013e31820cf1c6; SANTONIRUGIU P, 1966, PLAST RECONSTR SURG, V38, P98, DOI 10.1097/00006534-196608000-00003; Sarhane KA, 2013, CURR SURG REP, V1, P40, DOI 10.1007/s40137-012-0008-4; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P1875, DOI 10.1097/PRS.0b013e31820e90c3; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; WARIS T, 1983, PLAST RECONSTR SURG, V72, P439, DOI 10.1097/00006534-198310000-00001; Washington KM, 2009, PLAST RECONSTR SURG, V123, p26S, DOI 10.1097/PRS.0b013e318191bca2	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77646	10.1371/journal.pone.0077646	http://dx.doi.org/10.1371/journal.pone.0077646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204901	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300108
J	Nogueira, SV; Backstedt, BT; Smith, AA; Qin, JH; Wunder, EA; Ko, A; Pal, U				Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Wunder, Elsio A., Jr.; Ko, Albert; Pal, Utpal			Leptospira interrogans Enolase Is Secreted Extracellularly and Interacts with Plasminogen	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BORRELIA-BURGDORFERI; ALPHA-ENOLASE; BINDS PLASMINOGEN; SURFACE PROTEIN; IDENTIFICATION; INSIGHTS; LIPL32; ACQUISITION; COMPLEXES	Leptospira interrogans is the agent for leptospirosis, an important zoonosis in humans and animals across the globe. Surface proteins of invading pathogens, such as L. interrogans, are thought to be responsible for successful microbial persistence in vivo via interaction with specific host components. In particular, a number of invasive infectious agents exploit host proteolytic pathways, such as one involving plasminogen (Pg), which aid in efficient pathogen dissemination within the host. Here we show that L. interrogans serovar Lai binds host Pg and that the leptospiral gene product LA1951, annotated as enolase, is involved in this interaction. Interestingly, unlike in related pathogenic Spirochetes, such as Borrelia burgdorferi, LA1951 is not readily detectable in the L. interrogans outer membrane. We show that the antigen is indeed secreted extracellularly; however, it can reassociate with the pathogen surface, where it displays Pg-binding and measurable enzymatic activity. Hamsters infected with L. interrogans also develop readily detectable antibody responses against enolase. Taken together, our results suggest that the L. interrogans enolase has evolved to play a role in pathogen interaction with host molecules, which may contribute to the pathogenesis of leptospirosis.	[Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Wunder, Elsio A., Jr.; Ko, Albert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Yale University	Pal, U (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015; Wunder, Elsio Augusto/C-2733-2013; Ko, Albert/P-2343-2015	Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert/0000-0001-9023-2339	National Institutes of Health [AI080615, AI088752, AI052473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080615, R01AI080615, U01AI088752, R01AI052473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from National Institutes of Health (AI080615, AI088752 and AI052473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2011, VET MICROBIOL, V153, P73, DOI 10.1016/j.vetmic.2011.02.055; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Cinco M, 2010, NEW MICROBIOL, V33, P283; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481; Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002; Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Mundodi V, 2008, INFECT IMMUN, V76, P523, DOI 10.1128/IAI.01352-07; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Siqueira GH, 2013, AM J TROP MED HYG; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Velineni S, 2006, Indian J Med Microbiol, V24, P339; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira Monica L, 2009, Open Microbiol J, V3, P69, DOI 10.2174/1874285800903010069; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b; Zeng L, 2013, OMICS, DOI [10.1089/omi.2013.0043, DOI 10.1089/0MI.2013.0043.PUBMED:23895271]	63	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78150	10.1371/journal.pone.0078150	http://dx.doi.org/10.1371/journal.pone.0078150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205133	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300144
J	Hosseinzadeh, A; Urban, CF				Hosseinzadeh, Ava; Urban, Constantin F.			Novel Insight into Neutrophil Immune Responses by Dry Mass Determination of Candida albicans Morphotypes	PLOS ONE			English	Article							IN-VITRO; DENDRITIC CELLS; MORPHOGENESIS; GRANULOCYTES; RECOGNITION; INFECTIONS; DECTIN-1; OXIDASE; YEAST; ASSAY	The common fungal pathogen Candida albicans has the ability to grow as a yeast or as a hypha and can alternate between these morphotypes. The overall biomass of both morphotypes increases with growth. However, only yeasts, but not hyphae, exist as discrete cellular entities. Multiplicity of infection (MOI) is a useful parameter to determine the initial inoculum of yeasts for in vitro infection assays. Since the amount of hyphae is difficult to quantify, comparable starting conditions in such assays cannot be determined accurately for yeasts and hyphae using MOI. To circumvent this problem, we have established a set of correlation coefficients to convert fungal metabolic activity and optical density to dry mass. Using these correlations, we were able to accurately compare ROS production and IL-8 release by polymorphonuclear neutrophils upon infection with equal dry mass amounts of yeast and hyphal morphotypes. Neutrophil responses depended on the initial form of infection, irrespective of C. albicans wild-type yeasts transforming to hyphal growth during the assay. Infection with a high mass of live C. albicans yeasts resulted in lower neutrophil ROS and this decrease stems from efficient ROS detoxification by C. albicans without directly affecting the phagocyte ROS machinery. Moreover, we show that dead C. albicans induces significantly less ROS and IL-8 release than live fungi, but thimerosal-killed C. albicans were still able to detoxify neutrophil ROS. Thus, the dry mass approach presented in this study reveals neutrophil responses to different amounts and morphotypes of C. albicans and serves as a template for studies that aim to identify morphotype-specific responses in a variety of immune cells.	[Urban, Constantin F.] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Hosseinzadeh, Ava; Urban, Constantin F.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Hosseinzadeh, Ava] Umea Ctr Microbial Res, Umea, Sweden	Umea University; Umea University	Urban, CF (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	constantin.urban@mims.umu.se	Urban, Constantin/H-5121-2019	Urban, Constantin/0000-0003-1438-1134; hosseinzadeh, ava/0000-0003-3069-0295	Swedish Research Council VR-M [K2012-99X-21961-01-3]; Laboratory for Molecular Medicine Sweden (MIMS); Medial Faculty Umea [316-886-10]; J.C. Kempes Memorial Fund	Swedish Research Council VR-M(Swedish Research Council); Laboratory for Molecular Medicine Sweden (MIMS); Medial Faculty Umea; J.C. Kempes Memorial Fund	This work was supported by grants from the Swedish Research Council VR-M (K2012-99X-21961-01-3), the Laboratory for Molecular Medicine Sweden (MIMS) and the Medial Faculty Umea (316-886-10). AH acknowledges financial support from the J.C. Kempes Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cassatella MA, 1997, ANN NY ACAD SCI, V832, P233, DOI 10.1111/j.1749-6632.1997.tb46251.x; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Cheng SC, J LEUKOC BIOL, V90, P357; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GOW NAR, 1987, CRIT REV MICROBIOL, V15, P73, DOI 10.3109/10408418709104449; HADDAD SA, 1953, APPL MICROBIOL, V1, P153, DOI 10.1128/AEM.1.3.153-156.1953; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Losse J, 2011, MOL IMMUNOL, V48, P2135, DOI 10.1016/j.molimm.2011.07.007; MESHULAM T, 1995, J INFECT DIS, V172, P1153, DOI 10.1093/infdis/172.4.1153; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2010, CELL HOST MICROBE, V8, P219, DOI 10.1016/j.chom.2010.08.008; ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Wellington M, 2009, INFECT IMMUN, V77, P405, DOI 10.1128/IAI.00860-08; Wellington M, 2013, MBIO, V4, DOI 10.1128/mBio.00433-12; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; YOUNG G, 1958, J INFECT DIS, V102, P114, DOI 10.1093/infdis/102.2.114; Zavrel M, 2012, EUKARYOT CELL, V11, P129, DOI 10.1128/EC.05206-11	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77993	10.1371/journal.pone.0077993	http://dx.doi.org/10.1371/journal.pone.0077993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205058	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500087
J	Masson, M; Molnar, E; Donoghue, HD; Besra, GS; Minnikin, DE; Wu, HHT; Lee, OYC; Bull, ID; Palfi, G				Masson, Muriel; Molnar, Erika; Donoghue, Helen D.; Besra, Gurdyal S.; Minnikin, David E.; Wu, Houdini H. T.; Lee, Oona Y-C.; Bull, Ian D.; Palfi, Gyoergy			Osteological and Biomolecular Evidence of a 7000-Year-Old Case of Hypertrophic Pulmonary Osteopathy Secondary to Tuberculosis from Neolithic Hungary	PLOS ONE			English	Article							RADIOCARBON AGE CALIBRATION; SKELETAL; ANCIENT; OSTEOARTHROPATHY; DNA; SETTLEMENTS; COLLECTION; LIGURIA; REMAINS	Seventy-one individuals from the late Neolithic population of the 7000-year-old site of Hodmezovasarhely-Gorzsa were examined for their skeletal palaeopathology. This revealed numerous cases of infections and non-specific stress indicators in juveniles and adults, metabolic diseases in juveniles, and evidence of trauma and mechanical changes in adults. Several cases showed potential signs of tuberculosis, particularly the remains of the individual HGO-53. This is an important finding that has significant implications for our understanding of this community. The aim of the present study was to seek biomolecular evidence to confirm this diagnosis. HGO-53 was a young male with a striking case of hypertrophic pulmonary osteopathy (HPO), revealing rib changes and cavitations in the vertebral bodies. The initial macroscopic diagnosis of HPO secondary to tuberculosis was confirmed by analysis of Mycobacterium tuberculosis complex specific cell wall lipid biomarkers and corroborated by ancient DNA (aDNA) analysis. This case is the earliest known classical case of HPO on an adult human skeleton and is one of the oldest palaeopathological and palaeomicrobiological tuberculosis cases to date.	[Masson, Muriel] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Masson, Muriel; Molnar, Erika; Palfi, Gyoergy] Univ Szeged, Dept Biol Anthropol, Szeged, Hungary; [Donoghue, Helen D.] UCL, Ctr Clin Microbiol, London, England; [Donoghue, Helen D.] UCL, Ctr Hist Med, London, England; [Besra, Gurdyal S.; Minnikin, David E.; Wu, Houdini H. T.; Lee, Oona Y-C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Bull, Ian D.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol, Avon, England	University of Edinburgh; Szeged University; University of London; University College London; University of London; University College London; University of Birmingham; University of Bristol	Masson, M (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	murielmasson@gmail.com	Donoghue, Helen D./D-6805-2013; Molnar, Erika/A-8780-2015; Bull, Ian/AAV-1474-2020; Pálfi, György/M-3555-2018; Pálfi, György/AAL-7268-2020	Donoghue, Helen D./0000-0003-3918-5252; Molnar, Erika/0000-0001-6660-9239; Bull, Ian/0000-0002-5881-5654; Pálfi, György/0000-0003-0989-4090; Besra, Gurdyal/0000-0002-5605-0395	Leverhulme Trust [F/00094/BL]; United Kingdom National Environmental Research Council [R8/H12/15]; Hungarian Scientific Research Fund [78555]; NERC [lsmsf010001] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1239307] Funding Source: researchfish; Natural Environment Research Council [lsmsf010001] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United Kingdom National Environmental Research Council; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by Leverhulme Trust Project Grant F/00094/BL (GSB, DEM, OY-CL, HHTW). The United Kingdom National Environmental Research Council provided funding for the mass spectrometry facilities at Bristol (Contract no. R8/H12/15; www.lsmsf.co.uk). Additionally funding was provided by the Hungarian Scientific Research Fund Grant no. 78555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis S, 2011, INT J PALEOPATHOL, V1, P155, DOI 10.1016/j.ijpp.2012.02.009; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Blondiaux J., 1992, INT J OSTEOARCHAEOL, V2, P241, DOI [10.1002/oa.1390020308, DOI 10.1002/OA.1390020308]; Canci A, 1996, INT J OSTEOARCHAEOL, V6, P497, DOI 10.1002/(SICI)1099-1212(199612)6:5<497::AID-OA291>3.0.CO;2-O; Donoghue HD, 2011, CLIN MICROBIOL INFEC, V17, P821, DOI 10.1111/j.1469-0691.2011.03554.x; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Donoghue HD, 2010, P R SOC B, V277, P51, DOI 10.1098/rspb.2009.1484; Farkas G, 2005, SZAKVELEMENY HODMEZO; FORMICOLA V, 1987, AM J PHYS ANTHROPOL, V72, P1, DOI 10.1002/ajpa.1330720102; Gazdapusztai G, 1957, ARCHAEOLOGIAI ERTESI, V84, P3; Gazdapusztai G, 1963, KESONEOLITKORI TELEP, P21; Gernaey A.M., 1999, TUBERCULOSIS PAST PR, P275; Gernaey AM, 2001, TUBERCULOSIS, V81, P259, DOI 10.1054/tube.2001.0295; Gladykowska-Rzeczycka J., 1993, J PALEOPATHOLOGY, V5, P159; Gladykowska-Rzeczycka JJ, 1999, TUBERCULOSIS PRESENT, P561; Grubezy E, 1998, CR ACAD SCI III-VIE, V321, P941; Hajdu T, 2012, SPINE, V37, pE1598, DOI 10.1097/BRS.0b013e31827300dc; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; HERTELENDI E, 1992, RADIOCARBON, V34, P859, DOI 10.1017/S0033822200064171; Hertelendi E, 1998, RADIOCARBON, V40, P659; HERTELENDI E, 1998, ARCHAEOMETRICAL RES, V2, P61; Horvath F, 2005, HETKOZNAPOK VENUSZAI, P67; Horvath F, 1987, LATE NEOLITHIC TISZA, P31; Horvath F, 2003, HUNGARIAN ARCHEOLOGY, P100; Horvath F, 2005, EVERYDAY VENUSES LAT, P27; Horvath F, 2003, HUNGARIAN ARCHAEOLOG, P106; Horvath F, 1982, ARCHEOLOGIAI ERTESIT, V1, P201; Kohler K, 2012, INT J OSTEOARCHAEOL, DOI [10.1002/oa.2254, DOI 10.1002/0A.2254]; Lee OYC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041923; Maczel M., 2003, TRACES TUBERCULOSIS; Martinez-Lavin Manuel, 1997, Current Opinion in Rheumatology, V9, P83, DOI 10.1097/00002281-199701000-00016; Masson M, 2009, LESIONS MODERN DIAGN, P80; Matos V, 2006, AM J PHYS ANTHROPOL, V130, P190, DOI 10.1002/ajpa.20309; Mays S, 2002, J ARCHAEOL SCI, V29, P1267, DOI 10.1006/jasc.2001.0769; Minnikin DE, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P3; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Ortner D., 2003, IDENTIFICATIONS PATH; Posa Annamaria, 2012, Acta Biologica Szegediensis, V56, P125; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Redman JE, 2009, TUBERCULOSIS, V89, P267, DOI 10.1016/j.tube.2009.04.001; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Roberts C.A., 1999, TUBERCULOSIS PRESENT, P311; Rothschild B. M., 1999, TUBERCULOSIS PRESENT, P293; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; Santos AL, 2001, AM J PHYS ANTHROPOL, V115, P38, DOI 10.1002/ajpa.1054; Spekker Olga, 2012, Acta Biologica Szegediensis, V56, P115; Spigelman M, 2002, INT J OSTEOARCHAEOL, V12, P393, DOI 10.1002/oa.638; Taylor GM, 2007, MICROBIOL-SGM, V153, P1243, DOI 10.1099/mic.0.2006/002154-0; WEBB JG, 1986, TUBERCLE, V67, P225, DOI 10.1016/S0041-3879(86)80029-0; Yerkes RW, 2009, RADIOCARBON, V51, P1071, DOI 10.1017/S0033822200034123; Zink AR, 2007, INT J OSTEOARCHAEOL, V17, P380, DOI 10.1002/oa.909	53	32	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78252	10.1371/journal.pone.0078252	http://dx.doi.org/10.1371/journal.pone.0078252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205173	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500107
J	Partanen, E; Kujala, T; Tervaniemi, M; Huotilainen, M				Partanen, Eino; Kujala, Teija; Tervaniemi, Mari; Huotilainen, Minna			Prenatal Music Exposure Induces Long-Term Neural Effects	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; AUDITORY-CORTEX; EARLY INFANCY; FETAL; PLASTICITY; BRAIN; MATURATION; NEWBORNS; PREFER	We investigated the neural correlates induced by prenatal exposure to melodies using brains' event-related potentials (ERPs). During the last trimester of pregnancy, the mothers in the learning group played the 'Twinkle twinkle little star' melody 5 times per week. After birth and again at the age of 4 months, we played the infants a modified melody in which some of the notes were changed while ERPs to unchanged and changed notes were recorded. The ERPs were also recorded from a control group, who received no prenatal stimulation. Both at birth and at the age of 4 months, infants in the learning group had stronger ERPs to the unchanged notes than the control group. Furthermore, the ERP amplitudes to the changed and unchanged notes at birth were correlated with the amount of prenatal exposure. Our results show that extensive prenatal exposure to a melody induces neural representations that last for several months.	[Partanen, Eino; Kujala, Teija; Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Partanen, Eino; Tervaniemi, Mari; Huotilainen, Minna] Univ Jyvaskyla, Finnish Ctr Excellence Interdisciplinary Music Re, Deparment Mus, Jyvaskyla, Finland; [Kujala, Teija] Univ Helsinki, Cicero Learning, Helsinki, Finland; [Huotilainen, Minna] Finnish Inst Occupat Hlth, Helsinki, Finland	University of Helsinki; University of Jyvaskyla; University of Helsinki; Finnish Institute of Occupational Health	Partanen, E (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	eino.partanen@helsinki.fi	Kujala, Teija/G-6704-2016	Huotilainen, Minna/0000-0002-7251-6984; Kujala, Teija/0000-0002-8814-605X; Tervaniemi, Mari/0000-0002-9651-2929; Partanen, Eino/0000-0002-3569-1062	Academy of Finland [128840, 1135304, 1135161]; ERANET-NEURON project Probing the Auditory Novelty System (PANS); University of Helsinki; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); ERANET-NEURON project Probing the Auditory Novelty System (PANS); University of Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was financially supported by the Academy of Finland (grants 128840, 1135304, and 1135161; http://www.aka.fi/eng), ERANET-NEURON (http://www.neuron-eranet.eu/) project Probing the Auditory Novelty System (PANS), the University of Helsinki (http://www.helsinki.fi/university/index.html) graduate school grant and the Finnish Cultural Foundation (http://www.skr.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; ANDO Y, 1970, J ACOUST SOC AM, V47, P1128, DOI 10.1121/1.1912014; Aoun P, 2005, NEUROL RES, V27, P791, DOI 10.1179/016164105X63647; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; FIFER WP, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13270.x; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Friedrich M, 2004, PSYCHOPHYSIOLOGY, V41, P772, DOI 10.1111/j.1469-8986.2004.00202.x; Granier-Deferre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017304; GRIFFITHS SK, 1994, J ACOUST SOC AM, V96, P2055, DOI 10.1121/1.410147; He C, 2007, J COGNITIVE NEUROSCI, V19, P878, DOI 10.1162/jocn.2007.19.5.878; HEPPER PG, 1988, LANCET, V1, P1347, DOI 10.1016/S0140-6736(88)92170-8; HEPPER PG, 1994, ARCH DIS CHILD-FETAL, V71, pF81, DOI 10.1136/fn.71.2.F81; Johnson JK, 2011, COGN BEHAV NEUROL, V24, P74, DOI 10.1097/WNN.0b013e31821de326; Kujala T, 2010, PROG NEUROBIOL, V91, P55, DOI 10.1016/j.pneurobio.2010.01.006; Kushnerenko E, 2002, NEUROREPORT, V13, P1843, DOI 10.1097/00001756-200210280-00002; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lecanuet JP, 1996, EUR J OBSTET GYN R B, V68, P1, DOI 10.1016/0301-2115(96)02509-2; Leppanen PHT, 2010, CORTEX, V46, P1362, DOI 10.1016/j.cortex.2010.06.003; Mirmiran M, 2003, SLEEP MED REV, V7, P321, DOI 10.1053/smrv.2002.0243; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Moon C M, 2000, J Perinatol, V20, pS37; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Novitski N, 2007, CLIN NEUROPHYSIOL, V118, P412, DOI 10.1016/j.clinph.2006.10.008; PARMELEE AH, 1964, J PEDIATR-US, V65, P576, DOI 10.1016/S0022-3476(64)80291-2; Partanen E, 2013, P NATL ACAD SCI USA, V110, P15145, DOI 10.1073/pnas.1302159110; Peters A. J. M., 1993, Journal of Low Frequency Noise & Vibration, V12, P16; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Ruusuvirta T, 2003, NEUROREPORT, V14, P2117, DOI 10.1097/00001756-200311140-00021; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Seppanen M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00043; Shtyrov Y, 2010, J NEUROSCI, V30, P16864, DOI 10.1523/JNEUROSCI.1376-10.2010; Spence MJ, 1996, INFANT BEHAV DEV, V19, P199, DOI 10.1016/S0163-6383(96)90019-3; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Tervaniemi M, 2003, MUSIC SCI, V7, P241, DOI 10.1177/102986490300700203; Tew S, 2009, ANN NY ACAD SCI, V1169, P287, DOI 10.1111/j.1749-6632.2009.04845.x; Trainor LJ, 2012, ANN NY ACAD SCI, V1252, P129, DOI 10.1111/j.1749-6632.2012.06462.x; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; Xu JH, 2009, BEHAV BRAIN RES, V196, P49, DOI 10.1016/j.bbr.2008.07.018	43	75	78	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78946	10.1371/journal.pone.0078946	http://dx.doi.org/10.1371/journal.pone.0078946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205353	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500141
J	Chen, HY; Osuna, D; Colville, L; Lorenzo, O; Graeber, K; Kuster, H; Leubner-Metzger, G; Kranner, I				Chen, Hongying; Osuna, Daniel; Colville, Louise; Lorenzo, Oscar; Graeber, Kai; Kuester, Helge; Leubner-Metzger, Gerhard; Kranner, Ilse			Transcriptome-Wide Mapping of Pea Seed Ageing Reveals a Pivotal Role for Genes Related to Oxidative Stress and Programmed Cell Death	PLOS ONE			English	Article							PROTEIN S-GLUTATHIONYLATION; BAX INHIBITOR-1; DIFFERENTIAL EXPRESSION; LIPID-PEROXIDATION; INDUCED APOPTOSIS; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; CYSTEINE PROTEASES; MAILLARD REACTIONS; JASMONIC ACID	Understanding of seed ageing, which leads to viability loss during storage, is vital for ex situ plant conservation and agriculture alike. Yet the potential for regulation at the transcriptional level has not been fully investigated. Here, we studied the relationship between seed viability, gene expression and glutathione redox status during artificial ageing of pea (Pisum sativum) seeds. Transcriptome-wide analysis using microarrays was complemented with qRT-PCR analysis of selected genes and a multilevel analysis of the antioxidant glutathione. Partial degradation of DNA and RNA occurred from the onset of artificial ageing at 60% RH and 50 degrees C, and transcriptome profiling showed that the expression of genes associated with programmed cell death, oxidative stress and protein ubiquitination were altered prior to any sign of viability loss. After 25 days of ageing viability started to decline in conjunction with progressively oxidising cellular conditions, as indicated by a shift of the glutathione redox state towards more positive values (>-190 mV). The unravelling of the molecular basis of seed ageing revealed that transcriptome reprogramming is a key component of the ageing process, which influences the progression of programmed cell death and decline in antioxidant capacity that ultimately lead to seed viability loss.	[Chen, Hongying] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Chen, Hongying; Colville, Louise; Kranner, Ilse] Kew, Royal Bot Gardens, Seed Conservat Dept, Ardingly, W Sussex, England; [Osuna, Daniel; Lorenzo, Oscar] Univ Salamanca, Fac Biol, Ctr Hispano Luso Invest Agr CIALE, Dept Fisiol Vegetal, E-37008 Salamanca, Spain; [Graeber, Kai; Leubner-Metzger, Gerhard] Univ Freiburg, Fac Biol, Inst Biol 2, D-79106 Freiburg, Germany; [Graeber, Kai; Kuester, Helge] Leibniz Univ Hannover, Inst Plant Genet, Unit Plant Genom 4, D-30167 Hannover, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Royal Botanic Gardens, Kew; University of Salamanca; University of Freiburg; Leibniz University Hannover	Colville, L (corresponding author), Kew, Royal Bot Gardens, Seed Conservat Dept, Ardingly, W Sussex, England.	l.colville@kew.org	Lorenzo, Oscar/K-8170-2014; Osuna, Daniel/I-1535-2015; Leubner, Gerhard/A-1999-2013; Küster, Helge/A-4487-2013; Kranner, Ilse/B-1039-2011; Colville, Louise/I-7841-2012	Lorenzo, Oscar/0000-0001-9523-0789; Osuna, Daniel/0000-0002-7515-3007; Leubner, Gerhard/0000-0002-6045-8713; Küster, Helge/0000-0002-9197-9802; Kranner, Ilse/0000-0003-4959-9109; Colville, Louise/0000-0003-4626-4522	Spanish Ministerio de Educacion y Ciencia; Junta de Castilla y Leon [BIO2011-26940, CSD2007-00057, SA048A10-2]; German Research Foundation [DFGLe720/ 7]; Chinese Academy of Sciences [KSCX2-EW-J-24, Y3221411W1]; Millennium Commission; Wellcome Trust; Orange Plc.; Defra	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); German Research Foundation(German Research Foundation (DFG)); Chinese Academy of Sciences(Chinese Academy of Sciences); Millennium Commission; Wellcome Trust(Wellcome TrustEuropean Commission); Orange Plc.; Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the Spanish Ministerio de Educacion y Ciencia and Junta de Castilla y Leon [BIO2011-26940, CSD2007-00057(TRANSPLANTA) and SA048A10-2 to O.L.], the German Research Foundation [DFGLe720/ 7 to G. L. M.], and the Chinese Academy of Sciences [KSCX2-EW-J-24 and Y3221411W1 to H. C.]. The Millennium Seed Bank Project is supported by the Millennium Commission, The Wellcome Trust, Orange Plc. and Defra. The Royal Botanic Gardens, Kew receive grant-in-aid from Defra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Adamakis IDS, 2011, PLANTA, V234, P21, DOI 10.1007/s00425-011-1372-5; Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birtic S, 2011, FREE RADICAL RES, V45, P1093, DOI 10.3109/10715762.2011.595409; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Cazalis R, 2006, J EXP BOT, V57, P2165, DOI 10.1093/jxb/erj174; Cereser C, 2001, TOXICOLOGY, V163, P153, DOI 10.1016/S0300-483X(01)00401-2; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen X, 2009, PLANT PHYSIOL BIOCH, V47, P407, DOI 10.1016/j.plaphy.2008.12.021; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Colville L, 2012, J EXP BOT, V63, P6519, DOI 10.1093/jxb/ers307; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; De Pinto MC, 2012, PLANT CELL ENVIRON, V35, P234, DOI 10.1111/j.1365-3040.2011.02387.x; del Prete MJ, 2002, FASEB J, V16, P2003, DOI 10.1096/fj.02-0392fje; Dell'Aquila A, 1994, SEED SCI RES, V4, P293, DOI 10.1017/S0960258500002324; DELOUCHE J C, 1973, Seed Science and Technology, V1, P427; Desai MK, 2006, PLANT PHYSIOL BIOCH, V44, P483, DOI 10.1016/j.plaphy.2006.08.008; Di Stefano A, 2006, BBA-MOL CELL RES, V1763, P214, DOI 10.1016/j.bbamcr.2005.12.012; Diaz M, 2003, FEBS LETT, V543, P136, DOI 10.1016/S0014-5793(03)00426-5; Drake R, 1996, PLANT MOL BIOL, V30, P755, DOI 10.1007/BF00019009; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; El-Maarouf-Bouteau H, 2011, J EXP BOT, V62, P5003, DOI 10.1093/jxb/err198; FOYER CH, 1995, PLANT PHYSIOL, V109, P1047, DOI 10.1104/pp.109.3.1047; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Han JJ, 2012, PLANT J, V72, P129, DOI 10.1111/j.1365-313X.2012.05070.x; He X, 2010, PLANT CELL PHYSIOL, V51, P1707, DOI 10.1093/pcp/pcq130; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Huckelhoven R, 2001, PLANT MOL BIOL, V47, P739, DOI 10.1023/A:1013635427949; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Ishitani R, 1996, J NEUROCHEM, V66, P928; Johnson RR, 2000, SEED SCI RES, V10, P233, DOI 10.1017/S096025850000026X; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kibinza S, 2011, PLANT SCI, V181, P309, DOI 10.1016/j.plantsci.2011.06.003; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Kim M, 2006, PLANT CELL, V18, P2341, DOI 10.1105/tpc.106.041509; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Kranner I, 1996, PHYTOCHEM ANALYSIS, V7, P24, DOI 10.1002/(SICI)1099-1565(199601)7:1<24::AID-PCA277>3.0.CO;2-2; Kranner I., 2012, MYCORRHIZA MANUAL, V1st ed., P227; Kranner I, 2006, FREE RADICAL BIO MED, V40, P2155, DOI 10.1016/j.freeradbiomed.2006.02.013; Kranner I, 2011, PLANT GROWTH REGUL, V63, P63, DOI 10.1007/s10725-010-9512-7; Kranner I, 2010, P NATL ACAD SCI USA, V107, P3912, DOI 10.1073/pnas.0914197107; Kuthanova A, 2008, J EXP BOT, V59, P2233, DOI 10.1093/jxb/ern090; Lacomme C, 1999, FEBS LETT, V459, P149, DOI 10.1016/S0014-5793(99)01233-8; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Leymarie J, 2007, J EXP BOT, V58, P425, DOI 10.1093/jxb/erl211; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Martins LM, 1997, TRENDS CELL BIOL, V7, P111; Minami A, 1995, PLANT CELL PHYSIOL, V36, P1599; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Morigasaki S, 2008, MOL CELL, V30, P108, DOI 10.1016/j.molcel.2008.01.017; Murphy NB, 1997, CELL DEATH DIFFER, V4, P365, DOI 10.1038/sj.cdd.4400253; Murthy UMN, 2003, J EXP BOT, V54, P1057, DOI 10.1093/jxb/erg092; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nasirudeen AMA, 2001, PARASITOLOGY, V123, P235, DOI 10.1017/S0031182001008332; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Osborne DJ, 2002, CRIT REV PLANT SCI, V21, P127, DOI 10.1080/0735-260291044214; PASTORI GM, 1992, PLANT CELL PHYSIOL, V33, P957; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Perez-Novo CA, 2005, BIOTECHNIQUES, V39, P52; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Polci R, 2004, CANCER RES, V64, P8800, DOI 10.1158/0008-5472.CAN-04-2243; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schiebold S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-19; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; SITAL JS, 2008, INDIAN J AGR BIOCH, V21, P16; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Stein RJ, 2009, PLANT SCI, V177, P563, DOI 10.1016/j.plantsci.2009.08.001; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Swidzinski JA, 2004, PHYTOCHEMISTRY, V65, P1829, DOI 10.1016/j.phytochem.2004.04.020; Tateda C, 2009, PLANT CELL REP, V28, P41, DOI 10.1007/s00299-008-0630-x; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Wagstaff C, 2003, NEW PHYTOL, V160, P49, DOI 10.1046/j.1469-8137.2003.00853.x; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Weigelt K, 2008, PLANT J, V55, P909, DOI 10.1111/j.1365-313X.2008.03560.x; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	121	57	63	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78471	10.1371/journal.pone.0078471	http://dx.doi.org/10.1371/journal.pone.0078471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205239	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700090
J	Lai, PMR; Dasenbrock, H; Lin, N; Du, R				Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Lin, Ning; Du, Rose			The Impact of Insurance Status on the Outcomes after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; UNITED-STATES; TRAUMA MORTALITY; PAYER STATUS; SURGERY; REPAIR; RACE; NEUROSURGERY; DISPARITIES; MORBIDITY	Investigation into the association of insurance status with the outcomes of patients undergoing neurosurgical intervention has been limited: this is the first nationwide study to analyze the impact of primary payer on the outcomes of patients with aneurysmal subarachnoid hemorrhage who underwent endovascular coiling or microsurgical clipping. The Nationwide Inpatient Sample (2001-2010) was utilized to identify patients; those with both an ICD-9 diagnosis codes for subarachnoid hemorrhage and a procedure code for aneurysm repair (either via an endovascular or surgical approach) were included. Hierarchical multivariate regression analyses were utilized to evaluate the impact of primary payer on in-hospital mortality, hospital discharge disposition, and length of hospital stay with hospital as the random effects variable. Models were adjusted for patient age, sex, race, comorbidities, socioeconomic status, hospital region, location (urban versus rural), and teaching status, procedural volume, year of admission, and the proportion of patients who underwent ventriculostomy. Subsequent models were also adjusted for time to aneurysm repair and time to ventriculostomy; subgroup analyses evaluated for those who underwent endovascular and surgical procedures separately. 15,557 hospitalizations were included. In the initial model, the adjusted odds of in-hospital mortality were higher for Medicare (OR 1.23, p<0.001), Medicaid (OR 1.23, p<0.001), and uninsured patients (OR 1.49, p<0.001) compared to those with private insurance. After also adjusting for timing of intervention, Medicaid and uninsured patients had a reduced odds of non-routine discharge (OR 0.75, p<0.001 and OR 0.42, p<0.001) despite longer hospital stays (by 8.35 days, p<0.001 and 2.45 days, p = 0.005). Variations in outcomes by primary payer-including in-hospital post-procedural mortality-were more pronounced for patients of all insurance types who underwent microsurgical clipping. The observed differences by primary payer are likely multifactorial, attributable to varied socioeconomic factors and the complexities of the American healthcare delivery system.	[Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lin, Ning/AAP-7745-2020; Du, Rose/AAJ-2873-2020; Lai, Rosalind/AAG-3680-2021; Du, Rose/I-5402-2012	Lin, Ning/0000-0002-3638-4814; Du, Rose/0000-0003-2641-6496				Abdo A, 2012, INT UROL NEPHROL, V44, P343, DOI 10.1007/s11255-011-0056-1; Alosh H, 2009, SPINE, V34, P1956, DOI 10.1097/BRS.0b013e3181ab930e; Boxer LK, 2003, SURGERY, V134, P142, DOI 10.1067/msy.2003.214; Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986; Dasenbrock HH, 2012, CANCER-AM CANCER SOC, V118, P4833, DOI 10.1002/cncr.27388; El-Sayed AM, 2011, WORLD NEUROSURG, V76, P459, DOI 10.1016/j.wneu.2011.03.051; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; LaPar DJ, 2010, ANN SURG, V252, P544, DOI 10.1097/SLA.0b013e3181e8fd75; Lemaire A, 2008, J VASC SURG, V47, P1172, DOI 10.1016/j.jvs.2008.01.033; Lin N, 2011, WORLD NEUROSURG, V76, P398, DOI 10.1016/j.wneu.2011.05.011; Mannix R, 2012, J PEDIATR-US, V161, P536, DOI 10.1016/j.jpeds.2012.03.013; Momin EN, 2012, ARCH SURG-CHICAGO, V147, P1017, DOI 10.1001/archsurg.2012.1459; Moser JW, 2012, J AM COLL RADIOL, V9, P50, DOI 10.1016/j.jacr.2011.08.006; Murphy EH, 2010, J VASC SURG, V51, p14S, DOI 10.1016/j.jvs.2009.11.079; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Rinkel GJE, 2008, J NEURORADIOLOGY, V35, P99, DOI 10.1016/j.neurad.2007.11.004; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shen JJ, 2007, STROKE, V38, P1010, DOI 10.1161/01.STR.0000257312.12989.af; Slatore CG, 2010, AM J RESP CRIT CARE, V182, P1195, DOI 10.1164/rccm.2009-038ST; Trinh QD, 2012, CANCER-AM CANCER SOC, V118, P1803, DOI 10.1002/cncr.26475; Wong GKC, 2012, WORLD NEUROSURG, V77, P311, DOI 10.1016/j.wneu.2011.09.025	28	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78047	10.1371/journal.pone.0078047	http://dx.doi.org/10.1371/journal.pone.0078047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205085	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700067
J	Dias, FC; Medina, TD; Mendes, CT; Dantas, RO; Pissetti, CW; Rodrigues, V; Dellalibera-Joviliano, R; Marin-Neto, JA; Gutierrez, FRS; Moreau, P; Silva, JS; Donadi, EA				Dias, Fabricio C.; Medina, Tiago da S.; Mendes-Junior, Celso T.; Dantas, Roberto O.; Pissetti, Cristina W.; Rodrigues Junior, Virmondes; Dellalibera-Joviliano, Renata; Marin-Neto, Jose A.; Gutierrez, Fredy R. S.; Moreau, Philippe; Silva, Joao S.; Donadi, Eduardo A.			Polymorphic Sites at the Immunoregulatory CTLA-4 Gene Are Associated with Chronic Chagas Disease and Its Clinical Manifestations	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRYPANOSOMA-CRUZI INFECTION; B7 FAMILY; T-CELLS; SUSCEPTIBILITY; AUTOIMMUNE; PD-1; CYTOTOXIC-T-LYMPHOCYTE-ANTIGEN-4; CARDIOMYOPATHY; INDETERMINATE	Background: Chagas disease affects approximately 10 million people mainly in Latin America. The immune regulation by the host seems to be an essential factor for disease evolution, and immune system inhibitory molecules such as CTLA-4 and PD-1 favor the maintenance of peripheral tolerance. Considering that polymorphisms at the immunoregulatory CTLA-4 and PDCD1 genes may alter their inhibitory function, we investigated the association of alleles, genotypes and haplotypes of polymorphic sites observed at the CTLA-4 and PDCD1 genes with different clinical manifestations of chronic Chagas disease (indeterminate, cardiac, digestive and mixed). Methods: The polymorphisms at the CTLA-4 (-1722T/C, -318C/T and +49A/G) and PDCD1 (PD-1.3G/A) genes were typed using TaqMan methodology in 277 chronic Chagas disease patients classified into four groups, according to clinical characteristics, and 326 non-infected controls. Results: Our results showed that CTLA-4-1722CC genotype (22%), -1722C allele (27%) and CTLA-4 TCG (8.6%), TCA (26%) and CCA (15%) haplotypes were strongly associated with the indeterminate form, while the CTLA-4-318CT genotype (82%) and CTLA-4-318T allele (47%) were found mainly in patients with the mixed form of the disease. The CTLA-4 TCG haplotype (10.2%) was associated with the digestive form. On the other hand, the PD-1.3G/A polymorphism was not associated with chronic Chagas disease and its clinical manifestations. Conclusions: Here, we showed that alleles, genotypes and haplotypes reported to increase the expression of the regulatory molecule CTLA-4 were associated with the indeterminate form of the disease. Taken together, our data support the idea that polymorphic sites at immunoregulatory genes may influence the development of Chagas disease variants.	[Dias, Fabricio C.; Medina, Tiago da S.; Silva, Joao S.; Donadi, Eduardo A.] Univ Sao Paulo, Dept Bioquim & Imunol, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Mendes-Junior, Celso T.] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Dantas, Roberto O.; Marin-Neto, Jose A.; Donadi, Eduardo A.] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Pissetti, Cristina W.; Rodrigues Junior, Virmondes] Univ Triangulo Mineiro, Lab Imunol, Uberaba, MG, Brazil; [Dellalibera-Joviliano, Renata] Univ Sao Paulo, Dept Cirurgia & Anat, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Gutierrez, Fredy R. S.] Univ Antonio Narino, Sch Med, Bogota, Colombia; [Dias, Fabricio C.; Moreau, Philippe] St Louis Hosp, Inst Emerging Dis & Innovat Therapies, Res Div Hematol & Immunol, CEA, Paris, France	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo; Universidad Antonio Narino; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Donadi, EA (corresponding author), Univ Sao Paulo, Dept Bioquim & Imunol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.	eadonadi@fmrp.usp.br	Silva, Joao/A-4484-2008; Mendes-Junior, Celso Teixeira/B-1994-2010; Medina, Tiago S/B-3084-2018; Marin-Neto, Jose Antonio/F-6099-2012; DELLALIBERA-JOVILIANO, RENATA/E-3242-2019; donadi, eduardo A/H-7080-2013; Gutierrez, Fredy RS/C-3911-2009	Silva, Joao/0000-0002-3410-3927; Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Medina, Tiago S/0000-0001-8674-8842; DELLALIBERA-JOVILIANO, RENATA/0000-0002-5102-6724; donadi, eduardo A/0000-0002-9457-9601; Moreau, Philippe/0000-0002-2868-7401; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Rodrigues Jr, Virmondes/0000-0001-8706-4223; Gutierrez, Fredy RS/0000-0001-9873-8342	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PRODOC288/05-5, CAPES/COFECUB 653/09, PNPD 02883/09-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PRODOC288/05-5, CAPES/COFECUB 653/09 and PNPD 02883/09-0]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; Dong HD, 1999, NAT MED, V5, P1365; Duan SQ, 2011, MOL BIOL REP, V38, P5125, DOI 10.1007/s11033-010-0660-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Mestre M, 2009, HUM IMMUNOL, V70, P532, DOI 10.1016/j.humimm.2009.03.016; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; GeneCards, 2012, PROGR CELL DEATH; Gomes J. A. S., 2003, Infection and Immunity, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gutierrez FRS, 2011, INFECT IMMUN, V79, P1873, DOI 10.1128/IAI.01047-10; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Khalilzadeh O, 2009, ARCH DERMATOL RES, V301, P719, DOI 10.1007/s00403-008-0919-1; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kuo HC, 2011, J CLIN IMMUNOL, V31, P240, DOI 10.1007/s10875-010-9484-4; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Maciel BC, 2010, EVIDENCE BASED CARDI, P823; Marin Neto J A, 1999, Arq Bras Cardiol, V72, P247; Martin TM, 2009, MOL VIS, V15, P208; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Pincerati MR, 2010, INT J IMMUNOGENET, V37, P253, DOI 10.1111/j.1744-313X.2010.00917.x; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rahimifar S, 2010, GYNECOL ONCOL, V119, P136, DOI 10.1016/j.ygyno.2010.06.006; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rezende JM, 1994, SCI PUBLICATION, V547, P149; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Slot MC, 2008, CLIN IMMUNOL, V128, P39, DOI 10.1016/j.clim.2008.03.506; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x; Wang XB, 2002, GENES IMMUN, V3, P233, DOI 10.1038/sj.gene.6363869; World Health Organization (WHO), 2020, CHAG DIS AM TRYP	48	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78367	10.1371/journal.pone.0078367	http://dx.doi.org/10.1371/journal.pone.0078367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205212	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300055
J	Dougal, K; de la Fuente, G; Harris, PA; Girdwood, SE; Pinloche, E; Newbold, CJ				Dougal, Kirsty; de la Fuente, Gabriel; Harris, Patricia A.; Girdwood, Susan E.; Pinloche, Eric; Newbold, C. Jamie			Identification of a Core Bacterial Community within the Large Intestine of the Horse	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HAY-GRAIN RATIOS; MICROBIAL DISORDERS; METAGENOMIC ANALYSIS; MOLECULAR ANALYSIS; GUT MICROBIOME; IN-VITRO; DIVERSITY; GENE; ABUNDANT	The horse has a rich and complex microbial community within its gastrointestinal tract that plays a central role in both health and disease. The horse receives much of its dietary energy through microbial hydrolysis and fermentation of fiber predominantly in the large intestine/hindgut. The presence of a possible core bacterial community in the equine large intestine was investigated in this study. Samples were taken from the terminal ileum and 7 regions of the large intestine from ten animals, DNA extracted and the V1-V2 regions of 16SrDNA 454-pyrosequenced. A specific group of OTUs clustered in all ileal samples and a distinct and different signature existed for the proximal regions of the large intestine and the distal regions. A core group of bacterial families were identified in all gut regions with clear differences shown between the ileum and the various large intestine regions. The core in the ileum accounted for 32% of all sequences and comprised of only seven OTUs of varying abundance; the core in the large intestine was much smaller (5-15% of all sequences) with a much larger number of OTUs present but in low abundance. The most abundant member of the core community in the ileum was Lactobacillaceae, in the proximal large intestine the Lachnospiraceae and in the distal large intestine the Prevotellaceae. In conclusion, the presence of a core bacterial community in the large intestine of the horse that is made up of many low abundance OTUs may explain in part the susceptibility of horses to digestive upset.	[Dougal, Kirsty; de la Fuente, Gabriel; Girdwood, Susan E.; Pinloche, Eric; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	cjn@aber.ac.uk	de la Fuente Oliver, Gabriel/B-3793-2015; de la Fuente Oliver, Gabriel/M-6981-2019	de la Fuente Oliver, Gabriel/0000-0003-0083-776X; de la Fuente Oliver, Gabriel/0000-0003-0083-776X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G017271/1]; WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire	This research was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Case studentship (BB/G017271/1) and the WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire. LE14 4RT. The funders (with the exception of Patricia A. Harris, co-author and collaborator) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Bailey SR, 2002, J ANIM SCI, V80, P2656; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blackmore TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075079; BOCHRODER B, 1994, EQUINE VET J, V26, P131, DOI 10.1111/j.2042-3306.1994.tb04351.x; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; COHEN ND, 1995, J AM VET MED ASSOC, V206, P667; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Daly K, 2003, FEMS MICROBIOL ECOL, V44, P243, DOI 10.1016/S0168-6496(03)00032-1; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Drogoul C, 2001, J EQUINE VET SCI, V21, P487, DOI 10.1016/S0737-0806(01)70211-0; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Earing J.E., 2012, ADV MICROBIOL-IRVINE, V2, P79, DOI DOI 10.4236/AIM.2012.22010; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hillyer MH, 2001, EQUINE VET J, V33, P380, DOI 10.2746/042516401776249499; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hudson JM, 2001, J AM VET MED ASSOC, V219, P1419, DOI 10.2460/javma.2001.219.1419; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lopes MAF, 2004, AM J VET RES, V65, P687, DOI 10.2460/ajvr.2004.65.687; Lopes MAF, 2000, HISTOL HISTOPATHOL, V15, P983, DOI 10.14670/HH-15.983; Lowe BA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-20; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Medina B, 2002, J ANIM SCI, V80, P2600; Menzies-Gow NJ, 2010, VET REC, V167, P690, DOI 10.1136/vr.c5177; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; PROUDMAN CJ, 1992, EQUINE VET J, V24, P90, DOI 10.1111/j.2042-3306.1992.tb02789.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Shirazi-Beechey SP, 2008, EQUINE VET J, V40, P414, DOI 10.2746/042516408X314075; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; USDA, 2006, HIGHL EQ 2005 1; Varloud M, 2004, ANIM SCI, V79, P61, DOI 10.1017/S1357729800054539; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Wylie CE, 2013, EQUINE VET J, V45, P681, DOI 10.1111/evj.12047; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	68	94	97	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77660	10.1371/journal.pone.0077660	http://dx.doi.org/10.1371/journal.pone.0077660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204908	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300028
J	Planck, M; Edlund, K; Botling, J; Micke, P; Isaksson, S; Staaf, J				Planck, Maria; Edlund, Karolina; Botling, Johan; Micke, Patrick; Isaksson, Sofi; Staaf, Johan			Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; COPY-NUMBER ALTERATION; CANCER; PATHWAY; HETEROZYGOSITY; CLASSIFICATION; IDENTIFICATION; ACTIVATION; RESISTANCE; IMBALANCES	Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutations. Improved knowledge about genomic and transcriptional alterations in and between mutation-defined subgroups may identify genes involved in disease development or progression. Methods: Genomic profiles from 457 adenocarcinomas, including 113 EGFR-mutated, 134 KRAS-mutated and 210 EGFR and KRAS-wild type tumors (EGFRwt/KRASwt), and gene expression profiles from 914 adenocarcinomas, including 309 EGFR-mutated, 192 KRAS-mutated, and 413 EGFRwt/KRASwt tumors, were assembled from different repositories. Genomic and transcriptional differences between the three mutational groups were analyzed by both supervised and unsupervised methods. Results: EGFR-mutated adenocarcinomas displayed a larger number of copy number alterations and recurrent amplifications, a higher fraction of total loss-of-heterozygosity, higher genomic complexity, and a more distinct expression pattern than EGFR-wild type adenocarcinomas. Several of these differences were also consistent when the three mutational groups were stratified by stage, gender and smoking status. Specific copy number alterations were associated with mutation status, predominantly including regions of gain with the highest frequency in EGFR-mutated tumors. Differential regions included both large and small regions of gain on 1p, 5q34-q35.3, 7p, 7q11.21, 12p12.1, 16p, and 21q, and losses on 6q16.3-q21, 8p, and 9p, with 20-40% frequency differences between the mutational groups. Supervised gene expression analyses identified 96 consistently differentially expressed genes between the mutational groups, and together with unsupervised analyses these analyses highlighted the difficulty in broadly resolving the three mutational groups into distinct transcriptional entities. Conclusions: We provide a comprehensive overview of the genomic and transcriptional landscape in lung adenocarcinoma stratified by EGFR and KRAS mutations. Our analyses suggest that the overall genomic and transcriptional landscape of lung adenocarcinoma is affected, but only to a minor extent, by EGFR and KRAS mutation status.	[Planck, Maria; Isaksson, Sofi; Staaf, Johan] Lund Univ, Dept Oncol, Lund, Sweden; [Planck, Maria; Isaksson, Sofi; Staaf, Johan] Skane Univ Hosp, Lund, Sweden; [Edlund, Karolina; Botling, Johan; Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Uppsala University; Lund University	Staaf, J (corresponding author), Lund Univ, Dept Oncol, Lund, Sweden.	johan.staaf@med.lu.se	Botling, Johan/ABA-2586-2020	Botling, Johan/0000-0003-2226-3517	Swedish Cancer Society; Knut & Alice Wallenberg Foundation; Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health); Mrs Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Swedish Research Council; Lund University Hospital Research Funds; Gustav V:s Jubilee Foundation; IngaBritt and Arne Lundberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health); Mrs Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Hospital Research Funds; Gustav V:s Jubilee Foundation; IngaBritt and Arne Lundberg Foundation	Financial support for this study was provided by the Swedish Cancer Society, the Knut & Alice Wallenberg Foundation, the Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health), the Mrs Berta Kamprad Foundation, the Gunnar Nilsson Cancer Foundation, the Swedish Research Council, the Lund University Hospital Research Funds, the Gustav V:s Jubilee Foundation, and the IngaBritt and Arne Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Fong Y, 2010, RESPIROLOGY, V15, P700, DOI 10.1111/j.1440-1843.2010.01746.x; Fouret R, 2012, CLIN CANCER RES, V18, P5606, DOI 10.1158/1078-0432.CCR-12-0505; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Huang YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022961; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kitamura M, 2007, CANCER LETT, V252, P184, DOI 10.1016/j.canlet.2006.11.015; Kono SA, 2009, DRUG RESIST UPDATE, V12, P95, DOI 10.1016/j.drup.2009.05.001; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Micke P, 2011, J THORAC ONCOL, V6, P1833, DOI 10.1097/JTO.0b013e3182295917; Nakanishi H, 2009, CANCER RES, V69, P1615, DOI 10.1158/0008-5472.CAN-08-3218; Newnham GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-93; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Planck M, 2013, CLIN CANC RES; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shibata T, 2007, CANCER SCI, V98, P985, DOI 10.1111/j.1349-7006.2007.00483.x; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staaf J, 2013, INT J CANCER, V132, P2020, DOI 10.1002/ijc.27879; Staaf J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3075; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Terai H, 2013, MOL CANCER RES, V11, P759, DOI 10.1158/1541-7786.MCR-12-0652; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Travis W, 2004, WHO CLASSIFICATION T; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yuan SS, 2011, J CLIN ONCOL, V29, P3435, DOI 10.1200/JCO.2011.35.3979; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	56	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78614	10.1371/journal.pone.0078614	http://dx.doi.org/10.1371/journal.pone.0078614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205279	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300073
J	Devanathan, S; Nemanich, ST; Kovacs, A; Fettig, N; Gropler, RJ; Shoghi, KI				Devanathan, Sriram; Nemanich, Samuel T.; Kovacs, Attila; Fettig, Nicole; Gropler, Robert J.; Shoghi, Kooresh I.			Genomic and Metabolic Disposition of Non-Obese Type 2 Diabetic Rats to Increased Myocardial Fatty Acid Metabolism	PLOS ONE			English	Article							GOTO-KAKIZAKI RAT; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CORONARY; EXPRESSION; INFARCTION; MORTALITY; OXIDATION; TURNOVER; MELLITUS	Lipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese animal models of T2DM. Therefore, the present study investigates functional, metabolic, and genomic differences in myocardial FA metabolism in non-obese type 2 diabetic rats. The study utilized Goto-Kakizaki (GK) rats at the age of 24 weeks. Each rat was imaged with small animal positron emission tomography (PET) to estimate myocardial blood flow (MBF) and myocardial FA metabolism. Echocardiograms (ECHOs) were performed to assess cardiac function. Levels of triglycerides (TG) and non-esterified fatty acids (NEFA) were measured in both plasma and cardiac tissues. Finally, expression profiles for 168 genes that have been implicated in diabetes and FA metabolism were measured using quantitative PCR (qPCR) arrays. GK rats exhibited increased NEFA and TG in both plasma and cardiac tissue. Quantitative PET imaging suggests that GK rats have increased FA metabolism. ECHO data indicates that GK rats have a significant increase in left ventricle mass index (LVMI) and decrease in peak early diastolic mitral annular velocity (E') compared to Wistar rats, suggesting structural remodeling and impaired diastolic function. Of the 84 genes in each the diabetes and FA metabolism arrays, 17 genes in the diabetes array and 41 genes in the FA metabolism array were significantly up-regulated in GK rats. Our data suggest that GK rats' exhibit increased genomic disposition to FA and TG metabolism independent of obesity.	[Devanathan, Sriram; Nemanich, Samuel T.; Fettig, Nicole; Gropler, Robert J.; Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Kovacs, Attila] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res, St Louis, MO 63110 USA; [Gropler, Robert J.; Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Shoghi, Kooresh I.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Shoghi, KI (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	shoghik@wustl.edu	Shoghi, Kooresh/H-7398-2014; devanathan, sriram/H-6519-2014; Nemanich, Samuel/AAK-8775-2020	Shoghi, Kooresh/0000-0003-3204-457X; Nemanich, Samuel/0000-0001-6093-7266	NIH/NIDDK [5R01DK085298]; NIH/NHLBI [R01EB012284]; Diabetes Research Center (DRC) [P60DK020579]; Nutrition Obesity Research Center (NORC) [P30DK056341]; Center for Cardiovascular Research (CCR); NIH [S10RR026949]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579, P30DK056341, R01DK085298] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diabetes Research Center (DRC); Nutrition Obesity Research Center (NORC); Center for Cardiovascular Research (CCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NIDDK grant 5R01DK085298 and NIH/NHLBI grant R01EB012284. The work utilized core-services provided by the Diabetes Research Center (DRC) grant P60DK020579, the Nutrition Obesity Research Center (NORC) grant P30DK056341, and the Center for Cardiovascular Research (CCR) supported by NIH Shared Instrumentation Grant S10RR026949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth AM, 1998, DIABETES CARE, V21, P539, DOI 10.2337/diacare.21.4.539; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Chandler MP, 2007, AM J PHYSIOL-HEART C, V293, pH1609, DOI 10.1152/ajpheart.01338.2006; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Desrois M, 2004, CARDIOVASC RES, V61, P288, DOI 10.1016/j.cardiores.2003.11.021; El-Omar MM, 2004, BASIC RES CARDIOL, V99, P133, DOI 10.1007/s00395-004-0440-4; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Flier JS, 2001, NATURE, V409, P292, DOI 10.1038/35053251; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Herrero P, 2006, J NUCL MED, V47, P477; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; ORourke CM, 1997, METABOLISM, V46, P192, DOI 10.1016/S0026-0495(97)90301-2; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Rudolph W, 1973, Recent Adv Stud Cardiac Struct Metab, V2, P739; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SADDIK M, 1994, CAN J PHYSIOL PHARM, V72, P1110, DOI 10.1139/y94-157; Sharp TL, 2005, NUCL MED BIOL, V32, P875, DOI 10.1016/j.nucmedbio.2005.05.010; Shoghi KI, 2008, J NUCL MED, V49, P1320, DOI 10.2967/jnumed.108.051672; Shoghi KI, 2007, NUCL MED BIOL, V34, P989, DOI 10.1016/j.nucmedbio.2007.07.010; Shoghi KI, 2009, CIRC-CARDIOVASC IMAG, V2, P373, DOI 10.1161/CIRCIMAGING.108.843227; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Wang BW, 2007, AM J PHYSIOL-HEART C, V293, pH2305, DOI 10.1152/ajpheart.00361.2007; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2001, ENDOCRIN METAB CLIN, V30, P857, DOI 10.1016/S0889-8529(05)70219-X	33	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78477	10.1371/journal.pone.0078477	http://dx.doi.org/10.1371/journal.pone.0078477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205240	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600103
J	Jang, MY; Chun, SI; Mun, CW; Hong, KS; Shin, JW				Jang, Moo-Young; Chun, Song-I; Mun, Chi-Woong; Hong, Kwan Soo; Shin, Jung-Woog			Evaluation of Metabolomic Changes as a Biomarker of Chondrogenic Differentiation in 3D-cultured Human Mesenchymal Stem Cells Using Proton (H-1) Nuclear Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							IN-VITRO; ARTICULAR CHONDROCYTES; REGENERATIVE MEDICINE; CYTIDINE COENZYMES; SEEDING DENSITY; ALGINATE BEADS; STROMAL CELLS; PROLIFERATION; CULTURE; VIVO	Purpose: The purpose of this study was to evaluate the metabolomic changes in 3D-cultured human mesenchymal stem cells (hMSCs) in alginate beads, so as to identify biomarkers during chondrogenesis using H-1 nuclear magnetic resonance (NMR) spectroscopy. Materials and Methods: hMSCs (2x10(6) cells/mL) were seeded into alginate beads, and chondrogenesis was allowed to progress for 15 days. NMR spectra of the chondrogenic hMSCs were obtained at 4, 7, 11, and 15 days using a 14.1-T (600-MHz) NMR with the water suppression sequence, zgpr. Real-Time polymerase chain reaction (PCR) was performed to confirm that that the hMSCs differentiated into chondrocytes and to analyze the metabolomic changes indicated by the NMR spectra. Results: During chondrogenesis, changes were detected in several metabolomes as hMSC chondrogenesis biomarkers, e. g., fatty acids, alanine, glutamate, and phosphocholine. The metabolomic changes were compared with the Real-Time PCR results, and significant differences were determined using statistical analysis. We found that changes in metabolomes were closely related to biological reactions that occurred during the chondrogenesis of hMSCs. Conclusions: In this study, we confirm that metabolomic changes detected by H-1-NMR spectroscopy during chondrogenic differentiation of 3D-cultured hMSCs in alginate beads can be considered as biomarkers of stem cell differentiation.	[Jang, Moo-Young; Chun, Song-I; Mun, Chi-Woong; Shin, Jung-Woog] Inje Univ, Dept Biomed Engn UHRC, Gimhae, Gyeongnam, South Korea; [Mun, Chi-Woong; Shin, Jung-Woog] Inje Univ, Grad Sch Hlth Sci & Technol, Gimhae, Gyeongnam, South Korea; [Hong, Kwan Soo] Korea Basic Sci Inst, Ochang, Chungbuk, South Korea	Inje University; Inje University; Korea Basic Science Institute (KBSI)	Mun, CW (corresponding author), Inje Univ, Dept Biomed Engn UHRC, Gimhae, Gyeongnam, South Korea.	mcw@inje.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A4A01013961]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant No. 2012R1A1A4A01013961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; Bohari SPM, 2011, BIO-MED MATER ENG, V21, P159, DOI 10.3233/BME-2011-0665; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Campbell MK, 2006, BIOCHEMISTRY; Chun SI, 2012, TISSUE ENG REGEN MED, V9, P101, DOI 10.1007/s13770-012-0016-6; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606; Greenwood Heather L., 2006, International Journal of Biotechnology, V8, P60, DOI 10.1504/IJBT.2006.008964; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; KEMP GJ, 1994, J THEOR BIOL, V170, P239, DOI 10.1006/jtbi.1994.1184; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim HJ, 2009, TISSUE ENG REGEN MED, V6, P1343; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Lin YJ, 2009, J BIOMED MATER RES A, V88A, P23, DOI 10.1002/jbm.a.31841; Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370; Martinez-Bisbal MC, 2004, NMR BIOMED, V17, P191, DOI 10.1002/nbm.888; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Mironov V, 2004, EXPERT OPIN BIOL TH, V4, P773, DOI 10.1517/14712598.4.6.773; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Payne GS, 2006, BRIT J RADIOL, V79, pS16, DOI 10.1259/bjr/84072695; Rudin M, 2007, EUR RADIOL, V17, P2441, DOI 10.1007/s00330-007-0619-9; Rudin M, 2009, CURR OPIN CHEM BIOL, V13, P360, DOI 10.1016/j.cbpa.2009.03.025; Shi CM, 2008, J TISSUE ENG REGEN M, V2, P482, DOI 10.1002/term.120; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Srere PA, 1969, CITRIC ACID CYCLE, p[13, 3]; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang JS, 2000, J THORAC CARDIOV SUR, V120, P999, DOI 10.1067/mtc.2000.110250; WILLIAMSASHMAN HG, 1956, J BIOL CHEM, V223, P509; Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828	42	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78325	10.1371/journal.pone.0078325	http://dx.doi.org/10.1371/journal.pone.0078325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205199	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600095
J	Sedej, S; Klemen, MS; Schluter, OM; Rupnik, MS				Sedej, Simon; Klemen, Masa Skelin; Schlueter, Oliver M.; Rupnik, Marjan Slak			Rab3a Is Critical for Trapping Alpha-MSH Granules in the High Ca2+-Affinity Pool by Preventing Constitutive Exocytosis	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; PITUITARY TISSUE-SLICES; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; NEUROENDOCRINE CELLS; MEMBRANE CAPACITANCE; GENE-EXPRESSION; GTPASE RAB3A; PC12 CELLS; MELANOTROPHS	Rab3a is a small GTPase of the Rab3 subfamily that acts during late stages of Ca2+-regulated exocytosis. Previous functional analysis in pituitary melanotrophs described Rab3a as a positive regulator of Ca2+-dependent exocytosis. However, the precise role of the Rab3a isoform on the kinetics and intracellular [Ca2+] sensitivity of regulated exocytosis, which may affect the availability of two major peptide hormones, alpha-melanocyte stimulating hormone (alpha-MSH) and beta-endorphin in plasma, remain elusive. We employed Rab3a knock-out mice (Rab3a KO) to explore the secretory phenotype in melanotrophs from fresh pituitary tissue slices. High resolution capacitance measurements showed that Rab3a KO melanotrophs possessed impaired Ca2+-triggered secretory activity as compared to wild-type cells. The hampered secretion was associated with the absence of cAMP-guanine exchange factor II/ Epac2-dependent secretory component. This component has been attributed to high Ca2+-sensitive release-ready vesicles as determined by slow photo-release of caged Ca2+. Radioimmunoassay revealed that alpha-MSH, but not beta-endorphin, was elevated in the plasma of Rab3a KO mice, indicating increased constitutive exocytosis of alpha-MSH. Increased constitutive secretion of alpha-MSH from incubated tissue slices was associated with reduced alpha-MSH cellular content in Rab3a-deficient pituitary cells. Viral re-expression of the Rab3a protein in vitro rescued the secretory phenotype of melanotrophs from Rab3a KO mice. In conclusion, we suggest that Rab3a deficiency promotes constitutive secretion and underlies selective impairment of Ca2+-dependent release of alpha-MSH.	[Sedej, Simon] Med Univ Graz, Div Cardiol, Graz, Austria; [Sedej, Simon; Schlueter, Oliver M.; Rupnik, Marjan Slak] European Neurosci Inst, Gottingen, Germany; [Klemen, Masa Skelin; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Schlueter, Oliver M.] Gottingen Grad Sch Neurosci & Mol, Gottingen, Germany; [Rupnik, Marjan Slak] Univ Maribor, Ctr Open Innovat & Res, SLO-2000 Maribor, Slovenia; [Rupnik, Marjan Slak] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	Medical University of Graz; University of Maribor; University of Maribor	Sedej, S (corresponding author), Med Univ Graz, Div Cardiol, Graz, Austria.	simon.sedej@medunigraz.at; marjan.rupnik@um.si	Slak Rupnik, Marjan/E-6246-2015; Sedej, Simon/L-3066-2015; Rupnik, Marjan Slak/R-4738-2019	Slak Rupnik, Marjan/0000-0002-3744-4882; Sedej, Simon/0000-0002-4419-6821; Rupnik, Marjan Slak/0000-0002-3744-4882	The Centre for Molecular Physiology of the Brain; Max-Planck Society	The Centre for Molecular Physiology of the Brain; Max-Planck Society(Max Planck Society)	The Centre for Molecular Physiology of the Brain supported the work of Simon Sedej, while the European Neuroscience Institute-Gottingen (Neuroendocrinology group) as a whole has been supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DARCHEN F, 1995, J CELL SCI, V108, P1639; Doussau F, 1998, J NEUROSCI, V18, P3147; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Fass DM, 1999, J NEUROSCI, V19, P3345; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Gomora JC, 1996, J PHYSIOL-LONDON, V492, P763, DOI 10.1113/jphysiol.1996.sp021344; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Lin CC, 2007, J CELL PHYSIOL, V211, P316, DOI 10.1002/jcp.20938; Lipovsek S, 2013, GEN COMP ENDOCR, V185, P67, DOI 10.1016/j.ygcen.2013.01.007; MAINS RE, 1979, J BIOL CHEM, V254, P7885; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Pavlos Nathan J, 2011, Small GTPases, V2, P77; Rupnik M, 2007, AM J PHYSIOL-CELL PH, V292, pC98, DOI 10.1152/ajpcell.00005.2006; RUPNIK M, 1992, FEBS LETT, V303, P221, DOI 10.1016/0014-5793(92)80524-K; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Skelin M, 2011, CELL CALCIUM, V49, P89, DOI 10.1016/j.ceca.2010.12.005; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Thiagarajan R, 2004, J PHYSIOL-LONDON, V555, P439, DOI 10.1113/jphysiol.2003.056333; Turner JE, 2005, J PHYSIOL-LONDON, V566, P443, DOI 10.1113/jphysiol.2005.088997; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; ZOREC R, 1991, J GEN PHYSIOL, V97, P473, DOI 10.1085/jgp.97.3.473	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78883	10.1371/journal.pone.0078883	http://dx.doi.org/10.1371/journal.pone.0078883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205339	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600114
J	Keller, A; Grimmer, G; Steffan-Dewenter, I				Keller, Alexander; Grimmer, Gudrun; Steffan-Dewenter, Ingolf			Diverse Microbiota Identified in Whole Intact Nest Chambers of the Red Mason Bee Osmia bicornis (Linnaeus 1758)	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; HONEY-BEE; PAENIBACILLUS-LARVAE; SPIROPLASMA-MELLIFERUM; BACTERIAL COMMUNITIES; CORNUTA HYMENOPTERA; SYMBIOTIC BACTERIA; HYGIENIC BEHAVIOR; FLORAL NECTAR; ACID BACTERIA	Microbial activity is known to have profound impact on bee ecology and physiology, both by beneficial and pathogenic effects. Most information about such associations is available for colony-building organisms, and especially the honey bee. There, active manipulations through worker bees result in a restricted diversity of microbes present within the colony environment. Microbial diversity in solitary bee nests remains unstudied, although their larvae face a very different situation compared with social bees by growing up in isolated compartments. Here, we assessed the microbiota present in nests and pre-adults of Osmia bicornis, the red mason bee, by culture-independent pyrosequencing. We found high bacterial diversity not comparable with honey bee colonies. We identified a variety of bacteria potentially with positive or negative interactions for bee larvae. However, most of the other diverse bacteria present in the nests seem to originate from environmental sources through incorporated nest building material and stored pollen. This diversity of microorganisms may cause severe larval mortality and require specific physiological or symbiotic adaptations against microbial threats. They may however also profit from such a diverse environment through gain of mutualistic partners. We conclude that further studies of microbiota interaction in solitary bees will improve the understanding of fitness components and populations dynamics.	[Keller, Alexander; Grimmer, Gudrun; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany; [Keller, Alexander; Grimmer, Gudrun] Univ Wurzburg, DNA Analyt Core Facil, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Keller, A (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany.	a.keller@biozentrum.uni-wuerzburg.de	Keller, Alexander/D-1221-2009	Keller, Alexander/0000-0001-5716-3634; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	University of Wurzburg; German Research Foundation (DFG); University of Wuerzburg	University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	We are grateful for financial support of this study regarding consumables and staff by the University of Wurzburg. This publication was further funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, TRENDS ECOL EVOL, V26, P494, DOI 10.1016/j.tree.2011.06.008; Alippi AM, 2006, J INVERTEBR PATHOL, V91, P141, DOI 10.1016/j.jip.2005.12.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Bevivino A, 1998, FEMS MICROBIOL ECOL, V27, P225, DOI 10.1111/j.1574-6941.1998.tb00539.x; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brown SE, 2004, J BIOL CHEM, V279, P14595, DOI 10.1074/jbc.M309859200; BULLA LA, 1975, ANNU REV MICROBIOL, V29, P163, DOI 10.1146/annurev.mi.29.100175.001115; Burgett D. M., 1997, HONEY BEE PEST PREDA, P455; CANO RJ, 1994, APPL ENVIRON MICROB, V60, P2164, DOI 10.1128/AEM.60.6.2164-2167.1994; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Audisio MC, 2011, MICROBIOL RES, V166, P1, DOI 10.1016/j.micres.2010.01.003; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CLARK TB, 1985, INT J SYST BACTERIOL, V35, P296, DOI 10.1099/00207713-35-3-296; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; GILLIAM M, 1974, J INVERTEBR PATHOL, V23, P38, DOI 10.1016/0022-2011(74)90069-X; GILLIAM M, 1990, APIDOLOGIE, V21, P99, DOI 10.1051/apido:19900202; GILLIAM M, 1988, MICROBIOS, V55, P95; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M., 1990, Proceedings and abstracts, Vth International Colloquium on Invertebrate Pathology and Microbial Control, Adelaide, Australia, 20-24 August 1990., P398; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Jeong G, 2009, J MICROBIOL, V47, P28, DOI 10.1007/s12275-009-0198-3; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, FUNCT ECOL IN PRESS; Kaltenpoth M, 2011, MOL ECOL, V20, P439, DOI 10.1111/j.1365-294X.2010.04960.x; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kluge R, 1962, Z BIENENFORSCHUNG, V6, P141; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Krunic Miloje, 2005, Bulletin of Insectology, V58, P141; Kuczynski Justin, 2011, Curr Protoc Bioinformatics, VChapter 10, DOI [10.1002/9780471729259.mc01e05s27, 10.1002/0471250953.bi1007s36]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Ladurner E, 2004, J APICULT RES, V43, P118, DOI 10.1080/00218839.2004.11101121; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Mahar Ali Nawaz, 2005, J Zhejiang Univ Sci B, V6, P457, DOI 10.1631/jzus.2005.B0457; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McCauley DE, 2007, AM J BOT, V94, P1333, DOI 10.3732/ajb.94.8.1333; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; NAKANO H, 1994, INT J FOOD MICROBIOL, V21, P247, DOI 10.1016/0168-1605(94)90031-0; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Reynaldi F. J., 2004, Rev. argent. microbiol., V36, P52; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabate DC, 2009, RES MICROBIOL, V160, P193, DOI 10.1016/j.resmic.2009.03.002; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; Sugar DR, 2012, ENVIRON MICROBIOL, V14, P924, DOI 10.1111/j.1462-2920.2011.02663.x; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Torbeck Lynn, 2011, PDA J Pharm Sci Technol, V65, P535, DOI 10.5731/pdajpst.2011.00793; TULLY JG, 1993, INT J SYST BACTERIOL, V43, P378, DOI 10.1099/00207713-43-2-378; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	81	30	33	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78296	10.1371/journal.pone.0078296	http://dx.doi.org/10.1371/journal.pone.0078296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205188	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300151
J	Lemke, HW; Tarka, M; Klaassen, RHG; Akesson, M; Bensch, S; Hasselquist, D; Hansson, B				Lemke, Hilger W.; Tarka, Maja; Klaassen, Raymond H. G.; Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Hansson, Bengt			Annual Cycle and Migration Strategies of a Trans-Saharan Migratory Songbird: A Geolocator Study in the Great Reed Warbler	PLOS ONE			English	Article							LIGHT-LEVEL GEOLOCATORS; DISTANCE MIGRANT BIRD; ACROCEPHALUS-ARUNDINACEUS; SPRING MIGRATION; WINTERING AREAS; CLIMATE-CHANGE; ARRIVAL DATE; LONG-TERM; TRACKING; ROUTES	Recent technological advancements now allow us to obtain geographical position data for a wide range of animal movements. Here we used light-level geolocators to study the annual migration cycle in great reed warblers (Acrocephalus arundinaceus), a passerine bird breeding in Eurasia and wintering in sub-Saharan Africa. We were specifically interested in seasonal strategies in routes and schedules of migration. We found that the great reed warblers (all males, no females were included) migrated from the Swedish breeding site in early August. After spending up to three weeks at scattered stopover sites in central to south-eastern Europe, they resumed migration and crossed the Mediterranean Sea and Sahara Desert without lengthy stopovers. They then spread out over a large overwintering area and each bird utilised two (or even three) main wintering sites that were spatially separated by a distinct mid-winter movement. Spring migration initiation date differed widely between individuals (1-27 April). Several males took a more westerly route over the Sahara in spring than in autumn, and in general there were fewer long-distance travels and more frequent shorter stopovers, including one in northern Africa, in spring. The shorter stopovers made spring migration on average faster than autumn migration. There was a strong correlation between the spring departure dates from wintering sites and the arrival dates at the breeding ground. All males had a high migration speed in spring despite large variation in departure dates, indicating a time-minimization strategy to achieve an early arrival at the breeding site; the latter being decisive for high reproductive success in great reed warblers. Our results have important implications for the understanding of long-distance migrants' ability to predict conditions at distant breeding sites and adapt to rapid environmental change.	[Lemke, Hilger W.; Tarka, Maja; Bensch, Staffan; Hasselquist, Dennis; Hansson, Bengt] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden; [Klaassen, Raymond H. G.] Univ Groningen, Montagus Harrier Fdn, Groningen, Netherlands; [Klaassen, Raymond H. G.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Akesson, Mikael] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Lund University; University of Groningen; University of Groningen; Swedish University of Agricultural Sciences	Hansson, B (corresponding author), Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden.	bengt.hansson@biol.lu.se	Åkesson, Mikael/K-5370-2014; Hasselquist, Dennis/M-5223-2014; Hansson, Bengt/L-8874-2013; Klaassen, Raymond/K-3027-2013; Tarka, Maja/L-8065-2013	Hasselquist, Dennis/0000-0002-0056-6616; Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council; Oscar and Lili Lamm Foundation; Lunds Djurskyddsfond; Crafoord Foundation; Linnaeus Research Excellence Center CAnMove; Lund University; Kvismare Bird Observatory	Swedish Research Council(Swedish Research CouncilEuropean Commission); Oscar and Lili Lamm Foundation; Lunds Djurskyddsfond; Crafoord Foundation; Linnaeus Research Excellence Center CAnMove; Lund University; Kvismare Bird Observatory	This study was supported by grants from the Swedish Research Council (BH, DH, SB), the Oscar and Lili Lamm Foundation (to BH), Lunds Djurskyddsfond (to BH, MT, DH), the Crafoord Foundation (to BH), the Linnaeus Research Excellence Center CAnMove funded by the Swedish Research Council and Lund University, and the Kvismare Bird Observatory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; BAS, 2010, GEOLOCATOR MANUAL V8; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cramp S., 1992, HDB BIRDS EUROPE MID; De Roo A., 1969, Gerfaut, V59, P260; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Hansson B, 2002, OECOLOGIA, V130, P536, DOI 10.1007/s00442-001-0831-2; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; HEDENSTROM A, 1993, IBIS, V135, P177, DOI 10.1111/j.1474-919X.1993.tb02829.x; Jahn AE, 2013, AUK, V130, P223, DOI 10.1525/auk.2013.12077; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Kennerley P, 2010, REED BUSH WARBLERS; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kvist A, 2000, PHYSIOL BIOCHEM ZOOL, V73, P30, DOI 10.1086/316719; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Moreau RE, 1961, IBIS A, V103a, P372; Nilsson C, 2013, AM NAT; PEARSON DJ, 1975, IBIS, V117, P506, DOI 10.1111/j.1474-919X.1975.tb04244.x; PETTERSSON J, 1985, Ringing and Migration, V6, P66; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Robson D, 2011, J ANIM ECOL, V80, P320, DOI 10.1111/j.1365-2656.2010.01772.x; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Seavy NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034886; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tarka M, 2010, P ROY SOC B-BIOL SCI, V277, P2361, DOI 10.1098/rspb.2010.0033; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	55	68	71	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e79209	10.1371/journal.pone.0079209	http://dx.doi.org/10.1371/journal.pone.0079209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205374	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300171
J	Stevens, H; Bertelsen, MF; Sijmons, S; Van Ranst, M; Maes, P				Stevens, Hans; Bertelsen, Mads Frost; Sijmons, Steven; Van Ranst, Marc; Maes, Piet			Characterization of a Novel Polyomavirus Isolated from a Fibroma on the Trunk of an African Elephant (Loxodonta africana)	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; MERKEL CELL POLYOMAVIRUS; LARGE T-ANTIGEN; VIRUS; DNA; REPLICATION; INFECTION; BINDING; GENOME; SV40	Viruses of the family Polyomaviridae infect a wide variety of avian and mammalian hosts with a broad spectrum of outcomes including asymptomatic infection, acute systemic disease, and tumor induction. In this study a novel polyomavirus, the African elephant polyomavirus 1 (AelPyV-1) found in a protruding hyperplastic fibrous lesion on the trunk of an African elephant (Loxodonta africana) was characterized. The AelPyV-1 genome is 5722 bp in size and is one of the largest polyomaviruses characterized to date. Analysis of the AelPyV-1 genome reveals five putative open-reading frames coding for the classic small and large T antigens in the early region, and the VP1, VP2 and VP3 capsid proteins in the late region. In the area preceding the VP2 start codon three putative open-reading frames, possibly coding for an agnoprotein, could be localized. A regulatory, non-coding region separates the 2 coding regions. Unique for polyomaviruses is the presence of a second 854 bp long non-coding region between the end of the early region and the end of the late region. Based on maximum likelihood phylogenetic analyses of the large T antigen of the AelPyV-1 and 61 other polyomavirus sequences, AelPyV-1 clusters within a heterogeneous group of polyomaviruses that have been isolated from bats, new world primates and rodents.	[Stevens, Hans; Sijmons, Steven; Van Ranst, Marc; Maes, Piet] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Clin Virol, Louvain, Belgium; [Bertelsen, Mads Frost] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, Frederiksberg, Denmark	KU Leuven	Maes, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Clin Virol, Louvain, Belgium.	piet.maes@rega.kuleuven.be	Van Ranst, Marc/P-7522-2017; Maes, Piet/P-7782-2017; Bertelsen, Mads/AAA-5746-2022	Van Ranst, Marc/0000-0002-1674-4157; Maes, Piet/0000-0002-4571-5232; Bertelsen, Mads/0000-0001-9201-7499; Sijmons, Steven/0000-0003-3520-636X	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')(FWO)	Steven Sijmons and Piet Maes are supported by the Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen' - www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Alley M, 2013, NZ VET J; ARTHUR RR, 1986, NEW ENGL J MED, V315, P230, DOI 10.1056/NEJM198607243150405; Bennett MD, 2008, VIROLOGY, V376, P173, DOI 10.1016/j.virol.2008.03.014; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Fagrouch Z, 2012, J GEN VIROL, V93, P2652, DOI 10.1099/vir.0.044149-0; Fang NX, 1999, VIRUS RES, V60, P113, DOI 10.1016/S0168-1702(98)00117-8; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Groenewoud MJ, 2010, J GEN VIROL, V91, P653, DOI 10.1099/vir.0.017673-0; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1075; Johne R, 2005, J VIROL, V79, P3883, DOI 10.1128/JVI.79.6.3883-3887.2005; Johne R, 2007, J VIROL, V81, P11554, DOI 10.1128/JVI.01178-07; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Kreuter A, 2008, ARCH DERMATOL, V144, P1393, DOI 10.1001/archderm.144.10.1393; LI L, 1995, J VIROL, V69, P7570, DOI 10.1128/JVI.69.12.7570-7578.1995; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Literak I, 2006, AVIAN DIS, V50, P120, DOI 10.1637/7395-061605R.1; LOEBER G, 1989, J VIROL, V63, P94, DOI 10.1128/JVI.63.1.94-100.1989; Miksch K, 2002, BERL MUNCH TIERARZTL, V115, P390; Misra V, 2009, J GEN VIROL, V90, P2015, DOI 10.1099/vir.0.010694-0; Orba Y, 2011, J GEN VIROL, V92, P789, DOI 10.1099/vir.0.027854-0; PADGETT BL, 1971, LANCET, V1, P1257; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Renshaw RW, 2012, J VIROL, V86, P8903, DOI 10.1128/JVI.01261-12; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SCHMIDT M, 1989, J VIROL, V63, P429, DOI 10.1128/JVI.63.1.429-431.1989; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Stevens H., 2010, COLD SPRING HARB PRO; Stevens H, 2008, VET MICROBIOL, V129, P108, DOI 10.1016/j.vetmic.2007.11.037; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; SWEET BH, 1960, P SOC EXP BIOL MED, V105, P420, DOI 10.3181/00379727-105-26128; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Verschoor EJ, 2008, J GEN VIROL, V89, P130, DOI 10.1099/vir.0.83287-0; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Williams CK, 2012, ARCH BIOCHEM BIOPHYS, V518, P111, DOI 10.1016/j.abb.2011.12.014; Woolford L, 2008, VET PATHOL, V45, P95, DOI 10.1354/vp.45-1-95; WYCHOWSKI C, 1986, EMBO J, V5, P2569, DOI 10.1002/j.1460-2075.1986.tb04536.x; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	49	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77884	10.1371/journal.pone.0077884	http://dx.doi.org/10.1371/journal.pone.0077884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205012	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300122
J	Dai, CM; Zhang, J; Zhang, YL; Zhou, XF; Liu, SG				Dai, Chaomeng; Zhang, Juan; Zhang, Yalei; Zhou, Xuefei; Liu, Shuguang			Application of Molecularly Imprinted Polymers to Selective Removal of Clofibric Acid from Water	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING COMPOUNDS; PERSONAL CARE PRODUCTS; PHARMACEUTICAL RESIDUES; AQUATIC ENVIRONMENT; MUNICIPAL SEWAGE; AQUEOUS-SOLUTION; DRINKING-WATER; DICLOFENAC; SURFACE; FATE	A new molecularly imprinted polymer (MIP) adsorbent for clofibric acid (CA) was prepared by a non-covalent protocol. Characterization of the obtained MIP was achieved by scanning electron microscopy (SEM) and nitrogen sorption. Sorption experimental results showed that the MIP had excellent binding affinity for CA and the adsorption of CA by MIP was well described by pseudo-second-order model. Scatchard plot analysis revealed that two classes of binding sites were formed in the MIP with dissociation constants of 7.52 +/- 0.46 mg L-1 and 114 +/- 4.2 mg L-1, respectively. The selectivity of MIP demonstrated higher affinity for CA over competitive compound than that of non-imprinted polymers (NIP). The MIP synthesized was used to remove CA from spiked surface water and exhibited significant binding affinity towards CA in the presence of total dissolved solids (TDS). In addition, MIP reusability was demonstrated for at least 12 repeated cycles without significant loss in performance.	[Dai, Chaomeng; Liu, Shuguang] Tongji Univ, Coll Civil Engn, Shanghai 200092, Peoples R China; [Dai, Chaomeng; Zhang, Juan; Zhang, Yalei; Zhou, Xuefei] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhang, Yalei] Tongji Univ, UNEP Tongji Inst Environm Sustainable Dev, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Zhang, YL (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zhangyalei@tongji.edu.cn	ZHOU, XUE/F-6129-2013		Natural Science Foundation of China [41101480, 358 41070641]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRY11015]; China Postdoctoral Science Foundation [20110490698, 2013M531217]; Shanghai Postdoctoral Scientific Program [13R21416000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pollution Control and Resource Reuse Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program	This study was financed by the Natural Science Foundation of China (41101480, 358 41070641), State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRY11015), China Postdoctoral Science Foundation funded project (20110490698, 2013M531217) and Shanghai Postdoctoral Scientific Program (13R21416000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreozzi R, 2003, J HAZARD MATER, V103, P233, DOI 10.1016/j.jhazmat.2003.07.001; APHA A., 1999, STANDARD METHODS EXA; Boyd GR, 2003, SCI TOTAL ENVIRON, V311, P135, DOI 10.1016/S0048-9697(03)00138-4; Buser HR, 1998, ENVIRON SCI TECHNOL, V32, P3449, DOI 10.1021/es980301x; Byun HS, 2010, SEP PURIF TECHNOL, V74, P144, DOI 10.1016/j.seppur.2010.05.017; Debska J, 2004, CRIT REV ANAL CHEM, V34, P51, DOI 10.1080/10408340490273753; Doll TE, 2005, WATER RES, V39, P403, DOI 10.1016/j.watres.2004.09.016; Dunne M., 2000, ADVOCATE; Gao YH, 2011, ENVIRON TECHNOL, V32, P1719, DOI 10.1080/09593330.2011.554888; Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Krupadam RJ, 2010, WATER RES, V44, P681, DOI 10.1016/j.watres.2009.09.044; Le Noir M, 2007, WATER RES, V41, P2825, DOI 10.1016/j.watres.2007.03.023; Le Noir M, 2007, J CHROMATOGR A, V1154, P158, DOI 10.1016/j.chroma.2007.03.064; Le Noir M, 2009, ACS SYM SER, V1022, P25; Le Noir M, 2009, J SEP SCI, V32, P1471, DOI 10.1002/jssc.200800670; Li Y, 2009, BIOSENS BIOELECTRON, V25, P306, DOI 10.1016/j.bios.2009.07.001; Li Y, 2009, ENVIRON POLLUT, V157, P1879, DOI 10.1016/j.envpol.2009.01.014; Lopez C, 2011, ANAL CHIM ACTA, V683, P198, DOI 10.1016/j.aca.2010.09.051; Meng ZH, 2005, ENVIRON SCI TECHNOL, V39, P8958, DOI 10.1021/es0505292; Mestre AS, 2010, CARBON, V48, P972, DOI 10.1016/j.carbon.2009.11.013; Pan JM, 2010, CHEM ENG J, V162, P910, DOI 10.1016/j.cej.2010.06.039; Peng XZ, 2008, SCI TOTAL ENVIRON, V397, P158, DOI 10.1016/j.scitotenv.2008.02.059; Sun Z, 2008, ANAL CHIM ACTA, V620, P73, DOI 10.1016/j.aca.2008.05.020; Ternes TA, 2002, ENVIRON SCI TECHNOL, V36, P3855, DOI 10.1021/es015757k; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5; Yoon Y, 2007, DESALINATION, V202, P16, DOI 10.1016/j.desal.2005.12.033; Yu Q, 2008, WATER RES, V42, P3089, DOI 10.1016/j.watres.2008.02.024; Zorita S, 2009, SCI TOTAL ENVIRON, V407, P2760, DOI 10.1016/j.scitotenv.2008.12.030; Zwiener C, 2003, SCI TOTAL ENVIRON, V309, P201, DOI 10.1016/S0048-9697(03)00002-0	31	17	17	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78167	10.1371/journal.pone.0078167	http://dx.doi.org/10.1371/journal.pone.0078167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205143	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800015
J	Kwan, MWM; Wong, MCS; Wang, HHX; Liu, KQL; Lee, CLS; Yan, BPY; Yu, CM; Griffiths, SM				Kwan, Mandy Wing-Man; Wong, Martin Chi-Sang; Wang, Harry Hao-Xiang; Liu, Kirin Qi-Lin; Lee, Catherine Lok-Sze; Yan, Bryan Ping-Yen; Yu, Cheuk-Man; Griffiths, Sian Meryl			Compliance with the Dietary Approaches to Stop Hypertension (DASH) Diet: A Systematic Review	PLOS ONE			English	Review							BLOOD-PRESSURE; OLDER-ADULTS; WEIGHT-LOSS; ADHERENCE; EXERCISE; WOMEN; RISK	Background: The Dietary Approaches to Stop Hypertension (DASH) diet has been recognized as effective to lower blood pressure in feeding trials, but compliance with the diet must be persistent to maximize health benefits in clinical practice. This paper reports a systematic review of the latest evidence on the method to assess DASH compliance and the corresponding patients' compliance in interventional settings. Methods: The databases including MEDLINE, EBM Reviews, EMBASE, and CINAHL Plus were searched for original research studies published in the period of January 1992-December 2012 that evaluated compliance with DASH diet. Studies written in English language, with DASH intervention, with complete documentation of the degree of DASH compliance and the assessment method used were included in this review. The search terms included: dietary approaches to stop hypertension, DASH, compliance, adherence, consistency, and concordance. Results: Nine studies were included. Different types of interventions were identified, ranging from feeding trial to dietary counseling. These studies differed in the assessment methods used to evaluate DASH compliance, which included objective approaches like measurement of urinary excretion, and subjective approaches like dietary intake assessment for DASH target comparison and construction of DASH scoring systems. Compliance levels were lower in educational interventions than that of the original DASH feeding trial. Conclusions: To conclude, although no consensus existed regarding the best approach to assess DASH compliance, its suboptimal compliance warrants attention. This study implied a need to investigate effective approaches to sustain the DASH dietary pattern beyond counselling alone.	[Kwan, Mandy Wing-Man; Wong, Martin Chi-Sang; Wang, Harry Hao-Xiang; Liu, Kirin Qi-Lin; Lee, Catherine Lok-Sze; Griffiths, Sian Meryl] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Harry Hao-Xiang] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Yan, Bryan Ping-Yen; Yu, Cheuk-Man] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Glasgow; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Yan, Bryan P/P-5928-2015; Yu, Cheuk-man/P-3747-2015; Wang, Harry H.X./E-9027-2015	Wong, Martin/0000-0001-7706-9370; Wang, Harry H.X./0000-0002-0361-6527	Health and Health Services Research Fund, Food and Health Bureau, Hong Kong [09100701]	Health and Health Services Research Fund, Food and Health Bureau, Hong Kong	Funding support provided by Health and Health Services Research Fund, Food and Health Bureau, Hong Kong [Project No. 09100701]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, NUTR ASSESSMENT; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Bacon SL, 2004, SPORTS MED, V34, P307, DOI 10.2165/00007256-200434050-00003; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Blumenthal JA, 2010, ARCH INTERN MED, V170, P126, DOI 10.1001/archinternmed.2009.470; Booth AO, 2003, ASIA PAC J CLIN NU S, V12, pS10; Centre for Health Protection Department of Health, 2007, NONC DIS RISK FACT H; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Couch SC, 2008, J PEDIATR-US, V152, P494, DOI 10.1016/j.jpeds.2007.09.022; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Epstein DE, 2012, J ACAD NUTR DIETETIC; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Levitan EB, 2009, AM J CARDIOL, V104, P1416, DOI 10.1016/j.amjcard.2009.06.061; Liese AD, 2009, DIABETES CARE, V32, P1434, DOI 10.2337/dc09-0228; Lin PH, 2007, J AM DIET ASSOC, V107, P1541, DOI 10.1016/j.jada.2007.06.019; National Institutes of Health-National Heart Lung and Blood Institute, 2006, YOUR GUID LOW YOUR B; Nowson CA, 2004, J NUTR, V134, P2322, DOI 10.1093/jn/134.9.2322; Nowson CA, 2009, BRIT J NUTR, V102, P1161, DOI 10.1017/S0007114509371731; Nowson CA, 2009, NUTR RES, V29, P8, DOI 10.1016/j.nutres.2008.12.002; Obarzanek E, 2007, AM J HEALTH BEHAV, V31, P545, DOI 10.5993/AJHB.31.5.10; Racine E, 2011, J NUTR HEALTH AGING, V15, P868, DOI 10.1007/s12603-011-0102-9; Troyer JL, 2010, AM J CLIN NUTR, V91, P1204, DOI 10.3945/ajcn.2009.28780; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Windhauser MM, 1999, J AM DIET ASSOC, V99, pS76, DOI 10.1016/S0002-8223(99)00420-4; World Health Organization, 2012, WORLD HLTH STAT 2012	26	64	65	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78412	10.1371/journal.pone.0078412	http://dx.doi.org/10.1371/journal.pone.0078412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205227	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500118
J	Liu, Y; Xu, HB; Yan, QJ; Yang, SQ; Duan, XJ; Jiang, ZQ				Liu, Yu; Xu, Haibo; Yan, Qiaojuan; Yang, Shaoqing; Duan, Xiaojie; Jiang, Zhengqiang			Biochemical Characterization of a First Fungal Esterase from Rhizomucor miehei Showing High Efficiency of Ester Synthesis	PLOS ONE			English	Article							SOLVENT-TOLERANT ESTERASE; THERMOSTABLE ESTERASE; FAMILY; LIPASE; PURIFICATION; CLASSIFICATION; EXPRESSION; ENZYMES; CLONING	Background: Esterases with excellent merits suitable for commercial use in ester production field are still insufficient. The aim of this research is to advance our understanding by seeking for more unusual esterases and revealing their characterizations for ester synthesis. Methodology/Principal Findings: A novel esterase-encoding gene from Rhizomucor miehei (RmEstA) was cloned and expressed in Escherichia coli. Sequence analysis revealed a 975-bp ORF encoding a 324-amino-acid polypeptide belonging to the hormone-sensitive lipase (HSL) family IV and showing highest similarity (44%) to the Paenibacillus mucilaginosus esterase/lipase. Recombinant RmEstA was purified to homogeneity: it was 34 kDa by SDS-PAGE and showed optimal pH and temperature of 6.5 and 45 degrees C, respectively. The enzyme was stable to 50 degrees C, under a broad pH range (5.0-10.6). RmEstA exhibited broad substrate specificity toward p-nitrophenol esters and short-acyl-chain triglycerols, with highest activities (1,480 U mg(-1) and 228 U mg(-1)) for p-nitrophenyl hexanoate and tributyrin, respectively. RmEstA efficiently synthesized butyl butyrate (92% conversion yield) when immobilized on AOT-based organogel. Conclusion: RmEstA has great potential for industrial applications. RmEstA is the first reported esterase from Rhizomucor miehei.	[Liu, Yu; Yan, Qiaojuan] China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100094, Peoples R China; [Xu, Haibo; Yang, Shaoqing; Duan, Xiaojie; Jiang, Zhengqiang] China Agr Univ, Coll Food Sci & Nutr Engn, Dept Biotechnol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yan, QJ (corresponding author), China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100094, Peoples R China.	yanqj@cau.edu.cn; zhqjiang@cau.edu.cn	Yan, Qiaojuan/C-1669-2017					Ahmed EH, 2010, BIORESOURCE TECHNOL, V101, P3628, DOI 10.1016/j.biortech.2009.12.107; Al Khudary R, 2010, EXTREMOPHILES, V14, P273, DOI 10.1007/s00792-010-0306-7; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Chen MB, 2011, AFR J BIOTECHNOL, V10, P5166; Cieslinski H, 2007, ARCH MICROBIOL, V188, P27, DOI 10.1007/s00203-007-0220-2; Dandavate V, 2009, BIORESOURCE TECHNOL, V100, P3374, DOI 10.1016/j.biortech.2009.02.011; Dandavate V, 2007, ENZYME MICROB TECH, V41, P265, DOI 10.1016/j.enzmictec.2007.01.019; De Barros DPC, 2012, J FOOD BIOCHEM, V36, P275, DOI 10.1111/j.1745-4514.2010.00535.x; Eggert T, 2000, EUR J BIOCHEM, V267, P6459, DOI 10.1046/j.1432-1327.2000.01736.x; Fahmy AS, 2008, BIORESOURCE TECHNOL, V99, P437, DOI 10.1016/j.biortech.2006.11.062; Fan XL, 1999, BIOTECHNOL LETT, V21, P1071, DOI 10.1023/A:1005601030076; Jiang XW, 2012, EXTREMOPHILES, V13, P769; Jin P, 2012, BIORESOURCE TECHNOL, V116, P234, DOI 10.1016/j.biortech.2011.10.087; Kang CH, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-41; Karpushova A, 2005, APPL MICROBIOL BIOT, V67, P59, DOI 10.1007/s00253-004-1780-6; Kumar L, 2012, PROCESS BIOCHEM, V47, P983, DOI 10.1016/j.procbio.2012.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Linke D, 2013, APPL MICROBIOL BIOT, V97, P7241, DOI 10.1007/s00253-012-4598-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma BD, 2013, BIORESOURCE TECHNOL, V133, P354, DOI 10.1016/j.biortech.2013.01.089; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Oh KH, 2012, J MOL CATAL B-ENZYM, V80, P67, DOI 10.1016/j.molcatb.2012.04.015; Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119; Preetha S, 1997, WORLD J MICROB BIOT, V13, P573, DOI 10.1023/A:1018525711573; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; Rao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060645; Rao L, 2011, BBA-PROTEINS PROTEOM, V1814, P1695, DOI 10.1016/j.bbapap.2011.08.013; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Sambrook J, 2001, MOL CLONING LAB MANU; Sumby KM, 2009, APPL ENVIRON MICROB, V75, P6729, DOI 10.1128/AEM.01563-09; Tang YB, 2012, J AGR FOOD CHEM, V60, P2354, DOI 10.1021/jf2049799; Torres S, 2009, FOOD RES INT, V42, P454, DOI 10.1016/j.foodres.2008.12.005; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Virk AP, 2011, J MICROBIOL BIOTECHN, V21, P667, DOI 10.4014/jmb.1103.03008; Yang ZX, 2013, J BIOSCI BIOENG, V115, P133, DOI 10.1016/j.jbiosc.2012.08.016; Yassine BA, 2006, BIOCHEMISTRY-US, V45, P14183	39	18	18	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77856	10.1371/journal.pone.0077856	http://dx.doi.org/10.1371/journal.pone.0077856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204998	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500069
J	van Ittersum, K; Wansink, B				van Ittersum, Koert; Wansink, Brian			Extraverted Children Are More Biased by Bowl Sizes than Introverts	PLOS ONE			English	Article							ILLUSIONS BIAS; PORTION SIZES; PERSONALITY; CONSUMPTION; DIMENSIONS; EXTROVERTS; OVERWEIGHT; BEHAVIOR; OBESITY; TRAITS	Extraverted children are hypothesized to be most at risk for over-serving and overeating due to environmental cues - such as the size of dinnerware. A within-subject field study of elementary school students found that extraverted children served themselves 33.1% more cereal in larger bowls (16-oz) than in smaller (12-oz) bowls, whereas introverted children were unaffected by bowl size (+5.6%, ns). However, when children were asked by adults how much cereal they wanted to eat, both extraverted and introverted children requested more cereal when given a large versus small bowl. Insofar as extraverted children appear to be more biased by environmental cues, this pilot study suggests different serving styles are recommended for parents and other caregivers. They should serve extraverts, but allow introverts to serve themselves. Still, since the average child still served 23.2% more when serving themselves than when served by an adult, it might be best for caregivers to do the serving whenever possible - especially for extraverted children.	[van Ittersum, Koert] Univ Groningen, Dept Mkt, Groningen, Netherlands; [Wansink, Brian] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA	University of Groningen; Cornell University	Wansink, B (corresponding author), Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	foodandbrandlab@cornell.edu		Van Ittersum, Koert/0000-0002-3584-089X	Unilever	Unilever(Unilever)	Brian Wansink received funding during the analysis stage of "Happier Meals: New Children's Meals Lead to Fewer Purchased Calories" from September 2012 through December 2012. Brian Wansink became a member of the McDonald's Advisory Council in January 2012. He received royalties from the Bantam Dell book, Mindless Eating. He was part of the Blue Zones Keynote & Panel Project in Los Angeles; gave paid lectures on food psychology research conducted over the past 20 years. PKF Consulting: Brian Wansink acted as paid consultant on a project that PKF conducted for the Department of Defense related to improving overall health of military bases. Unilever: He gave paid lectures on food psychology research conducted over the past 20 years. In regards to the Mindless Products and Mindless Method mentioned in PLOS ONE's email to the authors, Dr. Wansink is not affiliated with either. Both projects were private ventures based upon Dr. Wansink's prior studies, but he is not connected to them and receives no royalties or payment.	Craeynest M, 2008, J BEHAV THER EXP PSY, V39, P354, DOI 10.1016/j.jbtep.2007.09.002; Doucet C, 1997, PERS INDIV DIFFER, V23, P775, DOI 10.1016/S0191-8869(97)00104-9; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Eysenck H.J., 1990, HDB PERSONALITY THEO, P244; Faith MS, 2001, OBES RES, V9, P647, DOI 10.1038/oby.2001.86; Ferguson E, 2001, BRIT J HEALTH PSYCH, V6, P311, DOI 10.1348/135910701169232; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Grant T, 2003, PERS INDIV DIFFER, V35, P633, DOI 10.1016/S0191-8869(02)00241-6; GRAYDON J, 1995, PERS INDIV DIFFER, V19, P265, DOI 10.1016/0191-8869(95)00052-8; Gudjonsson GH, 2004, EUR J PERSONALITY, V18, P435, DOI 10.1002/per.514; HALLSTROM T, 1981, J PSYCHOSOM RES, V25, P75, DOI 10.1016/0022-3999(81)90093-3; Harrington R, 2001, J PSYCHOL, V135, P439, DOI 10.1080/00223980109603710; Herman CP, 2005, APPETITE, V45, P108, DOI 10.1016/j.appet.2005.03.013; Kakizaki M, 2008, J PSYCHOSOM RES, V64, P71, DOI 10.1016/j.jpsychores.2007.07.008; Martsh CT, 1997, PERS INDIV DIFFER, V23, P153, DOI 10.1016/S0191-8869(97)00015-9; Pierobon A, 2008, SLEEP MED, V9, P882, DOI 10.1016/j.sleep.2007.10.017; Rustin RM, 1978, J PSYCHOSOM RES, V22, P145; Selby EC, 2004, J CREATIVE BEHAV, V38, P221, DOI 10.1002/j.2162-6057.2004.tb01242.x; van Ittersum K, 2007, J AM DIET ASSOC, V107, P1107, DOI 10.1016/j.jada.2007.05.020; Van Ittersum K, 2012, J CONSUM RES, V39, P215, DOI 10.1086/662615; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2014, J EXP PSYCHOL APPL; Wansink B, 2006, AM J PREV MED, V31, P240, DOI 10.1016/j.amepre.2006.04.003; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	25	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78224	10.1371/journal.pone.0078224	http://dx.doi.org/10.1371/journal.pone.0078224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205166	Green Published, gold			2022-12-25	WOS:000326334500106
J	Volberg, V; Heggeseth, B; Harley, K; Huen, K; Yousefi, P; Dave, V; Tyler, K; Vedar, M; Eskenazi, B; Holland, N				Volberg, Vitaly; Heggeseth, Brianna; Harley, Kim; Huen, Karen; Yousefi, Paul; Dave, Veronica; Tyler, Kristin; Vedar, Michelle; Eskenazi, Brenda; Holland, Nina			Adiponectin and Leptin Trajectories in Mexican-American Children from Birth to 9 Years of Age	PLOS ONE			English	Article							BODY-MASS INDEX; FOR-GESTATIONAL-AGE; CORD BLOOD; DEVELOPMENTAL TRAJECTORIES; SERUM ADIPONECTIN; INSULIN-RESISTANCE; PROSPECTIVE COHORT; CHILDHOOD; WEIGHT; GROWTH	Objectives: To address molecular mechanisms underlying obesity development, we examined patterns of critical metabolism-related hormones, adiponectin and leptin (adipokines), over childhood. Subjects and Design: Plasma adiponectin and leptin were measured in 80 Mexican-American children at birth and again at 2, 5, and 9 years from the ongoing prospective cohort followed by the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS). We used a mixture modeling approach to identify patterns in adipokine trajectories from birth to 9 years. Results: Leptin was positively related to child body size within all ages, however adiponectin had inverse and weaker associations with BMI at 2, 5, and 9 years. Correlations between adipokine levels over the 0-2, 2-5, and 5-9-year periods increased for both leptin (r = 0.06, 0.31 and 0.62) and adiponectin (r = 0.25, 0.41 and 0.46). Our mixture modeling approach identified three trajectory clusters for both leptin (1L [slowly-rising], 2L [rapidly-rising], and 3L [stable]) and adiponectin (1A [steep-dropping and rebounding], 2A [moderately-dropping], and 3A [stable]). While leptin groups were most separated over the 2-9-year period, adiponectin trajectories displayed greatest heterogeneity from birth to 2 years. Children in the rapidly-rising 2L group had highest BMI and waist circumference at 9 years. Further, children with greater birth weight had increased odds of belonging to this high risk group (OR = 1.21 95% CI 1.03, 1.43, compared to stable group 3L). Children whose mothers consumed more sugar-sweetened beverages during pregnancy were at risk of being in the steep-dropping 1A group (OR = 1.08, 95% CI 1.01, 1.17, compared to stable group 3A). Conclusion: Our results highlight developmental differences in leptin and adiponectin over the childhood period. Leptin closely reflects child body size however factors affecting adiponectin and long-term consequences of its changes over infancy need to be further explored.	[Volberg, Vitaly; Harley, Kim; Huen, Karen; Yousefi, Paul; Dave, Veronica; Tyler, Kristin; Vedar, Michelle; Eskenazi, Brenda; Holland, Nina] Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA; [Heggeseth, Brianna] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Volberg, V (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA.	vvolberg@gmail.com		Huen, Karen/0000-0003-3604-2096; Dave, Veronica/0000-0002-3791-192X	Environmental Protection Agency (EPA) [RD83273401, RD83171001]; National Institute of Environmental Health Sciences (NIEHS) [PO1ES009605, RO1ES012503-03]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012503, P01ES009605, R01ES021369] Funding Source: NIH RePORTER	Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Environmental Protection Agency (EPA) Grants RD83273401 and RD83171001, and the National Institute of Environmental Health Sciences (NIEHS) Grants PO1ES009605 and RO1ES012503-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay L, 2009, J CLIN ENDOCR METAB, V94, P2023, DOI 10.1210/jc.2008-2045; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Bozzola E, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-26; Butte NF, 2005, J CLIN ENDOCR METAB, V90, P4170, DOI 10.1210/jc.2004-2328; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cruz M, 2004, DIABETES CARE, V27, P1451, DOI 10.2337/diacare.27.6.1451; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P1419, DOI 10.1289/ehp.7670; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Giapros V, 2007, CLIN ENDOCRINOL, V66, P353, DOI 10.1111/j.1365-2265.2006.02736.x; Harley K, 2005, PAEDIATR PERINAT EP, V19, P125, DOI 10.1111/j.1365-3016.2005.00640.x; Harley KG, 2013, ENV HLTH PERSPECT; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Heggeseth B, 2013, 308 UC BERK DIV BIOS; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lammi N, 2009, DIABETOLOGIA, V52, P408, DOI 10.1007/s00125-008-1244-0; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Lindsay RS, 2003, DIABETES CARE, V26, P2244, DOI 10.2337/diacare.26.8.2244; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Lustig RH, 2011, ENDOCR UPDAT, P1, DOI 10.1007/978-1-4419-7034-3_1; Mantzoros C, 2004, EUR J ENDOCRINOL, V151, P741, DOI 10.1530/eje.0.1510741; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Mantzoros CS, 2010, CLIN NUTR, V29, P622, DOI 10.1016/j.clnu.2010.03.004; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Muthen B, 2001, DECADE BEHAV, P291, DOI 10.1037/10409-010; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nishimura R, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-30; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 1999, ACTA PAEDIATR, V88, P95, DOI 10.1111/j.1651-2227.1999.tb14413.x; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Shaibi GQ, 2007, J CLIN ENDOCR METAB, V92, P1809, DOI 10.1210/jc.2006-2294; Sharrock KCB, 2008, AM J HUM BIOL, V20, P392, DOI 10.1002/ajhb.20765; Sivan E, 2003, J CLIN ENDOCR METAB, V88, P5656, DOI 10.1210/jc.2003-031174; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Volberg V, 2013, PEDIAT OBES; Warner ML, 2006, OBESITY, V14, P1966, DOI 10.1038/oby.2006.230; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	47	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77964	10.1371/journal.pone.0077964	http://dx.doi.org/10.1371/journal.pone.0077964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205046	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500083
J	Mathot, S; Van der Linden, L; Grainger, J; Vitu, F				Mathot, Sebastiaan; Van der Linden, Lotje; Grainger, Jonathan; Vitu, Francoise			The Pupillary Light Response Reveals the Focus of Covert Visual Attention	PLOS ONE			English	Article							EYE-MOVEMENTS; DILATION; SEARCH; SIZE; MICROSTIMULATION; STIMULATION; DYNAMICS; STIMULUS; REFLEX	The pupillary light response is often assumed to be a reflex that is not susceptible to cognitive influences. In line with recent converging evidence, we show that this reflexive view is incomplete, and that the pupillary light response is modulated by covert visual attention: Covertly attending to a bright area causes a pupillary constriction, relative to attending to a dark area under identical visual input. This attention-related modulation of the pupillary light response predicts cuing effects in behavior, and can be used as an index of how strongly participants attend to a particular location. Therefore, we suggest that pupil size may offer a new way to continuously track the focus of covert visual attention, without requiring a manual response from the participant. The theoretical implication of this finding is that the pupillary light response is neither fully reflexive, nor under complete voluntary control, but is instead best characterized as a stereotyped response to a voluntarily selected target. In this sense, the pupillary light response is similar to saccadic and smooth pursuit eye movements. Together, eye movements and the pupillary light response maximize visual acuity, stabilize visual input, and selectively filter visual information as it enters the eye.	[Mathot, Sebastiaan; Van der Linden, Lotje; Grainger, Jonathan; Vitu, Francoise] Aix Marseille Univ, CNRS, Lab Psychol Cognit, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Mathot, S (corresponding author), Aix Marseille Univ, CNRS, Lab Psychol Cognit, Marseille, France.	s.mathot@cogsci.nl	Grainger, Jonathan/C-9299-2009	Vitu, Francoise/0000-0002-0627-8295; Mathot, Sebastiaan/0000-0003-3379-8584	ERC [230313]; French ministry of research	ERC(European Research Council (ERC)European Commission); French ministry of research(Ministry of Research, FranceEuropean Commission)	SM, JG, and FV were supported by ERC grant 230313. (http://erc.europa.eu..) LL was supported by a grant ("allocation de recherche") from the French ministry of research (2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SIMPLE WAY RECONSTRU; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BARANY EH, 1948, J NEUROPHYSIOL, V11, P25, DOI 10.1152/jn.1948.11.1.25; BARBUR JL, 1992, OPHTHAL PHYSL OPT, V12, P137, DOI 10.1111/j.1475-1313.1992.tb00276.x; Barbur JL, 1995, VISION RES; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Betts JG, 2013, ANATOMY PHYSL; Binda P, 2013, J VISION, V13, DOI 10.1167/13.6.8; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; BRENNER RL, 1969, ARCH OPHTHALMOL-CHIC, V82, P23; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; CAMPBELL FW, 1960, NATURE, V187, P1121, DOI 10.1038/1871121c0; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fahle MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00120; GOLDWATER BC, 1972, PSYCHOL BULL, V77, P340, DOI 10.1037/h0032456; Harms H., 1937, GRAEFES ARCH CLIN EX, V138, P149, DOI [10.1007/BF01854538, DOI 10.1007/BF01854538]; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Jainta Stephanie, 2011, Front Hum Neurosci, V5, P97, DOI 10.3389/fnhum.2011.00097; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; LOWE SW, 1966, ARCH OPHTHALMOL-CHIC, V75, P395; LOWENSTEIN O, 1950, ARCH NEURO PSYCHIATR, V64, P313, DOI 10.1001/archneurpsyc.1950.02310270002001; Mack A., 1998, INATTENTIONAL BLINDN; Mathot S, 2013, THESIS VU U AMSTERDA; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Mathot S, 2011, PHILOS T R SOC B, V366, P516, DOI 10.1098/rstb.2010.0187; Naber M, 2013, J VISION, V13, DOI 10.1167/13.6.7; Naber M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020910; Netser S, 2010, J NEUROPHYSIOL, V104, P108, DOI 10.1152/jn.01142.2009; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Prettyman R, 1997, J NEUROL NEUROSUR PS, V62, P665, DOI 10.1136/jnnp.62.6.665; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1968, SCIENCE, V161, P1219, DOI 10.1126/science.161.3847.1219; Sahraie A, 1997, GRAEF ARCH CLIN EXP, V235, P494, DOI 10.1007/BF00947006; SLOOTER J, 1980, INVEST OPHTH VIS SCI, V19, P105; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tanaka T, 2005, INVEST OPHTH VIS SCI, V46, P4267, DOI 10.1167/iovs.05-0088; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; UKAI K, 1985, J OPT SOC AM A, V2, P1094, DOI 10.1364/JOSAA.2.001094; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; WOODHOUSE JM, 1975, VISION RES, V15, P649, DOI 10.1016/0042-6989(75)90279-5; WOODHOUSE JM, 1975, VISION RES, V15, P645, DOI 10.1016/0042-6989(75)90278-3; WYATT HJ, 1995, VISION RES, V35, P2021, DOI 10.1016/0042-6989(94)00268-Q; Zylberberg A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00316	63	104	104	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78168	10.1371/journal.pone.0078168	http://dx.doi.org/10.1371/journal.pone.0078168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205144	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700080
J	Hartley, I; Elkhoury, FF; Shin, JH; Xie, B; Gu, XQ; Gao, Y; Zhou, D; Haddad, GG				Hartley, Iain; Elkhoury, Fuad F.; Shin, Joo Heon; Xie, Bin; Gu, Xiangqun; Gao, Yuan; Zhou, Dan; Haddad, Gabriel G.			Long-Lasting Changes in DNA Methylation Following Short-Term Hypoxic Exposure in Primary Hippocampal Neuronal Cultures	PLOS ONE			English	Article							CDNA MICROARRAY ANALYSIS; CREB-BINDING PROTEIN; GENE-EXPRESSION; EPIGENETIC REGULATION; BETA-CATENIN; CELL-DEATH; IDENTIFICATION; ACTIVATION; BRAIN; HYPOMETHYLATION	While the effects of hypoxia on gene expression have been investigated in the CNS to some extent, we currently do not know what role epigenetics plays in the transcription of many genes during such hypoxic stress. To start understanding the role of epigenetic changes during hypoxia, we investigated the long-term effect of hypoxia on gene expression and DNA methylation in hippocampal neuronal cells. Primary murine hippocampal neuronal cells were cultured for 7 days. Hypoxic stress of 1% O2, 5% CO2 for 24 hours was applied on Day 3, conditions we found to maximize cellular hypoxic stress response without inducing cell death. Cells were returned to normoxia for 4 days following the period of hypoxic stress. On Day 7, Methyl-Sensitive Cut Counting (MSCC) was used to identify a genome-wide methylation profile of the hippocampal cell lines to assess methylation changes resulting from hypoxia. RNA-Seq was also done on Day 7 to analyze changes in gene transcription. Phenotypic analysis showed that neuronal processes were significantly shorter after 1 day of hypoxia, but there was a catch-up growth of these processes after return to normoxia. Transcriptome profiling using RNA-Seq revealed 369 differentially expressed genes with 225 being upregulated, many of which form networks shown to affect CNS development and function. Importantly, the expression level of 59 genes could be correlated to the changes in DNA methylation in their promoter regions. CpG islands, in particular, had a strong tendency to remain hypomethylated long after hypoxic stress was removed. From this study, we conclude that short-term, sub-lethal hypoxia results in long-lasting changes to genome wide DNA methylation status and that some of these changes can be highly correlated with transcriptional modulation in a number of genes involved in functional pathways that have been previously implicated in neural growth and development.	[Hartley, Iain; Elkhoury, Fuad F.; Gu, Xiangqun; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Hartley, Iain; Elkhoury, Fuad F.; Gu, Xiangqun; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA; [Shin, Joo Heon; Xie, Bin; Gao, Yuan] Lieber Inst Brain Dev, Div Genom Epigen & Bioinformat, Baltimore, MD USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Haddad, GG (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu		Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [HL098053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, T35HL007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant HL098053 to GGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burgula S, 2010, J MOL NEUROSCI, V41, P36, DOI 10.1007/s12031-009-9275-7; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jin K, 2002, NEUROCHEM RES, V27, P1105, DOI 10.1023/A:1020913123054; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Lin JS, 2008, J PHYSIOL-LONDON, V586, P5757, DOI 10.1113/jphysiol.2008.160887; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; Obstetricians ACo, 2003, NEONATAL ENCEPHALOPA; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ralph GS, 2004, J CEREBR BLOOD F MET, V24, P245, DOI 10.1097/01.WCB.0000110532.48786.46; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Sekiya T, 2002, CANCER RES, V62, P3322; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	44	40	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77859	10.1371/journal.pone.0077859	http://dx.doi.org/10.1371/journal.pone.0077859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205000	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400059
J	Jia, L; Xing, J; Ding, Y; Shen, YC; Shi, XH; Ren, W; Wan, M; Guo, JJ; Zheng, SJ; Liu, Y; Liang, XB; Su, DM				Jia, Lu; Xing, Jing; Ding, Ying; Shen, Yachen; Shi, Xuhui; Ren, Wei; Wan, Meng; Guo, Jianjin; Zheng, Shujing; Liu, Yun; Liang, Xiubin; Su, Dongming			Hyperuricemia Causes Pancreatic beta-Cell Death and Dysfunction through NF-kappa B Signaling Pathway	PLOS ONE			English	Article							SERUM URIC-ACID; NITRIC-OXIDE PRODUCTION; METABOLIC SYNDROME; INSULIN-SECRETION; INDUCED APOPTOSIS; EXPRESSION; ISLETS; RELEASE; STRESS; MICE	Accumulating clinical evidence suggests that hyperuricemia is associated with an increased risk of type 2 diabetes. However, it is still unclear whether elevated levels of uric acid can cause direct injury of pancreatic beta-cells. In this study, we examined the effects of uric acid on beta-cell viability and function. Uric acid solution or normal saline was administered intraperitoneally to mice daily for 4 weeks. Uric acid-treated mice exhibited significantly impaired glucose tolerance and lower insulin levels in response to glucose challenge than did control mice. However, there were no significant differences in insulin sensitivity between the two groups. In comparison to the islets in control mice, the islets in the uric acid-treated mice were markedly smaller in size and contained less insulin. Treatment of beta-cells in vitro with uric acid activated the NF-kappa B signaling pathway through I kappa B alpha phosphorylation, resulting in upregulated inducible nitric oxide synthase (iNOS) expression and excessive nitric oxide (NO) production. Uric acid treatment also increased apoptosis and downregulated Bcl-2 expression in Min6 cells. In addition, a reduction in insulin secretion under glucose challenge was observed in the uric acid-treated mouse islets. These deleterious effects of uric acid on pancreatic beta-cells were attenuated by benzbromarone, an inhibitor of uric acid transporters, NOS inhibitor L-NMMA, and Bay 11-7082, an NF-kappa B inhibitor. Further investigation indicated that uric acid suppressed levels of MafA protein through enhancing its degradation. Collectively, our data suggested that an elevated level of uric acid causes beta-cell injury via the NF-kappa B-iNOS-NO signaling axis.	[Jia, Lu; Xing, Jing; Ding, Ying; Shen, Yachen; Shi, Xuhui; Zheng, Shujing; Liu, Yun; Liang, Xiubin; Su, Dongming] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China; [Su, Dongming] Nanjing Med Univ, Ctr Cellular Therapy, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Ren, Wei; Guo, Jianjin] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Ren, Wei; Guo, Jianjin] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Wan, Meng] Nanjing Med Univ, Nanjing Hosp 1, Dept Pharm, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University	Su, DM (corresponding author), Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China.	sudongming@njmu.edu.cn	Shen, Yachen/HGE-6370-2022	Shen, Yachen/0000-0003-2614-3387	National Basic Research Program of China [2011CB504000]; National Natural Science Foundation of China [81070656, 81171589]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Basic Research Program of China (2011CB504000, 973 Program) and the National Natural Science Foundation of China (81070656, 81171589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Estela, 2011, Acta Med Port, V24 Suppl 2, P565; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Banakh I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048977; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Chen F, 2011, ENDOCRINOLOGY, V152, P1779, DOI 10.1210/en.2010-1048; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; HEDESKOV CJ, 1975, BIOCHEM J, V152, P571, DOI 10.1042/bj1520571; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanter M, 2009, J MOL HISTOL, V40, P379, DOI 10.1007/s10735-009-9251-0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Lin Shi-Dou, 2006, J Chin Med Assoc, V69, P512; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Nan HR, 2008, DIABETES RES CLIN PR, V80, P321, DOI 10.1016/j.diabres.2008.01.002; Oda E, 2009, DIABETES CARE, V32, pauthor; Oda Eiji, 2009, Diabetes Care, V32, pe126, DOI 10.2337/dc09-1244; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Rabadi MM, 2012, AM J PHYSIOL-RENAL, V302, pF730, DOI 10.1152/ajprenal.00520.2011; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Simental-Mendia LE, 2009, DIABETES-METAB RES, V25, P535, DOI 10.1002/dmrr.988; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; ZHANG HJ, 1989, DIABETES, V38, P44, DOI 10.2337/diabetes.38.1.44; Zhang XF, 2009, ENDOCRINOLOGY, V150, P4065, DOI 10.1210/en.2009-0343; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039738; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zhu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056386	47	63	67	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78284	10.1371/journal.pone.0078284	http://dx.doi.org/10.1371/journal.pone.0078284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205181	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400075
J	Scranton, MA; Fowler, JH; Girke, T; Walling, LL				Scranton, Melissa A.; Fowler, Jonathan H.; Girke, Thomas; Walling, Linda L.			Microarray Analysis of Tomato's Early and Late Wound Response Reveals New Regulatory Targets for Leucine Aminopeptidase A	PLOS ONE			English	Article							MG-PROTOPORPHYRIN IX; NUCLEAR GENE-EXPRESSION; SYRINGAE PV. TOMATO; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; DEFENSE RESPONSES; METHYL JASMONATE; 9-LIPOXYGENASE-DERIVED OXYLIPINS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS	Wounding due to mechanical injury or insect feeding causes a wide array of damage to plant cells including cell disruption, desiccation, metabolite oxidation, and disruption of primary metabolism. In response, plants regulate a variety of genes and metabolic pathways to cope with injury. Tomato (Solanum lycopersicum) is a model for wound signaling but few studies have examined the comprehensive gene expression profiles in response to injury. A cross-species microarray approach using the TIGR potato 10-K cDNA array was analyzed for large-scale temporal (early and late) and spatial (locally and systemically) responses to mechanical wounding in tomato leaves. These analyses demonstrated that tomato regulates many primary and secondary metabolic pathways and this regulation is dependent on both timing and location. To determine if LAP-A, a known modulator of wound signaling, influences gene expression beyond the core of late wound-response genes, changes in RNAs from healthy and wounded Leucine aminopeptidase A-silenced (LapA-SI) and wild-type (WT) leaves were examined. While most of the changes in gene expression after wounding in LapA-SI leaves were similar to WT, overall responses were delayed in the LapA-SI leaves. Moreover, two pathogenesis-related 1 (PR-1c and PR-1a2) and two dehydrin (TAS14 and Dhn3) genes were negatively regulated by LAP-A. Collectively, this study has shown that tomato wound responses are complex and that LAP-A's role in modulation of wound responses extends beyond the well described late-wound gene core.	[Scranton, Melissa A.; Fowler, Jonathan H.; Girke, Thomas; Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	linda.walling@ucr.edu		Scranton, Melissa/0000-0003-1910-3117; Girke, Thomas/0000-0003-0710-3777	National Science Foundation [IOS 0725093, DGE 0504249]	National Science Foundation(National Science Foundation (NSF))	This work and JF were supported by the National Science Foundation grant (IOS 0725093) to LLW. MS was supported by supported in part by the National Science Foundation-funded ChemIGERT program (DGE 0504249) and IOS 0725093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; Bar-Or C, 2007, GENOMICS, V90, P636, DOI 10.1016/j.ygeno.2007.06.008; Bar-Or C, 2007, TRENDS GENET, V23, P200, DOI 10.1016/j.tig.2007.02.003; Bar-Or C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernards Mark A., 2008, P189; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Birkenmeier GF, 1998, PLANT PHYSIOL, V117, P687, DOI 10.1104/pp.117.2.687; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaventure Gustavo, 2010, Commun Integr Biol, V3, P313; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BOSTOCK RM, 1989, ANNU REV PHYTOPATHOL, V27, P343, DOI 10.1146/annurev.py.27.090189.002015; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chen H, 2006, FEBS LETT, V580, P2540, DOI 10.1016/j.febslet.2006.03.070; Chen Hui, 2008, P271, DOI 10.1007/978-1-4020-8182-8_13; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Dargeviciute A, 1998, PLANT CELL PHYSIOL, V39, P993, DOI 10.1093/oxfordjournals.pcp.a029311; Dempsey DM, 2011, SALICYLIC ACID BIOSY; Dobbin K, 2002, BIOINFORMATICS, V18, P1438, DOI 10.1093/bioinformatics/18.11.1438; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edreva AM, 2007, RUSS J PLANT PHYSL+, V54, P287, DOI 10.1134/S1021443707030016; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Estavillo GM, 2012, FRON PLANT SCI, V3, P1; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI [10.1111/j.1364-3703.2007.00419.x, 10.1111/J.1364-3703.2007.00419.X]; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Galvez-Valdivieso G, 2010, PHYSIOL PLANTARUM, V138, P430, DOI 10.1111/j.1399-3054.2009.01331.x; Gatz C, 2013, MOL PLANT MICROBE IN, V26, P151, DOI 10.1094/MPMI-04-12-0078-IA; GODOY JA, 1990, PLANT MOL BIOL, V15, P695, DOI 10.1007/BF00016120; Gu YQ, 2000, EUR J BIOCHEM, V267, P1178, DOI 10.1046/j.1432-1327.2000.01116.x; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Heil M, 2009, TRENDS PLANT SCI, V14, P356, DOI 10.1016/j.tplants.2009.04.002; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Leon-Morcillo RJ, 2012, J EXP BOT, V63, P3545, DOI 10.1093/jxb/ers010; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang JH, 2010, PLANT PHYSIOL, V154, P262, DOI 10.1104/pp.110.160192; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Krause K, 2012, INT J MOL SCI, V13, P11085, DOI 10.3390/ijms130911085; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Lawrence SD, 2008, J CHEM ECOL, V34, P1013, DOI 10.1007/s10886-008-9507-2; Li CY, 2009, INSECT BIOCHEM MOLEC, V39, P726, DOI 10.1016/j.ibmb.2009.08.008; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mithoe SC, 2011, PHYTOCHEMISTRY, V72, P997, DOI 10.1016/j.phytochem.2010.12.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narvaez-Vasquez J, 1999, PLANT CELL, V11, P2249, DOI 10.1105/tpc.11.11.2249; Narvaez-Vasquez J, 2008, PLANTA, V227, P341, DOI 10.1007/s00425-007-0621-0; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Padmanabhan MS, 2010, MOL PLANT MICROBE IN, V23, P1368, DOI 10.1094/MPMI-05-10-0113; Pautot V, 2001, MOL PLANT MICROBE IN, V14, P214, DOI 10.1094/MPMI.2001.14.2.214; Pearce G, 2011, CURR PROTEIN PEPT SC, V12, P399, DOI 10.2174/138920311796391106; PenaCortes H, 1996, PLANTA, V198, P447, DOI 10.1007/BF00620062; PENACORTES H, 1991, PLANT CELL, V3, P963, DOI 10.1105/tpc.3.9.963; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rietz S, 2004, PLANTA, V219, P743, DOI 10.1007/s00425-004-1275-9; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P1; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Scranton MA, 2013, ELUCIDATION ROLE LEU; Scranton MA, 2012, J BIOL CHEM, V287, P18408, DOI 10.1074/jbc.M111.309500; Seo S, 1997, PHYSIOL PLANTARUM, V101, P740, DOI 10.1111/j.1399-3054.1997.tb01058.x; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Steinbrenner AD, 2011, J CHEM ECOL, V37, P1294, DOI 10.1007/s10886-011-0042-1; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Tian ZD, 2003, ACTA BOT SIN, V45, P959; TORNERO P, 1994, MOL GEN GENET, V243, P47, DOI 10.1007/BF00283875; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Tu CJ, 2003, PLANT PHYSIOL, V132, P243, DOI 10.1104/pp.102.013854; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Uppalapati SR, 2008, MOL PLANT MICROBE IN, V21, P383, DOI 10.1094/MPMI-21-4-0383; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; VANKAN JAL, 1995, PLANT MOL BIOL, V27, P1205, DOI 10.1007/BF00020894; Vellosillo T, 2013, PLANT PHYSIOL, V161, P617, DOI 10.1104/pp.112.207514; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Woodson JD, 2012, CURR BIOL, V22, pR690, DOI 10.1016/j.cub.2012.07.028; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	137	17	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77889	10.1371/journal.pone.0077889	http://dx.doi.org/10.1371/journal.pone.0077889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205013	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300036
J	Bonnell, TR; Campenni, M; Chapman, CA; Gogarten, JF; Reyna-Hurtado, RA; Teichroeb, JA; Wasserman, MD; Sengupta, R				Bonnell, Tyler R.; Campenni, Marco; Chapman, Colin A.; Gogarten, Jan F.; Reyna-Hurtado, Rafael A.; Teichroeb, Julie A.; Wasserman, Michael D.; Sengupta, Raja			Emergent Group Level Navigation: An Agent-Based Evaluation of Movement Patterns in a Folivorous Primate	PLOS ONE			English	Article							FORAGING PATTERNS; SPATIAL MEMORY; MONKEYS; HYPOTHESES; MAPS	The foraging activity of many organisms reveal strategic movement patterns, showing efficient use of spatially distributed resources. The underlying mechanisms behind these movement patterns, such as the use of spatial memory, are topics of considerable debate. To augment existing evidence of spatial memory use in primates, we generated movement patterns from simulated primate agents with simple sensory and behavioral capabilities. We developed agents representing various hypotheses of memory use, and compared the movement patterns of simulated groups to those of an observed group of red colobus monkeys (Procolobus rufomitratus), testing for: the effects of memory type (Euclidian or landmark based), amount of memory retention, and the effects of social rules in making foraging choices at the scale of the group (independent or leader led). Our results indicate that red colobus movement patterns fit best with simulated groups that have landmark based memory and a follow the leader foraging strategy. Comparisons between simulated agents revealed that social rules had the greatest impact on a group's step length, whereas the type of memory had the highest impact on a group's path tortuosity and cohesion. Using simulation studies as experimental trials to test theories of spatial memory use allows the development of insight into the behavioral mechanisms behind animal movement, developing case-specific results, as well as general results informing how changes to perception and behavior influence movement patterns.	[Bonnell, Tyler R.; Sengupta, Raja] McGill Univ, Deptartment Geog, Montreal, PQ, Canada; [Campenni, Marco] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Chapman, Colin A.; Wasserman, Michael D.] McGill Univ, Deptartment Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Gogarten, Jan F.] McGill Univ, Deptartment Biol, Montreal, PQ, Canada; [Reyna-Hurtado, Rafael A.] ECOSUR Campeche, Lerma, Cempeche, Mexico; [Teichroeb, Julie A.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA	McGill University; Max Planck Society; McGill University; McGill University; Wildlife Conservation Society; McGill University; El Colegio de la Frontera Sur (ECOSUR); University of California System; University of California Santa Cruz	Bonnell, TR (corresponding author), McGill Univ, Deptartment Geog, Montreal, PQ, Canada.	Tyler.Bonnell@mail.McGill.ca	Wasserman, Michael/AAR-7279-2020; Chapman, Colin/S-1911-2019; Gogarten, Jan Frederik/A-4430-2014; Reyna-Hurtado, Rafael/M-7204-2019; Reyna-Hurtado, Rafael A/B-6223-2015	Wasserman, Michael/0000-0003-1611-024X; Chapman, Colin/0000-0002-8827-8140; Gogarten, Jan Frederik/0000-0003-1889-4113; Reyna-Hurtado, Rafael/0000-0003-4382-642X; Reyna-Hurtado, Rafael A/0000-0003-4382-642X; Sengupta, Raja/0000-0003-4914-5844	Canada Research Chairs Program; Natural Science and Engineering Research Council of Canada; National Science Foundation; National Geographic; Fonds de Recherche Nature et Technologies; Graduate Research Fellowship from the National Science Foundation; Explorers Club - Eddie Bauer Youth Grant; McGill University's Tomlinson Postdoctoral Fellowship; Government of Canada Postdoctoral Research Fellowship (PDRF)	Canada Research Chairs Program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); National Geographic(National Geographic Society); Fonds de Recherche Nature et Technologies; Graduate Research Fellowship from the National Science Foundation; Explorers Club - Eddie Bauer Youth Grant; McGill University's Tomlinson Postdoctoral Fellowship; Government of Canada Postdoctoral Research Fellowship (PDRF)	Funding for the research in Kibale was provided by the Canada Research Chairs Program, Natural Science and Engineering Research Council of Canada, National Science Foundation, and National Geographic. TB received support from Fonds de Recherche Nature et Technologies. Permission to conduct the research in Uganda was given by the National Council for Science and Technology and the Uganda Wildlife Authority. JFG was supported by a Graduate Research Fellowship from the National Science Foundation and the Explorers Club - Eddie Bauer Youth Grant. MDW received funding from McGill University's Tomlinson Postdoctoral Fellowship. MC was supported by Government of Canada Postdoctoral Research Fellowship (PDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R, 2006, HANDB ECON, V13, P1565; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bennett DA, 2006, INT J GEOGR INF SCI, V20, P1039, DOI 10.1080/13658810600830806; Boinski S, 2000, ON THE MOVE HOW AND; Bonnell TR, 2013, ANIM BEHAV, V85, P483, DOI 10.1016/j.anbehav.2012.12.014; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; Byrne RW, 2000, ON THE MOVE HOW AND; CHAPMAN CA, 2000, DETERMINANTS GROUP S, P24; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Cunningham E, 2007, ANIM COGN, V10, P273, DOI 10.1007/s10071-007-0078-3; Di Fiore A, 2007, ANIM COGN, V10, P317, DOI 10.1007/s10071-006-0067-y; GARBER PA, 1989, AM J PRIMATOL, V19, P203, DOI 10.1002/ajp.1350190403; GARBER PA, 1993, INT J PRIMATOL, V14, P827, DOI 10.1007/BF02220255; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Goldstone RL, 2005, TRENDS COGN SCI, V9, P424, DOI 10.1016/j.tics.2005.07.009; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Janmaat KRL, 2006, ANIM BEHAV, V72, P797, DOI 10.1016/j.anbehav.2005.12.009; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Janson CH, 2007, ANIM COGN, V10, P341, DOI 10.1007/s10071-007-0079-2; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Normand E, 2009, ANIM BEHAV, V77, P1195, DOI 10.1016/j.anbehav.2009.01.025; POUCET B, 1993, PSYCHOL REV, V100, P163, DOI 10.1037/0033-295X.100.2.163; Prescott TJ, 2007, PHILOS T R SOC B, V362, P1521, DOI 10.1098/rstb.2007.2050; Prete FR, 2005, COMPLEX WORLDS FROM; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Sellers WI, 2007, PHILOS T R SOC B, V362, P1699, DOI 10.1098/rstb.2007.2064; Snaith TV, 2008, BEHAV ECOL, V19, P1289, DOI 10.1093/beheco/arn076; Struhsaker TT, 1975, THE RED COLOBUS MONK; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; TEBOEKHORST IJA, 1994, BEHAVIOUR, V130, P229, DOI 10.1163/156853994X00541; Tombak KJ, 2012, PRIMATES, V53, P57, DOI 10.1007/s10329-011-0274-2; VANSCHAIK CP, 1983, BEHAVIOUR, V85, P91, DOI 10.1163/156853983X00057; Whittington J, 2004, ECOL SOC, V9	38	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78264	10.1371/journal.pone.0078264	http://dx.doi.org/10.1371/journal.pone.0078264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205174	Green Published, gold			2022-12-25	WOS:000326032600088
J	Choy, A; Severo, MS; Sun, RB; Girke, T; Gillespie, JJ; Pedra, JHF				Choy, Anthony; Severo, Maiara S.; Sun, Ruobai; Girke, Thomas; Gillespie, Joseph J.; Pedra, Joao H. F.			Decoding the Ubiquitin-Mediated Pathway of Arthropod Disease Vectors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; IMPROVEMENTS; INSECTICIDES; MECHANISMS; PROTEOMICS; EVOLUTION; INFECTION; RESOURCE; HOMOLOGY	Protein regulation by ubiquitin has been extensively described in model organisms. However, characterization of the ubiquitin machinery in disease vectors remains mostly unknown. This fundamental gap in knowledge presents a concern because new therapeutics are needed to control vector-borne diseases, and targeting the ubiquitin machinery as a means for disease intervention has been already adopted in the clinic. In this study, we employed a bioinformatics approach to uncover the ubiquitin-mediated pathway in the genomes of Anopheles gambiae, Aedes aegypti, Culex quinquefasciatus, Ixodes scapularis, Pediculus humanus and Rhodnius prolixus. We observed that (1) disease vectors encode a lower percentage of ubiquitin-related genes when compared to Drosophila melanogaster, Mus musculus and Homo sapiens but not Saccharomyces cerevisiae; (2) overall, there are more proteins categorized as E3 ubiquitin ligases when compared to E2-conjugating or E1-activating enzymes; (3) the ubiquitin machinery within the three mosquito genomes is highly similar; (4) ubiquitin genes are more than doubled in the Chagas disease vector (R. prolixus) when compared to other arthropod vectors; (5) the deer tick I. scapularis and the body louse (P. humanus) genomes carry low numbers of E1-activating enzymes and HECT-type E3 ubiquitin ligases; (6) R. prolixus have low numbers of RING-type E3 ubiquitin ligases; and (7) C. quinquefasciatus present elevated numbers of predicted F-box E3 ubiquitin ligases, JAB and UCH deubiquitinases. Taken together, these findings provide novel opportunities to study the interaction between a pathogen and an arthropod vector.	[Choy, Anthony; Severo, Maiara S.; Pedra, Joao H. F.] Univ Calif Riverside, Ctr Dis Vector Res, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Choy, Anthony; Severo, Maiara S.; Pedra, Joao H. F.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Sun, Ruobai; Girke, Thomas] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Gillespie, Joseph J.; Pedra, Joao H. F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University System of Maryland; University of Maryland Baltimore	Pedra, JHF (corresponding author), Univ Calif Riverside, Ctr Dis Vector Res, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jpedra@som.umaryland.edu		Severo, Maiara/0000-0001-5972-0035; Gillespie, Joseph/0000-0002-5447-7264; Girke, Thomas/0000-0003-0710-3777; Pedra, Joao/0000-0001-8740-2667	University of California, Riverside; National Institutes of Health [NIH R01AI043006, NIH AI093653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093653, R01AI043006] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California, Riverside and the National Institutes of Health NIH R01AI043006 and NIH AI093653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade VN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038294; Baron M, 2012, SEMIN CELL DEV BIOL, V23, P437, DOI 10.1016/j.semcdb.2012.01.008; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; *CDCP, 2010, LYMPH FIL; Centers for Disease Control and Prevention, 2010, LYM DIS; Chatterjee A, 2008, CELL CYCLE, V7, P1231, DOI 10.4161/cc.7.9.5795; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cooper PS, 2010, BRIEF BIOINFORM, V11, P563, DOI 10.1093/bib/bbq022; Correa RL, 2013, INT J MOL SCI, V14, P4030, DOI 10.3390/ijms14024030; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; Huang B, 2012, FEMS IMMUNOL MED MIC, V64, P32, DOI 10.1111/j.1574-695X.2011.00873.x; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; JIN J, 2012, FRONT ONCOL, V2; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Low TY, 2013, PROTEOMICS, V13, P526, DOI 10.1002/pmic.201200244; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-331; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mauri PL, 2006, FEBS J, V273, P4277, DOI 10.1111/j.1742-4658.2006.05419.x; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Neafsey DE, 2013, G3-GENES GENOM GENET, V3, P1191, DOI 10.1534/g3.113.006247; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peng JM, 2005, METHOD ENZYMOL, V399, P367, DOI 10.1016/S0076-6879(05)99025-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Severo MS, 2013, CELL MICROBIOL, V15, P1070, DOI 10.1111/cmi.12128; SEVERO MS, 2013, J INFECT DIS; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; World Health Organization, 2004, WORLD HLTH REP 2004	56	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78077	10.1371/journal.pone.0078077	http://dx.doi.org/10.1371/journal.pone.0078077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205097	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600068
J	Duddempudi, PK; Goyal, R; Date, SS; Jansen, M				Duddempudi, Phaneendra Kumar; Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela			Delineating the Extracellular Water-Accessible Surface of the Proton-Coupled Folate Transporter	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; FUNCTIONAL ROLES; GLUCOSE-TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MALABSORPTION; PCFT-SLC46A1; MECHANISM; MUTATION; GENE	The proton-coupled folate transporter (PCFT) was recently identified as the major uptake route for dietary folates in humans. The three-dimensional structure of PCFT and its detailed interplay with function remain to be determined. We screened the water-accessible extracellular surface of HsPCFT using the substituted-cysteine accessibility method, to investigate the boundaries between the water-accessible surface and inaccessible buried protein segments. Single-cysteines, engineered individually at 40 positions in a functional cysteine-less HsPCFT background construct, were probed for plasma-membrane expression in Xenopus oocytes with a bilayer-impermeant primary-amine-reactive biotinylating agent (sulfosuccinimidyl 6-(biotinamido) hexanoate), and additionally for water-accessibility of the respective engineered cysteine with the sulfhydryl-selective biotinylating agent 2-((biotinoyl)amino)ethyl methanethiosulfonate. The ratio between Cys-selective over amine-selective labeling was further used to evaluate three-dimensional models of HsPCFT generated by homology / threading modeling. The closest homologues of HsPCFT with a known experimentally-determined three-dimensional structure are all members of one of the largest membrane protein super-families, the major facilitator superfamily (MFS). The low sequence identity - 14% or less - between HsPCFT and these templates necessitates experiment-based evaluation and model refinement of homology / threading models. With the present set of single-cysteine accessibilities, the models based on GlpT and PepT(St) are most promising for further refinement.	[Duddempudi, Phaneendra Kumar] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Duddempudi, Phaneendra Kumar; Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA.	michaela.jansen@ttuhsc.edu	Duddempudi, Phaneendra/AAL-8015-2020; Goyal, Raman/AAG-8507-2019	Duddempudi, Phaneendra/0000-0002-2625-8179; Jansen, Michaela/0000-0003-1325-9700	Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center); seed-grant program of the Office of Research, TTUHSC	Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center); seed-grant program of the Office of Research, TTUHSC	This work was supported, in part, by grants provided by the Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center)(to MJ), and by the seed-grant program of the Office of Research, TTUHSC (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANTONY AC, 1992, BLOOD, V79, P2807; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Bao XY, 2004, J BIOL CHEM, V279, P9689, DOI 10.1074/jbc.M311438200; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; GAN ZR, 1990, ARCH BIOCHEM BIOPHYS, V282, P110, DOI 10.1016/0003-9861(90)90093-E; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hou ZJ, 2012, J BIOL CHEM, V287, P4982, DOI 10.1074/jbc.M111.306860; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kasahara T, 2010, J BIOL CHEM, V285, P26263, DOI 10.1074/jbc.M110.149716; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Shin D.S., 2012, AM J PHYSL CELL PHYS; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Smith AD, 2008, AM J CLIN NUTR, V87, P517; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; UNDERHILL TM, 1989, MOL CELL BIOL, V9, P1754, DOI 10.1128/MCB.9.4.1754; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78301	10.1371/journal.pone.0078301	http://dx.doi.org/10.1371/journal.pone.0078301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205192	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300152
J	Hublin, JSYN; Ryan, U; Trengove, R; Maker, G				Hublin, Josephine S. Y. Ng; Ryan, Una; Trengove, Robert; Maker, Garth			Metabolomic Profiling of Faecal Extracts from Cryptosporidium parvum Infection in Experimental Mouse Models	PLOS ONE			English	Article							BENZOIC-ACID; GENOME; MICE; RESPONSES; OOCYSTS; RATS	Cryptosporidiosis is a gastrointestinal disease in humans and animals caused by infection with the protozoan parasite Cryptosporidium. In healthy individuals, the disease manifests mainly as acute self-limiting diarrhoea, but may be chronic and life threatening for those with compromised immune systems. Control and treatment of the disease is challenged by the lack of sensitive diagnostic tools and broad-spectrum chemotherapy. Metabolomics, or metabolite profiling, is an emerging field of study, which enables characterisation of the end products of regulatory processes in a biological system. Analysis of changes in metabolite patterns reflects changes in biochemical regulation, production and control, and may contribute to understanding the effects of Cryptosporidium infection in the host environment. In the present study, metabolomic analysis of faecal samples from experimentally infected mice was carried out to assess metabolite profiles pertaining to the infection. Gas-chromatography mass spectrometry (GC-MS) carried out on faecal samples from a group of C. parvum infected mice and a group of uninfected control mice detected a mean total of 220 compounds. Multivariate analyses showed distinct differences between the profiles of C. parvum infected mice and uninfected control mice, identifying a total of 40 compounds, or metabolites that contributed most to the variance between the two groups. These metabolites consisted of amino acids (n = 17), carbohydrates (n = 8), lipids (n = 7), organic acids (n = 3) and other various metabolites (n = 5), which showed significant differences in levels of metabolite abundance between the infected and uninfected mice groups (p < 0.05). The metabolites detected in this study as well as the differences in abundance between the C. parvum infected and the uninfected control mice, highlights the effects of the infection on intestinal permeability and the fate of the metabolites as a result of nutrient scavenging by the parasite to supplement its streamlined metabolism.	[Hublin, Josephine S. Y. Ng; Ryan, Una; Maker, Garth] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Hublin, Josephine S. Y. Ng; Trengove, Robert] Murdoch Univ, Separat Sci & Metab Lab, Murdoch, WA 6150, Australia; [Trengove, Robert; Maker, Garth] Murdoch Univ Node, Metab Australia, Perth, WA, Australia	Murdoch University; Murdoch University; Murdoch University	Hublin, JSYN (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	J.Ng-Hublin@outlook.com	Maker, Garth/T-6222-2019	Ryan, Una/0000-0003-2710-9324; Maker, Garth/0000-0003-1666-9377; Trengove, Robert/0000-0003-2454-0477	NCRIS Bioplatforms Australia	NCRIS Bioplatforms Australia	Financial support was provided by NCRIS Bioplatforms Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Capet C, 1999, EXP PARASITOL, V91, P119, DOI 10.1006/expr.1998.4358; Ehrenman K, 2013, CELL MICROBIOL, V15, P1182, DOI 10.1111/cmi.12107; Fall A, 2003, J PARASITOL, V89, P399, DOI 10.1645/0022-3395(2003)089[0399:MINART]2.0.CO;2; Fayer R, 2000, INT J PARASITOL, V30, P1305, DOI 10.1016/S0020-7519(00)00135-1; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Frltzler JM, 2007, EUKARYOT CELL, V6, P2018, DOI 10.1128/EC.00210-07; Gookin JL, 2002, J VET INTERN MED, V16, P12, DOI 10.1892/0891-6640(2002)016&lt;0012:HRTCI&gt;2.3.CO;2; Krahenbuhl L, 1997, HEPATOLOGY, V25, P278, DOI 10.1053/jhep.1997.v25.pm0009021934; Leav BA, 2003, CLIN INFECT DIS, V36, P903, DOI 10.1086/368194; Li JV, 2008, J PROTEOME RES, V7, P3948, DOI 10.1021/pr800209d; Mauzy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031715; Meloni BP, 1996, J PARASITOL, V82, P757, DOI 10.2307/3283888; Ng JSY, 2012, MOL BIOCHEM PARASIT, V185, P145, DOI 10.1016/j.molbiopara.2012.08.006; Rider SD, 2010, EXP PARASITOL, V124, P2, DOI 10.1016/j.exppara.2008.12.014; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Scheltema RA, 2010, PARASITOLOGY, V137, P1291, DOI 10.1017/S0031182009992022; Topouchian A, 2005, PARASITOL RES, V96, P326, DOI 10.1007/s00436-005-1369-8; Topouchian A, 2003, PARASITOL RES, V91, P197, DOI 10.1007/s00436-003-0956-9; Vanee N, 2010, CHEM BIODIVERS, V7, P1026, DOI 10.1002/cbdv.200900323; Vejchapipat P, 2000, J PEDIATR SURG, V35, P759, DOI 10.1053/jpsu.2000.6062; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; Watson DG, 2010, PARASITOLOGY, V137, P1409, DOI 10.1017/S0031182009991648; WEBER R, 1991, J CLIN MICROBIOL, V29, P1323, DOI 10.1128/JCM.29.7.1323-1327.1991; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S13; Zhu Guan, 2007, P57, DOI 10.1201/9781420052275.ch3	31	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77803	10.1371/journal.pone.0077803	http://dx.doi.org/10.1371/journal.pone.0077803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204976	Green Published, gold			2022-12-25	WOS:000326029300115
J	Lapp, SA; Korir-Morrison, C; Jiang, JL; Bai, YH; Corredor, V; Galinski, MR				Lapp, Stacey A.; Korir-Morrison, Cindy; Jiang, Jianlin; Bai, Yaohui; Corredor, Vladimir; Galinski, Mary R.			Spleen-Dependent Regulation of Antigenic Variation in Malaria Parasites: Plasmodium knowlesi SICAvar Expression Profiles in Splenic and Asplenic Hosts	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; FALCIPARUM-VAR GENES; DEEP VASCULAR SCHIZOGONY; INFECTED ERYTHROCYTES; MEMBRANE; IDENTIFICATION; FAMILY; PROTEINS; REVEALS; CYTOADHERENCE	Background: Antigenic variation by malaria parasites was first described in Plasmodium knowlesi, which infects humans and macaque monkeys, and subsequently in P. falciparum, the most virulent human parasite. The schizont-infected cell agglutination (SICA) variant proteins encoded by the SICAvar multigene family in P. knowlesi, and Erythrocyte Membrane Protein-1 (EMP-1) antigens encoded by the SICAvar multigene family in P. falciparum, are expressed at the surface of infected erythrocytes, are associated with virulence, and serve as determinants of naturally acquired immunity. A parental P. knowlesi clone, Pk1(A+), and a related progeny clone, Pk1(B+)1+, derived by an in vivo induced variant antigen switch, were defined by the expression of distinct SICA variant protein doublets of 210/190 and 205/200 kDa, respectively. Passage of SICA[+] infected erythrocytes through splenectomized rhesus monkeys results in the SICA[-] phenotype, defined by the lack of surface expression and agglutination with variant specific antisera. Principal Findings: We have investigated SICAvar RNA and protein expression in Pk1(A+), Pk1(B+) 1+, and SICA[-] parasites. The Pk1(A+) and Pk1(B+) 1+ parasites express different distinct SICAvar transcript and protein repertoires. By comparison, SICA[-] parasites are characterized by a vast reduction in SICAvar RNA expression, the lack of full-length SICAvar transcript signals on northern blots, and correspondingly, the absence of any SICA protein detected by mass spectrometry. Significance: SICA protein expression may be under transcriptional as well as post-transcriptional control, and we show for the first time that the spleen, an organ central to blood-stage immunity in malaria, exerts an influence on these processes. Furthermore, proteomics has enabled the first in-depth characterization of SICA[+] protein phenotypes and we show that the in vivo switch from Pk1(A+) to Pk1(B+) 1+ parasites resulted in a complete change in SICA profiles. These results emphasize the importance of studying antigenic variation in the context of the host environment.	[Lapp, Stacey A.; Korir-Morrison, Cindy; Jiang, Jianlin; Bai, Yaohui; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Corredor, Vladimir] Univ Nacl Colombia, Fac Med, Dept Salud Publ, Bogota, Colombia; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University; Universidad Nacional de Colombia; Emory University	Galinski, MR (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	Mary.Galinski@gmail.com		CORREDOR, Vladimir/0000-0002-8597-8125	US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [R01 R01-AI065961, HHSN272201200031C]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI065961] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in whole or in part by federal funds from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant # R01 R01-AI065961 and contract # HHSN272201200031C and supported by the National Center for Research Resources P51RR165 and the Office of Research Infrastructure Programs/OD P51OD11132. Some qRT-PCR experiments were outsourced to the CFAR Core Service Center, which is funded by the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; ALEY SB, 1984, MOL BIOCHEM PARASIT, V12, P69, DOI 10.1016/0166-6851(84)90045-8; Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Arnot DE, 2011, ADV APPL MICROBIOL, V74, P77, DOI 10.1016/B978-0-12-387022-3.00007-0; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bachmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049540; Bachmann A, 2011, CELL MICROBIOL, V13, P1397, DOI 10.1111/j.1462-5822.2011.01629.x; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; BARNWELL JW, 1982, J IMMUNOL, V128, P224; BARNWELL JW, 1983, CIBA F SYMP, V94, P117; BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1992, J IMMUNOL, V149, P2047; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Borst P, 2006, NATURE, V439, P926, DOI 10.1038/439926b; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; BROWN KN, 1974, T ROY SOC TROP MED H, V68, P139, DOI 10.1016/0035-9203(74)90187-4; BROWN KN, 1973, NATURE, V242, P49, DOI 10.1038/242049a0; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Corredor V, 2004, MOL BIOCHEM PARASIT, V138, P37, DOI 10.1016/j.molbiopara.2004.05.017; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Deitsch KW, 2012, P NATL ACAD SCI USA, V109, P10130, DOI 10.1073/pnas.1207174109; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Demar M, 2004, AM J TROP MED HYG, V71, P290, DOI 10.4269/ajtmh.2004.71.290; DESOWITZ RS, 1969, T ROY SOC TROP MED H, V63, P198, DOI 10.1016/0035-9203(69)90147-3; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Eaton MD, 1938, J EXP MED, V67, P857, DOI 10.1084/jem.67.6.857; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Fastman Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034168; Frank M, 2010, WIEN KLIN WOCHENSCHR, V122, P7, DOI 10.1007/s00508-010-1326-0; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; Fried M, 2004, PROTEOMICS, V4, P1086, DOI 10.1002/pmic.200300666; Galinski MR, 2004, MOL BIOCHEM PARASIT, V134, P17, DOI 10.1016/j.molbiopara.2003.09.013; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; HANDUNNETTI SM, 1987, J EXP MED, V165, P1269, DOI 10.1084/jem.165.5.1269; HOMMEL M, 1983, J EXP MED, V157, P1137, DOI 10.1084/jem.157.4.1137; HOWARD RJ, 1984, J CELL BIOCHEM, V24, P297, DOI 10.1002/jcb.240240310; HOWARD RJ, 1984, PHILOS T R SOC B, V307, P141, DOI 10.1098/rstb.1984.0115; HOWARD RJ, 1988, MOL BIOCHEM PARASIT, V27, P207, DOI 10.1016/0166-6851(88)90040-0; HOWARD RJ, 1985, PARASITOLOGY, V91, P245, DOI 10.1017/S0031182000057346; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; HOWARD RJ, 1984, PARASITOLOGY, V88, P27, DOI 10.1017/S0031182000054317; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Korir CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/j.meegid.2005.01.003; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Lapp SA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-181; Leech J H, 1984, Prog Clin Biol Res, V155, P63; LEECH JH, 1984, J CELL BIOL, V98, P1256, DOI 10.1083/jcb.98.4.1256; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Melcher M, 2010, CELL MICROBIOL, V12, P1446, DOI 10.1111/j.1462-5822.2010.01481.x; Merrick CJ, 2012, J INFECT DIS, V205, P1593, DOI 10.1093/infdis/jis239; MILLER LH, 1971, AM J TROP MED HYG, V20, P816, DOI 10.4269/ajtmh.1971.20.816; Mitsui H, 2010, GENE, V450, P32, DOI 10.1016/j.gene.2009.10.001; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Munasinghe A, 2009, SCAND J INFECT DIS, V41, P538, DOI 10.1080/00365540902971195; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Patankar S, 2001, MOL BIOL CELL, V12, P3114, DOI 10.1091/mbc.12.10.3114; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; RUDZINSKA MA, 1968, J PROTOZOOL, V15, P73, DOI 10.1111/j.1550-7408.1968.tb02091.x; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Sierra-Miranda M, 2012, MOL BIOCHEM PARASIT, V185, P36, DOI 10.1016/j.molbiopara.2012.06.005; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Vargas-Serrato E, 2003, INFECT GENET EVOL, V3, P67, DOI 10.1016/S1567-1348(03)00007-8; Wang CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-147; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; Wunderlich Gerhard, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P195, DOI 10.1590/S0036-46652005000400004	85	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78014	10.1371/journal.pone.0078014	http://dx.doi.org/10.1371/journal.pone.0078014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205067	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300133
J	Liu, GB; Liu, RZ; Li, QQ; Tang, XH; Yu, M; Li, XY; Cao, JH; Zhao, SH				Liu, Guangbin; Liu, Ruize; Li, Qinqun; Tang, Xiaohui; Yu, Mei; Li, Xinyun; Cao, Jianhua; Zhao, Shuhong			Identification of microRNAs in Wool Follicles during Anagen, Catagen, and Telogen Phases in Tibetan Sheep	PLOS ONE			English	Article							HAIR CYCLE; DIFFERENTIATION; STEM; EXPRESSION; ACTIVATION; PREDICTION; MECHANISM; EPIDERMIS; PROGRAMS; MIRBASE	Background: Wool quality is one of the most important economic traits in sheep. The wool fiber is derived from specialized skin cells that are referred to as wool follicles. To understand the roles of microRNAs (miRNAs) in wool fiber growth, we detected the expression patterns of miRNAs in wool follicles at the anagen, catagen, and telogen stages from Tibetan sheep through Solexa sequencing. Results: A total of 244 mature miRNAs were identified. Of these, only five miRNAs are listed in the database of sheep miRNAs (miRBase Database V19), and the other 239 miRNAs have not been previously described in this species. Further analyses indicated that 204 miRNAs are evolutionarily conserved among mammal species, whereas 35 of the identified miRNAs were first found specifically in sheep. The expression pattern analyses showed that the expression levels of 39, 34, and 20 of the miRNAs significantly change between anagen and catagen, between anagen and telogen, and between catagen and telogen, respectively. The results of the bioinformatics analysis show that these differentially expressed miRNAs might regulate wool follicle development by targeting genes in many different pathways, such as the MAPK and Wnt pathways, as well as the pathways that regulate the actin cytoskeleton, focal adhesion, and tight junctions. Furthermore, we identified six differentially expressed miRNAs (oar-miR-103-3P, oar-miR-148b-3P, oar-miR-320-3P, oar-miR-31-5P, oar-novel-1-5P, and oar-novel-2-3P) that might target the key genes of the Wnt pathway. It has been reported that the Wnt pathway is critical for wool follicle development. Therefore, these miRNAs may regulate wool development through the Wnt pathway. Conclusions: Our results provide new information on the identification and expression pattern of miRNAs in wool follicles. Our data might therefore aid in the understanding of the mechanisms of wool follicle development in sheep.	[Liu, Guangbin; Liu, Ruize; Li, Qinqun; Yu, Mei; Li, Xinyun; Cao, Jianhua; Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China; [Tang, Xiaohui] Agr & Anim Husb Coll Tibet, Linzhi, Tibet, Peoples R China	Huazhong Agricultural University; Tibet Agriculture & Animal Husbandry University	Cao, JH (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	jhcao@mail.hzau.edu.cn; shzhao@mail.hzau.edu.cn			National Program of Transgenic Variety Development of China [2011ZX08009-004]; National Natural Science Foundation of China [30960163]	National Program of Transgenic Variety Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (2011ZX08009-004) from the National Program of Transgenic Variety Development of China and Regional project of the National Natural Science Foundation (30960163) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aubin-Houzelstein G, 2012, ADV EXP MED BIOL, V727, P142, DOI 10.1007/978-1-4614-0899-4_11; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Celso CL, 2004, DEVELOPMENT, V131, P1787, DOI DOI 10.1242/DEV.01052.PUBMED:15084463; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; He Y, 2012, CELL SIGNAL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hung PS, 2010, J DENT RES, V89, P252, DOI 10.1177/0022034509357411; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Niemann C, 2002, DEVELOPMENT, V129, P95; Ning MS, 2012, CELL MOL LIFE SCI, P1; Park PJ, 2012, LIFE SCI; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	49	27	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77801	10.1371/journal.pone.0077801	http://dx.doi.org/10.1371/journal.pone.0077801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204975	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200077
J	Seppala, O; Karvonen, A; Kuosa, M; Haataja, M; Jokela, J				Seppala, Otto; Karvonen, Anssi; Kuosa, Marja; Haataja, Maarit; Jokela, Jukka			Are Sick Individuals Weak Competitors? Competitive Ability of Snails Parasitized by a Gigantism-Inducing Trematode	PLOS ONE			English	Article							LARVAL TREMATODES; INTRASPECIFIC COMPETITION; GROWTH; INFECTION; GASTROPODA; FECUNDITY; PATTERNS; ECOLOGY; VIRUS	Parasitized individuals are often expected to be poor competitors because they are weakened by infections. Many trematode species, however, although extensively exploiting their mollusc hosts, also induce gigantism (increased host size) by diverting host resources towards growth instead of reproduction. In such systems, alternatively to reduced competitive ability due to negative effects of parasitism on host performance, larger size could allow more efficient resource acquisition and thus increase the relative competitive ability of host individuals. We addressed this hypothesis by testing the effect of a trematode parasite Diplostomum pseudospathaceum on the competitive ability of its snail host Lymnaea stagnalis. We experimentally examined the growth of snails kept in pairs in relation to their infection status and intensity of resource competition (i.e. food availability). We found that parasitized snails grew faster and their reproduction was reduced compared to unparasitized individuals indicating parasite-induced gigantism. However, growth of the snails was faster when competing with parasitized individuals compared to unparasitized snails indicating reduced competitive ability due to parasitism. The latter effect, however, was relatively weak suggesting that the effects of the parasite on snail physiology may partly override each other in determining competitive ability.	[Seppala, Otto; Jokela, Jukka] ETH, Inst Integrat Biol, Zurich, Switzerland; [Seppala, Otto; Jokela, Jukka] Eawag, Dept Aquat Ecol, Dubendorf, Switzerland; [Karvonen, Anssi] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kuosa, Marja] Univ Oulu, Dept Biol, Oulu, Finland; [Haataja, Maarit] Univ Helsinki, Res Funding Serv, Helsinki, Finland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Jyvaskyla; University of Oulu; University of Helsinki	Seppala, O (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	otto.seppaelae@eawag.ch		Karvonen, Anssi/0000-0002-2731-3344; Jokela, Jukka/0000-0002-1731-727X; Seppala, Otto/0000-0001-7902-3069	Emil Aaltonen Foundation; Swiss National Science Foundation [31003A 140876, 31003A 129961]; Centre of Excellence in Evolutionary Research (Academy of Finland); Centre of Excellence in Evolutionary Research (University of Jyvaskyla)	Emil Aaltonen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre of Excellence in Evolutionary Research (Academy of Finland)(Academy of Finland); Centre of Excellence in Evolutionary Research (University of Jyvaskyla)	This study was supported by the Emil Aaltonen Foundation (to OS), the Swiss National Science Foundation (grant 31003A 140876 to OS, grant 31003A 129961 to JJ), and the Centre of Excellence in Evolutionary Research (Academy of Finland and University of Jyvaskyla) (to AK and JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedhomme S, 2005, PLOS BIOL, V3, P1403, DOI 10.1371/journal.pbio.0030262; Bieger A, 2009, OECOLOGIA, V160, P247, DOI 10.1007/s00442-009-1297-x; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cameron TC, 2007, ECOLOGY, V88, P1225, DOI 10.1890/06-0661; CATHERALL PL, 1966, ANN APPL BIOL, V57, P155, DOI 10.1111/j.1744-7348.1966.tb06876.x; Faltynkova A, 2007, PARASITE, V14, P39, DOI 10.1051/parasite/2007141039; Faltynkova A, 2006, PARASITOL RES, V99, P572, DOI 10.1007/s00436-006-0197-9; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; HOCHBERG ME, 1991, OIKOS, V61, P297, DOI 10.2307/3545237; Jokela J, 1999, OECOLOGIA, V119, P320, DOI 10.1007/s004420050792; Karvonen A, 2006, PARASITOLOGY, V132, P357, DOI 10.1017/S0031182005009091; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Karvonen A, 2008, AQUACULTURE, V279, P6, DOI 10.1016/j.aquaculture.2008.04.013; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Koprivnikar J, 2008, OECOLOGIA, V155, P641, DOI 10.1007/s00442-007-0937-2; Kusch J, 2002, PROTIST, V153, P47, DOI 10.1078/1434-4610-00082; LAFFERTY KD, 1993, MAR ECOL PROG SER, V96, P229, DOI 10.3354/meps096229; LIVELY CM, 1995, ECOLOGY, V76, P1859, DOI 10.2307/1940718; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; MOURITSEN KN, 1994, J EXP MAR BIOL ECOL, V181, P53, DOI 10.1016/0022-0981(94)90103-1; Pagan I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000531; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; ROTHSCHILD MIRIAM, 1936, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V20, P537; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Seppala O, 2008, OIKOS, V117, P749, DOI 10.1111/j.0030-1299.2008.16396.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sisterson MS, 2003, OECOLOGIA, V135, P362, DOI 10.1007/s00442-003-1205-8; Sorensen RE, 1998, OECOLOGIA, V115, P188, DOI 10.1007/s004420050507; Vayrynen T, 2000, ANN ZOOL FENN, V37, P189; WASHBURN JO, 1991, SCIENCE, V253, P185, DOI 10.1126/science.1906637	35	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e79366	10.1371/journal.pone.0079366	http://dx.doi.org/10.1371/journal.pone.0079366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205383	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800027
J	Herold, C; Ramirez, A; Drichel, D; Lacour, A; Vaitsiakhovich, T; Nothen, MM; Jessen, F; Maier, W; Becker, T				Herold, Christine; Ramirez, Alfredo; Drichel, Dmitriy; Lacour, Andre; Vaitsiakhovich, Tatsiana; Noethen, Markus M.; Jessen, Frank; Maier, Wolfgang; Becker, Tim			A One-Degree-of-Freedom Test for Supra-Multiplicativity of SNP Effects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; MISSING HERITABILITY; IDENTIFIES VARIANTS; COMMON VARIANTS; LIABILITY; INTERSNP; MODELS; ONSET; CD2AP	Deviation from multiplicativity of genetic risk factors is biologically plausible and might explain why Genome-wide association studies (GWAS) so far could unravel only a portion of disease heritability. Still, evidence for SNP-SNP epistasis has rarely been reported, suggesting that 2-SNP models are overly simplistic. In this context, it was recently proposed that the genetic architecture of complex diseases could follow limiting pathway models. These models are defined by a critical risk allele load and imply multiple high-dimensional interactions. Here, we present a computationally efficient one-degree-of-freedom "supra-multiplicativity-test" (SMT) for SNP sets of size 2 to 500 that is designed to detect risk alleles whose joint effect is fortified when they occur together in the same individual. Via a simulation study we show that the SMT is powerful in the presence of threshold models, even when only about 30-45% of the model SNPs are available. In addition, we demonstrate that the SMT outperforms standard interaction analysis under recessive models involving just a few SNPs. We apply our test to 10 consensus Alzheimer's disease (AD) susceptibility SNPs that were previously identified by GWAS and obtain evidence for supra-multiplicativity (p = 0.008) that is not attributable to either two-way or three-way interaction.	[Herold, Christine; Drichel, Dmitriy; Lacour, Andre; Jessen, Frank; Maier, Wolfgang; Becker, Tim] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Herold, Christine] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vaitsiakhovich, Tatsiana; Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Ramirez, Alfredo; Jessen, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Ramirez, Alfredo; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Harvard T.H. Chan School of Public Health; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Becker, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	Tim.Becker@dzne.de	Ramirez, Alfredo/S-5126-2019; Jessen, Frank/AAK-6170-2020	Ramirez, Alfredo/0000-0003-4991-763X; Nothen, Markus/0000-0002-8770-2464; Lacour, Andre/0000-0003-2692-2583; Drichel, Dmitriy/0000-0001-5978-3458; Becker, Tim/0000-0002-6573-1109	Deutsche Forschungsgemeinschaft [BE 3828/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	TV was supported by the Deutsche Forschungsgemeinschaft grant BE 3828/3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Clayton D, 2012, GENET EPIDEMIOL, V36, P409, DOI 10.1002/gepi.21635; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herold C, 2012, HUM HERED, V73, P63, DOI 10.1159/000336196; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hindorffi L, 2012, CATALOG PUBLISHED GE; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li XY, 2012, BEHAV GENET, V42, P268, DOI 10.1007/s10519-011-9506-x; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mechanic LE, 2012, GENET EPIDEMIOL, V36, P22, DOI 10.1002/gepi.20652; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Phillips PC, 1998, GENETICS, V149, P1167; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78038	10.1371/journal.pone.0078038	http://dx.doi.org/10.1371/journal.pone.0078038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205078	Green Submitted, gold, Green Published			2022-12-25	WOS:000326334500091
J	Hyde, ER; Haarmann, DP; Lynne, AM; Bucheli, SR; Petrosino, JF				Hyde, Embriette R.; Haarmann, Daniel P.; Lynne, Aaron M.; Bucheli, Sibyl R.; Petrosino, Joseph F.			The Living Dead: Bacterial Community Structure of a Cadaver at the Onset and End of the Bloat Stage of Decomposition	PLOS ONE			English	Article							ACCUMULATED DEGREE-DAYS; TIME; INDICATOR	Human decomposition is a mosaic system with an intimate association between biotic and abiotic factors. Despite the integral role of bacteria in the decomposition process, few studies have catalogued bacterial biodiversity for terrestrial scenarios. To explore the microbiome of decomposition, two cadavers were placed at the Southeast Texas Applied Forensic Science facility and allowed to decompose under natural conditions. The bloat stage of decomposition, a stage easily identified in taphonomy and readily attributed to microbial physiology, was targeted. Each cadaver was sampled at two time points, at the onset and end of the bloat stage, from various body sites including internal locations. Bacterial samples were analyzed by pyrosequencing of the 16S rRNA gene. Our data show a shift from aerobic bacteria to anaerobic bacteria in all body sites sampled and demonstrate variation in community structure between bodies, between sample sites within a body, and between initial and end points of the bloat stage within a sample site. These data are best not viewed as points of comparison but rather additive data sets. While some species recovered are the same as those observed in culture-based studies, many are novel. Our results are preliminary and add to a larger emerging data set; a more comprehensive study is needed to further dissect the role of bacteria in human decomposition.	[Hyde, Embriette R.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Haarmann, Daniel P.; Lynne, Aaron M.; Bucheli, Sibyl R.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	Baylor College of Medicine; Texas State University System; Sam Houston State University	Bucheli, SR (corresponding author), Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA.	bucheli@shsu.edu	Petrosino, Joseph F./AAF-1621-2019		Sam Houston State University; Baylor College of Medicine through the Alkek Foundation	Sam Houston State University; Baylor College of Medicine through the Alkek Foundation	Funding for this project was provided by Sam Houston State University in the form of an Enhancement Research Grant and by Baylor College of Medicine through the Alkek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Butzbach DM, 2013, J FORENSIC SCI, V58, P90, DOI 10.1111/j.1556-4029.2012.02280.x; Byrd JH, 2000, INSECTS FORENSIC IMP, P43; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carter DO, 2008, FACULTY PUBLICATIONS; Catts EP, 1990, ENTOMOLOGY DEATH PRO; Dickson GC, 2011, FORENSIC SCI INT, V209, P1, DOI 10.1016/j.forsciint.2010.10.016; Evans W.E.D, 1963, CHEM DEATH; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Galloway A, 1996, PROCESS DECOMPOSITIO; Haskell N. H., 2008, ENTOMOLOGY DEATH PRO; HEWADIKARAM KA, 1991, AM J FOREN MED PATH, V12, P235, DOI 10.1097/00000433-199109000-00013; Hopkins DW, 2000, APPL SOIL ECOL, V14, P283, DOI 10.1016/S0929-1393(00)00063-9; Howard GT, 2010, INT BIODETER BIODEGR, V64, P300, DOI 10.1016/j.ibiod.2010.02.006; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Janaway Robert C., 2009, P313, DOI 10.1007/978-1-59745-327-1_14; Kakizaki E, 2008, FORENSIC SCI INT, V176, P236, DOI 10.1016/j.forsciint.2007.09.018; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lenz EJ, 2010, J FORENSIC SCI, V55, P1437, DOI 10.1111/j.1556-4029.2010.01464.x; Lindgren NK, 2011, FORENSIC SCI INT, V204, pE1, DOI 10.1016/j.forsciint.2010.05.016; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; MELVIN JR, 1984, J FORENSIC SCI, V29, P412; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyers MS, 2008, J FORENSIC SCI, V53, P652, DOI 10.1111/j.1556-4029.2008.00728.x; Michaud JP, 2011, J FORENSIC SCI, V56, P229, DOI 10.1111/j.1556-4029.2010.01559.x; Micozzi MS, 1996, FROZEN ENV SOFT TISS; Myburgh J, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.037; Ogden Cynthia L, 2004, Adv Data, P1; Parkinson RA, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P379, DOI 10.1007/978-1-4020-9204-6_24; Payen G, 1988, Acta Med Leg Soc (Liege), V38, P145; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pless JE, 1996, POSTMORTEM CHANGES S; Schoenen D, 2013, FORENSIC SCI INT, V226, DOI 10.1016/j.forsciint.2013.01.023; Schoenly KG, 2006, AM BIOL TEACH, V68, P402, DOI 10.1662/0002-7685(2006)68[402:RDAITS]2.0.CO;2; Simmons T, 2010, J FORENSIC SCI, V55, P8, DOI 10.1111/j.1556-4029.2009.01206.x; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Stokes KL, 2013, J FORENSIC SCI, V58, P583, DOI 10.1111/1556-4029.12115; Stokes KL, 2009, FORENSIC SCI INT, V183, P6, DOI 10.1016/j.forsciint.2008.08.013; Tuomisto S, 2013, J FORENSIC SCI, V58, P910, DOI 10.1111/1556-4029.12124; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vass A.A., 2001, MICROBIOL TODAY, V28, P190	45	128	138	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77733	10.1371/journal.pone.0077733	http://dx.doi.org/10.1371/journal.pone.0077733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204941	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500048
J	Mizuta, T; Ando, K; Uemura, T; Kawata, Y; Mizobata, T				Mizuta, Toshifumi; Ando, Kasumi; Uemura, Tatsuya; Kawata, Yasushi; Mizobata, Tomohiro			Probing the Dynamic Process of Encapsulation in Escherichia coli GroEL	PLOS ONE			English	Article							INDUCED ALLOSTERIC TRANSITIONS; INDUCED CONFORMATIONAL-CHANGES; SINGLE-RING MUTANT; CHAPERONIN GROEL; CIRCULAR PERMUTATION; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; EFFICIENT ENCAPSULATION; ANGSTROM RESOLUTION; APICAL DOMAIN	Kinetic analyses of GroE-assisted folding provide a dynamic sequence of molecular events that underlie chaperonin function. We used stopped-flow analysis of various fluorescent GroEL mutants to obtain details regarding the sequence of events that transpire immediately after ATP binding to GroEL and GroEL with prebound unfolded proteins. Characterization of GroEL CP86, a circularly permuted GroEL with the polypeptide ends relocated to the vicinity of the ATP binding site, showed that GroES binding and protection of unfolded protein from solution is achieved surprisingly early in the functional cycle, and in spite of greatly reduced apical domain movement. Analysis of fluorescent GroEL SR-1 and GroEL D398A variants suggested that among other factors, the presence of two GroEL rings and a specific conformational rearrangement of Helix M in GroEL contribute significantly to the rapid release of unfolded protein from the GroEL apical domain.	[Mizuta, Toshifumi; Ando, Kasumi; Kawata, Yasushi; Mizobata, Tomohiro] Grad Sch Engn, Dept Biotechnol, Tottori, Japan; [Uemura, Tatsuya; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Tottori 680, Japan	Tottori University	Mizobata, T (corresponding author), Grad Sch Engn, Dept Biotechnol, Tottori, Japan.	mizobata@bio.tottori-u.ac.jp	Mizobata, Tomohiro/V-6672-2019; Kawata, Yasushi/ABA-9608-2021	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) of Japan [22570119]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22020025]; Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University	Japan Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University	This study was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22570119 to TM) from the Japan Society for the Promotion of Science (JSPS) of Japan, a Grant-in-Aid for Scientific Research on Priority Areas (No. 22020025 to YK) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and also by grants to TM from the Faculty of Engineering, Tottori University and the Venture Business Laboratory, Tottori University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chatellier J, 2000, J MOL BIOL, V304, P897, DOI 10.1006/jmbi.2000.4278; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Fei X, 2013, P NATL ACAD SCI USA, V110, pE2958, DOI 10.1073/pnas.1311996110; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2000, METH MOL B, V140, P127; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Kovacs E, 2010, J MOL BIOL, V396, P1271, DOI 10.1016/j.jmb.2009.11.074; KUBO T, 1993, J BIOL CHEM, V268, P19346; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MIZOBATA T, 1994, BBA-PROTEIN STRUCT M, V1209, P83, DOI 10.1016/0167-4838(94)90140-6; Mizobata T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026462; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Taniguchi M, 2004, J BIOL CHEM, V279, P16368, DOI 10.1074/jbc.M311806200; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997; Yoshimi T, 2006, J BIOCHEM, V139, P407, DOI 10.1093/jb/mvj043	41	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78135	10.1371/journal.pone.0078135	http://dx.doi.org/10.1371/journal.pone.0078135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205127	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500097
J	Vu, BG; Gourronc, FA; Bernlohr, DA; Schlievert, PM; Klingelhutz, AJ				Vu, Bao G.; Gourronc, Francoise A.; Bernlohr, David A.; Schlievert, Patrick M.; Klingelhutz, Aloysius J.			Staphylococcal Superantigens Stimulate Immortalized Human Adipocytes to Produce Chemokines	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; NECROSIS-FACTOR-ALPHA; INNATE IMMUNE-SYSTEM; INSULIN-RESISTANCE; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; ADIPOSE-TISSUE; HLA-DR; AUREUS; OBESITY	Background: Human adipocytes may have significant functions in wound healing and the development of diabetes through production of pro-inflammatory cytokines after stimulation by gram-negative bacterial endotoxin. Diabetic foot ulcers are most often associated with staphylococcal infections. Adipocyte responses in the area of the wound may play a role in persistence and pathology. We studied the effect of staphylococcal superantigens (SAgs) on immortalized human adipocytes, alone and in the presence of bacterial endotoxin or staphylococcal alpha-toxin. Methodology/Principal Findings: Primary non-diabetic and diabetic human preadipocytes were immortalized by the reverse transcriptase component of telomerase (TERT) and the E6/E7 genes of human papillomavirus. The immortal cells were demonstrated to have properties of non-immortalized pre-adipocytes and could be differentiated into mature and functional adipocytes. Differentiated adipocytes exposed to staphylococcal SAgs produced robust levels of cytokines IL-6 and IL-8, but there were no significant differences in levels between the non-diabetic and diabetic cells. Cytokine production was increased by co-incubation of adipocytes with SAgs and endotoxin together. In contrast, alpha-toxin alone was cytotoxic at high concentrations, but, at sub-cytotoxic doses, did not stimulate production of IL-6 and IL-8. Conclusions/Significance: Endotoxin has been proposed to contribute to diabetes through enhanced insulin resistance after chronic exposure and stimulation of adipocytes to produce cytokines. Our data indicate staphylococcal SAgs TSST-1 and SEB alone and in combination with bacterial endotoxin also stimulate adipocytes to produce cytokines and thus may contribute to the inflammatory response found in chronic diabetic ulcers and in the systemic inflammation that is associated with the development and persistence of diabetes. The immortal human pre-adipocytes reported here will be useful for studies to understand further the mechanism by which toxins are involved in wound healing and the development and clinical manifestations of obesity and diabetes.	[Vu, Bao G.; Gourronc, Francoise A.; Schlievert, Patrick M.; Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Bernlohr, David A.] Univ Minnesota, Sch Med, Dept Biochem & Mol Biol Biophys, Minneapolis, MN 55455 USA	University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Klingelhutz, AJ (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	aloysius-klingelhutz@uiowa.edu	Klingelhutz, Aloysius/L-9081-2018	Klingelhutz, Aloysius/0000-0003-4258-5046; Schlievert, Patrick/0000-0001-8314-9369	University of Iowa Department of Microbiology Development Grant; United States Public Health Service [AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669] Funding Source: NIH RePORTER	University of Iowa Department of Microbiology Development Grant; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Iowa Department of Microbiology Development Grant (AJK) and United States Public Health Service research grant AI074283 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2000, DIABETIC MED, V17, P487; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; BERMAN DS, 1987, J INFECT DIS, V155, P829, DOI 10.1093/infdis/155.4.829-a; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; CHINTAGUMPALA MM, 1991, J IMMUNOL, V147, P3876; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hanses F, 2011, ENDOCRINOLOGY, V152, P4148, DOI 10.1210/en.2011-0103; Henry SL, 2012, INT J BIOCHEM CELL B, V44, P435, DOI 10.1016/j.biocel.2011.12.011; Hoch M, 2008, CYTOKINE, V41, P29, DOI 10.1016/j.cyto.2007.10.008; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leyvraz C, 2010, DIABETES OBES METAB, V12, P195, DOI 10.1111/j.1463-1326.2009.01149.x; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Nguyen MTA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034976; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Prevention CDC, 2011, NAT DIAB FACT SHEET; Purohit JS, 2013, OBESITY, V21, P737, DOI [10.1038/oby.2012.155, 10.1002/oby.20275]; ROODYN LEONARD, 1960, JOUR HYG, V58, P11; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; SCHOLL PR, 1989, J IMMUNOL, V143, P2583; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; TUAZON CU, 1975, JAMA-J AM MED ASSOC, V231, P1272, DOI 10.1001/jama.231.12.1272; WESTPHAL O, 1952, Z NATURFORSCH B, V7, P148, DOI 10.1515/znb-1952-0303; Wukich DK, 2013, FOOT ANKLE INT, V34, P351, DOI 10.1177/1071100712467980; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	55	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77988	10.1371/journal.pone.0077988	http://dx.doi.org/10.1371/journal.pone.0077988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205055	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500085
J	Campbell, MJ; Wolf, D; Mukhtar, RA; Tandon, V; Yau, C; Au, A; Baehner, F; van't Veer, L; Berry, D; Esserman, LJ				Campbell, Michael J.; Wolf, Denise; Mukhtar, Rita A.; Tandon, Vickram; Yau, Christina; Au, Alfred; Baehner, Frederick; van't Veer, Laura; Berry, Donald; Esserman, Laura J.			The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INFILTRATING LYMPHOCYTES; MICROENVIRONMENTS; POLARIZATION; RECURRENCE; CARCINOMA; SURVIVAL; CD68	Tumor associated macrophages (TAMs) are recruited from the circulation to the tumor site, and can undergo a spectrum of phenotypic changes, with two contrasting activation states described in the literature: the M1 and M2 phenotypes. We previously identified a population of TAMs that express proliferating cell nuclear antigen (PCNA) and are associated with high grade, hormone receptor negative breast cancers and poor outcomes. In the present exploratory study we again found that high PCNA(+) TAM counts in pre-treatment tumor biopsies (102 invasive breast cancer cases from the I-SPY 1 Trial, a prospective neoadjuvant trial with serial core biopsies and gene array data) were associated with high grade, hormone receptor negativity, and decreased recurrence free survival. We explored the association of these PCNA(+) TAMs with the expression of M1 and M2 related genes and, contrary to expectation, observed that high PCNA(+) TAM levels were associated with more M1- than M2-related genes. An immune gene signature, derived from cytotoxic T cell and MHC Class II genes (Tc/ClassII), was developed and we found that high PCNA(+) TAM counts, in the context of a low Tc/ClassII signature score, were associated with significantly worse recurrence free survival in all cases and in hormone receptor negative only cases. We observed similar results using a gene signature-proxy for PCNA(+) TAMs in a larger independent set of 425 neoadjuvant-treated breast cancer cases. The results of this exploratory study indicate that high numbers of PCNA(+) TAMs, in the absence of an anti-tumor immune microenvironment (as indicated by a low Tc/ClassII signature score), are associated with poor outcomes in breast cancer patients treated with neoadjuvant chemotherapy. This, along with the observation that PCNA(+) TAMs were associated predominantly with M1-related genes, may provide new insights into the role of the immune microenvironment in breast cancer.	[Campbell, Michael J.; Mukhtar, Rita A.; Tandon, Vickram; Esserman, Laura J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Wolf, Denise; Yau, Christina; van't Veer, Laura] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Au, Alfred; Baehner, Frederick] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Berry, Donald] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [van't Veer, Laura] Agendia, Amsterdam, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Agendia	Campbell, MJ (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.	michael.campbell@ucsfmedctr.org			National Cancer Institute Specialized Program of Research Excellence in Breast Cancer [CA58207]; Breast Cancer Research Foundation; National Cancer Institute [CA31946]; Alliance Statistics and Data Center [CA33601]; NATIONAL CANCER INSTITUTE [U10CA031946, U10CA033601, P50CA058207] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence in Breast Cancer; Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alliance Statistics and Data Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the National Cancer Institute Specialized Program of Research Excellence in Breast Cancer (CA58207) and the Breast Cancer Research Foundation. The research for CALGB 150007/150012 ACRIN 6657 (Alliance) was supported, in part, by grants from the National Cancer Institute (CA31946) to the Alliance for Clinical Trials in Oncology (Monica M. Bertagnolli, M. D., Chair) and to the Alliance Statistics and Data Center (Daniel J. Sargent, Ph.D., CA33601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXEVANIS CN, 1994, CANCER, V74, P1275, DOI 10.1002/1097-0142(19940815)74:4<1275::AID-CNCR2820740416>3.0.CO;2-Q; Berry D, 2012, J NATL CANCER I, V104, P1124, DOI 10.1093/jnci/djs301; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Campbell MJ, 2010, 33 ANN SAN ANT BREAS; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Esserman LJ, 2011, BREAST CANC RES TREA; FALINI B, 1993, AM J PATHOL, V142, P1359; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Guo XJ, 2008, MODERN PATHOL, V21, P1101, DOI 10.1038/modpathol.2008.72; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Leek RD, 1996, CANCER RES, V56, P4625; Leong PP, 2006, IMMUNOL LETT, V102, P229, DOI 10.1016/j.imlet.2005.09.006; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Mukhtar RA, 2011, BREAST CANCER RES TR, V130, P635, DOI 10.1007/s10549-011-1646-4; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volodko N, 1998, BREAST, V7, P99, DOI 10.1016/S0960-9776(98)90065-0	27	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79114	10.1371/journal.pone.0079114	http://dx.doi.org/10.1371/journal.pone.0079114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205370	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700103
J	Grigera, F; Bellacosa, A; Kenter, AL				Grigera, Fernando; Bellacosa, Alfonso; Kenter, Amy L.			Complex Relationship between Mismatch Repair Proteins and MBD4 during Immunoglobulin Class Switch Recombination	PLOS ONE			English	Article							BASE EXCISION-REPAIR; NUCLEAR-LOCALIZATION; B-CELLS; DNA; MLH1; RNA; GLYCOSYLASE; ACTIVATION; ALPHA; ACTIN	Mismatch repair (MMR) safeguards against genomic instability and is required for efficient Ig class switch recombination (CSR). Methyl CpG binding domain protein 4 (MBD4) binds to MutL homologue 1 (MLH1) and controls the post-transcriptional level of several MMR proteins, including MutS homologue 2 (MSH2). We show that in WT B cells activated for CSR, MBD4 is induced and interacts with MMR proteins, thereby implying a role for MBD4 in CSR. However, CSR is in the normal range in Mbd4 deficient mice deleted for exons 2-5 despite concomitant reduction of MSH2. We show by comparison in Msh2(+/-) B cells that a two-fold reduction of MSH2 and MBD4 proteins is correlated with impaired CSR. It is therefore surprising that CSR occurs at normal frequencies in the Mbd4 deficient B cells where MSH2 is reduced. We find that a variant Mbd4 transcript spanning exons 1,6-8 is expressed in Mbd4 deficient B cells. This transcript can be ectopically expressed and produces a truncated MBD4 peptide. Thus, the 3' end of the Mbd4 locus is not silent in Mbd4 deficient B cells and may contribute to CSR. Our findings highlight a complex relationship between MBD4 and MMR proteins in B cells and a potential reconsideration of their role in CSR.	[Grigera, Fernando; Kenter, Amy L.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fox Chase Cancer Center; Fox Chase Cancer Center	Kenter, AL (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	star1@uic.edu			National Institutes of Health [AI052400]; NATIONAL CANCER INSTITUTE [R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106328, R01AI052400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI052400) to A. L. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bardwell PD, 2003, J IMMUNOL, V170, P1620, DOI 10.4049/jimmunol.170.4.1620; Bellacosa A, 1999, P NATL ACAD SCI USA, V96, P3969, DOI 10.1073/pnas.96.7.3969; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Cerutti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025854; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Hashimoto H, 2012, NUCL ACIDS RES; Hendrich B, 1999, MAMM GENOME, V10, P906, DOI 10.1007/s003359901112; Kenter AL, 2012, SEMIN IMMUNOL, V24, P281, DOI 10.1016/j.smim.2012.06.001; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Lin SC, 1996, MOL CELL BIOL, V16, P4591; Maas S, 2009, NUCLEIC ACIDS RES, V37, P5822, DOI 10.1093/nar/gkp599; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Owen RM, 2007, ONCOL REP, V17, P111; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Stavnezer J, 2006, TRENDS GENET, V22, P23, DOI 10.1016/j.tig.2005.11.002; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	34	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78370	10.1371/journal.pone.0078370	http://dx.doi.org/10.1371/journal.pone.0078370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205214	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700089
J	Pillay, D; Izotte, J; Fikru, R; Buscher, P; Mucache, H; Neves, L; Boulange, A; Seck, MT; Bouyer, J; Napier, GB; Chevtzoff, C; Coustou, V; Baltz, T				Pillay, Davita; Izotte, Julien; Fikru, Regassa; Buescher, Philipe; Mucache, Hermogenes; Neves, Luis; Boulange, Alain; Seck, Momar Talla; Bouyer, Jeremy; Napier, Grant B.; Chevtzoff, Cyrille; Coustou, Virginie; Baltz, Theo			Trypanosoma vivax GM6 Antigen: A Candidate Antigen for Diagnosis of African Animal Trypanosomosis in Cattle	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BOVINE TRYPANOSOMOSIS; DUTTONELLA VIVAX; EAST-AFRICA; CONGOLENSE; ANTIBODY; TSETSE; BRUCEI; INFECTIONS; EXPRESSION	Background: Diagnosis of African animal trypanosomosis is vital to controlling this severe disease which hampers development across 10 million km(2) of Africa endemic to tsetse flies. Diagnosis at the point of treatment is currently dependent on parasite detection which is unreliable, and on clinical signs, which are common to several other prevalent bovine diseases. Methodology/Principle Findings: the repeat sequence of the GM6 antigen of Trypanosoma vivax (TvGM6), a flagellar-associated protein, was analysed from several isolates of T. vivax and found to be almost identical despite the fact that T. vivax is known to have high genetic variation. The TvGM6 repeat was recombinantly expressed in E. coli and purified. An indirect ELISA for bovine sera based on this antigen was developed. The TvGM6 indirect ELISA had a sensitivity of 91.4% (95% CI: 91.3 to 91.6) in the period following 10 days post experimental infection with T. vivax, which decreased ten-fold to 9.1% (95% CI: 7.3 to 10.9) one month post treatment. With field sera from cattle infected with T. vivax from two locations in East and West Africa, 91.5% (95% CI: 83.2 to 99.5) sensitivity and 91.3% (95% CI: 78.9 to 93.1) specificity was obtained for the TvGM6 ELISA using the whole trypanosome lysate ELISA as a reference. For heterologous T. congolense field infections, the TvGM6 ELISA had a sensitivity of 85.1% (95% CI: 76.8 to 94.4). Conclusion/Significance: this study is the first to analyse the GM6 antigen of T. vivax and the first to test the GM6 antigen on a large collection of sera from experimentally and naturally infected cattle. This study demonstrates that the TvGM6 is an excellent candidate antigen for the development of a point-of-treatment test for diagnosis of T. vivax, and to a lesser extent T. congolense, African animal trypanosomosis in cattle.	[Pillay, Davita; Izotte, Julien; Coustou, Virginie; Baltz, Theo] Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France; [Fikru, Regassa] Univ Addis Ababa, Coll Vet Med, Debre Zeit, Ethiopia; [Fikru, Regassa; Buescher, Philipe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fikru, Regassa] Katholieke Univ Leuven, Fac Biosci Engn, Dept Biosyst, Louvain, Belgium; [Mucache, Hermogenes; Neves, Luis; Boulange, Alain] Univ Eduardo Mondlane, Ctr Biotechnol, Maputo, Mozambique; [Seck, Momar Talla; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Serv Bioecol & Pathol Parasitaires, Dakar, Senegal; [Boulange, Alain; Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR CMAEE, Montpellier, France; [Bouyer, Jeremy] INRA, UMR CMAEE 1309, F-34060 Montpellier, France; [Napier, Grant B.] Global Alliance Vet Med GALVmed, Edinburgh, Midlothian, Scotland; [Chevtzoff, Cyrille] Ceva Sante Anim, Libourne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Addis Ababa University; Institute of Tropical Medicine (ITM); KU Leuven; Eduardo Mondlane University; CIRAD; INRAE; Ceva Sante Animale	Pillay, D (corresponding author), Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France.	davita.pillay@u-bordeaux2.fr	Bouyer, Jérémy/AAK-7370-2020; Büscher, Philippe/B-9956-2012	Bouyer, Jérémy/0000-0002-1913-416X; Büscher, Philippe/0000-0002-1926-7472; Neves, Luis/0000-0002-5435-5996; Pillay, Davita/0000-0002-7828-6841	GALVmed; UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT) [202040-101]; CEVA sante animale (Libourne, France); CNRS; Ministere de l'Education Nationale de la Recherche et de la Technologie; Conseil Regional d'Aquitaine; Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care) [ANR-11-LABX-0024]; Belgian Directorate General of Development Cooperation	GALVmed; UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT); CEVA sante animale (Libourne, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de la Recherche et de la Technologie; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care); Belgian Directorate General of Development Cooperation	This research was supported by the GALVmed with funding from the UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT) (Aries code 202040-101), and by CEVA sante animale (Libourne, France). This work was also supported by the CNRS, the Ministere de l'Education Nationale de la Recherche et de la Technologie, the Conseil Regional d'Aquitaine and the Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care) ANR-11-LABX-0024. Regassa Fikru received a PhD grant from the Belgian Directorate General of Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2010, PARASITOLOGY, V137, P641, DOI 10.1017/S0031182009991508; Osorio ALAR, 2008, MEM I OSWALDO CRUZ, V103, P1, DOI 10.1590/S0074-02762008000100001; AUTHIE E, 1993, PARASITE IMMUNOL, V15, P101, DOI 10.1111/j.1365-3024.1993.tb00589.x; Auty H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001828; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; Bossard G, 2010, VET PARASITOL, V173, P39, DOI 10.1016/j.vetpar.2010.06.016; Boulange A, 2002, EXP PARASITOL, V100, P6, DOI 10.1006/expr.2001.4667; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; COPPEL RL, 1984, NATURE, V310, P789, DOI 10.1038/310789a0; Cortez AP, 2006, PARASITOLOGY, V133, P159, DOI 10.1017/S0031182006000254; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; D'Archivio S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001461; Desquesnes M, 2004, LIVESTOCK TRYPANOSOM; Eisler MC, 1998, VET PARASITOL, V79, P187, DOI 10.1016/S0304-4017(98)00173-3; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; FASOGBON AI, 1990, INT J PARASITOL, V20, P389, DOI 10.1016/0020-7519(90)90156-H; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; Gibson W, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-71; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; GRUBER A, 1993, EXP PARASITOL, V76, P1, DOI 10.1006/expr.1993.1001; Habila N, 2012, RES VET SCI, V93, P13, DOI 10.1016/j.rvsc.2011.08.011; Hamilton PB, 2012, TRENDS PARASITOL, V28, P173, DOI 10.1016/j.pt.2012.02.003; IJAGBONE IF, 1989, VET PARASITOL, V32, P293, DOI 10.1016/0304-4017(89)90040-X; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; LUCKINS AG, 1978, TROP ANIM HEALTH PRO, V10, P149, DOI 10.1007/BF02235328; LUCKINS AG, 1977, TROP ANIM HEALTH PRO, V9, P53, DOI 10.1007/BF02297393; Magona JW, 2008, ACTA TROP, V107, P186, DOI 10.1016/j.actatropica.2008.05.019; Mamoudou A, 2006, REV ELEV MED VET PAY, V59, P11; McDermott JJ, 2002, AFRICAN TRYPANOSOMES, P25; Morrison LJ, 2010, INFECT IMMUN, V78, P1096, DOI 10.1128/IAI.00943-09; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; Murray M, 1983, LIVESTOCK PRODUCTIVI; Nantulya V.M., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P357; Thuy N, 2012, PARASITOL RES, V110, P733, DOI 10.1007/s00436-011-2632-9; Pagabeleguem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049762; Rebeski DE, 1999, PARASITOL RES, V85, P550, DOI 10.1007/s004360050594; Rodrigues AC, 2008, PARASITOLOGY, V135, P1317, DOI 10.1017/S0031182008004848; Seck MT, 2010, PARASITE, V17, P257, DOI 10.1051/parasite/2010173257; Smuts CM, 2009, THESIS MURDOCH U PER; Sullivan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002087; Taylor K., 2004, The trypanosomiases, P331, DOI 10.1079/9780851994758.0331; Van den Bossche P, 2000, ACTA TROP, V77, P263, DOI 10.1016/S0001-706X(00)00138-8; Woo P. T. K., 1970, Acta trop., V27, P384; Wright P F, 1993, Rev Sci Tech, V12, P435	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78565	10.1371/journal.pone.0078565	http://dx.doi.org/10.1371/journal.pone.0078565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205263	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400086
J	Asp, ML; Martindale, JJ; Metzger, JM				Asp, Michelle L.; Martindale, Joshua J.; Metzger, Joseph M.			Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling	PLOS ONE			English	Article							HIGH-DOSE TAMOXIFEN; SARCOPLASMIC-RETICULUM; ESTROGEN-RECEPTOR; VENTRICULAR MYOCYTES; K+ CURRENTS; CELL-LINES; STEM-CELLS; RAT-HEART; PHASE-I; INHIBITION	Tamoxifen (Tam), a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer. High Tam doses have been used for treatment of gliomas and cancers with multiple drug resistance, but long QT Syndrome is a side effect. Tam is also used experimentally in mice for inducible gene knockout in numerous tissues, including heart; however, the potential direct effects of Tam on cardiac myocyte mechanical function are not known. The goal of this study was to determine the direct, acute effects of Tam, its active metabolite 4-hydroxytamoxifen (4OHT), and related drug raloxifene (Ral) on isolated rat cardiac myocyte mechanical function and calcium handling. Tam decreased contraction amplitude, slowed relaxation, and decreased Ca2+ transient amplitude. Effects were primarily observed at 5 and 10 mu M Tam, which is relevant for high dose Tam treatment in cancer patients as well as Tam-mediated gene excision in mice. Myocytes treated with 4OHT responded similarly to Tam-treated cells with regard to both contractility and calcium handling, suggesting an estrogen-receptor independent mechanism is responsible for the effects. In contrast, Ral increased contraction and Ca2+ transient amplitudes. At 10 mu M, all drugs had a time-dependent effect to abolish cellular contraction. In conclusion, Tam, 4OHT, and Ral adversely and differentially alter cardiac myocyte contractility and Ca2+ handling. These findings have important implications for understanding the Tam-induced cardiomyopathy in gene excision studies and may be important for understanding effects on cardiac performance in patients undergoing high-dose Tam therapy.	[Asp, Michelle L.; Martindale, Joshua J.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu			NIH; NIH NRSA [1F32HL115876]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301, F32HL115876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by NIH (JMM) and NIH NRSA 1F32HL115876 (MLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beca S, 2008, PFLUG ARCH EUR J PHY, V457, P121, DOI 10.1007/s00424-008-0510-9; BERMAN E, 1991, BLOOD, V77, P818; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Duan JH, 2004, ENDOCRINE, V24, P33, DOI 10.1385/ENDO:24:1:033; Filice E, 2009, J PHYSIOL PHARMACOL, V60, P3; Filice E, 2011, CELL PHYSIOL BIOCHEM, V28, P41, DOI 10.1159/000331712; Furlanut M, 2007, THER DRUG MONIT, V29, P349, DOI 10.1097/FTD.0b013e318067ded7; Gomez-Casati ME, 2010, JARO-J ASSOC RES OTO, V11, P19, DOI 10.1007/s10162-009-0191-x; He JY, 2003, AM J PHYSIOL-HEART C, V285, pH661, DOI 10.1152/ajpheart.00686.2002; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Kargacin ME, 2000, PFLUG ARCH EUR J PHY, V440, P573, DOI 10.1007/s004240000318; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kravtsov GM, 2007, AM J PHYSIOL-CELL PH, V292, pC1625, DOI 10.1152/ajpcell.00368.2006; Kulpa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041076; LEWARTOWSKI B, 1990, J MOL CELL CARDIOL, V22, P1221, DOI 10.1016/0022-2828(90)90059-B; Liew R, 2004, BRIT J PHARMACOL, V142, P89, DOI 10.1038/sj.bjp.0705736; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Michalski A, 2010, J NEURO-ONCOL, V100, P81, DOI 10.1007/s11060-010-0141-9; OBRIAN CA, 1985, CANCER RES, V45, P2462; Patel S, 2012, INT J RADIAT ONCOL, V82, P739, DOI 10.1016/j.ijrobp.2010.12.053; Pollack IF, 1997, CLIN CANCER RES, V3, P1109; Ponce-Balbuena D, 2010, J PHARMACOL SCI, V113, P66, DOI 10.1254/jphs.10024FP; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, pC69, DOI 10.1016/0303-7207(90)90198-H; Sideras K, 2010, J CLIN ONCOL, V28, P2768, DOI 10.1200/JCO.2009.23.8931; Slovacek L, 2008, J CLIN PHARM THER, V33, P453, DOI 10.1111/j.1365-2710.2008.00928.x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Song JB, 1996, J PHARMACOL EXP THER, V277, P1444; STUART NSA, 1992, BRIT J CANCER, V66, P833, DOI 10.1038/bjc.1992.369; Tang PA, 2006, J NEURO-ONCOL, V78, P311, DOI 10.1007/s11060-005-9104-y; TRUMP DL, 1992, JNCI-J NATL CANCER I, V84, P1811, DOI 10.1093/jnci/84.23.1811; Ullrich ND, 2008, AM J PHYSIOL-HEART C, V294, pH2421, DOI 10.1152/ajpheart.01225.2007; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang W, 2013, NAT MED, V19, P305, DOI 10.1038/nm.3079; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	43	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78768	10.1371/journal.pone.0078768	http://dx.doi.org/10.1371/journal.pone.0078768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205315	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300083
J	Sengupta, A; Sarkar, A; Priya, P; Dastidar, SG; Das, S				Sengupta, Anindita; Sarkar, Anindya; Priya, Prerna; Dastidar, Shubhra Ghosh; Das, Sampa			New Insight to Structure-Function Relationship of GalNAc Mediated Primary Interaction between Insecticidal Cry1Ac Toxin and HaALP Receptor of Helicoverpa armigera	PLOS ONE			English	Article							MANDUCA-SEXTA AMINOPEPTIDASE; BRUSH-BORDER MEMBRANE; BACILLUS-THURINGIENSIS TOXIN; DELTA-ENDOTOXIN; DOMAIN III; ALKALINE-PHOSPHATASE; HELIOTHIS-VIRESCENS; PORE FORMATION; N-ACETYLGALACTOSAMINE; PROTEIN STRUCTURES	Over the last few decades Cry1Ac toxin has been widely used in controlling the insect attack due to its high specificity towards target insects. The pore-forming toxin undergoes a complex mechanism in the insect midgut involving sequential interaction with specific glycosylated receptors in which terminal GalNAc molecule plays a vital role. Recent studies on Cry toxins interactions with specific receptors revealed the importance of several amino acid residues in domain III of Cry1Ac, namely Q509, N510, R511, Y513 and W545, serve as potential binding sites that surround the putative GalNAc binding pocket and mediate the toxin-receptor interaction. In the present study, alanine substitution mutations were generated in the Cry1Ac domain III region and functional significance of those key residues was monitored by insect bioassay on Helicoverpa armigera larvae. In addition, ligand blot analysis and SPR binding assay was performed to monitor the binding characteristics of Cry1Ac wild type and mutant toxins towards HaALP receptor isolated from Helicoverpa armigera. Mutagenesis data revealed that, alanine substitutions in R511, Y513 and W545 substantially impacted the relative affinity towards HaALP receptor and toxicity toward target insect. Furthermore, in silico study of GalNAc-mediated interaction also confirmed the important roles of these residues. This structural analysis will provide a detail insight for evaluating and engineering new generation Cry toxins to address the problem of change in insect behavioral patterns.	[Sengupta, Anindita; Sarkar, Anindya; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Priya, Prerna; Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	sampa@jcbose.ac.in			Department of Biotechnology, Govt of India [BT/PR5426/BID/07/086/2004]; University Grant Commission, India [F.2-8/2002]	Department of Biotechnology, Govt of India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India)	This work was supported by the grant provided to A. Sengupta by Department of Biotechnology, Govt of India (Sanction number: BT/PR5426/BID/07/086/2004) and to PP by University Grant Commission, India (Sanction number: F.2-8/2002 (SA-I) dated 30.03.2012. Authors are thankful to Bose Institute for providing infrastructure facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; ARONSON AI, 1995, J BACTERIOL, V177, P4059, DOI 10.1128/jb.177.14.4059-4065.1995; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; BEEGLE CC, 1992, CAN ENTOMOL, V124, P587, DOI 10.4039/Ent124587-4; Beegle CC, 1990, BIOASSAY METHODS QUA, P14; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Chi H, 1997, COMPUTER PROGRAM PRO; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Daniel A, 2002, APPL ENVIRON MICROB, V68, P2106, DOI 10.1128/AEM.68.5.2106-2112.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Maagd RA, 1999, MOL MICROBIOL, V31, P463, DOI 10.1046/j.1365-2958.1999.01188.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; Derbyshire DJ, 2001, ACTA CRYSTALLOGR D, V57, P1938, DOI 10.1107/S090744490101040X; Escobar BF, 2013, APPL ENVIRON MICROB, DOI [10.1128/AEM.01062-13, DOI 10.1128/AEM.01062-13]; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; GE AZ, 1991, J BIOL CHEM, V266, P17954; George Z., 2012, INBACILLUS THURINGIE, P19, DOI 10.1007/978-94-007-3021-2_2; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingle SS, 2001, CURR MICROBIOL, V43, P255, DOI 10.1007/s002840010297; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Kegley SE, 1998, PESTICIDES FRUIT VEG; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1991, P ROY SOC B-BIOL SCI, V245, P31, DOI 10.1098/rspb.1991.0084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Liao CY, 2002, J INVERTEBR PATHOL, V80, P55, DOI 10.1016/S0022-2011(02)00035-6; Lu YJ, 1996, INSECT BIOCHEM MOLEC, V26, P33, DOI 10.1016/0965-1748(95)00058-5; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nayak P, 1997, P NATL ACAD SCI USA, V94, P2111, DOI 10.1073/pnas.94.6.2111; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Sangadala S, 2001, INSECT BIOCHEM MOLEC, V32, P97, DOI 10.1016/S0965-1748(01)00086-8; Saraswathy N, 2004, ELECTRON J BIOTECHN, V7, P178; Sarkar A, 2009, J PROTEOME RES, V8, P1838, DOI 10.1021/pr8006528; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Sharma H. C., 2001, CROP PROTECTION COMP; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Soberon M, 2010, ADV EXP MED BIOL, V677, P127; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; Valaitis AP, 2001, ARCH INSECT BIOCHEM, V46, P186, DOI 10.1002/arch.1028; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Wang GR, 2005, SCI CHINA SER C, V48, P346, DOI 10.1360/03yc0273; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolfersberger MG, 1996, APPL ENVIRON MICROB, V62, P279, DOI 10.1128/AEM.62.1.279-282.1996; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	70	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78249	10.1371/journal.pone.0078249	http://dx.doi.org/10.1371/journal.pone.0078249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205171	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300046
J	Marcombe, S; Paris, M; Paupy, C; Bringuier, C; Yebakima, A; Chandre, F; David, JP; Corbel, V; Despres, L				Marcombe, Sebastien; Paris, Margot; Paupy, Christophe; Bringuier, Charline; Yebakima, Andre; Chandre, Fabrice; David, Jean-Philippe; Corbel, Vincent; Despres, Laurence			Insecticide-Driven Patterns of Genetic Variation in the Dengue Vector Aedes aegypti in Martinique Island	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; PYRETHROID RESISTANCE; POPULATION-STRUCTURE; GENOME SCANS; F-STATISTICS; SPACE SPRAYS; MOSQUITO; METABOLISM; SULFOTRANSFERASES; PHYLOGEOGRAPHY	Effective vector control is currently challenged worldwide by the evolution of resistance to all classes of chemical insecticides in mosquitoes. In Martinique, populations of the dengue vector Aedes aegypti have been intensively treated with temephos and deltamethrin insecticides over the last fifty years, resulting in heterogeneous levels of resistance across the island. Resistance spreading depends on standing genetic variation, selection intensity and gene flow among populations. To determine gene flow intensity, we first investigated neutral patterns of genetic variability in sixteen populations representative of the many environments found in Martinique and experiencing various levels of insecticide pressure, using 6 microsatellites. Allelic richness was lower in populations resistant to deltamethrin, and consanguinity was higher in populations resistant to temephos, consistent with a negative effect of insecticide pressure on neutral genetic diversity. The global genetic differentiation was low, suggesting high gene flow among populations, but significant structure was found, with a pattern of isolation-by-distance at the global scale. Then, we investigated adaptive patterns of divergence in six out of the 16 populations using 319 single nucleotide polymorphisms (SNPs). Five SNP outliers displaying levels of genetic differentiation out of neutral expectations were detected, including the kdr-V1016I mutation in the voltage-gated sodium channel gene. Association tests revealed a total of seven SNPs associated with deltamethrin resistance. Six other SNPs were associated with temephos resistance, including two non-synonymous substitutions in an alkaline phosphatase and in a sulfotransferase respectively. Altogether, both neutral and adaptive patterns of genetic variation in mosquito populations appear to be largely driven by insecticide pressure in Martinique.	[Marcombe, Sebastien; Paupy, Christophe; Chandre, Fabrice; Corbel, Vincent] IRD, UMR MIVEGEC IRD 224 CNRS 5290 UM1 UM2, Montpellier, France; [Paris, Margot; Bringuier, Charline; David, Jean-Philippe; Despres, Laurence] Grenoble Alpes Univ, Lab Ecol Alpine LECA, CNRS, UMR 5553, Grenoble, France; [Paupy, Christophe] Ctr Int Rech Med Franceville CIRMF, Franceville, Gabon; [Yebakima, Andre] Conseil Gen Martinique, Ctr Demousticat, Fort De France, Martinique, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Despres, L (corresponding author), Grenoble Alpes Univ, Lab Ecol Alpine LECA, CNRS, UMR 5553, Grenoble, France.	laurence.despres@ujf-grenoble.fr	Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016; Despres, Laurence/AAC-9518-2021; Paris, Margot/AAD-1971-2020; Paupy, Christophe/I-4847-2017; Paris, Margot/C-8076-2012; DAVID, jean-philippe/F-3077-2012	Chandre, Fabrice/0000-0002-1994-9705; Despres, Laurence/0000-0002-0660-6260; Paris, Margot/0000-0001-7328-3820; Paupy, Christophe/0000-0002-7122-2079; DAVID, jean-philippe/0000-0002-3950-5909; corbel, vincent/0000-0003-0995-3257	Conseil General de la Martinique University J. Fourier	Conseil General de la Martinique University J. Fourier	Funding came from the Conseil General de la Martinique University J. Fourier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDELINES LAB FIELD; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Chen QX, 2000, INT J BIOCHEM CELL B, V32, P879, DOI 10.1016/S1357-2725(00)00026-1; Choi J, 2002, PESTIC BIOCHEM PHYS, V74, P117, DOI 10.1016/S0048-3575(02)00154-2; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; ElMousadik A, 1996, MOL ECOL, V5, P547, DOI 10.1046/j.1365-294X.1996.00123.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; HOLM S, 1979, SCAND J STAT, V6, P65; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Paris M, 2013, EVOL APPL, V6, P1012, DOI 10.1111/eva.12082; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Paris M, 2012, J INVERTEBR PATHOL, V109, P201, DOI 10.1016/j.jip.2011.11.004; Paupy C, 2008, J MED ENTOMOL, V45, P391, DOI 10.1603/0022-2585(2008)45[391:GFBDAS]2.0.CO;2; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 1997, GENETICS, V145, P1219; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Soper, 1977, VENTURES WORLD HLTH; Team RDC, 2019, R LANG ENV STAT COMP; Van Dyk JS, 2011, CHEMOSPHERE, V82, P291, DOI 10.1016/j.chemosphere.2010.10.033; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yebakima A, 2004, TROP MED INT HEALTH, V9, P582, DOI 10.1111/j.1365-3156.2004.01241.x	39	18	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77857	10.1371/journal.pone.0077857	http://dx.doi.org/10.1371/journal.pone.0077857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204999	Green Published, gold			2022-12-25	WOS:000326029300119
J	Zhu, B; Ferry, CH; Blazanin, N; Bility, MT; Khozoie, C; Kang, BH; Glick, AB; Gonzalez, FJ; Peters, JM				Zhu, B.; Ferry, C. H.; Blazanin, N.; Bility, M. T.; Khozoie, C.; Kang, B-H; Glick, A. B.; Gonzalez, F. J.; Peters, J. M.			PPAR beta/delta promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling	ONCOGENE			English	Article						peroxisome proliferator-activated receptor-beta/delta; HRAS-induced senescence; mechanisms of senescence; inhibition of tumorigenesis	ACTIVATED RECEPTOR-BETA/DELTA; INTEGRIN-LINKED KINASE; INHIBITS CELL-PROLIFERATION; LIGAND ACTIVATION; TRANSCRIPTION FACTORS; PROTEIN-KINASE; RAS ONCOGENE; MOUSE SKIN; HA-RAS; EXPRESSION	Peroxisome proliferator-activated receptor-beta/delta (PPAR beta/delta) inhibits skin tumorigenesis through mechanisms that may be dependent on HRAS signaling. The present study examined the hypothesis that PPAR beta/delta promotes HRAS-induced senescence resulting in suppression of tumorigenesis. PPAR beta/delta expression increased p-ERK and decreased p-AKT activity. Increased p-ERK activity results from the dampened HRAS-induced negative feedback response mediated in part through transcriptional upregulation of RAS guanyl-releasing protein 1 (RASGRP1) by PPAR beta/delta. Decreased p-AKT activity results from repression of integrin-linked kinase (ILK) and phosphoinositide-dependent protein kinase-1 (PDPK1) expression. Decreased p-AKT activity in turn promotes cellular senescence through upregulation of p53 and p27 expression. Both over-expression of RASGRP1 and shRNA-mediated knockdown of ILK partially restore cellular senescence in Ppar beta/delta-null cells. Higher PPAR beta/delta expression is also correlated with increased senescence observed in human benign neurofibromas and colon adenoma lesions in vivo. These results demonstrate that PPAR beta/delta promotes senescence to inhibit tumorigenesis and provide new mechanistic insights into HRAS-induced cellular senescence.	[Zhu, B.; Ferry, C. H.; Blazanin, N.; Bility, M. T.; Khozoie, C.; Glick, A. B.; Peters, J. M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Kang, B-H] Preclin Res Ctr, Chemon, Yongin Si, South Korea; [Gonzalez, F. J.] NCI, Lab Metab, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	jmp21@psu.edu	Zhu, Bokai/AAF-7502-2020	Zhu, Bokai/0000-0003-0827-5757; Peters, Jeffrey/0000-0003-2782-2998; Bility, Moses/0000-0001-5153-2718	National Institutes of Health [CA124533, CA141029, CA140369, AA018863, CA122109, CA117957]; National Cancer Institute Intramural Research Program [ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [R01CA126826, R01CA124533, R01CA117957, R01CA141029, R01CA140369, ZIABC005708, ZIABC005562, ZIABC005561, R01CA122109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We gratefully acknowledge Drs Andrew Billin and Timothy Willson for providing the GW0742, the Center for Quantitative Cell Analysis and the Genomic Core Facility at the Huck Institutes of Life Sciences of The Pennsylvania State University for their technical support with flow cytometry and data analysis. This work was supported by the National Institutes of Health (CA124533, CA141029, CA140369 and AA018863 to JMP; CA122109 and CA117957 to ABG) and the National Cancer Institute Intramural Research Program (ZIABC005561, ZIABC005562 and ZIABC005708 to FJG).	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Bility MT, 2010, TOXICOL SCI, V113, P27, DOI 10.1093/toxsci/kfp212; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Borland MG, 2008, MOL PHARMACOL, V74, P1429, DOI 10.1124/mol.108.050609; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; BROWN K, 1990, P NATL ACAD SCI USA, V87, P538, DOI 10.1073/pnas.87.2.538; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Burdick AD, 2007, CELL SIGNAL, V19, P1163, DOI 10.1016/j.cellsig.2006.12.007; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; Dai DL, 2003, CLIN CANCER RES, V9, P4409; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Girroir EE, 2008, BIOCHEM BIOPH RES CO, V371, P456, DOI 10.1016/j.bbrc.2008.04.086; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grimaldi PA, 2010, CURR OPIN LIPIDOL, V21, P186, DOI 10.1097/MOL.0b013e32833884a4; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; KNUTSEN GL, 1986, ENVIRON HEALTH PERSP, V68, P91, DOI 10.2307/3430253; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Modica S, 2010, GASTROENTEROLOGY, V138, P636, DOI 10.1053/j.gastro.2009.09.060; MORGAN D, 1992, CANCER RES, V52, P3145; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Notterman DA, 2001, CANCER RES, V61, P3124; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peters Jeffrey M, 2011, Drug Discov Today Dis Mech, V8, pe85; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Schramek H, 1997, J BIOL CHEM, V272, P11426; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharma A, 2010, J BIOL CHEM, V285, P15724, DOI 10.1074/jbc.M109.100016; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vijayachandra K, 2003, CANCER RES, V63, P3447; Yang L, 2010, ONCOGENE, V29, P516, DOI 10.1038/onc.2009.370; Yang L, 2011, CLIN CANCER RES, V17, P3760, DOI 10.1158/1078-0432.CCR-10-2779; Yu JH, 2011, VIRCHOWS ARCH, V458, P99, DOI 10.1007/s00428-010-1016-3; Zhu BK, 2012, MOL CELL BIOL, V32, P2065, DOI 10.1128/MCB.00092-12; Zhu BK, 2010, MOL CANCER THER, V9, P3267, DOI 10.1158/1535-7163.MCT-10-0820; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	72	38	38	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5348	5359		10.1038/onc.2013.477	http://dx.doi.org/10.1038/onc.2013.477			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24213576	Green Accepted			2022-12-25	WOS:000345120600005
J	Park, HJ; Guariento, M; Maciejewski, M; Hauhart, R; Tham, WH; Cowman, AF; Schmidt, CQ; Mertens, HDT; Liszewski, MK; Hourcade, DE; Barlow, PN; Atkinson, JP				Park, Hyon Ju; Guariento, Mara; Maciejewski, Mateusz; Hauhart, Richard; Tham, Wai-Hong; Cowman, Alan F.; Schmidt, Christoph Q.; Mertens, Haydyn D. T.; Liszewski, M. Kathryn; Hourcade, Dennis E.; Barlow, Paul N.; Atkinson, John P.			Using Mutagenesis and Structural Biology to Map the Binding Site for the Plasmodium falciparum Merozoite Protein PfRh4 on the Human Immune Adherence Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Complement System; Convertases; Malaria; NMR; Plasmodium; Protein Structure; Surface Plasmon Resonance (SPR); Reticulocyte-binding Homologue Proteins	MALARIA PARASITE INVASION; PAPUA-NEW-GUINEA; 2 ACTIVE-SITES; COMPLEMENT RECEPTOR; C3B/C4B RECEPTOR; ERYTHROCYTE INVASION; FACTOR-H; LIGAND-BINDING; GLYCOPHORIN-C; C3B BINDING	To survive and replicate within the human host, malaria parasites must invade erythrocytes. Invasion can be mediated by the P. falciparum reticulocyte-binding homologue protein 4 (PfRh4) on the merozoite surface interacting with complement receptor type 1 (CR1, CD35) on the erythrocyte membrane. The PfRh4 attachment site lies within the three N-terminal complement control protein modules (CCPs 1-3) of CR1, which intriguingly also accommodate binding and regulatory sites for the key complement activation-specific proteolytic products, C3b and C4b. One of these regulatory activities is decay-accelerating activity. Although PfRh4 does not impact C3b/C4b binding, it does inhibit this convertase disassociating capability. Here, we have employed ELISA, co-immunoprecipitation, and surface plasmon resonance to demonstrate that CCP 1 contains all the critical residues for PfRh4 interaction. We fine mapped by homologous substitution mutagenesis the PfRh4-binding site on CCP 1 and visualized it with a solution structure of CCPs 1-3 derived by NMR and small angle x-ray scattering. We cross-validated these results by creating an artificial PfRh4-binding site through substitution of putative PfRh4-interacting residues from CCP 1 into their homologous positions within CCP 8; strikingly, this engineered binding site had an approximate to 30-fold higher affinity for PfRh4 than the native one in CCP 1. These experiments define a candidate site on CR1 by which P. falciparum merozoites gain access to human erythrocytes in a non-sialic acid-dependent pathway of merozoite invasion.	[Park, Hyon Ju; Hauhart, Richard; Liszewski, M. Kathryn; Hourcade, Dennis E.; Atkinson, John P.] Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA; [Guariento, Mara; Maciejewski, Mateusz; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Guariento, Mara; Maciejewski, Mateusz; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JJ, Midlothian, Scotland; [Tham, Wai-Hong; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Div Infect & Immun, Parkville, Vic 3052, Australia; [Tham, Wai-Hong; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Mertens, Haydyn D. T.] Australian Natl Synchrotron, Melbourne, Vic 3168, Australia	Washington University (WUSTL); University of Edinburgh; University of Edinburgh; University of Melbourne; Walter & Eliza Hall Institute	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland.	paul.barlow@ed.ac.uk; jatkinso@dom.wustl.edu	Tham, Wai-Hong/P-6474-2019; Tham, Wai-Hong/L-3173-2018	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Atkinson, John/0000-0002-2514-3441; Mertens, Haydyn/0000-0002-5664-744X	National Institutes of Health [R01 AI041592, P30 AR48335, T32 AR07279, R01 AI051436]; Wellcome Trust [081179, 085025]; National Health and Medical Research Council [1026581]; Australian Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041592, R01AI051436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335, T32AR007279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI041592, P30 AR48335, and T32 AR07279 (to J. P. A.) and R01 AI051436 (to D. H.). This work was also supported by Wellcome Trust Grants 081179 (to P. N. B., C. Q. S., and M. G.) and 085025 (to M. M.), National Health and Medical Research Council Grant 1026581 (to W.-H. T.), and an Australian Research Council Future Fellowship (to W.-H. T.).	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alonso P. L., 2011, PLOS MED, V8; [Anonymous], 2010, WHO GLOB MAL PROGR; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Black G, 2004, J BIOMOL NMR, V30, P227, DOI 10.1023/B:JNMR.0000048853.72652.9a; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Daniels G. L., 2003, Vox Sanguinis, V84, P244, DOI 10.1046/j.1423-0410.2003.00282.x; DECORDOBA SR, 1985, J EXP MED, V161, P1189, DOI 10.1084/jem.161.5.1189; DECORDOBA SR, 1984, P NATL ACAD SCI-BIOL, V81, P7890, DOI 10.1073/pnas.81.24.7890; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; HOURCADE D, 1992, GENOMICS, V12, P289, DOI 10.1016/0888-7543(92)90376-4; HOURCADE D, 1988, J EXP MED, V168, P1255, DOI 10.1084/jem.168.4.1255; HOURCADE D, 1990, J BIOL CHEM, V265, P974; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Krych-Goldberg M, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P179; Krych-Goldberg M, 2005, J IMMUNOL, V175, P4528, DOI 10.4049/jimmunol.175.7.4528; Krych-Goldberg M, 2002, TRENDS MOL MED, V8, P531, DOI 10.1016/S1471-4914(02)02419-X; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moulds JM, 1998, EXP CLIN IMMUNOGENET, V15, P291, DOI 10.1159/000019084; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Patel SS, 2004, AM J HEMATOL, V75, P1, DOI 10.1002/ajh.10448; Peterson DS, 2000, MOL BIOCHEM PARASIT, V105, P105, DOI 10.1016/S0166-6851(99)00173-5; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Subramanian VB, 1996, J IMMUNOL, V157, P1242; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Tetteh-Quarcoo PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034820; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	67	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					450	463		10.1074/jbc.M113.520346	http://dx.doi.org/10.1074/jbc.M113.520346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214979	Green Published, hybrid			2022-12-25	WOS:000329370900039
J	Antosova, B; Smolikova, J; Borkovcova, R; Strnad, H; Lachova, J; Machon, O; Kozmik, Z				Antosova, Barbora; Smolikova, Jana; Borkovcova, Romana; Strnad, Hynek; Lachova, Jitka; Machon, Ondrej; Kozmik, Zbynek			Ectopic Activation of Wnt/beta-Catenin Signaling in Lens Fiber Cells Results in Cataract Formation and Aberrant Fiber Cell Differentiation	PLOS ONE			English	Article							BETA-CATENIN; CRYSTALLIN GENE; C-MAF; TRANSCRIPTION FACTOR; TRANSGENIC MICE; CYCLIN D1; EXPRESSION; MORPHOGENESIS; PAX6; GROWTH	The Wnt/beta-catenin signaling pathway controls many processes during development, including cell proliferation, cell differentiation and tissue homeostasis, and its aberrant regulation has been linked to various pathologies. In this study we investigated the effect of ectopic activation of Wnt/beta-catenin signaling during lens fiber cell differentiation. To activate Wnt/beta-catenin signaling in lens fiber cells, the transgenic mouse referred to as alpha A-CLEF was generated, in which the transactivation domain of beta-catenin was fused to the DNA-binding protein LEF1, and expression of the transgene was controlled by alpha A-crystallin promoter. Constitutive activation of Wnt/beta-catenin signaling in lens fiber cells of alpha A-CLEF mice resulted in abnormal and delayed fiber cell differentiation. Moreover, adult alpha A-CLEF mice developed cataract, microphthalmia and manifested downregulated levels of gamma-crystallins in lenses. We provide evidence of aberrant expression of cell cycle regulators in embryonic lenses of alpha A-CLEF transgenic mice resulting in the delay in cell cycle exit and in the shift of fiber cell differentiation to the central fiber cell compartment. Our results indicate that precise regulation of the Wnt/beta-catenin signaling activity during later stages of lens development is essential for proper lens fiber cell differentiation and lens transparency.	[Antosova, Barbora; Smolikova, Jana; Borkovcova, Romana; Strnad, Hynek; Lachova, Jitka; Machon, Ondrej; Kozmik, Zbynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Antosova, Barbora] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Kozmik, Z (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Kozmik, Zbynek/I-8807-2014; Strnad, Hynek/B-7361-2008; Kozmik, Zbynek/G-3581-2014; Machon, Ondrej/G-3587-2014	Strnad, Hynek/0000-0002-0141-8340; Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of the Czech Republic [P305/11/2198, P305/12/2042]; Grant Agency of Charles University in Prague [GAUK 243-253051]; Czech Ministry of Education [LK11214]; OP EC CZ [1.07/2.3.00/30.0027]; Ministry of Education, Youth and Sports, Czech Republic+European Social Fund; IMG [RVO68378050]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); OP EC CZ; Ministry of Education, Youth and Sports, Czech Republic+European Social Fund; IMG	This study was supported by the Grant Agency of the Czech Republic (P305/11/2198 and P305/12/2042), Grant Agency of Charles University in Prague (GAUK 243-253051), by Czech Ministry of Education (LK11214), by OP EC CZ 1.07/2.3.00/30.0027 "Founding the Centre of Transgenic Technologies" (Operational Program Education for Competitiveness by Ministry of Education, Youth and Sports, Czech Republic+European Social Fund), and by IMG institutional support RVO68378050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Belecky-Adams TL, 2002, DEVELOPMENT, V129, P3795; Blixt A, 2000, GENE DEV, V14, P245; Boswell BA, 2008, DEV BIOL, V324, P202, DOI 10.1016/j.ydbio.2008.09.003; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chen Q, 2000, INVEST OPHTH VIS SCI, V41, P4223; Chen Q, 2004, J BIOL CHEM, V279, P17667, DOI 10.1074/jbc.M311678200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; de Longh RU, 2001, DEVELOPMENT, V128, P3995; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Faber SC, 2002, DEVELOPMENT, V129, P3727; Faber SC, 2001, DEVELOPMENT, V128, P4425; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; MCAVOY JW, 1978, J EMBRYOL EXP MORPH, V45, P271; Miller LAD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-14; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; OVERBEEK PA, 1985, P NATL ACAD SCI USA, V82, P7815, DOI 10.1073/pnas.82.23.7815; Piatigorsky J, 1980, Curr Top Eye Res, V3, P1; Ring BZ, 2000, DEVELOPMENT, V127, P307; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yamamoto N, 2008, MED MOL MORPHOL, V41, P83, DOI 10.1007/s00795-008-0395-x; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	57	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78279	10.1371/journal.pone.0078279	http://dx.doi.org/10.1371/journal.pone.0078279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205179	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500108
J	Guillon, L; Altenburger, S; Graumann, PL; Schalk, IJ				Guillon, Laurent; Altenburger, Stephan; Graumann, Peter L.; Schalk, Isabelle J.			Deciphering Protein Dynamics of the Siderophore Pyoverdine Pathway in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; FPVA RECEPTOR; SPATIAL-DISTRIBUTION; IRON ACQUISITION; BINDING-PROTEINS; EFFLUX PUMP; TONB; MEMBRANE; EXBD	Pseudomonas aeruginosa produces the siderophore, pyoverdine (PVD), to obtain iron. Siderophore pathways involve complex mechanisms, and the machineries responsible for biosynthesis, secretion and uptake of the ferri-siderophore span both membranes of Gram-negative bacteria. Most proteins involved in the PVD pathway have been identified and characterized but the way the system functions as a whole remains unknown. By generating strains expressing fluorescent fusion proteins, we show that most of the proteins are homogeneously distributed throughout the bacterial cell. We also studied the dynamics of these proteins using fluorescence recovery after photobleaching (FRAP). This led to the first diffusion coefficients ever determined in P. aeruginosa. Cytoplasmic and periplamic diffusion appeared to be slower than in Escherichia coli but membrane proteins seemed to behave similarly in the two species. The diffusion of cytoplasmic and periplasmic tagged proteins involved in the PVD pathway was dependent on the interaction network to which they belong. Importantly, the TonB protein, motor of the PVD-Fe uptake process, was mostly immobile but its mobility increased substantially in the presence of PVD-Fe.	[Guillon, Laurent; Schalk, Isabelle J.] Univ Strasbourg, CNRS, UMR 7242, Strasbourg, France; [Altenburger, Stephan; Graumann, Peter L.] Univ Marburg, SYMMIKRO, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Altenburger, Stephan; Graumann, Peter L.] Univ Marburg, Dept Chem, Marburg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Philipps University Marburg; Philipps University Marburg	Schalk, IJ (corresponding author), Univ Strasbourg, CNRS, UMR 7242, Strasbourg, France.	isabelle.schalk@unistra.fr		Graumann, Peter/0000-0002-8033-5171	Centre National de la Recherche Scientifique; icFRC; Deutsche Forshungsgemeinschaft (DFG) [MemProtDynamic ANR-08-BLAN-0315-01, IronPath ANR-12-BSV8-0007-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); icFRC; Deutsche Forshungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Centre National de la Recherche Scientifique, grants from the icFRC (http://www.icfrc.fr/) and from the ANR (Agence Nationale de Recherche, MemProtDynamic ANR-08-BLAN-0315-01 and IronPath ANR-12-BSV8-0007-01) and from the Deutsche Forshungsgemeinschaft (DFG). L. Guillon received a fellowship from the icFRC (http://www.icfrc.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams H, 2006, J BACTERIOL, V188, P5752, DOI 10.1128/JB.00435-06; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Bratton BP, 2011, J BACTERIOL, V193, P5138, DOI 10.1128/JB.00198-11; Brillet K, 2007, STRUCTURE, V15, P1383, DOI 10.1016/j.str.2007.08.013; Brillet K, 2012, ACS CHEM BIOL, V7, P2036, DOI 10.1021/cb300330v; Carter DM, 2006, J BIOL CHEM, V281, P35413, DOI 10.1074/jbc.M607611200; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Greenwald J, 2007, J BIOL CHEM, V282, P2987, DOI 10.1074/jbc.M609238200; Gresock MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00206; Guillon L, 2012, ENVIRON MICROBIOL, V14, P1982, DOI 10.1111/j.1462-2920.2012.02741.x; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Hannauer M, 2010, FEBS LETT, V584, P4751, DOI 10.1016/j.febslet.2010.10.051; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Imperi F, 2009, P NATL ACAD SCI USA, V106, P20440, DOI 10.1073/pnas.0908760106; James HE, 2005, J BACTERIOL, V187, P4514, DOI 10.1128/JB.187.13.4514-4520.2005; James KJ, 2009, BIOCHEMISTRY-US, V48, P9212, DOI 10.1021/bi900722p; Jana B, 2011, J BACTERIOL, V193, P5649, DOI 10.1128/JB.05674-11; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nader M, 2007, BIOCHEMISTRY-US, V46, P11707, DOI 10.1021/bi700997w; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; R Core Team, 2012, R LANG ENV STAT COMP; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; Schalk IJ, 1999, BIOCHEMISTRY-US, V38, P9357, DOI 10.1021/bi990421x; Schalk IJ, 2002, BIOCHEMISTRY-US, V41, P1663, DOI 10.1021/bi0157767; Schalk IJ, 2013, ENV MICROBI IN PRESS; Schalk IJ, 2008, J INORG BIOCHEM, V102, P1159, DOI 10.1016/j.jinorgbio.2007.11.017; Schalk IJ, 2012, CURR TOP MEMBR, V69, P37, DOI 10.1016/B978-0-12-394390-3.00002-1; Schalk IJ, 2009, BIOMETALS, V22, P671, DOI 10.1007/s10534-008-9203-2; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Schulmeister S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-222; Shen JS, 2002, J BACTERIOL, V184, P3268, DOI 10.1128/JB.184.12.3268-3275.2002; Shirley M, 2009, J BACTERIOL, V191, P5634, DOI 10.1128/JB.00742-09; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takase H, 2000, INFECT IMMUN, V68, P4498, DOI 10.1128/IAI.68.8.4498-4504.2000; Tiburzi F, 2008, MOL MICROBIOL, V67, P213, DOI 10.1111/j.1365-2958.2007.06051.x; TUKEY JW, 1951, BIOMETRICS, V7, P33, DOI 10.2307/3001602; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Wirth C, 2007, J MOL BIOL, V368, P398, DOI 10.1016/j.jmb.2007.02.023; Yeterian E, 2010, ENV MICROBIOL REP, V2, P412, DOI 10.1111/j.1758-2229.2009.00115.x; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	64	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79111	10.1371/journal.pone.0079111	http://dx.doi.org/10.1371/journal.pone.0079111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205369	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500144
J	Rana, T; Chakrabarti, A; Freeman, M; Biswas, S				Rana, Tapasi; Chakrabarti, Anwesa; Freeman, Michael; Biswas, Swati			Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGF beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; I RECEPTOR KINASE; SUPEROXIDE-DISMUTASE SOD1; NF-KAPPA-B; MINERAL DENSITY; OSTEOBLASTIC DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; CHEMOTHERAPEUTIC-AGENTS; ADJUVANT CHEMOTHERAPY; STEM-CELLS	Breast cancer patients, who are already at increased risk of developing bone metastases and osteolytic bone damage, are often treated with doxorubicin. Unfortunately, doxorubicin has been reported to induce damage to bone. Moreover, we have previously reported that doxorubicin treatment increases circulating levels of TGF beta in murine pre-clinical models. TGF beta has been implicated in promoting osteolytic bone damage, a consequence of increased osteoclast-mediated resorption and suppression of osteoblast differentiation. Therefore, we hypothesized that in a preclinical breast cancer bone metastasis model, administration of doxorubicin would accelerate bone loss in a TGF beta-mediated manner. Administration of doxorubicin to 4T1 tumor-bearing mice produced an eightfold increase in osteolytic lesion areas compared untreated tumor-bearing mice (P = 0.002) and an almost 50% decrease in trabecular bone volume expressed in BV/TV (P = 0.0005), both of which were rescued by anti-TGF beta antibody (1D11). Doxorubicin, which is a known inducer of oxidative stress, decreased osteoblast survival and differentiation, which was rescued by N-acetyl cysteine (NAC). Furthermore, doxorubicin treatment decreased Cu-ZnSOD (SOD1) expression and enzyme activity in vitro, and treatment with anti-TGF beta antibody was able to rescue both. In conclusion, a combination therapy using doxorubicin and anti-TGFb antibody might be beneficial for preventing therapy-related bone loss in cancer patients.	[Rana, Tapasi; Freeman, Michael; Biswas, Swati] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Freeman, Michael; Biswas, Swati] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Chakrabarti, Anwesa] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Biswas, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	swati.biswas@vanderbilt.edu			Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant; American Physical Society funding; Academic Project Support (APS)	Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant; American Physical Society funding; Academic Project Support (APS)	This work was supported by Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant, American Physical Society funding and Academic Project Support (APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Anderson PH, 2008, J BONE MINER RES, V23, P1789, DOI 10.1359/JBMR.080616; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BELLOWS CG, 1989, CELL TISSUE RES, V256, P145; Beyer TA, 2008, CELL CYCLE, V7, P874, DOI 10.4161/cc.7.7.5617; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027090; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Buttiglieri S, 2011, EXP HEMATOL, V39, P1171, DOI 10.1016/j.exphem.2011.08.009; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Chen JH, 2005, ENDOCR-RELAT CANCER, V12, P93, DOI 10.1677/erc.1.00871; Choi YJ, 2012, INT J NANOMED, V7, P5091, DOI 10.2147/IJN.S31723; Delmas PD, 1998, EUR J CANCER, V34, P260, DOI 10.1016/S0959-8049(97)10135-6; Dittmar M., 2008, OPEN ANTHR J, V1, P38, DOI [10.2174/1874912700801010038, DOI 10.2174/1874912700801010038]; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Emerit J, 2006, BIOMED PHARMACOTHER, V60, P1, DOI 10.1016/j.biopha.2005.09.002; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDLAENDER GE, 1984, J BONE JOINT SURG AM, V66A, P602, DOI 10.2106/00004623-198466040-00016; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Gevorgyan A, 2008, PLAST RECONSTR SURG, V122, P1025, DOI 10.1097/PRS.0b013e3181845931; GLACKIN CA, 1992, BIOCHEM INT, V28, P67; Guest I, 2000, IMMUNOPHARMACOLOGY, V46, P103, DOI 10.1016/S0162-3109(99)00168-X; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Hadji P, 2009, EUR J CANCER, V45, P3205, DOI 10.1016/j.ejca.2009.09.026; HOEKSTRA HJ, 1984, ARCH ORTHOP TRAUM SU, V103, P224, DOI 10.1007/BF00435559; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; Jacot W, 2012, BREAST CANCER RES TR, V134, P709, DOI 10.1007/s10549-012-2084-7; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li JH, 2006, J AM SOC NEPHROL, V17, P2799, DOI 10.1681/ASN.2006020130; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; MUNDY GR, 1978, NATURE, V275, P132, DOI 10.1038/275132a0; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Noor Rana, 2002, Med Sci Monit, V8, pRA210; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-69; Proell Verena, 2007, Comp Hepatol, V6, P1, DOI 10.1186/1476-5926-6-1; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Rock E, 2003, J NUTR, V133, p3785S, DOI 10.1093/jn/133.11.3785S; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; ROSENSTOCK JG, 1978, EUR J CANCER, V14, P799, DOI 10.1016/0014-2964(78)90012-9; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shusterman S, 2000, CURR OPIN HEMATOL, V7, P217, DOI 10.1097/00062752-200007000-00004; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; van Leeuwen BL, 2000, ANN ONCOL, V11, P1121, DOI 10.1023/A:1008352620870; Vozenin-Brotons MC, 2001, FREE RADICAL BIO MED, V30, P30, DOI 10.1016/S0891-5849(00)00431-7; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; YOUNG DM, 1975, CALC TISS RES, V18, P47, DOI 10.1007/BF02546226; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; Zhu H, 2006, FREE RADICAL BIO MED, V41, P132, DOI 10.1016/j.freeradbiomed.2006.03.020	80	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78043	10.1371/journal.pone.0078043	http://dx.doi.org/10.1371/journal.pone.0078043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205081	Green Published, gold			2022-12-25	WOS:000326334500092
J	Chun, S; Plunkett, J; Teramo, K; Muglia, LJ; Fay, JC				Chun, Sung; Plunkett, Jevon; Teramo, Kari; Muglia, Louis J.; Fay, Justin C.			Fine-Mapping an Association of FSHR with Preterm Birth in a Finnish Population	PLOS ONE			English	Article							STIMULATING-HORMONE RECEPTOR; GENETIC CONTRIBUTIONS; REGULATORY ELEMENTS; DNA-BINDING; IN-VITRO; PREGNANCIES; PROTEIN; FERTILIZATION; EXPRESSION; MYOMETRIAL	Preterm birth is a complex disorder defined by gestations of less than 37 weeks. While preterm birth is estimated to have a significant genetic component, relative few genes have been associated with preterm birth. Polymorphism in one such gene, follicle-stimulating hormone receptor (FSHR), has been associated with preterm birth in Finnish and African American mothers but not other populations. To refine the genetic association of FSHR with preterm birth we conducted a fine-mapping study at the FSHR locus in a Finnish cohort. We sequenced a total of 44 kb, including protein-coding and conserved non-coding regions, in 127 preterm and 135 term mothers. Overall, we identified 288 single nucleotide variants and 65 insertion/deletions of 1-2 bp across all subjects. While no common SNPs in protein-coding regions were associated with preterm birth, including one previously associated with timing of fertilization, multiple SNPs spanning the first and second intron showed the strongest associations. Analysis of the associated SNPs revealed that they form both a protective (OR = 0.50, 95% CI = 0.25-0.93) as well as a risk (OR = 1.89, 95% CI = 1.08-3.39) haplotype with independent effects. In these haplotypes, two SNPs, rs12052281 and rs72822025, were predicted to disrupt ZEB1 and ELF3 transcription factor binding sites, respectively. Our results show that multiple haplotypes at FSHR are associated with preterm birth and we discuss the frequency and structure of these haplotypes outside of the Finnish population as a potential explanation for the absence of FSHR associations in some populations.	[Chun, Sung; Fay, Justin C.] Washington Univ, Computat & Syst Biol Program, St Louis, MO 63130 USA; [Plunkett, Jevon] Washington Univ, Program Human & Stat Genet, St Louis, MO USA; [Teramo, Kari] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH 45229 USA; [Fay, Justin C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fay, Justin C.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); University of Helsinki; Helsinki University Central Hospital; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Fay, JC (corresponding author), Washington Univ, Computat & Syst Biol Program, St Louis, MO 63130 USA.	jfay@genetics.wustl.edu	Chun, Sung/I-2212-2015	Chun, Sung/0000-0003-3440-1913; Fay, Justin/0000-0003-1893-877X	National Institutes of Health [GM080669]; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Institutes of Health Grant (GM080669) to JCF and by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bethin KE, 2003, MOL ENDOCRINOL, V17, P1454, DOI 10.1210/me.2003-0007; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Celik O, 2008, FERTIL STERIL, V90, P1348, DOI 10.1016/j.fertnstert.2007.07.1391; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Courbiere B, 2011, FERTIL STERIL, V95, P1629, DOI 10.1016/j.fertnstert.2010.12.015; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Dolan SM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S4; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268; Gromoll J, 2005, TRENDS ENDOCRIN MET, V16, P368, DOI 10.1016/j.tem.2005.05.011; GROMOLL J, 1994, MOL CELL ENDOCRINOL, V102, P93, DOI 10.1016/0303-7207(94)90102-3; Hascalik S, 2010, MOL HUM REPROD, V16, P200, DOI 10.1093/molehr/gap076; Hermann BP, 2005, MOL ENDOCRINOL, V19, P2112, DOI 10.1210/me.2004-0244; Hermann BP, 2007, MOL CELL ENDOCRINOL, V260, P49, DOI 10.1016/j.mce.2006.01.017; Holdsworth-Carson SJ, 2009, PLACENTA, V30, P176, DOI 10.1016/j.placenta.2008.11.013; Howson CP, 2012, BORN SOON GLOBAL ACT; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kistka ZA, 2008, AM J OBSTET GYNECOL, V199, pe1, DOI DOI 10.1016/J.AJ0G.2007.12.014; Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI [10.1016/j.ajog.2006.10.873, 10.1016/j.ajog.2006.06.093]; Kornyei JL, 1996, EUR J ENDOCRINOL, V134, P225, DOI 10.1530/eje.0.1340225; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lalioti MD, 2011, CURR OPIN OBSTET GYN, V23, P158, DOI 10.1097/GCO.0b013e3283455288; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Martin Joyce A, 2010, NCHS Data Brief, P1; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Omigbodun AO, 1997, J NATL MED ASSOC, V89, P617; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Plunkett J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-44; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Shemesh M, 2001, SEMIN REPROD MED, V19, P87, DOI 10.1055/s-2001-13915; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Urato AC, 2011, BEST PRACT RES CL OB, V25, P367, DOI 10.1016/j.bpobgyn.2011.01.003; Uzun A, 2013, GENOMICS, V101, P163, DOI 10.1016/j.ygeno.2012.12.005; Vallania F, 2012, JOVE-J VIS EXP, V64, P3943; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Ward K, 2005, OBSTET GYNECOL, V106, P1235, DOI 10.1097/01.AOG.0000189091.35982.85; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78032	10.1371/journal.pone.0078032	http://dx.doi.org/10.1371/journal.pone.0078032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205076	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700066
J	Cruz, SA; Lin, CH; Chao, PL; Hwang, PP				Cruz, Shelly Abad; Lin, Chia-Hao; Chao, Pei-Lin; Hwang, Pung-Pung			Glucocorticoid Receptor, but Not Mineralocorticoid Receptor, Mediates Cortisol Regulation of Epidermal Ionocyte Development and Ion Transport in Zebrafish (Danio Rerio)	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-MOSSAMBICUS; MITOCHONDRIA-RICH CELLS; MESSENGER-RNA LEVELS; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; IN-VITRO; GILL EPITHELIUM; CHLORIDE CELLS; JAPANESE EEL; PROTON PUMP	Cortisol is the major endogenous glucocorticoid (GC) both in human and fish, mediated by corticosteroid receptors. Due to the absence of aldosterone production in teleost fish, cortisol is also traditionally accepted to function as mineralocorticoid (MC); but whether it acts through the glucocorticoid receptor (GR) or the mineralocorticoid receptor (MR) remains a subject of debate. Here, we used loss-of-function and rescue assays to determine whether cortisol affects zebrafish epidermal ionocyte development and function via the GR and/or the MR. GR knockdown morphants displayed a significant decrease in the major ionocytes, namely Na+-K+-ATPase-rich cells (NaRCs) and H+-ATPase-rich cells (HRCs), as well as other cells, including epidermal stem cells (ESCs), keratinocytes, and mucus cells; conversely, cell numbers were unaffected in MR knockdown morphants. In agreement, GR morphants, but not MR morphants, exhibited decreased NaRC-mediated Ca2+ uptake and HRC-mediated H+ secretion. Rescue via GR capped mRNA injection or exogenous cortisol incubation normalized the number of epidermal ionocytes in GR morphants. We also provide evidence for GR localization in epidermal cells. At the transcript level, GR mRNA is ubiquitously expressed in gill sections and present in both NaRCs and HRCs, supporting the knockdown and functional assay results in embryo. Altogether, we have provided solid molecular evidence that GR is indeed present on ionocytes, where it mediates the effects of cortisol on ionocyte development and function. Hence, cortisol-GR axis performs the roles of both GC and MC in zebrafish skin and gills.	[Cruz, Shelly Abad; Lin, Chia-Hao; Chao, Pei-Lin; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Hwang, PP (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Lin, Chia-Hao/AHC-6514-2022; Hwang, Pung-Pung/AAH-1538-2022; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AEQ-4633-2022		National Science Council; Academia Sinica, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan, ROC(Academia Sinica - Taiwan)	This study was financially supported by grants to P. P. Hwang from the National Science Council, and Academia Sinica, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fifi Z. I. A., 2006, Biotechnology, V5, P455; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Aruna A, 2012, GEN COMP ENDOCR, V179, P465, DOI 10.1016/j.ygcen.2012.08.028; BOHN MC, 1994, ANN NY ACAD SCI, V746, P243; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Chang WJ, 2011, BIRTH DEFECTS RES C, V93, P205, DOI 10.1002/bdrc.20215; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Colombe L, 2000, STEROIDS, V65, P319, DOI 10.1016/S0039-128X(00)00090-8; COLOMBO L, 1972, ENDOCRINOLOGY, V91, P450, DOI 10.1210/endo-91-2-450; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Cruz SA, 2013, COMP BIOCHEM PHYS A, V164, P249, DOI 10.1016/j.cbpa.2012.09.011; Deane EE, 2005, BIOCHEM BIOPH RES CO, V331, P1229, DOI 10.1016/j.bbrc.2005.04.038; Delyani JA, 2000, KIDNEY INT, V57, P1408, DOI 10.1046/j.1523-1755.2000.00983.x; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Esaki M, 2007, AM J PHYSIOL-REG I, V292, pR470, DOI 10.1152/ajpregu.00200.2006; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fuller PJ, 2012, J ENDOCRINOL, V213, P15, DOI 10.1530/JOE-11-0372; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GALAVERNA O, 1992, BRAIN RES BULL, V28, P89, DOI 10.1016/0361-9230(92)90234-O; Hadley ME, 2000, ENDOCRINOLOGY; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hellal-Levy C, 2000, KIDNEY INT, V57, P1250, DOI 10.1046/j.1523-1755.2000.00958.x; Herzog W, 2004, MOL ENDOCRINOL, V18, P1185, DOI 10.1210/me.2003-0376; Hiroi J, 1999, J EXP BIOL, V202, P3485; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Katoh F, 2003, J EXP BIOL, V206, P793, DOI 10.1242/jeb.00159; Kiilerich P, 2007, J ENDOCRINOL, V194, P417, DOI 10.1677/JOE-07-0185; Kiilerich P, 2011, J ENDOCRINOL, V209, P221, DOI 10.1530/JOE-10-0371; Kiilerich P, 2011, J ENDOCRINOL, V209, P115, DOI 10.1530/JOE-10-0326; Kumai Y, 2012, MOL CELL ENDOCRINOL, V364, P113, DOI 10.1016/j.mce.2012.08.017; LAURENT P, 1994, FISH PHYSIOL BIOCHEM, V13, P353, DOI 10.1007/BF00003415; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045650; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023689; Lin GR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P397, DOI 10.1086/316682; LIN H, 1993, J EXP BIOL, V180, P163; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Liu NA, 2003, MOL ENDOCRINOL, V17, P959, DOI 10.1210/me.2002-0392; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MCCORMICK SD, 1990, AM J PHYSIOL, V259, pR857, DOI 10.1152/ajpregu.1990.259.4.R857; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; McCormick SD, 2008, GEN COMP ENDOCR, V157, P35, DOI 10.1016/j.ygcen.2008.03.024; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; PERRY SF, 1989, J EXP BIOL, V147, P147; Prunet P, 2006, GEN COMP ENDOCR, V147, P17, DOI 10.1016/j.ygcen.2006.01.015; Rashid S, 2005, CLIN BIOCHEM, V38, P401, DOI 10.1016/j.clinbiochem.2004.11.009; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Scott GR, 2001, J COMP PHYSIOL B, V175, P499; Shahsavarani A, 2006, AM J PHYSIOL-REG I, V291, pR1490, DOI 10.1152/ajpregu.00026.2006; Shih TH, 2013, AM J PHYSL REGUL INT; Shrimpton JM, 1999, J EXP BIOL, V202, P987; Sloman KA, 2001, J EXP BIOL, V204, P3953; STEPHENSON G, 1984, AM J PHYSIOL, V247, pF665, DOI 10.1152/ajprenal.1984.247.4.F665; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Uchida K, 1998, GEN COMP ENDOCR, V109, P175, DOI 10.1006/gcen.1997.7019; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wong CKC, 1999, AM J PHYSIOL-REG I, V277, pR517, DOI 10.1152/ajpregu.1999.277.2.R517; Wong CKC, 2001, J ENDOCRINOL, V168, P185, DOI 10.1677/joe.0.1680185; Yan JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1814, DOI 10.1152/ajpcell.00358.2007	78	60	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77997	10.1371/journal.pone.0077997	http://dx.doi.org/10.1371/journal.pone.0077997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205060	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700065
J	Merkado, G; Holzmann, M; Apotheloz-Perret-Gentil, L; Pawlowski, J; Abdu, U; Almogi-Labin, A; Hyams-Kaphzan, O; Bakhrat, A; Abramovich, S				Merkado, Gily; Holzmann, Maria; Apotheloz-Perret-Gentil, Laure; Pawlowski, Jan; Abdu, Uri; Almogi-Labin, Ahuva; Hyams-Kaphzan, Orit; Bakhrat, Anna; Abramovich, Sigal			Molecular Evidence for Lessepsian Invasion of Soritids (Larger Symbiont Bearing Benthic Foraminifera)	PLOS ONE			English	Article							MEDITERRANEAN SEA; SHELF; AMPHISTEGINA	The Mediterranean Sea is considered as one of the hotspots of marine bioinvasions, largely due to the influx of tropical species migrating through the Suez Canal, so-called Lessepsian migrants. Several cases of Lessepsian migration have been documented recently, however, little is known about the ecological characteristics of the migrating species and their aptitude to colonize the new areas. This study focused on Red Sea soritids, larger symbiont-bearing benthic foraminifera (LBF) that are indicative of tropical and subtropical environments and were recently found in the Israeli coast of the Eastern Mediterranean. We combined molecular phylogenetic analyses of soritids and their algal symbionts as well as network analysis of Sorites orbiculus Forskal to compare populations from the Gulf of Elat (northern Red Sea) and from a known hotspot in Shikmona (northern Israel) that consists of a single population of S. orbiculus. Our phylogenetic analyses show that all specimens found in Shikmona are genetically identical to a population of S. orbiculus living on a similar shallow water pebbles habitat in the Gulf of Elat. Our analyses also show that the symbionts found in Shikmona and Elat soritids belong to the Symbiodinium clade F5, which is common in the Red Sea and also present in the Indian Ocean and Caribbean Sea. Our study therefore provides the first genetic and ecological evidences that indicate that modern population of soritids found on the Mediterranean coast of Israel is probably Lessepsian, and is less likely the descendant of a native ancient Mediterranean species.	[Merkado, Gily; Abdu, Uri; Bakhrat, Anna; Abramovich, Sigal] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Holzmann, Maria; Apotheloz-Perret-Gentil, Laure; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Almogi-Labin, Ahuva; Hyams-Kaphzan, Orit] Geol Survey Israel, IL-95501 Jerusalem, Israel	Ben Gurion University; University of Geneva; Geological Survey Israel	Abramovich, S (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	sigalabr@bgu.ac.il	Abramovich, Sigal/AAR-5034-2021; Pawlowski, Jan/AAO-3306-2021	Abramovich, Sigal/0000-0003-3124-1387; Pawlowski, Jan/0000-0003-2421-388X; Almogi-Labin, Ahuva/0000-0002-4082-7120	Israel Science Foundation [587/2013]; Israeli Ministry of National Infrastructure [27-17-005]; Swiss National Science Foundation [31003A_140766]; G. & A. Claraz Donation	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of National Infrastructure; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); G. & A. Claraz Donation	The research was supported by the Israel Science Foundation grant No 587/2013, by the Israeli Ministry of National Infrastructure grant no. 27-17-005 and by the Swiss National Science Foundation grant 31003A_140766 and by a G. & A. Claraz Donation (JP, MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; AVITAL A, 2002, THESIS BENGURION U N; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Galil BS, 2008, HYDROBIOLOGIA, V606, P105, DOI 10.1007/s10750-008-9342-z; Garcia-Cuetos L, 2005, PROTIST, V156, P399, DOI 10.1016/j.protis.2005.08.003; GELABERT ER, 2007, MARINE COASTAL ENV E, P208; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber Limor, 2007, Rapport du Congress de la CIESM, V38, P491; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Holzmann M, 2001, MAR MICROPALEONTOL, V43, P57, DOI 10.1016/S0377-8398(01)00021-4; Hottinger L., 1993, DELA SLOVENSKA AKAD, V33, P179; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyams Orit, 2002, Israel Journal of Earth Sciences, V51, P169, DOI 10.1560/QAE1-KTEE-2K2L-QPCH; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; Koukousioura O, 2010, MEDITERR MAR SCI, V11, P155, DOI 10.12681/mms.98; Langer M.R., 1991, MEDITERRANEAN FORAMI; Langer M.R., 2008, AQABA EILAT IMPROBAB, P397; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Lazar S., 2007, GSI082007; Meric E, 2010, AQUAT INVASIONS, V5, P191, DOI 10.3391/ai.2010.5.2.10; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Perelis-Grossowicz L., 2008, AQABA EILAT IMPROBAB, P439; Por FD, 2010, INTEGR ZOOL, V5, P112, DOI 10.1111/j.1749-4877.2010.00194.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Reiss Z., 1984, GULF AQABA ECOLOGICA; Reiss Z, 1961, GEOLOGICAL SURVEY IS, V32, P10; Renema W., 2002, SCRIPTA GEOL-LEIDEN, V124, P1; Rilov G, 2002, MAR ENVIRON RES, V54, P85, DOI 10.1016/S0141-1136(02)00096-X; Rilov G, 2009, ECOLOGICAL STUDIES S; Rilov Gil, 2009, V204, P549; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; SPANIER E, 1991, ENDEAVOUR, V15, P102, DOI 10.1016/0160-9327(91)90152-2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STIPS AK, 2006, GEOPH RES ABSTR, V8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toueg R., 1996, THESIS U HAIFA HAIFA; VERA JD, 2006, MED SEA LEV AN 1992; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	41	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77725	10.1371/journal.pone.0077725	http://dx.doi.org/10.1371/journal.pone.0077725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204936	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700052
J	Gasymov, OK; Abduragimov, AR; Glasgow, BJ				Gasymov, Oktay K.; Abduragimov, Adil R.; Glasgow, Ben J.			Effect of Short- and Long-Range Interactions on Trp Rotamer Populations Determined by Site-Directed Tryptophan Fluorescence of Tear Lipocalin	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; INDUCED-FIT; CYCLIC HEXAPEPTIDES; LIGAND-BINDING; EXCITED-STATE; PEPTIDE-BOND; REVEALS; CONFORMATION; ACID	In the lipocalin family, the conserved interaction between the main alpha-helix and the beta-strand H is an ideal model to study protein side chain dynamics. Site-directed tryptophan fluorescence (SDTF) has successfully elucidated tryptophan rotamers at positions along the main alpha helical segment of tear lipocalin (TL). The rotamers assigned by fluorescent lifetimes of Trp residues corroborate the restriction expected based on secondary structure. Steric conflict constrains Trp residues to two (t, g(-)) of three possible chi(1) (t, g(-), g(+)) canonical rotamers. In this study, investigation focused on the interplay between rotamers for a single amino acid position, Trp 130 on the alpha-helix and amino acids Val 113 and Leu 115 on the H strand, i.e. long range interactions. Trp130 was substituted for Phe by point mutation (F130W). Mutations at positions 113 and 115 with combinations of Gly, Ala, Phe residues alter the rotamer distribution of Trp130. Mutations, which do not distort local structure, retain two rotamers (two lifetimes) populated in varying proportions. Replacement of either long range partner with a small amino acid, V113A or L115A, eliminates the dominance of the t rotamer. However, a mutation that distorts local structure around Trp130 adds a third fluorescence lifetime component. The results indicate that the energetics of long-range interactions with Trp 130 further tune rotamer populations. Diminished interactions, evident in W130G113A115, result in about a 22% increase of alpha-helix content. The data support a hierarchic model of protein folding. Initially the secondary structure is formed by short-range interactions. TL has non-native alpha-helix intermediates at this stage. Then, the long-range interactions produce the native fold, in which TL shows alpha-helix to beta-sheet transitions. The SDTF method is a valuable tool to assess long-range interaction energies through rotamer distribution as well as the characterization of low-populated rotameric states of functionally important excited protein states.	[Gasymov, Oktay K.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gasymov, OK (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	ogassymov@mednet.ucla.edu; bglasgow@mednet.ucla.edu			NIH, National Eye Institute; NATIONAL EYE INSTITUTE [R01EY011224, P30EY000331] Funding Source: NIH RePORTER	NIH, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH, National Eye Institute. The funders had no role in study design, data collection, analysis, decision to publish, preparation of the manuscript.	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Anderson JS., 1982, J PROTEIN CHEM, V1, P281, DOI [10.1007/BF01039553, DOI 10.1007/BF01039553]; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Breustedt DA, 2005, J BIOL CHEM, V280, P484, DOI 10.1074/jbc.M410466200; Breustedt DA, 2009, ACTA CRYSTALLOGR D, V65, P1118, DOI 10.1107/S0907444909031011; Callis PR, 2007, J PHYS CHEM B, V111, P10335, DOI 10.1021/jp0744883; Callis PR, 2004, J PHYS CHEM B, V108, P4248, DOI 10.1021/jp0310551; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chen Y, 1996, J AM CHEM SOC, V118, P9271, DOI 10.1021/ja961307u; Clayton AHA, 1999, BIOPHYS J, V76, P3235, DOI 10.1016/S0006-3495(99)77475-8; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Dean AW, 2012, INVEST OPHTH VIS SCI, V53, P1773, DOI 10.1167/iovs.11-9419; Flower DR, 1996, BIOCHEM J, V318, P1; Gasymov OK, 2004, BIOCHEMISTRY-US, V43, P12894, DOI 10.1021/bi049076o; Gasymov OK, 2002, BIOCHEMISTRY-US, V41, P8837, DOI 10.1021/bi0121003; Gasymov OK, 2001, BIOCHEMISTRY-US, V40, P14754, DOI 10.1021/bi0110342; Gasymov OK, 1999, BBA-PROTEIN STRUCT M, V1433, P307, DOI 10.1016/S0167-4838(99)00133-8; Gasymov Oktay K, 2007, Biochim Biophys Acta, V1774, P1307, DOI 10.1016/j.bbapap.2007.07.014; Gasymov OK, 2012, J PHYS CHEM B, V116, P13381, DOI 10.1021/jp309318r; Gasymov OK, 2012, BIOCHEMISTRY-US, V51, P2991, DOI 10.1021/bi3002902; Gasymov OK, 2011, BBA-PROTEINS PROTEOM, V1814, P671, DOI 10.1016/j.bbapap.2011.03.017; Gasymov OK, 2010, BIOCHEMISTRY-US, V49, P582, DOI 10.1021/bi901435q; Glasgow BJ, 2010, INVEST OPHTH VIS SCI, V51, P1981, DOI 10.1167/iovs.09-4622; GLASGOW BJ, 1995, GRAEF ARCH CLIN EXP, V233, P513, DOI 10.1007/BF00183433; GLASGOW BJ, 1995, CURR EYE RES, V14, P363, DOI 10.3109/02713689508999934; Glasgow BJ, 1999, BIOCHEMISTRY-US, V38, P13707, DOI 10.1021/bi9913449; GLASGOW BJ, 1993, CURR EYE RES, V12, P1019, DOI 10.3109/02713689309029229; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Liu B, 2002, J AM CHEM SOC, V124, P13329, DOI 10.1021/ja016542d; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; MacArthur MW, 1999, ACTA CRYSTALLOGR D, V55, P994, DOI 10.1107/S0907444999002231; McMahon LP, 1997, J PHYS CHEM B, V101, P3269, DOI 10.1021/jp963273i; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pan CP, 2011, J PHYS CHEM B, V115, P3245, DOI 10.1021/jp111925w; Pan CP, 2006, J PHYS CHEM B, V110, P7009, DOI 10.1021/jp056164p; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; REDL B, 1992, J BIOL CHEM, V267, P20282; SAITO I, 1984, J AM CHEM SOC, V106, P4286, DOI 10.1021/ja00327a048; Sakurai K, BIOCHEMISTRY, V50, P6498; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SHIZUKA H, 1988, J AM CHEM SOC, V110, P1726, DOI 10.1021/ja00214a011; Spyrakis F, 2011, CURR TOP MED CHEM, V11, P131, DOI 10.2174/156802611794863553; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tuttle LM, 2013, BIOCHEMISTRY-US, V52, P3464, DOI 10.1021/bi400322e; Vander Donckt E, 1969, B SOC CHIM BELG, V78, P60; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223	59	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78754	10.1371/journal.pone.0078754	http://dx.doi.org/10.1371/journal.pone.0078754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205305	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200059
J	Teo, BG; Dhillon, SK; Lim, LHS				Teo, Bee Guan; Dhillon, Sarinder Kaur; Lim, Lee Hong Susan			A Deformable Generic 3D Model of Haptoral Anchor of Monogenean	PLOS ONE			English	Article							ARIID FISHES; ANCYROCEPHALIDAE; POLYSTOMATIDAE; BYCHOWSKY; YAMAGUTI; NAGIBINA; NURBS	In this paper, a digital 3D model which allows for visualisation in three dimensions and interactive manipulation is explored as a tool to help us understand the structural morphology and elucidate the functions of morphological structures of fragile microorganisms which defy live studies. We developed a deformable generic 3D model of haptoral anchor of dactylogyridean monogeneans that can subsequently be deformed into different desired anchor shapes by using direct manipulation deformation technique. We used point primitives to construct the rectangular building blocks to develop our deformable 3D model. Point primitives are manually marked on a 2D illustration of an anchor on a Cartesian graph paper and a set of Cartesian coordinates for each point primitive is manually extracted from the graph paper. A Python script is then written in Blender to construct 3D rectangular building blocks based on the Cartesian coordinates. The rectangular building blocks are stacked on top or by the side of each other following their respective Cartesian coordinates of point primitive. More point primitives are added at the sites in the 3D model where more structural variations are likely to occur, in order to generate complex anchor structures. We used Catmull-Clark subdivision surface modifier to smoothen the surface and edge of the generic 3D model to obtain a smoother and more natural 3D shape and antialiasing option to reduce the jagged edges of the 3D model. This deformable generic 3D model can be deformed into different desired 3D anchor shapes through direct manipulation deformation technique by aligning the vertices (pilot points) of the newly developed deformable generic 3D model onto the 2D illustrations of the desired shapes and moving the vertices until the desire 3D shapes are formed. In this generic 3D model all the vertices present are deployed for displacement during deformation.	[Teo, Bee Guan; Dhillon, Sarinder Kaur; Lim, Lee Hong Susan] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Lim, LHS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	susan@um.edu.my	Lim, Susan Lee Hong/B-1075-2009; Dhillon, Sarinder Kaur/B-5320-2009	Dhillon, Sarinder Kaur/0000-0003-1922-2044	Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur [FL001-2011]	Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur	This project is funded by grant no. FL001-2011 provided by the Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur (http://susci.um.edu.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2012, 2012965 AIAA; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Berry RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010771; Chen Li, 2012, Proceedings of the 2012 International Conference on Wavelet Analysis and Pattern Recognition (ICWAPR), P62, DOI 10.1109/ICWAPR.2012.6294756; Chinthamani S., 2010, International Journal of Research and Reviews in Computer Science, V1, P29; COQUILLART S., 1990, COMPUT GRAPH, V24, P187, DOI [DOI 10.1145/97880.97900, DOI 10.1145/97879.97900]; CROW F, 1987, IEEE COMPUT GRAPH, V7, P8, DOI 10.1109/MCG.1987.277023; Dohnalkova A, 2007, MICROSC MICROANAL, V13, P1338; du Preez LH, 2000, FOLIA PARASIT, V47, P11, DOI 10.14411/fp.2000.003; du Preez LH, 2003, AFRICAN ZOOLOGY, V39, P225; Dunn F., 2011, 3D MATH PRIMER GRAPH, V2nd; Fu CS, 2010, INT ARCH PHOTOGRAMME, V37, P203; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gusev A.V., 1976, INDIAN J HELMINTH, V25, P1; Halton DW, 2004, CAN J ZOOL, V82, P316, DOI [10.1139/z03-221, 10.1139/Z03-221]; HSU WM, 1992, COMP GRAPH, V26, P177, DOI 10.1145/142920.134036; Johnson K, 2008, ILAR J, V49, P27, DOI 10.1093/ilar.49.1.27; Kamisaka Y, 2011, MAR BIOL, V158, P233, DOI 10.1007/s00227-010-1554-x; Kara LB, 2008, COMPUT AIDED DESIGN, V5, P867, DOI DOI 10.3722/CADAPS.2008.867-876; Karciauskas K, 2012, GRAPH MODELS, V74, P351, DOI 10.1016/j.gmod.2012.05.005; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001119; Kitamura A, 2006, SYST PARASITOL, V65, P151, DOI 10.1007/s11230-006-9046-6; KRAEVOY V., 2009, P 6 EUR S SKETCH BAS, P37, DOI DOI 10.1145/1572741.1572749]; Leadbeater BSC, 2009, P R SOC B, V276, P3, DOI 10.1098/rspb.2008.0844; Li L, 2013, COMPUT AIDED DESIGN, V45, P134, DOI 10.1016/j.cad.2012.08.007; Lim LHS, 2007, SYST PARASITOL, V67, P101, DOI 10.1007/s11230-006-9075-1; Lim LHS, 2009, SYST PARASITOL, V73, P13, DOI 10.1007/s11230-008-9167-1; Lim L.H.S., 1989, Malayan Nature Journal, V43, P59; Lim LHS, 1998, INT J PARASITOL, V28, P1495, DOI 10.1016/S0020-7519(98)00061-7; LIM LHS, 1994, SYST PARASITOL, V28, P99, DOI 10.1007/BF00009590; Lim LHS, 1996, SYST PARASITOL, V33, P53, DOI 10.1007/BF01526634; LIM LHS, 1995, SYST PARASITOL, V32, P211, DOI 10.1007/BF00008830; LIM LHS, 1995, SYST PARASITOL, V30, P141, DOI 10.1007/BF00010167; Lim LHS, 2001, SYST PARASITOL, V49, P223, DOI 10.1023/A:1010600804482; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; Mortenson M., 1989, COMPUTER GRAPHICS IN; Moustakides G, 2000, ADV ENG SOFTW, V31, P955, DOI 10.1016/S0965-9978(00)00060-0; Murakawa Jun, 2006, P EUR C SKETCH BAS I, P67, DOI [10.2312/SBM/SBM06/067-074, DOI 10.2312/SBM/SBM06/067-074]; Pourazady M, 2000, ADV ENG SOFTW, V31, P107, DOI 10.1016/S0965-9978(99)00026-5; Sederberg T. W., 1986, Computer Graphics, V20, P151, DOI 10.1145/15886.15903; Serra M, 2008, DISCOVERING GEOMETRY; Silva FG, 2009, P ACM SIGGRAPH ASIA, P1; Teo BG, 2010, TROP BIOMED, V27, P254; Wickes R, 2009, FDN BLENDER COMPOSIT; Wright R. S., 2010, OPENGL SUPERBIBLE CO; YAMAGUTI S, 1963, SYSTEMA HELMINTHIUM; Yuk-Ming T, 2011, COMPUT AIDED DESIGN, V43, P1841, DOI 10.1016/j.cad.2011.08.005	47	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77650	10.1371/journal.pone.0077650	http://dx.doi.org/10.1371/journal.pone.0077650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204903	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200035
J	Bjersing, JL; Lundborg, C; Bokarewa, MI; Mannerkorpi, K				Bjersing, Jan L.; Lundborg, Christopher; Bokarewa, Maria I.; Mannerkorpi, Kaisa			Profile of Cerebrospinal microRNAs in Fibromyalgia	PLOS ONE			English	Article							LONG-TERM; EXPRESSION; PAIN; GROWTH; PROTECTS; IMPACT; INFLAMMATION; RELIABILITY; INVOLVEMENT; EXERCISE	Introduction: Fibromyalgia (FM) is characterized by chronic pain and reduced pain threshold. The pathophysiology involves disturbed neuroendocrine function, including impaired function of the growth hormone/insulin-like growth factor-1 axis. Recently, microRNAs have been shown to be important regulatory factors in a number of diseases. The aim of this study was to try to identify cerebrospinal microRNAs with expression specific for FM and to determine their correlation to pain and fatigue. Methods: The genome-wide profile of microRNAs in cerebrospinal fluid was assessed in ten women with FM and eight healthy controls using real-time quantitative PCR. Pain thresholds were examined by algometry. Levels of pain (FIQ pain) were rated on a 0-100 mm scale (fibromyalgia impact questionnaire, FIQ). Levels of fatigue (FIQ fatigue) were rated on a 0-100 mm scale using FIQ and by multidimensional fatigue inventory (MFI-20) general fatigue (MFIGF). Results: Expression levels of nine microRNAs were significantly lower in patients with FM patients compared to healthy controls. The microRNAs identified were miR-21-5p, miR-145-5p, miR-29a-3p, miR-99b-5p, miR-125b-5p, miR-23a-3p, 23b-3p, miR-195-5p, miR-223-3p. The identified microRNAs with significantly lower expression in FM were assessed with regard to pain and fatigue. miR-145-5p correlated positively with FIQ pain (r=0.709, p=0.022, n=10) and with FIQ fatigue (r=0.687, p=0.028, n=10). Conclusion: To our knowledge, this is the first study to show a disease-specific pattern of cerebrospinal microRNAs in FM. We have identified nine microRNAs in cerebrospinal fluid that differed between FM patients and healthy controls. One of the identified microRNAs, miR-145 was associated with the cardinal symptoms of FM, pain and fatigue.	[Bjersing, Jan L.; Bokarewa, Maria I.; Mannerkorpi, Kaisa] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden; [Lundborg, Christopher] Univ Gothenburg, Inst Clin Sci, Dept Anaesthesiol & Intens Care Med, Sahlgrenska Acad, Gothenburg, Sweden; [Mannerkorpi, Kaisa] Univ Gothenburg, Sahlgrenska Acad, Univ Gothenburg Ctr Person Centred Care GPCC, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Bjersing, JL (corresponding author), Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	jan.bjersing@rheuma.gu.se	Bjersing, Jan/F-2901-2011; Bokarewa, Maria I/A-8114-2019	Bokarewa, Maria I/0000-0001-9424-5145; Mannerkorpi, Kaisa/0000-0003-4997-9523; Bjersing, Jan/0000-0002-3538-1240	Swedish Research Council; Medical Society of Goteborg; Swedish Rheumatism Association; King Gustaf V:s 80-year Foundation,; Wilhelm and Martina Lundgrens Foundation; Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust; University of Goteborg; Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF); Health and Medical Care Executive Board of Vastra Gotaland Region	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Society of Goteborg; Swedish Rheumatism Association; King Gustaf V:s 80-year Foundation,; Wilhelm and Martina Lundgrens Foundation; Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust; University of Goteborg; Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF); Health and Medical Care Executive Board of Vastra Gotaland Region	This work has been funded by grants from the Swedish Research Council, the Medical Society of Goteborg, the Swedish Rheumatism Association, the King Gustaf V:s 80-year Foundation, the Wilhelm and Martina Lundgrens Foundation, the Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust, the University of Goteborg, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF), the Health and Medical Care Executive Board of Vastra Gotaland Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221; Ai J, 2013, J NEUROSCI, V33, P3989, DOI 10.1523/JNEUROSCI.1997-12.2013; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bennett RM, 1997, J RHEUMATOL, V24, P1384; Bennett Robert M, 2002, Curr Rheumatol Rep, V4, P306, DOI 10.1007/s11926-002-0039-4; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bjersing JL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3902; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Ericsson A, 2007, DISABIL REHABIL, V29, P1665, DOI 10.1080/09638280601055782; Fei X, 2012, FEBS LETT, V586, P392, DOI 10.1016/j.febslet.2012.01.006; Harraz MM, 2012, P NATL ACAD SCI USA, V109, P18962, DOI 10.1073/pnas.1121288109; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; KOSEK E, 1993, SCAND J REHABIL MED, V25, P117; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Lee YH, 2012, RHEUMATOL INT, V32, P417, DOI 10.1007/s00296-010-1678-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mannerkorpi K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3159; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Mease PJ, 2011, J RHEUMATOL, V38, P1487, DOI 10.3899/jrheum.110277; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P94, DOI 10.1002/ibd.21742; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Schouten M, 2013, NEUROSCIENCE, V241, P188, DOI 10.1016/j.neuroscience.2013.02.065; Shi Y, 2012, RADIAT RES, V177, P124, DOI 10.1667/RR2764.1; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith SB, 2012, ARTHRITIS RHEUM-US, V64, P584, DOI 10.1002/art.33338; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Staud R, 2012, CURR RHEUMATOL REP, V14, P539, DOI 10.1007/s11926-012-0277-z; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang WT, 2013, J CLIN ENDOCR METAB, V98, P281, DOI 10.1210/jc.2012-2415; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	50	66	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78762	10.1371/journal.pone.0078762	http://dx.doi.org/10.1371/journal.pone.0078762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205312	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400104
J	Francisco-Ramos, V; Arias-Gonzalez, JE				Francisco-Ramos, Vanessa; Ernesto Arias-Gonzalez, Jesus			Additive Partitioning of Coral Reef Fish Diversity across Hierarchical Spatial Scales throughout the Caribbean	PLOS ONE			English	Article							SPECIES-DIVERSITY; BETA-DIVERSITY; ALPHA-DIVERSITY; GLOBAL PATTERNS; MARINE RESERVE; BIODIVERSITY; RESILIENCE; RICHNESS; COASTAL; BIOGEOGRAPHY	There is an increasing need to examine regional patterns of diversity in coral-reef systems since their biodiversity is declining globally. In this sense, additive partitioning might be useful since it quantifies the contribution of alpha and beta to total diversity across different scales. We applied this approach using an unbalanced design across four hierarchical scales (80 sites, 22 subregions, six ecoregions, and the Caribbean basin). Reef-fish species were compiled from the Reef Environmental Education Foundation (REEF) database and distributions were confirmed with published data. Permutation tests were used to compare observed values to those expected by chance. The primary objective was to identify patterns of reef-fish diversity across multiple spatial scales under different scenarios, examining factors such as fisheries and demographic connectivity. Total diversity at the Caribbean scale was attributed to beta-diversity (nearly 62% of the species), with the highest beta-diversity at the site scale. (alpha) over bar -diversity was higher than expected by chance in all scenarios and at all studied scales. This suggests that fish assemblages are more homogenous than expected, particularly at the ecoregion scale. Within each ecoregion, diversity was mainly attributed to alpha, except for the Southern ecoregion where there was a greater difference in species among sites. beta-components were lower than expected in all ecoregions, indicating that fishes within each ecoregion are a subsample of the same species pool. The scenario involving the effects of fisheries showed a shift in dominance for beta-diversity from regions to subregions, with no major changes to the diversity patterns. In contrast, demographic connectivity partially explained the diversity pattern. beta-components were low within connectivity regions and higher than expected by chance when comparing between them. Our results highlight the importance of ecoregions as a spatial scale to conserve local and regional coral reef-fish diversity.	[Francisco-Ramos, Vanessa; Ernesto Arias-Gonzalez, Jesus] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Recursos Mar, Unidad Merida, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico	Arias-Gonzalez, JE (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Recursos Mar, Unidad Merida, Merida, Yucatan, Mexico.	earias@mda.cinvestav.mx		Francisco, Vanessa/0000-0002-7736-7746; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X	CONACYT [229484]; Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global, Red Tematica de investigacion de Ecosistemas [CLAVE: 000000000194539]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global, Red Tematica de investigacion de Ecosistemas	The work was supported by the following: CONACYT (doctoral scholarship 229484). Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global. CLAVE: 000000000194539, Red Tematica de investigacion de Ecosistemas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Agardy T, 2000, ICES J MAR SCI, V57, P761, DOI 10.1006/jmsc.2000.0721; Albany GR, 2004, OIKOS, V106, P275, DOI [10.1111/j.0030-1299.2004.13193.x., DOI 10.1111/J.0030-1299.2004.13193.X]; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bohlke J.E., 1993, FISHES BAHAMAS ADJAC; Carpenter K.E., 2002, FAO SPECIES IDENTIFI, V5; Carpenter K.E., 2002, FAO SPECIES IDENTIFI, V5; CARPENTER KE, 2002, FAO SPECIES IDENTIFI, V5, P601; Cervigon F., 1993, PECES MARINOS VENEZU, V2; Cervigon F., 1994, PECES MARINOS VENEZU, V3; Cervigon F., 1991, PECES MARINOS VENEZU, V1; Cervigon F., 1992, GUIA CAMPO ESPECIES; Chandy S, 2006, J APPL ECOL, V43, P792, DOI 10.1111/j.1365-2664.2006.01178.x; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; Clarke A, 2010, DIVERS DISTRIB, V16, P725, DOI 10.1111/j.1472-4642.2010.00692.x; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Clifton KE, 1998, REV BIOL TROP, V46, P109; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Debrot D, 2007, P 60 GULF CAR FISH I, P335; FAO Statistics and Information Service of the Fisheries and Aquaculture Department, 2012, CAPT PROD 1950 2010; Fleishman E, 2003, LANDSCAPE ECOL, V18, P675, DOI 10.1023/B:LAND.0000004183.82140.48; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Froese R., 2012, FISHBASE; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geertjes GJ, 2004, MAR ECOL PROG SER, V279, P225, DOI 10.3354/meps279225; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gering JC, 2002, ECOL LETT, V5, P433, DOI 10.1046/j.1461-0248.2002.00335.x; Getty SR, 2001, GEOLOGY, V29, P639, DOI 10.1130/0091-7613(2001)029<0639:APCEIT>2.0.CO;2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holland SM, 2010, PALAEONTOLOGY, V53, P1237, DOI 10.1111/j.1475-4983.2010.01017.x; Holt BG, 2010, GLOBAL ECOL BIOGEOGR, V19, P432, DOI 10.1111/j.1466-8238.2010.00539.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jimenez-Valverde Alberto, 2003, Revista Iberica de Aracnologia, V8, P151; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Moreno CE, 2009, ENTOMOLOGIA MEXICANA, V9, P209; Morrison RA, 2011, CHANGING DIVERSITY IN CHANGING ENVIRONMENT, P299; Muller-Karger F, 2004, DEEP-SEA RES PT II, V51, P927, DOI 10.1016/j.dsr2.2003.10.010; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pech-Canche JM, 2011, ECOSCIENCE, V18, P42, DOI 10.2980/18-1-3392; Reyes-Nivia María Catalina, 2004, Bol. Invest. Mar. Cost., V33, P101; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Russel P., 1940, J MALAR I INDIA, V3, P154; Sadovy Y, 1999, 146 NOAANMFS; Sale PF, 2008, CAR CONN IMPL MAR PR, P12; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Smith C. L., 1997, NATL AUDUBON SOC FIE, P720; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; StatSoft Inc, 2005, TATISTICA DAT AN SOF; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Vanden Berghe E, 2007, OCEAN BIOGEOGRAPHIC; Vanderklift MA, 2013, OECOLOGIA, V171, P309, DOI 10.1007/s00442-012-2408-7; Veech JA, 2009, PARTITION 3 0 SOFTWA; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	88	20	20	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78761	10.1371/journal.pone.0078761	http://dx.doi.org/10.1371/journal.pone.0078761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205311	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400103
J	Nguyen, HM; Ruppender, N; Zhang, XT; Brown, LG; Gross, TS; Morrissey, C; Gulati, R; Vessella, RL; Schimmoller, F; Aftab, DT; Corey, E				Nguyen, Holly M.; Ruppender, Nazanin; Zhang, Xiaotun; Brown, Lisha G.; Gross, Ted S.; Morrissey, Colm; Gulati, Roman; Vessella, Robert L.; Schimmoller, Frauke; Aftab, Dana T.; Corey, Eva			Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling	PLOS ONE			English	Article							MEDULLARY-THYROID CARCINOMA; C-MET EXPRESSION; KINASE INHIBITOR; TUMOR-CELLS; PHASE-II; RECEPTOR; VEGF; METASTASES; ANGIOGENESIS; PROGRESSION	Cabozantinib is an inhibitor of multiple receptor tyrosine kinases, including MET and VEGFR2. In a phase II clinical trial in advanced prostate cancer (PCa), cabozantinib treatment improved bone scans in 68% of evaluable patients. Our studies aimed to determine the expression of cabozantinib targets during PCa progression and to evaluate its efficacy in hormone-sensitive and castration-resistant PCa in preclinical models while delineating its effects on tumor and bone. Using immunohistochemistry and tissue microarrays containing normal prostate, primary PCa, and soft tissue and bone metastases, our data show that levels of MET, P-MET, and VEGFR2 are increasing during PCa progression. Our data also show that the expression of cabozantinib targets are particularly pronounced in bone metastases. To evaluate cabozantinib efficacy on PCa growth in the bone environment and in soft tissues we used androgen-sensitive LuCaP 23.1 and castration-resistant C4-2B PCa tumors. In vivo, cabozantinib inhibited the growth of PCa in bone as well as growth of subcutaneous tumors. Furthermore, cabozantinib treatment attenuated the bone response to the tumor and resulted in increased normal bone volume. In summary, the expression pattern of cabozantinib targets in primary and castration-resistant metastatic PCa, and its efficacy in two different models of PCa suggest that this agent has a strong potential for the effective treatment of PCa at different stages of the disease.	[Nguyen, Holly M.; Ruppender, Nazanin; Zhang, Xiaotun; Brown, Lisha G.; Morrissey, Colm; Vessella, Robert L.; Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Gross, Ted S.] Univ Washington, Dept Orthoped, Seattle, WA 98195 USA; [Gulati, Roman] Fred Hutchinson Canc Res Ctr, Biostat & Biomath Program, Seattle, WA 98104 USA; [Schimmoller, Frauke; Aftab, Dana T.] Exelixis Inc, San Francisco, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Exelixis, Inc.	Corey, E (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	ecorey@uw.edu	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567	Exelixis Inc.	Exelixis Inc.	The studies in this manuscript were in part funded by Exelixis Inc. Two of the co-authors (DTA and FS) are employees of Exelixis. They were involved in study design, data analyses and in manuscript preparation.	Bok RA, 2001, CANCER RES, V61, P2533; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Ceolin L, 2012, EUR J ENDOCRINOL, V166, P847, DOI 10.1530/EJE-11-1060; Ceolin L, 2012, INT J MOL SCI, V13, P221, DOI 10.3390/ijms13010221; Coleman IM, 2006, NEOPLASIA, V8, P862, DOI 10.1593/neo.06328; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Corey Eva, 2007, P3, DOI 10.1007/978-1-59745-224-3_1; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Duque JLF, 1999, UROLOGY, V54, P523, DOI 10.1016/S0090-4295(99)00167-3; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Knudsen BS, 2009, APPL IMMUNOHISTO M M, V17, P57, DOI 10.1097/PAI.0b013e3181816ae2; Knudsen BS, 2004, ADV CANCER RES, V91, P31, DOI 10.1016/S0065-230X(04)91002-0; Koreckij TD, 2009, NEOPLASIA, V11, P1216, DOI 10.1593/neo.09960; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Maeda A, 2006, BIOCHEM BIOPH RES CO, V347, P1158, DOI 10.1016/j.bbrc.2006.07.040; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Nakashiro K, 2003, ONCOL REP, V10, P1149; Nurmio M, 2011, TOXICOL APPL PHARM, V254, P267, DOI 10.1016/j.taap.2011.04.019; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Pfitzenmaier J, 2003, J BONE MINER RES, V18, P1882, DOI 10.1359/jbmr.2003.18.10.1882; Ryan CJ, 2013, CLIN CANCER RES, V19, P215, DOI 10.1158/1078-0432.CCR-12-2605; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Shojaei F, 2012, CANCER LETT, V320, P48, DOI 10.1016/j.canlet.2012.01.026; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Small AC, 2012, EXPERT OPIN BIOL TH, V12, P1241, DOI 10.1517/14712598.2012.704015; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Strohmeyer D, 2004, ANTICANCER RES, V24, P1797; Tomic TT, 2012, PROSTATE, V72, P705, DOI 10.1002/pros.21472; Tu WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-556; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wiesner C, 2008, NEOPLASIA, V10, P996, DOI 10.1593/neo.08618; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78881	10.1371/journal.pone.0078881	http://dx.doi.org/10.1371/journal.pone.0078881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205338	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400110
J	Robertson, JL; Tsubouchi, A; Tracey, WD				Robertson, Jessica L.; Tsubouchi, Asako; Tracey, W. Daniel			Larval Defense against Attack from Parasitoid Wasps Requires Nociceptive Neurons	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SENSORY NEURONS; OVIPOSITOR CLIP; DENDRITE; DIFFERENTIATION; HYMENOPTERA; MECHANISMS; STRATEGIES; RESPONSES; DYNAMICS	Parasitoid wasps are a fierce predator of Drosophila larvae. Female Leptopilina boulardi (LB) wasps use a sharp ovipositor to inject eggs into the bodies of Drosophila melanogaster larvae. The wasp then eats the Drosophila larva alive from the inside, and an adult wasp ecloses from the Drosophila pupal case instead of a fly. However, the Drosophila larvae are not defenseless as they may resist the attack of the wasps through somatosensory-triggered behavioral responses. Here we describe the full range of behaviors performed by the larval prey in immediate response to attacks by the wasps. Our results suggest that Drosophila larvae primarily sense the wasps using their mechanosensory systems. The range of behavioral responses included both "gentle touch" like responses as well as nociceptive responses. We found that the precise larval response depended on both the somatotopic location of the attack, and whether or not the larval cuticle was successfully penetrated during the course of the attack. Interestingly, nociceptive responses are more likely to be triggered by attacks in which the cuticle had been successfully penetrated by the wasp. Finally, we found that the class IV neurons, which are necessary for mechanical nociception, were also necessary for a nociceptive response to wasp attacks. Thus, the class IV neurons allow for a nociceptive behavioral response to a naturally occurring predator of Drosophila.	[Robertson, Jessica L.; Tracey, W. Daniel] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Tsubouchi, Asako; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Tracey, W. Daniel] Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University; Duke University	Tracey, WD (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199; Tsubouchi, Asako/0000-0002-6284-8221	National Science Foundation; James B. Duke Fellowship; National Institutes of Health [5T32-GM007184-39]; Duke University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); James B. Duke Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Science Foundation (Graduate Research Fellowship (JLR)), the James B. Duke Fellowship (JLR), and the National Institutes of Health (5T32-GM007184-39). Support to WDT was through discretionary funding by Duke University Medical Center. nsf.govnih.gov http://gradschool.duke.edu/financial_support/phd%20support/incoming.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; Belshaw R, 2003, ZOOL J LINN SOC-LOND, V139, P213, DOI 10.1046/j.1096-3642.2003.00078.x; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Buffington ML, 2007, J NAT HIST, V41, P2267, DOI 10.1080/00222930701579732; Carton Y., 1986, P347; Dupas S, 1996, PARASITOLOGY, V113, P207, DOI 10.1017/S0031182000081981; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Goecks J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064125; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grueber WB, 2002, DEVELOPMENT, V129, P2867; HACCOU P, 1991, J ANIM ECOL, V60, P93, DOI 10.2307/5447; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Im SH, 2011, DEV DYNAMICS; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaiser L, 2009, ADV PARASIT, V70, P67, DOI 10.1016/S0065-308X(09)70003-X; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Lee MJ, 2009, ADV PARASIT, V70, P123, DOI 10.1016/S0065-308X(09)70005-3; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Oswald M, 2011, FLY, V5, P304, DOI 10.4161/fly.5.4.17810; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Perez-Maluf R, 2008, PHYSIOL ENTOMOL, V33, P226, DOI 10.1111/j.1365-3032.2008.00636.x; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; RUANGVORAVAT CP, 1992, DEV DYNAM, V193, P70, DOI 10.1002/aja.1001930110; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; SILVERS MJ, 1986, J PARASITOL, V72, P405, DOI 10.2307/3281680; SOKOLOWSKI MB, 1987, CAN J ZOOL, V65, P461, DOI 10.1139/z87-071; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; van Lenteren JC, 1998, INT J INSECT MORPHOL, V27, P263, DOI 10.1016/S0020-7322(98)00019-1; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Williams DW, 1999, J NEUROBIOL, V39, P275, DOI 10.1002/(SICI)1097-4695(199905)39:2<275::AID-NEU11>3.0.CO;2-0; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	47	45	45	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78704	10.1371/journal.pone.0078704	http://dx.doi.org/10.1371/journal.pone.0078704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205297	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400099
J	Sheidy, DT; Zielke, RA				Sheidy, Daniel T.; Zielke, Ryszard A.			Analysis and Expansion of the Role of the Escherichia coli Protein ProQ	PLOS ONE			English	Article							OSMOREGULATORY TRANSPORTER PROP; PROLINE PORTER-II; ANTISENSE RNA; TRANSCRIPTION; EXPRESSION; PREDICTION; REPRESSOR; FIS; IDENTIFICATION; PURIFICATION	The decrease in proline transport by the proline porter ProP in a Delta proQ strain has been well documented; however, the reason for this phenotype remains undefined. Previous studies have speculated that ProQ facilitates translation of proP mRNA. Here, we demonstrate that ProQ is enriched in the polysome fractions of sucrose gradient separations of E. coli lysates and the 30S fractions of lysates separated under conditions causing ribosomal subunit dissociation. Thus, ProQ is a bona fide ribosome associated protein. Analysis of proQ constructs lacking predicted structural domains implicates the N-terminal domain in ribosome association. Association with the ribosome appears to be mediated by an interaction with the mRNA being translated, as limited treatment of lysates with Micrococcal Nuclease maintains ribosome integrity but disrupts ProQ localization with polysomes. ProQ also fails to robustly bind to mRNA-free 70S ribosomes in vitro. Interestingly, deletion of proP does not disrupt the localization of ProQ with translating ribosomes, and deletion of proP in combination with the proU operon has no effect on ProQ localization. We also demonstrate that ProQ is necessary for robust biofilm formation, and this phenotype is independent of ProP. Binding studies were carried out using tryptophan fluorescence and in vitro transcribed proP mRNAs. proP is transcribed from two differentially regulated promoters, and ProQ interacts with proP mRNA transcribed from both promoters, as well as a control mRNA with similar affinities. In total, these data suggest that ProQ is positioned to function as a novel translational regulator, and its cellular role extends beyond its effects on proline uptake by ProP.	[Sheidy, Daniel T.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zielke, Ryszard A.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	University of Michigan System; University of Michigan; Oregon State University	Sheidy, DT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	dtsheidy@umich.edu			Department of Health and Human Services, National Institutes of Health [GM077628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077628] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Department of Health and Human Services, National Institutes of Health Grant No. GM077628 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brandi A, 1996, MOL MICROBIOL, V19, P231, DOI 10.1046/j.1365-2958.1996.362897.x; Chaulk SG, 2011, BIOCHEMISTRY-US, V50, P3095, DOI 10.1021/bi101683a; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fuentes JL, 2007, MOL GENET GENOMICS, V278, P105, DOI 10.1007/s00438-007-0233-1; Ghetu AF, 2000, NAT STRUCT BIOL, V7, P565; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koraimann G, 1996, MOL MICROBIOL, V21, P811, DOI 10.1046/j.1365-2958.1996.361401.x; Kunte HJ, 1999, J BACTERIOL, V181, P1537, DOI 10.1128/JB.181.5.1537-1543.1999; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Landis L, 1999, GENE DEV, V13, P3081, DOI 10.1101/gad.13.23.3081; LEDERBERG S, 1961, EXP CELL RES, V25, P198, DOI 10.1016/0014-4827(61)90325-1; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; MELLIES J, 1995, J BACTERIOL, V177, P144, DOI 10.1128/jb.177.1.144-151.1995; MILNER JL, 1988, J BIOL CHEM, V263, P14900; MILNER JL, 1989, J BACTERIOL, V171, P947, DOI 10.1128/jb.171.2.947-951.1989; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; SCHRENK WJ, 1974, MOL GEN GENET, V131, P9, DOI 10.1007/BF00269382; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Smith MN, 2007, BIOCHEMISTRY-US, V46, P3084, DOI 10.1021/bi6023786; Smith MN, 2004, BIOCHEMISTRY-US, V43, P12979, DOI 10.1021/bi048561g; Smith-Frieday MN, 2009, THESIS U GUELPH GUEL; VANBIESEN T, 1994, MOL MICROBIOL, V14, P427, DOI 10.1111/j.1365-2958.1994.tb02177.x; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Xu JM, 1997, J MOL BIOL, V270, P346, DOI 10.1006/jmbi.1997.1133; Xu JM, 1997, J BACTERIOL, V179, P2410, DOI 10.1128/jb.179.7.2410-2417.1997; XU JM, 1995, J BACTERIOL, V177, P5222, DOI 10.1128/jb.177.18.5222-5231.1995; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	40	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79656	10.1371/journal.pone.0079656	http://dx.doi.org/10.1371/journal.pone.0079656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205389	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400118
J	Hwang, J; Kim, JE; Kaufman, MJ; Renshaw, PF; Yoon, S; Yurgelun-Todd, DA; Choi, Y; Jun, C; Lyoo, IK				Hwang, Jaeuk; Kim, Jieun E.; Kaufman, Marc J.; Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.; Choi, Yera; Jun, Chansoo; Lyoo, In Kyoon			Enlarged Cavum Septum Pellucidum as a Neurodevelopmental Marker in Adolescent-Onset Opiate Dependence	PLOS ONE			English	Article							SCHIZOTYPAL PERSONALITY-DISORDER; 1ST-EPISODE SCHIZOPHRENIA; AMYGDALA VOLUME; SUBSTANCE USE; BRAIN; MRI; ABNORMALITIES; PREVALENCE; POSTMORTEM; ADDICTION	Objective: Adolescent-onset exposure to highly addictive substances such as opiates may induce far-reaching deleterious effects on later mental and physical health. However, little is known about the neurodevelopmental basis for adolescent-onset opiate dependence. Here we examined whether having an abnormally large cavum septum pellucidum (CSP), a putative marker of limbic structural maldevelopment, is associated with opiate dependence particularly beginning in adolescence. Method: The overall length of the CSP and the prevalence of abnormal enlargement of the CSP were assessed and compared in 65 opiate-dependent subjects (41 adolescent-onset opiate users and 24 adult-onset opiate users) and 67 healthy subjects. Results: Opiate-dependent subjects showed a greater prevalence of abnormal CSP enlargement relative to healthy subjects (odds ratio [OR]=3.64, p=0.034). The overall CSP length of adolescent-onset opiate-dependent subjects was greater, as compared not only with healthy subjects (F-1,F-104=11.03, p=0.001) but also with those who began opiate use during adulthood (F-1,F-61=4.43, p=0.039). Conclusions: The current findings provide the first evidence that abnormal CSP enlargement, which reflects limbic system dysgenesis of neurodevelopmental origin, may be linked to later development of opiate dependence. In addition, a greater CSP length, which indicates more severe limbic abnormalities, appears to confer higher risk for earlier onset of opiate use.	[Hwang, Jaeuk] Soonchunhyang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Jieun E.] Ewha Womans Univ, Dept Brain & Cognit Sci, Grad Sch, Seoul, South Korea; [Kaufman, Marc J.] McLean Hosp, McLean Imaging Ctr, Belmont, MA 02178 USA; [Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Yoon, Sujung] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Yera] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Brain Sci, Seoul 151742, South Korea; [Jun, Chansoo; Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Jun, Chansoo; Lyoo, In Kyoon] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea	Soonchunhyang University; Ewha Womans University; Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Catholic University of Korea; Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Lyoo, IK (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.	inkylyoo@ewha.ac.kr	Renshaw, Perry/O-1384-2018	Kaufman, Marc/0000-0002-4383-1264; Hwang, Jaeuk/0000-0003-0528-3305	National Institute of Health [DA024070]; Korean Health Technology R&D Project, the Korean Ministry of Health Welfare [A101219]; Global Top 5 program, the Ewha W. University; Basic Science Research Program, the National Research Foundation of Korea [2011-0014500]; Medi-Star Program, the Korean Ministry of Health and Welfare [A11200]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247, R01DA024070] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Health Technology R&D Project, the Korean Ministry of Health Welfare; Global Top 5 program, the Ewha W. University; Basic Science Research Program, the National Research Foundation of Korea; Medi-Star Program, the Korean Ministry of Health and Welfare; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The present study was supported by the grants from the National Institute of Health (DA024070, Drs. Renshaw and Lyoo), from the Korean Health Technology R&D Project, the Korean Ministry of Health & Welfare (A101219, Dr. Lyoo), from the Global Top 5 program, the Ewha W. University (Dr. Lyoo), from the Basic Science Research Program, the National Research Foundation of Korea (2011-0014500, Dr. Hwang), and from the Medi-Star Program, the Korean Ministry of Health and Welfare (A11200, Dr. Kim). The sponsors of the study had no role in the study design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Dickey CC, 2007, SCHIZOPHR RES, V89, P49, DOI 10.1016/j.schres.2006.08.004; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Fiellin DA, 2008, JAMA-J AM MED ASSOC, V300, P2057, DOI 10.1001/jama.2008.567; Filipovic B, 2005, PSYCHIAT CLIN NEUROS, V59, P106, DOI 10.1111/j.1440-1819.2005.01341.x; Filipovic B, 2004, EUR ARCH PSY CLIN N, V254, P228, DOI 10.1007/s00406-004-0483-4; First M. D., 1996, USERS GUIDE STRUCTUR; Fowler Joanna S, 2007, Sci Pract Perspect, V3, P4; Gallinat J, 2008, NEURODEGENER DIS, V5, P277, DOI 10.1159/000135612; Gavello-Baudy S, 2008, PSYCHOPHARMACOLOGY, V201, P219, DOI 10.1007/s00213-008-1263-z; GONG WH, 1995, BRAIN RES, V683, P221, DOI 10.1016/0006-8993(95)00376-2; Grella CE, 2011, DRUG ALCOHOL DEPEN, V118, P251, DOI 10.1016/j.drugalcdep.2011.04.004; Hill SY, 2001, BIOL PSYCHIAT, V49, P894, DOI 10.1016/S0006-3223(01)01088-5; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Kasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kirk RE, 1995, EXPT DESIGN; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kwon JS, 1998, AM J PSYCHIAT, V155, P509, DOI 10.1176/ajp.155.4.509; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lyoo IK, 2006, PSYCHOPHARMACOLOGY, V184, P139, DOI 10.1007/s00213-005-0198-x; Makris N, 2004, NEURON, V44, P729, DOI 10.1016/j.neuron.2004.10.027; May FS, 2004, BIOL PSYCHIAT, V55, P656, DOI 10.1016/j.biopsych.2003.09.018; Nopoulos PC, 1998, AM J PSYCHIAT, V155, P1074, DOI 10.1176/ajp.155.8.1074; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; Rajarethinam R, 2008, SCHIZOPHR RES, V103, P22, DOI 10.1016/j.schres.2007.11.031; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; SARWAR M, 1989, AM J NEURORADIOL, V10, P989; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Trzesniak C, 2011, SCHIZOPHR RES, V125, P1, DOI 10.1016/j.schres.2010.09.016; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78590	10.1371/journal.pone.0078590	http://dx.doi.org/10.1371/journal.pone.0078590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205275	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300071
J	Panganiban, RAM; Day, RM				Panganiban, Ronald Allan M.; Day, Regina M.			Inhibition of IGF-1R Prevents Ionizing Radiation-Induced Primary Endothelial Cell Senescence	PLOS ONE			English	Article							GROWTH-FACTOR-I; LIFE-SPAN; SENSITIZES CELLS; OXIDATIVE STRESS; INSULIN; RECEPTOR; MTOR; EXPRESSION; RAPAMYCIN; P53	Accelerated senescence is a primary response to cellular stresses including DNA damaging agents (e. g., ionizing radiation) and is widely believed to be caused by continuous proliferative signaling in the presence of cell cycle arrest. Studies of signal transduction pathways leading to accelerated senescence have revealed that inhibition of mammalian target of rapamycin (mTOR) by rapamycin rescues cells from senescence. However, the molecular mechanisms upstream of mTOR following ionizing radiation (IR) are not well defined. We investigated signal transduction leading to IR-induced accelerated senescence in human pulmonary artery endothelial cells (HPAEC). Exposure of HPAEC to X-rays (10 Gy, 2.4 Gy/min) upregulated senescence markers including p53, p21/waf1, and senescence-associated beta galactosidase (SA-beta-gal). Ly294002 (a phosphatidylinositol-3-kinase [PI3K] inhibitor) or rapamycin (an mTOR inhibitor) blocked the induction of cellular senescence markers suggesting roles for PI3K and mTOR. Pathway-directed microarrays revealed increased transcription of insulin-like growth factor I (IGF-1), a modulator of cell growth and proliferation upstream of mTOR. qRT-PCR confirmed that both IGF-1 and IGF-2 mRNA were increased in response to X-rays, and ELISA showed increased secretion of IGF-1 protein into the medium of irradiated HPAEC. Consistent with upregulation of these ligands, we found that X-ray exposure led to hyperphosphorylation of IGF-1R, the receptor for IGF-1 and -2. Treatment with AG1024, an IGF-1R inhibitor, suppressed IR-induced upregulation of p53, p21/waf1, and SA-beta-gal. Together these findings suggest that IGF-1R is a key regulator of IR-induced accelerated senescence in a pathway that requires intact mTOR activity upstream of both p53 and p21/waf1.	[Panganiban, Ronald Allan M.; Day, Regina M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Day, RM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.day@usuhs.edu	Panganiban, Ronald Allan/AAH-3859-2020	Panganiban, Ronald Allan/0000-0003-0894-1318	USUHS Intramural Grant; USUHS	USUHS Intramural Grant; USUHS	This study was supported by a USUHS Intramural Grant, and a USUHS predoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD SL, 1991, J CLIN INVEST, V88, P470, DOI 10.1172/JCI115327; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Bandyopadhyay Debdutta, 2005, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1809s27; Baserga R, 1999, EXP CELL RES; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Blagosklonny MV, 2011, AGING-US, V3, P685, DOI 10.18632/aging.100352; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Bouallegue A, 2009, FREE RADICAL BIO MED, V47, P858, DOI 10.1016/j.freeradbiomed.2009.06.022; Boucher MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG736, DOI 10.1152/ajpgi.00453.2003; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chenal J, 2008, EUR J NEUROSCI, V27, P53, DOI 10.1111/j.1460-9568.2007.05981.x; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Costantini C, 2010, J MOL NEUROSCI, V40, P342, DOI 10.1007/s12031-009-9305-5; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dricu A, 1997, GLYCOBIOLOGY, V7, P625, DOI 10.1093/glycob/7.5.625; Dricu A, 1997, CANCER RES, V57, P543; Drullion C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.111; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Floratou K, 2012, J RADIAT RES, V53, P672, DOI 10.1093/jrr/rrs019; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Khalid M, 2000, ANIM REPROD SCI, V58, P261, DOI 10.1016/S0378-4320(99)00075-5; Kojima K, 2008, LEUKEMIA, V22, P1728, DOI 10.1038/leu.2008.158; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leach JK, 2001, CANCER RES, V61, P3894; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Leontieva OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026126; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; LEROITH D, 1995, ANN INTERN MED, V122, P54, DOI 10.7326/0003-4819-122-1-199501010-00009; Leroith Derek, 1995, Progress in Growth Factor Research, V6, P433, DOI 10.1016/0955-2235(96)00009-9; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lopaczynski W, 2000, BIOCHEM BIOPH RES CO, V279, P955, DOI 10.1006/bbrc.2000.4046; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Qiu W, 2010, ONCOGENE, V29, P1622, DOI 10.1038/onc.2009.451; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Salatino M, 2004, ONCOGENE, V23, P5161, DOI 10.1038/sj.onc.1207659; Tezuka M, 2001, CLIN CANCER RES, V7, P3206; Tran D, 2008, THESIS BOSTON U; Tran D, 2008, IGF 1 INDUCES PREMAT; Turner BC, 1997, CANCER RES, V57, P3079; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Weitsman GE, 2009, BREAST CANCER RES TR, V118, P269, DOI 10.1007/s10549-008-0221-0; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828	62	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78589	10.1371/journal.pone.0078589	http://dx.doi.org/10.1371/journal.pone.0078589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205274	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300070
J	Qian, JX; Luo, YZ; Gu, XQ; Zhan, W; Wang, X				Qian, Jianxin; Luo, Yizhou; Gu, Xiaoqiang; Zhan, Wang; Wang, Xi			Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR FOXM1; FORKHEAD BOX M1; BREAST-CANCER; TUMOR-METASTASIS; LUNG-CANCER; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROGRESSION	Twist-related protein 1 (Twist1), also known as class A basic helix-loop-helix protein 38 (bHLHa38), has been implicated in cell lineage determination and differentiation. Previous studies demonstrate that Twist1 expression is up-regulated in gastric cancer with poor clinical outcomes. Besides, Twist1 is suggested to be involved in progression of human gastric cancer. However, its biological functions remain largely unexplored. In the present study, we show that Twist 1 overexpression leads to a significant up-regulation of FoxM1, which plays a key role in cell cycle progression in gastric cancer cells. In contrast, knockdown of Twist 1 reduces FoxM1 expression, suggesting that FoxM1 might be a direct transcriptional target of Twist 1. At the molecular level, we further reveal that Twist 1 could bind to the promoter region of FoxM1, and subsequently recruit p300 to induce FoxM1 mRNA transcription. Therefore, our results uncover a previous unknown Twist 1/FoxM1 regulatory pathway, which may help to understand the mechanisms of gastric cancer proliferation.	[Qian, Jianxin; Gu, Xiaoqiang; Zhan, Wang; Wang, Xi] Changzheng Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Luo, Yizhou] PLA, Hosp 454, Dept Hematol & Oncol, Nanjing, Jiangsu, Peoples R China	Naval Medical University	Qian, JX (corresponding author), Changzheng Hosp, Dept Med Oncol, Shanghai, Peoples R China.	Jianxinqiancz@hotmail.com						Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Feng Y, 2013, MOL CANC RES; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Horimoto Y, 2011, AM J PATHOL, V179, P1148, DOI 10.1016/j.ajpath.2011.05.052; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kong X, 2013, CANC RES; Li JP, 2012, FEBS LETT, V586, P3761, DOI 10.1016/j.febslet.2012.09.016; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Luo GQ, 2011, PATHOLOGY, V43, P697, DOI 10.1097/PAT.0b013e32834bf632; Michel L, 2013, BLOOD, V121, P1477, DOI 10.1182/blood-2012-10-460535; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Sullivan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051277; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530	32	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77625	10.1371/journal.pone.0077625	http://dx.doi.org/10.1371/journal.pone.0077625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204899	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300027
J	Sebastian, V; Estil, JB; Chen, D; Schrott, LM; Serrano, PA				Sebastian, Veronica; Estil, Jim Brian; Chen, Daniel; Schrott, Lisa M.; Serrano, Peter A.			Acute Physiological Stress Promotes Clustering of Synaptic Markers and Alters Spine Morphology in the Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; SPATIAL WORKING-MEMORY; DENDRITIC SPINES; PKM-ZETA; AMPA RECEPTORS; DENTATE GYRUS; PLASTICITY; CORTICOSTERONE; DYNAMICS	GluA2-containing AMPA receptors and their association with protein kinase M zeta (PKM zeta) and post-synaptic density-95 (PSD-95) are important for learning, memory and synaptic plasticity processes. Here we investigated these synaptic markers in the context of an acute 1h platform stress, which can disrupt spatial memory retrieval for a short-term memory on the object placement task and long-term memory retrieval on a well-learned radial arm maze task. Acute stress increased serum corticosterone and elevated the expression of synaptic PKM zeta while decreasing synaptic GluA2. Using co-immunoprecipitation, we found that this stressor promotes the clustering of GluA2, PKM zeta and PSD-95, which is consistent with effects reported from overexpression of PKM zeta in cell culture. Because PKM zeta overexpression has also been shown to induce spine maturation in culture, we examined how stress impacts synaptic markers within changing spines across various hippocampal subfields. To achieve this, we employed a new technique combining Golgi staining and immmunohistochemistry to perform 3D reconstruction of tertiary dendrites, which can be analyzed for differences in spine types and the colocalization of synaptic markers within these spines. In CA1, stress increased the densities of long-thin and mushroom spines and the colocalization of GluA2/PSD-95 within these spines. Conversely, in CA3, stress decreased the densities of filopodia and stubby spines, with a concomitant reduction in the colocalization of GluA2/PSD-95 within these spines. In the outer molecular layer (OML) of the dentate gyrus (DG), stress increased both stubby and long-thin spines, together with greater GluA2/PSD-95 colocalization. These data reflect the rapid effects of stress on inducing morphological changes within specific hippocampal subfields, highlighting a potential mechanism by which stress can modulate memory consolidation and retrieval.	[Sebastian, Veronica; Estil, Jim Brian; Chen, Daniel; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Schrott, Lisa M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Serrano, Peter A.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; City University of New York (CUNY) System	Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA.	serrano@genectr.hunter.cuny.edu		Chen, Daniel/0000-0003-3857-1741	National Institute on Minority Health and Health Disparities from the National Institutes of Health [MD007599]; Department of Defense [W81XWH-08-1-0243]; Professional Staff Congress-City University of New York [PSC-CUNY 43]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS080686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA012136] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities from the National Institutes of Health; Department of Defense(United States Department of Defense); Professional Staff Congress-City University of New York; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding was provided by the National Institute on Minority Health and Health Disparities (MD007599) from the National Institutes of Health to Hunter College, and by the Department of Defense (W81XWH-08-1-0243) and the Professional Staff Congress-City University of New York (PSC-CUNY 43) to P. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cazakoff BN, 2010, PROG NEURO-PSYCHOPH, V34, P733, DOI 10.1016/j.pnpbp.2010.04.002; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Deller T, 1996, J NEUROSCI, V16, P3322; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Diamond DM, 1996, BEHAV NEUROSCI, V110, P661, DOI 10.1037/0735-7044.110.4.661; Dorey R, 2012, NEUROPSYCHOPHARMACOL, V37, P2870, DOI 10.1038/npp.2012.170; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Finnie PSB, 2012, NEUROSCI BIOBEHAV R, V36, P1667, DOI 10.1016/j.neubiorev.2012.03.008; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Hardt O, 2010, HIPPOCAMPUS, V20, P691, DOI 10.1002/hipo.20708; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kesner RP, 2008, BEHAV NEUROSCI, V122, P1217, DOI 10.1037/a0013592; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; Kesner RP, 2013, FRONT CELL NEUROSCI, V122, P1217; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kole MHP, 2004, NEUROSCIENCE, V125, P337, DOI 10.1016/j.neuroscience.2004.02.014; Lee I, 2003, BEHAV NEUROSCI, V117, P1044, DOI 10.1037/0735-7044.117.5.1044; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010400; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Nakagawa S, 2011, NEUROSCI BIOBEHAV R, V35, P462, DOI 10.1016/j.neubiorev.2010.06.003; NOGUES X, 1994, HIPPOCAMPUS, V4, P71, DOI 10.1002/hipo.450040109; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pinto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033114; Ron S, 2012, CEREB CORTEX, V22, P2519, DOI 10.1093/cercor/bhr323; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Schrott LM, 2008, BRAIN RES, V1198, P132, DOI 10.1016/j.brainres.2008.01.020; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shao CY, 2012, HIPPOCAMPUS, V22, P1501, DOI 10.1002/hipo.20996; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Spiga S, 2011, BRAIN STRUCT FUNCT, V216, P171, DOI 10.1007/s00429-011-0312-2; VANEEKELEN JAM, 1992, PROG HISTOCHEM CYTOC, V26, P250, DOI 10.1016/S0079-6336(11)80102-6; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	75	50	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79077	10.1371/journal.pone.0079077	http://dx.doi.org/10.1371/journal.pone.0079077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205365	Green Published, gold			2022-12-25	WOS:000326152300090
J	Yeung, CY; Tso, AWK; Xu, AM; Wang, Y; Woo, YC; Lam, TH; Lo, SV; Fong, CHY; Wat, NMS; Woo, J; Cheung, BMY; Lam, KSL				Yeung, Chun-Yip; Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Woo, Yu-Cho; Lam, Tai-Hing; Lo, Su-Vui; Fong, Carol Ho-Yee; Wat, Nelson Ming-Sang; Woo, Jean; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling			Pro-Inflammatory Adipokines as Predictors of Incident Cancers in a Chinese Cohort of Low Obesity Prevalence in Hong Kong	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; PROSTATE-CANCER; GROWTH-FACTOR; RISK-FACTORS; ADIPONECTIN; IL-6; INTERLEUKIN-6; HYPERTENSION; ASSOCIATION	Background: Cytokines released from adipose tissues induce chronic low-grade inflammation, which may enhance cancer development. We investigated whether indices of obesity and circulating adipokine levels could predict incident cancer risk. Materials and Methods: This longitudinal community-based study included subjects from the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS) study commenced in 1995-1996 (CRISP-1) with baseline assessments including indices of obesity. Subjects were reassessed in 2000-2004 (CRISPS-2) with measurement of serum levels of adipokines including interleukin-6 (IL-6), soluble tumor necrosis factor receptor 2 (sTNFR2; as a surrogate marker of tumor necrosis factor-a activity), leptin, lipocalin 2, adiponectin and adipocyte-fatty acid binding protein (A-FABP). Incident cancer cases were identified up to 31 December 2011. Results: 205 of 2893 subjects recruited at CRISPS-1 had developed incident cancers. More of the subjects who developed cancers were obese (22.1 vs 16.1%) or had central obesity (36.6 vs 24.5%) according to Asian cut-offs. Waist circumference (adjusted HR 1.02 [1.00-1.03] per cm; p=0.013), but not body mass index (adjusted HR 1.04 [1.00-1.08] per kg/m(2); p=0.063), was a significant independent predictor for incident cancers after adjustment for age, sex and smoking status. 99 of 1899 subjects reassessed at CRISPS-2 had developed cancers. Subjects who developed cancers had significantly higher level of hsCRP, IL-6, sTNFR2 and lipocalin 2. After adjustment for conventional risk factors, only IL-6 (HR 1.51, 95% CI 1.18-1.95) and sTNFR2 (HR 3.27, 95% CI 1.65-6.47) predicted cancer development. Conclusions: Our data supported the increased risk of malignancy by chronic low grade inflammation related to central obesity.	[Yeung, Chun-Yip; Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Woo, Yu-Cho; Fong, Carol Ho-Yee; Wat, Nelson Ming-Sang; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China; [Lam, Tai-Hing] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Lo, Su-Vui] Hosp Author, Dept Strategy & Planning, Kowloon, Hong Kong, Peoples R China; [Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Cheung, BMY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Woo, Jean/K-2625-2014; /E-9829-2010; Lam, Tai Hing/C-4317-2009	Woo, Jean/0000-0001-7593-3081; /0000-0001-9106-7363; Lam, Tai Hing/0000-0002-2033-9971; wang, yu/0000-0001-8697-2940	Hong Kong Research Grants Council [HKU780210M]; Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (HHSRF) [06070951]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (HHSRF)	This study was finanically supported by funding from the Hong Kong Research Grants Council (http://www.ugc.edu.hk/eng/rgc/index.htm, reference number HKU780210M) and Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (http://www.fhb.gov.hk/grants/english/welcome/welcome.html, HHSRF reference number 06070951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ansary-Moghaddam A, 2006, CANCER EPIDEM BIOMAR, V15, P2435, DOI 10.1158/1055-9965.EPI-06-0368; Baillargeon J, 2006, CANCER EPIDEM BIOMAR, V15, P1331, DOI 10.1158/1055-9965.EPI-06-0082; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chan AT, 2011, GASTROENTEROLOGY, V140, P799, DOI 10.1053/j.gastro.2010.11.041; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Fernandez-Real JM, 2003, INT J OBESITY, V27, P1552, DOI 10.1038/sj.ijo.0802472; Folkerd EJ, 2010, J CLIN ONCOL, V28, P4038, DOI 10.1200/JCO.2009.27.4290; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Ho GYF, 2012, CANCER RES, V72, P3029, DOI 10.1158/0008-5472.CAN-11-2771; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Leung L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046677, DOI 10.1371/J0URNAL.P0NE.0046677.PUBMED:23056397]; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tworoger SS, 2007, OBESITY, V15, P2217, DOI 10.1038/oby.2007.263; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; World Health Organization Office of Health Communications and Public Relations, 2006, OB OV, P3	42	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78594	10.1371/journal.pone.0078594	http://dx.doi.org/10.1371/journal.pone.0078594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205276	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300072
J	Chuang, JY; Chang, AC; Chiang, IP; Tsai, MH; Tang, CH				Chuang, Jing-Yuan; Chang, An-Chen; Chiang, I-Ping; Tsai, Ming-Hsui; Tang, Chih-Hsin			Apoptosis Signal-Regulating Kinase 1 Is Involved in WISP-1-Promoted Cell Motility in Human Oral Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							HUMAN CHONDROSARCOMA CELLS; INFLAMMATORY BREAST-CANCER; GROWTH-FACTOR; ADHESION MOLECULES; CCN FAMILY; INCREASES MIGRATION; HUMAN OSTEOSARCOMA; ICAM-1 EXPRESSION; UP-REGULATION; LUNG-CANCER	Oral squamous cell carcinoma (OSCC) has a tendency to migrate and metastasize. WNT1-inducible signaling pathway protein 1 (WISP-1) is a cysteine-rich protein that belongs to the Cyr61, CTGF, Nov (CCN) family of matrix cellular proteins. The effect of WISP-1 on human OSCC cells, however, is unknown. Here, we showed that WISP-1 increased cell migration and intercellular adhesion molecule-1 (ICAM-1) expression in OSCC cells. Pretreatment of cells with integrin avb3 monoclonal antibody (mAb) significantly abolished WISP-1-induced cell migration and ICAM-1 expression. On the other hand, WISP-1-mediated cell motility and ICAM-1 upregulation were attenuated by ASK1, JNK, and p38 inhibitor. Furthermore, WISP-1 also enhanced activator protein 1 (AP-1) activation, and the integrin avb3 mAb, and ASK1, JNK, and p38 inhibitors reduced WISP-1-mediated AP-1 activation. Moreover, WISP-1 and ICAM-1 expression correlated with the tumor stage of patients with OSCC. Our results indicate that WISP-1 enhances the migration of OSCC cells by increasing ICAM-1 expression through the avb3 integrin receptor and the ASK1, JNK/p38, and AP-1 signal transduction pathways.	[Chuang, Jing-Yuan; Chang, An-Chen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Chiang, I-Ping] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Chang, An-Chen/ABB-6915-2021	Tang, Chih Hsin/0000-0002-7113-8352; Chang, An-Chen/0000-0002-9544-9980	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]; Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence [DOH102-TD-C-111-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3 and NSC100-2320-B-039-028-MY3); Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen LM, 2011, J CELL BIOCHEM, V112, P933, DOI 10.1002/jcb.23009; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Duperray A, 1997, J BIOL CHEM, V272, P435; Fong YC, 2012, J CELL PHYSIOL, V227, P223, DOI 10.1002/jcp.22720; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Hsia TC, 2013, MOL PHARMACOL, V83, P857, DOI 10.1124/mol.112.082743; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Kleer CG, 2004, NEOPLASIA, V6, P179, DOI 10.1593/neo.03316; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Lu KW, 2011, HUM EXP TOXICOL, V30, P406, DOI 10.1177/0960327110372405; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284; Tang CH, 2012, BIOMEDICINE-TAIWAN, V2, P92, DOI 10.1016/j.biomed.2012.01.001; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Tsou HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053974; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; VANDE SA, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xu LF, 2000, GENE DEV, V14, P585; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	40	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78022	10.1371/journal.pone.0078022	http://dx.doi.org/10.1371/journal.pone.0078022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205072	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600060
J	Ou, M; Sandri-Goldin, RM				Ou, Mark; Sandri-Goldin, Rozanne M.			Inhibition of cdk9 during Herpes Simplex Virus 1 Infection Impedes Viral Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; EARLY PROTEIN ICP22; P-TEFB; REPLICATION COMPARTMENTS; ARGININE METHYLATION; ELONGATION-FACTOR; NUCLEAR EXPORT; LARGE SUBUNIT; PHOSPHORYLATION	During herpes simplex virus 1 (HSV-1) infection there is a loss of the serine-2 phosphorylated form of RNA polymerase II (RNAP II) found in elongation complexes. This occurs in part because RNAP II undergoes ubiquitination and proteasomal degradation during times of highly active viral transcription, which may result from stalled elongating complexes. In addition, a viral protein, ICP22, was reported to trigger a loss of serine-2 RNAP II. These findings have led to some speculation that the serine-2 phosphorylated form of RNAP II may not be required for HSV-1 transcription, although this form is required for cellular transcription elongation and RNA processing. Cellular kinase cdk9 phosphorylates serine-2 in the C-terminal domain (CTD) of RNAP II. To determine if serine-2 phosphorylated RNAP II is required for HSV-1 transcription, we inhibited cdk9 during HSV-1 infection and measured viral gene expression. Inhibition was achieved by adding cdk9 inhibitors 5,6-dichlorobenzimidazone-1-beta-D-ribofuranoside (DRB) or flavopiridol (FVP) or by expression of a dominant-negative cdk9 or HEXIM1, which in conjunction with 7SK snRNA inhibits cdk9 in complex with cyclin 1. Here we report that inhibition of cdk9 resulted in decreased viral yields and levels of late proteins, poor formation of viral transcription-replication compartments, reduced levels of poly(A)+ mRNA and decreased RNA synthesis as measured by uptake of 5-bromouridine into nascent RNA. Importantly, a global reduction in viral mRNAs was seen as determined by microarray analysis. We conclude that serine-2 phosphorylation of the CTD of RNAP II is required for HSV-1 transcription.	[Ou, Mark; Sandri-Goldin, Rozanne M.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sandri-Goldin, RM (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	rmsandri@uci.edu			United Stated National Institutes of Health [R37 AI21515]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021515] Funding Source: NIH RePORTER	United Stated National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United Stated National Institutes of Health grant R37 AI21515. The funders had no role in study design, data collection and analysis, decision to publish. or preparation of the manuscript.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bastian TW, 2009, J VIROL, V83, P128, DOI 10.1128/JVI.01954-08; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bigalke JM, 2011, J MOL BIOL, V414, P639, DOI 10.1016/j.jmb.2011.10.022; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Feichtinger S, 2011, J GEN VIROL, V92, P1519, DOI 10.1099/vir.0.030494-0; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Garriga J, 2010, J CELL PHYSIOL, V222, P200, DOI 10.1002/jcp.21938; Grondin B, 2000, J VIROL, V74, P11504, DOI 10.1128/JVI.74.24.11504-11510.2000; Gu B, 2013, NUCLEIC ACIDS RES, V41, P1591, DOI 10.1093/nar/gks1327; Guo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045749; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kapasi AJ, 2009, J VIROL, V83, P5904, DOI 10.1128/JVI.02651-08; KNIPE DM, 1987, J VIROL, V61, P276, DOI 10.1128/JVI.61.2.276-284.1987; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Palermo RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002334; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; RICE SA, 1994, J VIROL, V68, P988, DOI 10.1128/JVI.68.2.988-1001.1994; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Souki SK, 2009, J VIROL, V83, P8970, DOI 10.1128/JVI.00801-09; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Sun AX, 2004, J VIROL, V78, P10470, DOI 10.1128/JVI.78.19.10470-10478.2004; Tamrakar S, 2005, J VIROL, V79, P15477, DOI 10.1128/JVI.79.24.15477-15493.2005; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Toth Z, 2012, J VIROL, V86, P9696, DOI 10.1128/JVI.01012-12; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	62	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e79007	10.1371/journal.pone.0079007	http://dx.doi.org/10.1371/journal.pone.0079007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205359	Green Published, gold			2022-12-25	WOS:000326029300169
J	Zhang, YS; Yang, LF; Lin, YT; Rong, ZX; Liu, XW; Li, D				Zhang, Yunsheng; Yang, Lifang; Lin, Yiting; Rong, Zhuoxian; Liu, Xiaowen; Li, Dan			SPATA12 and Its Possible Role in DNA Damage Induced by Ultraviolet-C	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DECOY; SIGNALING PATHWAYS; BINDING PROTEIN-2; GENE-EXPRESSION; AP-1; P53; PHOSPHORYLATION; ACTIVATION; STRESS; FAMILY	Our previous studies indicated that SPATA12, a novel spermatogenesis-associated gene, might be an inhibitor involved in spermatogenesis and tumorigenesis. To obtain a better understanding of the functions of SPATA12, a yeast two-hybrid screening system was used to search for interacting proteins, and chromodomain helicase DNA binding protein 2 (CHD2) was successfully identified. Bimolecular fluorescence complementation (BiFC) and subcellular co-localization assays further suggested a possible interaction between SPATA12 and CHD2 in the nuclei. CHD2 is known to be involved in the later stage of the DNA damage response pathway by influencing the transcriptional activity of p53. Thus, our hypothesis is that SPATA12 might play a role in DNA damage signaling. Western blotting results showed that SPATA12 expression could be induced in ultraviolet-C (UV-C) irradiated cells. Through reporter gene assays and the activator protein-1 (AP-1) decoy oligodeoxynucleotide method, we demonstrated that SPATA12 promoter activity could be up-regulated in response to UV-C radiation exposure and an AP-1 binding site in the SPATA12 promoter may have a role in transcriptional regulation of SPATA12. Using colony formation and host cell reactivation assays, it was demonstrated that SPATA12 might lead to inhibition of cellular proliferation in UV-C-irradiated DNA damage. Furthermore, SPATA12 was transfected into H1299, MCF-7 and HeLa cells, and flow cytometry (FCM) results suggested that there are some biological association between SPATA12 and p53 in UV-C-irradiated DNA damage. In addition, we investigated whether SPATA12 could up-regulate the expression of p53. Taken together, these findings indicate that SPATA12 could be induced under UV-C stress. During DNA damage process, AP-1 involves in the transcriptional up-regulation of SPATA12 in response to UV-C radiation and p53 involves in growth inhibitory effects of SPATA12 on UV-C irradiated cells.	[Zhang, Yunsheng; Lin, Yiting; Rong, Zhuoxian; Liu, Xiaowen; Li, Dan] Hunan Univ, Coll Biol, Dept Life Sci, Changsha 410082, Hunan, Peoples R China; [Yang, Lifang] Cent South Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China	Hunan University; Central South University	Li, D (corresponding author), Hunan Univ, Coll Biol, Dept Life Sci, Changsha 410082, Hunan, Peoples R China.	lidanie@hotmail.com	Yunsheng, ZHANG/K-8565-2013	Yunsheng, ZHANG/0000-0002-4748-1548	National Natural Science Foundation of China [30872763, 81270735]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (nos. 30872763, 81270735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; Ahn JD, 2001, DIABETOLOGIA, V44, P713, DOI 10.1007/s001250051680; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Costelloe T, 2006, EXP CELL RES, V312, P2677, DOI 10.1016/j.yexcr.2006.06.031; Dzau VJ, 2002, CIRC RES, V90, P1234, DOI 10.1161/01.RES.0000025209.24283.73; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Li D, 2007, J ANDROL, V28, P502, DOI 10.2164/jandrol.106.001560; Li D, 2012, GENE, V511, P18, DOI 10.1016/j.gene.2012.08.047; Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002; Li ZX, 2008, ASIAN J ANDROL, V10, P749, DOI 10.1111/j.1745-7262.2008.00400.x; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Liu Zhiwen, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P222, DOI 10.3969/j.issn.1672-7347.2012.03.002; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Morishita R, 1998, CIRC RES, V82, P1023, DOI 10.1161/01.RES.82.10.1023; Nagarajan P, 2009, ONCOGENE, V28, P1053, DOI 10.1038/onc.2008.440; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Rajagopalan S, 2012, ENVIRON MOL MUTAGEN, V53, P44, DOI 10.1002/em.20674; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Zhang YG, 2001, DNA CELL BIOL, V20, P769, DOI 10.1089/104454901753438589; Zhong JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1092, DOI 10.1111/j.1751-1097.2011.00963.x; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	33	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78201	10.1371/journal.pone.0078201	http://dx.doi.org/10.1371/journal.pone.0078201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205157	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300148
J	Temme, S; Zacharias, M; Neumann, J; Wohlfromm, S; Konig, A; Temme, N; Springer, S; Trowsdale, J; Koch, N				Temme, Sebastian; Zacharias, Martin; Neumann, Juergen; Wohlfromm, Sebastian; Koenig, Angelika; Temme, Nadine; Springer, Sebastian; Trowsdale, John; Koch, Norbert			A Novel Family of Human Leukocyte Antigen Class II Receptors May Have Its Origin in Archaic Human Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; MHC PROTEIN HLA-DR1; HLA-DR MOLECULES; INVARIANT-CHAIN; PEPTIDE BINDING; ENDOGENOUS PEPTIDE; CRYSTAL-STRUCTURE; DP MOLECULES; IA MOLECULE; ALPHA-CHAIN	HLA class II alpha and beta chains form receptors for antigen presentation to CD4(+) T cells. Numerous pairings of class II alpha and beta subunits from the wide range of haplotypes and isotypes may form, but most of these combinations, in particular those produced by isotype mixing, yielded mismatched dimers. It is unclear how selection of functional receptors is achieved. At the atomic level, it is not known which interactions of class II residues regulate selection of matched alpha beta heterodimers and the evolutionary origin of matched isotype mixed dimer formation. In this study we investigated assembly of isotype-mixed HLA class II alpha and beta heterodimers. Assembly and carbohydrate maturation of various HLA-class II isotype-mixed alpha and beta subunits was dependent on the groove binding section of the invariant chain (Ii). By mutation of polymorphic DP beta sequences, we identified two motifs, Lys-69 and GGPM-(8487), that are engaged in Ii-dependent assembly of DP beta with DR alpha. We identified five members of a family of DP beta chains containing Lys-69 and GGPM 84-87, which assemble with DR alpha. The Lys/GGPM motif is present in the DP beta sequence of the Neanderthal genome, and this ancient sequence is related to the human allele DPB1*0401. By site-directed mutagenesis, we inspected Neanderthal amino acid residues that differ from the DPB1*0401 allele and aimed to determine whether matched heterodimers are formed by assembly of DP beta mutants with DR alpha. Because the *0401 allele is rare in the sub-Saharan population but frequent in the European population, it may have arisen in modern humans by admixture with Neanderthals in Europe.	[Temme, Sebastian; Neumann, Juergen; Koenig, Angelika; Temme, Nadine] Univ Bonn, Immunobiol Sect, Inst Genet, D-53115 Bonn, Germany; [Temme, Sebastian] Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-85747 Garching, Germany; [Wohlfromm, Sebastian] Univ Dusseldorf, Biol Med Forschungszentrum, D-40225 Dusseldorf, Germany; [Temme, Nadine] Forschungszentrum Caesar, D-53175 Bonn, Germany; [Springer, Sebastian] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Bonn; Heinrich Heine University Dusseldorf; Technical University of Munich; Heinrich Heine University Dusseldorf; Center of Advanced European Studies & Research (CAESAR); Jacobs University; University of Cambridge	Koch, N (corresponding author), Univ Bonn, Abt Immunbiol, Inst Genet, Endenicher Allee 11-13, D-53115 Bonn, Germany.	norbert.koch@uni-bonn.de	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149	Deutsche Forschungsgemeinschaft; Wellcome Trust; Medical Research Council; National Institute of Health Cambridge Biomedical Research Centre; MRC [G0901682] Funding Source: UKRI; Medical Research Council [G0901682] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Cambridge Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft.; Supported by grants from the Wellcome Trust and the Medical Research Council with partial funding from the National Institute of Health Cambridge Biomedical Research Centre.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; ARROYO J, 1995, HUM IMMUNOL, V43, P219, DOI 10.1016/0198-8859(95)00022-V; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; BRAUNSTEIN NS, 1987, P NATL ACAD SCI USA, V84, P2921, DOI 10.1073/pnas.84.9.2921; BUERSTEDDE JM, 1988, J EXP MED, V168, P823, DOI 10.1084/jem.168.3.823; Charron D. J., 1980, J EXP MED, V152, p127s; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; GERMAIN RN, 1986, NATURE, V320, P72, DOI 10.1038/320072a0; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gruneberg U, 1997, HUM IMMUNOL, V53, P34, DOI 10.1016/S0198-8859(97)00025-6; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; KARP DR, 1990, J EXP MED, V171, P615, DOI 10.1084/jem.171.3.615; Koch N, 2000, IMMUNOL TODAY, V21, P546, DOI 10.1016/S0167-5699(00)01717-5; Koch N, 2007, TRENDS BIOCHEM SCI, V32, P532, DOI 10.1016/j.tibs.2007.09.007; Koch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017257; KOCH S, 1987, J IMMUNOL METHODS, V103, P211, DOI 10.1016/0022-1759(87)90292-4; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lancaster Alex, 2003, Pac Symp Biocomput, P514; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LECHLER RI, 1990, J IMMUNOL, V144, P329; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MALISSEN B, 1986, P NATL ACAD SCI USA, V83, P3958, DOI 10.1073/pnas.83.11.3958; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nagaraj S, 2008, PANCREAS, V37, P321, DOI 10.1097/MPA.0b013e318166722e7; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Neumann J, 2005, J IMMUNOL METHODS, V301, P66, DOI 10.1016/j.jim.2005.03.014; Neumann J, 2005, FEBS LETT, V579, P6055, DOI 10.1016/j.febslet.2005.09.070; Neumann J, 2006, J CELL SCI, V119, P4207, DOI 10.1242/jcs.03177; NORCROSS MA, 1986, J IMMUNOL, V137, P1714; PESANDO JM, 1986, J IMMUNOL, V136, P4311; RUBERTI G, 1992, J EXP MED, V175, P157, DOI 10.1084/jem.175.1.157; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SANT AJ, 1989, CELL, V57, P797, DOI 10.1016/0092-8674(89)90794-0; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; SCHAIFF WT, 1991, J IMMUNOL, V147, P603; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Silk JD, 2005, MOL IMMUNOL, V42, P1129, DOI 10.1016/j.molimm.2004.11.024; SPENCER JS, 1989, J EXP MED, V169, P625, DOI 10.1084/jem.169.3.625; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TEMPONI M, 1993, J IMMUNOL METHODS, V161, P239, DOI 10.1016/0022-1759(93)90300-V; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078	54	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					639	653		10.1074/jbc.M113.515767	http://dx.doi.org/10.1074/jbc.M113.515767			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24214983	Green Published, hybrid			2022-12-25	WOS:000330541200005
J	Basu, N; Saha, S; Khan, I; Ramachandra, SG; Visweswariah, SS				Basu, Nirmalya; Saha, Sayanti; Khan, Imran; Ramachandra, Subbaraya G.; Visweswariah, Sandhya S.			Intestinal Cell Proliferation and Senescence Are Regulated by Receptor Guanylyl Cyclase C and p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Intestinal Epithelium; Microarray; Protein Kinase G (PKG); Senescence; Sp1; GCC Knock-out mice; T84 Cell; p21; Receptor Guanylyl Cyclase C	DEPENDENT PROTEIN-KINASE; HEAT-STABLE ENTEROTOXIN; P53-MEDIATED G(1) ARREST; ABERRANT CRYPT FOCI; COLON-CANCER CELLS; COLORECTAL-CANCER; ESCHERICHIA-COLI; BACTERIAL ENTEROTOXINS; GENE-TRANSCRIPTION; CYCLIC-GMP	Guanylyl cyclase C (GC-C) is expressed in intestinal epithelial cells and serves as the receptor for bacterial heat-stable enterotoxin (ST) peptides and the guanylin family of gastrointestinal hormones. Activation of GC-C elevates intracellular cGMP, which modulates intestinal fluid-ion homeostasis and differentiation of enterocytes along the crypt-villus axis. GC-C activity can regulate colonic cell proliferation by inducing cell cycle arrest, and mice lacking GC-C display increased cell proliferation in colonic crypts. Activation of GC-C by administration of ST to wild type, but not Gucy2c(-/-), mice resulted in a reduction in carcinogen-induced aberrant crypt foci formation. In p53-deficient human colorectal carcinoma cells, ST led to a transcriptional up-regulation of p21, the cell cycle inhibitor, via activation of the cGMP-responsive kinase PKGII and p38 MAPK. Prolonged treatment of human colonic carcinoma cells with ST led to nuclear accumulation of p21, resulting in cellular senescence and reduced tumorigenic potential. Our results, therefore, identify downstream effectors for GC-C that contribute to regulating intestinal cell proliferation. Thus, genomic responses to a bacterial toxin can influence intestinal neoplasia and senescence.	[Basu, Nirmalya; Saha, Sayanti; Khan, Imran; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Ramachandra, Subbaraya G.] Indian Inst Sci, Cent Anim Facil, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; khan, imran/K-9921-2013	Visweswariah, Sandhya/0000-0003-2786-7344; khan, imran/0000-0001-6888-7347; Gudde, Ramachandra/0000-0002-0744-3627; Basu, Nirmalya/0000-0003-3041-2826	Central Animal Facility in the Indian Institute of Science	Central Animal Facility in the Indian Institute of Science	We thank Prof. P. Kondaiah and Neeraj Rana for help with the microarray and Pavithra Kumar, Vani R. Iyer, and members of the laboratory for useful discussions. We acknowledge the assistance of the late Prof. Parag P. Sadhale in early transcriptomic studies. Support from the Central Animal Facility in the Indian Institute of Science is acknowledged.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Bigler D, 2007, PROSTATE, V67, P1590, DOI 10.1002/pros.20644; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Camici M, 2008, BIOMED PHARMACOTHER, V62, P70, DOI 10.1016/j.biopha.2007.04.010; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; DWARAKANATH P, 1989, GENE, V81, P219, DOI 10.1016/0378-1119(89)90182-0; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Ghosh AR, 1996, EUR J EPIDEMIOL, V12, P81, DOI 10.1007/BF00144433; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; HARPER JW, 1993, CELL, V75, P805; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549; Kanthan R., 2012, PATHOLOG RES INT, V2012; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kazerounian S, 2005, J PHARMACOL EXP THER, V314, P1013, DOI 10.1124/jpet.105.089052; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MILLER JP, 1973, BIOCHEMISTRY-US, V12, P5310, DOI 10.1021/bi00750a014; Mohandas KM, 2011, INDIAN J GASTROENTER, V30, P3, DOI 10.1007/s12664-010-0076-2; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Pasz-Walczak G, 2001, PATHOL RES PRACT, V197, P683, DOI 10.1078/0344-0338-00146; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; PRETLOW TP, 1991, CANCER RES, V51, P1564; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Saha S, 2008, J APPL TOXICOL, V28, P475, DOI 10.1002/jat.1297; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shailubhai K, 2000, CANCER RES, V60, P5151; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Steinbrecher KA, 2000, BIOCHEM BIOPH RES CO, V273, P225, DOI 10.1006/bbrc.2000.2917; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu Y, 2012, ONCOL REP, V27, P553, DOI 10.3892/or.2011.1507; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	70	40	40	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					581	593		10.1074/jbc.M113.511311	http://dx.doi.org/10.1074/jbc.M113.511311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24217248	Green Published, hybrid			2022-12-25	WOS:000329370900049
J	Gena, P; Mastrodonato, M; Portincasa, P; Fanelli, E; Mentino, D; Rodriguez, A; Marinelli, RA; Brenner, C; Fruhbeck, G; Svelto, M; Calamita, G				Gena, Patrizia; Mastrodonato, Maria; Portincasa, Piero; Fanelli, Elena; Mentino, Donatella; Rodriguez, Amaia; Marinelli, Raul A.; Brenner, Catherine; Fruehbeck, Gema; Svelto, Maria; Calamita, Giuseppe			Liver Glycerol Permeability and Aquaporin-9 Are Dysregulated in a Murine Model of Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							EXPRESSION; AQP9; METABOLISM; CHANNELS; AQUAGLYCEROPORINS; HEPATOCYTES; MANAGEMENT; ADIPOSE; OBESITY; ROLES	One form of liver steatosis, namely Non-Alcoholic Fatty Liver Disease (NAFLD), is a worrisome health problem worldwide characterized by intrahepatic triacylglycerol (TG) overaccumulation. NAFLD is a common feature of metabolic syndrome being often associated with obesity, dyslipidemia and diabetes and mostly closely linked to insulin resistance. The mechanism of NAFLD pathogenesis is object of intense investigation especially regarding complex systems ultimately resulting in excessive TG deposition in hepatocytes. However, scarce is the attention about the relevance of hepatic import of glycerol, the other primary source (as glycerol-3-phosphate) of increased TG in hepatocytes. Obese leptin-deficient (ob/ob) mice, an animal model of NAFLD, were used to evaluate the functional involvement of Aquaporin-9 (AQP9), the major pathway of liver glycerol entry, in hepatosteatosis. By RT-PCR and qPCR, the level of Aqp9 mRNA in the liver of starved obese mice was comparable with the corresponding control lean littermates. By immunoblotting, the AQP9 protein at the hepatocyte sinusoidal plasma membrane of obese mice was markedly lower (33%) than lean mice, a finding fully confirmed by immunohistochemistry. By stopped-flow light scattering, the liver glycerol permeability of ob/ob mice was significantly lower (53%) than lean mice, a finding consistent with both the observed down-regulation of AQP9 protein and increased level of plasma glycerol characterizing obese mice. In summary, our results suggest implication of AQP9 in liver steatosis. The reduction of hepatocyte AQP9 and, consequently, glycerol permeability might be a defensive mechanism to counteract further fat infiltration in liver parenchyma.	[Gena, Patrizia; Fanelli, Elena; Svelto, Maria; Calamita, Giuseppe] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Mastrodonato, Maria; Mentino, Donatella] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Portincasa, Piero] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy; [Rodriguez, Amaia; Fruehbeck, Gema] Univ Navarra Clin, Metab Res Lab, Spanish Biomed Res Ctr Physiopathol Obes & Nutr, Pamplona, Spain; [Marinelli, Raul A.] Univ Nacl Rosario, Inst Fisiol Expt, CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Brenner, Catherine] Univ Paris 11, INSERM, U769, LabEx LERMIT, Chatenay Malabry, France; [Svelto, Maria; Calamita, Giuseppe] Ctr Eccellenza Genom Campo Biomed & Agr, Bari, Italy; [Calamita, Giuseppe] Network Apulian Publ Res Labs WAFITECH, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Navarra; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Calamita, G (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	giuseppe.calamita@uniba.it	Gena, patrizia/AAC-3396-2022; Svelto, Maria/P-6186-2014; brenner, catherine/AAE-8632-2020; mastrodonato, Maria/P-4513-2016; Fanelli, Elena/C-1712-2015; Rodriguez, Amaia/D-3044-2019	mastrodonato, Maria/0000-0002-0799-8032; portincasa, piero/0000-0001-5359-1471; Mentino, Donatella/0000-0002-0680-5251; Rodriguez, Amaia/0000-0002-2180-461X; Fanelli, Elena/0000-0002-3132-3908; Svelto, Maria/0000-0002-5584-9541; Calamita, Giuseppe/0000-0003-4666-9546	Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN20089SRS2X_003]; Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH)	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH)	Funding from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN20089SRS2X_003) and Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH) to GC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Cai C, 2013, INT IMMUNOPHARMACOL, V15, P550, DOI 10.1016/j.intimp.2013.01.020; Calamita G, 2005, J BIOL CHEM, V280, P17149, DOI 10.1074/jbc.C400595200; Calamita G, 2008, AM J PHYSIOL-GASTR L, V295, pG682, DOI 10.1152/ajpgi.90226.2008; Calamita G, 2007, EXPERT OPIN THER TAR, V11, P1231, DOI 10.1517/14728222.11.9.1231; Calamita G, 2012, BIOL CELL, V104, P342, DOI 10.1111/boc.201100061; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Catalan V, 2008, OBES SURG, V18, P695, DOI 10.1007/s11695-008-9453-7; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Gena P, 2011, FOOD BIOPHYS, V6, P241, DOI 10.1007/s11483-010-9193-9; Grattagliano I, 2013, ANN HEPATOL, V12, P70, DOI 10.1016/S1665-2681(19)31387-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Jelen S, 2012, AM J PHYSIOL-GASTR L, V303, pG1279, DOI 10.1152/ajpgi.00153.2012; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; Lebeck J, 2012, AM J PHYSIOL-GASTR L, V302, pG365, DOI 10.1152/ajpgi.00437.2011; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee DH, 2005, METABOLISM, V54, P1282, DOI 10.1016/j.metabol.2005.04.015; LI CC, 1983, J CELL PHYSIOL, V117, P230, DOI 10.1002/jcp.1041170214; Liquori GE, 2009, HISTOL HISTOPATHOL, V24, P49, DOI 10.14670/HH-24.49; Love-Osborne KA, 2008, J ADOLESCENT HEALTH, V42, P543, DOI 10.1016/j.jadohealth.2007.11.136; Maeda N, 2012, MOL ASPECTS MED, V33, P665, DOI 10.1016/j.mam.2012.02.004; Miranda M, 2009, METABOLISM, V58, P1762, DOI 10.1016/j.metabol.2009.06.004; Pastor-Soler N, 2001, BIOL REPROD, V65, P384, DOI 10.1095/biolreprod65.2.384; Portois L, 2012, INT J MOL MED, V29, P1121, DOI 10.3892/ijmm.2012.943; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2013, AM J PHYSIOL-GASTR L, V304, pG501, DOI 10.1152/ajpgi.00208.2012; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x	40	37	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78139	10.1371/journal.pone.0078139	http://dx.doi.org/10.1371/journal.pone.0078139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205128	Green Published, gold			2022-12-25	WOS:000326334500098
J	Maranga, IO; Hampson, L; Oliver, AW; Gamal, A; Gichangi, P; Opiyo, A; Holland, CM; Hampson, IN				Maranga, Innocent O.; Hampson, Lynne; Oliver, Anthony W.; Gamal, Anas; Gichangi, Peter; Opiyo, Anselmy; Holland, Catharine M.; Hampson, Ian N.			Analysis of Factors Contributing to the Low Survival of Cervical Cancer Patients Undergoing Radiotherapy in Kenya	PLOS ONE			English	Article							RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; HUMAN-PAPILLOMAVIRUS; PAP-SMEAR; CARCINOMA; CHEMORADIOTHERAPY; WOMEN; MANAGEMENT; IMPACT; OXYGENATION	Background: In contrast to the developed nations, invasive cervical cancer (ICC) is the most common womens malignancy in Kenya and many other locations in sub-Saharan Africa. However, studies on survival from this disease in this area of the world are severely restricted by lack of patient follow-up. We now report a prospective cohort study of ICC in Kenyan women analysing factors affecting tumour response and overall survival in patients undergoing radiotherapy. Methods and Findings: Between 2008 and 2010, 355 patients with histologically confirmed ICC were recruited at the Departments of Gynaecology and Radiotherapy at Kenyatta National Hospital (KNH). Structured questionnaires were completed recording socio-demographics, tumour response and overall survival following treatment with combinations of external beam radiation (EBRT), brachytherapy and adjuvant chemotherapy. Of the 355 patients, 42% (146) were lost to follow-up while 18% (64) died during the two year period. 80.5% of patients presented with advanced stage IIB disease or above, with only 6.7% of patients receiving optimal combined EBRT, brachytherapy and adjuvant chemotherapy. Kaplan Meier survival curves projected two year survival at <20%. Conclusion: Cervical cancer is preventable yet poverty, poor education, lack of cancer awareness coupled with an absence of regular screening programs, late patient presentation, sub-optimal diagnosis and treatments are major factors contributing to the alarmingly low survival rate of cervical cancer patients in Kenya. It is concluded that simple cost-effective changes in clinical practice could be introduced which would have a marked impact on patient survival in this setting.	[Maranga, Innocent O.; Hampson, Lynne; Oliver, Anthony W.; Holland, Catharine M.; Hampson, Ian N.] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Maranga, Innocent O.; Gichangi, Peter] Univ Nairobi, Nairobi, Kenya; [Opiyo, Anselmy] Kenyatta Natl Hosp, Canc Treatment Ctr, Nairobi, Kenya; [Gamal, Anas] Mansoura Univ Hosp, Cairo, Egypt	University of Manchester; University of Nairobi; Kenyatta National Hospital; Egyptian Knowledge Bank (EKB); Mansoura University	Hampson, IN (corresponding author), Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England.	Ian.n.hampson@manchester.ac.uk		Gamal Eldin Mansour, Mohamed/0000-0001-8443-476X; Hampson, Lynne/0000-0002-0656-0127	Janice Cholerton Cancer and Postgraduate Studentship Fund; Humane Research Trust; International Atomic Energy Agency (IAEA); Wellbeing of Women; Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer; Quest Cancer Research	Janice Cholerton Cancer and Postgraduate Studentship Fund; Humane Research Trust; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Wellbeing of Women(Wellbeing of Women (WoW)); Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer; Quest Cancer Research	The authors would like to thank The Janice Cholerton Cancer and Postgraduate Studentship Fund, The Humane Research Trust (http://www.humaneresearch.org.uk/), The International Atomic Energy Agency (IAEA; http://www.iaea.org/) and Wellbeing of Women (http://www.wellbeingofwomen.org.uk/) for their financial support. All work carried out in the Gynaecological Oncology laboratories at Manchester was also supported by The Caring Cancer Trust (http://www.caringcancertrust.com/), the Cancer Prevention Research Trust (http://www.cancer-prevention-research.co.uk/), United in Cancer, and Quest Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniebue PN, 2010, J CANCER EDUC, V25, P106, DOI 10.1007/s13187-009-0023-z; [Anonymous], 1996, B WORLD HEALTH ORGAN, V74, P345; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Berclaz G, 2002, INT J ONCOL, V20, P1313; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Brookfield KF, 2009, CANCER-AM CANCER SOC, V115, P166, DOI 10.1002/cncr.24007; Brown J, 2004, NATURE REV CANC, V4; Candelaria M, 2005, MED ONCOL, V22, P1357; Claeys P, 2002, TROP MED INT HEALTH, V7, P935, DOI 10.1046/j.1365-3156.2002.00953.x; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Curado MP EB, 2007, CANC INCIDENCE 5 CON; Dim CC, 2009, J OBSTET GYNAECOL, V29, P754, DOI 10.3109/01443610903225323; Dim Cyril C, 2009, Medscape J Med, V11, P19; Eifel Patricia J., 1997, P1433; Eifel PJ, 2006, NAT CLIN PRACT ONCOL, V3, P248, DOI 10.1038/ncponc0486; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Engin G, 2011, DIAGN INTERV RADIOL, V17, P44, DOI 10.4261/1305-3825.DIR.3114-09.1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatune JW, 2005, INT J GYNECOL CANCER, V15, P1049, DOI 10.1111/j.1525-1438.2005.00261.x; Gichangi P, 2006, GYNECOL ONCOL, V100, P405, DOI 10.1016/j.ygyno.2005.10.006; Gichangi P, 2002, INT J GYNECOL OBSTET, V76, P55, DOI 10.1016/S0020-7292(01)00560-4; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Harford JB, 2009, TUMORI, V95, P568; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kesic V, 2006, EJSO-EUR J SURG ONC, V32, P832, DOI 10.1016/j.ejso.2006.03.037; Kidanto H L, 2002, East Afr Med J, V79, P467; King M, 2006, CLIN ONCOL-UK, V18, P38, DOI 10.1016/j.clon.2005.09.001; Kitchener HC, 2010, INT J GYNECOL CANCER, V20, P1092, DOI 10.1111/IGC.0b013e3181e730aa; Kodaira T, 2003, INT J RADIAT ONCOL, V56, P769, DOI 10.1016/S0360-3016(03)00007-5; Korn AP, 1997, OBSTET GYN CLIN N AM, P855; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Maduro JH, 2003, CANCER TREAT REV, V29, P471, DOI 10.1016/S0305-7372(03)00117-8; Maiman M, 1997, OBSTET GYNECOL, V89, P76, DOI 10.1016/S0029-7844(96)00378-X; McArdle O, 2007, RADIOTHER ONCOL, V83, P94, DOI 10.1016/j.radonc.2007.02.006; MMH, 2007, CERV CANC CANC FEM R; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ndlovu N, 2003, Cent Afr J Med, V49, P107; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Obi SN, 2008, J OBSTET GYNAECOL, V28, P526, DOI 10.1080/01443610802273507; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Pearcey R, 2007, J CLIN ONCOL, V25, P2383, DOI 10.1200/JCO.2006.09.1926; PETEREIT DG, 1995, INT J RADIAT ONCOL, V32, P1301, DOI 10.1016/0360-3016(94)00635-X; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; RELLIHAN MA, 1990, GYNECOL ONCOL, V36, P435, DOI 10.1016/0090-8258(90)90159-I; Samant R, 2010, INT J GYNECOL CANCER, V20, P1087, DOI 10.1111/IGC.0b013e3181e0ef81; Schwartz L, 1991, GYNECOL ONCOL, P225; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Shanta V, 1091, ASIAN PAC J CANC PRE, V11, P1091; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Survey KDH, 2009, HIV PREVALENCE KENYA; Teh J, 2010, INT J GYNECOL CANCER, V20, P428, DOI 10.1111/IGC.0b013e3181d4a0d1; Vale CL, 2010, CLIN ONCOL-UK, V22, P590, DOI 10.1016/j.clon.2010.06.002; Watkins MM, 2002, INT J GYNECOL CANCER, V12, P475, DOI 10.1046/j.1525-1438.2002.01170.x; Wong LP, 2008, INT J BEHAV MED, V15, P289, DOI 10.1080/10705500802365490; World Health Organization (WHO), 2004, GLOB BURD DIS 2004 U	57	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78411	10.1371/journal.pone.0078411	http://dx.doi.org/10.1371/journal.pone.0078411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205226	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500117
J	Wohrle, S; Weiss, A; Ito, M; Kauffmann, A; Murakami, M; Jagani, Z; Thuery, A; Bauer-Probst, B; Reimann, F; Stamm, C; Pornon, A; Romanet, V; Guagnano, V; Mmendorf, TB; Sellers, WR; Hofmann, F; Roberts, CWM; Porta, DG				Woehrle, Simon; Weiss, Andreas; Ito, Moriko; Kauffmann, Audrey; Murakami, Masato; Jagani, Zainab; Thuery, Anne; Bauer-Probst, Beatrice; Reimann, Flavia; Stamm, Christelle; Pornon, Astrid; Romanet, Vincent; Guagnano, Vito; Mmendorf, Thomas Bru; Sellers, William R.; Hofmann, Francesco; Roberts, Charles W. M.; Porta, Diana Graus			Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; SOFT-TISSUE SARCOMAS; CELL-CYCLE ARREST; SYNOVIAL SARCOMA; SWI/SNF COMPLEX; SUPPRESSOR GENE; ONCOGENIC TRANSFORMATION; FAMILIAL SCHWANNOMATOSIS; SMARCB1/INI1 PROTEIN; INI1	Malignant rhabdoid tumors (MRTs) are aggressive pediatric cancers arising in brain, kidney and soft tissues, which are characterized by loss of the tumor suppressor SNF5/SMARCB1. MRTs are poorly responsive to chemotherapy and thus a high unmet clinical need exists for novel therapies for MRT patients. SNF5 is a core subunit of the SWI/SNF chromatin remodeling complex which affects gene expression by nucleosome remodeling. Here, we report that loss of SNF5 function correlates with increased expression of fibroblast growth factor receptors (FGFRs) in MRT cell lines and primary tumors and that re-expression of SNF5 in MRT cells causes a marked repression of FGFR expression. Conversely, siRNA-mediated impairment of SWI/SNF function leads to elevated levels of FGFR2 in human fibroblasts. In vivo, treatment with NVP-BGJ398, a selective FGFR inhibitor, blocks progression of a murine MRT model. Hence, we identify FGFR signaling as an aberrantly activated oncogenic pathway in MRTs and propose pharmacological inhibition of FGFRs as a potential novel clinical therapy for MRTs.	[Woehrle, Simon; Weiss, Andreas; Ito, Moriko; Kauffmann, Audrey; Murakami, Masato; Thuery, Anne; Bauer-Probst, Beatrice; Reimann, Flavia; Stamm, Christelle; Pornon, Astrid; Romanet, Vincent; Guagnano, Vito; Mmendorf, Thomas Bru; Hofmann, Francesco; Porta, Diana Graus] Novartis Inst BioMed Res, Basel, Switzerland; [Jagani, Zainab; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA USA; [Roberts, Charles W. M.] Childrens Hosp Boston, Div Hematol Oncol, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA	Novartis; Novartis; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Porta, DG (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	diana.graus_porta@novartis.com	Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896	NATIONAL CANCER INSTITUTE [R01CA113794] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113794] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold MA, 2013, HUM PATHOL, V44, P881, DOI 10.1016/j.humpath.2012.08.014; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Biegel JA, 1999, CANCER RES, V59, P74; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Guagnano V, 2012, CANC DISCOV; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Jackson EM, 2009, CLIN CANCER RES, V15, P1923, DOI 10.1158/1078-0432.CCR-08-2091; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Kohashi K, 2008, AM J SURG PATHOL, V32, P1168, DOI 10.1097/PAS.0b013e318161781a; Kohashi K, 2010, MODERN PATHOL, V23, P981, DOI 10.1038/modpathol.2010.71; Kreiger PA, 2009, MODERN PATHOL, V22, P142, DOI 10.1038/modpathol.2008.185; Kuwahara Y, 2010, CANCER RES, V70, P1854, DOI 10.1158/0008-5472.CAN-09-1922; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee S, 2011, CANCER RES, V71, P3225, DOI 10.1158/0008-5472.CAN-10-2167; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mobley BC, 2010, ACTA NEUROPATHOL, V120, P745, DOI 10.1007/s00401-010-0767-x; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; PARHAM DM, 1994, AM J SURG PATHOL, V18, P1010, DOI 10.1097/00000478-199410000-00005; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Trobaugh-Lotrario AD, 2011, PEDIATR BLOOD CANCER, V57, P423, DOI 10.1002/pbc.22857; Trobaugh-Lotrario AD, 2009, PEDIATR BLOOD CANCER, V52, P328, DOI 10.1002/pbc.21834; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WICK MR, 1995, SEMIN DIAGN PATHOL, V12, P233; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	52	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77652	10.1371/journal.pone.0077652	http://dx.doi.org/10.1371/journal.pone.0077652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204904	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500038
J	Yao, YL; Shao, J; Zhang, CF; Wu, JH; Zhang, QH; Wang, JJ; Zhu, W				Yao, Yong-Liang; Shao, Jie; Zhang, Chunfu; Wu, Jian-Hong; Zhang, Qing-Hui; Wang, Jian-Jun; Zhu, Wei			Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; COLON-CANCER; PREOPERATIVE CHEMOTHERAPY; MET; RESISTANCE; INHIBITORS; MUTATIONS; RECEPTOR; PATHWAY	One of the recent breakthroughs in cancer research is the identification of activating mutations in various receptor tyrosine kinase(RTK) pathways in many cancers including colorectal cancer(CRC). We hypothesize that, alternative to mutations, overexpression of various oncogenic RTKs may also underpin CRC pathogenesis, and different RTK may couple with distinct downstream signaling pathways in different subtypes of human CRC. By immunohistochemistry, we show here that RTK members ErbB2, ErbB3 and c-Met were in deed differentially overexpressed in colorectal cancer patient samples leading to constitutive activation of RTK signaling pathways. Using ErbB2 specific inhibitor Lapatinib and c-Met specific inhibitor PHA-665752, we further demonstrated that this constitutive activation of RTK signaling is necessary for the survival of colorectal cancer cells. Furthermore, we show that RTK overexpression pattern dictates the use of downstream AKT and/or MAPK pathways. Our data are important additions to current oncogenic mutation models, and further explain the clinical variation in therapeutic responses of colorectal cancer. Our findings advocate for more personalized therapy tailored to individual patients based on their type of RTK expression in addition to their mutation status.	[Yao, Yong-Liang; Wu, Jian-Hong; Zhang, Qing-Hui; Wang, Jian-Jun] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Clin Lab, Kunshan, Jiangsu, Peoples R China; [Zhu, Wei] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Shao, Jie] PLA, Hosp 359, Dept Clin Lab, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Chunfu] Second Peoples Hosp Kunshan, Dept Clin Lab, Kunshan, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Zhu, W (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.	zhuwei@ujs.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Social Development Foundation of Kunshan [KS1130]; Scientific Research Foundation of Jiangsu University [11JGD0090]	Social Development Foundation of Kunshan; Scientific Research Foundation of Jiangsu University	This work was supported by the Social Development Foundation of Kunshan (no. KS1130) and the Scientific Research Foundation of Jiangsu University (no. 11JGD0090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio LA, 2012, CANCER METAST REV, V31, P375, DOI 10.1007/s10555-012-9348-x; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Benson AB, 2013, J NATL COMPR CANC NE, V11, P141, DOI 10.6004/jnccn.2013.0022; Bentivegna S, 2008, HUM MUTAT, V29, P441, DOI 10.1002/humu.20672; Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cervantes A, 2012, LANCET ONCOL, V13, P1073, DOI 10.1016/S1470-2045(12)70389-3; Chow A, 2011, J MAMMARY GLAND BIOL, V16, P81, DOI 10.1007/s10911-011-9206-4; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Fan WW, 2011, CANCER RES, V71, P4494, DOI 10.1158/0008-5472.CAN-10-2668; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Gao JJ, 2011, DRUG DISCOV THER, V5, P2, DOI 10.5582/ddt.2011.v5.1.2; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kielbowna L, 2012, FOLIA BIOL-KRAKOW, V60, P107, DOI 10.3409/fb60_3-4.107-119; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Liu XD, 2011, EXPERT OPIN INV DRUG, V20, P1225, DOI 10.1517/13543784.2011.600687; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Sgambato A, 2012, CURR PHARM DESIGN, V18, P6155, DOI 10.2174/138161212803582478; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yap TA, 2011, CURR DRUG TARGETS, V12, P2045; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zhang LM, 2011, ANAL BIOCHEM, V412, P1, DOI 10.1016/j.ab.2011.01.028	32	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78086	10.1371/journal.pone.0078086	http://dx.doi.org/10.1371/journal.pone.0078086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205104	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500095
J	Zeng, H; Sun, MX; Zhou, CH; Yin, F; Wang, ZY; Hua, YQ; Cai, ZD				Zeng, Hui; Sun, Mengxiong; Zhou, Chenghao; Yin, Fei; Wang, Zhuoying; Hua, Yingqi; Cai, Zhengdong			Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy Selectively Kills Sarcomas by Inducing Apoptosis	PLOS ONE			English	Article							ACRIDINE-ORANGE; CANCER; CELLS; PATHWAYS; SURGERY	We investigated the antitumor effect and mechanism of hematoporphyrin monomethyl ether-mediated photodynamic therapy (HMME-PDT) in sarcomas. Intracellular uptake of HMME by osteosarcoma cells (LM8 and K7) was time-and dose-dependent, while this was not observed for myoblast cells (C2C12) and fibroblast cells (NIH/3T3). HMME-PDT markedly inhibited the proliferation of sarcoma cell lines (LM8, MG63, Saos-2, SW1353, TC71, and RD) (P<0.05), and the killing effect was improved with increased HMME concentration and energy intensity. Flow cytometry analysis revealed that LM8, MG63, and Saos-2 cells underwent apoptosis after treatment with HMME-PDT. Additionally, apoptosis was induced after HMME-PDT in a three-dimensional culture of osteosarcoma cells. Hoechst 33342 staining confirmed apoptosis. Cell death caused by PDT was rescued by an irreversible inhibitor (Z-VAD-FMK) of caspase. However, cell viability was not markedly decreased compared with the HMME-PDT group. Expression levels of caspase-1, caspase-3, caspase-6, caspase-9, and poly (ADP-ribose) polymerase (PARP) proteins were markedly up-regulated in the treatment groups and increased with HMME concentration as determined by western blot analysis. In vivo, tumor volume markedly decreased at 7-16 days post-PDT. Hematoxylin and eosin staining revealed widespread necrotic and infiltrative inflammatory cells in the HMME-PDT group. Immunohistochemistry analysis also showed that caspase-1, caspase-3, caspase-6, caspase-9, and PARP proteins were significantly increased in the HMME-PDT group. These results indicate that HMME-PDT has a potent killing effect on osteosarcoma cells in vitro and significantly inhibits tumor growth in vivo, which is associated with the caspase-dependent pathway.	[Zeng, Hui; Yin, Fei; Wang, Zhuoying; Hua, Yingqi; Cai, Zhengdong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthoped, Shanghai 200030, Peoples R China; [Sun, Mengxiong; Zhou, Chenghao; Hua, Yingqi; Cai, Zhengdong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Hua, Yingqi] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University; Tongji University	Hua, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthoped, Shanghai 200030, Peoples R China.	yingqi.hua@yahoo.com; zhdcai@gmail.com	Fan, Lin/L-3606-2014		Shanghai Science and Technology Commission [11JC1410100]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Basic Research Project of Shanghai Science and Technology Commission (NO. 11JC1410100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Akeda K, 2009, ONCOL REP, V22, P997, DOI 10.3892/or_00000527; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Cai H, 2011, PHOTODERMATOL PHOTO, V27, P90, DOI 10.1111/j.1600-0781.2011.00577.x; Chan YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038961; Chen XH, 2011, LASER MED SCI, V26, P69, DOI 10.1007/s10103-010-0810-0; Ding XM, 2004, CANCER LETT, V216, P43, DOI 10.1016/j.canlet.2004.07.005; Hashiguchi S, 2002, ONCOLOGY-BASEL, V62, P85, DOI 10.1159/000048251; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Kusuzaki K, 2005, PHOTOCHEM PHOTOBIOL, V81, P705, DOI 10.1562/2004-06-27-RA-218.1; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Liu TC, 2010, INT J ONCOL, V36, P777, DOI 10.3892/ijo_00000553; Liu Y, 2011, VET J, V188, P325, DOI 10.1016/j.tvjl.2010.05.013; Master A, 2013, MOL PHARMACEUT, V10, P1988, DOI 10.1021/mp400007k; Matsubara T, 2009, ONCOL REP, V21, P89, DOI 10.3892/or_00000193; Moan J, 2003, ANTICANCER RES, V23, P3591; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Nakamura T, 2008, J SURG ONCOL, V97, P523, DOI 10.1002/jso.21025; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; Reiners JJ, 2010, AUTOPHAGY, V6, P7, DOI 10.4161/auto.6.1.10220; Satonaka H, 2011, ANTICANCER RES, V31, P4163; Su XM, 2013, CANCER BIOTHER RADIO, V28, P207, DOI 10.1089/cbr.2012.1190; Takeda K, 2008, CLIN ORTHOP RELAT R, V466, P1726, DOI 10.1007/s11999-008-0284-6; Tan PHS, 2011, BIOMATERIALS, V32, P6131, DOI 10.1016/j.biomaterials.2011.04.084; Tang PMK, 2009, CANCER BIOL THER, V8, P533, DOI 10.4161/cbt.8.6.7694; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Wang XL, 2010, J PHARMACOL EXP THER, V334, P847, DOI 10.1124/jpet.110.168856; Won E, 2010, BREAST CANCER RES TR, V124, P111, DOI 10.1007/s10549-009-0712-7; Yanase S, 2009, PHOTOMED LASER SURG, V27, P791, DOI 10.1089/pho.2008.2329; Zhan Q, 2011, PHOTODIAGN PHOTODYN, V8, P314, DOI 10.1016/j.pdpdt.2011.04.002; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058855	33	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77727	10.1371/journal.pone.0077727	http://dx.doi.org/10.1371/journal.pone.0077727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204937	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500047
J	Seguin-Orlando, A; Schubert, M; Clary, J; Stagegaard, J; Alberdi, MT; Prado, JL; Prieto, A; Willerslev, E; Orlando, L				Seguin-Orlando, Andaine; Schubert, Mikkel; Clary, Joel; Stagegaard, Julia; Alberdi, Maria T.; Luis Prado, Jose; Prieto, Alfredo; Willerslev, Eske; Orlando, Ludovic			Ligation Bias in Illumina Next-Generation DNA Libraries: Implications for Sequencing Ancient Genomes	PLOS ONE			English	Article							EXTINCT; DAMAGE; CAVE; PATTERNS; INSIGHTS; HISTORY; HOMININ; REVEAL	Ancient DNA extracts consist of a mixture of endogenous molecules and contaminant DNA templates, often originating from environmental microbes. These two populations of templates exhibit different chemical characteristics, with the former showing depurination and cytosine deamination by-products, resulting from post-mortem DNA damage. Such chemical modifications can interfere with the molecular tools used for building second-generation DNA libraries, and limit our ability to fully characterize the true complexity of ancient DNA extracts. In this study, we first use fresh DNA extracts to demonstrate that library preparation based on adapter ligation at AT-overhangs are biased against DNA templates starting with thymine residues, contrarily to blunt-end adapter ligation. We observe the same bias on fresh DNA extracts sheared on Bioruptor, Covaris and nebulizers. This contradicts previous reports suggesting that this bias could originate from the methods used for shearing DNA. This also suggests that AT-overhang adapter ligation efficiency is affected in a sequence-dependent manner and results in an uneven representation of different genomic contexts. We then show how this bias could affect the base composition of ancient DNA libraries prepared following AT-overhang ligation, mainly by limiting the ability to ligate DNA templates starting with thymines and therefore deaminated cytosines. This results in particular nucleotide misincorporation damage patterns, deviating from the signature generally expected for authenticating ancient sequence data. Consequently, we show that models adequate for estimating post-mortem DNA damage levels must be robust to the molecular tools used for building ancient DNA libraries.	[Seguin-Orlando, Andaine; Schubert, Mikkel; Willerslev, Eske; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Clary, Joel] Musee Confluences, Ctr Conservat & Etud Collect, Lyon, France; [Stagegaard, Julia] Ebeltoft Safari, Ree Pk, Ebeltoft, Denmark; [Alberdi, Maria T.] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Luis Prado, Jose] Univ Nacl Ctr Prov Buenos Aires, Consejo Nacl Invest Cient & Tecn, Olavarria, Argentina; [Prieto, Alfredo] Univ Magallanes, Inst Patagonia, Punta Arenas, Chile; [Prieto, Alfredo] Univ Autonoma Barcelona, Programa Doctorado, E-08193 Barcelona, Spain	University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Magallanes; Autonomous University of Barcelona	Seguin-Orlando, A (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	ASOrlando@snm.ku.dk	Willerslev, Eske/AAA-5686-2019; Prado, Jose Luis/N-2001-2019; prieto, alfredo/D-5033-2013; Schubert, Mikkel/I-6911-2013; Willerslev, Eske/A-9619-2011; Orlando, Ludovic/A-8932-2013; Alberdi, Maria Teresa/ABG-8623-2020	Prado, Jose Luis/0000-0003-0579-8747; Schubert, Mikkel/0000-0003-2401-9921; Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; Alberdi, Maria Teresa/0000-0002-7071-360X; prieto, alfredo/0000-0001-7622-2353	Lundbeck Foundation [R52-A5062]; Danish Council for Independent Research (FNU); Danish National Research Foundation; Marie-Curie Career Integration Grant [FP7 CIG-293845]	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Marie-Curie Career Integration Grant	MS was supported by the Lundbeck Foundation (R52-A5062). This work was supported by the Danish Council for Independent Research (FNU); the Danish National Research Foundation and a Marie-Curie Career Integration Grant (FP7 CIG-293845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bon C, 2012, P ROY SOC B-BIOL SCI, V279, P2825, DOI 10.1098/rspb.2012.0358; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Ginolhac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-177; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, 2003, J MOL EVOL, V57, pS29, DOI 10.1007/s00239-003-0005-4; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	50	50	52	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78575	10.1371/journal.pone.0078575	http://dx.doi.org/10.1371/journal.pone.0078575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205269	Green Published, gold			2022-12-25	WOS:000326270700093
J	Courtney, HS; Li, Y				Courtney, Harry S.; Li, Yi			Non-Immune Binding of Human IgG to M-Related Proteins Confers Resistance to Phagocytosis of Group A Streptococci in Blood	PLOS ONE			English	Article							PYOGENES; PLASMINOGEN; REGION; FAMILY; GENE; IDENTIFICATION; EXPRESSION; SELECTION; ACID	The non-immune binding of immunoglobulins by bacteria is thought to contribute to the pathogenesis of infections. M-related proteins (Mrp) are group A streptococcal (GAS) receptors for immunoglobulins, but it is not known if this binding has any impact on virulence. To further investigate the binding of immunoglobulins to Mrp, we engineered mutants of an M type 4 strain of GAS by inactivating the genes for mrp, emm, enn, sof, and sfbX and tested these mutants in IgG-binding assays. Inactivation of mrp dramatically decreased the binding of human IgG, whereas inactivation of emm, enn, sof, and sfbx had only minor effects, indicating that Mrp is a major IgG-binding protein. Binding of human immunoglobulins to a purified, recombinant form of Mrp indicated that it selectively binds to the Fc domain of human IgG, but not IgA or IgM and that it preferentially bound subclasses IgG(1)>IgG(4)>IgG(2)>IgG(3). Recombinant proteins encompassing different regions of Mrp were engineered and used to map its IgG-binding domain to its A-repeat region and a recombinant protein with 3 A-repeats was a better inhibitor of IgG binding than one with a single A-repeat. A GAS mutant expressing Mrp with an in-frame deletion of DNA encoding the A-repeats had a dramatically reduced ability to bind human IgG and to grow in human blood. Mrp exhibited host specificity in binding IgG; human IgG was the best inhibitor of the binding of IgG followed by pig, horse, monkey, and rabbit IgG. IgG from goat, mouse, rat, cow, donkey, chicken, and guinea pig were poor inhibitors of binding. These findings indicate that Mrp preferentially binds human IgG and that this binding contributes to the ability of GAS to resist phagocytosis and may be a factor in the restriction of GAS infections to the human host.	[Courtney, Harry S.] Univ Tennessee, Ctr Hlth Sci, Vet Affairs Med Ctr, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center	Courtney, HS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vet Affairs Med Ctr, Memphis, TN 38163 USA.	hcourtney@uthsc.edu			US Department of Veterans Affairs; US Public Health Service [AI-095852]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI095852] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research funds from the US Department of Veterans Affairs (HSC) and from US Public Health Service grant AI-095852 (HSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer E A, 1979, Methods Enzymol, V62, P308; Berggard K, 2001, MOL MICROBIOL, V42, P539, DOI 10.1046/j.1365-2958.2001.02664.x; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; BESSEN DE, 1994, INFECT IMMUN, V62, P1968, DOI 10.1128/IAI.62.5.1968-1974.1994; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Courtney HS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956071; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 1997, INFECT IMMUN, V65, P2472, DOI 10.1128/IAI.65.6.2472-2474.1997; HEATH DG, 1987, INFECT IMMUN, V55, P1233, DOI 10.1128/IAI.55.5.1233-1238.1987; HEATH DG, 1990, MOL MICROBIOL, V4, P2071, DOI 10.1111/j.1365-2958.1990.tb00567.x; JOHNSSON E, 1994, J IMMUNOL, V153, P3557; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Krebs B, 1996, MED MICROBIOL IMMUN, V185, P39, DOI 10.1007/s004300050013; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Li Y, 2011, MICROBES INFECT, V13, P413, DOI 10.1016/j.micinf.2010.12.008; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; OTOOLE P, 1992, P NATL ACAD SCI USA, V89, P8661, DOI 10.1073/pnas.89.18.8661; Pack TD, 1996, GENE, V171, P65, DOI 10.1016/0378-1119(96)00102-3; Pack TD, 1995, MOL IMMUNOL, V32, P1235, DOI 10.1016/0161-5890(95)00074-7; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Su YF, 2011, MOL IMMUNOL, V49, P134, DOI 10.1016/j.molimm.2011.08.002; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Woof JM, 2002, BIOCHEM SOC T, V30, P491, DOI 10.1042/bst0300491	32	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78719	10.1371/journal.pone.0078719	http://dx.doi.org/10.1371/journal.pone.0078719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205299	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400100
J	Marti, E; Jofre, J; Balcazar, JL				Marti, Elisabet; Jofre, Juan; Luis Balcazar, Jose			Prevalence of Antibiotic Resistance Genes and Bacterial Community Composition in a River Influenced by a Wastewater Treatment Plant	PLOS ONE			English	Article							TIME PCR ASSAYS; EMERGING CONTAMINANTS; NATURAL ENVIRONMENTS; MASS-SPECTROMETRY; AQUATIC SYSTEMS; PLASMID; SEDIMENT; QUANTIFICATION; DETERMINANTS; MANAGEMENT	Antibiotic resistance represents a global health problem, requiring better understanding of the ecology of antibiotic resistance genes (ARGs), their selection and their spread in the environment. Antibiotics are constantly released to the environment through wastewater treatment plant (WWTP) effluents. We investigated, therefore, the effect of these discharges on the prevalence of ARGs and bacterial community composition in biofilm and sediment samples of a receiving river. We used culture-independent approaches such as quantitative PCR to determine the prevalence of eleven ARGs and 16S rRNA gene-based pyrosequencing to examine the composition of bacterial communities. Concentration of antibiotics in WWTP influent and effluent were also determined. ARGs such as qnrS, bla(TEM), bla(CTX-M), bla(SHV), erm(B), sul(I), sul(II), tet(O) and tet(W) were detected in all biofilm and sediment samples analyzed. Moreover, we observed a significant increase in the relative abundance of ARGs in biofilm samples collected downstream of the WWTP discharge. We also found significant differences with respect to community structure and composition between upstream and downstream samples. Therefore, our results indicate that WWTP discharges may contribute to the spread of ARGs into the environment and may also impact on the bacterial communities of the receiving river.	[Marti, Elisabet; Luis Balcazar, Jose] Univ Girona, Catalan Inst Water Res ICRA, Girona, Spain; [Jofre, Juan] Univ Barcelona, Dept Microbiol, Barcelona, Spain	Institut Catala de Recerca de l'Aigua (ICRA); Universitat de Girona; University of Barcelona	Balcazar, JL (corresponding author), Univ Girona, Catalan Inst Water Res ICRA, Sci & Technol Pk, Girona, Spain.	jlbalcazar@icra.cat	Balcazar, Jose Luis/A-8390-2008; Marti, Elisabet/AAJ-9027-2020	Balcazar, Jose Luis/0000-0002-6866-9347; Marti, Elisabet/0000-0002-5301-3548	Fundacion Eugenio Rodriguez Pascual, Spain; Ramon y Cajal research fellowship from the Spanish Ministry of Economy and Competitiveness [RYC-2011-08154]	Fundacion Eugenio Rodriguez Pascual, Spain; Ramon y Cajal research fellowship from the Spanish Ministry of Economy and Competitiveness	This study was supported by the Fundacion Eugenio Rodriguez Pascual, Spain. J. L. B. acknowledges the Ramon y Cajal research fellowship (RYC-2011-08154) from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Carneiro AR, 2012, J BACTERIOL, V194, P6689, DOI 10.1128/JB.01791-12; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Di Cesare A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062838; Engemann CA, 2008, ENVIRON SCI TECHNOL, V42, P5131, DOI 10.1021/es800238e; Gros M, 2012, J CHROMATOGR A, V1248, P104, DOI 10.1016/j.chroma.2012.05.084; Gros M, 2009, ANAL CHEM, V81, P898, DOI 10.1021/ac801358e; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Iwane T, 2001, WATER SCI TECHNOL, V43, P91; Janzon A, 2012, ANTIMICROBIAL RESIST, P483; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Lapara T., 2012, ANTIMICROBIAL RESIST, P241; LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Mak JK, 2009, J ANTIMICROB CHEMOTH, V63, P47, DOI 10.1093/jac/dkn454; Marti E, 2012, CLIN MICROBIOL INFEC, V18, pE366, DOI 10.1111/j.1469-0691.2012.03935.x; Marti E, 2013, APPL ENVIRON MICROB, V79, P1743, DOI 10.1128/AEM.03409-12; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; MCCOY E, 1954, ANNU REV MICROBIOL, V8, P257, DOI 10.1146/annurev.mi.08.100154.001353; Mokracka J, 2012, WATER RES, V46, P3353, DOI 10.1016/j.watres.2012.03.037; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Petrovic M, 2003, TRAC-TREND ANAL CHEM, V22, P685, DOI 10.1016/S0165-9936(03)01105-1; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sigee D.C., 2005, FRESHWATER MICROBIOL, P524, DOI [10.1002/0470011254, DOI 10.1002/0470011254]; Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Wakelin SA, 2008, APPL ENVIRON MICROB, V74, P2659, DOI 10.1128/AEM.02348-07; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang K, 2007, WATER RES, V41, P2816, DOI 10.1016/j.watres.2007.03.010; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	43	247	261	9	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78906	10.1371/journal.pone.0078906	http://dx.doi.org/10.1371/journal.pone.0078906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205347	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400112
J	Shao, YC; Wang, LB; Ye, EM; Jin, X; Ni, W; Yang, Y; Wen, B; Hu, DW; Yang, Z				Shao, Yongcong; Wang, Lubin; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Wen, Bo; Hu, Dewen; Yang, Zheng			Decreased Thalamocortical Functional Connectivity after 36 Hours of Total Sleep Deprivation: Evidence from Resting State fMRI	PLOS ONE			English	Article							DEFAULT NETWORK; WORKING-MEMORY; GLOBAL SIGNAL; BRAIN; WAKING; FREQUENCIES; IMPACT; MODE	Objectives: The thalamus and cerebral cortex are connected via topographically organized, reciprocal connections, which hold a key function in segregating internally and externally directed awareness information. Previous task-related studies have revealed altered activities of the thalamus after total sleep deprivation (TSD). However, it is still unclear how TSD impacts on the communication between the thalamus and cerebral cortex. In this study, we examined changes of thalamocortical functional connectivity after 36 hours of total sleep deprivation by using resting state function MRI (fMRI). Materials and Methods: Fourteen healthy volunteers were recruited and performed fMRI scans before and after 36 hours of TSD. Seed-based functional connectivity analysis was employed and differences of thalamocortical functional connectivity were tested between the rested wakefulness (RW) and TSD conditions. Results: We found that the right thalamus showed decreased functional connectivity with the right parahippocampal gyrus, right middle temporal gyrus and right superior frontal gyrus in the resting brain after TSD when compared with that after normal sleep. As to the left thalamus, decreased connectivity was found with the right medial frontal gyrus, bilateral middle temporal gyri and left superior frontal gyrus. Conclusion: These findings suggest disruptive changes of the thalamocortical functional connectivity after TSD, which may lead to the decline of the arousal level and information integration, and subsequently, influence the human cognitive functions.	[Shao, Yongcong; Wang, Lubin; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Shao, Yongcong; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Wang, Lubin; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Wen, Bo] Peoples Liberat Army, Gen Hosp, Dept Radiol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; National University of Defense Technology - China; Chinese People's Liberation Army General Hospital	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn; yangzhengchina@aliyun.com	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020		National Military Science Foundation of China [BWS11J045, 06z066]	National Military Science Foundation of China	This work was supported by the National Military Science Foundation of China, Grant No. BWS11J045 and No. 06z066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cajochen C, 1995, SLEEP, V18, P890, DOI 10.1093/sleep/18.10.890; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chen GY, 2011, BRAIN CONNECT, V1, P195, DOI 10.1089/brain.2011.0025; Chuah LYM, 2008, ANN ACAD MED SINGAP, V37, P689; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Galvert G.A., 2001, CEREB CORTEX, V11, P1110; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Strijkstra AM, 2003, NEUROSCI LETT, V340, P17, DOI 10.1016/S0304-3940(03)00033-8; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Wang WC, 2010, NEURON, V68, P835, DOI 10.1016/j.neuron.2010.11.009; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	36	68	71	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78830	10.1371/journal.pone.0078830	http://dx.doi.org/10.1371/journal.pone.0078830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205327	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400109
J	Nemecek, J; Nag, N; Carlson, CM; Schneider, JR; Heisey, DM; Johnson, CJ; Asher, DM; Gregori, L				Nemecek, Julie; Nag, Nabanita; Carlson, Christina M.; Schneider, Jay R.; Heisey, Dennis M.; Johnson, Christopher J.; Asher, David M.; Gregori, Luisa			Red-Backed Vole Brain Promotes Highly Efficient In Vitro Amplification of Abnormal Prion Protein from Macaque and Human Brains Infected with Variant Creutzfeldt-Jakob Disease Agent	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; BLOOD-TRANSFUSION; PRPSC; ASSAY; VCJD; PROPAGATION; CONVERSION; PATIENT; BSE; CJD	Rapid antemortem tests to detect individuals with transmissible spongiform encephalopathies (TSE) would contribute to public health. We investigated a technique known as protein misfolding cyclic amplification (PMCA) to amplify abnormal prion protein (PrPTSE) from highly diluted variant Creutzfeldt-Jakob disease (vCJD)-infected human and macaque brain homogenates, seeking to improve the rapid detection of PrPTSE in tissues and blood. Macaque vCJD PrPTSE did not amplify using normal macaque brain homogenate as substrate (intraspecies PMCA). Next, we tested interspecies PMCA with normal brain homogenate of the southern red-backed vole (RBV), a close relative of the bank vole, seeded with macaque vCJD PrPTSE. The RBV has a natural polymorphism at residue 170 of the PrP-encoding gene (N/N, S/S, and S/N). We investigated the effect of this polymorphism on amplification of human and macaque vCJD PrPTSE. Meadow vole brain (170N/N PrP genotype) was also included in the panel of substrates tested. Both humans and macaques have the same 170S/S PrP genotype. Macaque PrPTSE was best amplified with RBV 170S/S brain, although 170N/N and 170S/N were also competent substrates, while meadow vole brain was a poor substrate. In contrast, human PrPTSE demonstrated a striking narrow selectivity for PMCA substrate and was successfully amplified only with RBV 170S/S brain. These observations suggest that macaque PrPTSE was more permissive than human PrPTSE in selecting the competent RBV substrate. RBV 170S/S brain was used to assess the sensitivity of PMCA with PrPTSE from brains of humans and macaques with vCJD. PrPTSE signals were reproducibly detected by Western blot in dilutions through 10(-12) of vCJD-infected 10% brain homogenates. This is the first report showing PrPTSE from vCJD-infected human and macaque brains efficiently amplified with RBV brain as the substrate. Based on our estimates, PMCA showed a sensitivity that might be sufficient to detect PrPTSE in vCJD-infected human and macaque blood.	[Nemecek, Julie; Nag, Nabanita; Asher, David M.; Gregori, Luisa] US FDA, Lab Bacterial & TSE Agents, Div Emerging Transfus Transmitted Dis, Off Blood Res & Review,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Carlson, Christina M.; Schneider, Jay R.; Heisey, Dennis M.; Johnson, Christopher J.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Carlson, Christina M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA	US Food & Drug Administration (FDA); United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Gregori, L (corresponding author), US FDA, Lab Bacterial & TSE Agents, Div Emerging Transfus Transmitted Dis, Off Blood Res & Review,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	luisa.gregori@fda.hhs.gov	Johnson, Christopher/B-1436-2009; Carlson, Christina/P-6507-2015; Carlson, Christina/D-8327-2013	Johnson, Christopher/0000-0003-4539-2581; Carlson, Christina/0000-0002-4950-8273; Carlson, Christina/0000-0002-4950-8273	FDA Commissioner's fellowship program; FDA Chief Scientist Challenge Award; USGS Wildlife: Terrestrial and Endangered Resources Program	FDA Commissioner's fellowship program; FDA Chief Scientist Challenge Award; USGS Wildlife: Terrestrial and Endangered Resources Program	This work was supported by the FDA Commissioner's fellowship program and by an FDA Chief Scientist Challenge Award. Support also came from the USGS Wildlife: Terrestrial and Endangered Resources Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Dangerous Pathogens, 2012, SE RISK ASS SUBGR PO; Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Cooper JK, 2012, VOX SANG, V102, P100, DOI 10.1111/j.1423-0410.2011.01525.x; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gregori L, 2008, J VIROL METHODS, V149, P251, DOI 10.1016/j.jviromet.2008.01.028; Gregori L, 2011, TRANSFUSION, V51, P2596, DOI 10.1111/j.1537-2995.2011.03199.x; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, EMERG INFECT DIS, V15, P2013, DOI 10.3201/eid1512.090194; Jones M, 2008, NEUROREPORT, V19, P1783, DOI 10.1097/WNR.0b013e328318edfa; Kurt TD, 2011, J VIROL, V85, P8528, DOI 10.1128/JVI.00809-11; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Minor P, 2004, J GEN VIROL, V85, P1777, DOI 10.1099/vir.0.79959-0; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; UK Health Protection Agency, 2012, SUMM RES 2 NAT SURV; UK Health Protection Agency, 2006, EUROSURVEILLANCE, V11; UK Health Protection Agency, 2007, EUROSURVEILLANCE, V12	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78710	10.1371/journal.pone.0078710	http://dx.doi.org/10.1371/journal.pone.0078710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205298	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300080
J	Mizzau, TW; Garner, SR; Marklevitz, SAC; Thompson, GJ; Morbey, YE				Mizzau, Tosh W.; Garner, Shawn R.; Marklevitz, Stephen A. C.; Thompson, Graham J.; Morbey, Yolanda E.			A Genetic Test of Sexual Size Dimorphism in Pre-Emergent Chinook Salmon	PLOS ONE			English	Article							EARLY-LIFE HISTORY; MASU SALMON; ONCORHYNCHUS-MASOU; PACIFIC SALMON; DNA MARKERS; GROWTH; COHO; TEMPERATURE; EVOLUTION; MATURITY	Sex differences in early development may play an important role in the expression of sexual size dimorphism at the adult stage. To test whether sexual size dimorphism is present in pre-emergent chinook salmon (Oncorhynchus tshawytscha), alevins were reared at two temperatures (10 degrees C and 15 degrees C) and sexed using the OtY1 marker on the Y-chromosome. Linear mixed models were used to test for sex differences in alevin size within families while controlling for the random effects of sire and dam nested within sire. Males and females did not differ in weight at 10 degrees C but males were heavier than females at 15 degrees C. Sex accounted for 2% of the within-family variance in weight. In addition, at 15 degrees C, the relationship between weight and sex was greater in families with larger eggs. Whereas male-biased sexual size dimorphism was present at the juvenile stage, female-biased sexual size dimorphism was present at sexual maturity. Males were also younger than females at sexual maturity. A head start on growth by males may underlie their earlier maturation at a smaller size, thus leading to female-biased SSD at the adult stage.	[Mizzau, Tosh W.; Garner, Shawn R.; Marklevitz, Stephen A. C.; Thompson, Graham J.; Morbey, Yolanda E.] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Morbey, YE (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	ymorbey@uwo.ca	Thompson, Graham J/B-6508-2008; Morbey, Yolanda/F-9035-2013; Garner, Shawn/D-9170-2013		Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation - Leaders Opportunity Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation - Leaders Opportunity Fund(Canada Foundation for Innovation)	Funding was provided by Natural Sciences and Engineering Research Council of Canada Discovery Grants to GJT and YEM, and by a Canada Foundation for Innovation - Leaders Opportunity Fund to YEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; Beckman BR, 2008, T AM FISH SOC, V137, P1285, DOI 10.1577/T07-170.1; Burt JM, 2011, REV FISH BIOL FISHER, V21, P377, DOI 10.1007/s11160-010-9179-1; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Devlin RH, 2005, CAN J FISH AQUAT SCI, V62, P1386, DOI 10.1139/F05-048; Devlin RH, 2001, GENETICA, V111, P43, DOI 10.1023/A:1013759802604; DEVLIN RH, 1994, AQUACULTURE, V128, P211, DOI 10.1016/0044-8486(94)90310-7; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FEIST G, 1990, GEN COMP ENDOCR, V80, P299, DOI 10.1016/0016-6480(90)90174-K; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Healey M.C., 1991, PACIFIC SALMON LIFE, P312; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heath DD, 1996, J EXP MAR BIOL ECOL, V208, P239; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Jensen JOT, 2009, CAN TECH REP FISH AQ, V2389, P49; Lynch M., 1998, GENETICS ANAL QUANTI; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Nagata M, 1997, J FISH BIOL, V51, P601, DOI 10.1006/jfbi.1997.0463; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; R Core Development Team, 2009, R LANG ENV STAT COMP; Rhen Turk, 2007, P167; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tamate T, 2006, EVOLUTION, V60, P196, DOI 10.1111/j.0014-3820.2006.tb01094.x; Tamate T, 2004, ECOL FRESHW FISH, V13, P96, DOI 10.1111/j.1600-0633.2004.00043.x; Vollestad LA, 2004, T AM FISH SOC, V133, P495, DOI 10.1577/T03-033.1; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weeder JA, 2005, N AM J FISH MANAGE, V25, P861, DOI 10.1577/M03-227.1; Williamson KS, 2005, T AM FISH SOC, V134, P1253, DOI 10.1577/T04-208.1; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Yamamoto T, 2004, ECOL FRESHW FISH, V13, P203, DOI 10.1111/j.1600-0633.2004.00051.x; Young KA, 2005, P ROY SOC B-BIOL SCI, V272, P167, DOI 10.1098/rspb.2004.2931	33	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78421	10.1371/journal.pone.0078421	http://dx.doi.org/10.1371/journal.pone.0078421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205229	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600101
J	Piedrafita, D; Preston, S; Kemp, J; de Veer, M; Sherrard, J; Kraska, T; Elhay, M; Meeusen, E				Piedrafita, David; Preston, Sarah; Kemp, Joanna; de Veer, Michael; Sherrard, Jayne; Kraska, Troy; Elhay, Martin; Meeusen, Els			The Effect of Different Adjuvants on Immune Parameters and Protection following Vaccination of Sheep with a Larval-Specific Antigen of the Gastrointestinal Nematode, Haemonchus contortus	PLOS ONE			English	Article							MECHANISMS; IMMUNIZATION; CHALLENGE; INFECTION; PARASITES; ALUMINUM; KINETICS; VACCINES; ANTIBODY; CELLS	It has recently been recognised that vaccine adjuvants play a critical role in directing the nature of a vaccine induced effector response. In the present study, several adjuvants were evaluated for their ability to protect sheep after field vaccination with the larval-specific Haemonchus contortus antigen, HcsL3. Using a suboptimal antigen dose, aluminium adjuvant was shown to reduce the cumulative faecal egg counts (cFEC) and worm burden by 23% and 25% respectively, in agreement with a previous study. The addition of Quil A to the aluminium-adjuvanted vaccine brought cFEC back to control levels. Vaccination with the adjuvant DEAE-dextran almost doubled the protection compared to the aluminium-adjuvanted vaccine resulting in 40% and 41% reduction in cFEC and worm counts compared to controls. Examination of skin responses following i.d. injection of exsheathed L3, revealed that cFEC was negatively correlated with wheal size and tissue eosinophils for the DEAE-dextran and aluminium-adjuvanted groups respectively. These studies have for the first time shown the potential of DEAE-dextran adjuvant for helminth vaccines, and discovered significant cellular correlates of vaccine-induced protection.	[Piedrafita, David; Preston, Sarah; Kemp, Joanna; de Veer, Michael; Sherrard, Jayne; Kraska, Troy; Meeusen, Els] Monash Univ, Sch Biomed Sci, Clayton, Vic, Australia; [Piedrafita, David; Preston, Sarah; Meeusen, Els] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Elhay, Martin] Pfizer Anim Hlth, Vet Med Res & Dev, Parkville, Vic, Australia	Monash University; Monash University; Pfizer	Piedrafita, D (corresponding author), Monash Univ, Sch Biomed Sci, Clayton, Vic, Australia.	david.piedrafita@monash.edu		Preston, Sarah/0000-0002-4227-1664; piedrafita, david/0000-0001-8692-990X; Meeusen, Els/0000-0003-1239-6287	Australian Research Council [LP0668945]; ARC-Centre of Excellence in Structural and Functional Microbial Genomics	Australian Research Council(Australian Research Council); ARC-Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council)	Australian Research Council Linkage grant LP0668945 and the ARC-Centre of Excellence in Structural and Functional Microbial Genomics. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; BEH KJ, 1987, VET IMMUNOL IMMUNOP, V14, P187, DOI 10.1016/0165-2427(87)90053-5; Bethony JM, 2006, PARASITOLOGY, V133, pS63, DOI 10.1017/S0031182006001818; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; de Veer M, 2011, DISCOV MED, V12, P195; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Hein WR, 2010, PARASITE IMMUNOL, V32, P541, DOI 10.1111/j.1365-3024.2010.01213.x; Jacobs HJ, 1999, VACCINE, V17, P362, DOI 10.1016/S0264-410X(98)00206-0; Jankovic D, 2004, J IMMUNOL, V173, P2419, DOI 10.4049/jimmunol.173.4.2419; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Piedrafita DP, 2012, VACCINE, V30, P7199, DOI 10.1016/j.vaccine.2012.10.019; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rainbird MA, 1998, PARASITE IMMUNOL, V20, P93, DOI 10.1046/j.1365-3024.1998.00132.x; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; TURNBULL IF, 1992, INT J PARASITOL, V22, P537, DOI 10.1016/0020-7519(92)90157-G; Vizcarra JA, 2012, J ANIM SCI, V90, P1479, DOI 10.2527/jas.2011-4554; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	25	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78357	10.1371/journal.pone.0078357	http://dx.doi.org/10.1371/journal.pone.0078357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205209	Green Published, gold			2022-12-25	WOS:000326032600099
J	Ratcliffe, N; Takahashi, A; O'Sullivan, C; Adlard, S; Trathan, PN; Harris, MP; Wanless, S				Ratcliffe, Norman; Takahashi, Akinori; O'Sullivan, Claire; Adlard, Stacey; Trathan, Philip N.; Harris, Michael P.; Wanless, Sarah			The Roles of Sex, Mass and Individual Specialisation in Partitioning Foraging-Depth Niches of a Pursuit-Diving Predator	PLOS ONE			English	Article							BLUE-EYED SHAG; REARING CROZET SHAGS; ANTARCTIC FUR SEALS; PHALACROCORAX-ALBIVENTER; INTERSEXUAL DIFFERENCES; JAPANESE CORMORANTS; SPATIAL SEGREGATION; STABLE-ISOTOPES; KING CORMORANTS; SITE FIDELITY	Intra-specific foraging niche partitioning can arise due to gender differences or individual specialisation in behaviour or prey selection. These may in turn be related to sexual size dimorphism or individual variation in body size through allometry. These variables are often inter-related and challenging to separate statistically. We present a case study in which the effects of sex, body mass and individual specialisation on the dive depths of the South Georgia shag on Bird Island, South Georgia are investigated simultaneously using a linear mixed model. The nested random effects of trip within individual explained a highly significant amount of the variance. The effects of sex and body mass were both significant independently but could not be separated statistically owing to them being strongly interrelated. Variance components analysis revealed that 45.5% of the variation occurred among individuals, 22.6% among trips and 31.8% among Dives, while R-2 approximations showed gender explained 31.4% and body mass 55.9% of the variation among individuals. Male dive depths were more variable than those of females at the levels of individual, trip and dive. The effect of body mass on individual dive depths was only marginally significant within sexes. The percentage of individual variation in dive depths explained by mass was trivial in males (0.8%) but substantial in females (24.1%), suggesting that differences in dive depths among males was largely due to them adopting different behavioural strategies whereas in females allometry played an additional role. Niche partitioning in the study population therefore appears to be achieved through the interactive effects of individual specialisation and gender upon vertical foraging patch selection, and has the potential to interact in complex ways with other axes of the niche hypervolume such as foraging locations, timing of foraging and diet.	[Ratcliffe, Norman; O'Sullivan, Claire; Adlard, Stacey; Trathan, Philip N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Takahashi, Akinori] Natl Inst Polar Res, Tokyo, Japan; [Harris, Michael P.; Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Centre for Ecology & Hydrology (UKCEH)	Ratcliffe, N (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	notc@bas.ac.uk			Natural Environment Research Council (NERC); British Ecological Society and Akinori Takahashi; Natural Environment Research Council [bas0100025, CEH010021] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society and Akinori Takahashi; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) as part of the British Antarctic Ecosystems programme. SW received a travel grant from the British Ecological Society and Akinori Takahashi one from the Japan Society the Promotion of Science. BAS and CEH are institutions within the NERC funding organisation, but no member of NERC other than the authors had any role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2001, J FIELD ORNITHOL, V72, P22, DOI 10.1648/0273-8570-72.1.22; Coleman JTH, 2005, WATERBIRDS, V28, P498, DOI 10.1675/1524-4695(2005)28[498:FLASFO]2.0.CO;2; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056297; Cook TR, 2008, MAR BIOL, V154, P383, DOI 10.1007/s00227-008-0939-6; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; CROXALL JP, 1991, J ZOOL, V225, P177, DOI 10.1111/j.1469-7998.1991.tb03810.x; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2009, WATERBIRDS, V32, P491; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gremillet D, 1999, MAR ECOL PROG SER, V183, P263, DOI 10.3354/meps183263; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ishikawa K, 2002, J ETHOL, V20, P49, DOI 10.1007/s10164-002-0053-z; Kato A, 1999, CR ACAD SCI III-VIE, V322, P557, DOI 10.1016/S0764-4469(00)88525-X; Kato A, 1996, CONDOR, V98, P844, DOI 10.2307/1369867; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kock K-H, 1992, ANTARCTIC FISH FISHE; Kotzerka J, 2011, CONDOR, V113, P80, DOI 10.1525/cond.2011.090158; LABEELUND JH, 1993, J ANIM ECOL, V62, P160, DOI 10.2307/5490; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; MALACALAZA VE, 1988, COLON WATERBIRD, V11, P32, DOI 10.2307/1521167; McIntyre T, 2010, MAR ECOL PROG SER, V412, P293, DOI 10.3354/meps08680; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 2010, AQUAT BIOL, V8, P247, DOI 10.3354/ab00219; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; ORTA J, 1992, HDB BIRDS WORLD, P00326; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paredes R, 2008, CAN J ZOOL, V86, P610, DOI 10.1139/Z08-036; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Pinheiro J, 2001, R PACKAGE VERSION, P31; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2007, MAR ECOL PROG SER, V334, P299, DOI 10.3354/meps334299; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; Rey AR, 2012, EMU, V112, P90, DOI 10.1071/MU11065; Rezsu E, 2006, ECOL FRESHW FISH, V15, P339, DOI 10.1111/j.1600-0633.2006.00172.x; Ropert-Coudert Y, 2003, WATERBIRDS, V26, P403, DOI 10.1675/1524-4695(2003)026[0403:IDSITL]2.0.CO;2; Ruckstuhl K, 2005, SEXUAL SEGREGATION V; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Staniland IJ, 2004, MAR ECOL PROG SER, V275, P263, DOI 10.3354/meps275263; Svagelj WS, 2007, WATERBIRDS, V30, P97, DOI 10.1675/1524-4695(2007)030[0097:SSDASD]2.0.CO;2; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tremblay Y, 2005, CAN J ZOOL, V83, P971, DOI 10.1139/Z05-085; Wanless S, 1999, MAR ECOL PROG SER, V188, P219, DOI 10.3354/meps188219; WANLESS S, 1992, POLAR BIOL, V12, P713; WANLESS S, 1995, CONDOR, V97, P550, DOI 10.2307/1369040; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2004, MAR BIOL, V145, P427, DOI 10.1007/s00227-004-1345-3; Watanuki Y, 1996, CAN J ZOOL, V74, P1098, DOI 10.1139/z96-122; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Wilson RP, 2008, ECOL MONOGR, V78, P633, DOI 10.1890/07-0677.1; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zuur Alain F., 2009, P1	74	24	24	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79107	10.1371/journal.pone.0079107	http://dx.doi.org/10.1371/journal.pone.0079107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205368	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326032600118
J	Liu, X; Zhu, W; Guan, SH; Feng, RH; Zhang, H; Liu, QH; Sun, P; Lin, DH; Zhang, NX; Shen, J				Liu, Xia; Zhu, Wei; Guan, Shuhong; Feng, Ruihong; Zhang, Hui; Liu, Qiuhong; Sun, Peng; Lin, Donghai; Zhang, Naixia; Shen, Jun			Metabolomic Analysis of Anti-Hypoxia and Anti-anxiety Effects of Fu Fang Jin Jing Oral Liquid	PLOS ONE			English	Article							PLUS-MAZE; DEPRESSION; STRESS; MICE; RATS; SPECTROSCOPY; ADAPTATION; EXPRESSION; RECEPTORS; RESPONSES	Background: Herba Rhodiolae is a traditional Chinese medicine used by the Tibetan people for treating hypoxia related diseases such as anxiety. Based on the previous work, we developed and patented an anti-anxiety herbal formula Fu Fang Jin Jing Oral Liquid (FJJOL) with Herba Rhodiolae as a chief ingredient. In this study, the anti-hypoxia and anti-anxiety effects of FJJOL in a high altitude forced-swimming mouse model with anxiety symptoms will be elucidated by NMR-based metabolomics. Methods: In our experiments, the mice were divided randomly into four groups as flatland group, high altitude saline-treated group, high altitude FJJOL-treated group, and high altitude diazepam-treated group. To cause anxiety effects and hypoxic defects, a combination use of oxygen level decreasing (hypobaric cabin) and oxygen consumption increasing (exhaustive swimming) were applied to mice. After a three-day experimental handling, aqueous metabolites of mouse brain tissues were extracted and then subjected to NMR analysis. The therapeutic effects of FJJOL on the hypobaric hypoxia mice with anxiety symptoms were verified. Results: Upon hypoxic exposure, both energy metabolism defects and disorders of functional metabolites in brain tissues of mice were observed. PCA, PLS-DA and OPLS-DA scatter plots revealed a clear group clustering for metabolic profiles in the hypoxia versus normoxia samples. After a three-day treatment with FJJOL, significant rescue effects on energy metabolism were detected, and levels of ATP, fumarate, malate and lactate in brain tissues of hypoxic mice recovered. Meanwhile, FJJOL also up-regulated the neurotransmitter GABA, and the improvement of anxiety symptoms was highly related to this effect. Conclusions: FJJOL ameliorated hypobaric hypoxia effects by regulating energy metabolism, choline metabolism, and improving the symptoms of anxiety. The anti-anxiety therapeutic effects of FJJOL were comparable to the conventional anti-anxiety drug diazepam on the hypobaric hypoxia mice. FJJOL might serve as an alternative therapy for the hypoxia and anxiety disorders.	[Zhu, Wei; Zhang, Hui; Liu, Qiuhong; Shen, Jun] Naval Med Res Inst, Shanghai, Peoples R China; [Liu, Xia; Sun, Peng; Zhang, Naixia] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 200031, Peoples R China; [Guan, Shuhong; Feng, Ruihong] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Engn Lab TCM Standardizat Technol, Shanghai 200031, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Xiamen University	Lin, DH (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China.	dhlin@xmu.edu.cn; nxzhang@mail.shcnc.ac.cn; zhu_wei2002@163.com			National Natural Science Foundation of China [30900662]; Shanghai Foundation for Development of Science and Technology [08411965600]; "100 Talents Program" of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Foundation for Development of Science and Technology; "100 Talents Program" of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the National Natural Science Foundation of China (Grant No. 30900662), the Shanghai Foundation for Development of Science and Technology (Grant No. 08411965600), and the "100 Talents Program" of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglin RE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.107; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Beyoglu D, 2012, BIOCHEM PHARMACOL, V85, P12; Chen PJ, 2011, J MED FOOD, V14, P610, DOI 10.1089/jmf.2010.1209; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; CONNETT RJ, 1990, J APPL PHYSIOL, V68, P833, DOI 10.1152/jappl.1990.68.3.833; CzyzykKrzeska MF, 1997, RESP PHYSIOL, V110, P99, DOI 10.1016/S0034-5687(97)00076-5; D'Alessandro A, 2012, DRUG DISCOV TODAY, V17, P3, DOI 10.1016/j.drudis.2011.09.017; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Frey BN, 2007, BIPOLAR DISORD, V9, P119, DOI 10.1111/j.1399-5618.2007.00454.x; Hirani K, 2005, PSYCHOPHARMACOLOGY, V180, P267, DOI 10.1007/s00213-005-2169-7; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Kang M, 2005, AM J CHINESE MED, V33, P205, DOI 10.1142/S0192415X05002874; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Li T, 2008, CHEM PHARM BULL, V56, P807, DOI 10.1248/cpb.56.807; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Liu J, 2011, INT J MOL SCI, V12, P6469, DOI 10.3390/ijms12106469; Liu J, 2010, BIOMED ENVIRON SCI, V23, P312, DOI 10.1016/S0895-3988(10)60069-4; Lu XM, 2011, TALANTA, V83, P700, DOI 10.1016/j.talanta.2010.09.026; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; MONTELEONE P, 1990, J AFFECT DISORDERS, V20, P1, DOI 10.1016/0165-0327(90)90043-8; Nakanishi K, 1999, LAB INVEST, V79, P679; Nicholson G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002270; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Przegalinski E, 1997, NEUROPHARMACOLOGY, V36, P31, DOI 10.1016/S0028-3908(96)00157-8; RAGO L, 1988, N-S ARCH PHARMACOL, V337, P675; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; Rojas P, 2011, NEUROCHEM INT, V59, P628, DOI 10.1016/j.neuint.2011.05.007; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Solomon D, 2011, AUST NZ J PSYCHIAT, V45, P123, DOI 10.3109/00048674.2010.526094; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Vasilyev KY, 2007, B EXP BIOL MED+, V144, P695, DOI 10.1007/s10517-007-0408-0; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Weljie AM, 2011, J BIOMOL NMR, V49, P185, DOI 10.1007/s10858-011-9486-4; YANG YC, 1991, ZANG YAO ZHI, P34; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002; Zhong F, 2012, NEPHROL DIAL TRANSPL, V27, P556, DOI 10.1093/ndt/gfr368	47	24	26	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78281	10.1371/journal.pone.0078281	http://dx.doi.org/10.1371/journal.pone.0078281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205180	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300150
J	Geng, L; Chaudhuri, A; Talmon, G; Wisecarver, JL; Are, C; Brattain, M; Wang, J				Geng, L.; Chaudhuri, A.; Talmon, G.; Wisecarver, J. L.; Are, C.; Brattain, M.; Wang, J.			MicroRNA-192 suppresses liver metastasis of colon cancer	ONCOGENE			English	Article						colon cancer; liver metastasis; miR-192; Bcl-2; Zeb2; VEGFA	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; REPRESSORS ZEB1; EXPRESSION; RECEPTOR; CARCINOMA; CELLS; GENES	Metastasis causes most deaths from colon cancer yet mechanistic understanding and therapeutic options remain limited. Here we show that expression of microRNA (miR)-192 is inversely correlated with metastatic potential of colon cancer cells. Ectopic expression of miR-192 sensitizes colon cancer cells to growth factor deprivation stress-induced apoptosis, whereas inhibition of miR-192 confers resistance. Overexpression of miR-192 inhibits metastatic colonization to the liver in an orthotopic mouse model of colon cancer. Alterations associated with the metastatic phenotype in the primary tumors include increased apoptosis, decreased proliferation and angiogenesis. Further studies indicate that miR-192 downregulates expression of Bcl-2, Zeb2 and VEGFA in vitro and in vivo, which is responsible for enhanced apoptosis, increased expression of E-cadherin and decreased angiogenesis in vivo, respectively. Finally, studies performed on human colonic adenocarcinoma show that expression of miR-192 is significantly reduced in neoplastic cells as compared with normal colonic epithelium. Importantly, there is a significant decrease in miR-192 expression in stage IV tumors when compared with stage I or II lesions. These findings indicate that miR-192 has an important role in colon cancer development and progression. Our studies underscore the clinical relevance and prognostic significance of miR-192 expression in colon cancer. Therefore, a major implication of our studies is that restoration of miR-192 expression or antagonism of its target genes (Bcl-2, Zeb2 or VEGFA) may have considerable therapeutic potential for anti-metastatic therapy in patients with colon cancer.	[Geng, L.; Chaudhuri, A.; Brattain, M.; Wang, J.] Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Talmon, G.; Wisecarver, J. L.] Dept Pathol & Microbiol, Omaha, NE USA; [Are, C.] Univ Nebraska Med Ctr, Dept Surg Oncol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Wang, J.] Dept Genet Cell Biol & Anat, Omaha, NE USA; [Wang, J.] Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017	Chaudhuri, Anathbandhu/0000-0003-4833-3077	NIH/NCI [R01CA140988-01]; Nebraska Department of Health and Human Services [(LB506) 2013-40]; NATIONAL CANCER INSTITUTE [R01CA140988] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI funding R01CA140988-01 and Nebraska Department of Health and Human Services (LB506) 2013-40 to JW.	Agui T, 2002, ANTICANCER RES, V22, P1769; Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BOYD DD, 1988, CANCER RES, V48, P2469; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grady WM, 1999, CANCER RES, V59, P320; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Karakas T, 1998, ANN ONCOL, V9, P159, DOI 10.1023/A:1008255511404; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Klinger M, 2010, ANN SURG ONCOL, V17, P2059, DOI 10.1245/s10434-010-0972-9; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.221697; Majid S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046743; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Meng FY, 2012, CANCER METAST REV, V31, P455, DOI 10.1007/s10555-012-9379-3; Moreira JN, 2006, REV RECENT CLIN TRIA, V1, P217, DOI 10.2174/157488706778250050; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; Stoeltzing O, 2003, ANN SURG ONCOL, V10, P722, DOI 10.1245/ASO.2003.07.019; Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068; Tian Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048958; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye SC, 1999, CANCER RES, V59, P4725; Yokoi K, 2005, CANCER RES, V65, P3716, DOI 10.1158/0008-5472.CAN-04-3700; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Yue X, 2012, ONCOL REP, V27, P1200, DOI 10.3892/or.2011.1588; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zubeldia IG, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.11.004	59	99	108	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5332	5340		10.1038/onc.2013.478	http://dx.doi.org/10.1038/onc.2013.478			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24213572	Green Accepted			2022-12-25	WOS:000345120600003
J	Nehil, M; Paquette, J; Tokuyasu, T; McCormick, F				Nehil, M.; Paquette, J.; Tokuyasu, T.; McCormick, F.			High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A	ONCOGENE			English	Article						HMGB1; SEMA3A; migration; chromatin; metastasis	END-PRODUCTS RAGE; INCREASED EXPRESSION; MURINE COLITIS; HMGB1; CANCER; BINDING; PROTEIN; CARCINOMA; RECEPTOR; GROWTH	High mobility group box 1 (HMGB1) is a 25-kDa chromatin-associated protein that aids in transcription and DNA repair by directly binding to DNA and altering its conformation. Additionally, HMGB1 can act as an extracellular ligand. When released from dying or stressed cells, HMGB1 binds to the RAGE receptor and activates the p42/44 MAP kinase (MAPK) cascade. HMGB1 is overexpressed in many types of cancer and frequently associated with tumor stage and metastasis. This has predominantly been attributed to an autocrine function that drives MAPK pathway activity. However, by using tumor cells with activating MAPK pathway mutations, we have identified a role for HMGB1 in promoting metastasis and tumor growth that is independent of this pathway. In the absence of HMGB1, these tumor cells show defective in vitro migration as well as reduced metastasis and tumor growth in vivo despite high p42/44 phosphorylation. We found that semaphorin 3A (SEMA3A), previously shown to act as a suppressor of angiogenesis and migration, was highly increased during expression in the absence of HMGB1. SEMA3A/HMGB1 double knockdown rescued the migration defect in HMGB1 single knockdown cells. HMGB1 bound at the semaphorin 3A genomic locus, promoted hetrochromatin formation, and decreased occupancy of acetylated histones. Based on human tumor gene expression databases, HMGB1 was significantly inversely correlated with SEMA3A, suggesting that this mechanism may be more widely relevant in different cancer types.	[Nehil, M.] Harvard Univ, Med Scool, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Paquette, J.; Tokuyasu, T.; McCormick, F.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Program Biomed Sci, San Francisco, CA 94158 USA; [Paquette, J.; Tokuyasu, T.; McCormick, F.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Bioinformat Program, San Francisco, CA 94158 USA	Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	McCormick, F (corresponding author), Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, 1450 3rd St,Rm HD-371 UCSF Box 0128, San Francisco, CA 94158 USA.	mccormick@cc.ucsf.edu		Tokuyasu, Taku/0000-0003-3401-3195	UCSF Tetrad program	UCSF Tetrad program	We thank the UCSF Tetrad program for providing funding. We thank Dr Lewis Lanier for all of his advice. We thank Dr Byron Hann, Dr Paul Phojanakong and the UCSF Clinical Therapeutics core for all of their help with mouse xenograft experiments and the UCSF Genome core for their help with gene expression studies.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Cheng BQ, 2008, DIGEST LIVER DIS, V40, P446, DOI 10.1016/j.dld.2007.11.024; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; GE H, 1994, J BIOL CHEM, V269, P17136; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Joshi SR, 2012, NUCLEIC ACIDS RES, V40, P10161, DOI 10.1093/nar/gks815; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P599, DOI 10.1189/jlb.0908578; Lin Q, 2011, ARTERIOSCL THROM VAS, V31, P1024, DOI 10.1161/ATVBAHA.111.224048; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; McCauley MJ, 2007, J MOL BIOL, V374, P993, DOI 10.1016/j.jmb.2007.09.073; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Ranzato E, 2010, CELL BIOCHEM BIOPHYS, V57, P9, DOI 10.1007/s12013-010-9077-0; Sapojnikova N, 2005, BBA-GENE STRUCT EXPR, V1729, P57, DOI 10.1016/j.bbaexp.2005.03.002; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Yao XJ, 2010, J CANCER RES CLIN, V136, P677, DOI 10.1007/s00432-009-0706-1	34	17	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5151	5162		10.1038/onc.2013.459	http://dx.doi.org/10.1038/onc.2013.459			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24213571				2022-12-25	WOS:000343914900002
J	Denholm, SJ; Norman, RA; Hoyle, AS; Shinn, AP; Taylor, NGH				Denholm, Scott J.; Norman, Rachel A.; Hoyle, Andrew S.; Shinn, Andrew P.; Taylor, Nick G. H.			Reproductive Trade-Offs May Moderate the Impact of Gyrodactylus salaris in Warmer Climates	PLOS ONE			English	Article							SALMON SALMO-SALAR; ATLANTIC SALMON; RAINBOW-TROUT; COMPARATIVE SUSCEPTIBILITY; POPULATION-GROWTH; RIVER; RISK; INFECTION; MALMBERG; EXPRESSION	Gyrodactylus salaris is a notifiable freshwater ectoparasite of salmonids. Its primary host is Atlantic salmon (Salmo salar), upon which infections can cause death, and have led to massive declines in salmon numbers in Norway, where the parasite is widespread. Different strains of S. salar vary in their susceptibility, with Atlantic strains (such as those found in Norway) exhibiting no resistance to the parasite, and Baltic strains demonstrating an innate resistance sufficient to regulate parasite numbers on the host causing it to either die out or persist at a low level. In this study, Leslie matrix and compartmental models were used to generate data that demonstrated the population growth of G. salaris on an individual host is dependent on the total number of offspring per parasite, its longevity and the timing of its births. The data demonstrated that the key factor determining the rate of G. salaris population growth is the time at which the parasite first gives birth, with rapid birth rate giving rise to large population size. Furthermore, it was shown that though the parasite can give birth up to four times, only two births are required for the population to persist as long as the first birth occurs before a parasite is three days old. As temperature is known to influence the timing of the parasite's first birth, greater impact may be predicted if introduced to countries with warmer climates than Norway, such as the UK and Ireland which are currently recognised to be free of G. salaris. However, the outputs from the models developed in this study suggest that temperature induced trade-offs between the total number of offspring the parasite gives birth to and the first birth timing may prevent increased population growth rates over those observed in Norway.	[Denholm, Scott J.; Norman, Rachel A.; Hoyle, Andrew S.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Norman, Rachel A.; Shinn, Andrew P.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Taylor, Nick G. H.] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci Cefas, Weymouth, England	University of Stirling; University of Stirling; Centre for Environment Fisheries & Aquaculture Science	Denholm, SJ (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	sde@stir.ac.uk	Norman, Rachel A/A-2930-2009; Norman, R/AAI-8164-2021; Norman, R/AFT-9458-2022; Denholm, Scott J/L-2520-2015	Norman, Rachel A/0000-0002-7398-6064; Norman, R/0000-0002-7398-6064; Norman, R/0000-0002-7398-6064; Denholm, Scott J/0000-0002-6291-8269; Hoyle, Andrew/0000-0002-9117-7041	Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the English Government [FC1197]; Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the Welsh Government [FC1197]	Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the English Government; Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the Welsh Government	This research was supported by the Department of the Environment, Fisheries and Rural Affairs (DEFRA, http://www.defra.gov.uk/) of the English and Welsh Governments (project no. FC1197) awarded to NGHT and RAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PS, 1998, J HELMINTHOL, V72, P9, DOI 10.1017/S0022149X00000900; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 1998, CAN J FISH AQUAT SCI, V55, P247, DOI 10.1139/cjfas-55-S1-247; BAKKE TA, 1993, FISH RES, V17, P69, DOI 10.1016/0165-7836(93)90008-U; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; Buchmann K, 1999, FOLIA PARASIT, V46, P1; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2000, PARASITOLOGY, V121, P621, DOI 10.1017/S0031182000006971; Dalgaard MB, 2004, J AQUAT ANIM HEALTH, V16, P109, DOI 10.1577/H03-004.1; Dalgaard MB, 2003, DIS AQUAT ORGAN, V53, P173, DOI 10.3354/dao053173; Des Clers Sophie, 1993, Fisheries Research (Amsterdam), V17, P237, DOI 10.1016/0165-7836(93)90023-Z; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Harris PD, 2000, PARASITOLOGY, V120, P57, DOI 10.1017/S0031182099005223; HEGGBERGET TG, 1982, J FISH BIOL, V21, P15, DOI 10.1111/j.1095-8649.1982.tb02819.x; Hogasen HR, 2003, DIS AQUAT ORGAN, V57, P247, DOI 10.3354/dao057247; JANSEN PA, 1991, PARASITOLOGY, V102, P105, DOI 10.1017/S0031182000060406; Jansen PA, 2007, DIS AQUAT ORGAN, V74, P139, DOI 10.3354/dao074139; JOHNSEN BO, 1986, J FISH BIOL, V29, P233, DOI 10.1111/j.1095-8649.1986.tb04941.x; JOHNSEN BO, 1992, J FISH BIOL, V40, P433, DOI 10.1111/j.1095-8649.1992.tb02588.x; JOHNSEN BO, 1999, NINA OPPDRAGSMELDING, V617, P1; JOHNSEN BO, 2003, ATLANTIC SALMON BIOL, P38; Kania P, 2007, DIS AQUAT ORGAN, V76, P81, DOI 10.3354/dao076081; Kochin BF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000524; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Lindenstrom T, 2004, VET IMMUNOL IMMUNOP, V97, P137, DOI 10.1016/j.vetimm.2003.08.016; Lindenstrom T, 2003, FISH SHELLFISH IMMUN, V15, P107, DOI 10.1016/S1050-4648(02)00142-0; Malmberg G., 1989, P88; Malmberg G, 1998, INT J PARASITOL, V28, P1625, DOI 10.1016/S0020-7519(98)00058-7; Mo T.A., 1994, P43; MO TA, 2004, NORSK VETERINAERTIDS, V3, P164; NOU (Norges Offentlige Utredninger), 1999, LAKS KAN INGEN GJERA, P1; Paisley LG, 1999, DIS AQUAT ORGAN, V37, P145, DOI 10.3354/dao037145; Peeler E, 2006, AQUACULTURE, V258, P187, DOI 10.1016/j.aquaculture.2005.07.042; Peeler EJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-94; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Peeler EJ, 2004, DIS AQUAT ORGAN, V62, P103, DOI 10.3354/dao062103; Ramirez R, 2012, INT J PARASITOL, V42, P809, DOI 10.1016/j.ijpara.2012.05.012; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; Tanum K, 1983, THESIS U OSLO; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; 1999, NORGES OFFENTLIGE UT, V9, P1	43	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78909	10.1371/journal.pone.0078909	http://dx.doi.org/10.1371/journal.pone.0078909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205349	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500140
J	Di Luigi, L; Sottili, M; Antinozzi, C; Vannelli, GB; Romanelli, F; Riccieri, V; Valesini, G; Lenzi, A; Crescioli, C				Di Luigi, Luigi; Sottili, Mariangela; Antinozzi, Cristina; Vannelli, Gabriella Barbara; Romanelli, Francesco; Riccieri, Valeria; Valesini, Guido; Lenzi, Andrea; Crescioli, Clara			The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; SKELETAL-MUSCLE CELLS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; CLASS-I; HUMAN MYOBLASTS; D ANALOG; EXPRESSION; CHEMOKINES; CYTOKINES	Objective: This study aims to investigate in vitro the effect of the VDR agonist BXL-01-0029 onto IFN gamma/TNF alpha-induced CXCL10 secretion by human skeletal muscle cells compared to elocalcitol (VDR agonist), methylprednisolone, methotrexate, cyclosporin A, infliximab and leflunomide; to assess in vivo circulating CXCL10 level in subjects at time of diagnosis with IMs, before therapy, together with TNF alpha, IFN gamma, IL-8, IL-6, MCP-1, MIP-1 beta and IL-10, vs. healthy subjects. Methods: Human fetal skeletal muscle cells were used for in vitro studies; ELISA and Bio-Plex were used to measure cell supernatant and IC50 determination or serum cytokines; Western blot and Bio-Plex were for cell signaling analysis. Results: BXL-01-0029 decreased with the highest potency IFN gamma/TNF alpha-induced CXCL10 protein secretion and targeted cell signaling downstream of TNF alpha in human skeletal muscle cells; CXCL10 level was the highest in sera of subjects diagnosed with IMs before therapy and the only one significantly different vs. healthy controls. Conclusions: Our in vitro and in vivo data, while confirm the relevance of CXCL10 in IMs, suggested BXL-01-0029 as a novel pharmacological tool for IM treatment, hypothetically to be used in combination with the current immunosuppressants to minimize side effects.	[Di Luigi, Luigi; Antinozzi, Cristina; Crescioli, Clara] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Sottili, Mariangela] Univ Florence, Excellence Ctr Res Transfer & High Educ Novo Ther, Florence, Italy; [Vannelli, Gabriella Barbara] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Romanelli, Francesco; Lenzi, Andrea] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Riccieri, Valeria; Valesini, Guido] Univ Roma La Sapienza, Dept Internal Med & Clin Special, I-00185 Rome, Italy	Foro Italico University of Rome; University of Florence; University of Florence; Sapienza University Rome; Sapienza University Rome	Crescioli, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	clara.crescioli@uniroma4.it	Romanelli, Francesco/A-7925-2012; Lenzi, Andrea/I-7711-2015; Riccieri, Valeria/AAC-6079-2022	Lenzi, Andrea/0000-0002-7711-0465; Riccieri, Valeria/0000-0002-7507-5483	M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca)	M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This study was supported by M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca) (www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Adorini L, 2007, J STEROID BIOCHEM, V103, P689, DOI 10.1016/j.jsbmb.2006.12.065; Aggarwal R, 2012, CURR OPIN RHEUMATOL, V24, P635, DOI 10.1097/BOR.0b013e328358ac72; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Campbell J. Darren, 2004, FASEB Journal, V18, P329; Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145; Codner E, 2001, METABOLISM, V50, P830, DOI 10.1053/meta.2001.24929; Crescioli C, 2008, ENDOCRINOLOGY, V149, P3626, DOI 10.1210/en.2008-0078; Crescioli C, 2007, J ENDOCRINOL, V195, P145, DOI 10.1677/JOE-07-0240; Crescioli C, 2004, EUR J ENDOCRINOL, V150, P591, DOI 10.1530/eje.0.1500591; Crescioli C, 2008, EXP CELL RES, V314, P1337, DOI 10.1016/j.yexcr.2007.12.016; Crescioli C, 2012, EUR J CELL BIOL, V91, P139, DOI 10.1016/j.ejcb.2011.09.011; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; De Paepe B, 2005, MUSCLE NERVE, V31, P621, DOI 10.1002/mus.20294; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Dekel B, 2004, EXPERT OPIN BIOL TH, V4, P443, DOI 10.1517/eobt.4.4.443.29789; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dold S, 2007, CLIN RHEUMATOL, V26, P1186, DOI 10.1007/s10067-006-0325-z; Efthimiou P, 2006, SEMIN ARTHRITIS RHEU, V36, P168, DOI 10.1016/j.semarthrit.2006.07.003; Fall N, 2005, ARTHRITIS RHEUM-US, V52, P3175, DOI 10.1002/art.21303; Fichera A, 2007, J SURG RES, V142, P239, DOI 10.1016/j.jss.2007.02.038; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; FOGLIA RP, 1986, ANN SURG, V204, P402, DOI 10.1097/00000658-198610000-00008; Forsgren S, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/637452; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Grundtman C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2139; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; HOHLFELD R, 1990, AM J PATHOL, V136, P503; Hohlfeld Reinhard, 1997, Current Opinion in Rheumatology, V9, P520, DOI 10.1097/00002281-199711000-00007; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Lange U, 2006, AUTOIMMUNITY, V39, P261, DOI 10.1080/08916930600623874; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x; Liu ZG, 2003, MOL CELL, V12, P795, DOI 10.1016/S1097-2765(03)00399-X; Luigi Luigi Di, MEDIATORS I IN PRESS; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514; MANTEGAZZA R, 1991, NEUROLOGY, V41, P1128, DOI 10.1212/WNL.41.7.1128; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Nagaraju K, 1998, CLIN EXP IMMUNOL, V113, P407; Nyberg P, 2000, J RHEUMATOL, V27, P940; O'Herrin JK, 2002, AM J NEPHROL, V22, P515, DOI 10.1159/000065289; Pavlath GK, 2002, J NEUROIMMUNOL, V125, P42, DOI 10.1016/S0165-5728(02)00026-7; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sagrinati C, 2010, TRANSPL INT, V23, P914, DOI 10.1111/j.1432-2277.2010.01078.x; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; Sottili M, 2009, EXP CELL RES, V315, P264, DOI 10.1016/j.yexcr.2008.10.025; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Szelenyi ER, 2012, MUSCLE NERVE, V45, P552, DOI 10.1002/mus.22323; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Tournadre A, 2010, JOINT BONE SPINE, V77, P390, DOI 10.1016/j.jbspin.2010.04.007; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961	60	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77745	10.1371/journal.pone.0077745	http://dx.doi.org/10.1371/journal.pone.0077745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204948	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500052
J	Shi, LL; Zhang, S; Wu, HG; Zhang, LL; Dai, XF; Hu, JL; Xue, J; Liu, T; Liang, YC; Wu, G				Shi, Liangliang; Zhang, Sheng; Wu, Hongge; Zhang, Lilin; Dai, Xiaofang; Hu, Jianli; Xue, Jun; Liu, Tao; Liang, Yichen; Wu, Gang			MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway	PLOS ONE			English	Article							EXPRESSION; RADIATION; VEGF; ANGIOGENESIS; GLIOBLASTOMA; RADIOTHERAPY; SENSITIVITY; INVASION; EGFR	MicroRNAs (miRNAs) have been demonstrated to participate in many important cellular processes including radiosensitization. VEGF family, an important regulator of angiogenesis, also plays a crucial role in the regulation of cancer cell radiosensitivity. VEGFR2 mediates the major growth and permeability actions of VEGF in a paracrine/autocrine manner. MiR-200c, at the nexus of epithelial-mesenchymal transition (EMT), is predicted to target VEGFR2. The purpose of this study is to test the hypothesis that regulation of VEGFR2 pathway by miR-200c could modulate the radiosensitivity of cancer cells. Bioinformatic analysis, luciferase reporter assays and biochemical assays were carried out to validate VEGFR2 as a direct target of miR-200c. The radiosensitizing effects of miR-200c on A549 cells were determined by clonogenic assays. The downstream regulating mechanism of miR-200c was explored with western blotting assays, FCM, tube formation assays and migration assays. We identified VEGFR2 as a novel target of miR-200c. The ectopic miR-200c increased the radiosensitivity of A549 while miR-200c down-regulation decreased it. Besides, we proved that miR-200c radiosensitized A549 cells by targeting VEGF-VEGFR2 pathway specifically, thus leading to inhibition of its downstream pro-survival signaling transduction and angiogenesis, and serves as a potential target for radiosensitizition research.	[Shi, Liangliang; Zhang, Sheng; Wu, Hongge; Zhang, Lilin; Dai, Xiaofang; Hu, Jianli; Xue, Jun; Liu, Tao; Liang, Yichen; Wu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China.	wg1893@hotmail.com		Shi, Liangliang/0000-0001-6457-2890	Hubei Provincial Natural Science Foundation [2009CDA061]	Hubei Provincial Natural Science Foundation	This work was supported by Hubei Provincial Natural Science Foundation project (No: 2009CDA061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P3755; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Li J, 2005, INT J RADIAT ONCOL, V62, P1477, DOI 10.1016/j.ijrobp.2005.04.028; Li ZY, 2011, TUMOR BIOL, V32, P677, DOI 10.1007/s13277-011-0168-3; Peng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034646; Rowell NP, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002140.PUB2; Sechler M, 2013, PHARMACOGN PERS MED, V6, P25, DOI 10.2147/PGPM.S26058; Shibuya K, 2007, INT J RADIAT ONCOL, V69, P1534, DOI 10.1016/j.ijrobp.2007.07.2350; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solberg TD, 2008, INT J RADIAT ONCOL, V72, P918, DOI 10.1016/j.ijrobp.2008.06.1925; Wachsberger PR, 2007, INT J RADIAT ONCOL, V67, P1526, DOI 10.1016/j.ijrobp.2006.11.011; Wang N, 2012, BREAST CANCER RES TR, V134, P943, DOI 10.1007/s10549-012-1977-9; Wang Q, 2009, EUR J CANCER PREV, V18, P510, DOI 10.1097/CEJ.0b013e32832f9c00; Wang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-29; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029043; Zhu F, 2011, MED ONCOL, V28, P565, DOI 10.1007/s12032-010-9468-5	19	74	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78344	10.1371/journal.pone.0078344	http://dx.doi.org/10.1371/journal.pone.0078344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205206	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500113
J	Chen, L; Yang, ZF; Chen, B				Chen, Liang; Yang, Zhifeng; Chen, Bin			Scenario Analysis and Path Selection of Low-Carbon Transformation in China Based on a Modified IPAT Model	PLOS ONE			English	Article							ECONOMIC-GROWTH; DRIVING FORCES; STIRPAT MODEL; POPULATION; DECOMPOSITION; CONSUMPTION; AFFLUENCE; SCIENCE; IMPACT	This paper presents a forecast and analysis of population, economic development, energy consumption and CO2 emissions variation in China in the short- and long-term steps before 2020 with 2007 as the base year. The widely applied IPAT model, which is the basis for calculations, projections, and scenarios of greenhouse gases (GHGs) reformulated as the Kaya equation, is extended to analyze and predict the relations between human activities and the environment. Four scenarios of CO2 emissions are used including business as usual (BAU), energy efficiency improvement scenario (EEI), low carbon scenario (LC) and enhanced low carbon scenario (ELC). The results show that carbon intensity will be reduced by 40-45% as scheduled and economic growth rate will be 6% in China under LC scenario by 2020. The LC scenario, as the most appropriate and the most feasible scheme for China's low-carbon development in the future, can maximize the harmonious development of economy, society, energy and environmental systems. Assuming China's development follows the LC scenario, the paper further gives four paths of low-carbon transformation in China: technological innovation, industrial structure optimization, energy structure optimization and policy guidance.	[Chen, Liang; Yang, Zhifeng; Chen, Bin] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China	Beijing Normal University	Yang, ZF (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	zfyang@bnu.edu.cn; chenb@bnu.edu.cn	Chen, Bin/A-6951-2012	Chen, Bin/0000-0002-5488-6850	Fund for Creative Research Groups of the National Natural Science Foundation of China [51121003]; Key Program of National Natural Science Foundation [50939001]; National Key Technology RD Program [2012BAK30B03]	Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This study was supported by Fund for Creative Research Groups of the National Natural Science Foundation of China (No. 51121003), Key Program of National Natural Science Foundation (No. 50939001), and National Key Technology R&D Program (No. 2012BAK30B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci P, 2009, ECOL ECON, V68, P1652, DOI 10.1016/j.ecolecon.2007.09.005; Anderson K, 2004, 8 SCENARIOS DEV TYND; Ang BW, 2004, ENERG ECON, V26, P757, DOI 10.1016/j.eneco.2004.02.002; Ang BW, 2001, ENERGY, V26, P537, DOI 10.1016/S0360-5442(01)00022-6; Cai WJ, 2007, ENERG POLICY, V35, P6445, DOI 10.1016/j.enpol.2007.08.026; Center for Clean Air Policy, 2006, GREENH GAS MIT CHIN; Center for Clean Air Policy, 2006, GREENH GAS MIT BRAZ; Chertow RM, 2001, J IND ECOL, V4, P13; China Council for International Cooperation on Environment and Development (CCICED), 2009, CHIN PATHW LOW CARB; Dietz T, 1997, P NATL ACAD SCI USA, V94, P175, DOI 10.1073/pnas.94.1.175; Dietz T., 1994, HUM ECOL REV, V1, P277, DOI [10.2307/24706840, DOI 10.2307/24706840]; Ehrlich P., 1972, B SCI, V28, P16, DOI [DOI 10.1080/00963402.1972.11457930, 10.1080/00963402.1972.11457930]; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Feng KS, 2009, ECOL ECON, V69, P145, DOI 10.1016/j.ecolecon.2009.08.007; Gao CK, 2010, PROCEDIA ENVIRON SCI, V2, P1335, DOI 10.1016/j.proenv.2010.10.144; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Harrison Paul, 1993, 3 REVOLUTION; Hubacek K, 2007, FUTURES, V39, P1084, DOI 10.1016/j.futures.2007.03.010; Hubacek K, 2012, ENERGIES, V5, P22, DOI 10.3390/en5010022; IEA, 2009, CO2 EMISSIONS FUEL C; International Energy Agency (EIA), 2011, INT EN STAT; IPCC, 2001, IPCC SPECIAL REPORT; Jia JS, 2009, ECOL ECON, V68, P2818, DOI 10.1016/j.ecolecon.2009.05.012; Kaya Y, 1989, IMPACT CARBON DIOXID; Martin N., 1999, ENERGY EFFICIENCY CA; Menz T, 2011, POPUL ENVIRON, V33, P55, DOI 10.1007/s11111-011-0132-6; MNP (Netherlands Environmental Assessment Agency), 2007, CHIN NOW 1 CO2 EM US; Nakicenovic N, 2004, SCOPE SER, V62, P225; Raskin PD, 1995, ECOL ECON, V15, P225, DOI 10.1016/0921-8009(95)00047-X; Research Team of China Climate Change Country Study, 1999, CHIN CLIM CHANG COUN; Roberts TD, 2011, APPL GEOGR, V31, P731, DOI 10.1016/j.apgeog.2010.06.010; Rosa EA, 1998, INT SOCIOL, V13, P421, DOI 10.1177/026858098013004002; Shrestha RM, 2007, ENERG POLICY, V35, P3179, DOI 10.1016/j.enpol.2006.11.007; Sinton JE, 2000, ENERGY CARBON SCENAR; Song ML, 2011, RENEW SUST ENERG REV, V15, P5129, DOI 10.1016/j.rser.2011.07.043; State Council of the People's Republic of China, 2011, 12 5 YEAR PLAN FRAM; State Council of the People's Republic of China, 2006, 11 5 YEAR PLAN FRAM; Study Group for Sustainable Development Strategy of CAS, 2009, CHIN APPR LOW CARB F; Su W, 2010, CHINAS PLEDGE COP15; Tao ZP, 2010, ENERGY, V35, P168, DOI 10.1016/j.energy.2009.09.007; Waggoner PE, 2002, P NATL ACAD SCI USA, V99, P7860, DOI 10.1073/pnas.122235999; Wang C, 2007, ENERG CONVERS MANAGE, V48, P2110, DOI 10.1016/j.enconman.2006.12.022; Wang CM, 2010, PROCEDIA ENVIRON SCI, V2, P1701, DOI 10.1016/j.proenv.2010.10.181; Wang K, 2007, ENERG POLICY, V35, P2320, DOI 10.1016/j.enpol.2006.08.007; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068; Zhou D., 2003, CHINAS SUSTAINABLE E	47	11	13	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77699	10.1371/journal.pone.0077699	http://dx.doi.org/10.1371/journal.pone.0077699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204922	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700049
J	Gorse, P; Nordon, C; Rouillon, F; Pham-Scottez, A; Revah-Levy, A				Gorse, Pauline; Nordon, Clementine; Rouillon, Frederic; Pham-Scottez, Alexandra; Revah-Levy, Anne			Subjective Motives for Requesting In-Patient Treatment in Female with Anorexia Nervosa: A Qualitative Study	PLOS ONE			English	Article							EATING-DISORDERS; TREATMENT ACCEPTANCE; PREDICTORS; MORTALITY; READINESS; COMMUNITY; ADMISSION; TRIAL	Background: Anorexia nervosa is a severe psychiatric disorder mainly affecting women. Its treatment is long and accepted with much difficulty, in particular in-patient treatment. Aims: To describe the subjective motives of women with anorexia nervosa for requesting in-patient admission, from a qualitative analysis of application letters. Methods: Participants were adult women (18 years and older) with anorexia nervosa who were admitted as inpatients in a referral hospital unit in France from January 2008 to December 2010. The application letters, prerequisites to admission, were studied by the interpretative phenomenological method of content analysis. Results: 63 letters have been analysed, allowing the identification of six themes related to requests for in-patient care: loss of control of behaviour, and of thoughts, mental exhaustion, isolation, inner struggle and fear of recovery. Conclusions: Requests for in-patient admission were motivated by very personal, subjective experiences, unrelated to medical reasons for admission. These results may help improve pre-admission motivational work with individuals, by basing it on their subjective experience.	[Gorse, Pauline; Rouillon, Frederic; Pham-Scottez, Alexandra] St Anne Univ Hosp, CMME, Dept Adult Psychiat, Paris, France; [Nordon, Clementine; Revah-Levy, Anne] Univ Paris 11, INSERM, Res Unit 669, Paris, France; [Nordon, Clementine; Revah-Levy, Anne] Paris Descartes Univ, Paris, France; [Revah-Levy, Anne] Argenteuil Hosp Ctr, Argenteuil, France	GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Revah-Levy, A (corresponding author), Univ Paris 11, INSERM, Res Unit 669, Paris, France.	anne.revah-levy@ch-argenteuil.fr		revah-levy, anne/0000-0003-1805-6275	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2006, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ametller L, 2005, J CHILD PSYCHOL PSYC, V46, P394, DOI 10.1111/j.1469-7610.2004.00360.x; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Dupont Marie-Estelle, 2008, Rev Prat, V58, P141; Espeset EMS, 2012, CLIN PSYCHOL PSYCHOT, V19, P518, DOI 10.1002/cpp.760; Espindola CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056275; Espindola CR, 2009, ANN CLIN PSYCHIATRY, V21, P38; Feld R, 2001, INT J EAT DISORDER, V29, P393, DOI 10.1002/eat.1035; Fox JRE, 2009, CLIN PSYCHOL PSYCHOT, V16, P240, DOI 10.1002/cpp.626; Geller J, 2002, INT J EAT DISORDER, V31, P251, DOI 10.1002/eat.10045; Geller J, 2002, INT J EAT DISORDER, V32, P344, DOI 10.1002/eat.10083; Guarda AS, 2008, PHYSIOL BEHAV, V94, P113, DOI 10.1016/j.physbeh.2007.11.020; Guarda AS, 2007, AM J PSYCHIAT, V164, P108, DOI 10.1176/appi.ajp.164.1.108; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Huas C, 2011, ACTA PSYCHIAT SCAND, V123, P62, DOI 10.1111/j.1600-0447.2010.01627.x; Jenkins J, 2012, EUR EAT DISORD REV, V20, pe23, DOI 10.1002/erv.1085; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Miller WR, 2003, J CONSULT CLIN PSYCH, V71, P754, DOI 10.1037/0022-006X.71.4.754; Miotto P, 2002, ACTA PSYCHIAT SCAND, V105, P372, DOI 10.1034/j.1600-0447.2002.1o186.x; Morse J. M., 1995, QUALITATIVE RES METH; Mosher Catherine E, 2008, Eat Behav, V9, P497, DOI 10.1016/j.eatbeh.2008.04.002; Murnen SK, 1997, INT J EAT DISORDER, V22, P231, DOI 10.1002/(SICI)1098-108X(199711)22:3&lt;231::AID-EAT2&gt;3.0.CO;2-O; National Institute of Clinical Excellence, 2004, EAT DIS COR INT TREA, V9; Nordbo RHS, 2006, INT J EAT DISORDER, V39, P556, DOI 10.1002/eat.20276; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Paulson-Karlsson G, 2012, J MULTIDISCIP HEALTH, V5, P169, DOI 10.2147/JMDH.S33658; Qsr International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Reid M, 2008, J HEALTH PSYCHOL, V13, P956, DOI 10.1177/1359105308095070; Serpell L, 1999, INT J EAT DISORDER, V25, P177, DOI 10.1002/(SICI)1098-108X(199903)25:2<177::AID-EAT7>3.3.CO;2-4; Smith J, 2008, PRACTICAL GUIDE RES, V2nd ed.; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Strother L, 2010, CONSCIOUS COGN, V19, P12, DOI 10.1016/j.concog.2009.12.007; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tan J, 2003, INT J LAW PSYCHIAT, V26, P697, DOI 10.1016/j.ijlp.2003.09.010; Tasca GA, 2012, EUR EAT DISORD REV, V20, P155, DOI 10.1002/erv.1133; Treasure JL, 1997, CLIN GUIDE MANAGEMEN; Vitousek K, 1998, CLIN PSYCHOL REV, V18, P391, DOI 10.1016/S0272-7358(98)00012-9; Wallier J, 2009, INT J EAT DISORDER, V42, P636, DOI 10.1002/eat.20609; Yager J, 2012, PRACTICE GUIDELINE T, P2012	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77757	10.1371/journal.pone.0077757	http://dx.doi.org/10.1371/journal.pone.0077757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204951	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400055
J	Liu, XQ; Olsen, J; Agerbo, E; Yuan, W; Cnattingius, S; Gissler, M; Li, J				Liu, Xiaoqin; Olsen, Jorn; Agerbo, Esben; Yuan, Wei; Cnattingius, Sven; Gissler, Mika; Li, Jiong			Psychological Stress and Hospitalization for Childhood Asthma-a Nationwide Cohort Study in Two Nordic Countries	PLOS ONE			English	Article							MATERNAL DEPRESSIVE SYMPTOMS; TOBACCO-SMOKE; CHILDREN; POPULATION; EXPOSURE; VIOLENCE; ADULT; ONSET; LIFE; PRESCRIPTION	Objective: Exposures to psychological stress in early life may contribute to the development or exacerbation of asthma. We undertook a cohort study based on data from several population-based registers in Denmark and Sweden to examine whether bereavement in childhood led to increased asthma hospitalization. Methods: All singleton children born in Denmark during 1977-2008 and in Sweden during 1973-2006 were included in the study (N=5,202,576). The children were followed from birth to the date of first asthma hospitalization, emigration, death, their 18th birthday, or the end of study (31 December 2007 in Sweden and 31 December 2008 in Denmark), whichever came first. All the children were assigned to the non-bereaved group until they lost a close relative (mother, father or a sibling), from when they were included in the bereaved group. We evaluated the hazard ratio (HR) of first hospitalization for asthma in bereaved children using Cox proportional hazards regression models, compared to those who were in the non-bereaved group. We also did a sub-analysis on the association between bereavement and first asthma medication. Results: A total of 147,829 children were hospitalized for asthma. The overall adjusted HR of asthma hospitalization in bereaved children was 1.10 (95% confidence interval (CI): 1.04-1.16), compared to non-bereaved children. The risk of asthma hospitalization was increased in those who lost a close relative at age of 14-17 years (HR=1.54, 95% CI: 1.23-1.92), but not in younger age groups. The association between bereavement and asthma hospitalization did not change over time since bereavement. In the sub-analysis in singleton live births during 1996-2008 recorded in the DMBR, bereavement was associated with a lower use of asthma medication (HR=0.87, 95% CI: 0.80-0.95). Conclusions: Our data suggests that psychological stress following bereavement in late adolescence is associated with an increased risk of asthma hospitalization or lowers the threshold for asthma hospitalization.	[Liu, Xiaoqin; Olsen, Jorn; Li, Jiong] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Liu, Xiaoqin; Yuan, Wei] WHO Collaborating Ctr Res Human Reprod, Shanghai Inst Planned Parenthood Res, Dept Epidemiol & Social Sci Reprod Hlth, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China; [Olsen, Jorn] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Agerbo, Esben] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Agerbo, Esben] Aarhus Univ, CIRRAU Ctr Integrated Register Based Res, Aarhus, Denmark; [Cnattingius, Sven] Karolinska Univ Hosp, Karolinska Inst, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden; [Gissler, Mika] THL Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] NHV Nord Sch Publ Hlth, Gothenburg, Sweden	Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare	Liu, XQ (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	lxq@soci.au.dk	li, jiong/L-6534-2014; Agerbo, Esben/A-2645-2012; Liu, Xiaoqin/AAB-7509-2019	li, jiong/0000-0002-1716-8067; Agerbo, Esben/0000-0002-2849-524X; Liu, Xiaoqin/0000-0003-4519-1536; li, jiong/0000-0003-1125-026X; Gissler, Mika/0000-0001-8254-7525	European Research Council (ERC) 'Prog Euro' [260242]; Danish Medical Research Council [09-072986]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	European Research Council (ERC) 'Prog Euro'(European Research Council (ERC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the European Research Council (ERC, starting grant no. 260242, 'Prog Euro') and the Danish Medical Research Council (project no. 09-072986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1987, EUR J PERSONALITY, V1, P141, DOI DOI 10.1002/PER.2410010304; Bahreinian S, 2013, AM J RESP CRIT CARE, V187, P144, DOI 10.1164/rccm.201201-0025OC; Balk D., 2001, HDB BEREAVEMENT RES, P199, DOI DOI 10.1037/10436-008; Bartlett SJ, 2004, PEDIATRICS, V113, P229, DOI 10.1542/peds.113.2.229; Biank NM, 2011, OMEGA-J DEATH DYING, V63, P271, DOI 10.2190/OM.63.3.e; Black D, 1998, BMJ-BRIT MED J, V316, P931, DOI 10.1136/bmj.316.7135.931; Bloomberg GR, 2005, IMMUNOL ALLERGY CLIN, V25, P83, DOI 10.1016/j.iac.2004.09.001; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Burke W, 2003, AM J PREV MED, V24, P160, DOI 10.1016/S0749-3797(02)00589-5; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027202; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Hesselmar Bill, 2012, J Allergy (Cairo), V2012, P163089, DOI 10.1155/2012/163089; Juel K, 1999, DAN MED BULL, V46, P354; Kanter RK, 2006, J PEDIATR-US, V148, P637, DOI 10.1016/j.jpeds.2005.11.035; Kaugars AS, 2004, J PEDIATR PSYCHOL, V29, P475, DOI 10.1093/jpepsy/jsh051; Khashan AS, 2012, PSYCHOSOM MED, V74, P635, DOI 10.1097/PSY.0b013e31825ac5e7; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Lange NE, 2011, J ALLERGY CLIN IMMUN, V127, P734, DOI 10.1016/j.jaci.2010.11.010; Li J, 2011, INT J EPIDEMIOL, V40, P1161, DOI 10.1093/ije/dyq127; Lietzen R, 2011, EUR RESPIR J, V37, P1360, DOI 10.1183/09031936.00164609; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McLearn KT, 2006, ARCH PEDIAT ADOL MED, V160, P279, DOI 10.1001/archpedi.160.3.279; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; National Board of Health and Welfare, 2003, SWED MED BIRTH REG A; National Board of Health and Welfare, 2013, CAUS DEATH 2010; National Board of Health and Welfare, 2009, KVAL INN PAT UTSKR F; Pedersen CB, 2006, DAN MED BULL, V53, P441; Quinn K, 2010, J URBAN HEALTH, V87, P688, DOI 10.1007/s11524-010-9465-1; Raherison C, 2007, RESP MED, V101, P107, DOI 10.1016/j.rmed.2006.04.010; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Rosenkranz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040921; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Shalowitz MU, 2001, AMBUL PEDIATR, V1, P185, DOI 10.1367/1539-4409(2001)001<0185:TROLSA>2.0.CO;2; Statistics Sweden, 2010, BACKGR FACTS POP WEL, V3; Statistics Sweden, 2006, BACKGR FACTS EV SWED; Sternthal MJ, 2010, EUR RESPIR J, V36, P1400, DOI 10.1183/09031936.00003010; Sternthal MJ, 2011, J ALLERGY CLIN IMMUN, V128, P337, DOI 10.1016/j.jaci.2011.05.008; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Suglia SF, 2009, ARCH PEDIAT ADOL MED, V163, P244, DOI 10.1001/archpediatrics.2008.555; Timmermans B, 2010, DANISH INTEGRATED DA; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Willfuhr KP, 2009, AM J HUM BIOL, V21, P488, DOI 10.1002/ajhb.20909; Wisnivesky JP, 2010, J ASTHMA, V47, P100, DOI 10.3109/02770900903426989; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright Rosalind J, 2008, Allergy Asthma Clin Immunol, V4, P29, DOI 10.1186/1710-1492-4-1-29; Zuidgeest MG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-16	62	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78816	10.1371/journal.pone.0078816	http://dx.doi.org/10.1371/journal.pone.0078816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205324	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400108
J	Kemter, E; Pruckl, P; Rathkolb, B; Micklich, K; Adler, T; Becker, L; Beckers, J; Busch, DH; Gotz, AA; Hans, W; Horsch, M; Ivandic, B; Klingenspor, M; Klopstock, T; Rozman, J; Schrewe, A; Schulz, H; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Wolf, E; Aigner, B				Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Adler, Thure; Becker, Lore; Beckers, Johannes; Busch, Dirk H.; Goetz, Alexander A.; Hans, Wolfgang; Horsch, Marion; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Rozman, Jan; Schrewe, Anja; Schulz, Holger; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Wolf, Eckhard; Aigner, Bernhard			Standardized, Systemic Phenotypic Analysis of Umod(C93F) and Umod(A227T) Mutant Mice	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; KIDNEY-DISEASE; STONE FORMATION; UROMODULIN; GENE; MUTAGENESIS; MUTATION	Uromodulin-associated kidney disease (UAKD) summarizes different clinical features of an autosomal dominant heritable disease syndrome in humans with a proven uromodulin (UMOD) mutation involved. It is often characterized by hyperuricemia, gout, alteration of urine concentrating ability, as well as a variable rate of disease progression inconstantly leading to renal failure and histological alterations of the kidneys. We recently established the two Umod mutant mouse lines Umod(C93F) and Umod(A227T) on the C3H inbred genetic background both showing kidney defects analogous to those found in human UAKD patients. In addition, disease symptoms were revealed that were not yet described in other published mouse models of UAKD. To examine if further organ systems and/or metabolic pathways are affected by Umod mutations as primary or secondary effects, we describe a standardized, systemic phenotypic analysis of the two mutant mouse lines Umod(A227T) and Umod(C93F) in the German Mouse Clinic. Different genotypes as well as different ages were tested. Beside the already published changes in body weight, body composition and bone metabolism, the influence of the Umod mutation on energy metabolism was confirmed. Hematological analysis revealed a moderate microcytic and erythropenic anemia in older Umod mutant mice. Data of the other analyses in 7-10 month-old mutant mice showed single small additional effects.	[Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Wolf, Eckhard; Aigner, Bernhard] LMU, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Wolf, Eckhard; Aigner, Bernhard] LMU, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Rathkolb, Birgit; Micklich, Kateryna; Adler, Thure; Becker, Lore; Beckers, Johannes; Hans, Wolfgang; Horsch, Marion; Rozman, Jan; Schrewe, Anja; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Adler, Thure; Busch, Dirk H.] TU, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Becker, Lore; Klopstock, Thomas] LMU, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] TU, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [Goetz, Alexander A.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, German Mouse Clin,Comprehens Pneumol Ctr, Neuherberg, Germany; [Ivandic, Boris; Schrewe, Anja] Heidelberg Univ, Dept Med 3, Div Cardiol, Heidelberg, Germany; [Klingenspor, Martin; Rozman, Jan] TU, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Klopstock, Thomas; de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Schulz, Holger] Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Aigner, B (corresponding author), LMU, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany.	b.aigner@gen.vetmed.uni-muenchen.de	Beckers, Johannes/K-7237-2012; Fuchs, Helmut/M-7347-2014; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/E-3717-2010; Rozman, Jan/A-2540-2010; Becker, Lore/AAJ-1203-2020; Klingenspor, Martin/D-6930-2011; Schulz, Holger/J-5643-2015; Klingenspor, Martin/K-5033-2019; de Angelis, Martin Hrabe/F-5531-2012	Beckers, Johannes/0000-0001-7874-3822; Fuchs, Helmut/0000-0002-5143-2677; Rozman, Jan/0000-0002-8035-8904; Becker, Lore/0000-0002-6890-4984; Klingenspor, Martin/0000-0002-4502-6664; Schulz, Holger/0000-0002-1157-200X; de Angelis, Martin Hrabe/0000-0002-7898-2353; Aigner, Bernhard/0000-0003-1644-2711; Kemter, Elisabeth/0000-0001-7785-7502; Wolf, Eckhard/0000-0002-0430-9510	German Research Foundation (DFG) [KE1673/1-1]; German Federal Ministry of Education and Research [01 EO 0901, 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, 01GS0868, 01GS0869, 01KX1012]; Initiative and Networking Fund of the Helmholtz Association [HA-215]; Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Initiative and Networking Fund of the Helmholtz Association; Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association)	This work has been funded by the German Research Foundation (DFG) (grant KE1673/1-1), by the German Federal Ministry of Education and Research to the German Center for Vertigo and Balance Disorders (grant 01 EO 0901), to the DZD (German Center for Diabetes Research) and to the GMC (NGFN-Plus grants no. 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, 01GS0868, 01GS0869; Infrafrontier grant 01KX1012), and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society (HA-215) and the Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bleyer AJ, 2011, GENEREVIEWS; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Liu Y, 2012, J BIOL CHEM, V287, P16365, DOI 10.1074/jbc.M112.348243; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Takiue Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P596, DOI 10.1080/15257770802136065	21	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78337	10.1371/journal.pone.0078337	http://dx.doi.org/10.1371/journal.pone.0078337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205203	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300050
J	Kalashikam, RR; Battula, KK; Kirlampalli, V; Friedman, JM; Nappanveettil, G				Kalashikam, Rajender Rao; Battula, Kiran Kumar; Kirlampalli, Veerababu; Friedman, Jeffrey M.; Nappanveettil, Giridharan			Obese Locus in WNIN/Obese Rat Maps on Chromosome 5 Upstream of Leptin Receptor	PLOS ONE			English	Article							ANIMAL-MODELS; INDUCED HYPERCHOLESTEROLEMIA; PREVALENCE; DISEASE; TRENDS	WNIN/Obese (WNIN/Ob) rat a new mutant model of metabolic syndrome was identified in 1996 from an inbred Wistar rat strain, WNIN. So far several papers are published on this model highlighting its physical, biochemical and metabolic traits. WNIN/Ob is leptin resistant with unaltered leptin or its receptor coding sequences - the two well-known candidate genes for obesity. Genotyping analysis of F2 progeny (raised from WNIN/Ob x Fisher - 344) in the present study localized the mutation to a recombinant region of 14.15cM on chromosome 5. This was further corroborated by QTL analysis for body weight, which narrowed this region to 4.43 cM with flanking markers D5Rat256 & D5Wox37. Interval mapping of body weight QTL shows that the LOD score peak maps upstream of leptin receptor and shows an additive effect suggesting this as a novel mutation and signifying the model as a valuable resource for studies on obesity and metabolic syndrome.	[Kalashikam, Rajender Rao; Battula, Kiran Kumar; Kirlampalli, Veerababu; Nappanveettil, Giridharan] Natl Inst Nutr, NCLAS, Hyderabad 500007, Andhra Pradesh, India; [Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA.	Jeffrey.Friedman@rockefeller.edu; nappanveettil@yahoo.com			ICMR, INDIA; National Institutes of Health, USA [63/2/INDO-US/2005-RHN]	ICMR, INDIA(Indian Council of Medical Research (ICMR)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by ICMR, INDIA and National Institutes of Health, USA (No.63/2/INDO-US/2005-RHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; [Anonymous], 2013, RAT GENOME DATABASE; Asahina M, 2005, J LIPID RES, V46, P2289, DOI 10.1194/jlr.M500257-JLR200; Bandaru P, 2011, VACCINE, V29, P3038, DOI 10.1016/j.vaccine.2011.01.107; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; DOHERTY G.H., 2011, CURR GERONTOL GERIAT, V2011; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Giridharan N., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P131; Giridharan NV, 1998, INDIAN J MED RES, V108, P225; Harishankar N, 2011, ENDOCRINOLOGIST, V2011; Harishankar N, 2011, INDIAN J MED RES, V134, P330; Herrera VLM, 2007, J HYPERTENS, V25, P1608, DOI 10.1097/HJH.0b013e328182df1a; Jayaraman KS, 2005, NAT MED, V11, P108, DOI 10.1038/nm0205-108a; Jayaraman KS, 1997, NAT MED, V3, P823, DOI 10.1038/nm0897-823a; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Nobrega MA, 2009, PHYSIOL GENOMICS, V39, P38, DOI 10.1152/physiolgenomics.90389.2008; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067; Strachan T, 1999, HUMAN MOL GENETICS; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003	30	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77679	10.1371/journal.pone.0077679	http://dx.doi.org/10.1371/journal.pone.0077679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204914	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600040
J	Schaumburg, F; Mugisha, L; Kappeller, P; Fichtel, C; Kock, R; Kondgen, S; Becker, K; Boesch, C; Peters, G; Leendertz, F				Schaumburg, Frieder; Mugisha, Lawrence; Kappeller, Peter; Fichtel, Claudia; Koeck, Robin; Koendgen, Sophie; Becker, Karsten; Boesch, Christophe; Peters, Georg; Leendertz, Fabian			Evaluation of Non-Invasive Biological Samples to Monitor Staphylococcus aureus Colonization in Great Apes and Lemurs	PLOS ONE			English	Article							METHICILLIN-RESISTANT; SANCTUARY APES; NASAL CARRIAGE; NATIONAL-PARK; AMPLIFICATION; CHIMPANZEES; POPULATION; PREVALENCE; GORILLAS; DISEASE	Introduction: Reintroduction of endangered animals as part of conservational programs bears the risk of importing human pathogens from the sanctuary to the natural habitat. One bacterial pathogen that serves as a model organism to analyze this transmission is Staphylococcus aureus as it can colonize and infect both humans and animals. The aim of this study was to evaluate the utility of various biological samples to monitor S. aureus colonization in great apes and lemurs. Methods: Mucosal swabs from wild lemurs (n=25, Kirindy, Madagascar), feces, oral and genital swabs from captive chimpanzees (n=58, Ngamba and Entebbe, Uganda) and fruit wadges and feces from wild chimpanzees (n=21, Ta National Parc, Cote d'Ivoire) were screened for S. aureus. Antimicrobial resistance and selected virulence factors were tested for each isolate. Sequence based genotyping (spa typing, multilocus sequence typing) was applied to assess the population structure of S. aureus. Results: Oro-pharyngeal carriage of S. aureus was high in lemurs (72%, n=18) and captive chimpanzees (69.2%, n=27 and 100%, n=6, respectively). Wild chimpanzees shed S. aureus through feces (43.8, n=7) and fruit wadges (54.5, n=12). Analysis of multiple sampling revealed that two samples are sufficient to detect those animals which shed S. aureus through feces or fruit wadges. Genotyping showed that captive animals are more frequently colonized with human-associated S. aureus lineages. Conclusion: Oro-pharyngeal swabs are useful to screen for S. aureus colonization in apes and lemurs before reintroduction. Duplicates of stool and fruit wadges reliably detect S. aureus shedding in wild chimpanzees. We propose to apply these sampling strategies in future reintroduction programs to screen for S. aureus colonization. They may also be useful to monitor S. aureus in wild populations.	[Schaumburg, Frieder; Becker, Karsten; Peters, Georg] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Mugisha, Lawrence] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Mugisha, Lawrence] Conservat & Ecosyst Hlth Alliance, Kampala, Uganda; [Kappeller, Peter; Fichtel, Claudia] German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Koendgen, Sophie; Leendertz, Fabian] Robert Koch Inst, Project Grp Epidemiol Highly Pathogen Microorgani, Berlin, Germany; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	University of Munster; Makerere University; Deutsches Primatenzentrum (DPZ); University of Munster; Robert Koch Institute; Max Planck Society	Schaumburg, F (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	frieder.schaumburg@ukmuenster.de	Mugisha, Lawrence/N-4916-2017; Schaumburg, Frieder/E-4464-2016; Köck, Robin/AAC-1552-2019; Leendertz, Fabian Hubertus/H-8902-2019; Becker, Karsten/O-2302-2018	Mugisha, Lawrence/0000-0003-4932-3356; Becker, Karsten/0000-0002-6391-1341	'Deutsche Forschungsgemeinschaft' [PAK296, EI 247/8, LE 1813/4-1]	'Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG))	This study was funded by the 'Deutsche Forschungsgemeinschaft' (Infection Biology and Epidemiology of Staphylococci and Staphylococcal Diseases in Central and South Africa, PAK296, EI 247/8 and LE 1813/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; BLAKESLEE JR, 1987, CANCER LETT, V37, P1, DOI 10.1016/0304-3835(87)90139-X; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Eckmanns T, 2004, J HOSP INFECT, V57, P93, DOI 10.1016/j.jhin.2004.01.021; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Faust LJ, 2011, INT J PRIMATOL, V32, P849, DOI 10.1007/s10764-011-9505-z; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Kumar S, 2012, J MED PRIMATOL, V41, P266, DOI 10.1111/j.1600-0684.2012.00547.x; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2004, J GEN VIROL, V85, P3305, DOI 10.1099/vir.0.80052-0; Lilenbaum W, 2006, AM J PRIMATOL, V68, P825, DOI 10.1002/ajp.20282; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Nagel M, 2012, CLIN MICROBIOL INFEC; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2012, AM J PRIMATOL, V74, P1071, DOI 10.1002/ajp.22067; Unwin S, 2012, AM J PRIMATOL, V74, P1076, DOI 10.1002/ajp.22069; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	24	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78046	10.1371/journal.pone.0078046	http://dx.doi.org/10.1371/journal.pone.0078046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205084	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600064
J	Veenstra, AA; Tang, J; Kern, TS				Veenstra, Alexander A.; Tang, Jie; Kern, Timothy S.			Antagonism of CD11b with Neutrophil Inhibitory Factor (NIF) Inhibits Vascular Lesions in Diabetic Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL-CELL INJURY; ADHESION MOLECULE-1; MONOCLONAL-ANTIBODY; LEUKOSTASIS; MODEL; ALPHA(M)BETA(2); RECEPTOR; THERAPY; LEAKAGE; RETINA	Leukocytes and proteins that govern leukocyte adhesion to endothelial cells play a causal role in retinal abnormalities characteristic of the early stages of diabetic retinopathy, including diabetes-induced degeneration of retinal capillaries. Leukocyte integrin alpha m beta 2 (CD11b/CD18, MAC1), a protein mediating adhesion, has been shown to mediate damage to endothelial cells by activated leukocytes in vitro. We hypothesized that Neutrophil Inhibitory Factor (NIF), a selective antagonist of integrin alpha m beta 2, would inhibit the diabetes-induced degeneration of retinal capillaries by inhibiting the excessive interaction between leukocytes and retinal endothelial cells in diabetes. Wild type animals and transgenic animals expressing NIF were made diabetic with streptozotocin and assessed for diabetes-induced retinal vascular abnormalities and leukocyte activation. To assess if the leukocyte blocking therapy compromised the immune system, animals were challenged with bacteria. Retinal superoxide production, leukostasis and leukocyte superoxide production were increased in wild type mice diabetic for 10 weeks, as was the ability of leukocytes isolated from diabetic animals to kill retinal endothelial cells in vitro. Retinal capillary degeneration was significantly increased in wild type mice diabetic 40 weeks. In contrast, mice expressing NIF did not develop any of these abnormalities, with the exception that non-diabetic and diabetic mice expressing NIF generated greater amounts of superoxide than did similar mice not expressing NIF. Importantly, NIF did not significantly impair the ability of mice to clear an opportunistic bacterial challenge, suggesting that NIF did not compromise immune surveillance. We conclude that antagonism of CD11b (integrin alpha m beta 2) by NIF is sufficient to inhibit early stages of diabetic retinopathy, while not compromising the basic immune response.	[Veenstra, Alexander A.; Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Tang, Jie; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Stokes Vet Adm Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Veenstra, AA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	aav2@case.edu			National Institute of Health [EY000300]; Medical Research Service of the Department of Veterans Affairs; National Eye Institute [5T32EY007157]; CWRU Visual Science Research Center core facility [P30EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY000300, R56EY000300, T32EY007157] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CWRU Visual Science Research Center core facility; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institute of Health EY000300 and the Medical Research Service of the Department of Veterans Affairs. Support was also provided by the Visual Science Research Training Grant 5T32EY007157 from the National Eye Institute (AAV) and the CWRU Visual Science Research Center core facility (P30EY11373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2001, PARASITE IMMUNOL, V23, P237, DOI 10.1046/j.1365-3024.2001.00383.x; BARNARD JW, 1995, J IMMUNOL, V155, P4876; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; Bowen JD, 1998, CLIN PHARMACOL THER, V64, P339, DOI 10.1016/S0009-9236(98)90183-7; BRESNICK GH, 1976, T AM ACAD OPHTHALMOL, V81, pO694; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Ding J, 2012, CURR DIABETES REP, V12, P346, DOI 10.1007/s11892-012-0283-6; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; ENGERMAN RL, 1976, T AM ACAD OPHTHALMOL, V81, pO710; Faridi MH, 2013, BBA-GEN SUBJECTS, V1830, P3696, DOI 10.1016/j.bbagen.2013.02.018; Frank RN, 2011, ARCH OPHTHALMOL-CHIC, V129, P788, DOI 10.1001/archophthalmol.2011.125; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P858, DOI 10.1167/iovs.06-0495; Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; KERN TS, 2007, RETINAL VASCULAR DIS; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; LAVER NM, 1993, INVEST OPHTH VIS SCI, V34, P2097; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; LUM H, 1994, J LEUKOCYTE BIOL, V55, P58, DOI 10.1002/jlb.55.1.58; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Ohno S, 1997, J CELL PHYSIOL, V171, P212, DOI 10.1002/(SICI)1097-4652(199705)171:2<212::AID-JCP12>3.3.CO;2-0; RIEU P, 1994, J CELL BIOL, V127, P2081, DOI 10.1083/jcb.127.6.2081; SCHRODER S, 1991, AM J PATHOL, V139, P81; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Simon DI, 2011, CIRC RES, V109, P1199, DOI 10.1161/CIRCRESAHA.111.257980; Su XJ, 2003, MOL VIS, V9, P171; Takahashi K, 1998, AM J OPHTHALMOL, V126, P791, DOI 10.1016/S0002-9394(98)00242-6; Tamura H, 2005, INVEST OPHTH VIS SCI, V46, P1440, DOI 10.1167/iovs.04-0905; TIAN HGP, 2013, MOL VIS IN PRESS; Uettwiller F, 2011, MABS-AUSTIN, V3, P461, DOI 10.4161/mabs.3.5.16553; Ustinov VA, 2002, J BIOL CHEM, V277, P18769, DOI 10.1074/jbc.M110242200; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Zhang L, 2003, STROKE, V34, P1790, DOI 10.1161/01.STR.0000077016.55891.2E; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	46	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78405	10.1371/journal.pone.0078405	http://dx.doi.org/10.1371/journal.pone.0078405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205223	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600100
J	Fish, EW; Krouse, MC; Stringfield, SJ; DiBerto, JF; Robinson, JE; Malanga, CJ				Fish, Eric W.; Krouse, Michael C.; Stringfield, Sierra J.; DiBerto, Jeffrey F.; Robinson, J. Elliott; Malanga, C. J.			Changes in Sensitivity of Reward and Motor Behavior to Dopaminergic, Glutamatergic, and Cholinergic Drugs in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; VENTRAL TEGMENTAL AREA; FMR1 KNOCKOUT MOUSE; SYNAPTIC-TRANSMISSION; STEREOLOGICAL METHODS; RECEPTOR BLOCKADE; DENDRITIC SPINES; BRAIN DOPAMINE; MICE	Fragile X syndrome (FXS) is a leading cause of intellectual disability. FXS is caused by loss of function of the FMR1 gene, and mice in which Fmr1 has been inactivated have been used extensively as a preclinical model for FXS. We investigated the behavioral pharmacology of drugs acting through dopaminergic, glutamatergic, and cholinergic systems in fragile X (Fmr1(-/Y)) mice with intracranial self-stimulation (ICSS) and locomotor activity measurements. We also measured brain expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. Fmr1(-/Y) mice were more sensitive than wild type mice to the rewarding effects of cocaine, but less sensitive to its locomotor stimulating effects. Anhedonic but not motor depressant effects of the atypical neuroleptic, aripiprazole, were reduced in Fmr1(-/Y) mice. The mGluR5-selective antagonist, 6-methyl-2-(phenylethynyl) pyridine (MPEP), was more rewarding and the preferential M1 antagonist, trihexyphenidyl, was less rewarding in Fmr1(-/Y) than wild type mice. Motor stimulation by MPEP was unchanged, but stimulation by trihexyphenidyl was markedly increased, in Fmr1(-/Y) mice. Numbers of midbrain TH+ neurons in the ventral tegmental area were unchanged, but were lower in the substantia nigra of Fmr1(-/Y) mice, although no changes in TH levels were found in their forebrain targets. The data are discussed in the context of known changes in the synaptic physiology and pharmacology of limbic motor systems in the Fmr1(-/Y) mouse model. Preclinical findings suggest that drugs acting through multiple neurotransmitter systems may be necessary to fully address abnormal behaviors in individuals with FXS.	[Fish, Eric W.; Krouse, Michael C.; DiBerto, Jeffrey F.; Robinson, J. Elliott; Malanga, C. J.] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA; [Stringfield, Sierra J.; Robinson, J. Elliott; Malanga, C. J.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Malanga, C. J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Malanga, CJ (corresponding author), Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA.	malangacj@neurology.unc.edu	Cabrera, Mariel/GMX-2706-2022	Robinson, J. Elliott/0000-0001-9417-3938; Malanga, C.J./0000-0003-4808-3995; Stringfield, Sierra/0000-0003-4840-0866	Basic and Clinical Research Award from Autism Speaks [2670]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA021312] Funding Source: NIH RePORTER	Basic and Clinical Research Award from Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Basic and Clinical Research Award (#2670) from Autism Speaks (www.autismspeaks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Berry-Kravis E, 2011, J NEURODEV DISORD, V3, P193, DOI 10.1007/s11689-011-9074-7; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Chen M, 2011, J NEUROSCI, V31, P9563, DOI 10.1523/JNEUROSCI.1701-11.2011; Cornish K, 2004, MENT RETARD DEV D R, V10, P11, DOI 10.1002/mrdd.20003; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ebihara K, 2013, NEUROSCIENCE, V236, P332, DOI 10.1016/j.neuroscience.2013.01.012; Eliez S, 2001, BRAIN, V124, P1610, DOI 10.1093/brain/124.8.1610; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Erickson CA, 2011, PSYCHOPHARMACOLOGY, V216, P85, DOI 10.1007/s00213-011-2194-7; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fisch GS, 1999, AM J MED GENET, V84, P277, DOI 10.1002/(SICI)1096-8628(19990528)84:3<277::AID-AJMG22>3.0.CO;2-W; Fish E, 2010, TCE-THE CHEM ENG, P2; Fulks JL, 2010, ACS CHEM NEUROSCI, V1, P679, DOI 10.1021/cn100032f; Gallagher A, 2012, J NEUROL, V259, P401, DOI 10.1007/s00415-011-6161-3; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Grillner P, 2000, NEUROSCIENCE, V96, P299, DOI 10.1016/S0306-4522(99)00579-5; Gruss M, 2004, NEUROCHEM INT, V45, P81, DOI 10.1016/j.neuint.2003.12.001; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Hoeft F, 2007, HUM BRAIN MAPP, V28, P543, DOI 10.1002/hbm.20406; Hoeft F, 2010, P NATL ACAD SCI USA, V107, P9335, DOI 10.1073/pnas.1002762107; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Kenny PJ, 2005, PSYCHOPHARMACOLOGY, V179, P247, DOI 10.1007/s00213-004-2069-2; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; LOVAAS OI, 1989, J BEHAV THER EXP PSY, V20, P17; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; MAES B, 1994, AM J MED GENET, V50, P190, DOI 10.1002/ajmg.1320500211; Mavrikaki M, 2010, INT J NEUROPSYCHOPH, V13, P541, DOI 10.1017/S1461145709991143; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; MILIARESSIS E, 1986, PHYSIOL BEHAV, V37, P85, DOI 10.1016/0031-9384(86)90388-4; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nimitvilai S, 2013, J PHARMACOL EXP THER, V344, P253, DOI 10.1124/jpet.112.199844; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; POP AS, 2012, PSYCHOPHARMACOLOGY B, P54376; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; Riday TT, 2012, J CLIN INVEST, V122, P4544, DOI 10.1172/JCI61888; Robinson JE, 2012, BEHAV BRAIN RES, V234, P76, DOI 10.1016/j.bbr.2012.06.012; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Schotanus SM, 2008, NEUROPHARMACOLOGY, V54, P837, DOI 10.1016/j.neuropharm.2007.12.012; Sciamanna G, 2012, J NEUROSCI, V32, P11991, DOI 10.1523/JNEUROSCI.0041-12.2012; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tanda G, 2007, J PHARMACOL EXP THER, V321, P334, DOI 10.1124/jpet.106.118067; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Veeraragavan S, 2011, BEHAV NEUROSCI, V125, P783, DOI 10.1037/a0025202; Veeraragavan S, 2011, PSYCHOPHARMACOLOGY, V217, P143, DOI 10.1007/s00213-011-2276-6; Ventura R, 2004, BEHAV PHARMACOL, V15, P433, DOI 10.1097/00008877-200409000-00018; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wan YH, 2011, J NEUROSCI, V31, P16685, DOI 10.1523/JNEUROSCI.2533-11.2011; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang HS, 2010, J BIOL CHEM, V285, P21888, DOI 10.1074/jbc.M110.116293; Wassink TH, 2001, PSYCHIAT GENET, V11, P57, DOI 10.1097/00041444-200106000-00001; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	82	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77896	10.1371/journal.pone.0077896	http://dx.doi.org/10.1371/journal.pone.0077896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205018	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300124
J	Lindner, SE; Wissler, M; Grunder, A; Aumann, K; Ottina, E; Peintner, L; Brauns-Schubert, P; Preiss, F; Herzog, S; Borner, C; Charvet, C; Villunger, A; Pahl, HL; Maurer, U				Lindner, S. E.; Wissler, M.; Gruender, A.; Aumann, K.; Ottina, E.; Peintner, L.; Brauns-Schubert, P.; Preiss, F.; Herzog, S.; Borner, C.; Charvet, C.; Villunger, A.; Pahl, H. L.; Maurer, U.			Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation	ONCOGENE			English	Article						GSK-3; MCL-1; E mu-Myc; lymphoma; apoptosis	GLYCOGEN-SYNTHASE KINASE-3; APOPTOSIS; MYC; MEDIATE; PI3K	The antiapoptotic BCL-2 protein MCL-1, which opposes mitochondrial outer membrane permeabilization, was shown to have a crucial role in the survival of hematopoietic cells. We have previously shown that, upon loss of phosphatidylinositol 3-kinase signaling, S159 of MCL-1 is phosphorylated by glycogen synthase kinase-3 (GSK-3), earmarking MCL-1 for enhanced ubiquitylation and degradation. In this study, we introduced MCL-1(wt) or the phosphorylation-deficient mutant MCL-1(S159A) in mouse BM cells, followed by adoptive transfer to recipient mice. Mice expressing MCL-1(S159A) exhibited significantly elevated white blood cell and lymphocyte counts, whereas no effect was observed on the distribution of T and B lymphocyte subsets or the numbers of monocytes, red blood cells or platelets. Expression of MCL-1(S159A) in E mu-Myc transgenic bone marrow significantly accelerated the onset of disease, and these mice displayed increased spleen weights compared with E mu-Myc/MCL-1(wt) mice. Our data demonstrate that the absence of MCL-1 S159 phosphorylation provides a survival advantage for hematopoietic cells in vivo and facilitates oncogenesis.	[Lindner, S. E.; Wissler, M.; Brauns-Schubert, P.; Preiss, F.; Borner, C.; Maurer, U.] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Lindner, S. E.; Brauns-Schubert, P.; Preiss, F.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Gruender, A.; Pahl, H. L.] Univ Hosp, Clin Res Ctr, Dept Mol Hematol, Freiburg, Germany; [Aumann, K.] Univ Med Ctr Freiburg, Inst Pathol, Freiburg, Germany; [Ottina, E.; Peintner, L.; Herzog, S.; Villunger, A.] Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria; [Brauns-Schubert, P.; Preiss, F.; Borner, C.; Maurer, U.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Borner, C.; Maurer, U.] Ctr Biol Signaling Studies, BIOSS, Freiburg, Germany; [Charvet, C.] Univ Paris 05, CNRS UMR 8104, INSERM U1016, Inst Cochin, Paris, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Medical University of Innsbruck; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Maurer, U (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	ulrich.maurer@mol-med.uni-freiburg.de	Lindner, Silke/AAF-6063-2021; Pahl, Heike/AGM-5260-2022; Aumann, Konrad/GSN-1821-2022	Aumann, Konrad/0000-0001-8178-1571; Peintner, Lukas/0000-0002-0445-1445; Herzog, Sebastian/0000-0001-7167-3489; Ottina, Eleonora/0000-0002-9630-496X	Deutsche Forschungsgemeinschaft [Ma 1967/1, Ma 1967/2]; Deutsche Krebshilfe [109199, 107397]; Spemann Graduate School of Biology and Medicine (SGBM) - Excellence Initiative of the German Federal and State Governments, Germany [GSC-4]; Centre for Biological Signalling Studies (BIOSS) - Excellence Initiative, Germany [EXC-294]; Austrian Science Fund (FWF); Austrian Science Fund (FWF) [P 23510] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Spemann Graduate School of Biology and Medicine (SGBM) - Excellence Initiative of the German Federal and State Governments, Germany; Centre for Biological Signalling Studies (BIOSS) - Excellence Initiative, Germany; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Martin Brandenburg, Katharina Thumm, Heiko Bauer, Klaus Geiger, Jan Bodinek-Wersing and Karin Neubert. This study was supported by Grants Ma 1967/1 and Ma 1967/2 from the Deutsche Forschungsgemeinschaft to UM, Grants 109199 and 107397 from the Deutsche Krebshilfe to UM the Spemann Graduate School of Biology and Medicine (SGBM, GSC-4) funded by the Excellence Initiative of the German Federal and State Governments, Germany to PBS, FP and UM, by the Centre for Biological Signalling Studies (BIOSS, EXC-294) funded by the Excellence Initiative, Germany to UM and CB and a fellowship from the Dr Heinrich Kircher-Stiftung to SEL as well as the Austrian Science Fund (FWF) to AV.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Campbell KJ, 2010, BLOOD, V116, P3197, DOI 10.1182/blood-2010-04-281071; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Xiang ZF, 2010, J CLIN INVEST, V120, P2109, DOI 10.1172/JCI39964; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	20	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5221	5224		10.1038/onc.2013.469	http://dx.doi.org/10.1038/onc.2013.469			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24213575	Green Accepted			2022-12-25	WOS:000343914900009
J	Pandey, A; Gordon, DM; Pain, J; Stemmler, TL; Dancis, A; Pain, D				Pandey, Alok; Gordon, Donna M.; Pain, Jayashree; Stemmler, Timothy L.; Dancis, Andrew; Pain, Debkumar			Frataxin Directly Stimulates Mitochondrial Cysteine Desulfurase by Exposing Substrate-binding Sites, and a Mutant Fe-S Cluster Scaffold Protein with Frataxin-bypassing Ability Acts Similarly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron-Sulfur Protein; Metal Homeostasis; Metals; Mitochondria; Mitochondrial Metabolism; Pyridoxal Phosphate; Sulfur; Yeast	YEAST FRATAXIN; INTERACTING PROTEIN; IRON; BIOGENESIS; HOMOLOG; DEFICIENCY; IDENTIFICATION; MECHANISM; ACONITASE; INSIGHTS	For iron-sulfur (Fe-S) cluster synthesis in mitochondria, the sulfur is derived from the amino acid cysteine by the cysteine desulfurase activity of Nfs1. The enzyme binds the substrate cysteine in the pyridoxal phosphate-containing site, and a persulfide is formed on the active site cysteine in a manner depending on the accessory protein Isd11. The persulfide is then transferred to the scaffold Isu, where it combines with iron to form the Fe-S cluster intermediate. Frataxin is implicated in the process, although it is unclear where and how, and deficiency causes Friedreich ataxia. Using purified proteins and isolated mitochondria, we show here that the yeast frataxin homolog (Yfh1) directly and specifically stimulates cysteine binding to Nfs1 by exposing substrate-binding sites. This novel function of frataxin does not require iron, Isu1, or Isd11. Once bound to Nfs1, the substrate cysteine is the source of the Nfs1 persulfide, but this step is independent of frataxin and strictly dependent on Isd11. Recently, a point mutation in Isu1 was found to bypass many frataxin functions. The data presented here show that the Isu1 suppressor mimics the frataxin effects on Nfs1, explaining the bypassing activity. We propose a regulatory mechanism for the Nfs1 persulfide-forming activity. Specifically, at least two separate conformational changes must occur in the enzyme for optimum activity as follows: one is mediated by frataxin interaction that exposes the buried substrate-binding sites, and the other is mediated by Isd11 interaction that brings the bound substrate cysteine and the active site cysteine in proximity for persulfide formation.	[Pandey, Alok; Gordon, Donna M.; Pain, Jayashree; Pain, Debkumar] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07101 USA; [Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Wayne State University; University of Pennsylvania	Pain, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol, 185 South Orange Ave,MSB I-669, Newark, NJ 07101 USA.	painde@njms.rutgers.edu			National Institutes of Health from NIA [RO1AG030504, RO1DK068139, R37DK053953]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139, R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AG030504 from NIA (to D. P.), RO1DK068139 (to T. L. S.), and R37DK053953 (to A. D.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Lesuisse E, 2004, BIOCHEM J, V378, P599, DOI 10.1042/BJ20031387; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pandey A, 2012, MITOCHONDRION, V12, P539, DOI 10.1016/j.mito.2012.07.103; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; SANCHEZ-CASIS G, 1976, Canadian Journal of Neurological Sciences, V3, P349; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2009, CNS DRUGS, V23, P213, DOI 10.2165/00023210-200923030-00003; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	41	70	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36773	36786		10.1074/jbc.M113.525857	http://dx.doi.org/10.1074/jbc.M113.525857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217246	Green Published, hybrid			2022-12-25	WOS:000329189700002
J	Saura, M; Fernandez, A; Rodriguez, MC; Toro, MA; Barragan, C; Fernandez, AI; Villanueva, B				Saura, Maria; Fernandez, Almudena; Carmen Rodriguez, M.; Toro, Miguel A.; Barragan, Carmen; Fernandez, Ana I.; Villanueva, Beatriz			Genome-Wide Estimates of Coancestry and Inbreeding in a Closed Herd of Ancient Iberian Pigs	PLOS ONE			English	Article							GENETIC DIVERSITY; INFORMATION; DEPRESSION; PEDIGREE; GROWTH	Maintaining genetic variation and controlling the increase in inbreeding are crucial requirements in animal conservation programs. The most widely accepted strategy for achieving these objectives is to maximize the effective population size by minimizing the global coancestry obtained from a particular pedigree. However, for most natural or captive populations genealogical information is absent. In this situation, microsatellites have been traditionally the markers of choice to characterize genetic variation, and several estimators of genealogical coefficients have been developed using marker data, with unsatisfactory results. The development of high-throughput genotyping techniques states the necessity of reviewing the paradigm that genealogical coancestry is the best parameter for measuring genetic diversity. In this study, the Illumina PorcineSNP60 BeadChip was used to obtain genome-wide estimates of rates of coancestry and inbreeding and effective population size for an ancient strain of Iberian pigs that is now in serious danger of extinction and for which very accurate genealogical information is available (the Guadyerbas strain). Genome-wide estimates were compared with those obtained from microsatellite and from pedigree data. Estimates of coancestry and inbreeding computed from the SNP chip were strongly correlated with genealogical estimates and these correlations were substantially higher than those between microsatellite and genealogical coefficients. Also, molecular coancestry computed from SNP information was a better predictor of genealogical coancestry than coancestry computed from microsatellites. Rates of change in coancestry and inbreeding and effective population size estimated from molecular data were very similar to those estimated from genealogical data. However, estimates of effective population size obtained from changes in coancestry or inbreeding differed. Our results indicate that genome-wide information represents a useful alternative to genealogical information for measuring and maintaining genetic diversity.	[Saura, Maria; Fernandez, Almudena; Carmen Rodriguez, M.; Barragan, Carmen; Fernandez, Ana I.; Villanueva, Beatriz] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Toro, Miguel A.] Escuela Tecn Super Ingn Agron, Dept Anim Prod, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Saura, M (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain.	saura.maria@inia.es	Toro, Miguel Angel Angel/H-9370-2015; Saura, María/Q-1592-2018; Fernández, Ana Isabel/J-3265-2012; Toro, Miguel Angel/AAA-1309-2019; Alvarez, Saura/M-5098-2015; Muñoz, Almudena Fernández/AAB-4608-2019	Toro, Miguel Angel Angel/0000-0001-7460-2483; Fernández, Ana Isabel/0000-0002-1509-5191; Toro, Miguel Angel/0000-0001-7460-2483; Muñoz, Almudena Fernández/0000-0002-4495-9366; Saura, Maria/0000-0002-2744-2840	INIA [RZ2010-00009-00-00]; Juan de la Cierva fellowship from the Ministerio de Economia y Competitividad from Spain [JCI-2011-10896]	INIA(Instituto de Investigacion Agropecuaria (INIA)); Juan de la Cierva fellowship from the Ministerio de Economia y Competitividad from Spain	This work was supported by an INIA project (RZ2010-00009-00-00). MS was supported by a Juan de la Cierva fellowship (JCI-2011-10896) from the Ministerio de Economia y Competitividad from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; de Cara MAR, 2011, J ANIM BREED GENET, V128, P456, DOI 10.1111/j.1439-0388.2011.00971.x; DOBAO MT, 1983, LIVEST PROD SCI, V10, P601, DOI 10.1016/0301-6226(83)90052-0; Engelsma KA, 2012, J ANIM BREED GENET, V129, P195, DOI 10.1111/j.1439-0388.2012.00987.x; Esteve-Codina A, 2011, HEREDITY, V107, P256, DOI 10.1038/hdy.2011.13; Fabuel E, 2004, HEREDITY, V93, P104, DOI 10.1038/sj.hdy.6800488; Fernandez A, 2002, J ANIM SCI, V80, P2267; Fernandez AI, 2012, 4 INT C QUANT GEN JU; Fernandez J, 2005, GENETICS, V170, P1313, DOI 10.1534/genetics.104.037325; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hinrichs D, 2007, HEREDITY, V99, P81, DOI 10.1038/sj.hdy.6800968; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Li MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026256; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Malecot G, 1948, MATH IHEREDITE; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Silio L, 2013, J ANIM BREED GENET, DOI [10.1111/jbg12031, DOI 10.1111/JBG12031]; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Toro MA, 2000, CONSERV BIOL, V14, P1843, DOI 10.1111/j.1523-1739.2000.99322.x; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; Townsend S., 2004, BSAS OCCASIONAL PUBL, V30, P113; Varona L, 2002, GENET RES, V80, P145, DOI 10.1017/S0016672302005803	32	34	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78314	10.1371/journal.pone.0078314	http://dx.doi.org/10.1371/journal.pone.0078314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205195	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800018
J	Ferrier, J; Bayet-Robert, M; Pereira, B; Daulhac, L; Eschalier, A; Pezet, D; Moulinoux, JP; Balayssac, D				Ferrier, Jeremy; Bayet-Robert, Mathilde; Pereira, Bruno; Daulhac, Laurence; Eschalier, Alain; Pezet, Denis; Moulinoux, Jacques-Philippe; Balayssac, David			A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; NR2B SUBUNIT; SPINAL-CORD; PAINFUL NEUROPATHY; DORSAL-HORN; GLUTAMATE; ANTINOCICEPTION; NEUROTOXICITY; CHEMOTHERAPY; INVOLVEMENT	Background: Oxaliplatin is an anticancer drug used for the treatment of advanced colorectal cancer, but it can also cause painful peripheral neuropathies. The pathophysiology of these neuropathies has not been yet fully elucidated, but may involve spinal N-methyl-D-aspartate (NMDA) receptors, particularly the NR2B subunit. As polyamines are positive modulators of NMDA-NR2B receptors and mainly originate from dietary intake, the modulation of polyamines intake could represent an interesting way to prevent/modulate neuropathic pain symptoms by opposing glutamate neurotransmission. Methods: The effect of a polyamine deficient diet was investigated in an animal model of oxaliplatin-induced acute pain hypersensitivity using behavioral tests (mechanical and cold hypersensitivity). The involvement of spinal glutamate neurotransmission was monitored by using a proton nuclear magnetic resonance spectroscopy based metabolomic approach and by assessing the expression and phosphorylation of the NR2B subunit of the NMDA receptor. Results: A 7-day polyamine deficient diet totally prevented oxaliplatin-induced acute cold hypersensitivity and mechanical allodynia. Oxaliplatin-induced pain hypersensitivity was not associated with an increase in NR2B subunit expression or phosphorylation, but with an increase of glutamate level in the spinal dorsal horn which was completely prevented by a polyamine deficient diet. As a validation that the oxaliplatin-induced hypersensitivity could be due to an increased activity of the spinal glutamate system, an intrathecal administration of the specific NR2B antagonist, ifenprodil, totally reversed oxaliplatin-induced mechanical and cold hypersensitivity. Conclusion: A polyamine deficient diet could represent a promising and valuable nutritional therapy to prevent oxaliplatin-induced acute pain hypersensitivity.	[Ferrier, Jeremy; Bayet-Robert, Mathilde; Daulhac, Laurence; Eschalier, Alain; Balayssac, David] Clermont Univ, Univ Auvergne, Clermont Ferrand, France; [Ferrier, Jeremy; Bayet-Robert, Mathilde; Daulhac, Laurence; Eschalier, Alain; Balayssac, David] INSERM, NEURODOL U1107, Clermont Ferrand, France; [Pereira, Bruno; Eschalier, Alain; Pezet, Denis; Balayssac, David] CHU Clermont Ferrand, Clermont Ferrand, France; [Moulinoux, Jacques-Philippe] Univ Rennes 1, EA 3891, Grp Rech Therapeut Anticanc, Rennes, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Universite de Rennes	Balayssac, D (corresponding author), Clermont Univ, Univ Auvergne, Clermont Ferrand, France.	dbalayssac@chu-clermontferrand.fr	Pezet, Denis/I-4423-2017; ESCHALIER, Alain/L-9957-2015; Balayssac, David/AAZ-3007-2020; Balayssac, David/K-2265-2015	Pezet, Denis/0000-0001-9416-2876; Balayssac, David/0000-0002-6126-6588; Ferrier, Jeremy/0000-0001-9755-3565	University of Auvergne; INSERM; local branch of the Ligue contre le Cancer [French league against cancer]	University of Auvergne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); local branch of the Ligue contre le Cancer [French league against cancer]	This work was supported by the University of Auvergne, INSERM and the local branch of the Ligue contre le Cancer [French league against cancer]. JF has received a PhD grant from the regional council of Auvergne and the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenstein F, 2008, CEREB CORTEX, V18, P890, DOI 10.1093/cercor/bhm122; Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Bachrach U, 2005, CURR PROTEIN PEPT SC, V6, P559, DOI 10.2174/138920305774933240; Balayssac D, 2011, EXPERT OPIN DRUG SAF, V10, P407, DOI 10.1517/14740338.2011.543417; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; De Vry J, 2004, EUR J PHARMACOL, V491, P137, DOI 10.1016/j.ejphar.2004.03.051; Fisher K, 2000, J PAIN SYMPTOM MANAG, V20, P358, DOI 10.1016/S0885-3924(00)00213-X; FUHRMAN S, 1994, J NEUROCHEM, V62, P275; Gaboriau F, 2003, ANAL BIOCHEM, V318, P212, DOI 10.1016/S0003-2697(03)00214-8; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Gent P, 2001, Int J Palliat Nurs, V7, P354; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; Guo W, 2002, J NEUROSCI, V22, P6208; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Kergozien S, 1996, LIFE SCI, V58, P2209, DOI 10.1016/0024-3205(96)00215-9; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Narita M, 2007, LIFE SCI, V80, P852, DOI 10.1016/j.lfs.2006.11.015; Park SB, 2011, ONCOLOGIST, V16, P708, DOI 10.1634/theoncologist.2010-0248; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Tofthagen C, 2012, SUPPORT CARE CANCER, V20, P583, DOI 10.1007/s00520-011-1127-7; Tofthagen C, 2010, J PALLIAT MED, V13, P1389, DOI 10.1089/jpm.2010.0124; TORGNER I, 1990, MOL CHEM NEUROPATHOL, V12, P11, DOI 10.1007/BF03160053; Verbeke G, 2009, SPRINGER SER STAT, P1; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Zhang W, 2009, ANESTH ANALG, V108, P1015, DOI 10.1213/ane.0b013e318193ffd2	42	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77828	10.1371/journal.pone.0077828	http://dx.doi.org/10.1371/journal.pone.0077828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204988	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500066
J	Kling, JC; Mack, M; Korner, H				Kling, Jessica C.; Mack, Matthias; Koerner, Heinrich			The Absence of CCR7 Results in Dysregulated Monocyte Migration and Immunosuppression Facilitating Chronic Cutaneous Leishmaniasis	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSES; MAJOR INFECTION; DENDRITIC CELLS; WOUND REPAIR; LYMPH-NODES; NAIVE-LIKE; IN-VIVO; SUBSETS; EXPRESSION	The protozoan parasite Leishmania major causes cutaneous lesions to develop at the site of infection, which are resolved with a strong Th1 immune response in resistant hosts, such as C57BL/6 mice. In contrast, the lesions ulcerate in susceptible hosts which display a Th2 response, such as BALB/c mice. The migration of cells in the immune response to L. major is regulated by chemokines and their receptors. The chemokine receptor CCR7 is expressed on activated DCs and naive T cells, allowing them to migrate to the correct micro-anatomical positions within secondary lymphoid organs. While there have been many studies on the function of CCR7 during homeostasis or using model antigens, there are very few studies on the role of CCR7 during infection. In this study, we show that B6. CCR7(-/-) mice were unable to resolve the lesion and developed a chronic disease. The composition of the local infiltrate at the lesion was significantly skewed toward neutrophils while the proportion of CCR2(+) monocytes was reduced. Furthermore, a greater percentage of CCR2(+) monocytes expressed CCR7 in the footpad than in the lymph node or spleen of B6. WT mice. We also found an increased percentage of regulatory T cells in the draining lymph node of B6. CCR7(-/-) mice throughout infection. Additionally, the cytokine milieu of the lymph node showed a Th2 bias, rather than the resistant Th1 phenotype. This data shows that CCR7 is required for a protective immune response to intracellular L. major infection.	[Kling, Jessica C.; Koerner, Heinrich] Menzies Res Inst, Hobart, Australia; [Mack, Matthias] Univ Klinikum Regensburg, Regensburg, Germany	University of Tasmania; Menzies Institute for Medical Research; University of Regensburg	Korner, H (corresponding author), Menzies Res Inst, Hobart, Australia.	heinrich.korner@utas.edu.au	Korner, Heinrich/D-9970-2014	Korner, Heinrich/0000-0003-4610-2814	NHMRC [485807]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded by the NHMRC (http://www.nhmrc.gov.au/, grant: 485807 to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Conrad SM, 2007, INFECT IMMUN, V75, P653, DOI 10.1128/IAI.01314-06; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Eller K, 2010, J AM SOC NEPHROL, V21, P42, DOI 10.1681/ASN.2009020133; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fromm PD, 2012, J IMMUNOL, V188, P6258, DOI 10.4049/jimmunol.1100977; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kling J, 2011, EXP PARASITOL, V129, P270, DOI 10.1016/j.exppara.2011.07.015; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; LOCKSLEY RM, 1987, ANN INST PASTEUR IMM, V138, P744, DOI 10.1016/S0769-2625(87)80030-2; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Menezes-Souza D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001566; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P48, DOI 10.1002/eji.201141753; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Noor S, 2010, INFECT IMMUN, V78, P2257, DOI 10.1128/IAI.01314-09; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Quinones MP, 2007, PARASITE IMMUNOL, V29, P211, DOI 10.1111/j.1365-3024.2006.00935.x; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Sakthianandeswaren A, 2005, P NATL ACAD SCI USA, V102, P15551, DOI 10.1073/pnas.0505630102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; SOLBACH W, 1986, INFECT IMMUN, V54, P909, DOI 10.1128/IAI.54.3.909-912.1986; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Trujillo G, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-18; Unsoeld H, 2007, INT IMMUNOL, V19, P1281, DOI 10.1093/intimm/dxm098; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weaver CT, 2007, CURR BIOL, V17, pR61, DOI 10.1016/j.cub.2006.12.015; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79098	10.1371/journal.pone.0079098	http://dx.doi.org/10.1371/journal.pone.0079098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205367	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326334500143
J	Lillis, A; Eggleston, DB; Bohnenstiehl, DR				Lillis, Ashlee; Eggleston, David B.; Bohnenstiehl, DelWayne R.			Oyster Larvae Settle in Response to Habitat-Associated Underwater Sounds	PLOS ONE			English	Article							PELAGIC LARVAE; REEF FISHES; ORIENTATION; CUE; INVERTEBRATES; RECRUITMENT; DISPERSAL; INDUCTION; DYNAMICS; PATTERNS	Following a planktonic dispersal period of days to months, the larvae of benthic marine organisms must locate suitable seafloor habitat in which to settle and metamorphose. For animals that are sessile or sedentary as adults, settlement onto substrates that are adequate for survival and reproduction is particularly critical, yet represents a challenge since patchily distributed settlement sites may be difficult to find along a coast or within an estuary. Recent studies have demonstrated that the underwater soundscape, the distinct sounds that emanate from habitats and contain information about their biological and physical characteristics, may serve as broad-scale environmental cue for marine larvae to find satisfactory settlement sites. Here, we contrast the acoustic characteristics of oyster reef and off-reef soft bottoms, and investigate the effect of habitat-associated estuarine sound on the settlement patterns of an economically and ecologically important reef-building bivalve, the Eastern oyster (Crassostrea virginica). Subtidal oyster reefs in coastal North Carolina, USA show distinct acoustic signatures compared to adjacent off-reef soft bottom habitats, characterized by consistently higher levels of sound in the 1.5-20 kHz range. Manipulative laboratory playback experiments found increased settlement in larval oyster cultures exposed to oyster reef sound compared to unstructured soft bottom sound or no sound treatments. In field experiments, ambient reef sound produced higher levels of oyster settlement in larval cultures than did off-reef sound treatments. The results suggest that oyster larvae have the ability to respond to sounds indicative of optimal settlement sites, and this is the first evidence that habitat-related differences in estuarine sounds influence the settlement of a mollusk. Habitat-specific sound characteristics may represent an important settlement and habitat selection cue for estuarine invertebrates and could play a role in driving settlement and recruitment patterns in marine communities.	[Lillis, Ashlee; Eggleston, David B.; Bohnenstiehl, DelWayne R.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lillis, A (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	aslillis@ncsu.edu		Eggleston, David/0000-0001-7840-2665; Lillis, Ashlee/0000-0001-5754-2861	National Science Foundation [OCE-1234688, DDIG-1210292]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by National Science Foundation Grants OCE-1234688 and DDIG-1210292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W.W.L., 2008, PRINCIPLES MARINE BI; Boudreaux ML, 2006, J SHELLFISH RES, V25, P1079; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; BUDELMANN BU, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P141; Cotter AJR, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P451, DOI 10.1002/9781444302653.ch19; Gaylord B, 2013, P NATL ACAD SCI USA, V110, P6901, DOI 10.1073/pnas.1220680110; Glade S, 1982, SOUND INTENSITY 1; Hawkins A, 2008, BIOACOUSTICS, V17, P1; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Kalmijn A.J., 1988, P83; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; Kingsford MJ, 2002, B MAR SCI, V70, P309; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lillis A, 2010, MAR ECOL PROG SER, V401, P161, DOI 10.3354/meps08427; Luczkovich Joseph J., 2002, Bioacoustics, V12, P289; MacGillivray A., 2005, SOUND PRESSURE PARTI; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Mooney TA, 2010, J EXP BIOL, V213, P3748, DOI 10.1242/jeb.048348; Morgan SG, 2001, MARINE COMMUNITY ECOLOGY, P159; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; Okumura Tsuyoshi, 2002, Bioacoustics, V12, P330; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1991, SCIENCE, V251, P421, DOI 10.1126/science.251.4992.421; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Ritchie T. P., 1969, P NATL SHELLFISHERIE, V59, P116; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Rogers P.H., 1988, P131; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; SHAW R, 1970, J FISH RES BOARD CAN, V27, P743, DOI 10.1139/f70-078; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Sprague Mark W., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P124; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Stocks J.R., 2012, Open Marine Biology Journal, V6, P57; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; TURNER EJ, 1994, LIMNOL OCEANOGR, V39, P1579, DOI 10.4319/lo.1994.39.7.1579; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; Wilkens SL, 2012, BIOFOULING, V28, P65, DOI 10.1080/08927014.2011.651717; Zhadan P.M., 2005, RUSSIAN J MARINE BIO, V31, P28, DOI DOI 10.1007/S11179-005-0040-7; ZHADAN PM, 1984, COMP BIOCHEM PHYS A, V78, P865, DOI 10.1016/0300-9629(84)90647-9; Zimmer RK, 2009, ECOLOGY, V90, P1933, DOI 10.1890/08-0786.1	53	97	97	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79337	10.1371/journal.pone.0079337	http://dx.doi.org/10.1371/journal.pone.0079337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205381	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500149
J	Wu, PY; Wu, HDI; Chou, TC; Sung, FC				Wu, Po-Yuan; Wu, Hong-Dar Isaac; Chou, Tzu-Chieh; Sung, Fung-Chang			Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella	PLOS ONE			English	Article							EPIDEMIOLOGY; VIRUS; IMPACT; IMMUNIZATION; AUSTRALIA; EXPOSURE; CHILDREN; ADULTS; RISK; ERA	Background: Population studies on trends of varicella and herpes zoster (HZ) associated with varicella zoster vaccination and climate is limited. Methods: This study used insurance claims data to investigate the chronological changes in incident varicella and HZ associated with varicella zoster vaccination. Poisson regression was used to estimate the occurrence of varicella associated with the occurrence of HZ and vice versa by year, season, sex, temperature, and sunny hours. Results: The varicella incidence declined from 7.14 to 0.76 per 1,000 person-years in 2000-2009, whereas the HZ incidence increased from 4.04 to 6.24 per 1,000 person-years. Females tended to have a higher risk than men for HZ (p<0.0001) but not varicella. The monthly mean varicella incidence was the lowest in September (160 cases) and the highest in January (425 cases), while the mean HZ incidence was lower in February (370 cases) and higher in August (470 cases). HZ was negatively associated with the incidence of varicella before and after the varicella zoster vaccination (p<0.001), increased 1.6% within one week post-vaccination. The effect of temperature on HZ was attenuated by 18.5% (p<0.0001) in association with vaccination. The varicella risk was positively associated with sun exposure hours, but negatively associated with temperature only before vaccination. Conclusions: The varicella vaccination is effective in varicella prevention, but the incidence of HZ increases after vaccination. HZ has a stronger association with temperature and UV than with seasonality while varicella risk associated with temperature and UV is diminished.	[Wu, Po-Yuan; Chou, Tzu-Chieh; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wu, Po-Yuan] China Med Univ Hosp, Dept Dermatol, Taichung, Taiwan; [Wu, Po-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Sung, FC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	fcsung.tw@gmail.com	Chou, Tzu-Chieh/D-2372-2014	Chou, Tzu-Chieh/0000-0002-9634-0637	National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1]; Department of Health, Taiwan; Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Sciences Council, Executive Yuan; China Medical University Hospital; Department of Health, Taiwan; Clinical Trial and Research Center for Excellence; Cancer Research Center of Excellence	The present study was supported in parts by the National Sciences Council, Executive Yuan (grant number NSC 100-2621-M-039-001), China Medical University Hospital (grant number 1MS1), Department of Health, Taiwan, Clinical Trial and Research Center for Excellence (grant number DOH101-TD-B-111-004), and Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Chao DY, 2011, EPIDEMIOL INFECT, P1; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Fleming DM, 2004, EPIDEMIOL INFECT, V132, P1, DOI 10.1017/S0950268803001523; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P544, DOI 10.1111/j.1467-842X.2005.tb00248.x; Hambleton S, 2008, FRONT BIOSCI-LANDMRK, V13, P2696, DOI 10.2741/2876; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Jenke ACW, 2012, PEDIATR INFECT DIS J, V31, P1148, DOI 10.1097/INF.0b013e31826bac27; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Zak-Prelich M, 2002, EPIDEMIOL INFECT, V129, P593, DOI 10.1017/S0950268802007793	20	48	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77709	10.1371/journal.pone.0077709	http://dx.doi.org/10.1371/journal.pone.0077709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204928	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500045
J	Hojjat-Farsangi, M; Khan, AS; Daneshmanesh, AH; Moshfegh, A; Sandin, A; Mansouri, L; Palma, M; Lundin, J; Osterborg, A; Mellstedt, H				Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan			The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells	PLOS ONE			English	Article							BREAST-CANCER; SUBCELLULAR-LOCALIZATION; PROTEIN-PHOSPHORYLATION; NUCLEAR-LOCALIZATION; SURFACE RECEPTORS; EXPRESSION; AUTOPHOSPHORYLATION; FAMILY; WNT5A; HOMODIMERIZATION	Phosphorylation of receptor tyrosine kinases (RTKs) has a key role in cellular functions contributing to the malignant phenotype of tumor cells. We and others have previously demonstrated that RTK ROR1 is overexpressed in chronic lymphocytic leukemia (CLL). Silencing siRNA downregulated ROR1 and induced apoptosis of CLL cells. In the present study we analysed ROR1 isoforms and the phosphorylation pattern in CLL cells (n=38) applying western blot and flow-cytometry using anti-ROR1 antibodies and an anti-phospho-ROR1 antibody against the TK domain. Two major ROR1 bands with the size of 105 and 130 kDa respectively were identified, presumably representing unglycosylated (immature) and glycosylated (mature) ROR1 respectively as well as a 260 kDa band which may represent dimerized ROR1. A ROR1 band of 64 kDa that may correspond to a C-terminal fragment was also noted, present only in the nucleus. The 105 kDa ROR1 isoform was more frequently expressed in non-progressive as compared to progressive CLL patients (p=0.03). The 64, 105, 130 and 260 kDa bands were constitutively phosphorylated both at tyrosine and serine residues. Phosphorylation intensity of the mature (130 kDa) isoform was significantly higher in progressive than in non-progressive disease (p<0.001). Incubation of CLL cells with a mouse anti-ROR1 KNG or an anti-ROR1 CRD mAb respectively induced dephosphorylation of ROR1 before entering apoptosis. In conclusion CLL cells expressed different isoforms of ROR1 which were constitutively phosphorylated. The mature, phosphorylated ROR1 isoform was associated with a progressive disease stage. Targeting ROR1 by mAbs induced specific dephosphorylation and leukemic cell death. ROR1 might be an interesting therapeutic target.	[Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, CCK, Immune & Gene therapy Lab, Dept Oncol Pathol, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Inst, Stockholm, Sweden; [Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden; [Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Mellstedt, H (corresponding author), Karolinska Univ Hosp Solna, CCK, Immune & Gene therapy Lab, Dept Oncol Pathol, Stockholm, Sweden.	hakan.mellstedt@karolinska.se	Palma, Marzia/AGN-7362-2022; Hojjat-Farsangi, Mohammad/E-8171-2018	Hojjat-Farsangi, Mohammad/0000-0002-0589-5523; Khan, Salam/0000-0003-1171-8870; Palma, Marzia/0000-0003-4287-3179	VINNOVA [2009-00116, P36147-1]; CLL Global Research Foundation [10501300]; EU Seventh Framework Programme [EUCAAD 200755, 200755]; Swedish Research Council [C0235101, K2013-64X-21464-04-3]; Swedish Cancer Society [12 0842]; Cancer Society in Stockholm [121273]; King Gustaf Vth Jubilee Fund [124272]; Stockholm County Council [20120051]	VINNOVA(Vinnova); CLL Global Research Foundation; EU Seventh Framework Programme; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; King Gustaf Vth Jubilee Fund; Stockholm County Council(Stockholm County Council)	This study was supported by grants from VINNOVA (http://www.vinnova.se/sv/), Proj. No: 2009-00116, P36147-1. The CLL Global Research Foundation (http://www.cllglobal.org/), Proj No: 10501300. EUCAAD 200755 project funded under the auspices of the EU Seventh Framework Programme (http://ki.se/ki/jsp/polopoly.jsp?d=9877&a=128974&dispd=40337&l=sv). Grant Agreement No: 200755. The Swedish Research Council (http://www.vr.se/), Avtals-ID: C0235101, Proj. No: K2013-64X-21464-04-3. The Swedish Cancer Society (http://www.cancerfonden.se/), Contract No: 12 0842. The Cancer Society in Stockholm (http://www.uicc.org/membership/cancer-society-stockholm), Contract No: 121273. The King Gustaf Vth Jubilee Fund (http://www.rahfo.se/Om-Cancer/), Contract No: 124272. The Stockholm County Council (http://sll.se/), Proj No: 20120051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Bennasroune A, 2004, CRIT REV ONCOL HEMAT, V50, P23, DOI 10.1016/j.critrevonc.2003.08.004; Cheng CJ, 2007, MOL CANCER RES, V5, P675, DOI 10.1158/1541-7786.MCR-06-0306; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; Eksioglu-Demiralp E, 2011, CYTOM PART B-CLIN CY, V80B, P1, DOI 10.1002/cyto.b.20553; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; GULLICK WJ, 1991, BRIT J CANCER, V63, P434, DOI 10.1038/bjc.1991.100; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hashempoor T, 2010, IRAN J IMMUNOL, V7, P177, DOI IJIv7i3A5; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061167; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kaucka M, 2011, ACTA PHYSIOL, V203, P351, DOI 10.1111/j.1748-1716.2011.02306.x; Kazemi T, 2008, INT J CANCER, V123, P2113, DOI 10.1002/ijc.23751; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Memarian A, 2009, LEUKEMIA LYMPHOMA, V50, P2061, DOI 10.3109/10428190903331082; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; PATERSON MC, 1991, CANCER RES, V51, P556; Pillai G, 2005, HISTOPATHOLOGY, V46, P209, DOI 10.1111/j.1365-2559.2005.02081.x; Reddy UR, 1996, ONCOGENE, V13, P1555; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 1987, HUMAN BREAST CANC CO, DOI [10.1126/science.3798106, DOI 10.1126/SCIENCE.3798106.PUBMED:3798106]; Tseng HC, 2011, ANTICANCER RES, V31, P4239; Tseng HC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-48; Widhopf 2nd GF, 2011, 53 AM SOC HEM ASH DE; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	47	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78339	10.1371/journal.pone.0078339	http://dx.doi.org/10.1371/journal.pone.0078339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205204	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300051
J	Nagel, S; Rohr, F; Weber, C; Kier, J; Siemers, F; Kruse, C; Danner, S; Brandenburger, M; Matthiessen, AE				Nagel, Sabine; Rohr, Franziska; Weber, Caroline; Kier, Janina; Siemers, Frank; Kruse, Charli; Danner, Sandra; Brandenburger, Matthias; Matthiessen, Anna Emilia			Multipotent Nestin-Positive Stem Cells Reside in the Stroma of Human Eccrine and Apocrine Sweat Glands and Can Be Propagated Robustly In Vitro	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; PROGENITOR CELLS; GENE-EXPRESSION; GROWTH-FACTORS; SELF-RENEWAL; HFPS CELLS; HAIR; SKIN; DIFFERENTIATION; PLURIPOTENCY	Human skin harbours multiple different stem cell populations. In contrast to the relatively well-characterized niches of epidermal and hair follicle stem cells, the localization and niches of stem cells in other human skin compartments are as yet insufficiently investigated. Previously, we had shown in a pilot study that human sweat gland stroma contains Nestin-positive stem cells. Isolated sweat gland stroma-derived stem cells (SGSCs) proliferated in vitro and expressed Nestin in 80% of the cells. In this study, we were able to determine the precise localization of Nestin-positive cells in both eccrine and apocrine sweat glands of human axillary skin. We established a reproducible isolation procedure and characterized the spontaneous, long-lasting multipotent differentiation capacity of SGSCs. Thereby, a pronounced ectodermal differentiation was observed. Moreover, the secretion of prominent cytokines demonstrated the immunological potential of SGSCs. The comparison to human adult epidermal stem cells (EpiSCs) and bone marrow stem cells (BMSCs) revealed differences in protein expression and differentiation capacity. Furthermore, we found a coexpression of the stem cell markers Nestin and I alpha 6 within SGSCs and human sweat gland stroma. In conclusion the initial results of the pilot study were confirmed, indicating that human sweat glands are a new source of unique stem cells with multilineage differentiation potential, high proliferation capacity and remarkable self renewal. With regard to the easy accessibility of skin tissue biopsies, an autologous application of SGSCs in clinical therapies appears promising.	[Nagel, Sabine; Rohr, Franziska; Weber, Caroline; Kier, Janina; Kruse, Charli; Danner, Sandra; Brandenburger, Matthias; Matthiessen, Anna Emilia] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Siemers, Frank] Med Univ Lubeck, Dept Plast & Hand Surg, D-23538 Lubeck, Germany	University of Lubeck	Brandenburger, M (corresponding author), Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany.	Matthias.Brandenburger@emb.fraunhofer.de		Schumann, Sandra/0000-0001-5316-6424; Brandenburger, Matthias/0000-0001-8686-2186	European Union, European Regional Development Fund (ERDF)	European Union, European Regional Development Fund (ERDF)	This work was sponsored by the European Union, European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2010, METHODS MOL BIOL, V585, P401, DOI 10.1007/978-1-60761-380-0_28; Amoh Y, 2009, J DERMATOL, V36, P1, DOI 10.1111/j.1346-8138.2008.00578.x; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Biedermann T, 2010, J INVEST DERMATOL, V130, P1996, DOI 10.1038/jid.2010.83; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; Danner S, 2012, J INVEST DERMATOL, V132, P1707, DOI 10.1038/jid.2012.31; Distler JHW, 2003, Q J NUCL MED, V47, P149; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Ernst N, 2010, EXP DERMATOL, V19, P549, DOI 10.1111/j.1600-0625.2009.01041.x; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gho CG, 2004, BRIT J DERMATOL, V150, P860, DOI 10.1111/j.1365-2133.2004.05862.x; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoffman RM, 2007, EXPERT OPIN BIOL TH, V7, P289, DOI 10.1517/14712598.7.3.289; HOLBROOK KA, 1991, ANN NY ACAD SCI, V642, P167; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Ji KH, 2008, ANN HEMATOL, V87, P431, DOI 10.1007/s00277-008-0470-3; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim DS, 2004, CELL MOL LIFE SCI, V61, P2774, DOI 10.1007/s00018-004-4288-4; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kolar Z, 2007, VIRCHOWS ARCH, V450, P607, DOI 10.1007/s00428-007-0403-x; Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6; Kruse C, 2006, EXP DERMATOL, V15, P794, DOI 10.1111/j.1600-0625.2006.00471.x; Larouche Danielle, 2005, Methods Mol Biol, V289, P103; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 2007, CANCER RES, V67, P501, DOI 10.1158/0008-5472.CAN-05-4571; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Mokry Jaroslav, 2008, Acta Medica (Hradec Kralove), V51, P173; MOLL I, 1992, J INVEST DERMATOL, V98, P777, DOI 10.1111/1523-1747.ep12499950; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Petschnik AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024944; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontiggia L, 2009, J INVEST DERMATOL, V129, P480, DOI 10.1038/jid.2008.254; PURKIS PE, 1990, J CELL SCI, V97, P39; Rapoport DH, 2009, ANN ANAT, V191, P446, DOI 10.1016/j.aanat.2009.07.002; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rittie L, 2013, AM J PATHOL, V182, P163, DOI 10.1016/j.ajpath.2012.09.019; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schreder A, 2010, INT J MOL MED, V26, P171, DOI 10.3892/ijmm_00000449; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Sinha S, 2001, P NATL ACAD SCI USA, V98, P2455, DOI 10.1073/pnas.051633598; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Tiede S, 2009, J INVEST DERMATOL, V129, P2711, DOI 10.1038/jid.2009.148; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yang C, 2009, J AM PODIAT MED ASSN, V99, P489, DOI 10.7547/0990489; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052	77	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78365	10.1371/journal.pone.0078365	http://dx.doi.org/10.1371/journal.pone.0078365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205211	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300054
J	Aronovich, EL; Hall, BC; Bell, JB; McIvor, RS; Hackett, PB				Aronovich, Elena L.; Hall, Bryan C.; Bell, Jason B.; McIvor, R. Scott; Hackett, Perry B.			Quantitative Analysis of alpha-L-Iduronidase Expression in Immunocompetent Mice Treated with the Sleeping Beauty Transposon System	PLOS ONE			English	Article							TRANSGENE EXPRESSION; GENE-TRANSFER; IN-VIVO; INTRAPERITONEAL INJECTION; FACTOR-IX; DNA; LIVER; VECTORS; INCREASES; THERAPY	The Sleeping Beauty transposon system, a non-viral, integrating vector that can deliver the alpha-L-iduronidase-encoding gene, is efficient in correcting mucopolysaccharidosis type I in NOD/SCID mice. However, in previous studies we failed to attain reliable long-term alpha-L-iduronidase expression in immunocompetent mice. Here, we focused on achieving sustained high-level expression in immunocompetent C57BL/6 mice. In our standard liver-directed treatment we hydrodynamically infuse mice with plasmids containing a SB transposon-encoding human alpha-L-iduronidase, along with a source of SB transposase. We sought to 1) minimize expression of the therapeutic enzyme in antigen-presenting cells, while avoiding promoter shutdown and gender bias, 2) increase transposition efficiency and 3) improve immunosuppression. By using a liver-specific promoter to drive IDUA expression, the SB100X hyperactive transposase and transient cyclophosphamide immunosuppression we achieved therapeutic-level (>= 100 wild-type) stabilized expression for 1 year in 50% of C57BL/6 mice. To gain insights into the causes of variability in transgene expression, we quantified the rates of alpha-L-iduronidase activity decay vis-a-vis transposition and transgene maintenance using the data obtained in this and previous studies. Our analyses showed that immune responses are the most important variable to control in order to prevent loss of transgene expression. Cumulatively, our results allow transition to pre-clinical studies of SB-mediated alpha-L-iduronidase expression and correction of mucopolysaccharidosis type I in animal models.	[Aronovich, Elena L.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aronovich, EL (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	arono001@umn.edu	Wilson, Matthew H/K-3193-2013		National Institutes of Health [1R01DK082516, P01 HD32652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by grants 1R01DK082516 and P01 HD32652 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar Ismahen, 2012, Methods Mol Biol, V859, P229, DOI 10.1007/978-1-61779-603-6_13; Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Aronovich EL, 2011, HUM MOL GENET, V20, pR14, DOI 10.1093/hmg/ddr140; Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Arruda VR, 2009, MOL THER, V17, P1492, DOI 10.1038/mt.2009.150; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Das RG, 2007, LAB ANIM-UK, V41, P312, DOI 10.1258/002367707781282802; Garcia-Rivera MF, 2007, BRAIN RES BULL, V74, P429, DOI 10.1016/j.brainresbull.2007.07.018; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hackett PB, 2011, CURR GENE THER, V11, P341; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2004, MOL CELL, V13, P279, DOI 10.1016/S1097-2765(03)00524-0; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; MINER NA, 1969, APPL MICROBIOL, V17, P250, DOI 10.1128/AEM.17.2.250-251.1969; Neufeld EF, 2001, METABOLIC MOL BASES, VIII, P3427; Okuyama T, 1996, HUM GENE THER, V7, P637, DOI 10.1089/hum.1996.7.5-637; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Podetz-Pedersen KM, 2010, HUM GENE THER, V21, P210, DOI 10.1089/hum.2009.128; Score PR, 2006, MOL THER, V13, P617, DOI 10.1016/j.ymthe.2005.10.015; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.9239-9247.2004; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	34	14	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78161	10.1371/journal.pone.0078161	http://dx.doi.org/10.1371/journal.pone.0078161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205141	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600076
J	Kittan, NA; Allen, RM; Dhaliwal, A; Cavassani, KA; Schaller, M; Gallagher, KA; Carson, WF; Mukherjee, S; Grembecka, J; Cierpicki, T; Jarai, G; Westwick, J; Kunkel, SL; Hogaboam, CM				Kittan, Nicolai A.; Allen, Ronald M.; Dhaliwal, Abhay; Cavassani, Karen A.; Schaller, Matthew; Gallagher, Katherine A.; Carson, William F.; Mukherjee, Sumanta; Grembecka, Jolanta; Cierpicki, Tomasz; Jarai, Gabor; Westwick, John; Kunkel, Steven L.; Hogaboam, Cory M.			Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; TYPE-2 MACROPHAGES; MANNOSE RECEPTOR; GENE-EXPRESSION; DENDRITIC CELLS; IFN-GAMMA; POLARIZATION; MARKERS; CSF; INFLAMMATION	Macrophages (M Phi) play an essential role in innate immune responses and can either display a pro-inflammatory, classically activated phenotype (M1) or undergo an alternative activation program (M2) promoting immune regulation. M-CSF is used to differentiate monocytes into M Phi and IFN-gamma or IL-4+IL-13 to further polarize these cells towards M1 or M2, respectively. Recently, differentiation using only GM-CSF or M-CSF has been described to induce a M1- or M2-like phenotype, respectively. In this study, we combined both approaches by differentiating human M Phi in GMCSF or M-CSF followed by polarization with either IFN-gamma or IL-4+IL-13. We describe the phenotypic differences between CD14(hi) CD163(hi) CD206(int) FOLR2-expressing M-CSF M Phi and CD14(lo) CD163(lo) CD206(hi) GM-CSF M Phi but show that both macrophage populations reacted similarly to further polarization with IFN-gamma or IL-4+IL-13 with up-and down-regulation of common M1 and M2 marker genes. We also show that high expression of the mannose receptor (CD206), a marker of alternative activation, is a distinct feature of GM-CSF M Phi. Changes of the chromatin structure carried out by chromatin modification enzymes (CME) have been shown to regulate myeloid differentiation. We analyzed the expression patterns of CME during M Phi polarization and show that M1 up-regulate the histone methyltransferase MLL and demethylase KDM6B, while resting and M2 M Phi were characterized by DNA methyltransferases and histone deacetylases. We demonstrate that MLL regulates CXCL10 expression and that this effect could be abrogated using a MLL-Menin inhibitor. Taken together we describe the distinct phenotypic differences of GM-CSF or M-CSF M Phi and demonstrate that M Phi polarization is regulated by specific epigenetic mechanisms. In addition, we describe a novel role for MLL as marker for classical activation. Our findings provide new insights into M Phi polarization that could be helpful to distinguish M Phi activation states.	[Kittan, Nicolai A.; Allen, Ronald M.; Dhaliwal, Abhay; Cavassani, Karen A.; Schaller, Matthew; Carson, William F.; Mukherjee, Sumanta; Grembecka, Jolanta; Cierpicki, Tomasz; Kunkel, Steven L.; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Gallagher, Katherine A.] Univ Michigan Hosp, Div Vasc Surg, Ann Arbor, MI 48109 USA; [Jarai, Gabor; Westwick, John] Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Novartis	Hogaboam, CM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	hogaboam@med.umich.edu	Schaller, Matthew/AAL-7640-2020; hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924	NIH [HL-31237]; Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA160467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R01HL112897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by federal grants from the NIH (HL-31237) and in part by research funding from Novartis Pharmaceuticals (to Nicolai A. Kittan, Steven L. Kunkel and Cory M. Hogaboam). Gabor Jarai and John Westwick are employees of Novartis Institutes for Biomedical Research, UK (http://www.nibr.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Waldo SW, 2008, AM J PATHOL, V172, P1112, DOI 10.2353/ajpath.2008.070513; WANG X, 2012, J CELL SCI; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yeh CH, 2010, INFLAMMATION, V33, P10, DOI 10.1007/s10753-009-9153-z; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	44	115	122	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78045	10.1371/journal.pone.0078045	http://dx.doi.org/10.1371/journal.pone.0078045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205083	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600063
J	Xue, W; Huang, L; Dong, BC; Zhang, MX; Yu, FH				Xue, Wei; Huang, Lin; Dong, Bi-Cheng; Zhang, Ming-Xiang; Yu, Fei-Hai			Patchy Distributions of Competitors Affect the Growth of a Clonal Plant When the Competitor Density Is High	PLOS ONE			English	Article							MORPHOLOGICAL PLASTICITY; FORAGING BEHAVIOR; GRASSLAND PERENNIALS; SOLIDAGO-ALTISSIMA; SPATIAL-PATTERN; MODULAR CONCEPT; INTEGRATION; HETEROGENEITY; SPACE; OCCUPATION	Environments are patchy in not only abiotic factors but also biotic ones. Many studies have examined effects of spatial heterogeneity in abiotic factors such as light, water and nutrients on the growth of clonal plants, but few have tested those in biotic factors. We conducted a greenhouse experiment to examine how patchy distributions of competitors affect the growth of a rhizomatous wetland plant Bolboschoenus planiculmis and whether such effects depend on the density of the competitors. We grew one ramet of B. planiculmis in the center of each of the experimental boxes without competitors (Schoenoplectus triqueter), with a homogeneous distribution of the competitors of low or high density, and with a patchy distribution of the competitors of low or high density. The presence of competitors markedly decreased the growth (biomass, number of ramets, number of tubers and rhizome length) of the B. planiculmis clones. When the density of the competitors was low, the growth of B. planiculmis did not differ significantly between the competitor patches and competitor-free patches. However, when the density of the competitors was high, the growth of B. planiculmis was significantly higher in the competitor-free patches than in the competitor patches. Therefore, B. planiculmis can respond to patchy distributions of competitors by placing more ramets in competition-free patches when the density of competitors is high, but cannot do so when the density of competitors is low.	[Xue, Wei; Huang, Lin; Dong, Bi-Cheng; Zhang, Ming-Xiang; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, MX (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	zmx1972@126.com	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Forestry Commonwealth Project [201004078]; Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; Program for New Century Excellent Talents in University [NECT-10-0234]	Forestry Commonwealth Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the Forestry Commonwealth Project (201004078), the Fundamental Research Funds for the Central Universities (TD-JC-2013-1) and the Program for New Century Excellent Talents in University (NECT-10-0234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1991, AM J BOT, V78, P1508, DOI 10.2307/2444976; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Deegan B. M., 2004, Biology and Environment, V104B, P107, DOI 10.3318/BIOE.2004.104.2.107; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; He S, 1993, FLORA BEIJING; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Janecek S, 2004, FLORA, V199, P3, DOI 10.1078/0367-2530-00127; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; Kleijn D, 1999, J ECOL, V87, P873, DOI 10.1046/j.1365-2745.1999.00406.x; Kume T, 2006, ANN BOT-LONDON, V98, P1271, DOI 10.1093/aob/mcl216; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025629; Li HL, 2009, ECOL ENG, V35, P544, DOI 10.1016/j.ecoleng.2008.03.001; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; Lucero DW, 2000, PLANT SOIL, V227, P1, DOI 10.1023/A:1026560128042; MACDONALD SE, 1993, J ECOL, V81, P769, DOI 10.2307/2261674; Macek P, 2003, PLANT ECOL, V168, P31, DOI 10.1023/A:1024460525317; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; MCCONNAUGHAY KDM, 1992, FUNCT ECOL, V6, P711, DOI 10.2307/2389968; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; Monzeglio U, 2008, EVOL ECOL, V22, P723, DOI 10.1007/s10682-007-9197-1; Oborny B, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P155; Orrock JL, 2010, AM J BOT, V97, P694, DOI 10.3732/ajb.0900051; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Rich TCG, 2002, WATSONIA, V24, P56; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; SCHMID B, 1985, J ECOL, V73, P793, DOI 10.2307/2260147; SCHMID B, 1986, PROC R SOC SER B-BIO, V228, P173, DOI 10.1098/rspb.1986.0049; Semchenko M, 2008, NEW PHYTOL, V179, P1162, DOI 10.1111/j.1469-8137.2008.02543.x; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; SLADE AJ, 1987, J ECOL, V75, P639, DOI 10.2307/2260196; SLADE AJ, 1987, J ECOL, V75, P1023, DOI 10.2307/2260311; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Stark JM, 1994, EXPLOITATION ENV HET, P255; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Stoll P, 1998, J ECOL, V86, P341, DOI 10.1046/j.1365-2745.1998.00263.x; Stuefer Josef F., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P47, DOI 10.1078/1433-8319-00051; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; van Kleunen M, 2000, EVOLUTION, V54, P1947, DOI 10.1111/j.0014-3820.2000.tb01239.x; vanderMaarel E, 1996, J VEG SCI, V7, P19, DOI 10.2307/3236412; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; Whitlock MC, 2007, J EVOLUTION BIOL, V20, P1772, DOI 10.1111/j.1420-9101.2007.01387.x; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1111/j.1365-2745.2001.00618.x; Wu Z-Y, 2010, FLORA CHINA, V23; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yuan H. G., 1991, Journal of Weed Science, V5, P17; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002; Zheng Z-H, 2008, THESIS BEIJING FORES, P10	57	6	6	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78221	10.1371/journal.pone.0078221	http://dx.doi.org/10.1371/journal.pone.0078221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205165	Green Published, gold			2022-12-25	WOS:000326032600083
J	Belevych, AE; Ho, HT; Terentyeva, R; Bonilla, IM; Terentyev, D; Carnes, CA; Gyorke, S; Billman, GE				Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Bonilla, Ingrid M.; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.			Dietary Omega-3 Fatty Acids Promote Arrhythmogenic Remodeling of Cellular Ca2+ Handling in a Postinfarction Model of Sudden Cardiac Death	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; VENTRICULAR-FIBRILLATION; EICOSAPENTAENOIC ACID; MYOCARDIAL-ISCHEMIA; FISH CONSUMPTION; CANINE MODEL; TRIGGERED ARRHYTHMIAS; ISOLATED MYOCYTES; CALCIUM SPARKS; IN-VIVO	It has been proposed that dietary omega-3 polyunsaturated fatty acids (n-3 PUFAs) can reduce the risk of ventricular arrhythmias in post-MI patients. Abnormal Ca2+ handling has been implicated in the genesis of post-MI ventricular arrhythmias. Therefore, we tested the hypothesis that dietary n-3 PUFAs alter the vulnerability of ventricular myocytes to cellular arrhythmia by stabilizing intracellular Ca2+ cycling. To test this hypothesis, we used a canine model of post-MI ventricular fibrillation (VF) and assigned the animals to either placebo (1 g/day corn oil) or n-3 PUFAs (1-4 g/day) groups. Using Ca2+ imaging techniques, we examined the intracellular Ca2+ handling in myocytes isolated from post-MI hearts resistant (VF-) and susceptible (VF+) to VF. Frequency of occurrence of diastolic Ca2+ waves (DCWs) in VF+ myocytes from placebo group was significantly higher than in placebo-treated VF- myocytes. n-3 PUFA treatment did not decrease frequency of DCWs in VF+ myocytes. In contrast, VF- myocytes from the n-3 PUFA group had a significantly higher frequency of DCWs than myocytes from the placebo group. In addition, n-3 PUFA treatment increased beat-to-beat alterations in the amplitude of Ca2+ transients (Ca2+ alternans) in VF- myocytes. These n-3 PUFAs effects in VF- myocytes were associated with an increased Ca2+ spark frequency and reduced sarcoplasmic reticulum Ca2+ content, indicative of increased activity of ryanodine receptors. Thus, dietary n-3 PUFAs do not alleviate intracellular Ca2+ cycling remodeling in myocytes isolated from post-MI VF+ hearts. Furthermore, dietary n-3 PUFAs increase vulnerability of ventricular myocytes to cellular arrhythmia in post-MI VF- hearts by destabilizing intracellular Ca2+ handling.	[Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bonilla, Ingrid M.; Carnes, Cynthia A.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Terentyeva, Radmila; Terentyev, Dmitry] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Terentyeva, Radmila; Terentyev, Dmitry] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Ohio State University; Ohio State University; Ohio State University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Belevych, AE (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Andriy.Belevych@osumc.edu	Billman, George E/E-2758-2011; Terentyev, Dmitry/V-2037-2019	Terentyeva, Radmila/0000-0002-0133-3515; Terentyev, Dmitry/0000-0002-9530-7384; Belevych, Andriy/0000-0002-1272-5784	National Institute of Health [HL074045, HL063043, HL089836, HL086700]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089836, R01HL063043, R01HL086700, R01HL074045] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health Grants HL074045 and HL063043 (to Sandor Gyorke), HL089836 (to Cynthia A. Carnes), and HL086700 (to George E. Billman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdukeyum GG, 2008, J NUTR, V138, P1902, DOI 10.1093/jn/138.10.1902; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Berecki G, 2007, HEART RHYTHM, V4, P1452, DOI 10.1016/j.hrthm.2007.07.015; BILLMAN GE, 1994, P NATL ACAD SCI USA, V91, P4427, DOI 10.1073/pnas.91.10.4427; BILLMAN GE, 1982, CIRCULATION, V66, P874, DOI 10.1161/01.CIR.66.4.874; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Billman GE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P553, DOI 10.1161/CIRCEP.111.966739; Billman GE, 2010, AM J PHYSIOL-HEART C, V298, pH1219, DOI 10.1152/ajpheart.01065.2009; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Coronel R, 2007, CARDIOVASC RES, V73, P386, DOI 10.1016/j.cardiores.2006.10.006; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Den Ruijter HM, 2008, CIRCULATION, V117, P536, DOI 10.1161/CIRCULATIONAHA.107.733329; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; Di Stasi D, 2004, EUR J CLIN PHARMACOL, V60, P183, DOI 10.1007/s00228-004-0758-8; Ferrier GR, 2002, CARDIOVASC RES, V54, P601, DOI 10.1016/S0008-6363(02)00275-4; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; Honen BN, 2003, J MEMBRANE BIOL, V196, P95, DOI 10.1007/s00232-003-0628-9; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Leifert WR, 2001, J NUTR BIOCHEM, V12, P365, DOI 10.1016/S0955-2863(01)00151-6; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Negretti N, 2000, J PHYSIOL-LONDON, V523, P367, DOI 10.1111/j.1469-7793.2000.t01-1-00367.x; Niggli E, 2013, BBA-MOL CELL RES, V1833, P866, DOI 10.1016/j.bbamcr.2012.08.016; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Rauch B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00057; Richardson ES, 2011, J CARDIOVASC TRANSL, V4, P42, DOI 10.1007/s12265-010-9243-1; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Rodrigo GC, 1999, J MOL CELL CARDIOL, V31, P733, DOI 10.1006/jmcc.1998.0914; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; Sridhar A, 2008, AM J PHYSIOL-REG I, V295, pR1463, DOI 10.1152/ajpregu.90583.2008; Swan JS, 2003, CARDIOVASC RES, V60, P337, DOI 10.1016/S0008-6363(03)00545-5; Szentandrassy N, 2007, J PHYSIOL-LONDON, V582, P349, DOI 10.1113/jphysiol.2007.132753; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182	40	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78414	10.1371/journal.pone.0078414	http://dx.doi.org/10.1371/journal.pone.0078414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205228	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300154
J	Pascall, JC; Rotondo, S; Mukadam, AS; Oxley, D; Webster, J; Walker, SA; Piron, J; Carter, C; Ktistakis, NT; Butcher, GW				Pascall, John C.; Rotondo, Sergio; Mukadam, Aamir S.; Oxley, David; Webster, Judith; Walker, Simon A.; Piron, Jerry; Carter, Christine; Ktistakis, Nicholas T.; Butcher, Geoffrey W.			The Immune System GTPase GIMAP6 Interacts with the Atg8 Homologue GABARAPL2 and Is Recruited to Autophagosomes	PLOS ONE			English	Article							CELL-DEVELOPMENT; IAN FAMILY; GENE; SURVIVAL; RAT; EXPRESSION; LC3; IDENTIFICATION; POLYMORPHISM; DEGRADATION	The GIMAPs (GTPases of the immunity-associated proteins) are a family of small GTPases expressed prominently in the immune systems of mammals and other vertebrates. In mammals, studies of mutant or genetically-modified rodents have indicated important roles for the GIMAP GTPases in the development and survival of lymphocytes. No clear picture has yet emerged, however, of the molecular mechanisms by which they perform their function(s). Using biotin tag-affinity purification we identified a major, and highly specific, interaction between the human cytosolic family member GIMAP6 and GABARAPL2, one of the mammalian homologues of the yeast autophagy protein Atg8. Chemical cross-linking studies performed on Jurkat T cells, which express both GIMAP6 and GABARAPL2 endogenously, indicated that the two proteins in these cells readily associate with one another in the cytosol under normal conditions. The GIMAP6-GABARAPL2 interaction was disrupted by deletion of the last 10 amino acids of GIMAP6. The N-terminal region of GIMAP6, however, which includes a putative Atg8-family interacting motif, was not required. Over-expression of GIMAP6 resulted in increased levels of endogenous GABARAPL2 in cells. After culture of cells in starvation medium, GIMAP6 was found to localise in punctate structures with both GABARAPL2 and the autophagosomal marker MAP1LC3B, indicating that GIMAP6 re-locates to autophagosomes on starvation. Consistent with this finding, we have demonstrated that starvation of Jurkat T cells results in the degradation of GIMAP6. Whilst these findings raise the possibility that the GIMAPs play roles in the regulation of autophagy, we have been unable to demonstrate an effect of GIMAP6 over-expression on autophagic flux.	[Pascall, John C.; Rotondo, Sergio; Mukadam, Aamir S.; Carter, Christine; Butcher, Geoffrey W.] Babraham Inst, Cambridge, England; [Oxley, David; Webster, Judith] Babraham Inst, Mass Spectrometry Facil, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Walker, Simon A.] Babraham Inst, Imaging Facil, Cambridge, England; [Piron, Jerry] Babraham Inst, Monoclonal Antibody Unit, Cambridge, England; [Ktistakis, Nicholas T.] Babraham Inst, Inositide Lab, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Butcher, GW (corresponding author), Babraham Inst, Cambridge, England.	geoff.butcher@babraham.ac.uk		Walker, Simon/0000-0001-9185-4922	Core Strategic Grant and Institute Strategic Grant [BBS/E/B/0000C0409]; UK BBSRC; BBSRC [BBS/E/B/0000l763]; Babraham Institute; Cambridge Commonwealth Trusts; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0413, BBS/E/B/000H0116, BBS/E/B/0000C241] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C241, BBS/E/B/000C0413, BBS/E/B/0000C042, BBS/E/B/000H0116, BBS/E/B/000C0409] Funding Source: researchfish	Core Strategic Grant and Institute Strategic Grant; UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth Trusts; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Core Strategic Grant and Institute Strategic Grant (grant number BBS/E/B/0000C0409) funding by the UK BBSRC (http://www.bbsrc.ac.uk). SR was supported by PhD studentship funding (Grant number BBS/E/B/0000l763) from the BBSRC and The Babraham Institute; AM was supported by a PhD studentship from the Cambridge Commonwealth Trusts (http://www.admin.cam.ac.uk/students/studentregistry/fees/funding/trusts.html). The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Aravind L, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00089; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Carter C, 2007, J IMMUNOL, V179, P1784, DOI 10.4049/jimmunol.179.3.1784; Chadwick N, 2010, BLOOD CELL MOL DIS, V45, P201, DOI 10.1016/j.bcmd.2010.07.006; Chen YH, 2011, J EXP MED, V208, P923, DOI 10.1084/jem.20101192; Cousins L, 2006, GASTROENTEROLOGY, V131, P1475, DOI 10.1053/j.gastro.2006.09.023; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Drakas R, 2005, PROTEOMICS, V5, P132, DOI 10.1002/pmic.200400919; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; ELDER ME, 1983, J IMMUNOL, V130, P1723; Groen H, 1996, J IMMUNOL, V156, P1269; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; JACKSON R, 1981, DIABETES, V30, P887, DOI 10.2337/diabetes.30.10.887; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Lim MK, 2009, LUPUS, V18, P1045, DOI 10.1177/0961203309106830; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Pandarpurkar M, 2003, P NATL ACAD SCI USA, V100, P10382, DOI 10.1073/pnas.1832170100; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Saunders A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-53; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	52	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77782	10.1371/journal.pone.0077782	http://dx.doi.org/10.1371/journal.pone.0077782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204963	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200076
J	Jeong, AL; Lee, S; Park, JS; Han, S; Jang, CY; Lim, JS; Lee, MS; Yang, Y				Jeong, Ae Lee; Lee, Sunyi; Park, Jeong Su; Han, Sora; Jang, Chang-Young; Lim, Jong-Seok; Lee, Myung Sok; Yang, Young			Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Centrosome; Mitosis; Mitotic Spindle; PP2A; CIP2A; Centrosome Separation; NEK2	CELL-CYCLE; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC ROLE; POOR-PROGNOSIS; EXPRESSION; CHROMOSOME; PHOSPHORYLATION; ACTIVATION; SUBSTRATE; SENESCENCE	Cancerous inhibitor of protein phosphatase 2A (CIP2A) is overexpressed in most human cancers and has been described as being involved in the progression of several human malignancies via the inhibition of protein phosphatase 2A (PP2A) activity toward c-Myc. However, with the exception of this role, the cellular function of CIP2A remains poorly understood. On the basis of yeast two-hybrid and coimmunoprecipitation assays, we demonstrate here that NIMA (never in mitosis gene A)-related kinase 2 (NEK2) is a binding partner for CIP2A. CIP2A exhibited dynamic changes in distribution, including the cytoplasm and centrosome, depending on the cell cycle stage. When CIP2A was depleted, centrosome separation and the mitotic spindle dynamics were impaired, resulting in the activation of spindle assembly checkpoint signaling and, ultimately, extension of the cell division time. Our data imply that CIP2A strongly interacts with NEK2 during G(2)/M phase, thereby enhancing NEK2 kinase activity to facilitate centrosome separation in a PP1- and PP2A-independent manner. In conclusion, CIP2A is involved in cell cycle progression through centrosome separation and mitotic spindle dynamics.	[Jeong, Ae Lee; Lee, Sunyi; Park, Jeong Su; Han, Sora; Lim, Jong-Seok; Lee, Myung Sok; Yang, Young] Sookmyung Womens Univ, Dept Life Syst, Res Ctr Womens Dis, Coll Pharm, Seoul 140742, South Korea; [Jang, Chang-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 140742, South Korea	Sookmyung Women's University; Sookmyung Women's University	Yang, Y (corresponding author), Sookmyung Womens Univ, Dept Life Syst, Res Ctr Womens Dis, Seoul 140742, South Korea.	yyang@sookmyung.ac.kr		Yang, Young/0000-0003-4239-0804; Lim, Jong-Seok/0000-0003-4024-6868	National Research Foundation of Korea (NRF) [NRF-2012R1A2A1A03003709, 2011-0030074]; Korean government (Ministry of Science, ICT and Future Planning); Korea Health Industry Development Institute [B110053-1101-0000200]; Ministry of Health and Welfare	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT and Future Planning); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by National Research Foundation of Korea (NRF) Grants NRF-2012R1A2A1A03003709 and 2011-0030074 funded by the Korean government (Ministry of Science, ICT and Future Planning) and by Grant B110053-1101-0000200 of the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346; Bockelman C, 2011, BRIT J CANCER, V104, P1890, DOI 10.1038/bjc.2011.167; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Choi YA, 2011, FEBS LETT, V585, P755, DOI 10.1016/j.febslet.2011.01.018; Coenen EA, 2011, LEUKEMIA RES, V35, P133, DOI 10.1016/j.leukres.2010.08.017; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fang YY, 2012, TUMOR BIOL, V33, P2299, DOI 10.1007/s13277-012-0492-2; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fletcher L, 2005, BBA-MOL CELL RES, V1744, P89, DOI 10.1016/j.bbamcr.2005.01.007; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hames RS, 2002, BIOCHEM J, V361, P77, DOI 10.1042/0264-6021:3610077; He H, 2012, DIAGN MOL PATHOL, V21, P143, DOI 10.1097/PDM.0b013e318249fd8b; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huang LP, 2012, CANCER MED-US, V1, P76, DOI 10.1002/cam4.15; Huang LP, 2010, CANCER BIOMARK, V8, P309, DOI 10.3233/CBM-2011-0220; Huang PZ, 2012, BIOMARKERS, V17, P422, DOI 10.3109/1354750X.2012.680608; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Lin YC, 2012, ORAL ONCOL, V48, P585, DOI 10.1016/j.oraloncology.2012.01.012; Liu J, 2011, GYNECOL ONCOL, V122, P430, DOI 10.1016/j.ygyno.2011.04.031; Ma LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026310; Mardin BR, 2013, DEV CELL, V25, P229, DOI 10.1016/j.devcel.2013.03.012; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Mathiasen DP, 2012, ONCOGENE, V31, P390, DOI 10.1038/onc.2011.230; Mayor T, 2002, J CELL SCI, V115, P3275; Meraldi P, 2001, J CELL SCI, V114, P3749; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; Park J, 2013, BIOCHEM BIOPH RES CO, V431, P302, DOI 10.1016/j.bbrc.2012.12.106; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Qu W, 2012, MED ONCOL, V29, P113, DOI 10.1007/s12032-010-9768-9; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rhee K, 1997, DEVELOPMENT, V124, P2167; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Sonn S, 2004, J CELL SCI, V117, P5557, DOI 10.1242/jcs.01476; Teng HW, 2012, J GASTROINTEST SURG, V16, P1037, DOI 10.1007/s11605-012-1828-3; Thadani R, 2012, CURR BIOL, V22, pR1012, DOI 10.1016/j.cub.2012.10.023; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wang L, 2013, TUMOR BIOL, V34, P2309, DOI 10.1007/s13277-013-0775-2; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Xue YJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0406-6; Yi FX, 2013, MOL MED REP, V7, P1376, DOI 10.3892/mmr.2013.1357; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	66	27	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					28	40		10.1074/jbc.M113.507954	http://dx.doi.org/10.1074/jbc.M113.507954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214971	Green Published, hybrid			2022-12-25	WOS:000329370900003
J	Henderson, KA; Anand, M; Bauch, CT				Henderson, Kirsten A.; Anand, Madhur; Bauch, Chris T.			Carrot or Stick? Modelling How Landowner Behavioural Responses Can Cause Incentive-Based Forest Governance to Backfire	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; SOCIAL NORMS; LAND-USE; DEFORESTATION; DYNAMICS; PAYMENTS; LESSONS; COMMONS; POOR	Mitigating the negative impacts of declining worldwide forest cover remains a significant socio-ecological challenge, due to the dominant role of human decision-making. Here we use a Markov chain model of land-use dynamics to examine the impact of governance on forest cover in a region. Each land parcel can be either forested or barren (deforested), and landowners decide whether to deforest their parcel according to perceived value (utility). We focus on three governance strategies: yearly incentive for conservation, one-time penalty for deforestation and one-time incentive for reforestation. The incentive and penalty are incorporated into the expected utility of forested land, which decreases the net gain of deforestation. By analyzing the equilibrium and stability of the landscape dynamics, we observe four possible outcomes: a stationary-forested landscape, a stationary-deforested landscape, an unstable landscape fluctuating near the equilibrium, and a cyclic-forested landscape induced by synchronized deforestation. We find that the two incentive-based strategies often result in highly fluctuating forest cover over decadal time scales or longer, and in a few cases, reforestation incentives actually decrease the average forest cover. In contrast, a penalty for deforestation results in the stable persistence of forest cover (generally >30%). The idea that larger conservation incentives will always yield higher and more stable forest cover is not supported in our findings. The decision to deforest is influenced by more than a simple, "rational" cost-benefit analysis: social learning and myopic, stochastic decision-making also have important effects. We conclude that design of incentive programs may need to account for potential counter-productive long-term effects due to behavioural feedbacks.	[Henderson, Kirsten A.; Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Henderson, Kirsten A.; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Guelph; University of Waterloo	Bauch, CT (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	cbauch@uwaterloo.ca			James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada	James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a James S. McDonnell Foundation Complex Systems Scholar Award to MA, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to CTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Andersson KP, 2006, WORLD DEV, V34, P576, DOI 10.1016/j.worlddev.2005.08.009; Andersson K, 2007, J POLICY ANAL MANAG, V26, P99, DOI 10.1002/pam.20229; Angelsen A, 2008, VINNV PROGR REN MOV; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Banerjee O, 2009, FOREST POLICY ECON, V11, P244, DOI 10.1016/j.forpol.2009.04.004; Barbier E. B., 2004, American Journal of Agricultural Economics, V86, P1347, DOI 10.1111/j.0002-9092.2004.00688.x; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; BINSWANGER HP, 1991, WORLD DEV, V19, P821, DOI 10.1016/0305-750X(91)90135-5; Bockstael NE, 1996, AM J AGR ECON, V78, P1168, DOI 10.2307/1243487; Bryant D, 1997, LAST FRONTIERS FORES; Caviglia-Harris J. L., 2005, Agricultural and Resource Economics Review, V34, P145; Chhatre A, 2008, P NATL ACAD SCI USA, V105, P13286, DOI 10.1073/pnas.0803399105; Daniels AE, 2010, ECOL ECON, V69, P2116, DOI 10.1016/j.ecolecon.2010.06.011; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Fearnside PM, 2012, CLIM POLICY, V12, P70, DOI 10.1080/14693062.2011.581571; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Griffiths Tom, 2007, SEEING RED AVOIDED D; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Jarosz L., 1996, Liberation ecologies: environment, development, social movements., P148; Kaimowitz D.I.V, 1996, LIVESTOCK DEFORESTAT; Karsenty A, 2012, FOREST POLICY ECON, V18, P38, DOI [10.1016/j.forpol.2011.05.006, 10.1016/j.forpol.2012.03.001]; Kaufmann D, 2009, 4978 WORLD BANK; Klein J, 2002, GEOJOURNAL, V56, P1991; Liu WY, 2009, PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON ENVIRONMENTAL AND COMPUTER SCIENCE, P96, DOI 10.1109/ICECS.2009.68; McElwee PD, 2012, GEOFORUM, V43, P412, DOI 10.1016/j.geoforum.2011.04.010; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Minang P.A., 2010, REDD COPENHAGEN WAY; Morse WC, 2009, ECOL SOC, V14; Ortiz-Malavasie E, 2003, IMPACTO PROGRAMA PAG; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 2015, GOVERNING COMMONS, DOI DOI 10.1017/CBO9781316423936; Pfaff A., 2008, WORKING PAPER SERIES; Phelps J, 2010, SCIENCE, V328, P312, DOI 10.1126/science.1187774; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Satake A, 2006, ECOL RES, V21, P370, DOI 10.1007/s11284-006-0167-9; Satake A, 2008, GLOBAL ENVIRON CHANG, V18, P768, DOI 10.1016/j.gloenvcha.2008.07.007; Satake A, 2007, ECOL ECON, V63, P452, DOI 10.1016/j.ecolecon.2006.11.018; Satake A, 2007, ECOL RES, V22, P21, DOI 10.1007/s11284-006-0077-x; Simsik M. J., 2002, GeoJournal, V58, P233, DOI 10.1023/B:GEJO.0000017954.58269.69; Smith J, 2006, FOREST POLICY ECON, V8, P458, DOI 10.1016/j.forpol.2005.08.001; Thompson MC, 2011, ENVIRON SCI POLICY, V14, P100, DOI 10.1016/j.envsci.2010.11.006; Umemiya C, 2010, ENVIRON SCI POLICY, V13, P695, DOI 10.1016/j.envsci.2010.07.002; Vincent JR, 2007, ECOL RES, V22, P3, DOI 10.1007/s11284-006-0070-4; Wilensky U, 1999, NETLOGO 5 0 2; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; Zweibel E, 2010, CAN TAX J, V58, P25	49	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77735	10.1371/journal.pone.0077735	http://dx.doi.org/10.1371/journal.pone.0077735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204942	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500049
J	Zhao, DP; Yu, KL; Zhang, XH; Zheng, LB				Zhao, Dapeng; Yu, Keli; Zhang, Xinghua; Zheng, Lianbin			Digit Ratio (2D:4D) and Handgrip Strength in Hani Ethnicity	PLOS ONE			English	Article							GRIP STRENGTH; PRENATAL TESTOSTERONE; SEX-DIFFERENCES; FINGER-LENGTH; 2D/4D; 2ND; PERFORMANCE; MEN; BEHAVIOR; HORMONE	Introduction: The ratio of the length of the second finger to the fourth finger (2D:4D) in humans is considered as a putative marker of prenatal exposure to testosterone, and has been progressively adopted as one useful tool to evaluate the effect of prenatal hormones in some traits such as physical ability. Handgrip strength is one authentic measure of physical ability and is generally used on the anthropological research within an evolutionary viewpoint. Methods: Here we present the first evidence on 2D: 4D and handgrip strength on adult participants of Hani ethnicity and explore the relationship between digit ratio (2D: 4D) and handgrip strength. We examined 2D: 4D and handgrip strength of 80 males and 60 females at Bubeng village, in the Yunnan province of China. Results: The mean 2D: 4D in females was higher than that in males for each hand. Females showed significantly higher 2D: 4D than males in the right hand rather than in the left hand. Males displayed significantly higher handgrip strength than females for both hands. Handgrip strength decreased with age for both sexes. A significant negative correlation between 2D: 4D and handgrip strength was found in the right hand of males. Conclusion: The relationship between 2D: 4D and handgrip strength may be attributed to evolutionary drive of sexual selection operating on fetal programming.	[Zhao, Dapeng; Yu, Keli; Zhang, Xinghua; Zheng, Lianbin] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Zhao, Dapeng] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China	Tianjin Normal University; Northwest University Xi'an	Zhao, DP (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	dpzhao329@gmail.com			National Natural Science Foundation of China [NSFC 31200293]; Talent Introduction Fund of Tianjin Normal University [5RL115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Introduction Fund of Tianjin Normal University	This study was supported by grants from National Natural Science Foundation of China (NSFC 31200293), and Talent Introduction Fund of Tianjin Normal University (5RL115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; Beaton AA, 2011, LATERALITY, V16, P136, DOI 10.1080/13576500903410369; Bennett M, 2010, J SPORT SCI, V28, P1415, DOI 10.1080/02640414.2010.510143; Berenbaum SA, 2011, FRONT NEUROENDOCRIN, V32, P183, DOI 10.1016/j.yfrne.2011.03.001; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Coyne SM, 2007, PERS INDIV DIFFER, V43, P865, DOI 10.1016/j.paid.2007.02.010; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; GARN SM, 1975, AM J PHYS ANTHROPOL, V43, P327, DOI 10.1002/ajpa.1330430305; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Hone LSE, 2012, EVOL HUM BEHAV, V33, P780, DOI 10.1016/j.evolhumbehav.2012.07.003; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Kamarul T, 2006, J Orthop Surg (Hong Kong), V14, P172; Kemper CJ, 2009, AM J HUM BIOL, V21, P188, DOI 10.1002/ajhb.20843; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning J.T., 2008, FINGER BOOK SEX BEHA; Manning JT, 2007, ARCH SEX BEHAV, V36, P223, DOI 10.1007/s10508-007-9171-6; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; McIntyre MH, 2006, AM J PHYS ANTHROPOL, V129, P143, DOI 10.1002/ajpa.20240; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MONTOYE HJ, 1977, RES QUART, V48, P109, DOI 10.1080/10671315.1977.10762158; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Tamiya R, 2012, EVOL HUM BEHAV, V33, P130, DOI 10.1016/j.evolhumbehav.2011.07.003; Trivers R, 2006, HORM BEHAV, V49, P150, DOI 10.1016/j.yhbeh.2005.05.023; van Anders SM, 2007, AM J HUM BIOL, V19, P437, DOI 10.1002/ajhb.20634; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; Zhao DP, 2012, AM J PHYS ANTHROPOL, V149, P266, DOI 10.1002/ajpa.22130; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	56	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77958	10.1371/journal.pone.0077958	http://dx.doi.org/10.1371/journal.pone.0077958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205044	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500082
J	Kumari, S; Ware, D				Kumari, Sunita; Ware, Doreen			Genome-Wide Computational Prediction and Analysis of Core Promoter Elements across Plant Monocots and Dicots	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; CIS-ACTING ELEMENTS; FACTOR-BINDING SITES; TATA-BOX; POL-II; GENE-EXPRESSION; IN-VIVO; PREINITIATION COMPLEX; DNA MOTIFS; START SITE	Transcription initiation, essential to gene expression regulation, involves recruitment of basal transcription factors to the core promoter elements (CPEs). The distribution of currently known CPEs across plant genomes is largely unknown. This is the first large scale genome-wide report on the computational prediction of CPEs across eight plant genomes to help better understand the transcription initiation complex assembly. The distribution of thirteen known CPEs across four monocots (Brachypodium distachyon, Oryza sativa ssp. japonica, Sorghum bicolor, Zea mays) and four dicots (Arabidopsis thaliana, Populus trichocarpa, Vitis vinifera, Glycine max) reveals the structural organization of the core promoter in relation to the TATA-box as well as with respect to other CPEs. The distribution of known CPE motifs with respect to transcription start site (TSS) exhibited positional conservation within monocots and dicots with slight differences across all eight genomes. Further, a more refined subset of annotated genes based on orthologs of the model monocot (O. sativa ssp. japonica) and dicot (A. thaliana) genomes supported the positional distribution of these thirteen known CPEs. DNA free energy profiles provided evidence that the structural properties of promoter regions are distinctly different from that of the non-regulatory genome sequence. It also showed that monocot core promoters have lower DNA free energy than dicot core promoters. The comparison of monocot and dicot promoter sequences highlights both the similarities and differences in the core promoter architecture irrespective of the species-specific nucleotide bias. This study will be useful for future work related to genome annotation projects and can inspire research efforts aimed to better understand regulatory mechanisms of transcription.	[Kumari, Sunita; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ware, Doreen] ARS, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Cold Spring Harbor Laboratory; United States Department of Agriculture (USDA)	Ware, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	ware@cshl.edu			USDA [1907-21000-030]; Gramene [DBI 0703908]; Direct For Biological Sciences [1127112] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); Gramene; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is funded by USDA (1907-21000-030) and Gramene (DBI 0703908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Ali M, 2003, GENE, V320, P145, DOI 10.1016/S0378-1119(03)00821-7; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; ASO T, 1994, J BIOL CHEM, V269, P26575; AVRAHAM S, 1992, J BIOL CHEM, V267, P610; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Bernard V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-166; Bielinska B, 2005, GENETICS, V169, P161, DOI 10.1534/genetics.104.033118; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Bulyk ML, 2004, GENOME BIOL, V5; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cai YH, 2012, AMINO ACIDS, V43, P1141, DOI 10.1007/s00726-012-1377-9; Carmack CS, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-1; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; CARROLL SL, 1988, MOL CELL BIOL, V8, P241, DOI 10.1128/MCB.8.1.241; Casimiro AC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-89; CASSIDY B, 1987, BIOCHIM BIOPHYS ACTA, V909, P133, DOI 10.1016/0167-4781(87)90035-2; CHEN KH, 1995, GENE, V164, P323, DOI 10.1016/0378-1119(95)00498-U; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; CLOS J, 1986, NUCLEIC ACIDS RES, V14, P7581, DOI 10.1093/nar/14.19.7581; COLGAN J, 1995, P NATL ACAD SCI USA, V92, P1955, DOI 10.1073/pnas.92.6.1955; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Darvish H, 2011, GENE, V475, P79, DOI 10.1016/j.gene.2010.12.013; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Fukue Y, 2005, NUCLEIC ACIDS RES, V33, P3821, DOI 10.1093/nar/gki700; GARG LC, 1989, J BIOL CHEM, V264, P220; Gordan Raluca, 2008, Pac Symp Biocomput, P453; Grishkevich V, 2011, GENOME RES, V21, P707, DOI 10.1101/gr.113381.110; Halle JP, 1997, MOL CELL BIOL, V17, P4220, DOI 10.1128/MCB.17.8.4220; HAM J, 1994, EMBO J, V13, P147, DOI 10.1002/j.1460-2075.1994.tb06244.x; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; ISHIKAWA Y, 1991, J MOL BIOL, V218, P55, DOI 10.1016/0022-2836(91)90873-5; ITO T, 1995, PLANT CELL PHYSIOL, V36, P1281; Itoh A, 2004, BIOCHEM BIOPH RES CO, V313, P612, DOI 10.1016/j.bbrc.2003.11.152; JI Z, 1990, MOL CELL BIOL, V10, P5177, DOI 10.1128/MCB.10.10.5177; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KEHOE DM, 1994, PLANT CELL, V6, P1123, DOI 10.1105/tpc.6.8.1123; KHACHIGIAN LM, 1994, J BIOL CHEM, V269, P22647; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Klingenhoff A., 2002, In Silico Biology, V2, pS17; Kobayashi T, 1997, MAMM GENOME, V8, P554, DOI 10.1007/s003359900502; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Kuhlman TC, 1999, MOL CELL BIOL, V19, P2130; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Li N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez E, 1998, MOL CELL BIOL, V18, P6571, DOI 10.1128/MCB.18.11.6571; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Morey C, 2011, PLANT PHYSIOL, V156, P1300, DOI 10.1104/pp.110.167809; Nakamura M, 2002, PLANT J, V29, P1, DOI 10.1046/j.0960-7412.2001.01188.x; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Niu Huifeng, 1995, Gene Expression, V4, P111; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pandey SP, 2006, BIOSYSTEMS, V83, P38, DOI 10.1016/j.biosystems.2005.09.001; Pedersen AG, 1998, J MOL BIOL, V281, P663, DOI 10.1006/jmbi.1998.1972; Perier RC, 1999, NUCLEIC ACIDS RES, V27, P307, DOI 10.1093/nar/27.1.307; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rangannan V, 2009, MOL BIOSYST, V5, P1758, DOI [10.1039/B906535K, 10.1039/b906535k]; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Sakata-Takatani K, 2004, MATRIX BIOL, V23, P87, DOI 10.1016/j.matbio.2004.03.003; Sakurai H, 1996, FEBS LETT, V398, P113, DOI 10.1016/S0014-5793(96)01219-7; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santel A, 2000, NUCLEIC ACIDS RES, V28, P1439, DOI 10.1093/nar/28.6.1439; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shahmuradov IA, 2003, NUCLEIC ACIDS RES, V31, P114, DOI 10.1093/nar/gkg041; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2003, BIOINFORMATICS, V19, pi283, DOI 10.1093/bioinformatics/btg1039; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Solecki D, 1999, J BIOL CHEM, V274, P1791, DOI 10.1074/jbc.274.3.1791; Somboonthum P, 2005, NUCLEIC ACIDS RES, V33, P3401, DOI 10.1093/nar/gki652; Spooner W, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar056; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun H, 2011, NUCLEIC ACIDS RES, V39, P190, DOI 10.1093/nar/gkq775; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; TAMURA T, 1990, EMBO J, V9, P3101, DOI 10.1002/j.1460-2075.1990.tb07507.x; TAMURA TA, 1991, BIOCHIM BIOPHYS ACTA, V1129, P83, DOI 10.1016/0167-4781(91)90215-8; TASANEN K, 1992, J BIOL CHEM, V267, P11513; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WARIISHI S, 1995, BIOCHEM BIOPH RES CO, V216, P729, DOI 10.1006/bbrc.1995.2682; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YAMAMOTO Y, 1993, PLANT MOL BIOL, V22, P985, DOI 10.1007/BF00028971; Yamamoto YY, 2008, NUCLEIC ACIDS RES, V36, pD977, DOI 10.1093/nar/gkm785; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Yamamoto YY, 2011, DNA RES, V18, P333, DOI 10.1093/dnares/dsr020; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Zhao BW, 2001, MOL CARCINOGEN, V32, P92, DOI 10.1002/mc.1068; Zhou Qianjin, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P336; Zhou Q, 2008, NUCLEIC ACIDS RES, V36, P4137, DOI 10.1093/nar/gkn361; Zhou TY, 2002, NUCLEIC ACIDS RES, V30, P4145, DOI 10.1093/nar/gkf537	148	30	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79011	10.1371/journal.pone.0079011	http://dx.doi.org/10.1371/journal.pone.0079011			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205361	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326270700101
J	Li, XD; Guo, Q; Gao, JY; Yang, J; Zhang, W; Liang, YQ; Wu, DM; Liu, YF; Weng, JP; Li, QS; Zhang, Y				Li, Xiaodong; Guo, Qing; Gao, Jingying; Yang, Jing; Zhang, Wan; Liang, Yueqin; Wu, Dongmei; Liu, Yunfeng; Weng, Jianping; Li, Qingshan; Zhang, Yi			The Adenylyl Cyclase Inhibitor MDL-12,330A Potentiates Insulin Secretion via Blockade of Voltage-Dependent K+ Channels in Pancreatic Beta Cells	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; ELECTRICAL-ACTIVITY; CAMP; ISLETS; GLP-1; EPAC; CREB; GIP	Objective: Adenylyl cyclases (ACs) play important role in regulating pancreatic beta cell growth, survival and secretion through the synthesis of cyclic AMP (cAMP). MDL-12,330A and SQ 22536 are two AC inhibitors used widely to establish the role of ACs. The goal of this study was to examine the effects of MDL-12,330A and SQ 22536 on insulin secretion and underlying mechanisms. Methods: Patch-clamp recording, Ca2+ fluorescence imaging and radioimmunoassay were used to measure outward K+ currents, action potentials (APs), intracellular Ca2+ ([Ca2+](i)) and insulin secretion from rat pancreatic beta cells. Results: MDL-12,330A (10 mu mol/l) potentiated insulin secretion to 1.7 times of control in the presence of 8.3 mmol/l glucose, while SQ 22536 did not show significant effect on insulin secretion. MDL-12,330A prolonged AP durations (APDs) by inhibiting voltage-dependent K+ (K-V) channels, leading to an increase in [Ca2+](i) levels. It appeared that these effects induced by MDL-12,330A did not result from AC inhibition, since SQ 22536 did not show such effects. Furthermore, inhibition of the downstream effectors of AC/cAMP signaling by PKA inhibitor H89 and Epac inhibitor ESI-09, did not affect K-V channels and insulin secretion. Conclusion: The putative AC inhibitor MDL-12,330A enhances [Ca2+](i) and insulin secretion via inhibition of K-V channels rather than AC antagonism in beta cells, suggesting that the non-specific effects is needed to be considered for the right interpretation of the experimental results using this agent in the analyses of the role of AC in cell function.	[Li, Xiaodong; Guo, Qing; Gao, Jingying; Zhang, Wan; Liang, Yueqin; Wu, Dongmei; Zhang, Yi] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Peoples R China; [Yang, Jing; Liu, Yunfeng] Shanxi Med Univ, Hosp 1, Dept Endocrinol, Taiyuan, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Li, Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University; Sun Yat Sen University; Shanxi Medical University	Liu, YF (corresponding author), Shanxi Med Univ, Hosp 1, Dept Endocrinol, Taiyuan, Peoples R China.	nectarliu@163.com; nectarliu@163.com		Zhang, Yi/0000-0003-0305-3127; Liu, Yunfeng/0000-0003-2826-5804	National Natural Science Foundation of China [NSFC 81070662, 81273564, 81270882]; Natural Science Foundation of Shanxi Province [2012011039-8]; Shanxi Scholarship Council of China [2012-046]; Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars [2011-762]; Department of Health of Shanxi Province [201201062]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi [2011-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars; Department of Health of Shanxi Province; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This work was supported by grants to YZ (NSFC 81070662, 81273564) from National Natural Science Foundation of China, and by grants from Natural Science Foundation of Shanxi Province (2012011039-8), Shanxi Scholarship Council of China (2012-046) as well as Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars (2011-762). This work was also supported by grants from Department of Health of Shanxi Province (201201062 to Y.L), Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars (to YL) and National Natural Science Foundation of China (81270882 to JY). YZ was supported by Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (2011-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Gadea A, 1999, BRAIN RES, V838, P200, DOI 10.1016/S0006-8993(99)01683-2; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Nakazaki M, 2002, DIABETES, V51, P3440, DOI 10.2337/diabetes.51.12.3440; RAMPE D, 1987, J PHARMACOL EXP THER, V243, P402; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; RORSMAN P, 1994, DIABETES METAB, V20, P138; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Zhang Y, 2008, DIABETOLOGIA, V51, P2290, DOI 10.1007/s00125-008-1166-x; Zhang Y, 2009, J ENDOCRINOL, V203, P45, DOI 10.1677/JOE-09-0068	23	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77934	10.1371/journal.pone.0077934	http://dx.doi.org/10.1371/journal.pone.0077934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205033	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700061
J	Che, J; Mach, AJ; Go, DE; Talati, I; Ying, Y; Rao, JY; Kulkarni, RP; Di Carlo, D				Che, James; Mach, Albert J.; Go, Derek E.; Talati, Ish; Ying, Yong; Rao, Jianyu; Kulkarni, Rajan P.; Di Carlo, Dino			Microfluidic Purification and Concentration of Malignant Pleural Effusions for Improved Molecular and Cytomorphological Diagnostics	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; SAMPLE PREPARATION; SENSITIVE METHOD; CELLS; EGFR; MUTATIONS; CYTOLOGY	Evaluation of pleural fluids for metastatic cells is a key component of diagnostic cytopathology. However, a large background of smaller leukocytes and/or erythrocytes can make accurate diagnosis difficult and reduce specificity in identification of mutations of interest for targeted anti-cancer therapies. Here, we describe an automated microfluidic system (Centrifuge Chip) which employs microscale vortices for the size-based isolation and concentration of cancer cells and mesothelial cells from a background of blood cells. We are able to process non-diluted pleural fluids at 6 mL/min and enrich target cells significantly over the background; we achieved improved purity in all patient samples analyzed. The resulting isolated and viable cells are readily available for immunostaining, cytological analysis, and detection of gene mutations. To demonstrate the utility towards aiding companion diagnostics, we also show improved detection accuracy of KRAS gene mutations in lung cancer cells processed using the Centrifuge Chip, leading to an increase in the area under the curve (AUC) of the receiver operating characteristic from 0.90 to 0.99. The Centrifuge Chip allows for rapid concentration and processing of large volumes of bodily fluid samples for improved cytological diagnosis and purification of cells of interest for genetic testing, which will be helpful for enhancing diagnostic accuracy.	[Che, James; Mach, Albert J.; Go, Derek E.; Talati, Ish; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Ying, Yong; Rao, Jianyu] Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, Div Dermatol, Med Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Che, J (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	che@seas.ucla.edu; jrao@mednet.ucla.edu; rkulkarn@ucla.edu; dicarlo@seas.ucla.edu			Office of Naval Research Young Investigator Program [20101030]; Coulter Foundation Translational Research Award [N00014-12-1-0847]	Office of Naval Research Young Investigator Program(Office of Naval Research); Coulter Foundation Translational Research Award	This work was partially supported by the Office of Naval Research Young Investigator Program (D.D. #20101030, http://www.onr.navy.mil/Science-Technology/Directorates/office-research-discovery-invention/Sponsored-Research/YIP.aspx) and a Coulter Foundation Translational Research Award (D.D. #N00014-12-1-0847, http://www.whcf.org/research-award/overview). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billah S, 2011, CANCER CYTOPATHOL, V119, P111, DOI 10.1002/cncy.20151; Boldrini L, 2007, J THORAC ONCOL, V2, P1086, DOI 10.1097/JTO.0b013e31815ba1fa; Chen J, 2012, LAB CHIP, V12, P1753, DOI 10.1039/c2lc21273k; Chowdhuri SR, 2012, MODERN PATHOL, V25, P548, DOI 10.1038/modpathol.2011.184; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; KASHII T, 1994, J CANCER RES CLIN, V120, P143, DOI 10.1007/BF01202192; Kassis J, 2005, DIAGN CYTOPATHOL, V33, P316, DOI 10.1002/dc.20280; Kimura N, 2009, DIAGN CYTOPATHOL, V37, P885, DOI 10.1002/dc.21128; Mach AJ, 2013, LAB CHIP, V13, P1011, DOI 10.1039/c2lc41104k; Mach AJ, 2011, LAB CHIP, V11, P2827, DOI 10.1039/c1lc20330d; Malapelle U, 2012, J CLIN PATHOL, V65, P87, DOI 10.1136/jclinpath-2011-200296; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; SAHN SA, 1982, WESTERN J MED, V137, P99; Saliba AE, 2010, P NATL ACAD SCI USA, V107, P14524, DOI 10.1073/pnas.1001515107; Villena V, 2004, CHEST, V125, P156, DOI 10.1378/chest.125.1.156	24	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78194	10.1371/journal.pone.0078194	http://dx.doi.org/10.1371/journal.pone.0078194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205153	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200055
J	Kim, A; Im, M; Yim, NH; Jung, YP; Ma, JY				Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Jung, Young Pil; Ma, Jin Yeul			Aqueous Extract of Bambusae Caulis in Taeniam Inhibits PMA-Induced Tumor Cell Invasion and Pulmonary Metastasis: Suppression of NF-kappa B Activation through ROS Signaling	PLOS ONE			English	Article							TRITERPENOID-RICH EXTRACT; BAMBOO SHAVINGS; DOWN-REGULATION; IN-TAENIAM; CANCER; EXPRESSION; MMP-9; ANGIOGENESIS; MATRIX-METALLOPROTEINASE-9	Bamboo shavings (Bambusae Caulis in Taeniam, BCT) are widely used as a traditional Chinese medicine to control hypertension and cardiovascular disease, and to alleviate fever, vomiting, and diarrhea. It has been demonstrated that BCT reduces ovalbumin-induced airway inflammation by regulating pro-inflammatory cytokines, and decreases tumor growth in tumor-bearing mice. However, the effects of BCT on the metastatic potential of malignant cancer cells and the detailed mechanism of its anti-metastatic activity have not been examined previously. In this study, we investigated whether an aqueous extract of BCT (AE-BCT) reduces the metastatic potential of HT1080 cells, and elucidated the underlying anti-metastatic mechanism. In addition, we examined whether AE-BCT administration inhibits pulmonary metastasis of intravenously injected B16F10 cells in C57BL/6J mice. AE-BCT (50-250 mu g/ml) dose-dependently suppressed colony-forming activity under anchorage-dependent and -independent growth conditions. Pretreatment with AE-BCT efficiently inhibited cell migration, invasion, and adhesion. AE-BCT also dramatically suppressed PMA-induced MMP-9 activity and expression by blocking NF-kappa B activation and ERK phosphorylation. Production of intracellular ROS, a key regulator of NF-kappa B-induced MMP-9 activity, was almost completely blocked by pretreatment with AE-BCT. Furthermore, daily oral administration of AE-BCT at doses of 50 and 100 mg/kg efficiently inhibited lung metastasis of B16F10 cells injected into the tail veins of C57BL/6J mice with no systemic toxicity. These results demonstrate that AE-BCT significantly reduced the metastatic activity of highly malignant cancer cells by suppressing MMP-9 activity via inhibition of ROS-mediated NF-kappa B activation. These results indicate that AE-BCT may be a safe natural product for treatment of metastatic cancer.	[Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Jung, Young Pil; Ma, Jin Yeul] Korea Inst Oriental Med KIOM, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), Korea Inst Oriental Med KIOM, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea.	jyma@kiom.re.kr			Ministry of Education, Science and Technology (MEST), Republic of Korea [K12050]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the a Grant K12050 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binker MG, 2011, BIOCHEM BIOPH RES CO, V405, P140, DOI 10.1016/j.bbrc.2011.01.023; Bussemakers MJG, 1996, WORLD J UROL, V14, P151; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi JH, 2010, FOOD CHEM TOXICOL, V48, P564, DOI 10.1016/j.fct.2009.11.033; Eom HW, 2012, INT J MOL MED, V30, P1512, DOI 10.3892/ijmm.2012.1128; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Ham I, 2009, IMMUNOPHARM IMMUNOT, V31, P439, DOI 10.1080/08923970902769638; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Jiang Zhong-Qing, 2003, Ai Zheng, V22, P178; Jiao JJ, 2007, PHYTOTHER RES, V21, P1135, DOI 10.1002/ptr.2223; Jin GH, 2012, ENVIRON TOXICOL PHAR, V34, P315, DOI 10.1016/j.etap.2012.05.001; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Jung SH, 2007, BIOL PHARM BULL, V30, P1569, DOI 10.1248/bpb.30.1569; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Kim BH, 2013, MOL CELLS, V35, P410, DOI 10.1007/s10059-013-0031-z; Kim SC, 2010, FOOD CHEM TOXICOL, V48, P1478, DOI 10.1016/j.fct.2010.03.014; Kim TS, 1999, J KOREAN MED SCI, V14, P263, DOI 10.3346/jkms.1999.14.3.263; Lee KJ, 2008, CANCER LETT, V268, P233, DOI 10.1016/j.canlet.2008.03.058; Lee KJ, 2006, FOOD CHEM TOXICOL, V44, P1890, DOI 10.1016/j.fct.2006.06.009; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lu BY, 2010, AFR J BIOTECHNOL, V9, P6430; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Morais C, 2010, APOPTOSIS, V15, P412, DOI 10.1007/s10495-009-0414-y; Patel LR, 2011, FUTURE ONCOL, V7, P1285, DOI [10.2217/fon.11.112, 10.2217/FON.11.112]; Ra J, 2010, J ETHNOPHARMACOL, V128, P241, DOI 10.1016/j.jep.2010.01.023; Seki T, 2010, EVID-BASED COMPL ALT, V7, P447, DOI 10.1093/ecam/nen026; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Tsunoda S, 1998, ANTICANCER RES, V18, P153; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027	32	21	23	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78061	10.1371/journal.pone.0078061	http://dx.doi.org/10.1371/journal.pone.0078061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205091	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200052
J	Kang, KT; Chou, CH; Weng, WC; Lee, PL; Hsu, WC				Kang, Kun-Tai; Chou, Chen-Han; Weng, Wen-Chin; Lee, Pei-Lin; Hsu, Wei-Chung			Associations between Adenotonsillar Hypertrophy, Age, and Obesity in Children with Obstructive Sleep Apnea	PLOS ONE			English	Article							PEDIATRIC TONSIL SIZE; ADENOID HYPERTROPHY; RADIOGRAPHIC EVALUATION; BODY-WEIGHT; AIRWAY; CHILDHOOD; DIAGNOSIS; SEVERITY; POLYSOMNOGRAM; ADOLESCENTS	Objective: To investigate the contributions of adenoid and tonsil size to childhood obstructive sleep apnea (OSA) and the interactions between adenotonsillar hypertrophy, age, and obesity in children with OSA. Methods: In total, 495 symptomatic patients were recruited. The patients were assigned to four groups according to age: toddler (age 1-3, n=42), preschool (age 3-6, n=164), school (age 6-12, n=200), and adolescence (age 12-18, n=89). All subjects had tonsil size graded by otolaryngologists, adenoid size determined on lateral radiographs (Fujioka method), and a full-night polysomnography. The apnea-hypopnea index (AHI), adenoid size, and tonsil size were compared in obese and non-obese children in the four age groups. Adjusted odds ratios (ORs) and 95% confidence interval (CI) of adenotonsillar hypertrophy and OSA risk were estimated by multi-logistic regression. Results: The AHI was positively related to tonsil grade (r=0.33, p <0.001) and adenoid size (r=0.24, p <0.01) in all patients. Tonsil grade was positively related to AHI in all four age groups. Adenoid size was positively related to AHI in the toddler, preschool, school groups, but not in the adolescent group (r=0.11, p=0.37). Tonsil grade and adenoid size were both positively related to AHI in obese and non-obese children. In the regression model, obesity (OR=2.89; 95% CI 1.47-5.68), tonsillar hypertrophy (OR=3.15; 95% CI 2.04-4.88), and adenoidal hypertrophy (OR=1.89; 95% CI 1.19-3.00) significantly increased OSA risk. Conclusions: Adenotonsillar hypertrophy and obesity are the major determinants of OSA in children. However, the influence of adenoid size decreases in adolescence.	[Kang, Kun-Tai; Chou, Chen-Han; Hsu, Wei-Chung] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Kang, Kun-Tai] Minist Hlth & Welf, Taipei Hosp, Dept Otolaryngol, New Taipei City, Taiwan; [Kang, Kun-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Weng, Wen-Chin; Lee, Pei-Lin; Hsu, Wei-Chung] Natl Taiwan Univ Hosp, Sleep Ctr, Taipei, Taiwan; [Weng, Wen-Chin] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lee, Pei-Lin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsu, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	hsuwc@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Hsu, Wei-Chung/0000-0001-8583-8459; weng, wen-chin/0000-0002-6923-9138	National Taiwan University Hospital [NTUH 102-S2193]	National Taiwan University Hospital(National Taiwan University)	This study was supported partially by grand NTUH 102-S2193 from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abramson Z, 2010, J ORAL MAXIL SURG, V68, P354, DOI 10.1016/j.joms.2009.09.087; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; Brooks LJ, 1998, J PEDIATR-US, V132, P682, DOI 10.1016/S0022-3476(98)70360-9; Cahali MB, 2011, CLINICS, V66, P1347, DOI 10.1590/S1807-59322011000800007; Cappabianca S, 2013, INT J PEDIATR OTORHI, V77, P69, DOI 10.1016/j.ijporl.2012.09.035; Caylakli F, 2009, INT J PEDIATR OTORHI, V73, P1532, DOI 10.1016/j.ijporl.2009.07.018; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Cho JH, 1999, J LARYNGOL OTOL, V113, P899, DOI 10.1017/S0022215100145530; Chou CH, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.184, DOI 10.1038/IJ0.2013.184]; COHEN D, 1985, CLIN OTOLARYNGOL, V10, P73, DOI 10.1111/j.1365-2273.1985.tb01170.x; CREPEAU J, 1982, OTOLARYNG HEAD NECK, V90, P548, DOI 10.1177/019459988209000505; Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E; Dayyat E, 2009, CHEST, V136, P137, DOI 10.1378/chest.08-2568; Friedman M, 2009, OTOLARYNG HEAD NECK, V140, P800, DOI 10.1016/j.otohns.2009.01.043; FUJIOKA M, 1979, AM J ROENTGENOL, V133, P401, DOI 10.2214/ajr.133.3.401; GISLASON T, 1995, CHEST, V107, P963, DOI 10.1378/chest.107.4.963; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; HIBBERT J, 1979, CLIN OTOLARYNGOL, V4, P321, DOI 10.1111/j.1365-2273.1979.tb01760.x; Howard NS, 2009, OTOLARYNG HEAD NECK, V140, P675, DOI 10.1016/j.otohns.2009.01.008; Hsu WC, 2013, INT J OBESITY, V37, P527, DOI 10.1038/ijo.2012.194; Iber C., 2007, AASM MANUAL SCORING; JOHANNES.S, 1968, ACTA RADIOL DIAGN, V7, P299, DOI 10.1177/028418516800700402; Kaditis AG, 2009, PEDIATR PULM, V44, P1216, DOI 10.1002/ppul.21126; Kang KT, 2012, INT J OBESITY, V36, P920, DOI 10.1038/ijo.2012.5; Kang KT, 2014, J FORMOS MED ASSOC, V113, P454, DOI 10.1016/j.jfma.2012.10.002; Katz ES, 2012, AM J RESP CRIT CARE, V185, P805, DOI 10.1164/rccm.201108-1455CI; Kindermann CA, 2008, INT J PEDIATR OTORHI, V72, P63, DOI 10.1016/j.ijporl.2007.09.013; Kohler MJ, 2008, SLEEP MED REV, V12, P347, DOI 10.1016/j.smrv.2008.04.008; Kolo ES, 2011, EUR J RADIOL, V79, pE38, DOI 10.1016/j.ejrad.2010.09.027; Kolo ES, 2010, INT J PEDIATR OTORHI, V74, P532, DOI 10.1016/j.ijporl.2010.02.015; Lam YY, 2006, CHEST, V130, P1751, DOI 10.1378/chest.130.6.1751; Lertsburapa K, 2010, INT J PEDIATR OTORHI, V74, P1281, DOI 10.1016/j.ijporl.2010.08.005; Li AM, 2008, THORAX, V63, P803, DOI 10.1136/thx.2007.091132; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Major MP, 2006, AM J ORTHOD DENTOFAC, V130, P700, DOI 10.1016/j.ajodo.2005.05.050; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Feres MFN, 2012, BRAZ J OTORHINOLAR, V78, P80, DOI 10.1590/S1808-86942012000400016; Feres MFN, 2011, INT J PEDIATR OTORHI, V75, P1, DOI 10.1016/j.ijporl.2010.11.002; Nolan J, 2011, OTOLARYNG HEAD NECK, V144, P844, DOI 10.1177/0194599811400683; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Parikh SR, 2006, OTOLARYNG HEAD NECK, V135, P684, DOI 10.1016/j.otohns.2006.05.003; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Shine NP, 2005, INT J PEDIATR OTORHI, V69, P1475, DOI 10.1016/j.ijporl.2005.08.008; Tagaya M, 2012, INT J PEDIATR OTORHI, V76, P1827, DOI 10.1016/j.ijporl.2012.09.010; Uliel S, 2004, CHEST, V125, P872, DOI 10.1378/chest.125.3.872; Valera FCP, 2005, OTOLARYNG HEAD NECK, V132, P268, DOI 10.1016/j.otohns.2004.09.033; Wang DY, 1997, CLIN OTOLARYNGOL, V22, P172, DOI 10.1046/j.1365-2273.1997.00002.x; Wing YK, 2003, ARCH DIS CHILD, V88, P1043, DOI 10.1136/adc.88.12.1043; Ysunza A, 2008, INT J PEDIATR OTORHI, V72, P1159, DOI 10.1016/j.ijporl.2008.03.022	51	116	117	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78666	10.1371/journal.pone.0078666	http://dx.doi.org/10.1371/journal.pone.0078666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205291	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400095
J	Padte, NN; Boente-Carrera, M; Andrews, CD; McManus, J; Grasperge, BF; Gettie, A; Coelho-dos-Reis, JG; Li, XM; Wu, D; Bruder, JT; Sedegah, M; Patterson, N; Richie, TL; Wong, CH; Ho, DD; Vasan, S; Tsuji, M				Padte, Neal N.; Boente-Carrera, Mar; Andrews, Chasity D.; McManus, Jenny; Grasperge, Brooke F.; Gettie, Agegnehu; Coelho-dos-Reis, Jordana G.; Li, Xiangming; Wu, Douglass; Bruder, Joseph T.; Sedegah, Martha; Patterson, Noelle; Richie, Thomas L.; Wong, Chi-Huey; Ho, David D.; Vasan, Sandhya; Tsuji, Moriya			A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates	PLOS ONE			English	Article							KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PHASE I/II TRIAL; ALPHA-GALACTOSYLCERAMIDE; DENDRITIC CELLS; NKT CELLS; IN-VIVO; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE IMMUNITY; PERIPHERAL-BLOOD	A key strategy to a successful vaccine against malaria is to identify and develop new adjuvants that can enhance T-cell responses and improve protective immunity. Upon co-administration with a rodent malaria vaccine in mice, 7DW8-5, a recently identified novel analog of alpha-galactosylceramide (alpha-GalCer), enhances the level of malaria-specific protective immune responses more strongly than the parent compound. In this study, we sought to determine whether 7DW8-5 could provide a similar potent adjuvant effect on a candidate human malaria vaccine in the more relevant non-human primate (NHP) model, prior to committing to clinical development. The candidate human malaria vaccine, AdPfCA (NMRC-M3V-Ad-PfCA), consists of two non-replicating recombinant adenoviral (Ad) vectors, one expressing the circumsporozoite protein (CSP) and another expressing the apical membrane antigen-1 (AMA1) of Plasmodium falciparum. In several phase 1 clinical trials, AdPfCA was well tolerated and demonstrated immunogenicity for both humoral and cell-mediated responses. In the study described herein, 25 rhesus macaques received prime and boost intramuscular (IM) immunizations of AdPfCA alone or with an ascending dose of 7DW8-5. Our results indicate that 7DW8-5 is safe and well-tolerated and provides a significant enhancement (up to 9-fold) in malaria-specific CD8+ T-cell responses after both priming and boosting phases, supporting further clinical development.	[Padte, Neal N.; Boente-Carrera, Mar; Andrews, Chasity D.; McManus, Jenny; Coelho-dos-Reis, Jordana G.; Li, Xiangming; Ho, David D.; Vasan, Sandhya; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Grasperge, Brooke F.; Gettie, Agegnehu] Tulane Univ, Med Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Wu, Douglass; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Bruder, Joseph T.] GenVec Inc, Res, Gaithersburg, MD USA; [Sedegah, Martha; Patterson, Noelle; Richie, Thomas L.] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Patterson, Noelle] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Rockefeller University; Tulane University; Scripps Research Institute; Naval Medical Research Center (NMRC); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Vasan, S (corresponding author), Henry M Jackson Fdn, Armed Forces Res Inst Med Sci, US Mil HIV Res Program, Bangkok, Thailand.	sandhya.vasan@afrims.org; mtsuji@adarc.org	Coelho-dos-Reis, Jordana/HGU-6453-2022	Richie, Thomas/0000-0002-2946-5456; Tsuji, Moriya/0000-0001-8587-277X	NIH [AI070258]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [38648]; Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070258, R56AI070258] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by a grant from NIH AI070258 (M. T.), the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (Grant Number 38648 to D. D. H), and the Irene Diamond Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett JD, 2011, EXPERT REV VACCINES, V10, P1307, DOI [10.1586/ERV.11.88, 10.1586/erv.11.88]; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bontkes HJ, 2010, CLIN IMMUNOL, V136, P364, DOI 10.1016/j.clim.2010.04.019; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chackerian A, 2002, INFECT IMMUN, V70, P6302, DOI 10.1128/IAI.70.11.6302-6309.2002; Courtney AN, 2011, EUR J IMMUNOL, V41, P3312, DOI 10.1002/eji.201041359; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gansuvd B, 2008, J MED PRIMATOL, V37, P1, DOI 10.1111/j.1600-0684.2007.00222.x; Gardiner DF, 2006, VACCINE, V24, P287, DOI 10.1016/j.vaccine.2005.07.075; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawakami K, 2001, INFECT IMMUN, V69, P6643, DOI 10.1128/IAI.69.11.6643-6650.2001; Kawakami K, 2001, INFECT IMMUN, V69, P213, DOI 10.1128/IAI.69.1.213-220.2001; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Mitchell D, 2011, HUM VACCINES, V7, P85, DOI 10.4161/hv.7.0.14567; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rout N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009787; Schneiders FL, 2011, CLIN IMMUNOL, V140, P130, DOI 10.1016/j.clim.2010.11.010; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Veldt BJ, 2007, J HEPATOL, V47, P356, DOI 10.1016/j.jhep.2007.04.018; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Woltman AM, 2009, ANTIVIR THER, V14, P809, DOI 10.3851/IMP1295	57	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78407	10.1371/journal.pone.0078407	http://dx.doi.org/10.1371/journal.pone.0078407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205224	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400081
J	Metlapally, R; Gonzalez, P; Hawthorne, FA; Tran-Viet, KN; Wildsoet, CF; Young, TL				Metlapally, Ravikanth; Gonzalez, Pedro; Hawthorne, Felicia A.; Khanh-Nhat Tran-Viet; Wildsoet, Christine F.; Young, Terri L.			Scleral Micro-RNA Signatures in Adult and Fetal Eyes	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SEED REGION; EXPRESSION; MIR-29B; GROWTH; FIBROBLASTS; BIOGENESIS; CELLS; PI3K	Introduction: In human eyes, ocular enlargement/ growth reflects active extracellular matrix remodeling of the outer scleral shell. Micro-RNAs are small non-coding RNAs that regulate gene expression by base pairing with target sequences. They serve as nodes of signaling networks. We hypothesized that the sclera, like most tissues, expresses micro-RNAs, some of which modulate genes regulating ocular growth. In this study, the scleral micro-RNA expression profile of rapidly growing human fetal eyes was compared with that of stable adult donor eyes using highthroughput microarray and quantitative PCR analyses. Methods: Scleral samples from normal human fetal (24 wk) and normal adult donor eyes were obtained (n=4 to 6, each group), and RNA extracted. Genome-wide micro-RNA profiling was performed using the Agilent micro-RNA microarray platform. Micro-RNA target predictions were obtained using Microcosm, TargetScan and PicTar algorithms. TaqMan r micro-RNA assays targeting micro-RNAs showing either highest significance, detection, or fold differences, and collagen specificity, were applied to scleral samples from posterior and peripheral ocular regions (n=7, each group). Microarray data were analyzed using R, and quantitative PCR data with 2(Lambda)-deltaCt methods. Results: Human sclera was found to express micro-RNAs, and comparison of microarray results for adult and fetal samples revealed many to be differentially expressed (p<0.01, min p=6.5x1011). Specifically, fetal sclera showed increased expression of mir-214, let-7c, let-7e, mir-103, mir-107, and mir-98 (1.5 to 4 fold changes, p< 0.01). However, no significant regionally specific differences. i. e., posterior vs. peripheral sclera, were observed for either adult or fetal samples. Conclusion: For the first time, micro-RNA expression has been catalogued in human sclera. Some micro-RNAs show age-related differential regulation, higher in the sclera of rapidly growing fetal eyes, consistent with a role in ocular growth regulation. Thus micro-RNAs represent potential targets for ocular growth manipulation, related to myopia and/ or other disorders such as scleral ectasia.	[Metlapally, Ravikanth; Wildsoet, Christine F.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Gonzalez, Pedro; Young, Terri L.] Duke Univ Hlth Syst, Duke Eye Ctr, Durham, NC USA; [Hawthorne, Felicia A.; Khanh-Nhat Tran-Viet; Young, Terri L.] Duke Univ, Ctr Human Genet, Durham, NC USA	University of California System; University of California Berkeley; Duke University; Duke University	Metlapally, R (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	metlapally@berkeley.edu			Research to Prevent Blindness Inc. through the Duke Eye Center; NIH/NEI [K12EY017269, 1K08EY022670, R01EY023287, R01 EY012392, 1R01EY018246]; NATIONAL EYE INSTITUTE [K08EY022670] Funding Source: NIH RePORTER	Research to Prevent Blindness Inc. through the Duke Eye Center; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by funds from Research to Prevent Blindness Inc. Small Grant through the Duke Eye Center, NIH/NEI K12EY017269 (Berkeley Clinical Scientist Development Program), and NIH/NEI 1K08EY022670 to RM; NIH/NEI R01EY023287 to PG; NIH/NEI R01 EY012392 to CFW; NIH/NEI 1R01EY018246 and Research To Prevent Blindness Inc grant to TLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, ONTROLLING FALSE DIS, P289; BRON AJ, 1997, WOLFFS ANATOMY EYE O, P233; CHEN KC, INVEST OPHTHALMOL VI; CHRISTENSEN AM, 1991, INVEST OPHTH VIS SCI, V32, P2143; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r42; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luna C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051688; Luna C, 2009, MOL VIS, V15, P2488; Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120; Pattanayak Debasis, 2005, Indian Journal of Experimental Biology, V43, P7; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELLHEYER K, 1988, GRAEF ARCH CLIN EXP, V226, P89, DOI 10.1007/BF02172725; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Smith EL, 2007, INVEST OPHTH VIS SCI, V48, P3914, DOI 10.1167/iovs.06-1264; Smith EL, 2005, INVEST OPHTH VIS SCI, V46, P3965, DOI 10.1167/iovs.05-0445; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VANDERWERF F, 1992, DOC OPHTHALMOL, V81, P357, DOI 10.1007/BF00169097; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	42	18	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78984	10.1371/journal.pone.0078984	http://dx.doi.org/10.1371/journal.pone.0078984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205357	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600116
J	Zhu, DC; Tanabe, SH; Yang, C; Zhang, WM; Sun, JZ				Zhu, Daochen; Tanabe, Shoko-Hosoi; Yang, Chong; Zhang, Weimin; Sun, Jianzhong			Bacterial Community Composition of South China Sea Sediments through Pyrosequencing-Based Analysis of 16S rRNA Genes	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; PHYLOGENETIC DIVERSITY; MICROBIAL DIVERSITY; BIOMASS PRODUCTION; SURFACE SEDIMENT; RARE BIOSPHERE; ARCTIC-OCEAN; DEEP-SEA; MICROORGANISMS; BIOGEOGRAPHY	Background: Subseafloor sediments accumulate large amounts of organic and inorganic materials that contain a highly diverse microbial ecosystem. The aim of this study was to survey the bacterial community of subseafloor sediments from the South China Sea. Methodology/Principal Findings: Pyrosequencing of over 265,000 amplicons of the V3 hypervariable region of the 16S ribosomal RNA gene was performed on 16 sediment samples collected from multiple locations in the northern region of the South China Sea from depths ranging from 35 to 4000 m. A total of 9,726 operational taxonomic units (OTUs; between 695 and 2819 unique OTUs per sample) at 97% sequence similarity level were generated. In total, 40 bacterial phyla including 22 formally described phyla and 18 candidate phyla, with Proteobacteria, Firmicutes, Planctomycetes, Actinobacteria and Chloroflexi being most diverse, were identified. The most abundant phylotype, accounting for 42.6% of all sequences, belonged to Gammaproteobacteria, which possessed absolute predominance in the samples analyzed. Among the 18 candidate phyla, 12 were found for the first time in the South China Sea. Conclusions: This study provided a novel insight into the composition of bacterial communities of the South China Sea subseafloor. Furthermore, abundances and community similarity analysis showed that the compositions of the bacterial communities are very similar at phylum level at different depths from 35-4000 m.	[Zhu, Daochen; Sun, Jianzhong] Jiangsu Univ, Sch Environm Engn, Zhenjiang, Jiangsu, Peoples R China; [Zhu, Daochen; Zhang, Weimin] Guangdong Inst Microbiol, Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol South China, Guangzhou, Guangdong, Peoples R China; [Tanabe, Shoko-Hosoi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan; [Yang, Chong] Zhenjiang Bioinnova Biotech Co Ltd, Dept R&D, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University Shiga Prefecture	Zhu, DC (corresponding author), Jiangsu Univ, Sch Environm Engn, Zhenjiang, Jiangsu, Peoples R China.	dczhucn@hotmail.com; wmzhang58@qq.com	Zhu, Daochen/O-1941-2016	Zhu, Daochen/0000-0001-9646-9556	Natural Science Foundation of Jiangsu Province, China [BK2012695]; National High Technology Research and Development Program of China (863 Program) [2012AA092104]; Project Startup Foundation for Distinguished Scholars of Jiangsu University [10JDG084]; Chinese Academy of Sciences for Key Topics in Innovation Engineering [KSCX2-EW-G-12]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Project Startup Foundation for Distinguished Scholars of Jiangsu University; Chinese Academy of Sciences for Key Topics in Innovation Engineering(Chinese Academy of Sciences); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by a grant (Code: BK2012695) from the Natural Science Foundation of Jiangsu Province, China and by the grants from the National High Technology Research and Development Program of China (863 Program, 2012AA092104), as well as by the Project Startup Foundation for Distinguished Scholars of Jiangsu University (Code: 10JDG084), the Chinese Academy of Sciences for Key Topics in Innovation Engineering (KSCX2-EW-G-12) and Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Cao HL, 2011, ANTON LEEUW INT J G, V100, P545, DOI 10.1007/s10482-011-9610-1; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galli I, 2008, MEAT SCI, V79, P521, DOI 10.1016/j.meatsci.2007.10.007; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Klotz MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00241; Kobayashi T, 2008, EXTREMOPHILES, V12, P519, DOI 10.1007/s00792-008-0157-7; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Liao L, 2009, J ZHEJIANG UNIV-SC B, V10, P890, DOI 10.1631/jzus.B0920181; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sapp M, 2010, FEMS MICROBIOL ECOL, V74, P410, DOI 10.1111/j.1574-6941.2010.00957.x; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sievert SM, 2007, OCEANOGRAPHY, V20, P117, DOI 10.5670/oceanog.2007.55; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamburini F, 2003, MAR GEOL, V201, P147, DOI 10.1016/S0025-3227(03)00214-7; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Wang GH, 2010, ACTA OCEANOL SIN, V29, P98, DOI 10.1007/s13131-010-0054-7; Wang SH, 2012, CHINESE SCI BULL, V57, P1325, DOI 10.1007/s11434-012-4990-9; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233; Zhang Y, 2011, RES MICROBIOL, V162, P320, DOI 10.1016/j.resmic.2010.12.006; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	39	69	79	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78501	10.1371/journal.pone.0078501	http://dx.doi.org/10.1371/journal.pone.0078501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205246	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600104
J	Mesa-Torres, N; Fabelo-Rosa, I; Riverol, D; Yunta, C; Albert, A; Salido, E; Pey, AL				Mesa-Torres, Noel; Fabelo-Rosa, Israel; Riverol, Debora; Yunta, Cristina; Albert, Armando; Salido, Eduardo; Pey, Angel L.			The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I	PLOS ONE			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ALANINEGLYOXYLATE AMINOTRANSFERASE; KINETIC STABILITY; MUTATION ANALYSIS; DISEASE; PROTEOSTASIS; DIAGNOSIS; STATES	Primary hyperoxaluria type I (PH1) is a conformational disease which result in the loss of alanine: glyoxylate aminotransferase (AGT) function. The study of AGT has important implications for protein folding and trafficking because PH1 mutants may cause protein aggregation and mitochondrial mistargeting. We herein describe a multidisciplinary study aimed to understand the molecular basis of protein aggregation and mistargeting in PH1 by studying twelve AGT variants. Expression studies in cell cultures reveal strong protein folding defects in PH1 causing mutants leading to enhanced aggregation, and in two cases, mitochondrial mistargeting. Immunoprecipitation studies in a cell-free system reveal that most mutants enhance the interactions with Hsc70 chaperones along their folding process, while in vitro binding experiments show no changes in the interaction of folded AGT dimers with the peroxisomal receptor Pex5p. Thermal denaturation studies by calorimetry support that PH1 causing mutants often kinetically destabilize the folded apo-protein through significant changes in the denaturation free energy barrier, whereas coenzyme binding overcomes this destabilization. Modeling of the mutations on a 1.9 angstrom crystal structure suggests that PH1 causing mutants perturb locally the native structure. Our work support that a misbalance between denaturation energetics and interactions with chaperones underlie aggregation and mistargeting in PH1, suggesting that native state stabilizers and protein homeostasis modulators are potential drugs to restore the complex and delicate balance of AGT protein homeostasis in PH1.	[Mesa-Torres, Noel; Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Granada, Spain; [Fabelo-Rosa, Israel; Riverol, Debora; Salido, Eduardo] Univ La Laguna, Inst Tecnol Biomed, Ctr Biomed Res Rare Dis, Tenerife, Spain; [Yunta, Cristina; Albert, Armando] CSIC, Inst Quim Fis Rocasolano, Dept Crystallog & Struct Biol, Madrid, Spain	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Salido, E (corresponding author), Univ La Laguna, Inst Tecnol Biomed, Ctr Biomed Res Rare Dis, Tenerife, Spain.	esalido@ull.es; angelpey@ugr.es	Albert, Armando/J-2373-2012; Salido, Eduardo C/I-2232-2015	Albert, Armando/0000-0002-0026-6816; Salido, Eduardo C/0000-0001-9599-9854; Mesa-Torres, Noel/0000-0001-6653-6260; Pey, Angel Luis/0000-0001-7706-3243	Spanish ministry of Science and Innovation [RYC2009-04147, CSD2009-00088, SAF2011-23933, CSD2006-00015, S2010/BMD-2457, BFU2011-25384]; Junta de Andalucia [P11CTS-7187 ALP]; FPI predoctoral fellowships from the Spanish ministry of Science and Innovation	Spanish ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); FPI predoctoral fellowships from the Spanish ministry of Science and Innovation	This work was supported by the Spanish ministry of Science and Innovation (RYC2009-04147 and CSD2009-00088 to ALP, SAF2011-23933 to ES, and CSD2006-00015, S2010/BMD-2457 and BFU2011-25384 to AA) and Junta de Andalucia (P11CTS-7187 ALP); FPI predoctoral fellowships from the Spanish ministry of Science and Innovation to IF-R and NM-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert A, 2010, J BIOL CHEM, V285, P6371, DOI 10.1074/jbc.M109.062471; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2011, BBA-PROTEINS PROTEOM, V1814, P1577, DOI 10.1016/j.bbapap.2010.12.005; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Cellini B, 2009, J BIOL CHEM, V284, P8349, DOI 10.1074/jbc.M808965200; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cochat P, 2012, NEPHROL DIAL TRANSPL, V27, P1729, DOI 10.1093/ndt/gfs078; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; Danpure CJ, 2001, PRIMARY HYPEROXALURI; DeLano W, 2002, PYMOL 0 99; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; Djordjevic S, 2010, ACTA CRYSTALLOGR F, V66, P233, DOI 10.1107/S1744309109054645; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fargue S, 2013, BIOCH BIOPHYS ACTA; Fargue S, 2013, J BIOL CHEM, V288, P2475, DOI 10.1074/jbc.M112.432617; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Gomes CM, 2012, CURR TOP MED CHEM, V12, P2460; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Martin W, 2010, PHILOS T R SOC B, V365, P847, DOI 10.1098/rstb.2009.0252; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pey AL, 2013, BIOCHEMISTRY-US, V52, P1160, DOI 10.1021/bi301565m; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pittman AMC, 2012, GENETICS, V192, P831, DOI 10.1534/genetics.112.143750; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Salido E, 2012, BBA-MOL BASIS DIS, V1822, P1453, DOI 10.1016/j.bbadis.2012.03.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; van Woerden CS, 2004, KIDNEY INT, V66, P746, DOI 10.1111/j.1523-1755.2004.00796.x; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	47	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71963	10.1371/journal.pone.0071963	http://dx.doi.org/10.1371/journal.pone.0071963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24205397	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200023
J	Donadio, E; Giusti, L; Seccia, V; Ciregia, F; da Valle, Y; Dallan, I; Ventroni, T; Giannaccini, G; Sellari-Franceschini, S; Lucacchini, A				Donadio, Elena; Giusti, Laura; Seccia, Veronica; Ciregia, Federica; da Valle, Ylenia; Dallan, Iacopo; Ventroni, Tiziana; Giannaccini, Gino; Sellari-Franceschini, Stefano; Lucacchini, Antonio			New Insight into Benign Tumours of Major Salivary Glands by Proteomic Approach	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MACROPHAGE-CAPPING PROTEIN; WARTHINS TUMOR; PAROTID-GLAND; WHOLE SALIVA; IDENTIFICATION; CYTOLOGY; MANAGEMENT; CARCINOMA; DIAGNOSIS	Major salivary gland tumours are uncommon neoplasms of the head and neck. The increase of precise pre-operative diagnosis is crucial for their correct management and the identification of molecular markers would surely improve the required accuracy. In this study we performed a comparative proteomic analysis of fine needle aspiration fluids of the most frequent benign neoplasms of major salivary glands, namely pleomorphic adenoma and Warthin's tumour, in order to draw their proteomic profiles and to point out their significant features. Thirty-five patients submitted to parotidectomy were included in the study, 22 were identified to have pleomorphic adenoma and 14 Warthin's tumour. Fine needle aspiration samples were processed using a two-dimensional electrophoresis/mass spectrometry-based approach. A total of 26 differentially expressed proteins were identified. Ingenuity software was used to search the biological processes to which these proteins belong and to construct potential networks. Intriguingly, all Warthin's tumour up-regulated proteins such as Ig gamma-1 chain C region, Ig kappa chain C region and Ig alpha-1 chain C region and S100A9 were correlated to immunological and inflammatory diseases, while pleomorphic adenomas such as annexin A1, annexin A4, macrophage-capping protein, apolipoprotein E and alpha crystalline B chain were associated with cell death, apoptosis and tumorigenesis, showing different features of two benign tumours. Overall, our results shed new light on the potential usefulness of a proteomic approach to study parotid tumours and in particular up regulated proteins are able to discriminate two types of benign parotid lesions.	[Donadio, Elena; Giusti, Laura; Ciregia, Federica; da Valle, Ylenia; Ventroni, Tiziana; Giannaccini, Gino; Lucacchini, Antonio] Univ Pisa, Dept Pharm, Pisa, Italy; [Seccia, Veronica; Dallan, Iacopo; Sellari-Franceschini, Stefano] Azienda Osped Univ Pisana, Ear Nose Throat Unit 1, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Lucacchini, A (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	lucas@farm.unipi.it	Seccia, Veronica/AAN-9738-2020; Ciregia, Federica/K-6612-2016	Ciregia, Federica/0000-0002-5851-9249; LUCACCHINI, ANTONIO/0000-0002-0917-4491; Giusti, Laura/0000-0001-7366-1932; Giannaccini, Gino/0000-0001-6436-8187				Aude-Garcia C, 2011, PROTEOMICS, V11, P324, DOI 10.1002/pmic.201000370; Baldini C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-188; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Daguci L, 2011, ROM J MORPHOL EMBRYO, V52, P1319; Eveson J., 2005, PATHOLOGY GENETICS H, P209; EVESON JW, 1985, J ORAL PATHOL MED, V14, P500, DOI 10.1111/j.1600-0714.1985.tb00522.x; Fakhry N, 2012, EUR ANN OTORHINOLARY, V129, P131, DOI 10.1016/j.anorl.2011.10.008; Giusti L, 2007, J ENDOCRINOL INVEST, V30, P865, DOI 10.1007/BF03349229; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Giusti L, 2007, J RHEUMATOL, V34, P2063; Giusti L, 2007, PROTEOMICS, V7, P1634, DOI 10.1002/pmic.200600783; Giusti L, 2011, MOL BIOSYST, V7, P687, DOI 10.1039/c0mb00191k; Giusti L, 2010, PROTEOM CLIN APPL, V4, P315, DOI 10.1002/prca.200900082; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Ha ES, 2013, CLIN BIOCHEM, V46, P369, DOI 10.1016/j.clinbiochem.2012.11.014; HELLER KS, 1992, AM J SURG, V164, P667, DOI 10.1016/S0002-9610(05)80731-7; Kimura K, 2013, J PROTEOMICS, V78, P362, DOI 10.1016/j.jprot.2012.10.004; Li MX, 2010, MED ONCOL, V27, P134, DOI 10.1007/s12032-009-9184-1; Morofuji N, 2012, J PROTEOMICS, V75, P1577, DOI 10.1016/j.jprot.2011.11.030; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Nagel H, 1999, DIAGN CYTOPATHOL, V20, P358, DOI 10.1002/(SICI)1097-0339(199906)20:6<358::AID-DC6>3.0.CO;2-X; Nomura H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-39; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Ralhan R, 2011, PROTEOMICS, V11, P2363, DOI 10.1002/pmic.201000186; Renz M, 2008, INT J CANCER, V122, P1476, DOI 10.1002/ijc.23215; Soggiu A, 2012, ACTA DIABETOL, V49, P453, DOI 10.1007/s00592-012-0407-0; Stewart CJR, 2000, DIAGN CYTOPATHOL, V22, P139; Teymoortash A, 2011, HISTOPATHOLOGY, V59, P143, DOI 10.1111/j.1365-2559.2011.03891.x; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Tripathi SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019213; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Tryggvason G, 2013, LARYNGOSCOPE, V123, P158, DOI 10.1002/lary.23613; Viguer JM, 2010, CYTOPATHOLOGY, V21, P164, DOI 10.1111/j.1365-2303.2009.00667.x; Volkmann J, 2013, INT J CANCER, V132, P2820, DOI 10.1002/ijc.27975; Wu JH, 2011, HEPATO-GASTROENTEROL, V58, P1182, DOI 10.5754/hge11380; Yaranal PJ, 2013, J CLIN DIAGN RES, V7, P163, DOI 10.7860/JCDR/2012/4683.2697	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71874	10.1371/journal.pone.0071874	http://dx.doi.org/10.1371/journal.pone.0071874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	24205396	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800023
J	Draeger, HT; Assassi, S; Sharif, R; Gonzalez, EB; Harper, BE; Arnett, FC; Manzoor, A; Lange, RA; Mayes, MD				Draeger, Hilda T.; Assassi, Shervin; Sharif, Roozbeh; Gonzalez, Emilio B.; Harper, Brock E.; Arnett, Frank C.; Manzoor, Ameena; Lange, Richard A.; Mayes, Maureen D.			Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis	PLOS ONE			English	Article							SCLERODERMA; ELECTROCARDIOGRAM; DIAGNOSIS; DISEASE	Objective: To evaluate the prognostic significance of baseline electrocardiogram (ECG) abnormalities in a multiethnic cohort of patients with early systemic sclerosis (SSc) and to determine the serological, clinical, and echocardiogram correlates of ECG findings. Methods: SSc patients with disease duration of <= 5 years were enrolled in the GENISOS (Genetics versus Environment in Scleroderma Outcome Study) cohort. At the first visit, a standard 12 lead ECG was obtained along with demographic information, clinical data, and autoantibodies. The results of echocardiograms were also recorded. All ECGs were interpreted by a cardiologist unaware of the patients' clinical data. Results: Of 265 SSc patients with average disease duration at enrollment of 2.5 years, 140 (52.8%) had abnormal ECG findings. These findings were not associated with SSc disease type or autoantibody profile but were associated with more severe heart and lung involvement. A total of 75 patients (28.3%) died over a follow up time of 9.9 years. Complete right bundle branch block (+/- left anterior hemiblock) on ECG, present in 7 (2.6%) patients, predicted a higher risk of mortality (HR: 5.3; 95% CI: 2.1 to 13.4; p<0.001). The predictive significance of right bundle branch block was independent of age at enrollment, gender, ethnicity and risk factors for coronary artery disease. Conclusion: ECG abnormalities are common in patients with early SSc and are associated with the severity of lung and heart involvement. Right bundle branch block is an independent predictor of mortality, and should be considered a marker of disease severity in SSc.	[Draeger, Hilda T.] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol, Houston, TX 77030 USA; [Assassi, Shervin; Sharif, Roozbeh; Arnett, Frank C.; Manzoor, Ameena; Mayes, Maureen D.] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA; [Sharif, Roozbeh; Gonzalez, Emilio B.; Harper, Brock E.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, Div Cardiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Assassi, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA.	shervin.assassi@uth.tmc.edu	Sharif, Roozbeh/AAE-7492-2020; Lange, Richard/AAM-9594-2021		National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma [P50AR054144]; Department of Defense [PR1206877];  [NIH-KL2RR024149];  [K23AR061436]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061436, P50AR054144] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma; Department of Defense(United States Department of Defense); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding by the National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma P50AR054144 (Mayes); NIH-KL2RR024149 and K23AR061436 (Assassi); Department of Defense PR1206877 (Mayes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561; Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; BULKLEY BH, 1976, CIRCULATION, V53, P483, DOI 10.1161/01.CIR.53.3.483; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Desai CS, 2011, CURR OPIN RHEUMATOL, V23, P545, DOI 10.1097/BOR.0b013e32834b8975; FOLLANSBEE WP, 1985, AM J MED, V79, P183, DOI 10.1016/0002-9343(85)90008-7; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; LEROY EC, 1988, J RHEUMATOL, V15, P202; Medsger TA, 1999, J RHEUMATOL, V26, P2159; MEDSGER TA, 1971, ANN INTERN MED, V75, P369, DOI 10.7326/0003-4819-75-3-369; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P46, DOI 10.1016/j.acvd.2009.06.009; Morelli S, 1996, INT J CARDIOL, V57, P151, DOI 10.1016/S0167-5273(96)02808-2; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Prineas RJ, 2010, MINNESOTA CODE MANUA, P325; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; RIDOLFI RL, 1976, AM J MED, V61, P361, DOI 10.1016/0002-9343(76)90373-9; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1	21	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78808	10.1371/journal.pone.0078808	http://dx.doi.org/10.1371/journal.pone.0078808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205321	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800022
J	Korpetinou, A; Skandalis, SS; Moustakas, A; Happonen, KE; Tveit, H; Prydz, K; Labropoulou, VT; Giannopoulou, E; Kalofonos, HP; Blom, AM; Karamanos, NK; Theocharis, AD				Korpetinou, Angeliki; Skandalis, Spyros S.; Moustakas, Aristidis; Happonen, Kaisa E.; Tveit, Heidi; Prydz, Kristian; Labropoulou, Vassiliki T.; Giannopoulou, Efstathia; Kalofonos, Haralambos P.; Blom, Anna M.; Karamanos, Nikos K.; Theocharis, Achilleas D.			Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; CANINE KIDNEY-CELLS; COMPLEMENT ACTIVATION; REGULATORY PROTEINS; CARCINOMA-CELLS; TUMOR-CELLS; IN-VITRO; EXPRESSION; IMMUNOTHERAPY; LOCALIZATION	Serglycin is a proteoglycan expressed by some malignant cells. It promotes metastasis and protects some tumor cells from complement system attack. In the present study, we show for the first time the in situ expression of serglycin by breast cancer cells by immunohistochemistry in patients' material. Moreover, we demonstrate high expression and constitutive secretion of serglycin in the aggressive MDA-MB-231 breast cancer cell line. Serglycin exhibited a strong cytoplasmic staining in these cells, observable at the cell periphery in a thread of filaments near the cell membrane, but also in filopodia-like structures. Serglycin was purified from conditioned medium of MDA-MB-231 cells, and represented the major proteoglycan secreted by these cells, having a molecular size of similar to 250 kDa and carrying chondroitin sulfate side chains, mainly composed of 4-sulfated (similar to 87%), 6-sulfated (similar to 10%) and non-sulfated (similar to 3%) disaccharides. Purified serglycin inhibited early steps of both the classical and the lectin pathways of complement by binding to C1q and mannose-binding lectin. Stable expression of serglycin in less aggressive MCF-7 breast cancer cells induced their proliferation, anchorage-independent growth, migration and invasion. Interestingly, over-expression of serglycin lacking the glycosaminoglycan attachment sites failed to promote these cellular functions, suggesting that glycanation of serglycin is a pre-requisite for its oncogenic properties. Our findings suggest that serglycin promotes a more aggressive cancer cell phenotype and may protect breast cancer cells from complement attack supporting their survival and expansion.	[Korpetinou, Angeliki; Skandalis, Spyros S.; Karamanos, Nikos K.; Theocharis, Achilleas D.] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece; [Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden; [Happonen, Kaisa E.; Blom, Anna M.] Lund Univ, Dept Lab Med, Div Med Prot Chem, Malmo, Sweden; [Tveit, Heidi; Prydz, Kristian] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Labropoulou, Vassiliki T.] Karamandane Childrens Hosp, Patras, Greece; [Giannopoulou, Efstathia; Kalofonos, Haralambos P.] Univ Hosp Patras, Clin Oncol Lab, Div Oncol, Patras Med Sch, Patras, Greece	University of Patras; Ludwig Institute for Cancer Research; Uppsala University; Lund University; University of Oslo; University of Patras	Theocharis, AD (corresponding author), Univ Patras, Dept Chem, Biochem Lab, Patras, Greece.	atheoch@upatras.gr	Blom, Anna/B-9607-2009; Karamanos, Nikos/A-3616-2008; theocharis, achilleas/F-6903-2010; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Karamanos, Nikos/0000-0003-3618-0288; Theocharis, Achilleas/0000-0001-8611-2297; Happonen, Kaisa/0000-0002-8346-6302; Skandalis, Spyros/0000-0003-1156-2896	European Union (European Social Fund - ESF); Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); European Social Fund; Mizutani Foundation for Glycosciences; Swedish Research Foundation [K2012-66X-14928-09-5]; Cancerfonden	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); European Social Fund(European Social Fund (ESF)); Mizutani Foundation for Glycosciences; Swedish Research Foundation; Cancerfonden(Swedish Cancer Society)	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. This work was also supported in part by grants from Mizutani Foundation for Glycosciences (ADT), Swedish Research Foundation (K2012-66X-14928-09-5) and Cancerfonden (AMB, KEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; BAATRUP G, 1994, EUR J SURG, V160, P503; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; GROVER A, 1987, DIFFERENTIATION, V36, P138, DOI 10.1111/j.1432-0436.1987.tb00188.x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; KARAMANOS NK, 1995, J CHROMATOGR A, V696, P295, DOI 10.1016/0021-9673(94)01294-O; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; MAILLET P, 1992, LEUKEMIA, V6, P1143; Malla N, 2013, FEBS J, V280, P2870, DOI 10.1111/febs.12291; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Matsuda K, 2001, CANCER RES, V61, P5562; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; OLDBERG A, 1981, J BIOL CHEM, V256, P847; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; SCHICK BP, 1992, BIOCHEM J, V282, P651, DOI 10.1042/bj2820651; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Skandalis SS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-314; Skliris A., 2013, FEBS J; Skliris A, 2011, EUR J IMMUNOL, V41, P437, DOI 10.1002/eji.201040429; STELLRECHT CMM, 1993, J BIOL CHEM, V268, P4078; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Tveit H, 2005, J BIOL CHEM, V280, P29596, DOI 10.1074/jbc.M503691200; Tveit H, 2009, TRAFFIC, V10, P1685, DOI 10.1111/j.1600-0854.2009.00984.x; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Ytting H, 2004, SCAND J GASTROENTERO, V39, P674, DOI 10.1080/00365520410005603; Zernichow L, 2006, FEBS J, V273, P536, DOI 10.1111/j.1742-4658.2005.05085.x; Zhang L, 2010, CONNECT TISSUE RES, V51, P230, DOI 10.3109/03008200903288902; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	57	54	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78157	10.1371/journal.pone.0078157	http://dx.doi.org/10.1371/journal.pone.0078157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205138	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800014
J	Antony, AR; Alexopoulos, AV; Gonzalez-Martinez, JA; Mosher, JC; Jehi, L; Burgess, RC; So, NK; Galan, RF				Antony, Arun R.; Alexopoulos, Andreas V.; Gonzalez-Martinez, Jorge A.; Mosher, John C.; Jehi, Lara; Burgess, Richard C.; So, Norman K.; Galan, Roberto F.			Functional Connectivity Estimated from Intracranial EEG Predicts Surgical Outcome in Intractable Temporal Lobe Epilepsy	PLOS ONE			English	Article							NEURONAL COMPLEXITY LOSS; HUMAN CEREBRAL-CORTEX; NETWORKS; ONSET; MAGNETOENCEPHALOGRAPHY; SYNCHRONIZATION; LOBECTOMY; COHERENCE; SEIZURES; SYSTEM	This project aimed to determine if a correlation-based measure of functional connectivity can identify epileptogenic zones from intracranial EEG signals, as well as to investigate the prognostic significance of such a measure on seizure outcome following temporal lobe lobectomy. To this end, we retrospectively analyzed 23 adult patients with intractable temporal lobe epilepsy (TLE) who underwent an invasive stereo-EEG (SEEG) evaluation between January 2009 year and January 2012. A follow-up of at least one year was required. The primary outcome measure was complete seizure-freedom at last follow-up. Functional connectivity between two areas in the temporal lobe that were sampled by two SEEG electrode contacts was defined as Pearson's correlation coefficient of interictal activity between those areas. SEEG signals were filtered between 5 and 50 Hz prior to computing this correlation. The mean and standard deviation of the off diagonal elements in the connectivity matrix were also calculated. Analysis of the mean and standard deviation of the functional connections for each patient reveals that 90% of the patients who had weak and homogenous connections were seizure free one year after temporal lobectomy, whereas 85% of the patients who had stronger and more heterogeneous connections within the temporal lobe had recurrence of seizures. This suggests that temporal lobectomy is ineffective in preventing seizure recurrence for patients in whom the temporal lobe is characterized by weakly connected, homogenous networks. This pilot study shows promising potential of a simple measure of functional brain connectivity to identify epileptogenicity and predict the outcome of epilepsy surgery.	[Antony, Arun R.; Alexopoulos, Andreas V.; Gonzalez-Martinez, Jorge A.; Mosher, John C.; Jehi, Lara; Burgess, Richard C.; So, Norman K.] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA; [Galan, Roberto F.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Galan, RF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	rfgalan@case.edu	Antony, Arun/ABD-2041-2020; Antony, Arun/W-2439-2018	Antony, Arun/0000-0002-0368-4570; Antony, Arun/0000-0002-0368-4570; Fernandez Galan, Roberto/0000-0003-1426-1917	Mt. Sinai Health Care Foundation	Mt. Sinai Health Care Foundation	RFG thanks the Mt. Sinai Health Care Foundation for financial support. This foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Brazier M. A., 1972, EXPT NEUROLOGY, P263; BRAZIER MAB, 1968, ELECTROEN CLIN NEURO, V25, P309, DOI 10.1016/0013-4694(68)90171-5; BRAZIER MAB, 1952, ELECTROEN CLIN NEURO, V4, P201, DOI 10.1016/0013-4694(52)90010-2; Dauwels J, 2009, IEEE ENG MED BIO, P2180, DOI 10.1109/IEMBS.2009.5332447; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Elisevich K, 2011, EPILEPSIA, V52, P1110, DOI 10.1111/j.1528-1167.2011.02990.x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; GOTMAN J, 1987, ELECTROEN CLIN NEURO, V67, P120, DOI 10.1016/0013-4694(87)90034-4; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028196, 10.1371/journal.pone.0044847]; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jehi LE, 2012, EPILEPSY CURR, V12, P238, DOI 10.5698/1535-7511-12.6.238; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Masterton RA, 2012, EPILEPSY RES, V99, P327, DOI 10.1016/j.eplepsyres.2011.12.014; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Navarro V, 2005, EPILEPSIA, V46, P385, DOI 10.1111/j.0013-9580.2005.15504.x; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; RAPPELSBERGER P, 1989, Brain Topography, V2, P63, DOI 10.1007/BF01128844; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steinke GK, 2011, PLOS ONE, V3, pe2148; Stufflebeam SM, 2011, J NEUROSURG, V114, P1693, DOI 10.3171/2011.1.JNS10482; Stufflebeam SM, 2009, HUM BRAIN MAPP, V30, P1813, DOI 10.1002/hbm.20792; Vapnik V., 1998, STAT LEARNING THEORY; Varotto G, 2012, EPILEPSIA, V53, P359, DOI 10.1111/j.1528-1167.2011.03352.x; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weber B, 1998, EPILEPSIA, V39, P922, DOI 10.1111/j.1528-1157.1998.tb01441.x; Widman G, 2000, EPILEPSIA, V41, P811, DOI 10.1111/j.1528-1157.2000.tb00247.x; Zaveri HR, 2009, NEUROREPORT, V20, P891, DOI 10.1097/WNR.0b013e32832c78e0	43	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77916	10.1371/journal.pone.0077916	http://dx.doi.org/10.1371/journal.pone.0077916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205027	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500078
J	Cain, KE; Ketterson, ED				Cain, Kristal E.; Ketterson, Ellen D.			Costs and Benefits of Competitive Traits in Females: Aggression, Maternal Care and Reproductive Success	PLOS ONE			English	Article							DARK-EYED JUNCOS; HOME-RANGE SIZE; SEXUAL SELECTION; TESTOSTERONE PRODUCTION; OFFSPRING PHENOTYPE; TERRITORIAL DEFENSE; SOCIAL COMPETITION; YOLK ANDROGENS; NEST PREDATION; PARENTAL CARE	Recent research has shown that female expression of competitive traits can be advantageous, providing greater access to limited reproductive resources. In males increased competitive trait expression often comes at a cost, e. g. trading off with parental effort. However, it is currently unclear whether, and to what extent, females also face such tradeoffs, whether the costs associated with that tradeoff overwhelm the potential benefits of resource acquisition, and how environmental factors might alter those relationships. To address this gap, we examine the relationships between aggression, maternal effort, offspring quality and reproductive success in a common songbird, the dark-eyed junco (Junco hyemalis), over two breeding seasons. We found that compared to less aggressive females, more aggressive females spent less time brooding nestlings, but fed nestlings more frequently. In the year with better breeding conditions, more aggressive females produced smaller eggs and lighter hatchlings, but in the year with poorer breeding conditions they produced larger eggs and achieved greater nest success. There was no relationship between aggression and nestling mass after hatch day in either year. These findings suggest that though females appear to tradeoff competitive ability with some forms of maternal care, the costs may be less than previously thought. Further, the observed year effects suggest that costs and benefits vary according to environmental variables, which may help to account for variation in the level of trait expression.	[Cain, Kristal E.; Ketterson, Ellen D.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cain, Kristal E.; Ketterson, Ellen D.] Ctr Integrat Study Anim Behav, Bloomington, IN USA; [Cain, Kristal E.] Australian Natl Univ, Res Sch Biol, Acton, Australia	Indiana University System; Indiana University Bloomington; Australian National University	Cain, KE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN USA.	kristalcain@gmail.com		Cain, Kristal/0000-0002-6908-7015	National Science Foundation (NSF) [BSC 05-19211, IOS 08-20055, 09-10036]	National Science Foundation (NSF)(National Science Foundation (NSF))	Research was supported by National Science Foundation (NSF) grants to EK (BSC 05-19211 and IOS 08-20055) and an NSF Doctoral Dissertation Improvement Grant to KC (09-10036). KC was also supported by NSF Graduate Research Fellowship (www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 1997, P ROY SOC B-BIOL SCI, V264, P1579, DOI 10.1098/rspb.1997.0220; Andersson Malte, 1994; [Anonymous], 1996, ADAPTATION NATURAL S; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Arnott G, 2009, ANIM BEHAV, V78, P1221, DOI 10.1016/j.anbehav.2009.08.005; Badyaev AV, 2002, BEHAV ECOL, V13, P591, DOI 10.1093/beheco/13.5.591; BALPH MH, 1977, ANIM BEHAV, V25, P859, DOI 10.1016/0003-3472(77)90038-0; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BOX GEP, 1962, BIOMETRIKA, V49, P93, DOI 10.2307/2333470; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Cain KE, 2013, HORMONES BE IN PRESS; Cain KE, 2013, BEHAV ECOL, V24, P462, DOI 10.1093/beheco/ars186; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Cain KE, 2011, ETHOLOGY, V117, P786, DOI 10.1111/j.1439-0310.2011.01932.x; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Clotfelter ED, 2007, ETHOLOGY, V113, P18, DOI 10.1111/j.1439-0310.2006.01286.x; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; COONEY R, 1995, ANIM BEHAV, V49, P1635, DOI 10.1016/0003-3472(95)90086-1; Crowhurst CJ, 2012, ETHOLOGY, V118, P63, DOI 10.1111/j.1439-0310.2011.01986.x; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Duckworth RA, 2003, BEHAV ECOL SOCIOBIOL, V55, P176, DOI 10.1007/s00265-003-0671-7; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; Fedy BC, 2005, BEHAV ECOL SOCIOBIOL, V58, P414, DOI 10.1007/s00265-005-0928-4; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FITZPATRICK S, 1995, BIOL J LINN SOC, V55, P251, DOI 10.1111/j.1095-8312.1995.tb01063.x; Gil D, 2003, ARDEOLA, V50, P281; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Heinsohn R, 1997, ANIM BEHAV, V53, P1143, DOI 10.1006/anbe.1996.0316; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Hofer H, 2003, EVOL ECOL, V17, P315, DOI 10.1023/A:1027352517231; Holberton RL, 2008, GEN COMP ENDOCR, V155, P641, DOI 10.1016/j.ygcen.2007.11.001; HOLBERTON RL, 1989, ANIM BEHAV, V37, P681, DOI 10.1016/0003-3472(89)90047-X; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Jawor JM, 2004, ANIM BEHAV, V67, P875, DOI 10.1016/j.anbehav.2003.05.015; Jawor JM, 2007, FUNCT ECOL, V21, P767, DOI 10.1111/j.1365-2435.2007.01280.x; Johnstone Rufus A., 1997, P155; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Ketterson ED, 2002, DARK EYED JUNCO; KOPACHENA JG, 1993, WILSON BULL, V105, P48; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Langmore NE, 2002, P ROY SOC B-BIOL SCI, V269, P2473, DOI 10.1098/rspb.2002.2167; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2008, PHILOS T R SOC B, V363, P1663, DOI 10.1098/rstb.2007.0009; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Muller W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022675; Murphy TG, 2009, BEHAV ECOL, V20, P1348, DOI 10.1093/beheco/arp140; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Neudorf DL, 2002, ETHOLOGY, V108, P713, DOI 10.1046/j.1439-0310.2002.00806.x; O'Neal DM, 2008, HORM BEHAV, V54, P571, DOI 10.1016/j.yhbeh.2008.05.017; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Pryke SR, 2007, BEHAV ECOL, V18, P621, DOI 10.1093/beheco/arm020; Pryke SR, 2009, AM NAT, V174, P455, DOI 10.1086/605376; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reichard DG, 2012, WILSON J ORNITHOL, V124, P614, DOI 10.1676/11-189.1; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rosvall KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054120; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; Rubenstein DR, 2012, PHILOS T R SOC B, V367, P2248, DOI 10.1098/rstb.2011.0278; Rubenstein DR, 2009, NATURE, V462, P786, DOI 10.1038/nature08614; Sandell MI, 1998, P ROY SOC B-BIOL SCI, V265, P1307, DOI 10.1098/rspb.1998.0434; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 2007, AM NAT, V170, P196, DOI 10.1086/519397; Shuster S. M., 2003, MONOGRAPHS BEHAV ECO; Simmons LW, 2008, J EVOLUTION BIOL, V21, P1227, DOI 10.1111/j.1420-9101.2008.01575.x; SLAGSVOLD T, 1993, ORNIS SCAND, V24, P155, DOI 10.2307/3676366; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Starck J.M., 1998, AVIAN GROWTH DEV; Stiver KA, 2009, ETHOLOGY, V115, P1101, DOI 10.1111/j.1439-0310.2009.01707.x; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tuttle EM, 2003, BEHAV ECOL, V14, P425, DOI 10.1093/beheco/14.3.425; Valcu M, 2008, ANIM BEHAV, V75, P1949, DOI 10.1016/j.anbehav.2007.12.005; Vleck C.M., 1998, P WSPA 10 EUR POULTR, P163; Watson NL, 2010, P ROY SOC B-BIOL SCI, V277, P2035, DOI 10.1098/rspb.2009.2335; Weiss SL, 2009, BEHAV ECOL, V20, P1063, DOI 10.1093/beheco/arp098; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; Whittingham LA, 2007, CONDOR, V109, P585, DOI 10.1650/8247.1; WOLF L, 1990, ANIM BEHAV, V39, P125, DOI 10.1016/S0003-3472(05)80732-8; YASUKAWA K, 1982, BEHAV ECOL SOCIOBIOL, V11, P13, DOI 10.1007/BF00297660	98	35	35	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77816	10.1371/journal.pone.0077816	http://dx.doi.org/10.1371/journal.pone.0077816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204980	Green Published, gold			2022-12-25	WOS:000326334500064
J	Fuchs, A; Rempel, V; Muller, CE				Fuchs, Alexander; Rempel, Viktor; Mueller, Christa E.			The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists	PLOS ONE			English	Article							CB2 RECEPTORS; ENDOCANNABINOID SYSTEM; GPR55; PHARMACOLOGY; LOCALIZATION; ACTIVATION; LIGANDS; INVERSE; TARGET; GPR18	Magnolol (4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol), the main bioactive constituent of the medicinal plant Magnolia officinalis, and its main metabolite tetrahydromagnolol were recently found to activate cannabinoid (CB) receptors. We now investigated the structure-activity relationships of (tetrahydro) magnolol analogs with variations of the alkyl chains and the phenolic groups and could considerably improve potency. Among the most potent compounds were the dual CB1/CB2 full agonist 2-(2-methoxy-5-propyl-phenyl)-4-hexylphenol (61a, K-i CB1:0.00957 mu M; K-i CB2:0.0238 mu M), and the CB2-selective partial agonist 2-(2-hydroxy-5-propylphenyl)-4-pentylphenol (60, K-i CB1:0.362 mu M; K-i CB2:0.0371 mu M), which showed high selectivity versus GPR18 and GPR55. Compound 61b, an isomer of 61a, was the most potent GPR55 antagonist with an IC50 value of 3.25 mu M but was non-selective. The relatively simple structures, which possess no stereocenters, are easily accessible in a four-to five-step synthetic procedure from common starting materials. The central reaction step is the well-elaborated Suzuki-Miyaura cross-coupling reaction, which is suitable for a combinatorial chemistry approach. The scaffold is versatile and may be fine-tuned to obtain a broad range of receptor affinities, selectivities and efficacies.	[Fuchs, Alexander; Rempel, Viktor; Mueller, Christa E.] PharmaCtr Bonn, Inst Pharmaceut, Bonn, Germany		Muller, CE (corresponding author), PharmaCtr Bonn, Inst Pharmaceut, Bonn, Germany.	christa.mueller@uni-bonn.de	Müller, Christa Elisabeth/C-7748-2014	Müller, Christa Elisabeth/0000-0002-0013-6624	German Federal Ministery for Education and Research [BMBF 01EW0911]	German Federal Ministery for Education and Research	Funded by the German Federal Ministery for Education and Research (BMBF 01EW0911) in the frame of ERA-NET NEURON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHARAHIMI MR, 1995, J ORG CHEM, V60, P1856, DOI 10.1021/jo00111a052; Alexander SPH, 2012, BRIT J PHARMACOL, V165, P2411, DOI 10.1111/j.1476-5381.2011.01731.x; Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Bellocchio L, 2008, J NEUROENDOCRINOL, V20, P130, DOI 10.1111/j.1365-2826.2008.01682.x; Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Bradshaw HB, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-14; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Gertsch J, 2010, BRIT J PHARMACOL, V160, P523, DOI 10.1111/j.1476-5381.2010.00745.x; Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Heynen-Genel S., 2010, PROBE REPORTS NIH MO, P1; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kellenberger E, 2011, NAT PROD REP, V28, P1483, DOI 10.1039/c1np00026h; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Koetter U, 2009, J ETHNOPHARMACOL, V124, P421, DOI 10.1016/j.jep.2009.05.040; Konakahara T, 2010, TETRAHEDRON LETT, V51, P2335, DOI 10.1016/j.tetlet.2010.02.125; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Mancini I, 2009, BRIT J PHARMACOL, V158, P382, DOI 10.1111/j.1476-5381.2009.00154.x; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; MCKILLOP A, 1974, TETRAHEDRON, V30, P1379, DOI 10.1016/S0040-4020(01)97250-3; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NORDSTEDT C, 1990, ANAL BIOCHEM, V189, P231, DOI 10.1016/0003-2697(90)90113-N; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Rempel V, 2013, ACS MED CHEM LETT, V4, P41, DOI 10.1021/ml300235q; Rempel V, 2012, J MED CHEM, V55, P7967, DOI 10.1021/jm3008213; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Schuehly W, 2011, CHEM BIOL, V18, P1053, DOI 10.1016/j.chembiol.2011.05.012; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Ulrich O., 1986, CHEM BER, V119, P3507; Yao BB, 2006, BRIT J PHARMACOL, V149, P145, DOI 10.1038/sj.bjp.0706838	45	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77739	10.1371/journal.pone.0077739	http://dx.doi.org/10.1371/journal.pone.0077739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204944	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500050
J	Lan, WZ; Zhao, F; Lin, LX; Li, Z; Zeng, JW; Yang, ZK; Morgan, IG				Lan, Weizhong; Zhao, Feng; Lin, Lixia; Li, Zhen; Zeng, Junwen; Yang, Zhikuan; Morgan, Ian G.			Refractive Errors in 3-6 Year-Old Chinese Children: A Very Low Prevalence of Myopia?	PLOS ONE			English	Article							TABLE-MOUNTED AUTOREFRACTOR; HAND-HELD AUTOREFRACTOR; VISUAL IMPAIRMENT; PRESCHOOL-CHILDREN; SCHOOL-CHILDREN; SOUTHERN CHINA; RISK-FACTORS; POPULATION; INFANTS; RETINOSCOPY	Purpose: To examine the prevalence of refractive errors in children aged 3-6 years in China. Methods: Children were recruited for a trial of a home-based amblyopia screening kit in Guangzhou preschools, during which cycloplegic refractions were measured in both eyes of 2480 children. Cycloplegic refraction (from 3 to 4 drops of 1% cyclopentolate to ensure abolition of the light reflex) was measured by both autorefraction and retinoscopy. Refractive errors were defined as followed: myopia (at least -0.50 D in the worse eye), hyperopia (at least +2.00 D in the worse eye) and astigmatism (at least 1.50 D in the worse eye). Different definitions, as specified in the text, were also used to facilitate comparison with other studies. Results: The mean spherical equivalent refractive error was at least +1.22 D for all ages and both genders. The prevalence of myopia for any definition at any age was at most 2.5%, and lower in most cases. In contrast, the prevalence of hyperopia was generally over 20%, and declined slightly with age. The prevalence of astigmatism was between 6% and 11%. There was very little change in refractive error with age over this age range. Conclusions: Previous reports of less hyperopic mean spherical equivalent refractive error, and more myopia and less hyperopia in children of this age may be due to problems with achieving adequate cycloplegia in children with dark irises. Using up to 4 drops of 1% cyclopentolate may be necessary to accurately measure refractive error in paediatric studies of such children. Our results suggest that children from all ethnic groups may follow a similar pattern of early refractive development, with little myopia and a hyperopic mean spherical equivalent over +1.00 D up to the age of 5-6 yearsin most conditions.	[Lan, Weizhong; Zhao, Feng; Lin, Lixia; Zeng, Junwen; Yang, Zhikuan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhen] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Yang, Zhikuan] Aier Eye Hosp Grp, Changsha, Hunan, Peoples R China; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Morgan, Ian G.] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Dept Prevent Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Shanxi Medical University; Australian National University; Sun Yat Sen University	Yang, ZK (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xo_yo2000@hotmail.com	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574; Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, Beijing, China [81200714]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China [LYM 11009]; Science and Information Technology Bureau of Guangzhou, Guangdong Province, China [2011Y2-00018-3]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China; Science and Information Technology Bureau of Guangzhou, Guangdong Province, China	Supported by the National Natural Science Foundation of China, Beijing, China (grant no.: 81200714;http://www.nsfc.gov.cn/); Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China (grant no.: LYM 11009;http://www.gdhed.edu.cn/) and the Science and Information Technology Bureau of Guangzhou, Guangdong Province, China (grant no.: 2011Y2-00018-3;http://www.gzsi.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAN OYC, 1993, OPTOMETRY VISION SCI, V70, P501, DOI 10.1097/00006324-199306000-00009; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P2456, DOI 10.1167/iovs.10-5441; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Farook M, 2005, OPTOMETRY VISION SCI, V82, P1066, DOI 10.1097/01.opx.0000192344.72997.7c; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; Gole GA, 2003, CLIN EXP OPHTHALMOL, V31, P341, DOI 10.1046/j.1442-9071.2003.00668.x; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Lan WZ, 2012, OPHTHALMOLOGY, V119, P1265, DOI 10.1016/j.ophtha.2011.12.027; Maul E, 2000, AM J OPHTHALMOL, V129, P445, DOI 10.1016/S0002-9394(99)00454-7; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Prabakaran S, 2009, OPHTHAL PHYSL OPT, V29, P422, DOI 10.1111/j.1475-1313.2008.00616.x; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; SAUNDERS KJ, 1992, OPTOMETRY VISION SCI, V69, P615, DOI 10.1097/00006324-199208000-00004; SAUNDERS KJ, 1995, SURV OPHTHALMOL, V40, P207, DOI 10.1016/S0039-6257(95)80027-1; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; SORSBY A, 1961, Memo Med Res Counc, V301(Special), P1; SORSBY A, 1960, BRIT MED J, V1, P1394, DOI 10.1136/bmj.1.5183.1394; Sorsby A, 1969, MED RES COUNC SPEC R, V309, P1; Varma R, 2010, OPHTHALMOLOGY, V117, P140, DOI 10.1016/j.ophtha.2009.06.009; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Zhao F, 2010, CHINESE J OPTOM OPHT, V12, P138	38	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78003	10.1371/journal.pone.0078003	http://dx.doi.org/10.1371/journal.pone.0078003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205064	gold, Green Published			2022-12-25	WOS:000326334500089
J	Mao, Y; Chen, H; Liang, H; Meric-Bernstam, F; Mills, GB; Chen, K				Mao, Yong; Chen, Han; Liang, Han; Meric-Bernstam, Funda; Mills, Gordon B.; Chen, Ken			CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features	PLOS ONE			English	Article							K-RAS MUTATIONS; SOMATIC MUTATIONS; ACTIVATION; MECHANISM; PATTERNS	Driver mutations are somatic mutations that provide growth advantage to tumor cells, while passenger mutations are those not functionally related to oncogenesis. Distinguishing drivers from passengers is challenging because drivers occur much less frequently than passengers, they tend to have low prevalence, their functions are multifactorial and not intuitively obvious. Missense mutations are excellent candidates as drivers, as they occur more frequently and are potentially easier to identify than other types of mutations. Although several methods have been developed for predicting the functional impact of missense mutations, only a few have been specifically designed for identifying driver mutations. As more mutations are being discovered, more accurate predictive models can be developed using machine learning approaches that systematically characterize the commonality and peculiarity of missense mutations under the background of specific cancer types. Here, we present a cancer driver annotation (CanDrA) tool that predicts missense driver mutations based on a set of 95 structural and evolutionary features computed by over 10 functional prediction algorithms such as CHASM, SIFT, and MutationAssessor. Through feature optimization and supervised training, CanDrA outperforms existing tools in analyzing the glioblastoma multiforme and ovarian carcinoma data sets in The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia project.	[Mao, Yong; Chen, Han; Liang, Han; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	kchen3@mdanderson.org	Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279	National Institutes of Health [1R01CA172652, CA168394, CA083639, CA143883, UL1TR000371, 1U01CA180964]; MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy; National Cancer Institute Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [U01CA168394, P50CA098258, R01CA172652, U24CA143883, P50CA083639, U01CA180964, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the National Institutes of Health (http://www.nih.gov/) [grant number 1R01CA172652, CA168394, CA083639, CA143883, UL1TR000371 and 1U01CA180964]; the MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy (http://www.mdanderson.org/education-and-research/research-at-md-anderson/personalized-advanced-therapy/institute-for-personalized-cancer-therapy/index.html) and the National Cancer Institute Cancer Center Support Grant (http://cancercenters.cancer.gov/) [P30 CA016672]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cristianini N, 2000, INTRO SUPPORT VECTOR; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kris MG, 2011, J CLIN ONCOL, V29, P7506; Lin CF, 2002, IEEE T NEURAL NETWOR, V13, P464, DOI 10.1109/72.991432; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Peter EH., 2000, PATTERN CLASSIFICATI; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pratilas CA, 2011, CURR TOP MICROBIOL I; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	49	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77945	10.1371/journal.pone.0077945	http://dx.doi.org/10.1371/journal.pone.0077945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205039	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500080
J	Zhu, JQ; Kang, LY; Ye, QF; Fan, GW; Liang, YB; Yan, C; Orgah, J				Zhu, Jinqiang; Kang, Liyuan; Ye, Qiaofeng; Fan, Guanwei; Liang, Yubin; Yan, Chen; Orgah, John			Effects of Shenfu Injection and Its Main Components on the Contraction of Isolated Rat Thoracic Aortic Rings	PLOS ONE			English	Article							GINSENOSIDES; RELAXATION; INJURY; FU	Background and Purpose: Shenfu injection (SFI), derived from the ancient traditional Chinese medicine (Red Radix Ginseng and Radix Aconitum Carmichaeli), has been widely used in the clinical for the treatment of cardiovascular diseases for more than 20 years. The present study aims to investigate the effects of SFI and its main components on the contraction of isolated rat thoracic aorta rings and the potential mechanisms of this action. Methodology/Principal Findings: The isolated rat thoracic aorta rings were initially treated with different concentrations of SFI, Hongshen injection (HSI, mainly containing ginsenoside) or Fupian injection (FPI, mainly containing aconite total alkaloids) separately. The control group was added an equal volume Krebs-Henseleit (K-H) solution. All three injections exhibited no obviously effects on the basal tension of the rings in the resting state. However, in the isolated thoracic aorta rings with intact endothelium, when the rings were first induced by 60 mM potassium chloride (KCl) or 1 mu M norepinephrine (NE) to the maximal contraction and then treated with above injections, SFI and HSI significantly inhibited the vasoconstriction induced by KCl or NE. In addition, FPI has a tendency to inhibit KCl-induced vasoconstriction and facilitate NE-induced vasoconstriction, but no significant difference. None of them showed obvious effect on the endothelium denuded vessels. Moreover, this procedure was repeated after pre-incubation of nitric oxide synthase (NOS) inhibitor N-G-nitro-L-arginine methyl ester (L-NAME), which suppressed the vasorelaxation effect of SFI and HSI. Conclusions and Implications: These results demonstrate that both SFI and HSI caused an apparent thoracic aorta relaxation by endothelium-dependent manner, which was associated with eNOS system, while FPI had no detectable vasodilator effect. This suggested that the ginsenoside from red Radix Ginseng may be the main active ingredient of SFI's vasodilator effect.	[Zhu, Jinqiang; Kang, Liyuan; Ye, Qiaofeng; Fan, Guanwei; Liang, Yubin; Yan, Chen] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Chinese Med Pharmacol, Inst Tradit Chinese Med, Tianjin, Peoples R China; [Orgah, John] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine	Kang, LY (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Chinese Med Pharmacol, Inst Tradit Chinese Med, Tianjin, Peoples R China.	klyzm@163.com	FAN, GUANWEI/GWV-6480-2022; guanwei, fan/M-8193-2019; Orgah, John Owoicho/Q-7645-2019		National Key Basic Research and Development Program (973 Program) [2012CB518404]	National Key Basic Research and Development Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Key Basic Research and Development Program (973 Program)-Component Compatibility regulation of the effective prescription for the treatment of cardiovascular disease (No.: 2012CB518404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2003, BRIT J PHARMACOL, V138, P63, DOI 10.1038/sj.bjp.0705027; [Anonymous], [No title captured]; [Anonymous], 2005, CHIN J NAT MED; [Anonymous], [No title captured]; Deng Q. Y., 2012, J NEW CHINESE MED, V44, P15; Ding YD, 2009, SHANDONG MED J, V49, P64; Gu W, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/464650; [侯雅竹 Hou Yazhu], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P292; Hu HH, 2005, CHINESE J INTEGRATIV, V3, P67; Huang W, 2007, J LIAONING U TRADITI, V9, P5; Ji XF, 2013, CHINESE MED J-PEKING, V126, P697, DOI 10.3760/cma.j.issn.0366-6999.20121320; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; KANG SY, 1995, LIFE SCI, V56, P1577, DOI 10.1016/0024-3205(95)00124-O; KIM ND, 1994, GEN PHARMACOL-VASC S, V25, P1071, DOI 10.1016/0306-3623(94)90121-X; Li QB, 1999, J GUANGDONG MED COLL, V17, P138; Li QB, 1999, J GUANGDONG MED COLL, V17, P138; Liu J. W., 2010, J LIAONING U TRADITI, V12, P242; Liu XH, 2010, CHINA PHARM, V19, P12; Liu YH, 2010, LIAONING J TRADITI S, VS1, P42; Liu Z, 2001, J NEW CHINESE MED, V33, P6; Nie Y.J., 2012, CHIN MED PHARM CHIN, V2, P64; Tu QY, 2009, LIAONING J TRADITION, V36, P1908; Wang YS, 1983, CHINESE MED PHARM AP, P16; Wang ZC, 2008, INT J TRADITIONAL CH, V30, P445; Xu SY, 1994, PHARM EXPT METHODOLO, P886; [闫福曼 Yan Fuman], 2009, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V25, P8; Yang RJ, 2012, STUDY CHEM CONSTITUE; Zhang JZ, 2009, PRACTICAL J CARDIAC, V17, P470; [张晓膺 Zhang Xiaoying], 2005, [江苏医药, Jiangsu medical Journal], V31, P113; Zhao JR, 2009, PRACTICAL J CARDIAC, V17, P776; Zheng CD, 2008, CHIN J INTEGR MED, V14, P10, DOI 10.1007/s11655-008-0010-y; Zheng HK, 1997, TRADITIONAL CHINESE, P109; Zheng SY, 2004, AM J CHINESE MED, V32, P209, DOI 10.1142/S0192415X04001874; Zheng SY, 2004, J NANJING U NATURAL, V40, P193; Zhou LQ, 2007, J J LIAONING U TCM, V9, P209; [邹磊 ZOU Lei], 2009, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V34, P903	36	31	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78026	10.1371/journal.pone.0078026	http://dx.doi.org/10.1371/journal.pone.0078026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205074	Green Submitted, gold, Green Published			2022-12-25	WOS:000326334500090
J	Neri, S; Bourin, P; Peyrafitte, JA; Cattini, L; Facchini, A; Mariani, E				Neri, Simona; Bourin, Philippe; Peyrafitte, Julie-Anne; Cattini, Luca; Facchini, Andrea; Mariani, Erminia			Human Adipose Stromal Cells (ASC) for the Regeneration of Injured Cartilage Display Genetic Stability after In Vitro Culture Expansion	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MICROSATELLITE INSTABILITY; BONE-MARROW; CHROMOSOMAL-ABERRATIONS; TELOMERASE ACTIVITY; TISSUE; TRANSFORMATION; ACQUISITION; EXPRESSION; CHONDROCYTES	Mesenchymal stromal cells are emerging as an extremely promising therapeutic agent for tissue regeneration due to their multi-potency, immune-modulation and secretome activities, but safety remains one of the main concerns, particularly when in vitro manipulation, such as cell expansion, is performed before clinical application. Indeed, it is well documented that in vitro expansion reduces replicative potential and some multi-potency and promotes cell senescence. Furthermore, during in vitro aging there is a decrease in DNA synthesis and repair efficiency thus leading to DNA damage accumulation and possibly inducing genomic instability. The European Research Project ADIPOA aims at validating an innovative cell-based therapy where autologous adipose stromal cells (ASCs) are injected in the diseased articulation to activate regeneration of the cartilage. The primary objective of this paper was to assess the safety of cultured ASCs. The maintenance of genetic integrity was evaluated during in vitro culture by karyotype and microsatellite instability analysis. In addition, RT-PCR array-based evaluation of the expression of genes related to DNA damage signaling pathways was performed. Finally, the senescence and replicative potential of cultured cells was evaluated by telomere length and telomerase activity assessment, whereas anchorage-independent clone development was tested in vitro by soft agar growth. We found that cultured ASCs do not show genetic alterations and replicative senescence during the period of observation, nor anchorage-independent growth, supporting an argument for the safety of ASCs for clinical use.	[Neri, Simona; Cattini, Luca; Facchini, Andrea; Mariani, Erminia] Rizzoli Orthoped Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy; [Bourin, Philippe; Peyrafitte, Julie-Anne] EFS PM, Toulouse, France; [Bourin, Philippe] CSA21, Toulouse, France; [Peyrafitte, Julie-Anne] Univ Toulouse 3, CNRS, INSERM, STROMALAB,UMR 5273,U1031, F-31062 Toulouse, France; [Facchini, Andrea; Mariani, Erminia] Univ Bologna, Med & Surg Sci Dept, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bologna	Neri, S (corresponding author), Rizzoli Orthoped Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy.	simona.neri@ior.it	Mariani, Erminia/AAE-8110-2021; Neri, Simona/C-6874-2019; Mariani, Erminia/C-6881-2019; Bourin, Philippe/J-2693-2019	Mariani, Erminia/0000-0002-4407-6707; Neri, Simona/0000-0003-3257-6293; Mariani, Erminia/0000-0002-4407-6707; Bourin, Philippe/0000-0002-9652-4380	ADIPOA EU FP7 project [241719]; RFO Bologna University; MIUR-FIRB [RBAP10KCNS]; Italian Health Ministry	ADIPOA EU FP7 project; RFO Bologna University; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Health Ministry(Ministry of Health, Italy)	This work was supported by: ADIPOA EU FP7 project n. 241719; RFO Bologna University; MIUR-FIRB Project RBAP10KCNS, 5 per mille Funds, Italian Health Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett K, 2005, EXP GERONTOL, V40, P976, DOI 10.1016/j.exger.2005.09.001; Ben-David U, 2012, CELL STEM CELL, V10, P10, DOI 10.1016/j.stem.2011.12.007; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bourin P, 2011, METHODS MOL BIOL, V702, P331, DOI 10.1007/978-1-61737-960-4_24; Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Bukvic N, 2001, MUTAT RES-GEN TOX EN, V498, P159, DOI 10.1016/S1383-5718(01)00279-0; Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3; Caestecker KW, 2013, EXP CELL RES, V319, P575, DOI 10.1016/j.yexcr.2012.11.013; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796; Chai JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-512; Chang CL, 2002, AM J PHYSIOL-CELL PH, V283, pC148, DOI 10.1152/ajpcell.00422.2001; Choumerianou DM, 2008, CELL PROLIFERAT, V41, P909, DOI 10.1111/j.1365-2184.2008.00559.x; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Desando G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4156; Duarte DM, 2012, REGEN MED, V7, P147, DOI [10.2217/rme.11.113, 10.2217/RME.11.113]; Garcia S, 2010, EXP CELL RES, V316, P1648, DOI 10.1016/j.yexcr.2010.02.016; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Jackson AL, 1998, P NATL ACAD SCI USA, V95, P12468, DOI 10.1073/pnas.95.21.12468; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kenyon J, 2012, BLOOD, V120, P3229, DOI 10.1182/blood-2011-12-401950; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Krichevsky S, 2004, EXP GERONTOL, V39, P507, DOI 10.1016/j.exger.2003.12.016; Lee SH, 2003, J IMMUNOL, V170, P2214, DOI 10.4049/jimmunol.170.4.2214; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lopez-Iglesias Pilar, 2011, World J Stem Cells, V3, P53, DOI 10.4252/wjsc.v3.i6.53; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Mariani E, 2012, CURR PHARM DESIGN, V18, P1821, DOI 10.2174/138161212799859666; Mariani E, 2003, MECH AGEING DEV, V124, P403, DOI 10.1016/S0047-6374(03)00015-0; Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Neri S, 2005, J GERONTOL A-BIOL, V60, P285, DOI 10.1093/gerona/60.3.285; Neri S, 2004, EXP GERONTOL, V39, P499, DOI 10.1016/j.exger.2003.11.017; Neri S, 2008, REJUV RES, V11, P565, DOI 10.1089/rej.2007.0639; Neri S, 2007, REJUV RES, V10, P145, DOI 10.1089/rej.2006.0510; Neri S, 2011, J CELL PHYSIOL, V226, P2579, DOI 10.1002/jcp.22603; Philippe B, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/503593; Poloni A, 2011, CELL TRANSPLANT, V20, P643, DOI 10.3727/096368910X536518; Rada T, 2009, TISSUE ENG PART B-RE, V15, P113, DOI 10.1089/ten.teb.2008.0423; Russell LM, 2007, CYTOGENET GENOME RES, V116, P181, DOI 10.1159/000098184; Sachs PC, 2012, CELL TISSUE RES, V349, P505, DOI 10.1007/s00441-012-1423-7; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Torsvik A, 2012, INT J BIOL SCI, V8, P1051, DOI 10.7150/ijbs.3665; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Vaish M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-26; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Witkowska-Zimny M, 2011, CELL MOL BIOL LETT, V16, P236, DOI 10.2478/s11658-011-0005-0; Wojda A, 2006, J GERONTOL A-BIOL, V61, P763, DOI 10.1093/gerona/61.8.763; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Zhang ZX, 2007, CELL BIOL INT, V31, P645, DOI 10.1016/j.cellbi.2006.11.025; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	83	35	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77895	10.1371/journal.pone.0077895	http://dx.doi.org/10.1371/journal.pone.0077895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205017	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200048
J	Biswas, N; Rodriguez-Garcia, M; Crist, SG; Shen, Z; Bodwell, JE; Fahey, JV; Wira, CR				Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G.; Shen, Zheng; Bodwell, Jack E.; Fahey, John V.; Wira, Charles R.			Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DENDRITIC CELLS; IN-VITRO; ALPHA; 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE; ECTO-5-NUCLEOTIDASE; METABOLISM; ACTIVATION; EXPRESSION; INFECTION	Tenofovir (TFV) has been widely used for pre-exposure prophylaxis of HIV-1 infection with mixed results. While the use of TFV in uninfected individuals for prevention of HIV-1 acquisition is actively being investigated, the possible consequences of TFV exposure for the HIV-target cells and the mucosal microenvironment are unknown. In the current study, we evaluated the effects of TFV treatment on blood-derived CD4(+) T cells, monocyte-derived macrophages and dendritic cells (DC). Purified HIV-target cells were treated with different concentrations of TFV (0.001-1.0 mg/ml) for 2 to 24hr. RNA was isolated and RT-PCR was performed to compare the levels of mRNA expression of nucleotidases and pro-inflammatory cytokine genes (MIP3 alpha, IL-8 and TNF alpha) in the presence or absence of TFV. We found that TFV increases 5'-ecto-nucleotidase (NT5E) and inhibits mitochondrial nucleotidase (NT5M) gene expression and increases 5' nucleotidase activity in macrophages. We also observed that TFV stimulates the expression and secretion of IL-8 by macrophages, DC, and activated CD4(+) T cells and increases the expression and secretion of MIP3 alpha by macrophages. In contrast, TFV had no effect on TNF alpha secretion from macrophages, DC and CD4(+) T cells. Our results demonstrate that TFV alters innate immune responses in HIV-target cells with potential implications for increased inflammation at mucosal surfaces. As new preventive trials are designed, these findings should provide a foundation for understanding the effects of TFV on HIV-target cells in microbicide trials.	[Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G.; Shen, Zheng; Bodwell, Jack E.; Fahey, John V.; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA	Dartmouth College	Biswas, N (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA.	nabanita.biswas@gmail.com			National Institutes of Health [HHSN272201000001C]; Advanced BioScience Laboratories, Inc.; NIH [AI102838, AI071761, AI013541]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013541, R55AI013541, R56AI071761, R01AI102838, R01AI071761, R01AI013541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced BioScience Laboratories, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health contract HHSN272201000001C, which was indirectly funded by Advanced BioScience Laboratories, Inc., and by NIH grants AI102838, AI071761 and AI013541 (CRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; ARMSTRONG MA, 1988, ANN NEUROL, V24, P12, DOI 10.1002/ana.410240104; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P1499, DOI 10.1073/pnas.88.4.1499; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P4961, DOI 10.1073/pnas.88.11.4961; BIANCHI V, 1986, P NATL ACAD SCI USA, V83, P986, DOI 10.1073/pnas.83.4.986; Christensen LD, 1996, APMIS, V104, P126, DOI 10.1111/j.1699-0463.1996.tb00697.x; CHRISTENSEN LD, 1992, SCAND J IMMUNOL, V35, P407, DOI 10.1111/j.1365-3083.1992.tb02875.x; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Escribese MM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-118; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Krishna S, 2006, NUCLEIC ACIDS RES, V34, P2455, DOI 10.1093/nar/gkl140; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Mane Viraj P, 2008, J Biomol Tech, V19, P342; Melchjorsen J, 2011, JAIDS-J ACQ IMM DEF, V57, P265, DOI 10.1097/QAI.0b013e3182185276; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MTN, 2012, MTN MICROBICIDE TRIA; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Rampazzo C, 2002, GENE, V294, P109, DOI 10.1016/S0378-1119(02)00651-0; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Rodriguez-Garcia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062069; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; SAVIC V, 1990, IMMUNOLOGY, V70, P321; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Zidek Z, 2001, ANTIMICROB AGENTS CH, V45, P3381, DOI 10.1128/AAC.45.12.3381-3386.2001; Zidek Z, 2007, EUR J PHARMACOL, V574, P77, DOI 10.1016/j.ejphar.2007.07.024	45	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78814	10.1371/journal.pone.0078814	http://dx.doi.org/10.1371/journal.pone.0078814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205323	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400107
J	Dutta, S; Rani, TS; Podile, AR				Dutta, Swarnalee; Rani, T. Swaroopa; Podile, Appa Rao			Root Exudate-Induced Alterations in Bacillus cereus Cell Wall Contribute to Root Colonization and Plant Growth Promotion	PLOS ONE			English	Article							FTIR SPECTROSCOPIC CHARACTERIZATION; AZOSPIRILLUM-BRASILENSE; IR SPECTROSCOPY; ORGANIC-ACIDS; RHIZOSPHERE; BACTERIA; STRAINS; PROTEIN; WHEAT; IDENTIFICATION	The outcome of an interaction between plant growth promoting rhizobacteria and plants may depend on the chemical composition of root exudates (REs). We report the colonization of tobacco, and not groundnut, roots by a non-rhizospheric Bacillus cereus (MTCC 430). There was a differential alteration in the cell wall components of B. cereus in response to the REs from tobacco and groundnut. Attenuated total reflectance infrared spectroscopy revealed a split in amide I region of B. cereus cells exposed to tobacco-root exudates (TRE), compared to those exposed to groundnut-root exudates (GRE). In addition, changes in exopolysaccharides and lipid-packing were observed in B. cereus grown in TRE-amended minimal media that were not detectable in GRE-amended media. Cell-wall proteome analyses revealed upregulation of oxidative stress-related alkyl hydroperoxide reductase, and DNA-protecting protein chain (Dlp-2), in response to GRE and TRE, respectively. Metabolism-related enzymes like 2-amino-3-ketobutyrate coenzyme A ligase and 2-methylcitrate dehydratase and a 60 kDa chaperonin were up-regulated in response to TRE and GRE. In response to B. cereus, the plant roots altered their exudate-chemodiversity with respect to carbohydrates, organic acids, alkanes, and polyols. TRE-induced changes in surface components of B. cereus may contribute to successful root colonization and subsequent plant growth promotion.	[Dutta, Swarnalee; Rani, T. Swaroopa; Podile, Appa Rao] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Podile, AR (corresponding author), Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Podile, Appa Rao/W-5077-2018	Podile, Appa Rao/0000-0003-3208-765X	Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST); University Grants Commission Centre for Advanced Studies (UGC-CAS); Department of Biotechnology (DBT)-Research Associateship; DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); DST-INSPIRE	Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST)(Department of Science & Technology (India)); University Grants Commission Centre for Advanced Studies (UGC-CAS)(University Grants Commission, India); Department of Biotechnology (DBT)-Research Associateship(Department of Biotechnology (DBT) India); DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); DST-INSPIRE(Department of Science & Technology (India))	The authors gratefully acknowledge the financial support of the Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST) to the Department of Plant Sciences, and of the University Grants Commission Centre for Advanced Studies (UGC-CAS) to the School of Life Sciences. SD thanks the Department of Biotechnology (DBT)-Research Associateship. TSR thanks DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB) and DST-INSPIRE for research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Bergmeyer HU, 1963, METHOD ENZYMAT AN; Buensanteai N., 2008, J AGR SCI TECH-IRAN, V41, P101; Burdman S, 2001, MOL PLANT MICROBE IN, V14, P555, DOI 10.1094/MPMI.2001.14.4.555; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Carrillo AE, 2002, NATURWISSENSCHAFTEN, V89, P428, DOI 10.1007/s00114-002-0347-6; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chung JW, 2007, MICROBIOL-SGM, V153, P206, DOI 10.1099/mic.0.2006/000455-0; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Cyran MR, 2007, J AGR FOOD CHEM, V55, P2329, DOI 10.1021/jf062473g; Dardanelli MS, 2010, PLANT SOIL, V328, P483, DOI 10.1007/s11104-009-0127-6; Das SN, 2010, J PLANT GROWTH REGUL, V29, P409, DOI 10.1007/s00344-010-9152-1; Das SN, 2010, WORLD J MICROB BIOT, V26, P1875, DOI 10.1007/s11274-010-0369-8; Dogan A, 2007, FOOD CHEM, V100, P1106, DOI 10.1016/j.foodchem.2005.11.017; Dutta S, 2010, CRIT REV MICROBIOL, V36, P232, DOI 10.3109/10408411003766806; Filip Z, 2004, MICROBIOL RES, V159, P257, DOI 10.1016/j.micres.2004.05.002; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Garip S, 2009, FOOD CHEM, V113, P1301, DOI 10.1016/j.foodchem.2008.08.063; Gorgulu ST, 2007, APPL SPECTROSC, V61, P300, DOI 10.1366/000370207780220903; Haque MA, 2004, MICROBIOL-SGM, V150, P1397, DOI 10.1099/mic.0.26767-0; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; HELM D, 1995, FEMS MICROBIOL LETT, V126, P75, DOI 10.1111/j.1574-6968.1995.tb07393.x; HEULIN T, 1987, BIOL FERT SOILS, V4, P9; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kamnev AA, 2001, J MOL STRUCT, V563, P199, DOI 10.1016/S0022-2860(00)00877-2; Kamnev AA, 1997, J MOL STRUCT, V408, P201, DOI 10.1016/S0022-2860(96)09532-4; Kamnev AA, 2008, MICROB ECOL, V56, P615, DOI 10.1007/s00248-008-9381-z; Kamnev AA, 2008, SPECTROSC-INT J, V22, P83, DOI 10.1155/2008/862085; Kishore GK, 2005, J PHYTOPATHOL, V153, P169, DOI 10.1111/j.1439-0434.2005.00951.x; Kishore GK, 2005, LETT APPL MICROBIOL, V40, P260, DOI 10.1111/j.1472-765X.2005.01664.x; Kloepper JW, 1996, BIOSCIENCE, V46, P406, DOI 10.2307/1312874; Kravchenko LV, 2003, MICROBIOLOGY+, V72, P37, DOI 10.1023/A:1022269821379; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Mazzola M, 2004, MICROB ECOL, V48, P338, DOI 10.1007/s00248-003-1067-y; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Mohamed W, 2010, INFECT IMMUN, V78, P3306, DOI 10.1128/IAI.00210-10; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; Okubara PA, 2004, BIOL CONTROL, V30, P392, DOI 10.1016/j.biocontrol.2003.11.003; Persello-Cartieaux F, 2001, PLANTA, V212, P190, DOI 10.1007/s004250000384; PHILLIPS DA, 1992, PLANT PHYSIOL, V99, P1526, DOI 10.1104/pp.99.4.1526; Podile AR, 2006, PLANT-ASSOCIATED BACTERIA, P195; Robert P, 2005, J AGR FOOD CHEM, V53, P7014, DOI 10.1021/jf051145y; ROMANTSCHUK M, 1992, ANNU REV PHYTOPATHOL, V30, P225, DOI 10.1146/annurev.py.30.090192.001301; Rubio C, 2006, J MICROBIOL METH, V64, P287, DOI 10.1016/j.mimet.2005.05.013; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Seul KJ, 2007, J MICROBIOL BIOTECHN, V17, P934; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Slavov S, 2004, J PLANT PHYSIOL, V161, P847, DOI 10.1016/j.jplph.2003.11.007; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; Takatsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020985; Walz Alexander, 2007, Proteome Sci, V5, P11, DOI 10.1186/1477-5956-5-11; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wasim M, 2009, MICROBIOL-SGM, V155, P1192, DOI 10.1099/mic.0.022541-0	64	43	44	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78369	10.1371/journal.pone.0078369	http://dx.doi.org/10.1371/journal.pone.0078369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205213	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300056
J	Krawczyk-Balska, A; Lipiak, M				Krawczyk-Balska, Agata; Lipiak, Magdalena			Critical Role of a Ferritin-Like Protein in the Control of Listeria monocytogenes Cell Envelope Structure and Stability under beta-lactam Pressure	PLOS ONE			English	Article							WALL TEICHOIC-ACID; D-ALANINE; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; SECA2-DEPENDENT SECRETION; LIPOTEICHOIC ACID; VEGETATIVE GROWTH; BINDING PROTEIN; IRON STORAGE; IDENTIFICATION	The human pathogen Listeria monocytogenes is susceptible to the beta-lactam antibiotics penicillin G and ampicillin, and these are the drugs of choice for the treatment of listerial infections. However, these antibiotics exert only a bacteriostatic effect on this bacterium and consequently, L. monocytogenes is regarded as beta-lactam tolerant. It is widely accepted that the phenomenon of bacterial tolerance to beta-lactams is due to the lack of adequate autolysin activity, but the mechanisms of L. monocytogenes tolerance to this class of antibiotics are poorly characterized. A ferritin-like protein (Fri) was recently identified as a mediator of beta-lactam tolerance in L. monocytogenes, but its function in this process remains unknown. The present study was undertaken to improve our understanding of L. monocytogenes tolerance to beta-lactams and to characterize the role of Fri in this phenomenon. A comparative physiological analysis of wild-type L. monocytogenes and a fri deletion mutant provided evidence of a multilevel mechanism controlling autolysin activity in cells grown under beta-lactam pressure, which leads to a reduction in the level and/or activity of cell wall-associated autolysins. This is accompanied by increases in the amount of teichoic acids, cell wall thickness and cell envelope integrity of L. monocytogenes grown in the presence of penicillin G, and provides the basis for the innate beta-lactam tolerance of this bacterium. Furthermore, this study revealed the inability of the L. monocytogenes Delta fri mutant to deplete autolysins from the cell wall, to adjust the content of teichoic acids and to maintain their D-alanylation at the correct level when treated with penicillin G, thus providing further evidence that Fri is involved in the control of L. monocytogenes cell envelope structure and stability under beta-lactam pressure.	[Krawczyk-Balska, Agata; Lipiak, Magdalena] Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland	University of Warsaw	Krawczyk-Balska, A (corresponding author), Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland.	akra@biol.uw.edu.pl	Krawczyk-Balska, Agata/AAX-3428-2021	Krawczyk-Balska, Agata/0000-0001-9809-8402	Polish Ministry of Science and Higher Education [N N302 229738]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by the grant of Polish Ministry of Science and Higher Education N N302 229738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Begley M, 2006, APPL ENVIRON MICROB, V72, P2231, DOI 10.1128/AEM.72.3.2231-2234.2006; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; BUBERT A, 1992, J BACTERIOL, V174, P8166, DOI 10.1128/JB.174.24.8166-8171.1992; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Calhoun LN, 2011, INT J ANTIMICROB AG, V37, P261, DOI 10.1016/j.ijantimicag.2010.11.034; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Desvaux M, 2010, J PROTEOME RES, V9, P5076, DOI 10.1021/pr1003642; Dubail I, 2006, J BACTERIOL, V188, P6580, DOI 10.1128/JB.00771-06; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Fiorini F, 2008, GENE, V410, P113, DOI 10.1016/j.gene.2007.12.007; Forster BM, 2012, MOL MICROBIOL, V84, P405, DOI 10.1111/j.1365-2958.2012.08040.x; FOSTER SJ, 1992, J BACTERIOL, V174, P464, DOI 10.1128/jb.174.2.464-470.1992; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Glaser P, 2001, SCIENCE, V294, P849; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hebraud M, 2000, FEMS MICROBIOL LETT, V190, P29, DOI 10.1016/S0378-1097(00)00310-4; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Hof H, 2003, FEMS IMMUNOL MED MIC, V35, P203, DOI 10.1016/S0928-8244(02)00466-2; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Kallipolitis BH, 2003, ANTIMICROB AGENTS CH, V47, P3421, DOI 10.1128/AAC.47.11.3421-3429.2003; Koch AL, 2001, ANTIMICROB AGENTS CH, V45, P2671, DOI 10.1128/AAC.45.10.2671-2675.2001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korsak D, 2005, FEMS MICROBIOL LETT, V251, P281, DOI 10.1016/j.femsle.2005.08.009; Krawczyk-Balska A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-278; Krawczyk-Balska A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-57; KUHN M, 1989, INFECT IMMUN, V57, P55, DOI 10.1128/IAI.57.1.55-61.1989; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Machata S, 2005, J BACTERIOL, V187, P8385, DOI 10.1128/JB.187.24.8385-8394.2005; McLauchlin J, 1997, REV MED MICROBIOL, V8, P1; McLaughlan AM, 1998, MICROBIOL-SGM, V144, P1359, DOI 10.1099/00221287-144-5-1359; Mohamed W, 2006, MOL GENET GENOMICS, V275, P344, DOI 10.1007/s00438-005-0090-8; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Popowska M, 2012, ARCH MICROBIOL, V194, P255, DOI 10.1007/s00203-011-0752-3; Popowska Magdalena, 1999, Acta Microbiologica Polonica, V48, P141; Popowska M, 2009, J MICROBIOL BIOTECHN, V19, P932, DOI 10.4014/jmb.0810.557; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Renier S, 2013, J PROTEOMICS, V80, P183, DOI 10.1016/j.jprot.2012.11.027; Renier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042982; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sambrook J, 2001, MOL CLONING LAB MANU; Schubert K, 2000, ARCH MICROBIOL, V173, P21, DOI 10.1007/s002030050003; SCHUCHAT A, 1991, CLIN MICROBIOL REV, V4, P169, DOI 10.1128/CMR.4.2.169-183.1991; Shockman GD., 1994, BACTERIAL CELL WALL, P131, DOI 10.1016/S0167-7306(08)60410-X; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Wehmhoner D, 2005, ELECTROPHORESIS, V26, P2450, DOI 10.1002/elps.200410348; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wisniewski J, 2006, FEMS IMMUNOL MED MIC, V46, P330, DOI 10.1111/j.1574-695X.2006.00029.x; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	81	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77808	10.1371/journal.pone.0077808	http://dx.doi.org/10.1371/journal.pone.0077808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204978	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300031
J	Wong, FC; Woo, CC; Hsu, A; Tan, BKH				Wong, Fang Cheng; Woo, Chern Chiuh; Hsu, Annie; Tan, Benny Kwong Huat			The Anti-Cancer Activities of Vernonia amygdalina Extract in Human Breast Cancer Cell Lines Are Mediated through Caspase-Dependent and p53-Independent Pathways	PLOS ONE			English	Article							SESQUITERPENE LACTONES; INDEPENDENT APOPTOSIS; DNA-DAMAGE; P53; SUPPRESSION; TARGET; DEL	Breast cancer is currently the leading cause of cancer-related deaths among women globally. Notably, medicinal plant extracts may be a potential source for treatments of breast cancer. Vernonia amygdalina (VA) is a woody shrub reported to have not only diverse therapeutic effects but also anti-cancer properties. However, current research about the mechanisms of the anti-cancer potential of VA has been limited. This study aimed to investigate the mechanisms of action of VA that underlie its anti-cancer effects in human breast cancer cell lines (MCF-7 and MDA-MB-231 cells). Results from MTT assay revealed that VA inhibits the proliferation of MCF-7 and MDA-MB-231, in a time-and dose-dependent manner. The underlying mechanism of this growth inhibition involved the stimulation of cell-type specific G1/S phase cell cycle arrest in only MCF-7 cells, and not in MDA-MB-231 cells. While the growth arrest was associated with increased levels of p53 and p21, and a concomitant decrease in the levels of cyclin D1 and cyclin E, it was shown that VA causes cell cycle arrest through a p53-independent pathway as tested by the wild type p53 inhibitor, pifithrin-alpha. Furthermore, this study revealed that VA induces apoptosis in the two cell lines, as indicated by the increase in Annexin V-positive cells and sub-G1 population, and that this VA-induced apoptosis occurred through both extrinsic and intrinsic apoptotic pathways. The apoptosis in MCF-7 cells was also likely to be caspase-dependent and not p53 transcriptional-dependent. Given that approximately 70% of diagnosed breast cancers express ER-alpha, a crucial finding was that VA inhibits the expression of ER-alpha and its downstream player, Akt, highlighting the potential clinical significance of VA. Moreover, VA exhibits synergism when combined with doxorubicin, suggesting that it can complement current chemotherapy. Overall, this study demonstrates the potential applications of VA as an anti-cancer drug for breast cancer treatment.	[Wong, Fang Cheng; Woo, Chern Chiuh; Hsu, Annie; Tan, Benny Kwong Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore	Tan, BKH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	benny_tan@nuhs.edu.sg			Department of Pharmacology, National University of Singapore [C-184-000-610-031]	Department of Pharmacology, National University of Singapore	This study was supported by a grant (C-184-000-610-031) from the Department of Pharmacology, National University of Singapore (http://medicine.nus.edu.sg/medphc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawa CBI, 2003, VET PARASITOL, V113, P73, DOI 10.1016/S0304-4017(03)00040-2; Berger CE, 2012, J BIOL CHEM, V287, P30117, DOI 10.1074/jbc.M112.367326; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Farombi EO, 2011, INT J ENV RES PUB HE, V8, P2533, DOI 10.3390/ijerph8062533; Ford CHJ, 2011, ANTICANCER RES, V31, P521; Fukutomi Takashi, 2002, Breast Cancer, V9, P95, DOI 10.1007/BF02967572; Han K, 2007, GYMNANTHEMUM AMYGDAL; Hao TQ, 2008, CHIN MED J, V121, P602; Ijeh II, 2011, J MED PLANTS RES, V5, P1051; Izevbigie EB, 2003, EXP BIOL MED, V228, P293, DOI 10.1177/153537020322800308; JISAKA M, 1993, BIOSCI BIOTECH BIOCH, V57, P833, DOI 10.1271/bbb.57.833; KUPCHAN SM, 1969, J ORG CHEM, V34, P3908, DOI 10.1021/jo01264a035; Ligresti G, 2008, MOL MED REP, V1, P451; Lumachi F, 2013, CURR MED CHEM, V20, P596, DOI 10.2174/092986713804999303; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Opata Michael M, 2006, Int J Environ Res Public Health, V3, P174, DOI 10.3390/ijerph2006030019; Rang H.P., 2007, RANG DALES PHARM; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Wang DD, 2012, J BIOL CHEM, V287, P12612, DOI 10.1074/jbc.M111.334151; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Watson MI, 2005, MOL CANCER THER, V4, P1369; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yeap SK, 2010, J MED PLANTS RES, V4, P2787; Yedjou Clement, 2008, Int J Environ Res Public Health, V5, P337	30	54	55	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78021	10.1371/journal.pone.0078021	http://dx.doi.org/10.1371/journal.pone.0078021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205071	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300040
J	Deeley, Q; Walsh, E; Oakley, DA; Bell, V; Koppel, C; Mehta, MA; Halligan, PW				Deeley, Quinton; Walsh, Eamonn; Oakley, David A.; Bell, Vaughan; Koppel, Cristina; Mehta, Mitul A.; Halligan, Peter W.			Using Hypnotic Suggestion to Model Loss of Control and Awareness of Movements: An Exploratory fMRI Study	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; MOTOR; CORTEX; SUPPLEMENTARY; SCHIZOPHRENIA; DELUSIONS; HYPNOSIS; AREA; SELF	The feeling of voluntary control and awareness of movement is fundamental to our notions of selfhood and responsibility for actions, yet can be lost in neuropsychiatric syndromes (e. g. delusions of control, non-epileptic seizures) and culturally influenced dissociative states (e. g. attributions of spirit possession). The brain processes involved remain poorly understood. We used suggestion and functional magnetic resonance imaging (fMRI) to investigate loss of control and awareness of right hand movements in 15 highly hypnotically suggestible subjects. Loss of perceived control of movements was associated with reduced connectivity between supplementary motor area (SMA) and motor regions. Reduced awareness of involuntary movements was associated with less activation in parietal cortices (BA 7, BA 40) and insula. Collectively these results suggest that the sense of voluntary control of movement may critically depend on the functional coupling of SMA with motor systems, and provide a potential neural basis for the narrowing of awareness reported in pathological and culturally influenced dissociative phenomena.	[Deeley, Quinton; Walsh, Eamonn] Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, London, England; [Oakley, David A.] UCL, Div Psychol & Language Sci, London WC1E 6BT, England; [Bell, Vaughan; Mehta, Mitul A.] Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, Ctr Neuroimaging Sci, London, England; [Koppel, Cristina] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Halligan, Peter W.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	University of London; King's College London; University of London; University College London; University of London; King's College London; Imperial College London; Cardiff University	Deeley, Q (corresponding author), Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, London, England.	q.deeley@iop.kcl.ac.uk	Mehta, Mitul/F-3960-2010; Halligan, Peter W/A-1669-2010	Halligan, Peter W/0000-0003-2784-6690; Walsh, Eamonn/0000-0002-5614-6362; Deeley, Quinton/0000-0001-5306-0769	Psychiatry Research Trust; PAGTHZE; Panacea Society; PCFTXZA	Psychiatry Research Trust; PAGTHZE; Panacea Society; PCFTXZA	Funding came from The Psychiatry Research Trust, PAGTHZE, The Panacea Society, and PCFTXZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Blakemore SJ, 2003, NEUROPSYCHOLOGIA, V41, P1058, DOI 10.1016/S0028-3932(02)00313-5; Brown RJ, 2011, EPILEPSY BEHAV, V22, P85, DOI 10.1016/j.yebeh.2011.02.016; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Haan S, 1999, PHENOMENOLOGY COGN S, V9, P373; Deeley P. Q., 2003, PHILOS PSYCHIATR PSY, V10, P161, DOI [10.1353/ppp.2003.0095, DOI 10.1353/PPP.2003.0095]; Deeley Q, 2012, ENCY RELIG SCI; Deeley Q, 2013, CORTEX, V49, P411, DOI 10.1016/j.cortex.2012.09.016; Deeley Q, 2012, INT J CLIN EXP HYP, V60, P206, DOI 10.1080/00207144.2012.648070; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; FRIED I, 1991, J NEUROSCI, V11, P3656; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Meindl T, 2008, EUR RADIOL, V18, P1102, DOI 10.1007/s00330-008-0869-1; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; Oakley D A, 1999, Cogn Neuropsychiatry, V4, P243, DOI 10.1080/135468099395954; Oakley DA, 2007, INT J CLIN EXP HYP, V55, P32, DOI 10.1080/00207140600995844; Oakley DA, 2011, CONSCIOUS COGN, V20, P328, DOI 10.1016/j.concog.2010.01.013; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; Oyebode F, 2008, SIMS SYMPTOMS MIND; Passingham RE, 2006, DOES CONSCIOUSNESS C; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rocca MA, 2007, HUM BRAIN MAPP, V28, P218, DOI 10.1002/hbm.20271; Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x; ROUGET Gilbert, 1985, MUSIC TRANCE THEORY; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; Shor R. E., 1962, HARVARD GROUP SCALE; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004	44	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78324	10.1371/journal.pone.0078324	http://dx.doi.org/10.1371/journal.pone.0078324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205198	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000326032600094
J	Schijffelen, M; Konstantinov, SR; Lina, G; Spiliopoulou, I; van Duijkeren, E; Brouwer, EC; Fluit, AC				Schijffelen, Maarten; Konstantinov, Sergey R.; Lina, Gerard; Spiliopoulou, Iris; van Duijkeren, Engeline; Brouwer, Ellen C.; Fluit, Ad C.			Whole Genome Analysis of Epidemiologically Closely Related Staphylococcus aureus Isolates	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; METHICILLIN-RESISTANT; NASAL CARRIAGE; VIRULENCE; SEQUENCE; CARRIERS	The change of the bacteria from colonizers to pathogens is accompanied by a drastic change in expression profiles. These changes may be due to environmental signals or to mutational changes. We therefore compared the whole genome sequences of four sets of S. aureus isolates. Three sets were from the same patients. The isolates of each pair (S1800/S1805, S2396/S2395, S2398/S2397, an isolate from colonization and an isolate from infection, respectively) were obtained within <30 days of each other and the isolate from infection caused skin infections. The isolates were then compared for differences in gene content and SNPs. In addition, a set of isolates from a colonized pig and a farmer from the same farm at the same time (S0462 and S0460) were analyzed. The isolates pair S1800/S1805 showed a difference in a prophage, but these are easily lost or acquired. However, S1805 contained an integrative conjugative element not present in S1800. In addition, 92 SNPs were present in a variety of genes and the isolates S1800 and S1805 were not considered a pair. Between S2395/S2396 two SNPs were present: one was in an intergenic region and one was a synonymous mutation in a putative membrane protein. Between S2397/S2398 only one synonymous mutation in a putative lipoprotein was found. The two farm isolates were very similar and showed 12 SNPs in genes that belong to a number of different functional categories. However, we cannot pinpoint any gene that explains the change from carrier status to infection. The data indicate that differences between the isolate from infection and the colonizing isolate for S2395/S2396 and S2397/S2398 exist as well as between isolates from different hosts, but S1800/S1805 are not clonal.	[Schijffelen, Maarten; Konstantinov, Sergey R.; Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Lina, Gerard] Univ Lyon 1, Lab Bacteriol, CNR Staphylocoques, F-69365 Lyon, France; [Spiliopoulou, Iris] Univ Patras, Sch Med, Dept Microbiol, GR-26110 Patras, Greece; [van Duijkeren, Engeline] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, NL-3508 TC Utrecht, Netherlands; [van Duijkeren, Engeline] Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Patras; Utrecht University	Fluit, AC (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.c.fluit@umcutrecht.nl	Lina, Gerard J/L-9352-2014	Lina, Gerard/0000-0002-9236-7998	European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD) [222718]	European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD)	The study was funded in part by the European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD). Grant agreement number: 222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HU L, 1995, J MED MICROBIOL, V42, P127, DOI 10.1099/00222615-42-2-127; Kalmeijer MD, 2000, INFECT CONT HOSP EP, V21, P319, DOI 10.1086/501763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Ruef C, 1996, J THORAC CARDIOV SUR, V112, P681, DOI 10.1016/S0022-5223(96)70052-1; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78340	10.1371/journal.pone.0078340	http://dx.doi.org/10.1371/journal.pone.0078340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205205	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600098
J	Wu, XP; Adriany, G; Ugurbil, K; Van de Moortele, PF				Wu, Xiaoping; Adriany, Gregor; Ugurbil, Kamil; Van de Moortele, Pierre-Francois			Correcting for Strong Eddy Current Induced B0 Modulation Enables Two-Spoke RF Pulse Design with Parallel Transmission: Demonstration at 9.4T in the Human Brain	PLOS ONE			English	Article							RADIOFREQUENCY PULSES; 8 CHANNELS; EXCITATION; INHOMOGENEITY; TESLA; SENSE; COIL	Successful implementation of homogeneous slice-selective RF excitation in the human brain at 9.4T using 16-channel parallel transmission (pTX) is demonstrated. A novel three-step pulse design method incorporating fast real-time measurement of eddy current induced B0 variations as well as correction of resulting phase errors during excitation is described. To demonstrate the utility of the proposed method, phantom and in-vivo experiments targeting a uniform excitation in an axial slice were conducted using two-spoke pTX pulses. Even with the pre-emphasis activated, eddy current induced B0 variations with peak-to-peak values greater than 4 kHz were observed on our system during the rapid switches of slice selective gradients. This large B0 variation, when not corrected, resulted in drastically degraded excitation fidelity with the coefficient of variation (CV) of the flip angle calculated for the region of interest being large (similar to 12% in the phantom and similar to 35% in the brain). By comparison, excitation fidelity was effectively restored, and satisfactory flip angle uniformity was achieved when using the proposed method, with the CV value reduced to similar to 3% in the phantom and similar to 8% in the brain. Additionally, experimental results were in good agreement with the numerical predictions obtained from Bloch simulations. Slice-selective flip angle homogenization in the human brain at 9.4T using 16-channel 3D spoke pTX pulses is achievable despite of large eddy current induced excitation phase errors; correcting for the latter was critical in this success.	[Wu, Xiaoping; Adriany, Gregor; Ugurbil, Kamil; Van de Moortele, Pierre-Francois] Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Dept Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wu, XP (corresponding author), Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Dept Radiol, Minneapolis, MN 55455 USA.	xiaoping.wu2010@gmail.com	Wu, Xiaoping/K-5569-2012; Van de Moortele, Pierre-François/H-5087-2011; Ugurbil, Kamil/AAD-6058-2022; Adriany, Gregor/AAK-1323-2020; Adriany, Gregor/R-6656-2016	Wu, Xiaoping/0000-0001-6021-9088; Van de Moortele, Pierre-François/0000-0002-6941-5947; Adriany, Gregor/0000-0002-6428-9005	W.M. Keck Foundation; NIH NIBIB [P41 EB015894]; NIH [R01 EB006835, R01 EB007327, S10 RR25437, R21 EB009133]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, S10RR025437] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009133, R01EB006835, R01EB007327, P41EB015894] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the W.M. Keck Foundation, NIH NIBIB P41 EB015894 (previously NIH NCRR P41 RR008079), and NIH R01 EB006835, R01 EB007327, S10 RR25437, R21 EB009133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2009, P INT SOC MAG RESON, V17, P3005; Cloos MA, 2012, MAGN RESON MED, V67, P72, DOI 10.1002/mrm.22978; Deelchand DK, 2010, J MAGN RESON, V206, P74, DOI 10.1016/j.jmr.2010.06.006; Grissom W, 2006, MAGN RESON MED, V56, P620, DOI 10.1002/mrm.20978; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Papadakis NG, 2000, MAGNET RESON MED, V44, P616, DOI 10.1002/1522-2594(200010)44:4<616::AID-MRM16>3.0.CO;2-T; Sbrizzi A, 2012, MAGN RESON MED, V67, P824, DOI 10.1002/mrm.23049; Schneider JT, 2011, MAGN RESON MED, V65, P409, DOI 10.1002/mrm.22635; Setsompop K, 2008, MAGN RESON MED, V59, P908, DOI 10.1002/mrm.21513; Setsompop K, 2006, MAGN RESON MED, V56, P1163, DOI 10.1002/mrm.21042; Setsompop K, 2008, MAGN RESON MED, V60, P1422, DOI 10.1002/mrm.21739; Ullmann P, 2005, MAGNET RESON MED, V54, P994, DOI 10.1002/mrm.20646; Van de Moortele P-F, 2007, P INT SOC MAG RESON, V15, P1676; Wu X, 2010, P INT SOC MAG RESON, V18, P107; Wu X, 2011, P INT SOC MAG RESON, V19, P4441; Wu XP, 2010, J MAGN RESON, V205, P161, DOI 10.1016/j.jmr.2010.04.018; Wu XP, 2010, MAGN RESON MED, V63, P524, DOI 10.1002/mrm.22247; WYSONG RE, 1993, MAGNET RESON MED, V29, P119, DOI 10.1002/mrm.1910290121; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Zhang ZH, 2007, MAGN RESON MED, V57, P842, DOI 10.1002/mrm.21221; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78078	10.1371/journal.pone.0078078	http://dx.doi.org/10.1371/journal.pone.0078078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205098	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600069
J	Lai, LM; Wang, JJ; Tian, Y; Zhao, XC; Jiang, LH; Chen, X; Gao, Y; Wang, SM; Zheng, YR				Lai, Liming; Wang, Jianjian; Tian, Yuan; Zhao, Xuechun; Jiang, Lianhe; Chen, Xi; Gao, Yong; Wang, Shaoming; Zheng, Yuanrun			Organic Matter and Water Addition Enhance Soil Respiration in an Arid Region	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CARBON-DIOXIDE; CLIMATE-CHANGE; DESERT SHRUBS; ELEVATED CO2; DEPENDENCE; INCREASES; RESPONSES; DECOMPOSITION; FEEDBACKS	Climate change is generally predicted to increase net primary production, which could lead to additional C input to soil. In arid central Asia, precipitation has increased and is predicted to increase further. To assess the combined effects of these changes on soil CO2 efflux in arid land, a two factorial manipulation experiment in the shrubland of an arid region in northwest China was conducted. The experiment used a nested design with fresh organic matter and water as the two controlled parameters. It was found that both fresh organic matter and water enhanced soil respiration, and there was a synergistic effect of these two treatments on soil respiration increase. Water addition not only enhanced soil C emission, but also regulated soil C sequestration by fresh organic matter addition. The results indicated that the soil CO2 flux of the shrubland is likely to increase with climate change, and precipitation played a dominant role in regulating soil C balance in the shrubland of an arid region.	[Lai, Liming; Wang, Jianjian; Zhao, Xuechun; Jiang, Lianhe; Zheng, Yuanrun] Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, West China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China; [Wang, Jianjian] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tian, Yuan; Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Gao, Yong] Inner Mongolia Agr Univ, Hohhot, Inner Mongolia, Peoples R China; [Wang, Shaoming] Key Lab Oasis Ecol Agr Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Inner Mongolia Agricultural University	Zheng, YR (corresponding author), Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, West China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	liming, lai/HGB-0743-2022		China National Key Basic Research Program [2009CB825103, 2012CB956204]	China National Key Basic Research Program(National Basic Research Program of China)	This work was supported by China National Key Basic Research Program (2009CB825103, 2012CB956204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; GIFFORD RM, 1994, AUST J PLANT PHYSIOL, V21, P1, DOI 10.1071/PP9940001; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Graf A, 2008, BIOGEOSCIENCES, V5, P1175, DOI 10.5194/bg-5-1175-2008; Hanson PJ, 2003, ECOL STU AN, V166, P163; Hashimoto S, 2005, J FOREST RES-JPN, V10, P409, DOI 10.1007/s10310-005-0164-9; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jastrow JD, 2005, GLOBAL CHANGE BIOL, V11, P2057, DOI 10.1111/j.1365-2486.2005.01077.x; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Lai LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070224; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Lal R, 2009, LAND DEGRAD DEV, V20, P441, DOI 10.1002/ldr.934; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Y, 2006, SOIL RESP ENV, DOI DOI 10.1016/B978-0-12-088782-8; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Qian WH, 2001, CLIMATIC CHANGE, V50, P419, DOI 10.1023/A:1010673212131; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; SPSS, 2000, SPSS WIND VERS 13 0; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wilcox CS, 2004, J ARID ENVIRON, V56, P129, DOI 10.1016/S0140-1963(02)00324-5; Xiao CW, 2007, NEW PHYTOL, V174, P835, DOI 10.1111/j.1469-8137.2007.02054.x; [徐贵青 Xu Guiqing], 2004, [干旱区地理, Arid Land Geography], V27, P14; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zheng Y, 2006, J ARID ENVIRON, V66, P113, DOI 10.1016/j.jaridenv.2005.09.005; Zheng YR, 2010, ENVIRON EXP BOT, V68, P31, DOI 10.1016/j.envexpbot.2009.11.005	55	18	18	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77659	10.1371/journal.pone.0077659	http://dx.doi.org/10.1371/journal.pone.0077659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204907	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300109
J	Page, K; Guttery, DS; Zahra, N; Primrose, L; Elshaw, SR; Pringle, JH; Blighe, K; Marchese, SD; Hills, A; Woodley, L; Stebbing, J; Coombes, RC; Shaw, JA				Page, Karen; Guttery, David S.; Zahra, Nathalie; Primrose, Lindsay; Elshaw, Shona R.; Pringle, J. Howard; Blighe, Kevin; Marchese, Stephanie D.; Hills, Allison; Woodley, Laura; Stebbing, Justin; Coombes, R. Charles; Shaw, Jacqueline A.			Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids	PLOS ONE			English	Article							CANCER-PATIENTS; BREAST-CANCER; FREE DNA; MICRORNA; SERUM; EXPRESSION; QUANTIFICATION; FETAL	Circulating nucleic acids (CNAs) are under investigation as a liquid biopsy in cancer. However there is wide variation in blood processing and methods for isolation of circulating free DNA (cfDNA) and microRNAs (miRNAs). Here we compare the extraction efficiency and reproducibility of 4 commercially available kits for cfDNA and 3 for miRNA using spike-in of reference templates. We also compare the effects of increasing time between venepuncture and centrifugation and differential centrifugation force on recovery of CNAs. cfDNA was quantified by TaqMan qPCR and targeted deep sequencing. miRNA profiles were assessed with TaqMan low-density arrays and assays. The QIAamp (R) DNA Blood Mini and Circulating nucleic acid kits gave the highest recovery of cfDNA and efficient recovery (>90%) of a 564bp spike-in. Moreover, targeted sequencing revealed overlapping cfDNA profiles and variant depth, including detection of HER2 gene amplification, using the Ion AmpliSeq (TM) Cancer Hotspot Panel v2. Highest yields of miRNA and the synthetic Arabidopsis thaliana miR-159a spike-in were obtained using the miRNeasy Serum/Plasma kit, with saturation above 200 mu l of plasma. miRNA profiles showed significant variation with increasing time before centrifugation (p<0.001) and increasing centrifugation force, with depletion of platelet associated miRNAs, whereas cfDNA was unaffected. However, sample replicates showed excellent reproducibility on TaqMan low density arrays (rho = 0.96, p<0.0001). We also successfully generated miRNA profiles for plasma samples stored > 12 years, highlighting the potential for analysis of stored sample biobanks. In the era of the liquid biopsy, standardisation of methods is required to minimise variation, particularly for miRNA.	[Page, Karen; Guttery, David S.; Zahra, Nathalie; Primrose, Lindsay; Elshaw, Shona R.; Pringle, J. Howard; Blighe, Kevin; Shaw, Jacqueline A.] Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Marchese, Stephanie D.; Hills, Allison; Woodley, Laura; Stebbing, Justin; Coombes, R. Charles] ICTEM, Div Canc, London, England	University of Leicester	Shaw, JA (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England.	js39@le.ac.uk	Guttery, David/H-2011-2012	Guttery, David/0000-0003-0418-580X; Shaw, Jacqui/0000-0003-4227-503X; Blighe, Kevin/0000-0002-6322-6571; Page, Karen/0000-0003-0440-9244; Stebbing, Justin/0000-0002-1117-6947; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research UK Clinical and Translational Research Committee Programme Award [C14315/A13462X]; Roy Castle Lung Cancer Foundation [2012 08]; Maria Tilton Fellowship from Hope Against Cancer; Cancer Research UK [14549, 13462] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Cancer Research UK Clinical and Translational Research Committee Programme Award; Roy Castle Lung Cancer Foundation; Maria Tilton Fellowship from Hope Against Cancer; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Cancer Research UK Clinical and Translational Research Committee Programme Award (Grant number C14315/A13462X to JAS and RCC) and a Roy Castle Lung Cancer Foundation Project Grant (Grant number 2012 08 Shaw to JAS and JHP). SRE was supported by the Maria Tilton Fellowship from Hope Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No company was involved in the design, data collection, interpretation, or funding of this project.	Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jahr S, 2001, CANCER RES, V61, P1659; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Jorde Rolf, 2012, BMC Res Notes, V5, P245, DOI 10.1186/1756-0500-5-245; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhlmann JD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-325; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Page K, 2011, BRIT J CANCER, V104, P1342, DOI 10.1038/bjc.2011.89; Page K, 2006, ANN NY ACAD SCI, V1075, P313, DOI 10.1196/annals.1368.042; Patel RS, 2011, ARCH ORAL BIOL, V56, P1506, DOI 10.1016/j.archoralbio.2011.05.015; Schwarzenbach H, 2012, CLIN CANCER RES, V18, P5719, DOI 10.1158/1078-0432.CCR-12-0142; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Shaw JA, 2011, BIOMARK MED, V5, P87, DOI 10.2217/BMM.10.118; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Sozzi G, 2005, J NATL CANCER I, V97, P1848, DOI 10.1093/jnci/dji432; Su YH, 2008, ANN NY ACAD SCI, V1137, P197, DOI 10.1196/annals.1448.027; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539	31	128	134	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77963	10.1371/journal.pone.0077963	http://dx.doi.org/10.1371/journal.pone.0077963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205045	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300127
J	Taerum, SJ; Duong, TA; de Beer, ZW; Gillette, N; Sun, JH; Owen, DR; Wingfield, MJ				Taerum, Stephen J.; Duong, Tuan A.; de Beer, Z. Wilhelm; Gillette, Nancy; Sun, Jiang-Hua; Owen, Donald R.; Wingfield, Michael J.			Large Shift in Symbiont Assemblage in the Invasive Red Turpentine Beetle	PLOS ONE			English	Article							DENDROCTONUS BARK BEETLES; OPHIOSTOMATOID FUNGI; TOMICUS-PINIPERDA; PLANT INVASIONS; NORTH-AMERICA; VALENS COLEOPTERA; GENETIC-VARIATION; MYCANGIAL FUNGI; LODGEPOLE PINE; SP-NOV	Changes in symbiont assemblages can affect the success and impact of invasive species, and may provide knowledge regarding the invasion histories of their vectors. Bark beetle symbioses are ideal systems to study changes in symbiont assemblages resulting from invasions. The red turpentine beetle (Dendroctonus valens) is a bark beetle species that recently invaded China from its native range in North America. It is associated with ophiostomatalean fungi in both locations, although the fungi have previously been well-surveyed only in China. We surveyed the ophiostomatalean fungi associated with D. valens in eastern and western North America, and identified the fungal species using multi-gene phylogenies. From the 307 collected isolates (147 in eastern North America and 160 in western North America), we identified 20 species: 11 in eastern North America and 13 in western North America. Four species were shared between eastern North America and western North America, one species (Ophiostoma floccosum) was shared between western North America and China, and three species (Grosmannia koreana, Leptographium procerum, and Ophiostoma abietinum) were shared between eastern North America and China. Ophiostoma floccosum and O. abietinum have worldwide distributions, and were rarely isolated from D. valens. However, G. koreana and L. procerum are primarily limited to Asia and North America respectively. Leptographium procerum, which is thought to be native to North America, represented >45% of the symbionts of D. valens in eastern North America and China, suggesting D. valens may have been introduced to China from eastern North America. These results are surprising, as previous population genetics studies on D. valens based on the cytochrome oxidase I gene have suggested that the insect was introduced into China from western North America.	[Taerum, Stephen J.; Duong, Tuan A.; Wingfield, Michael J.] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [de Beer, Z. Wilhelm; Wingfield, Michael J.] Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [Gillette, Nancy] US Forest Serv, Pacific Southwest Res Stn, USDA, Albany, CA USA; [Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Owen, Donald R.] Calif Dept Forestry & Fire Protect, Redding, CA USA	University of Pretoria; University of Pretoria; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Sciences; Institute of Zoology, CAS; California Department of Forestry and Fire Protection	de Beer, ZW (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa.	Wilhelm.DeBeer@fabi.up.ac.za	Wingfield, Michael J/A-9473-2008; Duong, Tuan/I-9432-2012; de Beer, Z. Wilhelm/B-6353-2008; de Beer, Z. Wilhelm/O-3194-2019; de Beer, Wilhelm/AAK-9266-2020	Duong, Tuan/0000-0001-5110-1854; de Beer, Z. Wilhelm/0000-0001-9758-8987; de Beer, Z. Wilhelm/0000-0001-9758-8987; sun, jianghua/0000-0002-9465-3672	Tree Protection Cooperative Programme; USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA	Tree Protection Cooperative Programme; USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA	Funding came from Tree Protection Cooperative Programme http://www.fabinet.up.ac.za/research/tpcp, and the USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA http://www.fs.fed.us/wwetac/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2010, ENVIRON ENTOMOL, V39, P406, DOI 10.1603/EN09221; Alexander SA, 1988, LEPTOGRAPHIUM ROOT D, P97; Aschehoug ET, 2012, ECOLOGY, V93, P3, DOI 10.1890/11-1347.1; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Butin H., 1990, SYDOWIA, V42, P193; Cai Y, 2011, J APPL ENTOMOL, V135, P302, DOI 10.1111/j.1439-0418.2010.01545.x; Cai YW, 2008, INSECT SCI, V15, P291, DOI 10.1111/j.1744-7917.2008.00213.x; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; de Beer ZW, 2013, OPHIOSTOMATOID FUNGI, P21; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; DiGuistini S, 2007, FEMS MICROBIOL LETT, V267, P151, DOI 10.1111/j.1574-6968.2006.00565.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duong TA, 2012, MYCOLOGIA, V104, P715, DOI 10.3852/11-109; Erbilgin N, 2007, J CHEM ECOL, V33, P131, DOI 10.1007/s10886-006-9200-2; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Humble LM, 2006, CAN J PLANT PATHOL, V28, pS256, DOI 10.1080/07060660609507383; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Jacobs K, 2004, MYCOL RES, V108, P411, DOI 10.1017/S0953756204009748; Jacobs K, 2003, CAN J BOT, V81, P316, DOI [10.1139/B03-025, 10.1139/b03-025]; Jacobs K., 2001, LEPTOGRAPHIUM SPECIE; Jankowiak R, 2006, ANN FOREST SCI, V63, P801, DOI 10.1051/forest:2006063; Jankowiak R, 2012, DENDROBIOLOGY, V68, P43; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kim JJ, 2005, MYCOTAXON, V91, P481; Kim JJ, 2005, MYCOL RES, V109, P275, DOI 10.1017/S0953756204002060; Kirisits T, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P181, DOI 10.1007/978-1-4020-2241-8_10; Kirkendall LR, 2010, ZOOKEYS, P227, DOI 10.3897/zookeys.56.529; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; KLEPZIG KD, 1995, GREAT LAKES ENTOMOL, V28, P81; Knevel IC, 2004, OECOLOGIA, V141, P502, DOI 10.1007/s00442-004-1662-8; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Linnakoski R, 2012, ANTON LEEUW INT J G, V102, P375, DOI 10.1007/s10482-012-9747-6; Lombardero MJ, 2003, OIKOS, V102, P243, DOI 10.1034/j.1600-0706.2003.12599.x; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Lu M, 2009, FUNGAL DIVERS, V38, P133; Lu Q, 2008, MYCOLOGIA, V100, P275, DOI 10.3852/mycologia.100.2.275; Lu Q, 2009, ANTON LEEUW INT J G, V96, P275, DOI 10.1007/s10482-009-9343-6; Masuya H, 2005, MYCOTAXON, V94, P159; Masuya Hayato, 2000, Mycoscience, V41, P425, DOI 10.1007/BF02461660; Masuya H, 2009, MYCOSCIENCE, V50, P212, DOI 10.1007/s10267-008-0474-9; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Owen D.R., 2010, RED TURPENTINE BEETL; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PAJARES JA, 1990, ANN ENTOMOL SOC AM, V83, P171, DOI 10.1093/aesa/83.2.171; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Proctor HC, 2004, J PARASITOL, V90, P60, DOI 10.1645/GE-57R; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rambaut A., 2007, TRACER 1 4; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rudgers JA, 2005, OECOLOGIA, V144, P463, DOI 10.1007/s00442-005-0039-y; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Six DL, 2011, ANTON LEEUW INT J G, V100, P231, DOI 10.1007/s10482-011-9582-1; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2004, SYMBIOSIS, V37, P207; Six DL, 2003, CONT T ENT, P97; Six DL, 1999, ANN ENTOMOL SOC AM, V92, P159, DOI 10.1093/aesa/92.2.159; SPATAFORA JW, 1994, MYCOL RES, V98, P1, DOI 10.1016/S0953-7562(09)80327-4; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; Uchitel A, 2011, OECOLOGIA, V165, P465, DOI 10.1007/s00442-010-1740-z; US Department of Agriculture Forest Service, 2001, FED REGISTER, V66, P48361; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Whitney H.S., 1982, P183; WINGFIELD MJ, 1988, LEPTOGRAPHIUM ROOT D, P113; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Yamaoka Yuichi, 2007, Mycoscience, V48, P100, DOI 10.1007/s10267-006-0337-1; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; Zhou X.D., 2013, CBS KNAW FUNGAL BIOD, P91; Zhou XD, 2006, STUD MYCOL, P269, DOI 10.3114/sim.55.1.269; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109; Zipfel RD, 2006, STUD MYCOL, P75, DOI 10.3114/sim.55.1.75	94	47	47	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78126	10.1371/journal.pone.0078126	http://dx.doi.org/10.1371/journal.pone.0078126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205124	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300142
J	Takahashi, T; Kawakami, T; Mizuno, T; Minami, A; Uchida, Y; Saito, T; Matsui, S; Ogata, M; Usui, T; Sriwilaijaroen, N; Hiramatsu, H; Suzuki, Y; Suzuki, T				Takahashi, Tadanobu; Kawakami, Tatsuya; Mizuno, Takashi; Minami, Akira; Uchida, Yuko; Saito, Takehiko; Matsui, Shigeyuki; Ogata, Makoto; Usui, Taichi; Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo; Suzuki, Takashi			Sensitive and Direct Detection of Receptor Binding Specificity of Highly Pathogenic Avian Influenza A Virus in Clinical Samples	PLOS ONE			English	Article							CHEMOENZYMATIC SYNTHESIS; HEMAGGLUTININ; TRANSMISSION; GALACTOSE; ASSAY	Influenza A virus (IAV) recognizes two types of N-acetylneuraminic acid (Neu5Ac) by galactose (Gal) linkages, Neu5Ac alpha 2,3Gal and Neu5Ac alpha 2,6Gal. Avian IAV preferentially binds to Neu5Ac alpha 2,3Gal linkage, while human IAV preferentially binds to Neu5Ac alpha 2,6Gal linkage, as a virus receptor. Shift in receptor binding specificity of avian IAV from Neu5Ac alpha 2,3Gal linkage to Neu5Ac alpha 2,6Gal linkage is generally believed to be a critical factor for its transmission ability among humans. Surveillance of this shift of highly pathogenic H5N1 avian IAV (HPAI) is thought to be a very important for prediction and prevention of a catastrophic pandemic of HPAI among humans. In this study, we demonstrated that receptor binding specificity of IAV bound to sialo-glycoconjugates was sensitively detected by quantifying the HA gene with real-time reverse-transcription-PCR. The new assay enabled direct detection of receptor binding specificity of HPAIs in chicken clinical samples including trachea and cloaca swabs in only less than 4 h.	[Takahashi, Tadanobu; Kawakami, Tatsuya; Mizuno, Takashi; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Uchida, Yuko; Saito, Takehiko] Natl Agr & Food Res Org NARO, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan; [Uchida, Yuko; Saito, Takehiko] ZDCC, Bangkok, Thailand; [Matsui, Shigeyuki] Shizuoka Prefectural Livestock Inst, Swine & Poultry Res Ctr, Shizuoka, Japan; [Ogata, Makoto] Fukushima Natl Coll Technol, Dept Chem & Biochem, Iwaki, Fukushima, Japan; [Ogata, Makoto; Usui, Taichi] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka, Japan; [Usui, Taichi] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Pathum Thani, Thailand	University of Shizuoka; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Shizuoka University; Shizuoka University; Chubu University; Thammasat University	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	Suzukit@u-shizuoka-ken.ac.jp	Saito, Takehiko/AFM-3038-2022	Ogata, Makoto/0000-0002-8319-1265; Sriwilaijaroen, Nongluk/0000-0001-7351-6102; Yasuo, Suzuki/0000-0003-3518-5642	MEXT/JSPS KAKENHI Grant [23590549]; Ministry of Agriculture, Forestry and Fisheries; Grants-in-Aid for Scientific Research [23590549, 24790080] Funding Source: KAKEN	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by a MEXT/JSPS KAKENHI Grant (Number C; 23590549) and by a grant of Research and development projects for application in promoting new policy of Agriculture, Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hidari KIPJ, 2008, GLYCOBIOLOGY, V18, P779, DOI 10.1093/glycob/cwn067; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Ogata M, 2007, BIOORGAN MED CHEM, V15, P1383, DOI 10.1016/j.bmc.2006.11.006; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Suzuki T, 1997, FEBS LETT, V404, P192, DOI 10.1016/S0014-5793(97)00127-0; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; SUZUKI Y, 1992, VIROLOGY, V189, P121, DOI 10.1016/0042-6822(92)90687-K; Takahashi T, 2008, BIOCHEM BIOPH RES CO, V368, P550, DOI 10.1016/j.bbrc.2008.01.145; Takahashi T, 2012, FEBS OPEN BIO, V2, P261, DOI 10.1016/j.fob.2012.08.007; Takahashi T, 2009, FEBS LETT, V583, P3171, DOI 10.1016/j.febslet.2009.08.037; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Uchida Y, 2012, VIRUS RES, V170, P109, DOI 10.1016/j.virusres.2012.09.004; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	24	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78125	10.1371/journal.pone.0078125	http://dx.doi.org/10.1371/journal.pone.0078125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205123	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300141
J	Rogowski, A; Basle, A; Farinas, CS; Solovyova, A; Mortimer, JC; Dupree, P; Gilbert, HJ; Bolam, DN				Rogowski, Artur; Basle, Arnaud; Farinas, Cristiane S.; Solovyova, Alexandra; Mortimer, Jennifer C.; Dupree, Paul; Gilbert, Harry J.; Bolam, David N.			Evidence That GH115 alpha-Glucuronidase Activity, Which Is Required to Degrade Plant Biomass, Is Dependent on Conformational Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Enzyme Structure; Glycoside Hydrolases; Plant Cell Wall; X-ray Crystallography	CARBOHYDRATE-BINDING MODULES; STRUCTURAL BASIS; FAMILY; SUBSTRATE; POLYSACCHARIDE; BIOCHEMISTRY; RECOGNITION; SPECIFICITY; XYLANASE; REVEALS	The microbial degradation of the plant cell wall is an important biological process that is highly relevant to environmentally significant industries such as the bioenergy and biorefining sectors. A major component of the wall is glucuronoxylan, a 1,4-linked xylose polysaccharide that is decorated with -linked glucuronic and/or methylglucuronic acid (GlcA/MeGlcA). Recently three members of a glycoside hydrolase family, GH115, were shown to hydrolyze MeGlcA side chains from the internal regions of xylan, an activity that has not previously been described. Here we show that a dominant member of the human microbiota, Bacteroides ovatus, contains a GH115 enzyme, BoAgu115A, which displays glucuronoxylan -(4-O-methyl)-glucuronidase activity. The enzyme is significantly more active against substrates in which the xylose decorated with GlcA/MeGlcA is flanked by one or more xylose residues. The crystal structure of BoAgu115A revealed a four-domain protein in which the active site, comprising a pocket that abuts a cleft-like structure, is housed in the second domain that adopts a TIM barrel-fold. The third domain, a five-helical bundle, and the C-terminal -sandwich domain make inter-chain contacts leading to protein dimerization. Informed by the structure of the enzyme in complex with GlcA in its open ring form, in conjunction with mutagenesis studies, the potential substrate binding and catalytically significant amino acids were identified. Based on the catalytic importance of residues located on a highly flexible loop, the enzyme is required to undergo a substantial conformational change to form a productive Michaelis complex with glucuronoxylan.	[Rogowski, Artur; Basle, Arnaud; Solovyova, Alexandra; Gilbert, Harry J.; Bolam, David N.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Farinas, Cristiane S.; Mortimer, Jennifer C.; Dupree, Paul] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Newcastle University - UK; University of Cambridge	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk; david.bolam@ncl.ac.uk	Farinas, Cristiane/B-2576-2014; Mortimer, Jenny/A-8043-2008; Dupree, Paul/T-2568-2018; Mortimer, Jenny C/AAY-6648-2021	Farinas, Cristiane/0000-0002-9985-190X; Mortimer, Jenny/0000-0001-6624-636X; Dupree, Paul/0000-0001-9270-6286; Mortimer, Jenny C/0000-0001-6624-636X; Bolam, David/0000-0003-0314-3122; Solovyova, Alexandra/0000-0002-5682-7037; Basle, Arnaud/0000-0002-4899-3086	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G016240/1]; BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme; Wellcome Trust [WT097907MA]; Biotechnology and Biological Sciences Research Council [BB/G016186/1, BB/G016240/1] Funding Source: researchfish; BBSRC [BB/G016240/1, BB/G016186/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G016240/1 BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme and Wellcome Trust Grant WT097907MA.	BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brett C. T., 1996, TPOICS PLANT FUNCTIO; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujimoto Z, 2011, ACTA CRYSTALLOGR F, V67, P68, DOI 10.1107/S1744309110043721; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kolenova K, 2010, FEBS LETT, V584, P4063, DOI 10.1016/j.febslet.2010.08.031; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Nagy T, 2003, J BIOL CHEM, V278, P20286, DOI 10.1074/jbc.M302205200; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vardakou M, 2008, J MOL BIOL, V375, P1293, DOI 10.1016/j.jmb.2007.11.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	42	43	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					53	64		10.1074/jbc.M113.525295	http://dx.doi.org/10.1074/jbc.M113.525295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214982	hybrid, Green Published			2022-12-25	WOS:000329370900005
J	Hotzy, J; Schneider, N; Kovermann, P; Fahlke, C				Hotzy, Jasmin; Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph			Mutating a Conserved Proline Residue within the Trimerization Domain Modifies Na+ Binding to Excitatory Amino Acid Transporters and Associated Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Ataxia; Glutamate; Neurological Diseases; Neurotransmitter Transport; Voltage Clamp Fluorometry	NEURONAL GLUTAMATE TRANSPORTER; ANION CHANNELS; EPISODIC ATAXIA; SUBSTRATE; EAAC1; CURRENTS; SODIUM; TRANSLOCATION; MECHANISM; CYCLE	Background: The mutation P290R in the excitatory amino acid transporter 1 (EAAT1) causes episodic ataxia type 6. Results: Voltage clamp fluorometry demonstrates changes in the time course of EAAT3 fluorescence signals by the homologous P259R mutation. Conclusion: P259R alters EAAT3 transport functions by decelerating conformational changes associated with sodium binding. Significance: Studying naturally occurring mutations promises identification of unexpected determinants of transporter functions. Excitatory amino acid transporters (EAATs) are crucial for glutamate homeostasis in the mammalian central nervous system. They are not only secondary active glutamate transporters but also function as anion channels, and different EAATs vary considerably in glutamate transport rates and associated anion current amplitudes. A naturally occurring mutation, which was identified in a patient with episodic ataxia type 6 and that predicts the substitution of a highly conserved proline at position 290 by arginine (P290R), was recently shown to reduce glutamate uptake and to increase anion conduction by hEAAT1. We here used voltage clamp fluorometry to define how the homologous P259R mutation modifies the functional properties of hEAAT3. P259R inverts the voltage dependence, changes the sodium dependence, and alters the time dependence of hEAAT3 fluorescence signals. Kinetic analysis of fluorescence signals indicate that P259R decelerates a conformational change associated with sodium binding to the glutamate-free mutant transporters. This alteration in the glutamate uptake cycle accounts for the experimentally observed changes in glutamate transport and anion conduction by P259R hEAAT3.	[Hotzy, Jasmin; Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52428 Julich, Germany; [Schneider, Nicole; Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover, D-30559 Hannover, Germany	Hannover Medical School; Helmholtz Association; Research Center Julich	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, Wilhelm Johnen Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de	Kovermann, Peter/AAF-4411-2020; Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/9 to C. F.).	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hotzy J, 2012, J BIOL CHEM, V287, P20016, DOI 10.1074/jbc.M112.344077; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	29	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36492	36501		10.1074/jbc.M113.489385	http://dx.doi.org/10.1074/jbc.M113.489385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214974	hybrid, Green Published			2022-12-25	WOS:000328883400030
J	Huang, X; Pan, QM; Sun, DN; Chen, W; Shen, AJ; Huang, M; Ding, J; Geng, MY				Huang, Xun; Pan, Qiuming; Sun, Danni; Chen, Wei; Shen, Aijun; Huang, Min; Ding, Jian; Geng, Meiyu			O-GlcNAcylation of Cofilin Promotes Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Cell Motility; Cofilin; O-GlcNAcylation; Invadopodia; OGT	N-ACETYLGLUCOSAMINE; PHOSPHORYLATION; METASTASIS; GLCNAC; ADF/COFILIN; MIGRATION; DYNAMICS; GROWTH; SENSOR	Background:O-GlcNAcylation plays important roles in breast cancer metastasis, but the underlying mechanism is not fully known. Results: Cofilin is O-GlcNAcylated at Ser-108, which is required for its proper localization in invadopodia and is implicated in promoting breast cancer cell invasion. Conclusion:O-GlcNAcylation plays an important role in fine-tuning the regulation of cofilin. Significance: These findings reveal the implications of aberrant cofilin O-GlcNAcylation in cancer metastasis. O-GlcNAcylation is a post-translational modification that regulates a broad range of nuclear and cytoplasmic proteins and is emerging as a key regulator of various biological processes. Previous studies have shown that increased levels of global O-GlcNAcylation and O-GlcNAc transferase (OGT) are linked to the incidence of metastasis in breast cancer patients, but the molecular basis behind this is not fully known. In this study, we have determined that the actin-binding protein cofilin is O-GlcNAcylated by OGT and mainly, if not completely, mediates OGT modulation of cell mobility. O-GlcNAcylation at Ser-108 of cofilin is required for its proper localization in invadopodia at the leading edge of breast cancer cells during three-dimensional cell invasion. Loss of O-GlcNAcylation of cofilin leads to destabilization of invadopodia and impairs cell invasion, although the actin-severing activity or lamellipodial localization is not affected. Our study provides insights into the mechanism of post-translational modification in fine-tuning the regulation of cofilin activity and suggests its important implications in cancer metastasis.	[Huang, Xun; Pan, Qiuming; Sun, Danni; Shen, Aijun; Huang, Min; Ding, Jian; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China; [Chen, Wei] China Pharmaceut Univ, Ctr Drug Discovery, State Key Lab Nat Med, Nanjing 210009, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; China Pharmaceutical University	Ding, J (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China.	jding@simm.ac.cn; mygeng@simm.ac.cn	Huang, xun/AAM-3093-2020		Natural Science Foundation of China [81021062]; National Natural Science Foundation of China [91229204, 81302791]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China for Innovation Research Group Grant 81021062 and National Natural Science Foundation of China Grants 91229204 and 81302791.	Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carrillo LD, 2011, J BIOL CHEM, V286, P6650, DOI 10.1074/jbc.M110.191627; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Li R, 2013, CLIN EXP METASTAS, V30, P483, DOI 10.1007/s10585-012-9553-6; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; McConnell BV, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-75; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	35	51	53	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36418	36425		10.1074/jbc.M113.495713	http://dx.doi.org/10.1074/jbc.M113.495713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214978	Green Published, hybrid			2022-12-25	WOS:000328883400023
J	Humann, FC; Tiberio, GJ; Hartfelder, K				Humann, Fernanda C.; Tiberio, Gustavo J.; Hartfelder, Klaus			Sequence and Expression Characteristics of Long Noncoding RNAs in Honey Bee Caste Development - Potential Novel Regulators for Transgressive Ovary Size	PLOS ONE			English	Article							APIS-MELLIFERA; JUVENILE-HORMONE; OVARIOLE NUMBER; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CELL-DEATH; EVOLUTION; LARVAL; IDENTIFICATION; TRANSCRIPTION	Division of labor in social insect colonies relies on a strong reproductive bias that favors queens. Although the ecological and evolutionary success attained through caste systems is well sketched out in terms of ultimate causes, the molecular and cellular underpinnings driving the development of caste phenotypes are still far from understood. Recent genomics approaches on honey bee developmental biology revealed a set of genes that are differentially expressed genes in larval ovaries and associated with transgressive ovary size in queens and massive cell death in workers. Amongst these, two contigs called special attention, both being over 200 bp in size and lacking apparent coding potential. Herein, we obtained their full cDNA sequences. These and their secondary structure characteristics placed in evidence that they are bona fide long noncoding RNAs (lncRNA) differentially expressed in larval ovaries, thus named lncov1 and lncov2. Genomically, both map within a previously identified QTL on chromosome 11, associated with transgressive ovary size in honey bee workers. As lncov1 was over-expressed in worker ovaries we focused on this gene. Real-time qPCR analysis on larval worker ovaries evidenced an expression peak coinciding with the onset of autophagic cell death. Cellular localization analysis through fluorescence in situ hybridization revealed perinuclear spots resembling omega speckles known to regulate trafficking of RNA-binding proteins. With only four lncRNAs known so far in honey bees, two expressed in the ovaries, these findings open a novel perspective on regulatory factors acting in the fine tuning of developmental processes underlying phenotypic plasticity related to social life histories.	[Humann, Fernanda C.; Tiberio, Gustavo J.; Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Humann, FC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil.	fchumann@gmail.com	Hartfelder, Klaus/L-2300-2019; Hartfelder, Klaus/A-4293-2009	Hartfelder, Klaus/0000-0001-7981-8427; Hartfelder, Klaus/0000-0001-7981-8427	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03171-5, 2012/01808-9, FAPESP 2006/06521-9, FAPESP 2011/15810-2]; Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP [FAPESP 2004/08868-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, projects 2011/03171-5, and 2012/01808-9), fellowships to FCH (FAPESP 2006/06521-9) and GJT (FAPESP 2011/15810-2), Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP for granting use of its confocal microcopy facility (FAPESP 2004/08868-0). The funders had no role in study design, data collection and analisys, decision to publish, or preparation of the manuscript.	ASENCOT M, 1985, COMP BIOCHEM PHYS A, V81, P203, DOI 10.1016/0300-9629(85)90289-0; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Buning J., 1994, INSECT OVARY ULTRAST; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Colonello-Frattini NA, 2009, APIDOLOGIE, V40, P481, DOI 10.1051/apido/2009009; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Durham AM, 2005, BIOINFORMATICS, V21, P2812, DOI 10.1093/bioinformatics/bti424; Elsik CG, 2006, GENOME RES, V16, P1329, DOI 10.1101/gr.5580606; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; GODT D, 1995, DEVELOPMENT, V121, P173; Graham AM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-95; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hartfelder K, 1997, INVERTEBR REPROD DEV, V31, P237, DOI 10.1080/07924259.1997.9672582; Hodin J., 2009, PHENOTYPIC PLASTICIT, P423, DOI DOI 10.1201/B10201-12; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Humann FC, 2011, INSECT BIOCHEM MOLEC, V41, P602, DOI 10.1016/j.ibmb.2011.03.013; Jung CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-77; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kiya T, 2012, INT J MOL SCI, V13, P15496, DOI 10.3390/ijms131215496; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135; Leimar O, 2012, ECOL EVOL, V3, pe414; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Linksvayer TA, 2009, GENETICS, V183, P693, DOI 10.1534/genetics.109.105452; Liu F, 2011, J INSECT PHYSIOL, V57, P274, DOI 10.1016/j.jinsphys.2010.11.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Ma HD, 2012, SCI WORLD J, DOI 10.1100/2012/541786; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Mallik M, 2009, GENETICS, V183, P831, DOI 10.1534/genetics.109.108571; Mattick JS, 2011, BIOCHIMIE, V93, P8; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Onorati MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002096; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; RAO JP, 1988, BIOCHIM BIOPHYS ACTA, V950, P30, DOI 10.1016/0167-4781(88)90070-X; Reginato RD, 2002, CELL BIOL INT, V26, P243, DOI 10.1006/cbir.2001.0839; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sarikaya DP, 2012, DEV BIOL, V363, P279, DOI 10.1016/j.ydbio.2011.12.017; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Sawata M, 2004, RNA, V10, P1047, DOI 10.1261/rna.5231504; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Snodgras RE, 1956, ANATOMY HONEY BEE; Ulveling D, 2011, BIOCHIMIE, V93, P633, DOI 10.1016/j.biochi.2010.11.004; Wayne ML, 1997, EVOLUTION, V51, P1156, DOI 10.1111/j.1558-5646.1997.tb03963.x; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Zander E., 1916, Z ANGEW ENTOMOL, V3, P1, DOI DOI 10.1111/J.1439-0418.1916.TB00552.X	72	44	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78915	10.1371/journal.pone.0078915	http://dx.doi.org/10.1371/journal.pone.0078915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205350	Green Submitted, gold, Green Published			2022-12-25	WOS:000326373800025
J	Chan, JK; Bhattacharyya, D; Lassen, KG; Ruelas, D; Greene, WC				Chan, Jonathan K.; Bhattacharyya, Darshana; Lassen, Kara G.; Ruelas, Debbie; Greene, Warner C.			Calcium/Calcineurin Synergizes with Prostratin to Promote NF-kappa B Dependent Activation of Latent HIV	PLOS ONE			English	Article							T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-KINASE-C; ANTIRETROVIRAL THERAPY; GENE-EXPRESSION; NUCLEAR-FACTOR; CALCINEURIN; INFECTION; REPLICATION; LYMPHOCYTES	Attempts to eradicate HIV have been thwarted by the persistence of a small pool of quiescent memory CD4 T cells that harbor a transcriptionally silent, integrated form of the virus that can produce infectious virions following an anamnestic immune response. Transcription factors downstream of T-cell receptor activation, such as NF-kappa B/Rel and nuclear factor of activated T cells (NFAT) transcription members, are considered important regulators of HIV transcription during acute HIV infection. We now report studies exploring their precise role as antagonists of HIV latency using cell and primary CD4 T cell models of HIV-1 latency. Surprisingly, RNA interference studies performed in J-Lat CD4 T cells suggested that none of the NFATs, including NFATc1, NFATc2, NFATc3, and NFAT5, played a key role in the reactivation of latent HIV. However, cyclosporin A markedly inhibited the reactivation response. These results were reconciled when calcium signaling through calcineurin was shown to potentiate prostratin induced activation of NF-kappa B that in turn stimulated the latent HIV long terminal repeat (LTR). Similar effects of calcineurin were confirmed in a primary CD4 T cell model of HIV latency. These findings highlight an important role for calcineurin in NF-kappa B-dependent induction of latent HIV transcription. Innovative approaches exploiting the synergistic actions of calcineurin and prostratin in the absence of generalized T-cell activation merit exploration as a means to attack the latent viral reservoir.	[Chan, Jonathan K.; Bhattacharyya, Darshana; Lassen, Kara G.; Ruelas, Debbie; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	wgreene@gladstone.ucsf.edu			National Institutes of Health [P01 AI058708, P01 AI083050, P01 HD40543, R01 A065329, R01 MH064396, R21 AI080409]; University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS [P30 AI027763]; Arthritis Foundation [2PD-CHA-JO-A-8]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, P30AI027763, R21AI080409, P01AI083050, P01AI058708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS; Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants P01 AI058708, P01 AI083050. P01 HD40543, R01 A065329, R01 MH064396, and R21 AI080409 and by University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research grant P30 AI027763. Jonathan Chan was supported by an Arthritis Foundation Postdoctoral Fellowship (2PD-CHA-JO-A-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kanno T, 1996, J IMMUNOL, V157, P5277; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Oruganti SR, 2011, MOL IMMUNOL, V48, P1448, DOI 10.1016/j.molimm.2011.03.020; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106; Zhang MC, 2012, J IMMUNOL, V189, P2746, DOI 10.4049/jimmunol.1103129; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77749	10.1371/journal.pone.0077749	http://dx.doi.org/10.1371/journal.pone.0077749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204950	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500054
J	Reinhard, F; van der Meer, JR				Reinhard, Friedrich; van der Meer, Jan Roelof			Improved Statistical Analysis of Low Abundance Phenomena in Bimodal Bacterial Populations	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; SINGLE-CELL ANALYSIS; CLC GENOMIC ISLAND; BACILLUS-SUBTILIS; HETEROGENEITY; SPORULATION; ELEMENT; BISTABILITY; COLI; INDIVIDUALITY	Accurate detection of subpopulation size determinations in bimodal populations remains problematic yet it represents a powerful way by which cellular heterogeneity under different environmental conditions can be compared. So far, most studies have relied on qualitative descriptions of population distribution patterns, on population-independent descriptors, or on arbitrary placement of thresholds distinguishing biological ON from OFF states. We found that all these methods fall short of accurately describing small population sizes in bimodal populations. Here we propose a simple, statistics-based method for the analysis of small subpopulation sizes for use in the free software environment R and test this method on real as well as simulated data. Four so-called population splitting methods were designed with different algorithms that can estimate subpopulation sizes from bimodal populations. All four methods proved more precise than previously used methods when analyzing subpopulation sizes of transfer competent cells arising in populations of the bacterium Pseudomonas knackmussii B13. The methods' resolving powers were further explored by bootstrapping and simulations. Two of the methods were not severely limited by the proportions of subpopulations they could estimate correctly, but the two others only allowed accurate subpopulation quantification when this amounted to less than 25% of the total population. In contrast, only one method was still sufficiently accurate with subpopulations smaller than 1% of the total population. This study proposes a number of rational approximations to quantifying small subpopulations and offers an easy-to-use protocol for their implementation in the open source statistical software environment R.	[Reinhard, Friedrich; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	van der Meer, JR (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012	van der Meer, Jan Roelof/0000-0003-1485-3082	Swiss National Science Foundation [3100A0-108199/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation under contract: 3100A0-108199/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bates D, 2005, MOL MICROBIOL, V57, P380, DOI 10.1111/j.1365-2958.2005.04693.x; Bonifield HR, 2003, J BACTERIOL, V185, P3567, DOI 10.1128/JB.185.12.3567-3574.2003; Button DK, 2001, APPL ENVIRON MICROB, V67, P1636, DOI 10.1128/AEM.67.4.1636-1645.2001; Canty A, 2009, BOOT BOOTSTRAP R S P; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chastanet A, 2010, P NATL ACAD SCI USA, V107, P8486, DOI 10.1073/pnas.1002499107; Choonpradub C., 2005, SONGKLANAKARIN J SCI, V27, P649; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Cozy LM, 2010, MOL MICROBIOL, V76, P273, DOI 10.1111/j.1365-2958.2010.07112.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Davison AC, 1997, BOOTSTRAP METHODS TH; de Jong IG, 2012, ENVIRON MICROBIOL, V14, P3110, DOI 10.1111/j.1462-2920.2012.02892.x; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; de Jong IG, 2010, J BACTERIOL, V192, P2053, DOI 10.1128/JB.01484-09; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gaillard M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-153; Gerhardt P, 1981, MANUAL METHODS GEN B; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/NCHEMBIO.436, 10.1038/nchembio.436]; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; MacArthur BD, 2006, J R SOC INTERFACE, V3, P63, DOI 10.1098/rsif.2005.0080; Minoia M, 2008, P NATL ACAD SCI USA, V105, P20792, DOI 10.1073/pnas.0806164106; Miyazaki R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002818; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ptashne M, 2006, CURR BIOL, V16, pR459, DOI 10.1016/j.cub.2006.05.037; R Development Core Team R, 2009, R LANG ENV STAT COMP; Ravatn R, 1998, J BACTERIOL, V180, P4360, DOI 10.1128/JB.180.17.4360-4369.1998; Ravatn R, 1998, J BACTERIOL, V180, P5505, DOI 10.1128/JB.180.21.5505-5514.1998; Reinhard F, 2013, CURR BIOL, V23, P255, DOI 10.1016/j.cub.2012.12.025; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Sarkar D., 2009, LATTICE LATTICE GRAP; Sentchilo V, 2003, J BACTERIOL, V185, P4530, DOI 10.1128/JB.185.15.4530-4538.2003; Sentchilo V, 2003, MOL MICROBIOL, V49, P93, DOI 10.1046/j.1365-2958.2003.03548.x; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Strovas TJ, 2009, MICROBIOL-SGM, V155, P2040, DOI 10.1099/mic.0.025890-0; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tecon R, 2006, ENVIRON MICROBIOL, V8, P697, DOI 10.1111/j.1462-2920.2005.00948.x; Tecon R, 2012, ENVIRON MICROBIOL, V14, P1325, DOI 10.1111/j.1462-2920.2012.02715.x; Tukey JW, 1977, EXPLORATORY DATA ANA; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045	61	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78288	10.1371/journal.pone.0078288	http://dx.doi.org/10.1371/journal.pone.0078288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205184	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500109
J	Sarsam, M; Parkes, LM; Roberts, N; Reid, GS; Kinderman, P				Sarsam, May; Parkes, Laura M.; Roberts, Neil; Reid, Graeme S.; Kinderman, Peter			The Queen and I: Neural Correlates of Altered Self-Related Cognitions in Major Depressive Episode	PLOS ONE			English	Article							BRAIN GLUCOSE-METABOLISM; PAROXETINE; THERAPY	Background: Pervasive negative thoughts about the self are central to the experience of depression. Brain imaging studies in the general population have localised self-related cognitive processing to areas of the medial pre-frontal cortex. Aims: To use fMRI to compare the neural correlates of self-referential processing in depressed and non-depressed participants. Method: Cross-sectional comparison of regional activation using Blood Oxygen Level Dependent (BOLD) fMRI in 13 non-medicated participants with major depressive episode and 14 comparison participants, whilst carrying out a self-referential cognitive task. Results: Both groups showed significant activation of the dorsomedial pre-frontal cortex and posterior cingulate cortex in the 'self-referent' condition. The depressed group showed significantly greater activation in the medial superior frontal cortex during the self-referent task. No difference was observed between groups in the 'other-referent' condition. Conclusions: Major depressive episode is associated with specific neurofunctional changes related to self-referential processing.	[Sarsam, May; Kinderman, Peter] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Parkes, Laura M.] Univ Manchester, Inst Populat Hlth, Ctr Imaging Sci, Manchester, Lancs, England; [Roberts, Neil] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Reid, Graeme S.] Univ Lancaster, Div Hlth Res, Lancaster, England	University of Liverpool; University of Manchester; University of Edinburgh; Lancaster University	Kinderman, P (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	p.kinderman@liverpool.ac.uk	Reid, Graeme Stewart/AAG-5241-2019	Reid, Graeme Stewart/0000-0002-2869-787X; Parkes, Laura/0000-0001-6488-507X	University of Liverpool	University of Liverpool	The project was fully funded by the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Beck AT, 1996, PSYCHOL ASSESS; Brewin CR, 1996, ANNU REV PSYCHOL, V47, P33, DOI 10.1146/annurev.psych.47.1.33; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Colombo A, 2003, SOC SCI MED, V56, P1557, DOI 10.1016/S0277-9536(02)00156-9; Department of Health, 2005, NEW WAYS WORK PSYCH; First M. B., 1997, STRUCTURED CLIN INTE; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kinderman P, 2005, HARVARD REV PSYCHIAT, V13, P206, DOI 10.1080/10673220500243349; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Lemogne C, 2011, SOC COGN AFFECT NEUR, V6, P426, DOI 10.1093/scan/nsq049; Lemogne C, 2010, J AFFECT DISORDERS, V124, P196, DOI 10.1016/j.jad.2009.11.003; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Murphy FC, 2003, PSYCHOL MED, V33, P455, DOI 10.1017/S0033291702007018; Nelson HE., 1982, NATL ADULT READING T; Neurobehavioural Systems Inc, 2001, PRES VERS 9 5; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Yoshimura S, 2013, SOCIAL COGNITIVE AFF; Yoshimura S, 2010, J AFFECT DISORDERS, V122, P76, DOI 10.1016/j.jad.2009.06.017	32	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78844	10.1371/journal.pone.0078844	http://dx.doi.org/10.1371/journal.pone.0078844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205330	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500136
J	Bailis, JM; Gordon, ML; Gurgel, JL; Komor, AC; Barton, JK; Kirsch, IR				Bailis, Julie M.; Gordon, Marcia L.; Gurgel, Jesse L.; Komor, Alexis C.; Barton, Jacqueline K.; Kirsch, Ilan R.			An Inducible, Isogenic Cancer Cell Line System for Targeting the State of Mismatch Repair Deficiency	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; TUMOR-CELLS; RHODIUM METALLOINSERTORS; COLORECTAL-CANCER; EMBRYONIC FIBROBLASTS; SELECTIVELY LETHAL; DRUG-RESISTANCE; LUNG-CANCER; DNA-DAMAGE; MSH2	The DNA mismatch repair system (MMR) maintains genome stability through recognition and repair of single-base mismatches and small insertion-deletion loops. Inactivation of the MMR pathway causes microsatellite instability and the accumulation of genomic mutations that can cause or contribute to cancer. In fact, 10-20% of certain solid and hematologic cancers are MMR-deficient. MMR-deficient cancers do not respond to some standard of care chemotherapeutics because of presumed increased tolerance of DNA damage, highlighting the need for novel therapeutic drugs. Toward this goal, we generated isogenic cancer cell lines for direct comparison of MMR-proficient and MMR-deficient cells. We engineered NCI-H23 lung adenocarcinoma cells to contain a doxycycline-inducible shRNA designed to suppress the expression of the mismatch repair gene MLH1, and compared single cell subclones that were uninduced (MLH1-proficient) versus induced for the MLH1 shRNA (MLH1-deficient). Here we present the characterization of these MMR-inducible cell lines and validate a novel class of rhodium metalloinsertor compounds that differentially inhibit the proliferation of MMR-deficient cancer cells.	[Bailis, Julie M.] Amgen Inc, Oncol Res, San Francisco, CA USA; [Gordon, Marcia L.; Gurgel, Jesse L.; Kirsch, Ilan R.] Amgen Inc, Oncol Res, Seattle, WA USA; [Komor, Alexis C.; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Amgen; Amgen; California Institute of Technology	Bailis, JM (corresponding author), Amgen Inc, Oncol Res, San Francisco, CA USA.	jbailis@amgen.com		Komor, Alexis/0000-0001-5043-0998	NIH [GM33309]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033309, R01GM033309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the NIH (GM33309 to J.K.B.) and NSF (fellowship to A. C. K.) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AHK, 2011, MOL CARCINOGEN, V50, P89, DOI 10.1002/mc.20697; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Campbell MR, 2006, ONCOGENE, V25, P2531, DOI 10.1038/sj.onc.1209277; Castagnaro A, 2007, EXP LUNG RES, V33, P289, DOI 10.1080/01902140701539687; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Davis TW, 1998, CANCER RES, V58, P767; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Ernst RJ, 2011, BIOCHEMISTRY-US, V50, P10919, DOI 10.1021/bi2015822; Ernst RJ, 2009, J AM CHEM SOC, V131, P2359, DOI 10.1021/ja8081044; Fink D, 1998, CLIN CANCER RES, V4, P1; Hart JR, 2006, P NATL ACAD SCI USA, V103, P15359, DOI 10.1073/pnas.0607576103; Hewish M, 2013, BRIT J CANCER, V108, P983, DOI 10.1038/bjc.2013.3; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kawaguchi M, 2009, INT J ONCOL, V35, P977, DOI 10.3892/ijo_00000411; KOI M, 1994, CANCER RES, V54, P4308; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Komor AC, 2013, CHEM COMMUN, V49, P3617, DOI 10.1039/c3cc00177f; Komor AC, 2012, J AM CHEM SOC, V134, P19223, DOI 10.1021/ja3090687; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lawes DA, 2003, EUR J SURG ONCOL, V29, P201, DOI 10.1053/ejso.2002.1399; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Martin SA, 2011, CANCER RES, V71, P1836, DOI 10.1158/0008-5472.CAN-10-2836; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Rabinovich B, 2006, IMMUNOGENETICS, V58, P81, DOI 10.1007/s00251-005-0078-x; Reitmair AH, 1997, CANCER RES, V57, P3765; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Roschke AV, 2005, P NATL ACAD SCI USA, V102, P2964, DOI 10.1073/pnas.0405578102; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Umar A, 1997, CANCER RES, V57, P3949; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Vilar E, 2009, CLIN CANCER RES, V15, P2829, DOI 10.1158/1078-0432.CCR-08-2432; Yasin SL, 2011, INT J ONCOL, V39, P719, DOI 10.3892/ijo.2011.1065	45	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78726	10.1371/journal.pone.0078726	http://dx.doi.org/10.1371/journal.pone.0078726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205301	Green Published, Green Accepted, gold			2022-12-25	WOS:000326270700095
J	Serao, NVL; Gonzalez-Pena, D; Beever, JE; Bollero, GA; Southey, BR; Faulkner, DB; Rodriguez-Zas, SL				Serao, Nick V. L.; Gonzalez-Pena, Dianelys; Beever, Jonathan E.; Bollero, German A.; Southey, Bruce R.; Faulkner, Daniel B.; Rodriguez-Zas, Sandra L.			Bivariate Genome-Wide Association Analysis of the Growth and Intake Components of Feed Efficiency	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; CARCASS TRAITS; BOVINE CHROMOSOME-5; COMMERCIAL LINES; HORMONE RECEPTOR; BODY-WEIGHT; GENE; IDENTIFICATION; MULTIVARIATE	Single nucleotide polymorphisms (SNPs) associated with average daily gain (ADG) and dry matter intake (DMI), two major components of feed efficiency in cattle, were identified in a genome-wide association study (GWAS). Uni- and multi-SNP models were used to describe feed efficiency in a training data set and the results were confirmed in a validation data set. Results from the univariate and bivariate analyses of ADG and DMI, adjusted by the feedlot beef steer maintenance requirements, were compared. The bivariate uni-SNP analysis identified (P-value <0.0001) 11 SNPs, meanwhile the univariate analyses of ADG and DMI identified 8 and 9 SNPs, respectively. Among the six SNPs confirmed in the validation data set, five SNPs were mapped to KDELC2, PHOX2A, and TMEM40. Findings from the uni-SNP models were used to develop highly accurate predictive multi-SNP models in the training data set. Despite the substantially smaller size of the validation data set, the training multi-SNP models had slightly lower predictive ability when applied to the validation data set. Six Gene Ontology molecular functions related to ion transport activity were enriched (P-value <0.001) among the genes associated with the detected SNPs. The findings from this study demonstrate the complementary value of the uni- and multi-SNP models, and univariate and bivariate GWAS analyses. The identified SNPs can be used for genome-enabled improvement of feed efficiency in feedlot beef cattle, and can aid in the design of empirical studies to further confirm the associations.	[Serao, Nick V. L.; Gonzalez-Pena, Dianelys; Beever, Jonathan E.; Southey, Bruce R.; Faulkner, Daniel B.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Bollero, German A.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu	Serão, Nick/AAE-5868-2019; Peña, Dianelys Gonzalez/AAF-4021-2019	Serão, Nick/0000-0002-6758-208X; Peña, Dianelys Gonzalez/0000-0003-4846-7569; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Southey, Bruce/0000-0002-8959-7709	USDA NIFA [2010-85122-20620, 2013-68004-20361, 2012-38420-30209, 2009-35205-05310]; NIH/NIDA [R21 DA027548, P30 DA 018310]; David H. and Norraine Baker Graduate Fellowship in Animal Sciences; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310] Funding Source: NIH RePORTER	USDA NIFA(United States Department of Agriculture (USDA)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); David H. and Norraine Baker Graduate Fellowship in Animal Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors appreciate the support from USDA NIFA (2010-85122-20620; 2013-68004-20361; 2012-38420-30209; 2009-35205-05310), NIH/NIDA (R21 DA027548 and P30 DA 018310) and the David H. and Norraine Baker Graduate Fellowship in Animal Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Banos G, 2008, J DAIRY SCI, V91, P3190, DOI 10.3168/jds.2007-0930; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bolormaa S, 2010, J DAIRY SCI, V93, P3818, DOI 10.3168/jds.2009-2980; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Casas E, 2001, J ANIM SCI, V79, P854; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; FASS, 2010, GUID CAR US AGR AN R, V3rd; FERRELL CL, 1985, J ANIM SCI, V61, P725, DOI 10.2527/jas1985.613725x; Ganong W. F., 2005, REV MED PHYSL, V21; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YZ, 2010, ANIM BIOTECHNOL, V21, P170, DOI 10.1080/10495391003768813; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Knott SA, 2000, GENETICS, V156, P899; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Korol AB, 2001, GENETICS, V157, P1789; Kreimer A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks269; Lancaster PA, 2009, J ANIM SCI, V87, P3887, DOI 10.2527/jas.2009-2041; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li C, 2004, J ANIM SCI, V82, P1; Li C, 2002, J ANIM SCI, V80, P1187; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Lombard Z, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000873; Lowe M., 2009, VALUE CHAIN ANAL US; Lu AJ, 2011, MOL BIOL REP, V38, P261, DOI 10.1007/s11033-010-0103-5; Marquez GC, 2009, ANIM GENET, V40, P986, DOI 10.1111/j.1365-2052.2009.01946.x; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Martinez A, 2010, J ANIM SCI, V88, P1229, DOI 10.2527/jas.2009-2025; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mizoshita K, 2004, J ANIM SCI, V82, P3415; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Rincon G, 2009, ANIM GENET, V40, P878, DOI 10.1111/j.1365-2052.2009.01934.x; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Sandhiya S, 2009, INDIAN J MED RES, V129, P223; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Sherman EL, 2008, ANIM GENET, V39, P225, DOI 10.1111/j.1365-2052.2008.01704.x; Sherman EL, 2008, J ANIM SCI, V86, P1, DOI 10.2527/jas.2006-799; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Sherman EL, 2009, J ANIM SCI, V87, P37, DOI 10.2527/jas.2008-0876; Snelling WM, 2011, J ANIM SCI, V89, P1731, DOI 10.2527/jas.2010-3526; Southey BR, 2003, J ANIM SCI, V81, P1399; Stearns TM, 2005, J ANIM SCI, V83, P2471; Taylor JF, 1998, ANIM GENET, V29, P194, DOI 10.1111/j.1365-2052.1998.00317.x; Trejo C. O., 2010, Professional Animal Scientist, V26, P620; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Wang J, 2010, MOL BIOL REP, V37, P571, DOI 10.1007/s11033-009-9816-8; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040	66	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78530	10.1371/journal.pone.0078530	http://dx.doi.org/10.1371/journal.pone.0078530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205251	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700091
J	Toychiev, AH; Yee, CW; Sagdullaev, BT				Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.			Correlated Spontaneous Activity Persists in Adult Retina and Is Suppressed by Inhibitory Inputs	PLOS ONE			English	Article							PATTERNED SPONTANEOUS ACTIVITY; DEVELOPING MAMMALIAN RETINA; EYE-SPECIFIC SEGREGATION; TIGER SALAMANDER RETINA; GANGLION-CELLS; BIPOLAR CELLS; AMACRINE CELLS; MOUSE RETINA; DEVELOPMENTAL-CHANGES; ACTION-POTENTIALS	Spontaneous rhythmic activity is a hallmark feature of the developing retina, where propagating retinal waves instruct axonal targeting and synapse formation. Retinal waves cease around the time of eye-opening; however, the fate of the underlying synaptic circuitry is unknown. Whether retinal waves are unique to the developing retina or if they can be induced in adulthood is not known. Combining patch-clamp techniques with calcium imaging, we demonstrate that propagative events persist in adult mouse retina when it is deprived of inhibitory input. This activity originates in bipolar cells, resembling glutamatergic stage III retinal waves. We find that, as it develops, the network interactions progressively curtail this activity. Together, this provides evidence that the correlated propagative neuronal activity can be induced in adult retina following the blockade of inhibitory interactions.	[Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA; [Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.] Cornell Univ, Dept Ophthalmol, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Sagdullaev, BT (corresponding author), Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA.	bos2005@med.cornell.edu			NIH [R01-EY020535]; NATIONAL EYE INSTITUTE [R01EY020535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant R01-EY020535 (B. T. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrouh A, 2013, INTERSECTING CIRCUIT; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Bansal A, 2000, J NEUROSCI, V20, P7672; Barkis WB, 2010, P NATL ACAD SCI USA, V107, P22302, DOI 10.1073/pnas.1008775108; Blankenship AG, 2011, J NEUROSCI, V31, P9998, DOI 10.1523/JNEUROSCI.5640-10.2011; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BOOS R, 1993, J NEUROSCI, V13, P2874; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Eggers ED, 2006, J NEUROSCI, V26, P9413, DOI 10.1523/JNEUROSCI.2591-06.2006; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fischer KF, 1998, J NEUROSCI, V18, P3767; GRUN G, 1982, PROG NEUROBIOL, V18, P257, DOI 10.1016/0301-0082(82)90012-0; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Hennig MH, 2011, J NEUROSCI, V31, P12159, DOI 10.1523/JNEUROSCI.3112-11.2011; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Ichinose T, 2007, J NEUROSCI, V27, P4756, DOI 10.1523/JNEUROSCI.0183-07.2007; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; LUKASIEWICZ PD, 1990, J NEUROSCI, V10, P210; Lukasiewicz PD, 1998, J NEUROPHYSIOL, V79, P3157, DOI 10.1152/jn.1998.79.6.3157; Ma YP, 2003, VISUAL NEUROSCI, V20, P131, DOI 10.1017/s0952523803202042; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Miller ED, 1999, VISUAL NEUROSCI, V16, P1133, DOI 10.1017/S0952523899166136; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Petit-Jacques J, 2008, J NEUROPHYSIOL, V100, P993, DOI 10.1152/jn.01399.2007; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sagdullaev BT, 2011, J NEUROSCI, V31, P15102, DOI 10.1523/JNEUROSCI.1801-11.2011; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sernagor E, 2003, J NEUROSCI, V23, P7621; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Toychiev AH, 2013, J NEUROSCI METH, V214, P105, DOI 10.1016/j.jneumeth.2013.01.016; Vardi N, 2000, J NEUROSCI, V20, P7657; Volgyi Zoltan, 2009, Orvosi Hetilap, V150, P2313, DOI 10.1556/OH.2009.28767; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Wong WT, 1998, J NEUROSCI, V18, P8839; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zenisek D, 1998, VISUAL NEUROSCI, V15, P69, DOI 10.1017/S0952523898151064; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000	72	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77658	10.1371/journal.pone.0077658	http://dx.doi.org/10.1371/journal.pone.0077658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204906	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700046
J	Rinnerthaler, M; Lejskova, R; Grousl, T; Stradalova, V; Heeren, G; Richter, K; Breitenbach-Koller, L; Malinsky, J; Hasek, J; Breitenbach, M				Rinnerthaler, Mark; Lejskova, Renata; Grousl, Tomas; Stradalova, Vendula; Heeren, Gino; Richter, Klaus; Breitenbach-Koller, Lore; Malinsky, Jan; Hasek, Jiri; Breitenbach, Michael			Mmi1, the Yeast Homologue of Mammalian TCTP, Associates with Stress Granules in Heat-Shocked Cells and Modulates Proteasome Activity	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; FORTILIN; IDENTIFICATION; MICROTUBULES; ORGANIZATION; EXPRESSION; MEMBRANE; REVEALS	As we have shown previously, yeast Mmi1 protein translocates from the cytoplasm to the outer surface of mitochondria when vegetatively growing yeast cells are exposed to oxidative stress. Here we analyzed the effect of heat stress on Mmi1 distribution. We performed domain analyses and found that binding of Mmi1 to mitochondria is mediated by its central alpha-helical domain (V-domain) under all conditions tested. In contrast, the isolated N-terminal flexible loop domain of the protein always displays nuclear localization. Using immunoelectron microscopy we confirmed re-location of Mmi1 to the nucleus and showed association of Mmi1 with intact and heat shock-altered mitochondria. We also show here that mmi1 Delta mutant strains are resistant to robust heat shock with respect to clonogenicity of the cells. To elucidate this phenotype we found that the cytosolic Mmi1 holoprotein re-localized to the nucleus even in cells heat-shocked at 40 degrees C. Upon robust heat shock at 46 degrees C, Mmi1 partly co-localized with the proteasome marker Rpn1 in the nuclear region as well as with the cytoplasmic stress granules defined by Rpg1 (eIF3a). We co-localized Mmi1 also with Bre5, Ubp3 and Cdc48 which are involved in the protein de-ubiquitination machinery, protecting protein substrates from proteasomal degradation. A comparison of proteolytic activities of wild type and mmi1 Delta cells revealed that Mmi1 appears to be an inhibitor of the proteasome. We conclude that one of the physiological functions of the multifunctional protein module, Mmi1, is likely in regulating degradation and/or protection of proteins thereby indirectly regulating the pathways leading to cell death in stressed cells.	[Rinnerthaler, Mark; Heeren, Gino; Richter, Klaus; Breitenbach-Koller, Lore; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, Div Genet, A-5020 Salzburg, Austria; [Lejskova, Renata; Grousl, Tomas; Hasek, Jiri] AS CR, Lab Cell Reprod, Inst Microbiol, Vvi, Prague, Czech Republic; [Stradalova, Vendula; Malinsky, Jan] AS CR, Microscopy Unit, Inst Expt Med, Vvi, Prague, Czech Republic	Salzburg University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Hasek, J (corresponding author), AS CR, Lab Cell Reprod, Inst Microbiol, Vvi, Prague, Czech Republic.	hasek@biomed.cas.cz; michael.breitenbach@sbg.ac.at	Stradalova, Vendula/H-2458-2014; Groušl, Tomáš/I-1727-2014; Lejskova, Renata/I-1669-2014; Malinsky, Jan/H-2484-2014; Groušl, Tomáš/AAF-3655-2019; Hasek, Jiri/H-2427-2014; Rinnerthaler, Mark/AAE-3645-2020	Groušl, Tomáš/0000-0002-6996-1323; Lejskova, Renata/0000-0002-5664-7837; Malinsky, Jan/0000-0002-1433-0989; Groušl, Tomáš/0000-0002-6996-1323; Hasek, Jiri/0000-0001-6634-2386; Rinnerthaler, Mark/0000-0003-1190-0584; Breitenbach-Koller, Hannelore/0000-0002-8387-6408	Czech Science Foundation, CSF [P305/12/0480]; grant OeAD Aktion CZ [11/2012]; FWF Austria [S9302-B05]; EC, Brussels [512020 MIMAGE]; CSF [P302/11/0146];  [7AMB12ATOO2];  [RVO61388971]	Czech Science Foundation, CSF; grant OeAD Aktion CZ; FWF Austria(Austrian Science Fund (FWF)); EC, Brussels(European CommissionEuropean Commission Joint Research Centre); CSF; ; 	This work was supported by the grants P305/12/0480 (Czech Science Foundation, CSF), 7AMB12ATOO2 and RVO61388971 (to JH), by grant OeAD Aktion CZ 11/2012 (to MR), by grants S9302-B05 (FWF Austria) and 512020 MIMAGE (EC, Brussels) (to MB) and by grant P302/11/0146 (CSF) (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bommer UA, 2012, OPEN ALLERGY J, V5, P19, DOI DOI 10.2174/1874838401205010019; Brachmann CB, 1998, YEAST, V14, P115; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Diraison F, 2011, DIABETOLOGIA, V54, P368, DOI 10.1007/s00125-010-1958-7; Du L, 2007, BIOCHEMISTRY-MOSCOW+, V72, P843, DOI 10.1134/S0006297907080056; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; HAGHIGHAT NG, 1992, MOL BIOCHEM PARASIT, V51, P99, DOI 10.1016/0166-6851(92)90205-X; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lettner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011993; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Ma YP, 2012, BIOCH RES INT, V2012, P1; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Rid R, 2010, J STEROID BIOCHEM, V118, P29, DOI 10.1016/j.jsbmb.2009.09.015; Riezman H, 2004, CELL CYCLE, V3, P61; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roth V, 2006, NEURAL COMPUT, V18, P942, DOI 10.1162/089976606775774679; Rupec RA, 1998, ONCOL RES, V10, P69; Schmidt I, 2007, FEBS J, V274, P5416, DOI 10.1111/j.1742-4658.2007.06069.x; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Takahara T, 2012, CELL CYCLE, V11, P3707, DOI 10.4161/cc.22044; Takahashi T, 2010, J TOXICOL SCI, V35, P945, DOI 10.2131/jts.35.945; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yan Y, 2005, J PROTEOME RES, V4, P2007, DOI 10.1021/pr050175d; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	54	19	19	1	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77791	10.1371/journal.pone.0077791	http://dx.doi.org/10.1371/journal.pone.0077791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204967	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200040
J	Terashita, Y; Yamagata, K; Tokoro, M; Itoi, F; Wakayama, S; Li, C; Sato, E; Tanemura, K; Wakayama, T				Terashita, Yukari; Yamagata, Kazuo; Tokoro, Mikiko; Itoi, Fumiaki; Wakayama, Sayaka; Li, Chong; Sato, Eimei; Tanemura, Kentaro; Wakayama, Teruhiko			Latrunculin A Treatment Prevents Abnormal Chromosome Segregation for Successful Development of Cloned Embryos	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; BOVINE PREIMPLANTATION EMBRYOS; G9A HISTONE METHYLTRANSFERASE; FULL-TERM DEVELOPMENT; CUMULUS CELL-NUCLEI; MOUSE EMBRYOS; ACTIN POLYMERIZATION; CLONING EFFICIENCY; LYSINE 9; METHYLATION	Somatic cell nuclear transfer to an enucleated oocyte is used for reprogramming somatic cells with the aim of achieving totipotency, but most cloned embryos die in the uterus after transfer. While modifying epigenetic states of cloned embryos can improve their development, the production rate of cloned embryos can also be enhanced by changing other factors. It has already been shown that abnormal chromosome segregation (ACS) is a major cause of the developmental failure of cloned embryos and that Latrunculin A (LatA), an actin polymerization inhibitor, improves F-actin formation and birth rate of cloned embryos. Since F-actin is important for chromosome congression in embryos, here we examined the relation between ACS and F-actin in cloned embryos. Using LatA treatment, the occurrence of ACS decreased significantly whereas cloned embryo-specific epigenetic abnormalities such as dimethylation of histone H3 at lysine 9 (H3K9me2) could not be corrected. In contrast, when H3K9me2 was normalized using the G9a histone methyltransferase inhibitor BIX-01294, the Magea2 gene-essential for normal development but never before expressed in cloned embryos-was expressed. However, this did not increase the cloning success rate. Thus, non-epigenetic factors also play an important role in determining the efficiency of mouse cloning.	[Terashita, Yukari; Yamagata, Kazuo; Tokoro, Mikiko; Itoi, Fumiaki; Wakayama, Sayaka; Li, Chong; Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan; [Terashita, Yukari; Sato, Eimei; Tanemura, Kentaro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Yamagata, Kazuo] Osaka Univ, Microbial Dis Res Inst, Ctr Genet Anal Biol Responses, Suita, Osaka 565, Japan; [Tokoro, Mikiko; Itoi, Fumiaki] Asada Ladies Clin, Asada Inst Reprod Med, Kasugai, Aichi, Japan; [Li, Chong] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Wakayama, Sayaka; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Kofu, Yamanashi, Japan	RIKEN; Tohoku University; Osaka University; Tongji University; University of Yamanashi	Terashita, Y (corresponding author), RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan.	yterashita@cdb.riken.jp; twakayama@yamanashi.ac.jp	Itoi, Fumiaki/AAN-6110-2020	Tokoro, Mikiko/0000-0003-1589-0889; Itoi, Fumiaki/0000-0001-5915-5056	Japan Society for the Promotion of Science;  [20062015];  [23248048]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	Financial support for this research was provided by Research Fellow of the Japan Society for the Promotion of Science to YT and Grant-in-Aid for Scientific Research on Priority Areas (20062015) and Scientific Research (A) (23248048) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Inoue Kimiko, 2002, Science (Washington D C), V295, P297, DOI 10.1126/science.295.5553.297; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P1207, DOI 10.1262/jrd.19067; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Miyamoto K, 2013, CELL MOL LIFE SCI, V70, P3289, DOI 10.1007/s00018-012-1235-7; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Mori M, 2011, CURR BIOL, V21, P606, DOI 10.1016/j.cub.2011.03.002; Nakagata N, 1996, LAB ANIM SCI, V46, P236; Nowak-Imialek M, 2008, MOL REPROD DEV, V75, P731, DOI 10.1002/mrd.20816; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Terashita Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098764; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama S, 2003, CLONING STEM CELLS, V5, P181, DOI 10.1089/153623003769645848; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358	44	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78380	10.1371/journal.pone.0078380	http://dx.doi.org/10.1371/journal.pone.0078380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205216	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300057
J	Schmandke, A; Schmandke, A; Pietro, MA; Schwab, ME				Schmandke, Andre; Schmandke, Antonio; Pietro, Maurianne A.; Schwab, Martin E.			An Open Source Based High Content Screening Method for Cell Biology Laboratories Investigating Cell Spreading and Adhesion	PLOS ONE			English	Article							GLUCOCORTICOID RECEPTOR FUNCTION; NOGO-A; ANTIDEPRESSANT DRUGS; NERVOUS-SYSTEM; IN-VITRO; MIGRATION; GROWTH; ROLES; MOLECULE; CULTURE	Background: Adhesion dependent mechanisms are increasingly recognized to be important for a wide range of biological processes, diseases and therapeutics. This has led to a rising demand of pharmaceutical modulators. However, most currently available adhesion assays are time consuming and/or lack sensitivity and reproducibility or depend on specialized and expensive equipment often only available at screening facilities. Thus, rapid and economical high-content screening approaches are urgently needed. Results: We established a fully open source high-content screening method for identifying modulators of adhesion. We successfully used this method to detect small molecules that are able to influence cell adhesion and cell spreading of Swiss-3T3 fibroblasts in general and/or specifically counteract Nogo-A-Delta 20-induced inhibition of adhesion and cell spreading. The tricyclic anti-depressant clomipramine hydrochloride was shown to not only inhibit Nogo-A-Delta 20-induced cell spreading inhibition in 3T3 fibroblasts but also to promote growth and counteract neurite outgrowth inhibition in highly purified primary neurons isolated from rat cerebellum. Conclusions: We have developed and validated a high content screening approach that can be used in any ordinarily equipped cell biology laboratory employing exclusively freely available open-source software in order to find novel modulators of adhesion and cell spreading. The versatility and adjustability of the whole screening method will enable not only centers specialized in high-throughput screens but most importantly also labs not routinely employing screens in their daily work routine to investigate the effects of a wide range of different compounds or siRNAs on adhesion and adhesion-modulating molecules.	[Schmandke, Andre] Univ Zurich, Brain Res Inst, Zurich, Switzerland; Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmandke, A (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	Andre.Schmandke@hifo.uzh.ch	Schwab, Martin E/B-6818-2016		European Union's Framework 7 program (Marie Curie Training Network: AXREGEN); Swiss National Science Foundation [310030B_138676/1]; European Research Council (ERC) [294115-NOGORISE]	European Union's Framework 7 program (Marie Curie Training Network: AXREGEN); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by research grants from the European Union's Framework 7 program (Marie Curie Training Network: AXREGEN; http://cordis.europa.eu/fp7/people/), the Swiss National Science Foundation (grant nr. 310030B_138676/1; www.snf.ch/) and the European Research Council (ERC advanced grant nr. 294115-NOGORISE; erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RY, 2011, NEURO-ONCOLOGY, V13, P974, DOI 10.1093/neuonc/nor077; Budziszewska B, 2000, BRIT J PHARMACOL, V130, P1385, DOI 10.1038/sj.bjp.0703445; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen J, 1995, J NEUROCHEM; Clegg Dennis O., 2000, Molecular Cell Biology Research Communications, V3, P1, DOI 10.1006/mcbr.1999.0175; EARNEST DL, 1992, J CELL BIOCHEM, P156; Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Heemskerk Jill, 2005, Retina, V25, pS56, DOI 10.1097/00006982-200512001-00025; Huber AB, 2002, J NEUROSCI, V22, P3553; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Lah GJ, 2012, MOL CELL BIOL, V32, P968, DOI 10.1128/MCB.06128-11; Lai M, 2003, NEUROSCIENCE, V118, P975, DOI 10.1016/S0306-4522(03)00038-1; LOIKE JD, 1978, CANCER RES, V38, P2688; Maes M, 1999, NEGATIVE IMMUNOREGUL; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Miller AH, 2002, NEUROPSYCHOPHARMACOL, V27, P939, DOI 10.1016/S0893-133X(02)00381-0; Oertle T, 2003, J NEUROSCI, V23, P5393; Pariante C, 1997, MOLECULAR; Pariante CM, 2001, BRIT J PHARMACOL, V134, P1335, DOI 10.1038/sj.bjp.0704368; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PRICE EA, 1995, CLIN EXP METASTAS, V13, P155, DOI 10.1007/BF00132203; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Shutova MS, 2010, CELL TISSUE BIOL, V4, P572; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Szabo D, 1999, CANCER LETT, V139, P115, DOI 10.1016/S0304-3835(99)00020-8; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsujii M, 1995, CELL, P2; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Vedder H, 1999, J PSYCHIAT; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xia ZL, 1999, J BIOCHEM MOL TOXIC, V13, P338, DOI 10.1002/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.3.CO;2-Z; Yang HJ, 2011, J CELL SCI, V124, P2552, DOI 10.1242/jcs.085340; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78212	10.1371/journal.pone.0078212	http://dx.doi.org/10.1371/journal.pone.0078212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205161	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326032600082
J	Wang, YB; Vogelsang, M; Schafer, G; Matejcic, M; Parker, MI				Wang, Yabing; Vogelsang, Matjaz; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal			MicroRNA Polymorphisms and Environmental Smoke Exposure as Risk Factors for Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC-VARIATION; LUNG-CANCER; METASTASIS; DNA; DYSREGULATION; EPIDEMIOLOGY; ASSOCIATION; POLLUTION; MIRNAS	MicroRNAs (miRNAs) and related polymorphisms have been implicated in the susceptibility to oesophageal squamous cell carcinoma (OSCC). In our study, three miRNA-related SNPs: rs6505162 A>C (pre-miRNA of miR-423), rs213210 A>G (3'UTR of miR-219-1) and rs7372209 C>T (5'UTR of miR-26a-1) were investigated in the Black and Mixed Ancestry population groups in South Africa. The potential cumulative effects of these SNPs, as well as gene-environment interactions were also analysed. In Blacks, rs6505162 A>C was associated with OSCC under dominant, additive and recessive models with odds ratios (ORs) 1.353, 1.404, and 2.858, respectively. This locus showed very strong interactions with smoke inhalation from burning wood or charcoal used for heating and cooking in very poorly ventilated areas (OR(GE)=7.855, P-(GE)=9.17*10(-10) in the Black group). Furthermore, the miR-423-3p level was 1.39 fold up-regulated in tumour tissues compared to the adjacent normal tissue (paired t-test P value 0.0087). SNP-SNP interaction between rs2132210 and rs7372209 was found in both Black and Mixed Ancestry subjects. The AA(rs213210)-CTrs7372209 genotype had a protective effect on OSCC risk (in the Black, OR=0.229, P=0.012; and the Mixed Ancestry groups, OR=0.230, P=0.00014). This study is the first to link SNPs in miR-423 together with environmental smoke exposure to risk for developing OSCC.	[Wang, Yabing; Vogelsang, Matjaz; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Wang, Yabing; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] UCT Fac Hlth Sci, IIDMM, Cape Town, South Africa; [Wang, Yabing; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] UCT Fac Hlth Sci, Div Med Biochem, Cape Town, South Africa; [Vogelsang, Matjaz] Natl Inst Chem, Ljubljana, Slovenia	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; National Institute of Chemistry - Slovenia	Parker, MI (corresponding author), Int Ctr Genet Engn & Biotechnol, UCT Campus, Cape Town, South Africa.	Iqbal.Parker@icgeb.org			International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; South African Medical Research Council; University of Cape Town; PRF; MRC	International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town; PRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is based upon research supported by the International Centre for Genetic Engineering and Biotechnology (ICGEB), South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the South African Medical Research Council and the University of Cape Town. GS was funded by a grant from the PRF and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ibiebele TI, 2010, CANCER CAUSE CONTROL, V21, P1475, DOI 10.1007/s10552-010-9576-8; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kollarova Helena, 2007, Biomedical Papers (Olomouc), V151, P17; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kurmi OP, 2012, EUR RESPIR J, V40, P239, DOI 10.1183/09031936.00190211; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Lissowska J, 2005, AM J EPIDEMIOL, V162, P326, DOI 10.1093/aje/kwi204; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yu X, 2010, ASIAN PAC J CANCER P, V11, P1827; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32	39	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78520	10.1371/journal.pone.0078520	http://dx.doi.org/10.1371/journal.pone.0078520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205249	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600106
J	Yamawaki, K; Ueda, S; Okada, T; Oshima, T; Kakitani, M; Kato, T; Tomizuka, K				Yamawaki, Kengo; Ueda, Shinobu; Okada, Tsutomu; Oshima, Takeshi; Kakitani, Makoto; Kato, Takashi; Tomizuka, Kazuma			Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII	PLOS ONE			English	Article							BETA SUPERFAMILY; II RECEPTOR; MUSCLE MASS; PROTEIN; IDENTIFICATION; GROWTH; MICE; MUTATIONS; ANEMIA; DIFFERENTIATION	Bone morphogenetic proteins (BMPs)/growth differentiation factors (GDFs), which belong to the TGF-beta superfamily, are pleiotropic factors that play a role in regulating the embryonic development and postnatal homeostasis of various organs and tissues by controlling cellular differentiation, proliferation and apoptosis. Conventional transgenic and knockout (KO) mouse approaches have provided only limited information regarding the in vivo functions of BMP signaling in adult animals due to the effects on prenatal development and the difficulty in manipulating multiligand signals simultaneously. We recently produced transgenic chimeric mice(Tg chimeras) in which the soluble IgG1-Fc fusion protein of three BMP type II receptors (ActRIIA, ActRIIB, BMPRII) was highly circulated (281-709 mu g/ml), specifically in adult mouse blood. Since each BMP receptor can bind to multiple BMP ligands, these Tg chimeras should be useful to investigate the effects of trapping multiple BMP ligands. Remarkably, some phenotypes were unexpected based on previous studies, such as KO mouse analyses, presumably representing the effects of the multiple ligand trapping. These phenotypes included increased red blood cells (RBCs) and decreased viability in adults. In a further study, we focused on the phenotype of increased RBCs and found that extramedullary hematopoiesis in the spleen, not in the bone marrow, was increased using histological and flow cytometric analyses. Although it remains to be elucidated whether the transgene products affect the tissues directly or indirectly, our data provide novel and important insight into the biological functions of the soluble IgG1-Fc fusion protein of three BMP type II receptors in adults, and our approach should have broad applications to research on other ligand receptor families and studies involving mouse models.	[Yamawaki, Kengo; Okada, Tsutomu; Oshima, Takeshi; Kakitani, Makoto] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan; [Ueda, Shinobu] Waseda Univ, Comprehens Res Org, Inst Innovat Design, Shinjuku Ku, Tokyo, Japan; [Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Tomizuka, Kazuma] Kyowa Hakko Kirin Calif Inc, San Diego, CA USA	Kyowa Kirin Ltd; Waseda University; Waseda University	Yamawaki, K (corresponding author), Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan.	kengo.yamawaki@kyowa-kirin.co.jp; ktomizuka@kyowa-kirin-ca.com	Kato, Takashi/AFO-2557-2022	Kato, Takashi/0000-0003-0384-7971	Kyowa-Hakko Kirin Co. Ltd.; New Energy and Industrial Technology Development Organization (NEDO)	Kyowa-Hakko Kirin Co. Ltd.(Kyowa Kirin Ltd); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	Financial support for this study was provided by Kyowa-Hakko Kirin Co. Ltd. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bagarova J, 2013, MOL CELL BIOL, V33, P2413, DOI 10.1128/MCB.01595-12; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chantry AD, 2010, J BONE MINER RES, V25, P2357, DOI 10.1002/jbmr.142; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Gluhak-Heinrich J, 2010, BONE, V46, P1533, DOI 10.1016/j.bone.2010.02.024; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Javier AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042566; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kakitani M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni083; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Raje N, 2010, CURR OPIN MOL THER, V12, P586; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	54	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78076	10.1371/journal.pone.0078076	http://dx.doi.org/10.1371/journal.pone.0078076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205096	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600067
J	Brown, CE; Warden, CD; Starr, R; Deng, XT; Badie, B; Yuan, YC; Forman, SJ; Barish, ME				Brown, Christine E.; Warden, Charles D.; Starr, Renate; Deng, Xutao; Badie, Behnam; Yuan, Yate-Ching; Forman, Stephen J.; Barish, Michael E.			Glioma IL13R alpha 2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis	PLOS ONE			English	Article							INTERLEUKIN-13 RECEPTOR-ALPHA-2; GLIOBLASTOMA-MULTIFORME; MOLECULAR-BASIS; STEM-CELLS; CANCER; INFLAMMATION; IL-13; ANGIOGENESIS; RECOGNITION; FIBROSIS	A major challenge for successful immunotherapy against glioma is the identification and characterization of validated targets. We have taken a bioinformatics approach towards understanding the biological context of IL-13 receptor alpha 2 (IL13R alpha 2) expression in brain tumors, and its functional significance for patient survival. Querying multiple gene expression databases, we show that IL13R alpha 2 expression increases with glioma malignancy grade, and expression for high-grade tumors is bimodal, with approximately 58% of WHO grade IV gliomas over-expressing this receptor. By several measures, IL13R alpha 2 expression in patient samples and low-passage primary glioma lines most consistently correlates with the expression of signature genes defining mesenchymal subclass tumors and negatively correlates with proneural signature genes as defined by two studies. Positive associations were also noted with proliferative signature genes, whereas no consistent associations were found with either classical or neural signature genes. Probing the potential functional consequences of this mesenchymal association through IPA analysis suggests that IL13R alpha 2 expression is associated with activation of proinflammatory and immune pathways characteristic of mesenchymal subclass tumors. In addition, survival analyses indicate that IL13R alpha 2 over-expression is associated with poor patient prognosis, a single gene correlation ranking IL13R alpha 2 in the top similar to 1% of total gene expression probes with regard to survival association with WHO IV gliomas. This study better defines the functional consequences of IL13R alpha 2 expression by demonstrating association with mesenchymal signature gene expression and poor patient prognosis. It thus highlights the utility of IL13R alpha 2 as a therapeutic target, and helps define patient populations most likely to respond to immunotherapy in present and future clinical trials.	[Brown, Christine E.; Starr, Renate; Forman, Stephen J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol & Hematol, Duarte, CA 91010 USA; [Brown, Christine E.; Warden, Charles D.; Starr, Renate; Deng, Xutao; Badie, Behnam; Yuan, Yate-Ching; Forman, Stephen J.; Barish, Michael E.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Warden, Charles D.; Deng, Xutao; Yuan, Yate-Ching] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Badie, Behnam] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosurg, Duarte, CA 91010 USA; [Barish, Michael E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Brown, CE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol & Hematol, Duarte, CA 91010 USA.	cbrown@coh.org		Brown, Christine/0000-0003-4915-8207; Warden, Charles/0000-0002-1827-4486	NCI [P30 CA33572-26]; General Clinical Research Center [M01 RR00043]; California Institute for Regenerative Medicine [CIRM TR3-05641]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by NCI (P30 CA33572-26), General Clinical Research Center (M01 RR00043), California Institute for Regenerative Medicine (CIRM TR3-05641), and generous donations from the Chubb Charity Golf Tournament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicting financial interests.	Beier CP, 2012, STEM CELLS DEV, V21, P2753, DOI 10.1089/scd.2011.0660; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Debinski W, 1999, CLIN CANCER RES, V5, P985; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, CANCER RES, V68, P3467, DOI 10.1158/0008-5472.CAN-07-5301; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fujisawa T, 2011, INT J CANC; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hsi LC, 2011, MOL CANCER THER, V10, P1149, DOI 10.1158/1535-7163.MCT-10-1064; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi BH, 2008, NEURO-ONCOLOGY, V10, P265, DOI 10.1215/15228517-2007-066; Joshi BH, 2006, VITAM HORM, V74, P479, DOI 10.1016/S0083-6729(06)74019-5; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kawakami M, 2004, CANCER-AM CANCER SOC, V101, P1036, DOI 10.1002/cncr.20470; Kunwar S, 2010, NEURO-ONCOLOGY, V12, P871, DOI 10.1093/neuonc/nop054; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Lupardus PJ, 2010, STRUCTURE, V18, P332, DOI 10.1016/j.str.2010.01.003; MacDonald TT, 2006, NAT MED, V12, P13, DOI 10.1038/nm0106-13; McLendon RE, 2011, J ONCOL, V2011, DOI 10.1155/2011/397195; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Natsume A, 2011, BRAIN TUMOR PATHOL, V28, P1, DOI 10.1007/s10014-010-0011-3; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Saka M, 2010, J NEUROSURG, V113, P270, DOI 10.3171/2009.9.JNS09708; Stastny MJ, 2007, J PEDIAT HEMATOL ONC, V29, P669, DOI 10.1097/MPH.0b013e3181468c68; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; [No title captured]; [No title captured]	49	86	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77769	10.1371/journal.pone.0077769	http://dx.doi.org/10.1371/journal.pone.0077769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204956	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300114
J	Fischer, I; Steige, KA; Stephan, W; Mboup, M				Fischer, Iris; Steige, Kim A.; Stephan, Wolfgang; Mboup, Mamadou			Sequence Evolution and Expression Regulation of Stress-Responsive Genes in Natural Populations of Wild Tomato	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; WATER-USE EFFICIENCY; LOCAL ADAPTATION; ASR GENE; NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; CANDIDATE GENES; DNA-BINDING; DROUGHT	The wild tomato species Solanum chilense and S. peruvianum are a valuable non-model system for studying plant adaptation since they grow in diverse environments facing many abiotic constraints. Here we investigate the sequence evolution of regulatory regions of drought and cold responsive genes and their expression regulation. The coding regions of these genes were previously shown to exhibit signatures of positive selection. Expression profiles and sequence evolution of regulatory regions of members of the Asr (ABA/water stress/ripening induced) gene family and the dehydrin gene pLC30-15 were analyzed in wild tomato populations from contrasting environments. For S. chilense, we found that Asr4 and pLC30-15 appear to respond much faster to drought conditions in accessions from very dry environments than accessions from more mesic locations. Sequence analysis suggests that the promoter of Asr2 and the downstream region of pLC30-15 are under positive selection in some local populations of S. chilense. By investigating gene expression differences at the population level we provide further support of our previous conclusions that Asr2, Asr4, and pLC30-15 are promising candidates for functional studies of adaptation. Our analysis also demonstrates the power of the candidate gene approach in evolutionary biology research and highlights the importance of wild Solanum species as a genetic resource for their cultivated relatives.	[Fischer, Iris; Steige, Kim A.; Stephan, Wolfgang; Mboup, Mamadou] Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany	University of Munich	Fischer, I (corresponding author), INRA, AGAP 1334, UMR, F-34060 Montpellier, France.	irisfischer402@gmail.com	Stephan, Wolfgang/GOV-6503-2022		German Research Foundation [STE 325/13-1]; Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz	German Research Foundation(German Research Foundation (DFG)); Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz	This work was funded by grant STE 325/13-1 from the German Research Foundation to WS and a fellowship from the Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz to IF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Baker RL, 2012, NEW PHYTOL, V196, P271, DOI 10.1111/j.1469-8137.2012.04245.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Baudry E, 2001, GENETICS, V158, P1725; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Carrari F, 2004, TRENDS PLANT SCI, V9, P57, DOI 10.1016/j.tplants.2003.12.004; Catalan A, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-654; CHEN RD, 1993, PLANT PHYSIOL, V103, P301, DOI 10.1104/pp.103.1.301; Chetelat RT, 2009, EUPHYTICA, V167, P77, DOI 10.1007/s10681-008-9863-6; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Emerson JJ, 2010, PHILOS T R SOC B, V365, P2581, DOI 10.1098/rstb.2010.0005; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Fay JC, 2000, GENETICS, V155, P1405; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fischer I, 2011, NEW PHYTOL, V190, P1032, DOI 10.1111/j.1469-8137.2011.03648.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Frankel N, 2003, MOL BIOL EVOL, V20, P1955, DOI 10.1093/molbev/msg214; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; FU YX, 1993, GENETICS, V133, P693; Giombini MI, 2009, GENETICA, V136, P13, DOI 10.1007/s10709-008-9295-1; Grillo MA, 2009, EVOLUTION, V63, P870, DOI 10.1111/j.1558-5646.2008.00602.x; Guggisberg A, 2013, NEW PHYTOL, V199, P595, DOI 10.1111/nph.12258; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Ha M, 2007, TRENDS GENET, V23, P162, DOI 10.1016/j.tig.2007.02.005; He F, 2012, MOL BIOL EVOL, V29, P3385, DOI 10.1093/molbev/mss146; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jeanneau M, 2002, BIOCHIMIE, V84, P1127, DOI 10.1016/S0300-9084(02)00024-X; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kane NC, 2008, MOL ECOL, V17, P384, DOI 10.1111/j.1365-294X.2007.03467.x; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kirby DA, 1996, GENETICS, V144, P635, DOI 10.1093/genetics/144.2.635; Knight CA, 2006, MOL ECOL, V15, P1229, DOI 10.1111/j.1365-294X.2006.02818.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; LANGE BW, 1990, GENETICS, V126, P921; Leinonen PH, 2011, EVOLUTION, V65, P90, DOI 10.1111/j.1558-5646.2010.01119.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li CM, 2012, GENE, V506, P93, DOI 10.1016/j.gene.2012.06.034; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Maskin L, 2001, PLANT SCI, V161, P739, DOI 10.1016/S0168-9452(01)00464-2; Maskin L, 2008, MOL BIOL REP, V35, P501, DOI 10.1007/s11033-007-9114-2; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Matzkin LM, 2012, MOL ECOL, V21, P2428, DOI 10.1111/j.1365-294X.2012.05549.x; Mboup M, 2012, MOL BIOL EVOL, V29, P3641, DOI 10.1093/molbev/mss176; Moyle LC, 2008, EVOLUTION, V62, P2995, DOI 10.1111/j.1558-5646.2008.00487.x; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Padmanabhan V, 1997, PLANT MOL BIOL, V35, P801, DOI 10.1023/A:1005897921567; Peralta I. E., 2008, Systematic Botany Monographs, V84; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; R Development Core Team, 2012, R LANG ENV STAT COMP; Riihimaki M, 2005, GENETICA, V123, P63, DOI 10.1007/s10709-003-2711-7; Rorat T, 2006, PLANTA, V224, P205, DOI 10.1007/s00425-005-0200-1; Roselius K, 2005, GENETICS, V171, P753, DOI 10.1534/genetics.105.043877; ROSSI M, 1994, PLANT PHYSIOL, V104, P1073, DOI 10.1104/pp.104.3.1073; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Schaefke B, 2013, MOL BIOL EVOL, V30, P2121, DOI 10.1093/molbev/mst114; Schneider A, 1997, PLANT PHYSIOL, V113, P335, DOI 10.1104/pp.113.2.335; Shen G, 2005, PLANT PHYSIOL BIOCH, V43, P836, DOI 10.1016/j.plaphy.2005.06.010; SILHAVY D, 1995, PLANT MOL BIOL, V27, P587, DOI 10.1007/BF00019324; Smith G, 2013, EVOLUTION, V67, P1950, DOI 10.1111/evo.12082; Song BH, 2011, J SYST EVOL, V49, P17, DOI 10.1111/j.1759-6831.2010.00111.x; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Stadler T, 2005, EVOLUTION, V59, P1268, DOI 10.1111/j.0014-3820.2005.tb01777.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tellier A, 2011, P NATL ACAD SCI USA, V108, P17052, DOI 10.1073/pnas.1111266108; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Wang CS, 1998, PLANT CELL PHYSIOL, V39, P1307, DOI 10.1093/oxfordjournals.pcp.a029335; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x; Yanez M, 2009, PLANT CELL REP, V28, P1497, DOI 10.1007/s00299-009-0749-4; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458	96	20	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78182	10.1371/journal.pone.0078182	http://dx.doi.org/10.1371/journal.pone.0078182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205149	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300146
J	Regadas, I; Matos, MR; Monteiro, FA; Gomez-Skarmeta, JL; Lima, D; Bessa, J; Casares, F; Reguenga, C				Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Luis Gomez-Skarmeta, Jose; Lima, Deolinda; Bessa, Jose; Casares, Fernando; Reguenga, Carlos			Several Cis-regulatory Elements Control mRNA Stability, Translation Efficiency, and Expression Pattern of Prrxl1 (Paired Related Homeobox Protein-like 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Neurodevelopment; Pain; Promoters; Transcription; Developmental Factors; 5-UTR; Phox2b; Prrxl1; Alternative Promoters; Sensory Neurons	DORSAL SPINAL-CORD; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; SENSORY NEURONS; ALTERNATIVE PROMOTERS; BINDING-PROTEINS; CELL; PHOX2B; TRANSCRIPTION; ZEBRAFISH	Background: The mechanisms that control the Prrxl1 expression are poorly understood. Results: Several regulatory elements present in Prrxl1 alternative promoters are functionally characterized, including a binding motif for Phox2b required for Prrxl1 expression in visceral sensory neurons. Conclusion: We define diverse regulatory modules, which control the spatiotemporal expression of Prrxl1 in nociceptive neurons. Significance: A new mechanism involved in the ganglion specific action of Prrxl1 is described. The homeodomain transcription factor Prrxl1/DRG11 has emerged as a crucial molecule in the establishment of the pain circuitry, in particular spinal cord targeting of dorsal root ganglia (DRG) axons and differentiation of nociceptive glutamatergic spinal cord neurons. Despite Prrxl1 importance in the establishment of the DRG-spinal nociceptive circuit, the molecular mechanisms that regulate its expression along development remain largely unknown. Here, we show that Prrxl1 transcription is regulated by three alternative promoters (named P1, P2, and P3), which control the expression of three distinct Prrxl1 5-UTR variants, named 5-UTR-A, 5-UTR-B, and 5-UTR-C. These 5-UTR sequences confer distinct mRNA stability and translation efficiency to the Prrxl1 transcript. The most conserved promoter (P3) contains a TATA-box and displays in vivo enhancer activity in a pattern that overlaps with the zebrafish Prrxl1 homologue, drgx. Regulatory modules present in this sequence were identified and characterized, including a binding site for Phox2b. Concomitantly, we demonstrate that zebrafish Phox2b is required for the expression of drgx in the facial, glossopharyngeal, and vagal cranial ganglia.	[Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Lima, Deolinda; Reguenga, Carlos] Univ Porto, Dept Biol Expt, Fac Med Porto, P-4200319 Oporto, Portugal; [Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Lima, Deolinda; Bessa, Jose; Reguenga, Carlos] Univ Porto, Inst Biol Mol & Celular, P-4150 Oporto, Portugal; [Luis Gomez-Skarmeta, Jose; Bessa, Jose; Casares, Fernando] CABD Consejo Super Invest Cient UPO Junta Andaluc, Seville 41013, Spain	Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Reguenga, C (corresponding author), Fac Med Porto, Dept Expt Biol, 4th Floor, P-4200319 Oporto, Portugal.	cregueng@med.up.pt	Casares, Fernando/M-5451-2019; Monteiro, Filipe Almeida/N-8479-2018; Gomez-Skarmeta, Jose Luis/B-5268-2014; Bessa, Jose/I-8084-2013	Casares, Fernando/0000-0002-2181-3858; Monteiro, Filipe Almeida/0000-0003-0670-3658; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Lima, Deolinda/0000-0002-5723-0777; Bessa, Jose/0000-0002-8591-7138; Reguenga, Carlos/0000-0003-1219-9961	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/65300/2009, PTDC/SAU-OBD/099886/2008]; COMPETE [COMP-01-0124-FEDER-011262]; Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares)	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares)	This work was supported by the Fundacao para a Ciencia e a Tecnologia (SFRH/BD/65300/2009 (to I. R.) and PTDC/SAU-OBD/099886/2008), COMPETE: FCOMP-01-0124-FEDER-011262, and Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares).	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Banday AR, 2011, MOL CELL BIOCHEM, V357, P263, DOI 10.1007/s11010-011-0897-z; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Elworthy S, 2005, MECH DEVELOP, V122, P659, DOI 10.1016/j.mod.2004.12.008; Gauss KA, 2006, GENE, V366, P169, DOI 10.1016/j.gene.2005.09.012; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Grandien K, 1997, INT J BIOCHEM CELL B, V29, P1343, DOI 10.1016/S1357-2725(97)89967-0; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kim JD, 2011, MOL CELLS, V31, P141, DOI 10.1007/s10059-011-0018-6; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Knight RD, 2005, DEVELOPMENT, V132, P3127, DOI 10.1242/dev.01879; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; McCormick LJ, 2007, GENE EXPR PATTERNS, V7, P289, DOI 10.1016/j.modgep.2006.09.003; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Rebelo S, 2007, DEV DYNAM, V236, P2653, DOI 10.1002/dvdy.21271; Rebelo S, 2006, MOL CELL NEUROSCI, V33, P236, DOI 10.1016/j.mcn.2006.07.013; Rebelo S, 2010, DEV DYNAM, V239, P1684, DOI 10.1002/dvdy.22305; Rebelo S, 2009, INT J DEV BIOL, V53, P1089, DOI 10.1387/ijdb.072507sr; Riquet FB, 2001, J BIOL CHEM, V276, P38665, DOI 10.1074/jbc.M009881200; Rogozin IB, 2001, BIOINFORMATICS, V17, P890, DOI 10.1093/bioinformatics/17.10.890; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	65	10	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36285	36301		10.1074/jbc.M113.491993	http://dx.doi.org/10.1074/jbc.M113.491993			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214975	Green Published, hybrid			2022-12-25	WOS:000328883400012
J	Escudero, LV; Casamayor, EO; Chong, G; Pedros-Alio, C; Demergasso, C				Escudero, Lorena V.; Casamayor, Emilio O.; Chong, Guillermo; Pedros-Alio, Carles; Demergasso, Cecilia			Distribution of Microbial Arsenic Reduction, Oxidation and Extrusion Genes along a Wide Range of Environmental Arsenic Concentrations	PLOS ONE			English	Article							DISSIMILATORY ARSENATE; SULFATE REDUCTION; RESISTANCE GENES; OXIDASE GENES; BACTERIA; IDENTIFICATION; DETOXIFICATION; RESPIRATION; EXPRESSION; DIVERSITY	The presence of the arsenic oxidation, reduction, and extrusion genes arsC, arrA, aioA, and acr3 was explored in a range of natural environments in northern Chile, with arsenic concentrations spanning six orders of magnitude. A combination of primers from the literature and newly designed primers were used to explore the presence of the arsC gene, coding for the reduction of As (V) to As (III) in one of the most common detoxification mechanisms. Enterobacterial related arsC genes appeared only in the environments with the lowest As concentration, while Firmicutes-like genes were present throughout the range of As concentrations. The arrA gene, involved in anaerobic respiration using As (V) as electron acceptor, was found in all the systems studied. The As (III) oxidation gene aioA and the As (III) transport gene acr3 were tracked with two primer sets each and they were also found to be spread through the As concentration gradient. Sediment samples had a higher number of arsenic related genes than water samples. Considering the results of the bacterial community composition available for these samples, the higher microbial phylogenetic diversity of microbes inhabiting the sediments may explain the increased number of genetic resources found to cope with arsenic. Overall, the environmental distribution of arsenic related genes suggests that the occurrence of different ArsC families provides different degrees of protection against arsenic as previously described in laboratory strains, and that the glutaredoxin (Grx)-linked arsenate reductases related to Enterobacteria do not confer enough arsenic resistance to live above certain levels of As concentrations.	[Escudero, Lorena V.; Demergasso, Cecilia] Univ Catolica Norte, Ctr Invest Cient Tecnol Mineria CICITEM, Antofagasta, Chile; [Escudero, Lorena V.; Demergasso, Cecilia] Univ Catolica Norte, Ctr Biotecnol, Antofagasta, Chile; [Chong, Guillermo] Univ Catolica Norte, Dept Ciencias Geol, Antofagasta, Chile; [Casamayor, Emilio O.] CEAB CSIC, Ctr Estudis Avancats Blanes, Biogeodynam & Biodivers Grp, Blanes, Spain; [Pedros-Alio, Carles] CSIC, Inst Ciencias Mar, Barcelona, Spain	Universidad Catolica del Norte; Universidad Catolica del Norte; Universidad Catolica del Norte; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Demergasso, C (corresponding author), Univ Catolica Norte, Ctr Invest Cient Tecnol Mineria CICITEM, Antofagasta, Chile.	cdemerga@ucn.cl	Pedrós-Alió, Carlos/H-1222-2011; Casamayor, Emilio/A-3676-2010; Demergasso, Cecilia/A-7392-2013	Pedrós-Alió, Carlos/0000-0003-1009-4277; Casamayor, Emilio/0000-0001-7074-3318; Demergasso, Cecilia/0000-0003-4563-3066	BIOARSENICO from Fundacion BBVA, Spain; Chilean government through FONDECYT from the Science and Technology Chilean Commission (CONICYT) [1100795]; CICITEM, Antofagasta, Chile; EOC by DARKNESS from the Spanish MINECO [CGL2012-32747]	BIOARSENICO from Fundacion BBVA, Spain(BBVA Foundation); Chilean government through FONDECYT from the Science and Technology Chilean Commission (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CICITEM, Antofagasta, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CICITEM); EOC by DARKNESS from the Spanish MINECO	This research was funded by grant BIOARSENICO from Fundacion BBVA, Spain, and the Chilean government through FONDECYT Project 1100795 from the Science and Technology Chilean Commission (CONICYT). LVE was supported by a fellowship from CICITEM, Antofagasta, Chile, and EOC by DARKNESS CGL2012-32747, from the Spanish MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, DIVERSITY ARSENITE T; Achour-Rokbani A, 2010, APPL ENVIRON MICROB, V76, P948, DOI 10.1128/AEM.01738-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball P, 2005, NATURE, V436, P313, DOI 10.1038/436313a; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Campos VL, 2011, ARCH ENVIRON CON TOX, V61, P185, DOI 10.1007/s00244-010-9601-7; Croal LR, 2004, ANNU REV GENET, V38, P175, DOI 10.1146/annurev.genet.38.072902.091138; Cuebas M, 2011, MICROBIOL-SGM, V157, P2004, DOI 10.1099/mic.0.048678-0; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Demergasso CS, 2007, GEOMICROBIOL J, V24, P111, DOI 10.1080/01490450701266605; Dorador CI, 2007, THESIS; Dorador C, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000837; Escudero LV, 2009, THESIS U AUTONOMA BA; Giloteaux L, 2013, ISME J, V7, P370, DOI 10.1038/ismej.2012.109; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Handley KM, 2009, ENVIRON MICROBIOL, V11, P1601, DOI 10.1111/j.1462-2920.2009.01890.x; Hollibaugh JT, 2006, APPL ENVIRON MICROB, V72, P2043, DOI 10.1128/AEM.72.3.2043-2049.2006; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kulp TR, 2006, APPL ENVIRON MICROB, V72, P6514, DOI 10.1128/AEM.01066-06; Lara J, 2012, EXTREMOPHILES, V16, P523, DOI 10.1007/s00792-012-0452-1; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Lett MC, 2012, J BACTERIOL, V194, P207, DOI 10.1128/JB.06391-11; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mardones-Perez L, 1997, THESIS U PARSIS SUD; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Newman DK, 1997, ARCH MICROBIOL, V168, P380, DOI 10.1007/s002030050512; Newman DK, 1997, APPL ENVIRON MICROB, V63, P2022, DOI 10.1128/AEM.63.5.2022-2028.1997; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Quemeneur M, 2010, APPL ENVIRON MICROB, V76, P4566, DOI 10.1128/AEM.03104-09; Rhine ED, 2007, BIOCHEM BIOPH RES CO, V354, P662, DOI 10.1016/j.bbrc.2007.01.004; Richey C, 2009, BIOCHEM BIOPH RES CO, V382, P298, DOI 10.1016/j.bbrc.2009.03.045; Risacher F., 1999, GEOQUIMICA AGUAS CUE; Saltikov CW, 2005, J BACTERIOL, V187, P7390, DOI 10.1128/JB.187.21.7390-7396.2005; Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Silver S, 2011, FEMS MICROBIOL LETT, V315, P79, DOI 10.1111/j.1574-6968.2010.02202.x; Slyemi D, 2012, PROKARYOTES DEAL; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, ENVIRON HEALTH PERSP, V108, P617, DOI 10.2307/3434881; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Sun YM, 2004, J MICROBIOL METH, V58, P335, DOI 10.1016/j.mimet.2004.04.015; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Villadangos AF, 2011, MOL MICROBIOL, V82, P998, DOI 10.1111/j.1365-2958.2011.07882.x; Villegas-Torres MF, 2011, INT BIODETER BIODEGR, V65, P147, DOI 10.1016/j.ibiod.2010.10.007; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Zargar K, 2012, ENVIRON MICROBIOL, V14, P1635, DOI 10.1111/j.1462-2920.2012.02722.x; Zargar K, 2010, J BACTERIOL, V192, P3755, DOI 10.1128/JB.00244-10; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843	62	58	60	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78890	10.1371/journal.pone.0078890	http://dx.doi.org/10.1371/journal.pone.0078890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205341	gold, Green Submitted, Green Published			2022-12-25	WOS:000326373800023
J	Gonzalo-Asensio, J; Ortega, AD; Rico-Perez, G; Pucciarelli, MG; Garcia-del Portillo, F				Gonzalo-Asensio, Jesus; Ortega, Alvaro D.; Rico-Perez, Gadea; Pucciarelli, M. Graciela; Portillo, Francisco Garcia-del			A Novel Antisense RNA from the Salmonella Virulence Plasmid pSLT Expressed by Non-Growing Bacteria inside Eukaryotic Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; TRANSCRIPTIONAL LANDSCAPE; CHROMOSOMAL GENES; ENCODING GENES; MESSENGER-RNA; PERSISTENCE; SYSTEM; MACROPHAGES; ANTITOXIN	Bacterial small RNAs (sRNAs) are regulatory molecules playing relevant roles in response to environmental changes, stressful conditions and pathogenesis. The intracellular bacterial pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) is known to regulate expression of some sRNAs during colonization of fibroblasts. Here, we characterize a previously unknown sRNA encoded in the S. Typhimurium pSLT virulence plasmid that is specifically up-regulated by non-growing dormant bacteria persisting inside fibroblasts. This sRNA was inferred in microarray expression analyses, which unraveled enhanced transcriptional activity in the PSLT047-PSLT046 (mig5) intergenic region. The sRNA transcript was further identified as a 597-nucleotide molecule, which we named IesR-1, for 'Intracellular-expressed-sRNA-19. IesR-1 expression is low in bacteria growing in axenic cultures across a variety of experimental conditions but displays a marked increase (similar to 200-300 fold) following bacterial entry into fibroblasts. Remarkably, induction of IesR-1 expression is not prominent in bacteria proliferating within epithelial cells. IesR-1 deletion affects the control of bacterial growth in defined fibroblast cell lines and impairs virulence in a mouse infection model. Expression analyses performed in the PSLT047-iesR-1PSLT046 (mig5) region support a cis-acting regulatory mechanism of IesR-1 as antisense RNA over the PSLT047 transcript involving interaction at their respective 39 ends and modulation of PSLT047 protein levels. This model is sustained by the scarce production of PSLT047 protein observed in non-growing intracellular bacteria and the high amount of PSLT047 protein produced by bacteria carrying a truncated IesR-1 version with separated 59 and 39 regions. Taken together, these data reveal that S. Typhimurium sRNAs encoded in the pSLT virulence plasmid respond to a state of persistence inside the host cell. As exemplified by IesR-1, some of these sRNAs may contribute to diminish the relative levels of proteins, such as PSLT047, which are probably dispensable for the intracellular lifestyle.	[Gonzalo-Asensio, Jesus; Ortega, Alvaro D.; Rico-Perez, Gadea; Portillo, Francisco Garcia-del] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Pucciarelli, M. Graciela] Univ Autonoma Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa CBMSO CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Garcia-del Portillo, F (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	fgportillo@cnb.csic.es	Ortega, Alvaro Dario/K-5394-2018; Gonzalo-Asensio, Jesús/E-4122-2013; García-del Portillo, Francisco/D-2576-2009	Ortega, Alvaro Dario/0000-0003-0691-7154; Gonzalo-Asensio, Jesús/0000-0001-8841-6593; Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316; Garcia-del Portillo, Francisco/0000-0002-4120-0530	Spanish Ministry of Economy and Competitiveness [BIO2010-18885, Consolider-CSD2008-00013-INTERMODS]; Agencia Estatal CSIC [PIE-201320E020]; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Education and Culture;  [CSD2008-00013-INTERMODS]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Agencia Estatal CSIC; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education and Culture(Spanish Government); 	This work was supported by grants BIO2010-18885 and Consolider-CSD2008-00013-INTERMODS from the Spanish Ministry of Economy and Competitiveness; and, PIE-201320E020 from the 'Agencia Estatal CSIC' (to F. G.-P.). J. G. A. held a 'Juan de la Cierva' contract from the Spanish Ministry of Economy and Competitiveness. G. R. P. holds a FPU (Formacion de Profesorado Universitario) fellowship from the Spanish Ministry of Education and Culture. A. D. O. is contracted under the CSD2008-00013-INTERMODS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Cano DA, 2001, INFECT IMMUN, V69, P6463, DOI 10.1128/IAI.69.10.6463-6474.2001; Chinni SV, 2010, NUCL ACIDS RES; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dominguez-Bernal G, 2008, VET MICROBIOL, V130, P298, DOI 10.1016/j.vetmic.2008.01.008; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; FROST L, 1989, MOL GEN GENET, V218, P152, DOI 10.1007/BF00330578; Fu GK, 2004, GENOMICS, V84, P205, DOI 10.1016/j.ygeno.2004.01.011; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOTTESMAN S, 2010, COLD SPRING HARB PER; Greenfield TJ, 2000, MOL MICROBIOL, V37, P652, DOI 10.1046/j.1365-2958.2000.02035.x; Greenfield TJ, 2001, MOL MICROBIOL, V42, P527, DOI 10.1046/j.1365-2958.2001.02663.x; HEADLEY VL, 1990, P NATL ACAD SCI USA, V87, P4179, DOI 10.1073/pnas.87.11.4179; Hebrard M, 2012, RNA BIOL, V9, P437, DOI 10.4161/rna.20480; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Koraimann G, 1996, MOL MICROBIOL, V21, P811, DOI 10.1046/j.1365-2958.1996.361401.x; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Mariscotti JF, 2009, J BACTERIOL, V191, P1855, DOI 10.1128/JB.01604-08; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nunez-Hernandez C, 2013, INFECT IMMUN, V81, P154, DOI 10.1128/IAI.01080-12; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sahr T, 2009, MOL MICROBIOL, V72, P741, DOI 10.1111/j.1365-2958.2009.06677.x; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	57	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77939	10.1371/journal.pone.0077939	http://dx.doi.org/10.1371/journal.pone.0077939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205037	gold, Green Submitted, Green Published			2022-12-25	WOS:000326373800010
J	Basannagari, B; Kala, CP				Basannagari, Basavaraj; Kala, Chandra Prakash			Climate Change and Apple Farming in Indian Himalayas: A Study of Local Perceptions and Responses	PLOS ONE			English	Article								Apple farming is an important activity and profession of farmer communities in the Himalayan states of India. At present, the traditional apple farming is under stress due to changes in climate. The present study was undertaken in an Indian Himalayan state, Himachal Pradesh, with the major aim of studying perceptions of farmers on the effects of climate change on apple farming along the altitudinal gradient. Through questionnaire survey, the perceptions of farmers were recorded at low hills (<2500 m), mid-hills (2500-3000 m), and upper hills (>3000 m). At all elevation range the majority of farmers reported that there was increase in atmospheric temperature, and hence at low hills 72% farmers believed that this increase in temperature was responsible for decline in fruit size and so that the quality. Thirty five percent farmers at high hills and 30% at mid hills perceived frost as a major cause for damaging apple farming whereas at low hills 24% farmers perceived hailstorm as the major deterrent for apple farming. The majority of farmers, along the altitude (92% at high hills, 79% at mid hills and 83% at low hills), reported decrease in snowfall. The majority of farmers at low altitude and mid altitude reported decline in apple farming whereas 71% farmers at high hill areas refused decline in apple farming. About 73-83% farmers admitted delay in apple's harvesting period. At mid hills apple scab and at low hills pest attack on apple crops are considered as the indicators of climate change. The change in land use practices was attributed to climate change and in many areas the land under apple farming was replaced for production of coarse grains, seasonal vegetables and other horticulture species. Scientific investigation claiming changes in Indian Himalayan climate corroborates perceptions of farmers, as examined during the present study.	[Basannagari, Basavaraj; Kala, Chandra Prakash] Indian Inst Forest Management, Bhopal, Madhya Pradesh, India	Indian Institute of Forest Management	Kala, CP (corresponding author), Indian Inst Forest Management, Bhopal, Madhya Pradesh, India.	cpkala@yahoo.co.uk	Kala, Chandra Prakash/E-9123-2017	Kala, Chandra Prakash/0000-0002-7792-8646				[Anonymous], 2012, EC SURVEY HIMACHAL P; [Anonymous], 2006, EC SURVEY HIMACHAL P; Asghar A, 2012, PAK J BOT, V44, P1913; Awasthi R P, 2001, PRODUCTIVITY TEMPERA, P1; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Beattie BB, 1978, SCI HORTICULTURE, V7, P325; Byrne D.H, 1992, TEXAS HORTICULTURIST, V18, P8; Caprio JM, 1999, CAN J PLANT SCI, V79, P129, DOI 10.4141/P98-028; Dash SK, 2007, CURR SCI INDIA, V93, P782; Deodhar SY, 2007, INDIAN J EC BUSINESS, V6, P35; Forshey C G., 1990, P NEW YORK STATE HOR, V135, P71; Fujisawa M, 2013, REG ENVIRON CHANGE, V13, P1211, DOI 10.1007/s10113-013-0434-6; Ghosh SP, 1999, DECIDUOUS FRUIT PROD, P38; Jindal KK, 2000, PRODUCTIVITY TEMPERA, P12; JMAFF, 2008, COMPR COUNT GLOB WAR; Kala C. P., 2010, Journal of Forest Science (Prague), V56, P373, DOI 10.17221/113/2009-JFS; Kala CP, 2007, CURR SCI INDIA, V93, P1828; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; KRONENBERG HG, 1979, NETH J AGR SCI, V27, P131; Lee H.-G., 2010, J EXP BIOMED SCI, V16, P213; Luedeling E, 2009, CLIMATIC CHANGE, V96, P219, DOI 10.1007/s10584-009-9581-7; Partap U, 2002, PRODUCTIVITY POLLINA, P104; Rana Ranbir Singh, 2008, ISPRS ARCHIES 38, P131; Renton A., 2009, 130 OXF INT; RICHARDSON E A, 1974, Hortscience, V9, P331; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Seo HH, 2003, EFFECTS CLIMATIC CHA; Sharma RP., 2006, TEMPERATE HORTICULTU, P7; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Silori, 2013, BIODIVERSITY COMMUNI, P259; Thamaraikannan M, 2010, FACTS YOU        SEP, P7; Vedwan N, 2001, CLIM RES, V19, P109, DOI 10.3354/cr019109; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x	34	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77976	10.1371/journal.pone.0077976	http://dx.doi.org/10.1371/journal.pone.0077976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205051	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500084
J	Dilworth, MR; Andersson, I; Renshall, LJ; Cowley, E; Baker, P; Greenwood, S; Sibley, CP; Wareing, M				Dilworth, Mark Robert; Andersson, Irene; Renshall, Lewis James; Cowley, Elizabeth; Baker, Philip; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark			Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular Phenotype	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; KNOCKOUT MOUSE; PLACENTAL TRANSPORT; ADULT LIFE; RAT MODEL; INTRAUTERINE; PREECLAMPSIA; HYPERTENSION; PREGNANCIES; MORBIDITY	Fetal growth restriction (FGR) is defined as the inability of a fetus to achieve its genetic growth potential and is associated with a significantly increased risk of morbidity and mortality. Clinically, FGR is diagnosed as a fetus falling below the 5th centile of customised growth charts. Sildenafil citrate (SC, Viagra (TM)), a potent and selective phosphodiesterase-5 inhibitor, corrects ex vivo placental vascular dysfunction in FGR, demonstrating potential as a therapy for this condition. However, many FGR cases present without an abnormal vascular phenotype, as assessed by Doppler measures of uterine/umbilical artery blood flow velocity. Thus, we hypothesized that SC would not increase fetal growth in a mouse model of FGR, the placental-specific Igf2 knockout mouse, which has altered placental exchange capacity but normal placental blood flow. Fetal weights were increased (by 8%) in P0 mice following maternal SC treatment (0.4 mg/ml) via drinking water. There was also a trend towards increased placental weight in treated P0 mice (P = 0.056). Additionally, 75% of the P0 fetal weights were below the 5th centile, the criterion used to define human FGR, of the non-treated WT fetal weights; this was reduced to 51% when dams were treated with SC. Umbilical artery and vein blood flow velocity measures confirmed the lack of an abnormal vascular phenotype in the P0 mouse; and were unaffected by SC treatment. (14) C-methylaminoisobutyric acid transfer (measured to assess effects on placental nutrient transporter activity) per g placenta was unaffected by SC, versus untreated, though total transfer was increased, commensurate with the trend towards larger placentas in this group. These data suggest that SC may improve fetal growth even in the absence of an abnormal placental blood flow, potentially affording use in multiple sub-populations of individuals presenting with FGR.	[Dilworth, Mark Robert; Renshall, Lewis James; Cowley, Elizabeth; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Dilworth, Mark Robert; Renshall, Lewis James; Cowley, Elizabeth; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Andersson, Irene] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Baker, Philip] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Manchester; University of Manchester; University of Alberta; University of Auckland	Dilworth, MR (corresponding author), Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	m.r.dilworth@manchester.ac.uk	Dilworth, Mark/J-6395-2015; Wareing, Mark/J-6396-2015	Dilworth, Mark/0000-0002-7106-7451; Wareing, Mark/0000-0002-1333-0899; Greenwood, Susan/0000-0003-2867-4368	Medical Research Council Programme Grant [G0802770/92495]; Tommy's the Baby Charity, an Action Research Endowment Fund; Manchester Biomedical Research Centre; Greater Manchester Comprehensive Local Research Network; MRC [G0802770] Funding Source: UKRI; Medical Research Council [G0802770] Funding Source: researchfish	Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tommy's the Baby Charity, an Action Research Endowment Fund; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Greater Manchester Comprehensive Local Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a Medical Research Council Programme Grant (G0802770/92495) awarded to CPS, MW, SLG and PNB. The Maternal and Fetal Health Research Centre is supported by funding from Tommy's the Baby Charity, an Action Research Endowment Fund, the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acolet D., 2008, CONFIDENTIAL ENQUIRY; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Baschat AA, 2007, OBSTET NORMAL PROBLE, P771, DOI DOI 10.1016/B978-0-443-06930-7.50031-1; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bond H, 2008, J PHYSIOL-LONDON, V586, P2015, DOI 10.1113/jphysiol.2007.149104; Boolell M, 1996, Int J Impot Res, V8, P47; CHANG TC, 1994, BRIT J OBSTET GYNAEC, V101, P422, DOI 10.1111/j.1471-0528.1994.tb11916.x; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cox P, 2009, BEST PRACT RES CL OB, V23, P751, DOI 10.1016/j.bpobgyn.2009.06.006; Dilworth MR, 2011, PLACENTA, V32, P914, DOI 10.1016/j.placenta.2011.08.007; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Fisk NM, 2008, PLOS MED, V5, P22, DOI 10.1371/journal.pmed.0050022; Flexner LB, 1941, AM J PHYSIOL, V134, P0344, DOI 10.1152/ajplegacy.1941.134.2.344; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Herraiz S, 2012, BJOG-INT J OBSTET GY, V119, P1394, DOI 10.1111/j.1471-0528.2012.03430.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Kusinski LC, 2011, PLACENTA, V32, P871, DOI 10.1016/j.placenta.2011.07.086; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Lee J, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100438; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Marconi AM, 2009, REPROD SCI, V16, P373, DOI 10.1177/1933719108327591; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; Miller SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.029; Nassar AH, 2012, AM J PERINAT, V29, P429, DOI 10.1055/s-0032-1304823; Niknafs P, 2001, AM J PERINAT, V18, P325, DOI 10.1055/s-2001-17856; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Pellicer B, 2011, BJOG-INT J OBSTET GY, V118, P615, DOI 10.1111/j.1471-0528.2010.02839.x; Pomorski M, 2012, ARCH GYNECOL OBSTET, V285, P331, DOI 10.1007/s00404-011-1968-9; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Satterfield MC, 2010, J NUTR, V140, P251, DOI 10.3945/jn.109.114678; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; Villanueva-Garcia D, 2007, J OBSTET GYNAECOL, V27, P255, DOI 10.1080/01443610701194978; von Dadelszen P, 2011, BJOG-INT J OBSTET GY, V118, P624, DOI 10.1111/j.1471-0528.2010.02879.x; Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687; Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028	47	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77748	10.1371/journal.pone.0077748	http://dx.doi.org/10.1371/journal.pone.0077748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204949	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500053
J	Medina, KL; Tangen, SN; Seaburg, LM; Thapa, P; Gwin, KA; Shapiro, VS				Medina, Kay L.; Tangen, Sarah N.; Seaburg, Lauren M.; Thapa, Puspa; Gwin, Kimberly A.; Shapiro, Virginia Smith			Separation of Plasmacytoid Dendritic Cells from B-Cell-Biased Lymphoid Progenitor (BLP) and Pre-Pro B Cells Using PDCA-1	PLOS ONE			English	Article							MURINE BONE-MARROW; RECEPTOR-DEFICIENT MICE; IL-7 RECEPTOR; LINEAGE DIFFERENTIATION; RAG1 LOCUS; PRECURSORS; MOUSE; GENE; EXPRESSION; LACKING	B-cell-biased lymphoid progenitors (BLPs) and Pre-pro B cells lie at a critical juncture between B cell specification and commitment. However, both of these populations are heterogenous, which hampers investigation into the molecular changes that occur as lymphoid progenitors commit to the B cell lineage. Here, we demonstrate that there are PDCA-1(+)Siglec H+ plasmacytoid dendritic cells (pDCs) that co-purify with BLPs and Pre-pro B cells, which express little or no CD11c or Ly6C. Removal of PDCA-1(+) pDCs separates B cell progenitors that express high levels of a Rag1-GFP reporter from Rag1-GFP(low/neg) pDCs within the BLP and Pre-pro B populations. Analysis of Flt3-ligand knockout and IL-7R alpha knockout mice revealed that there is a block in B cell development at the all-lymphoid progenitor (ALP) stage, as the majority of cells within the BLP or Pre-pro B gates were PDCA-1+ pDCs. Thus, removal of PDCA-1+ pDCs is critical for analysis of BLP and Pre-pro B cell populations. Analysis of B cell potential within the B220(+)CD19(-) fraction demonstrated that AA4.1(+)Ly6D(+)PDCA-1(-) Prepro B cells gave rise to CD19(+) B cells at high frequency, while PDCA-1+ pDCs in this fraction did not. Interestingly, the presence of PDCA-1(+) pDCs within CLPs may help to explain the conflicting results regarding the origin of these cells.	[Medina, Kay L.; Tangen, Sarah N.; Seaburg, Lauren M.; Thapa, Puspa; Gwin, Kimberly A.; Shapiro, Virginia Smith] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Shapiro, VS (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	shapiro.virginia1@mayo.edu			NIH [R01 HL096108, R01 AI083279]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 HL096108 to K. L. M. and NIH R01 AI083279 to V. S. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Dolence JJ, 2011, EUR J IMMUNOL, V41, P324, DOI 10.1002/eji.201040710; Esashi E, 2012, EUR J IMMUNOL, V42, P573, DOI 10.1002/eji.201142045; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gwin K, 2010, J IMMUNOL, V185, P6572, DOI 10.4049/jimmunol.0904203; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Wang YH, 2004, IMMUNITY, V21, P1, DOI 10.1016/j.immuni.2004.07.003; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	40	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78408	10.1371/journal.pone.0078408	http://dx.doi.org/10.1371/journal.pone.0078408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205225	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500116
J	van Dam, LCJ; Ernst, MO				van Dam, Loes C. J.; Ernst, Marc O.			Knowing Each Random Error of Our Ways, but Hardly Correcting for It: An Instance of Optimal Performance	PLOS ONE			English	Article							INFORMATION; INTEGRATION; PERCEPTION; NOISE; MODEL	Random errors are omnipresent in sensorimotor tasks due to perceptual and motor noise. The question is, are humans aware of their random errors on an instance-by-instance basis? The appealing answer would be 'no' because it seems intuitive that humans would otherwise immediately correct for the errors online, thereby increasing sensorimotor precision. However, here we show the opposite. Participants pointed to visual targets with varying degree of feedback. After movement completion participants indicated whether they believed they landed left or right of target. Surprisingly, participants' left/right-discriminability was well above chance, even without visual feedback. Only when forced to correct for the error after movement completion did participants loose knowledge about the remaining error, indicating that random errors can only be accessed offline. When correcting, participants applied the optimal correction gain, a weighting factor between perceptual and motor noise, minimizing end-point variance. Together these results show that humans optimally combine direct information about sensorimotor noise in the system (the current random error), with indirect knowledge about the variance of the perceptual and motor noise distributions. Yet, they only appear to do so offline after movement completion, not while the movement is still in progress, suggesting that during movement proprioceptive information is less precise.	[van Dam, Loes C. J.; Ernst, Marc O.] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [van Dam, Loes C. J.; Ernst, Marc O.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Ernst, Marc O.] Bernstein Ctr Computat Neurosci, Tubingen, Germany	University of Bielefeld; University of Bielefeld	van Dam, LCJ (corresponding author), Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany.	Loes.van_Dam@uni-bielefeld.de	van Dam, Loes C.J./I-5141-2015	van Dam, Loes C.J./0000-0003-0590-9347; Ernst, Marc/0000-0003-4197-8569	Bernstein Centre for Computational Neuroscience, Tubingen (BMBF) [FKZ: 01GO1002]; EU [248587]	Bernstein Centre for Computational Neuroscience, Tubingen (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This research was supported by the Bernstein Centre for Computational Neuroscience, Tubingen (BMBF; FKZ: 01GO1002) and EU grant 248587 "THE.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2003, J NEUROSCI, V23, P3066; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; Cheron G, 2000, J CLIN NEUROPHYSIOL, V17, P280, DOI 10.1097/00004691-200005000-00006; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Goble DJ, 2010, NEUROSCI LETT, V481, P54, DOI 10.1016/j.neulet.2010.06.053; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; POST LJ, 1994, EXP BRAIN RES, V100, P107; Sabes PN, 1997, J NEUROSCI, V17, P7119; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Vitello MP, 2012, IMMERSIVE MULTIMODAL, P7, DOI DOI 10.1007/978-1-4471-2754-3; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78757	10.1371/journal.pone.0078757	http://dx.doi.org/10.1371/journal.pone.0078757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205308	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000326334500132
J	Vieira, DC; Fonseca, G				Vieira, Danilo Candido; Fonseca, Gustavo			The Importance of Vertical and Horizontal Dimensions of the Sediment Matrix in Structuring Nematodes Across Spatial Scales	PLOS ONE			English	Article							TURBULENT TIDAL CREEK; NORTH-SEA; COMMUNITY UNDERNEATH; SPECIES-DIVERSITY; MARINE NEMATODES; SULFIDE SYSTEM; FINE-SCALE; MEIOFAUNA; DISPERSAL; PATTERNS	Intensive surveys have been conducted to unravel spatial patterns of benthic infauna communities. Although it has been recognized that benthic organisms are spatially structured along the horizontal and vertical dimensions of the sediment, little is known on how these two dimensions interact with each other. In this study we investigated the interdependence between the vertical and horizontal dimensions in structuring marine nematodes assemblages. We tested whether the similarity in nematode species composition along the horizontal dimension was dependent on the vertical layer of the sediment. To test this hypothesis, three-cm interval sediment samples (15 cm depth) were taken independently from two bedforms in three estuaries. Results indicated that assemblages living in the top layers are more abundant, species rich and less variable, in terms of species presence/absence and relative abundances, than assemblages living in the deeper layers. Results showed that redox potential explained the greatest amount (12%) of variability in species composition, more than depth or particle size. The fauna inhabiting the more oxygenated layers were more homogeneous across the horizontal scales than those from the reduced layers. In contrast to previous studies, which suggested that reduced layers are characterized by a specific set of tolerant species, the present study showed that species assemblages in the deeper layers are more causal (characterized mainly by vagrant species). The proposed mechanism is that at the superficial oxygenated layers, species have higher chances of being resuspended and displaced over longer distances by passive transport, while at the deeper anoxic layers they are restricted to active dispersal from the above and nearby sediments. Such restriction in the dispersal potential together with the unfavorable environmental conditions leads to randomness in the presence of species resulting in the high variability between assemblages along the horizontal dimension.	[Vieira, Danilo Candido] Univ Fed Parana UFPR, CEM, Pontal Do Parana, Parana, Brazil; [Vieira, Danilo Candido; Fonseca, Gustavo] Univ Sao Paulo, Ctr Biol Marinha CEBIMar, Sao Paulo, Brazil	Universidade Federal do Parana; Universidade de Sao Paulo	Vieira, DC (corresponding author), Univ Fed Parana UFPR, CEM, Pontal Do Parana, Parana, Brazil.	vieiradc@yahoo.com.br	Vieira, Danilo/F-5176-2018; Fonseca, Gustavo/B-7673-2011; Fonseca, Gustavo/F-5138-2018	Vieira, Danilo/0000-0002-7989-6553; Fonseca, Gustavo/0000-0001-8625-4279; Fonseca, Gustavo/0000-0001-8625-4279	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/14019-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DCV was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI) (http://www.capes.gov.br/); and GF was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) number 2009/14019-0 (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2005, PERMUTATIONAL MULTIV; [Anonymous], 2004, PERMDISP FORTRAN COM; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; Bonsdorff E, 2003, BOREAL ENVIRON RES, V8, P135; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Chapman MG, 2010, MAR ECOL PROG SER, V398, P33, DOI 10.3354/meps08328; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; Danovaro R, 2000, PROG OCEANOGR, V46, P367, DOI 10.1016/S0079-6611(00)00026-4; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Camargo M.G., 2006, REV BRAS GEOCI NC, V36, P371, DOI DOI 10.25249/0375-7536.2006362371378; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; ESKIN RA, 1985, BIOL BULL, V169, P615, DOI 10.2307/1541303; FENCHEL TM, 1970, MAR BIOL, V7, P255, DOI 10.1007/BF00367496; FENCHEL TM, 1978, ANNU REV ECOL SYST, V9, P99, DOI 10.1146/annurev.es.09.110178.000531; Fenchel T, 2008, BIOL REV, V83, P553, DOI 10.1111/j.1469-185X.2008.00054.x; FINDLAY SEG, 1981, ESTUAR COAST SHELF S, V12, P471, DOI 10.1016/S0302-3524(81)80006-0; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; FLEEGER JW, 1987, STYGOLOGIA, V3, P35; FLEEGER JW, 1986, J EXP MAR BIOL ECOL, V95, P173, DOI 10.1016/0022-0981(86)90201-7; Fonseca G, 2011, AQUAT BIOL, V13, P27, DOI 10.3354/ab00347; Fonseca G, 2010, PROG OCEANOGR, V84, P174, DOI 10.1016/j.pocean.2009.11.001; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gallucci Fabiane, 2009, Marine Biodiversity, V39, P9; Gingold R, 2010, MAR BIOL, V157, P1741, DOI 10.1007/s00227-010-1447-z; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GOODAY AJ, 1986, DEEP-SEA RES, V33, P1345, DOI 10.1016/0198-0149(86)90040-3; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HODDA M, 1990, ESTUAR COAST SHELF S, V30, P325, DOI 10.1016/0272-7714(90)90001-8; Hodda M, 2007, ZOOTAXA, P265, DOI 10.11646/zootaxa.1668.1.14; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; JOINT IR, 1982, MAR BIOL, V72, P157, DOI 10.1007/BF00396916; Kotwicki L, 2005, HELGOLAND MAR RES, V59, P255, DOI 10.1007/s10152-005-0001-8; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Maria TF, 2012, ESTUAR COAST SHELF S, V97, P114, DOI 10.1016/j.ecss.2011.11.030; Modig H, 1998, J EXP MAR BIOL ECOL, V229, P133, DOI 10.1016/S0022-0981(98)00043-4; Moodley L, 2000, OPHELIA, V53, P203, DOI 10.1080/00785326.2000.10409450; OTT J, 1973, Netherlands Journal of Sea Research, V7, P233, DOI 10.1016/0077-7579(73)90047-1; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; PALMER MA, 1986, ESTUARIES, V9, P225, DOI 10.2307/1352134; PALMER MA, 1985, J MAR RES, V43, P179, DOI 10.1357/002224085788437280; Pinto TK, 2006, J MAR BIOL ASSOC UK, V86, P227, DOI 10.1017/S0025315406013075; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; REISE K, 1979, MAR BIOL, V54, P225, DOI 10.1007/BF00395785; Sandrini-Neto L., 2010, GAD GEN ANOVA DESIGN; Schratzberger M, 2007, MAR ENVIRON RES, V63, P368, DOI 10.1016/j.marenvres.2006.10.006; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; SOETAERT K, 1994, ESTUAR COAST SHELF S, V39, P367, DOI 10.1006/ecss.1994.1070; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Spray SL, 2004, WETLANDS, P157; Steyaert M, 1999, J MAR BIOL ASSOC UK, V79, P253, DOI 10.1017/S0025315498000289; Steyaert M, 2007, J EXP MAR BIOL ECOL, V345, P175, DOI 10.1016/j.jembe.2007.03.001; Steyaert M, 2003, ESTUAR COAST SHELF S, V58, P353, DOI 10.1016/S0272-7714(03)00086-6; Suguio K., 1973, INTRO SEDIMENTOLOGIA; Teiwes M, 2007, J FRESHWATER ECOL, V22, P429, DOI 10.1080/02705060.2007.9664173; TIETJEN JH, 1969, OECOLOGIA, V2, P251, DOI 10.1007/BF00386114; Udalov AA, 2005, PROG OCEANOGR, V67, P1, DOI 10.1016/j.pocean.2005.02.020; Van Colen C, 2009, MAR ECOL PROG SER, V381, P189, DOI 10.3354/meps07914; Warwick R, 1998, SYNOPSES BRIT FAUNA, V53, P1; Wells JT, 1995, DEV SEDIMENTOL, V53, P179, DOI DOI 10.1016/S0070-4571(05)80026-3; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3	63	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77704	10.1371/journal.pone.0077704	http://dx.doi.org/10.1371/journal.pone.0077704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204925	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500044
J	Li, DH; Chen, G; Yang, JC; Fan, XF; Gong, YS; Xu, GH; Cui, QH; Geng, B				Li, Danhua; Chen, Geng; Yang, Jichun; Fan, Xiaofang; Gong, Yongsheng; Xu, Guoheng; Cui, Qinghua; Geng, Bin			Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure	PLOS ONE			English	Article							HUMAN-DISEASE; BIOMARKERS; NEURODEGENERATION; EXPRESSION	Objective: To assess the global changes in and characteristics of the transcriptome of long noncoding RNAs (LncRNAs) in heart tissue, whole blood and plasma during heart failure (HF) and association with expression of paired coding genes. Methods: Here we used microarray assay to examine the transcriptome of LncRNAs deregulated in the heart, whole blood, and plasma during HF in mice. We confirmed the changes in LncRNAs by quantitative PCR. Results: We revealed and confirmed a number of LncRNAs that were deregulated during HF, which suggests a potential role of LncRNAs in HF. Strikingly, the patterns of expression of LncRNA differed between plasma and other tissue during HF. LncRNA expression was associated with LncRNA length in all samples but not in plasma during HF, which suggests that the global association of LncRNA expression and LncRNA length in plasma could be biomarkers for HF. In total, 32 LncRNAs all expressed in the heart, whole blood and plasma showed changed expression with HF, so they may be biomarkers in HF. In addition, sense-overlapped LncRNAs tended to show consistent expression with their paired coding genes, whereas antisense-overlapped LncRNAs tended to show the opposite expression in plasma; so different types of LncRNAs may have different characteristics in HF. Interestingly, we revealed an inverse correlation between changes in expression of LncRNAs in plasma and in heart, so circulating levels of LncRNAs may not represent just passive leakage from the HF heart but also active regulation or release of circulatory cells or other cells during HF. Conclusions: We reveal stable expression of LncRNAs in plasma during HF, which suggests a newly described component in plasma. The distinct expression patterns of circulatory LncRNAs during HF indicate that LncRNAs may actively respond to stress and thus serve as biomarkers of HF diagnosis and treatment.	[Li, Danhua; Yang, Jichun; Xu, Guoheng; Cui, Qinghua; Geng, Bin] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Chen, Geng] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China; [Cui, Qinghua] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China; [Li, Danhua; Chen, Geng; Yang, Jichun; Xu, Guoheng; Cui, Qinghua; Geng, Bin] Peking Univ, MOE Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China	Peking University; Peking University; Peking University; Peking University; Wenzhou Medical University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; bingeng@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major State Basic Research Development Program of China [2012CB517806, 2012CB5106, 2009CB941603]; National Natural Science Foundation of China [81170235, 81070114]; Program for New Century Excellent Talents in University	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the Major State Basic Research Development Program of China (Nos. 2012CB517806, 2012CB5106 and 2009CB941603), the National Natural Science Foundation of China (81170235 and 81070114), and the Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsheshet A, 2012, NAT REV CARDIOL, V9, P234, DOI 10.1038/nrcardio.2012.10; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Chen G, 2012, TRENDS MOL MED; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dorn GW, 2011, CIRC RES, V108, P1270, DOI 10.1161/CIRCRESAHA.110.229260; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Magistri M, 2012, TRENDS GENET, V28, P389, DOI 10.1016/j.tig.2012.03.013; Maisel AS, 2012, NAT REV CARDIOL, V9, P478, DOI 10.1038/nrcardio.2012.60; Mallardo M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-19; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qiu MT, 2013, TUMOUR BIOL; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spizzo R, 2012, ONCOGENE; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377	36	59	72	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77938	10.1371/journal.pone.0077938	http://dx.doi.org/10.1371/journal.pone.0077938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205036	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700062
J	Malingriaux, EA; Rupprecht, A; Gille, L; Jovanovic, O; Jezek, P; Jaburek, M; Pohl, EE				Malingriaux, Elena A.; Rupprecht, Anne; Gille, Lars; Jovanovic, Olga; Jezek, Petr; Jaburek, Martin; Pohl, Elena E.			Fatty Acids are Key in 4-Hydroxy-2-Nonenal-Mediated Activation of Uncoupling Proteins 1 and 2	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTON CONDUCTANCE; MEMBRANE-PROTEINS; MITOCHONDRIA; PRODUCT; RECONSTITUTION; CONFORMATION; ADDUCTION; TRANSPORT; MECHANISM	The production of reactive oxygen species (ROS) in mitochondria is very sensitive to the proton motive force and may be decreased by mild uncoupling, mediated e. g. by mitochondrial uncoupling proteins (UCPs). UCPs were conversely hypothesized to be activated by ROS. Conclusions from experiments studying the reactive product of lipid peroxidation 4-hydroxy-2-nonenal (HNE) in isolated mitochondria and UCP knock-out mice are highly controversial. Here we investigated the molecular mechanism of HNE action by evaluating the separate contributions of lipid and protein phases of the membrane and by comparing UCP1 and UCP2, which were reconstituted in planar lipid bilayers. We demonstrated that aldehyde does not directly activate either UCP1 or UCP2. However, HNE strongly potentiated the membrane conductance increase (G(m)) mediated by different long-chain fatty acids in UCP-containing and in UCP-free membranes and this suggest the involvement of both lipid-mediated and protein-mediated mechanisms with FA playing the central role. G(m) increase was concentration-dependent and exhibited a typical saturation kinetic with the binding constant 0.3 mM. By using Electron Paramagnetic Resonance, membrane fluidity change could be excluded as a cause for the HNE-mediated increase in the presence of FA. The impact of the HNE binding to definite positively charged UCP amino acid residues is discussed as a possible protein-mediated mechanism of the UCP activation.	[Malingriaux, Elena A.; Rupprecht, Anne; Jovanovic, Olga; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Gille, Lars] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Jezek, Petr; Jaburek, Martin] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Pohl, EE (corresponding author), Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	elena.pohl@vedmeduni.ac.at	Pohl, Elena E./A-4025-2009; Jaburek, Martin/B-9652-2012; Jabůrek, Martin/H-1114-2019; Jezek, Petr/B-9264-2012	Pohl, Elena E./0000-0002-0604-5950; Jabůrek, Martin/0000-0002-4357-1116; Jezek, Petr/0000-0002-2720-9395	Deutsche Forschungsgemeinschaft [Po 524/3-1]; Austrian Research Funds [P 25123-820]; Czech Science Foundation [P302/10/0346]; Austrian Science Fund (FWF) [P 25123] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Research Funds(Austrian Science Fund (FWF)); Czech Science Foundation(Grant Agency of the Czech Republic); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft (Po 524/3-1 to EP, http://www.dfg.de/), Austrian Research Funds (P 25123-820 to EP, http://www.fwf.ac.at/) and Czech Science Foundation (P302/10/0346 to PJ, www.gacr.czc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenko YN, 1996, ARCH BIOCHEM BIOPHYS, V333, P225, DOI 10.1006/abbi.1996.0385; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Beck V, 2006, BBA-BIOENERGETICS, V1757, P474, DOI 10.1016/j.bbabio.2006.03.006; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berliner Lj, 1976, SEELING SPIN LABELLI; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carini M, 2004, MASS SPECTROM REV, V23, P281, DOI 10.1002/mas.10076; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Guichardant M, 1998, FREE RADICAL BIO MED, V25, P1049, DOI 10.1016/S0891-5849(98)00149-X; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jezek J, 2010, PHYSIOL RES, V59, P737, DOI 10.33549/physiolres.931905; Korshunov S., 1997, FEBS LETT, V41, P15; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; SHIN G, 1989, J MOL CELL CARDIOL, V21, P1029, DOI 10.1016/0022-2828(89)90801-8; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Stuart LJ, 2006, ORG LETT, V8, P79, DOI 10.1021/ol052550d; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Woyda-Ploszczyca AM, 2012, J BIOENERG BIOMEMBR, V44, P525, DOI 10.1007/s10863-012-9456-x; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685	49	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77786	10.1371/journal.pone.0077786	http://dx.doi.org/10.1371/journal.pone.0077786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204965	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200039
J	Colombatti, R; De Bon, E; Bertomoro, A; Casonato, A; Pontara, E; Omenetto, E; Saggiorato, G; Steffan, A; Damian, T; Cella, G; Teso, S; Manara, R; Rampazzo, P; Meneghetti, G; Basso, G; Sartori, MT; Sainati, L				Colombatti, Raffaella; De Bon, Emiliano; Bertomoro, Antonella; Casonato, Alessandra; Pontara, Elena; Omenetto, Elisabetta; Saggiorato, Graziella; Steffan, Agostino; Damian, Tamara; Cella, Giuseppe; Teso, Simone; Manara, Renzo; Rampazzo, Patrizia; Meneghetti, Giorgio; Basso, Giuseppe; Sartori, Maria Teresa; Sainati, Laura			Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PULMONARY-HYPERTENSION; PLASMA-LEVELS; TISSUE FACTOR; RISK; HYPERCOAGULABILITY; HYDROXYCARBAMIDE; ADAMTS-13; ADHESION; ANEMIA	Background: Thrombotic complications in Sickle Cell Disease (SCD) arise since infancy, but the role of the coagulation system in children has been poorly explored. To determine its role in the development of clinical complications in childhood we measured coagulation and endothelial parameters in children with SCD at steady state. Methods: Markers of thrombin generation, fibrin dissolution and endothelial activation were evaluated in 38 children with SS-S beta degrees, 6 with SC disease and 50 age and blood group matched controls. Coagulation variables were correlated with markers of hemolysis and inflammation, with the presence of cerebral and lung vasculopathy and with the frequency of clinical complications. Results: SS-S beta degrees patients presented higher levels of factor VIII, von Willebrand factor antigen (VWF:Ag) and collagen binding activity, tissue plasminogen activator antigen (t-PA:Ag), D-dimer, p-selectin, prothrombin fragment1+2 (F1+2) and lower ADAMTS-13: activity/VWF: Ag (p<0.05) compared to controls and SC patients. In SS-S beta degrees patients coagulation variables correlated positively with markers of inflammation, hemolysis, and negatively with HbF (p<0.05). Patients with cerebral silent infarcts showed significant decrease in t-PA: Ag and ADAMTS-13 Antigen and a tendency toward higher D-dimer, F1+2, TAT compared to patients without them. D-dimer was associated with a six fold increased risk of cerebral silent infarcts. No correlation was found between coagulation activation and large vessel vasculopathy or other clinical events except for decreased t-PA: Ag in patients with tricuspid Rigurgitant Velocity >2.5m/sec. Conclusions: SS-S beta degrees disease is associated with extensive activation of the coagulation system at steady state since young age. ADAMTS-13 and t-PA: Ag are involved in the development of cerebral silent infarcts.	[Colombatti, Raffaella; Basso, Giuseppe; Sainati, Laura] Univ Padua, Dept Pediat, Clin Pediat Hematol Oncol, Azienda Osped, Padua, Italy; [De Bon, Emiliano; Bertomoro, Antonella; Casonato, Alessandra; Pontara, Elena; Omenetto, Elisabetta; Saggiorato, Graziella; Cella, Giuseppe; Sartori, Maria Teresa] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Azienda Osped, Padua, Italy; [Steffan, Agostino; Damian, Tamara] Ctr Riferimento Oncol, Dept Diagnost Lab & Cellular Therapy, I-33081 Aviano, Italy; [Teso, Simone] Univ Padua, Padua, Italy; [Manara, Renzo] Univ Padua, Neuroradiol Unit, Azienda Osped, Padua, Italy; [Rampazzo, Patrizia; Meneghetti, Giorgio] Univ Padua, Dept Neurol Sci, Neurosonol Unit, Azienda Osped, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Aviano (CRO); University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Colombatti, R (corresponding author), Univ Padua, Dept Pediat, Clin Pediat Hematol Oncol, Azienda Osped, Padua, Italy.	rcolombatti@gmail.com	Steffan, Agostino/ABE-5972-2020; Colombatti, Raffaella/D-2910-2017; Teso, Simone/F-3585-2015	Steffan, Agostino/0000-0002-6320-3054; Colombatti, Raffaella/0000-0001-9797-0457; Teso, Simone/0000-0002-6914-7567; Manara, Renzo/0000-0002-5130-3971; BASSO, GIUSEPPE/0000-0002-2634-9302	Fondazione Citta della Speranza [11/04]	Fondazione Citta della Speranza	The Research was performed at the Azienda Ospedaliera-Universita di Padova, with a Grant from the Fondazione Citta della Speranza 11/04. http://www.cittadellasperanza.org/web/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029786; Ataga KI, 2009, HAEMATOL-HEMATOL J, V94, P1481, DOI 10.3324/haematol.2009.013672; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Colombatti R, 2012, PEDIATR BLOOD CANCER, V59, P1275, DOI 10.1002/pbc.24110; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; Connes P, 2013, BRIT J HAEMATOL, V161, P484, DOI 10.1111/bjh.12300; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; FAMODU AA, 1987, J CLIN PATHOL, V40, P1487, DOI 10.1136/jcp.40.12.1487; Fujioka M, 2010, BLOOD, V115, P1650, DOI 10.1182/blood-2009-06-230110; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gavins F, 2007, MICROCIRCULATION, V14, P667, DOI 10.1080/10739680701404903; Gordeuk VR, 2011, HAEMATOL-HEMATOL J, V96, P33, DOI 10.3324/haematol.2010.030767; Hoppe C, 2004, BLOOD, V103, P2391, DOI 10.1182/blood-2003-09-3015; Kassim AA, 2013, ANNU REV MED, V64, P451, DOI 10.1146/annurev-med-120611-143127; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; KAUL DK, 1993, BLOOD, V81, P2429; Klarmann D, 2010, TRANSFUSION, V50, P1571, DOI 10.1111/j.1537-2995.2010.02604.x; Krishnan S, 2008, THROMB RES, V122, P455, DOI 10.1016/j.thromres.2007.12.004; Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; LESLIE J, 1975, BRIT J HAEMATOL, V30, P159, DOI 10.1111/j.1365-2141.1975.tb00530.x; Liesner R, 1998, BRIT J HAEMATOL, V103, P1037; Lipp G, 2007, SEMIN THROMB HEMOST, V33, P816, DOI 10.1055/s-2007-1000373; Mohan JS, 2005, BLOOD COAGUL FIBRIN, V16, P209, DOI 10.1097/01.mbc.0000164431.98169.8f; Monagle P, 2010, BLOOD REV, V24, P63, DOI 10.1016/j.blre.2009.12.001; Montanaro M, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-36; Morris CR, 2011, HAEMATOL-HEMATOL J, V96, P1, DOI 10.3324/haematol.2010.035097; Noubouossie DCF, 2012, THROMB RES, V130, P259, DOI 10.1016/j.thromres.2011.10.016; Noubouossie DF, 2012, AM J HEMATOL, V87, P145, DOI 10.1002/ajh.22206; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; PHILLIPS G, 1988, AM J HEMATOL, V29, P52, DOI 10.1002/ajh.2830290113; Schnog JJB, 2006, AM J HEMATOL, V81, P492, DOI 10.1002/ajh.20653; Setty BNY, 2012, BRIT J HAEMATOL, V157, P370, DOI 10.1111/j.1365-2141.2012.09065.x; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Shenkman B, 2006, THROMB HAEMOSTASIS, V96, P160, DOI 10.1160/TH06-01-0019; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P756, DOI 10.2174/157016112803520738; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677	44	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78801	10.1371/journal.pone.0078801	http://dx.doi.org/10.1371/journal.pone.0078801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205317	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400105
J	Takada, S				Takada, Shinobu			Post-Embryonic Induction of ATML1-SRDX Alters the Morphology of Seedlings	PLOS ONE			English	Article							LAYER-SPECIFIC GENE; EPIDERMAL-CELL DIFFERENTIATION; ABC TRANSPORTER; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; FIDDLEHEAD; RECEPTOR; SECRETION; PROTEINS	Arabidopsis thaliana MERISTEM LAYER 1 (ATML1), an HD-ZIP class IV homeobox gene, is one of the key regulators promoting epidermal cell differentiation in Arabidopsis thaliana. We recently showed that ATML1 was able to confer an ectopic shoot epidermis cell fate to non-epidermal tissues of seedlings, suggesting that ATML1 is a master regulator of epidermal cell fate. To further assess the roles of ATML1 and its homologs in epidermal cell differentiation, I generated transgenic plants expressing ATML1 fused with a transcriptional repressor sequence (ATML1-SRDX). Estradiol-induced expression of ATML1-SRDX in the seedlings decreased transcript levels of several epidermis-related genes. Moreover, these transgenic plants exhibited phenotypes such as increased permeability to a hydrophilic dye and fusion of leaves and cotyledons, which are reminiscent of epidermis and/or cuticle-deficient mutants. Epidermal cell morphology was severely affected in the strong lines: filamentous protrusions were formed on the surface of the cotyledons. Marker gene analyses showed that these protrusions did not have epidermis, mesophyll, root hair, or trichome cell identity, suggesting that post-embryonic expression of ATML1-SRDX was sufficient to alter cell identity in pre-existing protodermal cells of the cotyledons. Taken together, these results suggest that ATML1 and/or its target genes are not only necessary for the initial specification of epidermal cell fate but also may be necessary for the maintenance of epidermal cells in later stages.	Osaka Univ, Dept Biol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan	Osaka University	Takada, S (corresponding author), Osaka Univ, Dept Biol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan.	shinobu_takada@bio.sci.osaka-u.ac.jp	Takada, Shinobu/AAI-1590-2020	Takada, Shinobu/0000-0001-6587-2166	Japan Society for the Promotion of Science (JSPS) [20657012, 23657036, 22687003]; Grants-in-Aid for Scientific Research [23657036] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Challenging Exploratory Research (No. 20657012 and No. 23657036 to S. T.) from the Japan Society for the Promotion of Science (JSPS) and by a grant-in-aid for Young Scientists (No. 22687003 to S. T.) from JSPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, PLANT CELL PHYSIOL, V40, P571, DOI 10.1093/oxfordjournals.pcp.a029579; Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Goh T, 2012, DEVELOPMENT, V139, P883, DOI 10.1242/dev.071928; Heyl A, 2008, PLANT PHYSIOL, V147, P1380, DOI 10.1104/pp.107.115436; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; LOLLE SJ, 1992, DEV BIOL, V152, P383, DOI 10.1016/0012-1606(92)90145-7; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Lynn K, 1999, DEVELOPMENT, V126, P469; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Weijers D, 2001, DEVELOPMENT, V128, P4289; Yephremov A, 1999, PLANT CELL, V11, P2187, DOI 10.1105/tpc.11.11.2187; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	32	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79312	10.1371/journal.pone.0079312	http://dx.doi.org/10.1371/journal.pone.0079312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205380	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400115
J	Barbero, A; Astiz, S; Lopez-Bote, CJ; Perez-Solana, ML; Ayuso, M; Garcia-Real, I; Gonzalez-Bulnes, A				Barbero, Alicia; Astiz, Susana; Lopez-Bote, Clemente J.; Perez-Solana, Maria L.; Ayuso, Miriam; Garcia-Real, Isabel; Gonzalez-Bulnes, Antonio			Maternal Malnutrition and Offspring Sex Determine Juvenile Obesity and Metabolic Disorders in a Swine Model of Leptin Resistance	PLOS ONE			English	Article							BETA-CELL FUNCTION; STEAROYL-COA DESATURASE; NATIONAL-BIRTH-COHORT; INSULIN-RESISTANCE; GROWTH-RETARDATION; GLUCOSE-TOLERANCE; PRETERM BIRTH; IBERIAN PIGS; FETAL-GROWTH; ACID CONTENT	The present study aimed to determine, in a swine model of leptin resistance, the effects of type and timing of maternal malnutrition on growth patterns, adiposity and metabolic features of the progeny when exposed to an obesogenic diet during their juvenile development and possible concomitant effects of the offspring sex. Thus, four groups were considered. A CONTROL group involved pigs born from sows fed with a diet fulfilling their daily maintenance requirements for pregnancy. The treated groups involved the progeny of females fed with the same diet but fulfilling either 160% or 50% of pregnancy requirements during the entire gestation (OVERFED and UNDERFED, respectively) or 100% of requirements until Day 35 of pregnancy and 50% of such amount from Day 36 onwards (LATE-UNDERFED). OVERFED and UNDERFED offspring were more prone to higher corpulence and fat deposition from early postnatal stages, during breast-feeding; adiposity increased significantly when exposed to obesogenic diets, especially in females. The effects of sex were even more remarkable in LATE-UNDERFED offspring, which had similar corpulence to CONTROL piglets; however, females showed a clear predisposition to obesity. Furthermore, the three groups of pigs with maternal malnutrition showed evidences of metabolic syndrome and, in the case of individuals born from OVERFED sows, even of insulin resistance and the prodrome of type-2 diabetes. These findings support the main role of early nutritional programming in the current rise of obesity and associated diseases in ethnics with leptin resistance.	[Barbero, Alicia; Lopez-Bote, Clemente J.; Ayuso, Miriam; Garcia-Real, Isabel] UCM, Fac Vet, Madrid, Spain; [Astiz, Susana; Perez-Solana, Maria L.; Gonzalez-Bulnes, Antonio] INIA, Madrid, Spain	Complutense University of Madrid	Gonzalez-Bulnes, A (corresponding author), INIA, Madrid, Spain.	bulnes@inia.es	ayuso, miriam/GPX-8386-2022; Astiz, Susana/AAN-8769-2021; Hernando, Miriam Ayuso/AAY-3751-2020; Gonzalez-Bulnes, Antonio/K-7691-2015; bote, clemente lopez/AAQ-6503-2021; REAL, MARIA ISABEL GARCIA/AAC-3654-2020; Lopez-Bote, Clemente/F-5103-2014	ayuso, miriam/0000-0001-6045-394X; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Lopez-Bote, Clemente/0000-0002-6839-8057; Garcia Real, Maria Isabel/0000-0002-8886-3956; BARBERO, ALICIA/0000-0003-0213-6932	Spanish Ministry of Economy and Competitiveness [AGL2010-21991-C03-03]; FEDER	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission)	The experimental work was supported by funds from the Spanish Ministry of Economy and Competitiveness (project AGL2010-21991-C03-03), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2011, J PEDIATR ENDOCR MET, V24, P427, DOI 10.1515/JPEM.2011.246; Al-Shoumer KA, 2008, ANN SAUDI MED, V28, P367; Aschner P, 2010, EXPERT REV CARDIOVAS, V8, P407, DOI [10.1586/erc.10.13, 10.1586/ERC.10.13]; Ashworth CJ, 2001, J REP FER S, P233; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bauer R, 2003, EUR J OBSTET GYN R B, V110, pS40, DOI 10.1016/S0301-2115(03)00171-4; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Bee G, 2004, J ANIM SCI, V82, P826; Berard J, 2010, MEAT SCI, V86, P845, DOI 10.1016/j.meatsci.2010.07.007; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Caron-Jobin M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.19; Chandler-Laney PC, 2010, OBESITY, V18, P2086, DOI 10.1038/oby.2010.44; Chang J, 2011, J VET SCI, V12, P91, DOI 10.4142/jvs.2011.12.1.91; Church TS, 2009, DIABETES CARE, V32, P1289, DOI 10.2337/dc08-1871; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Elder DA, 2006, J CLIN ENDOCR METAB, V91, P185, DOI 10.1210/jc.2005-0853; FISHER DA, 1972, CALIF MED, V117, P34; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Foxcroft G R, 2009, Soc Reprod Fertil Suppl, V66, P213; Gherlan Iuliana, 2012, Maedica (Bucur), V7, P205; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gonzalez-Bulnes A, 2012, CURR DIABETES REV, V8, P144, DOI 10.2174/157339912799424537; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; HAUSMAN DB, 1991, BIOL NEONATE, V59, P257, DOI 10.1159/000243359; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, pE708, DOI 10.1152/ajpendo.1997.273.4.E708; Kwiterovich Peter O, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P727; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; MARMER WN, 1981, LIPIDS, V16, P365, DOI 10.1007/BF02534964; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metges CC, 2005, J ANIM FEED SCI, V14, P15; Mitchell AD, 2001, J ANIM SCI, V79, P1800; Nieto R, 2002, BRIT J NUTR, V88, P39, DOI 10.1079/BJN2002591; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Ollivier L, 2009, ANIMAL, V3, P915, DOI 10.1017/S1751731109004297; Olufadi R, 2008, J CLIN PATHOL, V61, P697, DOI 10.1136/jcp.2007.048363; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Poudyal Hemant, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P217; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rey AI, 1997, ANIM SCI, V65, P515, DOI 10.1017/S1357729800008729; Rhodes P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007393; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; RUWE PJ, 1991, J ANIM SCI, V69, P1935, DOI 10.2527/1991.6951935x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheen AJ, 2010, DIABETES METAB, V36, pS31, DOI 10.1016/S1262-3636(10)70464-X; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Slyper AH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e4; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2013, ENDOCRINOL METAB IMM; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yee JK, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-19; YEN JT, 1982, J ANIM SCI, V54, P796, DOI 10.2527/jas1982.544796x	69	29	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78424	10.1371/journal.pone.0078424	http://dx.doi.org/10.1371/journal.pone.0078424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205230	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300059
J	Yang, J; Yang, YM; Ren, YN; Xie, RF; Zou, HJ; Fan, HH				Yang, Jie; Yang, Yiming; Ren, Yana; Xie, Rufeng; Zou, Hejian; Fan, Huahua			A Mouse Model of Adoptive Immunotherapeutic Targeting of Autoimmune Arthritis Using Allo-Tolerogenic Dendritic Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; C57BL/6 MICE; SUPPRESSOR-CELLS; RESPONSES	Objective: Tolerogenic dendritic cells (tDCs) are immunosuppressive cells with potent tolerogenic ability and are promising immunotherapeutic tools for treating rheumatoid arthritis (RA). However, it is currently unknown whether allogeneic tDCs (allo-tDCs) induce tolerance in RA, and whether the numbers of adoptively transferred allo-tDCs, or the requirement for pulsing with relevant auto-antigens are important. Methods: tDCs were derived from bone marrow precursors of C57BL/B6 mice, which were induced in vitro by GMCSF, IL-10 and TGF-beta 1. Collagen-induced arthritis (CIA) was modeled in D1 mice by immunization with type II collagen (CII) to test the therapeutic ability of allo-tDCs against CIA. Clinical and histopathologic scores, arthritic incidence, cytokine and anti-CII antibody secretion, and CD4(+)Th subsets were analyzed. Results: tDCs were characterized in vitro by a stable immature phonotype and a potent immunosuppressive ability. Following adoptive transfer of low doses (5x10(5)) of CII-loaded allo-tDCs, a remarkable anti-arthritic activity, improved clinical scores and histological end-points were found. Serological levels of inflammatory cytokines and anti-CII antibodies were also significantly lower in CIA mice treated with CII-pulsed allo-tDCs as compared with allo-tDCs. Moreover, treatment with allo-tDCs altered the proportion of Treg/Th17 cells. Conclusion: These findings suggested that allo-tDCs, especially following antigen loading, reduced the severity of CIA in a dose-dependent manner. The dampening of CIA was associated with modulated cytokine secretion, Treg/Th17 polarization and inhibition of anti-CII secretion. This study highlights the potential therapeutic utility of allo-tDCs in autoimmune arthritis and should facilitate the future design of allo-tDC immunotherapeutic strategies against RA.	[Yang, Jie; Yang, Yiming; Ren, Yana; Xie, Rufeng; Fan, Huahua] Shanghai Blood Ctr, Blood Engn Lab, Shanghai, Peoples R China; [Yang, Jie; Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China	Fudan University	Fan, HH (corresponding author), Shanghai Blood Ctr, Blood Engn Lab, Shanghai, Peoples R China.	fanhuahua021@gmail.com			Science and Technology Commission of Shanghai Municipality [12GWZX0201, 11140902900]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by a grant (12GWZX0201, 11140902900) from the Science and Technology Commission of Shanghai Municipality. The authors thank the Department of Animal Science in Shanghai Jiaotong University School of Medicine for the laboratory animal husbandry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00233; Backlund J, 2013, ANN RHEUM DIS, V72, P1225, DOI 10.1136/annrheumdis-2012-202055; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Healy Louise J, 2008, Open Rheumatol J, V2, P71, DOI 10.2174/1874312900802010071; Heo YJ, 2010, IMMUNOL LETT, V127, P150, DOI 10.1016/j.imlet.2009.10.006; Inglis JJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2319; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Ko HJ, 2010, J AUTOIMMUN, V34, P111, DOI 10.1016/j.jaut.2009.07.006; Kong N, 2012, ARTHRITIS RHEUM-US, V64, P2548, DOI 10.1002/art.34513; Kornete M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00165; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Lutzky V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2200; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Martin E, 2007, ARTHRITIS RHEUM-US, V56, P2255, DOI 10.1002/art.22655; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popov I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2031; Rutella S, 2009, HUM IMMUNOL, V70, P360, DOI 10.1016/j.humimm.2009.01.023; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Stoop JN, 2010, ARTHRITIS RHEUM-US, V62, P3656, DOI 10.1002/art.27756; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Zhao YP, 2012, RHEUMATOL INT, V32, P837, DOI 10.1007/s00296-011-2133-2	32	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77729	10.1371/journal.pone.0077729	http://dx.doi.org/10.1371/journal.pone.0077729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204938	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300030
J	Zhang, ZL; Wang, J; He, JX; Zheng, ZG; Zeng, XS; Zhang, CT; Ye, JM; Zhang, YJ; Zhong, NS; Lu, WJ				Zhang, Zili; Wang, Jian; He, Jianxing; Zheng, Zeguang; Zeng, Xiansheng; Zhang, Chenting; Ye, Jinmei; Zhang, Yajie; Zhong, Nanshan; Lu, Wenju			Genetic Variants in MUC4 Gene Are Associated with Lung Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MUC4/SIALOMUCIN COMPLEX; MULTIPLE ASSOCIATIONS; PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; DISEASE GENES; EXPRESSION; ACTIVATION; INFLAMMATION; CYTOKINES	Mucin MUC4, which is encoded by the MUC4 gene, plays an important role in epithelial cell proliferation and differentiation. Aberrant MUC4 overexpression is associated with invasive tumor proliferation and poor outcome in epithelial cancers. Collectively, the existing evidence suggests that MUC4 has tumor-promoter functions. In this study, we performed a case-control study of 1,048 incident lung cancer cases and 1,048 age-and sex frequency-matched cancer-free controls in a Chinese population to investigate the role of MUC4 gene polymorphism in lung cancer etiology. We identified nine SNPs that were significantly associated with increased lung cancer risk (P = 0.0425 for rs863582, 0.0333 for rs842226, 0.0294 for rs842225, 0.0010 for rs2550236, 0.0149 for rs2688515, 0.0191 for rs 2641773, 0.0058 for rs3096337, 0.0077 for rs859769, and 0.0059 for rs842461 in an additive model). Consistent with these single-locus analysis results, the haplotype analyses revealed an adverse effect of the haplotype "GGC" of rs3096337, rs859769, and rs842461 on lung cancer. Both the haplotype and diplotype "CTGAGC" of rs863582, rs842226, rs2550236, rs842225, and rs2688515 had an adverse effect on lung cancer, which is also consistent with the single-locus analysis. Moreover, we observed statistically significant interactions for rs863582 and rs842461 in heavy smokers. Our results suggest that MUC4 gene polymorphisms and their interaction with smoking may contribute to lung cancer etiology.	[Zhang, Zili; Wang, Jian; He, Jianxing; Zheng, Zeguang; Zhang, Chenting; Ye, Jinmei; Zhong, Nanshan; Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zeng, Xiansheng] Xiangyang Cent Hosp, Dept Resp Med, Xiangyang, Hubei, Peoples R China; [Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Lu, Wenju] Guangzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com		He, Jianxing/0000-0003-1737-8192	National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Natural Science Foundation [1035101200300000]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B031600301]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education [cxzd1025]; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education; Guangzhou Department of Education Yangcheng Scholarship	This work was supported by the National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), the Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), a Changjiang Scholars and Innovative Research Team in University grant (IRT0961), a Guangdong Natural Science Foundation team grant (1035101200300000), the Guangdong Department of Science and Technology of China (2009B050700041, 2010B031600301), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, a Guangdong Department of Education research grant (cxzd1025), and a Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER KB, 1994, ANN NY ACAD SCI, V725, P128, DOI 10.1111/j.1749-6632.1994.tb00275.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Andrianifahanana M, 2005, ONCOGENE, V24, P6143, DOI 10.1038/sj.onc.1208756; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Buisine MP, 1999, AM J RESP CELL MOL, V20, P209, DOI 10.1165/ajrcmb.20.2.3259; Choudhury A, 2004, BRIT J CANCER, V90, P657, DOI 10.1038/sj.bjc.6601604; CHURCHILL GA, 1994, GENETICS, V138, P963; COHEN BH, 1977, LANCET, V2, P523; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Davies DE, 1999, ALLERGY, V54, P771; Dudbridge F, 2006, AM J HUM GENET, V78, P1094, DOI 10.1086/504527; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dudbridge Frank, 2006, Human Genomics, V2, P310; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Fitzpatrick FA, 2001, INT IMMUNOPHARMACOL, V1, P1651, DOI 10.1016/S1567-5769(01)00102-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Godschalk R, 2002, CARCINOGENESIS, V23, P2081, DOI 10.1093/carcin/23.12.2081; GROSS MS, 1992, ANN GENET-PARIS, V35, P21; Jankovic M, 2004, PEDIATR BLOOD CANCER, V42, P106, DOI 10.1002/pbc.10418; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; JONES DG, 1973, J ANAT, V116, P470; Komatsu M, 2001, ONCOGENE, V20, P461, DOI 10.1038/sj.onc.1204106; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Leikauf GD, 2002, CHEST, V121, p166S, DOI 10.1378/chest.121.5_suppl.166S; LEWONTIN RC, 1988, GENETICS, V120, P849; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Llinares K, 2004, MODERN PATHOL, V17, P150, DOI 10.1038/modpathol.3800027; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; MARIN MG, 1994, PHARMACOL REV, V46, P35; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; OGATA S, 1992, CANCER RES, V52, P5971; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Sasco AJ, 2002, CANCER CAUSE CONTROL, V13, P609, DOI 10.1023/A:1019504210176; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Vainio H, 2001, ANN NY ACAD SCI, V952, P177, DOI 10.1111/j.1749-6632.2001.tb02740.x; Weber B, 2006, CELL SIGNAL, V18, P1748, DOI 10.1016/j.cellsig.2006.01.017; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang Jie, 2009, Zhonghua Zhongliu Zazhi, V31, P66, DOI 10.3760/cma.j.issn.0253-3766.2009.01.017	53	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77723	10.1371/journal.pone.0077723	http://dx.doi.org/10.1371/journal.pone.0077723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204934	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600045
J	Tiwari, RP; Rajkonwar, C; Patel, SJ				Tiwari, Raghavendra Prasad; Rajkonwar, Chinmoy; Patel, Satish Jaychandbhai			Funalichnus bhubani isp nov from Bhuban Formation, Surma Group (Lower -Middle Miocene) of Aizawl, Mizoram, India	PLOS ONE			English	Article							ICHNOGENUS; BASIN	A new ichnospecies of the ichnogenus Funalichnus Pokorny is described from the Middle Bhuban Unit, Bhuban Formation, Surma Group (Lower - Middle Miocene) of Aizawl, Mizoram, India. Funalichnus bhubani isp. Nov. Is a large burrow displaying cylindrical segments that are oriented nearly perpendicular to the bedding plane. The new ichnospecies can be identified on the basis of general form, size, unlined passive filling and twisted rod-like structure. The association of Funalichnus bhubani isp. Nov. With Arenicolites, Diplocraterion, Ophiomorpha Psilonichnus Skolithos and Thalassinoides points to its bathymetric restriction. The deep extension of the burrow in clastic sediments provides a favourable condition for preservation in the shoreface environment and occurrence in fine-to medium-grained clastic sediments may be a preservational preference.	[Tiwari, Raghavendra Prasad; Rajkonwar, Chinmoy] Mizoram Univ, Dept Geol, Aizawl, Mizoram, India; [Patel, Satish Jaychandbhai] Maharaja Sayajirao Univ, Fac Sci, Dept Geol, Baroda, Gujarat, India	Mizoram University; Maharaja Sayajirao University Baroda	Tiwari, RP (corresponding author), Mizoram Univ, Dept Geol, Aizawl, Mizoram, India.	rptmzu@rediffmail.com	Tiwari, R P/AAS-8101-2020	Tiwari, Raghavendra/0000-0001-6083-4654	Department of Science & Technology, Govt. of India, New Delhi [ESS/16/254(3)/2005]	Department of Science & Technology, Govt. of India, New Delhi(Department of Science & Technology (India))	Department of Science & Technology, Govt. of India, New Delhi, grant received vide no. ESS/16/254(3)/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWN TM, 1983, PALAEOGEOGR PALAEOCL, V43, P95, DOI 10.1016/0031-0182(83)90050-0; d'Orbigny A, 1850, OURS ELEMENTAIRE PAL, V1, P1; Dasgupta S., 1982, Records of the Geological Survey of India, V112, P31; FREY RW, 1984, J PALEONTOL, V58, P333; Fritsch A, 1883, STUDIEN GEBIETE BOHM, VV, P139; Fritsch A, 1872, COMISSION BEI FRANTI, P51; Ganju J. L., 1975, B GEOLOGY MINERALOGI, V48, P28; GEINITZ H.B, 1842, CHARAKTERISTIK SCHIC, P63; Geinitz HB, 1850, CHARAKTERISTIK SCHIC, P63; Kachhara R. P., 2003, J PALEONTOL SOC INDI, V48, P59; Karunakaran, 1974, MISCELLANEOUS PUBLIC, V30, P93; MacEachern J.A., 1992, APPL ICHNOLOGY PETRO, V17, P57; MacEachern James A., 2007, P52, DOI 10.1016/B978-044452949-7/50130-3; Mehrotra R.C., 2001, Ichnos, V8, P63; Mehrotra R. C., 2002, Biological Memoirs, V28, P45; Pokorny R, 2008, ICHNOS, V15, P51, DOI 10.1080/10420940701192922; Rajkonwar C, 2013, HIMAL GEOL, V34, P18; Seilacher A., 1967, Marine Geology, V5, P413, DOI 10.1016/0025-3227(67)90051-5; Singh MC, 2010, J GEOL SOC INDIA, V76, P573, DOI 10.1007/s12594-010-0118-5; Tiwari R.P., 2001, Journal of the Palaeontological Society of India, V46, P147; Tiwari R. P., 2006, Journal of the Palaeontological Society of India, V51, P33; Tiwari RP, 2011, J EARTH SYST SCI, V120, P1127, DOI 10.1007/s12040-011-0131-0; Tiwari Raghavendra Prasad, 2000, Tertiary Research, V20, P79; Walker R.G., 1992, FACIES MODELS RESPON, P407	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77839	10.1371/journal.pone.0077839	http://dx.doi.org/10.1371/journal.pone.0077839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204992	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300118
J	Xu, PJ; Lu, B; Xiao, HJ; Fu, XW; Murphy, RW; Wu, KM				Xu, Pengjun; Lu, Bin; Xiao, Haijun; Fu, Xiaowei; Murphy, Robert W.; Wu, Kongming			The Evolution and Expression of the Moth Visual Opsin Family	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BAYESIAN POSTERIOR PROBABILITIES; COLOR-VISION; GENE-EXPRESSION; ADAPTIVE EVOLUTION; BLUE OPSIN; EYES; DUPLICATION; PIGMENTS; BUTTERFLIES	Because visual genes likely evolved in response to their ambient photic environment, the dichotomy between closely related nocturnal moths and diurnal butterflies forms an ideal basis for investigating their evolution. To investigate whether the visual genes of moths are associated with nocturnal dim-light environments or not, we cloned long-wavelength (R), blue (B) and ultraviolet (UV) opsin genes from 12 species of wild-captured moths and examined their evolutionary functions. Strong purifying selection appeared to constrain the functions of the genes. Dark-treatment altered the levels of mRNA expression in Helicoverpa armigera such that R and UV opsins were up-regulated after dark-treatment, the latter faster than the former. In contrast, B opsins were not significantly up-regulated. Diel changes of opsin mRNA levels in both wild-captured and lab-reared individuals showed no significant fluctuation within the same group. However, the former group had significantly elevated levels of expression compared with the latter. Consequently, environmental conditions appeared to affect the patterns of expression. These findings and the proportional expression of opsins suggested that moths potentially possessed color vision and the visual system played a more important role in the ecology of moths than previously appreciated. This aspect did not differ much from that of diurnal butterflies.	[Xu, Pengjun; Xiao, Haijun; Fu, Xiaowei; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Lu, Bin] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	XIAO, Haijun/AAJ-5321-2021; Xiao, Haijun/HGE-3088-2022	XIAO, Haijun/0000-0002-0832-0493; Xiao, Haijun/0000-0002-0832-0493	National Basic Research Program of China [2012CB114104]; Science Fund for Creative Research Groups of the National Science Foundation of China [31321004]	National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Groups of the National Science Foundation of China	This work was supported by National Basic Research Program of China (No. 2012CB114104) and Science Fund for Creative Research Groups of the National Science Foundation of China (No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; Baird E, 2011, BIOL LETTERS, V7, P499, DOI 10.1098/rsbl.2010.1205; BERNARD GD, 1979, J COMP PHYSIOL, V134, P95, DOI 10.1007/BF00610467; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Carleton K, 2009, INTEGR ZOOL, V4, P75, DOI 10.1111/j.1749-4877.2008.00137.x; Chittka L, 1996, NATURWISSENSCHAFTEN, V83, P136, DOI 10.1007/BF01142181; CUTLER DE, 1995, J EXP BIOL, V198, P1909; DANTHANARAYANA W, 1976, AUST J ZOOL, V24, P65, DOI 10.1071/ZO9760065; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; Drummond AJ, 2007, TRACER V1 4, V1.4; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Frentiu FD, 2007, MOL BIOL EVOL, V24, P2016, DOI 10.1093/molbev/msm132; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Hofmann CM, 2009, INTEGR COMP BIOL, V49, P630, DOI 10.1093/icb/icp079; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hunt DM, 2001, J EXP BIOL, V204, P3333; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kashiyama K, 2009, MOL BIOL EVOL, V26, P299, DOI 10.1093/molbev/msn251; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 1999, J EXP BIOL, V202, P2619; Koyanagi M, 2008, J MOL EVOL, V66, P130, DOI 10.1007/s00239-008-9065-9; Larmuseau MHD, 2010, MOL ECOL, V19, P2256, DOI 10.1111/j.1365-294X.2010.04643.x; Lewis T, 1984, ELEMENTS FRONTIERS I; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Nielsen R, 1998, GENETICS, V148, P929; O'Quin KE, 2010, MOL BIOL EVOL, V27, P2839, DOI 10.1093/molbev/msq171; Oba Y, 2009, GENE, V436, P66, DOI 10.1016/j.gene.2009.02.001; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schmitz L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-338; Sison-Mangus MP, 2008, J EXP BIOL, V211, P361, DOI 10.1242/jeb.012617; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Smith AR, 2011, MOL ECOL, V20, P299, DOI 10.1111/j.1365-294X.2010.04935.x; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobler M, 2010, BIOL LETTERS, V6, P98, DOI 10.1098/rsbl.2009.0549; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Wei Guo-Shu, 2002, Acta Entomologica Sinica, V45, P323; Weiss MR, 2001, VISION LEARNING SOME; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yack JE, 2007, ARTHROPOD STRUCT DEV, V36, P11, DOI 10.1016/j.asd.2006.07.001; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9	67	15	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78140	10.1371/journal.pone.0078140	http://dx.doi.org/10.1371/journal.pone.0078140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205129	Green Published, gold			2022-12-25	WOS:000326334500099
J	Chang, WP; Liu, ME; Chang, WC; Yang, AC; Ku, YC; Pai, JT; Huang, HL; Tsai, SJ				Chang, Wei-Pin; Liu, Mu-En; Chang, Wei-Chiao; Yang, Albert C.; Ku, Yan-Chiou; Pai, Jei-Tsung; Huang, Hsiao-Ling; Tsai, Shih-Jen			Sleep Apnea and the Risk of Dementia: A Population-Based 5-Year Follow-Up Study in Taiwan	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; ALZHEIMERS-DISEASE; WOMEN; MEMORY; ASSOCIATION; PERFORMANCE; CORTEX; RAT; AGE	Background: Sleep apnea (SA) has been associated with cognitive impairment. However, no data regarding the risk of dementia in patients with SA has been reported in the general population. This retrospective matched-control cohort study was designed to estimate and compare the risk of dementia in SA and non-SA patients among persons aged 40 and above over a 5-year period follow-up. Methods: We conducted a nationwide 5-year population-based study using data retrieved from the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan. The study cohort comprised 1414 patients with SA aged 40 years who had at least 1 inpatient service claim or 1 ambulatory care claim. The comparison cohort comprised 7070 randomly selected patients who were matched with the study group according to sex, age, and index year. We performed Cox proportional-hazards regressions to compute the 5-year dementia-free survival rates after adjusting for potentially confounding factors. Results: The SA patients in this study had a 1.70-times greater risk of developing dementia within 5 years of diagnosis compared to non-SA age-and sex-matched patients, after adjusting for other risk factors (95% confidence interval (CI) = 1.26-2.31; P < .01). For the gender-dependent effect, only females with SA were more likely to develop dementia (adjust HR: 2.38, 95% CI = 1.51-3.74; P < .001). For the age-dependent effect of different genders, males with SA aged 50-59 years had a 6.08 times greater risk for developing dementia (95% CI = 1.96-18.90), and females with SA aged >= 70 years had a 3.20 times greater risk of developing dementia (95% CI = 1.71-6.00). For the time-dependent effect, dementia may be most likely to occur in the first 2.5 years of follow-up (adjusted HR: 2.04, 95% CI = 1.35-3.07). Conclusions: SA may be a gender-dependent, age-dependent, and time-dependent risk factor for dementia.	[Chang, Wei-Pin; Pai, Jei-Tsung; Huang, Hsiao-Ling] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Ku, Yan-Chiou] Kaohsiung Vet Gen Hosp, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Chang, Wei-Chiao/0000-0002-8573-5924; Yang, Albert Chih-Chieh/0000-0003-2794-9649				Alchanatis M, 2008, SLEEP BREATH, V12, P17, DOI 10.1007/s11325-007-0133-y; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; Bliwise DL, 2002, J PSYCHOSOM RES, V53, P539, DOI 10.1016/S0022-3999(02)00436-1; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; KALES A, 1985, J CHRON DIS, V38, P427, DOI 10.1016/0021-9681(85)90138-9; Kheirandish L, 2005, PEDIATR RES, V58, P594, DOI 10.1203/01.pdr.0000176915.19287.e2; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; O'Hara R, 2005, NEUROLOGY, V65, P642, DOI 10.1212/01.wnl.0000173055.75950.bf; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; PICKETT CK, 1989, J APPL PHYSIOL, V66, P1656, DOI 10.1152/jappl.1989.66.4.1656; Popovic RM, 1998, J APPL PHYSIOL, V84, P1055, DOI 10.1152/jappl.1998.84.3.1055; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; REGENSTEINER JG, 1989, J APPL PHYSIOL, V66, P808, DOI 10.1152/jappl.1989.66.2.808; Saaresranta T, 2006, MATURITAS, V55, P255, DOI 10.1016/j.maturitas.2006.03.007; Schwartz DJ, 2007, J CLIN SLEEP MED, V3, P631; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zeng YM, 2009, CHINESE MED J-PEKING, V122, P68, DOI 10.3760/cma.j.issn.0366-6999.2009.01.013	29	80	86	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78655	10.1371/journal.pone.0078655	http://dx.doi.org/10.1371/journal.pone.0078655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205289	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300078
J	Hoey, SE; Buonocore, F; Cox, CJ; Hammond, VJ; Perkinton, MS; Williams, RJ				Hoey, Sarah E.; Buonocore, Federica; Cox, Carla J.; Hammond, Victoria J.; Perkinton, Michael S.; Williams, Robert J.			AMPA Receptor Activation Promotes Non-Amyloidogenic Amyloid Precursor Protein Processing and Suppresses Neuronal Amyloid-beta Production	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PHOSPHORYLATION; DISINTEGRIN; OLIGOMERS; TRANSMISSION; STIMULATION; TRAFFICKING	Soluble oligomeric amyloid beta peptide (A beta) generated from processing of the amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's Disease (AD) and through actions at glutamatergic synapses affects excitability and plasticity. The physiological control of APP processing is not fully understood but stimulation of synaptic NMDA receptors (NMDAR) can suppress A beta levels through an ERK-dependent increase in alpha-secretase activity. AMPA-type glutamate receptors (AMPAR) couple to ERK phosphorylation independently of NMDAR activation raising the possibility that stimulation of AMPAR might similarly promote non-amyloidogenic APP processing. We have tested this hypothesis by investigating whether AMPAR directly regulate APP processing in cultured mouse cortical neurons, by analyzing APP C-terminal fragments (CTFs), soluble APP (sAPP), A beta levels, and cleavage of an APP-GAL4 reporter protein. We report that direct stimulation of AMPAR increases non-amyloidogenic alpha-secretase-mediated APP processing and inhibits A beta production. Processing was blocked by the matrix metalloproteinase inhibitor TAPI-1 but was only partially dependent on Ca2+ influx and ERK activity. AMPAR can therefore, be added to the repertoire of receptors that couple to non-amyloidogenic APP processing at glutamatergic synapses and thus pharmacological targeting of AMPAR could potentially influence the development and progression of A beta pathology in AD.	[Hoey, Sarah E.; Buonocore, Federica; Perkinton, Michael S.; Williams, Robert J.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Cox, Carla J.; Hammond, Victoria J.; Williams, Robert J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; King's College London; University of Bath	Williams, RJ (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	r.j.williams@bath.ac.uk	Buonocore, Federica/AAT-7804-2020; Williams, Robert/A-9180-2008	Williams, Robert/0000-0002-2369-1989	Alzheimer's Society [126]; Research in Ageing [278]; MRC; BBSRC; Alzheimer&quot;s Society [126] Funding Source: researchfish	Alzheimer's Society; Research in Ageing; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer&quot;s Society	This work was supported by grants from the Alzheimer's Society to MSP and RJW (http://www.alzheimers.org.uk) SEH was supported by a studentship from Research in Ageing (Ref 278). CJC is supported by an MRC-doctoral training grant joint with the Alzheimer's Society (Ref 126) and VJH by a BBSRC doctoral training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JJ, 2008, NEUROBIOL AGING, V29, P992, DOI 10.1016/j.neurobiolaging.2007.01.003; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chappell AS, 2007, NEUROLOGY, V68, P1008, DOI 10.1212/01.wnl.0000260240.46070.7c; Choudhry F, 2012, NEUROBIOL AGING, V33, P960, DOI 10.1016/j.neurobiolaging.2010.07.008; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee RKK, 1996, ANN NY ACAD SCI, V777, P338, DOI 10.1111/j.1749-6632.1996.tb34443.x; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mills J, 1997, J NEUROSCI, V17, P9415; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Molina-Holgado F, 2008, J NEUROCHEM, V105, P2466, DOI 10.1111/j.1471-4159.2008.05332.x; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rainey-Smith SR, 2010, J NEUROCHEM, V113, P692, DOI 10.1111/j.1471-4159.2010.06634.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Schroeter H, 2007, J NEUROCHEM, V101, P1596, DOI 10.1111/j.1471-4159.2006.04434.x; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; Small DH, 2012, NEURODEGENER DIS, V10, P76, DOI 10.1159/000333126; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Verges DK, 2011, J NEUROSCI, V31, P11328, DOI 10.1523/JNEUROSCI.0607-11.2011; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78155	10.1371/journal.pone.0078155	http://dx.doi.org/10.1371/journal.pone.0078155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205136	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300043
J	Kang, C; Kim, SC; Lee, SH; Jeong, JH; Kim, DS; Kim, DH				Kang, Changwoo; Kim, Seong Chun; Lee, Soo Hoon; Jeong, Jin Hee; Kim, Dong Seob; Kim, Dong Hoon			Absolute Lymphocyte Count as a Predictor of Mortality in Emergency Department Patients with Paraquat Poisoning	PLOS ONE			English	Article							B-CELL-LYMPHOMA; FOLLICULAR LYMPHOMAS; CLINICAL-FEATURES; PROGNOSTIC-FACTOR; HEART-FAILURE; SURVIVAL; TOXICITY; DEATH; MECHANISMS	Background: Paraquat (PQ) is a potent, highly toxic and widely used herbicide. The major medical problems associated with PQ are accidental or suicidal ingestion. There are several prognostic markers of PQ poisoning, with the serum PQ concentration considered to be the best indicator of outcome. However, the measurement of such markers is limited in many hospitals. Objective: The present study was conducted to investigate the association of absolute lymphocyte count (ALC) and the 30-day mortality rate in patients with PQ poisoning. Methods: We performed a retrospective analysis of patients admitted to the emergency department after paraquat poisoning between January 2010 and April 2013. Independent risk factors including ALC for 30-day mortality were determined. The ALC was categorized in quartiles as <= 1700, 1700 to 3200, 3200 to 5000, and >5000. Univariate and multivariate Cox proportional hazard analysis were performed to determine the independent risk factors for mortality. Results: A total of 136 patients were included in the study, and the 30-day mortality was 73.5%. ALC was significantly higher in nonsurvivors than in survivors. The highest ALC quartile (ALC>5000; hazard ratio, 2.58; 95% CI, 1.08-6.21) was associated with increased mortality in multivariate analysis. In addition, old age, lower arterial PaCO2, increased peripheral neutrophil count, and high serum levels of creatinine were associated with mortality. Conclusion: The absolute lymphocyte count is associated with the 30-day mortality rate in patients with paraquat poisoning.	[Kang, Changwoo; Kim, Seong Chun; Lee, Soo Hoon; Jeong, Jin Hee; Kim, Dong Seob; Kim, Dong Hoon] Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital	Kim, SC (corresponding author), Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea.	gsimem@naver.com		Lee, Soo Hoon/0000-0002-2512-5905; Jeong, Jin Hee/0000-0002-1042-9359				Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Behl D, 2007, BRIT J HAEMATOL, V137, P409, DOI 10.1111/j.1365-2141.2007.06596.x; Castelino DJ, 1997, AUST NZ J MED, V27, P170, DOI 10.1111/j.1445-5994.1997.tb00934.x; Corsini E, 2013, TOXICOLOGY, V307, P123, DOI 10.1016/j.tox.2012.10.009; Cox MC, 2008, BRIT J HAEMATOL, V141, P265, DOI 10.1111/j.1365-2141.2008.07028.x; Cox MC, 2008, LEUKEMIA LYMPHOMA, V49, P1745, DOI 10.1080/10428190802226425; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lee Y, 2012, CLIN TOXICOL, V50, P52, DOI 10.3109/15563650.2011.639716; Liu X., 2013, ABSTR APPL ANAL, P1, DOI [10.1002/humu.22376, DOI 10.1002/HUMU.22376]; LUSTER MI, 1993, ENVIRON HEALTH PERSP, V100, P219, DOI 10.2307/3431528; Min YG, 2011, CLIN TOXICOL, V49, P840, DOI 10.3109/15563650.2011.619137; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Ommen SR, 2002, PACE, V25, P1424, DOI 10.1046/j.1460-9592.2002.01424.x; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19; Paolillo N, 2011, INT J IMMUNOPATH PH, V24, P861, DOI 10.1177/039463201102400405; Porrata LF, 2009, AM J HEMATOL, V84, P93, DOI 10.1002/ajh.21337; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Siddiqui M, 2006, BRIT J HAEMATOL, V134, P596, DOI 10.1111/j.1365-2141.2006.06232.x; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2	25	16	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78160	10.1371/journal.pone.0078160	http://dx.doi.org/10.1371/journal.pone.0078160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205140	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300044
J	Rodrigues, FS; Souza, MA; Magni, DV; Ferreira, APO; Mota, BC; Cardoso, AM; Paim, M; Xavier, LL; Ferreira, J; Schetinger, MRC; Da Costa, JC; Royes, LFF; Fighera, MR				Rodrigues, Fernanda S.; Souza, Mauren A.; Magni, Danieli V.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Cardoso, Andreia M.; Paim, Mariana; Xavier, Leder L.; Ferreira, Juliano; Schetinger, Maria Rosa C.; Da Costa, Jaderson C.; Royes, Luiz Fernando F.; Fighera, Michele R.			N-Acetylcysteine Prevents Spatial Memory Impairment Induced by Chronic Early Postnatal Glutaric Acid and Lipopolysaccharide in Rat Pups	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; NITRIC-OXIDE SYNTHASES; NA+-K+-ATPASE; NA+,K+-ATPASE ACTIVITY; OXIDATIVE STRESS; ALZHEIMER-DISEASE; REDOX STATE; COGNITIVE DEFICITS; DORSAL-HIPPOCAMPUS; HYDROGEN-PEROXIDE	Background and Aims: Glutaric aciduria type I (GA-I) is characterized by accumulation of glutaric acid (GA) and neurological symptoms, such as cognitive impairment. Although this disease is related to oxidative stress and inflammation, it is not known whether these processes facilitate the memory impairment. Our objective was to investigate the performance of rat pups chronically injected with GA and lipopolysaccharide (LPS) in spatial memory test, antioxidant defenses, cytokines levels, Na+, K+-ATPase activity, and hippocampal volume. We also evaluated the effect of N-acetylcysteine (NAC) on theses markers. Methods: Rat pups were injected with GA (5umol g of body weight-1, subcutaneously; twice per day; from 5th to 28th day of life), and were supplemented with NAC (150mg/kg/day; intragastric gavage; for the same period). LPS (2mg/kg; E. coli 055 B5) or vehicle (saline 0.9%) was injected intraperitoneally, once per day, from 25th to 28th day of life. Oxidative stress and inflammatory biomarkers as well as hippocampal volume were assessed. Results: GA caused spatial learning deficit in the Barnes maze and LPS potentiated this effect. GA and LPS increased TNF-alpha and IL-1 beta levels. The co-administration of these compounds potentiated the increase of IL-1 beta levels but not TNF-alpha levels in the hippocampus. GA and LPS increased TBARS (thiobarbituric acid-reactive substance) content, reduced antioxidant defenses and inhibited Na+, K+-ATPase activity. GA and LPS co-administration did not have additive effect on oxidative stress markers and Na+, K+ pump. The hippocampal volume did not change after GA or LPS administration. NAC protected against impairment of spatial learning and increase of cytokines levels. NAC Also protected against inhibition of Na+, K+-ATPase activity and oxidative markers. Conclusions: These results suggest that inflammatory and oxidative markers may underlie at least in part of the neuropathology of GA-I in this model. Thus, NAC could represent a possible adjuvant therapy in treatment of children with GA-I.	[Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Fighera, Michele R.] Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil; [Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Cardoso, Andreia M.; Ferreira, Juliano; Schetinger, Maria Rosa C.; Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97119900 Santa Maria, RS, Brazil; [Da Costa, Jaderson C.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Lab Neurociencias, Porto Alegre, RS, Brazil; [Da Costa, Jaderson C.] Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Porto Alegre, RS, Brazil; [Paim, Mariana; Xavier, Leder L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Dept Ciencias Fisiol, Porto Alegre, RS, Brazil; [Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Lab Bioquim Exercicio BIOEX, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97119900 Santa Maria, RS, Brazil; [Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Dept Fisiol & Farmacol, Programa Posgrad Farmacol, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil; [Magni, Danieli V.] Univ Reg Integrada Alto Uruguai & Missoes, Santiago, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Regional Integrada do Alto Uruguai e das Missoes (URI)	Fighera, MR (corresponding author), Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil.	mrfighera@yahoo.com.br	Fighera, Michele R/J-9576-2014; DaCosta, Jaderson/C-4968-2015; royes, luiz/T-3581-2019; Cardoso, Andréia M/ABH-9732-2020; Xavier, Leder Leal/G-4540-2014; de Abreu, Daniela dsa Souza/C-4103-2015; Ferreira, Juliano/A-9803-2013; Schetinger, Maria Rosa Chitolina/I-7658-2019; Souza, Mauren/A-7990-2015	DaCosta, Jaderson/0000-0001-6776-1515; Cardoso, Andréia M/0000-0003-4243-8855; Xavier, Leder Leal/0000-0002-7213-4935; de Abreu, Daniela dsa Souza/0000-0003-1142-7926; Ferreira, Juliano/0000-0002-9562-0602; royes, luiz/0000-0003-4045-4827; Fighera, Michele/0000-0002-3111-7530; Chitolina Schetinger, Maria Rosa/0000-0002-5240-8935	FAPERGS / CNPQ [Pronem: 11/2082-4]	FAPERGS / CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	The present work was supported by FAPERGS / CNPQ (grants: Pronem: 11/2082-4). The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Beauchamp MH, 2009, J INHERIT METAB DIS, V32, pS207, DOI 10.1007/s10545-009-1167-z; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bilbo SD, 2005, BEHAV NEUROSCI, V119, P293, DOI 10.1037/0735-7044.119.1.293; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Boneh A, 2008, MOL GENET METAB, V94, P287, DOI 10.1016/j.ymgme.2008.03.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton BK, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e69; Casadesus G, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-2; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; de Paula S, 2009, PEDIATR RES, V65, P631, DOI 10.1203/PDR.0b013e31819ed5c8; dos Reis EA, 2002, BRAIN RES, V951, P151, DOI 10.1016/S0006-8993(02)03077-9; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eriksson C, 2000, CYTOKINE, V12, P423, DOI 10.1006/cyto.1999.0582; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Farooqui T., 2011, PARKINSONS DIS, P247; Ferreira GD, 2005, NEUROCHEM RES, V30, P1123, DOI 10.1007/s11064-005-7711-9; Ferreira GD, 2008, BEHAV BRAIN RES, V187, P411, DOI 10.1016/j.bbr.2007.10.003; Fighera MR, 2006, NEUROBIOL DIS, V22, P611, DOI 10.1016/j.nbd.2006.01.002; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P123, DOI 10.1016/0091-3057(95)02108-6; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Goncalves JF, 2012, FOOD CHEM TOXICOL, V50, P3709, DOI 10.1016/j.fct.2012.07.016; Goncalves JF, 2010, CHEM-BIOL INTERACT, V186, P53, DOI 10.1016/j.cbi.2010.04.011; GOODMAN SI, 1987, ENZYME, V38, P76, DOI 10.1159/000469193; Goodman SI, 2001, PRENATAL DIAG, V21, P1167, DOI 10.1002/pd.201; GOODMAN SI, 1977, J PEDIATR-US, V90, P746, DOI 10.1016/S0022-3476(77)81240-7; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Hao LY, 2010, NEUROSCIENCE, V166, P763, DOI 10.1016/j.neuroscience.2010.01.006; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hellstrom IC, 2005, HIPPOCAMPUS, V15, P656, DOI 10.1002/hipo.20086; Hemmens B, 1998, METH MOL B, V100, P1; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Ikeda T, 2005, AM J OBSTET GYNECOL, V192, P719, DOI 10.1016/j.ajog.2004.12.048; Ikegaya Y, 2003, SYNAPSE, V47, P54, DOI 10.1002/syn.10154; Alles YCJ, 2010, BRAIN RES, V1356, P130, DOI 10.1016/j.brainres.2010.07.106; Kierdorf K, 2010, RESULTS PROBL CELL D, V51, P173, DOI 10.1007/400_2008_15; Kolker S, 2006, BRAIN, V129, pE54, DOI 10.1093/brain/awl137; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Kolker S, 1999, J INHERIT METAB DIS, V22, P259; Kolker S, 2002, J NEUROSCI RES, V68, P424, DOI 10.1002/jnr.10187; Kreydiyyeh SI, 2004, PFLUG ARCH EUR J PHY, V448, P231, DOI 10.1007/s00424-004-1242-0; Kreydiyyeh SI, 2004, CYTOKINE, V26, P1, DOI 10.1016/j.cyto.2003.11.014; Kulkens S, 2005, NEUROLOGY, V64, P2142, DOI 10.1212/01.WNL.0000167428.12417.B2; LEES GJ, 1993, NEUROSCIENCE, V54, P287, DOI 10.1016/0306-4522(93)90254-D; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima TTF, 1998, BRAIN RES, V802, P55, DOI 10.1016/S0006-8993(98)00563-0; Liu SH, 1997, NEUROSCI LETT, V234, P166, DOI 10.1016/S0304-3940(97)00686-1; Lundborg C, 2011, J NEUROCHEM, V119, P686, DOI 10.1111/j.1471-4159.2011.07465.x; Maeda Shigeru, 2008, Neuropsychiatr Dis Treat, V4, P663; Magni DV, 2007, BRAIN RES, V1185, P336, DOI 10.1016/j.brainres.2007.09.023; Magni DV, 2011, EPILEPSY RES, V93, P138, DOI 10.1016/j.eplepsyres.2010.11.007; Magni DV, 2009, INT J DEV NEUROSCI, V27, P65, DOI 10.1016/j.ijdevneu.2008.09.004; Martinovich GG, 2005, EUR BIOPHYS J BIOPHY, V34, P937, DOI 10.1007/s00249-005-0470-3; Matsumoto Y, 2001, EUR J PHARMACOL, V430, P283, DOI 10.1016/S0014-2999(01)01374-7; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mukhopadhyay C, 2008, J POSTGRAD MED, V54, P35, DOI 10.4103/0022-3859.39189; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nguyen KT, 1998, J NEUROSCI, V18, P2239; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Patil Neela, 2004, Indian J Pediatr, V71, P948; PERRELLA O, 1992, J NEUROL, V239, P387; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rosales-Corral S, 2004, J NEUROIMMUNOL, V150, P20, DOI 10.1016/j.jneuroim.2004.01.005; Rosales-Corral S, 2010, ANTIOXID REDOX SIGN, V13, P193, DOI 10.1089/ars.2009.2629; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Scaini G, 2012, BEHAV BRAIN RES, V231, P92, DOI 10.1016/j.bbr.2012.03.004; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Seminotti B, 2012, MOL GENET METAB, V106, P31, DOI 10.1016/j.ymgme.2012.03.002; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Strauss KA, 2007, BRAIN, V130, P1905, DOI 10.1093/brain/awm058; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Victor VM, 2003, FREE RADICAL RES, V37, P919, DOI 10.1080/1071576031000148727; Viviani B, 2003, J NEUROSCI, V23, P8692; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wyse ATS, 2000, NEUROREPORT, V11, P2331, DOI 10.1097/00001756-200007140-00052; Yang MJ, 2003, ACTA CRYSTALLOGR D, V59, P146, DOI 10.1107/S0907444902018024; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhan H, 2004, NEUROL RES, V26, P35, DOI 10.1179/016164104773026507; Zhang XY, 2007, JPN J OPHTHALMOL, V51, P14, DOI 10.1007/s10384-006-0382-5; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	101	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78332	10.1371/journal.pone.0078332	http://dx.doi.org/10.1371/journal.pone.0078332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205200	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300049
J	van der Wal, JEM; Dorenbosch, M; Immers, AK; Forteza, CV; Geurts, JJM; Peeters, ETHM; Koese, B; Bakker, ES				van der Wal, Jessica E. M.; Dorenbosch, Martijn; Immers, Anne K.; Forteza, Constanza Vidal; Geurts, Jeroen J. M.; Peeters, Edwin T. H. M.; Koese, Bram; Bakker, Elisabeth S.			Invasive Crayfish Threaten the Development of Submerged Macrophytes in Lake Restoration	PLOS ONE			English	Article							SEDIMENT PHOSPHORUS RELEASE; OF-THE-ART; PROCAMBARUS-CLARKII; EUTROPHIC LAKES; SHALLOW; IMPACT; WATERFOWL; FISH; DIVERSITY; HERBIVORY	Submerged macrophytes enhance water transparency and aquatic biodiversity in shallow water ecosystems. Therefore, the return of submerged macrophytes is the target of many lake restoration projects. However, at present, north-western European aquatic ecosystems are increasingly invaded by omnivorous exotic crayfish. We hypothesize that invasive crayfish pose a novel constraint on the regeneration of submerged macrophytes in restored lakes and may jeopardize restoration efforts. We experimentally investigated whether the invasive crayfish (Procambarus clarkii Girard) affects submerged macrophyte development in a Dutch peat lake where these crayfish are expanding rapidly. Seemingly favourable abiotic conditions for macrophyte growth existed in two 0.5 ha lake enclosures, which provided shelter and reduced turbidity, and in one lake enclosure iron was added to reduce internal nutrient loading, but macrophytes did not emerge. We transplanted three submerged macrophyte species in a full factorial exclosure experiment, where we separated the effect of crayfish from large vertebrates using different mesh sizes combined with a caging treatment stocked with crayfish only. The three transplanted macrophytes grew rapidly when protected from grazing in both lake enclosures, demonstrating that abiotic conditions for growth were suitable. Crayfish strongly reduced biomass and survival of all three macrophyte species while waterfowl and fish had no additive effects. Gut contents showed that crayfish were mostly carnivorous, but also consumed macrophytes. We show that P. clarkii strongly inhibit macrophyte development once favourable abiotic conditions for macrophyte growth are restored. Therefore, expansion of invasive crayfish poses a novel threat to the restoration of shallow water bodies in north-western Europe. Prevention of introduction and spread of crayfish is urgent, as management of invasive crayfish populations is very difficult.	[van der Wal, Jessica E. M.; Dorenbosch, Martijn; Immers, Anne K.; Forteza, Constanza Vidal; Bakker, Elisabeth S.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Geurts, Jeroen J. M.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Peeters, Edwin T. H. M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [Koese, Bram] European Invertebrate Survey Netherlands, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Radboud University Nijmegen; Wageningen University & Research	Bakker, ES (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	l.bakker@nioo.knaw.nl	Bakker, Elisabeth S/B-7185-2008; KNAW, NIOO-KNAW/A-4320-2012	Bakker, Elisabeth S/0000-0002-5900-9136; van der Wal, Jessica Eva Megan/0000-0002-6441-3598; KNAW, NIOO-KNAW/0000-0002-3835-159X; Peeters, Edwin T.H.M./0000-0003-2541-1829	Agentschap NL Innovation Programme Water Framework Directive from the Dutch Ministry of Economic Affairs, Agriculture and Innovation [KRW08079]	Agentschap NL Innovation Programme Water Framework Directive from the Dutch Ministry of Economic Affairs, Agriculture and Innovation	AI was funded by the Agentschap NL Innovation Programme Water Framework Directive (KRW08079) from the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastacio PM, 2005, ARCH HYDROBIOL, V162, P37, DOI 10.1127/0003-9136/2005/0162-0037; Bakker ES, 2013, HYDROBIOLOGIA, V710, P23, DOI 10.1007/s10750-012-1142-9; Bates D., 2011, PACKAGE LME4 LINEAR; BOERS P, 1994, ARCH HYDROBIOL, V129, P339; Burley KL, 2001, FRESHWATER BIOL, V46, P1061, DOI 10.1046/j.1365-2427.2001.00789.x; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; CHAMBERS PA, 1990, FRESHWATER BIOL, V24, P81, DOI 10.1111/j.1365-2427.1990.tb00309.x; Correia AM, 2002, ACTA OECOL, V23, P421, DOI 10.1016/S1146-609X(02)01166-9; Crawley MJ., 2007, R BOOK; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Dorenbosch M, 2012, FRESHWATER BIOL, V57, P1360, DOI 10.1111/j.1365-2427.2012.02790.x; Dorenbosch M, 2011, FRESHWATER BIOL, V56, P1783, DOI 10.1111/j.1365-2427.2011.02618.x; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Gherardi F, 2007, FRESHWATER BIOL, V52, P1249, DOI 10.1111/j.1365-2427.2007.01760.x; Gherardi F, 2006, MAR FRESHW BEHAV PHY, V39, P175, DOI 10.1080/10236240600869702; Gherardi F, 2011, AQUAT SCI, V73, P185, DOI 10.1007/s00027-011-0181-z; Giling D, 2009, J N AM BENTHOL SOC, V28, P626, DOI 10.1899/09-015.1; Grey J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042575; Gulati RD, 2008, LIMNOLOGICA, V38, P233, DOI 10.1016/j.limno.2008.05.008; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Hickey CW, 2009, NEW ZEAL J MAR FRESH, V43, P819, DOI 10.1080/00288330909510043; Hilt S, 2006, LIMNOLOGICA, V36, P155, DOI 10.1016/j.limno.2006.06.001; Hilt S, 2006, HYDROBIOLOGIA, V570, P95, DOI 10.1007/s10750-006-0167-3; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Irfanullah HM, 2004, AQUAT BOT, V80, P177, DOI 10.1016/j/aquabot.2004.07.010; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jeppesen E, 1998, ECOSYSTEMS, V1, P250, DOI 10.1007/s100219900020; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Koese B., 2011, NEDERLANDSE RIVIERKR, V6; Korner S, 2003, HYDROBIOLOGIA, V506, P497, DOI 10.1023/B:HYDR.0000008561.67513.ec; Lake MD, 2002, HYDROBIOLOGIA, V470, P13, DOI 10.1023/A:1015689432289; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Lauridsen TL, 2003, HYDROBIOLOGIA, V506, P641, DOI 10.1023/B:HYDR.0000008633.17385.70; LAURIDSEN TL, 1993, AQUAT BOT, V46, P1, DOI 10.1016/0304-3770(93)90061-Z; Lauridsen Torben L., 2003, Lakes & Reservoirs Research and Management, V8, P177, DOI 10.1111/j.1440-1770.2003.00224.x; LODGE DM, 1987, CAN J FISH AQUAT SCI, V44, P591, DOI 10.1139/f87-072; Marklund O, 2002, FRESHWATER BIOL, V47, P2049, DOI 10.1046/j.1365-2427.2002.00949.x; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Middelboe AL, 1997, FRESHWATER BIOL, V37, P553, DOI 10.1046/j.1365-2427.1997.00183.x; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Moss B., 1989, MORE EXACT ECOLOGY, P401; Nurminen L, 2003, HYDROBIOLOGIA, V506, P511, DOI 10.1023/B:HYDR.0000008577.16934.a9; Nystrom P, 1999, OIKOS, V85, P545, DOI 10.2307/3546704; Nystrom P, 1996, FRESHWATER BIOL, V36, P673, DOI 10.1046/j.1365-2427.1996.d01-508.x; Perrow MR, 1997, HYDROBIOLOGIA, V342, P241, DOI 10.1023/A:1017007911190; PHILLIPS G, 1994, HYDROBIOLOGIA, V275, P445, DOI 10.1007/BF00026733; R Development Core Team, 2011, R LANG ENV STAT COMP; Rodriguez CF, 2003, HYDROBIOLOGIA, V506, P421, DOI 10.1023/B:HYDR.0000008626.07042.87; Scheffer M., 2001, ECOLOGY SHALLOW LAKE; SMOLDERS A, 1995, ARCH HYDROBIOL, V133, P349; Sondergaard M, 1996, AQUAT BOT, V53, P73, DOI 10.1016/0304-3770(95)01013-0; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; Souty-Grosset C, 2006, ATLAS CRAYFISH EUROP; Strand JA, 2001, FRESHWATER BIOL, V46, P1397, DOI 10.1046/j.1365-2427.2001.00746.x; ter Heerdt G, 2007, HYDROBIOLOGIA, V584, P305, DOI 10.1007/s10750-007-0594-9; van de Haterd RJW, 2007, HYDROBIOLOGIA, V584, P277, DOI 10.1007/s10750-007-0593-x; Van Giels J, 2011, 2009023602 ATKB; VanDonk E, 1996, HYDROBIOLOGIA, V340, P285, DOI 10.1007/BF00012769	59	33	35	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78579	10.1371/journal.pone.0078579	http://dx.doi.org/10.1371/journal.pone.0078579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205271	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300069
J	Heilig, Y; Schmitt, K; Seiler, S				Heilig, Yvonne; Schmitt, Kerstin; Seiler, Stephan			Phospho-Regulation of the Neurospora crassa Septation Initiation Network	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; ASPERGILLUS-NIDULANS; SEPTUM FORMATION; CYTOKINESIS; SIN; PHOSPHORYLATION; GTPASE; YEAST; RING; MORPHOGENESIS	Proper cell division is essential for growth and development of uni- and multicellular organisms. The fungal septation initiation network (SIN) functions as kinase cascade that connects cell cycle progression with the initiation of cytokinesis. Miss-regulation of the homologous Hippo pathway in animals results in excessive cell proliferation and formation of tumors, underscoring the conservation of both pathways. How SIN proteins interact and transmit signals through the cascade is only beginning to be understood. Moreover, our understanding of septum formation and its regulation in filamentous fungi, which represent the vast majority of the fungal kingdom, is highly fragmentary. We determined that a tripartite kinase cascade, consisting of CDC-7, SID-1 and DBF-2, together with their regulatory subunits CDC-14 and MOB-1, is important for septum formation in the model mold Neurospora crassa. DBF-2 activity and septum formation requires auto-phosphorylation at Ser499 within the activation segment and phosphorylation of Thr671 in the hydrophobic motif by SID-1. Moreover, SID-1-stimulated DBF-2 activity is further enhanced by CDC-7, supporting a stepwise activation mechanism of the tripartite SIN kinase cascade in fungi. However, in contrast to the situation described for unicellular yeasts, the localization of the entire SIN cascade to spindle pole bodies is constitutive and cell cycle independent. Moreover, all SIN proteins except CDC-7 form cortical rings prior to septum initiation and localize to constricting septa. Thus, SIN localization and activity regulation significantly differs in unicellular versus syncytial ascomycete fungi.	[Heilig, Yvonne; Seiler, Stephan] Univ Freiburg, Inst Biol Mol Plant Physiol 2, D-79106 Freiburg, Germany; [Seiler, Stephan] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Schmitt, Kerstin] Univ Goettingen, Inst Microbiol & Genet, Gottingen, Germany	University of Freiburg; University of Freiburg; University of Gottingen	Seiler, S (corresponding author), Univ Freiburg, Inst Biol Mol Plant Physiol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	Stephan.Seiler@biologie.uni-freiburg.de			DFG [SE1054/6-1, SE1054/3-2, SE1054/7-1]; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG) [GSC 226/1]; Neurospora program [PO1 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG)(German Research Foundation (DFG)); Neurospora program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was financially supported through the DFG Heisenberg fellowship SE1054/6-1, the DFG grants SE1054/3-2 and SE1054/7-1 and by the Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG grant GSC 226/1). The authors acknowledge the Fungal Genetics Stock Center and the Neurospora program grant PO1 GM068087 for continuous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Attner MA, 2012, MOL BIOL CELL, V23, P3122, DOI 10.1091/mbc.E12-03-0235; Baker SE, 2012, NEUR C 2012; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gull K, 1978, FILAMENTOUS FUNGI DE, P78; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Harris SD, 2011, FUNGAL BIOL-UK, V115, P475, DOI 10.1016/j.funbio.2011.02.002; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Katayama S, 2012, J BIOCHEM, V152, P347, DOI 10.1093/jb/mvs075; Kawabata T, 2007, FUNGAL GENET NEWSL, V54, P5, DOI [10.4148/1941-4765.1096, DOI 10.4148/1941-4765.1096]; Kawabata T, 2007, CURR GENET, V52, P125, DOI 10.1007/s00294-007-0146-x; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037221; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, CURR OPIN MICROBIOL, V13, P663, DOI 10.1016/j.mib.2010.08.010; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mazanek M, 2010, J CHROMATOGR B, V878, P515, DOI 10.1016/j.jchromb.2009.12.017; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Meitinger F, 2012, CELL CYCLE, V11, P219, DOI 10.4161/cc.11.2.18857; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160; Mourino-Perez RR, 2013, FUNGAL BIOL REV, V27, P1, DOI 10.1016/j.fbr.2013.02.002; RAJU NB, 1977, EXP MYCOL, V1, P152, DOI 10.1016/S0147-5975(77)80040-6; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Wolkow TD, 1996, J CELL SCI, V109, P2179; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	55	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79464	10.1371/journal.pone.0079464	http://dx.doi.org/10.1371/journal.pone.0079464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205386	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600120
J	Lemonakis, N; Gikas, E; Halabalaki, M; Skaltsounis, AL				Lemonakis, Nikolaos; Gikas, Evagelos; Halabalaki, Maria; Skaltsounis, Alexios-Leandros			Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products - Application to Oleuropein Preparations	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; PHENOLIC-COMPOUNDS; OLIVE OIL; LEAF EXTRACT; RAT PLASMA; HYDROXYTYROSOL; ANTIOXIDANT; METABOLITES; LEAVES; HPLC	Oleuropein (OE) is a secoiridoid glycoside, which occurs mostly in the Oleaceae family presenting several pharmacological properties, including antioxidant, cardio-protective, anti-atherogenic effects etc. Based on these findings OE is commercially available, as Herbal Medicinal Product (HMP), claimed for its antioxidant effects. As there are general provisions of the medicine regulating bodies e. g. European Medicines Agency, the quality of the HMP's must always be demonstrated. Therefore, a novel LC-MS methodology was developed and validated for the simultaneous quantification of OE and its main degradation product, hydroxytyrosol (HT), for the relevant OE claimed HMP's. The internal standard (IS) methodology was employed and separation of OE, HT and IS was achieved on a C18 Fused Core column with 3.1 min overall run time employing the SIM method for the analytical signal acquisition. The method was validated according to the International Conference on Harmonisation requirements and the results show adequate linearity (r(2) > 0.99) over a wide concentration range [0.1-15 mu g/mL (n=12)] and a LLOQ value of 0.1 mu g/mL, for both OE and HT. Furthermore, as it would be beneficial to control the quality taking into account all the substances of the OE claimed HMP's; a metabolomics-like approach has been developed and applied for the total quality control of the different preparations employing UHPLC-HRMS-multivariate analysis (MVA). Four OE-claimed commercial HMP's have been randomly selected and MVA similarity-based measurements were performed. The results showed that the examined samples could also be differentiated as evidenced according to their scores plot. Batch to batch reproducibility between the samples of the same brand has also been determined and found to be acceptable. Overall, the developed combined methodology has been found to be an efficient tool for the monitoring of the HMP's total quality. Only one OE HMP has been found to be consistent to its label claim.	[Lemonakis, Nikolaos; Halabalaki, Maria; Skaltsounis, Alexios-Leandros] Natl & Kapodistrian Univ Athens, Dept Pharmacognosy & Nat Prod Chem, Fac Pharm, Athens 11528, Greece; [Gikas, Evagelos] Natl & Kapodistrian Univ Athens, Dept Pharmaceut Chem, Fac Pharm, Athens 11528, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Skaltsounis, AL (corresponding author), Natl & Kapodistrian Univ Athens, Dept Pharmacognosy & Nat Prod Chem, Fac Pharm, Athens 11528, Greece.	skaltsounis@pharm.uoa.gr	Gikas, Evagelos/H-6226-2019; skaltsounis, alexios leandros/AAE-9617-2019; Halabalaki, Maria/AAD-2127-2020	Gikas, Evagelos/0000-0002-0107-9991; Halabalaki, Maria/0000-0001-5620-0165	SYNERGASIA PROGRAMME; European Regional Development Fund; National Resources [OSTEOPRO-1076]; Commission of the European Community through the INsPiRE project [284460]	SYNERGASIA PROGRAMME; European Regional Development Fund(European Commission); National Resources; Commission of the European Community through the INsPiRE project	The present work was funded by SYNERGASIA 2009 PROGRAMME, which is co-funded by the European Regional Development Fund and National Resources (Project code: OSTEOPRO-1076) as well as by the Commission of the European Community through the INsPiRE project (EU-FP7-REGPOT-2011-1, proposal 284460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acquaviva R, 2012, INT J ONCOL, V41, P31, DOI 10.3892/ijo.2012.1428; Agalias A, 2005, J LIQ CHROMATOGR R T, V28, P1557, DOI 10.1081/JLC-200058355; Agalias A, 2007, J AGR FOOD CHEM, V55, P2671, DOI 10.1021/jf063091d; Andreadou I, 2006, J NUTR, V136, P2213, DOI 10.1093/jn/136.8.2213; [Anonymous], 2010, ICH HARM TRIP GUID V; Aouidi F, 2012, IND CROP PROD, V37, P292, DOI 10.1016/j.indcrop.2011.12.024; Aturki Z, 2008, ELECTROPHORESIS, V29, P1643, DOI 10.1002/elps.200700547; Bazoti FN, 2010, BIOMED CHROMATOGR, V24, P506, DOI 10.1002/bmc.1319; Briante R, 2002, J AGR FOOD CHEM, V50, P4934, DOI 10.1021/jf025540p; Dierkes G, 2012, J AGR FOOD CHEM, V60, P7597, DOI 10.1021/jf3020574; Galli C, 1999, LIPIDS, V34, pS23, DOI [10.1007/BF02562224, 10.1007/s11745-999-333-4]; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Hadad GM, 2012, J CHROMATOGR SCI, V50, P509, DOI 10.1093/chromsci/bms041; Japon-Lujan R, 2006, J CHROMATOGR A, V1136, P185, DOI 10.1016/j.chroma.2006.09.081; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Keys A, 1997, Nutrition, V13, P250; Kontogianni VG, 2012, NAT PROD RES, V26, P186, DOI 10.1080/14786419.2011.582842; Lan K, 2010, J CHROMATOGR A, V1217, P1414, DOI 10.1016/j.chroma.2009.12.031; Lozano-Sanchez J, 2011, J AGR FOOD CHEM, V59, P11491, DOI 10.1021/jf202596q; Manchon N, 2010, TALANTA, V82, P1986, DOI 10.1016/j.talanta.2010.08.050; Omar Syed Haris, 2010, Saudi Pharm J, V18, P111, DOI 10.1016/j.jsps.2010.05.005; Orozco-Solano MI, 2012, J CHROMATOGR A, V1258, P108, DOI 10.1016/j.chroma.2012.08.057; Ortega-Garcia F, 2010, J SCI FOOD AGR, V90, P2295, DOI 10.1002/jsfa.4085; Pereira AP, 2007, MOLECULES, V12, P1153, DOI 10.3390/12051153; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; RENAUD S, 1995, AM J CLIN NUTR, V61, p1360S, DOI 10.1093/ajcn/61.6.1360S; Romani A, 1999, J AGR FOOD CHEM, V47, P964, DOI 10.1021/jf980264t; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P4115, DOI 10.1016/j.fct.2012.08.033; Tan HW, 2003, J CHROMATOGR B, V785, P187, DOI 10.1016/S1570-0232(02)00855-3; Visioli F, 2001, Curr Atheroscler Rep, V3, P64, DOI 10.1007/s11883-001-0012-0; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Yang PL, 2009, J SEP SCI, V32, P1816, DOI 10.1002/jssc.200900005; Zhang HM, 2012, J PHARMACEUT BIOMED, V62, P258, DOI 10.1016/j.jpba.2012.01.010; Zhou T, 2011, BIOMED CHROMATOGR, V25, P1360, DOI 10.1002/bmc.1609; Zoidou E, 2010, J AGR FOOD CHEM, V58, P46, DOI 10.1021/jf903405e	36	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78277	10.1371/journal.pone.0078277	http://dx.doi.org/10.1371/journal.pone.0078277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205178	Green Submitted, gold, Green Published			2022-12-25	WOS:000326032600089
J	Beurskens, CJ; Aslami, H; de Beer, FM; Vroom, MB; Preckel, B; Horn, J; Juffermans, NP				Beurskens, Charlotte J.; Aslami, Hamid; de Beer, Friso M.; Vroom, Margreeth B.; Preckel, Benedikt; Horn, Janneke; Juffermans, Nicole P.			Heliox Allows for Lower Minute Volume Ventilation in an Animal Model of Ventilator-Induced Lung Injury	PLOS ONE			English	Article							LOW TIDAL VOLUME; OXYGEN MIXTURES; GAS-EXCHANGE; PROTECTION	Background: Helium is a noble gas with a low density, allowing for lower driving pressures and increased carbon dioxide (CO2) diffusion. Since application of protective ventilation can be limited by the development of hypoxemia or acidosis, we hypothesized that therefore heliox facilitates ventilation in an animal model of ventilator-induced lung injury. Methods: Sprague-Dawley rats (N=8 per group) were mechanically ventilated with heliox (50% oxygen; 50% helium). Controls received a standard gas mixture (50% oxygen; 50% air). VILI was induced by application of tidal volumes of 15 mL kg(-1); lung protective ventilated animals were ventilated with 6 mL kg-1. Respiratory parameters were monitored with a pneumotach system. Respiratory rate was adjusted to maintain arterial pCO(2) within 4.5-5.5 kPa, according to hourly drawn arterial blood gases. After 4 hours, bronchoalveolar lavage fluid (BALF) was obtained. Data are mean (SD). Results: VILI resulted in an increase in BALF protein compared to low tidal ventilation (629 (324) vs. 290 (181) mu g mL(-1); p<0.05) and IL-6 levels (640 (8.7) vs. 206 (8.7) pg mL(-1); p<0.05), whereas cell counts did not differ between groups after this short course of mechanical ventilation. Ventilation with heliox resulted in a decrease in mean respiratory minute volume ventilation compared to control (123 +/- 0.6 vs. 146 +/- 8.9 mL min(-1), P<0.001), due to a decrease in respiratory rate (22 (0.4) vs. 25 (2.1) breaths per minute; p<0.05), while pCO(2) levels and tidal volumes remained unchanged, according to protocol. There was no effect of heliox on inspiratory pressure, while compliance was reduced. In this mild lung injury model, heliox did not exert anti-inflammatory effects. Conclusions: Heliox allowed for a reduction in respiratory rate and respiratory minute volume during VILI, while maintaining normal acid-base balance. Use of heliox may be a useful approach when protective tidal volume ventilation is limited by the development of severe acidosis.	[Beurskens, Charlotte J.; Aslami, Hamid; de Beer, Friso M.; Preckel, Benedikt; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Dept Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Beurskens, Charlotte J.; de Beer, Friso M.; Vroom, Margreeth B.; Horn, Janneke; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Beurskens, CJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.beurskens@amc.nl	Horn, Janneke/ACB-3607-2022	Preckel, Benedikt/0000-0003-4412-9183	NWO ZonMW Clinical Fellowship [90700269]	NWO ZonMW Clinical Fellowship	This work was supported by a NWO ZonMW Clinical Fellowship to Dr. N.P. Juffermans (project number: 90700269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah Shamel A, 2003, Pediatr Crit Care Med, V4, P353, DOI 10.1097/01.PCC.0000074267.11280.78; Aslami H, 2013, CYTOKINE, V61, P614, DOI 10.1016/j.cyto.2012.11.018; Aslami H, 2012, TRANSL RES, V159, P110, DOI 10.1016/j.trsl.2011.10.005; Bein T, 2009, ANAESTHESIA, V64, P195, DOI 10.1111/j.1365-2044.2008.05735.x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chevrolet JC, 2001, CRIT CARE, V5, P179; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Frazier MD, 2010, PAEDIATR RESPIR REV, V11, P46, DOI 10.1016/j.prrv.2009.10.008; Gentile MA, 2011, RESP CARE, V56, P1341, DOI 10.4187/respcare.01442; George R, 2001, J Perinatol, V21, P395, DOI 10.1038/sj.jp.7210530; GLUCK EH, 1990, CHEST, V98, P693, DOI 10.1378/chest.98.3.693; Hegeman MA, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/435236; Hess DR, 2006, RESPIR CARE, V51, P608; Katz A, 2001, AM J RESP CRIT CARE, V164, P260, DOI 10.1164/ajrccm.164.2.2006105; Katz AL, 2003, CRIT CARE MED, V31, P2006, DOI 10.1097/01.CCM.0000070584.00490.7B; Kneyber MCJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7880; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lucchinetti E, 2009, ANESTH ANALG, V109, P101, DOI 10.1213/ane.0b013e3181a27e4b; Nawab US, 2005, PEDIATR PULM, V40, P524, DOI 10.1002/ppul.20304; Oei GTML, 2010, ANESTHESIOLOGY, V112, P1503, DOI 10.1097/ALN.0b013e3181d9cb5e; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Siddappa Rajashekhar, 2005, Pediatr Crit Care Med, V6, P70, DOI 10.1097/01.PCC.0000149138.65083.EF; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Venkataraman ST, 2006, RESPIR CARE, V51, P632; Yilmaz S, 2013, ANN THORAC MED, V8, P46, DOI 10.4103/1817-1737.105719	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78159	10.1371/journal.pone.0078159	http://dx.doi.org/10.1371/journal.pone.0078159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205139	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300145
J	Rensch, U; Klein, G; Kehrenberg, C				Rensch, Ulrike; Klein, Guenter; Kehrenberg, Corinna			Analysis of Triclosan-Selected Salmonella enterica Mutants of Eight Serovars Revealed Increased Aminoglycoside Susceptibility and Reduced Growth Rates	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMPS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; PREVENTION CONCENTRATIONS; BENZALKONIUM CHLORIDE; ANTIBIOTIC-RESISTANCE; ADAPTIVE RESISTANCE; TYPHIMURIUM; EXPRESSION	The biocide triclosan (TRC) is used in a wide range of household, personal care, veterinary, industrial and medical products to control microbial growth. This extended use raises concerns about a possible association between the application of triclosan and the development of antibiotic resistance. In the present study we determined triclosan mutant prevention concentrations (MPC) for Salmonella enterica isolates of eight serovars and investigated selected mutants for their mechanisms mediating decreased susceptibility to triclosan. MPCTRC values were 8 - 64-fold higher than MIC values and ranged between 1 - 16 mu g/ml. The frequencies at which mutants were selected varied between 1.3 x 10(-10) - 9.9 x 10(-11). Even if MIC values of mutants decreased by 3-7 dilution steps in the presence of the efflux pump inhibitor Phe-Arg-beta-naphtylamide, only minor changes were observed in the expression of genes encoding efflux components or regulators, indicating that neither the major multidrug efflux pump AcrAB-TolC nor AcrEF are up-regulated in triclosan-selected mutants. Nucleotide sequence comparisons confirmed the absence of alterations in the regulatory regions acrRA, soxRS, marORAB, acrSE and ramRA of selected mutants. Single bp and deduced Gly(93)-> Val amino acid exchanges were present in fabI, the target gene of triclosan, starting from a concentration of 1 mu g/ml TRC used for MPC determinations. The fabI genes were up to 12.4-fold up-regulated. Complementation experiments confirmed the contribution of Gly(93)-> Val exchanges and fabI overexpression to decreased triclosan susceptibility. MIC values of mutants compared to parent strains were even equal or resulted in a more susceptible phenotype (1-2 dilution steps) for the aminoglycoside antibiotics kanamycin and gentamicin as well as for the biocide chlorhexidine. Growth rates of selected mutants were significantly lower and hence, might partly explain the rare occurrence of Salmonella field isolates exhibiting decreased susceptibility to triclosan.	[Rensch, Ulrike; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022; Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701	Federal Institute for Risk Assessment [FK3 1329-450]	Federal Institute for Risk Assessment	The study was in parts financially supported by the Federal Institute for Risk Assessment (grant FK3 1329-450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004; Cerf O, 2010, INT J FOOD MICROBIOL, V136, P247, DOI 10.1016/j.ijfoodmicro.2009.10.002; Clinical and Laboratory Standards Institute, 2018, VET08 CLSI, V4th; Condell O, 2012, J PROTEOMICS, V75, P4505, DOI 10.1016/j.jprot.2012.04.044; Condell O, 2012, APPL ENVIRON MICROB, V78, P3087, DOI 10.1128/AEM.07534-11; Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012; Cottell A, 2009, J HOSP INFECT, V72, P71, DOI 10.1016/j.jhin.2009.01.014; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Joynson JA, 2002, J APPL MICROBIOL, V93, P96, DOI 10.1046/j.1365-2672.2002.01667.x; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V59, P886, DOI 10.1093/jac/dkm072; Kehrenberg C, 2009, J ANTIMICROB CHEMOTH, V64, P1175, DOI 10.1093/jac/dkp347; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Loughlin MF, 2002, J ANTIMICROB CHEMOTH, V49, P631, DOI 10.1093/jac/49.4.631; Lubarsky HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031183; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Michael GB, 2008, INT J ANTIMICROB AG, V32, P120, DOI 10.1016/j.ijantimicag.2008.02.024; Middleton JH, 2013, ECOTOX ENVIRON SAFE, V88, P79, DOI 10.1016/j.ecoenv.2012.10.025; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Preisler A, 2006, J ANTIMICROB CHEMOTH, V57, P430, DOI 10.1093/jac/dki475; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P688, DOI 10.1093/jac/dkh360; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P621, DOI 10.1093/jac/dkh376; Rensch U, 2013, J FOOD PROTECT, V76, P653, DOI 10.4315/0362-028X.JFP-12-420; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Stickler DJ, 2008, ANTIMICROB AGENTS CH, V52, P991, DOI 10.1128/AAC.01094-07; Tabak M, 2007, FEMS MICROBIOL LETT, V267, P200, DOI 10.1111/j.1574-6968.2006.00547.x; Webber MA, 2008, J ANTIMICROB CHEMOTH, V62, P83, DOI 10.1093/jac/dkn137; Whitehead RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022833; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448	43	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78310	10.1371/journal.pone.0078310	http://dx.doi.org/10.1371/journal.pone.0078310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205194	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300153
J	Sousounis, K; Ogura, A; Tsonis, PA				Sousounis, Konstantinos; Ogura, Atsushi; Tsonis, Panagiotis A.			Transcriptome Analysis of Nautilus and Pygmy Squid Developing Eye Provides Insights in Lens and Eye Evolution	PLOS ONE			English	Article							DROSOPHILA EYE; ALIGNMENT; PROTEINS; GENES; PAX-6; TOOL; GAP; NF1	Coleoid cephalopods like squids have a camera-type eye similar to vertebrates. On the other hand, Nautilus (Nautiloids) has a pinhole eye that lacks lens and cornea. Since pygmy squid and Nautilus are closely related species they are excellent model organisms to study eye evolution. Having being able to collect Nautilus embryos, we employed next-generation RNA sequencing using Nautilus and pygmy squid developing eyes. Their transcriptomes were compared and analyzed. Enrichment analysis of Gene Ontology revealed that contigs related to nucleic acid binding were largely up-regulated in squid, while the ones related to metabolic processes and extracellular matrix-related genes were up-regulated in Nautilus. These differences are most likely correlated with the complexity of tissue organization in these species. Moreover, when the analysis focused on the eye-related contigs several interesting patterns emerged. First, contigs from both species related to eye tissue differentiation and morphogenesis as well as to cilia showed best hits with their Human counterparts, while contigs related to rabdomeric photoreceptors showed the best hit with their Drosophila counterparts. This bolsters the idea that eye morphogenesis genes have been generally conserved in evolution, and compliments other studies showing that genes involved in photoreceptor differentiation clearly follow the diversification of invertebrate (rabdomeric) and vertebrate (ciliated) photoreceptors. Interestingly some contigs showed as good a hit with Drosophila and Human homologues in Nautilus and squid samples. One of them, capt/CAP1, is known to be preferentially expressed in Drosophila developing eye and in vertebrate lens. Importantly our analysis also provided evidence of gene duplication and diversification of their function in both species. One of these genes is the Neurofibromatosis 1 (NF1/Nf1), which in mice has been implicated in lens formation, suggesting a hitherto unsuspected role in the evolution of the lens in molluscs.	[Sousounis, Konstantinos; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Sousounis, Konstantinos; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA; [Ogura, Atsushi] Ochanomizu Univ, Ochadai Acad Prod, Tokyo 112, Japan	University of Dayton; University of Dayton; Ochanomizu University	Ogura, A (corresponding author), Ochanomizu Univ, Ochadai Acad Prod, Tokyo 112, Japan.	aogu@whelix.info; ptsonis1@udayton.edu		Sousounis, Konstantinos/0000-0002-5577-6207	NIH [EY10540]; University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24770002] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by NIH grant EY10540 to PAT, and Grant-in-Aid for Young Scientists (B) to AO. KS is supported in part by the University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Carbe C, 2011, HUM MOL GENET, V20, P1315, DOI 10.1093/hmg/ddr014; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Gehring WJ, 2012, EVOL DEV, V14, P34, DOI 10.1111/j.1525-142X.2011.00528.x; KhosrowShahian F, 2002, MECH DEVELOP, V113, P211, DOI 10.1016/S0925-4773(02)00033-3; Land MF, 2002, ANIMAL EYES; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Lin CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-46; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nilsson DE, 2013, VISUAL NEUROSCI, V30, P5, DOI 10.1017/S0952523813000035; Ogura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01432; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Shigeno S, 2008, J MORPHOL, V269, P1, DOI 10.1002/jmor.10564; Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Yoshida M, 2011, GENE, V483, P63, DOI 10.1016/j.gene.2011.05.027	22	6	6	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78054	10.1371/journal.pone.0078054	http://dx.doi.org/10.1371/journal.pone.0078054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24205087	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400148
J	Tarnutzer, AA; Bertolini, G; Bockisch, CJ; Straumann, D; Marti, S				Tarnutzer, Alexander A.; Bertolini, Giovanni; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah			Modulation of Internal Estimates of Gravity during and after Prolonged Roll-Tilts	PLOS ONE			English	Article							INNERVATING OTOLITH ORGANS; PERCEIVED DIRECTION; VESTIBULAR NEURONS; VISUAL ORIENTATION; DYNAMIC PROPERTIES; STATIC TILTS; BODY-TILT; HEAD; ADAPTATION; PERCEPTION	Perceived direction of gravity, as assessed by the subjective visual vertical (SVV), shows roll-angle dependent errors that drift over time and a bias upon return to upright. According to Bayesian observer theory, the estimated direction of gravity is derived from the posterior probability distribution by combining sensory input and prior knowledge about earth-vertical in a statistically optimal fashion. Here we aimed to further characterize the stability of SVV during and after prolonged roll-tilts. Specifically we asked whether the post-tilt bias is related to the drift pattern while roll-tilted. Twenty-nine healthy human subjects (23-56yo) repetitively adjusted a luminous arrow to the SVV over periods of 5min while upright, roll-tilted (+/- 45 degrees, +/- 90 degrees), and immediately after returning to upright. Significant (p<0.05) drifts (median absolute drift-amplitude: 10 degrees/5min) were found in 71% (+/- 45 degrees) and 78% (+/- 90 degrees) of runs. At +/- 90 degrees roll-tilt significant increases in absolute adjustment errors were more likely (76%), whereas significant increases (56%) and decreases (44%) were about equally frequent at +/- 45 degrees. When returning to upright, an initial bias towards the previous roll-position followed by significant exponential decay (median time-constant: 71sec) was noted in 47% of all runs (all subjects pooled). No significant correlations were found between the drift pattern during and immediately after prolonged roll-tilt. We conclude that the SVV is not stable during and after prolonged roll-tilt and that the direction and magnitude of drift are individually distinct and roll-angle-dependent. Likely sensory and central adaptation and random-walk processes contribute to drift while roll-tilted. Lack of correlation between the drift and the post-tilt bias suggests that it is not the inaccuracy of the SVV estimate while tilted that determines post-tilt bias, but rather the previous head-roll orientation relative to gravity. We therefore favor central adaptation, most likely a shift in prior knowledge towards the previous roll orientation, to explain the post-tilt bias.	[Tarnutzer, Alexander A.; Bertolini, Giovanni; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Tarnutzer, AA (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	alexander.tarnutzer@access.uzh.ch	Bertolini, Giovanni/H-3510-2016; Tarnutzer, Alexander/H-3236-2019; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Tarnutzer, Alexander/0000-0002-6984-6958; Bertolini, Giovanni/0000-0003-2428-9454; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation, Berne, Switzerland [32003B_130163/1]; Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland	Swiss National Science Foundation, Berne, Switzerland(Swiss National Science Foundation (SNSF)); Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland	Swiss National Science Foundation (grant number: 32003B_130163/1), Berne, Switzerland; the Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; the Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbonizio G, 2002, SPATIAL VISION, V16, P45, DOI 10.1163/15685680260433904; Adrian ED, 1943, J PHYSIOL-LONDON, V101, P389, DOI 10.1113/jphysiol.1943.sp003995; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Aubert H., 1861, ARCH PATHOL ANAT, V20, P381, DOI DOI 10.1007/BF02355256; Bensmaia SJ, 2005, J NEUROPHYSIOL, V94, P3023, DOI 10.1152/jn.00002.2005; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bockisch CJ, 2001, VISION RES, V41, P2127, DOI 10.1016/S0042-6989(01)00094-3; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; COLLEWIJN H, 1985, EXP BRAIN RES, V59, P185, DOI 10.1007/BF00237678; DAY RH, 1969, PSYCHOL BULL, V71, P33, DOI 10.1037/h0026872; DAY RH, 1966, SCIENCE, V154, P1201, DOI 10.1126/science.154.3753.1201; DAY RH, 1968, Q J EXP PSYCHOL, V20, P290, DOI 10.1080/14640746808400163; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; DIAMOND SG, 1982, ANN OTO RHINOL LARYN, V91, P225, DOI 10.1177/000348948209100222; DIAMOND SG, 1983, NEUROLOGY, V33, P1460, DOI 10.1212/WNL.33.11.1460; FERNANDEZ C, 1972, J NEUROPHYSIOL, V35, P978, DOI 10.1152/jn.1972.35.6.978; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; FURMAN JMR, 1989, BIOL CYBERN, V61, P255, DOI 10.1007/BF00203172; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Hahn JF, 1968, SKIN SENSES, P322; HAMMETT ST, 1994, VISION RES, V34, P31, DOI 10.1016/0042-6989(94)90254-2; Jaggi-Schwarz K, 2003, EXP BRAIN RES, V149, P340, DOI 10.1007/s00221-002-1343-y; Kaptein RG, 2004, J NEUROPHYSIOL, V91, P2205, DOI 10.1152/jn.00804.2003; Klier EM, 2005, J NEUROPHYSIOL, V94, P468, DOI 10.1152/jn.00700.2004; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; LECHNERSTEINLEITNER S, 1978, PSYCHOL RES-PSYCH FO, V40, P65, DOI 10.1007/BF00308464; LEIGH RJ, 1981, ANN NY ACAD SCI, V374, P619, DOI 10.1111/j.1749-6632.1981.tb30906.x; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P254; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; Lewis RF, 2011, J VESTIBUL RES-EQUIL, V21, P323, DOI 10.3233/VES-2011-0422; LOWENSTEIN O, 1949, J PHYSIOL-LONDON, V110, P392, DOI 10.1113/jphysiol.1949.sp004448; MACADAR O, 1984, EXP NEUROL, V86, P147, DOI 10.1016/0014-4886(84)90075-X; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Merfeld DM, 2001, J NEUROPHYSIOL, V85, P1648, DOI 10.1152/jn.2001.85.4.1648; MILLER E F 2nd, 1962, Acta Otolaryngol, V54, P479, DOI 10.3109/00016486209126967; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mueller GE, 1916, Z PSYCHOL PHYSL SINN, V49, P109; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Pansell T, 2005, ANN NY ACAD SCI, V1039, P554, DOI 10.1196/annals.1325.066; Pansell T, 2005, STRABISMUS, V13, P115, DOI 10.1080/09273970500216408; Pavlou M, 2003, J NEUROPHYSIOL, V90, P622, DOI 10.1152/jn.00960.2002; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; SCHONE H, 1968, Z VERGL PHYSIOL, V60, P440, DOI 10.1007/BF00297938; SCHOR RH, 1984, J NEUROPHYSIOL, V51, P136, DOI 10.1152/jn.1984.51.1.136; SCHOR RH, 1974, EXP BRAIN RES, V20, P347; Schuler JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-83; Series P, 2009, NEURAL COMPUT, V21, P3271, DOI 10.1162/neco.2009.09-08-869; Seydell A, 2010, J VISION, V10, DOI 10.1167/10.4.1; SHIMAZU H, 1965, J NEUROPHYSIOL, V28, P991, DOI 10.1152/jn.1965.28.6.991; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Tarnutzer AA, 2012, EXP BRAIN RES, V222, P427, DOI 10.1007/s00221-012-3230-5; Tarnutzer AA, 2012, J VESTIBUL RES-EQUIL, V22, P41, DOI 10.3233/VES-2011-0436; Tarnutzer AA, 2009, J NEUROPHYSIOL, V102, P1657, DOI 10.1152/jn.00007.2008; Tarnutzer AA, 2009, EXP BRAIN RES, V195, P621, DOI 10.1007/s00221-009-1823-4; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Tribukait A, 2003, NEUROBIOL LEARN MEM, V80, P1, DOI 10.1016/S1074-7427(03)00041-8; UDODEHAE.HA, 1970, PERCEPT PSYCHOPHYS, V8, P137, DOI 10.3758/BF03210192; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Van Huffel S, 1991, TOTAL LEAST SQUARES; VIDAL J, 1971, KYBERNETIK, V9, P205, DOI 10.1007/BF00289582; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P215, DOI 10.3758/BF03212730; WADE NJ, 1970, Q J EXP PSYCHOL, V22, P423, DOI 10.1080/14640747008401916; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P324, DOI 10.3758/BF03212477; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0	69	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78079	10.1371/journal.pone.0078079	http://dx.doi.org/10.1371/journal.pone.0078079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24205099	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200096
J	Tan, M; Li, H; Sun, Y				Tan, M.; Li, H.; Sun, Y.			Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis	ONCOGENE			English	Article						angiogenesis; anti-angiogenesis therapy; MLN4924; Sag cKO mouse model; SAG-CRL E3 ligase; vasculogenesis	CULLIN-RING LIGASES; FOCAL ADHESION KINASE; NEDD8-ACTIVATING ENZYME; CELL-GROWTH; NEOPLASTIC TRANSFORMATION; APOPTOSIS PROTECTION; ANTIOXIDANT PROTEIN; ANTICANCER TARGETS; CANCER CELLS; SCF	SAG (Sensitive to Apoptosis Gene), also known as RBX2 or ROC2, is a RING protein required for the activity of Cullin-RING ligase (CRL). Our recent study showed that Sag total knockout caused embryonic lethality at E11.5-12.5 days with associated defects in vasculogenesis. Whether Sag is required for de novo vasculogenesis in embryos and angiogenesis in tumors is totally unknown. Here, we report that Sag endothelial deletion also causes embryonic lethality at E15.5 with poor vasculogenesis. Sag deletion in primary endothelial cells (ECs) or knockdown in MS-1 ECs inhibits migration, proliferation and tube formation, with p27 accumulation being responsible for the suppression of migration and proliferation. Furthermore, Sag deletion significantly inhibits angiogenesis in an in vivo Matrigel plug assay, and tumor angiogenesis and tumorigenesis in a B16F10 melanoma model. Finally, MLN4924, an investigational small molecule inhibitor of NEDD8-activating enzyme (NAE) that inhibits CRL, suppresses in vitro migration, proliferation and tube formation, as well as in vivo angiogenesis and tumorigenesis. Taken together, our study, using both genetic and pharmaceutical approaches, demonstrates that Sag is essential for embryonic vasculogenesis and tumor angiogenesis, and provides the proof-of-concept evidence that targeting Sag E3 ubiquitin ligase may have clinical value for anti-angiogenesis therapy of human cancer.	[Tan, M.; Li, H.; Sun, Y.] Univ Michigan, Div Radiat & Canc Biol, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sun, Y (corresponding author), Univ Michigan, Div Radiat & Canc Biol, Dept Radiat Oncol, 4424B MS-1,1301 Catherine St, Ann Arbor, MI 48109 USA.	sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287	NCI [CA118762, CA156744, CA170995, CA171277]; NATIONAL CANCER INSTITUTE [R21CA170995, R01CA156744, R01CA171277, R01CA118762] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Millennium Pharmaceuticals, Inc. for providing MLN4924. This work is supported by the NCI grants (CA118762, CA156744, CA170995, and CA171277) to YS.	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diez-Juan Antonio, 2003, Current Vascular Pharmacology, V1, P99; Duan HJ, 1999, MOL CELL BIOL, V19, P3145; Duan HJ, 2001, MOL CARCINOGEN, V30, P37, DOI 10.1002/1098-2744(200101)30:1<37::AID-MC1011>3.0.CO;2-7; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Grunstein J, 1999, CANCER RES, V59, P1592; Gu QY, 2007, J CELL BIOL, V178, P1009, DOI 10.1083/jcb.200612067; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; He HB, 2008, CARCINOGENESIS, V29, P858, DOI 10.1093/carcin/bgn021; Huang YH, 2001, MOL CARCINOGEN, V30, P62, DOI 10.1002/1098-2744(200101)30:1<62::AID-MC1014>3.3.CO;2-1; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Jia LJ, 2010, CLIN CANCER RES, V16, P814, DOI 10.1158/1078-0432.CCR-09-1592; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Sun Y, 1999, CARCINOGENESIS, V20, P1899, DOI 10.1093/carcin/20.10.1899; Sun Y, 2013, PROTEIN CELL, V4, P103, DOI 10.1007/s13238-012-2105-7; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Tan MJ, 2010, FREE RADICAL BIO MED, V49, P976, DOI 10.1016/j.freeradbiomed.2010.05.030; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Wang XQ, 2008, TUMOR BIOL, V29, P217, DOI 10.1159/000152939; Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yang GY, 2001, J CEREBR BLOOD F MET, V21, P722, DOI 10.1097/00004647-200106000-00010; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	49	20	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5211	5220		10.1038/onc.2013.473	http://dx.doi.org/10.1038/onc.2013.473			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24213570	Green Accepted			2022-12-25	WOS:000343914900008
J	Ciarapica, R; De Salvo, M; Carcarino, E; Bracaglia, G; Adesso, L; Leoncini, PP; Dall'Agnese, A; Walters, ZS; Verginelli, F; De Sio, L; Boldrini, R; Inserra, A; Bisogno, G; Rosolen, A; Alaggio, R; Ferrari, A; Collini, P; Locatelli, M; Stifani, S; Screpanti, I; Rutella, S; Yu, Q; Marquez, VE; Shipley, J; Valente, S; Mai, A; Miele, L; Puri, PL; Locatelli, F; Palacios, D; Rota, R				Ciarapica, R.; De Salvo, M.; Carcarino, E.; Bracaglia, G.; Adesso, L.; Leoncini, P. P.; Dall'Agnese, A.; Walters, Z. S.; Verginelli, F.; De Sio, L.; Boldrini, R.; Inserra, A.; Bisogno, G.; Rosolen, A.; Alaggio, R.; Ferrari, A.; Collini, P.; Locatelli, M.; Stifani, S.; Screpanti, I.; Rutella, S.; Yu, Q.; Marquez, V. E.; Shipley, J.; Valente, S.; Mai, A.; Miele, L.; Puri, P. L.; Locatelli, F.; Palacios, D.; Rota, R.			The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)	ONCOGENE			English	Article						EZH2; FBXO32; histone methyltransferases; PAX3-FOXO1; rhabdomyosarcoma; Polycomb proteins	COMBINED EPIGENETIC THERAPY; SKELETAL-MUSCLE; GENE-EXPRESSION; INHIBITOR 3-DEAZANEPLANOCIN; TRANSCRIPTION FACTORS; HISTONE METHYLATION; SELF-RENEWAL; CELLS; ATROPHY; DIFFERENTIATION	The Polycomb group (PcG) proteins regulate stem cell differentiation via the repression of gene transcription, and their deregulation has been widely implicated in cancer development. The PcG protein Enhancer of Zeste Homolog 2 (EZH2) works as a catalytic subunit of the Polycomb Repressive Complex 2 (PRC2) by methylating lysine 27 on histone H3 (H3K27me3), a hallmark of PRC2-mediated gene repression. In skeletal muscle progenitors, EZH2 prevents an unscheduled differentiation by repressing muscle-specific gene expression and is downregulated during the course of differentiation. In rhabdomyosarcoma (RMS), a pediatric soft-tissue sarcoma thought to arise from myogenic precursors, EZH2 is abnormally expressed and its downregulation in vitro leads to muscle-like differentiation of RMS cells of the embryonal variant. However, the role of EZH2 in the clinically aggressive subgroup of alveolar RMS, characterized by the expression of PAX3-FOXO1 oncoprotein, remains unknown. We show here that EZH2 depletion in these cells leads to programmed cell death. Transcriptional derepression of F-box protein 32 (FBXO32) (Atrogin1/MAFbx), a gene associated with muscle homeostasis, was evidenced in PAX3-FOXO1 RMS cells silenced for EZH2. This phenomenon was associated with reduced EZH2 occupancy and H3K27me3 levels at the FBXO32 promoter. Simultaneous knockdown of FBXO32 and EZH2 in PAX3-FOXO1 RMS cells impaired the pro-apoptotic response, whereas the overexpression of FBXO32 facilitated programmed cell death in EZH2-depleted cells. Pharmacological inhibition of EZH2 by either 3-Deazaneplanocin A or a catalytic EZH2 inhibitor mirrored the phenotypic and molecular effects of EZH2 knockdown in vitro and prevented tumor growth in vivo. Collectively, these results indicate that EZH2 is a key factor in the proliferation and survival of PAX3-FOXO1 alveolar RMS cells working, at least in part, by repressing FBXO32. They also suggest that the reducing activity of EZH2 could represent a novel adjuvant strategy to eradicate high-risk PAX3-FOXO1 alveolar RMS.	[Ciarapica, R.; De Salvo, M.; Bracaglia, G.; Adesso, L.; Leoncini, P. P.; Verginelli, F.; De Sio, L.; Stifani, S.; Locatelli, F.; Rota, R.] IRCCS, Osped Pediat Bambino Gesu, Dept Oncohematol, Rome, Italy; [Carcarino, E.; Dall'Agnese, A.; Puri, P. L.; Palacios, D.] IRCCS Fdn Santa Lucia, Rome, Italy; [Walters, Z. S.; Shipley, J.] Inst Canc Res, Div Mol Pathol & Canc Therapeut, Sutton, Surrey, England; [Boldrini, R.] IRCCS, Osped Pediat Bambino Gesu, Dept Pathol, Rome, Italy; [Inserra, A.] IRCCS, Osped Pediat Bambino Gesu, Dept Surg, Rome, Italy; [Bisogno, G.; Rosolen, A.] Univ Padua, Dept Pediat, Oncohematol Unit, Padua, Italy; [Alaggio, R.] Univ Padua, Med DIMED, Pathol Unit, Padua, Italy; [Ferrari, A.] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy; [Collini, P.] Fdn IRCCS Ist Nazl Tumori, Anat Pathol Unit 2, Milan, Italy; [Locatelli, M.] IRCCS, Osped Pediat Bambino Gesu, Sci Directorate, Rome, Italy; [Stifani, S.] McGill Univ, Ctr Neuronal Survival, Montreal Neurol Inst, Montreal, PQ, Canada; [Screpanti, I.] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Yu, Q.] Genome Inst Singapore, Agcy Sci Technol & Res, Singapore, Singapore; [Marquez, V. E.] Natl Canc Inst, CCR, Frederick Natl Lab Canc Res, Chem Biol Lab, Frederick, MD USA; [Valente, S.; Mai, A.] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Miele, L.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Puri, P. L.] Sanford Burnham Med Res Inst, Muscle Dev & Regenerat Program, La Jolla, CA USA; [Locatelli, F.] Univ Pavia, Dipartimento Sci Pediat, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Santa Lucia; University of London; Institute of Cancer Research - UK; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Padua; University of Padua; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Bambino Gesu; McGill University; Sapienza University Rome; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione Cenci Bolognetti; Sapienza University Rome; University of Mississippi; University of Mississippi Medical Center; Sanford Burnham Prebys Medical Discovery Institute; University of Pavia	Rota, R (corresponding author), IRCCS, Osped Pediat Bambino Gesu, Dept Oncohematol, Rome, Italy.	d.palacios@hsantalucia.it; rossella.rota@opbg.net	Valente, Sergio/K-2198-2016; Adesso, Laura/AAA-7708-2020; Rutella, Sergio/AAF-9187-2020; Palacios, Daniela/AAA-7608-2019; Inserra, Alessandro/H-3120-2012; Rota, Rossella/AAB-2497-2019; Leoncini, Pier Paolo/AAH-9343-2019; verginelli, federica/HGU-3834-2022; Collini, Paola/K-7354-2016; alaggio, rita/AAC-2348-2019; Marquez, Victor/AAP-3549-2021; Palacios, Daniela/K-4698-2016; Locatelli, Mattia/AAA-6241-2020; Mai, Antonello/AAC-2144-2019; Ferrari, Andrea/R-1028-2016; Rutella, Sergio/AAF-9210-2020; Bisogno, Gianni/K-9282-2016	Valente, Sergio/0000-0002-2241-607X; Adesso, Laura/0000-0003-2121-4924; Palacios, Daniela/0000-0002-2207-2369; Rota, Rossella/0000-0002-9408-7711; verginelli, federica/0000-0002-8762-8815; Collini, Paola/0000-0002-6158-210X; alaggio, rita/0000-0003-3915-3816; Palacios, Daniela/0000-0002-2207-2369; Ferrari, Andrea/0000-0002-4724-0517; Rutella, Sergio/0000-0003-1970-7375; Mai, Antonello/0000-0001-9176-2382; Miele, Lucio/0000-0002-5853-7287; Walters, Zoe/0000-0002-1835-5868; Bisogno, Gianni/0000-0003-4462-5523; Shipley, Janet/0000-0001-6748-8678; Yu, Qiang/0000-0003-2132-8278	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10338]; Italian Ministry of Health Ricerca Corrente; Association for International Cancer Research (AICR-UK) [12-0168]; AIRC 5 per mille; NIH Intramural Research Program, National Cancer Institute, CCR; Cancer Research UK [C5066/A10399]; Sarcoma UK; Progetto IIT-Sapienza [A2]; FIRB [RBFR10ZJQT]; FP7 Project [BLUEPRINT/282510]; Worldwide Cancer Research [12-0168] Funding Source: researchfish	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca Corrente(Ministry of Health, Italy); Association for International Cancer Research (AICR-UK); AIRC 5 per mille(Fondazione AIRC per la ricerca sul cancro); NIH Intramural Research Program, National Cancer Institute, CCR; Cancer Research UK(Cancer Research UK); Sarcoma UK; Progetto IIT-Sapienza; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); FP7 Project; Worldwide Cancer Research	We thank E Giorda for fluorescence-activated cell sorting analysis. Myogenin (Wright WE) and MHC (Fishman DA) antibodies were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC, 10338) and Italian Ministry of Health Ricerca Corrente (RR); Association for International Cancer Research (AICR-UK, 12-0168) (DP); AIRC 5 per mille (FL); NIH Intramural Research Program, National Cancer Institute, CCR (VEM); Cancer Research UK (C5066/A10399) (ZSW); Sarcoma UK (ZSW, JS); Progetto IIT-Sapienza A2, FIRB RBFR10ZJQT and FP7 Project BLUEPRINT/282510 (AM). SS is a Chercheur National of the Fonds de la Recherche en Sante du Quebec.	Benoit YD, 2013, J CELL PHYSIOL, V228, P764, DOI 10.1002/jcp.24224; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; Davicioni E, 2010, J CLIN ONCOL, V28, P1240, DOI 10.1200/JCO.2008.21.1268; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gannon OM, 2013, CLIN CANCER RES, V19, P428, DOI 10.1158/1078-0432.CCR-12-2505; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hunt LC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-17; Jiang YL, 2013, J CELL PHYSIOL, V228, P1989, DOI 10.1002/jcp.24365; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kalushkova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011483; Kemp CD, 2012, CLIN CANCER RES, V18, P77, DOI 10.1158/1078-0432.CCR-11-0962; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Lawlor ER, 2012, CLIN CANCER RES, V18, P2768, DOI 10.1158/1078-0432.CCR-11-1921; Lee MH, 2011, CANCER RES, V71, P3921, DOI 10.1158/0008-5472.CAN-10-3358; Mai A, 2007, CHEMMEDCHEM, V2, P987, DOI 10.1002/cmdc.200700023; Marchesi I, 2012, CELL CYCLE, V11, P3828, DOI 10.4161/cc.22025; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Momparler RL, 2012, LEUKEMIA RES, V36, P1049, DOI 10.1016/j.leukres.2012.03.001; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Ogata T, 2009, MECH AGEING DEV, V130, P328, DOI 10.1016/j.mad.2009.02.001; Okada A, 2008, MUSCLE NERVE, V38, P1246, DOI 10.1002/mus.21110; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Puri PL, 2000, GENE DEV, V14, P574; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Valente S, 2012, BIOCHIMIE, V94, P2308, DOI 10.1016/j.biochi.2012.06.003; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vekony H, 2008, J CLIN PATHOL, V61, P744, DOI 10.1136/jcp.2007.054262; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang C, 2011, CANCER RES, V72, P315; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; Wu Z, 2011, CELL DEATH DIFFER, V18, P1771, DOI 10.1038/cdd.2011.48; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	73	51	52	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4173	4184		10.1038/onc.2013.471	http://dx.doi.org/10.1038/onc.2013.471			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24213577	hybrid, Green Accepted			2022-12-25	WOS:000340595700008
J	Chavez, JA; Siddique, MM; Wang, ST; Ching, JH; Shayman, JA; Summers, SA				Chavez, Jose A.; Siddique, M. Mobin; Wang, Siew Tein; Ching, Jianhong; Shayman, James A.; Summers, Scott A.			Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATURATED FATTY-ACIDS; MEMBRANE MICRODOMAIN DISORDER; SKELETAL-MUSCLE CELLS; HUMAN ADIPOSE-TISSUE; GANGLIOSIDE GM3; 3T3-L1 ADIPOCYTES; RESISTANCE; SENSITIVITY; SYNTHASE; MICE	Inhibitors of sphingolipid synthesis protect mice from diet induced-insulin resistance, and sphingolipids such as ceramides and glucosylated-ceramides (e.g., GM3) are putative nutritional intermediates linking obesity to diabetes risk. Herein we investigated the role of each of these sphingolipids in muscle and adipose tissue and conclude that they are independent and separable antagonists of insulin signaling. Of particular note, ceramides antagonize insulin signaling in both myotubes and adipocytes, whereas glucosyceramides are only efficacious in adipocytes: 1) In myotubes exposed to saturated fats, inhibitors of enzymes required for ceramide synthesis enhance insulin signaling, but those targeting glucosylceramide synthase have no effect. 2) Exogenous ceramides antagonize insulin signaling in myotubes, whereas ganglioside precursors do not. 3) Overexpression of glucosylceramide synthase in myotubes induces glucosylceramide but enhances insulin signaling. In contrast, glucosylated ceramides have profound effects in adipocytes. For example, either ganglioside addition or human glucosylceramide synthase overexpression suppresses insulin signaling in adipocytes. These data have important mechanistic implications for understanding how these sphingolipids contribute to energy sensing and the disruption of anabolism under conditions of nutrient oversupply.	[Chavez, Jose A.; Summers, Scott A.] Duke Univ Med Ctr, Stedman Ctr Nutr & Metab Res, Durham, NC 27710 USA; [Siddique, M. Mobin; Wang, Siew Tein; Ching, Jianhong; Summers, Scott A.] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Dis, Singapore 169857, Singapore; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Duke University; National University of Singapore; University of Michigan System; University of Michigan	Summers, SA (corresponding author), Duke NUS Grad Med Sch, Program Cardiovasc & Metab Dis, 8 Coll Rd 8-15, Singapore 169857, Singapore.	scott.summers@duke-nus.edu.sg	/AAE-5384-2020	Wang, Siew Tein/0000-0001-6306-2100	National Institutes of Health [R01DK081456-01]; National Medical Research Council [IRG09may004]; Singapore Ministry of Education Academic Research Fund Grant [MOE2009-T2-2-016]; Duke-NUS Signature Research Program; Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823, P30DK020572, R01DK081456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore Ministry of Education Academic Research Fund Grant(Ministry of Education, Singapore); Duke-NUS Signature Research Program; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081456-01 (to S. A. S.). This work was also supported by National Medical Research Council Grant IRG09may004 (to S. A. S.), Singapore Ministry of Education Academic Research Fund Grant MOE2009-T2-2-016 (to S. A. S.), and the Duke-NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore (to S. A. S.).	Abe A, 1998, J BIOL CHEM, V273, P8467, DOI 10.1074/jbc.273.14.8467; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Blachnio-Zabielska AU, 2012, J CELL PHYSIOL, V227, P550, DOI 10.1002/jcp.22745; Blachnio-Zabielska AU, 2012, OBESITY, V20, P2341, DOI 10.1038/oby.2012.126; Blachnio-Zabielska AU, 2012, LIPIDS, V47, P1131, DOI 10.1007/s11745-012-3722-x; Brozinick J. T., 2012, INT J OBES LOND, V37, P1064; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chocian G, 2010, MOL CELL BIOCHEM, V340, P125, DOI 10.1007/s11010-010-0409-6; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Deevska GM, 2011, BIOCHIMIE, V93, P32, DOI 10.1016/j.biochi.2010.05.016; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gill JMR, 2009, DIABETOLOGIA, V52, P2475, DOI 10.1007/s00125-009-1546-x; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Inokuchi J, 2007, YAKUGAKU ZASSHI, V127, P579, DOI 10.1248/yakushi.127.579; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Jennemann R, 2010, HEPATOLOGY, V51, P1799, DOI 10.1002/hep.23545; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kristensen D, 2013, ACTA DIABETOL, V50, P705, DOI 10.1007/s00592-012-0379-0; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Skovbro M, 2008, DIABETOLOGIA, V51, P1253, DOI 10.1007/s00125-008-1014-z; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	51	88	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					723	734		10.1074/jbc.M113.522847	http://dx.doi.org/10.1074/jbc.M113.522847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24214972	hybrid, Green Published			2022-12-25	WOS:000330541200012
J	Casado, C; Pernas, M; Sandonis, V; Alvaro-Cifuentes, T; Olivares, I; Fuentes, R; Martinez-Prats, L; Grau, E; Ruiz, L; Delgado, R; Rodriguez, C; del Romero, J; Lopez-Galindez, C				Casado, Concepcion; Pernas, Maria; Sandonis, Virginia; Alvaro-Cifuentes, Tamara; Olivares, Isabel; Fuentes, Rosa; Martinez-Prats, Lorena; Grau, Eulalia; Ruiz, Lidia; Delgado, Rafael; Rodriguez, Carmen; del Romero, Jorge; Lopez-Galindez, Cecilio			Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; ELITE SUPPRESSORS; VIRAL REPLICATION; CYTOPLASMIC TAIL; V3 LOOP; TYPE-1; SEQUENCE; GAG; DETERMINANTS; ASSOCIATION	Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infection. This control is related to host genetic, immunological and virological factors. In this work, phylogenetic analysis of the proviral nucleotide sequences in env gene from a Spanish HIV-1 LTNPs cohort identified a cluster of 6 HIV-1 controllers infected with closely-related viruses. The patients of the cluster showed common clinical and epidemiological features: drug user practices, infection in the same city (Madrid, Spain) and at the same time (late 70's-early 80's). All cluster patients displayed distinct host alleles associated with HIV control. Analysis of the virus envelope nucleotide sequences showed ancestral characteristic, lack of evolution and presence of rare amino-acids. Biological characterization of recombinant viruses with the envelope proteins from the cluster viruses showed very low replicative capacity in TZMbl and U87-CD4/CCR5 cells. The lack of clinical progression in the viral cluster patients with distinct combinations of protective host genotypes, but infected by low replicating viruses, indicate the important role of the virus in the non-progressor phenotype in these patients.	[Casado, Concepcion; Pernas, Maria; Sandonis, Virginia; Alvaro-Cifuentes, Tamara; Olivares, Isabel; Fuentes, Rosa; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Martinez-Prats, Lorena; Delgado, Rafael] Inst Invest Hosp 12 Octubre I 12, Lab Microbiol Mol, Madrid, Spain; [Grau, Eulalia; Ruiz, Lidia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa Fdn, E-08193 Barcelona, Spain; [Rodriguez, Carmen; del Romero, Jorge] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, CSS, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Lopez-Galindez, C (corresponding author), Inst Salud Carlos III, CNM, Madrid, Spain.	clopez@isciii.es	Lopez-Galindez, Cecilio/A-3603-2008; Pernas, Maria/E-3998-2018; Olivares, Isabel/F-3083-2016; Ruiz, Lidia/ABF-9720-2021; Sandonís, Virginia/K-2884-2014; DELGADO, RAFAEL/A-2938-2012; Casado, Concepcion/F-3060-2016; Delgado, Rafael/C-4910-2016	Lopez-Galindez, Cecilio/0000-0002-2324-9584; Pernas, Maria/0000-0003-2966-0160; Olivares, Isabel/0000-0002-2347-5717; Sandonís, Virginia/0000-0001-5762-7531; Casado, Concepcion/0000-0003-3412-2877; Delgado, Rafael/0000-0002-6912-4736; Grau, Eulalia/0000-0002-2442-9165	MICINN Spain [SAF 2007-61036, 2010-17226]; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain [36558/06, 36641/07, 36779/08, 360766/09]; RETIC de Investigacion en SIDA of the Fondo de Investigaciones Sanitarias (FISss) [RD06/006/0036]; FIPSE [36749]; ISCIII-FIS [PI080806, PI1101580]; Instituto de Salud Carlos III; Spanish Health Department [RD06/006/0035]	MICINN Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain; RETIC de Investigacion en SIDA of the Fondo de Investigaciones Sanitarias (FISss); FIPSE; ISCIII-FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Health Department	Work in CNM is supported by grants [SAF 2007-61036 and 2010-17226] from MICINN Spain, by grants [36558/06, 36641/07, 36779/08, 360766/09] from Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain, and in part by the RETIC de Investigacion en SIDA [RD06/006/0036] of the Fondo de Investigaciones Sanitarias (FISss). Work in H12 de Octubre was financed by FIPSE [36749], and ISCIII-FIS [PI080806 and PI1101580] to RD. The HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by the Instituto de Salud Carlos III, Spanish Health Department (Grant no RD06/006/0035) and FIPSE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBERT J, 1994, J VIROL, V68, P5918, DOI 10.1128/JVI.68.9.5918-5924.1994; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Antoni S, 2007, AIDS RES HUM RETROV, V23, P1377, DOI 10.1089/aid.2007.0113; Appay V, 2011, CURR OPIN HIV AIDS, V6, P157, DOI 10.1097/COH.0b013e3283453dfd; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bello G, 2004, J GEN VIROL, V85, P399, DOI 10.1099/vir.0.19365-0; Berger CT, 2011, CURR OPIN HIV AIDS, V6, P208, DOI 10.1097/COH.0b013e3283457798; Blaak H, 1998, J INFECT DIS, V177, P600, DOI 10.1086/514219; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Bobkov A, 2001, AIDS RES HUM RETROV, V17, P257, DOI 10.1089/088922201750063188; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Campbell TB, 2003, J VIROL, V77, P12105, DOI 10.1128/JVI.77.22.12105-12112.2003; Casado C, 2001, J GEN VIROL, V82, P2495, DOI 10.1099/0022-1317-82-10-2495; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Huthoff H, 2004, J VIROL, V78, P4907, DOI 10.1128/JVI.78.9.4907-4913.2004; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Julg B, CLIN INFECT DIS, V51, P233; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mascola Jr, 1999, METH MOLEC MED, V17, P317, DOI 10.1385/0-89603-369-4:317; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Olivares I, 1998, AIDS RES HUM RETROV, V14, P1649, DOI 10.1089/aid.1998.14.1649; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PERUCHO M, 1980, CELL, V22, P309, DOI 10.1016/0092-8674(80)90178-6; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Salgado M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-94; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Smith SM, 2003, J BIOL CHEM, V278, P44816, DOI 10.1074/jbc.M307546200; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Volz EM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002552; Wang B, 2003, VIROLOGY, V312, P135, DOI 10.1016/S0042-6822(03)00159-4; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; [No title captured]	63	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77663	10.1371/journal.pone.0077663	http://dx.doi.org/10.1371/journal.pone.0077663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204910	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500040
J	Gharbi, M; Flegg, JA; Pradines, B; Berenger, A; Ndiaye, M; Djimde, AA; Roper, C; Hubert, V; Kendjo, E; Venkatesan, M; Brasseur, P; Gaye, O; Offianan, AT; Penali, L; Le Bras, J; Guerin, PJ				Gharbi, Myriam; Flegg, Jennifer A.; Pradines, Bruno; Berenger, Ako; Ndiaye, Magatte; Djimde, Abdoulaye A.; Roper, Cally; Hubert, Veronique; Kendjo, Eric; Venkatesan, Meera; Brasseur, Philippe; Gaye, Oumar; Offianan, Andre T.; Penali, Louis; Le Bras, Jacques; Guerin, Philippe J.		French Natl Reference Ctr Imported	Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO RESISTANCE; SULFADOXINE-PYRIMETHAMINE; DIHYDROFOLATE-REDUCTASE; CHLOROQUINE RESISTANCE; MOLECULAR MARKERS; DIHYDROPTEROATE SYNTHASE; COMBINATION THERAPY; GENETIC DIVERSITY; SELECTIVE SWEEPS	Introduction: There are growing concerns about the emergence of resistance to artemisinin-based combination therapies (ACTs). Since the widespread adoption of ACTs, there has been a decrease in the systematic surveillance of antimalarial drug resistance in many malaria-endemic countries. The aim of this work was to test whether data on travellers returning from Africa with malaria could serve as an additional surveillance system of local information sources for the emergence of drug resistance in endemic-countries. Methodology: Data were collected from travellers with symptomatic Plasmodium falciparum malaria returning from Senegal (n = 1,993), Mali (n = 2,372), Cote d'Ivoire (n = 4,778) or Cameroon (n = 3,272) and recorded in the French Malaria Reference Centre during the period 1996-2011. Temporal trends of the proportion of parasite isolates that carried the mutant genotype, pfcrt 76T, a marker of resistance to chloroquine (CQ) and pfdhfr 108N, a marker of resistance to pyrimethamine, were compared for travellers and within-country surveys that were identified through a literature review in PubMed. The in vitro response to CQ was also compared between these two groups for parasites from Senegal. Results: The trends in the proportion of parasites that carried pfcrt 76T, and pfdhfr 108N, were compared for parasites from travellers and patients within-country using the slopes of the curves over time; no significant differences in the trends were found for any of the 4 countries. These results were supported by in vitro analysis of parasites from the field in Senegal and travellers returning to France, where the trends were also not significantly different. Conclusion: The results have not shown different trends in resistance between parasites derived from travellers or from parasites within-country. This work highlights the value of an international database of drug responses in travellers as an additional tool to assess the emergence of drug resistance in endemic areas where information is limited.	[Gharbi, Myriam; Le Bras, Jacques] Inst Rech & Dev, UMR 216, Paris, France; [Gharbi, Myriam; Le Bras, Jacques] Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Gharbi, Myriam; Flegg, Jennifer A.; Venkatesan, Meera; Penali, Louis; Le Bras, Jacques; Guerin, Philippe J.] WorldWide Antimalarial Resistance Network, Oxford, England; [Gharbi, Myriam; Guerin, Philippe J.] Sorbonne Paris Cite, Ecole Hautes Etud Sante Publ, Rennes, France; [Flegg, Jennifer A.; Guerin, Philippe J.] Univ Oxford, Ctr Trop Med, Oxford, England; [Flegg, Jennifer A.; Guerin, Philippe J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Pradines, Bruno] Inst Rech Biomed Armees, Dept Infectiol Terrain, Marseille, France; [Pradines, Bruno] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Pradines, Bruno] Ctr Natl Reference Paludisme, Marseille, France; [Berenger, Ako; Offianan, Andre T.] Inst Pasteur Cote Ivoire, Malariol Dept, Abidjan, Cote Ivoire; [Ndiaye, Magatte; Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med & Pharm, Serv Parasitol, Dakar, Senegal; [Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Malaria Res & Training Ctr, Bamako, Mali; [Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, Bamako, Mali; [Roper, Cally] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept Infect Trop Dis, London WC1, England; [Hubert, Veronique; Le Bras, Jacques] CHU Bichat Claude Bernard, AP HP, Ctr Natl Reference Paludisme, Paris, France; [Hubert, Veronique; Le Bras, Jacques] CHU Bichat Claude Bernard, AP HP, Serv Parasitol Mycol, Paris, France; [Kendjo, Eric] CHU Pitie Salpetriere, AP HP, Ctr Natl Reference Paludisme, Paris, France; [Kendjo, Eric] CHU Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France; [Venkatesan, Meera] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Brasseur, Philippe] Inst Rech Dev, UMR 198, Dakar, Senegal; [Guerin, Philippe J.] INSERM, UMR Epidemiol Informat Syst Modeling S 707, Paris, France; [Guerin, Philippe J.] Univ Paris 06, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Worldwide Antimalarial Resistance Network (WWARN); University of Oxford; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Science & Technology of Bamako; University of Science & Technology of Bamako; University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University System of Maryland; University of Maryland Baltimore; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gharbi, M (corresponding author), Inst Rech & Dev, UMR 216, Paris, France.	m.gharbi@yahoo.fr	Benoit-Vical, Francoise/E-3938-2016; Roper, Cally/K-2989-2013; KENDJO, Eric/AAI-7830-2021; Guerin, Philippe/AAH-8873-2021	Benoit-Vical, Francoise/0000-0002-9468-4823; Roper, Cally/0000-0002-6545-309X; KENDJO, Eric/0000-0002-2632-0964; Flegg, Jennifer/0000-0002-8809-726X; Pradines, Bruno/0000-0002-2360-3803; Guerin, Philippe/0000-0002-6008-2963; /0000-0001-7338-8745; Gharbi, Myriam/0000-0002-8994-2816	Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France; Institut National de Veille Sanitaire, St Maurice, France	Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France; Institut National de Veille Sanitaire, St Maurice, France	This study was supported in part by a grant for doctoral studies to MG from the Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France and a grant for CNRpaludisme from Institut National de Veille Sanitaire, St Maurice, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako Berenger Aristide, 2012, Infect Drug Resist, V5, P113, DOI 10.2147/IDR.S31409; [Anonymous], 2011, GLOB PLAN ART RES CO; Armitage P., 1980, STAT METHODS MED RES; Basco LK, 2002, AM J TROP MED HYG, V67, P388, DOI 10.4269/ajtmh.2002.67.388; Basco LK, 2002, AM J TROP MED HYG, V67, P378, DOI 10.4269/ajtmh.2002.67.378; Basco LK, 2002, AM J TROP MED HYG, V67, P392, DOI 10.4269/ajtmh.2002.67.392; Basco LK., 2007, FIELD APPL IN VITRO; Bertin G, 2005, J ANTIMICROB CHEMOTH, V55, P788, DOI 10.1093/jac/dki097; Bob NS, 2010, PLOS ONE, V5, pe9817, DOI DOI 10.1371/journal.pone.0009817; Brasseur P, 1999, T ROY SOC TROP MED H, V93, P645, DOI 10.1016/S0035-9203(99)90083-4; CHABASSE D, 1988, T ROY SOC TROP MED H, V82, P547, DOI 10.1016/0035-9203(88)90499-3; CHARMOT G, 1988, T ROY SOC TROP MED H, V82, P392, DOI 10.1016/0035-9203(88)90131-9; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dicko A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-9; Djaman JA, 2007, ANN TROP MED PARASIT, V101, P103, DOI 10.1179/136485907X154584; Djaman JA, 2010, EUR J SCI RES, V40, P10; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde AA, 2004, J INFECT DIS, V190, P853, DOI 10.1086/422758; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Djimde AA, 2010, FEMS IMMUNOL MED MIC, V58, P113, DOI 10.1111/j.1574-695X.2009.00641.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doumbo OK, 2000, J INFECT DIS, V182, P993, DOI 10.1086/315787; Durand R, 2001, MOL BIOCHEM PARASIT, V114, P95, DOI 10.1016/S0166-6851(01)00247-X; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Faye B, 2011, PARASITOL RES, V109, P133, DOI 10.1007/s00436-010-2236-9; FOGH S, 1979, T ROY SOC TROP MED H, V73, P228, DOI 10.1016/0035-9203(79)90220-7; Gautret P., 2012, EURO SURVEILL B EUR, P17; Guerin PJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-8; HELLGREN U, 1987, T ROY SOC TROP MED H, V81, P728, DOI 10.1016/0035-9203(87)90008-3; Henry M, 2006, AM J TROP MED HYG, V75, P146, DOI 10.4269/ajtmh.2006.75.146; Jafari S, 2004, J INFECT DIS, V189, P195, DOI 10.1086/380910; Kaddouri H, 2006, ANTIMICROB AGENTS CH, V50, P3343, DOI 10.1128/AAC.00367-06; KEAN BH, 1979, JAMA-J AM MED ASSOC, V241, P395, DOI 10.1001/jama.241.4.395; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Le Nagard H, 2011, COMPUT METH PROG BIO, V104, P10, DOI 10.1016/j.cmpb.2010.08.003; LEBRAS J, 1984, T ROY SOC TROP MED H, V78, P410, DOI 10.1016/0035-9203(84)90137-8; LEBRAS J, 1985, LANCET, V2, P1071; LEBRAS J, 1986, LANCET, V2, P1043; MacPherson DW, 2009, EMERG INFECT DIS, V15, P1727, DOI 10.3201/eid1511.090419; Mbacham WF, 2009, AFRICAN J BIOTECHNOL, V8, P6; Mbacham WF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-34; McCollum AM, 2008, ANTIMICROB AGENTS CH, V52, P4089, DOI 10.1128/AAC.00623-08; Menard S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-113; MORAN JS, 1983, LANCET, V2, P171; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709; Neequaye J, 1986, LANCET, V1, P2; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; OLSEN VV, 1984, LANCET, V1, P1462; Ouattara L, 2010, TROPICAL J PHARM RES, V9, P8; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Poumerol G, 2010, INT TRAV HLTH; Pradines B, 2006, J ANTIMICROB CHEMOTH, V57, P1093, DOI 10.1093/jac/dkl117; Pradines B, 2002, TROP MED INT HEALTH, V7, P265, DOI 10.1046/j.1365-3156.2002.00848.x; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Pradines B, 2006, J CLIN MICROBIOL, V44, P2404, DOI 10.1128/JCM.00623-06; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabatinelli G, 2001, Euro Surveill, V6, P61; SANSONETTI PJ, 1985, LANCET, V1, P1154; Sarr O, 2005, PARASITOL RES, V97, P136, DOI 10.1007/s00436-005-1406-7; Sarr O, 2008, PARASITOL RES, V103, P765, DOI 10.1007/s00436-008-1038-9; Sibley CH, 2008, TRENDS PARASITOL, V24, P43, DOI 10.1016/j.pt.2007.09.008; Tahar R, 2006, AM J TROP MED HYG, V75, P396, DOI 10.4269/ajtmh.2006.75.396; Tekete M, 2009, MALARIA J, V8, DOI [10.1186/1475-2875-8-S1-S4, 10.1186/1475-2875-8-34]; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; Wele M, 2011, ACTA TROP, V119, P11, DOI 10.1016/j.actatropica.2011.01.002; WHO, 2020, REP ANT DRUG EFF RES; Wilson ME, 2003, J APPL MICROBIOL, V94, p1S; Woodrow CJ, 2013, ANTIMICROB AGENTS CH, V57, P3121, DOI 10.1128/AAC.02350-12; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; World Health Organization, 2013, MAN SEV MAL PRACT HD; Wurtz N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-197	78	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77775	10.1371/journal.pone.0077775	http://dx.doi.org/10.1371/journal.pone.0077775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204960	Green Published, Green Accepted, gold			2022-12-25	WOS:000326334500058
J	Witsenburg, JJ; Glauner, H; Muller, JP; Groenewoud, JMM; Roth, G; Bohmer, FD; Adjobo-Hermans, MJW; Brock, R				Witsenburg, J. Joris; Glauner, Heike; Mueller, Joerg P.; Groenewoud, Johannes M. M.; Roth, Guenter; Boehmer, Frank-Dietmar; Adjobo-Hermans, Merel J. W.; Brock, Roland			A Quantitative Assessment of Costimulation and Phosphatase Activity on Microclusters in Early T Cell Signaling	PLOS ONE			English	Article							RECEPTOR MICROCLUSTERS; ANTIGEN-RECEPTOR; CO-STIMULATION; IMMUNOLOGICAL SYNAPSE; ACTIVATION; CD28; PROTEIN; KINASE; TCR; CLUSTERS	T cell signaling is triggered through stimulation of the T cell receptor and costimulatory receptors. Receptor activation leads to the formation of membrane-proximal protein microclusters. These clusters undergo tyrosine phosphorylation and organize multiprotein complexes thereby acting as molecular signaling platforms. Little is known about how the quantity and phosphorylation levels of microclusters are affected by costimulatory signals and the activity of specific signaling proteins. We combined micrometer-sized, microcontact printed, striped patterns of different stimuli and simultaneous analysis of different cell strains with image processing protocols to address this problem. First, we validated the stimulation protocol by showing that high expression levels CD28 result in increased cell spreading. Subsequently, we addressed the role of costimulation and a specific phosphotyrosine phosphatase in cluster formation by including a SHP2 knock-down strain in our system. Distinguishing cell strains using carboxyfluorescein succinimidyl ester enabled a comparison within single samples. SHP2 exerted its effect by lowering phosphorylation levels of individual clusters while CD28 costimulation mainly increased the number of signaling clusters and cell spreading. These effects were observed for general tyrosine phosphorylation of clusters and for phosphorylated PLC gamma 1. Our analysis enables a clear distinction between factors determining the number of microclusters and those that act on these signaling platforms.	[Witsenburg, J. Joris; Glauner, Heike; Adjobo-Hermans, Merel J. W.; Brock, Roland] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Mueller, Joerg P.; Boehmer, Frank-Dietmar] Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Groenewoud, Johannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Roth, Guenter] Univ Freiburg, Dept Microsyst Engn IMTEK, Lab MEMS Applicat, D-79106 Freiburg, Germany; [Roth, Guenter] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	Radboud University Nijmegen; Friedrich Schiller University of Jena; Radboud University Nijmegen; University of Freiburg; University of Freiburg	Brock, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands.	R.Brock@ncmls.ru.nl	Brock, Roland/O-9411-2019; Adjobo-Hermans, Merel/AAN-5989-2020; Groenewoud, Hans JMM/R-3588-2017; Adjobo-Hermans, M.J.W./L-4170-2015; Brock, Roland/K-2590-2012	Adjobo-Hermans, Merel/0000-0002-5947-2876; Groenewoud, Hans JMM/0000-0002-4974-150X; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Brock, Roland/0000-0003-1395-6127	Volkswagen Foundation [I/7 7 472]	Volkswagen Foundation(Volkswagen)	This work has been supported by the Volkswagen Foundation (http://www.volkswagenstiftung.de/" Nachwuchsgruppen an Universitaten'', I/7 7 472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cantrell DA, 2001, J CELL SCI, V114, P1439; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Hashimoto-Tane A, 2010, MOL CELL BIOL, V30, P3421, DOI 10.1128/MCB.00160-10; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032994; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Nguyen TV, 2006, J IMMUNOL, V177, P5990, DOI 10.4049/jimmunol.177.9.5990; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Osborn M, 1982, METHODS CELL BIOL CY, V97; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Perez-Villar JJ, 1999, J IMMUNOL, V163, P6435; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Wange R L, 2000, Sci STKE, V2000, pre1; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	65	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79277	10.1371/journal.pone.0079277	http://dx.doi.org/10.1371/journal.pone.0079277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205378	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500147
J	Mellor, RM; Greenfield, SM; Dowswell, G; Sheppard, JP; Quinn, T; McManus, RJ				Mellor, Ruth M.; Greenfield, Sheila M.; Dowswell, George; Sheppard, James P.; Quinn, Tom; McManus, Richard J.			Health Care Professionals' Views on Discussing Sexual Wellbeing with Patients Who Have Had a Stroke: A Qualitative Study	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; NATIONAL-SURVEY; OVARIAN-CANCER; ISSUES; REHABILITATION; CONSEQUENCES; INTIMACY; LIFE; MEN; COMMUNICATION	Objectives: To examine the experiences of health care professionals discussing sexual wellbeing with patients who have had a stroke. Design: In-depth qualitative interview study with purposive sampling and thematic analysis. Participants: 30 health care professionals purposively recruited to include different roles and settings along the stroke patient pathway in secondary and primary care. Setting: Two hospitals and three general practices in the West Midlands, UK. Results: Sexual wellbeing was a topic that participants did not raise with patients and was infrequently raised by patients. Barriers to raising discussion were on four levels: structural, health care professional, patient, and professional-patient interface. Barriers within these levels included: sexual wellbeing not present within hospital stroke policy; the perception that sexual wellbeing was not within participants' role; participants' concern that raising the issue could cause harm to the patient; and the views that discussion would be inappropriate with older people or unimportant to women. Resources exist to aid discussion but many participants were unaware of them, and most of those that were, did not use them routinely. Conclusions: Participants lacked motivation, ownership, and the confidence and skills to raise sexual wellbeing routinely after stroke. Similar findings have been reported in cancer care and other taboo subjects such as incontinence potentially resulting in a sub-optimal experience for patients. Normalisation of the inclusion of sensitive topics in discussions post-stroke does not seem to need significant structural intervention and simple changes such as information provision and legitimisation through consideration of the issue in standard care policies may be all that is required. The experiences recounted by professionals in this study suggest that such changes are needed now.	[Mellor, Ruth M.; Greenfield, Sheila M.; Dowswell, George] Univ Birmingham, Birmingham, W Midlands, England; [Sheppard, James P.; McManus, Richard J.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Quinn, Tom] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Birmingham; University of Oxford; University of Surrey	Greenfield, SM (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	s.m.greenfield@bham.ac.uk	Sheppard, James/AAR-6793-2021	Sheppard, James/0000-0002-4461-8756; Quinn, Tom/0000-0002-5116-0034	National Institute for Health Research (NIHR); National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme; NIHR Career Development Fellowship; National Institute for Health Research [NIHR-RP-02-12-015, CDF/01/017] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme; NIHR Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. All authors were funded by the National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme. RJM was funded by an NIHR Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom B, 2010, SCAND J CARING SCI, V24, P116, DOI 10.1111/j.1471-6712.2009.00694.x; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Bener A, 2008, INT UROL NEPHROL, V40, P701, DOI 10.1007/s11255-008-9334-y; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub3; Byrne M, 2013, EUR J CARDIOVASC NUR, V12, P558, DOI 10.1177/1474515113477273; Byrne M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-40; Cheung RTF, 2008, EUR J NEUROL, V15, P641, DOI 10.1111/j.1468-1331.2008.02177.x; Currie L, 1998, Nurs Stand, V12, P35; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.535088, 10.1161/STROKEAHA.108.534487]; Department of Health, 2007, NAT STROK STRAT; Dowswell G, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5824; Finch H., 2003, QUALITATIVE RES PRAC, P170, DOI https://doi.org/10.4135/9781452230108; Forbat L, 2012, BJU INT, V109, P98, DOI 10.1111/j.1464-410X.2011.10257.x; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, FAM PRACT, V20, P690, DOI 10.1093/fampra/cmg612; HAWTON K, 1984, J PSYCHOSOM RES, V28, P243, DOI 10.1016/0022-3999(84)90026-6; Higgins A, 2008, J ADV NURS, V62, P307, DOI 10.1111/j.1365-2648.2007.04586.x; Hinchliff S, 2005, HEALTH SOC CARE COMM, V13, P345, DOI 10.1111/j.1365-2524.2005.00566.x; Hinchliff S, 2011, J SEX RES, V48, P106, DOI 10.1080/00224499.2010.548610; Hordern A, 2008, CANCER NURS, V31, pE9, DOI 10.1097/01.NCC.0000305695.12873.d5; Hordern AJ, 2007, MED J AUSTRALIA, V186, P224, DOI 10.5694/j.1326-5377.2007.tb00877.x; Hughes MK, 2000, CANCER NURS, V23, P477, DOI 10.1097/00002820-200012000-00011; Jaarsma T, 2010, EUR J CARDIOVASC NUR, V9, P24, DOI 10.1016/j.ejcnurse.2009.11.003; Jung JH, 2008, UROLOGY, V71, P99, DOI 10.1016/j.urology.2007.08.045; Kautz DD, 2007, REHABIL NURS, V32, P95, DOI 10.1002/j.2048-7940.2007.tb00160.x; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Kim JR, 2008, J PSYCHOSOM RES, V65, P565, DOI 10.1016/j.jpsychores.2008.06.005; Kimura M, 2001, COMPR PSYCHIAT, V42, P217, DOI 10.1053/comp.2001.23141; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Lennon S, 2013, CLIN REHABIL, V27, P867, DOI 10.1177/0269215513481045; Lindau ST, 2012, AM J CARDIOL, V109, P1439, DOI 10.1016/j.amjcard.2012.01.355; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; Milne JL, 2008, INT J NURS STUD, V45, P765, DOI 10.1016/j.ijnurstu.2007.01.006; Mirone V, 2002, INT J IMPOT RES, V14, P256, DOI 10.1038/sj.ijir.3900879; MONGA TN, 1986, ARCH PHYS MED REHAB, V67, P415; Monz B, 2005, MATURITAS, V52, pS3, DOI 10.1016/j.maturitas.2005.09.007; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; QSR International, 1999, NVIVO QUAL DAT AN SO; Ritchie J, 2003, QUALITATIVE RES PRAC, P77; Sarkadi A, 2001, FAM PRACT, V18, P161, DOI 10.1093/fampra/18.2.161; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Shell J A, 1994, Oncol Nurs Forum, V21, P553; Sheppard JP, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001430; Sinclair Emma, 2014, Disabil Rehabil, V36, P409, DOI 10.3109/09638288.2013.793410; Stead ML, 2001, BRIT MED J, V323, P836, DOI 10.1136/bmj.323.7317.836; Stead ML, 2003, BRIT J CANCER, V88, P666, DOI 10.1038/sj.bjc.6600799; Steinke E, 1996, Clin Nurs Res, V5, P462, DOI 10.1177/105477389600500408; Strauss A., 2008, BASICS QUALITATIVE R, V3rd, P65, DOI [10.4135/9781452230153qu, DOI 10.4135/9781452230153]; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Stroke Association, 2012, SEX STROK, P2; Sundquist Kendra, 2003, Aust Fam Physician, V32, P19; Swanson JG, 2002, CAN FAM PHYSICIAN, V48, P86; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Whitehead WE, 2005, GASTROENTEROLOGY, V129, P6, DOI 10.1053/j.gastro.2005.05.043; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Yar Mohammed, 2006, Health Stat Q, P44; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	63	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78802	10.1371/journal.pone.0078802	http://dx.doi.org/10.1371/journal.pone.0078802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24205318	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000326270700098
J	Xia, XF; Wang, XY; Li, QR; Li, N; Li, JS				Xia, Xianfeng; Wang, Xinying; Li, Qiurong; Li, Ning; Li, Jieshou			Essential Amino Acid Enriched High-Protein Enteral Nutrition Modulates Insulin-Like Growth Factor-1 System Function in a Rat Model of Trauma-Hemorrhagic Shock	PLOS ONE			English	Article							IGF-BINDING PROTEIN-1; SKELETAL-MUSCLE; MOLECULAR-MECHANISMS; MAMMALIAN TARGET; LEUCINE; SUPPLEMENTATION; RESISTANCE; PLASMA; STIMULATION; RESTRICTION	Background: Nutrition support for critically ill patients supplemented with additional modular protein may promote skeletal muscle protein anabolism in addition to counteracting acute nitrogen loss. The present study was designed to investigate whether the essential amino acid (EAA) enriched high-protein enteral nutrition (EN) modulates the insulin-like growth factor-1 (IGF-1) system and activates the mammalian target of rapamycin (mTOR) anabolic signaling pathway in a trauma-hemorrhagic shock (T-HS) rat model. Methodology/Principal Findings: Male Sprague-Dawley rats (n = 90, 278.18 +/- 0.94 g) were randomly assigned to 5 groups: (1) normal control, (2) pair-fed, (3) T-HS, (4) T-HS and standard EN, and (5) T-HS and EAA enriched high-protein EN. Six animals from each group were harvested on days 2, 4, and 6 for serum, gastrocnemius, soleus, and extensor digitorum longus sample collection. T-HS significantly reduced muscle mass. Nutrition support maintained muscle mass, especially the EAA enriched high-protein EN. Meanwhile, a pronounced derangement in IGF-1-IGFBPs axis as well as impaired mTOR transduction was observed in the T-HS group. Compared with animals receiving standard EN, those receiving EAA enriched high-protein EN presented 18% higher serum free IGF-1 levels following 3 days of nutrition support and 22% higher after 5 days. These changes were consistent with the concomitant elevation in serum insulin and reduction in corticosterone levels. In addition, phosphorylations of downstream anabolic signaling effectors - including protein kinase B, mTOR, and ribosomal protein S6 kinase1 - increased significantly in rats receiving EAA enriched high-protein EN. Conclusion/Significance: Our findings firstly demonstrate the beneficial effect of EAA enriched high-protein EN on the metabolic modulation of skeletal muscle protein anabolism by regulating the IGF-1 system and downstream anabolic signaling transduction.	[Xia, Xianfeng; Wang, Xinying; Li, Qiurong; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Wang, XY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	wxinying@263.net	Xia, Xianfeng/Y-6601-2018; Li, jie/GXG-4583-2022	Xia, Xianfeng/0000-0003-4718-8189; 	National Natural Science Foundation in China [81070282]; Natural Science Foundation in Jiangsu Province [BK2010460]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation in Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors' research project is sponsored by the National Natural Science Foundation in China (81070282) and the Natural Science Foundation in Jiangsu Province (BK2010460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AG, 2010, PANCREAS, V39, P847, DOI 10.1097/MPA.0b013e3181d37210; Belizon A, 2007, SURG ENDOSC, V21, P653, DOI 10.1007/s00464-006-9103-x; Biolo G, 1997, NUTRITION, V13, pS52, DOI 10.1016/S0899-9007(97)00206-2; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; CAREY LC, 1970, ANN SURG, V172, P342, DOI 10.1097/00000658-197009000-00004; CHAUDRY IH, 1976, CAN J PHYSIOL PHARM, V54, P736, DOI 10.1139/y76-102; Chen Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE873, DOI 10.1152/ajpendo.00068.2011; Chevalley T, 2010, CLIN NUTR, V29, P78, DOI 10.1016/j.clnu.2009.07.003; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Elijah IE, 2011, BEST PRACT RES CL EN, V25, P759, DOI 10.1016/j.beem.2011.06.002; Foster EB, 2012, AMINO ACIDS, V42, P1405, DOI 10.1007/s00726-011-0837-y; Frost RA, 1999, ENDOCRINOLOGY, V140, P3962, DOI 10.1210/en.140.9.3962; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Gomes MR, 2003, NUTR RES, V23, P1239, DOI 10.1016/S0271-5317(03)00114-3; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Janssen JAMJL, 2003, J ENDOCRINOL INVEST, V26, P588, DOI 10.1007/BF03345225; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Klaude M, 2012, CLIN SCI, V122, P133, DOI 10.1042/CS20110233; Lang CH, 2002, AM J PHYSIOL-REG I, V282, pR207, DOI 10.1152/ajpregu.00319.2001; Lang CH, 2004, SHOCK, V22, P326, DOI 10.1097/01.shk.0000136096.03931.ed; Lang CH, 2003, ENDOCRINOLOGY, V144, P3922, DOI 10.1210/en.2002-0192; Li L, 2009, ENDOCRINOLOGY, V150, P24, DOI 10.1210/en.2008-0742; [罗楠 Luo Nan], 2004, [肠外与肠内营养, Parenteral & Enteral Nutrition], V11, P367; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ma YC, 2003, AM J PHYSIOL-GASTR L, V284, pG107, DOI 10.1152/ajpgi.00217.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Minard G, 1998, WORLD J SURG, V22, P213, DOI 10.1007/s002689900372; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Okamoto I, 2010, JPN J CLIN ONCOL, V40, P222, DOI 10.1093/jjco/hyp155; Pasiakos SM, 2011, AM J CLIN NUTR, V94, P809, DOI 10.3945/ajcn.111.017061; Pedrosa RG, 2010, APPL PHYSIOL NUTR ME, V35, P180, DOI 10.1139/H09-132; Sanchez-Gomez M, 1999, BRIT J NUTR, V81, P145, DOI 10.1017/S0007114599000288; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; Svanberg E, 2000, AM J PHYSIOL-ENDOC M, V279, pE1145, DOI 10.1152/ajpendo.2000.279.5.E1145; Takenaka A, 2000, J NUTR, V130, P2910, DOI 10.1093/jn/130.12.2910; Thompson LH, 2008, MOL MED, V14, P715, DOI 10.2119/2008-00081.Thompson; Thorell A, 1999, Curr Opin Clin Nutr Metab Care, V2, P69, DOI 10.1097/00075197-199901000-00012; Thorell A, 1992, CLIN NUTR, V11, P48; Wallin MKEB, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-2; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; WILMORE DW, 1976, ANN SURG, V183, P314, DOI 10.1097/00000658-197603000-00018; Wojnar MM, 1999, AM J PHYSIOL-ENDOC M, V276, pE455, DOI 10.1152/ajpendo.1999.276.3.E455; Yang J, 2012, J BIOL CHEM, V287, P24795, DOI 10.1074/jbc.M112.344259; Yang SY, 2010, LAB INVEST, V90, P391, DOI 10.1038/labinvest.2009.139; Zhai LD, 2009, J ENDOCRINOL, V203, P365, DOI 10.1677/JOE-09-0269	49	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77823	10.1371/journal.pone.0077823	http://dx.doi.org/10.1371/journal.pone.0077823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204984	Green Submitted, gold, Green Published			2022-12-25	WOS:000326241200044
J	Karakawa, A; Murata, H; Hirasawa, H; Mayama, C; Asaoka, R				Karakawa, Ayako; Murata, Hiroshi; Hirasawa, Hiroyo; Mayama, Chihiro; Asaoka, Ryo			Detection of Progression of Glaucomatous Visual Field Damage Using the Point-Wise Method with the Binomial Test	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; LINEAR-REGRESSION; SENSITIVITY; PREDICTION; AGREEMENT; PERIMETRY; DESIGN; INDEX; RATES; DECAY	Purpose: To compare the performance of newly proposed point-wise linear regression (PLR) with the binomial test (binomial PLR) against mean deviation (MD) trend analysis and permutation analyses of PLR (PoPLR), in detecting global visual field (VF) progression in glaucoma. Methods: 15 VFs (Humphrey Field Analyzer, SITA standard, 24-2) were collected from 96 eyes of 59 open angle glaucoma patients (6.0 +/- 1.5 [mean +/- standard deviation] years). Using the total deviation of each point on the 2nd to 16th VFs (VF2-16), linear regression analysis was carried out. The numbers of VF test points with a significant trend at various probability levels (p<0.025, 0.05, 0.075 and 0.1) were investigated with the binomial test (one-side). A VF series was defined as "significant" if the median p-value from the binomial test was <0.025. Similarly, the progression analysis was carried out using only second to sixth VFs (VF2-6). The performance of each method was evaluated using the 'consistency measures'; proportion both significant (PBS): both VF series (VF2-6 and VF2-16) were "significant", proportion both were not significant (PBNS): both were "not significant", proportion inconsistently significant (PIS): VF2-16 was "not significant" but VF2-6 was "significant". A similar analysis was carried out using VF2-7 and VF2-15 series, and the performance was compared with MD trend analysis and PoPLR. Results: The PBS of the binomial PLR method (0.14 to 0.86) was significantly higher than MD trend analysis (0.04 to 0.89) and PoPLR (0.09 to 0.93). The PIS of the proposed method (0.0 to 0.17) was significantly lower than the MD approach (0.0 to 0.67) and PoPLR (0.07 to 0.33). The PBNS of the three approaches were not significantly different. Conclusions: The binomial BLR method gives more consistent results than MD trend analysis and PoPLR, hence it will be helpful as a tool to 'flag' possible VF deterioration.	[Karakawa, Ayako; Murata, Hiroshi; Hirasawa, Hiroyo; Mayama, Chihiro; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25861618, 60645000, 50570701]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This was supported in part by Grant 25861618 (HM), 60645000 (HH), 50570701 (CM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang GS, 2011, J GLAUCOMA, V20, P223, DOI 10.1097/IJG.0b013e3181e08137; Anton A, 2012, EUR J OPHTHALMOL, P187; Anton A, 2013, EUR J OPHTHALMOL, V23, P187, DOI 10.5301/ejo.5000193; Artes PH, 2011, INVEST OPHTH VIS SCI, V52, P4030, DOI 10.1167/iovs.10-6905; Asaoka R, 2013, GRAEF ARCH CLIN EXP, V251, P1335, DOI 10.1007/s00417-012-2214-2; Azarbod P, 2012, INVEST OPHTH VIS SCI, V53, P5403, DOI 10.1167/iovs.12-9930; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bengtsson B, 2009, ARCH OPHTHALMOL-CHIC, V127, P1610, DOI 10.1001/archophthalmol.2009.297; BIRCH MK, 1995, PERIMETRY UPDATE 1994/1995, P31; Caprioli J, 2011, INVEST OPHTH VIS SCI, V52, P4765, DOI 10.1167/iovs.10-6414; Casas-Llera P, 2009, BRIT J OPHTHALMOL, V93, P1576, DOI 10.1136/bjo.2009.158097; CHAUHAN BC, 1990, INVEST OPHTH VIS SCI, V31, P512; Crabb DP, 2012, INVEST OPHTH VIS SCI, V53, P2770, DOI 10.1167/iovs.12-9476; Fisher R. A., 1992, STAT METHODS RES WOR; Fitzke FW, 1996, BRIT J OPHTHALMOL, V80, P40, DOI 10.1136/bjo.80.1.40; Heijl A, 1991, EXTENDED EMPIRICAL S; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; Katz J, 1997, OPHTHALMOLOGY, V104, P1017, DOI 10.1016/S0161-6420(97)30192-4; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; MCNAUGHT AI, 1995, GRAEF ARCH CLIN EXP, V233, P750, DOI 10.1007/BF00184085; McNaught AI, 1996, GRAEF ARCH CLIN EXP, V234, P411, DOI 10.1007/BF02539406; Medeiros FA, 2010, OPHTHALMOLOGY, V117, P2061, DOI 10.1016/j.ophtha.2010.02.015; MIKELBERG FS, 1986, AM J OPHTHALMOL, V101, P1; Musch DC, 1999, OPHTHALMOLOGY, V106, P653, DOI 10.1016/S0161-6420(99)90147-1; Nouri-Mahdavi K, 2007, ARCH OPHTHALMOL-CHIC, V125, P1176, DOI 10.1001/archopht.125.9.1176; NouriMahdavi K, 1997, OPHTHALMOLOGY, V104, P1228, DOI 10.1016/S0161-6420(97)30153-5; O'Brien C, 1992, POINT POINT LINEAR R; O'Leary N, 2012, INVEST OPHTH VIS SCI, V53, P6776, DOI 10.1167/iovs.12-10049; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao HL, 2013, INVEST OPHTH VIS SCI, V54, P307, DOI 10.1167/iovs.12-10836; Rao HL, 2011, OPHTHALMOLOGY, V118, P249, DOI 10.1016/j.ophtha.2010.05.027; Rao HL, 2012, INVEST OPHTH VIS SCI, V54, P307; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SPENCELEY SE, 1994, OPHTHAL PHYSL OPT, V14, P239, DOI 10.1111/j.1475-1313.1994.tb00004.x; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Team RDC, 2010, R LANG ENV STAT COMP; van de Wiel MA, 2009, BIOSTATISTICS, V10, P550, DOI 10.1093/biostatistics/kxp011; Viswanathan AC, 1997, BRIT J OPHTHALMOL, V81, P1037, DOI 10.1136/bjo.81.12.1037; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; WILD JM, 1993, INVEST OPHTH VIS SCI, V34, P1907	43	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78630	10.1371/journal.pone.0078630	http://dx.doi.org/10.1371/journal.pone.0078630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205283	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400092
J	Klaus, VH; Holzel, N; Prati, D; Schmitt, B; Schoning, I; Schrumpf, M; Fischer, M; Kleinebecker, T				Klaus, Valentin H.; Hoelzel, Norbert; Prati, Daniel; Schmitt, Barbara; Schoening, Ingo; Schrumpf, Marion; Fischer, Markus; Kleinebecker, Till			Organic vs. Conventional Grassland Management: Do N-15 and C-13 Isotopic Signatures of Hay and Soil Samples Differ?	PLOS ONE			English	Article							STABLE-ISOTOPE; PLANT-COMMUNITIES; DELTA-N-15 VALUES; RATIO ANALYSIS; CARBON; DELTA-C-13; FOLIAR; TOOL; FERTILIZATION; BIODIVERSITY	Distinguishing organic and conventional products is a major issue of food security and authenticity. Previous studies successfully used stable isotopes to separate organic and conventional products, but up to now, this approach was not tested for organic grassland hay and soil. Moreover, isotopic abundances could be a powerful tool to elucidate differences in ecosystem functioning and driving mechanisms of element cycling in organic and conventional management systems. Here, we studied the delta N-15 and delta C-13 isotopic composition of soil and hay samples of 21 organic and 34 conventional grasslands in two German regions. We also used Delta delta N-15 (delta N-15 plant - delta N-15 soil) to characterize nitrogen dynamics. In order to detect temporal trends, isotopic abundances in organic grasslands were related to the time since certification. Furthermore, discriminant analysis was used to test whether the respective management type can be deduced from observed isotopic abundances. Isotopic analyses revealed no significant differences in delta C-13 in hay and delta C-13 in both soil and hay between management types, but showed that delta C-13 abundances were significantly lower in soil of organic compared to conventional grasslands. delta C-15 values implied that management types did not substantially differ in nitrogen cycling. Only delta C-13 in soil and hay showed significant negative relationships with the time since certification. Thus, our result suggest that organic grasslands suffered less from drought stress compared to conventional grasslands most likely due to a benefit of higher plant species richness, as previously shown by manipulative biodiversity experiments. Finally, it was possible to correctly classify about two third of the samples according to their management using isotopic abundances in soil and hay. However, as more than half of the organic samples were incorrectly classified, we infer that more research is needed to improve this approach before it can be efficiently used in practice.	[Klaus, Valentin H.; Hoelzel, Norbert; Kleinebecker, Till] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Prati, Daniel; Schmitt, Barbara; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Schoening, Ingo; Schrumpf, Marion] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Munster; University of Bern; Max Planck Society	Klaus, VH (corresponding author), Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany.	v.klaus@uni-muenster.de	Schrumpf, Marion/C-1671-2013; Schöning, Ingo/D-3341-2009; Fischer, Markus/C-6411-2008; Hölzel, Norbert/H-8753-2013	Schöning, Ingo/0000-0002-9830-5026; Fischer, Markus/0000-0002-5589-5900; Hölzel, Norbert/0000-0002-6367-3400; Kleinebecker, Till/0000-0003-1121-2861; Schrumpf, Marion/0000-0003-4219-4125; Klaus, Valentin H./0000-0002-7469-6800	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI1246/9-1, HO 3830/2-2, SCHR 1181/2-1]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI1246/9-1, HO 3830/2-2, SCHR 1181/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2001, PLANT BIOLOGY, V3, P299, DOI 10.1055/s-2001-16454; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, P64, DOI DOI 10.1029/2001GB001822; Batary P, 2010, ECOSYSTEMS ENV, V136, P35; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Bateman AS, 2007, J AGR FOOD CHEM, V55, P2664, DOI 10.1021/jf0627726; Bateman AS, 2005, J AGR FOOD CHEM, V53, P5760, DOI 10.1021/jf050374h; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bol R, 2004, ISOT ENVIRON HEALT S, V40, P81, DOI 10.1080/10256010310001605955; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Camin F, 2011, FOOD CHEM, V125, P1072, DOI 10.1016/j.foodchem.2010.09.081; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; de Bello F, 2009, AGR ECOSYST ENVIRON, V131, P303, DOI 10.1016/j.agee.2009.02.002; del Amor FM, 2008, J ENVIRON QUAL, V37, P182, DOI 10.2134/jeq2007.0329; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Franke BM, 2005, EUR FOOD RES TECHNOL, V221, P493, DOI 10.1007/s00217-005-1158-8; Georgi M, 2005, PLANT SOIL, V275, P93, DOI 10.1007/s11104-005-0258-3; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Haas G, 2001, AGR ECOSYST ENVIRON, V83, P43, DOI 10.1016/S0167-8809(00)00160-2; Hobbie EA, 2012, NEW PHYTOL, V196, P367, DOI 10.1111/j.1469-8137.2012.04300.x; HOGBERG P, 1993, PLANT SOIL, V152, P207, DOI 10.1007/BF00029090; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Jumpponen A, 2005, J ECOL, V93, P1136, DOI 10.1111/j.1365-2745.2005.01045.x; Kahmen A, 2008, OECOLOGIA, V156, P861, DOI 10.1007/s00442-008-1028-8; Klaus VH, 2013, AGR ECOSYST ENVIRON, V177, P1, DOI 10.1016/j.agee.2013.05.019; Kleinebecker T, 15N NATURAL AB UNPUB; Molkentin J, 2009, J AGR FOOD CHEM, V57, P785, DOI 10.1021/jf8022029; Nakano A, 2003, PLANT SOIL, V255, P343, DOI 10.1023/A:1026180700963; Neilson R, 1998, SOIL BIOL BIOCHEM, V30, P1773, DOI 10.1016/S0038-0717(98)00038-8; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rapisarda P, 2005, J AGR FOOD CHEM, V53, P2664, DOI 10.1021/jf048733g; Santruckova H, 2000, FUNCT ECOL, V14, P108, DOI 10.1046/j.1365-2435.2000.00402.x; Schaack D., 2010, AMI MARKTBILANZ OKO; Schmidt O, 2005, FOOD CHEM, V91, P545, DOI 10.1016/j.foodchem.2004.08.036; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Watzka M, 2006, SOIL BIOL BIOCHEM, V38, P1564, DOI 10.1016/j.soilbio.2005.11.007; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; Wrage N, 2011, NUTR CYCL AGROECOSYS, V90, P189, DOI 10.1007/s10705-011-9421-9	41	10	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78134	10.1371/journal.pone.0078134	http://dx.doi.org/10.1371/journal.pone.0078134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205126	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400072
J	Romania, P; Castellano, A; Surace, C; Citti, A; De Ioris, MA; Sirleto, P; De Mariano, M; Longo, L; Boldrini, R; Angioni, A; Locatelli, F; Fruci, D				Romania, Paolo; Castellano, Aurora; Surace, Cecilia; Citti, Arianna; De Ioris, Maria Antonietta; Sirleto, Pietro; De Mariano, Marilena; Longo, Luca; Boldrini, Renata; Angioni, Adriano; Locatelli, Franco; Fruci, Doriana			High-Resolution Array CGH Profiling Identifies Na/K Transporting ATPase Interacting 2 (NKAIN2) as a Predisposing Candidate Gene in Neuroblastoma	PLOS ONE			English	Article							CELL-LINES; ACTIVATING MUTATIONS; GERMLINE MUTATIONS; PHOX2B MUTATIONS; ALK KINASE; EXPRESSION; PHENOTYPE; TUMORS; MYCN; CLASSIFICATION	Neuroblastoma (NB), the most common solid cancer in early childhood, usually occurs sporadically but also its familial occurance is known in 1-2% of NB patients. Germline mutations in the ALK and PHOX2B genes have been found in a subset of familial NBs. However, because some individuals harbouring mutations in these genes do not develop this tumor, additional genetic alterations appear to be required for NB pathogenesis. Herein, we studied an Italian family with three NB patients, two siblings and a first cousin, carrying an ALK germline-activating mutation R1192P, that was inherited from their unaffected mothers and with no mutations in the PHOX2B gene. A comparison between somatic and germline DNA copy number changes in the two affected siblings by a high resolution array-based Comparative Genomic Hybridization (CGH) analysis revealed a germline gain at NKAIN2 (Na/K transporting ATPase interacting 2) locus in one of the sibling, that was inherited from the parent who does not carry the ALK mutation. Surprisingly, NKAIN2 was expressed at high levels also in the affected sibling that lacks the genomic gain at this locus, clearly suggesting the existance of other regulatory mechanisms. High levels of NKAIN2 were detected in the MYCN-amplified NB cell lines and in the most aggressive NB lesions as well as in the peripheral blood of a large cohort of NB patients. Consistent with a role of NKAIN2 in NB development, NKAIN2 was down-regulated during all-trans retinoic acid differentiation in two NB cell lines. Taken together, these data indicate a potential role of NKAIN2 gene in NB growth and differentiation.	[Romania, Paolo; Castellano, Aurora; De Ioris, Maria Antonietta; Locatelli, Franco; Fruci, Doriana] IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy; [Surace, Cecilia; Sirleto, Pietro; Angioni, Adriano] IRCCS, Bambino Gesu Childrens Hosp, Cytogenet & Mol Genet Unit, Rome, Italy; [Citti, Arianna; Boldrini, Renata] IRCCS, Bambino Gesu Childrens Hosp, Dept Pathol, Rome, Italy; [De Mariano, Marilena; Longo, Luca] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Locatelli, Franco] Univ Pavia, Dept Pediat, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Genoa; IRCCS AOU San Martino IST; University of Pavia	Fruci, D (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy.	doriana.fruci@opbg.net	angioni, adriano/G-1160-2014; sirleto, pietro/G-3902-2014; Longo, Luca/K-6156-2018; Surace, Cecilia/AAA-8657-2020; DE IORIS, MARIA ANTONIETTA/AAA-9588-2022; Romania, Paolo/K-3839-2018; Surace, Cecilia/AAA-9163-2020; castellano, aurora/AAA-6535-2020; Fruci, Doriana/AAA-8218-2019	angioni, adriano/0000-0003-0862-2456; sirleto, pietro/0000-0001-5292-3315; Longo, Luca/0000-0002-5153-4243; DE IORIS, MARIA ANTONIETTA/0000-0002-2113-4505; Romania, Paolo/0000-0001-6855-1464; Surace, Cecilia/0000-0003-2344-6948; castellano, aurora/0000-0002-2316-4927; Fruci, Doriana/0000-0003-3388-7296; Sirleto, Pietro/0000-0002-3569-4829	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy); Italian Neuroblastoma foundation; AIRC special grant "5 x 1000''; Italian Ministry of Health [GR-2010-2311890]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Italian Neuroblastoma foundation; AIRC special grant "5 x 1000''; Italian Ministry of Health(Ministry of Health, Italy)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) to D. F., the Italian Neuroblastoma foundation to L. L., and the AIRC special grant "5 x 1000'' to F. L. L. Longo is the recipient of the pYoung Investigatorsq grant GR-2010-2311890 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Bocciardi R, 2005, HUM MUTAT, V26, P426, DOI 10.1002/humu.20235; Bourdeaut F, 2012, EUR J HUM GENET, V20, P291, DOI 10.1038/ejhg.2011.195; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Carr J, 2007, CANCER GENET CYTOGEN, V172, P127, DOI 10.1016/j.cancergencyto.2006.08.012; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; GARAVENTA A, 1993, J CLIN ONCOL, V11, P1770, DOI 10.1200/JCO.1993.11.9.1770; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gigliotti AR, 2009, EUR J CANCER, V45, P3220, DOI 10.1016/j.ejca.2009.08.020; Gorokhova S, 2007, HUM MOL GENET, V16, P2394, DOI 10.1093/hmg/ddm167; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Krona C, 2008, INT J ONCOL, V32, P575; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; McConville C, 2006, AM J MED GENET A, V140A, P1297, DOI 10.1002/ajmg.a.31278; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Reynolds C P, 1994, Prog Clin Biol Res, V385, P237; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Yue Y, 2006, J MED GENET, V43, P143, DOI 10.1136/jmg.2004.029660	36	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78481	10.1371/journal.pone.0078481	http://dx.doi.org/10.1371/journal.pone.0078481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205241	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400082
J	Sun, CX; Forster, C; Nakamura, F; Glogauer, M				Sun, Chunxiang; Forster, Carol; Nakamura, Fumihiko; Glogauer, Michael			Filamin-A Regulates Neutrophil Uropod Retraction through RhoA during Chemotaxis	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; CDC42 GTPASES; MICE; PHOSPHORYLATION; MYOSIN; RAC1; MALFORMATIONS; CYTOSKELETON; MACROPHAGES; ACTIVATION	Filamin-A (FLNa) has been shown to be a key cross-linker of actin filaments in the leading edge of a motile melanoma cell line, however its role in neutrophils undergoing chemotaxis is unknown. Using a murine transgenic model in which FLNa is selectively deleted in granulocytes, we report that, while neutrophils lacking FLNa show normal polarization and pseudopod extension, they exhibit obvious defects in uropod retraction. This uropod retraction defect was found to be a direct result of reduced FLNa mediated activation of the small GTPase RhoA and myosin mediated actin contraction in the FLNa null cells. This results in a neutrophil recruitment defect in FLNa null mice. The compensatory increase in FLNb levels that was observed in the FLNa null neutrophils may be sufficient to compensate for the lack of FLNa at the leading edge allowing for normal polarization, however this compensation is unable to regulate RhoA activated tail retraction at the rear of the cell.	[Sun, Chunxiang; Forster, Carol; Glogauer, Michael] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA	University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Toronto, ON, Canada.	Michael.Gloaguer@utoronto.ca	Glogauer, Michael/D-2504-2011; Nakamura, Fumihiko/N-5476-2016	Glogauer, Michael/0000-0002-6248-5977; Nakamura, Fumihiko/0000-0002-6872-4246	Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Canadian Institute of Health Research funded this work with an operating grant to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Benard V, 2002, METHOD ENZYMOL, V345, P349; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79009	10.1371/journal.pone.0079009	http://dx.doi.org/10.1371/journal.pone.0079009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205360	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400113
J	Mesa-Pereira, B; Medina, C; Camacho, EM; Flores, A; Santero, E				Mesa-Pereira, Beatriz; Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Santero, Eduardo			Novel Tools to Analyze the Function of Salmonella Effectors Show That SvpB Ectopic Expression Induces Cell Cycle Arrest in Tumor Cells	PLOS ONE			English	Article							ADP-RIBOSYLATES ACTIN; VIRULENCE PLASMID; GENE-EXPRESSION; MEDIATED APOPTOSIS; SECRETION SYSTEM; DELAYS ENTRY; SPV GENES; IN-VITRO; TYPHIMURIUM; PROTEIN	In order to further characterize its role in pathogenesis and to establish whether its overproduction can lead to eukaryotic tumor cell death, Salmonella strains able to express its virulence factor SpvB (an ADP-ribosyl transferase enzyme) in a salicylate-inducible way have been constructed and analyzed in different eukaryotic tumor cell lines. To do so, the bacterial strains bearing the expression system have been constructed in a Delta purD background, which allows control of bacterial proliferation inside the eukaryotic cell. In the absence of bacterial proliferation, salicylate-induced SpvB production resulted in activation of caspases 3 and 7 and apoptotic cell death. The results clearly indicated that controlled SpvB production leads to F-actin depolimerization and either G1/S or G2/M phase arrest in all cell lines tested, thus shedding light on the function of SpvB in Salmonella pathogenesis. In the first place, the combined control of protein production by salicylate regulated vectors and bacterial growth by adenine concentration offers the possibility to study the role of Salmonella effectors during eukaryotic cells infection. In the second place, the salicylate-controlled expression of SpvB by the bacterium provides a way to evaluate the potential of other homologous or heterologous proteins as antitumor agents, and, eventually to construct novel potential tools for cancer therapy, given that Salmonella preferentially proliferates in tumors.	[Mesa-Pereira, Beatriz; Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Santero, Eduardo] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Dept Biol Mol & Ingn Bioquim,Junta Andalucia, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Flores, A (corresponding author), Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Dept Biol Mol & Ingn Bioquim,Junta Andalucia, Seville, Spain.	aflodia@upo.es	Camacho, Eva/K-9839-2014; Santero, Eduardo/K-6510-2014; Mesa, Beatriz/O-9895-2019; Flores, Amando/K-9283-2017; Medina Morillas, Carlos/L-1773-2014	Camacho, Eva/0000-0002-6465-7381; Flores, Amando/0000-0002-1887-0659; Medina Morillas, Carlos/0000-0003-0069-7330; Santero, Eduardo/0000-0002-6111-7160	Andalusian government [P07-CVI02518]	Andalusian government	This work was supported by the grant "Proyecto de Excelencia P07-CVI02518" from the Andalusian government and by a fellowship from the Andalusian government to BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Andersson M, 2003, EXP EYE RES, V76, P175, DOI 10.1016/S0014-4835(02)00283-X; Barnett SJ, 2005, J PEDIATR SURG, V40, P993, DOI 10.1016/j.jpedsurg.2005.03.015; Barth H, 1999, INFECT IMMUN, V67, P5083, DOI 10.1128/IAI.67.10.5083-5090.1999; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Chae HD, 2005, ONCOGENE, V24, P4813, DOI 10.1038/sj.onc.1208640; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FIERER J, 1992, J INFECT DIS, V166, P639, DOI 10.1093/infdis/166.3.639; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; GARZON A, 1995, GENETICS, V140, P427; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; GUINEY DG, 1994, FEMS MICROBIOL LETT, V124, P1, DOI 10.1016/0378-1097(94)90324-7; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kim GY, 2011, MAR DRUGS, V9, P2176, DOI 10.3390/md9112176; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kim MO, 2008, CANCER LETT, V271, P25, DOI 10.1016/j.canlet.2008.05.034; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Lee KG, 2007, CELL CYCLE, V6, P1487; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; Medina C, 2012, J BIOTECHNOL, V157, P413, DOI 10.1016/j.jbiotec.2011.11.022; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Moon DO, 2008, BIOCHEM PHARMACOL, V76, P312, DOI 10.1016/j.bcp.2008.05.006; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nemunaitis J, 2003, CANCER GENE THER, V10, P737, DOI 10.1038/sj.cgt.7700634; Aguilera MO, 2012, AUTOPHAGY, V8, P1590, DOI 10.4161/auto.21459; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Pawelek JM, 1997, CANCER RES, V57, P4537; Royo JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni168; Royo JL, 2007, NAT METHODS, V4, P937, DOI 10.1038/NMETH1107; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Saltzman DA, 1996, CANCER BIOTHER RADIO, V11, P145, DOI 10.1089/cbr.1996.11.145; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Srivastava P, 2012, CARCINOGENESIS, V33, P2199, DOI 10.1093/carcin/bgs269; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tezcan-Merdol D, 2005, INT J MED MICROBIOL, V295, P201, DOI 10.1016/j.ijmm.2005.04.008; Tezcan-Merdol D, 2001, MOL MICROBIOL, V39, P606, DOI 10.1046/j.1365-2958.2001.02258.x; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Udagawa T, 2000, J PHARMACOL EXP THER, V294, P421; Valle E, 2005, INFECT IMMUN, V73, P2835, DOI 10.1128/IAI.73.5.2835-2840.2005; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	63	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78458	10.1371/journal.pone.0078458	http://dx.doi.org/10.1371/journal.pone.0078458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205236	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600102
J	Poon, E; Yan, B; Zhang, SH; Rushing, S; Keung, W; Ren, LH; Lieu, DK; Geng, L; Kong, CW; Wang, JX; Wong, HS; Boheler, KR; Li, RA				Poon, Ellen; Yan, Bin; Zhang, Shaohong; Rushing, Stephanie; Keung, Wendy; Ren, Lihuan; Lieu, Deborah K.; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Wong, Hau San; Boheler, Kenneth R.; Li, Ronald A.			Transcriptome-Guided Functional Analyses Reveal Novel Biological Properties and Regulatory Hierarchy of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes Crucial for Maturation	PLOS ONE			English	Article							FACILITATED MATURATION; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; GENE-EXPRESSION; HUMAN HEART; DIFFERENTIATION; CONDUCTION; PHOSPHORYLATION; MORPHOGENESIS; ENRICHMENT	Human (h) embryonic stem cells (ESC) represent an unlimited source of cardiomyocytes (CMs); however, these differentiated cells are immature. Thus far, gene profiling studies have been performed with non-purified or non-chamber specific CMs. Here we took a combinatorial approach of using systems biology to guide functional discoveries of novel biological properties of purified hESC-derived ventricular (V) CMs. We profiled the transcriptomes of hESCs, hESC-, fetal (hF) and adult (hA) VCMs, and showed that hESC-VCMs displayed a unique transcriptomic signature. Not only did a detailed comparison between hESC-VCMs and hF-VCMs confirm known expression changes in metabolic and contractile genes, it further revealed novel differences in genes associated with reactive oxygen species (ROS) metabolism, migration and cell cycle, as well as potassium and calcium ion transport. Following these guides, we functionally confirmed that hESC-VCMs expressed I-KATP with immature properties, and were accordingly vulnerable to hypoxia/reoxygenation-induced apoptosis. For mechanistic insights, our coexpression and promoter analyses uncovered a novel transcriptional hierarchy involving select transcription factors (GATA4, HAND1, NKX2.5, PPARGC1A and TCF8), and genes involved in contraction, calcium homeostasis and metabolism. These data highlight novel expression and functional differences between hESC-VCMs and their fetal counterparts, and offer insights into the underlying cell developmental state. These findings may lead to mechanism-based methods for in vitro driven maturation.	[Poon, Ellen; Keung, Wendy; Ren, Lihuan; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Boheler, Kenneth R.; Li, Ronald A.] Univ Hong Kong, LKS Fac Med, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China; [Keung, Wendy; Ren, Lihuan; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Li, Ronald A.] Univ Hong Kong, LKS Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Yan, Bin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Shaohong; Wong, Hau San] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Shaohong] Guangzhou Univ, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China; [Rushing, Stephanie; Lieu, Deborah K.; Wang, Jiaxian; Li, Ronald A.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Lieu, Deborah K.] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Boheler, Kenneth R.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA	University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; City University of Hong Kong; Guangzhou University; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; Johns Hopkins University	Li, RA (corresponding author), Univ Hong Kong, LKS Fac Med, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China.	ronaldli@hku.hk	Poon, Ellen/ABD-6962-2020	Poon, Ellen/0000-0002-9280-3681; Lieu, Deborah/0000-0002-3765-3203; WONG, Hau-San/0000-0002-1530-7529; Keung, Wendy/0000-0002-6827-6754	Research Grant Council of HKSAR (TBRS) [T13-706/11]; SCRMC of the University of Hong Kong; Faculty Cores of the University of Hong Kong; Science Faculty of Hong Kong Baptist University [FRG2/12-13/066]	Research Grant Council of HKSAR (TBRS); SCRMC of the University of Hong Kong; Faculty Cores of the University of Hong Kong; Science Faculty of Hong Kong Baptist University	"This work was supported by the Research Grant Council of HKSAR (TBRS, T13-706/11), SCRMC and Faculty Cores of the University of Hong Kong, and the Science Faculty of Hong Kong Baptist University (FRG2/12-13/066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Briggs LE, 2008, CIRC RES, V103, P580, DOI 10.1161/CIRCRESAHA.108.171835; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Charron F, 1999, MOL CELL BIOL, V19, P4355; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; FERRARI R, 1993, EUR HEART J, V14, P25; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; IWASA T, 1985, J BIOCHEM-TOKYO, V98, P577, DOI 10.1093/oxfordjournals.jbchem.a135313; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837; Lieu DK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P191, DOI 10.1161/CIRCEP.111.973420; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Lieu DK, 2013, DRUG DISCOV TODAY DI; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; Pillekamp F, 2012, STEM CELLS DEV, V21, P2111, DOI 10.1089/scd.2011.0312; Poon E, 2011, MOL PHARMACEUT, V8, P1495, DOI 10.1021/mp2002363; Rust W, 2009, REGEN MED, V4, P225, DOI 10.2217/17460751.4.2.225; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Synnergren J, 2011, PHYSL GENOMICS; Synnergren J, 2008, J BIOTECHNOL, V134, P162, DOI 10.1016/j.jbiotec.2007.11.011; Synnergren J, 2011, PHYSIOL GENOMICS, V43, P581, DOI 10.1152/physiolgenomics.00074.2010; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	55	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77784	10.1371/journal.pone.0077784	http://dx.doi.org/10.1371/journal.pone.0077784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204964	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600048
J	Song, WJ; Morice, AH; Kim, MH; Lee, SE; Jo, EJ; Lee, SM; Han, JW; Kim, TH; Kim, SH; Jang, HC; Kim, KW; Cho, SH; Min, KU; Chang, YS				Song, Woo-Jung; Morice, Alyn H.; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Lee, Sang-Min; Han, Ji-Won; Kim, Tae Hui; Kim, Sae-Hoon; Jang, Hak-Chul; Kim, Ki Woong; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok			Cough in the Elderly Population: Relationships with Multiple Comorbidity	PLOS ONE			English	Article							QUALITY-OF-LIFE; RESPIRATORY SYMPTOMS; PREVALENCE; CONSTIPATION; COMMUNITY; DIAGNOSIS; ASTHMA; MANAGEMENT; NEUROPATHY; THRESHOLD	Background: The epidemiology of cough in the elderly population has not been studied comprehensively. The present study aimed to investigate the epidemiology of cough in a community elderly population, particularly in relation with their comorbidity. Methods: A cross-sectional analysis was performed using a baseline dataset from the Korean Longitudinal Study on Health and Aging, a community-based elderly population cohort study. Three types of cough (frequent cough, chronic persistent cough, and nocturnal cough) were defined using questionnaires. Comorbidity was examined using a structured questionnaire. Health-related quality of life was assessed using the Short Form 36 questionnaire. Results: The prevalence was 9.3% for frequent cough, 4.6% for chronic persistent cough, and 7.3% for nocturnal cough. In multivariate logistic regression analyses, smoking, asthma and allergic rhinitis were found to be risk factors for cough in the elderly. Interestingly, among comorbidities, constipation and uncontrolled diabetes mellitus (HbA1c >= 8%) were also found to have positive associations with elderly cough. In the Short Form 36 scores, chronic persistent cough was independently related to impairment of quality of life, predominantly in the mental component. Conclusions: Cough has a high prevalence and is detrimental to quality of life in the elderly. Associations with smoking, asthma and rhinitis confirmed previous findings in younger populations. Previously unrecognised relationships with constipation and uncontrolled diabetes mellitus suggested the multi-faceted nature of cough in the elderly.	[Song, Woo-Jung; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Song, Woo-Jung; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Morice, Alyn H.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Cottingham, East Yorkshire, England; [Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Jang, Hak-Chul; Chang, Yoon-Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Lee, Sang-Min] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon, South Korea; [Han, Ji-Won; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, Gyeonggi Do, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Hull; University of York - UK; Seoul National University (SNU); Gachon University; Seoul National University (SNU); Seoul National University (SNU)	Chang, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	addchang@snu.ac.kr	Jang, Hak Chul/D-9637-2012; Lee, Seung Eun/ABG-1607-2021; Kim, Ki Woong/D-5801-2012; Kim, Tae Hui/AAR-9213-2020; Chang, Yoon-Seok/J-5628-2012	Jang, Hak Chul/0000-0002-4188-6536; Lee, Seung Eun/0000-0002-4266-7722; Kim, Ki Woong/0000-0002-1103-3858; Chang, Yoon-Seok/0000-0003-3157-0447; Lee, Sang Min/0000-0002-9568-2096; Song, Woo-Jung/0000-0002-4630-9922; Kim, Tae Hui/0000-0003-0133-5227	Seongnam City Government in Republic of Korea [800-20050211]; Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea [A092077]	Seongnam City Government in Republic of Korea; Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea	This study was supported by the grant for Developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Republic of Korea (Grant No. 800-20050211), and by the grant from the Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea (grant no. A092077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bair MJ, 2010, DIABETIC MED, V27, P578, DOI 10.1111/j.1464-5491.2010.02971.x; Bende M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00251; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Birring SS, 2011, AM J RESP CRIT CARE, V183, P708, DOI 10.1164/rccm.201007-1017CI; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dicpinigaitis PV, 2012, LUNG, V190, P593, DOI 10.1007/s00408-012-9420-x; Faruqi S, 2011, RESPIROLOGY, V16, P1150, DOI 10.1111/j.1440-1843.2011.02014.x; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Gallegos-Orozco JF, 2012, AM J GASTROENTEROL, V107, P18, DOI 10.1038/ajg.2011.349; Grassi M, 2011, NUTR HOSP, V26, P659, DOI [10.1590/S0212-16112011000400001, 10.3305/nh.2011.26.4.5109]; Hamdan AL, 2013, J VOICE, V27, P495, DOI 10.1016/j.jvoice.2012.07.010; Herbert M, 2013, DIABET MED IN PRESS; Irwin RS, 2006, CHEST, V129, p1S, DOI 10.1378/chest.129.1_suppl.1S; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Kagamimori S, 1996, CLIN EXP ALLERGY, V26, P262; Karur PS, 2012, EUR RESPIR REV, V21, P257, DOI 10.1183/09059180.00000212; Kinekawa F, 2001, AM J GASTROENTEROL, V96, P2026, DOI 10.1016/S0002-9270(01)02425-X; Kinekawa Fumihiko, 2004, Nihon Rinsho, V62, P1546; Kinsella K, 2009, INT POPULATION REPOR; LEE JH, 1992, PAIN, V50, P231, DOI 10.1016/0304-3959(92)90167-A; Liard R., 2000, EUR RESP MON, V5, P154; Lodefalk M, 2010, PEDIATR DIABETES, V11, P265, DOI 10.1111/j.1399-5448.2010.00664.x; Ludviksdottir D, 1996, CHEST, V109, P1262, DOI 10.1378/chest.109.5.1262; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mirabelli MC, 2012, J OCCUP ENVIRON MED, V54, P157, DOI 10.1097/JOM.0b013e31823e3a52; Morice AH, 2011, LUNG, V189, P73, DOI 10.1007/s00408-010-9272-1; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2004, PULM PHARMACOL THER, V17, P343, DOI 10.1016/j.pupt.2004.09.005; Morice AH, 2002, PULM PHARMACOL THER, V15, P253, DOI 10.1006/pupt.2002.0352; MORRIS JF, 1976, WESTERN J MED, V125, P110; Nam BH, 2003, J HLTH INFO STAT, V28, P3; Nellesen D, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.03.2640; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Pratter MR, 2006, CHEST, V129, p59S, DOI 10.1378/chest.129.1_suppl.59S; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; 성예나, 2009, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V19, P167; Varechova S, 2007, J PHYSIOL PHARMACOL, V58, P705; VIANNA LG, 1988, THORAX, V43, P569, DOI 10.1136/thx.43.7.569; Voll-Aanerud M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-107; Wang XB, 2008, WORLD J GASTROENTERO, V14, P709, DOI 10.3748/wjg.14.709; Winge K, 2003, J NEUROL NEUROSUR PS, V74, P13, DOI 10.1136/jnnp.74.1.13; Yamanda Shinsuke, 2008, Cough, V4, P11, DOI 10.1186/1745-9974-4-11	49	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78081	10.1371/journal.pone.0078081	http://dx.doi.org/10.1371/journal.pone.0078081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205100	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600070
J	Zhao, HS; Chen, DL; Peng, ZH; Wang, LL; Gao, ZM				Zhao, Hansheng; Chen, Dongliang; Peng, Zhenhua; Wang, Lili; Gao, Zhimin			Identification and Characterization of MicroRNAs in the Leaf of Ma Bamboo (Dendrocalamus latiflorus) by Deep Sequencing	PLOS ONE			English	Article							SMALL RNAS; TRANSCRIPTION FACTOR; TARGET GENES; CONSERVED MICRORNAS; REGULATED MICRORNAS; EXPRESSION ANALYSIS; RT-PCR; ARABIDOPSIS; CLONING; STRESS	MicroRNAs (miRNAs), a class of non-coding small endogenous RNAs of approximately 22 nucleotides, regulate gene expression at the post-transcriptional levels by targeting mRNAs for degradation or by inhibiting protein translation. Thousands of miRNAs have been identified in many species. However, there is no information available concerning miRNAs in ma bamboo (Dendrocalamus latiflorus), one of the most important non-timber forest products, which has essential ecological roles in forests. To identify miRNAs in D. latiflorus, a small RNA library was constructed from leaf tissues. Using next generation high-throughput sequencing technology and bioinformatics analysis, we obtained 11,513,607 raw sequence reads and identified 84 conserved miRNAs (54 mature miRNAs and 30 star miRNAs) belonging to 17 families, and 81 novel miRNAs (76 mature miRNAs and five star miRNAs) in D. latiflorus. One hundred and sixty-two potential targets were identified for the 81 novel bamboo miRNAs. Several targets for the novel miRNAs are transcription factors that play important roles in plant development. Among the novel miRNAs, 30 were selected and their expression profiles in response to different light conditions were validated by qRT-PCR. This study provides the first large-scale cloning and characterization of miRNAs in D. latiflorus. Eighty-four conserved and 81 novel miRNAs were identified in D. latiflorus. Our results present a broad survey of bamboo miRNAs based on experimental and bioinformatics analysis. Although it will be necessary to validate the functions of miRNAs by further experimental research, these results represent a starting point for future research on D. latiflorus and related species.	[Zhao, Hansheng; Chen, Dongliang; Peng, Zhenhua; Wang, Lili; Gao, Zhimin] Int Ctr Bamboo, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China; [Peng, Zhenhua] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	International Centre for Bamboo & Rattan; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Peng, ZH (corresponding author), Int Ctr Bamboo, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China.	pengzh@icbr.ac.cn; gaozhimin@icbr.ac.cn	wang, lili/HDL-7210-2022; zhao, hansheng/GRS-2764-2022		State Forestry Administration of China [2011-4-55]; special funds for scientific research on forestry public causes [200704001]; Fundamental Research Funds for ICBR [1632013009]	State Forestry Administration of China; special funds for scientific research on forestry public causes; Fundamental Research Funds for ICBR	This work was financially supported under the introduction project of "948" by the State Forestry Administration of China (No. 2011-4-55), the special funds for scientific research on forestry public causes (No. 200704001) and Fundamental Research Funds for ICBR (No. 1632013009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Fu XY, 2007, BIOTECHNOL LETT, V29, P1293, DOI 10.1007/s10529-007-9370-1; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lertpanyasampatha M, 2012, PLANTA, V236, P437, DOI 10.1007/s00425-012-1622-1; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; LIN CS, 2007, NEW FORESTS, V9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Singh SR, 2013, PHYSIOL MOL BIOL PLA, V19, P21, DOI 10.1007/s12298-012-0147-1; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Thomas MF, 2010, METHODS MOL BIOL, V667, P93, DOI 10.1007/978-1-60761-811-9_7; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wollmann H, 2010, EUR J CELL BIOL, V89, P250, DOI 10.1016/j.ejcb.2009.11.004; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Yin ZJ, 2010, GENET MOL RES, V9, P1186, DOI 10.4238/vol9-2gmr805; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064642; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083	84	19	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78755	10.1371/journal.pone.0078755	http://dx.doi.org/10.1371/journal.pone.0078755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205306	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600109
J	Kong, LQ; Zhu, XD; Xu, HX; Zhang, JB; Lu, L; Wang, WQ; Zhang, QB; Wu, WZ; Wang, L; Fan, J; Tang, ZY; Sun, HC				Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan			The Clinical Significance of the CD163+and CD68+Macrophages in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HEMOGLOBIN SCAVENGER RECEPTOR; SOLUBLE CD163; CURATIVE RESECTION; HUMAN MONOCYTES; BREAST-CANCER; EXPRESSION; INFILTRATION; SURVIVAL; ANTIGEN	Our previous study has found that the abundance of peritumoral CD68(+) macrophages was associated with poor prognosis in hepatocellular carcinoma (HCC) after resection. However, CD68 staining could not discriminate the protumoral or tumoricidal subpopulations from pan-macrophages. CD163 is a marker of alternatively activated macrophages. In this study, the clinical significance of CD163(+) cells in tumors and peritumoral liver tissues was evaluated in a cohort of 295 patients with HCC after curative resection. We found that the density of CD163(+) cells was well correlated with that of CD68(+) cells in both tumors and peritumoral liver tissues but was much more. Immunostaining on consecutive sections and flow cytometry assay on surgical resected specimens further supported the findings that the CD163+ cells was more abundant than CD68(+) cells. The density of peritumoral CD68(+) cells was associated with poor recurrence-free survival (RFS) and poor overall survival (OS) (P = 0.004 and P = 0.001, respectively), whereas the CD163(+) cells have no prognostic values either in tumors or in peritumoral liver tissues. In another cohort of 107 HCC patients, preoperative plasma concentration of soluble form of CD163 (sCD163) was associated with active hepatitis-related factors but not associated with the markers of tumor invasion. In conclusion, both the CD163(+) cells local infiltration and plasma sCD163 were of limited significance in HCC, and they were more likely markers related to active hepatitis rather than tumor progression.	[Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Xu, Hua-Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China	Fudan University; Ministry of Education, China; Fudan University; Ministry of Education, China; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China.	sun.huichuan@zs-hospital.sh.cn	Zhu, Xiao-Dong/A-8197-2010; Fan, Jia/C-6689-2017	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [30872504, 81020108025]; China National "211'' Project for Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "211'' Project for Higher Education	This study was jointly supported by National Natural Science Foundation of China (30872504, 81020108025), and China National "211'' Project for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FALINI B, 1993, AM J PATHOL, V142, P1359; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Hamada I, 2002, ANTICANCER RES, V22, P4281; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hogger P, 1998, J IMMUNOL, V161, P1883; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moller HJ, 2007, J HEPATOL, V47, P671, DOI 10.1016/j.jhep.2007.05.014; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Ohno S, 2004, ANTICANCER RES, V24, P3335; Qian YB, 2006, CANCER, V107, P1562, DOI 10.1002/cncr.22206; Ritter M, 1999, PATHOBIOLOGY, V67, P257, DOI 10.1159/000028105; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Sanchez C, 1999, J IMMUNOL, V162, P5230; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Tsutsui S, 2005, ONCOL REP, V14, P425; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	85	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59771	10.1371/journal.pone.0059771	http://dx.doi.org/10.1371/journal.pone.0059771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	24205176	Green Submitted, Green Published, gold			2022-12-25	WOS:000317263900027
J	Shi, ZJ; Cao, Z; Qin, D; Zhu, WT; Wang, Q; Li, MS; Wang, GJ				Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao			Correlation Models between Environmental Factors and Bacterial Resistance to Antimony and Copper	PLOS ONE			English	Article							ARSENATE-REDUCING BACTERIA; SOIL; DIVERSITY; ARSENITE; GENES; CONTAMINATION; OXIDATION; SEQUENCE	Antimony (Sb) and copper (Cu) are toxic heavy metals that are associated with a wide variety of minerals. Sb(III)-oxidizing bacteria that convert the toxic Sb(III) to the less toxic Sb(V) are potentially useful for environmental Sb bioremediation. A total of 125 culturable Sb(III)/Cu(II)-resistant bacteria from 11 different types of mining soils were isolated. Four strains identified as Arthrobacter, Acinetobacter and Janibacter exhibited notably high minimum inhibitory concentrations (MICs) for Sb(III) (>10 mM), making them the most highly Sb(III)-resistant bacteria to date. Thirty-six strains were able to oxidize Sb(III), including Pseudomonas-, Comamonas-, Acinetobacter-, Sphingopyxis-, Paracoccus-Aminobacter-, Arthrobacter-, Bacillus-, Janibacter-and Variovorax-like isolates. Canonical correspondence analysis (CCA) revealed that the soil concentrations of Sb and Cu were the most obvious environmental factors affecting the culturable bacterial population structures. Stepwise linear regression was used to create two predictive models for the correlation between soil characteristics and the bacterial Sb(III) or Cu(II) resistance. The concentrations of Sb and Cu in the soil was the significant factors affecting the bacterial Sb(III) resistance, whereas the concentrations of S and P in the soil greatly affected the bacterial Cu(II) resistance. The two stepwise linear regression models that we derived are as follows. MICSb(III) = 606.605+0.14533 x C-Sb +0.24128 x C-Cu and MICCu(II) = 58. 3844+0.02119 x C-S + 0.00199 + C-P [where the MICSb(III) and MICCu(II) represent the average bacterial MIC for the metal of each soil (mu M), and the C-Sb, C-Cu, C-S and C-P represent concentrations for Sb, Cu, S and P (mg/kg) in soil, respectively, p<0.01]. The stepwise linear regression models we developed suggest that metals as well as other soil physicochemical parameters can contribute to bacterial resistance to metals.	[Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Major International Joint Research Project, National Natural Science Foundation of China [31010103903]; Chinese 863 project [2012AA101402-3]	Major International Joint Research Project, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 project(National High Technology Research and Development Program of China)	This work was supported by a Major International Joint Research Project, National Natural Science Foundation of China (31010103903) and by the Chinese 863 project (2012AA101402-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Green H. H., 1918, S AFR J SCI, V14, P465; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamamura N, 2013, MICROBES ENVIRON, V28, P257, DOI 10.1264/jsme2.ME12217; Hao XL, 2012, J BACTERIOL, V194, P903, DOI 10.1128/JB.06585-11; [何孟常 He Mengchang], 2002, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V38, P417; Hong YG, 2009, INT BIODETER BIODEGR, V63, P973, DOI 10.1016/j.ibiod.2009.08.001; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Jenkins RO, 2002, TRENDS ORGANOMET CHE, V4, P109; JOHNSTON SE, 1979, SOIL SCI SOC AM J, V43, P304, DOI 10.2136/sssaj1979.03615995004300020013x; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Lialikova N N, 1974, Mikrobiologiia, V43, P941; Liao SJ, 2013, GEOMICROBIOL J, V30, P150, DOI 10.1080/01490451.2011.654379; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu FY, 2010, ENVIRON GEOCHEM HLTH, V32, P401, DOI 10.1007/s10653-010-9284-z; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Okkenhaug G, 2011, ENVIRON POLLUT, V159, P2427, DOI 10.1016/j.envpol.2011.06.028; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; Pepi M, 2007, J APPL MICROBIOL, V103, P2299, DOI 10.1111/j.1365-2672.2007.03471.x; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Smichowski P, 2008, TALANTA, V75, P2, DOI 10.1016/j.talanta.2007.11.005; Statistix, 2003, STAT 8 0 US MAN; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QY, 2007, FIELD CROP RES, V102, P219, DOI 10.1016/j.fcr.2007.04.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Wang Q, 2011, J APPL MICROBIOL, V111, P1065, DOI 10.1111/j.1365-2672.2011.05142.x; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328; WHITE C, 1995, INT BIODETER BIODEGR, V35, P17, DOI 10.1016/0964-8305(95)00036-5; WHITESIDE LS, 1986, CAN MINERAL, V24, P247; Xiong J, 2012, PLOS ONE; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Zao LH, 2001, APPL ENVIRON MICROB, V67, P2129, DOI 10.1128/AEM.67.5.2129-2135.2001; Zhang DY, 2010, J APPL PHYCOL, V22, P479, DOI 10.1007/s10811-009-9482-1; [张晓军 Zhang Xiaojun], 2005, [环境科学与技术, Enuivonmental science and technology], V28, P40	54	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78533	10.1371/journal.pone.0078533	http://dx.doi.org/10.1371/journal.pone.0078533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	23671712	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700092
J	Zhang, XY; Nie, ZH; Wang, WJ; Leung, DWM; Xu, DG; Chen, BL; Chen, Z; Zeng, LX; Liu, EE				Zhang, Xian Yong; Nie, Zhuan Hua; Wang, Wen Juan; Leung, David W. M.; Xu, Da Gao; Chen, Bai Ling; Chen, Zhe; Zeng, Lie Xian; Liu, E. E.			Relationship between Disease Resistance and Rice Oxalate Oxidases in Transgenic Rice	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; SCLEROTINIA-SCLEROTIORUM; BRASSICA-NAPUS; GENE; WHEAT; ASSOCIATION; DEFENSE; BARLEY; FAMILY; SENSITIVITY	Differential expression of rice oxalate oxidase genes (OsOxO1-4) in rice leaves (Oryza sativa L.) in response to biotic stress was assayed using RT-PCR. OsOxO4 was induced transiently at 12 h in plants inoculated with the pathogens of bacterial blight and that of the wounding control. Inoculation with the rice blast pathogen induced OsOxO2 expression compared to the mock spray control. Overexpressing OsOxO1 or OsOxO4 in rice resulted in elevated transcript levels of the respective transgene as well as OsOxO3 in leaves compared to that in untransformed wild type (WT). In a line of RNA-i transgenic rice plants (i-12), expression of all four OsOxO genes except that of OsOxO2 was severely inhibited. Oxalate oxidase (OxO, EC 1.2.3.4) activity in plants overexpressing OsOxO1 or OsOxO4 was substantially higher than that in WT and the RNA-i lines. It was found that transgenic rice plants with substantially higher OxO activity were not more resistant to rice blast and bacterial blight than WT. In contrast, some RNA-i lines with less OxO activity seemed to be more resistant to rice blast while some overexpressing lines were more susceptible to rice blast than WT. Therefore, OxO might not be a disease resistance factor in rice.	[Zhang, Xian Yong; Nie, Zhuan Hua; Chen, Bai Ling; Chen, Zhe; Liu, E. E.] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Wen Juan; Zeng, Lie Xian] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Leung, David W. M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Xu, Da Gao] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences; University of Canterbury; South China Agricultural University	Liu, EE (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	eeliu70@163.com			National Natural Science Foundation of China [31071345]; Guangdong Province Science and technology plan project [2010B020301007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and technology plan project	This work was supported by the National Natural Science Foundation of China (31071345) and Guangdong Province Science and technology plan project (2010B020301007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Carrillo MGC, 2009, RICE, V2, P67, DOI 10.1007/s12284-009-9024-0; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Davidson RM, 2010, RICE, V3, P43, DOI 10.1007/s12284-010-9038-7; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Feng Jie, 2004, Journal of Agricultural Biotechnology, V12, P312; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; GRZELCZAK ZF, 1984, CAN J BIOCHEM CELL B, V62, P1351, DOI 10.1139/o84-172; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Liang HY, 2001, PLANT MOL BIOL, V45, P619, DOI 10.1023/A:1010631318831; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Xin GL, 1987, CHINESE J RICE SCI, V1, P118; Yadav S, 2012, WORLD J MICROB BIOT, V28, P3197, DOI 10.1007/s11274-012-1130-2; Yang JY, 2008, RICE SCI, V15, P311, DOI 10.1016/S1672-6308(09)60009-3; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang ZG, 1996, PLANT MOL BIOL REP, V14, P266, DOI 10.1007/BF02671662; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	33	53	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78348	10.1371/journal.pone.0078348	http://dx.doi.org/10.1371/journal.pone.0078348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205207	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300052
J	Krementsov, DN; Wall, EH; Martin, RA; Subramanian, M; Noubade, R; Del Rio, R; Mawe, GM; Bond, JP; Poynter, ME; Blankenhorn, EP; Teuscher, C				Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Blankenhorn, Elizabeth P.; Teuscher, Cory			Histamine H-3 Receptor Integrates Peripheral Inflammatory Signals in the Neurogenic Control of Immune Responses and Autoimmune Disease Susceptibility	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SUBCAPSULAR SINUS MACROPHAGES; REGULATE ACTH RELEASE; DRAINING LYMPH-NODES; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; B-CELLS; T-CELL; ANTAGONISTS/INVERSE AGONISTS; NEURAL REFLEXES	Histamine H-3 receptor (Hrh3/H3R) is primarily expressed by neurons in the central nervous system (CNS) where it functions as a presynaptic inhibitory autoreceptor and heteroreceptor. Previously, we identified an H3R-mediated central component in susceptibility to experimental allergic encephalomyelitis (EAE), the principal autoimmune model of multiple sclerosis (MS), related to neurogenic control of blood brain barrier permeability and peripheral T cell effector responses. Furthermore, we identified Hrh3 as a positional candidate for the EAE susceptibility locus Eae8. Here, we characterize Hrh3 polymorphisms between EAE-susceptible and resistant SJL and B10.S mice, respectively, and show that Hrh3 isoform expression in the CNS is differentially regulated by acute peripheral inflammatory stimuli in an allele-specific fashion. Next, we show that Hrh3 is not expressed in any subpopulations of the immune compartment, and that secondary lymphoid tissue is anatomically poised to be regulated by central H3R signaling. Accordingly, using transcriptome analysis, we show that, inflammatory stimuli elicit unique transcriptional profiles in the lymph nodes of H3RKO mice compared to WT mice, which is indicative of negative regulation of peripheral immune responses by central H3R signaling. These results further support a functional link between the neurogenic control of T cell responses and susceptibility to CNS autoimmune disease coincident with acute and/or chronic peripheral inflammation. Pharmacological targeting of H3R may therefore be useful in preventing the development and formation of new lesions in MS, thereby limiting disease progression.	[Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Teuscher, Cory] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	University of Vermont; Drexel University; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.	C.Teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019; Gonzalez, Victor M/F-7396-2010	Krementsov, Dimitry/0000-0003-2709-7466; Poynter, Matthew/0000-0002-7578-4570; Gonzalez, Victor M/0000-0001-7538-0552; del Rio-Guerra, Roxana/0000-0001-6871-3259	National Institute of Health [AI041747, NS036526, NS060901]; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036526, R01NS060901] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants AI041747, NS036526, and NS060901 to CT. This work was also supported in part by a postdoctoral fellowship from the National Multiple Sclerosis Society to DNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Affymetrix, 2005, GENECHIP EXPR AN TEC; Aicher SA, 2004, PAIN, V110, P560, DOI 10.1016/j.pain.2004.03.025; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Bakker RA, 2006, MOL PHARMACOL, V69, P1194, DOI 10.1124/mol.105.019299; Bakker RA, 2004, INFLAMM RES, V53, P509, DOI 10.1007/s00011-004-1286-9; Bannerman DD, 1999, LAB INVEST, V79, P1181; Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI 10.2307/2346101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bongers G, 2007, J PHARMACOL EXP THER, V323, P888, DOI 10.1124/jpet.107.127639; Brooks TA, 2006, BRAIN RES, V1120, P172, DOI 10.1016/j.brainres.2006.08.085; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; CLARK MA, 1992, EUR J PHARMACOL, V210, P31, DOI 10.1016/0014-2999(92)90648-N; Coge F, 2001, BIOCHEM J, V355, P279, DOI 10.1042/0264-6021:3550279; Courtney AM, 2009, MED CLIN N AM, V93, P451, DOI 10.1016/j.mcna.2008.09.014; DeLuca J, 2011, NEUROREHABILITATION, V29, P197, DOI 10.3233/NRE-2011-0695; Drutel G, 2001, MOL PHARMACOL, V59, P1; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Encinas JA, 2001, INT IMMUNOL, V13, P257, DOI 10.1093/intimm/13.3.257; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; FELTEN DL, 1985, J IMMUNOL, V135, pS755; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Hancock AA, 2005, EXPERT OPIN INV DRUG, V14, P223, DOI 10.1517/13543784.14.3.223; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x; Lebois EP, 2011, CURR TOP MED CHEM, V11, P648; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Lu CM, 2008, J NEUROSCI RES, V86, P2624, DOI 10.1002/jnr.21716; Lynch JL, 2008, PAIN, V136, P293, DOI 10.1016/j.pain.2007.07.007; Ma RLZ, 2002, SCIENCE, V297, P620, DOI 10.1126/science.1072810; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Matthews PM, 2001, CURR OPIN NEUROL, V14, P279, DOI 10.1097/00019052-200106000-00004; Meng J, 2008, EUR J PHARMACOL, V587, P336, DOI 10.1016/j.ejphar.2008.03.019; Millan-Guerrero RO, 2011, ARCH MED RES, V42, P44, DOI 10.1016/j.arcmed.2011.01.009; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Noubade R, 2008, J IMMUNOL, V180, P7471, DOI 10.4049/jimmunol.180.11.7471; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Ramagopalan SV, 2008, J NEUROIMMUNOL, V201, P183, DOI 10.1016/j.jneuroim.2008.02.016; Ramagopalan SV, 2008, TRENDS NEUROSCI, V31, P645, DOI 10.1016/j.tins.2008.09.001; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Rovaris M, 2009, NEUROLOGY, V72, P1693, DOI 10.1212/WNL.0b013e3181a55feb; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; SHEPPARD MN, 1983, THORAX, V38, P333, DOI 10.1136/thx.38.5.333; Solaro C, 2011, NAT REV NEUROL, V7, P519, DOI 10.1038/nrneurol.2011.120; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Takahashi K, 2002, J CLIN INVEST, V110, P1791, DOI 10.1172/JCI200215784; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wellendorph P, 2002, NEUROPHARMACOLOGY, V42, P929, DOI 10.1016/S0028-3908(02)00041-2; WEST RE, 1994, EUR J PHARM-MOLEC PH, V267, P343, DOI 10.1016/0922-4106(94)90160-0; Wiedemann P, 2002, J NEURAL TRANSM, V109, P443, DOI 10.1007/s007020200036; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	83	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e62743	10.1371/journal.pone.0062743	http://dx.doi.org/10.1371/journal.pone.0062743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894272	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100001
J	Xu, XJ; Shou, XJ; Li, J; Jia, MX; Zhang, JS; Guo, Y; Wei, QY; Zhang, XT; Han, SP; Zhang, R; Han, JS				Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Jia, Mei-Xiang; Zhang, Ji-Shui; Guo, Yan; Wei, Qing-Yun; Zhang, Xiu-Ting; Han, Song-Ping; Zhang, Rong; Han, Ji-Sheng			Mothers of Autistic Children: Lower Plasma Levels of Oxytocin and Arg-Vasopressin and a Higher Level of Testosterone	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; SPECTRUM; GENES; BRAIN; DISORDERS; PHENOTYPE; PARENTS; BROADER; WOMEN	Background: Autism is a pervasive neurodevelopmental disorder, thought to be caused by a combination of genetic heritability and environmental risk factors. Some autistic-like traits have been reported in mothers of autistic children. We hypothesized that dysregulation of oxytocin (OXT), Arg-vasopressin (AVP) and sex hormones, found in autistic children, may also exist in their mothers. Methods: We determined plasma levels of OXT (40 in autism vs. 26 in control group), AVP (40 vs. 17) and sex hormones (61 vs. 47) in mothers of autistic and normal children by enzyme immunoassay and radioimmunoassay, respectively and investigated their relationships with the children's autistic behavior scores (Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC)). Results: Significantly lower plasma concentrations of OXT (p<0.001) and AVP (p<0.001), as well as a higher level of plasma testosterone (p<0.05), were found in mothers of autistic children vs. those of control. The children's autistic behavior scores were negatively associated with maternal plasma levels of OXT and AVP. Conclusions: These results suggest that dysregulation of OXT, AVP and/or testosterone systems exist in mothers of autistic children, which may impact children's susceptibility to autism.	[Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Minist Educ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China; [Jia, Mei-Xiang] Peking Univ, Mental Hlth Inst, Beijing 100871, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Ctr Rehabil, Beijing, Peoples R China; [Guo, Yan] Beijing Univ Chinese Med, Dept Ophthalmol, Affiliated Hosp 3, Beijing, Peoples R China; [Wei, Qing-Yun] Beijing Yangguang Youyi Rehabil Ctr, Beijing, Peoples R China; [Zhang, Xiu-Ting] Beijing Tongkang Rehabil Ctr, Beijing, Peoples R China; [Han, Song-Ping] HANS Int Inc, Belle Mead, NJ USA	Peking University; Peking University; Peking University; Peking University; Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine	Zhang, R (corresponding author), Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China.	zhangrong@bjmu.edu.cn; hanjisheng@bjmu.edu.cn	XU, XINJIE/GQH-5210-2022; Jia, Mei/GXZ-9967-2022; Zhang, Rong/O-5078-2017; Wang, Minggui/AAR-8281-2020	Zhang, Rong/0000-0002-6889-5571; Wang, Minggui/0000-0001-7682-5859	National Natural Science Foundation of China [81271507]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University)	This project was supported by grants from the National Natural Science Foundation of China (81271507, http://www.nsfc.gov.cn/) to JSH. The study was also supported by Peking University Special Project for promoting joint research between basic and clinical sciences (http://www.pku.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Green JJ, 2010, NEUROTHERAPEUTICS, V7, P250, DOI 10.1016/j.nurt.2010.05.006; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Keefe DL, 2002, ARCH SEX BEHAV, V31, P401, DOI 10.1023/A:1019883923346; Kose S, 2013, PSYCHIAT CLIN NEUROS, V67, P20, DOI 10.1111/pcn.12005; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lukas M, 2012, BEHAV BRAIN RES; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Mohammadi Mohammad Reza, 2012, Iran J Psychiatry, V7, P157; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Ufer F, 2013, CLIN ENDOCRINOL, V78, P431, DOI 10.1111/cen.12006; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Xu XJ, 2012, NEUROCHEM RES, V37, P2270; Zhang R, 2012, RES DEV DISABIL, V33, P1136, DOI 10.1016/j.ridd.2012.02.001	37	50	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74849	10.1371/journal.pone.0074849	http://dx.doi.org/10.1371/journal.pone.0074849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086383	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700043
J	Shi, ZH; Long, W; Zhao, C; Guo, XR; Shen, R; Ding, HJ				Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan			Comparative Proteomics Analysis Suggests that Placental Mitochondria are Involved in the Development of Pre-Eclampsia	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PROSTATE-CANCER; ITRAQ; STRESS; EXPRESSION; DISORDERS; APOPTOSIS; PROTEINS	Introduction: Pre-eclampsia (PE), a severe pregnancy-specific disease characterized by the new onset of hypertension, proteinuria, edema, and a series of other systematic disorders, is a state of widespread mitochondrial dysfunction of the placenta. Methods: We compared the morphology of mitochondria in pre-eclamptic and normotensive placentae using electron microscopy. To reveal the systematic protein expression changes of placental mitochondria that might explain the pathogenesis of PE, we performed iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) on differentially expressed placental mitochondria proteins from 4 normotensive and 4 pre-eclamptic pregnancies. Bioinformatics analysis was used to find the relative processes that these differentially expressed proteins were involved in. Three differentially expressed proteins were chosen to confirm by Western blotting and immunohistochemistry. Results: Morphological data demonstrated degenerative and apoptotic changes in the mitochondria of pre-eclamptic placentae. We found four proteins were upregulated and 22 proteins were downregulated in pre-eclamptic placentae compared with normotensive placentae. Bioinformatics analysis showed that these proteins were involved in many critical processes in the development of pre-eclampsia such as apoptosis, fatty acid oxidation, the respiratory chain, reactive oxygen species generation, the tricarboxylic acid cycle and oxidative stress. Conclusions: This preliminary work provides a better understanding of the proteomic alterations of mitochondria from pre-eclamptic placentae and may aid in our understanding of the importance of mitochondria in the development of pre-eclampsia.	[Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Shen, R (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	shenr_njfy@163.com; dinghj_njfy@163.com	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health [YKK12099]	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health	This work was financially supported by the Nanjing Medical Science and Technique Development Foundation and the Medical Science and Technology Development Foundation of Nanjing Department of Health (YKK12099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2012, PLACENTA, V33, P132, DOI 10.1016/j.placenta.2011.11.027; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Cunningham G.F., 2005, WILLIAMS OBSTET, V22nd ed., DOI [10.1097/00001888-193609000-00027, DOI 10.1097/00001888-193609000-00027]; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Glen A, 2010, PROSTATE, V70, P1313, DOI 10.1002/pros.21167; Haggarty P, 2002, PLACENTA, V23, P86, DOI 10.1053/plac.2001.0743; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Illsinger S, 2010, REPROD SCI, V17, P219, DOI 10.1177/1933719109351597; Jiang Y, 2012, J HEMATOL ONCOL, V18, P11; Khatun R, 2003, PLACENTA, V24, P870, DOI 10.1016/S0143-4004(03)00138-3; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Rakheja D, 2002, PLACENTA, V23, P447, DOI 10.1053/plac.2002.0808; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 2004, MATERNAL FETAL MED P, P859; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Shekhawat P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1098, DOI 10.1152/ajpendo.00481.2002; Shekhawat PS, 2005, PEDIATR RES, V57, p78R, DOI 10.1203/01.PDR.0000159631.63843.3E; Shibata E, 2003, PLACENTA, V24, P698, DOI 10.1016/S0143-4004(03)00083-3; Sun CY, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-22; TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; Widschwendter M, 1998, MOL MED TODAY, V4, P286, DOI 10.1016/S1357-4310(98)01293-3; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Young NK, 2007, PROTEOM CLIN APPL, V1, P1625	35	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64351	10.1371/journal.pone.0064351	http://dx.doi.org/10.1371/journal.pone.0064351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671712	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700070
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300065
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-25	WOS:000319081900089
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
